PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wackowski, OA; Delnevo, CD; Steinberg, MB				Wackowski, Olivia A.; Delnevo, Cristine D.; Steinberg, Michael B.			Perspectives for Clinicians on Regulation of Electronic Cigarettes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Wackowski, Olivia A.; Delnevo, Cristine D.] Rutgers Sch Publ Hlth, 683 Hoes Lane West, Piscataway, NJ 08854 USA; Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA; [Steinberg, Michael B.] Rutgers Robert Wood Johnson Med Sch, Div Gen Internal Med, 125 Paterson St,Suite 2300, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Steinberg, MB (corresponding author), Rutgers Robert Wood Johnson Med Sch, Div Gen Internal Med, 125 Paterson St,Suite 2300, New Brunswick, NJ 08903 USA.	michael.steinberg@rutgers.edu	Delnevo, Cristine D/D-5002-2015	Delnevo, Cristine D/0000-0001-9597-4307; Wackowski, Olivia/0000-0001-9159-5473	NATIONAL CANCER INSTITUTE [K01CA189301, R01CA190444] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA189301, R01 CA190444] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barrington-Trimis JL, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0379; Delnevo CD, 2016, NICOTINE TOB RES, V18, P715, DOI 10.1093/ntr/ntv237; Food and Drug Administration HHS, 2016, Fed Regist, V81, P28973; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; McRobbie H, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010216.pub2; Niaura RS, 2014, JAMA-J AM MED ASSOC, V312, P641, DOI 10.1001/jama.2014.6894; Royal College of Physicians, 2016, NIC SMOK TOB HARM RE; Singh T, 2016, MMWR-MORBID MORTAL W, V65, P361, DOI 10.15585/mmwr.mm6514a1; Steinberg MB, 2014, J GEN INTERN MED, V29, P1444, DOI 10.1007/s11606-014-2889-7; US Department of Health and Human Services, 2014, HLTH CONSMOK 50 YE	10	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	2016	165	9					665	+		10.7326/M16-1345	http://dx.doi.org/10.7326/M16-1345			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA8SJ	27571380	Green Accepted			2022-12-28	WOS:000386908600009
J	Green, AK; Wood, WA; Basch, EM				Green, Angela K.; Wood, William A.; Basch, Ethan M.			Time to Reassess the Cancer Compendia for Off-label Drug Coverage in Oncology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Green, Angela K.; Wood, William A.; Basch, Ethan M.] Univ N Carolina, Canc Outcomes Res Program, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill	Basch, EM (corresponding author), Univ N Carolina, Canc Outcomes Res Program, 170 Manning Dr,CB 7305, Chapel Hill, NC 27599 USA.	ebasch@med.unc.edu						Abernethy AP, 2009, ANN INTERN MED, V150, P336, DOI 10.7326/0003-4819-150-5-200903030-00107; [Anonymous], 2015, ERL AM HOSP FORM SER; [Anonymous], 2015, ERL HYDR; Conti RM, 2013, J CLIN ONCOL, V31, P1134, DOI 10.1200/JCO.2012.42.7252; Gold Standard, 2015, ERL HYDR CLIN PHARM; Institute of Medicine, 2011, CLIN PRACTICE GUIDEL; McKinney R, 2009, 290200710066I HHSA A; Micromedex, 2015, DRUGDEX ERL TRUV HLT; Mitchell AP, 2016, JAMA ONCOL, V2, P1628, DOI 10.1001/jamaoncol.2016.2710	9	16	17	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2016	316	15					1541	1542		10.1001/jama.2016.12770	http://dx.doi.org/10.1001/jama.2016.12770			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ0KM	27561002				2022-12-28	WOS:000385527600011
J	Zhang, L; Huang, Y; Hong, SD; Yang, YP; Yu, GS; Jia, J; Peng, PJ; Wu, X; Lin, Q; Xi, XP; Peng, JW; Xu, MJ; Chen, DP; Lu, XJ; Wang, RS; Cao, XL; Chen, XZ; Lin, ZX; Xiong, JP; Lin, Q; Xie, CH; Li, ZH; Pan, JJ; Li, JG; Wu, SX; Lian, YN; Yang, QL; Zhao, C				Zhang, Li; Huang, Yan; Hong, Shaodong; Yang, Yunpeng; Yu, Gengsheng; Jia, Jun; Peng, Peijian; Wu, Xuan; Lin, Qing; Xi, Xuping; Peng, Jiewen; Xu, Mingjun; Chen, Dongping; Lu, Xiaojun; Wang, Rensheng; Cao, Xiaolong; Chen, Xiaozhong; Lin, Zhixiong; Xiong, Jianping; Lin, Qin; Xie, Conghua; Li, Zhihua; Pan, Jianji; Li, Jingao; Wu, Shixiu; Lian, Yingni; Yang, Quanlie; Zhao, Chong			Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial	LANCET			English	Article							DISTANT METASTASIS; CHEMOTHERAPY; RADIOTHERAPY; VINORELBINE; MANAGEMENT; PATTERNS; SURVIVAL; REGIMENS	Background Outcomes are poor for patients with recurrent or metastatic nasopharyngeal carcinoma and no well established first-line chemotherapy is available for the disease. We compared the efficacy and safety of gemcitabine plus cisplatin versus fluorouracil plus cisplatin in patients with recurrent or metastatic nasopharyngeal carcinoma. Methods In this multicentre, randomised, open-label, phase 3 trial, patients with recurrent or metastatic nasopharyngeal carcinoma were recruited from 22 hospitals in China. Key inclusion criteria were Eastern Cooperative Oncology Group performance status of 0 or 1, adequate organ function, and measurable lesions according to Response Evaluation Criteria in Solid Tumors version 1.1. Patients were randomly assigned in a 1: 1 ratio to receive either gemcitabine (1 g/m(2) intravenously on days 1 and 8) and cisplatin (80 mg/m(2) intravenously on day 1), or fluorouracil (4 g/m(2) in continuous intravenous infusion over 96 h) and cisplatin (80 mg/m(2) on day 1 given intravenously) once every 3 weeks for a maximum of six cycles. The randomisation was done centrally via an interactive phone response system using block randomisation with a size of six. The primary endpoint was progression-free survival assessed by the independent image committee in the intention-to-treat population. Safety analyses were done in patients who received at least one cycle of study drug. This study is ongoing and is registered with ClinicalTrials. gov, number NCT01528618. Findings Between Feb 20, 2012, and Oct 30, 2015, 362 patients were randomly assigned to a group (181 to the gemcitabine [ plus cisplatin] group and 181 to the fluorouracil [plus cisplatin] group). Median follow-up time for progression-free survival was 19.4 months (IQR 12.1-35.6). The median progression-free survival was 7.0 months (4.4-10.9) in the gemcitabine group and 5.6 months (3.0-7.0) in the fl uorouracil group (hazard ratio [HR] 0.55 [ 95% CI 0.44-0.68]; p< 0.0001). A total of 180 patients in the gemcitabine group and 173 patients in the fl uorouracil group were included in the safety analysis. Significantly different treatment-related grade 3 or 4 adverse events between the gemcitabine and fl uorouracil groups were leucopenia (52 [29%] vs 15 [9%]; < 0.0001), neutropenia (41 [23%] vs 23 [13%]; p= 0.0251), thrombocytopenia (24 [13%] vs three [2%]; p= 0.0007), and mucosal inflammation (0 vs 25 [14%]; < 0.0001). Serious treatment-related adverse events occurred in seven (4%) patients in the gemcitabine group and ten (6%) in the fluorouracil group. Six (3%) patients in the gemcitabine group and 14 (8%) patients in the fluorouracil group discontinued treatment because of drug-related adverse events. No treatment-related deaths occurred in either group. Interpretation Gemcitabine plus cisplatin prolongs progression-free survival in patients with recurrent or metastatic nasopharyngeal carcinoma. The results establish gemcitabine plus cisplatin as the standard first-line treatment option for this population.	[Zhang, Li; Huang, Yan; Hong, Shaodong; Yang, Yunpeng; Wu, Xuan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Dept Med Oncol, Guangzhou 510060, Guangdong, Peoples R China; [Zhao, Chong] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Dept Radiotherapy, Guangzhou, Guangdong, Peoples R China; [Yu, Gengsheng] Jiangmen Cent Hosp, Dept Med Oncol, Jiangmen, Peoples R China; [Jia, Jun] Dongguan Peoples Hosp, Dept Med Oncol, Dongguan, Peoples R China; [Peng, Peijian] Sun Yat Sen Univ, Dept Med Oncol, Affiliated Hosp 5, Zhuhai, Peoples R China; [Lin, Qing] Shunde Hosp Tradit Chinese Med, Dept Oncol, Foshan, Peoples R China; [Xi, Xuping] Canc Hosp Hunan Prov, Dept Radiotherapy, Changsha, Hunan, Peoples R China; [Peng, Jiewen] Zhongshan Peoples Hosp, Dept Med Oncol, Zhongshan, Peoples R China; [Lu, Xiaojun] Zhongshan Peoples Hosp, Dept Radiotherapy, Zhongshan, Peoples R China; [Xu, Mingjun] Gangnan Med Coll, Affiliated Hosp 1, Dept Oncol, Gangnan, Peoples R China; [Chen, Dongping] Guangzhou Med Univ, Dept Radiotherapy, Affiliated Canc Hosp, Guangzhou, Guangdong, Peoples R China; [Wang, Rensheng] Guangxi Med Univ, Affiliated Hosp 1, Dept Radiotherapy, Nanning, Peoples R China; [Cao, Xiaolong] Panyu Cent Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China; [Chen, Xiaozhong] Canc Hosp Zhejiang Prov, Dept Radiotherapy, Hangzhou, Zhejiang, Peoples R China; [Lin, Zhixiong] Shantou Univ, Affiliated Canc Hosp, Dept Med Oncol, Shantou, Peoples R China; [Xiong, Jianping] Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang, Peoples R China; [Lin, Qin] Xiamen Univ, Affiliated Hosp 1, Dept Radiotherapy, Xiamen, Peoples R China; [Xie, Conghua] Wuhan Univ, Dept Oncol, Zhongnan Hosp, Wuhan, Peoples R China; [Li, Zhihua] Sun Yat Sen Mem Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China; [Pan, Jianji] Fujian Prov Canc Hosp, Dept Radiotherapy, Fuzhou, Peoples R China; [Li, Jingao] Jiangxi Prov Canc Hosp, Dept Radiotherapy, Nanchang, Peoples R China; [Wu, Shixiu] Canc Hosp Hangzhou City, Dept Radiotherapy, Hangzhou, Zhejiang, Peoples R China; [Lian, Yingni] First Peoples Hosp Zhaoqing City, Dept Med Oncol, Zhaoqing, Peoples R China; [Yang, Quanlie] Peoples Hosp Meizhou, Dept Chemotherapy, Meizhou, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University; Guangxi Medical University; Shantou University; Nanchang University; Xiamen University; Wuhan University; Sun Yat Sen University	Zhang, L (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Dept Med Oncol, Guangzhou 510060, Guangdong, Peoples R China.	zhangli6@mail.sysu.edu.cn	Wu, Xuan/AAE-4778-2020	Xiong, Jianping/0000-0002-9856-7747; Lin, Zhixiong/0000-0003-4898-7441; Pan, Jianji/0000-0002-3211-7874	Sun Yat-Sen University Clinical Research Programme [5010]; Chinese National Natural Science Foundation [81372502, 81201917]; National High Technology Research and Development Program of China (863 program) [2012AA02A501, 2012AA02A502]; Natural Science Foundation of Guangdong [S2013010016564]	Sun Yat-Sen University Clinical Research Programme; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province)	Sun Yat-Sen University Clinical Research 5010 Programme, Chinese National Natural Science Foundation project (grant numbers 81372502 and 81201917), the National High Technology Research and Development Program of China (863 program numbers 2012AA02A501 and 2012AA02A502), and the Natural Science Foundation of Guangdong (grant number S2013010016564).	AU E, 1994, ANN ONCOL, V5, P87, DOI 10.1093/oxfordjournals.annonc.a058703; Bergman AM, 1996, CLIN CANCER RES, V2, P521; Blanchard P, 2015, LANCET ONCOL, V16, P645, DOI 10.1016/S1470-2045(15)70126-9; Chen C, 2012, ORAL ONCOL, V48, P1146, DOI 10.1016/j.oraloncology.2012.05.021; Chen YP, 2015, RADIOTHER ONCOL, V116, P157, DOI 10.1016/j.radonc.2015.07.030; CHOO R, 1991, CANCER, V68, P2120, DOI 10.1002/1097-0142(19911115)68:10<2120::AID-CNCR2820681005>3.0.CO;2-7; Chua MLK, 2016, LANCET, V387, P1012, DOI 10.1016/S0140-6736(15)00055-0; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Foo KF, 2002, ANN ONCOL, V13, P150, DOI 10.1093/annonc/mdf002; Her C, 2001, AM FAM PHYSICIAN, V63, P1776; Hsieh JCH, 2015, JPN J CLIN ONCOL, V45, P819, DOI 10.1093/jjco/hyv083; Hui EP, 2004, CANCER-AM CANCER SOC, V101, P300, DOI 10.1002/cncr.20358; Jiang Y, 2005, CANCER INVEST, V23, P123, DOI 10.1081/CNV-200050438; Jin Y, 2012, J CANCER RES CLIN, V138, P1717, DOI 10.1007/s00432-012-1219-x; Lee AWM, 2015, J CLIN ONCOL, V33, P3356, DOI 10.1200/JCO.2015.60.9347; LEE AWM, 1992, INT J RADIAT ONCOL, V23, P261, DOI 10.1016/0360-3016(92)90740-9; Li AC, 2015, ONCOTARGET, V6, P24511, DOI 10.18632/oncotarget.4312; Ma BBY, 2009, ANN ONCOL, V20, P1854, DOI 10.1093/annonc/mdp065; Ma BBY, 2005, CANCER-AM CANCER SOC, V103, P22, DOI 10.1002/cncr.20768; Ma BBY, 2002, CANCER-AM CANCER SOC, V95, P2516, DOI 10.1002/cncr.10995; Ngan RKC, 2002, ANN ONCOL, V13, P1252, DOI 10.1093/annonc/mdf200; Pan CC, 2012, EXP THER MED, V4, P334, DOI 10.3892/etm.2012.584; Peng PJ, 2016, THER ADV MED ONCOL, V8, P153, DOI 10.1177/1758834016637592; Tang LQ, 2013, J CLIN ONCOL, V31, P2861, DOI 10.1200/JCO.2012.46.0816; Wang CC, 2006, HEAD NECK-J SCI SPEC, V28, P74, DOI 10.1002/hed.20310; Wang JL, 2008, ORAL ONCOL, V44, P464, DOI 10.1016/j.oraloncology.2007.06.004; Wang T L, 1991, Ann Acad Med Singap, V20, P601; Wang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep10534; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Zhang L, 2008, CANCER CHEMOTH PHARM, V61, P33, DOI 10.1007/s00280-007-0441-8	30	296	325	5	68	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 15	2016	388	10054					1883	1892		10.1016/S0140-6736(16)31388-5	http://dx.doi.org/10.1016/S0140-6736(16)31388-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ0AM	27567279				2022-12-28	WOS:000385499000032
J	Ettayebi, K; Crawford, SE; Murakami, K; Broughman, JR; Karandikar, U; Tenge, VR; Neill, FH; Blutt, SE; Zeng, XL; Qu, L; Kou, B; Opekun, AR; Burrin, D; Graham, DY; Ramani, S; Atmar, RL; Estes, MK				Ettayebi, Khalil; Crawford, Sue E.; Murakami, Kosuke; Broughman, James R.; Karandikar, Umesh; Tenge, Victoria R.; Neill, Frederick H.; Blutt, Sarah E.; Zeng, Xi-Lei; Qu, Lin; Kou, Baijun; Opekun, Antone R.; Burrin, Douglas; Graham, David Y.; Ramani, Sasirekha; Atmar, Robert L.; Estes, Mary K.			Replication of human noroviruses in stem cell-derived human enteroids	SCIENCE			English	Article							INFECTIOUS NONBACTERIAL GASTROENTERITIS; NORWALK VIRUS; B-CELLS; VACCINE DEVELOPMENT; CULTURE; BLOOD; MODEL; PATHOPHYSIOLOGY; PATHOGENESIS; ORGANOIDS	The major barrier to research and development of effective interventions for human noroviruses (HuNoVs) has been the lack of a robust and reproducible in vitro cultivation system. HuNoVs are the leading cause of gastroenteritis worldwide. We report the successful cultivation of multiple HuNoV strains in enterocytes in stem cell-derived, nontransformed human intestinal enteroid monolayer cultures. Bile, a critical factor of the intestinal milieu, is required for strain-dependent HuNoV replication. Lack of appropriate histoblood group antigen expression in intestinal cells restricts virus replication, and infectivity is abrogated by inactivation (e.g., irradiation, heating) and serum neutralization. This culture system recapitulates the human intestinal epithelium, permits human host-pathogen studies of previously noncultivatable pathogens, and allows the assessment of methods to prevent and treat HuNoV infections.	[Ettayebi, Khalil; Crawford, Sue E.; Murakami, Kosuke; Broughman, James R.; Karandikar, Umesh; Tenge, Victoria R.; Neill, Frederick H.; Blutt, Sarah E.; Zeng, Xi-Lei; Qu, Lin; Kou, Baijun; Graham, David Y.; Ramani, Sasirekha; Atmar, Robert L.; Estes, Mary K.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Opekun, Antone R.; Graham, David Y.; Atmar, Robert L.; Estes, Mary K.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Opekun, Antone R.; Burrin, Douglas] Baylor Coll Med, Dept Pediat, Sect Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Opekun, Antone R.; Burrin, Douglas] ARS, USDA, Childrens Nutr Res Ctr, Houston, TX USA; [Graham, David Y.] Michael E DeBakey VA Med Ctr, Dept Med, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; United States Department of Agriculture (USDA); Baylor College of Medicine	Estes, MK (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.; Estes, MK (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	mestes@bcm.edu	Graham, David/AAL-2165-2021; Ettayebi, Khalil/ABH-6158-2020; Atmar, Robert/AFQ-5392-2022; Burrin, Douglas/AID-0081-2022	Atmar, Robert/0000-0001-9989-6772; Burrin, Douglas/0000-0002-8792-3339; Karandikar, Umesh/0000-0003-2659-9675; Ettayebi, Khalil/0000-0003-3011-4693; Qu, Lin/0000-0001-8744-2378; Tenge, Victoria/0000-0002-9429-7161	Public Health Service [PO1 AI 057788, P30 DK-56338, P30 CA-125123]; Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture [2011-68003-30395]; National Institute of Allergy and Infectious Diseases [AI036211]; Dan L. Duncan Cancer Center at Baylor College of Medicine; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI116497, P01AI057788, P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER; ARS [ARS-0426348] Funding Source: Federal RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Dan L. Duncan Cancer Center at Baylor College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Supported in part by Public Health Service grant PO1 AI 057788 (M.K.E.) and Agriculture and Food Research Initiative competitive grant 2011-68003-30395 from the USDA National Institute of Food and Agriculture. We acknowledge the assistance of the Study Design and Clinical Research Core and Cellular and Molecular Morphology Core of the Texas Medical Center Digestive Diseases Center and the Cytometry and Cell Sorting Core, which are supported in part by Public Health Service grants P30 DK-56338, P30 CA-125123 (to C. K. Osborne), National Institute of Allergy and Infectious Diseases grant AI036211, and the Dan L. Duncan Cancer Center at Baylor College of Medicine. We thank B.V.V. Prasad, T. Palzkill, S. Marriott, and M. Donowitz for critical reading of the manuscript.	AGUS SG, 1973, ANN INTERN MED, V79, P18, DOI 10.7326/0003-4819-79-1-18; Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Atmar RL, 2008, EMERG INFECT DIS, V14, P1553, DOI 10.3201/eid1410.080117; Atmar RL, 2006, GASTROENTEROL CLIN N, V35, P275, DOI 10.1016/j.gtc.2006.03.001; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Belliot G, 2014, CLIN MICROBIOL INFEC, V20, P724, DOI 10.1111/1469-0691.12722; Bok K, 2011, P NATL ACAD SCI USA, V108, P325, DOI 10.1073/pnas.1014577107; Brown JR, 2016, CLIN INFECT DIS, V62, P1136, DOI 10.1093/cid/ciw060; Chang KO, 2004, P NATL ACAD SCI USA, V101, P8733, DOI 10.1073/pnas.0401126101; Cheetham S, 2006, J VIROL, V80, P10372, DOI 10.1128/JVI.00809-06; Duizer E, 2004, J GEN VIROL, V85, P79, DOI 10.1099/vir.0.19478-0; FLYNN WT, 1988, J CLIN MICROBIOL, V26, P206, DOI 10.1128/JCM.26.2.206-212.1988; Green K., 2013, FIELDS VIROLOGY, V1, P583; Green KY, 2014, CLIN MICROBIOL INFEC, V20, P717, DOI 10.1111/1469-0691.12761; Green KY, 2016, CLIN INFECT DIS, V62, P1139, DOI 10.1093/cid/ciw063; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Hofmann Alan F., 1994, P1555; Jones MK, 2015, NAT PROTOC, V10, P1939, DOI 10.1038/nprot.2015.121; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; KAPIKIAN AZ, 1972, J VIROL, V10, P1075, DOI 10.1128/JVI.10.5.1075-1081.1972; Karandikar UC, 2016, J GEN VIROL, V97, P2291, DOI 10.1099/jgv.0.000545; Lay MK, 2010, VIROLOGY, V406, P1, DOI 10.1016/j.virol.2010.07.001; LeGuyader F, 1996, APPL ENVIRON MICROB, V62, P4268, DOI 10.1128/AEM.62.11.4268-4272.1996; Middendorp S, 2014, STEM CELLS, V32, P1083, DOI 10.1002/stem.1655; Moore MD, 2015, ANNU REV FOOD SCI T, V6, P411, DOI 10.1146/annurev-food-022814-015643; Otto PH, 2011, J VIROL, V85, P12013, DOI 10.1128/JVI.05342-11; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Ramani S, 2014, CURR OPIN GASTROEN, V30, P25, DOI 10.1097/MOG.0000000000000022; Reeck A, 2010, J INFECT DIS, V202, P1212, DOI 10.1086/656364; REED L. J., 1938, AMER JOUR HYG, V27, P493; Richardson C, 2013, EXPERT REV VACCINES, V12, P155, DOI [10.1586/erv.12.145, 10.1586/ERV.12.145]; Ruvoen-Clouet N, 2013, REV MED VIROL, V23, P355, DOI 10.1002/rmv.1757; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Saxena K, 2016, J VIROL, V90, P43, DOI 10.1128/JVI.01930-15; Straub TM, 2007, EMERG INFECT DIS, V13, P396, DOI 10.3201/eid1303.060549; Tan M, 2005, TRENDS MICROBIOL, V13, P285, DOI 10.1016/j.tim.2005.04.004; Taube S, 2013, MBIO, V4, DOI 10.1128/mBio.00450-13; VanDussen KL, 2015, GUT, V64, P911, DOI 10.1136/gutjnl-2013-306651; White LJ, 1997, J VIROL, V71, P8066, DOI 10.1128/JVI.71.10.8066-8072.1997; Zachos NC, 2016, J BIOL CHEM, V291, P3759, DOI 10.1074/jbc.R114.635995	40	771	806	17	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2016	353	6306					1387	1393		10.1126/science.aaf5211	http://dx.doi.org/10.1126/science.aaf5211			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5TB	27562956	Green Accepted			2022-12-28	WOS:000383708700033
J	Hutchinson, PJ; Kolias, AG; Timofeev, IS; Corteen, EA; Czosnyka, M; Timothy, J; Anderson, I; Bulters, DO; Belli, A; Eynon, CA; Wadley, J; Mendelow, AD; Mitchell, PM; Wilson, MH; Critchley, G; Sahuquillo, J; Unterberg, A; Servadei, F; Teasdale, GM; Pickard, JD; Menon, DK; Murray, GD; Kirkpatrick, PJ				Hutchinson, P. J.; Kolias, A. G.; Timofeev, I. S.; Corteen, E. A.; Czosnyka, M.; Timothy, J.; Anderson, I.; Bulters, D. O.; Belli, A.; Eynon, C. A.; Wadley, J.; Mendelow, A. D.; Mitchell, P. M.; Wilson, M. H.; Critchley, G.; Sahuquillo, J.; Unterberg, A.; Servadei, F.; Teasdale, G. M.; Pickard, J. D.; Menon, D. K.; Murray, G. D.; Kirkpatrick, P. J.		RESCUEicp Trial Collaborators	Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MIDDLE-CEREBRAL-ARTERY; GLASGOW OUTCOME SCALE; BRAIN-INJURY; HEAD-INJURY; DISABILITY; PRESSURE	BACKGROUND The effect of decompressive craniectomy on clinical outcomes in patients with refractory traumatic intracranial hypertension remains unclear. METHODS From 2004 through 2014, we randomly assigned 408 patients, 10 to 65 years of age, with traumatic brain injury and refractory elevated intracranial pressure (>25 mm Hg) to undergo decompressive craniectomy or receive ongoing medical care. The primary outcome was the rating on the Extended Glasgow Outcome Scale (GOS-E) (an 8-point scale, ranging from death to "upper good recovery" [no injury-related problems]) at 6 months. The primary-outcome measure was analyzed with an ordinal method based on the proportional-odds model. If the model was rejected, that would indicate a significant difference in the GOS-E distribution, and results would be reported descriptively. RESULTS The GOS-E distribution differed between the two groups (P<0.001). The proportional-odds assumption was rejected, and therefore results are reported descriptively. At 6 months, the GOS-E distributions were as follows: death, 26.9% among 201 patients in the surgical group versus 48.9% among 188 patients in the medical group; vegetative state, 8.5% versus 2.1%; lower severe disability (dependent on others for care), 21.9% versus 14.4%; upper severe disability (independent at home), 15.4% versus 8.0%; moderate disability, 23.4% versus 19.7%; and good recovery, 4.0% versus 6.9%. At 12 months, the GOS-E distributions were as follows: death, 30.4% among 194 surgical patients versus 52.0% among 179 medical patients; vegetative state, 6.2% versus 1.7%; lower severe disability, 18.0% versus 14.0%; upper severe disability, 13.4% versus 3.9%; moderate disability, 22.2% versus 20.1%; and good recovery, 9.8% versus 8.4%. Surgical patients had fewer hours than medical patients with intracranial pressure above 25 mm Hg after randomization (median, 5.0 vs. 17.0 hours; P<0.001) but had a higher rate of adverse events (16.3% vs. 9.2%, P=0.03). CONCLUSIONS At 6 months, decompressive craniectomy in patients with traumatic brain injury and refractory intracranial hypertension resulted in lower mortality and higher rates of vegetative state, lower severe disability, and upper severe disability than medical care. The rates of moderate disability and good recovery were similar in the two groups. (Funded by the Medical Research Council and others; RESCUEicp Current Controlled Trials number, ISRCTN66202560.)	[Hutchinson, P. J.; Kolias, A. G.; Timofeev, I. S.; Corteen, E. A.; Czosnyka, M.; Pickard, J. D.; Kirkpatrick, P. J.] Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge, England; [Menon, D. K.] Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; Univ Cambridge, Cambridge, England; [Timothy, J.; Anderson, I.] Leeds Gen Infirm, Dept Neurosurg, Leeds, W Yorkshire, England; [Bulters, D. O.] Southampton Univ Hosp, Dept Neurosurg, Wessex Neurol Ctr, Southampton, Hants, England; [Eynon, C. A.] Southampton Univ Hosp, Neurosci Intens Care Unit, Wessex Neurol Ctr, Southampton, Hants, England; [Belli, A.] Univ Birmingham, NIHR Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England; [Wadley, J.] St Bartholomews & Royal London Hosp, Dept Neurosurg, London, England; [Wilson, M. H.] St Marys Hosp, Dept Neurosurg, London, England; [Mendelow, A. D.] Newcastle Univ, Neurosurg Trials Grp, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Mitchell, P. M.] Royal Victoria Infirm, Dept Neurosurg, Newcastle Upon Tyne, Tyne & Wear, England; [Critchley, G.] Brighton & Sussex Univ Hosp, Hurstwood Pk Neurosci Ctr, Haywards Heath, England; [Teasdale, G. M.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Murray, G. D.] Univ Edinburgh, Sch Med, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Sahuquillo, J.] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Neurosurg, Barcelona, Spain; [Unterberg, A.] Heidelberg Univ, Dept Neurosurg, Heidelberg, Germany; [Servadei, F.] Univ Parma, Azienda Osped Univ Parma, Arcispedale S Maria Nuova IRCCS Reggio Emilia, Neurosurg Neurotraumatol Unit, Parma, Italy	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Leeds General Infirmary; University of Leeds; University of Southampton; University of Southampton; University of Birmingham; Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London; Imperial College London; Newcastle University - UK; Newcastle University - UK; University of Glasgow; University of Edinburgh; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Ruprecht Karls University Heidelberg; University of Parma; University Hospital of Parma	Hutchinson, PJ (corresponding author), Univ Cambridge, Div Neurosurg, Box 167,Cambridge Biomed Campus, Cambridge CB2 0QQ, England.	pjah2@cam.ac.uk	Idris, Badrisyah/E-3201-2012; Belli, Antonio/I-3799-2015; Bulters, Diederik/ABH-3573-2020; Mendelow, Alexander/AAW-2878-2021; SABANCI, PULAT AKIN/AAT-1325-2020; Sabancı, Pulat Akın/GWU-7929-2022; Chan, Matthew/J-2884-2013; Mrlian, Andrej/ABD-5480-2020; GANESAN, DHARMENDRA/B-8437-2010; NARAYANAN, VAIRAVAN/B-9191-2010; Abdullah, J/C-2828-2011; Sahuquillo, Juan/B-3577-2008; Idris, Badrisyah/C-8355-2016; Servadei, Franco/ABX-4656-2022	Idris, Badrisyah/0000-0002-7753-7389; Belli, Antonio/0000-0002-3211-9933; Chan, Matthew/0000-0002-3574-7855; Mrlian, Andrej/0000-0002-5362-1084; GANESAN, DHARMENDRA/0000-0003-1595-3659; NARAYANAN, VAIRAVAN/0000-0002-1118-5042; Abdullah, J/0000-0002-0258-7410; Sahuquillo, Juan/0000-0003-0713-5875; Idris, Badrisyah/0000-0002-7753-7389; Samandouras, George/0000-0001-7166-5729; Papadopoulos, Marios/0000-0001-9174-4176; Sakowitz, Oliver/0000-0003-3248-6335; Timofeev, Ivan/0000-0002-1168-0393; Kolias, Angelos/0000-0003-3992-0587; Servadei, Franco/0000-0002-3595-3464; Whitfield, Peter/0000-0003-0566-1820; Wilson, Mark/0000-0002-2346-4911; King, Andrew/0000-0002-6546-7248; Solodov, Aleksandr/0000-0002-8263-1433; Bulters, Diederik/0000-0001-9884-9050	Medical Research Council; Medical Research Council [G9439390, G1000183B, G0001237, G0600986] Funding Source: researchfish; National Institute for Health Research [12/35/57, NF-SI-0508-10327, NIHR-RP-R3-12-013, NF-SI-0512-10090] Funding Source: researchfish; MRC [G0001237, G0600986, G9439390] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by the Medical Research Council and others; RESCUEicp Current Controlled Trials number, ISRCTN66202560.	Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Arikan R, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson PJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1000; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Kolias AG, LANCET; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Kramer AH, 2016, NEUROCRIT CARE, V25, P10, DOI 10.1007/s12028-015-0232-8; Mahmoodpoor A, 2014, NEW ENGL J MED, V371, P971, DOI 10.1056/NEJMc1407775; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Timofeev I, 2012, Adv Tech Stand Neurosurg, V38, P115, DOI 10.1007/978-3-7091-0676-1_6; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	20	536	558	0	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2016	375	12					1119	1130		10.1056/NEJMoa1605215	http://dx.doi.org/10.1056/NEJMoa1605215			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW3JE	27602507	Green Accepted, Green Published			2022-12-28	WOS:000383537100005
J	Dance, A				Dance, Amber			Medical histories	NATURE			English	Editorial Material																			0	18	18	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					S52	S53		10.1038/537S52a	http://dx.doi.org/10.1038/537S52a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VH2UI	27602739	Bronze			2022-12-28	WOS:000452224700001
J	Plotkin, SA				Plotkin, Stanley A.			Need for a New Lyme Disease Vaccine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Plotkin, Stanley A.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Plotkin, Stanley A.] Vaxconsult, Doylestown, PA USA	University of Pennsylvania	Plotkin, SA (corresponding author), Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA.; Plotkin, SA (corresponding author), Vaxconsult, Doylestown, PA USA.							Comstedt P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113294; Earnhart CG, 2007, HUM VACCINES, V3, P281, DOI 10.4161/hv.4661; Koide S, 2005, J MOL BIOL, V350, P290, DOI 10.1016/j.jmb.2005.04.066; Livey I, 2011, CLIN INFECT DIS, V52, pS266, DOI 10.1093/cid/ciq118; Sykes RA, 2016, J PUBLIC HLTH OXF	5	14	14	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2016	375	10					911	913		10.1056/NEJMp1607146	http://dx.doi.org/10.1056/NEJMp1607146			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU9IG	27602662				2022-12-28	WOS:000382529500002
J	Moon, RE; Potter, JVF				Moon, Richard E.; Potter, Jennifer V. F.			Follow-up to Nonfatal Opioid Overdoses	ANNALS OF INTERNAL MEDICINE			English	Letter									[Moon, Richard E.] Duke Univ, Med Ctr, Durham, NC 27708 USA; [Potter, Jennifer V. F.] Univ Virginia, Charlottesville, VA USA	Duke University; University of Virginia	Moon, RE (corresponding author), Duke Univ, Med Ctr, Durham, NC 27708 USA.		Moon, Richard/AAF-2170-2019	Moon, Richard/0000-0003-4432-0332				Bates ML, 2014, NEW ENGL J MED, V370, P584, DOI 10.1056/NEJMc1311092; Gregg J, 2016, ANN INTERN MED, V164, P62, DOI 10.7326/M15-2687; Nelson James A, 2011, J Emerg Med, V40, pe67, DOI 10.1016/j.jemermed.2007.12.022; Potter JVF, 2015, J APPL PHYSIOL, V119, P420, DOI 10.1152/japplphysiol.00034.2015; White JM, 1999, ADDICTION, V94, P961, DOI 10.1046/j.1360-0443.1999.9479612.x	5	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2016	165	5					377	378		10.7326/L16-0110	http://dx.doi.org/10.7326/L16-0110			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3BC	27595220				2022-12-28	WOS:000382795000012
J	McCall, C				McCall, Chris			As Hajj nears, concerns about public safety linger	LANCET			English	Editorial Material																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2016	388	10048					950	950		10.1016/S0140-6736(16)31524-0	http://dx.doi.org/10.1016/S0140-6736(16)31524-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU9GL	27598667				2022-12-28	WOS:000382524400011
J	Balder, B				Balder, Bo			SKIN HUNGER	NATURE			English	Editorial Material																			0	0	0	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					128	128		10.1038/537128a	http://dx.doi.org/10.1038/537128a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU7XC	27582224	Bronze			2022-12-28	WOS:000382426900056
J	Mikkelsen, EM; Riis, AH; Wise, LA; Hatch, EE; Rothman, KJ; Cueto, HT; Sorensen, HT				Mikkelsen, Ellen M.; Riis, Anders H.; Wise, Lauren A.; Hatch, Elizabeth E.; Rothman, Kenneth J.; Cueto, Heidi T.; Sorensen, Henrik Toft			Alcohol consumption and fecundability: prospective Danish cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CAFFEINE CONSUMPTION; CIGARETTE-SMOKING; SELECTION BIAS; HORMONE-LEVELS; UNITED-STATES; WAITING TIME; LIFE-STYLE; INFERTILITY; WOMEN; PREGNANCY	OBJECTIVE To investigate to what extent alcohol consumption affects female fecundability. DESIGN Prospective cohort study. SETTING Denmark, 1 June 2007 to 5 January 2016. Participants 6120 female Danish residents, aged 21-45 years, in a stable relationship with a male partner, who were trying to conceive and not receiving fertility treatment. MAIN OUTCOME MEASURES Alcohol consumption was self reported as beer (330 mL bottles), red or white wine (120 mL glasses), dessert wine (50 mL glasses), and spirits (20 mL) and categorized in standard servings per week (none, 1-3, 4-7, 8-13, and >= 14). Participants contributed menstrual cycles at risk until the report of pregnancy, start of fertility treatment, loss to follow-up, or end of observation (maximum 12 menstrual cycles). A proportional probability regression model was used to estimate fecundability ratios (cycle specific probability of conception among exposed women divided by that among unexposed women). RESULTS 4210 (69%) participants achieved a pregnancy during follow-up. Median alcohol intake was 2.0 (interquartile range 0-3.5) servings per week. Compared with no alcohol consumption, the adjusted fecundability ratios for alcohol consumption of 1-3, 4-7, 8-13, and 14 or more servings per week were 0.97 (95% confidence interval 0.91 to 1.03), 1.01 (0.93 to 1.10), 1.01 (0.87 to 1.16) and 0.82 (0.60 to 1.12), respectively. Compared with no alcohol intake, the adjusted fecundability ratios for women who consumed only wine (>= 3 servings), beer (>= 3 servings), or spirits (>= 2 servings) were 1.05 (0.91 to1.21), 0.92 (0.65 to 1.29), and 0.85 (0.61 to 1.17), respectively. The data did not distinguish between regular and binge drinking, which may be important if large amounts of alcohol are consumed during the fertile window. CONCLUSION Consumption of less than 14 servings of alcohol per week seemed to have no discernible effect on fertility. No appreciable difference in fecundability was observed by level of consumption of beer and wine.	[Mikkelsen, Ellen M.; Riis, Anders H.; Cueto, Heidi T.; Sorensen, Henrik Toft] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8200 Aarhus N, Denmark; [Wise, Lauren A.; Hatch, Elizabeth E.; Rothman, Kenneth J.; Sorensen, Henrik Toft] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Rothman, Kenneth J.] RTI Hlth Solut, Res Triangle Pk, NC 27709 USA	Aarhus University; Boston University; Research Triangle Institute	Mikkelsen, EM (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8200 Aarhus N, Denmark.	em@dce.au.dk	Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040; Mikkelsen, Ellen Margrethe/0000-0003-0158-7950; Wise, Lauren/0000-0003-2138-3752; Riis, Anders Hammerich/0000-0002-6684-4068	National Institute of Child Health and Human Development [R21-HD050264, R01-HD060690]; Danish Medical Research Council [271-07-0338]	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by the National Institute of Child Health and Human Development (R21-HD050264 and R01-HD060690) and the Danish Medical Research Council (271-07-0338). The researchers are all independent of the funders.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Al-Kubaisy W, 2012, PROCD SOC BEHV, V38, P59, DOI 10.1016/j.sbspro.2012.03.324; Artero A, 2015, MATURITAS, V80, P3, DOI 10.1016/j.maturitas.2014.09.007; Augustynska B, 2007, ALCOHOL ALCOHOLISM, V42, P80; Christensen AI, 2014, HLTH DANES DANISH NA; Curtis KM, 1997, AM J EPIDEMIOL, V146, P32, DOI 10.1093/oxfordjournals.aje.a009189; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Feunekes GIJ, 1999, AM J EPIDEMIOL, V150, P105; FLORACK EIM, 1994, PREV MED, V23, P175, DOI 10.1006/pmed.1994.1024; Gill J, 2000, ALCOHOL ALCOHOLISM, V35, P417, DOI 10.1093/alcalc/35.5.417; GRODSTEIN F, 1994, AM J PUBLIC HEALTH, V84, P1429, DOI 10.2105/AJPH.84.9.1429; Hakim RB, 1998, FERTIL STERIL, V70, P632, DOI 10.1016/S0015-0282(98)00257-X; Hassan MAM, 2004, FERTIL STERIL, V81, P384, DOI 10.1016/j.fertnstert.2003.06.027; Hatch EE, 2016, EPIDEMIOLOGY, V27, P98, DOI 10.1097/EDE.0000000000000400; Homan GF, 2007, HUM REPROD UPDATE, V13, P209, DOI 10.1093/humupd/dml056; International Alliance for Responsible Drinking, 2016, DRINK GUID GEN POP; Jensen TW, 2014, ANN RHEUM DIS, V73, P1123, DOI 10.1136/annrheumdis-2012-203171; Jensen TK, 1998, BRIT MED J, V317, P505, DOI 10.1136/bmj.317.7157.505; Juhl M, 2003, HUM REPROD, V18, P1967, DOI 10.1093/humrep/deg376; Juhl M, 2001, HUM REPROD, V16, P2705, DOI 10.1093/humrep/16.12.2705; Knudsen VK, 2016, PUBLIC HEALTH NUTR, V19, P1027, DOI 10.1017/S1368980015002189; Lopez-del Burgo C, 2015, NUTRIENTS, V7, P6167, DOI 10.3390/nu7085278; Lucero J, 2001, FERTIL STERIL, V76, P723, DOI 10.1016/S0015-0282(01)02005-2; Marchetta Claire M., 2012, Morbidity and Mortality Weekly Report, V61, P534; May PA, 2013, DRUG ALCOHOL DEPEN, V133, P502, DOI 10.1016/j.drugalcdep.2013.07.013; Mikkelsen EM, 2009, INT J EPIDEMIOL, V38, P938, DOI 10.1093/ije/dyn191; Olsen J, 1997, ALCOHOL CLIN EXP RES, V21, P206, DOI 10.1111/j.1530-0277.1997.tb03751.x; OLSEN J, 1983, INT J EPIDEMIOL, V12, P179, DOI 10.1093/ije/12.2.179; Patra J, 2011, BJOG-INT J OBSTET GY, V118, P1411, DOI 10.1111/j.1471-0528.2011.03050.x; REICHMAN ME, 1993, J NATL CANCER I, V85, P722, DOI 10.1093/jnci/85.9.722; Rinaldi S, 2006, CANCER CAUSE CONTROL, V17, P1033, DOI 10.1007/s10552-006-0041-7; Sadeu JC, 2010, CRIT REV TOXICOL, V40, P633, DOI 10.3109/10408444.2010.493552; Schisterman EF, 2013, PAEDIATR PERINAT EP, V27, P491, DOI 10.1111/ppe.12073; Slama R, 2012, HUM REPROD, V27, P1489, DOI 10.1093/humrep/des070; Stephen EH, 1998, FERTIL STERIL, V70, P30, DOI 10.1016/S0015-0282(98)00103-4; Thoma ME, 2013, FERTIL STERIL, V99, P1324, DOI 10.1016/j.fertnstert.2012.11.037; U.S. Department of Health and Human Services and U.S. Department of Agriculture, DIET GUID AM 2015 20; WEINBERG CR, 1989, AM J EPIDEMIOL, V129, P1072, DOI 10.1093/oxfordjournals.aje.a115211; WEINBERG CR, 1994, STAT MED, V13, P671, DOI 10.1002/sim.4780130528; Wise LA, 2011, AM J EPIDEMIOL, V174, P701, DOI 10.1093/aje/kwr130; Wise LA, 2010, HUM REPROD, V25, P253, DOI 10.1093/humrep/dep360; ZAADSTRA BM, 1994, FERTIL STERIL, V62, P948; Zhou XH, 2001, STAT MED, V20, P1541, DOI 10.1002/sim.689	43	24	24	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 31	2016	354								i4262	10.1136/bmj.i4262	http://dx.doi.org/10.1136/bmj.i4262			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AD	27581754	hybrid, Green Published			2022-12-28	WOS:000382792500002
J	Chen, WW; Freinkman, E; Wang, T; Birsoy, K; Sabatini, DM				Chen, Walter W.; Freinkman, Elizaveta; Wang, Tim; Birsoy, Kivanc; Sabatini, David M.			Absolute Quantification of Matrix Metabolites Reveals the Dynamics of Mitochondrial Metabolism	CELL			English	Article							TRANSFER-RNA SYNTHETASE; CELLS; ACID; METABOLOMICS; RESPIRATION; INHIBITION; PROTEINS; SYNTHASE; GROWTH; POOLS	Mitochondria house metabolic pathways that impact most aspects of cellular physiology. While metabolite profiling by mass spectrometry is widely applied at the whole-cell level, it is not routinely possible to measure the concentrations of small molecules in mammalian organelles. We describe a method for the rapid and specific isolation of mitochondria and use it in tandem with a database of predicted mitochondrial metabolites ("MITObolome") to measure the matrix concentrations of more than 100 metabolites across various states of respiratory chain (RC) function. Disruption of the RC reveals extensive compartmentalization of mitochondrial metabolism and signatures unique to the inhibition of each RC complex. Pyruvate enables the proliferation of RC-deficient cells but has surprisingly limited effects on matrix contents. Interestingly, despite failing to restore matrix NADH/NAD balance, pyruvate does increase aspartate, likely through the exchange of matrix glutamate for cytosolic aspartate. We demonstrate the value of mitochondrial metabolite profiling and describe a strategy applicable to other organelles.	[Chen, Walter W.; Freinkman, Elizaveta; Wang, Tim; Sabatini, David M.] MIT, Dept Biol, Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Chen, Walter W.; Wang, Tim; Sabatini, David M.] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Chen, Walter W.; Wang, Tim; Sabatini, David M.] Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Chen, Walter W.; Wang, Tim; Sabatini, David M.] Broad Inst Harvard & Massachusetts Inst Technol, 7 Cambridge Ctr, Cambridge, MA 02142 USA; [Birsoy, Kivanc] Rockefeller Univ, Lab Metab Regulat & Genet, New York, NY 10065 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Rockefeller University	Sabatini, DM (corresponding author), MIT, Dept Biol, Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA.; Sabatini, DM (corresponding author), MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA.; Sabatini, DM (corresponding author), Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Sabatini, DM (corresponding author), Broad Inst Harvard & Massachusetts Inst Technol, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		/0000-0002-1446-7256; Wang, Timothy/0000-0001-5730-3019; Chen, Walter/0000-0002-7752-9581	NIH [R01CA103866, R01CA129105, R37AI047389, F30 AG046047, F31 CA189437, K22 CA193660]; Department of Defense [W81XWH-15-1-0230, W81XWH-15-1-0337]; NATIONAL CANCER INSTITUTE [R01CA129105, R01CA103866, F31CA189437, K22CA193660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389, R37AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, T32GM007287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG046047] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank all members of the D.M.S. lab and Hoi See Tsao for helpful suggestions. C4- and C5-carnitines were kindly synthesized by Rajan Pragani and provided by Jared Mayers. This work was supported by grants from the NIH (R01CA103866, R01CA129105, and R37AI047389) and the Department of Defense (W81XWH-15-1-0230 to D.M.S; W81XWH-15-1-0337 to E.F.). Fellowship support was provided by the NIH (F30 AG046047 to W.W.C.; F31 CA189437 to T.W.; K22 CA193660 to K.B.). D.M.S is an investigator of the Howard Hughes Medical Institute.	Berry M, 1991, ISOLATED HEPATOCYTES; BERTHET J, 1967, J CELL BIOL, V34, P701, DOI 10.1083/jcb.34.2.701; BESTWICK RK, 1982, J BIOL CHEM, V257, P9300; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; BOGENHAGEN D, 1974, J BIOL CHEM, V249, P7991; Bowsher CG, 2001, J EXP BOT, V52, P513, DOI 10.1093/jexbot/52.356.513; Cacciatore S, 2015, ANN NY ACAD SCI, V1346, P57, DOI 10.1111/nyas.12775; Cardaci S, 2015, NAT CELL BIOL, V17, P1317, DOI 10.1038/ncb3233; Chantranupong L, 2014, CELL REP, V9, P1, DOI 10.1016/j.celrep.2014.09.014; Chen WW, 2014, CELL REP, V7, P27, DOI 10.1016/j.celrep.2014.02.046; Corcelli A, 2010, BBA-BIOMEMBRANES, V1798, P681, DOI 10.1016/j.bbamem.2010.01.005; Elo JM, 2012, HUM MOL GENET, V21, P4521, DOI 10.1093/hmg/dds294; ERECINSKA M, 1978, AM J PHYSIOL, V234, pC82, DOI 10.1152/ajpcell.1978.234.3.C82; Fly R, 2015, METHODS MOL BIOL, V1305, P197, DOI 10.1007/978-1-4939-2639-8_14; Gerencser AA, 2012, J PHYSIOL-LONDON, V590, P2845, DOI 10.1113/jphysiol.2012.228387; HARRIS M, 1980, SOMAT CELL GENET, V6, P699, DOI 10.1007/BF01538969; IDELLWENGER JA, 1978, J BIOL CHEM, V253, P4310; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Ke HJ, 2015, CELL REP, V11, P164, DOI 10.1016/j.celrep.2015.03.011; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Linskens H.F., 2012, CELL COMPONENTS; MARKOVITZ PJ, 1984, J BIOL CHEM, V259, P1643; Matuszczyk JC, 2015, BIOTECHNOL J, V10, P1639, DOI 10.1002/biot.201500060; Messmer M, 2009, BIOCHIMIE, V91, P596, DOI 10.1016/j.biochi.2009.02.005; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Nemoto Y, 1999, EMBO J, V18, P2991, DOI 10.1093/emboj/18.11.2991; NISHIKI K, 1978, AM J PHYSIOL, V234, pC73, DOI 10.1152/ajpcell.1978.234.3.C73; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Roede JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033020; Ross-Inta C, 2008, BIOSCIENCE REP, V28, P239, DOI 10.1042/BSR20080090; SAFER B, 1975, CIRC RES, V37, P527, DOI 10.1161/01.RES.37.5.527; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Scovassi AI, 2004, FASEB J, V18, P1487, DOI 10.1096/fj.04-1841rev; Shaham O, 2010, P NATL ACAD SCI USA, V107, P1571, DOI 10.1073/pnas.0906039107; Srere P A, 1986, Adv Exp Med Biol, V194, P13; Stark R, 2009, J BIOL CHEM, V284, P26578, DOI 10.1074/jbc.M109.011775; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; TISCHLER ME, 1977, ARCH BIOCHEM BIOPHYS, V181, P278, DOI 10.1016/0003-9861(77)90506-9; Van Vranken JG, 2015, CELL, V162, P471, DOI 10.1016/j.cell.2015.07.027; VIANEYLIAUD C, 1987, J INHERIT METAB DIS, V10, P159, DOI 10.1007/BF01812855; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; WIEGAND G, 1986, ANNU REV BIOPHYS BIO, V15, P97; Williamson J R, 1979, Methods Enzymol, V55, P200; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338	47	225	226	9	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1324	+		10.1016/j.cell.2016.07.040	http://dx.doi.org/10.1016/j.cell.2016.07.040			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27565352	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000382259500026
J	Matheson, S				Matheson, Susan			DNA Phenotyping: Snapshot of a Criminal	CELL			English	Editorial Material								Recent progresses in genomic technologies provide both opportunities and challenges to forensics.											0	6	7	1	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1061	1064		10.1016/j.cell.2016.08.016	http://dx.doi.org/10.1016/j.cell.2016.08.016			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27565333	Bronze			2022-12-28	WOS:000382259500002
J	Maxmen, A				Maxmen, Amy			Dip your toes	NATURE			English	Editorial Material																			0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					489	491		10.1038/nj7617-489a	http://dx.doi.org/10.1038/nj7617-489a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV0YL	27563709	Bronze			2022-12-28	WOS:000382646600051
J	Yang, H				Yang, Hong			China's soil plan needs strong support	NATURE			English	Editorial Material									[Yang, Hong] Norwegian Inst Bioecon Res NIBIO, As, Norway; [Yang, Hong] Univ Oslo, N-0316 Oslo, Norway	Norwegian Institute of Bioeconomy Research; University of Oslo	Yang, H (corresponding author), Norwegian Inst Bioecon Res NIBIO, As, Norway.; Yang, H (corresponding author), Univ Oslo, N-0316 Oslo, Norway.	hongyanghy@gmail.com	Hong, YANG/C-1739-2008	Hong, YANG/0000-0001-9940-8273					0	29	33	3	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					375	375		10.1038/536375a	http://dx.doi.org/10.1038/536375a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV0YL	27558029				2022-12-28	WOS:000382646600011
J	Zeng, ML; Shang, Y; Araki, Y; Guo, TF; Huganir, RL; Zhang, MJ				Zeng, Menglong; Shang, Yuan; Araki, Yoichi; Guo, Tingfeng; Huganir, Richard L.; Zhang, Mingjie			Phase Transition in Postsynaptic Densities Underlies Formation of Synaptic Complexes and Synaptic Plasticity	CELL			English	Article							SUPERTERTIARY STRUCTURE; SCAFFOLD PROTEINS; SYNGAP1 CAUSE; DOMAINS; MUTATIONS; FAMILY; CORE; FORM; ORGANIZATION; RECOGNITION	Postsynaptic densities (PSDs) are membrane semi-enclosed, submicron protein-enriched cellular compartments beneath postsynaptic membranes, which constantly exchange their components with bulk aqueous cytoplasm in synaptic spines. Formation and activity-dependent modulation of PSDs is considered as one of the most basic molecular events governing synaptic plasticity in the nervous system. In this study, we discover that SynGAP, one of the most abundant PSD proteins and a Ras/Rap GTPase activator, forms a homo-trimer and binds to multiple copies of PSD-95. Binding of SynGAP to PSD-95 induces phase separation of the complex, forming highly concentrated liquid-like droplets reminiscent of the PSD. The multivalent nature of the SynGAP/PSD-95 complex is critical for the phase separation to occur and for proper activity-dependent SynGAP dispersions from the PSD. In addition to revealing a dynamic anchoring mechanism of SynGAP at the PSD, our results also suggest a model for phase-transition-mediated formation of PSD.	[Zeng, Menglong; Shang, Yuan; Guo, Tingfeng; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Zhang, Mingjie] Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, Kowloon, Hong Kong, Peoples R China; [Araki, Yoichi; Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Araki, Yoichi; Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Kavli Neurosci Discovery Inst, Baltimore, MD 21205 USA	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Johns Hopkins University; Johns Hopkins University	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China.; Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk	SHANG, Raymond Yuan/AAV-3446-2020; Guo, Tingfeng/HHD-2752-2022	Guo, Tingfeng/0000-0003-2441-653X; Zhang, Mingjie/0000-0001-9404-0190; SHANG, Yuan/0000-0002-7093-4234	RGC of Hong Kong [664113, 16103614, AoE-M09-12, T13-607/12R]; 973 program grant from the Minister of Science and Technology of China [2014CB910204]; NIH [R01NS036715]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036715] Funding Source: NIH RePORTER	RGC of Hong Kong(Hong Kong Research Grants Council); 973 program grant from the Minister of Science and Technology of China(National Basic Research Program of China); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank the Shanghai Synchrotron Radiation Facility (SSRF) BL17U and B19U1 for X-ray beam time. Dr. Fei Ye helped with NMR analysis. This work was supported by grants from RGC of Hong Kong (664113, 16103614, AoE-M09-12, and T13-607/12R) and a 973 program grant from the Minister of Science and Technology of China (2014CB910204) (to M.Z.). The work was also supported by a grant from the NIH (R01NS036715) (to R.L.H.). M.Z. is a Kerry Holdings Professor in Science and a Senior Fellow of IAS at HKUST.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Araki Y, 2015, NEURON, V85, P173, DOI 10.1016/j.neuron.2014.12.023; Banjade S, 2014, ELIFE, V3, DOI 10.7554/eLife.04123; Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Berryer MH, 2013, HUM MUTAT, V34, P385, DOI 10.1002/humu.22248; Bosch M, 2014, NEURON, V82, P444, DOI 10.1016/j.neuron.2014.03.021; Brangwynne CP, 2013, J CELL BIOL, V203, P875, DOI 10.1083/jcb.201308087; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Chen XB, 2008, P NATL ACAD SCI USA, V105, P4453, DOI 10.1073/pnas.0800897105; Chen XB, 2015, P NATL ACAD SCI USA, V112, pE6983, DOI 10.1073/pnas.1517045112; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Choquet D, 2013, NEURON, V80, P691, DOI 10.1016/j.neuron.2013.10.013; Colgan LA, 2014, ANNU REV PHYSIOL, V76, P365, DOI 10.1146/annurev-physiol-021113-170400; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Harris KM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005587; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Jiang H, 2015, CELL, V163, P108, DOI 10.1016/j.cell.2015.08.010; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Levy JM, 2015, NEURON, V87, P534, DOI 10.1016/j.neuron.2015.07.015; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Li YJ, 2014, P NATL ACAD SCI USA, V111, P17444, DOI 10.1073/pnas.1416515111; Lowenthal MS, 2015, J PROTEOME RES, V14, P2528, DOI 10.1021/acs.jproteome.5b00109; MacGillavry HD, 2013, NEURON, V78, P615, DOI 10.1016/j.neuron.2013.03.009; Maglione M, 2013, NAT NEUROSCI, V16, P790, DOI 10.1038/nn.3403; McCann JJ, 2012, P NATL ACAD SCI USA, V109, P15775, DOI 10.1073/pnas.1200254109; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Nair D, 2013, J NEUROSCI, V33, P13204, DOI 10.1523/JNEUROSCI.2381-12.2013; Nishiyama J, 2015, NEURON, V87, P63, DOI 10.1016/j.neuron.2015.05.043; O'Connell JD, 2012, ANNU REV CELL DEV BI, V28, P89, DOI 10.1146/annurev-cellbio-101011-155841; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan LF, 2011, J BIOL CHEM, V286, P40069, DOI 10.1074/jbc.C111.293084; Parker MJ, 2015, AM J MED GENET A, V167, P2231, DOI 10.1002/ajmg.a.37189; Petit CM, 2009, P NATL ACAD SCI USA, V106, P18249, DOI 10.1073/pnas.0904492106; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Trinidad JC, 2008, MOL CELL PROTEOMICS, V7, P684, DOI 10.1074/mcp.M700170-MCP200; Vazquez LE, 2004, J NEUROSCI, V24, P8862, DOI 10.1523/JNEUROSCI.3213-04.2004; Woodruff JB, 2015, SCIENCE, V348, P808, DOI 10.1126/science.aaa3923; Ye F, 2013, BIOCHEM J, V455, P1, DOI 10.1042/BJ20130783; Zeng ML, 2016, P NATL ACAD SCI USA, V113, pE3081, DOI 10.1073/pnas.1523265113; Zhang J, 2013, STRUCTURE, V21, P402, DOI 10.1016/j.str.2012.12.014; Zhu JW, 2016, NAT REV NEUROSCI, V17, P209, DOI 10.1038/nrn.2016.18; Zhu JW, 2011, EMBO J, V30, P4986, DOI 10.1038/emboj.2011.428	50	258	267	11	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1163	1175		10.1016/j.cell.2016.07.008	http://dx.doi.org/10.1016/j.cell.2016.07.008			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27565345	Green Accepted, Bronze			2022-12-28	WOS:000382259500014
J	McCarthy, M				McCarthy, Michael			Drug prices are kept high in US by protection and price negotiations, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Kesselheim AS, 2016, JAMA-J AM MED ASSOC, V316, P858, DOI 10.1001/jama.2016.11237	1	1	1	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2016	354								i4640	10.1136/bmj.i4640	http://dx.doi.org/10.1136/bmj.i4640			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV2ZY	27553038				2022-12-28	WOS:000382792000020
J	Wise, J				Wise, Jacqui			Combined HRT may raise breast cancer risk, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Jones ME, 2016, BRIT J CANCER, V115, P607, DOI 10.1038/bjc.2016.231	1	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2016	354								i4612	10.1136/bmj.i4612	http://dx.doi.org/10.1136/bmj.i4612			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV2ZY	27554520				2022-12-28	WOS:000382792000013
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Wishful thinking won't save the NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Allen K, 2010, BILLION DOLLAR QUEST; Birmingham Policy Commission, 2014, HLTH AG 21 CENT BEST; Campbell D, 2016, GUARDIAN; Castle-Clark S, 2015, NUFFIELD TRUST 0630; Curry N, 2010, CLIN SERVICE INTEGRA; Davies A, 2016, QUALITYWATCH FOCUS P; Department of Health, 2016, OP PROD PERF ENGL NH; Dowler C., 2016, HLTH SERV J; Gretton C, 2016, KINGS FUND BLOG 0101; Health Foundation, 2016, HEALTH LIF ALL CAS C; McKenna H., 2016, KINGS FUND BLOG 0729; National Collaboration for Integrated Care and Support, 2013, INT CAR SUPP OUR SHA; NHS Confederation, 2010, DEAL DOWNT US EV; NHS England, 2014, 5 YEAR FORW VIEW; Nuffield Trust, 2014, RED STAT NHS FIN; Oliver D., 2014, KINGS FUND BLOG 0828; Oliver D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5661; Oliver D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5538; Royal College of General Practitioners, 2015, STEPP FORW COMM PRIN	19	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 22	2016	354								i4544	10.1136/bmj.i4544	http://dx.doi.org/10.1136/bmj.i4544			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV2ZX	27550192	Green Published, Bronze			2022-12-28	WOS:000382791900003
J	Hirsch, FR; Scagliotti, GV; Mulshine, JL; Kwon, R; Curran, WJ; Wu, YL; Paz-Ares, L				Hirsch, Fred R.; Scagliotti, Giorgio V.; Mulshine, James L.; Kwon, Regina; Curran, Walter J.; Wu, Yi-Long; Paz-Ares, Luis			Lung cancer: current therapies and new targeted treatments	LANCET			English	Review							ANAPLASTIC LYMPHOMA KINASE; BODY RADIATION-THERAPY; MULTICENTER PHASE-II; ADULT PATIENTS PTS; OPEN-LABEL; EGFR MUTATIONS; DOUBLE-BLIND; SINGLE-ARM; MAINTENANCE THERAPY; 1ST-LINE CHEMOTHERAPY	Lung cancer is the most frequent cause of cancer-related deaths worldwide. Every year, 1 . 8 million people are diagnosed with lung cancer, and 1 . 6 million people die as a result of the disease. 5-year survival rates vary from 4-17% depending on stage and regional differences. In this Seminar, we discuss existing treatment for patients with lung cancer and the promise of precision medicine, with special emphasis on new targeted therapies. Some subgroups, eg-patients with poor performance status and elderly patients-are not specifically addressed, because these groups require special treatment considerations and no frameworks have been established in terms of new targeted therapies. We discuss prevention and early detection of lung cancer with an emphasis on lung cancer screening. Although we acknowledge the importance of smoking prevention and cessation, this is a large topic beyond the scope of this Seminar.	[Hirsch, Fred R.] Univ Colorado, Ctr Canc, Dept Med, Div Med Oncol, Denver, CO 80262 USA; [Hirsch, Fred R.] Univ Colorado, Ctr Canc, Dept Pathol, Denver, CO 80262 USA; [Hirsch, Fred R.] Int Assoc Study Lung Canc, Aurora, CO USA; [Scagliotti, Giorgio V.] Univ Turin, San Luigi Hosp Orbassano, Dept Oncol, Div Oncol, Orbassano, Italy; [Mulshine, James L.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Kwon, Regina] Univ Colorado, Sch Med, Denver, CO USA; [Curran, Walter J.] Emory Univ, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Curran, Walter J.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Wu, Yi-Long] Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China; [Wu, Yi-Long] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China; [Paz-Ares, Luis] Hosp Univ Doce Octubre, Dept Med Oncol, Madrid, Spain; [Paz-Ares, Luis] CNIO, Madrid, Spain	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Denver; University of Turin; Rush University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Emory University; Emory University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Hospital Universitario 12 de Octubre; Centro Nacional de Investigaciones Oncologicas (CNIO)	Hirsch, FR (corresponding author), Univ Colorado, Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA.	fred.hirsch@ucdenver.edu	Paz-Ares, Luis/AAH-2750-2019; Wu, Yi-Long/AAW-9832-2020; Wu, Yi-Long/AAB-9137-2022; Scagliotti, Giorgio/K-6359-2016; Wu, Yi-Long/C-3396-2008; Wu, Yi-Long/GRJ-9238-2022	Wu, Yi-Long/0000-0002-3611-0258; Wu, Yi-Long/0000-0002-3611-0258; Scagliotti, Giorgio/0000-0001-6646-958X				Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Alley EW, 2015, IASLC 16 WORLD C LUN; Almquist D, 2016, J ONCOL PRACT, V12, P111, DOI 10.1200/JOP.2015.009068; American Cancer Society, 2015, CANC FACTS FIG 2015; Antonia SJ, 2015, ASCO M, V33, P7503, DOI DOI 10.1200/JC0.2015.33.15_; Auperin A, 2010, J CLIN ONCOL, V28, P2181, DOI 10.1200/JCO.2009.26.2543; Awad MM, 2013, NEW ENGL J MED, V368, P2395, DOI 10.1056/NEJMoa1215530; BAILAR JC, 1984, AM REV RESPIR DIS, V130, P541; Bauer TM, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.2534; Behera M, 2012, LUNG CANCER, V77, P331, DOI 10.1016/j.lungcan.2012.03.019; Belani CP, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.7506; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Besse B, 2015, EUR J CANCER, V51, pS717, DOI 10.1016/S0959-8049(16)31938-4; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Boyle TA, 2015, CLIN LUNG CANCER, V16, P106, DOI 10.1016/j.cllc.2014.10.003; Bradley JD, 2015, LANCET ONCOL, V16, P187, DOI 10.1016/S1470-2045(14)71207-0; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Brodowicz T, 2006, LUNG CANCER, V52, P155, DOI 10.1016/j.lungcan.2006.01.006; Bunn PA, 2016, J THORAC ONCOL, V11, P453, DOI 10.1016/j.jtho.2016.01.012; Burdett S, 2014, LANCET, V383, P1561, DOI 10.1016/S0140-6736(13)62159-5; Califano R, 2015, CANCER TREAT REV, V41, P401, DOI 10.1016/j.ctrv.2015.03.009; Camidge DR, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.8001; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Cao C, 2013, INTERACT CARDIOV TH, V16, P244, DOI 10.1093/icvts/ivs472; Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1; Ciuleanu T, 2009, LANCET, V374, P1432, DOI 10.1016/S0140-6736(09)61497-5; Committee for Medicinal Products for Human Use, 2015, SUMM OP PORTR; Costa DB, 2015, J CLIN ONCOL, V33, P1881, DOI 10.1200/JCO.2014.59.0539; Curran WJ, 2011, J NATL CANCER I, V103, P1452, DOI 10.1093/jnci/djr325; Dearden S, 2013, ANN ONCOL, V24, P2371, DOI 10.1093/annonc/mdt205; Doebele RC, 2015, CANCER DISCOV, V5, P1049, DOI 10.1158/2159-8290.CD-15-0443; Doebele RC, 2012, CLIN CANCER RES, V18, P1472, DOI 10.1158/1078-0432.CCR-11-2906; Drilon A, 2013, CANCER DISCOV, V3, P630, DOI 10.1158/2159-8290.CD-13-0035; Drilon AE, 2015, J CLIN ONCOL, V33; Ercan D, 2015, CLIN CANCER RES, V21, P3913, DOI 10.1158/1078-0432.CCR-14-2789; Fakiris AJ, 2009, INT J RADIAT ONCOL, V75, P677, DOI 10.1016/j.ijrobp.2008.11.042; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Felip E, 2015, J CLIN ONCOL, V33; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fidias PM, 2009, J CLIN ONCOL, V27, P591, DOI 10.1200/JCO.2008.17.1405; Field JK, 2016, THORAX, V71, P161, DOI 10.1136/thoraxjnl-2015-207140; Flores R, 2014, J THORAC CARDIOV SUR, V147, P1619, DOI 10.1016/j.jtcvs.2013.11.001; Forde PM, 2014, CLIN CANCER RES, V20, P1067, DOI 10.1158/1078-0432.CCR-13-0731; Frank L, 2013, SEMIN RESP CRIT CARE, V34, P738, DOI 10.1055/s-0033-1358615; Friboulet L, 2014, CANCER DISCOV, V4, P662, DOI 10.1158/2159-8290.CD-13-0846; Gadgeel SM, 2014, LANCET ONCOL, V15, P1119, DOI 10.1016/S1470-2045(14)70362-6; Gainor JF, 2013, CLIN CANCER RES, V19, P4273, DOI 10.1158/1078-0432.CCR-13-0318; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Garon EB, 2014, LANCET, V384, P665, DOI 10.1016/S0140-6736(14)60845-X; Gettinger S, 2014, ANN ONCOL, V25, DOI 10.1093/annonc/mdu349.71; Gettinger SN, 2015, J CLIN ONCOL, V33, P2004, DOI 10.1200/JCO.2014.58.3708; Goldstraw P, 2016, J THORAC ONCOL, V11, P39, DOI 10.1016/j.jtho.2015.09.009; Goss GD, 2013, J CLIN ONCOL, V31, P3320, DOI 10.1200/JCO.2013.51.1816; Gulley JL, 2015, J CLIN ONCOL S, V33, P8034, DOI DOI 10.1200/JC0.2015.33.15_; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; Henschke CI, 2013, ANN INTERN MED, V158, P246, DOI 10.7326/0003-4819-158-4-201302190-00004; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hirsch FR, 2015, NAT REV CLIN ONCOL, V12, P689, DOI 10.1038/nrclinonc.2015.202; Horeweg N, 2014, LANCET ONCOL, V15, P1332, DOI 10.1016/S1470-2045(14)70389-4; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Karachaliou N, 2015, JAMA ONCOL, V1, P149, DOI 10.1001/jamaoncol.2014.257; Katayama R, 2015, CLIN CANCER RES, V21, P2227, DOI 10.1158/1078-0432.CCR-14-2791; Kazerooni EA, 2015, J AM COLL RADIOL, V12, P38, DOI 10.1016/j.jacr.2014.10.002; Kelly K, 2015, J CLIN ONCOL, V33, P4007, DOI 10.1200/JCO.2015.61.8918; Kerr KM, 2016, ARCH PATHOL LAB MED, V140, P326, DOI 10.5858/arpa.2015-0522-SA; Kim DW, 2012, J CLIN ONCOL, V30; Kris MG, 2015, ANN ONCOL, V26, P1421, DOI 10.1093/annonc/mdv186; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lewin G, 2016, CAN MED ASSOC J, V188, P425, DOI 10.1503/cmaj.151421; Marchetti A, 2011, J CLIN ONCOL, V29, P3574, DOI 10.1200/JCO.2011.35.9638; Masters GA, 2015, J CLIN ONCOL, V33, P3488, DOI 10.1200/JCO.2015.62.1342; Mazieres J, 2015, J CLIN ONCOL, V33, P992, DOI 10.1200/JCO.2014.58.3302; Mazieres J, 2013, J THORAC ONCOL, V8, P923, DOI 10.1097/JTO.0b013e3182904dfb; Mazieres J, 2013, J CLIN ONCOL, V31, P1997, DOI 10.1200/JCO.2012.45.6095; Michels S, 2016, J THORAC ONCOL, V11, P122, DOI 10.1016/j.jtho.2015.09.016; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok T, 2015, J CLIN ONCOL, V33; Mok T, 2015, CLIN CANCER RES, V21, P3196, DOI 10.1158/1078-0432.CCR-14-2594; Mulshine JL, 2014, CA-CANCER J CLIN, V64, P352, DOI 10.3322/caac.21239; National Cancer Institute, ALCHEMIST ADJ LUNG C; Nokihara H, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.9008; Ostroff JS, 2016, NICOTINE TOB RES, V18, P1067, DOI 10.1093/ntr/ntv177; Oxnard GR, 2014, CLIN CANCER RES, V20, P1698, DOI 10.1158/1078-0432.CCR-13-2482; Paik PK, 2015, CANCER DISCOV, V5, P842, DOI 10.1158/2159-8290.CD-14-1467; Paik PK, 2011, J CLIN ONCOL, V29, P2046, DOI 10.1200/JCO.2010.33.1280; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Park K, 2016, LANCET ONCOL, V17, P577, DOI 10.1016/S1470-2045(16)30033-X; Park K, 2016, JAMA ONCOL, V2, P305, DOI 10.1001/jamaoncol.2015.4921; Park K, 2015, J CLIN ONCOL, V33; Paz-Ares LG, 2013, J CLIN ONCOL, V31, P2895, DOI 10.1200/JCO.2012.47.1102; Perol M, 2012, J CLIN ONCOL, V30, P3516, DOI 10.1200/JCO.2011.39.9782; Pietanza MC, 2015, CLIN CANCER RES, V21, P2244, DOI 10.1158/1078-0432.CCR-14-2958; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Pinsky PF, 2015, ANN INTERN MED, V162, P485, DOI 10.7326/M14-2086; Piotrowska Z, 2015, CANCER DISCOV, V5, P713, DOI 10.1158/2159-8290.CD-15-0399; Planchard D, 2016, LANCET ONCOL, V17, P642, DOI 10.1016/S1470-2045(16)00077-2; Planchard D, 2015, J CLIN ONCOL, V33; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Quoix E, 2016, LANCET ONCOL, V17, P212, DOI 10.1016/S1470-2045(15)00483-0; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Reck M, 2014, LANCET ONCOL, V15, P143, DOI 10.1016/S1470-2045(13)70586-2; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rizvi NA, 2015, J CLIN ONCOL, V33; Rolfo C, 2014, TRANSL LUNG CANCER R, V3, P250, DOI 10.3978/j.issn.2218-6751.2014.03.01; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sadiq AA, 2013, J CLIN ONCOL, V31, P1089, DOI 10.1200/JCO.2012.43.9422; Scagliotti G, 2015, J CLIN ONCOL, V33, P2667, DOI 10.1200/JCO.2014.60.7317; Senan S, 2016, J CLIN ONCOL, V34, P953, DOI 10.1200/JCO.2015.64.8824; Sequist LV, 2015, NEW ENGL J MED, V373, P578, DOI 10.1056/NEJMc1506831; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Seto T, 2014, LANCET ONCOL, V15, P1236, DOI 10.1016/S1470-2045(14)70381-X; Seto T, 2013, LANCET ONCOL, V14, P590, DOI 10.1016/S1470-2045(13)70142-6; Shaw AT, 2016, LANCET ONCOL, V17, P234, DOI 10.1016/S1470-2045(15)00488-X; Shaw AT, 2014, NEW ENGL J MED, V371, P1963, DOI 10.1056/NEJMoa1406766; Shaw AT, 2014, NEW ENGL J MED, V370, P2537, DOI 10.1056/NEJMc1404894; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Soria JC, 2015, ANN ONCOL, V26; Soria JC, 2015, LANCET ONCOL, V16, P990, DOI 10.1016/S1470-2045(15)00121-7; Stahel RA, 2015, EUR J CANCER, V51, pS711, DOI 10.1016/S0959-8049(15)30068-X; Tan DSW, 2016, J THORAC ONCOL, V11, P946, DOI 10.1016/j.jtho.2016.05.008; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Tsao AS, 2016, J THORAC ONCOL, V11, P613, DOI 10.1016/j.jtho.2016.03.012; Vansteenkiste J, 2014, ANN ONCOL, V25, P1462, DOI 10.1093/annonc/mdu089; Vansteenkiste JF, 2016, LANCET ONCOL, V17, P822, DOI 10.1016/S1470-2045(16)00099-1; Villanti AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071379; Wakelee HA, 2015, WORLD C LUNG CANC DE; Wang R, 2012, J CLIN ONCOL, V30, P4352, DOI 10.1200/JCO.2012.44.1477; Weickhardt AJ, 2012, J THORAC ONCOL, V7, P1807, DOI 10.1097/JTO.0b013e3182745948; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Westeel F, 2005, JNCI-J NATL CANCER I, V97, P499, DOI 10.1093/jnci/dji096; Wu YL, 2015, ANN ONCOL, V26, P1883, DOI 10.1093/annonc/mdv270; Wu YL, 2013, LANCET ONCOL, V14, P777, DOI 10.1016/S1470-2045(13)70254-7; Yang JCH, 2015, LANCET ONCOL, V16, P830, DOI 10.1016/S1470-2045(15)00026-1; Yang JJ, 2013, LUNG CANCER, V79, P33, DOI 10.1016/j.lungcan.2012.09.016; Yankelevitz DF, 2015, RADIOLOGY, V277, P555, DOI 10.1148/radiol.2015142554; Yoshizawa A, 2011, MODERN PATHOL, V24, P653, DOI 10.1038/modpathol.2010.232; Zeng QB, 2015, J MED CHEM, V58, P8200, DOI 10.1021/acs.jmedchem.5b01073; Zhang XJ, 2011, CHEST, V140, P117, DOI 10.1378/chest.10-2745; Zhao HY, 2015, J THORAC ONCOL, V10, P655, DOI 10.1097/JTO.0000000000000445; Zhou QH, 2015, THORAC CANCER, V6, P812, DOI 10.1111/1759-7714.12287; Zou HLY, 2015, P NATL ACAD SCI USA, V112, P3493, DOI 10.1073/pnas.1420785112	151	1629	1719	47	576	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 21	2017	389	10066					299	311		10.1016/S0140-6736(16)30958-8	http://dx.doi.org/10.1016/S0140-6736(16)30958-8			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI9BC	27574741				2022-12-28	WOS:000392801200032
J	Chen, WF; Hill, H; Christie, A; Kim, MS; Holloman, E; Pavia-Jimenez, A; Homayoun, F; Ma, YQ; Patel, N; Yell, P; Hao, GY; Yousuf, Q; Joyce, A; Pedrosa, I; Geiger, H; Zhang, H; Chang, J; Gardner, KH; Bruick, RK; Reeves, C; Hwang, TH; Courtney, K; Frenkel, E; Sun, XK; Zojwalla, N; Wong, T; Rizzi, JP; Wallace, EM; Josey, JA; Xie, Y; Xie, XJ; Kapur, P; McKay, RM; Brugarolas, J				Chen, Wenfang; Hill, Haley; Christie, Alana; Kim, Min Soo; Holloman, Eboni; Pavia-Jimenez, Andrea; Homayoun, Farrah; Ma, Yuanqing; Patel, Nirav; Yell, Paul; Hao, Guiyang; Yousuf, Qurratulain; Joyce, Allison; Pedrosa, Ivan; Geiger, Heather; Zhang, He; Chang, Jenny; Gardner, Kevin H.; Bruick, Richard K.; Reeves, Catherine; Hwang, Tae Hyun; Courtney, Kevin; Frenkel, Eugene; Sun, Xiankai; Zojwalla, Naseem; Wong, Tai; Rizzi, James P.; Wallace, Eli M.; Josey, John A.; Xie, Yang; Xie, Xian-Jin; Kapur, Payal; McKay, Renee M.; Brugarolas, James			Targeting renal cell carcinoma with a HIF-2 antagonist	NATURE			English	Article							HYPOXIA-INDUCIBLE FACTOR-2; PAS-B DOMAIN; TRANSCRIPTION FACTOR; HIF-2-ALPHA; INHIBITION; HIF2-ALPHA; RNA; EXPRESSION; GENE; DNA	Clear cell renal cell carcinoma (ccRCC) is characterized by inactivation of the von Hippel-Lindau tumour suppressor gene (VHL)(1,2). Because no other gene is mutated as frequently in ccRCC and VHL mutations are truncal(3), VHL inactivation is regarded as the governing event(4). VHL loss activates the HIF-2 transcription factor, and constitutive HIF-2 activity restores tumorigenesis in VHL-reconstituted ccRCC cells(5). HIF-2 has been implicated in angiogenesis and multiple other processes(6-9), but angiogenesis is the main target of drugs such as the tyrosine kinase inhibitor sunitinib(10). HIF-2 has been regarded as undruggable(11). Here we use a tumourgraft/patient-derived xenograft platform(12,13) to evaluate PT2399, a selective HIF-2 antagonist that was identified using a structure-based design approach. PT2399 dissociated HIF-2 (an obligatory heterodimer of HIF-2 alpha-HIF-1 beta)(14) in human ccRCC cells and suppressed tumorigenesis in 56% (10 out of 18) of such lines. PT2399 had greater activity than sunitinib, was active in sunitinib-progressing tumours, and was better tolerated. Unexpectedly, some VHL-mutant ccRCCs were resistant to PT2399. Resistance occurred despite HIF-2 dissociation in tumours and evidence of Hif-2 inhibition in the mouse, as determined by suppression of circulating erythropoietin, a HIF-2 target(15) and possible pharmacodynamic marker. We identified a HIF-2-dependent gene signature in sensitive tumours. Gene expression was largely unaffected by PT2399 in resistant tumours, illustrating the specificity of the drug. Sensitive tumours exhibited a distinguishing gene expression signature and generally higher levels of HIF-2 alpha. Prolonged PT2399 treatment led to resistance. We identified binding site and second site suppressor mutations in HIF-2 alpha and HIF-1 beta, respectively. Both mutations preserved HIF-2 dimers despite treatment with PT2399. Finally, an extensively pretreated patient whose tumour had given rise to a sensitive tumourgraft showed disease control for more than 11 months when treated with a close analogue of PT2399, PT2385. We validate HIF-2 as a target in ccRCC, show that some ccRCCs are HIF-2 independent, and set the stage for biomarker-driven clinical trials.	[Chen, Wenfang; Hill, Haley; Christie, Alana; Kim, Min Soo; Holloman, Eboni; Pavia-Jimenez, Andrea; Homayoun, Farrah; Ma, Yuanqing; Patel, Nirav; Yousuf, Qurratulain; Joyce, Allison; Pedrosa, Ivan; Zhang, He; Chang, Jenny; Bruick, Richard K.; Hwang, Tae Hyun; Courtney, Kevin; Frenkel, Eugene; Sun, Xiankai; Xie, Yang; Xie, Xian-Jin; Kapur, Payal; McKay, Renee M.; Brugarolas, James] Univ Texas Southwestern Med Ctr Dallas, Simmons Comprehens Canc Ctr, Kidney Canc Program, Dallas, TX 75390 USA; [Chen, Wenfang; Hill, Haley; Holloman, Eboni; Pavia-Jimenez, Andrea; Homayoun, Farrah; Ma, Yuanqing; Patel, Nirav; Yousuf, Qurratulain; Joyce, Allison; Courtney, Kevin; Frenkel, Eugene; McKay, Renee M.; Brugarolas, James] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Chen, Wenfang] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou 510080, Guangdong, Peoples R China; [Kim, Min Soo; Zhang, He; Hwang, Tae Hyun; Xie, Yang; Xie, Xian-Jin] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Yell, Paul] Parkland Hlth & Hosp Syst, Dallas, TX 75235 USA; [Hao, Guiyang; Pedrosa, Ivan; Sun, Xiankai] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Geiger, Heather; Reeves, Catherine] New York Genome Ctr, New York, NY 10013 USA; [Gardner, Kevin H.] CUNY, Adv Sci Res Ctr, Struct Biol Initiat, New York, NY 10031 USA; [Gardner, Kevin H.] CUNY, Dept Chem & Biochem, New York, NY 10031 USA; [Gardner, Kevin H.] CUNY, Grad Ctr, Biochem Chem & Biol PhD Programs, New York, NY 10016 USA; [Bruick, Richard K.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Zojwalla, Naseem; Wong, Tai; Rizzi, James P.; Wallace, Eli M.; Josey, John A.] Peloton Therapeut Inc, Dallas, TX 75235 USA; [Kapur, Payal] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Sun Yat Sen University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Brugarolas, J (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Simmons Comprehens Canc Ctr, Kidney Canc Program, Dallas, TX 75390 USA.; Brugarolas, J (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	james.brugarolas@utsouthwestern.edu	Gardner, Kevin H./K-7802-2012; Gardner, Kevin/K-5493-2019; Hao, Guiyang/D-5312-2011	Gardner, Kevin H./0000-0002-8671-2556; Christie, Alana/0000-0002-7034-818X; Kim, Min Soo/0000-0001-7035-9092; Ma, Yuanqing/0000-0002-6637-4414; Yell, Paul/0000-0002-0867-5884; Hao, Guiyang/0000-0001-6695-5123; Zhang, He/0000-0001-9198-6503; Brugarolas, James/0000-0002-8575-499X	Peloton Therapeutics, Inc. [OTD-105466]; CPRIT [RP160440, RP150596, RP110771, RP130603, RP130513]; National Natural Science Foundation of China [811011934]; Science and Technology Program of Guangzhou, China [2012J5100031]; NIH [R01CA154475, P50CA196516, R01CA175754, P30CA142543]; National Center for Advancing Translational Sciences (Center for Translational Medicine) [UL1TR001105]; NATIONAL CANCER INSTITUTE [P50CA196516, R01CA175754, P30CA142543, R01CA154475] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER	Peloton Therapeutics, Inc.; CPRIT; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guangzhou, China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences (Center for Translational Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank the patients who generously provided tissues and participated in our studies. PT2399 was provided by Peloton Therapeutics, Inc. Funding was provided by Peloton Therapeutics, Inc. (OTD-105466), CPRIT (RP160440) and philanthropy, including the Tom Green memorial. W.C. is supported by grants from the National Natural Science Foundation of China (No. 811011934) and the Science and Technology Program of Guangzhou, China (No. 2012J5100031). M.S.K. and H.Z. are supported by a grant from CPRIT (RP150596). I.P. is supported by grants from the NIH (R01CA154475, P50CA196516). X.S. is supported by a grant from CPRIT (RP110771). J.B. is a Virginia Murchison Linthicum endowed scholar and is supported by grants from the NIH (R01CA175754, P50CA196516, P30CA142543) and CPRIT (RP130603). R.K.B. is the Michael L. Rosenberg Scholar in Medical Research and was supported by CPRIT (RP130513). Histology equipment was purchased with funding from the National Center for Advancing Translational Sciences (Center for Translational Medicine UL1TR001105).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bertout JA, 2009, P NATL ACAD SCI USA, V106, P14391, DOI 10.1073/pnas.0907357106; Brugarolas J, 2014, J CLIN ONCOL, V32, P1968, DOI 10.1200/JCO.2012.45.2003; Cho H., 2016, NATURE; Courtney KD, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.2506; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Erbel PJA, 2003, P NATL ACAD SCI USA, V100, P15504, DOI 10.1073/pnas.2533374100; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Koehler AN, 2010, CURR OPIN CHEM BIOL, V14, P331, DOI 10.1016/j.cbpa.2010.03.022; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Li B, 2014, NATURE, V513, P251, DOI 10.1038/nature13557; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Pavia-Jimenez A, 2014, NAT PROTOC, V9, P1848, DOI 10.1038/nprot.2014.108; Pedrosa I, 2008, EUR RADIOL, V18, P365, DOI 10.1007/s00330-007-0757-0; Pena-Llopis S, 2013, NAT PROTOC, V8, P2240, DOI 10.1038/nprot.2013.141; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rogers JL, 2013, J MED CHEM, V56, P1739, DOI 10.1021/jm301847z; Scheuermann TH, 2013, NAT CHEM BIOL, V9, P271, DOI [10.1038/NCHEMBIO.1185, 10.1038/nchembio.1185]; Scheuermann TH, 2009, P NATL ACAD SCI USA, V106, P450, DOI 10.1073/pnas.0808092106; Sivanand S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003643; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Wallace EM, 2016, CANCER RES, V76, P5491, DOI 10.1158/0008-5472.CAN-16-0473; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wu DL, 2015, NATURE, V524, P303, DOI 10.1038/nature14883	37	398	410	6	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2016	539	7627					112	+		10.1038/nature19796	http://dx.doi.org/10.1038/nature19796			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA5OJ	27595394	Green Accepted			2022-12-28	WOS:000386670100040
J	Clark, W; Bird, P; Gonski, P; Diamond, TH; Smerdely, P; McNeil, HP; Schlaphoff, G; Bryant, C; Barnes, E; Gebski, V				Clark, William; Bird, Paul; Gonski, Peter; Diamond, Terrence H.; Smerdely, Peter; McNeil, H. Patrick; Schlaphoff, Glen; Bryant, Carl; Barnes, Elizabeth; Gebski, Val			Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double-blind, placebo-controlled trial	LANCET			English	Article							VERTEBRAL FRACTURE; PERCUTANEOUS VERTEBROPLASTY; COMPRESSION FRACTURES; RISK-FACTOR; QUESTIONNAIRE; KYPHOPLASTY; MOBILITY	Background We hypothesised that vertebroplasty provides effective analgesia for patients with poorly controlled pain and osteoporotic spinal fractures of less than 6 weeks' duration. The effectiveness of vertebroplasty, using an adequate vertebral fill technique, in fractures of less than 6 weeks' duration has not been specifically assessed by previously published masked trials. Methods This was a multicentre, randomised, double-blind, placebo-controlled trial of vertebroplasty in four hospitals in Sydney, Australia. We recruited patients with one or two osteoporotic vertebral fractures of less than 6 weeks' duration and Numeric Rated Scale (NRS) back pain greater than or equal to 7 out of 10. We used an automated telephone randomisation service provided by the National Health and Medical Research Council to assign patients (1:1; stratified according to age, degree of vertebral compression, trauma, corticosteroid use, and hospital) to either vertebroplasty or placebo, immediately before the procedure. Patients received conscious sedation. Vertebroplasty was done with the adequate vertebral fill technique and the placebo procedure with simulated vertebroplasty. Followup was for 6 months. Outcome assessors and patients were masked to treatment allocation. The primary outcome was the proportion of patients with NRS pain below 4 out of 10 at 14 days post-intervention in the intention-to-treat population. This study is registered with ClinicalTrials.gov, number NCT01482793. Findings Between Nov 4, 2011, and Dec 5, 2014, 120 patients were enrolled. 61 patients were randomly assigned to vertebroplasty and 59 to placebo. 24 (44%) patients in the vertebroplasty group and 12 (21%) in the control group had an NRS pain score below 4 out of 10 at 14 days (between-group difference 23 percentage points, 95% CI 6-39; p = 0.011). Three patients in each group died from causes judged unrelated to the procedure. There were two serious adverse events in each group, related to the procedure (vertebroplasty group) and the fracture (control group). Interpretation Vertebroplasty is superior to placebo intervention for pain reduction in patients with acute osteoporotic spinal fractures of less than 6 weeks' in duration. These findings will allow patients with acute painful fractures to have an additional means of pain management that is known to be effective.	[Bird, Paul; Diamond, Terrence H.] Univ New South Wales, St George & Sutherland Clin Sch, Sydney, NSW, Australia; [Gonski, Peter; Smerdely, Peter] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Schlaphoff, Glen] Univ New South Wales, South Western Sydney Clin Sch, Sydney, NSW, Australia; [Gonski, Peter] Sutherland Hosp, Dept Aged Care, Caringbah, NSW, Australia; [Diamond, Terrence H.] St George Hosp, Dept Endocrinol, Kogarah, NSW, Australia; [Smerdely, Peter] St George Hosp, Dept Aged Care, Kogarah, NSW, Australia; [McNeil, H. Patrick] Macquarie Univ, Fac Med & Hlth Sci, Sydney, NSW, Australia; [Schlaphoff, Glen] Liverpool Hosp, Dept Intervent Radiol, Liverpool, NSW, Australia; [Clark, William; Bryant, Carl] St George Private Hosp, Dept Radiol, Kogarah, NSW, Australia; [Barnes, Elizabeth; Gebski, Val] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; St George Hospital; St George Hospital; Macquarie University; Liverpool Hospital; University of Sydney	Clark, W (corresponding author), St George Private Hosp, Dept Intervent Radiol, Kogarah, NSW, Australia.	williamxrayclark@bigpond.com	Smerdely, Peter/I-4405-2019	Smerdely, Peter/0000-0003-4651-5846; McNeil, Hugh Patrick/0000-0003-4336-2960; Bird, Paul/0000-0002-2277-8337; Gebski, Val/0000-0001-8748-1844	CareFusion Corporation	CareFusion Corporation	The study was funded by an unrestricted research grant from CareFusion Corporation. We thank the patients, their partners, and families. We thank the researchers from Optimus Clinical Research. We thank the interventional radiology nurses and radiographers in the interventional radiology departments. We extend special thanks to L McGuigan (safety monitoring committee), C Dedousis, D Glenn, A Goh, P J Papantoniou, and T Harrington for their participation as investigators in the trial. We thank L Buizen for his work on the statistical analysis.	Boszczyk B, 2010, EUR SPINE J, V19, P1837, DOI 10.1007/s00586-010-1525-4; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Buchbinder R, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006349.pub2; Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429; Clark W, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0671-8; Dohm M, 2014, AM J NEURORADIOL, V35, P2227, DOI 10.3174/ajnr.A4127; Doidge J, 2011, REV INTERIM FUNDED S; Evans AJ, 2016, J NEUROINTERV SURG, V8, DOI 10.1136/neurintsurg-2015-011811; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Goldstein CL, 2015, NEUROSURGERY, V77, pS33, DOI 10.1227/NEU.0000000000000947; Gu CN, 2016, J NEUROINTERV SURG, V8, P636, DOI 10.1136/neurintsurg-2015-011714; Han SL, 2015, OSTEOPOROSIS INT, V26, P113, DOI 10.1007/s00198-014-2848-5; JACOBSEN SJ, 1992, EPIDEMIOLOGY, V3, P515, DOI 10.1097/00001648-199211000-00009; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563; Klazen CAH, 2010, AM J NEURORADIOL, V31, P1447, DOI 10.3174/ajnr.A2148; Klazen CAH, 2010, LANCET, V376, P1085, DOI 10.1016/S0140-6736(10)60954-3; Kroon F, 2014, J BONE MINER RES, V29, P1346, DOI 10.1002/jbmr.2157; Lips P, 1999, OSTEOPOROSIS INT, V10, P150, DOI 10.1007/s001980050210; Liu JT, 2010, OSTEOPOROSIS INT, V21, P359, DOI 10.1007/s00198-009-0952-8; McKiernan F, 2003, ARTHRITIS RHEUM-US, V48, P1414, DOI 10.1002/art.10984; McKiernan F, 2003, J BONE MINER RES, V18, P24, DOI 10.1359/jbmr.2003.18.1.24; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Roland M, 2000, SPINE, V25, P3115, DOI 10.1097/00007632-200012150-00006; Rousing R, 2010, SPINE, V35, P478, DOI 10.1097/BRS.0b013e3181b71bd1; Rousing Rikke, 2009, Spine (Phila Pa 1976), V34, P1349, DOI 10.1097/BRS.0b013e3181a4e628; Staples MP, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3952; Wardlaw D, 2009, LANCET, V373, P1016, DOI 10.1016/S0140-6736(09)60010-6; Wilson DJ, 2011, EUR RADIOL, V21, P1772, DOI 10.1007/s00330-011-2115-5	30	207	228	4	48	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2016	388	10052					1408	1416		10.1016/S0140-6736(16)31341-1	http://dx.doi.org/10.1016/S0140-6736(16)31341-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DX5FD	27544377				2022-12-28	WOS:000384404300035
J	Frobisch, NB				Froebisch, Nadia B.			Teenage tetrapods	NATURE			English	Editorial Material							DEVELOPMENTAL PLASTICITY; ORIGIN		[Froebisch, Nadia B.] Museum Nat Kunde, Leibniz Inst Evolut & Biodivers Sci, D-10115 Berlin, Germany	Leibniz Institut fur Evolutions und Biodiversitatsforschung	Frobisch, NB (corresponding author), Museum Nat Kunde, Leibniz Inst Evolut & Biodivers Sci, D-10115 Berlin, Germany.	nadia.froebisch@mfn-berlin.de						Clack J. A., 2012, GAINING GROUND ORIGI; Frobisch NB, 2010, SEMIN CELL DEV BIOL, V21, P424, DOI 10.1016/j.semcdb.2009.11.001; Moczek AP, 2011, P ROY SOC B-BIOL SCI, V278, P2705, DOI 10.1098/rspb.2011.0971; Sanchez S, 2016, NATURE, V537, P408, DOI 10.1038/nature19354; Schneider I, 2013, TRENDS GENET, V29, P419, DOI 10.1016/j.tig.2013.01.012; Schoch RR, 2009, EVOLUTION, V63, P2738, DOI 10.1111/j.1558-5646.2009.00769.x; Schoch RR, 2009, ANNU REV EARTH PL SC, V37, P135, DOI 10.1146/annurev.earth.031208.100113; Standen EM, 2014, NATURE, V513, P54, DOI 10.1038/nature13708; Urban MC, 2014, EVOL APPL, V7, P88, DOI 10.1111/eva.12114; West-Eberhard Mary Jane, 2003, pi; Whiteman HH, 2012, OECOLOGIA, V168, P109, DOI 10.1007/s00442-011-2076-z	11	0	0	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2016	537	7620					311	312		10.1038/nature19432	http://dx.doi.org/10.1038/nature19432			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV7EC	27602516				2022-12-28	WOS:000383098000034
J	Bender, E				Bender, Eric			Industrial strength	NATURE			English	Editorial Material																			0	24	29	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					S57	S59		10.1038/537S57a	http://dx.doi.org/10.1038/537S57a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU9LQ	27602741	Bronze			2022-12-28	WOS:000382539100002
J	Sullivan, CT				Sullivan, Charles T.			Opioid Prescribing After Nonfatal Overdose and Association With Repeated Overdose	ANNALS OF INTERNAL MEDICINE			English	Letter									[Sullivan, Charles T.] North Florida South Georgia Vet Hlth Syst, Gainesville, FL 32608 USA		Sullivan, CT (corresponding author), North Florida South Georgia Vet Hlth Syst, Gainesville, FL 32608 USA.							Beyersmann J, 2006, AM STAT, V60, P295; Larochelle MR, 2016, ANN INTERN MED, V164, P1, DOI 10.7326/M15-0038; Vigen R, 2013, JAMA-J AM MED ASSOC, V310, P1829, DOI 10.1001/jama.2013.280386	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2016	165	5					376	376		10.7326/L16-0169	http://dx.doi.org/10.7326/L16-0169			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3BC	27595219				2022-12-28	WOS:000382795000010
J	Whitehead, KJ; Sautter, NB; McWilliams, JP; Chakinala, MM; Merlo, CA; Johnson, MH; James, M; Everett, EM; Clancy, MS; Faughnan, ME; Oh, SP; Olitsky, SE; Pyeritz, RE; Gossage, JR				Whitehead, Kevin J.; Sautter, Nathan B.; McWilliams, Justin P.; Chakinala, Murali M.; Merlo, Christian A.; Johnson, Maribeth H.; James, Melissa; Everett, Eric M.; Clancy, Marianne S.; Faughnan, Marie E.; Oh, S. Paul; Olitsky, Scott E.; Pyeritz, Reed E.; Gossage, James R.			Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOUBLE-BLIND; TRANEXAMIC ACID; SEVERITY SCORE; NASAL-MUCOSA; BEVACIZUMAB; MANAGEMENT	IMPORTANCE Epistaxis is a major factor negatively affecting quality of life in patients with hereditary hemorrhagic telangiectasia (HHT; also known as Osler-Weber-Rendu disease). Optimal treatment for HHT-related epistaxis is uncertain. OBJECTIVE To determine whether topical therapy with any of 3 drugs with differing mechanisms of action is effective in reducing HHT-related epistaxis. DESIGN, SETTING, AND PARTICIPANTS The North American Study of Epistaxis in HHT was a double-blind, placebo-controlled randomized clinical trial performed at 6 HHT centers of excellence. From August 2011 through March 2014, there were 121 adult patients who met the clinical criteria for HHT and had experienced HHT-related epistaxis with an Epistaxis Severity Score of at least 3.0. Follow-up was completed in September 2014. INTERVENTIONS Patients received twice-daily nose sprays for 12 weeks with either bevacizumab 1% (4mg/d), estriol 0.1% (0.4mg/d), tranexamic acid 10% (40mg/d), or placebo (0.9% saline). MAIN OUTCOMES AND MEASURES The primary outcome was median weekly epistaxis frequency during weeks 5 through 12. Secondary outcomes included median duration of epistaxis during weeks 5 through 12, Epistaxis Severity Score, level of hemoglobin, level of ferritin, need for transfusion, emergency department visits, and treatment failure. RESULTS Among the 121 patients who were randomized (mean age, 52.8 years [SD, 12.9 years]; 44% women with a median of 7.0 weekly episodes of epistaxis [interquartile range {IQR}, 3.0-14.0]), 106 patients completed the study duration for the primary outcome measure (43 were women [41%]). Drug therapy did not significantly reduce epistaxis frequency (P = .97). After 12 weeks of treatment, the median weekly number of bleeding episodes was 7.0 (IQR, 4.5-10.5) for patients in the bevacizumab group, 8.0 (IQR, 4.0-12.0) for the estriol group, 7.5 (IQR, 3.0-11.0) for the tranexamic acid group, and 8.0 (IQR, 3.0-14.0) for the placebo group. No drug treatment was significantly different from placebo for epistaxis duration. All groups had a significant improvement in Epistaxis Severity Score at weeks 12 and 24. There were no significant differences between groups for hemoglobin level, ferritin level, treatment failure, need for transfusion, or emergency department visits. CONCLUSIONS AND RELEVANCE Among patients with HHT, there were no significant between-group differences in the use of topical intranasal treatment with bevacizumab vs estriol vs tranexamic acid vs placebo and epistaxis frequency.	[Whitehead, Kevin J.] Univ Utah, Utah HHT Ctr Excellence, Div Cardiovasc Med & Pediat Cardiol, Salt Lake City, UT USA; [Whitehead, Kevin J.] George E Wahlen Vet Affairs Med Ctr, Salt Lake City, UT USA; [Sautter, Nathan B.] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Oregon Sinus Ctr, Portland, OR 97201 USA; [McWilliams, Justin P.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA HHT Ctr Excellence, Div Intervent Radiol,Dept Radiol, Los Angeles, CA 90095 USA; [Chakinala, Murali M.] Washington Univ, Sch Med, Div Pulm & Crit Care, St Louis, MO USA; [Merlo, Christian A.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care, Baltimore, MD USA; [Johnson, Maribeth H.] Augusta Univ, Dept Biostat & Epidemiol, Augusta, GA USA; [James, Melissa; Gossage, James R.] Augusta Univ, Div Pulm & Crit Care Med, Augusta, GA USA; [Everett, Eric M.] OBrien Pharm, Mission, KS USA; [Clancy, Marianne S.] Cure HHT, Monkton, MD USA; [Faughnan, Marie E.] Univ Toronto, St Michaels Hosp, Dept Med, Toronto HHT Program,Div Respirol, Toronto, ON, Canada; [Faughnan, Marie E.] St Michaels Hosp, Keenan Res Ctr, Toronto, ON, Canada; [Faughnan, Marie E.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Oh, S. Paul] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL USA; [Olitsky, Scott E.] Childrens Mercy Hosp, Dept Ophthalmol, Kansas City, MO 64108 USA; [Pyeritz, Reed E.] Univ Penn, Perelman Sch Med, Div Translat Med & Human Genet, Philadelphia, PA 19104 USA	Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Oregon Health & Science University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Washington University (WUSTL); Johns Hopkins University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; State University System of Florida; University of Florida; Children's Mercy Hospital; University of Pennsylvania; Pennsylvania Medicine	Whitehead, KJ (corresponding author), Univ Utah, Utah HHT Ctr Excellence, 30 N 1900 E, Salt Lake City, UT 84132 USA.	kevin.whitehead@hsc.utah.edu			Cure HHT, a nonprofit patient organization	Cure HHT, a nonprofit patient organization	The North American Study of Epistaxis in HHT (NOSE) trial was funded by Cure HHT, a nonprofit patient organization supporting the HHT community.	Bergler W, 2002, ANN OTO RHINOL LARYN, V111, P222, DOI 10.1177/000348940211100306; Bose P, 2009, NEW ENGL J MED, V360, P2143, DOI 10.1056/NEJMc0901421; Boyer H, 2015, INT FORUM ALLERGY RH, V5, P435, DOI 10.1002/alr.21484; Davidson TM, 2010, LARYNGOSCOPE, V120, P432, DOI 10.1002/lary.20757; Dupuis-Girod S, 2014, MABS-AUSTIN, V6, P793, DOI 10.4161/mabs.28025; Faughnan ME, 2011, J MED GENET, V48, P73, DOI 10.1136/jmg.2009.069013; Fernandez-L A, 2007, THROMB HAEMOSTASIS, V97, P254, DOI 10.1160/TH06-07-0373; Flieger D, 2006, ANN HEMATOL, V85, P631, DOI 10.1007/s00277-006-0147-8; Folz BJ, 2005, AM J RHINOL, V19, P65, DOI 10.1177/194589240501900111; Gaillard S, 2014, J THROMB HAEMOST, V12, P1494, DOI 10.1111/jth.12654; Geisthoff UW, 2007, OTOLARYNG HEAD NECK, V136, P726, DOI 10.1016/j.otohns.2006.12.019; Geisthoff UW, 2014, THROMB RES, V134, P565, DOI 10.1016/j.thromres.2014.06.012; Hoag JB, 2010, LARYNGOSCOPE, V120, P838, DOI 10.1002/lary.20818; McDonald J, 2011, GENET MED, V13, P607, DOI 10.1097/GIM.0b013e3182136d32; Riss D, 2015, HEAD NECK-J SCI SPEC, V37, P783, DOI 10.1002/hed.23655; Sadick H, 2005, ARCH MED RES, V36, P468, DOI 10.1016/j.arcmed.2005.03.037; Samson G, 2012, EUR J PHARM BIOPHARM, V80, P465, DOI 10.1016/j.ejpb.2011.11.004; Sautter NB, 2012, INT FORUM ALLERGY RH, V2, P422, DOI 10.1002/alr.21046; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Simonds J, 2009, LARYNGOSCOPE, V119, P988, DOI 10.1002/lary.20159; Suppressa Patrizia, 2011, Br J Haematol, V152, P365, DOI 10.1111/j.1365-2141.2010.08481.x; Suppressa P, 2011, BRIT J HAEMATOL, V154, P156, DOI 10.1111/j.1365-2141.2011.08767.x; Thompson AB, 2014, ALLERGY RHINOL, V5, pE91, DOI 10.2500/ar.2014.5.0091; VASE P, 1981, ACTA MED SCAND, V209, P393; Yaniv E, 2009, LARYNGOSCOPE, V119, P284, DOI 10.1002/lary.20065; Yin LDX, 2016, LARYNGOSCOPE, V126, P1029, DOI 10.1002/lary.25669	26	54	56	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2016	316	9					943	951		10.1001/jama.2016.11724	http://dx.doi.org/10.1001/jama.2016.11724			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU8JV	27599329	Bronze			2022-12-28	WOS:000382460200017
J	Fidler, MM; Reulen, RC; Winter, DL; Kelly, J; Jenkinson, HC; Skinner, R; Frobisher, C; Hawkins, MM				Fidler, Miranda M.; Reulen, Raoul C.; Winter, David L.; Kelly, Julie; Jenkinson, Helen C.; Skinner, Rod; Frobisher, Clare; Hawkins, Michael M.		British Childhood Canc Survivor	Long term cause specific mortality among 34489 five year survivors of childhood cancer in Great Britain: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE; HEALTH OUTCOMES; LATE DEATHS; ADOLESCENT; CARDIOTOXICITY; EXPERIENCE; CHILDREN; RISK; AML	OBJECTIVE To determine whether modern treatments for cancer are associated with a net increased or decreased risk of death from neoplastic and non-neoplastic causes among survivors of childhood cancer. DESIGN Population based cohort study. SETTING British Childhood Cancer Survivor Study. PARTICIPANTS Nationwide population based cohort of 34489 five year survivors of childhood cancer with a diagnosis from 1940 to 2006 and followed up until 28 February 2014. MAIN OUTCOME MEASURES Cause specific standardised mortality ratios and absolute excess risks are reported. Multivariable Poisson regression models were utilised to evaluate the simultaneous effect of risk factors. Likelihood ratio tests were used to test for heterogeneity or trend. RESULTS Overall, 4475 deaths were observed, which was 9.1 (95% confidence interval 8.9 to 9.4) times that expected in the general population, corresponding to 64.2 (95% confidence interval 62.1 to 66.3) excess deaths per 10 000 person years. The number of excess deaths from all causes declined among those treated more recently; those treated during 1990-2006 experienced 30% of the excess number of deaths experienced by those treated before 1970. The corresponding percentages for the decline in excess deaths from recurrence or progression and nonneoplastic causes were 30% and 60%, respectively. Among survivors aged 50-59 years, 41% and 22% of excess deaths were attributable to subsequent primary neoplasms and circulatory conditions, respectively, whereas the corresponding percentages among those aged 60 years or more were 31% and 37%. CONCLUSIONS The net effects of changes in cancer treatments, and surveillance and management for late effects, over the period 1940 to 2006 was to reduce the excess number of deaths from both recurrence or progression and non-neoplastic causes among those treated more recently. Among survivors aged 60 years or more, the excess number of deaths from circulatory causes exceeds the excess number of deaths from subsequent primary neoplasms. The important message for the evidence based surveillance aimed at preventing excess mortality and morbidity in survivors aged 60 years or more is that circulatory disease overtakes subsequent primary neoplasms as the leading cause of excess mortality.	[Fidler, Miranda M.; Reulen, Raoul C.; Winter, David L.; Kelly, Julie; Frobisher, Clare; Hawkins, Michael M.] Univ Birmingham, Ctr Childhood Canc Survivor Studies, Inst Appl Hlth Res, Birmingham B15 2TT, W Midlands, England; [Jenkinson, Helen C.] NHS Fdn Trust, Birmingham Childrens Hosp, Dept Oncol, Birmingham, W Midlands, England; [Skinner, Rod] Royal Victoria Infirm, Great North Childrens Hosp, Dept Paediat & Adolescent Haematol & Oncol, Newcastle Upon Tyne, Tyne & Wear, England; [Skinner, Rod] Royal Victoria Infirm, Great North Childrens Hosp, Childrens BMT Unit, Newcastle Upon Tyne, Tyne & Wear, England	University of Birmingham; Oxford University Hospitals NHS Foundation Trust; University of Birmingham; Newcastle University - UK; Newcastle University - UK	Hawkins, MM (corresponding author), Univ Birmingham, Ctr Childhood Canc Survivor Studies, Inst Appl Hlth Res, Birmingham B15 2TT, W Midlands, England.	m.m.hawkins@bham.ac.uk	Frobisher, Clare/AAC-5728-2020; Reulen, Raoul/AAO-1033-2020	Frobisher, Clare/0000-0003-1099-163X; Reulen, Raoul/0000-0002-7328-0467; Fidler-Benaoudia, Miranda/0000-0001-9594-9881; Kelly, Julie S/0000-0003-1155-735X	Cancer Research UK [C386/A10422]; PanCareSurFup from the European 7th Framework Programme	Cancer Research UK(Cancer Research UK); PanCareSurFup from the European 7th Framework Programme	This work was supported by grant number C386/A10422 from Cancer Research UK, and PanCareSurFup from the European 7th Framework Programme. Neither funder had a role in the study design; collection, analysis, interpretation of the data; writing of the report; or in the decision to submit the article for publication.	Abid SH, 2001, CURR OPIN ONCOL, V13, P242, DOI 10.1097/00001622-200107000-00006; Adams MJ, 2003, SEMIN RADIAT ONCOL, V13, P346, DOI 10.1016/S1053-4296(03)00026-2; [Anonymous], STAT 13 1; Armstrong GT, 2016, NEW ENGL J MED, V374, P833, DOI 10.1056/NEJMoa1510795; Armstrong GT, 2010, J CLIN ONCOL, V28, P1224, DOI 10.1200/JCO.2009.24.4608; Bowers DC, 2006, J CLIN ONCOL, V24, P5277, DOI 10.1200/JCO.2006.07.2884; Breslow N E, 1987, IARC Sci Publ, P1; Brewster DH, 2013, EUR J CANCER, V49, P3274, DOI 10.1016/j.ejca.2013.05.004; Cardous-Ubbink MC, 2004, PEDIATR BLOOD CANCER, V42, P563, DOI 10.1002/pbc.20028; Dama E, 2006, HAEMATOLOGICA, V91, P1084; Devis T, 1999, OFFICE NATL STAT; Garwicz S, 2012, INT J CANCER, V131, P1659, DOI 10.1002/ijc.27393; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Gibson BES, 2005, LEUKEMIA, V19, P2130, DOI 10.1038/sj.leu.2403924; Gupta M, 2002, PEDIATR HEMAT ONCOL, V19, P533, DOI 10.1080/08880010290097387; HAWKINS MM, 1990, ARCH DIS CHILD, V65, P1356, DOI 10.1136/adc.65.12.1356; Hudson MM, 2013, JAMA-J AM MED ASSOC, V309, P2371, DOI 10.1001/jama.2013.6296; Hudson MM, 1997, J CLIN ONCOL, V15, P2205, DOI 10.1200/JCO.1997.15.6.2205; Kremer LCM, 2002, ANN ONCOL, V13, P819, DOI 10.1093/annonc/mdf167; Krischer JP, 1997, J CLIN ONCOL, V15, P1544, DOI 10.1200/JCO.1997.15.4.1544; Kroll ME, 2011, BRIT J CANCER, V104, P1227, DOI 10.1038/bjc.2011.70; LI FP, 1978, J PEDIATR-US, V93, P185, DOI 10.1016/S0022-3476(78)80492-2; Lie SO, 2005, LEUKEMIA, V19, P2090, DOI 10.1038/sj.leu.2403962; MacArthur AC, 2007, PEDIATR BLOOD CANCER, V48, P460, DOI 10.1002/pbc.20922; Mertens AC, 2002, CANCER, V95, P2431, DOI 10.1002/cncr.10978; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; Messite J, 1996, JAMA-J AM MED ASSOC, V275, P794, DOI 10.1001/jama.275.10.794; Moller TR, 2001, J CLIN ONCOL, V19, P3173; Ness KK, 2007, ANNU REV PUBL HEALTH, V28, P279, DOI 10.1146/annurev.publhealth.28.021406.144049; NICHOLSON HS, 1994, CANCER, V73, P3094; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Office for National Statistics, 2012, SERIES DR; Office for National Statistics, 2012, DEATH CERT REF CAS S; Packer RJ, 2003, J CLIN ONCOL, V21, P3255, DOI 10.1200/JCO.2003.01.202; Reulen RC, 2010, JAMA-J AM MED ASSOC, V304, P172, DOI 10.1001/jama.2010.923; Sehdev AES, 2001, ARCH INTERN MED, V161, P277, DOI 10.1001/archinte.161.2.277; Stiller C., 2007, CHILDHOOD CANCER IN, DOI [10.1093/acprof:oso/9780198520702.001.0001., DOI 10.1093/ACPROF:OSO/9780198520702.001.0001]; SWERDLOW AJ, 1989, BRIT J CANCER, V59, P787, DOI 10.1038/bjc.1989.164; van der Pal HJH, 2005, CANCER TREAT REV, V31, P173, DOI 10.1016/j.ctrv.2005.03.008	39	73	73	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2016	354								i4351	10.1136/bmj.i4351	http://dx.doi.org/10.1136/bmj.i4351			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AE	27586237	Green Published, hybrid			2022-12-28	WOS:000382792600002
J	Lucia, A; Ramirez, M				Lucia, Alejandro; Ramirez, Manuel			Muscling In on Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EXERCISE; GROWTH		[Lucia, Alejandro] European Univ & Res Inst, Hosp 12 Octubre, Madrid, Spain; [Ramirez, Manuel] Childrens Hosp Nino Jesus, Oncohematol Dept, Madrid, Spain	Hospital Universitario 12 de Octubre	Lucia, A (corresponding author), European Univ & Res Inst, Hosp 12 Octubre, Madrid, Spain.		Ramirez, Manuel/H-7710-2015	Ramirez, Manuel/0000-0003-0332-6973; Lucia, Alejandro/0000-0002-5565-0997				Aoi W, 2013, GUT, V62, P882, DOI 10.1136/gutjnl-2011-300776; Garatachea N, 2014, MAYO CLIN PROC, V89, P1195, DOI 10.1016/j.mayocp.2014.06.004; Hojman P, 2011, AM J PHYSIOL-ENDOC M, V301, pE504, DOI 10.1152/ajpendo.00520.2010; Pedersen L, 2016, CELL METAB, V23, P554, DOI 10.1016/j.cmet.2016.01.011; Stone RL, 2012, NEW ENGL J MED, V366, P610, DOI 10.1056/NEJMoa1110352; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324	6	34	34	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2016	375	9					892	894		10.1056/NEJMcibr1606456	http://dx.doi.org/10.1056/NEJMcibr1606456			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU9HA	27579642				2022-12-28	WOS:000382526000017
J	Maksym, T				Maksym, Ted			Southern Ocean freshened by sea ice	NATURE			English	Editorial Material							CLIMATE-CHANGE; TRENDS		[Maksym, Ted] Woods Hole Oceanog Inst, Appl Ocean Phys & Engn Dept, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Maksym, T (corresponding author), Woods Hole Oceanog Inst, Appl Ocean Phys & Engn Dept, Woods Hole, MA 02543 USA.	tmaksym@whoi.edu						Abernathey RP, 2016, NAT GEOSCI, V9, P596, DOI [10.1038/ngeo2749, 10.1038/NGEO2749]; Boning CW, 2008, NAT GEOSCI, V1, P864, DOI 10.1038/ngeo362; de Lavergne C, 2014, NAT CLIM CHANGE, V4, P278, DOI [10.1038/nclimate2132, 10.1038/NCLIMATE2132]; Frolicher TL, 2015, J CLIMATE, V28, P862, DOI 10.1175/JCLI-D-14-00117.1; Helm KP, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044222; Hobbs WR, 2016, GLOBAL PLANET CHANGE, V143, P228, DOI 10.1016/j.gloplacha.2016.06.008; Holland PR, 2012, NAT GEOSCI, V5, P872, DOI [10.1038/ngeo1627, 10.1038/NGEO1627]; Jacobs SS, 2010, J CLIMATE, V23, P4508, DOI 10.1175/2010JCLI3284.1; Kurtz NT, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008141; Naumann F. A., 2016, NATURE, V537, P89; Parkinson CL, 2012, CRYOSPHERE, V6, P871, DOI 10.5194/tc-6-871-2012; Purkey SG, 2013, J CLIMATE, V26, P6105, DOI 10.1175/JCLI-D-12-00834.1; Wong APS, 1999, NATURE, V400, P440, DOI 10.1038/22733; Worby AP, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004254	14	2	3	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					40	41		10.1038/537040a	http://dx.doi.org/10.1038/537040a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU7XC	27582217				2022-12-28	WOS:000382426900031
J	Stempel, DA; Szefler, SJ; Pedersen, S; Zeiger, RS; Yeakey, AM; Lee, LA; Liu, AH; Mitchell, H; Kral, KM; Raphiou, IH; Prillaman, BA; Buaron, KS; Kirby, SY; Pascoe, SJ				Stempel, David A.; Szefler, Stanley J.; Pedersen, Soren; Zeiger, Robert S.; Yeakey, Anne M.; Lee, Laurie A.; Liu, Andrew H.; Mitchell, Herman; Kral, Kenneth M.; Raphiou, Ibrahim H.; Prillaman, Barbara A.; Buaron, Kathleen S.; Kirby, Suyong Yun; Pascoe, Steven J.		VESTRI Investigators	Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BETA-AGONISTS; MORTALITY; THERAPY; RISKS; DEATH	BACKGROUND Long-acting beta-agonists (LABAs) have been shown to increase the risk of asthma-related death among adults and the risk of asthma-related hospitalization among children. It is unknown whether the concomitant use of inhaled glucocorticoids with LABAs mitigates those risks. This trial prospectively evaluated the safety of the LABA salmeterol, added to fluticasone propionate, in a fixed-dose combination in children. METHODS We randomly assigned, in a 1: 1 ratio, children 4 to 11 years of age who required daily asthma medications and had a history of asthma exacerbations in the previous year to receive fluticasone propionate plus salmeterol or fluticasone alone for 26 weeks. The primary safety end point was the first serious asthma-related event (death, endotracheal intubation, or hospitalization), as assessed in a time-to-event analysis. The statistical design specified that noninferiority would be shown if the upper boundary of the 95% confidence interval of the hazard ratio for the primary safety end point was less than 2.675. The main efficacy end point was the first severe asthma exacerbation that led to treatment with systemic glucocorticoids, as assessed in a time-to-event analysis. RESULTS Among the 6208 patients, 27 patients in the fluticasone-salmeterol group and 21 in the fluticasone-alone group had a serious asthma-related event (all were hospitalizations); the hazard ratio with fluticasone-salmeterol versus fluticasone alone was 1.28 (95% confidence interval [CI], 0.73 to 2.27), which showed the noninferiority of fluticasone-salmeterol (P = 0.006). A total of 265 patients (8.5%) in the fluticasone-salmeterol group and 309 (10.0%) in the fluticasone-alone group had a severe asthma exacerbation (hazard ratio, 0.86; 95% CI, 0.73 to 1.01). CONCLUSIONS In this trial involving children with asthma, salmeterol in a fixed-dose combination with fluticasone was associated with the risk of a serious asthma-related event that was similar to the risk with fluticasone alone. (Funded by GlaxoSmithKline; VESTRI ClinicalTrials.gov number, NCT01462344.)	[Stempel, David A.; Yeakey, Anne M.; Lee, Laurie A.; Raphiou, Ibrahim H.; Buaron, Kathleen S.; Kirby, Suyong Yun; Pascoe, Steven J.] GlaxoSmithKline, Resp Clin Dev, 5 Moore Dr,POB 13398, Res Triangle Pk, NC 27709 USA; [Kral, Kenneth M.] GlaxoSmithKline, Res & Dev, Clin Platforms & Sci, Clin Stat, Res Triangle Pk, NC USA; [Mitchell, Herman] Rho, Chapel Hill, NC USA; [Prillaman, Barbara A.] Parexel Internatl, Biostat, Durham, NC USA; [Szefler, Stanley J.; Liu, Andrew H.] Childrens Hosp Colorado, Dept Pediat, Breathing Inst, Pediat Pulm Sect, Aurora, CO USA; [Szefler, Stanley J.; Liu, Andrew H.] Univ Colorado, Sch Med, Aurora, CO USA; [Pedersen, Soren] Fredericia & Kolding Hosp, Ctr Lillebaelt, Dept Pediat, Odense, Denmark; [Zeiger, Robert S.] Kaiser Permanente Res, Dept Allergy & Res & Evaluat, San Diego, CA USA	GlaxoSmithKline; GlaxoSmithKline; Rho; Parexel International; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Kolding Hospital	Stempel, DA (corresponding author), GlaxoSmithKline, Resp Clin Dev, 5 Moore Dr,POB 13398, Res Triangle Pk, NC 27709 USA.	david.a.stempel@gsk.com	La Grutta, Stefania/N-3615-2014; Craiu, Mihai C/V-5025-2017; Kryuchko, T. A./W-4506-2017; Bullens, Dominique M A/T-6211-2017	La Grutta, Stefania/0000-0001-8026-0715; Craiu, Mihai C/0000-0001-6194-6797; Kryuchko, T. A./0000-0002-5034-4181; Bullens, Dominique M A/0000-0002-4595-9579; Barkai, Laszlo Lajos/0000-0003-2970-3263; /0000-0002-8537-9165; Pavlov, Neven/0000-0002-3580-4020; Teper, Alejandro/0000-0002-7835-9713; Szefler, Stanley/0000-0002-6911-3199; Zeiger, Robert/0000-0001-5788-5063; Seddon, Paul/0000-0003-2136-958X; Bozek, Andrzej/0000-0003-2263-2263; Robinson, Paul/0000-0001-7397-105X	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	Funded by GlaxoSmithKline; VESTRI ClinicalTrials.gov number, NCT01462344.	[Anonymous], [No title captured]; [Anonymous], 2014, PRESCR INF ADV DISK; [Anonymous], 2007, CYT E 5 US MAN; Bauman LJ, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.e6; CASTLE W, 1993, BRIT MED J, V306, P1034, DOI 10.1136/bmj.306.6884.1034; CRANE J, 1989, LANCET, V1, P917; Drazen JM, 2009, NEW ENGL J MED, V360, P1671, DOI 10.1056/NEJMe0902057; ERNST P, 1993, AM REV RESPIR DIS, V148, P75, DOI 10.1164/ajrccm/148.1.75; Global Initiative for Asthma, 2021, GLOB STRAT ASTHM MAN; Jennison C, 2000, GROUP SEQUENTIAL MET; Lemanske RF, 2010, NEW ENGL J MED, V362, P975, DOI 10.1056/NEJMoa1001278; Liu AH, 2007, J ALLERGY CLIN IMMUN, V119, P817, DOI 10.1016/j.jaci.2006.12.662; McMahon AW, 2011, PEDIATRICS, V128, pE1147, DOI 10.1542/peds.2010-1720; Moorman J.E., 2012, VITAL HEALTH STAT, V3, P1; National Institute of Health, 2007, GUID DIAGN MAN ASTHM; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; RUSSELL G, 1995, ANN ALLERG ASTHMA IM, V75, P423; SPEIZER FE, 1968, BRIT MED J, V1, P335, DOI 10.1136/bmj.1.5588.335; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; Stempel DA, 2016, NEW ENGL J MED, V374, P1822, DOI 10.1056/NEJMoa1511049; SUISSA S, 1994, AM J RESP CRIT CARE, V149, P604, DOI 10.1164/ajrccm.149.3.8118625; Vaessen-Verberne AAPH, 2010, AM J RESP CRIT CARE, V182, P1221, DOI 10.1164/rccm.201002-0193OC; Voorend-van Bergen S, 2014, J ALLERGY CLIN IMMUN, V133, P1599; Weatherall M, 2010, THORAX, V65, P39, DOI 10.1136/thx.2009.116608; Zimmerman B, 2004, PEDIATR PULM, V37, P122, DOI 10.1002/ppul.10404	25	91	93	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2016	375	9					840	849		10.1056/NEJMoa1606356	http://dx.doi.org/10.1056/NEJMoa1606356			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU9HA	27579634	Bronze, Green Published			2022-12-28	WOS:000382526000007
J	Wang, HS; Shih, MC				Wang, Hsun-Shuan; Shih, Ming-Chen			Emphysematous Prostatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wang, Hsun-Shuan] Kaohsiung Municipal Hsiaokang Hosp, Kaohsiung, Taiwan; [Shih, Ming-Chen] Kaohsiung Med Univ, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University	Wang, HS (corresponding author), Kaohsiung Municipal Hsiaokang Hosp, Kaohsiung, Taiwan.	whs524@gmail.com							0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2016	375	9					879	879		10.1056/NEJMicm1507124	http://dx.doi.org/10.1056/NEJMicm1507124			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU9HA	27579638				2022-12-28	WOS:000382526000011
J	Kosik, KS; Sejnowski, TJ; Raichle, ME; Ciechanover, A; Baltimore, D				Kosik, K. S.; Sejnowski, T. J.; Raichle, M. E.; Ciechanover, A.; Baltimore, D.			A path toward understanding neurodegeneration	SCIENCE			English	Editorial Material							ALZHEIMERS-DISEASE RESEARCH		[Kosik, K. S.] Univ Calif Santa Barbara, Neurosci Res Inst, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Sejnowski, T. J.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Sejnowski, T. J.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Raichle, M. E.] Washington Univ, Mallinckrodt Inst Radiol, Dept Anat & Neurobiol, Dept Neurol,Dept Biomed Engn, St Louis, MO 63110 USA; [Ciechanover, A.] Technion Israel Inst Technol, Fac Med, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel; [Baltimore, D.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	University of California System; University of California Santa Barbara; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego; Washington University (WUSTL); Technion Israel Institute of Technology; Rappaport Faculty of Medicine; California Institute of Technology	Kosik, KS (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	kosik@lifesci.ucsb.edu; baltimo@caltech.edu	Sejnowski, Terrence/AAV-5558-2021; Ciechanover, Aaron J/C-9166-2017		NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009282] Funding Source: NIH RePORTER; NIBIB NIH HHS [R01 EB009282] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Bingol B, 2016, FREE RADICAL BIO MED, V100, P210, DOI 10.1016/j.freeradbiomed.2016.04.015; Lee D, 2015, J ALZHEIMERS DIS, V45, P1207, DOI 10.3233/JAD-142688; Mollereau B, 2016, BRAIN RES, V1648, P603, DOI 10.1016/j.brainres.2016.02.033; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Rockey S., RETENTION RATES 1 TI; Song M, 2015, SCIENTOMETRICS, V102, P905, DOI 10.1007/s11192-014-1372-x; Theillet FX, 2016, NATURE, V530, P45, DOI 10.1038/nature16531	7	10	10	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					872	873		10.1126/science.aai7622	http://dx.doi.org/10.1126/science.aai7622			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU0CA	27563087	Green Accepted			2022-12-28	WOS:000381867700020
J	Goette, A; Merino, JL; Ezekowitz, MD; Zamoryakhin, D; Melino, M; Jin, J; Mercuri, MF; Grosso, MA; Fernandez, V; Al-Saady, N; Pelekh, N; Zenin, S; Kushnir, M; Spinar, J; Batushkin, V; Lip, GYH; Weitz, J; Freemantle, N; Klein, H; Buller, H; Segers, A; Roos, Y; Slagboom, T; Thijs, V; van Mechelen, R; Larrey, D; Laleman, W; Huber, K; Heidbuchel, H; Goudev, A; Kautzner, J; Rasmussen, L; Cohen, A; Le Heuzey, JY; Glikson, M; Themistoclakis, S; De Caterina, R; Banach, M; Dan, GA; Ruda, M; Lundqvist, CB; Sychov, O; Ellenbogen, K; Ezekowitz, M; Gwechenberger, M; Huber, K; Purerfellner, H; Roithinger, F; Scherr, D; Stuhlinger, M; Delforge, M; Rivero-Ayerza, M; Thoeng, J; Vervoort, G; Vijgen, J; Willems, R; Benov, H; Dimov, B; Nikolov, F; Godev, A; Jorgova-Makedonska, J; Lazov, P; Marchev, S; Mihov, L; Petranov, S; Raev, D; Stoyanov, M; Tarnovska-Kadreva, R; Todorov, G; Tumbev, H; Cermak, O; Slany, N; Jarkovsky, P; Kautzner, J; Lukac, B; Nadenickova, P; Peterka, K; Slaby, J; Spinar, J; Vesely, J; Vitovec, M; Zavada, F; Al-Hashimi, S; Bronnum-Schou, J; Egstrup, K; Frost, L; Gislason, G; Lomholdt, J; Malczynski, J; Moller, DS; Nielsen, T; Raymond, I; Riahi, S; Tuxen, C; Cohen, A; Cottin, Y; Defaye, P; Deharo, JC; Depuis, JM; Elbaz, M; Ferrari, E; Gosse, P; Goube, P; Paganelli, F; Pineau, J; Piot, O; Biermann, J; Bosch, R; Brachmann, J; Darius, H; Dengler, T; Hartmann, A; Kreis, I; Lamparter, S; Licka, M; Maier, L; Schellong, S; Schmitt, J; Stellbrink, C; Walkili, R; Willems, S; vom Dahl, J; Dezsi, A; Edes, I; Laszlo, S; Lupkovics, G; Matoltsy, A; Merkely, B; Nagy, A; Nagy, L; Palinkas, A; Simor, T; Tomcsanyi, J; Toth, L; Alcalai, R; Hayek, T; Katz, A; Mazen, E; Shechter, M; Shochat, M; Zeltser, D; Zimlichman, R; Boriani, G; De Caterina, R; Di Pasquale, G; Fattore, L; Grimaldi, M; Gulizia, M; Mazzone, C; Themistoclakis, S; Volpe, M; Allaart, C; de Groot, J; Elvan, A; Folkeringa, R; Hazeleger, R; Jansen, W; Nierop, P; Willems, A; de Ruiter, G; Czarnecka, D; Gniot, J; Januszewicz, A; Jaworska, K; Loboz-Grudzien, K; Niezgoda, K; Ptaszynski, P; Wysokinski, A; Bartos, D; Bengus, C; Bolohan, R; Chioncel, O; Coman, IM; Crisu, D; Dan, GA; Dobreanu, D; Dumitrescu, S; Gurghean, A; Lighezan, D; Militaru, C; Minescu, B; Podoleanu, CCG; Pop, C; Popescu, MI; Rosu, RO; Tase, A; Voicu, OC; Belenky, D; Bolshakova, O; Chumakova, G; Demko, A; Goloshchekin, B; Kostenko, V; Kuznetsov, V; Libov, I; Nevzorova, V; Nikolaev, K; Popov, S; Shubik, Y; Staroverov, I; Timofeev, A; Zrazhevskiy, K; Valladares, FA; Lopez, MA; Arenal, A; Gonzalez, VB; Cosin-Sales, J; Gonzalez-Juanatey, JR; Rubio, AM; Martinez, JG; Falconi, E; Mont, L; Bermejo, MAP; Sabate, X; Camano, MV; Vida, M; Vinolas, X; Gomez, JLZ; Lindquist, CB; Fredholm, O; Savelieva, I; Haywood, G; Aggarwal, R; Bakhai, A; Balasubramaniam, R; Betts, T; Campbell, P; Choy, AM; Davis, G; Izzat, L; Kadr, H; Lindsay, S; Lip, G; More, R; Ng, GA; Payne, G; Schilling, R; Senior, R; Tayebjee, M; Travill, C; Rishko, M; Batushkin, V; Fushtey, I; Karpenko, O; Karpenko, Y; Klantsa, A; Kraiz, I; Kushnir, M; Kutniy, O; Parkhomenko, A; Petrovskyy, R; Reshotko, D; Stanislavchuk, M; Sychov, O; Tseluyko, V; Vasylets, V; Minakova, PO; Volkov, D; Zharinov, O; Zhurba, S; Aggarwal, R; Bahu, M; Bashir, F; Berk, M; Cheirif, J; Clay, A; Crenshaw, J; Ellenbogen, K; Ganeshram, V; Halpern, S; Heiman, M; Henderson, D; Ho, A; Kovach, T; Mckenzie, M; Nadar, V; Penny-Peterson, E; Rao, S; Sawhney, N; Shaoulian, E; Sheikh, K; Torres-Heisecke, R; Weiss, R				Goette, Andreas; Merino, Jose L.; Ezekowitz, Michael D.; Zamoryakhin, Dmitry; Melino, Michael; Jin, James; Mercuri, Michele F.; Grosso, Michael A.; Fernandez, Victor; Al-Saady, Naab; Pelekh, Natalya; Zenin, Sergey; Kushnir, Mykola; Spinar, Jindrich; Batushkin, Valeriy; Lip, Gregory Y. H.; Weitz, Jeffrey; Freemantle, Nicholas; Klein, Helmut; Buller, Harry; Segers, Annelise; Roos, Yvo; Slagboom, Ton; Thijs, Vincent; van Mechelen, Rob; Larrey, Dominique; Laleman, Wim; Huber, Kurt; Heidbuchel, Hein; Goudev, Assen; Kautzner, Josef; Rasmussen, Lars; Cohen, Ariel; Le Heuzey, Jean-Yves; Glikson, Michael; Themistoclakis, Sakis; De Caterina, Raffaele; Banach, Maciej; Dan, Gheorghe-Andrei; Ruda, Mikhail; Lundqvist, Carina Blomstrom; Sychov, Oleg; Ellenbogen, Kenneth; Ezekowitz, Michael; Gwechenberger, Marianne; Huber, Kurt; Purerfellner, Helmut; Roithinger, Franz; Scherr, Daniel; Stuhlinger, Markus; Delforge, Marc; Rivero-Ayerza, Maximo; Thoeng, John; Vervoort, Geert; Vijgen, Johan; Willems, Rik; Benov, Haralambi; Dimov, Bojidar; Nikolov, Fedya; Godev, Assen; Jorgova-Makedonska, Julia; Lazov, Petar; Marchev, Sotir; Mihov, Lenko; Petranov, Stanislav; Raev, Dimitar; Stoyanov, Miroslav; Tarnovska-Kadreva, Rumiana; Todorov, Georgi; Tumbev, Haralin; Cermak, Ondrej; Slany, Nemocnice; Jarkovsky, Patrik; Kautzner, Josef; Lukac, Bohdan; Nadenickova, Pavla; Peterka, Karel; Slaby, Josef; Spinar, Jindrich; Vesely, Jiri; Vitovec, Miroslav; Zavada, Filip; Al-hashimi, Souhad; Bronnum-Schou, Jens; Egstrup, Kenneth; Frost, Lars; Gislason, Gunnar; Lomholdt, Jens; Malczynski, Jerzy; Moller, Dorthe Svendstrup; Nielsen, Tonni; Raymond, Ilan; Riahi, Sam; Tuxen, Christian; Cohen, Ariel; Cottin, Yves; Defaye, Pascal; Deharo, Jean-Claude; Depuis, Jean-Marc; Elbaz, Meyer; Ferrari, Emile; Gosse, Philippe; Goube, Pascal; Paganelli, Franck; Pineau, Julien; Piot, Olivier; Biermann, Jurgen; Bosch, Ralph; Brachmann, Johannes; Darius, Harald; Dengler, Thomas; Hartmann, Andreas; Kreis, Ingo; Lamparter, Steffen; Licka, Manuela; Maier, Lars; Schellong, Sebastian; Schmitt, Jorn; Stellbrink, Christoph; Walkili, Reza; Willems, Stephan; vom Dahl, Juergen; Dezsi, Andras; Edes, Istvan; Laszlo, Saghy; Lupkovics, Geza; Matoltsy, Andras; Merkely, Bela; Nagy, Andras; Nagy, Lajos; Palinkas, Attila; Simor, Tamas; Tomcsanyi, Janos; Toth, Laszlo; Alcalai, Ronny; Hayek, Tony; Katz, Amos; Mazen, Elias; Shechter, Michael; Shochat, Michael; Zeltser, David; Zimlichman, Reuven; Boriani, Guiseppe; De Caterina, Raffaele; Di Pasquale, Giuseppe; Fattore, Luciano; Grimaldi, Massimo; Gulizia, Michele; Mazzone, Carmine; Themistoclakis, Sakis; Volpe, Massimo; Allaart, Cornelis; de Groot, Joris; Elvan, Arif; Folkeringa, Richard; Hazeleger, Ronald; Jansen, Ward; Nierop, Pieter; Willems, Albert; de Ruiter, Gijsbert; Czarnecka, Danuta; Gniot, Jacek; Januszewicz, Andrzey; Jaworska, Krystyna; Loboz-Grudzien, Krystyna; Niezgoda, Krzysztof; Ptaszynski, Pawel; Wysokinski, Andrzej; Bartos, Daniela; Bengus, Cristina; Bolohan, Romi; Chioncel, Ovidiu; Coman, Ioan-Mircea; Crisu, Daniela; Dan, Gheorghe-Andrei; Dobreanu, Dan; Dumitrescu, Silviu; Gurghean, Adriana; Lighezan, Daniel; Militaru, Constantin; Minescu, Bogdan; Podoleanu, Cristian Calin Gheorghe; Pop, Calin; Popescu, Mircea Ioachim; Rosu, Radu Ovidiu; Tase, Adrian; Voicu, Olga Cristina; Belenky, Dmitry; Bolshakova, Olga; Chumakova, Galina; Demko, Arkadiy; Goloshchekin, Boris; Kostenko, Viktor; Kuznetsov, Vadim; Libov, Igor; Nevzorova, Vera; Nikolaev, Konstantin; Popov, Sergey; Shubik, Yuriy; Staroverov, Ilya; Timofeev, Alexander; Zrazhevskiy, Konstantin; Alonso Valladares, Francisco; Alvarez Lopez, Miguel; Arenal, Angel; Bertomeu Gonzalez, Vicente; Cosin-Sales, Juan; Ramon Gonzalez-Juanatey, Jose; Martinez Rubio, Antoni; Gabriel Martinez, Juan; Falconi, Estela; Mont, Lluis; Paz Bermejo, Marco Antonio; Sabate, Xavier; Vazquez Camano, Maria; Vida, Manuel; Vinolas, Xavier; Zamorano Gomez, Jose Luis; Lindquist, Carina Blomstrom; Fredholm, Olle; Savelieva, Irina; Haywood, Guy; Aggarwal, Rajesh; Bakhai, Ameet; Balasubramaniam, Richard; Betts, Tim; Campbell, Phillip; Choy, Anna Maria; Davis, Gershan; Izzat, Lena; Kadr, Honer; Lindsay, Steven; Lip, Gregory; More, Ranjit; Ng, Ghulam Andre; Payne, Gillian; Schilling, Richard; Senior, Roxy; Tayebjee, Muzahir; Travill, Chris; Rishko, Mykola; Batushkin, Valerii; Fushtey, Ivan; Karpenko, Oleksandr; Karpenko, Yuriy; Klantsa, Andriy; Kraiz, Igor; Kushnir, Mykola; Kutniy, Oles; Parkhomenko, Aleksander; Petrovskyy, Roman; Reshotko, Dmytro; Stanislavchuk, Mykola; Sychov, Oleg; Tseluyko, Vira; Vasylets, Victoria; Minakova, Prof. O. I.; Volkov, Dmytro; Zharinov, Oleg; Zhurba, Svitlana; Aggarwal, Rahul; Bahu, Marwan; Bashir, Faran; Berk, Martin; Cheirif, Jorge; Clay, Anthony; Crenshaw, James; Ellenbogen, Kenneth; Ganeshram, Vedampattu; Halpern, Stephen; Heiman, Mark; Henderson, David; Ho, Andrew; Kovach, Todd; Mckenzie, Marcus; Nadar, Venkatesh; Penny-Peterson, Erica; Rao, Sunder; Sawhney, Navinder; Shaoulian, Emanuel; Sheikh, Khalid; Torres-Heisecke, Raul; Weiss, Robert		ENSURE-AF Investigators	Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial	LANCET			English	Article							ORAL ANTICOAGULANTS; EFFICACY; SAFETY	Background Edoxaban, an oral factor Xa inhibitor, is non-inferior for prevention of stroke and systemic embolism in patients with atrial fibrillation and is associated with less bleeding than well controlled warfarin therapy. Few safety data about edoxaban in patients undergoing electrical cardioversion are available. Methods We did a multicentre, prospective, randomised, open-label, blinded-endpoint evaluation trial in 19 countries with 239 sites comparing edoxaban 60 mg per day with enoxaparin-warfarin in patients undergoing electrical cardioversion of non-valvular atrial fibrillation. The dose of edoxaban was reduced to 30 mg per day if one or more factors (creatinine clearance 15-50 mL/min, low bodyweight [<= 60 kg], or concomitant use of P-glycoprotein inhibitors) were present. Block randomisation (block size four)-stratified by cardioversion approach (transoesophageal echocardiography [TEE] or not), anticoagulant experience, selected edoxaban dose, and region-was done through a voice-web system. The primary efficacy endpoint was a composite of stroke, systemic embolic event, myocardial infarction, and cardiovascular mortality, analysed by intention to treat. The primary safety endpoint was major and clinically relevant non-major (CRNM) bleeding in patients who received at least one dose of study drug. Follow-up was 28 days on study drug after cardioversion plus 30 days to assess safety. This trial is registered with ClinicalTrials.gov, number NCT02072434. Findings Between March 25, 2014, and Oct 28, 2015, 2199 patients were enrolled and randomly assigned to receive edoxaban (n= 1095) or enoxaparin-warfarin (n= 1104). The mean age was 64 years (SD 10 . 54) and mean CHA(2)DS(2)-VASc score was 2.6 (SD 1.4). Mean time in therapeutic range on warfarin was 70.8% (SD 27.4). The primary efficacy endpoint occurred in five (<1%) patients in the edoxaban group versus 11 (1%) in the enoxaparin-warfarin group (odds ratio [OR] 0.46, 95% CI 0.12-1.43). The primary safety endpoint occurred in 16 (1%) of 1067 patients given edoxaban versus 11 (1%) of 1082 patients given enoxaparin-warfarin (OR 1.48, 95% CI 0.64-3.55). The results were independent of the TEE-guided strategy and anticoagulation status. Interpretation ENSURE-AF is the largest prospective randomised clinical trial of anticoagulation for cardioversion of patients with non-valvular atrial fibrillation. Rates of major and CRNM bleeding and thromboembolism were low in the two treatment groups. Funding Daiichi Sankyo provided financial support for the study.	[Goette, Andreas] St Vincenz Hosp, Cardiol & Intens Care Med, D-33098 Paderborn, Nordrhein Westf, Germany; [Goette, Andreas] Univ Hosp Magdeburg, Working Grp Mol Electrophysiol, Magdeburg, Germany; [Merino, Jose L.] Univ Europea, Hosp Univ La Paz, Arrhythmia & Robot Electrophysiol Unit, Madrid, Spain; [Ezekowitz, Michael D.] Thomas Jefferson Univ, Sidney Kimmel Jefferson Med Coll, Dept Cardiovasc Med, Broomall, PA USA; [Zamoryakhin, Dmitry] Lankenau Med Ctr, Broomall, PA USA; [Melino, Michael; Mercuri, Michele F.; Grosso, Michael A.; Fernandez, Victor] Daiichi Sankyo Pharma Dev, Clin Dev Cardiovas & Metab, Edison, NJ USA; [Jin, James] Daiichi Sankyo Pharma Dev, Biostat, Edison, NJ USA; [Al-Saady, Naab] Cardiovasc Metab Covance, Maidenshead, England; [Pelekh, Natalya] Covance, Clin Res, Kiev, Ukraine; [Merkely, Bela] Semmelweis Univ, Heart & Vasc Ctr, Budapest, Hungary; [Zenin, Sergey] Novosibirsk Reg Clin Cardiol Hosp, State Budget Healthcare Inst Novosibirsk Reg, Novosibirsk, Russia; [Kushnir, Mykola] Zhytomyr Reg Clin Hosp, Dept Cardiol, Chervonogo Khresta Str, Zhytomyr, Ukraine; [Spinar, Jindrich] Fak Nemocnice Brno, Brno, Czech Republic; [Batushkin, Valeriy] Kiev City Clin Hosp 5, Cardiol & Intens Care Dept, Kiev, Ukraine; [de Groot, Joris] Acad Med Ctr, Ctr Heart, Dept Cardiol, Clin Electrophysiol, Amsterdam, Netherlands; [Lip, Gregory Y. H.] Univ Birmingham, City Hosp, Inst Cardiovasc Sci, Birmingham, W Midlands, England; [Lip, Gregory Y. H.] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark; [Gwechenberger, Marianne] Univ Vet Med Vienna, Vienna, Austria; [Huber, Kurt] Wilhelminenspital Stadt Wien, Vienna, Austria; [Purerfellner, Helmut] Krankenhaus Elisabethinen Linz, Linz, Austria; [Roithinger, Franz] Landesklinikum Modling, Modling, Austria; [Scherr, Daniel] Med Univ Graz, Graz, Austria; [Stuhlinger, Markus] Med Univ Innsbruck, Innsbruck, Austria; [Delforge, Marc] Ctr Hosp Reg de Huy, Huy, Belgium; [Rivero-Ayerza, Maximo] Ziekenhuis Oost Limburg, Limburg, Belgium; [Thoeng, John] AZ Turnhout VZW, Turnhout, Belgium; [Vervoort, Geert] AZ Sint Maarten, Mechelen, Belgium; [Vijgen, Johan] Jessa Ziekenhuis, Hasselt, Belgium; [Willems, Rik] UZ Leuven, Leuven, Belgium; [Benov, Haralambi] Multiprofile Dist Hosp Act Treatment Dr Stefan Ch, Veliko Tarnovo, Bulgaria; [Dimov, Bojidar] Fifth Multiprofile Hosp Act Treatment Sofia EAD, Sofia, Bulgaria; [Nikolov, Fedya] Univ Multiprofile Hosp Act Treatment Sveti Georgi, Sofia, Bulgaria; [Godev, Assen] Univ Multiprofile Hosp Act Treatment Tsaritsa Joa, Sofia, Bulgaria; [Jorgova-Makedonska, Julia] Univ Multiprofile Hosp Act Treatment Sveta Ekater, Sofia, Bulgaria; [Lazov, Petar] Multiprofile Hosp Act Treatment Pazardzhik AD, Sofia, Bulgaria; [Marchev, Sotir] Specialized Hosp Act Treatment Cardiol EAD, Sofia, Bulgaria; [Mihov, Lenko] Multiprofile Hosp Act Treatment Sveti Ivan Rilski, Sofia, Bulgaria; [Petranov, Stanislav] Multiprofile Hosp Act Treatment Burgas AD, Sofia, Bulgaria; [Raev, Dimitar] Diagnost Consultat Ctr Sveta Anna EOOD, Sofia, Bulgaria; [Stoyanov, Miroslav] Multiprofile Hosp Act Treatment Dr Tota Venkova J, Sofia, Bulgaria; [Tarnovska-Kadreva, Rumiana] Univ Multiprofile Hosp Act Treatment Alexandrovsk, Sofia, Bulgaria; [Todorov, Georgi] Second Multiprofile Hosp Act Treatment Sofia EAD, Sofia, Bulgaria; [Tumbev, Haralin] Specialized Hosp Act Cardiol Treatment Cardiolife, Sofia, Bulgaria; [Cermak, Ondrej] Nemocnice Slany, Slany, Czech Republic; [Jarkovsky, Patrik] Ustoedni Vojenska Nemocnice Vojenska Fak Nemocnic, Prague, Czech Republic; [Kautzner, Josef] Inst Klin Expt Med, Prague, Czech Republic; [Lukac, Bohdan] Nemocnice Eesky Krumlov As, Prague, Czech Republic; [Nadenickova, Pavla] Kromioizska Nemocnice As, Prague, Czech Republic; [Peterka, Karel] Nemocnice Havliekuv Brod, Prague, Czech Republic; [Slaby, Josef] Oblastni Nemocnice Kolin As, Prague, Czech Republic; [Spinar, Jindrich] Fak Nemocnice Brno, Brno, Czech Republic; [Vesely, Jiri] Oblastni Nemocnice Nachod As, Brno, Czech Republic; [Vitovec, Miroslav] Affidea Praha Sro, Brno, Czech Republic; [Zavada, Filip] Oblastni Nemocnice Pribram As, Brno, Czech Republic; [Al-hashimi, Souhad] Holbaek Sygehus, Holbaek, Denmark; [Bronnum-Schou, Jens] Amager Hosp, Glostrup, Denmark; [Egstrup, Kenneth] Odense Univ Hosp, Svendborg Sygehus, Odense, Denmark; [Frost, Lars] Regionshosp Silkeborg, Silkeborg, Denmark; [Gislason, Gunnar] Gentofte Univ Hosp, Gentofte, Denmark; [Lomholdt, Jens] Slagelse Sygehus, Slagelse, Denmark; [Malczynski, Jerzy] Herning Reg Hosp, Herning, Denmark; [Moller, Dorthe Svendstrup] Reg Hosp Viborg, Viborg, Denmark; [Nielsen, Tonni] Koge Sygehus, Koge, Denmark; [Raymond, Ilan] Frederiksberg Univ Hosp, Frederiksberg, Denmark; [Riahi, Sam] Aalborg Univ, Aalborg, Denmark; [Tuxen, Christian] Bispebjerg Hosp, Bispebjerg, Denmark; [Cohen, Ariel] Hop St Antoine, St Antoine, France; [Cottin, Yves] Hop Bocage, CHU Dijon, Dijon, France; [Defaye, Pascal] CHU Grenoble, Grenoble, France; [Deharo, Jean-Claude] CHU Hop Timone, Marseille, France; [Depuis, Jean-Marc] CHU Angers, Angers, France; [Elbaz, Meyer] Hop Rangueil, Rangueil, France; [Ferrari, Emile] Hop Louis Pasteur, CHU Nice, Nice, France; [Gosse, Philippe] Hop St Andre, CHU Hop Bordeaux, St Andre, France; [Goube, Pascal] Ctr Hosp Sud Francilien, Corbeil Essonnes, France; [Paganelli, Franck] Hop Nord, Nord, France; [Pineau, Julien] Ctr Hosp St Joseph St Luc, St Luc, France; [Piot, Olivier] Ctr Cardiol Nord, Nord, France; [Biermann, Jurgen] Univ Herzzentrum Freiburg Bad Krozingen, Freiburg, Germany; [Bosch, Ralph] Cardio Ctr Ludwigsburg Bietigheim, Bietigheim, Germany; [Brachmann, Johannes] Klinikum Coburg GmbH, Coburg, Germany; [Darius, Harald] Vivantes Klinikum Neukolln, Berlin, Germany; [Dengler, Thomas] SLK Kliniken Heilbronn GmbH, Heilbronn, Germany; [Goette, Andreas] St Vincenz Hosp, Paderborn, Germany; [Hartmann, Andreas] Klinikum St Georg GmbH, Leipzig, Germany; [Kreis, Ingo] St Johannes Hosp, Dortmund, Germany; [Lamparter, Steffen] Diakonie Krankenhaus Wehrda, Marburg, Germany; [Licka, Manuela] Univ Klinikum Heidelberg, Heidelberg, Germany; [Maier, Lars] Univ Hosp Regensburg, Regensburg, Germany; [Schellong, Sebastian] Krankenhaus Dresden Friedrichstadt, Friedrichstadt, Germany; [Schmitt, Jorn] Univ Giessen & Marburg GmbH, Giessen, Germany; [Stellbrink, Christoph] Klinikum Bielefeld Mitte, Bielefeld, Germany; [Walkili, Reza] Klinikum Univ Munchen, Munich, Germany; [Willems, Stephan] Univ Hamburg Eppendorf, Hamburg, Germany; [vom Dahl, Juergen] Kliniken Maria Hilf GmbH, Monchengladbach, Germany; [Dezsi, Andras] Petz Aladar Cty Teaching Hosp, Gyor, Hungary; [Edes, Istvan] Debreceni Egyet Klin Kozpont, Kozpont, Hungary; [Laszlo, Saghy] Szegedi Tudomanyegyet, Belgyogyaszati Klin, Szeged, Hungary; [Lupkovics, Geza] Zala Megyei Korhaz, Zalaegerszeg, Hungary; [Matoltsy, Andras] Kanizsai Dorottya Korhaz, Nagykanizsa, Hungary; [Merkely, Bela] Semmelweis Univ, Budapest, Hungary; [Nagy, Andras] Bacs Kiskun Megyei Korhaz, Kecskemet, Hungary; [Nagy, Lajos] Vas Megyei Markusovszky Korhaz Nonprofit Zrt, Szombathely, Hungary; [Palinkas, Attila] CSMEK Hodmezovasarhel, Hodmezovasarhely, Hungary; [Simor, Tamas] Pecsi Tudomanyegyetem Klin Kozpont, Pecs, Hungary; [Tomcsanyi, Janos] Budai Irgalmasrendi Korhaz, Budapest, Hungary; [Toth, Laszlo] Fejer Megyei Szent Gyorgy Egyet Oktato Korhaz, Szekesfehervar, Hungary; [Alcalai, Ronny] Hadassah Univ Med Ctr, Jerusalem, Israel; [Hayek, Tony] Rambam Med Ctr, Haifa, Israel; [Katz, Amos] Barzilai Govt Hosp, Ashqelon, Israel; [Mazen, Elias] Emek Med Ctr, Afula, Israel; [Shechter, Michael] Chaim Sheba Med Ctr, Ramat Gan, Israel; [Shochat, Michael] Hillel Yaffe Med Ctr, Hadera, Israel; [Zeltser, David] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel; [Zimlichman, Reuven] Edith Wolfson Med Ctr, Holon, Israel; [Boriani, Guiseppe] Azienda Osped Univ Bologna Policlin S Orsola Malp, Bologna, Italy; [De Caterina, Raffaele] Osped SS Annunziata, Naples, Italy; [Di Pasquale, Giuseppe] Osped Maggiore CA Pizzardi, Bologna, Italy; [Fattore, Luciano] Osped San Giuseppe Melorio, Santa Maria Capua Vetere, Italy; [Grimaldi, Massimo] Ente Ecclesiastico Osped Gen Reg F Miulli, Acquaviva Delle Fonti, Italy; [Gulizia, Michele] Presidio Osped Garibaldi Nesima, Catania, Italy; [Mazzone, Carmine] Ctr Cardiovasc, Catania, Italy; [Themistoclakis, Sakis] Osped dellAngelo, Venice, Italy; [Volpe, Massimo] Azienda Osped St Andrea, Rome, Italy; [Allaart, Cornelis] VU Univ Med Ctr, Leiden, Netherlands; [de Groot, Joris] Acad Med Ctr AMC, Amsterdam, Netherlands; [Elvan, Arif] Isala, Zwolle, Netherlands; [Folkeringa, Richard] Med Ctr Leeuwarden, Leeuwarden, Netherlands; [Hazeleger, Ronald] VieCuri, Venray, Netherlands; [Jansen, Ward] Tergooi Hilversum, Hilversum, Netherlands; [Nierop, Pieter] St Franciscus Gasthuis, Rotterdam, Netherlands; [Willems, Albert] Sint Lucas Andreas Ziekenhuis, Amsterdam, Netherlands; [de Ruiter, Gijsbert] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands; [Czarnecka, Danuta] Univ Hosp Krakow, Krakow, Poland; [Gniot, Jacek] Samodzielny Publ Zaklad Opieki Zdrowotnej Pulawac, Pulawy, Poland; [Januszewicz, Andrzey] Inst Kardiol, Krakow, Poland; [Jaworska, Krystyna] Wojewodzki Szpital Zespolony Ludwika Rydygiera To, Torun, Poland; [Loboz-Grudzien, Krystyna] Lower Silesian Specialist Hosp Tadeusz Marciniak, Ctr Emergency Med, Wroclaw, Poland; [Niezgoda, Krzysztof] Elblaski Szpital Specjalisty Przychodnia Elblagu, Elblag, Poland; [Ptaszynski, Pawel] Med Univ Lodz, Lodz, Poland; [Wysokinski, Andrzej] Samodzielny Publ Szpital Klin 4 SPSK4, Lublin, Poland; [Bartos, Daniela] Spitalul Clin Urgenta Bucuresti, Bucharest, Romania; [Bengus, Cristina] Spitalul Clin Urgenta Sfantul Pantelimon, Bucharest, Romania; [Bolohan, Romi; Dumitrescu, Silviu] Ctr Clin Urgenta Boli Cardiovasc Armatei, Bucharest, Romania; [Chioncel, Ovidiu; Coman, Ioan-Mircea] Inst Urgenta Pentru Boli Cardiovasc Prof Dr CC Il, Bucharest, Romania; [Crisu, Daniela] Ctr Med Consultmed, Bucharest, Romania; [Dan, Gheorghe-Andrei] Spitalul Clin Colentina, Bucharest, Romania; [Dobreanu, Dan] Inst Urgenta Pentru Boli Cardiovasc & Transplant, Targu Mures, Romania; [Gurghean, Adriana] Spitalul Clin Coltea, Bucharest, Romania; [Lighezan, Daniel] Spitalul Clin Municipal Urgenta Timisoara, Timisoara, Romania; [Militaru, Constantin] Spitalul Clin Judetean Urgenta Craiova, Craiova, Romania; [Minescu, Bogdan] Spitalul Judetean Urgenta Braila, Urgenta Braila, Romania; [Podoleanu, Cristian Calin Gheorghe] Spitalul Clin Judetean Mures, Targu Mures, Romania; [Pop, Calin] Spitalul Judetean Urgenta Dr Constantin Opris Bai, Baia Mare, Romania; [Popescu, Mircea Ioachim] Spitalul Clin Judetean Urgenta Oradea, Urgenta Oradea, Romania; [Rosu, Radu Ovidiu] Spitalul Clin Recuperare Cluj Napoca, Cluj Napoca, Romania; [Tase, Adrian] Spitalul Judetean Urgenta Arges, Urgenta Arges, Romania; [Voicu, Olga Cristina] Spitalul Judetean Urgenta Targoviste, Urgenta Targoviste, Romania; [Belenky, Dmitry] City Hosp Ambulance 2, State Budget Inst Hlth Novosibirsk Oblast, Novosibirsk, Russia; [Bolshakova, Olga] Fed Almazov Med Res Ctr, St Petersburg, Russia; [Chumakova, Galina] Altai Reg Clin Hosp, Barnaul, Russia; [Demko, Arkadiy] Sci Clin Ctr Russian Railways JSC, Moscow, Russia; [Goloshchekin, Boris] City Hosp 15, St Petersburg State Budget Inst Healthcare, St Petersburg, Russia; [Kostenko, Viktor] St Petersburg II Dzhanelidze Res Inst Emergency M, St Petersburg, Russia; [Kuznetsov, Vadim] Tyumen Cardiol Ctr, Tyumen, Russia; [Libov, Igor; Timofeev, Alexander] SBHI Clin Oncol Dispensary 1 Minist Healthcare Kr, Krasnodar, Russia; [Nevzorova, Vera] Vladivostok Clin Hosp 1, Vladivostok, Russia; [Nikolaev, Konstantin] City Clin Hosp 34, State Budgetary Inst Healthcare, Novosibirsk, Russia; [Popov, Sergey] Res Inst Cardiol, Tomsk, Russia; [Shubik, Yuriy] Natl Med Surg Ctr, Moscow, Russia; [Staroverov, Ilya] Yaroslavl Reg Clin Hosp, Yaroslavl, Russia; [Zenin, Sergey] Novosibirsk Reg Clin Cardiol Clin, Novosibirsk, Russia; [Alonso Valladares, Francisco] Complejo Hosp Univ Ourense, Orense, Spain; [Alvarez Lopez, Miguel] Hosp Virgen Nieves, Granada, Spain; [Arenal, Angel] Hosp Gen Univ Gregorio Maranon, Madrid, Spain; [Bertomeu Gonzalez, Vicente] San Juan Alicante Univ Hosp, Alicante, Spain; [Cosin-Sales, Juan] Hosp Arnau Vilanova, Lleida, Spain; [Ramon Gonzalez-Juanatey, Jose] CHUS, Hosp Clin Univ, Santiago De Compostela, Spain; [Martinez Rubio, Antoni] Parc Tauli Sabadell Hosp Univ, Barcelona, Spain; [Gabriel Martinez, Juan] Hosp Gen Univ Alicante, Alicante, Spain; [Falconi, Estela] Hosp Univ La Paz, Madrid, Spain; [Mont, Lluis] Hosp Clin Barcelona, Barcelona, Spain; [Paz Bermejo, Marco Antonio] Hosp Santa Caterina, Girona, Spain; [Sabate, Xavier] Hosp Univ Bellvitge, Barcelona, Spain; [Vazquez Camano, Maria] Povisa Hosp, Vigo, Spain; [Vida, Manuel] Hosp Torrecardenas, Almeria, Spain; [Vinolas, Xavier] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Zamorano Gomez, Jose Luis] Hosp Univ Ramon & Cajal, Madrid, Spain; [Lindquist, Carina Blomstrom] Univ Uppsala Hosp, Uppsala, Sweden; [Fredholm, Olle] Helsingborgs Lasaret, Helsingborg, Sweden; [Savelieva, Irina] St Georges Univ Hosp NHS Fdn Trust, St Georges Hosp, London, England; [Haywood, Guy] Plymouth Hosp NHS Trust, Derriford Hosp, Plymouth, Devon, England; [Aggarwal, Rajesh] Basildon & Thurrock Univ Hosp NHS Fdn Trust, Basildon, England; [Bakhai, Ameet] Barnet & Chase Farm Hosp NHS Trust, Barnet Hosp, Barnet, England; [Balasubramaniam, Richard] Royal Bournemouth & Christchurch Hosp NHS Fdn Tru, Bournemouth, Dorset, England; [Betts, Tim] Oxford Univ Hosp NHS Trust, John Radcliffe Hosp, Oxford, England; [Campbell, Phillip] Royal Gwent Hosp, Newport, Gwent, Wales; [Choy, Anna Maria] NHS Tayside, Dundee, Scotland; [Davis, Gershan] Aintree Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England; [Izzat, Lena] Prince Philip Hosp, Llanelli, Wales; [Kadr, Honer] Barking Havering & Redbridge Univ Hosp NHS Trust, Queens Hosp, London, England; [Lindsay, Steven] Bradford Teaching Hosp NHS Fdn Trust, Bradford Royal Infirm, Bradford, W Yorkshire, England; [Lip, Gregory] Sandwell & West Birmingham Hosp NHS Trust, Birmingham City Hosp, Birmingham, W Midlands, England; [More, Ranjit] Blackpool Teaching Hosp NHS Fdn Trust, Blackpool Victoria Hosp, Blackpool, England; [Ng, Ghulam Andre] Univ Hosp Leicester NHS Trust, Glenfield Hosp, Leicester, Leics, England; [Payne, Gillian] Doncaster Royal Infirm, Doncaster, England; [Schilling, Richard] Barts Hlth NHS Trust, Whipps Cross Univ Hosp, London, England; London North West Healthcare NHS Trust, Northwick Park Hosp, London, England; [Tayebjee, Muzahir] Leeds Teaching Hosp NHS Trust, Leeds Gen Infirm, Leeds, W Yorkshire, England; [Travill, Chris] Luton & Dunstable Univ Hosp NHS Fdn Trust, Luton, Beds, England; [Rishko, Mykola] Uzhgorod Natl Univ, Uzhgorod, Ukraine; [Batushkin, Valerii] Kiev City Clin Hosp 5, Kiev, Ukraine; [Fushtey, Ivan] Ordzhonikidze Dist Cent Hosp, Pokrov, Ukraine; [Karpenko, Oleksandr] Kyiv City Clin Hosp 1, Kiev, Ukraine; [Karpenko, Yuriy] Odessa Reg Cardiol Dispensary, Odessa, Ukraine; [Klantsa, Andriy] Khmelnytskyi Reg Hosp, Khmelnytskyi, Ukraine; [Kraiz, Igor] Tsentralnaya Klinicheskaya Bolnitsa, Donetsk, Ukraine; [Kushnir, Mykola] Zhitomir Reg Clin Hosp, Zhytomyr, Ukraine; [Kutniy, Oles] Municipal Inst Cent City Hosp 2, Zhytomyr, Ukraine; [Sychov, Oleg; Parkhomenko, Aleksander] MAS Ukraine, Natl Sci Ctr MD Strazhesko Inst Cardiol, Kiev, Ukraine; [Petrovskyy, Roman] Ivano Frankivsk Reg Clin Hosp, Ivano Frankivsk, Ukraine; [Reshotko, Dmytro] Oleksandrivska Clin Hosp, Kiev, Ukraine; [Stanislavchuk, Mykola] Vinnitsa Reg Clin Hosp NI Pirogov, Vinnitsa, Ukraine; [Tseluyko, Vira] Kharkiv City Clin Hosp 8, Kharkov, Ukraine; [Vasylets, Victoria] City Clin Hosp 9, Dnipro, Ukraine; [Minakova, Prof. O. I.; Volkov, Dmytro] Inst Gen & Emergency Surg, Kharkov, Ukraine; [Zharinov, Oleg] Kyiv City Heart Ctr, Kiev, Ukraine; [Zhurba, Svitlana] Cherkasy Reg Cardiol Ctr, Cherkassy, Ukraine; [Aggarwal, Rahul] Siteman Canc Ctr, Ctr Adv Med, St Louis, MO USA; [Bahu, Marwan] Phoenix Cardiovasc Res Grp LLC, Phoenix, AZ USA; [Bashir, Faran] Affiliated Cardiologists Arizona, Phoenix, AZ USA; [Berk, Martin] Cardiovasc Res Inst Dallas, Dallas, TX USA; [Cheirif, Jorge] Texas Hlth Presbyterian Hosp Dallas, Dallas, TX USA; [Clay, Anthony] Cardiol Physicians PA, Newark, DE USA; [Crenshaw, James] Jackson Clin, Jackson, TN USA; [Ellenbogen, Kenneth] Virginia Commonwealth Univ VCU Med Ctr, Richmond, VA USA; [Ganeshram, Vedampattu] Wichita Falls Heart Clin PLLC, Wichita, KS USA; [Halpern, Stephen] Radiant Res Ctr, Phoenix, AZ USA; [Heiman, Mark] Cardiol Associates Fairfield Cty P C, Fairfield, CT USA; [Henderson, David] Cardiol Res Associates, Daytona Beach, FL USA; [Ho, Andrew] Riverside Community Hosp, Riverside, CA USA; [Kovach, Todd] Heart & Vasc Inst Florida, Clearwater, FL USA; [Mckenzie, Marcus] Baylor Univ Med Ctr, Dallas, TX USA; [Nadar, Venkatesh] Capital Area Res LLC, Camp Hill, PA 17011 USA; [Penny-Peterson, Erica] Penn State Milton S Hershey Med Ctr, Hershey, PA USA; [Rao, Sunder] Butler Hlth Providers, Butler, PA USA; [Sawhney, Navinder] Arch Hlth Partners, Poway, CA USA; [Shaoulian, Emanuel] Pacific Coast Cardiol & Res, Newport Beach, CA USA; [Sheikh, Khalid] Brevard Cardiovasc Res Associates Inc, Rockledge, FL USA; [Torres-Heisecke, Raul] Tyler Cardiovasc Consultants PA, Tyler, TX USA; [Weiss, Robert] Maine Res Associates, Auburn, ME USA	University Hospital Magdeburg; Hospital Universitario La Paz; Jefferson University; Lankenau Medical Center; Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; Semmelweis University; University Hospital Brno; University of Amsterdam; Academic Medical Center Amsterdam; University of Birmingham; Aalborg University; University of Veterinary Medicine Vienna; Wilhelminenspital; Ordensklinikum Linz Elisabethinen; Medical University of Graz; Medical University of Innsbruck; East Limburg Hospital; KU Leuven; Medical University Sofia; Institute for Clinical & Experimental Medicine (IKEM); University Hospital Brno; Holbaek Hospital; University of Southern Denmark; Odense University Hospital; University of Copenhagen; Herlev & Gentofte Hospital; Aarhus University; Aalborg University; University of Copenhagen; Bispebjerg Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Dijon Bourgogne; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU de Toulouse; CHU Nice; CHU Bordeaux; Centre Hospitalier Sud Francilien; Universitats Herzzentrum Freiburg; Klinikum Coburg; VIivantes Klinikum Neukolln; SLK-Kliniken Heilbronn GmbH; St. Johannes Hospital; Ruprecht Karls University Heidelberg; University of Regensburg; Technische Universitat Dresden; Municipal Hospital Dresden; University Hospital of Giessen & Marburg; University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Szeged University; Semmelweis University; University of Pecs; Hebrew University of Jerusalem; Rambam Health Care Campus; Technion Israel Institute of Technology; Ben Gurion University; Barzilai Medical Center; Emek Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; AUSL di Bologna; Presidio Ospedaliero Garibaldi-Nesima; ULSS 3 Serenissima; Ospedale dell'Angelo Mestre; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; University of Amsterdam; Academic Medical Center Amsterdam; Medical Center Leeuwarden; Franciscus Gasthuis; Sint Lucas Andreas Hospital; Onze Lieve Vrouwe Gasthuis Hospital; Medical University Lodz; Almazov National Medical Research Centre; Tyumen Cardiology Research Center; Russian Academy of Sciences; Tomsk National Research Medical Center; Cardiology Research Institute - Tomsk; Complexo Hospitalario Universitario de Ourense, Verin e O Barco de Valdeorras; Hospital Universitario Virgen de las Nieves; General University Gregorio Maranon Hospital; University Hospital Arnau de Vilanova; Complexo Hospitalario Universitario de Santiago de Compostela; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; General University Hospital of Alicante; Hospital Universitario La Paz; University of Barcelona; Hospital Clinic de Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Hospital Torrecardenas; Hospital of Santa Creu i Sant Pau; Hospital Universitario Ramon y Cajal; Uppsala University; Uppsala University Hospital; Helsingborgs Hospital; St Georges University London; Derriford Hospital; University of Plymouth; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Royal Gwent Hospital; Aintree University Hospitals NHS Foundation Trust; Bradford Royal Infirmary; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Barts Health NHS Trust; University of London; Queen Mary University London; Leeds General Infirmary; University of Leeds; Ministry of Education & Science of Ukraine; Uzhgorod National University; National Academy of Medical Sciences of Ukraine; National Scientific Center M.D. Strazhesko Institute of Cardiology of the National Academy of Medical Sciences of Ukraine; National Academy of Medical Sciences of Ukraine; Zaycev V.T. Institute of General & Urgent Surgery of National Academy of Medical Sciences of Ukraine; Siteman Cancer Center; Baylor University Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Goette, A (corresponding author), St Vincenz Hosp, Cardiol & Intens Care Med, D-33098 Paderborn, Nordrhein Westf, Germany.	andreas.goette@vincenz.de	Stellbrink, Christoph/AAX-7701-2021; Ezekowitz, Michael/AAJ-2543-2021; Podoleanu, Cristian/E-2850-2010; Brachmann, Johannes/AAD-1499-2021; Zharinov, Oleg J/U-8033-2018; de Groot, Joris R/M-3282-2017; Shochat, Michael Kleiner/ABI-2898-2020; Licka, Manuela/AAA-7609-2020; Stanislavchuk, Mykola/GRX-8902-2022; Mircea Ioachim, Popescu/AAD-2887-2022; Volpe, Massimo/K-5240-2016; VIJGEN, Johan M/AFQ-1297-2022; Libov, Igor/GRN-8152-2022; Heidbuchel, Hein/AAU-2711-2021; Willems, Rik/AAM-2392-2020; Gurghean, Adriana/AAN-1243-2021; Nikolaev, Konstantin/P-4750-2017; Thijs, Vincent/C-3647-2009; Dan, G.Andrei/N-6744-2015; Staroverov, Ilya/M-8174-2014; Riahi, Sam/AAI-5298-2021; Gislason, Gunnar/B-7561-2009; Marchev, Sotir/AAH-6529-2020; COTTIN, YVES/ABA-4622-2020; Chioncel, Ovidiu/R-7556-2017; Banach, Maciej/A-1271-2009; Ellenbogen, Kenneth/AAJ-3992-2021; Ptaszynski, Pawel Andrzej/S-9684-2016; Grimaldi, Massimo/AAX-9576-2021; Puererfellner, Helmut/AAJ-2367-2020; Scherr, Daniel/D-4098-2019; Weitz, Jeffrey/AAD-1929-2019	Podoleanu, Cristian/0000-0001-9987-2519; de Groot, Joris R/0000-0002-8122-7017; Mircea Ioachim, Popescu/0000-0002-8273-4416; Volpe, Massimo/0000-0002-9642-8380; Heidbuchel, Hein/0000-0001-9301-8127; Willems, Rik/0000-0002-5469-9609; Nikolaev, Konstantin/0000-0003-4601-6203; Thijs, Vincent/0000-0002-6614-8417; Dan, G.Andrei/0000-0001-9867-2582; Riahi, Sam/0000-0003-1849-9463; Gislason, Gunnar/0000-0002-0548-402X; Marchev, Sotir/0000-0001-9250-510X; Chioncel, Ovidiu/0000-0002-3197-3628; Banach, Maciej/0000-0001-6690-6874; Ptaszynski, Pawel Andrzej/0000-0001-6084-7324; Scherr, Daniel/0000-0001-5868-5493; Weitz, Jeffrey/0000-0002-1092-7550; Merino, Jose Luis/0000-0002-1737-1903; Laleman, Wim/0000-0002-0842-7813; Ng, G. Andre/0000-0001-5965-0671; Merkely, Bela/0000-0001-6514-0723	Daiichi Sankyo; Daiichi Sankyo Pharma Development; Daiichi Sankyo Development	Daiichi Sankyo(Daiichi Sankyo Company Limited); Daiichi Sankyo Pharma Development(Daiichi Sankyo Company Limited); Daiichi Sankyo Development(Daiichi Sankyo Company Limited)	Daiichi Sankyo provided financial support for the study.r The ENSURE-AF study was sponsored and funded by Daiichi Sankyo Pharma Development and Daiichi Sankyo Development. We thank Ming Sun (Covance), for support with statistical analyses and Shannon Winters (Daiichi Sankyo) for editorial assistance in the preparation of the report.	Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/europace/eus305, 10.1093/eurheartj/ehs253]; Cappato R, 2014, EUR HEART J, V35, P3346, DOI 10.1093/eurheartj/ehu367; Flaker G, 2014, J AM COLL CARDIOL, V63, P1082, DOI 10.1016/j.jacc.2013.09.062; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Goette A., 2016, EUROPACE; Heidbuchel H, 2013, EUROPACE, V15, P625, DOI 10.1093/europace/eut083; Lip GYH, 2015, AM HEART J, V169, P597, DOI 10.1016/j.ahj.2015.02.009; Nagarakanti R, 2011, CIRCULATION, V123, P131, DOI 10.1161/CIRCULATIONAHA.110.977546; Piccini JP, 2013, J AM COLL CARDIOL, V61, P1998, DOI 10.1016/j.jacc.2013.02.025; Plitt A, 2016, CLIN CARDIOL, V39, P345, DOI 10.1002/clc.22537; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Sjogren V, 2015, THROMB HAEMOSTASIS, V113, P1370, DOI 10.1160/TH14-10-0859; You JJ, 2012, CHEST, V141, pE531S, DOI 10.1378/chest.11-2304	13	176	177	0	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2016	388	10055					1995	2003		10.1016/S0140-6736(16)31474-X	http://dx.doi.org/10.1016/S0140-6736(16)31474-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ6EQ	27590218				2022-12-28	WOS:000385954800029
J	Mulvenna, P; Nankivell, M; Barton, R; Faivre-Finn, C; Wilson, P; McColl, E; Moore, B; Brisbane, I; Ardron, D; Holt, T; Morgan, S; Lee, C; Waite, K; Bayman, N; Pugh, C; Sydes, B; Stephens, R; Parmar, MK; Langley, RE				Mulvenna, Paula; Nankivell, Matthew; Barton, Rachael; Faivre-Finn, Corinne; Wilson, Paula; McColl, Elaine; Moore, Barbara; Brisbane, Iona; Ardron, David; Holt, Tanya; Morgan, Sally; Lee, Caroline; Waite, Kathryn; Bayman, Neil; Pugh, Cheryl; Sydes, Benjamin; Stephens, Richard; Parmar, Mahesh K.; Langley, Ruth E.			Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial	LANCET			English	Article							PARTITIONING ANALYSIS RPA; THERAPY-ONCOLOGY-GROUP; QUALITY-OF-LIFE; RADIATION-THERAPY; PROGNOSTIC-FACTORS; MOTEXAFIN GADOLINIUM; CEREBRAL METASTASES; CONSENSUS WORKSHOP; 1ST 2; MANAGEMENT	Background Whole brain radiotherapy (WBRT) and dexamethasone are widely used to treat brain metastases from non-small cell lung cancer (NSCLC), although there have been no randomised clinical trials showing that WBRT improves either quality of life or overall survival. Even after treatment with WBRT, the prognosis of this patient group is poor. We aimed to establish whether WBRT could be omitted without a significant effect on survival or quality of life. Methods The Quality of Life after Treatment for Brain Metastases (QUARTZ) study is a non-inferiority, phase 3 randomised trial done at 69 UK and three Australian centres. NSCLC patients with brain metastases unsuitable for surgical resection or stereotactic radiotherapy were randomly assigned (1: 1) to optimal supportive care (OSC) including dexamethasone plus WBRT (20 Gy in five daily fractions) or OSC alone (including dexamethasone). The dose of dexamethasone was determined by the patients' symptoms and titrated downwards if symptoms improved. Allocation to treatment group was done by a phone call from the hospital to the Medical Research Council Clinical Trials Unit at University College London using a minimisation programme with a random element and stratification by centre, Karnofsky Performance Status (KPS), gender, status of brain metastases, and the status of primary lung cancer. The primary outcome measure was quality-adjusted life-years (QALYs). QALYs were generated from overall survival and patients' weekly completion of the EQ-5D questionnaire. Treatment with OSC alone was considered noninferior if it was no more than 7 QALY days worse than treatment with WBRT plus OSC, which required 534 patients (80% power, 5% [one-sided] significance level). Analysis was done by intention to treat for all randomly assigned patients. The trial is registered with ISRCTN, number ISRCTN3826061. Findings Between March 2, 2007, and Aug 29, 2014, 538 patients were recruited from 69 UK and three Australian centres, and were randomly assigned to receive either OSC plus WBRT (269) or OSC alone (269). Baseline characteristics were balanced between groups, and the median age of participants was 66 years (range 38-85). Significantly more episodes of drowsiness, hair loss, nausea, and dry or itchy scalp were reported while patients were receiving WBRT, although there was no evidence of a difference in the rate of serious adverse events between the two groups. There was no evidence of a difference in overall survival (hazard ratio 1.06, 95% CI 0.90-1.26), overall quality of life, or dexamethasone use between the two groups. The difference between the mean QALYs was 4.7 days (46.4 QALY days for the OSC plus WBRT group vs 41.7 QALY days for the OSC group), with two-sided 90% CI of -12.7 to 3.3. Interpretation Although the primary outcome measure result includes the prespecified non-inferiority margin, the combination of the small difference in QALYs and the absence of a difference in survival and quality of life between the two groups suggests that WBRT provides little additional clinically significant benefit for this patient group. Funding Cancer Research UK, Medical Research Council Clinical Trials Unit at University College London, and the National Health and Medical Research Council in Australia. Copyright (C) The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license.	[Mulvenna, Paula] Newcastle Hosp NHS Fdn Trust, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, England; [Nankivell, Matthew; Pugh, Cheryl; Sydes, Benjamin; Stephens, Richard; Parmar, Mahesh K.; Langley, Ruth E.] UCL, Med Res Council Clin Trials Unit, London, England; [Barton, Rachael] Castle Hill Hosp, Queens Ctr Oncol & Haematol, Kingston Upon Hull, N Humberside, England; [Faivre-Finn, Corinne; Bayman, Neil] Univ Manchester, Christie NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Inst Canc Sci, Manchester, Lancs, England; [Wilson, Paula] Bristol Haematol & Oncol Ctr, Bristol, Avon, England; [McColl, Elaine] Newcastle Univ, Newcastle Clin Trials Unit, Newcastle Upon Tyne, Tyne & Wear, England; [McColl, Elaine] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England; [Moore, Barbara] Wales Canc Res Network, Cardiff, S Glam, Wales; [Brisbane, Iona] Greater Glasgow Hlth Board & Clyde, Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland; [Holt, Tanya] Trans Tasman Radiat Oncol Grp, Waratah, NSW, Australia; [Holt, Tanya] Univ Queensland, Brisbane, Qld 4072, Australia; [Morgan, Sally] Univ Nottingham Hosp, Nottingham, England; [Lee, Caroline] Weston Pk Hosp, Sheffield, S Yorkshire, England; [Waite, Kathryn] Queen Elizabeth Hosp, Kings Lynn, England	Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Medical Research Council Clinical Trials Unit; University of London; University College London; University of Hull; Christie NHS Foundation Trust; University of Manchester; Bristol Haematology & Oncology Centre; Newcastle University - UK; Newcastle University - UK; Beatson Oncology Centre; University of Queensland; University of Nottingham; Weston Park Hospital	Langley, RE (corresponding author), UCL, Inst Clin Trials & Methodol, Med Res Council Clin Trials Unit, London WC2B 6NH, England.	ruth.langley@ucl.ac.uk	McColl, Elaine/V-9906-2019	McColl, Elaine/0000-0001-8300-3204; Faivre-Finn, Corinne/0000-0001-5617-9781	Cancer Research UK; Medical Research Council Clinical Trials Unit at University College London; National Health and Medical Research Council in Australia; Cancer Research UK [C17956/A6414]; Medical Research Council in the UK; Trans Tasman Radiation Oncology Group in Australia; National Health and Medical Research Council Australia (NHMRC) [441402]; MRC [MC_UU_12023/28] Funding Source: UKRI; Cancer Research UK [20465, 6414] Funding Source: researchfish; Medical Research Council [MC_UU_12023/28] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council Clinical Trials Unit at University College London(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health and Medical Research Council in Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Research UK(Cancer Research UK); Medical Research Council in the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Trans Tasman Radiation Oncology Group in Australia; National Health and Medical Research Council Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Cancer Research UK, Medical Research Council Clinical Trials Unit at University College London, and the National Health and Medical Research Council in Australia.; Funding was provided by Cancer Research UK (C17956/A6414). The trial sponsor was the Medical Research Council in the UK, and the Trans Tasman Radiation Oncology Group in Australia. Funding for Australia sites was provided by the National Health and Medical Research Council Australia (NHMRC 441402). The trial was done and analysed at the MRC CTU at UCL. We thank all patients, their families, and carers who agreed to participate in QUARTZ, and the investigators and research staff at the trial centres and the MRC CTU at UCL.	American College of Radiology, 2014, ACR APPR CRIT; Andrews DW, 2004, LANCET, V363, P1665, DOI 10.1016/S0140-6736(04)16250-8; Barnholtz-Sloan JS, 2004, J CLIN ONCOL, V22, P2865, DOI 10.1200/JCO.2004.12.149; Billingham LJ, 2002, STAT METHODS MED RES, V11, P25, DOI 10.1191/0962280202sm269ra; BORGELT B, 1981, INT J RADIAT ONCOL, V7, P1633, DOI 10.1016/0360-3016(81)90184-X; BORGELT B, 1980, INT J RADIAT ONCOL, V6, P1, DOI 10.1016/0360-3016(80)90195-9; Brown PD, 2015, ASCO M S, V33, pLBA4; CHAO JH, 1954, CANCER, V7, P682, DOI 10.1002/1097-0142(195407)7:4<682::AID-CNCR2820070409>3.0.CO;2-S; Chen AM, 2007, CANCER-AM CANCER SOC, V109, P1668, DOI 10.1002/cncr.22565; COIA LR, 1992, INT J RADIAT ONCOL, V23, P223, DOI 10.1016/0360-3016(92)90566-Z; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gaspar L, 1997, INT J RADIAT ONCOL, V37, P745, DOI 10.1016/S0360-3016(96)00619-0; Gerrard GE, 2003, CLIN ONCOL-UK, V15, P422, DOI 10.1016/S0936-6555(03)00148-1; HORTON J, 1971, AMER J ROENTGENOL RA, V111, P334, DOI 10.2214/ajr.111.2.334; Hoskin PJ, 2001, CLIN ONCOL-UK, V13, P91, DOI 10.1053/clon.2001.9226; Kaal EC, 2005, LANCET NEUROL, V4, P289, DOI 10.1016/S1474-4422(05)70072-7; Khuntia D, 2006, J CLIN ONCOL, V24, P1295, DOI 10.1200/JCO.2005.04.6185; Langer CJ, 2005, J CLIN ONCOL, V23, P6207, DOI 10.1200/JCO.2005.03.145; Langley RE, 2013, CLIN ONCOL-UK, V25, pE23, DOI 10.1016/j.clon.2012.11.002; Law A, 2001, CANCER, V92, P160, DOI 10.1002/1097-0142(20010701)92:1<160::AID-CNCR1304>3.0.CO;2-X; Lee SM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju151; Lin XL, 2015, J CLIN ONCOL, V33, P3475, DOI 10.1200/JCO.2015.60.9503; Lutterbach J, 2002, RADIOTHER ONCOL, V63, P339, DOI 10.1016/S0167-8140(02)00119-6; Mehta M, 2011, J CLIN ONCOL, V29, P121, DOI 10.1200/JCO.2010.33.3294; Mehta MP, 2009, INT J RADIAT ONCOL, V73, P1069, DOI 10.1016/j.ijrobp.2008.05.068; Mehta MP, 2003, J CLIN ONCOL, V21, P2529, DOI 10.1200/JCO.2003.12.122; Mulvenna PM, 2010, CLIN ONCOL-UK, V22, P365, DOI 10.1016/j.clon.2010.03.011; Nieder C, 2000, INT J RADIAT ONCOL, V46, P297, DOI 10.1016/S0360-3016(99)00416-2; ORDER SE, 1968, RADIOLOGY, V91, P149, DOI 10.1148/91.1.149; Owen S, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00248; Priestman T J, 1996, Clin Oncol (R Coll Radiol), V8, P308, DOI 10.1016/S0936-6555(05)80717-4; Rades D, 2007, CANCER, V110, P1077, DOI 10.1002/cncr.22877; Sneed PK, 1996, NEUROSURG CLIN N AM, V7, P505; Soffietti R, 2005, J NEURO-ONCOL, V75, P31, DOI 10.1007/s11060-004-8096-3; Sperduto PW, 2010, INT J RADIAT ONCOL, V77, P655, DOI 10.1016/j.ijrobp.2009.08.025; Stuschke M, 1999, J CLIN ONCOL, V17, P2700, DOI 10.1200/JCO.1999.17.9.2700; Taphoorn MJB, 2010, EUR J CANCER, V46, P1033, DOI 10.1016/j.ejca.2010.01.012; Tsao MN, 2012, CLIN ONCOL-UK, V24, pE81, DOI 10.1016/j.clon.2012.03.008; Tsao MN, 2012, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003869.PUB3; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Yamamoto M, 2014, LANCET ONCOL, V15, P387, DOI 10.1016/S1470-2045(14)70061-0; ZIMM S, 1981, CANCER, V48, P384, DOI 10.1002/1097-0142(19810715)48:2<384::AID-CNCR2820480227>3.0.CO;2-8	42	381	397	0	26	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2016	388	10055					2004	2014		10.1016/S0140-6736(16)30825-X	http://dx.doi.org/10.1016/S0140-6736(16)30825-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ6EQ	27604504	Green Published, hybrid			2022-12-28	WOS:000385954800030
J	Diaz-Siso, JR; Rodriguez, ED				Diaz-Siso, J. Rodrigo; Rodriguez, Eduardo D.			Facial transplantation: knowledge arrives, questions remain	LANCET			English	Editorial Material							STATISTICAL COMPARATIVE-ASSESSMENT; FACE TRANSPLANTATION; DETERMINE WHETHER; CARE THRESHOLD; OUTCOMES; ALLOTRANSPLANTATION; STANDARD		[Diaz-Siso, J. Rodrigo; Rodriguez, Eduardo D.] NYU, Hansjorg Wyss Dept Plast Surg, Langone Med Ctr, New York, NY 10016 USA	New York University; NYU Langone Medical Center	Rodriguez, ED (corresponding author), NYU, Hansjorg Wyss Dept Plast Surg, Langone Med Ctr, New York, NY 10016 USA.	Eduardo.Rodriguez@nyumc.org						[Anonymous], 2016, LANCET, V387, P2575; Breidenbach WC, 2016, PLAST RECONSTR SURG, V137, p214E, DOI 10.1097/PRS.0000000000001893; Bueno EM, 2011, J PLAST RECONSTR AES, V64, P1572, DOI 10.1016/j.bjps.2011.07.008; Caterson EJ, 2012, J CRANIOFAC SURG, V23, P1234, DOI 10.1097/SCS.0b013e318252d406; Diaz-Siso JR, 2016, PLAST RECONSTR SURG, V137, p223E, DOI 10.1097/PRS.0000000000001890; Diaz-Siso JR, 2013, J PLAST RECONSTR AES, V66, P1458, DOI 10.1016/j.bjps.2013.06.046; Dubernard Jean-Michel, 2013, Clin Transpl, P113; Guo SZ, 2008, LANCET, V372, P631, DOI 10.1016/S0140-6736(08)61276-3; Khalifian S, 2014, LANCET, V384, P2153, DOI 10.1016/S0140-6736(13)62632-X; Lantieri L, 2011, AM J TRANSPLANT, V11, P367, DOI 10.1111/j.1600-6143.2010.03406.x; Lantieri L, 2016, LANCET; Petruzzo P, 2012, TRANSPLANTATION, V93, P236, DOI 10.1097/TP.0b013e31823d4af6; Sosin M, 2016, PLAST RECONSTR SURG, V138, P205, DOI 10.1097/PRS.0000000000002322	13	12	15	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2016	388	10052					1355	1356		10.1016/S0140-6736(16)31396-4	http://dx.doi.org/10.1016/S0140-6736(16)31396-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DX5FD	27567682				2022-12-28	WOS:000384404300008
J	Prasad, V				Prasad, Vinay			The precision-oncology illusion	NATURE			English	Editorial Material									[Prasad, Vinay] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA	Oregon Health & Science University	Prasad, V (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA.	prasad@ohsu.edu		Prasad, Vinayak/0000-0002-6110-8221				Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Le Tourneau C, 2015, LANCET ONCOL, V16, P1324, DOI 10.1016/S1470-2045(15)00188-6; Meric-Bernstam F, 2015, J CLIN ONCOL, V33, P2753, DOI 10.1200/JCO.2014.60.4165; Prasad V, 2015, MAYO CLIN PROC, V90, P1639, DOI 10.1016/j.mayocp.2015.08.017; Schwaederle M, 2016, JAMA ONCOL	5	175	187	4	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					S63	S63		10.1038/537S63a	http://dx.doi.org/10.1038/537S63a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU9LQ	27602743				2022-12-28	WOS:000382539100004
J	Hampton, T				Hampton, Tracy			Study Provides Insights on ALS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																		Burberry A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6038	1	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2016	316	9					917	917		10.1001/jama.2016.11071	http://dx.doi.org/10.1001/jama.2016.11071			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU8JV	27599319				2022-12-28	WOS:000382460200004
J	Krieger, A				Krieger, Anja			Equality or excellence	NATURE			English	Editorial Material																			0	1	1	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					S12	S13		10.1038/537S12a	http://dx.doi.org/10.1038/537S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU7XC	27580134	Bronze			2022-12-28	WOS:000382426900022
J	Martinez, FD				Martinez, Fernando D.			Early-Life Origins of Chronic Obstructive Pulmonary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							LUNG-FUNCTION; AIR-POLLUTION; CHILDHOOD ASTHMA; PNEUMONIA; SMOKING; BIRTH; RISK; ASSOCIATION; NICOTINE; GROWTH		[Martinez, Fernando D.] Univ Arizona, Asthma & Airway Dis Res Ctr, POB 210240, Tucson, AZ 85724 USA	University of Arizona	Martinez, FD (corresponding author), Univ Arizona, Asthma & Airway Dis Res Ctr, POB 210240, Tucson, AZ 85724 USA.	fdmartin@email.arizona.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056177] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL056177] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akeson AL, 2005, PEDIATR RES, V57, P82, DOI 10.1203/01.PDR.0000148070.89006.3F; [Anonymous], 2016, LANCET RESP MED, V4, P463, DOI DOI 10.1016/S2213-2600(16)00096-5; [Anonymous], 2016, TRENDS AD TOB US; Bisgaard H, 2012, AM J RESP CRIT CARE, V185, P1183, DOI 10.1164/rccm.201110-1922OC; Blennow M, 2009, JAMA-J AM MED ASSOC, V301, P2225, DOI 10.1001/jama.2009.771; Bosco A, 2010, MUCOSAL IMMUNOL, V3, P399, DOI 10.1038/mi.2010.13; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Castro-Rodriguez JA, 1999, AM J RESP CRIT CARE, V159, P1891, DOI 10.1164/ajrccm.159.6.9811035; Chan JYC, 2015, PEDIATRICS, V135, P607, DOI 10.1542/peds.2014-3060; Checkley W, 2010, NEW ENGL J MED, V362, P1784, DOI 10.1056/NEJMoa0907441; Colom AJ, 2015, THORAX, V70, P169, DOI 10.1136/thoraxjnl-2014-205328; Cook DG, 1998, THORAX, V53, P884, DOI 10.1136/thx.53.10.884; Corey C, 2013, MMWR-MORBID MORTAL W, V62, P729; Cox DW, 2015, EUR RESPIR J, V46, P1654, DOI 10.1183/13993003.00397-2015; Edmond K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031239; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Fullerton DG, 2008, T ROY SOC TROP MED H, V102, P843, DOI 10.1016/j.trstmh.2008.05.028; Gauderman WJ, 2015, NEW ENGL J MED, V372, P905, DOI 10.1056/NEJMoa1414123; Gauderman WJ, 2004, NEW ENGL J MED, V351, P1057, DOI 10.1056/NEJMoa040610; Gold DR, 1996, NEW ENGL J MED, V335, P931, DOI 10.1056/NEJM199609263351304; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; Guerra S, 2013, THORAX, V68, P1021, DOI 10.1136/thoraxjnl-2013-203538; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Haland G, 2006, NEW ENGL J MED, V355, P1682, DOI 10.1056/NEJMoa052885; Hayden LP, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0273-8; Higgins D, 2016, VACCINE, V34, P2870, DOI 10.1016/j.vaccine.2016.03.109; Jackson Daniel J, 2014, Ann Am Thorac Soc, V11 Suppl 3, pS139, DOI 10.1513/AnnalsATS.201312-448LD; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; James AL, 2005, AM J RESP CRIT CARE, V171, P109, DOI 10.1164/rccm.200402-230OC; Kicic A, 2010, AM J RESP CRIT CARE, V181, P889, DOI 10.1164/rccm.200907-1071OC; Klimentidis Yann C., 2013, Frontiers in Genetics, V4, P174, DOI 10.3389/fgene.2013.00174; Kochanek Kenneth D, 2014, NCHS Data Brief, P1; Kotecha SJ, 2013, THORAX, V68, P760, DOI 10.1136/thoraxjnl-2012-203079; Lange P, 2015, NEW ENGL J MED, V373, P111, DOI 10.1056/NEJMoa1411532; Martinez FD, 2013, LANCET, V382, P1360, DOI 10.1016/S0140-6736(13)61536-6; Massaro GD, 2000, PHYSIOL GENOMICS, V4, P51, DOI 10.1152/physiolgenomics.2000.4.1.51; McGeachie MJ, 2016, NEW ENGL J MED, V374, P1842, DOI 10.1056/NEJMoa1513737; Morales E, 2015, THORAX, V70, P64, DOI 10.1136/thoraxjnl-2014-205413; Morgan WJ, 2005, AM J RESP CRIT CARE, V172, P1253, DOI 10.1164/rccm.200504-525OC; Obeidat M, 2015, LANCET RESP MED, V3, P782, DOI 10.1016/S2213-2600(15)00380-X; Postma DS, 2015, NEW ENGL J MED, V373, P1241, DOI 10.1056/NEJMra1411863; Saglani S, 2005, AM J RESP CRIT CARE, V171, P722, DOI 10.1164/rccm.200410-1404OC; Saglani S, 2007, AM J RESP CRIT CARE, V176, P858, DOI 10.1164/rccm.200702-212OC; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Sekhon HS, 2001, AM J RESP CRIT CARE, V164, P989, DOI 10.1164/ajrccm.164.6.2011097; Simpson A, 2012, AM J RESP CRIT CARE, V185, P1197, DOI 10.1164/rccm.201112-2191OC; SLY PD, 1984, ARCH DIS CHILD, V59, P935, DOI 10.1136/adc.59.10.935; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Spindel ER, 2016, AM J RESP CRIT CARE, V193, P486, DOI 10.1164/rccm.201510-2013PP; Stern DA, 2007, LANCET, V370, P758, DOI 10.1016/S0140-6736(07)61379-8; Strunk RC, 2006, J ALLERGY CLIN IMMUN, V118, P1040, DOI 10.1016/j.jaci.2006.07.053; Suresh S, 2015, CHEST, V147, P1118, DOI 10.1378/chest.14-0698; Svanes C, 2010, THORAX, V65, P14, DOI 10.1136/thx.2008.112136; Szefler S, 2000, NEW ENGL J MED, V343, P1054; Tai A, 2014, THORAX, V69, P805, DOI 10.1136/thoraxjnl-2013-204815; van Abeelen AFM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082636; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Voraphani N, 2014, AM J RESP CRIT CARE, V190, P392, DOI 10.1164/rccm.201311-2095OC; Wongtrakool C, 2007, AM J PHYSIOL-LUNG C, V293, pL611, DOI 10.1152/ajplung.00038.2007; Yeh TF, 2016, AM J RESP CRIT CARE, V193, P86, DOI 10.1164/rccm.201505-0861OC; Zar HJ, 2016, LANCET RESP MED, V4, P463, DOI 10.1016/S2213-2600(16)00096-5	61	290	302	4	64	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2016	375	9					871	878		10.1056/NEJMra1603287	http://dx.doi.org/10.1056/NEJMra1603287			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU9HA	27579637				2022-12-28	WOS:000382526000010
J	Savage, N				Savage, Neil			Mass effect	NATURE			English	Editorial Material																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					S18	S19		10.1038/537S18a	http://dx.doi.org/10.1038/537S18a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU7XC	27580137	Bronze			2022-12-28	WOS:000382426900025
J	Sevigny, J; Chiao, P; Bussiere, T; Weinreb, PH; Williams, L; Maier, M; Dunstan, R; Salloway, S; Chen, T; Ling, Y; O'Gorman, J; Qian, F; Arastu, M; Li, MW; Chollate, S; Brennan, MS; Quintero-Monzon, O; Scannevin, RH; Arnold, HM; Engber, T; Rhodes, K; Ferrero, J; Hang, YM; Mikulskis, A; Grimm, J; Hock, C; Nitsch, RM; Sandrock, A				Sevigny, Jeff; Chiao, Ping; Bussiere, Thierry; Weinreb, Paul H.; Williams, Leslie; Maier, Marcel; Dunstan, Robert; Salloway, Stephen; Chen, Tianle; Ling, Yan; O'Gorman, John; Qian, Fang; Arastu, Mahin; Li, Mingwei; Chollate, Sowmya; Brennan, Melanie S.; Quintero-Monzon, Omar; Scannevin, Robert H.; Arnold, H. Moore; Engber, Thomas; Rhodes, Kenneth; Ferrero, James; Hang, Yaming; Mikulskis, Alvydas; Grimm, Jan; Hock, Christoph; Nitsch, Roger M.; Sandrock, Alfred			The antibody aducanumab reduces A beta plaques in Alzheimer's disease	NATURE			English	Article							AMYLOID-BETA; IMAGING ABNORMALITIES; MOUSE MODEL; DRUG-DEVELOPMENT; PRION PROTEIN; TRIALS; NEURODEGENERATION; THERAPEUTICS; BAPINEUZUMAB; GANTENERUMAB	Alzheimer's disease (AD) is characterized by deposition of amyloid-beta (A beta) plaques and neurofibrillary tangles in the brain, accompanied by synaptic dysfunction and neurodegeneration. Antibody-based immunotherapy against A beta to trigger its clearance or mitigate its neurotoxicity has so far been unsuccessful. Here we report the generation of aducanumab, a human monoclonal antibody that selectively targets aggregated A beta. In a transgenic mouse model of AD, aducanumab is shown to enter the brain, bind parenchymal A beta, and reduce soluble and insoluble A beta in a dose-dependent manner. In patients with prodromal or mild AD, one year of monthly intravenous infusions of aducanumab reduces brain A beta in a dose- and time-dependent manner. This is accompanied by a slowing of clinical decline measured by Clinical Dementia Rating Sum of Boxes and Mini Mental State Examination scores. The main safety and tolerability findings are amyloid-related imaging abnormalities. These results justify further development of aducanumab for the treatment of AD. Should the slowing of clinical decline be confirmed in ongoing phase 3 clinical trials, it would provide compelling support for the amyloid hypothesis.	[Sevigny, Jeff; Chiao, Ping; Bussiere, Thierry; Weinreb, Paul H.; Williams, Leslie; Dunstan, Robert; Chen, Tianle; Ling, Yan; O'Gorman, John; Qian, Fang; Arastu, Mahin; Li, Mingwei; Chollate, Sowmya; Brennan, Melanie S.; Quintero-Monzon, Omar; Scannevin, Robert H.; Arnold, H. Moore; Engber, Thomas; Rhodes, Kenneth; Ferrero, James; Hang, Yaming; Mikulskis, Alvydas; Sandrock, Alfred] Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA; [Maier, Marcel; Grimm, Jan; Hock, Christoph; Nitsch, Roger M.] Neurimmune, CH-8952 Schlieren, Switzerland; [Salloway, Stephen] Butler Hosp, Providence, RI 02906 USA; [Hock, Christoph; Nitsch, Roger M.] Univ Zurich, Inst Regenerat Med, CH-8952 Zurich, Switzerland	Biogen; Butler Hospital Rhode Island; University of Zurich	Sandrock, A (corresponding author), Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA.	alfred.sandrock@biogen.com		Weinreb, Paul/0000-0002-0802-0052; Scannevin, Robert/0000-0002-5749-2785	Biogen	Biogen(Biogen)	These studies were funded by Biogen. The authors thank the patients and their family members participating in the aducanumab studies, and the PRIME investigators (Supplementary Information) and staff conducting these studies. Medical writing support, under direction of the authors, was provided by A. Smith at Complete Medical Communications, and was funded by Biogen. We thank N. Pederson, J. Dolnikova and E. Garber for help in generating the recombinant antibodies, D. Fahrer, C. Quigley, M. Themeles, X. Zhang and P. Auluck for help in generating the histological data, and K. Mack for editorial support and coordination of the authors in combining the preclinical and clinical work in this manuscript.	Banks WA, 2002, PEPTIDES, V23, P2223, DOI 10.1016/S0196-9781(02)00261-9; Barakos J, 2013, AM J NEURORADIOL, V34, P1958, DOI 10.3174/ajnr.A3500; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Boche D, 2008, BRAIN, V131, P3299, DOI 10.1093/brain/awn261; Bohrmann B, 2012, J ALZHEIMERS DIS, V28, P49, DOI 10.3233/JAD-2011-110977; Condello C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7176; Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269; Dennis J, 2013, ANN NEUROL, V74, P328, DOI 10.1002/ana.24001; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Ferrero J., ALZHEIMERS IN PRESS; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Ising C, 2015, CLIN PHARMACOL THER, V98, P469, DOI 10.1002/cpt.200; Jarosz-Griffiths HH, 2016, J BIOL CHEM, V291, P3174, DOI 10.1074/jbc.R115.702704; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kastanenka K., 2013, ALZHEIMERS DEMENT, V9, pP508; Kayed R., J ALZHEIMERS DIS S1, V33, pS67; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Landau SM, 2013, J NUCL MED, V54, P70, DOI 10.2967/jnumed.112.109009; Levites Y, 2006, FASEB J, V20, P2576, DOI 10.1096/fj.06-6463fje; Morkuniene R., 2015, NEUROSCI RES, V486, P475; Ostrowitzki S, 2012, ARCH NEUROL-CHICAGO, V69, P198, DOI 10.1001/archneurol.2011.1538; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Sevigny J, 2016, ALZ DIS ASSOC DIS, V30, P1, DOI 10.1097/WAD.0000000000000144; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sperling R, 2012, LANCET NEUROL, V11, P241, DOI 10.1016/S1474-4422(12)70015-7; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P367, DOI 10.1016/j.jalz.2011.05.2351; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Wang A, 2011, J NEUROSCI, V31, P4124, DOI 10.1523/JNEUROSCI.5077-10.2011; Zago Wagner, 2013, Alzheimers Dement, V9, pS105, DOI 10.1016/j.jalz.2012.11.010	33	1464	1507	33	901	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					50	56		10.1038/nature19323	http://dx.doi.org/10.1038/nature19323			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27582220				2022-12-28	WOS:000382426900036
J	Hunter, DJ				Hunter, David J.			Uncertainty in the Era of Precision Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hunter, David J.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Hunter, DJ (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA.							Feinstein A, 2011, MULT SCLER J, V17, P1276, DOI 10.1177/1352458511417835; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366	2	81	83	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2016	375	8					711	+		10.1056/NEJMp1608282	http://dx.doi.org/10.1056/NEJMp1608282			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT9ET	27557298				2022-12-28	WOS:000381799300009
J	Lane, R				Lane, Richard			Shengshou Hu: leader of cardiac surgery and health reform in China	LANCET			English	Biographical-Item																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 20	2016	388	10046					752	752		10.1016/S0140-6736(16)31350-2	http://dx.doi.org/10.1016/S0140-6736(16)31350-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT6UH	27560267				2022-12-28	WOS:000381619200015
J	Sibbing, D; Massberg, S				Sibbing, Dirk; Massberg, Steffen			Antiplatelet strategies in elderly people: still a long way to go	LANCET			English	Editorial Material							ACUTE CORONARY SYNDROMES; PLATELET REACTIVITY; STENT THROMBOSIS; CLOPIDOGREL; PRASUGREL; THERAPY; REVASCULARIZATION; INTERVENTION; TICAGRELOR		[Sibbing, Dirk; Massberg, Steffen] Univ Munich, Klinikum Univ Munchen, Med Klin & Poliklin 1, D-81377 Munich, Germany; [Sibbing, Dirk; Massberg, Steffen] DZHK German Ctr Cardiovasc Res, Munich Heart Alliance, Partner Site, Munich, Germany	University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance	Sibbing, D (corresponding author), Univ Munich, Klinikum Univ Munchen, Med Klin & Poliklin 1, D-81377 Munich, Germany.; Sibbing, D (corresponding author), DZHK German Ctr Cardiovasc Res, Munich Heart Alliance, Partner Site, Munich, Germany.	dirk@sibbing.net	Massberg, Steffen/AAN-6054-2021					Aradi D, 2015, EUR HEART J, V36, P1762, DOI 10.1093/eurheartj/ehv104; Aradi D, 2014, EUR HEART J, V35, P209, DOI 10.1093/eurheartj/eht375; Cayla G., 2016, LANCET; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Erlinge D, 2013, J AM COLL CARDIOL, V62, P577, DOI 10.1016/j.jacc.2013.05.023; Gurbel PA, 2012, JAMA-J AM MED ASSOC, V308, P1785, DOI 10.1001/jama.2012.17312; Qaderdan K, 2015, AM HEART J, V170, P981, DOI 10.1016/j.ahj.2015.07.030; Roe MT, 2013, CIRCULATION, V128, P823, DOI 10.1161/CIRCULATIONAHA.113.002303; Sibbing D, 2010, J AM COLL CARDIOL, V56, P317, DOI 10.1016/j.jacc.2010.03.048; Tantry US, 2013, J AM COLL CARDIOL, V62, P2261, DOI 10.1016/j.jacc.2013.07.101; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	12	3	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2016	388	10055					1962	1964		10.1016/S0140-6736(16)31387-3	http://dx.doi.org/10.1016/S0140-6736(16)31387-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ6EQ	27581529				2022-12-28	WOS:000385954800007
J	Gu, YN; Zebell, SG; Liang, ZZ; Wang, S; Kang, BH; Dong, XN				Gu, Yangnan; Zebell, Sophia G.; Liang, Zizhen; Wang, Shui; Kang, Byung-Ho; Dong, Xinnian			Nuclear Pore Permeabilization Is a Convergent Signaling Event in Effector-Triggered Immunity	CELL			English	Article							PLANT INNATE IMMUNITY; CELL-DEATH; ARABIDOPSIS-THALIANA; DEFENSE RESPONSES; PATHOGEN-DEFENSE; GOING PROTEIN; GENE; COMPLEX; IDENTIFICATION; RESISTANCE	Nuclear transport of immune receptors, signal transducers, and transcription factors is an essential regulatory mechanism for immune activation. Whether and how this process is regulated at the level of the nuclear pore complex (NPC) remains unclear. Here, we report that CPR5, which plays a key inhibitory role in effector-triggered immunity (ETI) and programmed cell death (PCD) in plants, is a novel transmembrane nucleoporin. CPR5 associates with anchors of the NPC selective barrier to constrain nuclear access of signaling cargos and sequesters cyclin-dependent kinase inhibitors (CKIs) involved in ETI signal transduction. Upon activation by immunoreceptors, CPR5 undergoes an oligomer to monomer conformational switch, which coordinates CKI release for ETI signaling and reconfigures the selective barrier to allow significant influx of nuclear signaling cargos through the NPC. Consequently, these coordinated NPC actions result in simultaneous activation of diverse stress-related signaling pathways and constitute an essential regulatory mechanism specific for ETI/PCD induction.	[Gu, Yangnan; Zebell, Sophia G.; Dong, Xinnian] Duke Univ, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Dept Biol, POB 90338, Durham, NC 27708 USA; [Liang, Zizhen; Kang, Byung-Ho] Chinese Univ Hong Kong, Ctr Cell & Dev Biol, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Liang, Zizhen; Kang, Byung-Ho] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Hong Kong, Hong Kong, Peoples R China; [Wang, Shui] Shanghai Normal Univ, Coll Life & Environm Sci, Dev Ctr Plant Germplasm Resources, Shanghai 200234, Peoples R China	Duke University; Howard Hughes Medical Institute; Chinese University of Hong Kong; Chinese University of Hong Kong; Shanghai Normal University	Dong, XN (corresponding author), Duke Univ, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Dept Biol, POB 90338, Durham, NC 27708 USA.	xdong@duke.edu	Kang, Byung-Ho/G-9312-2017; Gu, Yangnan/AAE-5745-2019; Wang, Shui/GLU-0896-2022; Zebell, Sophia/AAZ-9247-2020; Gu, Yangnan/B-7285-2016	Kang, Byung-Ho/0000-0002-4299-2170; Wang, Shui/0000-0002-5687-8715; Gu, Yangnan/0000-0001-5135-0180; Zebell, Sophia/0000-0003-1854-6389	Howard Hughes Medical Institute; Gordon and Betty Moore Foundation [GBMF3032]; NIH [R01-GM069594]; National Natural Science Foundation of China [31571254]; Rural Development Administration, Republic of Korea [10953092015]; Research Grants Council of Hong Kong [AoE/M-05/12, C4011-14R]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007184, R35GM118036, R01GM069594, R01GM099839] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Research Grants Council of Hong Kong(Hong Kong Research Grants Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Roger Innes for providing membrane organelle markers and Dr. Iris Meier for sharing the 35S:GFP-WIP1 and 35S:RanGAP1-GFP transgenic lines. We also thank Drs. Iris Meier, Paul Zwack, and John Withers for critical reading of the manuscript. This work was supported by the Howard Hughes Medical Institute and the Gordon and Betty Moore Foundation (through grant GBMF3032) and grants from the NIH (R01-GM069594 to X.D.), the National Natural Science Foundation of China (grant 31571254 to S.W.), the Rural Development Administration, Republic of Korea (project 10953092015), and the Research Grants Council of Hong Kong (AoE/M-05/12, C4011-14R to B.K.).	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Anderson L.K., 2006, THESIS; Boch J, 1998, MOL PLANT MICROBE IN, V11, P1196, DOI 10.1094/MPMI.1998.11.12.1196; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Brkljacic J, 2009, PLANT PHYSIOL, V151, P142, DOI 10.1104/pp.109.143404; Chakraborty P, 2008, DEV CELL, V15, P657, DOI 10.1016/j.devcel.2008.08.020; Cheng YT, 2009, PLANT CELL, V21, P2503, DOI 10.1105/tpc.108.064519; Deslandes L, 2011, PLANT SIGNAL BEHAV, V6, P42, DOI 10.4161/psb.6.1.13978; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Dong CH, 2006, MOL CELL BIOL, V26, P9533, DOI 10.1128/MCB.01063-06; Du JB, 2016, PLANT J, V85, P520, DOI 10.1111/tpj.13125; Elmore JM, 2011, CURR OPIN PLANT BIOL, V14, P365, DOI 10.1016/j.pbi.2011.03.011; Garcia AV, 2009, TRENDS PLANT SCI, V14, P479, DOI 10.1016/j.tplants.2009.07.004; Geisler-Lee J, 2007, PLANT PHYSIOL, V145, P317, DOI 10.1104/pp.107.103465; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gong FC, 1996, P NATL ACAD SCI USA, V93, P2219, DOI 10.1073/pnas.93.5.2219; Gu YN, 2012, PLANT CELL, V24, P4717, DOI 10.1105/tpc.112.105254; Gu YN, 2011, PLANT PHYSIOL, V155, P1827, DOI 10.1104/pp.110.171785; Jevtic P, 2014, CURR OPIN CELL BIOL, V28, P16, DOI 10.1016/j.ceb.2014.01.003; Jing HC, 2007, J EXP BOT, V58, P3885, DOI 10.1093/jxb/erm237; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kang BH, 2010, METHOD CELL BIOL, V96, P259, DOI 10.1016/S0091-679X(10)96012-3; Lee HJ, 2001, GENE DEV, V15, P912, DOI 10.1101/gad.866801; Lee Y, 2008, J EXP BOT, V59, P3229, DOI 10.1093/jxb/ern200; Mans BJ, 2004, CELL CYCLE, V3, P1612; McNellis TW, 1998, PLANT J, V14, P247, DOI 10.1046/j.1365-313X.1998.00106.x; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; O'Connor TR, 2005, BIOINFORMATICS, V21, P4411, DOI 10.1093/bioinformatics/bti714; Palma K, 2005, CURR BIOL, V15, P1129, DOI 10.1016/j.cub.2005.05.022; Parry G, 2014, J EXP BOT, V65, P6057, DOI 10.1093/jxb/eru346; Reina-Pinto JJ, 2010, PLANT J, V61, P166, DOI 10.1111/j.1365-313X.2009.04043.x; Rivas S, 2012, PLANT PHYSIOL, V158, P87, DOI 10.1104/pp.111.186163; Shulga N, 2000, J CELL BIOL, V149, P1027, DOI 10.1083/jcb.149.5.1027; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Stuart LM, 2013, NAT REV IMMUNOL, V13, P199, DOI 10.1038/nri3398; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tamura K, 2010, PLANT CELL, V22, P4084, DOI 10.1105/tpc.110.079947; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Toyama BH, 2013, CELL, V154, P971, DOI 10.1016/j.cell.2013.07.037; Tsuda K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000772; Verslues PE, 2006, PLANT J, V47, P776, DOI 10.1111/j.1365-313X.2006.02833.x; Wang S, 2014, CELL HOST MICROBE, V16, P787, DOI 10.1016/j.chom.2014.10.005; Wiermer M, 2012, PLANT J, V70, P796, DOI 10.1111/j.1365-313X.2012.04928.x; Wirthmueller L, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00149; Yi X, 2013, NUCLEIC ACIDS RES, V41, pW98, DOI 10.1093/nar/gkt281; Yoshida S, 2002, PLANT J, V29, P427, DOI 10.1046/j.0960-7412.2001.01228.x; Zhang YL, 2005, PLANT CELL, V17, P1306, DOI 10.1105/tpc.104.029926	47	79	84	7	81	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2016	166	6					1526	+		10.1016/j.cell.2016.07.042	http://dx.doi.org/10.1016/j.cell.2016.07.042			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EA1GG	27569911	Green Accepted, Bronze			2022-12-28	WOS:000386339900023
J	Warren, WS				Warren, Warren S.			Ahmed Hassan Zewail (1946-2016) OBITUARY	NATURE			English	Biographical-Item									[Warren, Warren S.] Duke Univ, Dept Phys, Durham, NC 27706 USA	Duke University	Warren, WS (corresponding author), Duke Univ, Dept Phys, Durham, NC 27706 USA.	warren.warren@duke.edu	Khan, Sameen/K-6146-2013	Khan, Sameen/0000-0003-1264-2302				ZEWAIL AH, PUBLICATION LIST	1	0	0	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					168	168		10.1038/537168a	http://dx.doi.org/10.1038/537168a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9LQ	27604942	Bronze			2022-12-28	WOS:000382539100030
J	Wise, J				Wise, Jacqui			Sexual problems are common in under 55s after acute MI, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Lindau S, 2016, JAMA CARDIOL, DOI [10.1001/jamacardio.2016.23622, DOI 10.1001/JAMACARDIO.2016.23622]; Weinfurt KP, 2016, JAMA CARDIOL, V1, P765, DOI 10.1001/jamacardio.2016.2436	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2016	354								i4737	10.1136/bmj.i4737	http://dx.doi.org/10.1136/bmj.i4737			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AE	27585453				2022-12-28	WOS:000382792600011
J	Chen, Y; Clarke, OB; Kim, J; Stowe, S; Kim, YK; Assur, Z; Cavalier, M; Godoy-Ruiz, R; von Alpen, DC; Manzini, C; Blaner, WS; Frank, J; Quadro, L; Weber, DJ; Shapiro, L; Hendrickson, WA; Mancia, F				Chen, Yunting; Clarke, Oliver B.; Kim, Jonathan; Stowe, Sean; Kim, Youn-Kyung; Assur, Zahra; Cavalier, Michael; Godoy-Ruiz, Raquel; von Alpen, Desiree C.; Manzini, Chiara; Blaner, William S.; Frank, Joachim; Quadro, Loredana; Weber, David J.; Shapiro, Lawrence; Hendrickson, Wayne A.; Mancia, Filippo			Structure of the STRA6 receptor for retinol uptake	SCIENCE			English	Article							BINDING-PROTEIN-RECEPTOR; MULTIPLE SEQUENCE ALIGNMENT; VITAMIN-A TRANSPORT; MEMBRANE-RECEPTOR; CELLULAR UPTAKE; WEB SERVER; HOLO-RBP; APO-RBP; ACTIVATION; CALMODULIN	Vitamin A homeostasis is critical to normal cellular function. Retinol-binding protein (RBP) is the sole specific carrier in the bloodstream for hydrophobic retinol, the main form in which vitamin A is transported. The integral membrane receptor STRA6 mediates cellular uptake of vitamin A by recognizing RBP-retinol to trigger release and internalization of retinol. We present the structure of zebrafish STRA6 determined to 3.9-angstrom resolution by single-particle cryo-electron microscopy. STRA6 has one intramembrane and nine transmembrane helices in an intricate dimeric assembly. Unexpectedly, calmodulin is bound tightly to STRA6 in a noncanonical arrangement. Residues involved with RBP binding map to an archlike structure that covers a deep lipophilic cleft. This cleft is open to the membrane, suggesting a possible mode for internalization of retinol through direct diffusion into the lipid bilayer.	[Chen, Yunting; Kim, Jonathan; Assur, Zahra; Hendrickson, Wayne A.; Mancia, Filippo] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Clarke, Oliver B.; Frank, Joachim; Shapiro, Lawrence; Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA; [Stowe, Sean; Cavalier, Michael; Godoy-Ruiz, Raquel; Weber, David J.] Univ Maryland, Sch Med, Ctr Biomol Therapeut, Baltimore, MD 21201 USA; [Stowe, Sean; Cavalier, Michael; Godoy-Ruiz, Raquel; Weber, David J.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Kim, Youn-Kyung; Quadro, Loredana] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; [Kim, Youn-Kyung; Quadro, Loredana] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [von Alpen, Desiree C.; Manzini, Chiara] George Washington Univ, Dept Physiol & Pharmacol, Washington, DC 20037 USA; [von Alpen, Desiree C.; Manzini, Chiara] George Washington Univ, Dept Integrat Syst Biol, Washington, DC 20037 USA; [Blaner, William S.] Columbia Univ, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Rutgers State University New Brunswick; Rutgers State University New Brunswick; George Washington University; George Washington University; Columbia University	Mancia, F (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA.	fm123@cumc.columbia.edu	Weber, David J/B-5349-2011; Godoy Ruiz, Raquel/GOH-1617-2022; Shapiro, Lawrence/AAE-7172-2019	Weber, David J/0000-0002-8824-1110; Kim, Jonathan/0000-0003-2594-3251; Manzini, M. Chiara/0000-0001-7175-1096; GODOY-RUIZ, RAQUEL/0000-0003-4569-0781; Mancia, Filippo/0000-0003-3293-2200	NIH National Institute of General Medical Sciences [U54 GM095315]; Charles H. Revson Senior Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD083331] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA154274] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY027405] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL120826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068437, R01DK101251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097089, P41GM116799, R01GM029169, R01GM111980, U54GM075026, U54GM095315] Funding Source: NIH RePORTER	NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Charles H. Revson Senior Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a NIH National Institute of General Medical Sciences initiative to the New York Consortium on Membrane Protein Structure (U54 GM095315). O.B.C. was supported by a Charles H. Revson Senior Fellowship. We thank G. Sciara and G. Ahlsen for sharing with us their expertise for the light-scattering experiments; F. Insaidoo, L. A. White, I. Ubarretxena, Y. Gomez, S. Brenner-Morton, and A. Nemes for their contributions during the initial stages of this work; B. Kloss, R. Bruni, and R. Kalathur from the New York Structural Biology Center for their many contributions to the project; R. Grassucci for assistance with data collection; A. des Georges, A. Marks, and R. Axel for advice and helpful discussions; and L. Hamberger for assistance with running the Mancia laboratory. The CaM-CaMBP2 structure has been deposited in the PDB under accession code 5K8Q. The STRA6-CaM coordinates have been deposited in the PDB under accession code 5SY1, and the map has been deposited in the Electron Microscopy Data Bank under accession code EMD-8315.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Al Tanoury Z, 2013, J LIPID RES, V54, P1761, DOI 10.1194/jlr.R030833; Alapatt P, 2013, J BIOL CHEM, V288, P1250, DOI 10.1074/jbc.M112.369132; Amengual J, 2014, HUM MOL GENET, V23, P5402, DOI 10.1093/hmg/ddu258; Assur Z, 2012, METHODS MOL BIOL, V801, P173, DOI 10.1007/978-1-61779-352-3_12; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Berry DC, 2013, J BIOL CHEM, V288, P24528, DOI 10.1074/jbc.M113.484014; Berry DC, 2012, MOL CELL BIOL, V32, P3164, DOI 10.1128/MCB.00505-12; Berry DC, 2011, P NATL ACAD SCI USA, V108, P4340, DOI 10.1073/pnas.1011115108; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chassaing N, 2009, HUM MUTAT, V30, pE673, DOI 10.1002/humu.21023; COGAN U, 1976, EUR J BIOCHEM, V65, P71, DOI 10.1111/j.1432-1033.1976.tb10390.x; di Masi A, 2015, MOL ASPECTS MED, V41, P1, DOI 10.1016/j.mam.2014.12.003; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GOODMAN DS, 1984, NEW ENGL J MED, V310, P1023, DOI 10.1056/NEJM198404193101605; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Hesselink RW, 2013, MOL MEMBR BIOL, V30, P327, DOI 10.3109/09687688.2013.823018; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Isken A, 2008, CELL METAB, V7, P258, DOI 10.1016/j.cmet.2008.01.009; Kawaguchi R, 2008, J BIOL CHEM, V283, P15160, DOI 10.1074/jbc.M801060200; Kawaguchi R, 2008, BIOCHEMISTRY-US, V47, P5387, DOI 10.1021/bi8002082; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kawaguchi R, 2013, J MEMBRANE BIOL, V246, P647, DOI 10.1007/s00232-013-9578-z; Kawaguchi R, 2012, J MEMBRANE BIOL, V245, P731, DOI 10.1007/s00232-012-9463-1; Kawaguchi R, 2011, ACS CHEM BIOL, V6, P1041, DOI 10.1021/cb200178w; Kendrick BS, 2001, ANAL BIOCHEM, V299, P136, DOI 10.1006/abio.2001.5411; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li Yang, 2014, Hepatobiliary Surg Nutr, V3, P126, DOI 10.3978/j.issn.2304-3881.2014.05.04; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Mancusso R, 2011, METHODS, V55, P324, DOI 10.1016/j.ymeth.2011.07.008; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MELHUS H, 1995, BIOCHEM BIOPH RES CO, V210, P105, DOI 10.1006/bbrc.1995.1633; Noy N, 2015, PROSTAG LEUKOTR ESS, V93, P3, DOI 10.1016/j.plefa.2014.10.004; Noy N, 2014, MOL CELL BIOL, V34, P2107, DOI 10.1128/MCB.01699-12; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Redondo C, 2008, FASEB J, V22, P1043, DOI 10.1096/fj.07-8939com; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; ROSS AC, 1993, FASEB J, V7, P317, DOI 10.1096/fasebj.7.2.8440409; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Ruiz A, 2012, INVEST OPHTH VIS SCI, V53, P3027, DOI 10.1167/iovs.11-8476; Russo CJ, 2014, SCIENCE, V346, P1377, DOI 10.1126/science.1259530; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Shirakami Y, 2012, BBA-MOL CELL BIOL L, V1821, P124, DOI 10.1016/j.bbalip.2011.06.023; SIVAPRASADARAO A, 1994, BIOCHEM J, V302, P245, DOI 10.1042/bj3020245; Slabinski L, 2007, BIOINFORMATICS, V23, P3403, DOI 10.1093/bioinformatics/btm477; Soprano Dianne Robert, 1994, P257; Sundaram M, 1998, J BIOL CHEM, V273, P3336, DOI 10.1074/jbc.273.6.3336; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tidow H, 2013, FEBS J, V280, P5551, DOI 10.1111/febs.12296; Usacheva A, 2002, J BIOL CHEM, V277, P48220, DOI 10.1074/jbc.M205757200; Van Esch H, 2007, AM J MED GENET A, V143A, P364, DOI 10.1002/ajmg.a.31572; Vieira Marta, 2014, Biomol Concepts, V5, P45, DOI 10.1515/bmc-2013-0038; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Wallweber HJA, 2014, NAT STRUCT MOL BIOL, V21, P443, DOI 10.1038/nsmb.2807; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wernimont AK, 2011, PROTEINS, V79, P803, DOI 10.1002/prot.22919; West KP, 2002, J NUTR, V132, p2857S, DOI 10.1093/jn/132.9.2857S; Zhong M, 2014, MOL CELL BIOL, V34, P2105, DOI 10.1128/MCB.01425-12; Zhong M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073838	71	83	84	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302							aad8266	10.1126/science.aad8266	http://dx.doi.org/10.1126/science.aad8266			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU0CA	27563101	Green Accepted			2022-12-28	WOS:000381867700029
J	Dupas, P; Hoffmann, V; Kremer, M; Zwane, AP				Dupas, Pascaline; Hoffmann, Vivian; Kremer, Michael; Zwane, Alix Peterson			Targeting health subsidies through a nonprice mechanism: A randomized controlled trial in Kenya	SCIENCE			English	Article							INSECTICIDE-TREATED BEDNETS; FIELD EXPERIMENT; DEVELOPING-COUNTRIES; SYSTEMATIC ANALYSIS; MALARIA PREVENTION; CHILD-MORTALITY; NATIONAL CAUSES; WATER; PRODUCTS	Each cycle of pre-messenger RNA splicing, carried out by the spliceosome, comprises two sequential transesterification reactions, which result in the removal of an intron and the joining of two exons. Here we report an atomic structure of a catalytic step I spliceosome (known as the C complex) from Saccharomyces cerevisiae, as determined by cryo-electron microscopy at an average resolution of 3.4 angstroms. In the structure, the 2'-OH of the invariant adenine nucleotide in the branch point sequence (BPS) is covalently joined to the phosphate at the 5' end of the 5' splice site (5' SS), forming an intron lariat. The freed 5' exon remains anchored to loop I of U5 small nuclear RNA (snRNA), and the 5' SS and BPS of the intron form duplexes with conserved U6 and U2 snRNA sequences, respectively. Specific placement of these RNA elements at the catalytic cavity of Prp8 is stabilized by 15 protein components, including Snu114 and the splicing factors Cwc21, Cwc22, Cwc25, and Yju2. These features, representing the conformation of the spliceosome after the first-step reaction, predict structural changes that are needed for the execution of the second-step transesterification reaction.	[Dupas, Pascaline] Stanford Univ, Stanford, CA 94305 USA; [Dupas, Pascaline; Kremer, Michael] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Hoffmann, Vivian] Int Food Policy Res Inst, Washington, DC 20036 USA; [Kremer, Michael] Harvard Univ, Cambridge, MA 02138 USA; [Zwane, Alix Peterson] Global Innovat Fund, Washington, DC 20036 USA	Stanford University; National Bureau of Economic Research; CGIAR; International Food Policy Research Institute (IFPRI); Harvard University	Dupas, P (corresponding author), Stanford Univ, Stanford, CA 94305 USA.; Dupas, P; Kremer, M (corresponding author), Natl Bur Econ Res, Cambridge, MA 02138 USA.; Hoffmann, V (corresponding author), Int Food Policy Res Inst, Washington, DC 20036 USA.; Kremer, M (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.; Zwane, AP (corresponding author), Global Innovat Fund, Washington, DC 20036 USA.	pdupas@stanford.edu; v.hoffmann@cgiar.org; mkremer@fas.harvard.edu; alix.zwane@globalinnovation.fund		Hoffmann, Vivian/0000-0002-6464-3748; Dupas, Pascaline/0000-0003-0140-9417	Bill & Melinda Gates Foundation; NIH [P01HD061315-01]; NSF [1254167]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD061315] Funding Source: NIH RePORTER; Direct For Social, Behav & Economic Scie [1254167] Funding Source: National Science Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	We thank IPA Kenya for its collaboration; E. Chuang, K. Gatobu, B. Michel, S. Sylvia, A. Sebastian, N. Studer, and S. Ruiz for research assistance; and M. Baraza and his team for outstanding data collection. This study was funded by the Bill & Melinda Gates Foundation. P.D. gratefully acknowledges the support of NIH grant P01HD061315-01 and NSF grant 1254167. The research protocol for the study was approved by the ethical review committees of the Kenya Medical Research Institute (KEMRI), University of California at Berkeley, and Innovations for Poverty Action Kenya. The study is registered in the American Economic Association's registry for randomized controlled trials under ID AEARCTR-0001076. The data and code are publicly available on Dataverse (doi: 10.7910/DVN/PBLJXJ).	Alatas V, 2016, J POLIT ECON, V124, P371, DOI 10.1086/685299; Arnold BF, 2007, AM J TROP MED HYG, V76, P354, DOI 10.4269/ajtmh.2007.76.354; Ashraf N, 2010, AM ECON REV, V100, P2383, DOI 10.1257/aer.100.5.2383; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Cohen J, 2015, AM ECON REV, V105, P609, DOI 10.1257/aer.20130267; Cohen J, 2010, Q J ECON, V125, P1, DOI 10.1162/qjec.2010.125.1.1; Dupas P, 2014, SCIENCE, V345, P1279, DOI 10.1126/science.1256973; Dupas P, 2014, ECONOMETRICA, V82, P197, DOI 10.3982/ECTA9508; Dupas P, 2011, ANNU REV ECON, V3, P425, DOI 10.1146/annurev-economics-111809-125029; Dupas P, 2009, AM ECON REV, V99, P224, DOI 10.1257/aer.99.2.224; Hoffmann V, 2009, WORLD DEV, V37, P607, DOI 10.1016/j.worlddev.2008.08.003; Holla A, 2009, 158 CTR GLOB DEV; Kenya National Bureau of Statistics (KNBS) and ICF Macro, 2010, KENY DEM HLTH SURV 2; Kremer M., 2012, HDB HLTH EC, V2; Kremer M., WORKING PAPER; Lantagne D, 2011, J ENVIRON ENG-ASCE, V137, P131, DOI 10.1061/(ASCE)EE.1943-7870.0000299; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Loharikar A, 2013, AM J TROP MED HYG, V88, P267, DOI 10.4269/ajtmh.2012.11-0375; Luoto J, 2014, J DEV ECON, V110, P13, DOI 10.1016/j.jdeveco.2014.02.010; Ma X., 2014, 266 REAP; Mulligan JA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-32; NICHOLS AL, 1982, AM ECON REV, V72, P372; PSI (Population Services International), HOUS WAT TREATM; Tarozzi A, 2014, AM ECON REV, V104, P1909, DOI 10.1257/aer.104.7.1909; UN Inter-agency Group for Child Mortality Estimation, 2015, CME INF DAT; US Centers for Disease Control and Prevention, SAF WAT SYST PROJ SO; WHO, 2002, REP COMM MACR HLTH; World Bank, 1993, WORLD DEV RREP 1993; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	29	33	33	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					889	895		10.1126/science.aaf6288	http://dx.doi.org/10.1126/science.aaf6288			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU0CA	27563091	Green Accepted			2022-12-28	WOS:000381867700031
J	Iacobucci, G				Iacobucci, Gareth			Details emerge of plans to cut NHS services in England	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Gulland A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4449; Incisive Health, 2016, STPS EARL AR ACT	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 26	2016	354								i4688	10.1136/bmj.i4688	http://dx.doi.org/10.1136/bmj.i4688			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AB	27566231				2022-12-28	WOS:000382792300009
J	Verdaguer, X				Verdaguer, Xavier			Building molecular complexity from scratch	SCIENCE			English	Editorial Material									[Verdaguer, Xavier] Barcelona Inst Sci & Technol, Inst Res & Biomed IRB Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain; [Verdaguer, Xavier] Univ Barcelona, Dept Quim Inorgan & Organ, Seccio Organ, Marti i Franques 1, E-08028 Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona	Verdaguer, X (corresponding author), Barcelona Inst Sci & Technol, Inst Res & Biomed IRB Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain.; Verdaguer, X (corresponding author), Univ Barcelona, Dept Quim Inorgan & Organ, Seccio Organ, Marti i Franques 1, E-08028 Barcelona, Spain.	xavier.verdaguer@irbbarcelona.org	Verdaguer, Xavier/J-9879-2014	Verdaguer, Xavier/0000-0002-9229-969X				Aiguabella N, 2013, ORG LETT, V15, P2696, DOI 10.1021/ol400999a; Chuang KV, 2016, SCIENCE, V353, P912, DOI 10.1126/science.aag1028; KHAND IU, 1973, J CHEM SOC PERK T 1, P977, DOI 10.1039/p19730000977; Orgue S, 2015, ORG LETT, V17, P250, DOI 10.1021/ol503329g; Rios R, 2012, PAUSON KHAND REACTIO; Seeman JI, 2016, NAT CHEM, V8, P193, DOI 10.1038/nchem.2455; Shibata T, 2006, ADV SYNTH CATAL, V348, P2328, DOI 10.1002/adsc.200600328; Su S, 2011, J AM CHEM SOC, V133, P13922, DOI 10.1021/ja206191g; Vazquez-Romero A, 2008, ORG LETT, V10, P4509, DOI 10.1021/ol8017352; Werner H, 2014, ANGEW CHEM INT EDIT, V53, P3309, DOI 10.1002/anie.201400432; You L, 2015, J AM CHEM SOC, V137, P10120, DOI 10.1021/jacs.5b06480	11	3	3	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					866	867		10.1126/science.aah5871	http://dx.doi.org/10.1126/science.aah5871			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU0CA	27563083				2022-12-28	WOS:000381867700016
J	Mazzolai, B; Mattoli, V				Mazzolai, Barbara; Mattoli, Virgilio			ROBOTICS Generation soft	NATURE			English	Editorial Material							MICRO		[Mazzolai, Barbara; Mattoli, Virgilio] Ist Italiano Tecnol, Ctr MicrobioRobot, I-56025 Pisa, Italy	Istituto Italiano di Tecnologia - IIT	Mazzolai, B (corresponding author), Ist Italiano Tecnol, Ctr MicrobioRobot, I-56025 Pisa, Italy.	barbara.mazzolai@iit.it	Mattoli, Virgilio/A-6744-2017; Mazzolai, Barbara/I-8876-2016	Mattoli, Virgilio/0000-0002-4715-8353; Mazzolai, Barbara/0000-0003-0722-8350				Heckele M, 2004, J MICROMECH MICROENG, V14, pR1, DOI 10.1088/0960-1317/14/3/R01; Lin HT, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/2/026007; Mazzolai B, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/2/025005; Park YL, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/1/016007; Paul C, 2006, ROBOT AUTON SYST, V54, P619, DOI 10.1016/j.robot.2006.03.003; Pfeifer R, 2007, SCIENCE, V318, P1088, DOI 10.1126/science.1145803; Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234; Ranzani T, 2015, BIOINSPIR BIOMIM, V10, DOI 10.1088/1748-3190/10/3/035008; Rus D, 2015, NATURE, V521, P467, DOI 10.1038/nature14543; Shepherd RF, 2011, P NATL ACAD SCI USA, V108, P20400, DOI 10.1073/pnas.1116564108; Wehner M, 2016, NATURE, V536, P451, DOI 10.1038/nature19100; Wu W, 2011, ADV MATER, V23, pH178, DOI 10.1002/adma.201004625	12	21	21	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					400	401		10.1038/536400a	http://dx.doi.org/10.1038/536400a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV0YL	27558058				2022-12-28	WOS:000382646600026
J	McCall, B				McCall, Becky			Child poverty continues to rise in the UK	LANCET			English	Editorial Material																			0	4	4	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 20	2016	388	10046					747	747		10.1016/S0140-6736(16)31416-7	http://dx.doi.org/10.1016/S0140-6736(16)31416-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT6UH	27560264				2022-12-28	WOS:000381619200012
J	Jean, N; Burke, M; Xie, M; Davis, WM; Lobell, DB; Ermon, S				Jean, Neal; Burke, Marshall; Xie, Michael; Davis, W. Matthew; Lobell, David B.; Ermon, Stefano			Combining satellite imagery and machine learning to predict poverty	SCIENCE			English	Article							WEALTH	Reliable data on economic livelihoods remain scarce in the developing world, hampering efforts to study these outcomes and to design policies that improve them. Here we demonstrate an accurate, inexpensive, and scalable method for estimating consumption expenditure and asset wealth from high-resolution satellite imagery. Using survey and satellite data from five African countries-Nigeria, Tanzania, Uganda, Malawi, and Rwanda-we show how a convolutional neural network can be trained to identify image features that can explain up to 75% of the variation in local-level economic outcomes. Our method, which requires only publicly available data, could transform efforts to track and target poverty in developing countries. It also demonstrates how powerful machine learning techniques can be applied in a setting with limited training data, suggesting broad potential application across many scientific domains.	[Jean, Neal; Xie, Michael; Ermon, Stefano] Stanford Univ, Dept Comp Sci, Stanford, CA USA; [Jean, Neal] Stanford Univ, Dept Elect Engn, Stanford, CA USA; [Burke, Marshall; Lobell, David B.] Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA; [Burke, Marshall; Davis, W. Matthew; Lobell, David B.] Stanford Univ, Ctr Food Secur & Environm, Stanford, CA 94305 USA; [Burke, Marshall] NBER, Boston, MA 02115 USA	Stanford University; Stanford University; Stanford University; Stanford University; National Bureau of Economic Research	Burke, M (corresponding author), Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA.; Burke, M (corresponding author), Stanford Univ, Ctr Food Secur & Environm, Stanford, CA 94305 USA.; Burke, M (corresponding author), NBER, Boston, MA 02115 USA.	mburke@stanford.edu		Alampay Davis, William Matthew/0000-0002-9502-2450; Burke, Marshall/0000-0003-4288-5858; Xie, Sang Michael/0000-0002-0820-2753; Lobell, David/0000-0002-5969-3476	NVIDIA Corporation through an NVIDIA Academic Hardware Grant; Stanford's Global Development and Poverty Initiative; AidData Project at the College of William Mary; National Defense Science and Engineering Graduate Fellowship Program; NSF [1522054, 72954-10597]; Division of Computing and Communication Foundations [1522054] Funding Source: National Science Foundation	NVIDIA Corporation through an NVIDIA Academic Hardware Grant; Stanford's Global Development and Poverty Initiative; AidData Project at the College of William Mary; National Defense Science and Engineering Graduate Fellowship Program; NSF(National Science Foundation (NSF)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We gratefully acknowledge support from NVIDIA Corporation through an NVIDIA Academic Hardware Grant, from Stanford's Global Development and Poverty Initiative, and from the AidData Project at the College of William & Mary. N.J. acknowledges support from the National Defense Science and Engineering Graduate Fellowship Program. S.E. is partially supported by NSF grant 1522054 through subcontract 72954-10597. We declare no conflicts of interest. All data and code needed to replicate these results are available at http://purl.stanford.edu/cz134jc5378.	Blumenstock J, 2015, SCIENCE, V350, P1073, DOI 10.1126/science.aac4420; Chen X, 2011, P NATL ACAD SCI USA, V108, P8589, DOI 10.1073/pnas.1017031108; Devarajan S, 2013, REV INCOME WEALTH, V59, pS9, DOI 10.1111/roiw.12013; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Hand E, 2015, SCIENCE, V348, P172, DOI 10.1126/science.348.6231.172; Henderson JV, 2012, AM ECON REV, V102, P994, DOI 10.1257/aer.102.2.994; Hong L., 2016, AAAI C ART INT; Jerven M., 2013, POOR NUMBERS WE ARE; Jerven M., 2014, BENEFITS COSTS DATA; Krizhevsky A., P 25 INT C NEUR INF, P1097; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Michalopoulos S, 2014, Q J ECON, V129, P151, DOI 10.1093/qje/qjt029; Mnih V, 2010, LECT NOTES COMPUT SC, V6316, P210, DOI 10.1007/978-3-642-15567-3_16; National Geophysical Data Center, 2010, VERS 4 DMSP OLS NIGH; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Pinkovskiy M, 2016, Q J ECON, V131, P579, DOI 10.1093/qje/qjw003; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Sahn DE, 2003, REV INCOME WEALTH, P463, DOI 10.1111/j.0034-6586.2003.00100.x; Sandefur J, 2015, J DEV STUD, V51, P116, DOI 10.1080/00220388.2014.968138; United Nations, 2014, WORLD COUNTS MOB DAT; World Bank, 2015, POVCALNET ONL POV ON; Xie M, 2016, AAAI CONF ARTIF INTE, P3929	22	599	630	41	356	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					790	794		10.1126/science.aaf7894	http://dx.doi.org/10.1126/science.aaf7894			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5ZE	27540167				2022-12-28	WOS:000381561400038
J	Koh, DY; McCool, BA; Deckman, HW; Lively, RP				Koh, Dong-Yeun; McCool, Benjamin A.; Deckman, Harry W.; Lively, Ryan P.			Reverse osmosis molecular differentiation of organic liquids using carbon molecular sieve membranes	SCIENCE			English	Article							HOLLOW-FIBER MEMBRANES; GAS SEPARATION PROPERTIES; ORIENTED MFI MEMBRANES; ZEOLITE MEMBRANES; SECONDARY GROWTH; PERMEATION; PERVAPORATION; VAPORS	Liquid-phase separations of similarly sized organic molecules using membranes is a major challenge for energy-intensive industrial separation processes. We created free-standing carbon molecular sieve membranes that translate the advantages of reverse osmosis for aqueous separations to the separation of organic liquids. Polymer precursors were cross-linked with a one-pot technique that protected the porous morphology of the membranes from thermally induced structural rearrangement during carbonization. Permeation studies using benzene derivatives whose kinetic diameters differ by less than an angstrom show kinetically selective organic liquid reverse osmosis. Ratios of single-component fluxes for para-and ortho-xylene exceeding 25 were observed and para-and ortho-liquid mixtures were efficiently separated, with an equimolar feed enriched to 81 mole % para-xylene, without phase change and at ambient temperature.	[Koh, Dong-Yeun; Lively, Ryan P.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [McCool, Benjamin A.; Deckman, Harry W.] ExxonMobil Res & Engn Co, Corp Strateg Res, Separat & Proc Chem, Annandale, NJ 08801 USA	University System of Georgia; Georgia Institute of Technology; Exxon Mobil Corporation	Lively, RP (corresponding author), Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.	ryan.lively@chbe.gatech.edu	Koh, Dong-Yeun/N-7408-2017	Koh, Dong-Yeun/0000-0002-6049-9371	ExxonMobil Research and Engineering	ExxonMobil Research and Engineering(Exxon Mobil Corporation)	Supported by ExxonMobil Research and Engineering. Membrane fabrication, characterization, and testing were carried out by D.-Y.K. Mass transport analysis was conducted by B.A.M. and H.W.D. R.P.L. conceived the research. We thank R. J. Colby (ExxonMobil Corporate Strategic Research) for assistance with the helium ion microscopy images. We thank S. H. Pang (Georgia Institute of Technology) for assistance with the TEM images and F. Zhang (Georgia Institute of Technology) for assistance with the dynamic mechanical analysis. Detailed descriptions of materials and methods, membrane fabrication protocols, membrane spectroscopic characterization, mass transport experiments, OSRO experiments, and mass transport analysis are in the supplementary materials. D.-Y.K., B.A.M., H.W.D., and R.P.L. are inventors on a provisional patent application (62/254792) submitted by ExxonMobil Research and Engineering that covers hydrocarbon reverse osmosis membranes and applications.	Agrawal KV, 2015, ADV MATER, V27, P3243, DOI 10.1002/adma.201405893; Baertsch CD, 1996, J PHYS CHEM-US, V100, P7676, DOI 10.1021/jp960226h; Baker RW, 2010, J MEMBRANE SCI, V348, P346, DOI 10.1016/j.memsci.2009.11.022; Bhuwania N, 2014, CARBON, V76, P417, DOI 10.1016/j.carbon.2014.05.008; Centeno TA, 1999, J MEMBRANE SCI, V160, P201, DOI 10.1016/S0376-7388(99)00083-6; Choi J, 2009, SCIENCE, V325, P590, DOI 10.1126/science.1176095; Fahim MA, 2010, FUNDAMENTALS OF PETROLEUM REFINING, P1; Hedlund J, 2002, MICROPOR MESOPOR MAT, V52, P179, DOI 10.1016/S1387-1811(02)00316-5; Humphrey J. L., 1997, SEPARATION PROCESS T; Kim YK, 2004, J MEMBRANE SCI, V243, P9, DOI 10.1016/j.memsci.2004.05.001; Lai ZP, 2003, SCIENCE, V300, P456, DOI 10.1126/science.1082169; Marchetti P, 2014, CHEM REV, V114, P10735, DOI 10.1021/cr500006j; Ogawa M, 1999, J MEMBRANE SCI, V162, P189, DOI 10.1016/S0376-7388(99)00140-4; Rungta M, 2015, CARBON, V85, P429, DOI 10.1016/j.carbon.2015.01.008; Rungta M, 2012, CARBON, V50, P1488, DOI 10.1016/j.carbon.2011.11.019; Steel KM, 2003, CARBON, V41, P253, DOI 10.1016/S0008-6223(02)00309-3; Suda H, 1997, J PHYS CHEM B, V101, P3988, DOI 10.1021/jp963997u; Szostak R., 1992, HDB MOL SIEVES STRUC; Tin PS, 2011, CARBON, V49, P369, DOI 10.1016/j.carbon.2010.09.031; Pham TCT, 2013, ANGEW CHEM INT EDIT, V52, P8693, DOI 10.1002/anie.201301766; Wang HT, 2000, J MEMBRANE SCI, V177, P25, DOI 10.1016/S0376-7388(00)00444-0; Wegner K, 1999, J MEMBRANE SCI, V158, P17, DOI 10.1016/S0376-7388(98)00339-1; Xomeritakis G, 2001, IND ENG CHEM RES, V40, P544, DOI 10.1021/ie000613k; Xu LR, 2012, J MEMBRANE SCI, V423, P314, DOI 10.1016/j.memsci.2012.08.028; Yuan WH, 2004, J AM CHEM SOC, V126, P4776, DOI 10.1021/ja031653t	25	147	158	41	572	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					804	807		10.1126/science.aaf1343	http://dx.doi.org/10.1126/science.aaf1343			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZE	27540170				2022-12-28	WOS:000381561400041
J	Speer, SD; Pierson, TC				Speer, Scott D.; Pierson, Theodore C.			Diagnostics for Zika virus on the horizon	SCIENCE			English	Editorial Material							WEST-NILE-VIRUS; INFECTION; ANTIBODY		[Speer, Scott D.; Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Pierson, TC (corresponding author), NIAID, Viral Pathogenesis Sect, Bethesda, MD 20892 USA.	piersontc@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001209] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006; Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049; Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203; Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1; Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16; Watterson D., 2016, ANTIVIRAL RES, V130; Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020	15	25	26	0	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					750	751		10.1126/science.aah6187	http://dx.doi.org/10.1126/science.aah6187			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZE	27540152				2022-12-28	WOS:000381561400020
J	Mayor, S				Mayor, Susan			Paracetamol is no more likely to exacerbate asthma in children than ibuprofen, shows study	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Sheehan WJ, 2016, NEW ENGL J MED, V375, P619, DOI 10.1056/NEJMoa1515990	1	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 18	2016	354								i4558	10.1136/bmj.i4558	http://dx.doi.org/10.1136/bmj.i4558			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9HB	27540037				2022-12-28	WOS:000381806600005
J	Elder, A; Japp, A; Verghese, A				Elder, Andrew; Japp, Alan; Verghese, Abraham			How valuable is physical examination of the cardiovascular system?	BMJ-BRITISH MEDICAL JOURNAL			English	Review							3RD HEART-SOUND; ABDOMINAL AORTIC-ANEURYSM; CLINICAL-PREDICTION RULE; CENTRAL VENOUS-PRESSURE; PULSED DOPPLER-ECHOCARDIOGRAPHY; CAPILLARY REFILL TIME; DIAGNOSTIC-ACCURACY; ATRIAL-FIBRILLATION; SYSTOLIC MURMURS; PRIMARY-CARE	Physical examination of the cardiovascular system is central to contemporary teaching and practice in clinical medicine. Evidence about its value focuses on its diagnostic accuracy and varies widely in methodological quality and statistical power. This makes collation, analysis, and understanding of results difficult and limits their application to daily clinical practice. Specific factors affecting interpretation and clinical application include poor standardisation of observers' technique and training, the study of single signs rather than multiple signs or signs in combination with symptoms, and the tendency to compare physical examination directly with technological aids to diagnosis rather than explore diagnostic strategies that combine both. Other potential aspects of the value of physical examination, such as cost effectiveness or patients' perceptions, are poorly studied. This review summarises the evidence for the clinical value of physical examination of the cardiovascular system. The best was judged to relate to the detection and evaluation of valvular heart disease, the diagnosis and treatment of heart failure, the jugular venous pulse in the assessment of central venous pressure, and the detection of atrial fibrillation, peripheral arterial disease, impaired perfusion, and aortic and carotid disease. Although technological aids to diagnosis are likely to become even more widely available at the point of care, the evidence suggests that further research into the value of physical examination of the cardiovascular system is needed, particularly in low resource settings and as a potential means of limiting inappropriate overuse of technological aids to diagnosis.	[Elder, Andrew] Univ Edinburgh Sch Med, Dept Geriatr Med, Edinburgh, Midlothian, Scotland; [Japp, Alan] Univ Edinburgh Sch Med, Dept Cardiol, Edinburgh, Midlothian, Scotland; [Verghese, Abraham] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA	University of Edinburgh; University of Edinburgh; Stanford University	Elder, A (corresponding author), Western Gen Hosp, Dept Acute Med Older Age, Edinburgh EH4 2XU, Midlothian, Scotland.	atelder@gmail.com		Elder, Andrew/0000-0003-3229-9601				Ahuja I M, 1982, Indian Heart J, V34, P241; Aird WC, 2011, J THROMB HAEMOST, V9, P118, DOI 10.1111/j.1538-7836.2011.04312.x; Ait-Oufella H, 2014, INTENS CARE MED, V40, P958, DOI 10.1007/s00134-014-3326-4; al-Zahrani H A, 1996, Cardiovasc Surg, V4, P87, DOI 10.1016/0967-2109(96)83791-4; ALEXANDER WD, 1977, BRIT HEART J, V39, P900; ALLEN PIM, 1987, LANCET, V2, P736; Ambrosy AP, 2013, EUR HEART J, V34, P835, DOI 10.1093/eurheartj/ehs444; ANDERSSON AP, 1991, VASCULAR SURG, V25, P516, DOI 10.1177/153857449102500702; Armstrong DWJ, 2010, CAN J CARDIOL, V26, pE346, DOI 10.1016/S0828-282X(10)70467-0; Arnell TD, 1996, AM SURGEON, V62, P815; ARONOW WS, 1987, AM J CARDIOL, V60, P399, DOI 10.1016/0002-9149(87)90262-1; ARONOW WS, 1989, AM J CARDIOL, V63, P128, DOI 10.1016/0002-9149(89)91098-9; Ashrafian H, 2006, INT J CARDIOL, V107, P421, DOI 10.1016/j.ijcard.2005.01.060; Barrett PM, 2016, LANCET, V387, P1268, DOI 10.1016/S0140-6736(16)30027-7; Bergan JJ, 2006, NEW ENGL J MED, V355, P488, DOI 10.1056/NEJMra055289; Bergl P, 2015, AM J MED, V128, P109, DOI 10.1016/j.amjmed.2014.10.003; Bossone E, 2002, AM J CARDIOL, V89, P851, DOI 10.1016/S0002-9149(02)02198-7; Brennan JM, 2007, AM J CARDIOL, V99, P1614, DOI 10.1016/j.amjcard.2007.01.037; Brott TG, 2011, CIRCULATION, V124, P489, DOI 10.1161/CIR.0b013e31820d8d78; Brueseke TJ, 2009, ARCH DERMATOL, V145, P1456, DOI 10.1001/archdermatol.2009.310; BUTMAN SM, 1993, J AM COLL CARDIOL, V22, P968, DOI 10.1016/0735-1097(93)90405-P; Caldentey G, 2014, JACC-HEART FAIL, V2, P15, DOI 10.1016/j.jchf.2013.10.004; CARMICHAEL DJS, 1986, LANCET, V1, P667; Cheraghi-Sohi S, 2008, ANN FAM MED, V6, P107, DOI 10.1370/afm.816; Choudhry NK, 1999, JAMA-J AM MED ASSOC, V281, P2231, DOI 10.1001/jama.281.23.2231; Christoffersen M, 2014, CIRCULATION, V129, P990, DOI 10.1161/CIRCULATIONAHA.113.001696; CONNORS AF, 1983, NEW ENGL J MED, V308, P263, DOI 10.1056/NEJM198302033080508; COOK DJ, 1990, AM J MED SCI, V299, P175, DOI 10.1097/00000441-199003000-00006; Cooke G, 2006, J FAM PRACTICE, V55, P130; Cournot M, 2007, J VASC SURG, V46, P1215, DOI 10.1016/j.jvs.2007.08.022; CRAIGE E, 1988, NEW ENGL J MED, V318, P1611, DOI 10.1056/NEJM198806163182409; CURTISS EI, 1988, AM HEART J, V115, P391, DOI 10.1016/0002-8703(88)90487-5; Damman K, 2010, EUR J HEART FAIL, V12, P974, DOI 10.1093/eurjhf/hfq118; Damy T, 2011, EUR J HEART FAIL, V13, P1340, DOI 10.1093/eurjhf/hfr128; Danford DA, 2002, AM J CARDIOL, V89, P878, DOI 10.1016/S0002-9149(02)02208-7; DAVISON R, 1974, AM HEART J, V87, P279, DOI 10.1016/0002-8703(74)90064-7; Deakin CD, 2000, BRIT MED J, V321, P673, DOI 10.1136/bmj.321.7262.673; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-012-2769-8]; Deol GR, 2011, CHEST, V139, P95, DOI 10.1378/chest.10-1301; Desjardins VA, 1996, AM J MED, V100, P149, DOI 10.1016/S0002-9343(97)89452-1; Douglas PS, 2011, J AM SOC ECHOCARDIOG, V24, P229, DOI 10.1016/j.echo.2010.12.008; Drazner MH, 2001, NEW ENGL J MED, V345, P574, DOI 10.1056/NEJMoa010641; Drazner MH, 2003, AM J MED, V114, P431, DOI 10.1016/S0002-9343(03)00058-5; DUCAS J, 1983, AM J CARDIOL, V52, P1299, DOI 10.1016/0002-9149(83)90592-1; Elder A, 2013, JAMA-J AM MED ASSOC, V310, P799, DOI 10.1001/jama.2013.227195; Etchells E, 1998, J GEN INTERN MED, V13, P699, DOI 10.1046/j.1525-1497.1998.00207.x; Etchells E, 1997, JAMA-J AM MED ASSOC, V277, P564, DOI 10.1001/jama.277.7.564; Eusebi P, 2013, CEREBROVASC DIS, V36, P267, DOI 10.1159/000353863; EWY GA, 1988, ANN INTERN MED, V109, P456, DOI 10.7326/0003-4819-109-6-456; Fahey T, 2007, FAM PRACT, V24, P628, DOI 10.1093/fampra/cmm055; FIELDS WS, 1972, J AMER MED ASSOC, V222, P1139, DOI 10.1001/jama.222.9.1139; Fink HA, 2000, ARCH INTERN MED, V160, P833, DOI 10.1001/archinte.160.6.833; FOWLER NO, 1955, AM HEART J, V49, P237, DOI 10.1016/0002-8703(55)90196-4; Fred HL, 2005, TEX HEART I J, V32, P255; GARRATT CJ, 1994, CIRCULATION, V90, P3103, DOI 10.1161/01.CIR.90.6.3103; GRAYBURN PA, 1986, ANN INTERN MED, V104, P599, DOI 10.7326/0003-4819-104-5-599; GRIM CE, 1979, ANN INTERN MED, V91, P617, DOI 10.7326/0003-4819-91-4-617; Grissom CK, 2009, CRIT CARE MED, V37, P2720, DOI 10.1097/CCM.0b013e3181a59532; Grosso A, 2005, BRIT J OPHTHALMOL, V89, P1646, DOI 10.1136/bjo.2005.072546; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; Haring CM, 2013, MED TEACH, V35, pE1472, DOI 10.3109/0142159X.2013.778396; Harris K, 2012, J R Coll Physicians Edinb, V42 Suppl 18, P5, DOI 10.4997/JRCPE.2012.S02; HECKERLING PS, 1991, AM J MED, V91, P328, DOI 10.1016/0002-9343(91)90149-R; Herrle SR, 2011, ACAD MED, V86, P618, DOI 10.1097/ACM.0b013e318212eb00; INSALL RL, 1989, J ROY SOC MED, V82, P729, DOI 10.1177/014107688908201209; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; JOHNSON JE, 1986, ARCH INTERN MED, V146, P937, DOI 10.1001/archinte.146.5.937; Jost CHA, 2000, AM J MED, V108, P614, DOI 10.1016/S0002-9343(00)00361-2; Karkos CD, 2000, EUR J VASC ENDOVASC, V19, P299, DOI 10.1053/ejvs.1999.1002; Kelder JC, 2011, CIRCULATION, V124, P2865, DOI 10.1161/CIRCULATIONAHA.111.019216; Khan NA, 2006, JAMA-J AM MED ASSOC, V295, P536, DOI 10.1001/jama.295.5.536; KILLIP T, 1967, AM J CARDIOL, V20, P457, DOI 10.1016/0002-9149(67)90023-9; Krijnen P, 1998, ANN INTERN MED, V129, P705, DOI 10.7326/0003-4819-129-9-199811010-00005; Lala A, 2015, CIRC-HEART FAIL, V8, P741, DOI 10.1161/CIRCHEARTFAILURE.114.001957; Lederle FA, 1999, JAMA-J AM MED ASSOC, V281, P77, DOI 10.1001/jama.281.1.77; LEDERLE FA, 1988, ARCH INTERN MED, V148, P1753, DOI 10.1001/archinte.148.8.1753; LEHMANN KG, 1992, ANN INTERN MED, V117, P10, DOI 10.7326/0003-4819-117-1-10; LOCKHART PB, 1989, J AM DENT ASSOC, V119, P417, DOI 10.14219/jada.archive.1989.0060; Loxdale SJ, 2012, ANAESTHESIA, V67, P51, DOI 10.1111/j.1365-2044.2011.06942.x; Lucas C, 2000, AM HEART J, V140, P840, DOI 10.1067/mhj.2000.110933; MACSWEENEY STR, 1993, BRIT J SURG, V80, P582, DOI 10.1002/bjs.1800800510; Madhok V, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-56; MAISEL AS, 1984, ANN INTERN MED, V101, P781, DOI 10.7326/0003-4819-101-6-781; Mallett S, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3999; Mangione S, 1997, JAMA-J AM MED ASSOC, V278, P717, DOI 10.1001/jama.278.9.717; Marcus G, 2006, ARCH INTERN MED, V166, P617, DOI 10.1001/archinte.166.6.617; McColgan P, 2012, QJM-INT J MED, V105, P1171, DOI 10.1093/qjmed/hcs140; McGee S, 1999, JAMA-J AM MED ASSOC, V281, P1022, DOI 10.1001/jama.281.11.1022; McGee S, 2002, J GEN INTERN MED, V17, P646; McGee SR, 1998, AM HEART J, V136, P10, DOI 10.1016/S0002-8703(98)70175-9; McGee S, 2010, AM J MED, V123, P913, DOI 10.1016/j.amjmed.2010.04.027; McKibbon K A, 1994, ACP J Club, V121 Suppl 2, pA10; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Minami Y, 2015, INT J CLIN PRACT, V69, P820, DOI 10.1111/ijcp.12603; MISHRA M, 1992, BRIT MED J, V304, P1413, DOI 10.1136/bmj.304.6839.1413; Mookherjee S, 2013, J GEN INTERN MED, V28, P1090, DOI 10.1007/s11606-013-2380-x; Morgan S, 2002, BRIT J GEN PRACT, V52, P373; Mrgan M, 2014, EMERG MED J, V31, P954, DOI 10.1136/emermed-2013-202925; Paley L, 2011, ARCH INTERN MED, V171, P1394, DOI 10.1001/archinternmed.2011.340; PANIDIS IP, 1986, J AM COLL CARDIOL, V7, P975, DOI 10.1016/S0735-1097(86)80214-5; PERLOFF JK, 1958, CIRCULATION, V18, P998, DOI 10.1161/01.CIR.18.5.998; Prendergast BD, 2004, HEART, V90, P611, DOI 10.1136/hrt.2003.029850; RAHKO PS, 1989, ANN INTERN MED, V111, P466, DOI 10.7326/0003-4819-111-6-466; Reichlin S, 2004, AM J EMERG MED, V22, P71, DOI 10.1016/S0735-6757(03)00093-7; Rizkallah J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109215; Roelandt JRTC, 2014, EUR HEART J-CARD IMG, V15, P249, DOI 10.1093/ehjci/jet195; Roldan CA, 1996, AM J CARDIOL, V77, P1327, DOI 10.1016/S0002-9149(96)00200-7; Rothberg MB, 2014, JAMA-J AM MED ASSOC, V311, P2175, DOI 10.1001/jama.2014.3415; Roy CL, 2007, JAMA-J AM MED ASSOC, V297, P1810, DOI 10.1001/jama.297.16.1810; Sankoff J, 2008, WEST J EMERG MED, V9, P201; SCHMIDT DE, 1993, AM J CARDIOL, V71, P462, DOI 10.1016/0002-9149(93)90458-O; Seth R, 2002, J GEN INTERN MED, V17, P861, DOI 10.1046/j.1525-1497.2002.20101.x; Simel DL, 2008, J GEN INTERN MED, V23, P768, DOI 10.1007/s11606-008-0583-3; SIMON N, 1972, J AMER MED ASSOC, V220, P1209, DOI 10.1001/jama.220.9.1209; Sinisalo J, 2007, AM J CARDIOL, V100, P1779, DOI 10.1016/j.amjcard.2007.07.030; Smith M E Beth, 2014, Ann Am Thorac Soc, V11, P1454, DOI 10.1513/AnnalsATS.201403-102OC; SOCHOWSKI RA, 1990, AM J CARDIOL, V66, P1002, DOI 10.1016/0002-9149(90)90940-3; Somerville S, 2000, BRIT J GEN PRACT, V50, P727; STCLAIR EW, 1992, ANN INTERN MED, V117, P751, DOI 10.7326/0003-4819-117-9-751; Stein JH, 1997, AM J CARDIOL, V80, P1615, DOI 10.1016/S0002-9149(97)00776-5; Sudlow M, 1998, BRIT MED J, V317, P327, DOI 10.1136/bmj.317.7154.327; SURAWICZ B, 1992, J AM COLL CARDIOL, V20, P483, DOI 10.1016/0735-1097(92)90122-4; SVETKEY LP, 1990, SOUTHERN MED J, V83, P743, DOI 10.1097/00007611-199007000-00005; Sztajzel JM, 2010, INT J CARDIOL, V138, P308, DOI 10.1016/j.ijcard.2008.06.066; Tavel ME, 1996, CIRCULATION, V93, P1250, DOI 10.1161/01.CIR.93.6.1250; TEI C, 1982, NEW ENGL J MED, V307, P334, DOI 10.1056/NEJM198208053070602; Tribouilloy CM, 2001, AM J MED, V111, P96, DOI 10.1016/S0002-9343(01)00769-0; TWOMEY A, 1986, INT ANGIOL, V5, P269; Unzek S, 2011, JACC-CARDIOVASC IMAG, V4, P460, DOI 10.1016/j.jcmg.2011.01.016; Verghese A, 2015, AM J MED, V128, P1322, DOI 10.1016/j.amjmed.2015.06.004; Verghese A, 2011, ANN INTERN MED, V155, P550, DOI 10.7326/0003-4819-155-8-201110180-00013; Vinayak AG, 2006, ARCH INTERN MED, V166, P2132, DOI 10.1001/archinte.166.19.2132; von Kodolitsch Y, 2000, ARCH INTERN MED, V160, P2977, DOI 10.1001/archinte.160.19.2977; Vukanovic-Criley JM, 2006, ARCH INTERN MED, V166, P610, DOI 10.1001/archinte.166.6.610; Wang CS, 2005, JAMA-J AM MED ASSOC, V294, P1944, DOI 10.1001/jama.294.15.1944; WELLS PS, 1995, LANCET, V345, P1326, DOI 10.1016/S0140-6736(95)92535-X; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; WHITAKER W, 1954, Q J MED, V23, P105; Whiting PF, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008155; Wildes Troy, 2004, WMJ, V103, P60; Wiley B, 2014, J AM COLL CARDIOL, V64, P229, DOI 10.1016/j.jacc.2014.05.011; WOOD P, 1954, Br Med J, V1, P1051; WOOD P, 1954, BMJ-BRIT MED J, V1, P1113, DOI 10.1136/bmj.1.4871.1113; Wood PW, 2014, ECHOCARDIOGR-J CARD, V31, P87, DOI 10.1111/echo.12331; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807; Zhang DF, 2016, CAN MED ASSOC J, V188, pE53, DOI 10.1503/cmaj.150535; [No title captured]; [No title captured]; [No title captured]	150	29	29	1	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2016	354								i3309	10.1136/bmj.i3309	http://dx.doi.org/10.1136/bmj.i3309			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS6ZH	27598000				2022-12-28	WOS:000380931600001
J	Trentham-Dietz, A; Kerlikowske, K; Stout, NK; Miglioretti, DL; Schechter, CB; Ergun, MA; van den Broek, JJ; Alagoz, O; Sprague, BL; van Ravesteyn, NT; Near, AM; Gangnon, RE; Hampton, JM; Chandler, Y; de Koning, HJ; Mandelblatt, JS; Tosteson, ANA				Trentham-Dietz, Amy; Kerlikowske, Karla; Stout, Natasha K.; Miglioretti, Diana L.; Schechter, Clyde B.; Ergun, Mehmet Ali; van den Broek, Jeroen J.; Alagoz, Oguzhan; Sprague, Brian L.; van Ravesteyn, Nicolien T.; Near, Aimee M.; Gangnon, Ronald E.; Hampton, John M.; Chandler, Young; de Koning, Harry J.; Mandelblatt, Jeanne S.; Tosteson, Anna N. A.		Breast Cancer Surveillance Consor; Cancer Intervention Surveillance M	Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes	ANNALS OF INTERNAL MEDICINE			English	Article							TASK-FORCE RECOMMENDATION; ESTROGEN PLUS PROGESTIN; COST-EFFECTIVENESS; UNITED-STATES; POSTMENOPAUSAL WOMEN; MAMMOGRAPHY; BENEFITS; HARMS; HEALTH; METAANALYSIS	Background: Biennial screening is generally recommended for average-risk women aged 50 to 74 years, but tailored screening may provide greater benefits. Objective: To estimate outcomes for various screening intervals after age 50 years based on breast density and risk for breast cancer. Design: Collaborative simulation modeling using national incidence, breast density, and screening performance data. Setting: United States. Patients: Women aged 50 years or older with various combinations of breast density and relative risk (RR) of 1.0, 1.3, 2.0, or 4.0. Intervention: Annual, biennial, or triennial digital mammography screening from ages 50 to 74 years (vs. no screening) and ages 65 to 74 years (vs. biennial digital mammography from ages 50 to 64 years). Measurements: Lifetime breast cancer deaths, life expectancy and quality-adjusted life-years (QALYs), false-positive mammo-grams, benign biopsy results, overdiagnosis, cost-effectiveness, and ratio of false-positive results to breast cancer deaths averted. Results: Screening benefits and overdiagnosis increase with breast density and RR. False-positive mammograms and benign results on biopsy decrease with increasing risk. Among women with fatty breasts or scattered fibroglandular density and an RR of 1.0 or 1.3, breast cancer deaths averted were similar for triennial versus biennial screening for both age groups (50 to 74years, median of 3.4 to 5.1 vs. 4.1 to 6.5 deaths averted; 65 to 74 years, median of 1.5 to 2.1 vs. 1.8 to 2.6 deaths averted). Breast cancer deaths averted increased with annual versus biennial screening for women aged 50 to 74 years at all levels of breast density and an RR of 4.0, and those aged 65 to 74 years with heterogeneously or extremely dense breasts and an RR of 4.0. However, harms were almost 2-fold higher. Triennial screening for the average-risk subgroup and annual screening for the highest-risk subgroup cost less than $100 000 per QALY gained. Limitation: Models did not consider women younger than 50 years, those with an RR less than 1, or other imaging methods. Conclusion: Average-risk women with low breast density undergoing triennial screening and higher-risk women with high breast density receiving annual screening will maintain a similar or better balance of benefits and harms than average-risk women receiving biennial screening.	[Trentham-Dietz, Amy; Hampton, John M.] Univ Wisconsin, Carbone Canc Ctr, 610 Walnut St,WARF Room 307, Madison, WI 53726 USA; [Kerlikowske, Karla] VAMC, 4150 Clement St,111A1, San Francisco, CA 94121 USA; [Stout, Natasha K.] Harvard Med Sch, Dept Populat Med, 401 Pk Dr,Suite 401, Boston, MA 02215 USA; [Stout, Natasha K.] Harvard Pilgrim Hlth Care Inst, Landmark Ctr, 401 Pk Dr,Suite 401, Boston, MA 02215 USA; [Miglioretti, Diana L.] Univ Calif Davis, Dept Publ Hlth Sci, Sch Med, One Shields Ave Med Sci 1C,Room 145, Davis, CA 95616 USA; [Schechter, Clyde B.] Albert Einstein Coll Med, Dept Family & Social Med, 1300 Morris Pk Ave,Block Bldg 406, Bronx, NY 10461 USA; [Ergun, Mehmet Ali; Alagoz, Oguzhan] Univ Wisconsin, Univ Ave, Dept Ind & Sys tems Engn, 1513 Univ Ave, Madison, WI 53706 USA; [van den Broek, Jeroen J.; van Ravesteyn, Nicolien T.; de Koning, Harry J.] Univ Med Ctr Rotterdam, Erasmus Med Ctr, POB 2040, NL-3000 CA Rottterdam, Netherlands; [Sprague, Brian L.] Univ Vermont, Off Hlth Promot Res, 1 South Prospect St, Burlington, VT 05401 USA; [Near, Aimee M.; Chandler, Young; Mandelblatt, Jeanne S.] Georgetown Univ, Lombardi Comprehens Canc Ctr, 3300 Whitehaven St Northwest,Suite 4100, Washington, DC 20007 USA; [Gangnon, Ronald E.] Univ Wisconsin, Dept Populat Hlth Sci, 610 Walnut St, Madison, WI 53726 USA; [Tosteson, Anna N. A.] Geisel Sch Med Dartmouth, One Med Ctr Dr HB7505, Lebanon, NH 03756 USA	University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of California System; University of California Davis; Yeshiva University; Albert Einstein College of Medicine; University of Wisconsin System; University of Wisconsin Madison; Erasmus University Rotterdam; Erasmus MC; University of Vermont; Georgetown University; University of Wisconsin System; University of Wisconsin Madison; Dartmouth College	Trentham-Dietz, A (corresponding author), Univ Wisconsin, Carbone Canc Ctr, 610 Walnut St,WARF Room 307, Madison, WI 53726 USA.	trentham@wisc.edu	Ergun, Mehmet/AAB-9782-2019; de+Koning, Harry/AAF-9062-2019	Ergun, Mehmet/0000-0002-2480-8077; de+Koning, Harry/0000-0003-4682-3646; Alagoz, Oguzhan/0000-0002-5133-1382; Heckman-Stoddard, Brandy/0000-0003-1686-7154; Gangnon, Ronald/0000-0003-2587-6714	National Cancer Institute; NATIONAL CANCER INSTITUTE [U01CA152958, P30CA093373, U01CA199218, P01CA154292, P30CA023108, U54CA163303, P30CA014520] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute.	Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; American College of Radiology, 2003, AM CLOO RAD BREAST I; Beral V, 2012, LANCET ONCOL, V13, P1141, DOI 10.1016/S1470-2045(12)70425-4; Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Carter SB, 2006, HIST STAT US; Chlebowski RT, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv327; Chlebowski RT, 2010, JAMA-J AM MED ASSOC, V304, P1684, DOI 10.1001/jama.2010.1500; Cronin KA, 2005, CANCER CAUSE CONTROL, V16, P701, DOI 10.1007/s10552-005-0693-8; Cronin Kathleen A, 2006, J Natl Cancer Inst Monogr, P26, DOI 10.1093/jncimonographs/lgj005; DEHAES JCJM, 1991, INT J CANCER, V49, P538, DOI 10.1002/ijc.2910490411; Dyrstad SW, 2015, BREAST CANCER RES TR, V149, P569, DOI 10.1007/s10549-014-3254-6; Fryback Dennis G, 2006, J Natl Cancer Inst Monogr, P37, DOI 10.1093/jncimonographs/lgj007; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gangnon RE, 2015, CANCER EPIDEM BIOMAR, V24, P905, DOI 10.1158/1055-9965.EPI-14-1286; Giordano L, 2012, J MED SCREEN, V19, P72, DOI 10.1258/jms.2012.012085; Hanmer J, 2006, MED DECIS MAKING, V26, P391, DOI 10.1177/0272989X06290497; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, AL CONS ETH CARB; Kerlikowske K, 2015, JAMA INTERN MED, V175, P1970, DOI 10.1001/jamainternmed.2015.6466; Kerlikowske K, 2015, ANN INTERN MED, V162, P673, DOI 10.7326/M14-1465; Kerlikowske K, 2013, JAMA INTERN MED, V173, P807, DOI 10.1001/jamainternmed.2013.307; Lansdorp-Vogelaar I, 2014, ANN INTERN MED, V161, P104, DOI 10.7326/M13-2867; Lauby-Secretan B, 2015, NEW ENGL J MED, V372, P2353, DOI 10.1056/NEJMsr1504363; Mandelblatt JCK, 2015, AHRQ PUBLICATION; Mandelblatt Jeanne, 2006, J Natl Cancer Inst Monogr, P47, DOI 10.1093/jncimonographs/lgj008; Mandelblatt JS, 2016, ANN INTERN MED, V164, P215, DOI 10.7326/M15-1536; Mariotto Angela B, 2006, J Natl Cancer Inst Monogr, P7, DOI 10.1093/jncimonographs/lgj003; Mavaddat N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv036; Munoz D, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju289; Munsell MF, 2014, EPIDEMIOL REV, V36, P114, DOI 10.1093/epirev/mxt010; Myers ER, 2015, JAMA-J AM MED ASSOC, V314, P1615, DOI 10.1001/jama.2015.13183; National Cancer Institute, 2015, SURV EP END RES PROG; National Cancer Institute, 2015, BREAST CANC SURV CON; National Comprehensive Cancer Network, 2015, NCCN CLIN PRACT GUID; Nelson HD, 2016, ANN INTERN MED, V164, P256, DOI 10.7326/M15-0970; Nelson HD, 2012, ANN INTERN MED, V156, P635, DOI 10.7326/0003-4819-156-9-201205010-00006; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783; Pharoah PDP, 1997, INT J CANCER, V71, P800, DOI 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.3.CO;2-R; Rosenberg RD, 2006, RADIOLOGY, V241, P55, DOI 10.1148/radiol.2411051504; Rosner B, 1996, J NATL CANCER I, V88, P359, DOI 10.1093/jnci/88.6.359; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schousboe JT, 2011, ANN INTERN MED, V155, P10, DOI 10.7326/0003-4819-155-1-201107050-00003; Siu AL, 2016, ANN INTERN MED, V164, P279, DOI 10.7326/M15-2886; Siu AL, 2016, ANN INTERN MED, V164, P301, DOI 10.7326/M15-3065; Sprague BL, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju255; Stout NK, 2006, JNCI-J NATL CANCER I, V98, P774, DOI 10.1093/jnci/djj210; Stout NK, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju092; Tan Sita Y G L, 2006, J Natl Cancer Inst Monogr, P56, DOI 10.1093/jncimonographs/lgj009; Tice JA, 2015, J CLIN ONCOL, V33, P3137, DOI 10.1200/JCO.2015.60.8869; Trentham-Dietz A, 2014, BREAST CANCER RES TR, V145, P165, DOI 10.1007/s10549-014-2905-y; Tyrer J, 2004, STAT MED, V23, P1111, DOI 10.1002/sim.1668; van Ravesteyn NT, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv103; van Ravesteyn NT, 2012, ANN INTERN MED, V156, P609, DOI 10.7326/0003-4819-156-9-201205010-00002; Vilaprinyo E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086858; von Karsa L., 2008, CANC SCREENING EUROP; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103	57	77	78	1	33	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	2016	165	10					700	+		10.7326/M16-0476	http://dx.doi.org/10.7326/M16-0476			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC2RB	27548583	Green Accepted			2022-12-28	WOS:000387970500014
J	Lantieri, L; Grimbert, P; Ortonne, N; Suberbielle, C; Bories, D; Gil-Vernet, S; Lemogne, C; Bellivier, F; Lefaucheur, JP; Schaffer, N; Martin, F; Meningaud, JP; Wolkenstein, P; Hivelin, M				Lantieri, Laurent; Grimbert, Philippe; Ortonne, Nicolas; Suberbielle, Caroline; Bories, Dominique; Gil-Vernet, Salvador; Lemogne, Cedric; Bellivier, Frank; Lefaucheur, Jean Pascal; Schaffer, Nathaniel; Martin, Frederic; Meningaud, Jean Paul; Wolkenstein, Pierre; Hivelin, Mikael			Face transplant: long-term follow-up and results of a prospective open study	LANCET			English	Article							COMPOSITE TISSUE ALLOTRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; MAINTENANCE IMMUNOSUPPRESSION; FACIAL TRANSPLANTATION; HLA SENSITIZATION; HAND; ALLOGRAFT; EXPERIENCE; RECIPIENTS; OUTCOMES	Background More than 30 face transplantations have been done worldwide since 2005 but no documented long-term follow-up has been reported in the literature. We aimed to answer remaining question about the long-term risks and benefits of face transplant. Methods In this single-centre, prospective, open study, we assessed 20 patients presenting with facial defects. Ten patients were selected, and, after three were secondarily excluded, seven were transplanted: two with neurofibromatosis 1, one with a burn, and four with self-inflicted facial gunshot injuries. We report the long-term outcomes of six face allotransplant recipients at an average of 6 years (range 3.4-9 years) after the transplantation. All admissions to hospital except for planned revisions and immunosuppressive follow-up therapy were reported as adverse events (safety endpoint). Predefined immunological, metabolic, surgical, and social integration endpoints were collected prospectively. Patients underwent quantitative health-related quality of life assessments through Short Form 36 health questionnaires. This study was registered with ClinicalTrials.gov, number NCT00527280. Findings Two of seven patients died: one at 65 days due to transplant destruction with concomitant pseudomonas infection and the second at 3.4 years after transplantation by suicide. The six patients alive at long-term follow-up presented with functional transplants. Safety endpoints were related to infection in the first month, acute rejection from 1 day to 7 years after transplantation, or side-effects of immunosuppressive therapy. Recurrent rejection episodes justified maintenance therapy with high-dose steroids at high levels in all patients at last follow-up, yet none of the patients developed diabetes. Three patients were found to have hypertension with one requiring therapy. All patients had a noticeable reduction in glomerular filtration rate. All recipients and their families accepted their transplant. Improvements in social integration and quality of life were highly variable among the patients and depended on baseline levels and psychiatric comorbidities. Interpretation These long-term results show the crucial effect of patients' social support and pre-existing psychiatric conditions on the risk-benefit ratio of facial transplantation. Careful preoperative patient selection and long-term postoperative follow-up programmes under strict institutional review board controls should be used for any future grafts of this type.	[Lantieri, Laurent; Schaffer, Nathaniel; Hivelin, Mikael] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Serv Chirurg Plast, F-75015 Paris, France; [Grimbert, Philippe] Hop Henri Mondor, AP HP, Serv Nephrol & Transplantat, Creteil, France; [Ortonne, Nicolas] Hop Henri Mondor, AP HP, Dept Pathol, Creteil, France; [Bories, Dominique] Hop Henri Mondor, AP HP, Hematol Biol & Mol, Creteil, France; [Lefaucheur, Jean Pascal] Hop Henri Mondor, AP HP, Serv Explorat Fonct, Creteil, France; [Meningaud, Jean Paul] Hop Henri Mondor, AP HP, Serv Chirurg Plast & Reconstructrice, Creteil, France; [Wolkenstein, Pierre] Hop Henri Mondor, AP HP, Serv Dermatol, Creteil, France; [Martin, Frederic] Univ Paris Est Creteil, Paris, France; [Suberbielle, Caroline] Hop St Louis, AP HP, Lab Reg Histocompatibilite Jean Dausset, Paris, France; [Suberbielle, Caroline] Univ Paris Diderot, Paris, France; [Gil-Vernet, Salvador] Bellvitge Hosp Univ, Unitat Assistencial Trasplantament, Barcelona, Spain; [Lemogne, Cedric] Univ Paris 05, Hop Europeen Georges Pompidou, Psychiat Serv, Paris, France; [Bellivier, Frank] GH St Louis Lariboisiere F Widal, AP HP, INSERM UMR S 1144, Dept Psychiat & Med Addictol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Hivelin, M (corresponding author), Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Serv Chirurg Plast, F-75015 Paris, France.	mikael.hivelin@aphp.fr	Lantieri, Laurent/AAD-2025-2019; Lemogne, Cédric/Q-6091-2019; BELLIVIER, FRANK/H-5197-2012; grimbert, philippe/Q-5337-2018	Ortonne, Nicolas/0000-0003-0111-7422; Wolkenstein, Pierre/0000-0001-8194-457X; BELLIVIER, FRANK/0000-0002-3660-6640; Lemogne, Cedric/0000-0002-3487-4721				[Anonymous], 2006, South Med J, V99, P432; Carty MJ, 2013, PLAST RECONSTR SURG, V132, P423, DOI 10.1097/PRS.0b013e318295883d; Cendales LC, 2008, AM J TRANSPLANT, V8, P1396, DOI 10.1111/j.1600-6143.2008.02243.x; Chandraker A, 2014, AM J TRANSPLANT, V14, P1446, DOI 10.1111/ajt.12715; Devauchelle B, 2006, LANCET, V368, P203, DOI 10.1016/S0140-6736(06)68935-6; Diaz-Siso JR, 2015, AM J TRANSPLANT, V15, P1421, DOI 10.1111/ajt.13103; Dorafshar AH, 2013, PLAST RECONSTR SURG, V131, P241, DOI 10.1097/PRS.0b013e3182789d38; Dubernard JM, 1999, LANCET, V353, P1315, DOI 10.1016/S0140-6736(99)02062-0; Duhamel P, 2015, TRANSPL INT, V28, P1229, DOI 10.1111/tri.12610; Duhamel P, 2015, TRANSPL INT, V28, P582, DOI 10.1111/tri.12540; Gordon CR, 2009, ANN PLAS SURG, V63, P572, DOI 10.1097/SAP.0b013e3181ba5245; Guo SZ, 2008, LANCET, V372, P631, DOI 10.1016/S0140-6736(08)61276-3; Hettiaratchy S, 2002, LANCET, V360, P5, DOI 10.1016/S0140-6736(02)09361-3; Hivelin M, 2013, PLAST RECONSTR SURG, V131, P88; Hivelin M, 2009, TRANSPL IMMUNOL, V21, P117, DOI 10.1016/j.trim.2009.04.005; Kaufman C, 2014, AM SOC REC TRANSPL B; Kaufman CL, 2012, AM J TRANSPLANT, V12, P1004, DOI 10.1111/j.1600-6143.2011.03915.x; Kaufman CL, 2013, CURR OPIN ORGAN TRAN, V18, P652, DOI 10.1097/MOT.0000000000000025; Kawai T, 2014, AM J TRANSPLANT, V14, P1599, DOI 10.1111/ajt.12731; Khalifian S, 2014, LANCET, V384, P2153, DOI 10.1016/S0140-6736(13)62632-X; Klein HJ, 2016, BURNS, V42, P246, DOI 10.1016/j.burns.2015.05.019; Lantieri L, 2011, AM J TRANSPLANT, V11, P367, DOI 10.1111/j.1600-6143.2010.03406.x; Lantieri L, 2008, LANCET, V372, P639, DOI 10.1016/S0140-6736(08)61277-5; Levi DM, 2003, LANCET, V361, P2173, DOI 10.1016/S0140-6736(03)13769-5; Meningaud JP, 2011, PLAST RECONSTR SURG, V127, P1892, DOI 10.1097/PRS.0b013e31820e915a; Meningaud JP, 2010, PLAST RECONSTR SURG, V126, P1181, DOI 10.1097/PRS.0b013e3181ec2089; Morelon E, 2013, AM J TRANSPLANT, V13, P202; Morelon E, 2012, TRANSPLANTATION, V93, P855, DOI 10.1097/TP.0b013e31824728b8; Petruzzo P, 2011, AM J TRANSPLANT, V11, P808, DOI 10.1111/j.1600-6143.2011.03469.x; Petruzzo Palmina, 2011, Clin Transpl, P247; Pomahac B, 2012, NEW ENGL J MED, V366, P715, DOI 10.1056/NEJMoa1111432; Schneeberger S, 2013, ANN SURG, V257, P345, DOI 10.1097/SLA.0b013e31826d90bb; Siemionow M, 2013, INT HAND COMP TISS A	33	97	100	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2016	388	10052					1398	1407		10.1016/S0140-6736(16)31138-2	http://dx.doi.org/10.1016/S0140-6736(16)31138-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DX5FD	27567680				2022-12-28	WOS:000384404300034
J	Bonaa, KH; Mannsverk, J; Wiseth, R; Aaberge, L; Myreng, Y; Nygard, O; Nilsen, DW; Klow, NE; Uchto, M; Trovik, T; Bendz, B; Stavnes, S; Bjornerheim, R; Larsen, AI; Slette, M; Steigen, T; Jakobsen, OJ; Bleie, O; Fossum, E; Hanssen, TA; Dahl-Eriksen, O; Njolstad, I; Rasmussen, K; Wilsgaard, T; Nordrehaug, JE				Bonaa, K. H.; Mannsverk, J.; Wiseth, R.; Aaberge, L.; Myreng, Y.; Nygard, O.; Nilsen, D. W.; Klow, N. -E.; Uchto, M.; Trovik, T.; Bendz, B.; Stavnes, S.; Bjornerheim, R.; Larsen, A. -I.; Slette, M.; Steigen, T.; Jakobsen, O. J.; Bleie, O.; Fossum, E.; Hanssen, T. A.; Dahl-Eriksen, O.; Njolstad, I.; Rasmussen, K.; Wilsgaard, T.; Nordrehaug, J. E.		NORSTENT Investigators	Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYOCARDIAL-INFARCTION; THROMBOSIS; TRIALS; OUTCOMES	BACKGROUND Limited data are available on the long-term effects of contemporary drug-eluting stents versus contemporary bare-metal stents on rates of death, myocardial infarction, repeat revascularization, and stent thrombosis and on quality of life. METHODS We randomly assigned 9013 patients who had stable or unstable coronary artery disease to undergo percutaneous coronary intervention (PCI) with the implantation of either contemporary drug-eluting stents or bare-metal stents. In the group receiving drug-eluting stents, 96% of the patients received either everolimus-or zotarolimus-eluting stents. The primary outcome was a composite of death from any cause and nonfatal spontaneous myocardial infarction after a median of 5 years of follow-up. Secondary outcomes included repeat revascularization, stent thrombosis, and quality of life. RESULTS At 6 years, the rates of the primary outcome were 16.6% in the group receiving drug-eluting stents and 17.1% in the group receiving bare-metal stents (hazard ratio, 0.98; 95% confidence interval [CI], 0.88 to 1.09; P = 0.66). There were no significant between-group differences in the components of the primary outcome. The 6-year rates of any repeat revascularization were 16.5% in the group receiving drug-eluting stents and 19.8% in the group receiving bare-metal stents (hazard ratio, 0.76; 95% CI, 0.69 to 0.85; P< 0.001); the rates of definite stent thrombosis were 0.8% and 1.2%, respectively (P = 0.0498). Quality-of-life measures did not differ significantly between the two groups. CONCLUSIONS In patients undergoing PCI, there were no significant differences between those receiving drug-eluting stents and those receiving bare-metal stents in the composite outcome of death from any cause and nonfatal spontaneous myocardial infarction. Rates of repeat revascularization were lower in the group receiving drugeluting stents. (Funded by the Norwegian Research Council and others; NORSTENT ClinicalTrials.gov number, NCT00811772.)	[Bonaa, K. H.; Wiseth, R.; Slette, M.] St Olavs Univ Hosp, Clin Heart Dis, N-7006 Trondheim, Norway; [Bonaa, K. H.; Njolstad, I.; Wilsgaard, T.] Univ Tromso, Dept Community Med, Tromso, Norway; [Steigen, T.; Hanssen, T. A.; Rasmussen, K.] Univ Tromso, Dept Clin Med, Tromso, Norway; [Mannsverk, J.; Trovik, T.; Steigen, T.; Hanssen, T. A.; Dahl-Eriksen, O.; Rasmussen, K.] Univ Hosp North Norway, Dept Cardiol, Tromso, Norway; [Bonaa, K. H.] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Med, Trondheim, Norway; [Wiseth, R.] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway; [Aaberge, L.; Bendz, B.; Fossum, E.] Oslo Univ Hosp, Dept Cardiol, Oslo, Norway; [Klow, N. -E.] Oslo Univ Hosp, Dept Radiol, Oslo, Norway; [Bjornerheim, R.] Oslo Univ Hosp, Dept Heart Dis, Oslo, Norway; [Klow, N. -E.; Bendz, B.] Univ Oslo, Fac Med, Oslo, Norway; [Myreng, Y.; Stavnes, S.] Feiring Heart Clin, Dept Cardiol, Feiring, Norway; [Nygard, O.; Bleie, O.] Haukeland Hosp, Dept Heart Dis, Bergen, Norway; [Nygard, O.; Nilsen, D. W.; Larsen, A. -I.; Nordrehaug, J. E.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Nilsen, D. W.; Larsen, A. -I.; Nordrehaug, J. E.] Stavanger Univ Hosp, Dept Cardiol, Stavanger, Norway; [Uchto, M.; Jakobsen, O. J.] Sorlandet Hosp, Dept Med, Arendal, Norway	Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Bergen; Haukeland University Hospital; University of Bergen; Stavanger University Hospital	Bonaa, KH (corresponding author), St Olavs Univ Hosp, Clin Heart Dis, N-7006 Trondheim, Norway.	kaare.harald.bonaa@ntnu.no	Nilsen, Dennis/AAM-4344-2020; Wiseth, Rune/AAE-4568-2021; Njolstad, Inger/X-3784-2019	Wiseth, Rune/0000-0002-5097-4554; Hanssen, Tove/0000-0003-3185-2364	Norwegian Research Council; Northern Norway Regional Health Authority; University of Tromso - the Arctic University of Norway; Western Norway Regional Health Authority; Norwegian Council on Cardiovascular Disease; Northern Norway University Hospital; St. Olav's University Hospital; Haukeland University Hospital; Stavanger University Hospital; Sorlandet Hospital; Oslo University Hospital; Feiring Heart Clinic	Norwegian Research Council(Research Council of NorwayEuropean Commission); Northern Norway Regional Health Authority; University of Tromso - the Arctic University of Norway; Western Norway Regional Health Authority; Norwegian Council on Cardiovascular Disease; Northern Norway University Hospital; St. Olav's University Hospital; Haukeland University Hospital; Stavanger University Hospital; Sorlandet Hospital; Oslo University Hospital; Feiring Heart Clinic	Supported by the Norwegian Research Council, the Northern Norway Regional Health Authority, University of Tromso - the Arctic University of Norway, the Western Norway Regional Health Authority, the Norwegian Council on Cardiovascular Disease, the Northern Norway University Hospital, St. Olav's University Hospital, Haukeland University Hospital, Stavanger University Hospital, Sorlandet Hospital, Oslo University Hospital, and Feiring Heart Clinic.	Alfonso F, 2011, J AM COLL CARDIOL, V58, P26, DOI 10.1016/j.jacc.2011.03.013; Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Bhatt DL, 2012, LANCET, V380, P1453, DOI 10.1016/S0140-6736(12)61021-6; Camenzind E, 2007, CIRCULATION, V115, P1440, DOI 10.1161/CIRCULATIONAHA.106.666800; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Jensen LO, 2016, J AM COLL CARDIOL, V67, P751, DOI 10.1016/j.jacc.2015.11.051; Kaiser C, 2010, NEW ENGL J MED, V363, P2310, DOI 10.1056/NEJMoa1009406; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Nordmann AJ, 2006, EUR HEART J, V27, P2784, DOI 10.1093/eurheartj/ehl282; Palmerini T, 2013, J AM COLL CARDIOL, V62, P496, DOI 10.1016/j.jacc.2013.05.022; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Prasad A, 2011, NEW ENGL J MED, V364, P453, DOI 10.1056/NEJMra0912134; Raber L, 2012, CIRCULATION, V125, P1110, DOI 10.1161/CIRCULATIONAHA.111.058560; Sabate M, 2016, LANCET, V387, P357, DOI 10.1016/S0140-6736(15)00548-6; Sabate M, 2012, LANCET, V380, P1482, DOI 10.1016/S0140-6736(12)61223-9; Sarno G, 2012, EUR HEART J, V33, P606, DOI 10.1093/eurheartj/ehr479; SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9; Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816; Stone GW, 2010, J AM COLL CARDIOL, V55, P428, DOI 10.1016/j.jacc.2009.06.066; Venkitachalam L, 2011, CIRC-CARDIOVASC QUAL, V4, P587, DOI 10.1161/CIRCOUTCOMES.111.960971; Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771	21	340	356	4	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 29	2016	375	13					1242	1252		10.1056/NEJMoa1607991	http://dx.doi.org/10.1056/NEJMoa1607991			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DX3HU	27572953	Bronze			2022-12-28	WOS:000384265000006
J	Triaud, A				Triaud, Amaury			Migration of giants	NATURE			English	Editorial Material							HOT JUPITERS; PLANETS; MASS; EXOPLANETS; TRANSIT; SEARCH		[Triaud, Amaury] Univ Cambridge, Inst Astron, Madingley Rd, Cambridge CB3 0HA, England	University of Cambridge	Triaud, A (corresponding author), Univ Cambridge, Inst Astron, Madingley Rd, Cambridge CB3 0HA, England.	aht34@cam.ac.uk	Triaud, Amaury/AAT-5603-2021	Triaud, Amaury/0000-0002-5510-8751				Brucalassi A, 2016, ASTRON ASTROPHYS, V592, DOI 10.1051/0004-6361/201527561; Cumming A, 2008, PUBL ASTRON SOC PAC, V120, P531, DOI 10.1086/588487; Heng K, 2012, ASTROPHYS J LETT, V761, DOI 10.1088/2041-8205/761/1/L1; Howard AW, 2010, SCIENCE, V330, P653, DOI 10.1126/science.1194854; Huang C, 2016, ASTROPHYS J, V825, DOI 10.3847/0004-637X/825/2/98; Leconte J, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201015811; Madhusudhan N, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/191; Malmberg D, 2011, MON NOT R ASTRON SOC, V411, P859, DOI 10.1111/j.1365-2966.2010.17730.x; Mayor M., 2011, HARPS SEARCH SO EXTR; Nagasawa M, 2008, ASTROPHYS J, V678, P498, DOI 10.1086/529369; Petrovich C, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/1/27; Queloz D, 2000, ASTRON ASTROPHYS, V359, pL13; Santerne A, 2016, ASTRON ASTROPHYS, V587, DOI 10.1051/0004-6361/201527329; Shara MM, 2016, ASTROPHYS J, V816, DOI 10.3847/0004-637X/816/2/59; Triaud AHMJ, 2014, MON NOT R ASTRON SOC, V439, pL61, DOI 10.1093/mnrasl/slt180; Vidal-Madjar A, 2003, NATURE, V422, P143, DOI 10.1038/nature01448; Winn JN, 2015, ANNU REV ASTRON ASTR, V53, P409, DOI 10.1146/annurev-astro-082214-122246; Wu YQ, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/2/109	20	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2016	537	7621					496	497		10.1038/nature19430	http://dx.doi.org/10.1038/nature19430			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW3MO	27580038				2022-12-28	WOS:000383545900042
J	Torjesen, I				Torjesen, Ingrid			MEDICINE AND THE MEDIA The cricketer promoting shockwave therapy for erectile dysfunction	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WAVE THERAPY					ingrid_torjesen@hotmail.com						Hamilton M, 2016, SUN; Vardi Y, 2012, J UROLOGY, V187, P1769, DOI 10.1016/j.juro.2011.12.117; Wang WX, 2016, J CARDIOVASC PHARM T, V21, P381, DOI 10.1177/1074248415616189	3	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 7	2016	354								i4808	10.1136/bmj.i4808	http://dx.doi.org/10.1136/bmj.i4808			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV7FG	27604623				2022-12-28	WOS:000383101100009
J	Bui, VL; Kermani, TA				Bui, Viet L.; Kermani, Tanaz A.			Clinical Significance of a Positive Antineutrophil Cytoplasmic Antibody (ANCA) Test	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AUTOANTIBODIES; GRANULOMATOSIS; POLYANGIITIS; VASCULITIS; DISEASE		[Bui, Viet L.; Kermani, Tanaz A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Rheumatol, 2020 Santa Monica Blvd,Ste 540, Los Angeles, CA 90404 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kermani, TA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Rheumatol, 2020 Santa Monica Blvd,Ste 540, Los Angeles, CA 90404 USA.	tkermani@mednet.ucla.edu						Comarmond C, 2013, ARTHRITIS RHEUM-US, V65, P270, DOI 10.1002/art.37721; Finkielman JD, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.08.016; Guillevin L, 1999, ARTHRITIS RHEUM-US, V42, P421, DOI 10.1002/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Jennette JC, 2014, NAT REV RHEUMATOL, V10, P463, DOI 10.1038/nrrheum.2014.103; Kallenberg CGM, 2016, CURR OPIN RHEUMATOL, V28, P8, DOI 10.1097/BOR.0000000000000233; Savige J, 2003, AM J CLIN PATHOL, V120, P312, DOI 10.1309/WAEPADW0K4LPUHFN; Stone JH, 2000, ARTHRIT CARE RES, V13, P424, DOI 10.1002/1529-0131(200012)13:6<424::AID-ART14>3.0.CO;2-Q; VANDERWOUDE FJ, 1985, LANCET, V1, P425; Watts RA, 2015, NEPHROL DIAL TRANSPL, V30, pi14, DOI 10.1093/ndt/gfv022	10	2	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2016	316	9					984	985		10.1001/jama.2016.8307	http://dx.doi.org/10.1001/jama.2016.8307			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU8JV	27599333				2022-12-28	WOS:000382460200021
J	Johnston, AM; Singleton, J				Johnston, Andrew McDonald; Singleton, Joseph			SPOT DIAGNOSIS Cold feet	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Johnston, Andrew McDonald] Queen Elizabeth Hosp Birmingham, Royal Ctr Def Med, Birmingham, W Midlands, England; [Singleton, Joseph] Queen Elizabeth Hosp Birmingham, Birmingham, W Midlands, England	Royal Centre for Defence Medicine; University of Birmingham; University of Birmingham	Johnston, AM (corresponding author), Queen Elizabeth Hosp Birmingham, Royal Ctr Def Med, Birmingham, W Midlands, England.	amcdjohnston@gmail.com	Johnston, Andy/GOK-2428-2022	Johnston, Andrew McDonald/0000-0002-0220-0589				Frost HM, 1917, BOSTON MED SURG J, V176, P301, DOI 10.1056/NEJM191703011760903; Golden FS, 2013, EXTREME PHYSIOL MED, V2, DOI 10.1186/2046-7648-2-23; Imray C, 2009, POSTGRAD MED J, V85, P481, DOI 10.1136/pgmj.2008.068635; RAMSTEAD KD, 1980, POSTGRAD MED J, V56, P879, DOI 10.1136/pgmj.56.662.879	4	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2016	354								i4584	10.1136/bmj.i4584	http://dx.doi.org/10.1136/bmj.i4584			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV7EX	27596105				2022-12-28	WOS:000383100200002
J	Iacobucci, G				Iacobucci, Gareth			One in 10 children becomes obese or overweight in primary school years	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		O'Dowd A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4576	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2016	354								i4743	10.1136/bmj.i4743	http://dx.doi.org/10.1136/bmj.i4743			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AE	27585606				2022-12-28	WOS:000382792600013
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Evidence based protest for the NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material													mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	1	1	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2016	354								i4745	10.1136/bmj.i4745	http://dx.doi.org/10.1136/bmj.i4745			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AE	27585705	Bronze, Green Published			2022-12-28	WOS:000382792600014
J	Nakamura, T; Okamoto, I; Sasaki, K; Yabuta, Y; Iwatani, C; Tsuchiya, H; Seita, Y; Nakamura, S; Yamamoto, T; Saitou, M				Nakamura, Tomonori; Okamoto, Ikuhiro; Sasaki, Kotaro; Yabuta, Yukihiro; Iwatani, Chizuru; Tsuchiya, Hideaki; Seita, Yasunari; Nakamura, Shinichiro; Yamamoto, Takuya; Saitou, Mitinori			A developmental coordinate of pluripotency among mice, monkeys and humans	NATURE			English	Article							EMBRYONIC STEM-CELLS; RHESUS-MONKEY; MOUSE EMBRYO; NAIVE PLURIPOTENCY; SELF-ORGANIZATION; HUMAN BLASTOCYST; GENE-EXPRESSION; GROUND-STATE; MASS CELLS; YOLK-SAC	The epiblast (EPI) is the origin of all somatic and germ cells in mammals, and of pluripotent stem cells in vitro. To explore the ontogeny of human and primate pluripotency, here we perform comprehensive single-cell RNA sequencing for pre and post-implantation EPI development in cynomolgus monkeys (Macacafascicularis). We show that after specification in the blastocysts, EPI from cynomolgus monkeys (cyEPI) undergoes major transcriptome changes on implantation. Thereafter, while generating gastrulating cells, cyEPI stably maintains its transcriptome over a week, retains a unique set of pluripotency genes and acquires properties for 'neuron differentiation'. Human and monkey pluripotent stem cells show the highest similarity to post-implantation late cyEPI, which, despite co-existing with gastrulating cells, bears characteristics of pre-gastrulating mouse EPI and epiblast-like cells in vitro. These findings not only reveal the divergence and coherence of EPI development, but also identify a developmental coordinate of the spectrum of pluripotency among key species, providing a basis for better regulation of human pluripotency in vitro.	[Nakamura, Tomonori; Okamoto, Ikuhiro; Sasaki, Kotaro; Yabuta, Yukihiro; Saitou, Mitinori] Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan; [Nakamura, Tomonori; Okamoto, Ikuhiro; Sasaki, Kotaro; Yabuta, Yukihiro; Saitou, Mitinori] JST, ERATO, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan; [Iwatani, Chizuru; Tsuchiya, Hideaki; Seita, Yasunari; Nakamura, Shinichiro] Shiga Univ Med Sci, Res Ctr Anim Life Sci, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan; [Yamamoto, Takuya; Saitou, Mitinori] Kyoto Univ, Ctr iPS Cell Res & Applicat, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan; [Yamamoto, Takuya; Saitou, Mitinori] Kyoto Univ, Inst Integrated Cell Material Sci, Sakyo Ku, Yoshida Ushinomiya Cho, Kyoto 6068501, Japan; [Yamamoto, Takuya] AMED, CREST, Chiyoda Ku, 1-7-1 Otemachi, Tokyo 1000004, Japan	Kyoto University; Japan Science & Technology Agency (JST); Shiga University of Medical Science; Kyoto University; Kyoto University; Japan Science & Technology Agency (JST)	Saitou, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.; Saitou, M (corresponding author), JST, ERATO, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.; Saitou, M (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.; Saitou, M (corresponding author), Kyoto Univ, Inst Integrated Cell Material Sci, Sakyo Ku, Yoshida Ushinomiya Cho, Kyoto 6068501, Japan.	saitou@anat2.med.kyoto-u.ac.jp	Seita, Yasunari/AAF-5173-2020; Yamamoto, Takuya/H-2792-2017; Nakamura, Tomonori/V-8828-2019	Yamamoto, Takuya/0000-0002-0022-3947; Nakamura, Tomonori/0000-0002-0173-0780	MEXT; JST-ERATO	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST-ERATO(Japan Science & Technology Agency (JST))	This work was supported in part by a Grant-in-Aid from MEXT and by JST-ERATO. We thank Y. Nagai, R. Kabata, N. Konishi, Y. Sakaguchi, M. Kasawaki, T. Sato, M. Kabata, J. Matsushita, and M. Matsutani for their technical assistance. We are grateful to the Center for Anatomical, Pathological and Forensic Medical Researches, Kyoto University, for histology, to H. Suemori for CMK6/9, to M. Ema for encouragement, and to the animal care staff at Research Center for Animal Life Science, Shiga University of Medical Science for assistance.	Acampora D, 2013, DEVELOPMENT, V140, P43, DOI 10.1242/dev.085290; Blakeley P, 2015, DEVELOPMENT, V142, P3151, DOI 10.1242/dev.123547; Boroviak T, 2015, DEV CELL, V35, P366, DOI 10.1016/j.devcel.2015.10.011; Boroviak T, 2014, NAT CELL BIOL, V16, P513, DOI 10.1038/ncb2965; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Camus A, 2006, DEV BIOL, V295, P743, DOI 10.1016/j.ydbio.2006.03.047; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chen YC, 2015, CELL STEM CELL, V17, P116, DOI 10.1016/j.stem.2015.06.004; Deglincerti A, 2016, NATURE, V533, P251, DOI 10.1038/nature17948; ENDERS AC, 1988, AM J ANAT, V181, P327, DOI 10.1002/aja.1001810402; ENDERS AC, 1986, AM J ANAT, V177, P161, DOI 10.1002/aja.1001770205; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; GARDNER RL, 1979, J EMBRYOL EXP MORPH, V52, P141; Guo G, 2016, STEM CELL REP, V6, P437, DOI 10.1016/j.stemcr.2016.02.005; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Heuser CF, 1941, CONTRIB EMBRYOL, V29; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Kajiwara M, 2012, P NATL ACAD SCI USA, V109, P12538, DOI 10.1073/pnas.1209979109; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Lin L, 2011, DEV DYNAM, V240, P52, DOI 10.1002/dvdy.22489; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; LUCKETT WP, 1978, AM J ANAT, V152, P59, DOI 10.1002/aja.1001520106; Nakamura T, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv134; Niakan KK, 2013, DEV BIOL, V375, P54, DOI 10.1016/j.ydbio.2012.12.008; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Rossant J, 2015, DEVELOPMENT, V142, P9, DOI 10.1242/dev.115451; Sasaki K, 2015, CELL STEM CELL, V17, P178, DOI 10.1016/j.stem.2015.06.014; Shahbazi MN, 2016, NAT CELL BIOL, V18, P700, DOI 10.1038/ncb3347; Souilhol C, 2015, DEVELOPMENT, V142, P3649, DOI 10.1242/dev.121145; Suemori H, 2001, DEV DYNAM, V222, P273, DOI 10.1002/dvdy.1191; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi K, 2013, DEVELOPMENT, V140, P2457, DOI 10.1242/dev.092551; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Yamasaki J, 2011, THERIOGENOLOGY, V76, P33, DOI 10.1016/j.theriogenology.2011.01.010; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	43	286	288	3	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					57	62		10.1038/nature19096	http://dx.doi.org/10.1038/nature19096			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27556940				2022-12-28	WOS:000382426900037
J	Nordling, L				Nordling, Linda			From killing fields to technopolis	NATURE			English	Editorial Material																			0	0	0	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					S4	S5		10.1038/537S4a	http://dx.doi.org/10.1038/537S4a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU7XC	27580140	Bronze			2022-12-28	WOS:000382426900018
J	Pocock, SJ; Stone, GW				Pocock, Stuart J.; Stone, Gregg W.			The Primary Outcome Fails - What Next?	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ARTERY-BYPASS SURGERY; HEART-FAILURE; THROMBUS ASPIRATION; ISCHEMIC EVENTS; CLINICAL-TRIAL; 4-PART SERIES; FOLLOW-UP; PREVENTION; STATISTICS; DISEASE	A well-designed trial derives its credibility from the inclusion of a prespecified, a priori hypothesis that helps its authors avoid making potentially false positive claims on the basis of an exploratory analysis of the data. Nevertheless, an unreasonable yet widespread practice is the labeling of all randomized trials as either positive or negative on the basis of whether the P value for the primary outcome is less than 0.05. This view is overly simplistic. P values should be interpreted as a continuum wherein the smaller the P value, the greater the strength of the evidence for a real treatment effect. 1-3 Confidence intervals are also useful in indicating the range of uncertainty around the estimated treatment effect. Moreover, the interpretation of any trial should depend on the totality of the evidence (i.e., the primary, secondary, and safety outcomes), not just a single end point. Herein we outline the thought processes to follow when the primary outcome of a trial is first perceived as negative. In a subsequent issue of the Journal, we will review the questions to ask when the outcomes of a trial appear to be positive. We illustrate our points with examples from trials-primarily from cardiovascular studies, which constitute our sphere of expertise-but the underlying issues apply to the whole of medicine.	[Pocock, Stuart J.] London Sch Hyg & Trop Med, Dept Med Stat, Keppel St, London WC1E 7HT, England; [Stone, Gregg W.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY USA; [Stone, Gregg W.] Cardiovasc Res Fdn, New York, NY USA	University of London; London School of Hygiene & Tropical Medicine; Columbia University; NewYork-Presbyterian Hospital; Cardiovascular Research Foundation (CRF)	Pocock, SJ (corresponding author), London Sch Hyg & Trop Med, Dept Med Stat, Keppel St, London WC1E 7HT, England.	Stuart.Pocock@lshtm.ac.uk						Amarenco P, 2006, NEW ENGL J MED, V355, P549; Bari D Study Grp, 2009, NEW ENGL J MED, V360, P2503, DOI 10.1056/NEJMoa0805796; Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; Bhatt DL, 2013, NEW ENGL J MED, V368, P1303, DOI 10.1056/NEJMoa1300815; Bhatt DL, 2009, NEW ENGL J MED, V361, P2330, DOI 10.1056/NEJMoa0908629; Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Bousser MG, 2011, LANCET, V377, P2013, DOI 10.1016/S0140-6736(11)60600-4; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Cohn JN, 2003, EUR J HEART FAIL, V5, P659, DOI 10.1016/S1388-9842(03)00163-6; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Fox K, 2014, NEW ENGL J MED, V371, P1091, DOI 10.1056/NEJMoa1406430; Frobert O, 2013, NEW ENGL J MED, V369, P1587, DOI 10.1056/NEJMoa1308789; Gupta Sandeep K, 2011, Perspect Clin Res, V2, P109, DOI 10.4103/2229-3485.83221; Jolly SS, 2016, LANCET, V387, P127, DOI 10.1016/S0140-6736(15)00448-1; Kappetein AP, 2016, EURO INTERV IN PRESS; Knopp RH, 2006, DIABETES CARE, V29, P1478, DOI 10.2337/dc05-2415; Lechat P, 1999, LANCET, V353, P9; LECHAT P, 1994, CIRCULATION, V90, P1765, DOI 10.1161/01.CIR.90.4.1765; Leonardi S, 2013, HEART, V99, P1282, DOI 10.1136/heartjnl-2012-303103; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Pfeffer MA, 2015, CIRCULATION, V131, P34, DOI 10.1161/CIRCULATIONAHA.114.013255; Pitt B, 2014, NEW ENGL J MED, V370, P1383, DOI 10.1056/NEJMoa1313731; Pocock SJ, 2015, J AM COLL CARDIOL, V66, P2536, DOI 10.1016/j.jacc.2015.10.014; Pocock SJ, 2015, J AM COLL CARDIOL, V66, P2648, DOI 10.1016/j.jacc.2015.10.023; Rader DJ, 2014, ANNU REV MED, V65, P385, DOI 10.1146/annurev-med-050311-163305; Rogers JK, 2014, EUR J HEART FAIL, V16, P33, DOI 10.1002/ejhf.29; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Stone GW, 2010, J AM COLL CARDIOL, V55, P428, DOI 10.1016/j.jacc.2009.06.066; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; Topol EJ, 2001, NEW ENGL J MED, V344, P1888, DOI 10.1056/NEJM200106213442502; Valgimigli M, 2015, NEW ENGL J MED, V373, P997, DOI 10.1056/NEJMoa1507854; Velazquez EJ, 2016, NEW ENGL J MED, V374, P1511, DOI 10.1056/NEJMoa1602001; Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003	39	161	165	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2016	375	9					861	870		10.1056/NEJMra1510064	http://dx.doi.org/10.1056/NEJMra1510064			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU9HA	27579636	Green Published			2022-12-28	WOS:000382526000009
J	Straube, C; Vazan, M				Straube, Christoph; Vazan, Martin			Pneumorrhachis, Pneumothorax, and Subcutaneous Emphysema	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Straube, Christoph; Vazan, Martin] Klinikum Rechts Der Isar, Munich, Germany	Technical University of Munich	Straube, C (corresponding author), Klinikum Rechts Der Isar, Munich, Germany.	christoph.straube@gmail.com							0	1	1	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2016	375	9					E18	E18		10.1056/NEJMicm1506684	http://dx.doi.org/10.1056/NEJMicm1506684			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU9HA	27579660				2022-12-28	WOS:000382526000012
J	Jaffe, S				Jaffe, Susan			US presidential candidates' proposals to reduce drug prices	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 27	2016	388	10047					855	856		10.1016/S0140-6736(16)31479-9	http://dx.doi.org/10.1016/S0140-6736(16)31479-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU0RI	27597455				2022-12-28	WOS:000381911800011
J	Lucchini, M; Sato, SA; Ludwig, A; Herrmann, J; Volkov, M; Kasmi, L; Shinohara, Y; Yabana, K; Gallmann, L; Keller, U				Lucchini, M.; Sato, S. A.; Ludwig, A.; Herrmann, J.; Volkov, M.; Kasmi, L.; Shinohara, Y.; Yabana, K.; Gallmann, L.; Keller, U.			Attosecond dynamical Franz-Keldysh effect in polycrystalline diamond	SCIENCE			English	Article							SPECTROSCOPY	Short, intense laser pulses can be used to access the transition regime between classical and quantum optical responses in dielectrics. In this regime, the relative roles of inter-and intraband light-driven electronic transitions remain uncertain. We applied attosecond transient absorption spectroscopy to investigate the interaction between polycrystalline diamond and a few-femtosecond infrared pulse with intensity below the critical intensity of optical breakdown. Ab initio time-dependent density functional theory calculations, in tandem with a two-band parabolic model, accounted for the experimental results in the framework of the dynamical Franz-Keldysh effect and identified infrared induction of intraband currents as the main physical mechanism responsible for the observations.	[Lucchini, M.; Ludwig, A.; Herrmann, J.; Volkov, M.; Kasmi, L.; Gallmann, L.; Keller, U.] ETH, Dept Phys, CH-8093 Zurich, Switzerland; [Sato, S. A.; Yabana, K.] Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki 3058577, Japan; [Shinohara, Y.] Univ Tokyo, Photon Sci Ctr, Tokyo 1138656, Japan; [Shinohara, Y.] Univ Bern, Inst Appl Phys, CH-3012 Bern, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Tsukuba; University of Tokyo; University of Bern	Lucchini, M (corresponding author), ETH, Dept Phys, CH-8093 Zurich, Switzerland.	mlucchini@phys.ethz.ch	Lucchini, Matteo/L-2007-2015; Lucchini, Matteo/AAN-2150-2021; Volkov, Mikhail/ABD-4080-2021; Keller, Ursula/N-2437-2016; Volkov, Mikhail/X-6240-2019; Gallmann, Lukas/E-5204-2014; Shinohara, Yasushi/E-2709-2014; Yabana, Kazuhiro/Q-7396-2019; Sato, Shunsuke/I-3294-2015	Lucchini, Matteo/0000-0001-6476-100X; Lucchini, Matteo/0000-0001-6476-100X; Volkov, Mikhail/0000-0003-1594-8542; Keller, Ursula/0000-0002-1689-8041; Gallmann, Lukas/0000-0003-3167-8271; Shinohara, Yasushi/0000-0003-3291-6980; Sato, Shunsuke/0000-0001-9543-2620; Kasmi, Lamia/0000-0003-0467-6959	National Center of Competence in Research Molecular Ultrafast Science and Technology (NCCR MUST) - Swiss National Science Foundation; JSPS KAKENHI [15H03674, 26-1511]; RIKEN AICS through the HPCI System Research project [hp150101]; MEXT	National Center of Competence in Research Molecular Ultrafast Science and Technology (NCCR MUST) - Swiss National Science Foundation; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); RIKEN AICS through the HPCI System Research project; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported by the National Center of Competence in Research Molecular Ultrafast Science and Technology (NCCR MUST) funded by the Swiss National Science Foundation, and by JSPS KAKENHI grants 15H03674 and 26-1511. This research used computational resources of the K computer provided by RIKEN AICS through the HPCI System Research project (Project ID hp150101), and was supported in part by MEXT as a priority issue theme 7 to be tackled by using Post K Computer.	Auston D. H., 1985, PICOSECOND ELECT OPT; AUSTON DH, 1988, TOP APPL PHYS, V60, P183; Caulfield HJ, 2010, NAT PHOTONICS, V4, P261, DOI 10.1038/nphoton.2010.94; Chin AH, 2000, PHYS REV LETT, V85, P3293, DOI 10.1103/PhysRevLett.85.3293; Goulielmakis E, 2010, NATURE, V466, P739, DOI 10.1038/nature09212; GRISCHKOWSKY D, 1990, J OPT SOC AM B, V7, P2006, DOI 10.1364/JOSAB.7.002006; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Holler M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.123601; Houston WV, 1940, PHYS REV, V57, P184, DOI 10.1103/PhysRev.57.184; Jauho AP, 1996, PHYS REV LETT, V76, P4576, DOI 10.1103/PhysRevLett.76.4576; KELDYSH LV, 1965, SOV PHYS JETP-USSR, V20, P1307; Krausz F, 2014, NAT PHOTONICS, V8, P205, DOI 10.1038/nphoton.2014.28; Locher R, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4862656; Luu TT, 2015, NATURE, V521, P498, DOI 10.1038/nature14456; Mashiko H, 2016, NAT PHYS, V12, P741, DOI [10.1038/nphys3711, 10.1038/NPHYS3711]; Mizumoto Y, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.045216; Nordstrom KB, 1998, PHYS REV LETT, V81, P457, DOI 10.1103/PhysRevLett.81.457; Novelli F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01227; Otobe T, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.045124; Paul PM, 2001, SCIENCE, V292, P1689, DOI 10.1126/science.1059413; Sato SA, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.064304; Schultze M, 2014, SCIENCE, V346, P1348, DOI 10.1126/science.1260311; Schultze M, 2013, NATURE, V493, P75, DOI 10.1038/nature11720; Srivastava A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.157401; Steinmeyer G, 1999, SCIENCE, V286, P1507, DOI 10.1126/science.286.5444.1507; Telle HR, 1999, APPL PHYS B-LASERS O, V69, P327, DOI 10.1007/s003400050813; Vampa G, 2015, NATURE, V522, P462, DOI 10.1038/nature14517; Wang H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.143002; Wannier G. H., 1960, ELEMENTS SOLID STATE; Yabana K, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.045134; Yu PY, 2010, GRAD TEXTS PHYS, P1, DOI 10.1007/978-3-642-00710-1	31	155	156	4	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					916	919		10.1126/science.aag1268	http://dx.doi.org/10.1126/science.aag1268			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU0CA	27563093	Green Submitted			2022-12-28	WOS:000381867700035
J	Silver, MA; Cary, SK; Johnson, JA; Baumbach, RE; Arico, AA; Luckey, M; Urban, M; Wang, JC; Polinski, MJ; Chemey, A; Liu, G; Chen, KW; Van Cleve, SM; Marsh, ML; Eaton, TM; de Burgt, LJV; Gray, AL; Hobart, DE; Hanson, K; Maron, L; Gendron, F; Autschbach, J; Speldrich, M; Kogerler, P; Yang, P; Braley, J; Albrecht-Schmitt, TE				Silver, Mark A.; Cary, Samantha K.; Johnson, Jason A.; Baumbach, Ryan E.; Arico, Alexandra A.; Luckey, Morgan; Urban, Matthew; Wang, Jamie C.; Polinski, Matthew J.; Chemey, Alexander; Liu, Guokui; Chen, Kuan-Wen; Van Cleve, Shelley M.; Marsh, Matthew L.; Eaton, Teresa M.; de Burgt, Lambertus J. van; Gray, Ashley L.; Hobart, David E.; Hanson, Kenneth; Maron, Laurent; Gendron, Frederic; Autschbach, Jochen; Speldrich, Manfred; Koegerler, Paul; Yang, Ping; Braley, Jenifer; Albrecht-Schmitt, Thomas E.			Characterization of berkelium(III) dipicolinate and borate compounds in solution and the solid state	SCIENCE			English	Article							MOLECULAR-ORBITAL METHODS; VALENCE BASIS-SETS; TRIVALENT ACTINIDE; CRYSTAL-STRUCTURES; CALIFORNIUM; ENERGY; ELEMENT; COVALENCY; PSEUDOPOTENTIALS; PLUTONIUM(III)	Berkelium is positioned at a crucial location in the actinide series between the inherently stable half-filled 5f(7) configuration of curium and the abrupt transition in chemical behavior created by the onset of a metastable divalent state that starts at californium. However, the mere 320-day half-life of berkelium's only available isotope, Bk-249, has hindered in-depth studies of the element's coordination chemistry. Herein, we report the synthesis and detailed solid-state and solution-phase characterization of a berkelium coordination complex, Bk(III)tris(dipicolinate), as well as a chemically distinct Bk(III) borate material for comparison. We demonstrate that berkelium's complexation is analogous to that of californium. However, from a range of spectroscopic techniques and quantum mechanical calculations, it is clear that spin-orbit coupling contributes significantly to berkelium's multiconfigurational ground state.	[Silver, Mark A.; Cary, Samantha K.; Arico, Alexandra A.; Wang, Jamie C.; Chemey, Alexander; Marsh, Matthew L.; Eaton, Teresa M.; de Burgt, Lambertus J. van; Hobart, David E.; Hanson, Kenneth; Albrecht-Schmitt, Thomas E.] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Johnson, Jason A.; Gray, Ashley L.] Florida State Univ, Environm Hlth & Safety, Tallahassee, FL 32306 USA; [Baumbach, Ryan E.; Chen, Kuan-Wen] Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Luckey, Morgan; Urban, Matthew; Braley, Jenifer] Colorado Sch Mines, Dept Chem & Geochem, Golden, CO 80401 USA; [Luckey, Morgan; Urban, Matthew; Braley, Jenifer] Colorado Sch Mines, Dept Nucl Engn, Golden, CO 80401 USA; [Polinski, Matthew J.] Bloomsburg Univ Penn, Dept Chem & Biochem, Bloomsburg, PA 17815 USA; [Liu, Guokui] Argonne Natl Lab, Chem Sci & Engn Div, 9700 S Cass Ave, Argonne, IL 60439 USA; [Van Cleve, Shelley M.] Oak Ridge Natl Lab, Nucl Mat Proc Grp, One Bethel Valley Rd, Oak Ridge, TN 37830 USA; [Maron, Laurent] Inst Natl Sci Appl, Lab Phys & Chim Nanoobjets, F-31077 Toulouse 4, France; [Gendron, Frederic; Autschbach, Jochen] SUNY Buffalo, Univ Buffalo, Dept Chem, Buffalo, NY 14260 USA; [Speldrich, Manfred; Koegerler, Paul] Univ Aachen, Inst Anorgan Chem, Rheinisch Westfal Tech Hsch, D-52074 Aachen, Germany; [Yang, Ping] Los Alamos Natl Lab, Div Theory, Los Alamos, NM 87545 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Colorado School of Mines; Colorado School of Mines; Pennsylvania State System of Higher Education (PASSHE); Bloomsburg University of Pennsylvania; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; RWTH Aachen University; United States Department of Energy (DOE); Los Alamos National Laboratory	Albrecht-Schmitt, TE (corresponding author), Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA.; Braley, J (corresponding author), Colorado Sch Mines, Dept Chem & Geochem, Golden, CO 80401 USA.; Braley, J (corresponding author), Colorado Sch Mines, Dept Nucl Engn, Golden, CO 80401 USA.	jbraley@mines.edu; albrecht-schmitt@chem.fsu.edu	Gendron, Frédéric/AAM-2329-2021; Cary, Samantha K/I-7416-2017; Autschbach, Jochen/S-5472-2016; Speldrich, Manfred Felix/P-3615-2016; Kögerler, Paul/H-5866-2013; Hanson, Kenneth/H-4314-2019; Speldrich, Manfred Felix/ABB-1659-2021; Polinski, Matthew/E-8432-2019; Shafer, Jenifer/F-1846-2017	Gendron, Frédéric/0000-0002-1896-3978; Cary, Samantha K/0000-0003-0398-7106; Autschbach, Jochen/0000-0001-9392-877X; Speldrich, Manfred Felix/0000-0002-8626-6410; Kögerler, Paul/0000-0001-7831-3953; Hanson, Kenneth/0000-0001-7219-7808; Speldrich, Manfred Felix/0000-0002-8626-6410; Chemey, Alexander/0000-0002-0679-7845; Polinski, Matthew/0000-0002-3789-9414; Shafer, Jenifer/0000-0001-9702-1534; Luckey, Morgan/0000-0001-9264-6316; Johnson, Jason/0000-0001-7049-0197; Gray, Ashley/0000-0003-3749-596X; Yang, Ping/0000-0003-4726-2860	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Heavy Elements Chemistry Program [DE-FG02-13ER16414, DE-SC0012039, DE-SC0001136]; European Research Council [StG 308051 MOLSPINTRON]; National Science Foundation [DMR-1157490, DGE-1449440]; State of Florida; U.S. Department of Energy	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Heavy Elements Chemistry Program(United States Department of Energy (DOE)); European Research Council(European Research Council (ERC)European Commission); National Science Foundation(National Science Foundation (NSF)); State of Florida; U.S. Department of Energy(United States Department of Energy (DOE))	This material is based on work supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Heavy Elements Chemistry Program under Award Number DE-FG02-13ER16414 (Florida State University) and DE-SC0012039 (Colorado School of Mines), and DE-SC0001136 (formerly DE-FG02-09ER16066) (F.G. and J.A.). M.S. and P.K. were supported by European Research Council StG 308051 MOLSPINTRON. The isotopes used in this research were supplied by the U.S. Department of Energy, Office of Science, by the Isotope Program in the Office of Nuclear Physics. The <SUP>249</SUP>Bk was provided to Florida State University and the Colorado School of Mines via the Isotope Development and Production for Research and Applications Program through the Radiochemical Engineering and Development Center at Oak Ridge National Laboratory. We are especially grateful for assistance and supervision by the Office of Environmental Health and Safety at Florida State University/Colorado School of Mines and the Office of Radiation Safety for their facilitation of these studies. Magnetization measurements using the vibrating sample magnetometer SQUID magnetic properties measurement system were performed at the National High Magnetic Field Laboratory, which is supported by National Science Foundation Cooperative Agreement no. DMR-1157490, the State of Florida, and the U.S. Department of Energy. We are indebted to the Office of Safety at the National High Magnetic Field Laboratory for helping to facilitate these studies as well. J.C.W. is supported by the National Science Foundation Graduate Research Fellowship under grant no. DGE-1449440. This research was support in part by an appointment to the CBFO Fellowship Program, sponsored by the U.S. Department of Energy and administered by the Oak Ridge Institute for Science and Education. Metrical parameters for the structures of Bk(HDPA)<INF>3</INF>center dot nH<INF>2</INF>O and Bk[B<INF>6</INF>O<INF>8</INF>(OH)<INF>5</INF>] are available free of charge from the Cambridge Crystallographic Data Centre under accession numbers CCDC-1451021 and 1490887, respectively.	Ahmad I., 2013, AM PHYS REV C, V87, DOI 10.1103/; Albrecht-Schmitt T, 2014, NAT CHEM, V6, P840, DOI 10.1038/nchem.2035; Antonio MR, 2002, RADIOCHIM ACTA, V90, P851, DOI 10.1524/ract.2002.90.12_2002.851; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bilewicz A, 1996, RADIOCHIM ACTA, V75, P121; BINKLEY JS, 1980, J AM CHEM SOC, V102, P939, DOI 10.1021/ja00523a008; Braley JC, 2012, IND ENG CHEM RES, V51, P629, DOI 10.1021/ie200285r; BURNS JH, 1971, INORG CHEM, V10, P147, DOI 10.1021/ic50095a029; BURNS JH, 1973, J INORG NUCL CHEM, V35, P1171, DOI 10.1016/0022-1902(73)80189-7; Cao XY, 2004, J MOL STRUC-THEOCHEM, V673, P203, DOI 10.1016/j.theochem.2003.12.015; Cao XY, 2003, J CHEM PHYS, V118, P487, DOI 10.1063/1.1521431; CARNALL WT, 1984, J CHEM PHYS, V80, P2301, DOI 10.1063/1.446980; CARNALL WT, 1992, J CHEM PHYS, V96, P8713, DOI 10.1063/1.462278; Cary SK, 2015, INORG CHEM, V54, P11399, DOI 10.1021/acs.inorgchem.5b02052; Cary SK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7827; Chibotaru LF, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4739763; Choppin GR, 2002, J ALLOY COMPD, V344, P55, DOI 10.1016/S0925-8388(02)00305-5; Drader JA, 2016, SOLVENT EXTR ION EXC, V34, P114, DOI 10.1080/07366299.2016.1140436; Even J, 2014, SCIENCE, V345, P1491, DOI 10.1126/science.1255720; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Galbis E, 2010, ANGEW CHEM INT EDIT, V49, P3811, DOI 10.1002/anie.200906129; Gendron F, 2015, DALTON T, V44, P19886, DOI 10.1039/c5dt02858b; GRENTHE I, 1963, ACTA CHEM SCAND, V17, P2487, DOI 10.3891/acta.chem.scand.17-2487; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; Heathman CR, 2012, SEP SCI TECHNOL, V47, P2029, DOI 10.1080/01496395.2012.704225; Heathman S, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.214111; HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527; Janoschek M, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500188; JURSICH GM, 1987, INORG CHIM ACTA, V139, P273, DOI 10.1016/S0020-1693(00)84093-1; KUCHLE W, 1994, J CHEM PHYS, V100, P7535, DOI 10.1063/1.466847; LAUBEREAU PG, 1970, INORG CHEM, V9, P1091, DOI 10.1021/ic50087a018; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Liu GK, 2015, PHYS CHEM CHEM PHYS, V17, P16151, DOI 10.1039/c5cp01855b; Miguirditchian M, 2005, INORG CHEM, V44, P1404, DOI 10.1021/ic0488785; Moritz A, 2007, THEOR CHEM ACC, V118, P845, DOI 10.1007/s00214-007-0330-6; Neidig ML, 2013, COORDIN CHEM REV, V257, P394, DOI 10.1016/j.ccr.2012.04.029; PERDEW JP, 1992, PHYS REV B, V45, P13244, DOI 10.1103/PhysRevB.45.13244; PETERSON JR, 1986, INORG CHEM, V25, P3779, DOI 10.1021/ic00241a015; Polinski MJ, 2014, NAT CHEM, V6, P387, DOI [10.1038/nchem.1896, 10.1038/NCHEM.1896]; Polinski MJ, 2012, J AM CHEM SOC, V134, P10682, DOI 10.1021/ja303804r; Polinski MJ, 2012, ANGEW CHEM INT EDIT, V51, P1869, DOI 10.1002/anie.201107956; Polinski MJ, 2011, ANGEW CHEM INT EDIT, V50, P8891, DOI 10.1002/anie.201103502; Sato TK, 2015, NATURE, V520, P209, DOI 10.1038/nature14342; Spek AL, 2003, J APPL CRYSTALLOGR, V36, P7, DOI 10.1107/S0021889802022112; Stoyer NJ, 2007, NUCL PHYS A, V787, p388C, DOI 10.1016/j.nuclphysa.2006.12.060; van Leusen J, 2015, COORDIN CHEM REV, V289, P137, DOI 10.1016/j.ccr.2014.10.011; Wang W, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.155120; Weaver B., 1964, ORNL3559; Zhurko G. A., CHEMCRAFT VERSION 1	49	70	71	1	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302							aaf3762	10.1126/science.aaf3762	http://dx.doi.org/10.1126/science.aaf3762			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU0CA	27563098				2022-12-28	WOS:000381867700030
J	Starr, D				Starr, Douglas			THE CARBON ACCOUNTANT	SCIENCE			English	Editorial Material									[Starr, Douglas] Boston Univ, Program Sci Journalism, Boston, MA 02215 USA	Boston University	Starr, D (corresponding author), Boston Univ, Program Sci Journalism, Boston, MA 02215 USA.								0	3	3	3	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					858	861		10.1126/science.353.6302.858	http://dx.doi.org/10.1126/science.353.6302.858			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU0CA	27563080				2022-12-28	WOS:000381867700013
J	Abram, NJ; McGregor, HV; Tierney, JE; Evans, MN; McKay, NP; Kaufman, DS; Kaustubh, T; Martrat, B; Goosse, H; Phipps, SJ; Steig, EJ; Kilbourne, KH; Saenger, CP; Zinke, J; Leduc, G; Addison, JA; Mortyn, PG; Seidenkrantz, MS; Sicre, MA; Selvaraj, K; Filipsson, HL; Neukom, R; Gergis, J; Curran, MAJ; von Gunten, L				Abram, Nerilie J.; McGregor, Helen V.; Tierney, Jessica E.; Evans, Michael N.; McKay, Nicholas P.; Kaufman, Darrell S.; Kaustubh, Thirumalai; Martrat, Belen; Goosse, Hugues; Phipps, Steven J.; Steig, Eric J.; Kilbourne, K. Halimeda; Saenger, Casey P.; Zinke, Jens; Leduc, Guillaume; Addison, Jason A.; Mortyn, P. Graham; Seidenkrantz, Marit-Solveig; Sicre, Marie-Alexandrine; Selvaraj, Kandasamy; Filipsson, Helena L.; Neukom, Raphael; Gergis, Joelle; Curran, Mark A. J.; von Gunten, Lucien		PAGES 2K Consortium	Early onset of industrial-era warming across the oceans and continents	NATURE			English	Article							SEA-SURFACE TEMPERATURE; PACIFIC CONVERGENCE ZONE; CLIMATE FORCING RECONSTRUCTIONS; CARBON ISOTOPIC RECORD; WESTERN INDIAN-OCEAN; TROPICAL PACIFIC; SOUTHERN-OSCILLATION; STABLE OXYGEN; RECENT INTENSIFICATION; PMIP SIMULATIONS	The evolution of industrial-era warming across the continents and oceans provides a context for future climate change and is important for determining climate sensitivity and the processes that control regional warming. Here we use post-AD 1500 palaeoclimate records to show that sustained industrial-era warming of the tropical oceans first developed during the mid-nineteenth century and was nearly synchronous with Northern Hemisphere continental warming. The early onset of sustained, significant warming in palaeoclimate records and model simulations suggests that greenhouse forcing of industrial-era warming commenced as early as the mid-nineteenth century and included an enhanced equatorial ocean response mechanism. The development of Southern Hemisphere warming is delayed in reconstructions, but this apparent delay is not reproduced in climate simulations. Our findings imply that instrumental records are too short to comprehensively assess anthropogenic climate change and that, in some regions, about 180 years of industrial-era warming has already caused surface temperatures to emerge above pre-industrial values, even when taking natural variability into account.	[Abram, Nerilie J.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 2601, Australia; [Abram, Nerilie J.] Australian Natl Univ, ARC Ctr Excellence Climate Syst Sci, Canberra, ACT 2601, Australia; [McGregor, Helen V.] Univ Wollongong, Sch Earth & Environm Sci, Wollongong, NSW 2522, Australia; [Tierney, Jessica E.] Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA; [Tierney, Jessica E.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Evans, Michael N.] Univ Maryland, Dept Geol, College Pk, MD 20742 USA; [Evans, Michael N.] Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; [McKay, Nicholas P.; Kaufman, Darrell S.] No Arizona Univ, Sch Earth Sci & Environm Sustainabil, Flagstaff, AZ 86011 USA; [Kaustubh, Thirumalai] Univ Texas Austin, Jackson Sch Geosci, Inst Geophys, Austin, TX 78758 USA; [Martrat, Belen] CSIC, Inst Environm Assessment & Water Res IDAEA, Dept Environm Chem, ES-08034 Barcelona, Spain; [Martrat, Belen] Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England; [Goosse, Hugues] Univ Louvain, Earth & Life Inst, Pl Pasteur 3, B-1348 Louvain, Belgium; [Phipps, Steven J.] Univ New S Wales, ARC Ctr Excellence Climate Syst Sci, Sydney, NSW 2052, Australia; [Phipps, Steven J.] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW 2052, Australia; [Phipps, Steven J.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas 7001, Australia; [Steig, Eric J.] Univ Edinburgh, Sch Geosci, Edinburgh EH9 3FE, Midlothian, Scotland; [Steig, Eric J.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Kilbourne, K. Halimeda] Univ Maryland, Chesapeake Biol Lab, Ctr Environm Sci, Solomons, MD 20688 USA; [Saenger, Casey P.] Univ Washington, Joint Inst Study Atmosphere & Ocean, Seattle, WA USA; [Zinke, Jens] Curtin Univ Technol, Dept Environm & Agr, Bentley, WA 6845, Australia; [Zinke, Jens] Australian Inst Marine Sci, 39 Fairway, Nedlands, WA 6009, Australia; [Zinke, Jens] Free Univ Berlin, Inst Geol Sci, Sect Palaeontol, Malteserstr 74-100, D-12249 Berlin, Germany; [Leduc, Guillaume] Aix Marseille Univ, CNRS, IRD, Coll France,CEREGE, F-13545 Aix En Provence, France; [Addison, Jason A.] US Geol Survey, 345 Middlefield Rd,MS 910, Menlo Pk, CA 94025 USA; [Mortyn, P. Graham] Univ Autonoma Barcelona, Inst Environm Sci & Technol ICTA, Bellaterra 08193, Spain; [Mortyn, P. Graham] Univ Autonoma Barcelona, Dept Geog, Bellaterra 08193, Spain; [Seidenkrantz, Marit-Solveig] Aarhus Univ, Ctr Past Climate Studies, Hoegh-Guldbergs Gade 2, DK-8000 Aarhus C, Denmark; [Seidenkrantz, Marit-Solveig] Aarhus Univ, Arctic Res Ctr, Dept Geosci, Hoegh-Guldbergs Gade 2, DK-8000 Aarhus C, Denmark; [Sicre, Marie-Alexandrine] Sorbonne Univ, UPMC, Univ Paris 06, CNRS IRD MNHN,LOCEAN Lab, 4 Pl Jussieu, F-75005 Paris, France; [Selvaraj, Kandasamy] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen 361102, Peoples R China; [Selvaraj, Kandasamy] Xiamen Univ, Dept Geol Oceanog, Xiamen 361102, Peoples R China; [Filipsson, Helena L.] Lund Univ, Dept Geol, Solvegatan 12, SE-22362 Lund, Sweden; [Neukom, Raphael] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland; [Neukom, Raphael] Univ Bern, Inst Geog, CH-3012 Bern, Switzerland; [Gergis, Joelle] Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia; [Gergis, Joelle] Univ Melbourne, ARC Ctr Excellence Climate Syst Sci, Melbourne, Vic 3010, Australia; [Curran, Mark A. J.] Australian Antarctic Div, Hobart, Tas 7000, Australia; [Curran, Mark A. J.] Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas 7000, Australia; [von Gunten, Lucien] PAGES Int Project Off, Falkenpl 16, CH-3012 Bern, Switzerland	Australian National University; ARC Centre of Excellence for Climate System Science; Australian National University; University of Wollongong; University of Arizona; Woods Hole Oceanographic Institution; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Northern Arizona University; University of Texas System; University of Texas Austin; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Diagnostico Ambiental y Estudios del Agua (IDAEA); University of Cambridge; ARC Centre of Excellence for Climate System Science; University of New South Wales Sydney; University of New South Wales Sydney; University of Tasmania; University of Edinburgh; University of Washington; University of Washington Seattle; University System of Maryland; University of Maryland Center for Environmental Science; University of Washington; University of Washington Seattle; Curtin University; Australian Institute of Marine Science; Free University of Berlin; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; PSL Research University Paris; College de France; United States Department of the Interior; United States Geological Survey; Autonomous University of Barcelona; Autonomous University of Barcelona; Aarhus University; Aarhus University; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Xiamen University; Xiamen University; Lund University; University of Bern; University of Bern; University of Melbourne; ARC Centre of Excellence for Climate System Science; University of Melbourne; Australian Antarctic Division; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC)	Abram, NJ (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 2601, Australia.; Abram, NJ (corresponding author), Australian Natl Univ, ARC Ctr Excellence Climate Syst Sci, Canberra, ACT 2601, Australia.	nerilie.abram@anu.edu.au	Kaufman, Darrell/A-2471-2008; Steig, Eric J/G-9088-2015; Kilbourne, Kelly H/D-6560-2012; Seidenkrantz, Marit-Solveig/T-7198-2019; Zinke, Jens/G-5026-2011; Filipsson, Helena L/F-7419-2011; Neukom, Raphael/J-7842-2017; Marie-Alexandrine, Sicre/AAR-1516-2020; Mortyn, P. Graham/I-3860-2015; Phipps, Steven J/B-3135-2008; Kilbourne, Hali/AAD-6043-2022; Abram, Nerilie/AAT-5171-2021; Seidenkrantz, Marit-Solveig/A-3451-2012; Kandasamy, Selvaraj/H-5812-2013; Thirumalai, Kaustubh/N-2511-2014; McGregor, Helen/I-1479-2013; Martrat, Belen/I-5952-2015	Kaufman, Darrell/0000-0002-7572-1414; Steig, Eric J/0000-0002-8191-5549; Kilbourne, Kelly H/0000-0001-7864-8438; Zinke, Jens/0000-0002-0634-8281; Filipsson, Helena L/0000-0001-7200-8608; Neukom, Raphael/0000-0001-9392-0997; Marie-Alexandrine, Sicre/0000-0002-5015-1400; Mortyn, P. Graham/0000-0002-9473-4309; Phipps, Steven J/0000-0001-5657-8782; Kilbourne, Hali/0000-0001-7864-8438; Seidenkrantz, Marit-Solveig/0000-0002-1973-5969; Kandasamy, Selvaraj/0000-0003-2916-5055; McKay, Nicholas/0000-0003-3598-5113; Thirumalai, Kaustubh/0000-0002-7875-4182; McGregor, Helen/0000-0002-4031-2282; Tierney, Jessica/0000-0002-9080-9289; Abram, Nerilie/0000-0003-1246-2344; Addison, Jason/0000-0003-2416-9743; Hegerl, Gabriele/0000-0002-4159-1295; von Gunten, Lucien/0000-0003-0425-2881; Martrat, Belen/0000-0001-9904-9178; GERGIS, JOELLE/0000-0002-4168-7924	PAGES - US National Science Foundation (NSF); PAGES - Swiss National Science Foundation (NSF); NOAA; Australian Research Council (ARC) QEII [DP110101161]; ARC Centre of Excellence for Climate System Science; ARC [FT140100286, DP1092945]; CSIC-Ramon y Cajal post-doctoral programme [RYC-2013-14073]; Clare Hall College Cambridge Shackleton Fellowship; ARC DECRA fellowship [DE130100668]; US NSF [OCE1536249]; ARC Special Research Initiative for the Antarctic Gateway Partnership [SR140300001]; Red CONSOLIDER GRACCIE [CTM2014-59111-REDC]; Swiss NSF [PZ00P2_154802]; Danish Council for Independent Research; Natural Science OCEANHEAT [12-126709/FNU]; National Natural Science Foundation of China [(41273083]; Shanghai Fund [2013SH012];  [DP140102059]; Division Of Earth Sciences [1440015] Funding Source: National Science Foundation; ICER [1450657] Funding Source: National Science Foundation	PAGES - US National Science Foundation (NSF)(National Science Foundation (NSF)); PAGES - Swiss National Science Foundation (NSF); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Australian Research Council (ARC) QEII(Australian Research Council); ARC Centre of Excellence for Climate System Science(Australian Research Council); ARC(Australian Research Council); CSIC-Ramon y Cajal post-doctoral programme; Clare Hall College Cambridge Shackleton Fellowship; ARC DECRA fellowship(Australian Research Council); US NSF(National Science Foundation (NSF)); ARC Special Research Initiative for the Antarctic Gateway Partnership(Australian Research Council); Red CONSOLIDER GRACCIE; Swiss NSF(Swiss National Science Foundation (SNSF)); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Natural Science OCEANHEAT; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Fund; ; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); ICER(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the many scientists who made their published palaeoclimate datasets available via public data repositories. This work developed out of the PAGES (Past Global Changes) Ocean2k working group; we are grateful to K. Anchukaitis, H. Wu, C. Giry, D. Oppo and V. Ersek for their contributions to the Ocean2k syntheses, to the more than 75 volunteers who constructed the Ocean2k phase 1 metadatabase<SUP>14,15</SUP>, and to K. Anchukaitis and V. Trouet for discussions. We thank P. Petrelli, F. Klein and A. Schurer for assistance in obtaining model datasets, and K. McGregor for editorial assistance. We acknowledge support from PAGES funded by the US and Swiss National Science Foundations (NSF) and NOAA, and thank T. Kiefer, M.-F. Loutre and the PAGES 2k Network Coordinators for organizational support. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modelling groups for producing and making available their model output. The US Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support for CMIP and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals. N.J.A. is supported by an Australian Research Council (ARC) QEII fellowship awarded under DP110101161 and this work contributes to ARC Discovery Project DP140102059 (N.J.A., M.A.J.C.) and the ARC Centre of Excellence for Climate System Science (N.J.A., S.J.P.,J.G.). H.V.M. is supported by ARC Future Fellowship FT140100286 and acknowledges funding from ARC Discovery Project DP1092945 (H.M.V., S.J.P.). We acknowledge fellowship support from a CSIC-Ramon y Cajal post-doctoral programme RYC-2013-14073 (B.M.), a Clare Hall College Cambridge Shackleton Fellowship (B.M.), and an ARC DECRA fellowship DE130100668 (J.G.). We acknowledge research support from US NSF grant OCE1536249 (M.N.E.), the ARC Special Research Initiative for the Antarctic Gateway Partnership (Project ID SR140300001; S.J.P.), Red CONSOLIDER GRACCIE CTM2014-59111-REDC (B.M.), Swiss NSF grant PZ00P2_154802 (R.N.), the Danish Council for Independent Research, Natural Science OCEANHEAT project 12-126709/FNU (M.-S.S.), the National Natural Science Foundation of China (41273083; K.S.) and Shanghai Fund (2013SH012; K.S.). This is University of Maryland Center for Environmental Science contribution 5206.	Abram NJ, 2014, NAT CLIM CHANGE, V4, P564, DOI [10.1038/nclimate2235, 10.1038/NCLIMATE2235]; Abram NJ, 2013, NAT GEOSCI, V6, P404, DOI [10.1038/ngeo1787, 10.1038/NGEO1787]; Abram NJ, 2008, NAT GEOSCI, V1, P849, DOI 10.1038/ngeo357; Abrantes F, 2005, QUATERNARY SCI REV, V24, P2477, DOI 10.1016/j.quascirev.2004.04.009; Ahmed M, 2013, NAT GEOSCI, V6, P339, DOI [10.1038/NGEO1797, 10.1038/ngeo1797]; Alibert C, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2006JC003979; Armour KC, 2016, NAT GEOSCI, V9, P549, DOI [10.1038/ngeo2731, 10.1038/NGEO2731]; Asami R, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002555; Bagnato S, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000879; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Black DE, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2007PA001427; Boiseau M, 1999, GEOPHYS RES LETT, V26, P2881, DOI 10.1029/1999GL900595; Boiseau M, 1998, PALEOCEANOGRAPHY, V13, P671, DOI 10.1029/98PA02502; Bonnet S, 2010, MAR MICROPALEONTOL, V74, P59, DOI 10.1016/j.marmicro.2009.12.001; Bothe O, 2015, CLIM PAST, V11, P1673, DOI 10.5194/cp-11-1673-2015; Bothe O, 2013, CLIM PAST, V9, P2471, DOI 10.5194/cp-9-2471-2013; Bracegirdle TJ, 2015, GEOPHYS RES LETT, V42, P10832, DOI 10.1002/2015GL067055; Bronnimann S, 2015, NAT GEOSCI, V8, P969, DOI [10.1038/ngeo2568, 10.1038/NGEO2568]; Charles CD, 2003, MAR GEOL, V201, P207, DOI 10.1016/S0025-3227(03)00217-2; Charles CD, 1997, SCIENCE, V277, P925, DOI 10.1126/science.277.5328.925; Chen XY, 2014, SCIENCE, V345, P897, DOI 10.1126/science.1254937; Cobb KM, 2003, NATURE, V424, P271, DOI 10.1038/nature01779; Cole JE, 2000, SCIENCE, V287, P617, DOI 10.1126/science.287.5453.617; COLE JE, 1993, SCIENCE, V260, P1790, DOI 10.1126/science.260.5115.1790; Cole JE, 1990, PALEOCEANOGRAPHY, V5, P669, DOI 10.1029/PA005i005p00669; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; Crespin E, 2013, HOLOCENE, V23, P321, DOI 10.1177/0959683612463095; Crowley TJ, 2014, EARTHS FUTURE, V2, P281, DOI 10.1002/2013EF000216; Crowley TJ, 2000, SCIENCE, V289, P270, DOI 10.1126/science.289.5477.270; Damassa TD, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001217; DeLong KL, 2014, PALEOCEANOGRAPHY, V29, P403, DOI 10.1002/2013PA002524; DeLong KL, 2013, PALAEOGEOGR PALAEOCL, V373, P6, DOI 10.1016/j.palaeo.2012.08.019; DeLong KL, 2012, NAT CLIM CHANGE, V2, P799, DOI [10.1038/NCLIMATE1583, 10.1038/nclimate1583]; Diffenbaugh NS, 2011, CLIMATIC CHANGE, V107, P615, DOI 10.1007/s10584-011-0112-y; Doose-Rolinski H, 2001, PALEOCEANOGRAPHY, V16, P358, DOI 10.1029/2000PA000511; Druffel ERM, 1999, J GEOPHYS RES-OCEANS, V104, P23607, DOI 10.1029/1999JC900212; DUNBAR RB, 1994, PALEOCEANOGRAPHY, V9, P291, DOI 10.1029/93PA03501; England MH, 2014, NAT CLIM CHANGE, V4, P222, DOI [10.1038/NCLIMATE2106, 10.1038/nclimate2106]; Felis T, 2000, PALEOCEANOGRAPHY, V15, P679, DOI 10.1029/1999PA000477; Felis T, 2009, GEOLOGY, V37, P527, DOI 10.1130/G25581A.1; Vasquez-Bedoya LF, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002313; Frank DC, 2010, NATURE, V463, P527, DOI 10.1038/nature08769; Goni MA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026415; Goodkin NF, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001532; Gorman MK, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002302; Guilderson TP, 1999, PALEOCEANOGRAPHY, V14, P457, DOI 10.1029/1999PA900024; Gutierrez D, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046324; Hannig J, 2006, J AM STAT ASSOC, V101, P484, DOI 10.1198/016214505000001294; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Hawkins E, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050087; Hegerl GC, 2006, NATURE, V440, P1029, DOI 10.1038/nature04679; Heiss G. A., 1994, THESIS; Hendy EJ, 2002, SCIENCE, V295, P1511, DOI 10.1126/science.1067693; Hendy IL, 2013, QUATERN INT, V310, P155, DOI 10.1016/j.quaint.2012.09.006; Hetzinger S, 2010, PALAEOGEOGR PALAEOCL, V296, P111, DOI 10.1016/j.palaeo.2010.06.019; Hu YY, 2011, ADV ATMOS SCI, V28, P33, DOI 10.1007/s00376-010-0032-1; Ji F, 2014, NAT CLIM CHANGE, V4, P462, DOI [10.1038/nclimate2223, 10.1038/NCLIMATE2223]; Jones J. M., NAT CLIM CH IN PRESS; Karl TR, 2015, SCIENCE, V348, P1469, DOI 10.1126/science.aaa5632; Kilbourne KH, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001598; Kuhnert H, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000786; Kuhnert H, 1999, CORAL REEFS, V18, P1, DOI 10.1007/s003380050147; Kuhnert H, 2000, INT J EARTH SCI, V88, P725, DOI 10.1007/s005310050300; Kuhnert H, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2011PA002130; Landrum L, 2013, J CLIMATE, V26, P1085, DOI 10.1175/JCLI-D-11-00326.1; Leduc G, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044353; Levitus S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051106; Lewis SL, 2015, NATURE, V519, P171, DOI 10.1038/nature14258; Linsley BK, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001115; LINSLEY BK, 1994, J GEOPHYS RES-OCEANS, V99, P9977, DOI 10.1029/94JC00360; Linsley RK, 2000, PALEOCEANOGRAPHY, V15, P322; Liu ZY, 2005, J CLIMATE, V18, P4684, DOI 10.1175/JCLI3579.1; Lyu KW, 2014, NAT CLIM CHANGE, V4, P1006, DOI 10.1038/NCLIMATE2397; Meure CM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026152; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; Marshall J, 2015, CLIM DYNAM, V44, P2287, DOI 10.1007/s00382-014-2308-0; McGregor HV, 2007, SCIENCE, V315, P637, DOI 10.1126/science.1134839; McGregor HV, 2015, NAT GEOSCI, V8, P671, DOI 10.1038/NGEO2510; McKay NP, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.26; Mora C, 2013, NATURE, V502, P183, DOI 10.1038/nature12540; Moreno A, 2012, QUATERNARY SCI REV, V43, P16, DOI 10.1016/j.quascirev.2012.04.007; Moustafa Y., 2000, THESIS; Mudelsee M, 2009, EUR PHYS J-SPEC TOP, V174, P49, DOI 10.1140/epjst/e2009-01089-3; Nakamura N, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040590; Narayan N, 2010, OCEAN SCI, V6, P815, DOI 10.5194/os-6-815-2010; Neukom R, 2014, NAT CLIM CHANGE, V4, P362, DOI [10.1038/nclimate2174, 10.1038/NCLIMATE2174]; Nicolas JP, 2014, J CLIMATE, V27, P8070, DOI 10.1175/JCLI-D-13-00733.1; Nieto-Moreno V, 2013, ORG GEOCHEM, V55, P1, DOI 10.1016/j.orggeochem.2012.11.001; Nurhati IS, 2011, J CLIMATE, V24, P3294, DOI 10.1175/2011JCLI3852.1; Nurhati IS, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040270; Oppo DW, 2009, NATURE, V460, P1113, DOI 10.1038/nature08233; Otto-Bliesner BL, 2016, B AM METEOROL SOC, V97, P735, DOI 10.1175/BAMS-D-14-00233.1; Pahnke K, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2007PA001468; Pfeiffer M, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000964; Phipps SJ, 2013, J CLIMATE, V26, P6915, DOI 10.1175/JCLI-D-12-00108.1; Quinn TM, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003243; Quinn TM, 1996, GEOPHYS RES LETT, V23, P3413, DOI 10.1029/96GL03169; Quinn TM, 1998, PALEOCEANOGRAPHY, V13, P412, DOI 10.1029/98PA00401; Rahmstorf S, 2015, NAT CLIM CHANGE, V5, P475, DOI [10.1038/nclimate2554, 10.1038/NCLIMATE2554]; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Richter TO, 2009, QUATERNARY SCI REV, V28, P1941, DOI 10.1016/j.quascirev.2009.04.008; Ricke KL, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/12/124002; Ruddiman WF, 2013, ANNU REV EARTH PL SC, V41, P45, DOI 10.1146/annurev-earth-050212-123944; Ruggieri E, 2013, INT J CLIMATOL, V33, P520, DOI 10.1002/joc.3447; Saenger C, 2009, NAT GEOSCI, V2, P492, DOI 10.1038/ngeo552; Schimmelmann A, 2013, GFF, V135, P258, DOI 10.1080/11035897.2013.773066; Schmidt GA, 2012, GEOSCI MODEL DEV, V5, P185, DOI 10.5194/gmd-5-185-2012; Schmidt GA, 2011, GEOSCI MODEL DEV, V4, P33, DOI 10.5194/gmd-4-33-2011; Schurer AP, 2015, GEOPHYS RES LETT, V42, P5974, DOI 10.1002/2015GL064458; Schurer AP, 2014, NAT GEOSCI, V7, P104, DOI [10.1038/NGEO2040, 10.1038/ngeo2040]; Screen JA, 2010, NATURE, V464, P1334, DOI 10.1038/nature09051; Seidel DJ, 2008, NAT GEOSCI, V1, P21, DOI 10.1038/ngeo.2007.38; Sicre MA, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2011PA002169; Sigl M, 2015, NATURE, V523, P543, DOI 10.1038/nature14565; Staten PW, 2012, CLIM DYNAM, V39, P2361, DOI 10.1007/s00382-011-1267-y; Steig EJ, 2009, NATURE, V457, P459, DOI 10.1038/nature07669; Stott PA, 2010, WIRES CLIM CHANGE, V1, P192, DOI 10.1002/wcc.34; Swart PK, 1996, PALAIOS, V11, P362, DOI 10.2307/3515246; Swart PK, 1996, PALAEOGEOGR PALAEOCL, V123, P219, DOI 10.1016/0031-0182(95)00078-X; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Tierney JE, 2015, PALEOCEANOGRAPHY, V30, P226, DOI 10.1002/2014PA002717; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; Urban FE, 2000, NATURE, V407, P989, DOI 10.1038/35039597; Versteegh GJM, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001543; Watanabe S, 2011, GEOSCI MODEL DEV, V4, P845, DOI 10.5194/gmd-4-845-2011; Wu HC, 2013, GEOCHEM GEOPHY GEOSY, V14, P1435, DOI 10.1029/2012GC004293; Xie SP, 2010, J CLIMATE, V23, P966, DOI 10.1175/2009JCLI3329.1; Zhao MX, 2000, ORG GEOCHEM, V31, P903, DOI 10.1016/S0146-6380(00)00034-6; Zinke J, 2004, EARTH PLANET SC LETT, V228, P177, DOI 10.1016/j.epsl.2004.09.028; Zinke J, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035634; Zinke J, 2009, INT J EARTH SCI, V98, P115, DOI 10.1007/s00531-008-0365-5	131	172	177	9	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					411	+		10.1038/nature19082	http://dx.doi.org/10.1038/nature19082			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0YL	27558063	Green Published			2022-12-28	WOS:000382646600033
J	Mayor, S				Mayor, Susan			Being overweight may raise risk of eight more cancers, review finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Lauby-Secretan B, 2016, NEW ENGL J MED, V375, P794, DOI 10.1056/NEJMsr1606602	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 25	2016	354								i4650	10.1136/bmj.i4650	http://dx.doi.org/10.1136/bmj.i4650			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AA	27561683				2022-12-28	WOS:000382792200007
J	Fan, WW; Evans, R				Fan, Weiwei; Evans, Ronald			The quest to burn fat, effortlessly and safely	SCIENCE			English	Editorial Material									[Fan, Weiwei; Evans, Ronald] Salk Inst Biol Studies, Gene Express Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA	Salk Institute	Evans, R (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA.	evans@salk.edu	Frank, Viki/GXZ-9902-2022; Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965				Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Colman E, 2007, REGUL TOXICOL PHARM, V48, P115, DOI 10.1016/j.yrtph.2007.03.006; Deak AT, 2013, J CELL SCI, V126, P879, DOI 10.1242/jcs.118075; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Iainter M. L., 1934, AM J PUBLIC HLTH NAT, V10, P1045; Iao H., 2014, NAT MED, V11, P1263; Jamdar SN, 2015, ARCH BIOCHEM BIOPHYS, V587, P18, DOI 10.1016/j.abb.2015.10.003; Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035; Long JZ, 2016, CELL, V166, P424, DOI 10.1016/j.cell.2016.05.071; Perry RJ, 2015, SCIENCE, V347, P1253, DOI 10.1126/science.aaa0672; Perry RJ, 2013, CELL METAB, V18, P740, DOI 10.1016/j.cmet.2013.10.004	11	4	4	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					749	750		10.1126/science.aah6189	http://dx.doi.org/10.1126/science.aah6189			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZE	27540151				2022-12-28	WOS:000381561400019
J	Mariette, MM; Buchanan, KL				Mariette, Mylene M.; Buchanan, Katherine L.			Prenatal acoustic communication programs offspring for high posthatching temperatures in a songbird	SCIENCE			English	Article							ADAPTIVE SIGNIFICANCE; GROWTH; BEHAVIOR; EMBRYOS	In many species, embryos can perceive and learn external sounds. Yet, the possibility that parents may use these embryonic capacities to alter their offspring's developmental trajectories has not been considered. Here, we demonstrate that zebra finch parents acoustically signal high ambient temperatures (above 26 degrees C) to their embryos. We show that exposure of embryos to these acoustic cues alone adaptively alters subsequent nestling begging and growth in response to nest temperature and influences individuals' reproductive success and thermal preferences as adults. These findings have implications for our understanding of maternal effects, phenotypic plasticity, developmental programming, and the adaptation of endothermic species to a warming world.	[Mariette, Mylene M.; Buchanan, Katherine L.] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Waurn Ponds Campus,75 Pigdons Rd, Waurn Ponds, Vic 3216, Australia	Deakin University	Mariette, MM (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Waurn Ponds Campus,75 Pigdons Rd, Waurn Ponds, Vic 3216, Australia.	m.mariette@deakin.edu.au	Buchanan, Kate/A-8178-2012; Mariette, Mylene M/AAA-9966-2020	Buchanan, Kate/0000-0002-6648-5819; Mariette, Mylene M/0000-0003-0567-4111	Australian Research Council [DP130100417, LP140100691, FT140100131]; Deakin University	Australian Research Council(Australian Research Council); Deakin University	This project was supported by Australian Research Council grants DP130100417 and LP140100691 and Future Fellowship FT140100131 to K.L.B. and a research fellowship from Deakin University to M.M.M. We have no conflict of interest. We thank I. Goedegebuur, K. Pinch, B. Oliver, and N. Wells for assistance with data collection and processing and W. Buttemer, J. Endler, S. Kleindorfer, M. Klaassen, M. Ramenofsky, J. Wingfield, the Centre for Integrative Ecology discussion group, and three anonymous reviewers for providing comments on the manuscript. Data have been deposited in the Dryad Digital Repository (accession number doi:10.5061/dryad.v8969).	BOLHUIS JJ, 1991, BIOL REV, V66, P303, DOI 10.1111/j.1469-185X.1991.tb01145.x; Boncoraglio G, 2006, HORM BEHAV, V50, P442, DOI 10.1016/j.yhbeh.2006.05.005; Brua RB, 1996, AUK, V113, P525, DOI 10.2307/4088972; Colombelli-Negrel D, 2016, AUK, V133, P273, DOI 10.1642/AUK-15-162.1; Colombelli-Negrel D, 2012, CURR BIOL, V22, P2155, DOI 10.1016/j.cub.2012.09.025; Cunningham SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074613; Dantzer B, 2013, SCIENCE, V340, P1215, DOI 10.1126/science.1235765; Donelson JM, 2012, NAT CLIM CHANGE, V2, P30, DOI 10.1038/NCLIMATE1323; Duckworth RA, 2015, SCIENCE, V347, P875, DOI 10.1126/science.1260154; EVANS RM, 1994, AUK, V111, P596; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; GOTTLIEB G, 1965, SCIENCE, V147, P1596, DOI 10.1126/science.147.3665.1596; GROETERS FR, 1988, J EVOLUTION BIOL, V1, P317, DOI 10.1046/j.1420-9101.1988.1040317.x; Hall ME, 2010, FUNCT ECOL, V24, P365, DOI 10.1111/j.1365-2435.2009.01635.x; Kleindorfer S, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0046; LICKLITER R, 1992, DEV PSYCHOBIOL, V25, P7; Lipar JL, 2000, P ROY SOC B-BIOL SCI, V267, P2005, DOI 10.1098/rspb.2000.1242; Mariette MM, 2015, AM NAT, V185, P270, DOI 10.1086/679441; Mariette MM, 2013, ECOLOGY, V94, P325, DOI 10.1890/12-0572.1; MILLER DB, 1978, ANIM BEHAV, V26, P1178, DOI 10.1016/0003-3472(78)90108-2; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Salinas S, 2012, ECOL LETT, V15, P159, DOI 10.1111/j.1461-0248.2011.01721.x; Sanyal T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067347; Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006; Sheriff MJ, 2013, ECOL LETT, V16, P271, DOI 10.1111/ele.12042; Teplitsky C, 2008, P NATL ACAD SCI USA, V105, P13492, DOI 10.1073/pnas.0800999105; van Gils JA, 2016, SCIENCE, V352, P819, DOI 10.1126/science.aad6351; Vedder O, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001605; WOOLF NK, 1976, SCIENCE, V194, P959, DOI 10.1126/science.982054; Zann R. A., 1996, THE ZEBRA FINCH	30	73	74	3	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					812	814		10.1126/science.aaf7049	http://dx.doi.org/10.1126/science.aaf7049			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZE	27540172				2022-12-28	WOS:000381561400043
J	Fray, N; Bardyn, A; Cottin, H; Altwegg, K; Baklouti, D; Briois, C; Colangeli, L; Engrand, C; Fischer, H; Glasmachers, A; Grun, E; Haerendel, G; Henkel, H; Hofner, H; Hornung, K; Jessberger, EK; Koch, A; Kruger, H; Langevin, Y; Lehto, H; Lehto, K; Le Roy, L; Merouane, S; Modica, P; Orthous-Daunay, FR; Paquette, J; Raulin, F; Ryno, J; Schulz, R; Silen, J; Siljestrom, S; Steiger, W; Stenzel, O; Stephan, T; Thirkell, L; Thomas, R; Torkar, K; Varmuza, K; Wanczek, KP; Zaprudin, B; Kissel, J; Hilchenbach, M				Fray, Nicolas; Bardyn, Anais; Cottin, Herve; Altwegg, Kathrin; Baklouti, Donia; Briois, Christelle; Colangeli, Luigi; Engrand, Cecile; Fischer, Henning; Glasmachers, Albrecht; Gruen, Eberhard; Haerendel, Gerhard; Henkel, Hartmut; Hoefner, Herwig; Hornung, Klaus; Jessberger, Elmar K.; Koch, Andreas; Kruger, Harald; Langevin, Yves; Lehto, Harry; Lehto, Kirsi; Le Roy, Lena; Merouane, Sihane; Modica, Paola; Orthous-Daunay, Francois-Regis; Paquette, John; Raulin, Francois; Ryno, Jouni; Schulz, Rita; Silen, Johan; Siljestrom, Sandra; Steiger, Wolfgang; Stenzel, Oliver; Stephan, Thomas; Thirkell, Laurent; Thomas, Roger; Torkar, Klaus; Varmuza, Kurt; Wanczek, Karl-Peter; Zaprudin, Boris; Kissel, Jochen; Hilchenbach, Martin			High-molecular-weight organic matter in the particles of comet 67P/Churyumov-Gerasimenko	NATURE			English	Article							HALLEY DUST PARTICLES; MASS-SPECTROMETER; SOLAR-SYSTEM; ORIGIN; COSIMA; CHONDRITES	The presence of solid carbonaceous matter in cometary dust was established by the detection of elements such as carbon, hydrogen, oxygen and nitrogen in particles from comet 1P/Halley(1,2). Such matter is generally thought to have originated in the interstellar medium(3), but it might have formed in the solar nebula-the cloud of gas and dust that was left over after the Sun formed(4). This solid carbonaceous material cannot be observed from Earth, so it has eluded unambiguous characterization(5). Many gaseous organic molecules, however, have been observed(6-9); they come mostly from the sublimation of ices at the surface or in the subsurface of cometary nuclei(8). These ices could have been formed from material inherited from the interstellar medium that suffered little processing in the solar nebula(10). Here we report the in situ detection of solid organic matter in the dust particles emitted by comet 67P/Churyumov-Gerasimenko; the carbon in this organic material is bound in very large macromolecular compounds, analogous to the insoluble organic matter found in the carbonaceous chondrite meteorites(11,12). The organic matter in meteorites might have formed in the interstellar medium and/or the solar nebula, but was almost certainly modified in the meteorites' parent bodies(11). We conclude that the observed cometary carbonaceous solid matter could have the same origin as the meteoritic insoluble organic matter, but suffered less modification before and/or after being incorporated into the comet.	[Fray, Nicolas; Bardyn, Anais; Cottin, Herve; Modica, Paola; Raulin, Francois] Univ Paris Est Creteil, UMR CNRS 7583, LISA, F-94000 Creteil, France; [Fray, Nicolas; Bardyn, Anais; Cottin, Herve; Modica, Paola; Raulin, Francois] Univ Paris Diderot, Inst Pierre Simon Laplace, F-94000 Creteil, France; [Bardyn, Anais; Briois, Christelle; Modica, Paola; Thirkell, Laurent; Thomas, Roger] Univ Orleans, CNRS, LPC2E, F-45071 Orleans, France; [Altwegg, Kathrin; Le Roy, Lena] Univ Bern, CSH, Sidlerstr 5, CH-3012 Bern, Switzerland; [Baklouti, Donia; Langevin, Yves] Univ Paris Sud, CNRS, Inst Astrophys Spatiale, Batiment 121, F-91405 Orsay, France; [Colangeli, Luigi] European Space Agcy, European Space Res & Technol Ctr, Keplerlaan 1,Postbus 299, NL-2200 AG Noordwijk, Netherlands; [Engrand, Cecile] Univ Paris Saclay, Univ Paris Sud, CNRS IN2P3, Ctr Sci Nucl & Sci Mat,UMR 8609, F-91405 Orsay, France; [Fischer, Henning; Kruger, Harald; Merouane, Sihane; Paquette, John; Stenzel, Oliver; Kissel, Jochen; Hilchenbach, Martin] Max Planck Inst Sonnensyst Forsch, Justus von Liebig Weg 3, D-37077 Gottingen, Germany; [Glasmachers, Albrecht] Univ Wuppertal, FB, Lehrstuhl Messtech, Rainer Gruenter Str 21, D-42119 Wuppertal, Germany; [Gruen, Eberhard] Max Planck Inst Kernphys, Saupfercheckweg 1, D-69115 Heidelberg, Germany; [Haerendel, Gerhard; Hoefner, Herwig] Max Planck Inst Extraterr Phys, Giessenbachstr, D-85748 Garching, Germany; [Henkel, Hartmut; Koch, Andreas] von Hoerner & Sulger GmbH, Schlosspl 8, D-68723 Schwetzingen, Germany; [Hornung, Klaus] Univ Bundeswehr LRT 7, Werner Heisenberg Weg 39, D-85577 Neubiberg, Germany; [Jessberger, Elmar K.] Univ Munster, Inst Planetol, Berghalde 31f, D-69126 Heidelberg, Germany; [Lehto, Harry; Zaprudin, Boris] Univ Turku, Dept Phys & Astron, Tuorla Observ, Vaisalantie 20, Piikkio 21500, Finland; [Lehto, Kirsi] Univ Turku, Dept Biochem, Lab Mol Plant Biol, PharmaCity, Itainen Pitkakatu 4B 6 Krs, FIN-20520 Turku, Finland; [Orthous-Daunay, Francois-Regis] Univ Grenoble Alpes, CNRS, UMR 5274, Inst Planetol & Astrophys Grenoble, F-38000 Grenoble, France; [Ryno, Jouni; Silen, Johan] Finnish Meteorol Inst, Observat Serv, Erik Palmenin Aukio 1, Helsinki 00560, Finland; [Schulz, Rita] European Space Agcy, Sci Support Off, Keplerlaan 1,Postbus 299, NL-2200 AG Noordwijk, Netherlands; [Siljestrom, Sandra] SP Tech Res Inst Sweden, Dept Chem Mat & Surfaces, Box 857, S-50115 Boras, Sweden; [Steiger, Wolfgang] RC Seibersdorf Res GmbH Business Field Aerosp Tec, A-2444 Seibersdorf, Austria; [Stephan, Thomas] Univ Chicago, Dept Geophys Sci, 5734 South Ellis Ave, Chicago, IL 60637 USA; [Torkar, Klaus] Austrian Acad Sci, Space Res Inst, Schmiedlstr 6, A-8042 Graz, Austria; [Varmuza, Kurt] Vienna Univ Technol, Inst Stat & Math Methods Econ, Wiedner Hauptstr 7 105-6, A-1040 Vienna, Austria; [Wanczek, Karl-Peter] Univ Bremen, Inst Anorgan & Phys Chem, FB 2,NW 2, D-28334 Bremen, Germany	UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; University of Bern; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; European Space Agency; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite Paris Saclay; Max Planck Society; University of Wuppertal; Max Planck Society; Max Planck Society; Bundeswehr University Munich; University of Munster; University of Turku; Finland National Institute for Health & Welfare; University of Turku; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); Finnish Meteorological Institute; SP Technical Research Institute of Sweden; University of Chicago; Austrian Academy of Sciences; Technische Universitat Wien; University of Bremen	Fray, N (corresponding author), Univ Paris Est Creteil, UMR CNRS 7583, LISA, F-94000 Creteil, France.; Fray, N (corresponding author), Univ Paris Diderot, Inst Pierre Simon Laplace, F-94000 Creteil, France.	nicolas.fray@lisa.u-pec.fr	Cottin, Hervé/M-6154-2019; Stephan, Thomas/C-1023-2008; briois, christelle/B-2170-2015	Cottin, Hervé/0000-0001-9170-5265; Stephan, Thomas/0000-0001-6377-8731; Stenzel, Oliver/0000-0001-7253-8588; Colangeli, Luigi/0000-0001-6801-9152; Fray, Nicolas/0000-0002-9140-5462; Orthous-Daunay, Francois-Regis/0000-0002-1170-0550; BRIOIS, Christelle/0000-0002-5616-0180; Baklouti, Donia/0000-0002-2754-7829; Le Roy, Lena/0000-0002-5984-6153; Siljestrom, Sandra/0000-0002-4975-6074	Deutsches Zentrum fur Luft- und Raumfahrt (DLR) [50 QP 1302]; Centre National d'Etude Spatiales (CNES); European Space Agency (ESA) Technical Directorate; CNES; Labex Exploration Spatiale des Environnements Planetaires (ESEP) [2011-LABX-030]; Idex Paris Sciences et Lettres (PSL) [ANR-10-IDEX-0001-02]; Swedish National Space Board [121/11, 198/15]; Academy of Finland [277375]	Deutsches Zentrum fur Luft- und Raumfahrt (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); Centre National d'Etude Spatiales (CNES)(Centre National D'etudes Spatiales); European Space Agency (ESA) Technical Directorate; CNES(Centre National D'etudes Spatiales); Labex Exploration Spatiale des Environnements Planetaires (ESEP); Idex Paris Sciences et Lettres (PSL); Swedish National Space Board; Academy of Finland(Academy of Finland)	COSIMA was built by a consortium led by the Max-Planck-Institut fur Extraterrestrische Physik, Garching, Germany, in collaboration with: the Laboratoire de Physique et Chimie de l'Environnement et de l'Espace, Orleans, France; the Institut d'Astrophysique Spatiale, CNRS/Universit, Paris Sud, Orsay, France; the Finnish Meteorological Institute, Helsinki, Finland; the Universitat Wuppertal, Wuppertal, Germany; von Hoerner und Sulger GmbH, Schwetzingen, Germany; the Universitat der Bundeswehr, Neubiberg, Germany; the Institut fur Physik, Forschungszentrum Seibersdorf, Seibersdorf, Austria; and the Institut fur Weltraumforschung, Osterreichische Akademie der Wissenschaften, Graz, Austria; and is led by the Max-Planck-Institut fur Sonnensystemforschung, Gottingen, Germany. We acknowledge the support of the national funding agencies of Germany (Deutsches Zentrum fur Luft- und Raumfahrt (DLR), grant 50 QP 1302), France (Centre National d'Etude Spatiales (CNES)), Austria, Finland and the European Space Agency (ESA) Technical Directorate. A.B. acknowledges support from the CNES and the Labex Exploration Spatiale des Environnements Planetaires (ESEP; no. 2011-LABX-030), and funding from the Idex Paris Sciences et Lettres (PSL; no. ANR-10-IDEX-0001-02). S.S. acknowledges support from the Swedish National Space Board grant (contracts 121/11 and 198/15). H.L., B.Z. and K.L. acknowledge Academy of Finland grant 277375. We thank the Rosetta Science Ground Segment at the European Space Astronomy Centre, the Rosetta Mission Operations Centre at the European Space Operations Centre, and the Rosetta Project at the European Space Research and Technology Centre for their work, which enabled the scientific return of the Rosetta mission.	Alexander C. M. O. D., 2008, ORGANIC MATTER SPACE, V251, P293; Altwegg K, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600285; Biver N, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500863; Brownlee D, 2014, ANNU REV EARTH PL SC, V42, P179, DOI 10.1146/annurev-earth-050212-124203; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Cottin H, 2008, SPACE SCI REV, V138, P179, DOI 10.1007/s11214-008-9399-z; Danger G, 2013, GEOCHIM COSMOCHIM AC, V118, P184, DOI 10.1016/j.gca.2013.05.015; Dartois E, 2013, ICARUS, V224, P243, DOI 10.1016/j.icarus.2013.03.002; Flynn GJ, 2003, GEOCHIM COSMOCHIM AC, V67, P4791, DOI 10.1016/j.gca.2003.09.001; Goesmann F, 2015, SCIENCE, V349, DOI 10.1126/science.aab0689; Greenberg JM, 1998, ASTRON ASTROPHYS, V330, P375; Hilchenbach M, 2016, ASTROPHYS J LETT, V816, DOI 10.3847/2041-8205/816/2/L32; Hornung K, 2014, PLANET SPACE SCI, V103, P309, DOI 10.1016/j.pss.2014.08.011; KERRIDGE JF, 1987, GEOCHIM COSMOCHIM AC, V51, P2527, DOI 10.1016/0016-7037(87)90303-6; Kissel J, 2007, SPACE SCI REV, V128, P823, DOI 10.1007/s11214-006-9083-0; KISSEL J, 1987, NATURE, V326, P755, DOI 10.1038/326755a0; Kissel J, 2004, SCIENCE, V304, P1774, DOI 10.1126/science.1098836; KISSEL J, 1986, NATURE, V321, P280, DOI 10.1038/321280a0; KISSEL J, 1986, NATURE, V321, P336, DOI 10.1038/321336a0; Langevin Y, 2016, ICARUS, V271, P76, DOI 10.1016/j.icarus.2016.01.027; Le Roy L, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201526450; Le Roy L, 2015, PLANET SPACE SCI, V105, P1, DOI 10.1016/j.pss.2014.08.015; Mumma MJ, 2011, ANNU REV ASTRON ASTR, V49, P471, DOI 10.1146/annurev-astro-081309-130811; Nuth JA, 2008, ASTROPHYS J LETT, V673, pL225, DOI 10.1086/528741; Quirico E, 2014, GEOCHIM COSMOCHIM AC, V136, P80, DOI 10.1016/j.gca.2014.03.025; Schmitt-Kopplin P, 2010, P NATL ACAD SCI USA, V107, P2763, DOI 10.1073/pnas.0912157107; Schulz R, 2015, NATURE, V518, P216, DOI 10.1038/nature14159; Sephton MA, 2002, NAT PROD REP, V19, P292, DOI 10.1039/b103775g; Wright IP, 2015, SCIENCE, V349, DOI 10.1126/science.aab0673	34	111	112	1	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2016	538	7623					72	+		10.1038/nature19320	http://dx.doi.org/10.1038/nature19320			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX8LD	27602514				2022-12-28	WOS:000384638900035
J	Huang, XH; Yang, SH; Gong, JY; Zhao, Q; Feng, Q; Zhan, QL; Zhao, Y; Li, WJ; Cheng, BY; Xia, JH; Chen, N; Huang, T; Zhang, L; Fan, DL; Chen, JY; Zhou, CC; Lu, YQ; Weng, QJ; Han, B				Huang, Xuehui; Yang, Shihua; Gong, Junyi; Zhao, Qiang; Feng, Qi; Zhan, Qilin; Zhao, Yan; Li, Wenjun; Cheng, Benyi; Xia, Junhui; Chen, Neng; Huang, Tao; Zhang, Lei; Fan, Danlin; Chen, Jiaying; Zhou, Congcong; Lu, Yiqi; Weng, Qijun; Han, Bin			Genomic architecture of heterosis for yield traits in rice	NATURE			English	Article							CYTOPLASMIC MALE-STERILITY; HYBRID RICE; WIDE ASSOCIATION; GENE; LOCUS; MAIZE; COMPONENT; OSSPL14; SYSTEM; ALLELE	Increasing grain yield is a long-term goal in crop breeding to meet the demand for global food security. Heterosis, when a hybrid shows higher performance for a trait than both parents, offers an important strategy for crop breeding. To examine the genetic basis of heterosis for yield in rice, here we generate, sequence and record the phenotypes of 10,074 F-2 lines from 17 representative hybrid rice crosses. We classify modern hybrid rice varieties into three groups, representing different hybrid breeding systems. Although we do not find any heterosis-associated loci shared across all lines, within each group, a small number of genomic loci from female parents explain a large proportion of the yield advantage of hybrids over their male parents. For some of these loci, we find support for partial dominance of heterozygous locus for yield-related traits and better-parent heterosis for overall performance when all of the grain-yield traits are considered together. These results inform on the genomic architecture of heterosis and rice hybrid breeding.	[Huang, Xuehui; Zhao, Qiang; Feng, Qi; Zhan, Qilin; Zhao, Yan; Li, Wenjun; Huang, Tao; Zhang, Lei; Fan, Danlin; Chen, Jiaying; Zhou, Congcong; Lu, Yiqi; Weng, Qijun; Han, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Ctr Gene Res,CAS Ctr Excellence Mol Plant Sc, Shanghai 200233, Peoples R China; [Yang, Shihua; Gong, Junyi; Cheng, Benyi; Xia, Junhui; Chen, Neng] Chinese Acad Agr Sci, China Natl Rice Res Inst, Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS	Huang, XH; Han, B (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Ctr Gene Res,CAS Ctr Excellence Mol Plant Sc, Shanghai 200233, Peoples R China.	xhhuang@ncgr.ac.cn; bhan@ncgr.ac.cn		Huang, Xuehui/0000-0003-0529-1532; Han, Bin/0000-0001-8695-0274	Chinese Academy of Sciences [XDA08020101]; National Natural Science Foundation of China [31322028, 91535202, 31421093, 31301302]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Chinese Academy of Sciences (XDA08020101) and the National Natural Science Foundation of China (31322028, 91535202, 31421093 and 31301302).	Birchler JA, 2016, PLANT SCI, V245, P128, DOI 10.1016/j.plantsci.2016.02.002; Cheng SH, 2007, ANN BOT-LONDON, V100, P959, DOI 10.1093/aob/mcm121; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ding JH, 2012, P NATL ACAD SCI USA, V109, P2654, DOI 10.1073/pnas.1121374109; Fujita D, 2013, P NATL ACAD SCI USA, V110, P20431, DOI 10.1073/pnas.1310790110; Gao ZY, 2013, P NATL ACAD SCI USA, V110, P14492, DOI 10.1073/pnas.1306579110; Gao ZY, 2003, SCI CHINA SER C, V46, P661, DOI 10.1360/03yc0099; Hollick JB, 1998, GENETICS, V150, P891; Hua JP, 2002, GENETICS, V162, P1885; Huang XH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7258; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Izawa T, 2011, PLANT CELL, V23, P1741, DOI 10.1105/tpc.111.083238; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kim SL, 2007, PLANT PHYSIOL, V145, P1484, DOI 10.1104/pp.107.103291; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Komatsu M, 2001, DEV BIOL, V231, P364, DOI 10.1006/dbio.2000.9988; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SQ, 2007, J INTEGR PLANT BIOL, V49, P791, DOI 10.1111/j.1744-7909.2007.00513.x; Li X, 2015, P NATL ACAD SCI USA, V112, P11823, DOI 10.1073/pnas.1509229112; Liu G, 2002, MOL GENET GENOMICS, V267, P472, DOI 10.1007/s00438-002-0677-2; Luo DP, 2013, NAT GENET, V45, P573, DOI 10.1038/ng.2570; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Picelli S, 2014, GENOME RES, V24, P2033, DOI 10.1101/gr.177881.114; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Song XJ, 2015, P NATL ACAD SCI USA, V112, P76, DOI 10.1073/pnas.1421127112; Sun HY, 2014, NAT GENET, V46, P652, DOI 10.1038/ng.2958; Suresh PB, 2012, EUPHYTICA, V187, P421, DOI 10.1007/s10681-012-0737-6; Tang HW, 2014, MOL PLANT, V7, P1497, DOI 10.1093/mp/ssu047; Wang S., 2007, WINDOWS QTL CARTOGRA; Wang YH, 2005, TRENDS PLANT SCI, V10, P610, DOI 10.1016/j.tplants.2005.10.008; WANG ZY, 1995, PLANT J, V7, P613, DOI 10.1046/j.1365-313X.1995.7040613.x; XIAO JH, 1995, GENETICS, V140, P745; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yan WH, 2011, MOL PLANT, V4, P319, DOI 10.1093/mp/ssq070; Yang JY, 2012, SCIENCE, V337, P1336, DOI 10.1126/science.1223702; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yao H, 2013, P NATL ACAD SCI USA, V110, P2665, DOI 10.1073/pnas.1221966110; Yu BS, 2007, PLANT J, V52, P891, DOI 10.1111/j.1365-313X.2007.03284.x; Zhou G, 2012, P NATL ACAD SCI USA, V109, P15847, DOI 10.1073/pnas.1214141109; Zhou H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5884	45	217	252	18	288	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2016	537	7622					629	+		10.1038/nature19760	http://dx.doi.org/10.1038/nature19760			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4DR	27602511				2022-12-28	WOS:000384331700039
J	Weiss, Y; Class, C; Goldstein, SL; Hanyu, T				Weiss, Yaakov; Class, Cornelia; Goldstein, Steven L.; Hanyu, Takeshi			Key new pieces of the HIMU puzzle from olivines and diamond inclusions	NATURE			English	Article							OCEANIC ISLAND BASALTS; MANTLE; PB; ISOTOPES; SR; ND; CARBONATITE; KIMBERLITES; LAVAS; CRUST	Mantle melting, which leads to the formation of oceanic and continental crust, together with crust recycling through plate tectonics, are the primary processes that drive the chemical differentiation of the silicate Earth. The present-day mantle, as sampled by oceanic basalts, shows large chemical and isotopic variability bounded by a few end-member compositions(1). Among these, the HIMU end-member (having a high U/Pb ratio, mu) has been generally considered to represent subducted/recycled basaltic oceanic crust(2-5). However, this concept has been challenged by recent studies of the mantle source of HIMU magmas. For example, analyses of olivine phenocrysts in HIMU lavas indicate derivation from the partial melting of peridotite, rather than from the pyroxenitic remnants of recycled oceanic basalt(6). Here we report data that elucidate the source of these lavas: high-precision trace-element analyses of olivine phenocrysts point to peridotite that has been metasomatized by carbonatite fluids. Moreover, similarities in the trace-element patterns of carbonatitic melt inclusions in diamonds(7) and HIMU lavas indicate that the metasomatism occurred in the subcontinental lithospheric mantle, fused to the base of the continental crust and isolated from mantle convection. Taking into account evidence from sulfur isotope data(8) for Archean to early Proterozoic surface material in the deep HIMU mantle source, a multi-stage evolution is revealed for the HIMU end-member, spanning more than half of Earth's history. Before entrainment in the convecting mantle, storage in a boundary layer, upwelling as a mantle plume and partial melting to become ocean island basalt, the HIMU source formed as Archean-early Proterozoic subduction-related carbonatite-metasomatized subcontinental lithospheric mantle.	[Weiss, Yaakov; Class, Cornelia; Goldstein, Steven L.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Goldstein, Steven L.] Columbia Univ, Dept Earth & Environm Sci, Palisades, NY 10964 USA; [Hanyu, Takeshi] Japan Agcy Marine Earth Sci & Technol, Dept Solid Earth Geochem, Yokosuka, Kanagawa 2370061, Japan	Columbia University; Columbia University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Weiss, Y; Class, C; Goldstein, SL (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.; Goldstein, SL (corresponding author), Columbia Univ, Dept Earth & Environm Sci, Palisades, NY 10964 USA.; Hanyu, T (corresponding author), Japan Agcy Marine Earth Sci & Technol, Dept Solid Earth Geochem, Yokosuka, Kanagawa 2370061, Japan.	yweiss@ldeo.columbia.edu; class@ldeo.columbia.edu; steveg@ldeo.columbia.edu; hanyut@jamstec.go.jp	Hanyu, Takeshi/AAD-1453-2019	Hanyu, Takeshi/0000-0001-9525-8343	LDEO Postdoctoral Fellowship; NSF [EAR13-48045]; Storke Endowment of the Columbia University Department of Earth and Environmental Sciences; Directorate For Geosciences [1348045] Funding Source: National Science Foundation; Grants-in-Aid for Scientific Research [26400527] Funding Source: KAKEN	LDEO Postdoctoral Fellowship; NSF(National Science Foundation (NSF)); Storke Endowment of the Columbia University Department of Earth and Environmental Sciences; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Lambart, D. G. Pearson, S. Aulbach and D. Walker for discussions, A. W. Hofmann for discussions and an informal review, J. Gross and B. A Goldoff for help with the EPMA analyses, and K Lehnert and A. Johansson for help with accessing the xenolith data in EarthChernis PetDB database. This work was supported by an LDEO Postdoctoral Fellowship for Y.W., NSF grant EAR13-48045 to Y.W., C.C. and S.L.G., and the Storke Endowment of the Columbia University Department of Earth and Environmental Sciences. This is Lamont Doherty Earth Observatory contribution number 8046.	AGEE CB, 1990, CONTRIB MINERAL PETR, V105, P243, DOI 10.1007/BF00306537; Balta JB, 2011, GEOCHIM COSMOCHIM AC, V75, P5819, DOI 10.1016/j.gca.2011.05.026; Becker M, 2006, J PETROL, V47, P673, DOI 10.1093/petrology/egi089; Bell K, 2001, J PETROL, V42, P1927, DOI 10.1093/petrology/42.10.1927; Bizimis M, 2003, CONTRIB MINERAL PETR, V145, P281, DOI 10.1007/s00410-003-0452-3; Braun MG, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000289; Cabral RA, 2013, NATURE, V496, P490, DOI 10.1038/nature12020; Castillo PR, 2015, LITHOS, V216, P254, DOI 10.1016/j.lithos.2014.12.005; CHAUVEL C, 1992, EARTH PLANET SC LETT, V110, P99, DOI 10.1016/0012-821X(92)90042-T; Class C, 2005, EARTH PLANET SC LETT, V233, P391, DOI 10.1016/j.epsl.2005.02.029; Class C, 1998, J PETROL, V39, P881, DOI 10.1093/petrology/39.5.881; Class C, 2009, EARTH PLANET SC LETT, V284, P219, DOI 10.1016/j.epsl.2009.04.031; Collerson KD, 2010, PHYS EARTH PLANET IN, V181, P112, DOI 10.1016/j.pepi.2010.05.008; Coogan LA, 2014, CHEM GEOL, V368, P1, DOI 10.1016/j.chemgeo.2014.01.004; De Hoog JCM, 2010, CHEM GEOL, V270, P196, DOI 10.1016/j.chemgeo.2009.11.017; Farquhar J, 2002, SCIENCE, V298, P2369, DOI 10.1126/science.1078617; Graham S, 2004, LITHOS, V76, P519, DOI 10.1016/j.lithos.2004.03.031; Gregoire M, 2003, J PETROL, V44, P629, DOI 10.1093/petrology/44.4.629; Hanyu T, 2011, EARTH PLANET SC LETT, V307, P377, DOI 10.1016/j.epsl.2011.05.012; Hanyu T, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003252; HART SR, 1986, GEOCHIM COSMOCHIM AC, V50, P1551, DOI 10.1016/0016-7037(86)90329-7; HAURI EH, 1993, EARTH PLANET SC LETT, V114, P353, DOI 10.1016/0012-821X(93)90036-9; Herzberg C, 2014, EARTH PLANET SC LETT, V396, P97, DOI 10.1016/j.epsl.2014.03.065; Herzberg C, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002057; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; Jackson MG, 2008, EARTH PLANET SC LETT, V276, P175, DOI 10.1016/j.epsl.2008.09.023; Korenaga J, 2000, EARTH PLANET SC LETT, V184, P251, DOI 10.1016/S0012-821X(00)00308-3; KRAMERS JD, 1977, EARTH PLANET SC LETT, V34, P419, DOI 10.1016/0012-821X(77)90053-X; Matzen AK, 2013, J PETROL, V54, P2521, DOI 10.1093/petrology/egt055; MCDONOUGH WF, 1990, EARTH PLANET SC LETT, V101, P1, DOI 10.1016/0012-821X(90)90119-I; MCKENZIE D, 1983, NATURE, V301, P229, DOI 10.1038/301229a0; MCNUTT MK, 1995, REV GEOPHYS, V33, P413, DOI 10.1029/95RG00436; RUDNICK RL, 1993, EARTH PLANET SC LETT, V114, P463, DOI 10.1016/0012-821X(93)90076-L; Saal AE, 1998, SCIENCE, V282, P1481, DOI 10.1126/science.282.5393.1481; Shirey SB, 1998, ANNU REV EARTH PL SC, V26, P423, DOI 10.1146/annurev.earth.26.1.423; Sobolev AV, 2007, SCIENCE, V316, P412, DOI 10.1126/science.1138113; Stein M, 1997, EARTH PLANET SC LETT, V152, P75, DOI 10.1016/S0012-821X(97)00156-8; Stracke A, 2012, CHEM GEOL, V330, P274, DOI 10.1016/j.chemgeo.2012.08.007; TILTON GR, 1994, GEOCHIM COSMOCHIM AC, V58, P3145, DOI 10.1016/0016-7037(94)90042-6; VEIZER J, 1976, GEOCHIM COSMOCHIM AC, V40, P905, DOI 10.1016/0016-7037(76)90139-3; Weiss Y, 2011, EARTH PLANET SC LETT, V309, P337, DOI 10.1016/j.epsl.2011.07.012; Willbold M, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001005; ZINDLER A, 1982, NATURE, V298, P519, DOI 10.1038/298519a0; ZINDLER A, 1986, ANNU REV EARTH PL SC, V14, P493, DOI 10.1146/annurev.ea.14.050186.002425	44	91	94	3	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2016	537	7622					666	+		10.1038/nature19113	http://dx.doi.org/10.1038/nature19113			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4DR	27595333				2022-12-28	WOS:000384331700047
J	Sciacovelli, M; Goncalves, E; Johnson, TI; Zecchini, VR; da Costa, ASH; Gaude, E; Drubbel, AV; Theobald, SJ; Abbo, SR; Tran, MGB; Rajeeve, V; Cardaci, S; Foster, S; Yun, HY; Cutillas, P; Warren, A; Gnanapragasam, V; Gottlieb, E; Franze, K; Huntly, B; Maher, ER; Maxwell, PH; Saez-Rodriguez, J; Frezza, C				Sciacovelli, Marco; Goncalves, Emanuel; Johnson, Timothy Isaac; Zecchini, Vincent Roberto; da Costa, Ana Sofia Henriques; Gaude, Edoardo; Drubbel, Alizee Vercauteren; Theobald, Sebastian Julian; Abbo, Sandra Riekje; Tran, Maxine Gia Binh; Rajeeve, Vinothini; Cardaci, Simone; Foster, Sarah; Yun, Haiyang; Cutillas, Pedro; Warren, Anne; Gnanapragasam, Vincent; Gottlieb, Eyal; Franze, Kristian; Huntly, Brian; Maher, Eamonn Richard; Maxwell, Patrick Henry; Saez-Rodriguez, Julio; Frezza, Christian			Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition	NATURE			English	Article							ENRICHMENT ANALYSIS; EXPRESSION; CANCER; MUTATIONS; SUCCINATE; TET; DEMETHYLASES; GLUTATHIONE; INHIBITION; HEREDITARY	Mutations of the tricarboxylic acid cycle enzyme fumarate hydratase cause hereditary leiomyomatosis and renal cell cancer(1). Fumarate hydratase-deficient renal cancers are highly aggressive and metastasize even when small, leading to a very poor clinical outcome2. Fumarate, a small molecule metabolite that accumulates in fumarate hydratase-deficient cells, plays a key role in cell transformation, making it a bona fide oncometabolite(3). Fumarate has been shown to inhibit a-ketoglutarate-dependent dioxygenases that are involved in DNA and histone demethylation(4,5). However, the link between fumarate accumulation, epigenetic changes, and tumorigenesis is unclear. Here we show that loss of fumarate hydratase and the subsequent accumulation of fumarate in mouse and human cells elicits an epithelial-to-mesenchymal-transition (EMT), a phenotypic switch associated with cancer initiation, invasion, and metastasis(6). We demonstrate that fumarate inhibits Tet-mediated demethylation of a regulatory region of the antimetastatic miRNA cluster(6) mir-200ba429, leading to the expression of EMT-related transcription factors and enhanced migratory properties. These epigenetic and phenotypic changes are recapitulated by the incubation of fumarate hydratase-proficient cells with cell-permeable fumarate. Loss of fumarate hydratase is associated with suppression of miR-200 and the EMT signature in renal cancer and is associated with poor clinical outcome. These results imply that loss of fumarate hydratase and fumarate accumulation contribute to the aggressive features of fumarate hydratase-deficient tumours.	[Sciacovelli, Marco; Johnson, Timothy Isaac; Zecchini, Vincent Roberto; da Costa, Ana Sofia Henriques; Gaude, Edoardo; Drubbel, Alizee Vercauteren; Theobald, Sebastian Julian; Abbo, Sandra Riekje; Frezza, Christian] Univ Cambridge, MRC, Canc Unit, Cambridge CB2 0XZ, England; [Goncalves, Emanuel; Saez-Rodriguez, Julio] EBI, EMBL, Cambridge CB10 1SD, England; [Tran, Maxine Gia Binh] Univ Cambridge, Urooncol Res Grp, Dept Oncol, Cambridge CB2 0QL, England; [Rajeeve, Vinothini; Cutillas, Pedro] Queen Mary Univ London, Barts Canc Inst, Ctr Haematooncol, Integrat Cell Signalling & Prote,John Vane Sci Ct, Charterhouse Sq, London EC1M 6BQ, England; [Cardaci, Simone; Gottlieb, Eyal] Cancer Res UK, Beatson Inst, Glasgow G61 1BD, Lanark, Scotland; [Foster, Sarah; Franze, Kristian] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; [Yun, Haiyang; Huntly, Brian] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England; [Yun, Haiyang; Huntly, Brian] Univ Cambridge, Addenbrookes Hosp, Cambridge CB2 0XY, England; [Yun, Haiyang; Huntly, Brian] Univ Cambridge, Wellcome Trust Med Res Council, Cambridge Stem Cell Inst, Cambridge CB2 0XY, England; [Warren, Anne] Univ Cambridge, Dept Pathol, Cambridge CB2 0QQ, England; [Gnanapragasam, Vincent] Univ Cambridge, Acad Urol Grp, Dept Surg, Cambridge CB2 0QQ, England; [Maher, Eamonn Richard] Univ Cambridge, Dept Med Genet, Cambridge CB2 0QQ, England; [Maher, Eamonn Richard] NIHR Cambridge Biomed Res Ctr, Cambridge CB2 0QQ, England; [Maxwell, Patrick Henry] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Saez-Rodriguez, Julio] Rhein Westfal TH Aachen, Joint Res Ctr Computat Biomed, Fac Med, D-52074 Aachen, Germany; [Tran, Maxine Gia Binh] Royal Free Hosp, Renal Canc Ctr, UCL Div Surg & Intervent Sci, Pond St, London NW3 2QG, England	University of Cambridge; European Molecular Biology Laboratory (EMBL); University of Cambridge; University of London; Queen Mary University London; Beatson Institute; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; RWTH Aachen University; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Frezza, C (corresponding author), Univ Cambridge, MRC, Canc Unit, Cambridge CB2 0XZ, England.	cf366@mrc-cu.cam.ac.uk	Frezza, Christian/G-2174-2010; Gottlieb, Eyal/G-6450-2010; Saez-Rodriguez, Julio/H-7114-2019; Costa, Ana/HDL-9297-2022; Tran, Maxine/ABF-4197-2021; Cardaci, Simone/J-2295-2018; Maxwell, Patrick H/C-5557-2008; Sciacovelli, Marco/AAJ-1145-2020; MAHER, EAMONN R/A-9507-2008; Costa, Ana SH/H-2852-2012; huntly, brian/E-6725-2014	Frezza, Christian/0000-0002-3293-7397; Gottlieb, Eyal/0000-0002-9770-0956; Saez-Rodriguez, Julio/0000-0002-8552-8976; Cardaci, Simone/0000-0002-5955-3422; Maxwell, Patrick H/0000-0002-0338-2679; MAHER, EAMONN R/0000-0002-6226-6918; Costa, Ana SH/0000-0001-8932-6370; Vercauteren Drubbel, Alizee/0000-0002-6365-3418; Yun, Haiyang/0000-0001-8714-205X; Johnson, Timothy I/0000-0002-1606-8849; Franze, Kristian/0000-0002-8425-7297; Tran, Maxine Gia Binh/0000-0002-6034-4433; Gaude, Edoardo/0000-0001-8523-7792; huntly, brian/0000-0003-0312-161X; Goncalves, Emanuel/0000-0002-9967-5205	Medical Research Council (UK); Herchel Smith Research Studentship; MRC; ERC [323004-ONCOTREAT]; Wellcome Trust; NIHR; NIHR Cambridge Biomedical Research Centre; MRC [MR/M010392/1, G1100312, MC_UU_12022/6] Funding Source: UKRI; Cancer Research UK [18278] Funding Source: researchfish; Medical Research Council [G1100312, MC_PC_12009, MR/M010392/1, MC_UU_12022/6] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10122] Funding Source: researchfish; Wellcome Trust [096956/Z/11/Z] Funding Source: researchfish; Worldwide Cancer Research [14-1069] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Herchel Smith Research Studentship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NIHR(National Institute for Health Research (NIHR)); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Worldwide Cancer Research	This work was supported by the Medical Research Council (UK). S.F. was supported by a Herchel Smith Research Studentship and K.F. by an MRC Career Development Award. E.R.M is supported by the ERC Advanced Researcher award 323004-ONCOTREAT. P.H.M. is supported by Senior Investigator Awards from the Wellcome Trust and NIHR. The Cambridge Human Research Tissue Bank and A.W. are supported by the NIHR Cambridge Biomedical Research Centre. We thank the UOB Tumor Cell Line Repository and W. Linehan for UOK262 cell lines. We thank E. Clemente, J. Bauer, and the staff at Cambridge Genomic Services for miRNA profiling; the CRUK Cambridge Institute (Genomics facility), especially J. Hadfield, and the CRUK Cambridge Institute (Bioinformatics facility), especially C. S. R. Chilamakuri for RNA-seq sample processing and analysis. We also thank C. Martins and A. Rasola for critical reading of the manuscript.	Ashrafian H, 2010, CANCER RES, V70, P9153, DOI 10.1158/0008-5472.CAN-10-1949; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Buchmaier BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068301; Cardaci S, 2015, NAT CELL BIOL, V17, P1317, DOI 10.1038/ncb3233; Casado P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003573; Casado P, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003079; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Cutillas PR, 2007, MOL CELL PROTEOMICS, V6, P1560, DOI 10.1074/mcp.M700037-MCP200; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Fang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062558; Fieuw A, 2012, INT J CANCER, V130, P2599, DOI 10.1002/ijc.26317; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Heinemann B, 2014, NATURE, V514, pE1, DOI 10.1038/nature13688; Hu X, 2014, CELL STEM CELL, V14, P512, DOI 10.1016/j.stem.2014.01.001; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Laukka T, 2016, J BIOL CHEM, V291, P4256, DOI 10.1074/jbc.M115.688762; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Letouze E, 2013, CANCER CELL, V23, P739, DOI 10.1016/j.ccr.2013.04.018; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Linehan WM, 2016, NEW ENGL J MED, V374, P135, DOI 10.1056/NEJMoa1505917; MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06; Ooi A, 2011, CANCER CELL, V20, P511, DOI 10.1016/j.ccr.2011.08.024; Piccinini F, 2016, BIOINFORMATICS, V32, P955, DOI 10.1093/bioinformatics/btv686; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Rajeeve V, 2014, MOL CELL PROTEOMICS, V13, P1457, DOI 10.1074/mcp.M113.035204; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Schmidt LS, 2014, INT J NEPHROL RENOV, V7, P253, DOI 10.2147/IJNRD.S42097; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan LB, 2013, MOL CELL, V51, P236, DOI 10.1016/j.molcel.2013.05.003; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Yang M, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00085; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Zheng L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7001	40	319	328	8	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2016	537	7621					544	+		10.1038/nature19353	http://dx.doi.org/10.1038/nature19353			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW3MO	27580029	Green Accepted, Green Submitted			2022-12-28	WOS:000383545900055
J	Drew, L				Drew, Liam			The right drug for you	NATURE			English	Editorial Material																			0	37	37	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					S60	S62		10.1038/537S60a	http://dx.doi.org/10.1038/537S60a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU9LQ	27602742	Bronze			2022-12-28	WOS:000382539100003
J	Singh, D; Papi, A; Corradi, M; Pavlisova, I; Montagna, I; Francisco, C; Cohuet, G; Vezzoli, S; Scuri, M; Vestbo, J				Singh, Dave; Papi, Alberto; Corradi, Massimo; Pavlisova, Ilona; Montagna, Isabella; Francisco, Catherine; Cohuet, Geraldine; Vezzoli, Stefano; Scuri, Mario; Vestbo, Jorgen			Single inhaler triple therapy versus inhaled corticosteroid plus long-acting beta(2)-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial	LANCET			English	Article							FLUTICASONE PROPIONATE/SALMETEROL; LUNG-FUNCTION; INDIVIDUAL COMPONENTS; TIOTROPIUM; COPD; GLYCOPYRRONIUM; EXACERBATIONS; SALMETEROL; SALMETEROL/FLUTICASONE; POPULATION	Background Few data are available for the efficacy of "triple therapy" with two long-acting bronchodilators and an inhaled corticosteroid in chronic obstructive pulmonary disease (COPD). We designed this study to assess efficacy of single-inhaler combination of an extra fine formulation of beclometasone dipropionate, formoterol fumarate, and glycopyrronium bromide (BDP/FF/GB) in COPD compared with beclometasone dipropionate and formoterol fumarate (BDP/FF) treatment. Methods TRILOGY was a randomised, parallel group, double-blind, active-controlled study done in 159 sites across 14 countries. The sites were a mixture of primary, secondary, and tertiary care providers, and specialist investigation units. Eligible patients with COPD had post-bronchodilator forced expiratory volume in 1 s (FEV 1) of lower than 50%, one or more moderate-to-severe COPD exacerbation in the previous 12 months, COPD Assessment Test total score of 10 or more, and a Baseline Dyspnea Index focal score of 10 or less. Patients who met the inclusion and exclusion criteria at screening entered a 2-week open-label run-in period where they received beclometasone dipropionate (100 mu g) and formoterol fumarate (6 mu g) in two actuations twice daily. Patients were then randomly assigned (1: 1) with an interactive response technology system to either continue BDP (100 mu g) and FF (6 mu g) or step-up to BDP (100 mu g), FF (6 mu g), and GB (12 . 5 mu g) in two actuations twice daily for 52 weeks via pressurised metered-dose inhaler. The three co-primary endpoints were pre-dose FEV1, 2-h post-dose FEV1, and Transition Dyspnea Index (TDI) focal score, all measured at week 26 in the intention-to-treat population (all patients who were randomly assigned and received at least one dose of study drug and had at least one post-baseline efficacy assessment). Safety outcomes were measured in the safety population (all patients who were randomly assigned and received at least one dose of study drug). Secondary endpoints included moderate-to-severe COPD exacerbation rate over 52 weeks. This study is registered with ClinicalTrials.gov, number NCT01917331. Findings Between March 21, 2014, and Jan 14, 2016, 1368 patients received either BDP/FF/GB (n=687) or BDP/FF (n= 681). At week 26, BDP/FF/GB improved pre-dose FEV 1 by 0.081 L (95% CI 0.052-0.109; p< 0.001) and 2-h post-dose FEV 1 by 0.117 L (0.086-0.147; p< 0.001) compared with BDP/FF. Mean TDI focal scores at week 26 were 1.71 for BDP/FF/GB and 1.50 for BDP/FF, with a difference of 0.21 (95% CI -0.08 to 0.51; p=0.160). Adjusted annual moderate-to-severe exacerbation frequencies were 0.41 for BDP/FF/GB and 0.53 for BDP/FF (rate ratio 0.77 [ 95% CI 0.65-0.92]; p= 0.005), corresponding to a 23% reduction in exacerbations with BDP/FF/GB compared with BDP/FF. Adverse events were reported by 368 (54%) patients with BDP/FF/GB and 379 (56%) with BDP/FF. One serious treatment-related adverse event occurred (atrial fibrillation) in a patient in the BDP/FF/GB group. Interpretation We provide evidence for the clinical benefits of stepping up patients with COPD from an inhaled corticosteroid/long-acting beta(2) -agonist combination treatment to triple therapy using a single inhaler.	[Singh, Dave; Vestbo, Jorgen] Univ Manchester, Ctr Resp Med & Allergy, Manchester M13 9PL, Lancs, England; [Papi, Alberto] Univ Ferrara, Ctr Asthma, Ferrara, Italy; [Papi, Alberto] Univ Ferrara, COPD, Ferrara, Italy; [Corradi, Massimo] Univ Parma, Dept Clin & Expt Med, I-43100 Parma, Italy; [Pavlisova, Ilona] Poliklin Moravsky Krumlov, Odborny Plicni Lekar, Moravsky, Krumlov, Czech Republic; [Montagna, Isabella; Vezzoli, Stefano; Scuri, Mario] Chiesi Farmaceutici SpA, Global Clin Dev, Parma, Italy; [Francisco, Catherine; Cohuet, Geraldine] Chiesi SAS, Global Clin Dev, Courbevoie, France	University of Manchester; University of Ferrara; University of Ferrara; University of Parma; University Hospital of Parma; Chiesi Pharmaceuticals Inc; Chiesi Pharmaceuticals Inc	Singh, D (corresponding author), Univ Manchester, Ctr Resp Med & Allergy, Manchester M13 9PL, Lancs, England.	dsingh@meu.org.uk	Singh, Dave/AAH-4342-2020; Papi, alberto/AAC-1888-2019; Vestbo, Jorgen/Y-2912-2019	Singh, Dave/0000-0001-8918-7075; Vestbo, Jorgen/0000-0001-6355-6362	Chiesi Farmaceutici SpA	Chiesi Farmaceutici SpA(Chiesi Pharmaceuticals Inc)	Chiesi Farmaceutici SpA.	Aaron SD, 2007, ANN INTERN MED, V146, P545, DOI 10.7326/0003-4819-146-8-200704170-00152; AbuDagga A, 2013, INT J CHRONIC OBSTR, V8, P175, DOI 10.2147/COPD.S40437; Bateman ED, 2013, EUR RESPIR J, V42, P1484, DOI 10.1183/09031936.00200212; Brusselle G, 2015, INT J CHRONIC OBSTR, V10, P2207, DOI 10.2147/COPD.S91694; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Cazzola M, 2007, PULM PHARMACOL THER, V20, P556, DOI 10.1016/j.pupt.2006.06.001; Celli BR, 2008, AM J RESP CRIT CARE, V178, P332, DOI 10.1164/rccm.200712-1869OC; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; European Medicines Agency. Committee for medicinal products for human use (CHMP), 2012, EMACHMP4835722012; Frith PA, 2015, THORAX, V70, P519, DOI 10.1136/thoraxjnl-2014-206670; Global Initiative for Chronic Obstructive Lung Disease, 2016, GLOBAL STRATEGY DIAG; Hanania NA, 2012, RESP MED, V106, P91, DOI 10.1016/j.rmed.2011.09.002; Hoshino M, 2013, RESPIRATION, V86, P280, DOI 10.1159/000351116; Johannesdottir Sigrun A, 2013, J Med Econ, V16, P897, DOI 10.3111/13696998.2013.800525; Jones PW, 2014, AM J RESP CRIT CARE, V189, P250, DOI 10.1164/rccm.201310-1863PP; Jung KS, 2012, RESP MED, V106, P382, DOI 10.1016/j.rmed.2011.09.004; Kew KM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010115.pub2; Mullerova H, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006171; Rennard S, 2013, COPD, V10, P393, DOI 10.3109/15412555.2013.795423; Short PM, 2012, CHEST, V141, P81, DOI 10.1378/chest.11-0038; Siler TM, 2015, RESP MED, V109, P1155, DOI 10.1016/j.rmed.2015.06.006; Singh D, 2008, THORAX, V63, P592, DOI 10.1136/thx.2007.087213; Singh D, 2016, NPJ PRIM CARE RESP M, V26, DOI 10.1038/npjpcrm.2016.30; Singh D, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-178; Solem CT, 2013, INT J CHRONIC OBSTR, V8, P641, DOI 10.2147/COPD.S51245; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; US Department of Health and Human Services, 2016, CHRON OBST PULM DIS; Wedzicha JA, 2016, NEW ENGL J MED, V374, P2222, DOI 10.1056/NEJMoa1516385; Wedzicha JA, 2013, LANCET RESP MED, V1, P199, DOI 10.1016/S2213-2600(13)70052-3; Welte T, 2009, AM J RESP CRIT CARE, V180, P741, DOI 10.1164/rccm.200904-0492OC	30	259	281	2	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2016	388	10048					963	973		10.1016/S0140-6736(16)31354-X	http://dx.doi.org/10.1016/S0140-6736(16)31354-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU9GL	27598678	Green Submitted			2022-12-28	WOS:000382524400026
J	Brody, H				Brody, Herb			Science-led economies	NATURE			English	Editorial Material																			0	0	0	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					S1	S1		10.1038/537S1a	http://dx.doi.org/10.1038/537S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU7XC	27580132	Bronze			2022-12-28	WOS:000382426900017
J	Wise, J				Wise, Jacqui			Unnecessary angiography could be reduced by using non-invasive imaging, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Greenwood JP, 2016, JAMA-J AM MED ASSOC, V316, P1051, DOI 10.1001/jama.2016.12680; Kmietowicz Z, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4662	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 31	2016	354								i4710	10.1136/bmj.i4710	http://dx.doi.org/10.1136/bmj.i4710			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AD	27582360				2022-12-28	WOS:000382792500016
J	Keren, L; Hausser, J; Lotan-Pompan, M; Slutskin, IV; Alisar, H; Kaminski, S; Weinberger, A; Alon, U; Milo, R; Segal, E				Keren, Leeat; Hausser, Jean; Lotan-Pompan, Maya; Slutskin, Ilya Vainberg; Alisar, Hadas; Kaminski, Sivan; Weinberger, Adina; Alon, Uri; Milo, Ron; Segal, Eran			Massively Parallel Interrogation of the Effects of Gene Expression Levels on Fitness	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; LELOIR PATHWAY; YEAST; PROTEINS; COST; PHOSPHOGLUCOMUTASE; ENZYMES; BINDING; NOISE; TOOL	Data of gene expression levels across individuals, cell types, and disease states is expanding, yet our understanding of how expression levels impact phenotype is limited. Here, we present a massively parallel system for assaying the effect of gene expression levels on fitness in Saccharomyces cerevisiae by systematically altering the expression level of similar to 100 genes at similar to 100 distinct levels spanning a 500-fold range at high resolution. We show that the relationship between expression levels and growth is gene and environment specific and provides information on the function, stoichiometry, and interactions of genes. Wild-type expression levels in some conditions are not optimal for growth, and genes whose fitness is greatly affected by small changes in expression level tend to exhibit lower cell-to-cell variability in expression. Our study addresses a fundamental gap in understanding the functional significance of gene expression regulation and offers a framework for evaluating the phenotypic effects of expression variation.	[Keren, Leeat; Lotan-Pompan, Maya; Slutskin, Ilya Vainberg; Alisar, Hadas; Weinberger, Adina; Segal, Eran] Weizmann Inst Sci, Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Keren, Leeat; Hausser, Jean; Lotan-Pompan, Maya; Slutskin, Ilya Vainberg; Alisar, Hadas; Weinberger, Adina; Alon, Uri; Segal, Eran] Weizmann Inst Sci, Mol Cell Biol, IL-76100 Rehovot, Israel; [Kaminski, Sivan] Weizmann Inst Sci, Mol Genet, IL-76100 Rehovot, Israel; [Keren, Leeat; Milo, Ron] Weizmann Inst Sci, Plant & Environm Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Segal, E (corresponding author), Weizmann Inst Sci, Comp Sci & Appl Math, IL-76100 Rehovot, Israel.; Segal, E (corresponding author), Weizmann Inst Sci, Mol Cell Biol, IL-76100 Rehovot, Israel.	eran.segal@weizmann.ac.il	Segal, Eran/AAF-4855-2019	Hausser, Jean/0000-0002-3321-7199; Segal, Eran/0000-0002-6859-1164	European Research Council (ERC); NIH; Kahn Center; Azrieli Center for Systems Biology	European Research Council (ERC)(European Research Council (ERC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kahn Center; Azrieli Center for Systems Biology	This work was supported by grants from the European Research Council (ERC) and the NIH to E.S. and student grants from the Kahn Center and Azrieli Center for Systems Biology to L.K. We thank Michal Levo, Shira Weingarten-Gabbay, Dan Davidi, Niv Antonovski, Martin Mikl, David Zeevi, and Eran Kotler for valuable input.	Alon U., 2006, INTRO SYSTEMS BIOL D; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Bauer CR, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145264; BERNSTEIN M, 1985, J CELL BIOL, V101, P2374, DOI 10.1083/jcb.101.6.2374; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Borneman AR, 2006, GENE DEV, V20, P435, DOI 10.1101/gad.1389306; Bro C, 2005, APPL ENVIRON MICROB, V71, P6465, DOI 10.1128/AEM.71.11.6465-6472.2005; Chambers A, 1995, CURR GENET, V29, P1, DOI 10.1007/BF00313187; Chechik G, 2008, NAT BIOTECHNOL, V26, P1251, DOI 10.1038/nbt.1499; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; de Jongh WA, 2008, BIOTECHNOL BIOENG, V101, P317, DOI 10.1002/bit.21890; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fendt SM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-12; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; Holden HM, 2003, J BIOL CHEM, V278, P43885, DOI 10.1074/jbc.R300025200; Hong KK, 2011, P NATL ACAD SCI USA, V108, P12179, DOI 10.1073/pnas.1103219108; Kafri M, 2016, CELL REP, V14, P22, DOI 10.1016/j.celrep.2015.12.015; Kalisky T, 2007, PHYS BIOL, V4, P229, DOI 10.1088/1478-3975/4/4/001; Kemmeren P, 2014, CELL, V157, P740, DOI 10.1016/j.cell.2014.02.054; Keren L., 2015, GENOME RES; Keren L, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.59; KODADEK T, 1993, CELL MOL BIOL RES, V39, P355; Lee KS, 2011, BIOTECHNOL BIOENG, V108, P621, DOI 10.1002/bit.22988; Metzger BPH, 2015, NATURE, V521, P344, DOI 10.1038/nature14244; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Perfeito L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002160; Pierce SE, 2007, NAT PROTOC, V2, P2958, DOI 10.1038/nprot.2007.427; Rest JS, 2013, MOL BIOL EVOL, V30, P448, DOI 10.1093/molbev/mss248; Sellick CA, 2008, INT REV CEL MOL BIO, V269, P111, DOI 10.1016/S1937-6448(08)01003-4; Shalem O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002934; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Stoebel DM, 2008, GENETICS, V178, P1653, DOI 10.1534/genetics.107.085399; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Winsor B, 1997, YEAST, V13, P399; Zampar GG, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.11; Zeevi D, 2011, GENOME RES, V21, P2114, DOI 10.1101/gr.119669.110	49	89	89	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1282	+		10.1016/j.cell.2016.07.024	http://dx.doi.org/10.1016/j.cell.2016.07.024			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27545349	Bronze			2022-12-28	WOS:000382259500023
J	Smith, P				Smith, Paul			Suicide crisis among indigenous Australians tests rural services	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Fitzpatrick JP, 2015, J PAEDIATR CHILD H, V51, P450, DOI 10.1111/jpc.12814; McHugh C, 2016, MED J AUSTRALIA, V205, P33, DOI 10.5694/mja15.01368	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 24	2016	354								i4652	10.1136/bmj.i4652	http://dx.doi.org/10.1136/bmj.i4652			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV2ZZ	27558739				2022-12-28	WOS:000382792100005
J	Kesselheim, AS; Avorn, J; Sarpatwari, A				Kesselheim, Aaron S.; Avorn, Jerry; Sarpatwari, Ameet			The High Cost of Prescription Drugs in the United States Origins and Prospects for Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RESEARCH-AND-DEVELOPMENT; OF-POCKET COSTS; HEALTH-CARE; PEDIATRIC EXCLUSIVITY; MARKET EXCLUSIVITY; PATIENT OUTCOMES; MEDICARE; US; PATENT; MEDICATIONS	IMPORTANCE The increasing cost of prescription drugs in the United States has become a source of concern for patients, prescribers, payers, and policy makers. OBJECTIVES To review the origins and effects of high drug prices in the US market and to consider policy options that could contain the cost of prescription drugs. EVIDENCE We reviewed the peer-reviewed medical and health policy literature from January 2005 to July 2016 for articles addressing the sources of drug prices in the United States, the justifications and consequences of high prices, and possible solutions. FINDINGS Per capita prescription drug spending in the United States exceeds that in all other countries, largely driven by brand-name drug prices that have been increasing in recent years at rates far beyond the consumer price index. In 2013, per capita spending on prescription drugs was $858 compared with an average of $400 for 19 other industrialized nations. In the United States, prescription medications now comprise an estimated 17% of overall personal health care services. The most important factor that allows manufacturers to set high drug prices is market exclusivity, protected by monopoly rights awarded upon Food and Drug Administration approval and by patents. The availability of generic drugs after this exclusivity period is the main means of reducing prices in the United States, but access to them may be delayed by numerous business and legal strategies. The primary counterweight against excessive pricing during market exclusivity is the negotiating power of the payer, which is currently constrained by several factors, including the requirement that most government drug payment plans cover nearly all products. Another key contributor to drug spending is physician prescribing choices when comparable alternatives are available at different costs. Although prices are often justified by the high cost of drug development, there is no evidence of an association between research and development costs and prices; rather, prescription drugs are priced in the United States primarily on the basis of what the market will bear. CONCLUSIONS AND RELEVANCE High drug prices are the result of the approach the United States has taken to granting government-protected monopolies to drug manufacturers, combined with coverage requirements imposed on government-funded drug benefits. The most realistic short-term strategies to address high prices include enforcing more stringent requirements for the award and extension of exclusivity rights; enhancing competition by ensuring timely generic drug availability; providing greater opportunities for meaningful price negotiation by governmental payers; generating more evidence about comparative cost-effectiveness of therapeutic alternatives; and more effectively educating patients, prescribers, payers, and policy makers about these choices.	[Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA; [Kesselheim, Aaron S.] Harvard Med Sch, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.; Kesselheim, AS (corresponding author), Harvard Med Sch, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017; Liles, Nathan W/C-9819-2018	Kesselheim, Aaron/0000-0002-8867-2666; Liles, Nathan W/0000-0002-3710-7296	Laura and John Arnold Foundation; Engelberg Foundation	Laura and John Arnold Foundation; Engelberg Foundation	This work was funded by a grant from the Laura and John Arnold Foundation. Additional support was provided by the Engelberg Foundation.	Allan GM, 2007, PLOS MED, V4, P1486, DOI 10.1371/journal.pmed.0040283; Alpern JD, 2014, NEW ENGL J MED, V371, P1859, DOI 10.1056/NEJMp1408376; Altman D, 2015, WASHINGTON POST; Anell A., 2008, INT PROFILES HLTH CA, P46; [Anonymous], 2012, CONSUMER REPORTS; [Anonymous], 2015, WALL STREET J; Arno Peter S., 2001, TULANE LAW REV, V75, P631; ASPE, 2016, OBS TRENDS PRESCR DR; Avorn J, 2015, NEW ENGL J MED, V373, P967, DOI 10.1056/NEJMhle1506365; Avorn J, 2015, NEW ENGL J MED, V372, P1877, DOI 10.1056/NEJMp1500848; Azoulay P, 2002, J ECON MANAGE STRAT, V11, P551, DOI 10.1162/105864002320757262; Bach PB, 2015, JAMA-J AM MED ASSOC, V314, P2503, DOI 10.1001/jama.2015.16843; Bach PB, 2014, JAMA-J AM MED ASSOC, V312, P1629, DOI 10.1001/jama.2014.13235; Barua S, 2015, ANN INTERN MED, V163, P215, DOI 10.7326/M15-0406; Brekke KR, 2016, J HLTH EC, P30021; Bureau of Consumer Protection, 1979, STAFF REP FED TRAD C; Bureau of Labor Statistics, 2016, DAT TABL CALC SUBJ; Burns LR, 2009, HEALTH AFFAIR, V28, pW76, DOI 10.1377/hlthaff.28.1.w76; Canary LA, 2015, ANN INTERN MED, V163, P226, DOI 10.7326/M15-0320; Chalkidou K, 2009, COMP EFFECTIVENESS R; Chandra A, 2016, JAMA-J AM MED ASSOC, V315, P2069, DOI 10.1001/jama.2016.4915; Chokshi DA, 2014, NEW ENGL J MED, V371, P297, DOI 10.1056/NEJMp1406868; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Choudhry NK, 2010, HEALTH AFFAIR, V29, P1995, DOI 10.1377/hlthaff.2010.0336; Claxton G, 2015, HEALTH AFFAIR, V34, P1779, DOI 10.1377/hlthaff.2015.0885; Cohen RA, 2015, EARLY RELEASE SELECT; Community Catalyst, 2005, RE NEX CONS PAYOR AD; Conti RM, 2016, NEW ENGL J MED, V374, P703, DOI 10.1056/NEJMp1515068; Daniel H, 2016, ANN INTERN MED, V165, P50, DOI 10.7326/M15-2768; DiJulio B, 2015, KAISER HLTH TRACKING; DiMasi JA, 2016, J HEALTH ECON, V47, P20, DOI 10.1016/j.jhealeco.2016.01.012; DiMasi JA, 2015, NEW ENGL J MED, V372, P1972, DOI 10.1056/NEJMc1504317; Directorate-General for Internal Policies, 2011, DIFF COSTS ACC PHARM; Donohue JM, 2007, NEW ENGL J MED, V357, P673, DOI 10.1056/NEJMsa070502; Dusetzina SB, 2016, JAMA ONCOL, V2, P960, DOI 10.1001/jamaoncol.2016.0648; Express Scripts, 2015, 2015 DRUG TREND REP; Federal Trade Commission, 2010, PAY FOR DEL DRUG CO; Findlay SD, 2006, HEALTH AFFAIR, V25, pW283, DOI 10.1377/hlthaff.25.w283; Fischer MA, 2012, HEALTH AFFAIR, V31, P2206, DOI 10.1377/hlthaff.2012.0817; Fisher LM, 1994, NY TIMES; Food and Drug Administration, 2016, PED EXCL GRANT; Frakt AB, 2008, J HEALTH POLIT POLIC, V33, P1079, DOI 10.1215/03616878-2008-032; Fung V, 2013, HEALTH SERV RES, V48, P1653, DOI 10.1111/1475-6773.12062; Gabble R, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-3; Gagne JJ, 2014, ANN INTERN MED, V161, P400, DOI 10.7326/M13-2942; Gastala NM, 2016, HEALTH AFFAIR, V35, P1237, DOI 10.1377/hlthaff.2016.0146; Generic Pharmaceutical Association, 2015, GEN DRUG SAV US; Goldman DP, 2007, JAMA-J AM MED ASSOC, V298, P61, DOI 10.1001/jama.298.1.61; Government Accountability Office, 2012, DRUG PRIC RES SAV GE; Grabowski H, 2016, J MED ECON, V20, P1; Greene JA, 2016, JAMA-J AM MED ASSOC, V315, P461, DOI 10.1001/jama.2015.18720; Hawkins N, 2011, HEALTH ECON, V20, P688, DOI 10.1002/hec.1625; Hayes JM, 2005, JAMA-J AM MED ASSOC, V294, P427, DOI 10.1001/jama.294.4.427-b; Hemphill CS, 2006, NEW YORK U LAW REV, V81, P1553; Hennessy S, 2010, CLIN PHARMACOL THER, V87, P157, DOI 10.1038/clpt.2009.249; Henry J Kaiser Family Foundation, 2015, 2015 EMPL HLTH BEN S; Henry J Kaiser Family Foundation, 2016, TOT MONTHL MED CHIP; Herefordshire CCG., 2016, USE MED ASSURANCE SC; Hirschler B., 2015, REUTERS; Hollis A, 2016, PHARMACOECONOMICS, V34, P971, DOI 10.1007/s40273-016-0416-x; Howard DH, 2015, J ECON PERSPECT, V29, P139, DOI 10.1257/jep.29.1.139; Hsu J, 2006, NEW ENGL J MED, V354, P2349, DOI 10.1056/NEJMsa054436; Hua XY, 2016, JAMA-J AM MED ASSOC, V315, P1400, DOI 10.1001/jama.2016.0126; IMS Institute for Health Informatics, 2014, ASS BIOS UPT COMP EU; IMS Institute for Healthcare Informatics, 2013, AV COSTS US HEALTHC; Jacobs DB, 2015, NEW ENGL J MED, V372, P399, DOI 10.1056/NEJMp1411376; Jena AB, 2015, JAMA INTERN MED, V175, P1171, DOI 10.1001/jamainternmed.2015.1665; Jung K, 2014, HEALTH SERV RES, V49, P910, DOI 10.1111/1475-6773.12145; Kaitin KI, 2011, CLIN PHARMACOL THER, V89, P183, DOI 10.1038/clpt.2010.286; Kanavos P, 2013, HEALTH AFFAIR, V32, P753, DOI 10.1377/hlthaff.2012.0920; Kantarjian H, 2015, MAYO CLIN PROC, V90, P500, DOI 10.1016/j.mayocp.2015.01.014; Kapczynski A, 2016, HEALTH AFFAIR, V35, P791, DOI 10.1377/hlthaff.2015.1120; Kapczynski A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049470; Keehan SP, 2015, HEALTH AFFAIR, V34, P1407, DOI 10.1377/hlthaff.2015.0600; Kesselheim AS, 2015, J GEN INTERN MED, V30, P1633, DOI 10.1007/s11606-015-3285-7; Kesselheim AS, 2015, HEALTH AFFAIR, V34, P286, DOI 10.1377/hlthaff.2014.1038; Keyhani S, 2006, HEALTH AFFAIR, V25, P461, DOI 10.1377/hlthaff.25.2.461; Keyhani S, 2010, AM J PUBLIC HEALTH, V100, P1075, DOI 10.2105/AJPH.2009.178491; Kneller R, 2010, NAT REV DRUG DISCOV, V9, P867, DOI 10.1038/nrd3251; LaMattina J., 2016, FORBES          0518; Langreth R., 2015, BLOOMBERG BUSINESS; Lee TH, 2008, NEW ENGL J MED, V359, P333, DOI 10.1056/NEJMp0804261; Leonard K., 2015, US NEWS WORLD REPORT; Li JS, 2007, JAMA-J AM MED ASSOC, V297, P480, DOI 10.1001/jama.297.5.480; Lichtenberg FR, 2002, J LAW ECON, V45, P643, DOI 10.1086/374703; Light DW, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4348; Loftus P., 2014, WALL STREET J; Love J., 2014, NONVOLUNTARY USE PAT; Mailankody S, 2016, JAMA-J AM MED ASSOC, V316, P271, DOI 10.1001/jama.2016.5998; Mailankody S, 2015, JAMA ONCOL, V1, P539, DOI 10.1001/jamaoncol.2015.0373; Martinez B, WALL STREET J; Megerlin F, 2013, HEALTH AFFAIR, V32, P1803, DOI 10.1377/hlthaff.2009.0196; Menges Group, 2015, AN MED COSTS US SEL; Mintzes B, 2003, CAN MED ASSOC J, V169, P405; Moses H, 2015, JAMA-J AM MED ASSOC, V313, P174, DOI 10.1001/jama.2014.15939; Najafzadeh M, 2015, ANN INTERN MED, V162, P407, DOI 10.7326/M14-1152; Neumann PJ, 2006, HEALTH AFFAIR, V25, pW262, DOI 10.1377/hlthaff.25.w262; Neumann PJ, 2015, NEW ENGL J MED, V373, P2595, DOI 10.1056/NEJMp1512009; Newcomer LN, 2012, HEALTH AFFAIR, V31, P780, DOI 10.1377/hlthaff.2012.0002; Niederdeppe J, 2013, J GEN INTERN MED, V28, P886, DOI 10.1007/s11606-013-2379-3; O'Brien E., 2015, WHY DRUG PRICES REMA; O'Brien MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000409.pub2; O'Donnell JC, 2009, VALUE HEALTH, V12, pS1, DOI 10.1111/j.1524-4733.2009.00550.x; Obama B, 2016, JAMA-J AM MED ASSOC, V316, P525, DOI 10.1001/jama.2016.9797; Office of the Assistant Secretary for Planning and Evaluation Department of Health and Human Services, 2015, SOM OBS REL GEN DRUG; Oliver TR, 2004, MILBANK Q, V82, P283, DOI 10.1111/j.0887-378X.2004.00311.x; Organisation for Economic Co-operation and Development, 2015, HLTH GLANC 2015 OECD; Outterson K, 2009, HEALTH AFFAIR, V28, pW832, DOI 10.1377/hlthaff.28.5.w832; Pollack A., 2014, NY TIMES; Pollack A, 2015, NY TIMES, pB2; Pollack Andrew, 2016, NY TIMES; Quon BS, 2005, ANN INTERN MED, V143, P397, DOI 10.7326/0003-4819-143-6-200509200-00004; Ramsey SD, 2015, HEALTH AFFAIR, V34, P571, DOI 10.1377/hlthaff.2015.0112; Reinhardt U, 2015, JAMA-J AM MED ASSOC, V314, P981, DOI 10.1001/jama.2015.9593; Reinke T, 2012, FREE STATINS DISRUPT; Robinson J. C., 2013, Annales Pharmaceutiques Francaises, V71, P285, DOI 10.1016/j.pharma.2013.08.003; Rockoff Jonathan D., 2015, WALL STREET J; Ross JS, 2013, NEW ENGL J MED, V369, P1188, DOI 10.1056/NEJMp1301993; Sachs J, 2015, HUFFINGTON POST; Saku K, 2011, CIRC J, V75, P1493, DOI 10.1253/circj.CJ-10-1281; Saltz LB, 2016, JAMA ONCOL, V2, P19, DOI 10.1001/jamaoncol.2015.4191; Sarpatwari A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001955; Sarpatwari A, 2014, NEW ENGL J MED, V370, P1476, DOI 10.1056/NEJMp1400488; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Schnipper LE, 2015, J CLIN ONCOL, V33, P2563, DOI 10.1200/JCO.2015.61.6706; Schulte F., 2015, OBAMACARE RES I PLAN; Selby JV, 2012, JAMA-J AM MED ASSOC, V307, P1583, DOI 10.1001/jama.2012.500; Shajarizadeh A, 2015, HEALTH ECON, V24, P966, DOI 10.1002/hec.3075; Shrank WH, 2006, ARCH INTERN MED, V166, P332, DOI 10.1001/archinte.166.3.332; Shrank WH, 2011, AM J MED, V124, P309, DOI 10.1016/j.amjmed.2010.11.020; Shrank WH, 2010, HEALTH AFFAIR, V29, P1383, DOI 10.1377/hlthaff.2009.0424; Silverman E., 2012, FORBES; Sorenson C, 2014, J HEALTH POLIT POLIC, V39, P139, DOI 10.1215/03616878-2395199; Stabile M, 2013, HEALTH AFFAIR, V32, P643, DOI 10.1377/hlthaff.2012.1252; Starner CI, 2014, HEALTH AFFAIR, V33, P1761, DOI 10.1377/hlthaff.2014.0497; Treasure CL, 2015, MILBANK Q, V93, P761, DOI 10.1111/1468-0009.12164; Tucker RJ, 2015, MONDAQ          0519; Ubel PA, 2013, NEW ENGL J MED, V369, P1484, DOI 10.1056/NEJMp1306826; US Congressional Budget Office, 2005, PRIC BRAND NAM DRUGS; US Senate Committee on Finance, 2015, PRIC SOV ITS IMP US; Vogler S, 2016, LANCET ONCOL, V17, P39, DOI 10.1016/S1470-2045(15)00449-0; Walker J, 2016, WALL STREET J; Wang B, 2015, JAMA INTERN MED, V175, P635, DOI 10.1001/jamainternmed.2014.7968; Weisman R, 2014, BOSTON GLOBE; Wharton GT, 2014, PEDIATRICS, V134, pE512, DOI 10.1542/peds.2013-2987; Wiske CP, 2015, JAMA-J AM MED ASSOC, V314, P2129, DOI 10.1001/jama.2015.13498; Woodcock J, 2013, CLIN PHARMACOL THER, V93, P170, DOI 10.1038/clpt.2012.220	147	380	382	6	186	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2016	316	8					858	871		10.1001/jama.2016.11237	http://dx.doi.org/10.1001/jama.2016.11237			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT8JL	27552619				2022-12-28	WOS:000381736200016
J	Packer, M; Armstrong, WM; Rothstein, JM; Emmett, M				Packer, Milton; Armstrong, W. Mark; Rothstein, Joseph M.; Emmett, Michael			Sacubitril-Valsartan in Heart Failure: Why Are More Physicians Not Prescribing It?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							NEPRILYSIN INHIBITION; ENALAPRIL		[Packer, Milton] Baylor Univ, Med Ctr, Baylor Heart & Vasc Inst, 621 North Hall St, Dallas, TX 75226 USA; Baylor Univ, Med Ctr, Dept Med, Dallas, TX USA; [Armstrong, W. Mark; Rothstein, Joseph M.; Emmett, Michael] Baylor Univ, Med Ctr, 3500 Gaston Ave, Dallas, TX 75246 USA	Baylor University; Baylor University Medical Center; Baylor University; Baylor University Medical Center; Baylor University; Baylor University Medical Center	Packer, M (corresponding author), Baylor Univ, Med Ctr, Baylor Heart & Vasc Inst, 621 North Hall St, Dallas, TX 75226 USA.							Claggett B, 2015, NEW ENGL J MED, V373, P2289, DOI 10.1056/NEJMc1509753; Desai AS, 2015, EUR HEART J, V36, P1990, DOI 10.1093/eurheartj/ehv186; Gaziano TA, 2016, JAMA CARDIOL, V1, P666, DOI 10.1001/jamacardio.2016.1747; King JB, 2016, JACC-HEART FAIL, V4, P392, DOI 10.1016/j.jchf.2016.02.007; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Packer M, 2016, JACC-HEART FAIL, V4, P403, DOI 10.1016/j.jchf.2016.02.012; Packer M, 2015, CIRCULATION, V131, P54, DOI 10.1161/CIRCULATIONAHA.114.013748; Sandhu AT, 2016, ANN INTERN MED, V165, P681, DOI 10.7326/M16-0057; Solomon SD, 2016, JACC-HEART FAIL, V4, P816, DOI 10.1016/j.jchf.2016.05.002; Yancy CW, 2016, CIRCULATION	10	18	18	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	2016	165	10					735	+		10.7326/M16-1932	http://dx.doi.org/10.7326/M16-1932			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC2RB	27571568				2022-12-28	WOS:000387970500020
J	Cho, H; Du, XL; Rizzi, JP; Liberzon, E; Chakraborty, AA; Gao, WH; Carvo, I; Signoretti, S; Bruick, RK; Josey, JA; Wallace, EM; Kaelin, WG				Cho, Hyejin; Du, Xinlin; Rizzi, James P.; Liberzon, Ella; Chakraborty, Abhishek A.; Gao, Wenhua; Carvo, Ingrid; Signoretti, Sabina; Bruick, Richard K.; Josey, John A.; Wallace, Eli M.; Kaelin, William G., Jr.			On-target efficacy of a HIF-2 alpha antagonist in preclinical kidney cancer models	NATURE			English	Article							PAS-B DOMAIN; TRANSCRIPTION FACTOR; CELL; INHIBITION; CARCINOMA; GENE	Clear cell renal cell carcinoma, the most common form of kidney cancer, is usually linked to inactivation of the pVHL tumour suppressor protein and consequent accumulation of the HIF-2 alpha transcription factor (also known as EPAS1)(1). Here we show that a small molecule (PT2399) that directly inhibits HIF-2 alpha causes tumour regression in preclinical mouse models of primary and metastatic pVHL-defective clear cell renal cell carcinoma in an ontarget fashion. pVHL-defective clear cell renal cell carcinoma cell lines display unexpectedly variable sensitivity to PT2399, however, suggesting the need for predictive biomarkers to be developed to use this approach optimally in the clinic.	[Cho, Hyejin; Liberzon, Ella; Chakraborty, Abhishek A.; Gao, Wenhua; Carvo, Ingrid; Signoretti, Sabina; Kaelin, William G., Jr.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Cho, Hyejin; Liberzon, Ella; Chakraborty, Abhishek A.; Gao, Wenhua; Carvo, Ingrid; Signoretti, Sabina; Kaelin, William G., Jr.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02215 USA; [Du, Xinlin; Rizzi, James P.; Josey, John A.; Wallace, Eli M.] Peloton Therapeut Inc, Dallas, TX 75235 USA; [Carvo, Ingrid; Signoretti, Sabina] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Bruick, Richard K.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75235 USA; [Kaelin, William G., Jr.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute	Kaelin, WG (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.; Wallace, EM; Kaelin, WG (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02215 USA.; Wallace, EM (corresponding author), Peloton Therapeut Inc, Dallas, TX 75235 USA.; Kaelin, WG (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	eli.wallace@pelotontx.com; william_kaelin@dfci.harvard.edu			NIH; Cancer Prevention and Research Institute of Texas [RP130513]; NATIONAL CANCER INSTITUTE [P50CA101942, R35CA210068] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Massague for 786-M1A and M2A cells. Supported by grants from the NIH. W.G.K. is an HHMI Investigator. R.K.B. is the Michael L. Rosenberg Scholar in Medical Research and was supported by the Cancer Prevention and Research Institute of Texas (RP130513).	Bertout JA, 2009, P NATL ACAD SCI USA, V106, P14391, DOI 10.1073/pnas.0907357106; Chen W., 2016, NATURE; Dixon D. D., 2015, [No title captured], Patent No. [WO2015035223, 2015035223, WO 2015035223]; Fay AP, 2016, J NATL COMPR CANC NE, V14, P820, DOI 10.6004/jnccn.2016.0086; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Roberts AM, 2009, CANCER RES, V69, P9056, DOI 10.1158/0008-5472.CAN-09-1770; Rogers JL, 2013, J MED CHEM, V56, P1739, DOI 10.1021/jm301847z; Scheuermann TH, 2013, NAT CHEM BIOL, V9, P271, DOI [10.1038/NCHEMBIO.1185, 10.1038/nchembio.1185]; Scheuermann TH, 2009, P NATL ACAD SCI USA, V106, P450, DOI 10.1073/pnas.0808092106; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Vanharanta S, 2013, NAT MED, V19, P50, DOI 10.1038/nm.3029; Wallace EM, 2016, CANCER RES, V76, P5491, DOI 10.1158/0008-5472.CAN-16-0473	15	267	278	2	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2016	539	7627					107	+		10.1038/nature19795	http://dx.doi.org/10.1038/nature19795			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA5OJ	27595393	Green Accepted			2022-12-28	WOS:000386670100039
J	Kato, N; Comer, E; Sakata-Kato, T; Sharma, A; Sharma, M; Maetani, M; Bastien, J; Brancucci, NM; Bittker, JA; Corey, V; Clarke, D; Derbyshire, ER; Dornan, GL; Duffy, S; Eckley, S; Itoe, MA; Koolen, KMJ; Lewis, TA; Lui, PS; Lukens, AK; Lund, E; March, S; Meibalan, E; Meier, BC; McPhail, JA; Mitasev, B; Moss, EL; Sayes, M; Van Gessel, Y; Wawer, MJ; Yoshinaga, T; Zeeman, AM; Avery, VM; Bhatia, SN; Burke, JE; Catteruccia, F; Clardy, JC; Clemons, PA; Dechering, KJ; Duvall, JR; Foley, MA; Gusovsky, F; Kocken, CHM; Marti, M; Morningstar, ML; Munoz, B; Neafsey, DE; Sharma, A; Winzeler, EA; Wirth, DF; Scherer, CA; Schreiber, SL				Kato, Nobutaka; Comer, Eamon; Sakata-Kato, Tomoyo; Sharma, Arvind; Sharma, Manmohan; Maetani, Micah; Bastien, Jessica; Brancucci, Nicolas M.; Bittker, Joshua A.; Corey, Victoria; Clarke, David; Derbyshire, Emily R.; Dornan, Gillian L.; Duffy, Sandra; Eckley, Sean; Itoe, Maurice A.; Koolen, Karin M. J.; Lewis, Timothy A.; Lui, Ping S.; Lukens, Amanda K.; Lund, Emily; March, Sandra; Meibalan, Elamaran; Meier, Bennett C.; McPhail, Jacob A.; Mitasev, Branko; Moss, Eli L.; Sayes, Morgane; Van Gessel, Yvonne; Wawer, Mathias J.; Yoshinaga, Takashi; Zeeman, Anne-Marie; Avery, Vicky M.; Bhatia, Sangeeta N.; Burke, John E.; Catteruccia, Flaminia; Clardy, Jon C.; Clemons, Paul A.; Dechering, Koen J.; Duvall, Jeremy R.; Foley, Michael A.; Gusovsky, Fabian; Kocken, Clemens H. M.; Marti, Matthias; Morningstar, Marshall L.; Munoz, Benito; Neafsey, Daniel E.; Sharma, Amit; Winzeler, Elizabeth A.; Wirth, Dyann F.; Scherer, Christina A.; Schreiber, Stuart L.			Diversity-oriented synthesis yields novel multistage antimalarial inhibitors	NATURE			English	Article							TRANSFER-RNA SYNTHETASE; PLASMODIUM-FALCIPARUM; DRUG DISCOVERY; HEPATIC STAGES; MALARIA; TARGETS; MODEL; ASSAY; LEAD; IDENTIFICATION	Antimalarial drugs have thus far been chiefly derived from two sources-natural products and synthetic drug-like compounds. Here we investigate whether antimalarial agents with novel mechanisms of action could be discovered using a diverse collection of synthetic compounds that have three-dimensional features reminiscent of natural products and are underrepresented in typical screening collections. We report the identification of such compounds with both previously reported and undescribed mechanisms of action, including a series of bicyclic azetidines that inhibit a new antimalarial target, phenylalanyl-tRNA synthetase. These molecules are curative in mice at a single, low dose and show activity against all parasite life stages in multiple in vivo efficacy models. Our findings identify bicyclic azetidines with the potential to both cure and prevent transmission of the disease as well as protect at-risk populations with a single oral dose, highlighting the strength of diversity-oriented synthesis in revealing promising therapeutic targets.	[Kato, Nobutaka; Comer, Eamon; Maetani, Micah; Bastien, Jessica; Bittker, Joshua A.; Derbyshire, Emily R.; Lewis, Timothy A.; Lukens, Amanda K.; March, Sandra; Meier, Bennett C.; Moss, Eli L.; Sayes, Morgane; Wawer, Mathias J.; Bhatia, Sangeeta N.; Clardy, Jon C.; Clemons, Paul A.; Duvall, Jeremy R.; Foley, Michael A.; Morningstar, Marshall L.; Munoz, Benito; Neafsey, Daniel E.; Wirth, Dyann F.; Scherer, Christina A.; Schreiber, Stuart L.] Broad Inst Harvard & MIT, 415 Main St, Cambridge, MA 02142 USA; [Sakata-Kato, Tomoyo; Brancucci, Nicolas M.; Clarke, David; Itoe, Maurice A.; Lui, Ping S.; Lukens, Amanda K.; Lund, Emily; Meibalan, Elamaran; Catteruccia, Flaminia; Marti, Matthias; Wirth, Dyann F.] Harvard TH Chan Sch Publ Hlth, 665 Huntington Ave Boston, Boston, MA 02115 USA; [Sharma, Arvind; Sharma, Manmohan; Sharma, Amit] Int Ctr Genet Engn & Biotechnol, Mol Med Grp, Aruna Asaf Ali Rd, New Delhi 110067, India; [Maetani, Micah; Meier, Bennett C.; Schreiber, Stuart L.] Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA; [Corey, Victoria; Winzeler, Elizabeth A.] Univ Calif San Diego, Sch Med, 9500 Gilman Dr 0760, La Jolla, CA 92093 USA; [Derbyshire, Emily R.; Clardy, Jon C.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA; [Derbyshire, Emily R.] Duke Univ, Dept Chem, 124 Sci Dr, Durham, NC 27708 USA; [Derbyshire, Emily R.] Duke Univ, Dept Mol Genet & Microbiol, 124 Sci Dr, Durham, NC 27708 USA; [Dornan, Gillian L.; McPhail, Jacob A.; Burke, John E.] Univ Victoria, Dept Biochem & Microbiol, 270 Petch Hall, Victoria, BC V8P 5C2, Canada; [Duffy, Sandra; Avery, Vicky M.] Griffith Univ, Eskitis Inst Drug Discovery, Nathan Campus, Brisbane, Qld 4111, Australia; [Eckley, Sean; Mitasev, Branko; Van Gessel, Yvonne; Gusovsky, Fabian] Eisai Inc, 4 Corp Dr, Andover, MA 01810 USA; [Koolen, Karin M. J.; Dechering, Koen J.] TropIQ Hlth Sci, Geert Grootepl 28,Huispost 268, NL-6525 GA Nijmegen, Netherlands; [March, Sandra; Bhatia, Sangeeta N.] MIT, Dept Elect Engn & Comp Sci, 500 Main St, Cambridge, MA 02142 USA; [Yoshinaga, Takashi] Eisai & Co Ltd, 5-1-3 Tokodai, Tsukuba, Ibaraki 3002635, Japan; [Zeeman, Anne-Marie; Kocken, Clemens H. M.] Biochem Primate Res Ctr, Dept Parasitol, NL-2280 GH Rijswijk, Netherlands	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Harvard University; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Duke University; Duke University; University of Victoria; Griffith University; Eisai Co Ltd; Massachusetts Institute of Technology (MIT); Eisai Co Ltd	Schreiber, SL (corresponding author), Broad Inst Harvard & MIT, 415 Main St, Cambridge, MA 02142 USA.; Schreiber, SL (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	stuart_schreiber@harvard.edu	Meibalan, Elamaran/P-9256-2016; Avery, Vicky M/A-5449-2010; Winzeler, Elizabeth/AAP-6752-2020; duffy, sandra/AAX-7527-2021; Burke, John/H-3922-2019; Sharma, Arvind/ABG-2614-2021; duffy, sandra/B-8479-2017; Itoe, Maurice A./AAQ-5634-2020	Meibalan, Elamaran/0000-0002-3832-8955; Avery, Vicky M/0000-0003-4914-2299; Winzeler, Elizabeth/0000-0002-4049-2113; duffy, sandra/0000-0002-2814-1193; Burke, John/0000-0001-7904-9859; Sharma, Arvind/0000-0002-7029-9867; duffy, sandra/0000-0002-2814-1193; Dornan, Gillian Leigh/0000-0002-5170-9015; McPhail, Jacob/0000-0003-1490-808X; Kocken, Clemens/0000-0002-4784-1734; sharma, Manmohan/0000-0002-0215-6223; Zeeman, Anne-Marie/0000-0002-0157-4669; Lewis, Timothy/0000-0001-9748-9575; Brancucci, Nicolas/0000-0003-0655-3266	Bill and Melinda Gates Foundation [OPP1032518, OPP1054480, OPP1023607]; Global Health Innovative Technology Fund [G2014-107]; Medicines for Malaria Venture; Wellcome Trust [WT078285]; Canadian Institute of Health Research [FRN 142393]; Medicines for Malaria Venture [12-2400]; National Science Foundation [DGE1144152]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103058, R01AI090141, R01AI093716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Global Health Innovative Technology Fund; Medicines for Malaria Venture; Wellcome Trust(Wellcome TrustEuropean Commission); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Medicines for Malaria Venture; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Bill and Melinda Gates Foundation (grant OPP1032518 to S.L.S., grant OPP1054480 to E.A.W. and D.F.W., grant OPP1023607 to S.N.B.), the Global Health Innovative Technology Fund (grant G2014-107 to S.L.S.), Medicines for Malaria Venture and the Wellcome Trust (grant WT078285 to C.H.M.K.), a New Investigator and Open Operating Grant from Canadian Institute of Health Research (grant FRN 142393 to J.E.B.) and Medicines for Malaria Venture (grant 12-2400 to V.M.A.). S.L.S. is an Investigator at the Howard Hughes Medical Institute. Mi.M. was supported by a fellowship from the National Science Foundation (DGE1144152). The authors thank R. Elliott, K. Duncan, and O. Vandal as well as J. Burrows, J. Duffy, F. Escudie and colleagues for discussions and access to invaluable scientific and experimental resources; K. Emmith for assistance with data processing and management; I. Goldowitz for assistance with establishing a gametocyte assay; N. van der Werff for technical assistance with the P. cynomolgi assay; J. Kotz and B. Melillo for discussions and assistance with the manuscript; J. Pu, M. Leighty, B. Braibant, S. LeQuement and J. Beaudoin for assistance with compound synthesis; E. Garcia-Rivera for assistance with molecular modelling; A. Hakura for performing the Ames test; Broad Institute Comparative Medicine Platform and Facility for assistance with animal studies; and the Broad Institute Compound Management and analytical teams for assistance with compound access and characterization. We also acknowledge WuXi AppTec and ChemPartner Co., Ltd for in vitro and in vivo pharmacokinetics assays, and Cyprotek for the phototoxicity analysis. P. falciparum scDHODH transgenic strain was a gift from A. B. Vaidya, P. falciparum 3D7<SUP>HLH</SUP> strain from D. Fidock and P. falciparum NF54HT-GFP-luc from S. H. Kappe.	Angulo-Barturen I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002252; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baragana B, 2015, NATURE, V522, P315, DOI 10.1038/nature14451; Jimenez-Diaz MB, 2009, ANTIMICROB AGENTS CH, V53, P4533, DOI 10.1128/AAC.00519-09; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bhatt TK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-644; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Burke JE, 2014, SCIENCE, V344, P1035, DOI 10.1126/science.1253397; Burke John E., 2013, Advances in Biological Regulation, V53, P97, DOI 10.1016/j.jbior.2012.09.005; Burke MD, 2004, ANGEW CHEM INT EDIT, V43, P46, DOI 10.1002/anie.200300626; Burrows JN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-187; Campo B, 2015, PATHOG GLOB HEALTH, V109, P107, DOI 10.1179/2047773215Y.0000000013; Cestari I, 2013, J BIOMOL SCREEN, V18, P490, DOI 10.1177/1087057112465980; Chang HH, 2016, SCI REP-UK, V6, DOI 10.1038/srep26330; Comer E, 2014, J MED CHEM, V57, P8496, DOI 10.1021/jm500994n; Dancik V, 2010, J AM CHEM SOC, V132, P9259, DOI 10.1021/ja102798t; Dandapani S, 2010, NAT CHEM BIOL, V6, P861, DOI 10.1038/nchembio.479; Dembele L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018162; Ding XC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-292; Duffy S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-408; Ekland EH, 2011, FASEB J, V25, P3583, DOI 10.1096/fj.11-187401; Flannery EL, 2013, NAT REV MICROBIOL, V11, P849, DOI 10.1038/nrmicro3138; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; GhidelliDisse S., 2014, MALARIA J S1, V13, P38, DOI DOI 10.1186/1475-2875-13-51-P38; GUGUENGUILLOUZO C, 1982, CELL BIOL INT REP, V6, P625, DOI 10.1016/0309-1651(82)90187-4; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; Hameed SP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7715; Hansen M, 2004, PROTEIN SCI, V13, P1031, DOI 10.1110/ps.03533004; Heidebrecht RW, 2012, ACS MED CHEM LETT, V3, P112, DOI 10.1021/ml200244k; Herman JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3575; Hoepfner D, 2012, CELL HOST MICROBE, V11, P654, DOI 10.1016/j.chom.2012.04.015; Hussain T, 2015, ANTIMICROB AGENTS CH, V59, P1856, DOI 10.1128/AAC.02220-13; Istvan ES, 2011, P NATL ACAD SCI USA, V108, P1627, DOI 10.1073/pnas.1011560108; Jaccard P., 1902, B SOC VAUD SCI NAT, V38, P69, DOI [DOI 10.5169/SEALS-266762, 10.5169/seals-266762]; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Joice R, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008882; Joice R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003392; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e; Lowe JT, 2012, J ORG CHEM, V77, P7187, DOI 10.1021/jo300974j; Lukens AK, 2015, J INFECT DIS, V211, P1097, DOI 10.1093/infdis/jiu565; Lukens AK, 2014, P NATL ACAD SCI USA, V111, P799, DOI 10.1073/pnas.1320886110; Manard M, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-7; Marcaurelle LA, 2010, J AM CHEM SOC, V132, P16962, DOI 10.1021/ja105119r; March S, 2015, NAT PROTOC, V10, P2027, DOI 10.1038/nprot.2015.128; March S, 2013, CELL HOST MICROBE, V14, P104, DOI 10.1016/j.chom.2013.06.005; Novoa EM, 2014, P NATL ACAD SCI USA, V111, pE5508, DOI 10.1073/pnas.1405994111; MAZIER D, 1985, SCIENCE, V227, P440, DOI 10.1126/science.3880923; McNamara CW, 2013, NATURE, V504, P248, DOI 10.1038/nature12782; Meister S, 2011, SCIENCE, V334, P1372, DOI 10.1126/science.1211936; Ng PY, 2007, ANGEW CHEM INT EDIT, V46, P5352, DOI 10.1002/anie.200700762; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Pham JS, 2014, INT J PARASITOL-DRUG, V4, P1, DOI 10.1016/j.ijpddr.2013.10.001; Phillips MA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa6645; PONNUDURAI T, 1989, PARASITOLOGY, V98, P165, DOI 10.1017/S0031182000062065; R Core Development Team, 2013, R LANG ENV STAT COMP; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Ross LS, 2014, J BIOL CHEM, V289, P17980, DOI 10.1074/jbc.M114.558353; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Ruecker A, 2014, ANTIMICROB AGENTS CH, V58, P7292, DOI 10.1128/AAC.03666-14; Sharma A, 2015, BIOCHEM J, V465, P459, DOI 10.1042/BJ20140998; Sherlin LD, 2001, RNA, V7, P1671; Stone WJR, 2014, J INFECT DIS, V210, P1456, DOI 10.1093/infdis/jiu271; Vaughan AM, 2015, NAT METHODS, V12, P631, DOI [10.1038/NMETH.3432, 10.1038/nmeth.3432]; Vaughan AM, 2012, MOL BIOCHEM PARASIT, V186, P143, DOI 10.1016/j.molbiopara.2012.10.004; Wells Timothy N. C., 2013, Infectious Disorders - Drug Targets, V13, P292; Younis Y, 2012, J MED CHEM, V55, P3479, DOI 10.1021/jm3001373; Yu CN, 2016, NAT BIOTECHNOL, V34, P419, DOI 10.1038/nbt.3460; Zeeman AM, 2014, ANTIMICROB AGENTS CH, V58, P1586, DOI 10.1128/AAC.01927-13	72	169	176	2	175	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2016	538	7625					344	+		10.1038/nature19804	http://dx.doi.org/10.1038/nature19804			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA5PJ	27602946	Green Accepted			2022-12-28	WOS:000386673100031
J	Kim, A				Kim, Arthur			Hepatitis C Virus	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TREATMENT-EXPERIENCED PATIENTS; SUSTAINED VIROLOGICAL RESPONSE; GENOTYPE 1 INFECTION; ALL-CAUSE MORTALITY; TREATMENT-NAIVE; UNITED-STATES; PRIMARY-CARE; HEPATOCELLULAR-CARCINOMA; SPONTANEOUS CLEARANCE; ANTIVIRAL THERAPY											Aberg JA, 2014, CLIN INFECT DIS, V58, pE1, DOI [10.1093/cid/cit665, 10.1093/cid/cit757]; Arora S, 2011, NEW ENGL J MED, V364, P2199, DOI 10.1056/NEJMoa1009370; Barreiro P, 2013, J CLIN VIROL, V58, P391, DOI 10.1016/j.jcv.2013.06.031; Barua S, 2015, ANN INTERN MED, V163, P215, DOI 10.7326/M15-0406; Benova L, 2014, CLIN INFECT DIS, V59, P765, DOI 10.1093/cid/ciu447; Bravi F, 2013, CLIN GASTROENTEROL H, V11, P1413, DOI 10.1016/j.cgh.2013.04.039; Charlton M, 2015, GASTROENTEROLOGY, V148, P108, DOI 10.1053/j.gastro.2014.10.001; Chou R, 2013, ANN INTERN MED, V158, P807, DOI 10.7326/0003-4819-158-11-201306040-00005; Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950; ConryCantilena C, 1996, NEW ENGL J MED, V334, P1691, DOI 10.1056/NEJM199606273342602; Curry MP, 2015, NEW ENGL J MED, V373, P2618, DOI 10.1056/NEJMoa1512614; Curry MP, 2013, J INFECT DIS, V207, pS40, DOI 10.1093/infdis/jis763; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Edlin BR, 2015, HEPATOLOGY, V62, P1353, DOI 10.1002/hep.27978; Everson GT, 2015, ANN INTERN MED, V163, P818, DOI 10.7326/M15-1000; Fabrizi F, 2013, J MED VIROL, V85, P1019, DOI 10.1002/jmv.23562; Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Foster GR, 2015, NEW ENGL J MED, V373, P2608, DOI 10.1056/NEJMoa1512612; Foster GR, 2015, GASTROENTEROLOGY, V149, P1462, DOI 10.1053/j.gastro.2015.07.043; Fried MW, 2012, JAMA-J AM MED ASSOC, V308, P274, DOI 10.1001/jama.2012.8265; Galbraith JW, 2015, HEPATOLOGY, V61, P776, DOI 10.1002/hep.27410; Getchell JP, 2013, MMWR-MORBID MORTAL W, V62, P362; Gordon SC, 2015, AM J GASTROENTEROL, V110, P1169, DOI 10.1038/ajg.2015.203; Grebely J, 2015, INT J DRUG POLICY, V26, P1028, DOI 10.1016/j.drugpo.2015.07.005; Grebely J, 2014, HEPATOLOGY, V59, P109, DOI 10.1002/hep.26639; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Hagan H, 2011, J INFECT DIS, V204, P74, DOI 10.1093/infdis/jir196; He TH, 2016, ANN INTERN MED, V164, P84, DOI 10.7326/M15-0617; Hezode C, 2015, LANCET, V385, P2502, DOI 10.1016/S0140-6736(15)60159-3; Jezequel C, 2015, 50 ANN M EUR ASS STU, pS589; Jou JH, 2012, ANN INTERN MED, V157, DOI DOI 10.7326/0; Khalaf N, 2015, CLIN GASTROENTEROL H, V13, P1521, DOI 10.1016/j.cgh.2015.01.030; Kiser JJ, 2013, NAT REV GASTRO HEPAT, V10, P596, DOI 10.1038/nrgastro.2013.106; Lahey T, 2015, CLIN INFECT DIS, V60, P1816, DOI 10.1093/cid/civ203; Lomtadze N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083892; Ly KN, 2014, CLIN INFECT DIS, V58, P40, DOI 10.1093/cid/cit642; Maheshwari A, 2008, LANCET, V372, P321, DOI 10.1016/S0140-6736(08)61116-2; Manns MP, 2013, J VIRAL HEPATITIS, V20, P524, DOI 10.1111/jvh.12074; Marrie TJ, 2011, MEDICINE, V90, P171, DOI 10.1097/MD.0b013e31821a5a76; Martin NK, 2013, CLIN INFECT DIS, V57, pS39, DOI 10.1093/cid/cit296; McGovern BH, 2009, CLIN INFECT DIS, V49, P1051, DOI 10.1086/605561; Mohanty A, 2016, GASTROENTEROLOGY, V150, P430, DOI 10.1053/j.gastro.2015.10.007; Monto A, 2004, HEPATOLOGY, V39, P826, DOI 10.1002/hep.20127; Moyer VA, 2013, ANN INTERN MED, V159, P349, DOI 10.7326/0003-4819-159-5-201309030-00672; Naggie S, 2015, NEW ENGL J MED, V373, P705, DOI 10.1056/NEJMoa1501315; Osinusi A, 2014, ANN INTERN MED, V161, P634, DOI 10.7326/M14-1211; Perez-Alvarez R, 2012, REV ESP ENFERM DIG, V104, P21, DOI 10.4321/s1130-01082012000100005; Pianko S, 2015, ANN INTERN MED, V163, P809, DOI 10.7326/M15-1014; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Roth D, 2015, LANCET, V386, P1537, DOI 10.1016/S0140-6736(15)00349-9; Section on Breastfeeding, 2012, Pediatrics, V129, pe827, DOI 10.1542/peds.2011-3552; Song JY, 2007, J CLIN VIROL, V39, P159, DOI 10.1016/j.jcv.2007.04.018; Suryaprasad AG, 2014, CLIN INFECT DIS, V59, P1411, DOI 10.1093/cid/ciu643; Svarovskaia ES, 2014, CLIN INFECT DIS, V59, P1666, DOI 10.1093/cid/ciu697; Swain MG, 2010, GASTROENTEROLOGY, V139, P1593, DOI 10.1053/j.gastro.2010.07.009; Tapper EB, 2013, J VIRAL HEPATITIS, V20, P669, DOI 10.1111/jvh.12168; Terrault NA, 2013, HEPATOLOGY, V57, P881, DOI 10.1002/hep.26164; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Tsui JI, 2014, JAMA INTERN MED, V174, P1974, DOI 10.1001/jamainternmed.2014.5416; Turner BJ, 2015, HEPATOLOGY, V62, P1388, DOI 10.1002/hep.28018; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Vento S, 1998, NEW ENGL J MED, V338, P286, DOI 10.1056/NEJM199801293380503; Wilkin T, 2015, NEW ENGL J MED, V373, P854, DOI 10.1056/NEJMcp1401303; Wyles DL, 2015, NEW ENGL J MED, V373, P714, DOI 10.1056/NEJMoa1503153; Xu FJ, 2016, CLIN INFECT DIS, V62, P289, DOI 10.1093/cid/civ860; Yehia BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101554; Younossi ZM, 2013, ALIMENT PHARM THER, V37, P703, DOI 10.1111/apt.12265; Younossi ZM, 2014, HEPATOLOGY, V59, P2161, DOI 10.1002/hep.27161; Younossi ZM, 2014, CLIN GASTROENTEROL H, V12, P1349, DOI 10.1016/j.cgh.2013.11.032	71	9	10	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2016	165	5					ITC33	ITC49		10.7326/AITC201609060	http://dx.doi.org/10.7326/AITC201609060			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ0XW	27595226				2022-12-28	WOS:000385564000001
J	Yusuf, S				Yusuf, Salim			Why do people not take life-saving medications? The case of statins	LANCET			English	Editorial Material							CARDIOVASCULAR-DISEASE; LOW-RISK		[Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8N 3Z5, Canada; [Yusuf, Salim] Hamilton Hlth Sci, Hamilton, ON L8N 3Z5, Canada	McMaster University; Population Health Research Institute; McMaster University	Yusuf, S (corresponding author), McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8N 3Z5, Canada.; Yusuf, S (corresponding author), Hamilton Hlth Sci, Hamilton, ON L8N 3Z5, Canada.	yusufs@mcmaster.ca		Yusuf, Salim/0000-0003-4776-5601				Abramson JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6123; Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8; BOHAN H, 2016, PERCEPTIONS STATINS; Kocas C, 2015, INT J CARDIOL, V201, P139, DOI 10.1016/j.ijcard.2015.07.095; Malhotra A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6340; Matthews A, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3283; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; National Institute for Health and Care Excellence, 2014, CARD DIS RISK ASS RE; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Nielsen SF, 2016, EUR HEART J, V37, P908, DOI 10.1093/eurheartj/ehv641; Saib A, 2013, ARCH CARDIOVASC DIS, V106, P511, DOI 10.1016/j.acvd.2013.06.053; Schaffer AL, 2015, MED J AUSTRALIA, V202, P591, DOI 10.5694/mja15.00103; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	14	15	15	1	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2016	388	10048					943	+		10.1016/S0140-6736(16)31532-X	http://dx.doi.org/10.1016/S0140-6736(16)31532-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU9GL	27598664				2022-12-28	WOS:000382524400008
J	Chuang, KV; Xu, C; Reisman, SE				Chuang, Kangway V.; Xu, Chen; Reisman, Sarah E.			A 15-step synthesis of (+)-ryanodol	SCIENCE			English	Article							KEY PENTACYCLIC INTERMEDIATE; RYANODINE RECEPTOR; SARCOPLASMIC-RETICULUM; RELEASE CHANNEL; (+)-ANHYDRORYANODOL; OXIDATION; CONSTITUENTS; CINNZEYLANOL; CYCLIZATIONS; INHIBITION	(+)-Ryanodine and (+)-ryanodol are complex diterpenoids that modulate intracellular calcium-ion release at ryanodine receptors, ion channels critical for skeletal and cardiac muscle excitation-contraction coupling and synaptic transmission. Chemical derivatization of these diterpenoids has demonstrated that certain peripheral structural modifications can alter binding affinity and selectivity among ryanodine receptor isoforms. Here, we report a short chemical synthesis of (+)-ryanodol that proceeds in only 15 steps from the commercially available terpene (S)-pulegone. The efficiency of the synthesis derives from the use of a Pauson-Khand reaction to rapidly build the carbon framework and a SeO2-mediated oxidation to install three oxygen atoms in a single step. This work highlights how strategic C-O bond constructions can streamline the synthesis of polyhydroxylated terpenes by minimizing protecting group and redox adjustments.	[Chuang, Kangway V.; Xu, Chen; Reisman, Sarah E.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Reisman, SE (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	reisman@caltech.edu		Chuang, Kangway/0000-0002-0652-8071	National Science Foundation [DGE-1144469]; Shenzhen UV-ChemTech Inc.; NIH (National Institute of General Medical Sciences) [RGM097582-01]; Eli Lilly; Novartis; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097582] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Shenzhen UV-ChemTech Inc.; NIH (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Eli Lilly(Eli Lilly); Novartis(Novartis); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The California Institute of Technology Center for Catalysis and Chemical Synthesis is gratefully acknowledged for access to analytical equipment. We thank S. Virgil and J. Hofstra for assistance in obtaining x-ray-quality crystals and solving the structure of 15, respectively. M. Takase and L. Henling are acknowledged for acquiring the x-ray diffraction data for 15 (CCDC deposition no. 1478621; the data are available free of charge from The Cambridge Crystallographic Data Centre). M. Kieffer is gratefully acknowledged for critical feedback and helpful suggestions. Fellowship support was provided by the National Science Foundation (graduate research fellowship to K.V.C., grant DGE-1144469) and the Shenzhen UV-ChemTech Inc. (postdoctoral fellowship to C.X.). S.E.R. is an American Cancer Society Research Scholar and Heritage Medical Research Institute investigator. Financial support from the NIH (National Institute of General Medical Sciences grant RGM097582-01), Eli Lilly, and Novartis is gratefully acknowledged. The California Institute of Technology has filed a provisional patent on this work (application no. 62/269,760).	ACHENBACH H, 1995, J NAT PRODUCTS, V58, P1092, DOI 10.1021/np50121a019; Adrio J, 2005, ORG LETT, V7, P431, DOI 10.1021/ol047678u; BELANGER A, 1979, CAN J CHEM, V57, P3348, DOI 10.1139/v79-547; Breitmaier E., 2006, TERPENES FLAVORS FRA; Catino AJ, 2004, J AM CHEM SOC, V126, P13622, DOI 10.1021/ja045330o; CHUNG YK, 1993, ORGANOMETALLICS, V12, P220, DOI 10.1021/om00025a036; DESLONGCHAMPS P, 1990, CAN J CHEM, V68, P115, DOI 10.1139/v90-021; DESLONGCHAMPS P, 1990, CAN J CHEM, V68, P186, DOI 10.1139/v90-024; DESLONGCHAMPS P, 1990, CAN J CHEM, V68, P153, DOI 10.1139/v90-023; DESLONGCHAMPS P, 1990, CAN J CHEM, V68, P127, DOI 10.1139/v90-022; Egi M, 2013, ORG LETT, V15, P4150, DOI 10.1021/ol401824v; GONZALEZCOLOMA A, 1990, J CHEM ECOL, V16, P2723, DOI 10.1007/BF00988081; GonzalezColoma A, 1996, J AGR FOOD CHEM, V44, P296, DOI 10.1021/jf9500593; HARVEY RG, 1968, J ORG CHEM, V33, P2570, DOI 10.1021/jo01270a108; ISOGAI A, 1977, AGR BIOL CHEM TOKYO, V41, P1779, DOI 10.1080/00021369.1977.10862725; Jorgensen L, 2013, SCIENCE, V341, P878, DOI 10.1126/science.1241606; Kawamura S, 2016, NATURE, V532, P90, DOI 10.1038/nature17153; Kelliher M, 1999, NEUROSCIENCE, V92, P499, DOI 10.1016/S0306-4522(99)00042-1; Khand I. U., 1973, J CHEM SOC P1, V1973, P977; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Koga Y, 1998, CHEM LETT, P249; Koshimizu M, 2016, ANGEW CHEM INT EDIT, V55, P2493, DOI 10.1002/anie.201511116; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Lu HH, 2015, NAT CHEM, V7, P604, DOI [10.1038/NCHEM.2283, 10.1038/nchem.2283]; Maimone TJ, 2007, NAT CHEM BIOL, V3, P396, DOI 10.1038/nchembio.2007.1; Masuda K, 2016, CHEM-EUR J, V22, P230, DOI 10.1002/chem.201503641; McCarthy TV, 2000, HUM MUTAT, V15, P410, DOI 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; Nagatomo M, 2016, CHEM-EUR J, V22, P222, DOI 10.1002/chem.201503640; Nagatomo M, 2014, J AM CHEM SOC, V136, P5916, DOI 10.1021/ja502770n; NOHARA T, 1980, CHEM PHARM BULL, V28, P2682; PESSAH IN, 1985, BIOCHEM BIOPH RES CO, V128, P449, DOI 10.1016/0006-291X(85)91699-7; Ramos-Franco J, 2010, PFLUG ARCH EUR J PHY, V460, P767, DOI 10.1007/s00424-010-0839-8; Riley R., 1932, J CHEM SOC, V1932, P1875; ROGERS EF, 1948, J AM CHEM SOC, V70, P3086, DOI 10.1021/ja01189a074; SHAMBAYATI S, 1990, TETRAHEDRON LETT, V31, P5289, DOI 10.1016/S0040-4039(00)98052-3; SRIVASTAVA SN, 1968, CAN J CHEMISTRY, V46, P795, DOI 10.1139/v68-133; Sutko JL, 1997, PHARMACOL REV, V49, P53; VISHWAKARMA LC, 1988, ORG SYNTH, V66, P203; WATERHOUSE AL, 1987, J MED CHEM, V30, P710, DOI 10.1021/jm00387a022; WELCH W, 1994, BIOCHEMISTRY-US, V33, P6074, DOI 10.1021/bi00186a006; Welch W, 1997, BIOCHEMISTRY-US, V36, P2939, DOI 10.1021/bi9623901; WIESNER K, 1967, TETRAHEDRON LETT, P221; Yu JQ, 2002, ORG LETT, V4, P2727, DOI 10.1021/ol0262340	44	75	76	14	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					912	915		10.1126/science.aag1028	http://dx.doi.org/10.1126/science.aag1028			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU0CA	27563092	Green Accepted			2022-12-28	WOS:000381867700034
J	Vockley, CM; D'Ippolito, AM; McDowell, IC; Majoros, WH; Safi, A; Song, LY; Crawford, GE; Reddy, TE				Vockley, Christopher M.; D'Ippolito, Anthony M.; McDowell, Ian C.; Majoros, William H.; Safi, Alexias; Song, Lingyun; Crawford, Gregory E.; Reddy, Timothy E.			Direct GR Binding Sites Potentiate Clusters of TF Binding across the Human Genome	CELL			English	Article							GLUCOCORTICOID RESPONSE ELEMENT; CHROMATIN ACCESSIBILITY; SYSTEMATIC DISSECTION; HETEROLOGOUS PROMOTER; GENETIC-VARIATION; RECEPTOR-BINDING; DNA-SEQUENCES; TRANSCRIPTION; PROTEIN; EXPRESSION	The glucocorticoid receptor (GR) binds the human genome at >10,000 sites but only regulates the expression of hundreds of genes. To determine the functional effect of each site, we measured the glucocorticoid (GC) responsive activity of nearly all GR binding sites (GBSs) captured using chromatin immunoprecipitation (ChIP) in A549 cells. 13% of GBSs assayed had GC-induced activity. The responsive sites were defined by direct GR binding via a GC response element (GRE) and exclusively increased reporter-gene expression. Meanwhile, most GBSs lacked GC-induced reporter activity. The non-responsive sites had epigenetic features of steady-state enhancers and clustered around direct GBSs. Together, our data support a model in which clusters of GBSs observed with ChIP-seq reflect interactions between direct and tethered GBSs over tens of kilobases. We further show that those interactions can synergistically modulate the activity of direct GBSs and may therefore play a major role in driving gene activation in response to GCs.	[Vockley, Christopher M.] Duke Univ, Dept Cell Biol, Durham, NC 27708 USA; [Vockley, Christopher M.; D'Ippolito, Anthony M.; McDowell, Ian C.; Majoros, William H.; Safi, Alexias; Song, Lingyun; Crawford, Gregory E.; Reddy, Timothy E.] Duke Univ, Ctr Genom & Computat Biol, Durham, NC 27708 USA; [D'Ippolito, Anthony M.] Duke Univ, Univ Program Genet & Genom, Durham, NC 27708 USA; [McDowell, Ian C.; Majoros, William H.] Duke Univ, Program Computat Biol & Bioinformat, Durham, NC 27708 USA; [Safi, Alexias; Song, Lingyun; Crawford, Gregory E.] Duke Univ, Div Med Genet, Dept Pediat, Durham, NC 27708 USA; [Reddy, Timothy E.] Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27708 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	Reddy, TE (corresponding author), Duke Univ, Ctr Genom & Computat Biol, Durham, NC 27708 USA.; Reddy, TE (corresponding author), Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27708 USA.	tim.reddy@duke.edu	song, ling/GQZ-5934-2022		NIH [U01 HG007900, F31 HL129743, T32s GM007754, GM071340, U01 HL111018]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040372] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL129743, U01HL111018] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI124563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007754, T32GM071340] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the following grants: NIH U01 HG007900 (all authors), NIH F31 HL129743 (to C.M.V.), NIH T32s GM007754 (to A.M.D.), and GM071340 (to I.C.M. and W.H.M.). C.M.V. is an NHLBI LRRC Young Investigator and was also supported by NIH U01 HL111018 through Brigid Hogan, who we thank for her helpful comments and support. We thank Alexander Stark for plasmid materials.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Belikov S, 2009, MOL CELL BIOL, V29, P5413, DOI 10.1128/MCB.00368-09; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Botta M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.79; CHANDLER VL, 1983, CELL, V33, P489, DOI 10.1016/0092-8674(83)90430-0; COLEMAN RA, 1995, J BIOL CHEM, V270, P13850, DOI 10.1074/jbc.270.23.13850; Devonshire AS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-662; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gao X, 2013, P NATL ACAD SCI USA, V110, P9356, DOI 10.1073/pnas.1307589110; Gertz J, 2013, MOL CELL, V52, P25, DOI 10.1016/j.molcel.2013.08.037; Gertz J, 2012, GENOME RES, V22, P134, DOI 10.1101/gr.127373.111; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Herrlich P, 2001, ONCOGENE, V20, P2465, DOI 10.1038/sj.onc.1204388; Hertel KJ, 1997, CURR OPIN CELL BIOL, V9, P350, DOI 10.1016/S0955-0674(97)80007-5; Jiang MH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-192; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Joseph R, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.109; Kheradpour P, 2013, GENOME RES, V23, P800, DOI 10.1101/gr.144899.112; Kuznetsova T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0832-9; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEE DH, 1989, P NATL ACAD SCI USA, V86, P476, DOI 10.1073/pnas.86.2.476; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; MITTAL R, 1994, MOL ENDOCRINOL, V8, P1701, DOI 10.1210/me.8.12.1701; OLANSKY L, 1992, J CLIN INVEST, V89, P1596, DOI 10.1172/JCI115754; Pearce D, 1998, J BIOL CHEM, V273, P30081, DOI 10.1074/jbc.273.46.30081; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; R Development Core Team, 2016, R LANG ENV STAT COMP; Ratman D, 2013, MOL CELL ENDOCRINOL, V380, P41, DOI 10.1016/j.mce.2012.12.014; Reddy TE, 2012, MOL CELL BIOL, V32, P3756, DOI 10.1128/MCB.00062-12; Reddy TE, 2012, GENOME RES, V22, P860, DOI 10.1101/gr.131201.111; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rye M, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-80; SAKAI DD, 1988, GENE DEV, V2, P1144, DOI 10.1101/gad.2.9.1144; Salmon-Divon M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-415; Sheppard KA, 1998, J BIOL CHEM, V273, P29291, DOI 10.1074/jbc.273.45.29291; SLATER EP, 1985, MOL CELL BIOL, V5, P2984, DOI 10.1128/MCB.5.11.2984; Smith RP, 2013, NAT GENET, V45, P1021, DOI 10.1038/ng.2713; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Soccio RE, 2015, CELL, V162, P33, DOI 10.1016/j.cell.2015.06.025; SOMMA MP, 1991, NUCLEIC ACIDS RES, V19, P2817, DOI 10.1093/nar/19.11.2817; Song Lingyun, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5384; Stadhouders R, 2014, J CLIN INVEST, V124, P1699, DOI 10.1172/JCI71520; Staller MV, 2015, P NATL ACAD SCI USA, V112, P785, DOI 10.1073/pnas.1413877112; Starick SR, 2015, GENOME RES, V25, P825, DOI 10.1101/gr.185157.114; TEURICH S, 1995, CHEM SENSES, V20, P251, DOI 10.1093/chemse/20.2.251; Tyedmers J, 1996, J BIOL CHEM, V271, P19509, DOI 10.1074/jbc.271.32.19509; Vockley CM, 2015, GENOME RES, V25, P1206, DOI 10.1101/gr.190090.115; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Wang YS, 1997, J IMMUNOL, V159, P534; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	66	105	106	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1269	+		10.1016/j.cell.2016.07.049	http://dx.doi.org/10.1016/j.cell.2016.07.049			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27565349	Green Accepted, Bronze			2022-12-28	WOS:000382259500022
J	Wise, J				Wise, Jacqui			Anxiety in teenage girls rises sharply in past decade, finds study	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department for Education, 2016, LONG STUD YOUNG PEOP	1	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 24	2016	354								i4649	10.1136/bmj.i4649	http://dx.doi.org/10.1136/bmj.i4649			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV2ZZ	27558499				2022-12-28	WOS:000382792100004
J	Butt, CA				Butt, Carrie A.			An Old Pond, a Frog Leaps in the Sound of Water	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2016	316	8					800	806		10.1001/jama.2015.14447	http://dx.doi.org/10.1001/jama.2015.14447			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT8JL	27552604				2022-12-28	WOS:000381736200001
J	Rosenberg, AR				Rosenberg, Abby R.			Nondisclosure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rosenberg, Abby R.] Seattle Childrens Hosp, Canc & Blood Disorders Ctr, Seattle, WA 98105 USA; [Rosenberg, Abby R.] Treuman Katz Ctr Pediat Bioeth, Seattle, WA 98101 USA; [Rosenberg, Abby R.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Rosenberg, Abby R.] Univ Washington, Sch Med, Seattle, WA 98122 USA	Seattle Children's Hospital; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Rosenberg, AR (corresponding author), Seattle Childrens Hosp, Canc & Blood Disorders Ctr, Seattle, WA 98105 USA.; Rosenberg, AR (corresponding author), Treuman Katz Ctr Pediat Bioeth, Seattle, WA 98101 USA.; Rosenberg, AR (corresponding author), Univ Washington, Sch Med, Seattle, WA 98122 USA.	abby.rosenberg@seattlechildrens.org						Bluebond-Langner M., 1980, PRIVATE WORLDS DYING; Kreicbergs U, 2004, NEW ENGL J MED, V351, P1175, DOI 10.1056/NEJMoa040366; Wiener L, 2013, PEDIATR BLOOD CANCER, V60, P715, DOI 10.1002/pbc.24490	3	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2016	316	8					821	821		10.1001/jama.2016.5348	http://dx.doi.org/10.1001/jama.2016.5348			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT8JL	27552613				2022-12-28	WOS:000381736200010
J	Allwood, AC				Allwood, Abigail C.			Evidence of life in Earth's oldest rocks	NATURE			English	Editorial Material							CARBON		[Allwood, Abigail C.] CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Allwood, AC (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	abigail.c.allwood@jpl.nasa.gov						Allwood AC, 2006, NATURE, V441, P714, DOI 10.1038/nature04764; Grotzinger JP, 2014, SCIENCE, V343, P386, DOI 10.1126/science.1249944; Rosing MT, 1999, SCIENCE, V283, P674, DOI 10.1126/science.283.5402.674; SCHIDLOWSKI M, 1979, GEOCHIM COSMOCHIM AC, V43, P189, DOI 10.1016/0016-7037(79)90238-2	5	8	9	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2016	537	7621					500	501		10.1038/nature19429	http://dx.doi.org/10.1038/nature19429			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW3MO	27580031				2022-12-28	WOS:000383545900045
J	Patil, DP; Chen, CK; Pickering, BF; Chow, A; Jackson, C; Guttman, M; Jaffrey, SR				Patil, Deepak P.; Chen, Chun-Kan; Pickering, Brian F.; Chow, Amy; Jackson, Constanza; Guttman, Mitchell; Jaffrey, Samie R.			m(6)A RNA methylation promotes XIST-mediated transcriptional repression	NATURE			English	Article							X-CHROMOSOME INACTIVATION; MESSENGER-RNA; NUCLEOTIDE-RESOLUTION; PROTEIN INTERACTIONS; NUCLEAR-RNA; REVEALS; INTERACTS; N-6-METHYLADENOSINE; N6-METHYLADENOSINE; METHYLTRANSFERASE	The long non-coding RNA X-inactive specific transcript (XIST) mediates the transcriptional silencing of genes on the X chromosome. Here we show that, in human cells, XIST is highly methylated with at least 78 N-6-methyladenosine (m(6)A) residues-a reversible base modification of unknown function in long non-coding RNAs. We show that m(6)A formation in XIST, as well as in cellular mRNAs, is mediated by RNA-binding motif protein 15 (RBM15) and its paralogue RBM15B, which bind the m(6)A-methylation complex and recruit it to specific sites in RNA. This results in the methylation of adenosine nucleotides in adjacent m(6)A consensus motifs. Furthermore, we show that knockdown of RBM15 and RBM15B, or knockdown of methyltransferase like 3 (METTL3), an m(6)A methyltransferase, impairs XIST-mediated gene silencing. A systematic comparison of m(6)A-binding proteins shows that YTH domain containing 1 (YTHDC1) preferentially recognizes m(6)A residues on XIST and is required for XIST function. Additionally, artificial tethering of YTHDC1 to XIST rescues XIST-mediated silencing upon loss of m(6)A. These data reveal a pathway of m(6)A formation and recognition required for XIST-mediated transcriptional repression.	[Patil, Deepak P.; Pickering, Brian F.; Jaffrey, Samie R.] Cornell Univ, Dept Pharmacol, Weill Cornell Med Coll, New York, NY 10065 USA; [Chen, Chun-Kan; Chow, Amy; Jackson, Constanza; Guttman, Mitchell] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	Cornell University; California Institute of Technology	Jaffrey, SR (corresponding author), Cornell Univ, Dept Pharmacol, Weill Cornell Med Coll, New York, NY 10065 USA.	srj2003@med.cornell.edu		Patil, Deepak/0000-0001-8825-0327; Jaffrey, Samie/0000-0003-3615-6958	NIH [R01CA186702, T32CA062948, T32GM07616, DP5OD012190]; Rose Hills Foundation; Edward Mallinckrodt Foundation; Sontag Foundation; Searle Scholars Program; Pew-Stewart Scholars program; California Institute of Technology; NATIONAL CANCER INSTITUTE [R01CA186702, T32CA062948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012190] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rose Hills Foundation; Edward Mallinckrodt Foundation; Sontag Foundation; Searle Scholars Program; Pew-Stewart Scholars program; California Institute of Technology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Jaffrey and Guttman laboratories for comments and suggestions, A. Olarerin-George for discussions on computational analysis, J. -Y. Kim for discussions on immunostaining and imaging, the members of the Weill Cornell Epigenomics Core for their assistance in high-throughput sequencing, A. North and other staff members of the Bio-Imaging Resource Center at the Rockefeller University for their assistance with 3D-SIM imaging, and S. Mukherjee for input on image analysis. This work was supported by NIH grants R01CA186702 (to S.R.J.); T32CA062948 (B.F.P.); T32GM07616 (C.-K.C.) and an NIH Director's Early Independence Award (DP5OD012190), the Rose Hills Foundation, Edward Mallinckrodt Foundation, Sontag Foundation, Searle Scholars Program, the Pew-Stewart Scholars program, and funds from the California Institute of Technology (M.G.).	Agarwala SD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002732; Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; BOKAR JA, 1994, J BIOL CHEM, V269, P17697; Bylund L, 2004, CYTOGENET GENOME RES, V106, P28, DOI 10.1159/000078556; Cao Q, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4127; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Cowley MJ, 2012, NUCLEIC ACIDS RES, V40, pD862, DOI 10.1093/nar/gkr967; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Harfmann AM, 1999, MOL BIOL CELL, V10, P3909, DOI 10.1091/mbc.10.11.3909; Hasegawa Y, 2010, DEV CELL, V19, P469, DOI 10.1016/j.devcel.2010.08.006; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Horiuchi K, 2013, J BIOL CHEM, V288, P33292, DOI 10.1074/jbc.M113.500397; Huppertz I, 2014, METHODS, V65, P274, DOI 10.1016/j.ymeth.2013.10.011; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kochan J, 2015, BIOTECHNIQUES, V59, P209, DOI 10.2144/000114340; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Kwon SC, 2013, NAT STRUCT MOL BIOL, V20, P1122, DOI 10.1038/nsmb.2638; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/nmeth.3453, 10.1038/NMETH.3453]; Link A. J., 2009, PROTEOMICS COLD SPRI, P117; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Ma WX, 2014, NAT PROTOC, V9, P1428, DOI 10.1038/nprot.2014.083; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Minajigi A, 2015, SCIENCE, V349, DOI [10.1126/science.aab2276, 10.1126/science.aab2276 aab2276]; Moindrot B, 2015, CELL REP, V12, P562, DOI 10.1016/j.celrep.2015.06.053; Morohashi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018285; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singh G, 2012, CELL, V151, P750, DOI 10.1016/j.cell.2012.10.007; Uranishi H, 2009, J BIOL CHEM, V284, P26106, DOI 10.1074/jbc.M109.040113; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; WEI CM, 1976, BIOCHEMISTRY-US, V15, P397, DOI 10.1021/bi00647a024; Weyn-Vanhentenryck SM, 2014, CELL REP, V6, P1139, DOI 10.1016/j.celrep.2014.02.005; Wilkinson FL, 2003, EUR J BIOCHEM, V270, P2459, DOI 10.1046/j.1432-1033.2003.03617.x; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883	52	834	878	17	192	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2016	537	7620					369	+		10.1038/nature19342	http://dx.doi.org/10.1038/nature19342			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV7EC	27602518	Green Accepted, Green Submitted			2022-12-28	WOS:000383098000047
J	Ahmad, SS; Reinius, MAV; Hatcher, HM; Ajithkumar, TV				Ahmad, Saif S.; Reinius, Marika A. V.; Hatcher, Helen M.; Ajithkumar, Thankamma V.			Anticancer chemotherapy in teenagers and young adults: managing long term side effects	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FERTILITY PRESERVATION; CARDIOVASCULAR-DISEASE; TESTICULAR SPERM; CHILDHOOD-CANCER; ADOLESCENT; SURVIVORS; IMPACT; RISK; RADIOTHERAPY; AZOOSPERMIA		[Ahmad, Saif S.; Reinius, Marika A. V.; Hatcher, Helen M.; Ajithkumar, Thankamma V.] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Oncol, Cambridge, England; [Ahmad, Saif S.] Univ Cambridge, MRC Canc Unit, Cambridge Biomed Campus, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Ahmad, SS (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Oncol, Cambridge, England.	saif.ahmad@nhs.net		/0000-0002-1348-832X; Ahmad, Saif/0000-0003-1020-2346; Ajithkumar, Thankamma/0000-0002-5685-5898; Reinius, Marika/0000-0002-9778-3317				Agarwal A, 2014, TRANSL ANDROL UROL, V3, P27, DOI 10.3978/j.issn.2223-4683.2014.02.06; Aleman BMP, 2007, BLOOD, V109, P1878, DOI 10.1182/blood-2006-07-034405; Amer Soc Reprod Med, 2013, FERTIL STERIL, V99, P37, DOI 10.1016/j.fertnstert.2012.09.028; Barnett M, 2016, J CANC SURVIV, DOI [10.1007/s11764-016-0527-6, DOI 10.1007/S11764-016-0527-6PMID:26920873]; Bellizzi KM, 2012, CANCER-AM CANCER SOC, V118, P5155, DOI 10.1002/cncr.27512; Benedict C, 2016, J ADOLESC YOUNG ADUL, V5, P48, DOI 10.1089/jayao.2015.0024; Berger AM, 2010, J NATL COMPR CANC NE, V8, P904, DOI 10.6004/jnccn.2010.0067; Buizer AI, 2009, PEDIATR BLOOD CANCER, V52, P447, DOI 10.1002/pbc.21869; Cancer Research UK, TEEN YOUNG AD CANC S; Cardinale D, 2015, CIRCULATION, V131, P1981, DOI 10.1161/CIRCULATIONAHA.114.013777; Cardinale D, 2010, J AM COLL CARDIOL, V55, P213, DOI 10.1016/j.jacc.2009.03.095; Centers for Disease Control and Prevention, 2013, ASS REPR TECHN; Chao C, 2016, J CLIN ONCOL, V34, P1626, DOI 10.1200/JCO.2015.65.5845; Children's Oncology Group, 2013, LONG TERM FOLL UP GU; Coccia PF, 2012, J NATL COMPR CANC NE, V10, P1112, DOI 10.6004/jnccn.2012.0117; Curigliano G, 2012, ANN ONCOL, V23, P155, DOI 10.1093/annonc/mds293; Curtis R, 2006, NEW MALIGNANCIES CAN; De Bruin ML, 2008, BLOOD, V111, P101, DOI 10.1182/blood-2007-05-090225; Denlinger CS, 2014, J NATL COMPR CANC NE, V12, P876, DOI 10.6004/jnccn.2014.0082; Deyell RJ, 2013, PEDIATR BLOOD CANCER, V60, P816, DOI 10.1002/pbc.24446; Evan EE, 2006, CANCER-AM CANCER SOC, V107, P1672, DOI 10.1002/cncr.22101; Ferrari S, 2016, REPROD BIOMED ONLINE, V33, P29, DOI 10.1016/j.rbmo.2016.04.002; Gracia CR, 2012, FERTIL STERIL, V97, P134, DOI 10.1016/j.fertnstert.2011.10.040; Green, 1997, Oncologist, V2, P171; Green DM, 2009, J CLIN ONCOL, V27, P2677, DOI 10.1200/JCO.2008.20.1541; Grinyer A, 2007, CHRONIC ILLN, V3, P265, DOI 10.1177/1742395307085335; Howell SJ, 1999, J CLIN ONCOL, V17, P1493, DOI 10.1200/JCO.1999.17.5.1493; Hsiao W, 2011, J CLIN ONCOL, V29, P1607, DOI 10.1200/JCO.2010.33.7808; Kent EE, 2012, J PSYCHOSOC ONCOL, V30, P260, DOI 10.1080/07347332.2011.644396; Kry SF, 2005, INT J RADIAT ONCOL, V62, P1195, DOI 10.1016/j.ijrobp.2005.03.053; Lambertini M, 2016, BMC MED, V14, DOI 10.1186/s12916-015-0545-7; Levine J, 2010, J CLIN ONCOL, V28, P4831, DOI 10.1200/JCO.2009.22.8312; Levine JM, 2015, CANCER-AM CANCER SOC, V121, P1532, DOI 10.1002/cncr.29181; Loren AW, 2013, J CLIN ONCOL, V31, P2500, DOI 10.1200/JCO.2013.49.2678; McCarthy MC, 2016, J ADOLESC YOUNG ADUL, DOI [10.1089/jayao.2016.0015, DOI 10.1089/JAYAO.2016.0015PMID:27214245]; Monsuez JJ, 2010, INT J CARDIOL, V144, P3, DOI 10.1016/j.ijcard.2010.03.003; Morton Lindsay M, 2014, EJC Suppl, V12, P5, DOI 10.1016/j.ejcsup.2014.05.001; Morton LM, 2013, BLOOD, V121, P2996, DOI 10.1182/blood-2012-08-448068; National Cancer Institute, SNAPSH AD YOUNG AD C; National Cancer Survivorship Initiative, 2014, REC PACK; National Institute for Health and Care Excellence, 2014, CANC SERV CHILDR YOU; Park YS, 2003, FERTIL STERIL, V80, P526, DOI 10.1016/S0015-0282(03)00798-2; Parsons HM, 2012, J CLIN ONCOL, V30, P2393, DOI 10.1200/JCO.2011.39.6333; Peccatori FA, 2013, ANN ONCOL, V24, P160, DOI 10.1093/annonc/mdt199; Prasad PK, 2015, J CLIN ONCOL, V33, P2545, DOI 10.1200/JCO.2014.57.7528; Rugbjerg K, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju110; Spathis A, 2015, J ADOLESC YOUNG ADUL, V4, P3, DOI 10.1089/jayao.2014.0023; Trama A, 2016, LANCET ONCOL, V17, P896, DOI 10.1016/S1470-2045(16)00162-5; Travis LB, 2013, NAT REV CLIN ONCOL, V10, P289, DOI 10.1038/nrclinonc.2013.41; van den Belt-Dusebout AW, 2006, J CLIN ONCOL, V24, P467, DOI 10.1200/JCO.2005.02.7193; van Wely M, 2015, HUM REPROD, V30, P761, DOI 10.1093/humrep/dev032; Warner EL, 2016, CANCER-AM CANCER SOC, V122, P1029, DOI 10.1002/cncr.29866; Wo JY, 2009, INT J RADIAT ONCOL, V73, P1304, DOI 10.1016/j.ijrobp.2008.12.016; Woodward E, 2011, ANN ONCOL, V22, P2561, DOI 10.1093/annonc/mdr044; Yang L, 2009, ANN ONCOL, V20, P758, DOI 10.1093/annonc/mdn664	55	22	27	3	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 7	2016	354								i4567	10.1136/bmj.i4567	http://dx.doi.org/10.1136/bmj.i4567			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV7FG	27604249	Green Published, hybrid			2022-12-28	WOS:000383101100004
J	Cheong-See, F; Schuit, E; Arroyo-Manzano, D; Khalil, A; Barrett, J; Joseph, KS; Asztalos, E; Hack, K; Lewi, L; Lim, A; Liem, S; Norman, JE; Morrison, J; Combs, CA; Garite, TJ; Maurel, K; Serra, V; Perales, A; Rode, L; Worda, K; Nassar, A; Aboulghar, M; Rouse, D; Thom, E; Breathnach, F; Nakayama, S; Russo, FM; Robinson, JN; Dodd, JM; Newman, RB; Bhattacharya, S; Tang, S; Mol, BWJ; Zamora, J; Thilaganathan, B; Thangaratinam, S				Cheong-See, Fiona; Schuit, Ewoud; Arroyo-Manzano, David; Khalil, Asma; Barrett, Jon; Joseph, K. S.; Asztalos, Elizabeth; Hack, Karien; Lewi, Liesbeth; Lim, Arianne; Liem, Sophie; Norman, Jane E.; Morrison, John; Combs, C. Andrew; Garite, Thomas J.; Maurel, Kimberly; Serra, Vicente; Perales, Alfredo; Rode, Line; Worda, Katharina; Nassar, Anwar; Aboulghar, Mona; Rouse, Dwight; Thom, Elizabeth; Breathnach, Fionnuala; Nakayama, Soichiro; Russo, Francesca Maria; Robinson, Julian N.; Dodd, Jodie M.; Newman, Roger B.; Bhattacharya, Sohinee; Tang, Selphee; Mol, Ben Willem J.; Zamora, Javier; Thilaganathan, Basky; Thangaratinam, Shakila		A Global Obstet Network GONET Coll	Prospective risk of stillbirth and neonatal complications in twin pregnancies: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							UNCOMPLICATED MONOCHORIONIC TWINS; PRETERM BIRTH; FETAL-DEATH; PERINATAL-MORTALITY; GESTATIONAL-AGE; DOUBLE-BLIND; 17-ALPHA-HYDROXYPROGESTERONE CAPROATE; CLINICAL-TRIAL; SHORT-TERM; PREVENTION	OBJECTIVE To determine the risks of stillbirth and neonatal complications by gestational age in uncomplicated monochorionic and dichorionic twin pregnancies. Design Systematic review and meta-analysis. Data sources Medline, Embase, and Cochrane databases (until December 2015). Review methods Databases were searched without language restrictions for studies of women with uncomplicated twin pregnancies that reported rates of stillbirth and neonatal outcomes at various gestational ages. Pregnancies with unclear chorionicity, monoamnionicity, and twin to twin transfusion syndrome were excluded. Meta-analyses of observational studies and cohorts nested within randomised studies were undertaken. Prospective risk of stillbirth was computed for each study at a given week of gestation and compared with the risk of neonatal death among deliveries in the same week. Gestational age specific differences in risk were estimated for stillbirths and neonatal deaths in monochorionic and dichorionic twin pregnancies after 34 weeks' gestation. Results 32 studies (29 685 dichorionic, 5486 monochorionic pregnancies) were included. In dichorionic twin pregnancies beyond 34 weeks (15 studies, 17 830 pregnancies), the prospective weekly risk of stillbirths from expectant management and the risk of neonatal death from delivery were balanced at 37 weeks' gestation (risk difference 1.2/1000, 95% confidence interval -1.3 to 3.6; I-2=0%). Delay in delivery by a week (to 38 weeks) led to an additional 8.8 perinatal deaths per 1000 pregnancies (95% confidence interval 3.6 to 14.0/1000; I-2=0%) compared with the previous week. In monochorionic pregnancies beyond 34 weeks (13 studies, 2149 pregnancies), there was a trend towards an increase in stillbirths compared with neonatal deaths after 36 weeks, with an additional 2.5 per 1000 perinatal deaths, which was not significant (-12.4 to 17.4/1000; I-2=0%). The rates of neonatal morbidity showed a consistent reduction with increasing gestational age in monochorionic and dichorionic pregnancies, and admission to the neonatal intensive care unit was the commonest neonatal complication. The actual risk of stillbirth near term might be higher than reported estimates because of the policy of planned delivery in twin pregnancies. Conclusions To minimise perinatal deaths, in uncomplicated dichorionic twin pregnancies delivery should be considered at 37 weeks' gestation; in monochorionic pregnancies delivery should be considered at 36 weeks. Systematic review registration PROSPERO CRD42014007538.	[Cheong-See, Fiona; Thangaratinam, Shakila] Queen Mary Univ London, Womens Hlth Res Unit, Barts & London Sch Med & Dent, London E1 2AB, England; [Schuit, Ewoud] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Schuit, Ewoud; Lim, Arianne; Liem, Sophie] Acad Med Ctr, Dept Obstet & Gynaecol, NL-1105 AZ Amsterdam, Netherlands; [Schuit, Ewoud] Stanford Univ, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Arroyo-Manzano, David] IRYCIS, Clin Biostat Unit, Madrid, Spain; [Khalil, Asma; Thilaganathan, Basky] St Georges Healthcare NHS Trust, Fetal Med Unit, London SW17 0QT, England; [Barrett, Jon] Sunnybrook Res Inst, Women & Babies Res Program, Evaluat Clin Sci, Toronto, ON M4N 3M5, Canada; [Joseph, K. S.] Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC V6Z 2K5, Canada; [Asztalos, Elizabeth] Sunnybrook Hlth Sci Ctr, Dept Newborn & Dev Paediat, Women & Babies Res Program, Toronto, ON M4N 3M5, Canada; [Hack, Karien] Diakonessen Hosp, Dept Gynaecol & Obstet, NL-3582 KE Utrecht, Netherlands; [Lewi, Liesbeth] Univ Hosp, Dept Obstet Gynaecol, B-3000 Leuven, Belgium; [Lewi, Liesbeth] Katholieke Univ Leuven, Dept Dev & Regenerat Pregnancy Fetus & Neonate, Leuven, Belgium; [Norman, Jane E.] Univ Edinburgh, MRC, Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh EH16 4TY, Midlothian, Scotland; [Morrison, John] Univ Mississippi, Med Ctr, Dept Obstet & Gynecol, Jackson, MS 39216 USA; [Combs, C. Andrew; Garite, Thomas J.; Maurel, Kimberly] Mednax Natl Med Grp, Ctr Res Educ & Qual, Obstetrix Collaborat Res Network, Sunrise, FL 33323 USA; [Garite, Thomas J.] Univ Calif Irvine, Irvine, CA 92697 USA; [Serra, Vicente] Univ Valencia, Inst Valenciano Infertilidad, Maternal Fetal Med Unit, Valencia, Spain; [Serra, Vicente; Perales, Alfredo] Univ Valencia, Fac Med, Dept Obstet & Gynaecol, Jefe Servicio Obstet Hosp U P La FE,Torre F, Valencia, Spain; [Perales, Alfredo] Univ Hosp La Fe, Dept Obstet, Valencia, Spain; [Rode, Line] Rigshosp, Copenhagen Univ Hosp, Dept Obstet, Ctr Fetal Med, Copenhagen, Denmark; [Worda, Katharina] Med Univ Vienna, Dept Obstet & Gynaecol, A-1090 Vienna, Austria; [Nassar, Anwar] Amer Univ Beirut, Med Ctr, Dept Obstet & Gynaecol, Beirut 11072020, Lebanon; [Aboulghar, Mona] Egyptian IVF Ctr, Maadi, Egypt; [Aboulghar, Mona] Cairo Univ, Dept Obstet & Gynaecol, Fac Med, Giza, Egypt; [Rouse, Dwight] Brown Univ, Women & Infants Hosp, Dept Obstet & Gynecol, Providence, RI 02905 USA; [Thom, Elizabeth; Breathnach, Fionnuala] Rotunda Hosp, Royal Coll Surg Ireland, Dublin, Ireland; [Nakayama, Soichiro] Osaka Med Ctr, Dept Maternal Fetal Med, Izumi, Osaka 5941101, Japan; [Nakayama, Soichiro] Res Inst Maternal & Child Hlth, Izumi, Osaka 5941101, Japan; [Russo, Francesca Maria] Univ Milano Bicocca, Dept Obstet & Gynecol, I-20126 Milan, Italy; [Robinson, Julian N.] Harvard Med Sch, Brigham & Womens Hosp, Dept Obstet & Gynecol, Div Maternal Fetal Med, Boston, MA 02115 USA; [Dodd, Jodie M.] Univ Adelaide, Robinson Res Inst, Adelaide, SA 5006, Australia; [Dodd, Jodie M.] Univ Adelaide, Discipline Obstet & Gynaecol, Adelaide, SA 5006, Australia; [Newman, Roger B.] Med Univ South Carolina, Dept Obstet & Gynecol, Charleston, SC 29403 USA; [Bhattacharya, Sohinee] Univ Aberdeen, Dugald Baird Ctr Res Womens Hlth, Aberdeen Matern Hosp, Aberdeen AB25 2ZL, Scotland; [Tang, Selphee] Alberta Hlth Serv, Dept Obstet & Gynecol, Calgary, AB T2N 2T9, Canada; [Mol, Ben Willem J.] Univ Adelaide, Robinson Inst, Australian Res Ctr Hlth Women & Babies, Adelaide, SA 5006, Australia; [Zamora, Javier] Hosp Ramon y Cajal IRYCIS, Clin Biostat Unit, Madrid, Spain; [Zamora, Javier] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain	University of London; Queen Mary University London; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Stanford University; St Georges University London; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of British Columbia; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Diakonessenhuis; KU Leuven; University of Edinburgh; University of Mississippi; University of Mississippi Medical Center; University of California System; University of California Irvine; University of Valencia; University of Valencia; Rigshospitalet; University of Copenhagen; Medical University of Vienna; American University of Beirut; Egyptian Knowledge Bank (EKB); Egyptian IVF Center; Egyptian Knowledge Bank (EKB); Cairo University; Brown University; Women & Infants Hospital Rhode Island; Royal College of Surgeons - Ireland; Osaka Medical Center for Cancer & Cardiovascular Diseases; University of Milano-Bicocca; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Robinson Research Institute; University of Adelaide; University of Adelaide; Medical University of South Carolina; University of Aberdeen; Alberta Health Services (AHS); University of Calgary; Robinson Research Institute; University of Adelaide; Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Zamora, J (corresponding author), Hosp Ramon y Cajal IRYCIS, Clin Biostat Unit, Madrid, Spain.; Zamora, J (corresponding author), CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain.	javier.zamora@hrc.es	Zamora, Javier/B-1722-2009; Zamora, Javier/AEO-0608-2022; Asztalos, Elizabeth/L-8834-2019; Schuit, Ewoud/N-1869-2014; Thangaratinam, Shakila/AAP-3724-2021; Perales-Marín, Alfredo/AAC-8052-2020; Lewi, Liesbeth/A-1454-2015; Dodd, Jodie/Y-6849-2019; Khall, Asma/AAC-1459-2020; Rode, Line/P-7625-2018	Zamora, Javier/0000-0003-4901-588X; Zamora, Javier/0000-0003-4901-588X; Asztalos, Elizabeth/0000-0002-9468-2860; Schuit, Ewoud/0000-0002-9548-3214; Thangaratinam, Shakila/0000-0002-4254-460X; Lewi, Liesbeth/0000-0002-9884-5778; Dodd, Jodie/0000-0002-6363-4874; Khall, Asma/0000-0003-2802-7670; Rode, Line/0000-0002-9080-3389; Joseph, K.S./0000-0003-2317-5607; Cheong-See, Fiona/0000-0002-7688-0492; Serra, Vicente/0000-0002-6400-9886; Norman, Jane/0000-0001-6031-6953	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD036801] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aboulghar MM, 2012, REPROD BIOMED ONLINE, V25, P133, DOI 10.1016/j.rbmo.2012.03.013; [Anonymous], 2014, Obstet Gynecol, V123, P1118, DOI 10.1097/01.AOG.0000446856.51061.3e; Awwad J, 2015, BJOG-INT J OBSTET GY, V122, P71, DOI 10.1111/1471-0528.13031; Barigye O, 2005, PLOS MED, V2, P521, DOI 10.1371/journal.pmed.0020172; Barrett JFR, 2013, NEW ENGL J MED, V369, P1295, DOI 10.1056/NEJMoa1214939; Berard A, 2012, ARCH DIS CHILD-FETAL, V97, pF329, DOI 10.1136/fetalneonatal-2011-300969; Berezowsky A, 2014, AM J OBSTET GYNECOL, V210, pS101, DOI 10.1016/j.ajog.2013.10.213; Bhattacharya S, 2015, ABERDEEN MATER UNPUB; Braunholtz DA, 2001, J CLIN EPIDEMIOL, V54, P217, DOI 10.1016/S0895-4356(00)00305-X; Breathnach FM, 2012, OBSTET GYNECOL, V119, P50, DOI 10.1097/AOG.0b013e31823d7b06; Briery CM, 2009, SOUTH MED J, V102, P900, DOI 10.1097/SMJ.0b013e3181afee12; Burgess JL, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.03.003; CHAN A, 2008, PREGNANCY OUTCOME S; Cheong-See F, OPTIMAL TIMING DELIV; Cheung YB, 2000, AM J EPIDEMIOL, V152, P1107, DOI 10.1093/aje/152.12.1107; Cleary-Goldman Jane, 2007, Am J Obstet Gynecol, V196, pe11, DOI 10.1016/j.ajog.2006.09.047; Combs CA, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.042; Danon D, 2013, OBSTET GYNECOL, V121, P1318, DOI 10.1097/AOG.0b013e318292766b; Dias T, 2012, ULTRASOUND OBST GYN, V39, P500, DOI 10.1002/uog.11110; Dodd JM, 2012, BJOG-INT J OBSTET GY, V119, P964, DOI 10.1111/j.1471-0528.2012.03356.x; Domingues AP, 2009, J MATERN-FETAL NEO M, V22, P1077, DOI 10.3109/14767050903042579; Draper ES, 1999, BRIT MED J, V319, P1093, DOI 10.1136/bmj.319.7217.1093; Elliott JP, 2005, SEMIN PERINATOL, V29, P305, DOI 10.1053/j.semperi.2005.08.001; Farah N, 2012, ACTA OBSTET GYN SCAN, V91, P382, DOI 10.1111/j.1600-0412.2011.01288.x; Flenady V, 2016, LANCET, V387, P691, DOI 10.1016/S0140-6736(15)01020-X; Fong F, 2013, OBSTET GYNECOL, V122, P1302, DOI 10.1097/AOG.0000000000000026; Glasziou P, 2004, SYSTEMATIC REV HLTH, P67; Hack KE, 2008, BJOG-INT J OBSTET GY, V115, P58, DOI 10.1111/j.1471-0528.2007.01556.x; Hack KEA, 2011, BJOG-INT J OBSTET GY, V118, P1090, DOI 10.1111/j.1471-0528.2011.02955.x; Heazell AEP, 2015, ULTRASOUND OBST GYN, V46, P641, DOI 10.1002/uog.15738; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; Hillman SC, 2011, OBSTET GYNECOL, V118, P928, DOI 10.1097/AOG.0b013e31822f129d; Hunter JP, 2014, J CLIN EPIDEMIOL, V67, P897, DOI 10.1016/j.jclinepi.2014.03.003; Kahn B, 2003, OBSTET GYNECOL, V102, P685, DOI 10.1016/S0029-7844(03)00616-1; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kramer MS, 2002, AM J EPIDEMIOL, V156, P493, DOI 10.1093/aje/kwf077; Latthe P, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-177; Laws PJ., 2008, AUSTR MOTHERS BABIES; Lee YM, 2008, OBSTET GYNECOL, V111, P301, DOI 10.1097/AOG.0b013e318160d65d; Lee YM, 2012, SEMIN PERINATOL, V36, P195, DOI 10.1053/j.semperi.2012.02.004; Lewi L, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.03.050; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liem S, 2013, LANCET, V382, P1341, DOI 10.1016/S0140-6736(13)61408-7; Lim AC, 2011, OBSTET GYNECOL, V118, P513, DOI 10.1097/AOG.0b013e31822ad6aa; Lorenz JM, 2012, SEMIN PERINATOL, V36, P201, DOI 10.1053/j.semperi.2012.02.005; Mahony R, 2011, ACTA OBSTET GYN SCAN, V90, P1274, DOI 10.1111/j.1600-0412.2011.01239.x; McPherson JA, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.031; Mol B, 2013, AM J PERINAT, V30, P163, DOI 10.1055/s-0032-1322512; Moreno SG, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-2; Morikawa M, 2012, J PERINAT MED, V40, P245, DOI 10.1515/jpm-2011-0205; Nakayama S, 2012, J OBSTET GYNAECOL RE, V38, P692, DOI 10.1111/j.1447-0756.2011.01759.x; National Institute for Health and Care Excellence (NICE), 2011, MULT PREGN MAN TWIN; Norman JE, 2009, LANCET, V373, P2034, DOI 10.1016/S0140-6736(09)60947-8; Ortibus E, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.048; Peter C., 2013, OPEN J OBSTETR GYNEC, V3, P78, DOI [10.4236/ojog.2013.31017, DOI 10.4236/OJOG.2013.31017]; Poulter D, 2004, MULTIPLE BIRTHS PARL; RCOG RCoOaG, 2016, EACH BABY COUNTS; Rode L, 2011, ULTRASOUND OBST GYN, V38, P272, DOI 10.1002/uog.9093; Rouse DJ, 2007, NEW ENGL J MED, V357, P454, DOI 10.1056/NEJMoa070641; Royal Australain and New Zealand Colleges of Obstetricians and Gynaecologists, 2014, MAN MON TWIN PREGN, P1; Russo FM, 2013, EUR J OBSTET GYN R B, V170, P131, DOI 10.1016/j.ejogrb.2013.06.014; Schuit E, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-13; Serra V, 2013, BJOG-INT J OBSTET GY, V120, P50, DOI 10.1111/j.1471-0528.2012.03448.x; Smith NA, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.066; Spong CY, 2011, OBSTET GYNECOL, V118, P323, DOI 10.1097/AOG.0b013e3182255999; Sullivan AE, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.016; Suzuki S, 2010, J OBSTET GYNAECOL, V30, P574, DOI 10.3109/01443615.2010.494207; Suzuki S, 2000, GYNECOL OBSTET INVES, V49, P24, DOI 10.1159/000010207; Tang ML, 2004, BIOMETRICAL J, V46, P72, DOI 10.1002/bimj.200210003; Vayssiere C, 2011, EUR J OBSTET GYN R B, V156, P12, DOI 10.1016/j.ejogrb.2010.12.045; Wood S, 2014, BJOG-INT J OBSTET GY, V121, P1284, DOI 10.1111/1471-0528.12866; Woythaler MA, 2011, PEDIATRICS, V127, pE622, DOI 10.1542/peds.2009-3598	72	71	81	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2016	354								i4353	10.1136/bmj.i4353	http://dx.doi.org/10.1136/bmj.i4353			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV7FB	27599496	Green Submitted, Green Published, hybrid, Green Accepted			2022-12-28	WOS:000383100600001
J	Arnold, C				Arnold, Carrie			The snakebite fight	NATURE			English	News Item																		Brown NI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001670; Laustsen AH, 2015, TOXICON, V104, P43, DOI 10.1016/j.toxicon.2015.07.334; Mohapatra B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001018; Ramos HR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004484	4	21	22	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					26	28		10.1038/537026a	http://dx.doi.org/10.1038/537026a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27582205	Bronze			2022-12-28	WOS:000382426900009
J	Lane, J				Lane, Julia			Fix the incentives	NATURE			English	Editorial Material									[Lane, Julia] NYU, Wagner Sch Publ Policy, New York, NY 10003 USA	New York University	Lane, J (corresponding author), NYU, Wagner Sch Publ Policy, New York, NY 10003 USA.	jil4@nyu.edu		Lane, Julia/0000-0002-8139-2960				Callaghan P., 2013, WOOL TO WETA; Lane J, 2010, NATURE, V464, P488, DOI 10.1038/464488a; Rzhetsky A, 2015, P NATL ACAD SCI USA, V112, P14569, DOI 10.1073/pnas.1509757112; Zolas N, 2015, SCIENCE, V350, P1367, DOI 10.1126/science.aac5949	4	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					S20	S20		10.1038/537S20a	http://dx.doi.org/10.1038/537S20a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27580139				2022-12-28	WOS:000382426900026
J	Nishida, K; Takagi, R				Nishida, Kiwamu; Takagi, Ryota			Teleseismic S wave microseisms	SCIENCE			English	Article							SEISMIC NOISE; OCEAN; ARRAY; TIMES	Although observations of microseisms excited by ocean swells were firmly established in the 1940s, the source locations remain difficult to track. Delineation of the source locations and energy partition of the seismic wave components are key to understanding the excitation mechanisms. Using a seismic array in Japan, we observed both P and S wave microseisms excited by a severe distant storm in the Atlantic Ocean. Although nonlinear forcing of an ocean swell with a one-dimensional Earth model can explain P waves and vertically polarized S waves (SV waves), it cannot explain horizontally polarized S waves (SH waves). The precise source locations may provide a new catalog for exploring Earth's interior.	[Nishida, Kiwamu] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, 1-1-1 Yayoi 1, Tokyo 1130032, Japan; [Takagi, Ryota] Tohoku Univ, Res Ctr Predict Earthquakes & Volcan Erupt, Grad Sch Sci, Aoba Ku, 6-6 Aza Aoba, Sendai, Miyagi 9808578, Japan	University of Tokyo; Tohoku University	Nishida, K (corresponding author), Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, 1-1-1 Yayoi 1, Tokyo 1130032, Japan.	knishida@eri.u-tokyo.ac.jp	Nishida, Kiwamu/B-5416-2012; Takagi, Ryota/ABD-5378-2020	Nishida, Kiwamu/0000-0001-6778-8080; Takagi, Ryota/0000-0002-4200-9869	Japan Society for the Promotion of Science KAKENHI [26400448, 15J11322]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Kedar, an anonymous reviewer, and E. Stutzmann for constructive comments. Hi-net seismic records were provided by NIED at www.hinet.bosai.go.jp. This work was supported by Japan Society for the Promotion of Science KAKENHI grants 26400448 and 15J11322.	[Anonymous], 2015, WEATHER, V70, P54; Ardhuin F, 2015, GEOPHYS RES LETT, V42, P765, DOI 10.1002/2014GL062782; Ardhuin F, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC006952; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Gerstoft P, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027270; Gualtieri L, 2014, GEOPHYS J INT, V197, P1096, DOI 10.1093/gji/ggu042; GUTENBERG B, 1947, J METEOROL, V4, P21, DOI 10.1175/1520-0469(1947)004<0021:MAWF>2.0.CO;2; Ishii M, 2005, NATURE, V435, P933, DOI 10.1038/nature03675; Kawakatsu H., 1998, B EARTHQ RES I TOKYO, V73, P267; Kedar S, 2008, P ROY SOC A-MATH PHY, V464, P777, DOI 10.1098/rspa.2007.0277; KENNETT BLN, 1995, GEOPHYS J INT, V122, P108, DOI 10.1111/j.1365-246X.1995.tb03540.x; Landes M, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006918; Liu QX, 2016, EARTH PLANET SC LETT, V449, P39, DOI 10.1016/j.epsl.2016.05.035; LONGUETHIGGINS MS, 1950, PHILOS TR R SOC S-A, V243, P1, DOI 10.1098/rsta.1950.0012; Maeda T, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008464; Matsuzawa T, 2012, B SEISMOL SOC AM, V102, P1864, DOI 10.1785/0120110269; Nishida K, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034753; Poli P, 2012, SCIENCE, V338, P1063, DOI 10.1126/science.1228194; Snieder R, 2013, ANNU REV EARTH PL SC, V41, P183, DOI 10.1146/annurev-earth-050212-123936; Takagi R, 2015, SEISMOL RES LETT, V86, P901, DOI 10.1785/0220150030; TOKSOZ MN, 1968, SCIENCE, V159, P872, DOI 10.1126/science.159.3817.872; Tolman HL, 2008, OCEAN MODEL, V25, P35, DOI 10.1016/j.ocemod.2008.06.005; VANDECAR JC, 1990, B SEISMOL SOC AM, V80, P150; VINNIK LP, 1973, PURE APPL GEOPHYS, V103, P282, DOI 10.1007/BF00876404	25	57	58	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					919	921		10.1126/science.aaf7573	http://dx.doi.org/10.1126/science.aaf7573			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU0CA	27563094				2022-12-28	WOS:000381867700036
J	Nayfach, S; Pollard, KS				Nayfach, Stephen; Pollard, Katherine S.			Toward Accurate and Quantitative Comparative Metagenomics	CELL			English	Review							DIFFERENTIAL EXPRESSION ANALYSIS; SINGLE-CELL GENOMICS; PACIFIC BIOSCIENCES; GENE-EXPRESSION; DIVERSITY; SEQUENCES; ECOLOGY; CONTAMINATION; CHALLENGES; ASSIGNMENT	Shotgun metagenomics and computational analysis are used to compare the taxonomic and functional profiles of microbial communities. Leveraging this approach to understand roles of microbes in human biology and other environments requires quantitative data summaries whose values are comparable across samples and studies. Comparability is currently hampered by the use of abundance statistics that do not estimate a meaningful parameter of the microbial community and biases introduced by experimental protocols and data-cleaning approaches. Addressing these challenges, along with improving study design, data access, metadata standardization, and analysis tools, will enable accurate comparative metagenomics. We envision a future in which microbiome studies are replicable and new metagenomes are easily and rapidly integrated with existing data. Only then can the potential of metagenomics for predictive ecological modeling, well-powered association studies, and effective microbiome medicine be fully realized.	[Nayfach, Stephen] Univ Calif San Francisco, Integrat Program Quantitat Biol, San Francisco, CA 94158 USA; [Nayfach, Stephen; Pollard, Katherine S.] Gladstone Inst, San Francisco, CA 94158 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Inst Human Genet, Div Biostat, San Francisco, CA 94158 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Inst Computat Hlth Sci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Pollard, KS (corresponding author), Gladstone Inst, San Francisco, CA 94158 USA.; Pollard, KS (corresponding author), Univ Calif San Francisco, Inst Human Genet, Div Biostat, San Francisco, CA 94158 USA.; Pollard, KS (corresponding author), Univ Calif San Francisco, Inst Computat Hlth Sci, San Francisco, CA 94158 USA.	kpollard@gladstone.ucsf.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI108953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067547] Funding Source: NIH RePORTER; NIAID NIH HHS [R21 AI108953] Funding Source: Medline; NIGMS NIH HHS [T32 GM067547] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Aitchison J., 2003, STAT ANAL COMPOSITIO; Alivisatos AP, 2015, SCIENCE, V350, P507, DOI 10.1126/science.aac8480; Alneberg J, 2014, NAT METHODS, V11, P1144, DOI [10.1038/NMETH.3103, 10.1038/nmeth.3103]; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aronesty E ea-utils, 2011, COMMAND LINE TOOLS P; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Barrett T, 2012, NUCLEIC ACIDS RES, V40, pD57, DOI 10.1093/nar/gkr1163; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Beszteri B, 2010, ISME J, V4, P1075, DOI 10.1038/ismej.2010.29; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/NMETH.2276, 10.1038/nmeth.2276]; Carneiro MO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-375; Carr R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105776; Carr R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003292; Chase JH, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00010-15; Cleary B, 2015, NAT BIOTECHNOL, V33, P1053, DOI 10.1038/nbt.3329; Donia MS, 2015, SCIENCE, V349, DOI 10.1126/science.1254766; Dubilier N, 2015, NATURE, V526, P631, DOI 10.1038/526631a; Dutilh BE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5498; Ehrlich SD, 2011, METAGENOMICS OF THE HUMAN BODY, P307, DOI 10.1007/978-1-4419-7089-3_15; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Finucane MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084689; Fisher CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102451; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041294; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Franzosa EA, 2015, NAT REV MICROBIOL, V13, P360, DOI 10.1038/nrmicro3451; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P249, DOI 10.4056/sigs.1433550; Glass EM, 2014, ISME J, V8, P1, DOI 10.1038/ismej.2013.176; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Greenblum S, 2015, CELL, V160, P583, DOI 10.1016/j.cell.2014.12.038; Greenblum S, 2013, CURR OPIN BIOTECH, V24, P810, DOI 10.1016/j.copbio.2013.04.001; Hingamp P, 2013, ISME J, V7, P1678, DOI 10.1038/ismej.2013.59; Howe AC, 2014, P NATL ACAD SCI USA, V111, P4904, DOI 10.1073/pnas.1402564111; Huttenhower C, 2014, CELL, V159, P227, DOI 10.1016/j.cell.2014.09.022; Jones MB, 2015, P NATL ACAD SCI USA, V112, P14024, DOI 10.1073/pnas.1519288112; Joseph SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099290; Kashtan N, 2014, SCIENCE, V344, P416, DOI 10.1126/science.1248575; Keeling PJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001889; Kennedy NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088982; Keylock CJ, 2005, OIKOS, V109, P203, DOI 10.1111/j.0030-1299.2005.13735.x; Knight R, 2012, NAT BIOTECHNOL, V30, P513, DOI 10.1038/nbt.2235; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; Korem T, 2015, SCIENCE, V349, P1101, DOI 10.1126/science.aac4812; Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863; Kuleshov V, 2016, NAT BIOTECHNOL, V34, P64, DOI 10.1038/nbt.3416; Kurtz ZD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004226; Ladau J, 2013, ISME J, V7, P1669, DOI 10.1038/ismej.2013.37; Lam LH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004527; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levy R, 2013, P NATL ACAD SCI USA, V110, P12804, DOI 10.1073/pnas.1300926110; Li B, 2015, ISME J, V9, P2490, DOI 10.1038/ismej.2015.59; Li J., 2014, GIGASCIENCE DATABASE; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Lindgreen S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19233; Liu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S4; Liu CM, 2012, BMC MICROBIOL, V12, DOI [10.1186/1471-2180-12-56, 10.1186/1471-2180-12-255]; Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112; Luo CW, 2015, NAT BIOTECHNOL, V33, P1045, DOI 10.1038/nbt.3319; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Malmstrom RR, 2013, ISME J, V7, P184, DOI 10.1038/ismej.2012.89; Manor O, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0610-8; Marbouty M, 2015, TRENDS GENET, V31, P673, DOI 10.1016/j.tig.2015.10.003; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Mizuno CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003987; Mende DR, 2013, NAT METHODS, V10, P881, DOI [10.1038/NMETH.2575, 10.1038/nmeth.2575]; Mende DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031386; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Nguyen NP, 2014, BIOINFORMATICS, V30, P3548, DOI 10.1093/bioinformatics/btu721; Nayfach S., 2016, BIORXIV; Nayfach S, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004573; Nayfach S, 2015, BIOINFORMATICS, V31, P3368, DOI 10.1093/bioinformatics/btv382; Nayfach S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0611-7; O'Sullivan DM, 2014, INT J MOL SCI, V15, P21476, DOI 10.3390/ijms151121476; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Poptsova MS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04532; Prakash T, 2012, BRIEF BIOINFORM, V13, P711, DOI 10.1093/bib/bbs033; Preheim SP, 2013, APPL ENVIRON MICROB, V79, P6593, DOI 10.1128/AEM.00342-13; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Ravel J, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-8; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Satinsky BM, 2013, METHOD ENZYMOL, V531, P237, DOI 10.1016/B978-0-12-407863-5.00012-5; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Schloss PD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-34; Segata N, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.22; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Shapiro BJ, 2012, SCIENCE, V336, P48, DOI 10.1126/science.1218198; Sharpton TJ, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00209; Sharpton TJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001061; Sinha R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0841-8; Spencer SJ, 2016, ISME J, V10, P427, DOI 10.1038/ismej.2015.124; Stepanauskas R, 2015, ENV MICROBIOL REP, V7, P36, DOI 10.1111/1758-2229.12226; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]; Tanner MA, 1998, APPL ENVIRON MICROB, V64, P3110; Tikhonov M, 2015, ISME J, V9, P68, DOI 10.1038/ismej.2014.117; Voigt AY, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0639-8; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weiss S.J., 2015, PEERJ PREPRINTS, DOI [10.7287/peerj.preprints.1157v1, DOI 10.7287/PEERJ.PREPRINTS.1157V1, http://dx.doi.org/10.7287/peerj.preprints.1157v1]; Weiss S, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0564-2; Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268; Wilson MC, 2014, NATURE, V506, P58, DOI 10.1038/nature12959; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07; Wu DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077033; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Xia LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027992; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823; Zelezniak A, 2015, P NATL ACAD SCI USA, V112, P6449, DOI 10.1073/pnas.1421834112; Zhu YL, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-19	117	156	158	4	130	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1103	1116		10.1016/j.cell.2016.08.007	http://dx.doi.org/10.1016/j.cell.2016.08.007			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27565341	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000382259500010
J	Hawkes, N				Hawkes, Nigel			Head injuries in youth are often linked to psychiatric disorders and disability, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 24	2016	354								i4642	10.1136/bmj.i4642	http://dx.doi.org/10.1136/bmj.i4642			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DV2ZZ	27558388				2022-12-28	WOS:000382792100002
J	Herberg, JA; Kaforou, M; Wright, VJ; Shailes, H; Eleftherohorinou, H; Hoggart, CJ; Cebey-Lopez, M; Carter, MJ; Janes, VA; Gormley, S; Shimizu, C; Tremoulet, AH; Barendregt, AM; Salas, A; Kanegaye, J; Pollard, AJ; Faust, SN; Patel, S; Kuijpers, T; Martinon-Torres, F; Burns, JC; Coin, LJM; Levin, M				Herberg, Jethro A.; Kaforou, Myrsini; Wright, Victoria J.; Shailes, Hannah; Eleftherohorinou, Hariklia; Hoggart, Clive J.; Cebey-Lopez, Miriam; Carter, Michael J.; Janes, Victoria A.; Gormley, Stuart; Shimizu, Chisato; Tremoulet, Adriana H.; Barendregt, Anouk M.; Salas, Antonio; Kanegaye, John; Pollard, Andrew J.; Faust, Saul N.; Patel, Sanjay; Kuijpers, Taco; Martinon-Torres, Federico; Burns, Jane C.; Coin, Lachlan J. M.; Levin, Michael		IRIS Consortium	Diagnostic Test Accuracy of a 2-Transcript Host RNA Signature for Discriminating Bacterial vs Viral Infection in Febrile Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EXPRESSION; MENINGITIS; RATES	IMPORTANCE Because clinical features do not reliably distinguish bacterial from viral infection, many children worldwide receive unnecessary antibiotic treatment, while bacterial infection is missed in others. OBJECTIVE To identify a blood RNA expression signature that distinguishes bacterial from viral infection in febrile children. DESIGN, SETTING, AND PARTICIPANTS Febrile children presenting to participating hospitals in the United Kingdom, Spain, the Netherlands, and the United States between 2009-2013 were prospectively recruited, comprising a discovery group and validation group. Each group was classified after microbiological investigation as having definite bacterial infection, definite viral infection, or indeterminate infection. RNA expression signatures distinguishing definite bacterial from viral infection were identified in the discovery group and diagnostic performance assessed in the validation group. Additional validation was undertaken in separate studies of children with meningococcal disease (n = 24) and inflammatory diseases (n = 48) and on published gene expression datasets. EXPOSURES A 2-transcript RNA expression signature distinguishing bacterial infection from viral infection was evaluated against clinical and microbiological diagnosis. MAIN OUTCOMES AND MEASURES Definite bacterial and viral infection was confirmed by culture or molecular detection of the pathogens. Performance of the RNA signature was evaluated in the definite bacterial and viral group and in the indeterminate infection group. RESULTS The discovery group of 240 children (median age, 19 months; 62% male) included 52 with definite bacterial infection, of whom 36 (69%) required intensive care, and 92 with definite viral infection, of whom 32 (35%) required intensive care. Ninety-six children had indeterminate infection. Analysis of RNA expression data identified a 38-transcript signature distinguishing bacterial from viral infection. A smaller (2-transcript) signature (FAM89A and IFI44L) was identified by removing highly correlated transcripts. When this 2-transcript signature was implemented as a disease risk score in the validation group (130 children, with 23 definite bacterial, 28 definite viral, and 79 indeterminate infections; median age, 17 months; 57% male), all 23 patients with microbiologically confirmed definite bacterial infection were classified as bacterial (sensitivity, 100% [95% CI, 100%-100%]) and 27 of 28 patients with definite viral infection were classified as viral (specificity, 96.4%[95% CI, 89.3%-100%]). When applied to additional validation datasets from patients with meningococcal and inflammatory diseases, bacterial infection was identified with a sensitivity of 91.7%(95% CI, 79.2%-100%) and 90.0%(95% CI, 70.0%-100%), respectively, and with specificity of 96.0% (95% CI, 88.0%-100%) and 95.8% (95% CI, 89.6%-100%). Of the children in the indeterminate groups, 46.3%(63/136) were classified as having bacterial infection, although 94.9%(129/136) received antibiotic treatment. CONCLUSIONS AND RELEVANCE This study provides preliminary data regarding test accuracy of a 2-transcript host RNA signature discriminating bacterial from viral infection in febrile children. Further studies are needed in diverse groups of patients to assess accuracy and clinical utility of this test in different clinical settings.	[Herberg, Jethro A.; Kaforou, Myrsini; Wright, Victoria J.; Shailes, Hannah; Eleftherohorinou, Hariklia; Hoggart, Clive J.; Carter, Michael J.; Janes, Victoria A.; Gormley, Stuart; Levin, Michael] Imperial Coll London, Paediat Sect, Div Infect Dis, Dept Med, Norfolk Pl, London W2 1PG, England; [Cebey-Lopez, Miriam; Salas, Antonio; Martinon-Torres, Federico] Hosp Clin Univ Santiago, Translat Paediat & Infect Dis Sect, Dept Paediat, Santiago De Compostela, Galicia, Spain; [Cebey-Lopez, Miriam; Salas, Antonio; Martinon-Torres, Federico] Healthcare Res Inst Santiago de Compostela, Grp Invest Genet Vacunas Infecc & Pediat GENVIP, Santiago De Compostela, Spain; [Cebey-Lopez, Miriam; Salas, Antonio; Martinon-Torres, Federico] Univ Santiago de Compostela, Santiago De Compostela, Spain; [Shimizu, Chisato; Tremoulet, Adriana H.; Kanegaye, John; Burns, Jane C.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Barendregt, Anouk M.; Kuijpers, Taco] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Paediat Haematol Immunol & Infect Dis, Amsterdam, Netherlands; [Coin, Lachlan J. M.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	Imperial College London; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; University of California System; University of California San Diego; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Queensland	Levin, M (corresponding author), Imperial Coll London, Paediat Sect, Div Infect Dis, Dept Med, Norfolk Pl, London W2 1PG, England.	m.levin@imperial.ac.uk	Coin, Lachlan JM/A-9001-2014; Coin, Lachlan/O-4976-2019; Martinon-Torres, Federico/E-4982-2016; Cebey, Miriam/K-9347-2014; Salas, Antonio/U-2029-2019; Salas, Antonio/E-3977-2012; Faust, Saul/J-9779-2014; Pardo-Seco, Jacobo/G-3752-2016	Coin, Lachlan JM/0000-0002-4300-455X; Coin, Lachlan/0000-0002-4300-455X; Martinon-Torres, Federico/0000-0002-9023-581X; Cebey, Miriam/0000-0003-0599-7519; Salas, Antonio/0000-0002-2336-702X; Salas, Antonio/0000-0002-2336-702X; Herberg, Jethro/0000-0001-6941-6491; Inwald, David/0000-0001-9518-7821; CARTER, Michael/0000-0003-3403-4746; Wright, Victoria/0000-0001-7826-1516; Levin, Michael/0000-0003-2767-6919; Shimizu, Chisato/0000-0002-3149-2699; Pathan, Nazima/0000-0001-7656-9453; Rivero Calle, Irene/0000-0002-3678-9264; Janes, Victoria/0000-0001-6574-1449; Jones, Kelsey/0000-0002-1237-0127; Faust, Saul/0000-0003-3410-7642; Redondo Collazo, Lorenzo/0000-0002-3521-678X; Hibberd, Martin/0000-0001-8587-1849; Pardo-Seco, Jacobo/0000-0002-8059-8908; Kaforou, Myrsini/0000-0001-9878-4007	Imperial College Comprehensive Biomedical Research Centre [DMPED P26077]; National Institute of Health Research (NIHR); Great Ormond St Hospital Charity [V1401]; European Union [EC-GA 279185]; Imperial College-Wellcome Trust Antimicrobial Research Collaborative (ARC) Early Career Fellowship [RSRO 54990]; Spanish Research Program (FIS) [PI10/00540]; Regional Galician funds (Promotion of Research Project) [10 PXIB 918 184 PR]; Southampton NIHR Wellcome Trust Clinical Research Facility; NIHR Wessex Local Clinical Research Network; Academic Medical Centre Amsterdam MD/PhD program; Meningitis Research Foundation (United Kingdom); Macklin Foundation; National Institutes of Health [U54-HL108460]; Hartwell Foundation; Harold Amos Medical Faculty Development Program/Robert Wood Johnson Foundation; National Institute for Health Research [ACF-2009-18-023, NF-SI-0611-10230] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL108460] Funding Source: NIH RePORTER	Imperial College Comprehensive Biomedical Research Centre; National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); Great Ormond St Hospital Charity; European Union(European Commission); Imperial College-Wellcome Trust Antimicrobial Research Collaborative (ARC) Early Career Fellowship; Spanish Research Program (FIS); Regional Galician funds (Promotion of Research Project); Southampton NIHR Wellcome Trust Clinical Research Facility; NIHR Wessex Local Clinical Research Network; Academic Medical Centre Amsterdam MD/PhD program; Meningitis Research Foundation (United Kingdom)(Meningitis Research Foundation (MRF)); Macklin Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation; Harold Amos Medical Faculty Development Program/Robert Wood Johnson Foundation; National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Imperial College Comprehensive Biomedical Research Centre (DMPED P26077); National Institute of Health Research (NIHR) Senior Investigator award (Dr Levin); Great Ormond St Hospital Charity (V1401) (Dr Wright); European Union's Seventh Framework Program (EC-GA 279185) (EUCLIDS) (Dr Herberg); Imperial College-Wellcome Trust Antimicrobial Research Collaborative (ARC) Early Career Fellowship (RSRO 54990) (Dr Kaforou); Spanish Research Program (FIS; PI10/00540 and Intensificacion actividad investigadora of National Plan I + D + I and FEDER funds) and Regional Galician funds (Promotion of Research Project 10 PXIB 918 184 PR) (Dr Martinon-Torres); Southampton NIHR Wellcome Trust Clinical Research Facility and NIHR Wessex Local Clinical Research Network; and Academic Medical Centre Amsterdam MD/PhD program 2013 (Ms Barendregt). The UK meningococcal disease cohort was established with grant support from the Meningitis Research Foundation (United Kingdom); the inflammatory disease cohort was supported by a Macklin Foundation grant (Dr Burns), National Institutes of Health grant U54-HL108460 (Dr Burns); and The Hartwell Foundation and The Harold Amos Medical Faculty Development Program/Robert Wood Johnson Foundation (Dr Tremoulet).	Anderson ST, 2014, NEW ENGL J MED, V370, P1712, DOI 10.1056/NEJMoa1303657; [Anonymous], BMJ; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Cebey-Lopez M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136526; Colvin JM, 2012, PEDIATRICS, V130, pE1455, DOI 10.1542/peds.2012-1391; Gardner-Medwin JMM, 2002, LANCET, V360, P1197, DOI 10.1016/S0140-6736(02)11279-7; Gurion R, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/271569; Herberg JA, 2013, J INFECT DIS, V208, P1664, DOI 10.1093/infdis/jit348; Hu XR, 2013, P NATL ACAD SCI USA, V110, P12792, DOI 10.1073/pnas.1302968110; Iroh Tam Pui-Ying, 2015, Hosp Pediatr, V5, P324, DOI 10.1542/hpeds.2014-0138; Kaforou M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001538; Le Doare K, 2014, ARCH DIS CHILD, V99, P526, DOI 10.1136/archdischild-2013-305565; Martin NG, 2014, LANCET INFECT DIS, V14, P397, DOI 10.1016/S1473-3099(14)70027-1; Mejias A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001549; Nijman RG, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1706; Pathan N, 2004, LANCET, V363, P203, DOI 10.1016/S0140-6736(03)15326-3; Rabizadeh S, 2013, RHEUM DIS CLIN N AM, V39, P789, DOI 10.1016/j.rdc.2013.03.010; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sadarangani M, 2015, ARCH DIS CHILD, V100, P292, DOI 10.1136/archdischild-2014-306813; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Suarez NM, 2015, J INFECT DIS, V212, P213, DOI 10.1093/infdis/jiv047; Thierry S, 2014, JOINT BONE SPINE, V81, P112, DOI 10.1016/j.jbspin.2013.09.003; van den Kieboom CH, 2015, EUR J CLIN MICROBIOL, V34, P2209, DOI 10.1007/s10096-015-2470-2; Warhurst G, 2015, HEALTH TECHNOL ASSES, V19, DOI 10.3310/hta19350; Wong HR, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-34; Zaas AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006280; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	30	163	169	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2016	316	8					835	845		10.1001/jama.2016.11236	http://dx.doi.org/10.1001/jama.2016.11236			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT8JL	27552617	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000381736200014
J	Yang, Y; Yang, J; Jiang, L				Yang, Yu; Yang, Jun; Jiang, Lei			Comment on "A bacterium that degrades and assimilates poly(ethylene terephthalate)"	SCIENCE			English	Editorial Material							BIODEGRADATION; MINERALIZATION; POLYSTYRENE; DEGRADATION		[Yang, Yu; Yang, Jun; Jiang, Lei] Beihang Univ, Sch Chem & Environm, Key Lab Bioinspired Smart Interfacial Sci & Tech, Minist Educ, Beijing 100191, Peoples R China	Beihang University	Yang, J; Jiang, L (corresponding author), Beihang Univ, Sch Chem & Environm, Key Lab Bioinspired Smart Interfacial Sci & Tech, Minist Educ, Beijing 100191, Peoples R China.	yangjun@buaa.edu.cn; jianglei@iccas.ac.cn	, 许永傲/AAC-2581-2019; Jiang, Lei/B-1066-2011	Yang, Yu/0000-0002-4663-9753				[Anonymous], 2016, SCIENCE; Bode HB, 2000, APPL ENVIRON MICROB, V66, P3680, DOI 10.1128/AEM.66.9.3680-3685.2000; Chetna Sharon, 2012, Journal of Microbiology and Biotechnology Research, V2, P248; Deguchi T, 1998, APPL ENVIRON MICROB, V64, P1366; Muller RJ, 2005, MACROMOL RAPID COMM, V26, P1400, DOI 10.1002/marc.200500410; Ronkvist AM, 2009, MACROMOLECULES, V42, P5128, DOI 10.1021/ma9005318; Vertommen MAME, 2005, J BIOTECHNOL, V120, P376, DOI 10.1016/j.jbiotec.2005.06.015; Yang J, 2014, ENVIRON SCI TECHNOL, V48, P13776, DOI 10.1021/es504038a; Yang Y, 2015, ENVIRON SCI TECHNOL, V49, P12087, DOI 10.1021/acs.est.5b02663; Yang Y, 2015, ENVIRON SCI TECHNOL, V49, P12080, DOI 10.1021/acs.est.5b02661; Yoshida S, 2016, SCIENCE, V351, P1196, DOI 10.1126/science.aad6359	11	23	25	91	397	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301								10.1126/science.aaf8305	http://dx.doi.org/10.1126/science.aaf8305			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZE	27540159				2022-12-28	WOS:000381561400029
J	Samberg, LH				Samberg, Leah H.			FOOD SECURITY A collaboration worth its weight in grain	NATURE			English	Editorial Material							CLOSING YIELD GAPS; POVERTY TRAPS	Interventions to improve crop yields in rural China through collaboration between researchers and farmers illustrate how the goal of increasing global food production can be approached locally. See Letter p.671	[Samberg, Leah H.] Univ Minnesota, Inst Environm, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Samberg, LH (corresponding author), Univ Minnesota, Inst Environm, St Paul, MN 55108 USA.	lsamberg@umn.edu	Samberg, Leah/AAW-5804-2020		NERC [NE/M021327/1] Funding Source: UKRI; Natural Environment Research Council [NE/M021327/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Dercon S, 2011, J DEV ECON, V96, P159, DOI 10.1016/j.jdeveco.2010.08.003; Frelat R, 2016, P NATL ACAD SCI USA, V113, P458, DOI 10.1073/pnas.1518384112; Larsen AF, 2014, WORLD DEV, V64, P843, DOI 10.1016/j.worlddev.2014.07.003; Licker R, 2010, GLOBAL ECOL BIOGEOGR, V19, P769, DOI 10.1111/j.1466-8238.2010.00563.x; Lobell DB, 2009, ANNU REV ENV RESOUR, V34, P179, DOI 10.1146/annurev.environ.041008.093740; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Tittonell P, 2013, FIELD CROP RES, V143, P76, DOI 10.1016/j.fcr.2012.10.007; van Ittersum MK, 2013, FIELD CROP RES, V143, P4, DOI 10.1016/j.fcr.2012.09.009; Zhang WF, 2016, NATURE, V537, P671, DOI 10.1038/nature19368	9	4	4	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2016	537	7622					624	625		10.1038/nature19431	http://dx.doi.org/10.1038/nature19431			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DX4DR	27602520				2022-12-28	WOS:000384331700035
J	Takeuchi, T; Duszkiewicz, AJ; Sonneborn, A; Spooner, PA; Yamasaki, M; Watanabe, M; Smith, CC; Fernandez, G; Deisseroth, K; Greene, RW; Morris, RGM				Takeuchi, Tomonori; Duszkiewicz, Adrian J.; Sonneborn, Alex; Spooner, Patrick A.; Yamasaki, Miwako; Watanabe, Masahiko; Smith, Caroline C.; Fernandez, Guillen; Deisseroth, Karl; Greene, Robert W.; Morris, Richard G. M.			Locus coeruleus and dopaminergic consolidation of everyday memory	NATURE			English	Article							LONG-TERM POTENTIATION; PROTEIN-SYNTHESIS; CA1 REGION; NEURONS; RECEPTORS; EXPRESSION; NOVELTY; RAT; INFORMATION; ACQUISITION	The retention of episodic-like memory is enhanced, in humans and animals, when something novel happens shortly before or after encoding. Using an everyday memory task in mice, we sought the neurons mediating this dopamine-dependent novelty effect, previously thought to originate exclusively from the tyrosine-hydroxylase-expressing (TH+) neurons in the ventral tegmental area. Here we report that neuronal firing in the locus coeruleus is especially sensitive to environmental novelty, locus coeruleus TH+ neurons project more profusely than ventral tegmental area TH+ neurons to the hippocampus, optogenetic activation of locus coeruleus TH+ neurons mimics the novelty effect, and this novelty-associated memory enhancement is unaffected by ventral tegmental area inactivation. Surprisingly, two effects of locus coeruleus TH+ photoactivation are sensitive to hippocampal D-1/D-5 receptor blockade and resistant to adrenoceptor blockade: memory enhancement and long-lasting potentiation of synaptic transmission in CA1 ex vivo. Thus, locus coeruleus TH+ neurons can mediate post-encoding memory enhancement in a manner consistent with possible co-release of dopamine in the hippocampus.	[Takeuchi, Tomonori; Duszkiewicz, Adrian J.; Spooner, Patrick A.; Morris, Richard G. M.] Univ Edinburgh, Edinburgh Neurosci, Ctr Cognit & Neural Syst, 1 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland; [Sonneborn, Alex; Smith, Caroline C.; Greene, Robert W.] Univ Texas Southwestern Med Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Yamasaki, Miwako; Watanabe, Masahiko] Hokkaido Univ, Dept Anat, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan; [Fernandez, Guillen] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Med Ctr, NL-6525 EZ Nijmegen, Netherlands; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Greene, Robert W.] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki 3058575, Japan; [Morris, Richard G. M.] CSIC UMH, Inst Neurociencias, Alicante 03550, Spain	University of Edinburgh; University of Texas System; University of Texas Southwestern Medical Center Dallas; Hokkaido University; Radboud University Nijmegen; Stanford University; Stanford University; University of Tsukuba; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Morris, RGM (corresponding author), Univ Edinburgh, Edinburgh Neurosci, Ctr Cognit & Neural Syst, 1 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland.; Greene, RW (corresponding author), Univ Texas Southwestern Med Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.; Greene, RW (corresponding author), Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki 3058575, Japan.; Morris, RGM (corresponding author), CSIC UMH, Inst Neurociencias, Alicante 03550, Spain.	robertw.greene@utsouthwestern.edu; R.G.M.Morris@ed.ac.uk	Watanabe, Masahiko/S-3614-2019; WATANABE, Masahiko/A-4055-2012; Morris, Richard G M/C-9982-2013; Fernandez, Guillen/B-3771-2009; Yamasaki, Miwako/I-8053-2014; Core, Vector/CAF-4832-2022; Takeuchi, Tomonori/P-5988-2016	Watanabe, Masahiko/0000-0001-5037-7138; WATANABE, Masahiko/0000-0001-5037-7138; Fernandez, Guillen/0000-0002-5522-0604; Yamasaki, Miwako/0000-0003-4974-9349; Takeuchi, Tomonori/0000-0002-9981-4260; Duszkiewicz, Adrian/0000-0001-5381-4663; Greene, Robert/0000-0003-1355-9797; Sonneborn, Alex/0000-0001-9847-0200	European Research Council [ERC-2010-AdG-268800-NEUROSCHEMA]; UK Medical Research Council; European Commission [600725-GRIDMAP]; Department Veterans Affairs, National Institutes of Health [5R01MH080297];  [NIDA-T32-DA7290]; MRC [G0700447] Funding Source: UKRI; Medical Research Council [1177572, 1101577, G0700447] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007290] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Department Veterans Affairs, National Institutes of Health; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. Evans for Th-Cre mice; H. Rowe and D. Tse for pilot studies; M. Lo, H-C. Tsai and C. Ramakrishnan for optogenetics training; UNC Viral Cores for producing AAVs; J. Cala, R. Fitzpatrick, J. Tulloch and T. Thai for technical support; R. Watson for animal care; N. Uchida and J. Cohen for assistance with optogenetic identification of TH<SUP>+</SUP> neurons; P. Pedarzani, S. Canals, L. Genzel, M. Kroes, J. Lisman, D. Manahan-Vaughan, M. Munoz, T. Spires-Jones, S.-H. Wang, O. Eschenko and E. Wood for scientific discussion. The study was funded by the European Research Council (G.F., R.G.M.M.: ERC-2010-AdG-268800-NEUROSCHEMA), UK Medical Research Council (A.J.D., R.G.M.M.), the European Commission's 7th Framework 2011 ICT Programme for Future Emerging Technologies (A.J.D., R.G.M.M.: 600725-GRIDMAP), Department Veterans Affairs, National Institutes of Health grant 5R01MH080297 (R.W.G.), and NIDA-T32-DA7290 Basic Science Training Program in Drug Abuse (principal investigator A. Eisch (A.S.)). The Instituto de Neurociencias at Alicante is 'Centre of Excellence Severo Ochoa'.	Anikeeva P, 2012, NAT NEUROSCI, V15, P163, DOI 10.1038/nn.2992; ASTONJONES G, 1981, J NEUROSCI, V1, P876; BROWN R, 1977, COGNITION, V5, P73, DOI 10.1016/0010-0277(77)90018-X; Bunzeck N, 2014, CEREB CORTEX, V24, P1351, DOI 10.1093/cercor/bhs420; Chuhma N, 2004, J NEUROSCI, V24, P972, DOI 10.1523/JNEUROSCI.4317-03.2004; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Devoto P, 2006, CURR NEUROPHARMACOL, V4, P115, DOI 10.2174/157015906776359559; Dudai Y, 2000, BRAIN, PERCEPTION, MEMORY, P149; Dunsmoor JE, 2015, NATURE, V520, P345, DOI 10.1038/nature14106; Ebbinghaus H., 1885, MEMORY CONTRIBUTION; Eschenko O, 2012, CEREB CORTEX, V22, P426, DOI 10.1093/cercor/bhr121; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; Franklin K., 2007, MOUSE BRAIN STEREOTA; FREY U, 1991, NEUROSCI LETT, V129, P111, DOI 10.1016/0304-3940(91)90732-9; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; GASBARRI A, 1994, BRAIN RES, V668, P71, DOI 10.1016/0006-8993(94)90512-6; GRACE AA, 1983, NEUROSCIENCE, V10, P301, DOI 10.1016/0306-4522(83)90135-5; GRENHOFF J, 1989, EUR J PHARMACOL, V165, P11, DOI 10.1016/0014-2999(89)90765-6; Gruber MJ, 2016, NEURON, V89, P1110, DOI 10.1016/j.neuron.2016.01.017; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Hansen N, 2014, CEREB CORTEX, V24, P845, DOI 10.1093/cercor/bhs362; Harley C., 1991, PROG BRAIN RES, V88, P307; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14; Lemon N, 2006, J NEUROSCI, V26, P7723, DOI 10.1523/JNEUROSCI.1454-06.2006; Lemon N, 2012, CEREB CORTEX, V22, P2131, DOI 10.1093/cercor/bhr297; Lerner TN, 2016, CELL, V164, P1136, DOI 10.1016/j.cell.2016.02.027; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Lindeberg J, 2004, GENESIS, V40, P67, DOI 10.1002/gene.20065; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Mahn M, 2016, NAT NEUROSCI, V19, P554, DOI 10.1038/nn.4266; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McNamara CG, 2014, NAT NEUROSCI, V17, P1658, DOI 10.1038/nn.3843; Moncada D, 2007, J NEUROSCI, V27, P7476, DOI 10.1523/JNEUROSCI.1083-07.2007; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Otmakhova N., 2013, INTRINSICALLY MOTIVA, P235, DOI DOI 10.1007/978-3-642-32375-1; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; Rogerson T, 2014, NAT REV NEUROSCI, V15, P157, DOI 10.1038/nrn3667; Rosen ZB, 2015, NAT NEUROSCI, V18, P1763, DOI 10.1038/nn.4152; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Savitt JM, 2005, J NEUROSCI, V25, P6721, DOI 10.1523/JNEUROSCI.0760-05.2005; SCHULTZ W, 1993, PROG BRAIN RES, V99, P227; Schwarz LA, 2015, NATURE, V524, P88, DOI 10.1038/nature14600; Smith CC, 2012, J NEUROSCI, V32, P6072, DOI 10.1523/JNEUROSCI.6486-11.2012; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Steinberg EE, 2013, NAT NEUROSCI, V16, P966, DOI 10.1038/nn.3413; Stujenske JM, 2015, CELL REP, V12, P525, DOI 10.1016/j.celrep.2015.06.036; Takasaki C, 2010, EUR J NEUROSCI, V32, P1326, DOI 10.1111/j.1460-9568.2010.07377.x; Takeuchi T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0288; Tritsch NX, 2012, NATURE, V490, P262, DOI 10.1038/nature11466; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; VANKOV A, 1995, EUR J NEUROSCI, V7, P1180, DOI 10.1111/j.1460-9568.1995.tb01108.x; Wang SH, 2010, P NATL ACAD SCI USA, V107, P19537, DOI 10.1073/pnas.1008638107; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555; Wu MF, 1999, NEUROSCIENCE, V91, P1389, DOI 10.1016/S0306-4522(98)00600-9; Yamasaki M, 2010, J NEUROSCI, V30, P4408, DOI 10.1523/JNEUROSCI.5719-09.2010	59	344	348	4	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2016	537	7620					357	+		10.1038/nature19325	http://dx.doi.org/10.1038/nature19325			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV7EC	27602521	Green Accepted			2022-12-28	WOS:000383098000045
J	Perkowitz, S				Perkowitz, Sidney			Boldly going for 50 years	NATURE			English	Editorial Material							CLOAK		[Perkowitz, Sidney] Emory Univ, Phys, Atlanta, GA 30322 USA	Emory University	Perkowitz, S (corresponding author), Emory Univ, Phys, Atlanta, GA 30322 USA.	physp@emory.edu						ALCUBIERRE M, 1994, CLASSICAL QUANT GRAV, V11, pL73, DOI 10.1088/0264-9381/11/5/001; Ni XJ, 2015, SCIENCE, V349, P1310, DOI 10.1126/science.aac9411; Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628; Takesue H, 2015, OPTICA, V2, P832, DOI 10.1364/OPTICA.2.000832	4	3	3	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					165	166		10.1038/537165a	http://dx.doi.org/10.1038/537165a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU9LQ	27604936	Bronze			2022-12-28	WOS:000382539100024
J	Hampton, T				Hampton, Tracy			Researchers Develop Tissue-Engineered Cartilage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																		MOUTOS FT, P NATL ACAD SCI USA, DOI DOI 10.1073/PNAS.1601639113	1	0	0	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2016	316	9					917	917		10.1001/jama.2016.12070	http://dx.doi.org/10.1001/jama.2016.12070			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU8JV	27599321				2022-12-28	WOS:000382460200006
J	McNally, S				McNally, Scarlett			COMMENTARY Sexual harassment and bullying in UK surgery: no room for complacency	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[McNally, Scarlett] Royal Coll Surgeons England, London, England	Royal College of Surgeons of England	McNally, S (corresponding author), Royal Coll Surgeons England, London, England.	scarlett.mcnally@nhs.net						Academy of Medical Royal Colleges, 2015, EX MIR CUR ROL DOCT; Nagpal K, 2012, BMJ QUAL SAF, V21, P843, DOI 10.1136/bmjqs-2012-000886; Peters K, 2011, ATTEMPTING POSSIBLE; RACS, 2016, LETS OP RESP	4	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2016	354								i4682	10.1136/bmj.i4682	http://dx.doi.org/10.1136/bmj.i4682			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AE	27586886				2022-12-28	WOS:000382792600005
J	Murray, DH; Jahnel, M; Lauer, J; Avellaneda, MJ; Brouilly, N; Cezanne, A; Morales-Navarrete, H; Perini, ED; Ferguson, C; Lupas, AN; Kalaidzidis, Y; Parton, RG; Grill, SW; Zerial, M				Murray, David H.; Jahnel, Marcus; Lauer, Janelle; Avellaneda, Mario J.; Brouilly, Nicolas; Cezanne, Alice; Morales-Navarrete, Hernan; Perini, Enrico D.; Ferguson, Charles; Lupas, Andrei N.; Kalaidzidis, Yannis; Parton, Robert G.; Grill, Stephan W.; Zerial, Marino			An endosomal tether undergoes an entropic collapse to bring vesicles together	NATURE			English	Article							MEMBRANE-FUSION; COILED COILS; EEA1; RAB; CONVERSION; COMPLEXES; TRANSPORT; PROTEINS; DOCKING; BINDING	An early step in intracellular transport is the selective recognition of a vesicle by its appropriate target membrane, a process regulated by Rab GTPases via the recruitment of tethering effectors(1-4). Membrane tethering confers higher selectivity and efficiency to membrane fusion than the pairing of SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptors) alone(5-7). Here we address the mechanism whereby a tethered vesicle comes closer towards its target membrane for fusion by reconstituting an endosomal asymmetric tethering machinery consisting of the dimeric coiled-coil protein EEA1 (refs 6, 7) recruited to phosphatidylinositol 3-phosphate membranes and binding vesicles harbouring Rab5. Surprisingly, structural analysis reveals that Rab5:GTP induces an allosteric conformational change in EEA1, from extended to flexible and collapsed. Through dynamic analysis by optical tweezers, we confirm that EEA1 captures a vesicle at a distance corresponding to its extended conformation, and directly measure its flexibility and the forces induced during the tethering reaction. Expression of engineered EEA1 variants defective in the conformational change induce prominent clusters of tethered vesicles in vivo. Our results suggest a new mechanism in which Rab5 induces a change in flexibility of EEA1, generating an entropic collapse force that pulls the captured vesicle towards the target membrane to initiate docking and fusion.	[Murray, David H.; Jahnel, Marcus; Lauer, Janelle; Avellaneda, Mario J.; Brouilly, Nicolas; Cezanne, Alice; Morales-Navarrete, Hernan; Perini, Enrico D.; Kalaidzidis, Yannis; Grill, Stephan W.; Zerial, Marino] Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany; [Jahnel, Marcus; Avellaneda, Mario J.; Perini, Enrico D.; Grill, Stephan W.] Tech Univ Dresden, Ctr Biotechnol, Tatzberg 47-49, D-01307 Dresden, Germany; [Jahnel, Marcus; Grill, Stephan W.] Max Planck Inst Phys Komplexer Syst, Nothnitzerstr 38, D-01187 Dresden, Germany; [Ferguson, Charles; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Lupas, Andrei N.] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, St Lucia, Qld 4072, Australia; [Avellaneda, Mario J.] FOM Inst AMOLF, Sci Pk 104, NL-1098 XG Amsterdam, Netherlands	Max Planck Society; Technische Universitat Dresden; Max Planck Society; University of Queensland; Max Planck Society; University of Queensland; AMOLF	Murray, DH (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.		Grill, Stephan/D-9427-2012; Morales-Navarrete, Hernan/AAE-2316-2019; Kalaidzidis, Yannis/H-3094-2016; Parton, Robert/C-5673-2009	Morales-Navarrete, Hernan/0000-0002-9578-2556; Kalaidzidis, Yannis/0000-0002-6137-1193; Cezanne, Alice Dimitra/0000-0002-6319-9235; Avellaneda, Mario/0000-0001-6406-524X; Parton, Robert/0000-0002-7494-5248; Jahnel, Marcus/0000-0002-8355-277X	Bohringer Ingelheim Fonds; La Caixa; Deutscher Akademischer Austauschdienst scholarship; National Health and Medical Research Council of Australia [APP1037320, 569452]; Australian Research Council Centre of Excellence [CE140100036]; Deutsche Forschungsgemeinschaft [SPP 1782, GSC 97, GR 3271/2, GR 3271/3, GR 3271/4, Transregio 83]; European Research Council [281903]; Human Frontier Science Program [RGP0023/2014]; Max Planck Society	Bohringer Ingelheim Fonds; La Caixa(La Caixa Foundation); Deutscher Akademischer Austauschdienst scholarship(Deutscher Akademischer Austausch Dienst (DAAD)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Centre of Excellence(Australian Research Council); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Human Frontier Science Program(Human Frontier Science Program); Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank R. Schafer for project support. We acknowledge discussions with J. Morin, U. Coskun, A. Honigmann, S. Sturm and T. Leonard, and F. Julicher, E. Schafer and K. Simons for reading the manuscript. We thank M. Brandstetter and the electron microscopy facility of the Vienna Biocenter. We thank the Light Microscopy, Protein Expression, Chromatography, and High-throughput Technology Development Studio of the Max Planck Institute of Molecular Cell Biology and Genetics. During part of the work, M.J. was supported by a PhD scholarship of the Bohringer Ingelheim Fonds. M.J.A. was supported by the La Caixa and Deutscher Akademischer Austauschdienst scholarship. R.P. was supported by the National Health and Medical Research Council of Australia (program grant APP1037320 and Senior Principal Research Fellowship 569452) and the Australian Research Council Centre of Excellence (CE140100036). We acknowledge the Australian Microscopy & Microanalysis Research Facility at the Center for Microscopy and Microanalysis at The University of Queensland. S.W.G. was supported by the Deutsche Forschungsgemeinschaft (SPP 1782, GSC 97, GR 3271/2, GR 3271/3, GR 3271/4), the European Research Council (grant number 281903) and the Human Frontier Science Program (RGP0023/2014). This research was supported by the Max Planck Society and funds of the Deutsche Forschungsgemeinschaft (Transregio 83).	Brocker C, 2010, CURR BIOL, V20, pR943, DOI 10.1016/j.cub.2010.09.015; Brown FC, 2010, MOL MEMBR BIOL, V27, P457, DOI 10.3109/09687688.2010.501765; Cheung PYP, 2015, ELIFE, V4, DOI 10.7554/eLife.12790; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Degtyar VE, 2007, P NATL ACAD SCI USA, V104, P15929, DOI 10.1073/pnas.0705406104; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Kiessling V, 2003, BIOPHYS J, V84, P408, DOI 10.1016/S0006-3495(03)74861-9; Kon T, 2009, NAT STRUCT MOL BIOL, V16, P325, DOI 10.1038/nsmb.1555; Landau L D., 1980, STATISTICAL PHYSIC 1, V5, P396; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mayer A, 1997, J CELL BIOL, V136, P307, DOI 10.1083/jcb.136.2.307; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; MILNER ST, 1991, SCIENCE, V251, P905, DOI 10.1126/science.251.4996.905; Mishra A, 2010, P NATL ACAD SCI USA, V107, P10866, DOI 10.1073/pnas.1000843107; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Munro S, 2004, NAT CELL BIOL, V6, P469, DOI 10.1038/ncb0604-469; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Otto O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2790; Perini ED, 2014, TRAFFIC, V15, P1366, DOI 10.1111/tra.12232; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rubino M, 2000, J BIOL CHEM, V275, P3745, DOI 10.1074/jbc.275.6.3745; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; Schmidt H, 2015, NATURE, V518, P435, DOI 10.1038/nature14023; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Taylor KC, 2015, P NATL ACAD SCI USA, V112, pE3806, DOI 10.1073/pnas.1505813112; Wilhelm J, 1996, PHYS REV LETT, V77, P2581, DOI 10.1103/PhysRevLett.77.2581; Wilson JM, 2000, MOL BIOL CELL, V11, P2657, DOI 10.1091/mbc.11.8.2657; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	29	79	81	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					107	111		10.1038/nature19326	http://dx.doi.org/10.1038/nature19326			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27556945	Green Accepted			2022-12-28	WOS:000382426900048
J	Mayor, S				Mayor, Susan			Acute MI is initially misdiagnosed in nearly a third of patients, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Wu JH, 2018, EUR HEART J-ACUTE CA, V7, P139, DOI 10.1177/2048872616661693	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 31	2016	354								i4713	10.1136/bmj.i4713	http://dx.doi.org/10.1136/bmj.i4713			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AD	27582291				2022-12-28	WOS:000382792500017
J	Shen, Q; Lu, DH; Schelin, MEC; Joud, A; Cao, Y; Adami, HO; Cnattingius, S; Fall, K; Valdimarsdottir, U; Fang, F				Shen, Qing; Lu, Donghao; Schelin, Maria E. C.; Joud, Anna; Cao, Yang; Adami, Hans-Olov; Cnattingius, Sven; Fall, Katja; Valdimarsdottir, Unnur; Fang, Fang			Injuries before and after diagnosis of cancer: nationwide register based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PSYCHOLOGICAL DISTRESS; SUICIDE; DEATH; STRESS	OBJECTIVE To examine the relative risks of iatrogenic and non-iatrogenic injuries during the period shortly before and after a diagnosis of cancer. DESIGN Nationwide register based study. SETTING Swedish national population and health registers. PARTICIPANTS 720 901 patients with diagnosis of cancer, 1991-2009, in Sweden. MAIN OUTCOME MEASURES All hospital admissions in patients with cancer with a main discharge diagnosis of iatrogenic (from medical complications) or non-iatrogenic injuries in 1990-2010 identified from the Swedish patient register. Conditional Poisson regression was used to compare the incidence rate of injuries during the "diagnostic period" (16 weeks before to 16 weeks after diagnosis) with the incidence rate during a "pre-diagnostic period" (the same 32 weeks one year before diagnosis) among the same patients. RESULTS During the diagnostic period, there were 7306 iatrogenic (incidence rate 0.60 per 1000 person months) and 8331 non-iatrogenic injuries (incidence rate 0.69 per 1000 person months). For iatrogenic injuries, the incidence rate ratio was 7.0 (95% confidence interval 6.6 to 7.4) during the diagnostic period compared with the pre-diagnostic period. The increase in risk started two weeks before cancer diagnosis and peaked during the two weeks after diagnosis (48.6, 37.3 to 63.5). For non-iatrogenic injuries, the incidence rate ratio was 1.9 (1.8 to 2.0) during the diagnostic period compared with the pre-diagnostic period. The increase in risk began four weeks before diagnosis and peaked during the two weeks before diagnosis (5.3, 4.6 to 6.1). There were increased risks of both types of injury during the diagnostic period for all common cancers, with the smallest risk increase noted for non-melanoma skin cancer. CONCLUSIONS Patients with cancer have highly increased risks of both iatrogenic and non-iatrogenic injuries requiring inpatient care shortly before and after their diagnosis. These findings shed further light on the total burden of medical complications and call for prevention of intentional and unintentional injuries during the diagnostic process of cancer.	[Shen, Qing; Lu, Donghao; Adami, Hans-Olov; Valdimarsdottir, Unnur; Fang, Fang] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Schelin, Maria E. C.; Joud, Anna] Epidemiol & Register Ctr South, SE-22185 Lund, Sweden; [Schelin, Maria E. C.] Karolinska Inst, Inst Environm Med, Unit Cardiovasc Dis, SE-17177 Stockholm, Sweden; [Joud, Anna] Lund Univ, Dept Lab Med, Div Occupat & Environm Med, SE-22100 Lund, Sweden; [Cao, Yang] Karolinska Inst, Inst Environm Med, Unit Biostat, SE-17177 Stockholm, Sweden; [Cao, Yang; Fall, Katja] Univ Orebro, Sch Med Sci, Clin Epidemiol & Biostat, SE-70182 Orebro, Sweden; [Adami, Hans-Olov] Univ Oslo, Inst Hlth & Soc, NO-0316 Oslo, Norway; [Adami, Hans-Olov; Valdimarsdottir, Unnur] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Cnattingius, Sven] Karolinska Univ Hosp, Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, SE-17177 Stockholm, Sweden; [Valdimarsdottir, Unnur] Univ Iceland, Fac Med, Ctr Publ Hlth Sci, IS-101 Reykjavik, Iceland	Karolinska Institutet; Karolinska Institutet; Lund University; Karolinska Institutet; Orebro University; University of Oslo; Harvard University; Harvard T.H. Chan School of Public Health; Karolinska Institutet; Karolinska University Hospital; University of Iceland	Shen, Q (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden.	qing.shen@ki.se	Fall, Katja/AAE-1876-2021; Lu, Donghao/AAH-6445-2019; Cao, Yang/HGD-6463-2022; Shen, Qing/U-1321-2019; Shen, Qing/AFV-8487-2022; Cao, Yang/C-6185-2008; Jöud, Anna/AAA-3277-2022	Fall, Katja/0000-0002-3649-2639; Lu, Donghao/0000-0002-4186-8661; Shen, Qing/0000-0002-7214-4797; Cao, Yang/0000-0002-3552-9153; Schelin, Maria EC./0000-0001-5486-7556; Fang, Fang/0000-0002-3310-6456; Valdimarsdottir, Unnur/0000-0001-5382-946X	Swedish Cancer Society [CAN 2014/417]; Swedish Research Council for Health, Working Life and Welfare [2012-0498]; China Scholarship Council; Swedish Society for Medical Research; Karolinska Institute [2368/10-221]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); China Scholarship Council(China Scholarship Council); Swedish Society for Medical Research; Karolinska Institute(Karolinska Institutet)	This work was supported by the Swedish Cancer Society (grant No CAN 2014/417), the Swedish Research Council for Health, Working Life and Welfare (grant No 2012-0498), and the China Scholarship Council. FF received a Swedish Society for Medical Research and Karolinska Institute research associate award. H-OA (Dnr: 2368/10-221) and SC (Dnr: 2368/10-221) received Karolinska Institute distinguished professor awards.	Anguiano L, 2012, CANCER NURS, V35, pE14, DOI 10.1097/NCC.0b013e31822fc76c; Armstrong BG, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-122; Awsare NS, 2008, PROSTATE CANCER P D, V11, P384, DOI 10.1038/pcan.2008.21; Baade PD, 2006, CANCER CAUSE CONTROL, V17, P287, DOI 10.1007/s10552-005-0530-0; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Bellardita L, 2015, EUR UROL, V67, P637, DOI 10.1016/j.eururo.2014.10.028; Brasso K, 2010, SCAND J GASTROENTERO, V45, P1211, DOI 10.3109/00365521.2010.485355; Camidge DR, 2007, BRIT J CANCER, V96, P752, DOI 10.1038/sj.bjc.6603617; Dalela D, 2016, BJU INT, V118, P286, DOI 10.1111/bju.13257; Fang F, 2012, NEW ENGL J MED, V366, P1310, DOI 10.1056/NEJMoa1110307; GOODWIN JS, 1993, CANCER-AM CANCER SOC, V72, P594, DOI 10.1002/1097-0142(19930715)72:2<594::AID-CNCR2820720243>3.0.CO;2-#; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Heimans JJ, 2002, J NEUROL, V249, P955, DOI 10.1007/s00415-002-0839-5; Herman JP, 2012, ALCOHOL RES-CURR REV, V34, P441; Hoang-Xuan K, 2004, CURR OPIN ONCOL, V16, P601, DOI 10.1097/01.cco.0000142927.88773.7e; Iversen LH, 2008, BRIT J SURG, V95, P1012, DOI 10.1002/bjs.6114; Kassel JD, 2003, PSYCHOL BULL, V129, P270, DOI 10.1037/0033-2909.129.2.270; Lu D, 2013, ANN ONCOL, V24, P3112, DOI 10.1093/annonc/mdt415; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Makary MA, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2139; Merrill RM, 2007, J PSYCHOSOC ONCOL, V25, P1, DOI 10.1300/J077v25n03_01; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Riihimaki M, 2012, ANN ONCOL, V23, P604, DOI 10.1093/annonc/mdr160; Riihimaki M, 2011, ONCOLOGIST, V16, P175, DOI 10.1634/theoncologist.2010-0338; Riihimki M, 2012, FRONTLINE GASTROENTE, V3, P143, DOI 10.1136/flgastro-2012-100141; Socialstyrelsen, 2012, VANT CANC FRAN REM D; Urban D, 2013, CHEST, V144, P1245, DOI 10.1378/chest.12-2986; Weingart SN, 2000, BRIT MED J, V320, P774, DOI 10.1136/bmj.320.7237.774; Whitaker HJ, 2009, STAT METHODS MED RES, V18, P7, DOI 10.1177/0962280208092342; Yamauchi T, 2014, PSYCHO-ONCOLOGY, V23, P1034, DOI 10.1002/pon.3529	30	18	18	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 31	2016	354								i4218	10.1136/bmj.i4218	http://dx.doi.org/10.1136/bmj.i4218			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AD	27582045	Green Published, hybrid			2022-12-28	WOS:000382792500001
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Don't undervalue non-clinical work	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Academy of Medical Royal Colleges, 2010, ADV SUPP PROF ACT CO; Buchan J, 2016, STAFFING MATTERS FUN; General Medical Council, 2013, GOOD MED PRACT FRAM; King's Fund, 2012, LEAD ENG IMPR NHS WE; Monitor Trust Development Authority NHS England, 2015, EST BAS SEV DAY SERV; Public Accounts Committee, 2013, INCR CONS PAY FAILS; Rimmer A, 2015, BMJ CAREERS; Santry C., 2010, HLTH SERV J	8	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 26	2016	354								i4656	10.1136/bmj.i4656	http://dx.doi.org/10.1136/bmj.i4656			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AB	27565513	Green Published, Bronze			2022-12-28	WOS:000382792300004
J	Cardoso, F; van't Veer, LJ; Bogaerts, J; Slaets, L; Viale, G; Delaloge, S; Pierga, JY; Brain, E; Causeret, S; DeLorenzi, M; Glas, AM; Golfinopoulos, V; Goulioti, T; Knox, S; Matos, E; Meulemans, B; Neijenhuis, PA; Nitz, U; Passalacqua, R; Ravdin, P; Rubio, IT; Saghatchian, M; Smilde, TJ; Sotiriou, C; Stork, L; Straehle, C; Thomas, G; Thompson, AM; van der Hoeven, JM; Vuylsteke, P; Bernards, R; Tryfonidis, K; Rutgers, E; Piccart, M				Cardoso, F.; van't Veer, L. J.; Bogaerts, J.; Slaets, L.; Viale, G.; Delaloge, S.; Pierga, J. -Y.; Brain, E.; Causeret, S.; DeLorenzi, M.; Glas, A. M.; Golfinopoulos, V.; Goulioti, T.; Knox, S.; Matos, E.; Meulemans, B.; Neijenhuis, P. A.; Nitz, U.; Passalacqua, R.; Ravdin, P.; Rubio, I. T.; Saghatchian, M.; Smilde, T. J.; Sotiriou, C.; Stork, L.; Straehle, C.; Thomas, G.; Thompson, A. M.; van der Hoeven, J. M.; Vuylsteke, P.; Bernards, R.; Tryfonidis, K.; Rutgers, E.; Piccart, M.		MINDACT Investigators	70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							03-04 MINDACT TRIAL; PROGNOSTIC MODEL; CLINICAL UTILITY; ADJUVANT THERAPY; GENE; VALIDATION; WOMEN; BIOMARKERS; HER2	BACKGROUND The 70-gene signature test (MammaPrint) has been shown to improve prediction of clinical outcome in women with early-stage breast cancer. We sought to provide prospective evidence of the clinical utility of the addition of the 70-gene signature to standard clinical-pathological criteria in selecting patients for adjuvant chemotherapy. METHODS In this randomized, phase 3 study, we enrolled 6693 women with early-stage breast cancer and determined their genomic risk (using the 70-gene signature) and their clinical risk (using a modified version of Adjuvant! Online). Women at low clinical and genomic risk did not receive chemotherapy, whereas those at high clinical and genomic risk did receive such therapy. In patients with discordant risk results, either the genomic risk or the clinical risk was used to determine the use of chemotherapy. The primary goal was to assess whether, among patients with high-risk clinical features and a low-risk gene-expression profile who did not receive chemotherapy, the lower boundary of the 95% confidence interval for the rate of 5-year survival without distant metastasis would be 92% (i.e., the noninferiority boundary) or higher. RESULTS A total of 1550 patients (23.2%) were deemed to be at high clinical risk and low genomic risk. At 5 years, the rate of survival without distant metastasis in this group was 94.7% (95% confidence interval, 92.5 to 96.2) among those not receiving chemotherapy. The absolute difference in this survival rate between these patients and those who received chemotherapy was 1.5 percentage points, with the rate being lower without chemotherapy. Similar rates of survival without distant metastasis were reported in the subgroup of patients who had estrogen-receptor-positive, human epidermal growth factor receptor 2-negative, and either node-negative or node-positive disease. CONCLUSIONS Among women with early-stage breast cancer who were at high clinical risk and low genomic risk for recurrence, the receipt of no chemotherapy on the basis of the 70-gene signature led to a 5-year rate of survival without distant metastasis that was 1.5 percentage points lower than the rate with chemotherapy. Given these findings, approximately 46% of women with breast cancer who are at high clinical risk might not require chemotherapy. (Funded by the European Commission Sixth Framework Program and others; ClinicalTrials.gov number, NCT00433589; EudraCT number, 2005-002625-31.)	[Cardoso, F.] Champalimaud Fdn, Champalimaud Clin Ctr, Lisbon, Portugal; [van't Veer, L. J.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Bogaerts, J.; Slaets, L.; Golfinopoulos, V.; Meulemans, B.; Tryfonidis, K.] Univ Libre Bruxelles, European Org Res & Treatment Canc Headquarters, Brussels, Belgium; [Goulioti, T.; Straehle, C.] Univ Libre Bruxelles, Breast Int Grp Headquarters, Brussels, Belgium; [Sotiriou, C.; Piccart, M.] Univ Libre Bruxelles, Inst Jules Bordet, Brussels, Belgium; [Vuylsteke, P.] Catholic Univ Louvain, Ctr Hosp Univ, Namur, Belgium; [Viale, G.] Univ Milan, Milan, Italy; [Viale, G.] Ist Europeo Oncol, Milan, Italy; [Knox, S.] Europa Donna European Breast Canc Coalit, Milan, Italy; [Passalacqua, R.] Azienda Ist Ospitalieri Cremona, Cremona, Italy; [Delaloge, S.; Saghatchian, M.] Gustave Roussy, Villejuif, France; [Pierga, J. -Y.] Univ Paris 05, Inst Curie Paris Sci & Lettres, Sorbonne Paris Cite, Paris, France; [Brain, E.] Hop Rene Huguenin, Inst Curie, St Cloud, France; [Causeret, S.] Ctr Georges Francois Leclerc, Dijon, France; [DeLorenzi, M.] Swiss Inst Bioinformat, Lausanne, Switzerland; [DeLorenzi, M.] Univ Lausanne, Lausanne, Switzerland; [Glas, A. M.; Stork, L.] Agendia, Amsterdam, Netherlands; [Bernards, R.; Rutgers, E.] Netherlands Canc Inst, Amsterdam, Netherlands; [Neijenhuis, P. A.] Alrijne Ziekenhuis, Rijnland Leiderdorp, Netherlands; [Smilde, T. J.] Jeroen Bosch Hosp, Shertogenbosch, Netherlands; [van der Hoeven, J. M.] Med Ctr Alkmaar, Alkmaar, Netherlands; [Matos, E.] Inst Oncol, Ljubljana, Slovenia; [Nitz, U.] Evangel Krankenhaus Bethesda, Duisburg, Germany; [Ravdin, P.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Rubio, I. T.] Hosp Univ Vall dHebron, Barcelona, Spain; [Thomas, G.] Imperial Coll London, London, England; [Thompson, A. M.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Fundacao Champalimaud; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; European Organisation for Research & Treatment of Cancer; Universite Libre de Bruxelles; Breast International Group; Universite Libre de Bruxelles; Institut Jules Bordet; Universite Libre de Bruxelles; Universite Catholique Louvain; University of Milan; IRCCS European Institute of Oncology (IEO); UNICANCER; Gustave Roussy; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite; Rene Huguenin Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UNICANCER; Centre Georges-Francois Leclerc; Swiss Institute of Bioinformatics; University of Lausanne; Agendia; Netherlands Cancer Institute; Rijnland Hospital; Jeroen Bosch Ziekenhuis; Medical Center Of Alkmaar; Institute of Oncology - Slovenia; University of Texas System; University of Texas Health San Antonio; Hospital Universitari Vall d'Hebron; Imperial College London; University of Texas System; UTMD Anderson Cancer Center	Cardoso, F (corresponding author), Champalimaud Fdn, Champalimaud Clin Ctr, Breast Unit, Lisbon, Portugal.	mindact@eortc.be	van der Hoeven, Koos JM/S-3281-2017; rubio, isabel/U-4259-2018; Vuylsteke, peter/GXW-1169-2022; Loi, Sherene/H-1979-2016; Viale, Giuseppe/AAE-8921-2019	rubio, isabel/0000-0003-0035-0679; Loi, Sherene/0000-0001-6137-9171; Vuylsteke, Peter/0000-0001-6401-3722; Gkolfinopoulos, Vasileios/0000-0002-8667-9477; Bernards, Rene/0000-0001-8677-3423; Bedard, Philippe/0000-0002-6771-2999; Ciruelos, Eva/0000-0002-2796-1042; Glas, Annuska/0000-0002-0775-138X	European Commission [FP6-LSHC-CT-2004-503426]; Breast Cancer Research Foundation; Novartis; F. Hoffmann-La Roche; Sanofi-Aventis; Eli Lilly; Veridex; U.S. National Cancer Institute; European Breast Cancer Council-Breast Cancer Working Group (BCWG grant for the MINDACT biobank); Jacqueline Seroussi Memorial Foundation for Cancer Research (JSMF); Prix Mois du Cancer du Sein; Susan G. Komen for the Cure [SG05-0922-02]; Fondation Belge contre le Cancer [SCIE 2005-27]; Dutch Cancer Society (KWF); Netherlands Genomics Initiative-Cancer Genomics Center; Association le Cancer du Sein; Parlons-enl; Brussels Breast Cancer Walk-Run; American Women's Club of Brussels; NIF Trust; German Cancer Aid; Grant Simpson Trust; Cancer Research UK; Ligue Nationale contre le Cancer; EORTC Cancer Research Fund; Cancer Research UK [7714] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); Breast Cancer Research Foundation; Novartis(Novartis); F. Hoffmann-La Roche(Hoffmann-La Roche); Sanofi-Aventis(Sanofi-Aventis); Eli Lilly(Eli Lilly); Veridex; U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Breast Cancer Council-Breast Cancer Working Group (BCWG grant for the MINDACT biobank); Jacqueline Seroussi Memorial Foundation for Cancer Research (JSMF); Prix Mois du Cancer du Sein; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Fondation Belge contre le Cancer; Dutch Cancer Society (KWF)(KWF Kankerbestrijding); Netherlands Genomics Initiative-Cancer Genomics Center; Association le Cancer du Sein; Parlons-enl; Brussels Breast Cancer Walk-Run; American Women's Club of Brussels; NIF Trust; German Cancer Aid(Deutsche Krebshilfe); Grant Simpson Trust; Cancer Research UK(Cancer Research UK); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); EORTC Cancer Research Fund; Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the European Commission Sixth Framework Program (FP6-LSHC-CT-2004-503426, to the TRANSBIG Network of Excellence), the Breast Cancer Research Foundation, Novartis, F. Hoffmann-La Roche, Sanofi-Aventis, Eli Lilly, Veridex, the U.S. National Cancer Institute, the European Breast Cancer Council-Breast Cancer Working Group (BCWG grant for the MINDACT biobank), the Jacqueline Seroussi Memorial Foundation for Cancer Research (JSMF; 2006 JSMF Award), Prix Mois du Cancer du Sein (2004 award), Susan G. Komen for the Cure (SG05-0922-02), Fondation Belge contre le Cancer (SCIE 2005-27), Dutch Cancer Society (KWF), the Netherlands Genomics Initiative-Cancer Genomics Center (2008-2012), Association le Cancer du Sein, Parlons-enl, the Brussels Breast Cancer Walk-Run and the American Women's Club of Brussels, NIF Trust, German Cancer Aid, the Grant Simpson Trust and Cancer Research UK, Ligue Nationale contre le Cancer, and the EORTC Cancer Research Fund. Whole-genome analysis was provided by Agendia without cost.	Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Beumer I, 2016, BREAST CANCER RES TR, V156, P279, DOI 10.1007/s10549-016-3764-5; Bogaerts J, 2006, NAT CLIN PRACT ONCOL, V3, P540, DOI 10.1038/ncponc0591; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; Cardoso F, 2008, J CLIN ONCOL, V26, P729, DOI 10.1200/JCO.2007.14.3222; Coates AS, 2015, ANN ONCOL, V26, P1533, DOI 10.1093/annonc/mdv221; Dowsett M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1798; Hayes DF, 2015, MOL ONCOL, V9, P960, DOI 10.1016/j.molonc.2014.10.004; Hayes DF, 1996, JNCI-J NATL CANCER I, V88, P1456, DOI 10.1093/jnci/88.20.1456; Mook S, 2009, EUR J CANCER, V45, P1201, DOI 10.1016/j.ejca.2009.01.004; Mook S, 2009, BREAST CANCER RES TR, V116, P295, DOI 10.1007/s10549-008-0130-2; Oakman C, 2010, NAT REV CLIN ONCOL, V7, P725, DOI 10.1038/nrclinonc.2010.170; Olivotto IA, 2005, J CLIN ONCOL, V23, P2716, DOI 10.1200/JCO.2005.06.178; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Ravdin PM, 2001, J CLIN ONCOL, V19, P980, DOI 10.1200/JCO.2001.19.4.980; Rutgers E, 2011, EUR J CANCER, V47, P2742, DOI 10.1016/j.ejca.2011.09.016; Simon RM, 2009, J NATL CANCER I, V101, P1446, DOI 10.1093/jnci/djp335; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Viale G, 2014, ANN ONCOL, V25, P816, DOI 10.1093/annonc/mdu026; Viale G, 2016, BREAST CANCER RES TR, V155, P463, DOI 10.1007/s10549-016-3690-6; Wishart GC, 2012, BRIT J CANCER, V107, P800, DOI 10.1038/bjc.2012.338	24	997	1018	1	126	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2016	375	8					717	729		10.1056/NEJMoa1602253	http://dx.doi.org/10.1056/NEJMoa1602253			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9ET	27557300	Green Published			2022-12-28	WOS:000381799300010
J	Blumenstock, JE				Blumenstock, Joshua Evan			Fighting poverty with data	SCIENCE			English	Editorial Material									[Blumenstock, Joshua Evan] Univ Calif Berkeley, Sch Informat, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Blumenstock, JE (corresponding author), Univ Calif Berkeley, Sch Informat, Berkeley, CA 94720 USA.	jblumenstock@berkeley.edu	Blumenstock, Joshua/ADN-3685-2022	Blumenstock, Joshua/0000-0002-1813-7414				Blumenstock J, 2015, SCIENCE, V350, P1073, DOI 10.1126/science.aac4420; Blumenstock JE, 2016, J DEV ECON, V120, P157, DOI 10.1016/j.jdeveco.2016.01.003; Chen X, 2011, P NATL ACAD SCI USA, V108, P8589, DOI 10.1073/pnas.1017031108; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Deaton A., 1997, The analysis of household surveys: a microeconometric approach to development policy.; Eagle N, 2010, SCIENCE, V328, P1029, DOI 10.1126/science.1186605; Grissen D., 2015, WORKING PAPER; Haushofer J, 2016, Q J ECON, V131, P1973, DOI 10.1093/qje/qjw025; Henderson JV, 2012, AM ECON REV, V102, P994, DOI 10.1257/aer.102.2.994; Jean N, 2016, SCIENCE, V353, P790, DOI 10.1126/science.aaf7894; Lee Y. S., 2016, WORKING PAPER; Llorente A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128692; Mullainathan S, 2016, NY TIMES; Storeygard A., 2016, WORKING PAPER	15	49	50	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					753	754		10.1126/science.aah5217	http://dx.doi.org/10.1126/science.aah5217			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5ZE	27540154				2022-12-28	WOS:000381561400022
J	Khoury, MJ; Galea, S				Khoury, Muin J.; Galea, Sandro			Will Precision Medicine Improve Population Health?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Khoury, Muin J.] Ctr Dis Control & Prevent, Off Publ Hlth Genom, 1600 Clifton Rd, Atlanta, GA 30329 USA; [Galea, Sandro] Boston Univ, Sch Publ Hlth, Boston, MA USA	Centers for Disease Control & Prevention - USA; Boston University	Khoury, MJ (corresponding author), Ctr Dis Control & Prevent, Off Publ Hlth Genom, 1600 Clifton Rd, Atlanta, GA 30329 USA.	muk1@cdc.gov	Galea, Sandro/GLR-6066-2022	Galea, Sandro/0000-0002-7534-0945	Intramural NIH HHS [Z99 CA999999] Funding Source: Medline; Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural CDC HHS		Ashley EA, 2015, JAMA-J AM MED ASSOC, V313, P2119, DOI 10.1001/jama.2015.3595; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Hollands GJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1102; Joyner MJ, 2015, JAMA-J AM MED ASSOC, V314, P999, DOI 10.1001/jama.2015.7725; Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031; Khoury MJ, 2015, JAMA-J AM MED ASSOC, V313, P2117, DOI 10.1001/jama.2015.3382; Maas P, 2016, JAMA ONCOL, V2, P1295, DOI 10.1001/jamaoncol.2016.1025; Schubauer-Berigan MK, 2015, J OCCUP ENVIRON HYG, V12, P69, DOI [10.1080/15459624.2014.946515, 10.1080/15459624.2015.1060323]	8	123	124	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2016	316	13					1357	1358		10.1001/jama.2016.12260	http://dx.doi.org/10.1001/jama.2016.12260			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DX7TC	27541310	Green Accepted			2022-12-28	WOS:000384591300012
J	Vermeij, WP; Dolle, MET; Reiling, E; Jaarsma, D; Payan-Gomez, C; Bombardieri, CR; Wu, H; Roks, AJM; Botter, SM; van der Eerden, BC; Youssef, SA; Kuiper, RV; Nagarajah, B; van Oostrom, CT; Brandt, RMC; Barnhoorn, S; Imholz, S; Pennings, JLA; de Bruin, A; Gyenis, A; Pothof, J; Vijg, J; van Steeg, H; Hoeijmakers, JHJ				Vermeij, W. P.; Dolle, M. E. T.; Reiling, E.; Jaarsma, D.; Payan-Gomez, C.; Bombardieri, C. R.; Wu, H.; Roks, A. J. M.; Botter, S. M.; van der Eerden, B. C.; Youssef, S. A.; Kuiper, R. V.; Nagarajah, B.; van Oostrom, C. T.; Brandt, R. M. C.; Barnhoorn, S.; Imholz, S.; Pennings, J. L. A.; de Bruin, A.; Gyenis, A.; Pothof, J.; Vijg, J.; van Steeg, H.; Hoeijmakers, J. H. J.			Restricted diet delays accelerated ageing and genomic stress in DNA-repair-deficient mice	NATURE			English	Article							CALORIC RESTRICTION; NUCLEAR ABNORMALITIES; COCKAYNE-SYNDROME; GROWTH; DEGENERATION; COMPONENT; MODELS; CANCER; P53	Mice deficient in the DNA excision-repair gene Ercc1 (Ercc1(Delta/-)) show numerous accelerated ageing features that limit their lifespan to 4-6 months(1-4). They also exhibit a 'survival response', which suppresses growth and enhances cellular maintenance. Such a response resembles the anti-ageing response induced by dietary restriction (also known as caloric restriction)(1,5). Here we report that a dietary restriction of 30% tripled the median and maximal remaining lifespans of these progeroid mice, strongly retarding numerous aspects of accelerated ageing. Mice undergoing dietary restriction retained 50% more neurons and maintained full motor function far beyond the lifespan of mice fed ad libitum. Other DNA-repair-deficient, progeroid Xpg(-/-) (also known as Ercc5(-/-)) mice, a model of Cockayne syndrome(6), responded similarly. The dietary restriction response in Ercc1(Delta/-) mice closely resembled the effects of dietary restriction in wild-type animals. Notably, liver tissue from Ercc1(Delta/-) mice fed ad libitum showed preferential extinction of the expression of long genes, a phenomenon we also observed in several tissues ageing normally. This is consistent with the accumulation of stochastic, transcription-blocking lesions that affect long genes more than short ones. Dietary restriction largely prevented this declining transcriptional output and reduced the number of gamma H2AX DNA damage foci, indicating that dietary restriction preserves genome function by alleviating DNA damage. Our findings establish the Ercc1(Delta/-) mouse as a powerful model organism for health-sustaining interventions, reveal potential for reducing endogenous DNA damage, facilitate a better understanding of the molecular mechanism of dietary restriction and suggest a role for counterintuitive dietary-restriction-like therapy for human progeroid genome instability syndromes and possibly neurodegeneration in general.	[Vermeij, W. P.; Reiling, E.; Payan-Gomez, C.; Bombardieri, C. R.; Botter, S. M.; Brandt, R. M. C.; Barnhoorn, S.; Gyenis, A.; Pothof, J.; Hoeijmakers, J. H. J.] Erasmus Univ, Dept Mol Genet, Med Ctr Rotterdam, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Dolle, M. E. T.; Reiling, E.; Nagarajah, B.; van Oostrom, C. T.; Imholz, S.; Pennings, J. L. A.; van Steeg, H.] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, POB 1, NL-3720 BA Bilthoven, Netherlands; [Jaarsma, D.] Erasmus Univ, Med Ctr Rotterdam, Dept Neurosci, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Payan-Gomez, C.] Univ Rosario, Fac Ciencias Nat & Matemat, Carrera 24,63C-69, Bogota, Colombia; [Wu, H.; Roks, A. J. M.] Erasmus Univ, Div Vasc Med & Pharmacol, Dept Internal Med, Med Ctr Rotterdam, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Botter, S. M.] Balgrist Univ Hosp, Lab Orthoped Res, Forchstr 340, CH-8008 Zurich, Switzerland; [van der Eerden, B. C.] Erasmus Univ, Dept Internal Med, Med Ctr Rotterdam, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Youssef, S. A.; Kuiper, R. V.; de Bruin, A.] Univ Utrecht, Dept Pathobiol, Dutch Mol Pathol Ctr, Fac Vet Med, POB 80125, NL-3508 TC Utrecht, Netherlands; [de Bruin, A.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Div Mol Genet, POB 30001, NL-9700 RB Groningen, Netherlands; [Vijg, J.] Albert Einstein Coll Med, Dept Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [van Steeg, H.] Leiden Univ, Med Ctr, Dept Human Genet, POB 9600, NL-2300 RC Leiden, Netherlands; [Hoeijmakers, J. H. J.] Univ Cologne, CECAD Forschungszentrum, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Kuiper, R. V.] Karolinska Inst, Dept Lab Med, SE-17177 Stockholm, Sweden	Erasmus University Rotterdam; Erasmus MC; Netherlands National Institute for Public Health & the Environment; Erasmus University Rotterdam; Erasmus MC; Universidad del Rosario; Erasmus University Rotterdam; Erasmus MC; University of Zurich; Erasmus University Rotterdam; Erasmus MC; Utrecht University; University of Groningen; Yeshiva University; Albert Einstein College of Medicine; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Cologne; Karolinska Institutet	Hoeijmakers, JHJ (corresponding author), Erasmus Univ, Dept Mol Genet, Med Ctr Rotterdam, POB 2040, NL-3000 CA Rotterdam, Netherlands.; Dolle, MET (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, POB 1, NL-3720 BA Bilthoven, Netherlands.	martijn.dolle@rivm.nl; j.hoeijmakers@erasmusmc.nl	Hoeijmakers, Jan/AAX-6972-2021; van der Eerden, Bram CJ/I-7496-2012; de Bruin, Alain/AAL-9195-2020; Payan-Gomez, Cesar/G-8589-2016	van der Eerden, Bram CJ/0000-0003-4403-6497; Payan-Gomez, Cesar/0000-0002-0633-1332; Gyenis, Akos/0000-0002-8104-7681; Pennings, Jeroen L.A./0000-0002-9188-6358; Roks, Anton J.M./0000-0001-7155-1756; Brandt, Renata M. C./0000-0003-0514-5623; Vermeij, Wilbert/0000-0002-9690-1385; Kuiper, Raoul/0000-0001-5645-2389; Dolle, Martijn/0000-0001-6137-6544	National Institute of Health (NIH)/National Institute of Ageing (NIA) [1PO1 AG-17242-02]; National Institute for Public Health and the Environment; Ministry of Health, Welfare and Sport of The Netherlands [S/340005]; European Research Council; European commission [FP7-Health-2008-200880]; DNA Repair [LSHG-CT-2005-512113]; EU ITN Address [GA-316390]; KWO Dutch Cancer Society [5030]; Dutch CAA Foundation; Royal Academy of Arts and Sciences of the Netherlands; European Community [HEALTH-F2-2010-259893]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017242] Funding Source: NIH RePORTER	National Institute of Health (NIH)/National Institute of Ageing (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute for Public Health and the Environment; Ministry of Health, Welfare and Sport of The Netherlands; European Research Council(European Research Council (ERC)European Commission); European commission(European CommissionEuropean Commission Joint Research Centre); DNA Repair; EU ITN Address; KWO Dutch Cancer Society; Dutch CAA Foundation; Royal Academy of Arts and Sciences of the Netherlands; European Community(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank P. de With, J. Rigters, E. Haasdijk, S. Gabriels, E. J. M. Stynenbosch, N. van Vliet, Y. van Loon, J. Baan and the animal caretakers for general assistance with mouse experiments. We thank A. H. J. Danser and J. P. van Leeuwen for support. We acknowledge financial support from the National Institute of Health (NIH)/National Institute of Ageing (NIA) (1PO1 AG-17242-02), the National Institute for Public Health and the Environment and the Ministry of Health, Welfare and Sport of The Netherlands (S/340005), European Research Council Advanced Grant DamAge and Proof of Concept Grant Dementia to J. H. J. H., the European commission FP7 Markage (FP7-Health-2008-200880), DNA Repair (LSHG-CT-2005-512113), EU ITN Address (GA-316390), the KWO Dutch Cancer Society (5030), the Dutch CAA Foundation and the Royal Academy of Arts and Sciences of the Netherlands (academia professorship to J. H. J. H.). The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number HEALTH-F2-2010-259893. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnhoorn S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004686; Bartke A, 2013, PHYSIOL REV, V93, P571, DOI 10.1152/physrev.00006.2012; Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300; Bogliolo M, 2013, AM J HUM GENET, V92, P800, DOI 10.1016/j.ajhg.2013.04.002; Borgesius NZ, 2011, J NEUROSCI, V31, P12543, DOI 10.1523/JNEUROSCI.1589-11.2011; Botter SM, 2009, OSTEOARTHR CARTILAGE, V17, P636, DOI 10.1016/j.joca.2008.09.018; Campisi J, 2014, INTERD T GERONT GERI, V39, P45, DOI 10.1159/000358899; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; de Graaf EL, 2013, MOL CELL PROTEOMICS, V12, P1350, DOI 10.1074/mcp.M112.024950; de Waard MC, 2010, ACTA NEUROPATHOL, V120, P461, DOI 10.1007/s00401-010-0715-9; Derks KWJ, 2015, RNA BIOL, V12, P30, DOI 10.1080/15476286.2015.1017202; Dolle MET, 2011, PATHOBIOL AGING AGE, V1, DOI 10.3402/pba.v1i0.7219; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; Durik M, 2012, CIRCULATION, V126, P468, DOI 10.1161/CIRCULATIONAHA.112.104380; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Garinis GA, 2009, NAT CELL BIOL, V11, P604, DOI 10.1038/ncb1866; Gates KS, 2009, CHEM RES TOXICOL, V22, P1747, DOI 10.1021/tx900242k; Halagappa VKM, 2007, NEUROBIOL DIS, V26, P212, DOI 10.1016/j.nbd.2006.12.019; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Jaarsma D, 2013, MECH AGEING DEV, V134, P180, DOI 10.1016/j.mad.2013.04.003; Jonker MJ, 2013, AGING CELL, V12, P901, DOI 10.1111/acel.12118; Kashiyama K, 2013, AM J HUM GENET, V92, P807, DOI 10.1016/j.ajhg.2013.04.007; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; Navarro F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132767; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Partridge L, 2007, NATURE, V450, P165, DOI 10.1038/450165a; Raj DDA, 2014, NEUROBIOL AGING, V35, P2147, DOI 10.1016/j.neurobiolaging.2014.03.025; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Stranahan AM, 2012, J ALZHEIMERS DIS, V30, pS5, DOI 10.3233/JAD-2011-110899; Swenberg JA, 2011, TOXICOL SCI, V120, pS130, DOI 10.1093/toxsci/kfq371; Swindell WR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-585; van der Pluijm I, 2007, PLOS BIOL, V5, P23, DOI 10.1371/journal.pbio.0050002; Vermeij WP, 2016, ANNU REV PHARMACOL, V56, P427, DOI 10.1146/annurev-pharmtox-010814-124316; Waarsing JH, 2004, J BONE MINER RES, V19, P1640, DOI 10.1359/JBMR.040705; Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4; Wijnhoven SWP, 2005, DNA REPAIR, V4, P1314, DOI 10.1016/j.dnarep.2005.07.002; Wilson BT, 2016, GENET MED, V18, P483, DOI 10.1038/gim.2015.110	46	141	146	4	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2016	537	7620					427	+		10.1038/nature19329	http://dx.doi.org/10.1038/nature19329			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV7EC	27556946	Green Published, Green Accepted			2022-12-28	WOS:000383098000059
J	Shu, YL; Wang, DY				Shu, Yuelong; Wang, Dayan			More on Probable Hospital Cluster of H7N9 Influenza Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Shu, Yuelong; Wang, Dayan] Chinese Natl Influenza Ctr, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Shu, YL (corresponding author), Chinese Natl Influenza Ctr, Beijing, Peoples R China.	yshu@cnic.org.cn						Farooqui A, 2016, NEW ENGL J MED, V374, P596, DOI 10.1056/NEJMc1505359; Wang D, 2014, EUROSURVEILLANCE, V2013, P19, DOI DOI 10.2807/1560-7917.ES2014.19.25.20836; Wang X, 2014, CLIN INFECT DIS, V59, pE76, DOI 10.1093/cid/ciu399	3	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2016	375	10								10.1056/NEJMc1608034	http://dx.doi.org/10.1056/NEJMc1608034			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU9IG	27602687				2022-12-28	WOS:000382529500029
J	Marcinkiewcz, CA; Mazzone, CM; D'Agostino, G; Halladay, LR; Hardaway, JA; DiBerto, JF; Navarro, M; Burnham, N; Cristiano, C; Dorrier, CE; Tipton, GJ; Ramakrishnan, C; Kozicz, T; Deisseroth, K; Thiele, TE; McElligott, ZA; Holmes, A; Heisler, LK; Kash, TL				Marcinkiewcz, Catherine A.; Mazzone, Christopher M.; D'Agostino, Giuseppe; Halladay, Lindsay R.; Hardaway, J. Andrew; DiBerto, Jeffrey F.; Navarro, Montserrat; Burnham, Nathan; Cristiano, Claudia; Dorrier, Cayce E.; Tipton, Gregory J.; Ramakrishnan, Charu; Kozicz, Tamas; Deisseroth, Karl; Thiele, Todd E.; McElligott, Zoe A.; Holmes, Andrew; Heisler, Lora K.; Kash, Thomas L.			Serotonin engages an anxiety and fear-promoting circuit in the extended amygdala	NATURE			English	Article							STRIA TERMINALIS; BED NUCLEUS; CITALOPRAM; FLUOXETINE	Serotonin (also known as 5-hydroxytryptamine (5-HT)) is a neurotransmitter that has an essential role in the regulation of emotion. However, the precise circuits have not yet been defined through which aversive states are orchestrated by 5-HT. Here we show that 5-HT from the dorsal raphe nucleus (5-HTDRN) enhances fear and anxiety and activates a subpopulation of corticotropin-releasing factor (CRF) neurons in the bed nucleus of the stria terminal's (CRFBNST,) in mice. Specifically, 5-HTDRN projections to the BNST, via actions at 5-HT2C receptors (5-HT(2C)Rs), engage a CRFBNST inhibitory microcircuit that silences anxiolytic BNST outputs to the ventral tegmental area and lateral hypothalamus. Furthermore, we demonstrate that this CRFBNST inhibitory circuit underlies aversive behaviour following acute exposure to selective serotonin reuptake inhibitors (SSRIs). This early aversive effect is mediated via the corticotrophin-releasing factor type 1 receptor (CRF1R, also known as CRHR1), given that CRF1R antagonism is sufficient to prevent acute SSRI-induced enhancements in aversive learning. These results reveal an essential 5-HTDRN -> CRFBNST circuit governing fear and anxiety, and provide a potential mechanistic explanation for the clinical observation of early adverse events to SSRI treatment in some patients with anxiety disorders(1,2).	[Marcinkiewcz, Catherine A.; Mazzone, Christopher M.; Hardaway, J. Andrew; DiBerto, Jeffrey F.; Dorrier, Cayce E.; Tipton, Gregory J.; Thiele, Todd E.; McElligott, Zoe A.; Kash, Thomas L.] Univ North Carolina Chapel Hill, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA; [Mazzone, Christopher M.; Kash, Thomas L.] Univ North Carolina Chapel Hill, Sch Med, Curriculum Neurobiol, Chapel Hill, NC 27599 USA; [D'Agostino, Giuseppe; Cristiano, Claudia; Heisler, Lora K.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen AB25 2ZD, Scotland; [Halladay, Lindsay R.; Holmes, Andrew] NIAAA, NIH, Rockville, MD 20852 USA; [Navarro, Montserrat; Burnham, Nathan; Thiele, Todd E.; Kash, Thomas L.] Univ North Carolina Chapel Hill, Coll Arts & Sci, Dept Psychol & Neurosci, Chapel Hill, NC 27599 USA; [Ramakrishnan, Charu; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Kozicz, Tamas] Tulane Univ, Hayward Genet Ctr, New Orleans, LA 70112 USA; [Kozicz, Tamas] Radboud Univ Nijmegen, Med Ctr, Dept Anat, NL-6500 HB Nijmegen, Netherlands; [McElligott, Zoe A.] Univ North Carolina Chapel Hill, Sch Med, Dept Psychiat, Chapel Hill, NC 27599 USA; [Kash, Thomas L.] Univ North Carolina Chapel Hill, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Aberdeen; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Stanford University; Tulane University; Radboud University Nijmegen; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Marcinkiewcz, CA (corresponding author), Univ North Carolina Chapel Hill, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA.		Kash, Thomas/G-9625-2013; Marcinkiewcz, Catherine/X-2339-2019; Halladay, Lindsay/AAC-9950-2020; McElligott, Zoe/AAX-5415-2021; Cristiano, Claudia/ABH-2794-2021; D'Agostino, Giuseppe/F-3399-2012	Marcinkiewcz, Catherine/0000-0001-7161-7815; Halladay, Lindsay/0000-0003-2232-6709; Cristiano, Claudia/0000-0002-4806-1764; Heisler, Lora/0000-0002-7731-1419; D'Agostino, Giuseppe/0000-0002-3502-4251	NIH [AA019454, AA011605, K01AA023555]; Wellcome Trust [098012]; Biotechnology and Biological Sciences Research Council [BB/K001418/1]; Alcohol Beverage Medical Research Fund; NIAAA [AA021319-02, F31AA023440]; BBSRC [BB/K001418/1] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH076694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA019454, F32AA021319, K01AA023555, ZIAAA000411, P50AA011605, P60AA011605, F31AA023440] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Alcohol Beverage Medical Research Fund; NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We acknowledge B. Roth for providing DREADD viral constructs and Sert<SUP>Cre</SUP> mice, and B. Lowell for providing Crf<SUP>Cre</SUP> mice. We also thank A. Lopez, D. Perron, and A. Kendra for technical assistance with stereotaxic surgeries on mice, B. Geenen for technical assistance with immunohistochemistry and E. Dankoski for technical assistance with the FSCV. This work was supported by NIH grants AA019454, AA011605 (T.L.K.), the Wellcome Trust (098012) and the Biotechnology and Biological Sciences Research Council grant (BB/K001418/1) (L.K.H.) and by NIH grant K01AA023555 and the Alcohol Beverage Medical Research Fund (Z.A.M.). C.A.M. was supported by a postdoctoral NIAAA F32 fellowship (AA021319-02). C.M.M. is supported by a predoctoral NIAAA F31 fellowship (F31AA023440).	Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Belzung C, 2001, BEHAV PHARMACOL, V12, P151, DOI 10.1097/00008877-200105000-00001; Burghardt NS, 2007, BIOL PSYCHIAT, V62, P1111, DOI 10.1016/j.biopsych.2006.11.023; Burke LK, 2016, MOL METAB, V5, P245, DOI 10.1016/j.molmet.2016.01.005; Dabrowska J, 2011, PSYCHONEUROENDOCRINO, V36, P1312, DOI 10.1016/j.psyneuen.2011.03.003; Dekeyne A, 2000, NEUROPHARMACOLOGY, V39, P1114, DOI 10.1016/S0028-3908(99)00268-3; Fenno LE, 2014, NAT METHODS, V11, P763, DOI [10.1038/NMETH.2996, 10.1038/nmeth.2996]; GORMAN JM, 1987, J CLIN PSYCHOPHARM, V7, P329; Heisler LK, 2007, GENES BRAIN BEHAV, V6, P491, DOI 10.1111/j.1601-183X.2007.00316.x; Huang MM, 2010, J PHARMACOL EXP THER, V332, P298, DOI 10.1124/jpet.109.159186; Javelot Herve, 2011, Depress Res Treat, V2011, P531435, DOI 10.1155/2011/531435; Jennings JH, 2013, NATURE, V496, P224, DOI 10.1038/nature12041; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; Liu J, 2010, PSYCHOPHARMACOLOGY, V207, P535, DOI 10.1007/s00213-009-1684-3; Liu ZX, 2014, NEURON, V81, P1360, DOI 10.1016/j.neuron.2014.02.010; Mombereau C, 2010, INT J NEUROPSYCHOPH, V13, P321, DOI 10.1017/S1461145709990630; Olive MF, 2002, PHARMACOL BIOCHEM BE, V72, P213, DOI 10.1016/S0091-3057(01)00748-1; PHELIX CF, 1992, BRAIN RES BULL, V28, P943, DOI 10.1016/0361-9230(92)90217-L; Ravinder S, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.137; WESTENBERG HGM, 1989, PSYCHOPATHOLOGY, V22, P68, DOI 10.1159/000284628	20	233	234	12	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					97	101		10.1038/nature19318	http://dx.doi.org/10.1038/nature19318			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27556938	Green Accepted, Green Submitted			2022-12-28	WOS:000382426900046
J	Clery, D				Clery, Daniel			ASTRONOMY The exoplanet next door	SCIENCE			English	News Item														Clery, Daniel/0000-0002-8742-3596					0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					857	857		10.1126/science.353.6302.857	http://dx.doi.org/10.1126/science.353.6302.857			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU0CA	27563079				2022-12-28	WOS:000381867700012
J	Iacobucci, G				Iacobucci, Gareth			Sixty seconds on ... the childhood obesity strategy	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department of Health, CHILDH OB PLAN ACT; Iacobucci G, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4597; O'Dowd A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4576; Wise J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6026	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 26	2016	354								i4684	10.1136/bmj.i4684	http://dx.doi.org/10.1136/bmj.i4684			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AB	27565682				2022-12-28	WOS:000382792300007
J	Elias, WJ; Lipsman, N; Ondo, WG; Ghanouni, P; Kim, YG; Lee, W; Schwartz, M; Hynynen, K; Lozano, AM; Shah, BB; Huss, D; Dallapiazza, RF; Gwinn, R; Witt, J; Ro, S; Eisenberg, HM; Fishman, PS; Gandhi, D; Halpern, CH; Chuang, R; Pauly, KB; Tierney, TS; Hayes, MT; Cosgrove, GR; Yamaguchi, T; Abe, K; Taira, T; Chang, JW				Elias, W. Jeffrey; Lipsman, Nir; Ondo, William G.; Ghanouni, Pejman; Kim, Young G.; Lee, Wonhee; Schwartz, Michael; Hynynen, Kullervo; Lozano, Andres M.; Shah, Binit B.; Huss, Diane; Dallapiazza, Robert F.; Gwinn, Ryder; Witt, Jennifer; Ro, Susie; Eisenberg, Howard M.; Fishman, Paul S.; Gandhi, Dheeraj; Halpern, Casey H.; Chuang, Rosalind; Pauly, Kim Butts; Tierney, Travis S.; Hayes, Michael T.; Cosgrove, G. Rees; Yamaguchi, Toshio; Abe, Keiichi; Taira, Takaomi; Chang, Jin W.			A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEEP BRAIN-STIMULATION; QUALITY-OF-LIFE; THALAMIC-STIMULATION; PARKINSONS-DISEASE; MOVEMENT; IRRADIATION; SUPPRESSION; SURGERY; BLIND	BACKGROUND Uncontrolled pilot studies have suggested the efficacy of focused ultrasound thalamotomy with magnetic resonance imaging (MRI) guidance for the treatment of essential tremor. METHODS We enrolled patients with moderate-to-severe essential tremor that had not responded to at least two trials of medical therapy and randomly assigned them in a 3:1 ratio to undergo unilateral focused ultrasound thalamotomy or a sham procedure. The Clinical Rating Scale for Tremor and the Quality of Life in Essential Tremor Questionnaire were administered at baseline and at 1, 3, 6, and 12 months. Tremor assessments were videotaped and rated by an independent group of neurologists who were unaware of the treatment assignments. The primary outcome was the between-group difference in the change from baseline to 3 months in hand tremor, rated on a 32-point scale (with higher scores indicating more severe tremor). After 3 months, patients in the sham-procedure group could cross over to active treatment (the openlabel extension cohort). RESULTS Seventy-six patients were included in the analysis. Hand-tremor scores improved more after focused ultrasound thalamotomy (from 18.1 points at baseline to 9.6 at 3 months) than after the sham procedure (from 16.0 to 15.8 points); the between-group difference in the mean change was 8.3 points (95% confidence interval [CI], 5.9 to 10.7; P < 0.001). The improvement in the thalamotomy group was maintained at 12 months (change from baseline, 7.2 points; 95% CI, 6.1 to 8.3). Secondary outcome measures assessing disability and quality of life also improved with active treatment (the blinded thalamotomy cohort) as compared with the sham procedure (P < 0.001 for both comparisons). Adverse events in the thalamotomy group included gait disturbance in 36% of patients and paresthesias or numbness in 38%; these adverse events persisted at 12 months in 9% and 14% of patients, respectively. CONCLUSIONS MRI-guided focused ultrasound thalamotomy reduced hand tremor in patients with essential tremor. Side effects included sensory and gait disturbances. (Funded by InSightec and others; ClinicalTrials.gov number, NCT01827904.)	[Elias, W. Jeffrey; Shah, Binit B.; Huss, Diane; Dallapiazza, Robert F.] Univ Virginia, Hlth Sci Ctr, Box 800212, Charlottesville, VA 22908 USA; [Schwartz, Michael; Hynynen, Kullervo] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Ondo, William G.] Methodist Neurol Inst, Houston, TX USA; [Ghanouni, Pejman; Halpern, Casey H.; Pauly, Kim Butts] Stanford Univ, Sch Med, Stanford, CA USA; [Kim, Young G.; Lee, Wonhee; Chang, Jin W.] Yonsei Univ, Coll Med, Seoul, South Korea; [Gwinn, Ryder; Witt, Jennifer; Ro, Susie; Chuang, Rosalind] Swedish Neurosci Inst, Seattle, WA USA; [Eisenberg, Howard M.; Fishman, Paul S.; Gandhi, Dheeraj] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Tierney, Travis S.] Univ Miami, Sch Med, Nicklaus Childrens Hosp, Miami, FL USA; [Hayes, Michael T.; Cosgrove, G. Rees] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Yamaguchi, Toshio] Shin Yurigaoka Gen Hosp, Kawasaki, Kanagawa, Japan; [Abe, Keiichi; Taira, Takaomi] Tokyo Womens Med Univ, Tokyo, Japan	University of Virginia; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; The Methodist Hospital System; The Methodist Hospital - Houston; Stanford University; Yonsei University; Yonsei University Health System; Swedish Medical Center; University System of Maryland; University of Maryland Baltimore; University of Miami; Harvard University; Brigham & Women's Hospital; Tokyo Women's Medical University	Elias, WJ (corresponding author), Univ Virginia, Dept Neurol Surg, Box 800212, Charlottesville, VA 22908 USA.	ksh5m@virginia.edu	Lozano, Andres M/A-5058-2012	Taira, Takaomi/0000-0002-9982-4493; Chang, Jin Woo/0000-0002-2717-0101; Lozano, Andres M./0000-0001-8257-3694; Chen, Hong/0000-0003-1904-0857	InSightec; Focused Ultrasound Foundation; Binational Industrial Research and Development (BIRD) Foundation; GE Healthcare; NeuroPace; Boston Scientific; Daiichi-Sankyo; Eisai; GlaxoSmithKline; Otsuka; Pfizer; Hisamitsu; Dainippon-Sumitomo; Takeda; Kyowa-Hakko; St. Jude Medical	InSightec; Focused Ultrasound Foundation; Binational Industrial Research and Development (BIRD) Foundation; GE Healthcare(General ElectricGE Healthcare); NeuroPace; Boston Scientific(Boston Scientific); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Eisai(Eisai Co Ltd); GlaxoSmithKline(GlaxoSmithKline); Otsuka(Otsuka Pharmaceutical); Pfizer(Pfizer); Hisamitsu; Dainippon-Sumitomo(Dainippon Sumitomo Pharma Co., Ltd.); Takeda(Takeda Pharmaceutical Company Ltd); Kyowa-Hakko; St. Jude Medical(St. Jude Medical)	Supported by InSightec, the Focused Ultrasound Foundation, and the Binational Industrial Research and Development (BIRD) Foundation.; Dr. Elias reports receiving grant support from InSightec and the Focused Ultrasound Foundation; Dr. Lipsman, receiving fees from the Focused Ultrasound Foundation for serving on a steering committee; Dr. Ghanouni and Dr. Butts Pauly, receiving grant support from InSightec and GE Healthcare; Dr. Hynynen, receiving royalties from a patent related to ultrasound therapy (US6770031 B2); Dr. Lozano, receiving grant support from InSightec; Dr. Gwinn, receiving teaching fees from NeuroPace and Boston Scientific; Dr. Cosgrove, receiving consulting fees from InSightec; and Dr. Taira, receiving lecture fees from Daiichi-Sankyo, Eisai, GlaxoSmithKline, Otsuka, Pfizer, Hisamitsu, Dainippon-Sumitomo, Takeda, and Kyowa-Hakko, and grant support from St. Jude Medical. No other potential conflict of interest relevant to this article was reported.	Anderson VC, 2009, NEUROSCI LETT, V462, P166, DOI 10.1016/j.neulet.2009.07.003; [Anonymous], 2015, J THER ULTRASOUND, DOI [DOI 10.1186/2050-5736-3-S1-P26, 10.1186/2050-5736-3-S1-P26]; BENABID AL, 1993, ACTA NEUROCHIR, P39; Chang WS, 2015, J NEUROL NEUROSUR PS, V86, P257, DOI 10.1136/jnnp-2014-307642; Clement GT, 2000, PHYS MED BIOL, V45, P1071, DOI 10.1088/0031-9155/45/4/319; Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303; Deuschl G, 2011, LANCET NEUROL, V10, P148, DOI 10.1016/S1474-4422(10)70322-7; Elias WJ, 2013, J NEUROSURG, V119, P307, DOI 10.3171/2013.5.JNS122327; Elias WJ, 2014, JAMA-J AM MED ASSOC, V311, P948, DOI 10.1001/jama.2014.1397; Elias WJ, 2013, NEW ENGL J MED, V369, P640, DOI 10.1056/NEJMoa1300962; FINDLEY LJ, 1982, BRIT MED J, V285, P608, DOI 10.1136/bmj.285.6342.608; FRY WJ, 1954, J NEUROSURG, V11, P471, DOI 10.3171/jns.1954.11.5.0471; GOLDMAN MS, 1992, STEREOT FUNCT NEUROS, V58, P22, DOI 10.1159/000098966; Ho AL, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2015.3.FOCUS1537; Hynynen K, 1997, RADIOLOGY, V204, P247, DOI 10.1148/radiology.204.1.9205255; Koller W, 1997, ANN NEUROL, V42, P292, DOI 10.1002/ana.410420304; Kumar K, 1999, STEREOT FUNCT NEUROS, V72, P47, DOI 10.1159/000029671; Lipsman N, 2013, LANCET NEUROL, V12, P462, DOI 10.1016/S1474-4422(13)70048-6; Lorenz D, 2006, MOVEMENT DISORD, V21, P1114, DOI 10.1002/mds.20884; Louis ED, 2015, PARKINSONISM RELAT D, V21, P729, DOI 10.1016/j.parkreldis.2015.04.019; Louis ED, 2010, MOVEMENT DISORD, V25, P534, DOI 10.1002/mds.22838; McDannold N, 2003, MAGNET RESON MED, V49, P1188, DOI 10.1002/mrm.10453; MEYERS R, 1959, J NEUROSURG, V16, P32, DOI 10.3171/jns.1959.16.1.0032; NELSON E, 1959, J NEUROPATH EXP NEUR, V18, P489, DOI 10.1097/00005072-195910000-00001; Schneier FR, 2001, J CLIN PSYCHIAT, V62, P367, DOI 10.4088/JCP.v62n0511; Schuurman PR, 2000, NEW ENGL J MED, V342, P461, DOI 10.1056/NEJM200002173420703; Stacy MA, 2007, MOVEMENT DISORD, V22, P833, DOI 10.1002/mds.21412; Tasker RR, 1998, SURG NEUROL, V49, P145, DOI 10.1016/S0090-3019(97)00459-X; Troster AI, 2005, PARKINSONISM RELAT D, V11, P367, DOI 10.1016/j.parkreldis.2005.05.009; WINKLER GF, 1974, NEW ENGL J MED, V290, P984, DOI 10.1056/NEJM197405022901802; Wintermark M, 2014, AM J NEURORADIOL, V35, P891, DOI 10.3174/ajnr.A3808; Witjas T, 2015, NEUROLOGY, V85, P1562, DOI 10.1212/WNL.0000000000002087; Zesiewicz TA, 2005, NEUROLOGY, V64, P2008, DOI 10.1212/01.WNL.0000163769.28552.CD; Zirh A, 1999, J NEUROL NEUROSUR PS, V66, P772, DOI 10.1136/jnnp.66.6.772	34	521	537	6	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2016	375	8					730	739		10.1056/NEJMoa1600159	http://dx.doi.org/10.1056/NEJMoa1600159			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9ET	27557301	Bronze			2022-12-28	WOS:000381799300011
J	Weisfeld-Adams, JD				Weisfeld-Adams, James D.			The Abyss	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Weisfeld-Adams, James D.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Weisfeld-Adams, JD (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA.							Feinstein A, 2011, MULT SCLER J, V17, P1276, DOI 10.1177/1352458511417835; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366	2	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2016	375	8					713	715		10.1056/NEJMp1507437	http://dx.doi.org/10.1056/NEJMp1507437			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL8UI	27557299				2022-12-28	WOS:000394895200001
J	Estes, ML; McAllister, AK				Estes, Myka L.; McAllister, A. Kimberley			Maternal immune activation: Implications for neuropsychiatric disorders	SCIENCE			English	Review							AUTISM SPECTRUM DISORDERS; ADOLESCENT CANNABINOID EXPOSURE; PRENATAL EXPOSURE; NEURODEVELOPMENTAL DISORDERS; HIPPOCAMPAL-NEURONS; ENTORHINAL CORTEX; BRAIN-DEVELOPMENT; SYNAPSE DENSITY; ANIMAL-MODELS; T(H)17 CELLS	Epidemiological evidence implicates maternal infection as a risk factor for autism spectrum disorder and schizophrenia. Animal models corroborate this link and demonstrate that maternal immune activation (MIA) alone is sufficient to impart lifelong neuropathology and altered behaviors in offspring. This Review describes common principles revealed by these models, highlighting recent findings that strengthen their relevance for schizophrenia and autism and are starting to reveal the molecular mechanisms underlying the effects of MIA on offspring. The role of MIA as a primer for a much wider range of psychiatric and neurologic disorders is also discussed. Finally, the need for more research in this nascent field and the implications for identifying and developing new treatments for individuals at heightened risk for neuroimmune disorders are considered.	[Estes, Myka L.; McAllister, A. Kimberley] Univ Calif Davis, Ctr Neurosci, One Shields Ave, Davis, CA 95618 USA	University of California System; University of California Davis	McAllister, AK (corresponding author), Univ Calif Davis, Ctr Neurosci, One Shields Ave, Davis, CA 95618 USA.	kmcallister@ucdavis.edu		McAllister, A. Kimberley/0000-0001-9177-9889	Stanley and Jacqueline Schilling Neuroscience Postdoctoral Research Fellowship; Dennis Weatherstone Predoctoral Fellowship from Autism Speaks [7825]; Letty and James Callinan and Cathy and Andrew Moley Fellowship from the ARCS (Achievement Rewards for College Scientists) Foundation; Dissertation Year Fellowship from the University of California Office of the President; National Institute of Neurological Disorders and Stroke [R01-NS060125-05]; National Institute of Mental Health [P50-MH106438-01]; Simons Foundation (SFARI) [321998]; University of California Davis Research Investments in Science and Engineering Program; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH106438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060125] Funding Source: NIH RePORTER	Stanley and Jacqueline Schilling Neuroscience Postdoctoral Research Fellowship; Dennis Weatherstone Predoctoral Fellowship from Autism Speaks; Letty and James Callinan and Cathy and Andrew Moley Fellowship from the ARCS (Achievement Rewards for College Scientists) Foundation; Dissertation Year Fellowship from the University of California Office of the President; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation (SFARI); University of California Davis Research Investments in Science and Engineering Program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank members of the McAllister laboratory for ongoing discussions about the topics covered in this Review. Due to journal guidelines, we were not permitted to cite many of the original reports, and we apologize to those whose articles are not referenced. Please see referenced reviews for primary source articles. A.K.M. and M.L.E. are listed as inventors on a patent application (U.S. Patent Application 61/989,791) entitled "Methods for Diagnosing and Treating Neuroimmune-Based Psychiatric Disorders." M.L.E. has been supported by a Stanley and Jacqueline Schilling Neuroscience Postdoctoral Research Fellowship, a Dennis Weatherstone Predoctoral Fellowship from Autism Speaks (no. 7825), the Letty and James Callinan and Cathy and Andrew Moley Fellowship from the ARCS (Achievement Rewards for College Scientists) Foundation, and a Dissertation Year Fellowship from the University of California Office of the President. A.K.M. is supported by grants from the National Institute of Neurological Disorders and Stroke (R01-NS060125-05), the National Institute of Mental Health (P50-MH106438-01), the Simons Foundation (SFARI no. 321998), and the University of California Davis Research Investments in Science and Engineering Program.	Arsenault D, 2014, BRAIN BEHAV IMMUN, V38, P77, DOI 10.1016/j.bbi.2013.12.016; Ayhan Y, 2016, PROG NEUROBIOL, V136, P1, DOI 10.1016/j.pneurobio.2015.10.002; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Blomstrom A, 2016, SCHIZOPHRENIA BULL, V42, P125, DOI 10.1093/schbul/sbv112; Boyle CA, 2011, PEDIATRICS, V127, P1034, DOI 10.1542/peds.2010-2989; Brimberg L, 2013, MOL PSYCHIATR, V18, P1171, DOI 10.1038/mp.2013.101; Bronson SL, 2011, BEHAV BRAIN RES, V220, P55, DOI 10.1016/j.bbr.2010.12.040; Brown AS, 2009, AM J PSYCHIAT, V166, P683, DOI 10.1176/appi.ajp.2008.08010089; Caccamo A, 2014, J NEUROSCI, V34, P7988, DOI 10.1523/JNEUROSCI.0777-14.2014; Camacho J, 2014, BEHAV BRAIN RES, V266, P46, DOI 10.1016/j.bbr.2014.02.045; Canetta S, 2016, MOL PSYCHIATR, V21, P956, DOI 10.1038/mp.2015.222; Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314; Chua JSC, 2012, BRAIN BEHAV IMMUN, V26, P326, DOI 10.1016/j.bbi.2011.10.002; Clancy B, 2007, NEUROINFORMATICS, V5, P79, DOI 10.1385/NI:5:1:79; Coiro P, 2015, BRAIN BEHAV IMMUN, V50, P249, DOI 10.1016/j.bbi.2015.07.022; Connor CM, 2012, SCHIZOPHR RES, V140, P175, DOI 10.1016/j.schres.2012.06.037; Connors EJ, 2014, BRAIN BEHAV IMMUN, V42, P178, DOI 10.1016/j.bbi.2014.06.020; Coyle P, 2009, BEHAV BRAIN RES, V197, P210, DOI 10.1016/j.bbr.2008.08.022; Debost J. P., 2016, SCHIZOPHR B, V2016; Depino AM, 2015, NEUROSCIENCE, V299, P56, DOI 10.1016/j.neuroscience.2015.04.065; Dowling DJ, 2014, TRENDS IMMUNOL, V35, P299, DOI 10.1016/j.it.2014.04.007; Dube E, 2015, EXPERT REV VACCINES, V14, P99, DOI 10.1586/14760584.2015.964212; Elmer BM, 2013, J NEUROSCI, V33, P13791, DOI 10.1523/JNEUROSCI.2366-13.2013; Estes ML, 2016, SCIENCE, V351, P919, DOI 10.1126/science.aaf2850; Estes ML, 2015, NAT REV NEUROSCI, V16, P469, DOI 10.1038/nrn3978; Estes ML, 2014, BRAIN PATHOL, V24, P623, DOI 10.1111/bpa.12198; Gao R, 2015, CURR MOL MED, V15, P146, DOI 10.2174/1566524015666150303003028; Garay PA, 2013, BRAIN BEHAV IMMUN, V31, P54, DOI 10.1016/j.bbi.2012.07.008; Giovanoli S, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.38; Giovanoli S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0437-y; Glynn MW, 2011, NAT NEUROSCI, V14, P442, DOI 10.1038/nn.2764; Harvey L, 2012, NEUROPHARMACOLOGY, V62, P1767, DOI 10.1016/j.neuropharm.2011.11.022; Hemmerle AM, 2015, SCHIZOPHR RES, V168, P411, DOI 10.1016/j.schres.2015.07.006; Hoftman GD, 2015, SCHIZOPHRENIA BULL, V41, P180, DOI 10.1093/schbul/sbt178; Hollins SL, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.99; Hollins SL, 2016, BRAIN BEHAV IMMUN, V56, P187, DOI 10.1016/j.bbi.2016.02.021; Howerton CL, 2012, HORM BEHAV, V62, P237, DOI 10.1016/j.yhbeh.2012.03.007; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Ignacio Z. M., 2016, BR J CLIN PHARM, V2016; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Kipnis J, 2016, SCIENCE, V353, P766, DOI 10.1126/science.aag2638; Knuesel I, 2014, NAT REV NEUROL, V10, P643, DOI 10.1038/nrneurol.2014.187; Krstic D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-151; Lante F, 2008, HIPPOCAMPUS, V18, P602, DOI 10.1002/hipo.20421; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lepeta K, 2016, J NEUROCHEM, V138, P785, DOI 10.1111/jnc.13713; Li Q, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.126; Machado CJ, 2015, BIOL PSYCHIAT, V77, P823, DOI 10.1016/j.biopsych.2014.07.035; Malishkevich A, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2014.138; Meyer U, 2014, BIOL PSYCHIAT, V75, P307, DOI 10.1016/j.biopsych.2013.07.011; Meyer U, 2011, PEDIATR RES, V69, p26R, DOI 10.1203/PDR.0b013e318212c196; Meyer U, 2009, NEUROSCI BIOBEHAV R, V33, P1061, DOI 10.1016/j.neubiorev.2009.05.001; Nielsen PR, 2016, SCHIZOPHR RES, V172, P35, DOI 10.1016/j.schres.2016.02.025; Nielsen PR, 2014, SCHIZOPHRENIA BULL, V40, P1526, DOI 10.1093/schbul/sbt200; Nielsen PR, 2013, SCHIZOPHRENIA BULL, V39, P230, DOI 10.1093/schbul/sbr149; Parboosing R, 2013, JAMA PSYCHIAT, V70, P677, DOI 10.1001/jamapsychiatry.2013.896; Patrich E, 2016, SCI REP-UK, V6, DOI 10.1038/srep19106; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; Ponzio NM, 2007, ANN NY ACAD SCI, V1107, P118, DOI 10.1196/annals.1381.013; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Reisinger S, 2015, PHARMACOL THERAPEUT, V149, P213, DOI 10.1016/j.pharmthera.2015.01.001; Richetto J, 2014, SCHIZOPHRENIA BULL, V40, P351, DOI 10.1093/schbul/sbs195; Ronovsky M., 2015, CURR NEUROPHARMACOL, V14, P1; Sahin M, 2015, SCIENCE, V350, P890, DOI 10.1126/science.aab3897; Santini E, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005832; Schmidt MJ, 2015, NEUROPSYCHOPHARMACOL, V40, P190, DOI 10.1038/npp.2014.95; Schwartzer JJ, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.16; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Selten JP, 2010, BIPOLAR DISORD, V12, P753, DOI 10.1111/j.1399-5618.2010.00849.x; Selten JP, 2010, SCHIZOPHRENIA BULL, V36, P219, DOI 10.1093/schbul/sbp147; Shatz CJ, 2009, NEURON, V64, P40, DOI 10.1016/j.neuron.2009.09.044; Simanek AM, 2015, CURR PROB PEDIATR AD, V45, P325, DOI 10.1016/j.cppeds.2015.06.008; Simon AK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3085; Smith KF, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0950; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Tang B, 2013, BRAIN BEHAV IMMUN, V30, P168, DOI 10.1016/j.bbi.2013.01.086; Tang GM, 2014, NEURON, V83, P1131, DOI 10.1016/j.neuron.2014.07.040; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Voineagu I, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00738; Wang HS, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00043; Weir RK, 2015, BRAIN BEHAV IMMUN, V48, P139, DOI 10.1016/j.bbi.2015.03.009; Weiser MJ, 2016, PROSTAG LEUKOTR ESS, V106, P27, DOI 10.1016/j.plefa.2015.10.005; Wolff AR, 2015, BRAIN BEHAV IMMUN, V48, P232, DOI 10.1016/j.bbi.2015.03.012; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Zhang Z, 2015, BRAIN BEHAV IMMUN, V45, P60, DOI 10.1016/j.bbi.2014.10.010	85	539	543	10	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					772	777		10.1126/science.aag3194	http://dx.doi.org/10.1126/science.aag3194			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZE	27540164	Green Accepted			2022-12-28	WOS:000381561400034
J	Yoshida, S; Hiraga, K; Takehana, T; Taniguchi, I; Yamaji, H; Maeda, Y; Toyohara, K; Miyamoto, K; Kimura, Y; Oda, K				Yoshida, Shosuke; Hiraga, Kazumi; Takehana, Toshihiko; Taniguchi, Ikuo; Yamaji, Hironao; Maeda, Yasuhito; Toyohara, Kiyotsuna; Miyamoto, Kenji; Kimura, Yoshiharu; Oda, Kohei			Response to Comment on "A bacterium that degrades and assimilates poly(ethylene terephthalate)"	SCIENCE			English	Editorial Material							POLYETHYLENE TEREPHTHALATE FIBERS; SURFACE MODIFICATION; CUTINASE; HYDROLYSIS; HYDROLASE		[Yoshida, Shosuke; Hiraga, Kazumi; Yamaji, Hironao; Oda, Kohei] Kyoto Inst Technol, Fac Text Sci, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan; [Yoshida, Shosuke; Miyamoto, Kenji] Keio Univ, Dept Biosci & Informat, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan; [Takehana, Toshihiko] ADEKA Corp, Life Sci Mat Lab, Arakawa Ku, 7-2-34 Higashiogu, Tokyo 1168553, Japan; [Taniguchi, Ikuo; Kimura, Yoshiharu] Kyoto Inst Technol, Fac Text Sci, Dept Polymer Sci, Sakyo Ku, Kyoto 6068585, Japan; [Maeda, Yasuhito; Toyohara, Kiyotsuna] Teijin Ltd, Ecol Related Mat Grp Innovat Res Inst, Hinode Cho 2-1, Iwakuni, Yamaguchi 7408511, Japan; [Yoshida, Shosuke] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158530, Japan	Kyoto Institute of Technology; Keio University; Kyoto Institute of Technology; Teijin Limited; Kyoto University	Oda, K (corresponding author), Kyoto Inst Technol, Fac Text Sci, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan.; Miyamoto, K (corresponding author), Keio Univ, Dept Biosci & Informat, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	kmiyamoto@bio.keio.ac.jp; bika@kit.ac.jp		Kimura, Yoshiharu/0000-0003-4431-0193	Grants-in-Aid for Scientific Research [26850053] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Chen W, 1998, MACROMOLECULES, V31, P3648, DOI 10.1021/ma9710601; Chetna Sharon, 2012, Journal of Microbiology and Biotechnology Research, V2, P248; Muller RJ, 2005, MACROMOL RAPID COMM, V26, P1400, DOI 10.1002/marc.200500410; Nimchua T, 2008, J IND MICROBIOL BIOT, V35, P843, DOI 10.1007/s10295-008-0356-3; Nimchua Thidarat, 2007, Biotechnology Journal, V2, P361, DOI 10.1002/biot.200600095; O'Neill A, 2007, ENZYME MICROB TECH, V40, P1801, DOI 10.1016/j.enzmictec.2007.02.012; Ribitsch D, 2012, BIOCATAL BIOTRANSFOR, V30, P2, DOI 10.3109/10242422.2012.644435; Ronkvist AM, 2009, MACROMOLECULES, V42, P5128, DOI 10.1021/ma9005318; Silva CM, 2005, J POLYM SCI POL CHEM, V43, P2448, DOI 10.1002/pola.20684; Sulaiman S, 2012, APPL ENVIRON MICROB, V78, P1556, DOI 10.1128/AEM.06725-11; Vertommen MAME, 2005, J BIOTECHNOL, V120, P376, DOI 10.1016/j.jbiotec.2005.06.015; Yang Y, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8305; Yoshida S, 2016, SCIENCE, V351, P1196, DOI 10.1126/science.aad6359; Zimmermann W, 2011, ADV BIOCHEM ENG BIOT, V125, P97, DOI 10.1007/10_2010_87	14	40	49	32	237	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301								10.1126/science.aaf8625	http://dx.doi.org/10.1126/science.aaf8625			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZE	27540160				2022-12-28	WOS:000381561400030
J	Florin, TA; Plint, AC; Zorc, JJ				Florin, Todd A.; Plint, Amy C.; Zorc, Joseph J.			Viral bronchiolitis	LANCET			English	Review							RESPIRATORY SYNCYTIAL VIRUS; NEBULIZED HYPERTONIC SALINE; SERIOUS BACTERIAL-INFECTION; LENGTH-OF-STAY; CLINICAL-PRACTICE GUIDELINE; HOSPITALIZED INFANTS; UNITED-STATES; EMERGENCY-DEPARTMENT; FEBRILE INFANTS; YOUNG-CHILDREN	Viral bronchiolitis is a common clinical syndrome affecting infants and young children. Concern about its associated morbidity and cost has led to a large body of research that has been summarised in systematic reviews and integrated into clinical practice guidelines in several countries. The evidence and guideline recommendations consistently support a clinical diagnosis with the limited role for diagnostic testing for children presenting with the typical clinical syndrome of viral upper respiratory infection progressing to the lower respiratory tract. Management is largely supportive, focusing on maintaining oxygenation and hydration of the patient. Evidence suggests no benefit from bronchodilator or corticosteroid use in infants with a first episode of bronchiolitis. Evidence for other treatments such as hypertonic saline is evolving but not clearly defined yet. For infants with severe disease, the insufficient available data suggest a role for high-flow nasal cannula and continuous positive airway pressure use in a monitored setting to prevent respiratory failure.	[Florin, Todd A.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Emergency Med, Cincinnati, OH 45229 USA; [Florin, Todd A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Plint, Amy C.] Childrens Hosp Eastern Ontario, Div Emergency Med, Ottawa, ON, Canada; [Plint, Amy C.] Univ Ottawa, Dept Pediat, Ottawa, ON, Canada; [Zorc, Joseph J.] Childrens Hosp Philadelphia, Div Emergency Med, Philadelphia, PA 19104 USA; [Zorc, Joseph J.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Florin, TA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Emergency Med, Cincinnati, OH 45229 USA.	todd.florin@cchmc.org	Plint, Amy/AAE-2250-2020; Florin, Todd/J-6637-2019	Florin, Todd/0000-0002-4387-2605	National Institutes of Health-National Institute of Allergy and Infectious Diseases [1K23AI121325-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI121325] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	TAF receives funding from the National Institutes of Health-National Institute of Allergy and Infectious Diseases (grant 1K23AI121325-01). The NIH had no role in the writing of this manuscript, and in the decision to submit the paper for publication. We would like to thank Kerry Aicholtz for her administrative support.	AHERNE W, 1970, J CLIN PATHOL, V23, P7, DOI 10.1136/jcp.23.1.7; Ali S., 2012, KENDIG CHERNICKS DIS, V8th ed., P443; Andrade MA, 1998, PEDIATRICS, V101, P617, DOI 10.1542/peds.101.4.617; [Anonymous], 2013, LANCET RESP MED, V1, P113, DOI 10.1016/S2213-2600(12)70053-X; [Anonymous], 2015, BRONCHIOLITIS CHILDR; Bacharier LB, 2015, JAMA-J AM MED ASSOC, V314, P2034, DOI 10.1001/jama.2015.13896; Baraldi E, 2014, ITAL J PEDIATR, V40, DOI 10.1186/1824-7288-40-65; Barnes PJ, 2007, EUR RESPIR J, V29, P587, DOI 10.1183/09031936.00080306; Basile V, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0380-1; Beigelman A, 2015, J ALLERGY CLIN IMMUN, V135, P1171, DOI 10.1016/j.jaci.2014.10.001; Bradley JP, 2005, PEDIATRICS, V115, pE7, DOI 10.1542/peds.2004-0059; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Breese C, 2013, PEDIATRICS, V132, pE341, DOI 10.1542/peds.2013-0303; Brooks CG, 2016, JAMA PEDIATR, V170, P577, DOI 10.1001/jamapediatrics.2016.0079; Campana MB, 2014, ARCH DIS CHILD, V99, P511, DOI 10.1136/archdischild-2013-305443; Caiulo VA, 2011, EUR J PEDIATR, V170, P1427, DOI 10.1007/s00431-011-1461-2; Calvo C, 2010, ACTA PAEDIATR, V99, P883, DOI 10.1111/j.1651-2227.2010.01714.x; CARLSEN KH, 1987, PEDIATR PULM, V3, P153, DOI 10.1002/ppul.1950030308; Carroll KN, 2009, J ALLERGY CLIN IMMUN, V123, P1055, DOI 10.1016/j.jaci.2009.02.021; Corneli HM, 2007, NEW ENGL J MED, V357, P331, DOI 10.1056/NEJMoa071255; COURT SDM, 1973, POSTGRAD MED J, V49, P771, DOI 10.1136/pgmj.49.577.771; Cunningham S, 2015, LANCET, V386, P1041, DOI 10.1016/S0140-6736(15)00163-4; Darrow LA, 2014, AM J EPIDEMIOL, V180, P968, DOI 10.1093/aje/kwu234; DiFranza JR, 2012, BMC PEDIATR, V12, P81, DOI DOI 10.1186/1471-2431-12-81; Donaldson SH, 2008, PEDIATR PULM, V43, pS18, DOI 10.1002/ppul.20857; Ecochard-Dugelay E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096189; Ecochard-Dugelay E, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-143; Elkhunovich MA, 2015, PEDIATR EMERG CARE, V31, P616, DOI 10.1097/PEC.0000000000000359; Everard ML, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19660; Everard ML, 2014, THORAX, V69, P1105, DOI 10.1136/thoraxjnl-2014-205953; Fabian M, 2005, EXACERBATIONS ASTHMA, V2007, P1; Farley R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005189.pub4; Fernandes RM, 2015, PEDIATRICS, V135, pE1399, DOI 10.1542/peds.2014-3557; Fernandes RM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004878.pub4; Fjaerli Hans-Olav, 2005, BMC Pediatr, V5, P31, DOI 10.1186/1471-2431-5-31; Flores P, 2016, PEDIATR PULM, V51, P418, DOI 10.1002/ppul.23306; Florin TA, 2014, JAMA PEDIATR, V168, P664, DOI 10.1001/jamapediatrics.2013.5306; Foxman EF, 2015, P NATL ACAD SCI USA, V112, P827, DOI 10.1073/pnas.1411030112; Friedman JN, 2014, PAED CHILD HEALT-CAN, V19, P484, DOI 10.1093/pch/19.9.485; Gadomski AM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001266.pub4; Gajdos V, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000345; Giembycz MA, 2008, BRIT J PHARMACOL, V153, P1090, DOI 10.1038/sj.bjp.0707627; GREENING AP, 1994, LANCET, V344, P219, DOI 10.1016/S0140-6736(94)92996-3; Grewal S, 2014, JAMA PEDIATR, V168, P607, DOI 10.1001/jamapediatrics.2014.423; Hall CB, 2007, CLIN INFECT DIS, V45, P353, DOI 10.1086/519433; Hartling L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003123.pub3; Hasegawa Kohei, 2015, BMC Res Notes, V8, P718, DOI 10.1186/s13104-015-1695-6; Hasegawa K, 2015, J INFECT DIS, V211, P1550, DOI 10.1093/infdis/jiu658; Hasegawa K, 2014, PEDIATR INFECT DIS J, V33, P11, DOI 10.1097/INF.0b013e3182a5f324; Hasegawa K, 2013, PEDIATRICS, V132, P28, DOI 10.1542/peds.2012-3877; Haynes AK, 2014, MMWR-MORBID MORTAL W, V63, P1133; Haynes AK, 2013, J INFECT DIS, V208, pS246, DOI 10.1093/infdis/jit515; Holden NS, 2011, P NATL ACAD SCI USA, V108, P19713, DOI 10.1073/pnas.1110226108; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; Jeng MJ, 2014, PLOS ONE, V10; Kaur M, 2008, MOL PHARMACOL, V73, P203, DOI 10.1124/mol.107.040121; Kim BJ, 2013, ALLERGY, V68, P517, DOI 10.1111/all.12104; Kuzik BA, 2007, J PEDIATR-US, V151, P266, DOI 10.1016/j.jpeds.2007.04.010; Kyu HH, 2016, JAMA PEDIATR, V170, P267, DOI 10.1001/jamapediatrics.2015.4276; Levine DA, 2004, PEDIATRICS, V113, P1728, DOI 10.1542/peds.113.6.1728; Librizzi Jamie, 2014, Hosp Pediatr, V4, P33, DOI 10.1542/hpeds.2013-0073; Lieberthal AS, 2013, PEDIATRICS, V131, pE964, DOI 10.1542/peds.2012-3488; Luo ZX, 2010, PEDIATR INT, V52, P199, DOI 10.1111/j.1442-200X.2009.02941.x; Maguire C, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0140-x; Mahabee-Gittens EM, 1999, CLIN PEDIATR, V38, P395, DOI 10.1177/000992289903800703; Mahabee-Gittens EM, 2000, CLIN PEDIATR, V39, P387, DOI 10.1177/000992280003900702; Mandelberg A, 2003, CHEST, V123, P481, DOI 10.1378/chest.123.2.481; Mandelberg A, 2010, PEDIATR PULM, V45, P36, DOI 10.1002/ppul.21185; Mansbach JM, 2008, PEDIATRICS, V122, P177, DOI 10.1542/peds.2007-3323; Mansbach JM, 2008, ACAD EMERG MED, V15, P111, DOI 10.1111/j.1553-2712.2007.00034.x; Mansbach JM, 2012, ARCH PEDIAT ADOL MED, V166, P700, DOI 10.1001/archpediatrics.2011.1669; Marguet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004596; Mathews B, 2009, PEDIATRICS, V124, pE29, DOI 10.1542/peds.2008-2062; Mazur N, 2015, LANCET RESP MED, V3, P888, DOI 10.1016/S2213-2600(15)00255-6; McCallum GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074316; McCallum GB, 2013, PEDIATR PULM, V48, P797, DOI 10.1002/ppul.22627; McCulloh R, 2015, JAMA PEDIATR, V169, P898, DOI 10.1001/jamapediatrics.2015.1746; Meissner HC, 2016, NEW ENGL J MED, V374, P62, DOI 10.1056/NEJMra1413456; Midulla F, 2010, ARCH DIS CHILD, V95, P35, DOI 10.1136/adc.2008.153361; Miller EK, 2013, PEDIATR INFECT DIS J, V32, P950, DOI 10.1097/INF.0b013e31829b7e43; Moschino L, 2016, ARCH DIS CHILD, V101, P114, DOI 10.1136/archdischild-2015-309587; Mussman GM, 2013, JAMA PEDIATR, V167, P414, DOI 10.1001/jamapediatrics.2013.36; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nenna R, 2015, PEDIATR INFECT DIS J, V34, P1131, DOI 10.1097/INF.0000000000000825; Papadopoulos NG, 2002, AM J RESP CRIT CARE, V165, P1285, DOI 10.1164/rccm.200112-118BC; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Pinto LA, 2012, J PEDIATR-US, V161, P1104, DOI 10.1016/j.jpeds.2012.05.053; Plint AC, 2015, CAN J EMERG MED, V17, P46, DOI 10.2310/8000.2013.131325; Plint AC, 2009, NEW ENGL J MED, V360, P2079, DOI 10.1056/NEJMoa0900544; Principi T, 2016, JAMA PEDIATR, V170, P602, DOI 10.1001/jamapediatrics.2016.0114; Purcell K, 2007, PEDIATR INFECT DIS J, V26, P311, DOI 10.1097/01.inf.0000258627.23337.00; Ralston S, 2013, J HOSP MED, V8, P25, DOI 10.1002/jhm.1982; Ralston S, 2011, ARCH PEDIAT ADOL MED, V165, P951, DOI 10.1001/archpediatrics.2011.155; Ralston SL, 2014, PEDIATRICS, V134, pE1474, DOI 10.1542/peds.2014-2742; Rice MB, 2015, PEDIATR PULM, V50, P252, DOI 10.1002/ppul.23029; Roberts KB, 2011, PEDIATRICS, V128, P595, DOI 10.1542/peds.2011-1330; Figuls MRI, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004873.pub5; SALAH B, 1988, EUR RESPIR J, V1, P852; Scagnolari C, 2012, MED MICROBIOL IMMUN, V201, P311, DOI 10.1007/s00430-012-0233-6; Schreiber S, 2016, ACTA PAEDIATR, V105, P292, DOI 10.1111/apa.13282; Schuh S, 2007, J PEDIATR-US, V150, P429, DOI 10.1016/j.jpeds.2007.01.005; Schuh S, 2014, JAMA-J AM MED ASSOC, V312, P712, DOI 10.1001/jama.2014.8637; Schuurhof A, 2010, PEDIATR PULM, V45, P608, DOI 10.1002/ppul.21229; Scottish Intercollegiate Guidelines Network (SIGN), 2006, BRONCH CHILDR NAT CL; Self WH, 2016, J INFECT DIS, V213, P584, DOI 10.1093/infdis/jiv323; Semple MG, 2005, J INFECT DIS, V191, P382, DOI 10.1086/426457; Shazberg G, 2000, ARCH DIS CHILD, V83, P317, DOI 10.1136/adc.83.4.317; Sigurs N, 2010, THORAX, V65, P1045, DOI 10.1136/thx.2009.121582; Silver AH, 2015, PEDIATRICS, V136, P1036, DOI 10.1542/peds.2015-1037; Sinha IP, 2015, CHEST, V148, P810, DOI 10.1378/chest.14-1589; Skjerven HO, 2016, J INFECT DIS, V213, P915, DOI 10.1093/infdis/jiv513; Skjerven HO, 2013, NEW ENGL J MED, V368, P2286, DOI 10.1056/NEJMoa1301839; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Stockman LJ, 2012, PEDIATR INFECT DIS J, V31, P5, DOI 10.1097/INF.0b013e31822e68e6; Stollar F, 2014, EUR J PEDIATR, V173, P1429, DOI 10.1007/s00431-014-2334-2; Teunissen J, 2014, EUR RESPIR J, V44, P913, DOI 10.1183/09031936.00159613; Turner T, 2008, Aust Fam Physician, V37, P6; Verstraete M, 2014, ARCH PEDIATRIE, V21, P53, DOI 10.1016/j.arcped.2013.10.020; Wang VJ, 2012, J ENVIRON HEALTH, V75, P8; Wills PJ, 1997, J CLIN INVEST, V99, P9, DOI 10.1172/JCI119138; Willwerth BM, 2006, ANN EMERG MED, V48, P441, DOI 10.1016/j.annemergmed.2006.03.021; Working Group of the Clinical Practice Guideline on Acute Bronchiolitis, 2010, QUAL PLAN SPAN NAT H; Wu SS, 2014, JAMA PEDIATR, V168, P657, DOI 10.1001/jamapediatrics.2014.301; Yusuf S, 2007, EPIDEMIOL INFECT, V135, P1077, DOI 10.1017/S095026880600776X; Zhang LJ, 2015, PEDIATRICS, V136, P687, DOI 10.1542/peds.2015-1914	125	176	185	1	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2017	389	10065					211	225		10.1016/S0140-6736(16)30951-5	http://dx.doi.org/10.1016/S0140-6736(16)30951-5			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH9UT	27549684	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000392117600033
J	Katayama, Y; Nishiyama, M; Shoji, H; Ohkawa, Y; Kawamura, A; Sato, T; Suyama, M; Takumi, T; Miyakawa, T; Nakayama, KI				Katayama, Yuta; Nishiyama, Masaaki; Shoji, Hirotaka; Ohkawa, Yasuyuki; Kawamura, Atsuki; Sato, Tetsuya; Suyama, Mikita; Takumi, Toru; Miyakawa, Tsuyoshi; Nakayama, Keiichi I.			CHD8 haploinsufficiency results in autistic-like phenotypes in mice	NATURE			English	Article							DE-NOVO MUTATIONS; HISTONE H1 RECRUITMENT; BEHAVIORAL PHENOTYPES; SPECTRUM DISORDERS; BINDING PROTEIN; CHROMATIN; GENES; GENETICS; BRAIN; MOUSE	Autism spectrum disorder (ASD) comprises a range of neurodevelopmental disorders characterized by deficits in social interaction and communication as well as by restricted and repetitive behaviours(1). ASD has a strong genetic component with high heritability. Exome sequencing analysis has recently identified many de novo mutations in a variety of genes in individuals with ASD(2,3), with CHD8, a gene encoding a chromatin remodeller, being most frequently affected(4-8). Whether CHD8 mutations are causative for ASD and how they might establish ASD traits have remained unknown. Here we show that mice heterozygous for Chd8 mutations manifest ASD-like behavioural characteristics including increased anxiety, repetitive behaviour, and altered social behaviour. CHD8 haploinsufficiency did not result in prominent changes in the expression of a few specific genes but instead gave rise to small but global changes in gene expression in the mouse brain, reminiscent of those in the brains of patients with ASD. Gene set enrichment analysis revealed that neurodevelopment was delayed in the mutant mouse embryos. Furthermore, reduced expression of CHD8 was associated with abnormal activation of RE-1 silencing transcription factor (REST), which suppresses the transcription of many neuronal genes. REST activation was also observed in the brains of humans with ASD, and CHD8 was found to interact physically with REST in the mouse brain. Our results are thus consistent with the notion that CHD8 haploinsufficiency is a highly penetrant risk factor for ASD, with disease pathogenesis probably resulting from a delay in neurodevelopment.	[Katayama, Yuta; Nishiyama, Masaaki; Kawamura, Atsuki; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan; [Shoji, Hirotaka; Miyakawa, Tsuyoshi] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Syst Med Sci, Toyoake, Aichi 4701192, Japan; [Ohkawa, Yasuyuki] Kyushu Univ, Med Inst Bioregulat, Div Transcript, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan; [Sato, Tetsuya; Suyama, Mikita] Kyushu Univ, Med Inst Bioregulat, Div Bioinformat, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan; [Takumi, Toru] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan	Kyushu University; Fujita Health University; Kyushu University; Kyushu University; RIKEN	Nishiyama, M; Nakayama, KI (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan.	nishiyam@bioreg.kyushu-u.ac.jp; nakayak1@bioreg.kyushu-u.ac.jp	Nishiyama, Masaaki/GWU-5575-2022; Ohkawa, Yasuyuki/C-4087-2016; Ohkawa, Yasuyuki/ABG-1839-2021	Ohkawa, Yasuyuki/0000-0001-6440-9954; Ohkawa, Yasuyuki/0000-0001-6440-9954; Suyama, Mikita/0000-0001-9526-3193	Center for Advanced Instrumental and Educational Support, Faculty of Agriculture, Kyushu University; KAKENHI; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [16H06462, 16H06276, 15K06835, 16H06316, 16H06463] Funding Source: KAKEN	Center for Advanced Instrumental and Educational Support, Faculty of Agriculture, Kyushu University; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Kita, K. Tsunematsu, K. Maehara, S. Hirata, M. Kato, Y. Nakajo, T. Akasaka, M. Tanaka, Y. Yamada and K. Takeda for technical assistance; as well as K Tamada for discussion. Computed tomography was supported by the Center for Advanced Instrumental and Educational Support, Faculty of Agriculture, Kyushu University. This study was supported in part by KAKENHI and by a Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Cluny NL, 2009, NEUROGASTROENT MOTIL, V21, P420, DOI 10.1111/j.1365-2982.2008.01248.x; Cotney J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7404; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hall JA, 2007, BIOCHEM CELL BIOL, V85, P463, DOI 10.1139/O07-063; Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kazdoba TM, 2016, GENES BRAIN BEHAV, V15, P7, DOI 10.1111/gbb.12256; Koshimizu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089584; Krumm N, 2014, TRENDS NEUROSCI, V37, P95, DOI 10.1016/j.tins.2013.11.005; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; Nishiyama M, 2004, MOL CELL BIOL, V24, P8386, DOI 10.1128/MCB.24.19.8386-8394.2004; Nishiyama M, 2012, MOL CELL BIOL, V32, P501, DOI 10.1128/MCB.06409-11; Nishiyama M, 2009, NAT CELL BIOL, V11, P172, DOI 10.1038/ncb1831; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Odawara J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-516; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; SADO Y, 1995, HISTOCHEM CELL BIOL, V104, P267, DOI 10.1007/BF01464322; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Shoji Hirotaka, 2012, J Vis Exp, DOI 10.3791/3300; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subtil-Rodriguez A, 2014, NUCLEIC ACIDS RES, V42, P2185, DOI 10.1093/nar/gkt1161; Sugathan A, 2014, P NATL ACAD SCI USA, V111, pE4468, DOI 10.1073/pnas.1405266111; Takao K, 2013, NEUROPSYCHOPHARMACOL, V38, P1409, DOI 10.1038/npp.2013.38; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Thiel G, 2015, CELL TISSUE RES, V359, P99, DOI 10.1007/s00441-014-1963-0; Thompson BA, 2008, MOL CELL BIOL, V28, P3894, DOI 10.1128/MCB.00322-08; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020	46	174	180	4	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2016	537	7622					675	+		10.1038/nature19357	http://dx.doi.org/10.1038/nature19357			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4DR	27602517	Green Accepted			2022-12-28	WOS:000384331700049
J	Nguyen, QD; Merrill, PT; Jaffe, GJ; Dick, AD; Kurup, SK; Sheppard, J; Schlaen, A; Pavesio, C; Cimino, L; Van Calster, J; Camez, AA; Kwatra, NV; Song, AP; Kron, M; Tari, S; Brezin, AP				Quan Dong Nguyen; Merrill, Pauline T.; Jaffe, Glenn J.; Dick, Andrew D.; Kurup, Shree Kumar; Sheppard, John; Schlaen, Ariel; Pavesio, Carlos; Cimino, Luca; Van Calster, Joachim; Camez, Anne A.; Kwatra, Nisha V.; Song, Alexandra P.; Kron, Martina; Tari, Samir; Brezin, Antoine P.			Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial	LANCET			English	Article							JUVENILE IDIOPATHIC ARTHRITIS; OCULAR INFLAMMATORY DISORDERS; NECROSIS-FACTOR INHIBITORS; REFRACTORY UVEITIS; RHEUMATOID-ARTHRITIS; POSTERIOR UVEITIS; CLINICAL-TRIALS; EXPERT PANEL; DISEASE; INFLIXIMAB	Background Non-infectious uveitis is a potentially sight-threatening ocular disorder caused by chronic inflammation and its complications. Therapeutic success is limited by systemic adverse effects associated with long-term corticosteroid and immunomodulator use if topical medication is not sufficient to control the inflammation. We aimed to assess the efficacy and safety of adalimumab in patients with inactive, non-infectious uveitis controlled by systemic corticosteroids. Methods We did this multicentre, double-masked, randomised, placebo-controlled phase 3 trial at 62 study sites in 21 countries in the USA, Canada, Europe, Israel, Australia, and Latin America. Patients (aged >= 18 years) with inactive, non-infectious intermediate, posterior, or panuveitic uveitis controlled by 10-35 mg/day of prednisone were randomly assigned (1: 1), via an interactive voice and web response system with a block size of four, to receive either subcutaneous adalimumab (loading dose 80 mg; biweekly dose 40 mg) or placebo, with a mandatory prednisone taper from week 2. Randomisation was stratified by baseline immunosuppressant treatment. Sponsor personnel with direct oversight of the conduct and management of the study, investigators, study site personnel, and patients were masked to treatment allocation. The primary efficacy endpoint was time to treatment failure, a multicomponent endpoint encompassing new active inflammatory chorioretinal or inflammatory retinal vascular lesions, anterior chamber cell grade, vitreous haze grade, and visual acuity. Analysis was done in the intention-to-treat population. This trial is registered with ClinicalTrials.gov, number NCT01124838. Findings Between Aug 10, 2010, and May 14, 2015, we randomly assigned 229 patients to receive placebo (n=114) or adalimumab (n=115); 226 patients comprised the intention-to-treat population. Median follow-up time was 155 days (IQR 77-357) in the placebo group and 245 days (119-564) in the adalimumab group. Treatment failure occurred in 61 (55%) of 111 patients in the placebo group compared with 45 (39%) of 115 patients in the adalimumab group. Time to treatment failure was significantly improved in the adalimumab group compared with the placebo group (median not estimated [>18 months] vs 8.3 months; hazard ratio 0.57, 95% CI 0.39-0.84; p=0.004). The 40th percentile for time to treatment failure was 4.8 months in the placebo group and 10.2 months in the adalimumab group. No patients in either group had opportunistic infections (excluding oral candidiasis and tuberculosis). No malignancies were reported in the placebo group whereas one (1%) patient in the adalimumab group reported non-serious squamous cell carcinoma. The most common adverse events were arthralgia (12 [11%] patients in the placebo group and 27 [23%] patients in the adalimumab group), nasopharyngitis (16 [17%] and eight [16%] patients, respectively), and headache (17 [15%] patients in each group). Interpretation Adalimumab significantly lowered the risk of uveitic flare or loss of visual acuity upon corticosteroid withdrawal in patients with inactive, non-infectious intermediate, posterior, or panuveitic uveitis controlled by systemic corticosteroids. No new safety signals were observed and the rate of adverse events was similar between groups. These findings suggest that adalimumab is well tolerated and could be an effective treatment option in this patient population. An open-label extension study (NCT01148225) is ongoing to provide long-term safety data for adalimumab in patients with non-infectious uveitis.	[Quan Dong Nguyen] OIRRC, Omaha, NE 68198 USA; [Merrill, Pauline T.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Jaffe, Glenn J.] Duke Univ, Durham, NC USA; [Dick, Andrew D.] Univ Bristol, Bristol Eye Hosp, Bristol, Avon, England; [Dick, Andrew D.] Moorfields Eye Hosp, Natl Inst Hlth Res NIHR Biomed Res Ctr, London, England; [Pavesio, Carlos] UCL, Inst Ophthalmol, London, England; [Kurup, Shree Kumar] Wake Forest Baptist Med Ctr, Winston Salem, NC USA; [Sheppard, John] Eastern Virginia Med Sch, Lions Med Eye Bank Eastern Virginia, Norfolk, VA 23501 USA; [Sheppard, John] Virginia Eye Consultants, Norfolk, VA USA; [Schlaen, Ariel] Austral Univ, Buenos Aires, DF, Argentina; [Cimino, Luca] Arcispedale Santa Maria Nuova IRCCS, Reggio Emilia, RE, Italy; [Van Calster, Joachim] Univ Hosp Leuven, Leuven, Belgium; [Camez, Anne A.; Kron, Martina] AbbVie Deutschland, Ludwigshafen, Germany; [Kwatra, Nisha V.; Song, Alexandra P.; Tari, Samir] AbbVie, N Chicago, IL USA; [Brezin, Antoine P.] Univ Paris 05, Hop Cochin, Paris, France	Rush University; Duke University; Bristol Eye Hospital; University of Bristol; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Wake Forest University; Wake Forest Baptist Medical Center; Eastern Virginia Medical School; Austral University; IRCCS Arcispedale S. Maria Nuova; KU Leuven; University Hospital Leuven; AbbVie; AbbVie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Nguyen, QD (corresponding author), OIRRC, Omaha, NE 68198 USA.	quan.nguyen@unmc.edu	Cimino, Luca/AAA-7523-2021; Schlaen, Ariel/J-2986-2019	Cimino, Luca/0000-0001-7956-9950; Schlaen, Ariel/0000-0003-1202-8660; Merrill, Pauline/0000-0003-2085-3548; Dick, Andrew/0000-0002-0742-3159	AbbVie	AbbVie(AbbVie)	AbbVie.; This study was funded by AbbVie. We thank Friederike Mackensen for her contribution to the study conception and design, and data analysis and interpretation. Dr Mackensen passed away during the development of the manuscript. We thank Amin Kherani, Andrew Logan, Antonio Ciardella, Justus Garweg, Chloe Gottlieb, David Scales, De Schryver, Eric Fortin, Farzin Forooghian, G Pertile, Hiroshi Goto, Jennifer Thorne, Kenichi Namba, Koh-Hei Sonoda, Koju Kamoi, Lourdes Arellanes-Garcia, Lucia Kuffova, Lyndell Lim, Maria Pia Paroli, Marta Misiuk-Hojlo, Masahiro Zako, Michal Kramer, Nicholas Beare, Nobuhisa Mizuki, Noriyasu Hashida, Pablo Franco, Rene Cervantes-Castaneda, Robert Wang, Rui Proenca, Sanjay Kedhar, Sarju Patel, Sofia Androudi, Talin Barisani-Asenbauer, Theresa Larson, Thomas Flynn, Thomas Ness, Toshiaki Abe, Toshikatsu Kaburaki, and Yan Guex-Crosier for their contribution and assistance for the study. Gaurav Patki (AbbVie, North Chicago, IL, USA) provided medical writing assistance.	Becker MD, 2005, DRUGS, V65, P497, DOI 10.2165/00003495-200565040-00005; BECKHAM JC, 1992, J CLIN IMMUNOL, V12, P353, DOI 10.1007/BF00920793; BRENNAN FM, 1992, CURR OPIN IMMUNOL, V4, P754, DOI 10.1016/0952-7915(92)90057-L; Burmester GR, 2013, ANN RHEUM DIS, V72, P517, DOI 10.1136/annrheumdis-2011-201244; Cervantes-Castaneda RA, 2007, RETIN PHYS, V4, P30; Chew EY, 2010, OPHTHALMOLOGY, V117, P2112, DOI 10.1016/j.ophtha.2010.02.033; Diaz-Llopis M, 2008, J OCUL PHARMACOL TH, V24, P351, DOI 10.1089/jop.2007.0104; Diaz-Llopis M, 2012, OPHTHALMOLOGY, V119, P1575, DOI 10.1016/j.ophtha.2012.02.018; Dick AD, 2016, OPHTHALMOLOGY, V123, P655, DOI 10.1016/j.ophtha.2015.10.028; Dick AD, 2013, OPHTHALMOLOGY, V120, P777, DOI 10.1016/j.ophtha.2012.09.040; Durrani OM, 2004, BRIT J OPHTHALMOL, V88, P1159, DOI 10.1136/bjo.2003.037226; Foster CS, 2003, ARCH OPHTHALMOL-CHIC, V121, P437, DOI 10.1001/archopht.121.4.437; GARNIER MB, 2014, ACTA OPHTHALMOL S253, V92; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Heiligenhaus A, 2013, GRAEF ARCH CLIN EXP, V251, P143, DOI 10.1007/s00417-012-2163-9; Jabs DA, 2000, AM J OPHTHALMOL, V130, P492, DOI 10.1016/S0002-9394(00)00659-0; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Jaffe GJ, 2015, ANN RHEUM DIS, V74, P849, DOI 10.1136/annrheumdis-2015-eular.2799; Levy-Clarke G, 2014, OPHTHALMOLOGY, V121, P785, DOI 10.1016/j.ophtha.2013.09.048; Medscape, 2011, VOCL WITHDR APPR UV; NUSSENBLATT RB, 1985, OPHTHALMOLOGY, V92, P467; Okada AA, 2012, ARCH OPHTHALMOL-CHIC, V130, P592, DOI 10.1001/archophthalmol.2011.2698; Pasadhika S, 2014, BIOL-TARGETS THER, V8, P67, DOI 10.2147/BTT.S41477; Rabinovich CE, 2007, CURR OPIN RHEUMATOL, V19, P482, DOI 10.1097/BOR.0b013e32825f5481; Schmeling H, 2005, RHEUMATOLOGY, V44, P1008, DOI 10.1093/rheumatology/keh658; Suhler EB, 2013, BRIT J OPHTHALMOL, V97, P481, DOI 10.1136/bjophthalmol-2012-302292; Suhler EB, 2009, ARCH OPHTHALMOL-CHIC, V127, P819, DOI 10.1001/archophthalmol.2009.141; Tomkins-Netzer O, 2014, OPHTHALMOLOGY, V121, P2387, DOI 10.1016/j.ophtha.2014.07.007; Turan B, 1997, J RHEUMATOL, V24, P128; Tynjala P, 2008, RHEUMATOLOGY, V47, P339, DOI 10.1093/rheumatology/kem356; Vallet H, 2016, ARTHRITIS RHEUMATOL, V68, P1522, DOI 10.1002/art.39667	31	276	279	2	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2016	388	10050					1183	1192		10.1016/S0140-6736(16)31339-3	http://dx.doi.org/10.1016/S0140-6736(16)31339-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW5RA	27542302	Green Submitted			2022-12-28	WOS:000383703100032
J	Ma, CS; Tangye, SG				Ma, Cindy S.; Tangye, Stuart G.			Cytotoxic T cells that escape exhaustion	NATURE			English	Editorial Material							MEMORY CELLS; FH; DIFFERENTIATION; DISEASE		[Ma, Cindy S.; Tangye, Stuart G.] Garvan Inst Med Res, Div Immunol, Darlinghurst, NSW 2010, Australia; [Ma, Cindy S.; Tangye, Stuart G.] Univ New South Wales, St Vincents Clin Sch, Kensington, NSW, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney	Ma, CS (corresponding author), Garvan Inst Med Res, Div Immunol, Darlinghurst, NSW 2010, Australia.; Ma, CS (corresponding author), Univ New South Wales, St Vincents Clin Sch, Kensington, NSW, Australia.	c.ma@garvan.org.au; s.tangye@garvan.org.au	Tangye, Stuart G/H-4023-2014; S, Cindy/B-2340-2012	Tangye, Stuart G/0000-0002-5360-5180; S, Cindy/0000-0001-5387-8413				Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x; FORSTER R, 1994, BLOOD, V84, P830; Fukazawa Y, 2015, NAT MED, V21, P132, DOI 10.1038/nm.3781; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Leong Y. A., 2016, NATURE IMMUNOL; Quigley MF, 2007, EUR J IMMUNOL, V37, P3352, DOI 10.1002/eji.200636746; Shaw LA, 2016, NAT IMMUNOL, V17, P834, DOI 10.1038/ni.3461; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862	14	3	3	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2016	537	7620					312	314		10.1038/nature19428	http://dx.doi.org/10.1038/nature19428			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV7EC	27556942				2022-12-28	WOS:000383098000035
J	Hall, M; Dondo, TB; Yan, AT; Goodman, SG; Bueno, H; Chew, DP; Brieger, D; Timmis, A; Batin, PD; Deanfield, JE; Hemingway, H; Fox, KAA; Gale, CP				Hall, Marlous; Dondo, Tatendashe B.; Yan, Andrew T.; Goodman, Shaun G.; Bueno, Hector; Chew, Derek P.; Brieger, David; Timmis, Adam; Batin, Phillip D.; Deanfield, John E.; Hemingway, Harry; Fox, Keith A. A.; Gale, Christopher P.			Association of Clinical Factors and Therapeutic Strategies With Improvements in Survival Following Non-ST-Elevation Myocardial Infarction, 2003-2013	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE CORONARY SYNDROME; SENSITIVITY CARDIAC TROPONIN; NATIONAL INSTITUTE; TEMPORAL TRENDS; OUTCOMES; RISK; MORTALITY; REGISTRY; DEATH; ROUTINE	IMPORTANCE International studies report a decline in mortality following non-ST-elevation myocardial infarction (NSTEMI). Whether this is due to lower baseline risk or increased utilization of guideline-indicated treatments is unknown. OBJECTIVE To determine whether changes in characteristics of patients with NSTEMI are associated with improvements in outcomes. DESIGN, SETTING, AND PARTICIPANTS Data on patients with NSTEMI in 247 hospitals in England and Wales were obtained from the Myocardial Ischaemia National Audit Project between January 1, 2003, and June 30, 2013 (final follow-up, December 31, 2013). EXPOSURES Baseline demographics, clinical risk (GRACE risk score), and pharmacological and invasive coronary treatments. MAIN OUTCOMES AND MEASURES Adjusted all-cause 180-day postdischarge mortality time trends estimated using flexible parametric survival modeling. RESULTS Among 389 057 patients with NSTEMI (median age, 72.7 years [IQR, 61.7-81.2 years]; 63.1% men), there were 113 586 deaths (29.2%). From 20 03-20 04 to 2012-2013, proportions with intermediate to high GRACE risk decreased (87.2% vs 82.0%); proportions with lowest risk increased (4.2% vs 7.6%; P=.01 for trend). The prevalence of diabetes, hypertension, cerebrovascular disease, chronic obstructive pulmonary disease, chronic renal failure, previous invasive coronary strategy, and current or ex-smoking status increased (all P <.001). Unadjusted all-cause mortality rates at 180 days decreased from 10.8% to 7.6% (unadjusted hazard ratio [HR], 0.968 [95% Cl, 0.966-0.971]; difference in absolute mortality rate per 100 patients [AMR/100],-1.81[95% Cl,-1.95 to-1.67]). These findings were not substantially changed when adjusted additively by baseline GRACE risk score (HR, 0.975 [95% Cl, 0.972-0.977]; AMR/100,-0.18 [95% Cl,-0,21 to-0.16]), sex and socioeconomic status (HR, 0.975 [95% Cl, 0.973-0.978]; difference in AMR/100,-0.24 [95% Cl,-0.27 to -0.21]), comorbidities (HR, 0.973 [95% Cl, 0.970-0.976]; difference in AMR/10 0,-0.44 [95% Cl,-0.49 to-0.39]), and pharmacological therapies (HR, 0.972 [95% Cl, 0.964-0.980]; difference in AMR/100,-0.53 [95% Cl,-0.70 to-0.36]). However, the direction of association was reversed after further adjustment for use of an invasive coronary strategy (HR, 1.02 [95% CI, 1.01-1.03]; difference in AMR/10 0, 0.59 [95% Cl, 0.33-0.86]), which was associated with a relative decrease in mortality of 46.1% (95% Cl, 38.9%-52.0%). CONCLUSIONS AND RELEVANCE Among patients hospitalized with NSTEMI in England and Wales, improvements in all-cause mortality were observed between 20 03 and 2013. This was significantly associated with use of an invasive coronary strategy and not entirely related to a decline in baseline clinical risk or increased use of pharmacological therapies.	[Hall, Marlous; Dondo, Tatendashe B.; Gale, Christopher P.] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds LS2 9JT, W Yorkshire, England; [Yan, Andrew T.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Goodman, Shaun G.] Univ Toronto, Terrence Donnelly Heart Ctr, St Michaels Hosp, Toronto, ON, Canada; [Bueno, Hector] Ctr Nacl Invest Cardiovasc, Madrid, Spain; [Bueno, Hector] Hosp Univ 12 Octubre, Inst Invest I 12, Madrid, Spain; [Bueno, Hector] Hosp Univ 12 Octubre, Dept Cardiol, Madrid, Spain; [Bueno, Hector] Univ Complutense Madrid, Madrid, Spain; [Chew, Derek P.] Flinders Univ S Australia, Dept Cardiovasc Med, Adelaide, SA, Australia; [Brieger, David] Univ Sydney, Dept Cardiol, Concord Hosp, Sydney, NSW, Australia; [Timmis, Adam] Barts Heart Ctr, NIHR Cardiovasc Biomed Res Unit, London, England; [Batin, Phillip D.] Pinderfields Gen Hosp, Aberford Rd, Wakefield, England; [Deanfield, John E.] UCL, Natl Inst Cardiovasc Outcomes Res, London, England; [Hemingway, Harry] UCL, Farr Inst Hlth Informat Res, London, England; [Fox, Keith A. A.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Gale, Christopher P.] York Teaching Hosp NHS Fdn Trust, York, N Yorkshire, England	University of Leeds; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre; Complutense University of Madrid; Flinders University South Australia; Concord Repatriation General Hospital; University of Sydney; Pinderfields Hospital; University of London; University College London; University of London; University College London; University of Edinburgh	Hall, M (corresponding author), Univ Leeds, Leeds Inst Cardiovasc & Metab Med, MRC Bioinformat Ctr, Worsley Bldg,Level 11,Clarendon Way, Leeds LS2 9JT, W Yorkshire, England.	m.s.hall@leeds.ac.uk	Bueno, Hector/I-3910-2015; Kwong, Raymond Y/R-1925-2016; Fox, keith A A/I-3742-2013; Hall, Marlous/O-9985-2019; Hemingway, Harry/C-1219-2009	Bueno, Hector/0000-0003-0277-7596; Kwong, Raymond Y/0000-0001-8212-0759; Hall, Marlous/0000-0003-1246-2627; Hemingway, Harry/0000-0003-2279-0624; Fox, Keith/0000-0002-0140-2752; Gale, Chris/0000-0003-4732-382X; Brieger, David/0000-0001-6115-0326; Dondo, Tatendashe/0000-0002-8337-8425; Chew, Derek/0000-0003-3593-296X; Deanfield, John/0000-0001-8806-6052	British Heart Foundation [PG/13/81/30474]; Heart and Stroke Foundation of Ontario; Medical Research Council [K006584/1]; Arthritis Research UK; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Engineering and Physical Sciences Research Council; National Institute for Health Research; National Institute for Social Care and Health Research (Welsh Assembly Government); Chief Scientist Office (Scottish Government Health Directorates); Wellcome Trust; National Institute for Health Research [NIHR-CTF-2014-03-03, NIHR/C5009/004]; MRC [MR/L01629X/1] Funding Source: UKRI; Medical Research Council [MR/K006584/1, MR/L01629X/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10130] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research (Welsh Assembly Government); Chief Scientist Office (Scottish Government Health Directorates); Wellcome Trust(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	MINAP is commissioned by the Health Quality Improvement Partnership as part of the National Clinical Audit and Patient Outcomes Programme. Dr Hall and Ms Dondo are funded by the British Heart Foundation (project grant PG/13/81/30474). Dr Goodman is supported by the Heart and Stroke Foundation of Ontario in his role as Heart and Stroke Foundation (Polo) chair at the University of Toronto. Dr Hemingway and the Farr Institute of Health Informatics Research are funded by the Medical Research Council (grant K006584/1) in partnership with Arthritis Research UK, the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the National Institute for Health Research, the National Institute for Social Care and Health Research (Welsh Assembly Government), the Chief Scientist Office (Scottish Government Health Directorates), and the Wellcome Trust, Dr Gale is funded by the National Institute for Health Research (grant NIHR-CTF-2014-03-03; NIHR/C5009/004) as associate professor and honorary consultant cardiologist.	Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2645, DOI [10.1016/j.jacc.2014.09.016, 10.1016/j.jacc.2014.09.017]; Birkhead JS, 2009, HEART, V95, P1593, DOI 10.1136/hrt.2008.164426; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Cattle BA, 2011, STAT MED, V30, P2736, DOI 10.1002/sim.4314; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Fox KAA, 2007, HEART, V93, P177, DOI 10.1136/hrt.2005.084830; Fox KAA, 2005, LANCET, V366, P914, DOI 10.1016/S0140-6736(05)67222-4; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; Gale CP, 2014, HEART, V100, P582, DOI 10.1136/heartjnl-2013-304517; Gale CP, 2012, EUR HEART J, V33, P630, DOI 10.1093/eurheartj/ehr381; Gierlotka M, 2012, AM J CARDIOL, V109, P779, DOI 10.1016/j.amjcard.2011.10.041; Goldberg RJ, 2004, AM J CARDIOL, V94, P1373, DOI 10.1016/j.amjcard.2004.07.142; Henderson RA, 2015, J AM COLL CARDIOL, V66, P511, DOI 10.1016/j.jacc.2015.05.051; Herrett E, 2010, HEART, V96, P1264, DOI 10.1136/hrt.2009.192328; Hoenig MR, 2010, COCHRANE DB SYST REV, V3; Khera S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000995; Lagerqvist B, 2006, LANCET, V368, P998, DOI 10.1016/S0140-6736(06)69416-6; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Mills NL, 2011, JAMA-J AM MED ASSOC, V305, P1210, DOI 10.1001/jama.2011.338; Mills NL, 2012, BMJ-BRIT MED J, V344, pe1533; National Institute for Health and Care Excellence, 2010, CLIN GUID 94; O'Donoghue M, 2008, JAMA-J AM MED ASSOC, V300, P71, DOI 10.1001/jama.300.1.71; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Royston P, 2011, FLEXIBLE PARAMETRIC; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Shah ASV, 2015, LANCET, V386, P2481, DOI 10.1016/S0140-6736(15)00391-8; Shah ASV, 2015, AM J MED, V128, P493, DOI 10.1016/j.amjmed.2014.10.056; Shah ASV, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/bmj.h626, 10.1136/bmj.g7873]; Simms AD, 2015, EUR HEART J-ACUTE CA, V4, P241, DOI 10.1177/2048872614548602; Simms AD, 2013, HEART, V99, P35, DOI 10.1136/heartjnl-2012-302632; Spencer FA, 2005, AM HEART J, V150, P838, DOI 10.1016/j.ahj.2004.11.005	34	66	67	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2016	316	10					1073	1082		10.1001/jama.2016.10766	http://dx.doi.org/10.1001/jama.2016.10766			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV5TB	27574717	Green Published, Bronze			2022-12-28	WOS:000382991100019
J	Manian, FA; Barshak, MB; Lowry, KP; Basnet, KM; Stowell, CP				Manian, Farrin A.; Barshak, Miriam B.; Lowry, Kathryn P.; Basnet, Kristen M.; Stowell, Christopher P.			Case 27-2016: A 71-Year-Old Woman with Mullerian Carcinoma, Fever, Fatigue, and Myalgias	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COST-EFFECTIVENESS; HUMAN BABESIOSIS; PRIMARY SURGERY; RISK; SPLENECTOMY; READMISSION; GUIDELINES; DIAGNOSIS; DISEASES; MICROTI		[Manian, Farrin A.; Barshak, Miriam B.] Harvard Med Sch, Dept Med, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Lowry, Kathryn P.] Harvard Med Sch, Dept Radiol, Massachusetts Gen Hosp, Boston, MA USA; [Basnet, Kristen M.; Stowell, Christopher P.] Harvard Med Sch, Dept Pathol, Massachusetts Gen Hosp, Boston, MA USA; [Manian, Farrin A.; Barshak, Miriam B.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Lowry, Kathryn P.] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Basnet, Kristen M.; Stowell, Christopher P.] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Manian, FA (corresponding author), Harvard Med Sch, Dept Med, Massachusetts Gen Hosp, Boston, MA 02115 USA.							AlHilli M, 2015, INT J GYNECOL CANCER, V25, P193, DOI 10.1097/IGC.0000000000000339; [Anonymous], 2014, FAT REP FDA FOLL BLO; Arauz D, 2016, EMERG INFECT DI 0428; Bern C, 2011, CLIN MICROBIOL REV, V24, P655, DOI 10.1128/CMR.00005-11; Bihl F, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-25; Bish EK, 2015, TRANSFUSION, V55, P2256, DOI 10.1111/trf.13136; Brouwer EE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-439; Centers for Disease Control and Prevention, 2016, ZIK VIR TRANSM RISKS; Clark RM, 2013, GYNECOL ONCOL, V130, P407, DOI 10.1016/j.ygyno.2013.05.034; Cursino-Santos JR, 2014, TRANSFUSION, V54, P585, DOI 10.1111/trf.12357; Edgren G, 2014, ANN SURG, V260, P1081, DOI 10.1097/SLA.0000000000000439; Ejstrud P, 2000, SCAND J INFECT DIS, V32, P521, DOI 10.1080/003655400458811; Fekety R, 1997, AM J GASTROENTEROL, V92, P739; FRY DE, 1994, SURG CLIN N AM, V74, P693, DOI 10.1016/S0039-6109(16)46337-1; Herwaldt BL, 2011, ANN INTERN MED, V155, P509, DOI 10.7326/0003-4819-155-8-201110180-00362; Homer MJ, 2000, CLIN MICROBIOL REV, V13, P451, DOI 10.1128/CMR.13.3.451-469.2000; Hyman N, 2007, ANN SURG, V245, P254, DOI 10.1097/01.sla.0000225083.27182.85; Kawsar HI, 2012, BMJ CASE REP, V2012, P13; Kornmann VNN, 2014, INT J COLORECTAL DIS, V29, P445, DOI 10.1007/s00384-013-1815-5; Krause PJ, 2008, CLIN INFECT DIS, V46, P370, DOI 10.1086/525852; Krause PJ, 2003, AM J TROP MED HYG, V68, P431, DOI 10.4269/ajtmh.2003.68.431; Maldonado O, 1998, J CLIN GASTROENTEROL, V27, P342, DOI 10.1097/00004836-199812000-00013; Moffett Sandra L, 2009, JAAPA, V22, P36; Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9; Nichols KG, 2003, BLOOD, V101, P4195, DOI 10.1182/blood-2002-10-3143; Perlmutter BL, 1999, AM FAM PHYSICIAN, V60, P535; Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042; Pozzetto Bruno, 2015, World J Virol, V4, P113, DOI 10.5501/wjv.v4.i2.113; Ryder SD, 2001, BRIT MED J, V322, P151, DOI 10.1136/bmj.322.7279.151; Simon MS, 2014, TRANSFUSION, V54, P889, DOI 10.1111/trf.12492; Singal AK, 2013, MAYO CLIN PROC, V88, P285, DOI 10.1016/j.mayocp.2013.01.012; Staples J, 2015, INFECT DIS RELATED T; Taylor GH, 2003, AM FAM PHYSICIAN, V67, P519; Teal AE, 2012, J CLIN MICROBIOL, V50, P903, DOI 10.1128/JCM.05848-11; Tran CW, 2015, GYNECOL ONCOL, V136, P278, DOI 10.1016/j.ygyno.2014.12.007; White DJ, 1998, ARCH INTERN MED, V158, P2149, DOI 10.1001/archinte.158.19.2149; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667	37	0	0	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2016	375	10					981	991		10.1056/NEJMcpc1607091	http://dx.doi.org/10.1056/NEJMcpc1607091			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU9IG	27602671				2022-12-28	WOS:000382529500013
J	McGowan, PJK				McGowan, Philip J. K.			CONSERVATION Mapping the terrestrial human footprint	NATURE			English	Editorial Material									[McGowan, Philip J. K.] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	McGowan, PJK (corresponding author), Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	philip.mcgowan@newcastle.ac.uk						Corlett RT, 2015, TRENDS ECOL EVOL, V30, P36, DOI 10.1016/j.tree.2014.10.007; Crutzen P, 2000, GLOBAL CHANGE NEWSLE, V41, P17; Maxwell S, 2016, NATURE, V536, P143, DOI 10.1038/536143a; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Venter O., 2016, NATURE COMMUN; Venter O, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.67	8	19	19	2	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					172	173		10.1038/537172a	http://dx.doi.org/10.1038/537172a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU9LQ	27604944				2022-12-28	WOS:000382539100033
J	Ran, ML; Wang, Y				Ran, Menglong; Wang, Yang			Generalized Granuloma Annulare Associated with Diabetes Mellitus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ran, Menglong; Wang, Yang] Peking Univ, Hosp 1, Beijing, Peoples R China	Peking University	Wang, Y (corresponding author), Peking Univ, Hosp 1, Beijing, Peoples R China.	yangwang_dr@bjmu.edu.cn		, Yang/0000-0001-7805-2861					0	3	3	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2016	375	10					E21	E21		10.1056/NEJMicm1513798	http://dx.doi.org/10.1056/NEJMicm1513798			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU9IG	27602682				2022-12-28	WOS:000382529500012
J	Paynter, NP; Cook, NR				Paynter, Nina P.; Cook, Nancy R.			Adding tests to risk based guidelines: evaluating improvements in prediction for an intermediate risk group	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR RISK; DISEASE; TRIAL	Using an additional test in patients who are not at high enough risk of developing disease to confidently treat, or low enough risk to confidently not treat would seem to be a straightforward way to resolve the clinical equipoise and is recommended by many guidelines. However, clear methods for evaluating the population utility of additional tests in this group have not been established. This paper includes worked examples and simulation data to show that focus on the intermediate risk group alone can be misleading and that population utility is best evaluated across the full range of risk.	[Paynter, Nina P.; Cook, Nancy R.] Brigham & Womens Hosp, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Paynter, NP (corresponding author), Brigham & Womens Hosp, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA.	npaynter@partners.org			National Heart, Lung, and Blood Institute [HL113080]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113080] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported by grant HL113080 from the National Heart, Lung, and Blood Institute. The funder had no role in the study design, analysis, or reporting.	Cook NR, 2011, BIOMETRICAL J, V53, P237, DOI 10.1002/bimj.201000078; Deanfield J, 2014, HEART, V100, P1, DOI 10.1136/heartjnl-2014-305693; Demler OV, 2012, STAT MED, V31, P2577, DOI 10.1002/sim.5328; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Hippisley-Cox J, 2008, PREDICTING CARDIOVAS; Kullo IJ, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0122-0; National Institute for Health and Care Excellence, 2014, CARDIOVASCULAR DISEA; Paynter NP, 2013, MED DECIS MAKING, V33, P154, DOI 10.1177/0272989X12461856; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pepe MS, 2013, STAT MED, V32, P1467, DOI 10.1002/sim.5727; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	15	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 7	2016	354								i4450	10.1136/bmj.i4450	http://dx.doi.org/10.1136/bmj.i4450			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV7FG	27604897	Green Published, Bronze			2022-12-28	WOS:000383101100003
J	Fraser, B; Willer, H				Fraser, Barbara; Willer, Hildegard			Venezuela: aid needed to ease health crisis	LANCET			English	Editorial Material																			0	9	10	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2016	388	10048					947	949		10.1016/S0140-6736(16)31523-9	http://dx.doi.org/10.1016/S0140-6736(16)31523-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU9GL	27598666				2022-12-28	WOS:000382524400010
J	Rudin, RS; Bates, DW; MacRae, C				Rudin, Robert S.; Bates, David W.; MacRae, Calum			Accelerating Innovation in Health IT	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rudin, Robert S.] RAND, Boston, MA 02116 USA; [Bates, David W.] Brigham & Womens Hosp, Div Gen Med & Primary Care, 75 Francis St, Boston, MA 02115 USA; [MacRae, Calum] Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Bates, David W.] Harvard Med Sch, Boston, MA USA; [Bates, David W.] Harvard Sch Publ Hlth, Boston, MA USA; [MacRae, Calum] Broad Inst Harvard & MIT, Cambridge, MA USA	RAND Corporation; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Rudin, RS (corresponding author), RAND, Boston, MA 02116 USA.		Bates, David/AAE-7283-2019		NHGRI NIH HHS [R01 HG009174] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009174] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Friedberg M.W., 2013, FACTORS AFFECTING PH; Jones SS, 2012, NEW ENGL J MED, V366, P2243, DOI 10.1056/NEJMp1204980; Ratwani RM, 2015, J AM MED INFORM ASSN, V22, P1179, DOI 10.1093/jamia/ocv050	3	27	27	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2016	375	9					815	817		10.1056/NEJMp1606884	http://dx.doi.org/10.1056/NEJMp1606884			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU9HA	27579633	Green Accepted			2022-12-28	WOS:000382526000004
J	Sarant, L				Sarant, Louise			An end to oil dependency	NATURE			English	Editorial Material																			0	4	4	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					S6	S7		10.1038/537S6a	http://dx.doi.org/10.1038/537S6a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU7XC	27580141	Bronze			2022-12-28	WOS:000382426900019
J	Sokol, D				Sokol, Daniel			ETHICS MAN Preparing for when things go wrong	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sokol, Daniel] 12 Kings Bench Walk, London, England		Sokol, D (corresponding author), 12 Kings Bench Walk, London, England.	Sokol@12kbw.co.uk						Marsh H., 2014, DO NO HARM	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 25	2016	354								i4627	10.1136/bmj.i4627	http://dx.doi.org/10.1136/bmj.i4627			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AA	27562766				2022-12-28	WOS:000382792200004
J	Mueller, KL; Hines, PJ; Travis, J				Mueller, Kristen L.; Hines, Pamela J.; Travis, John			NEUROIMMUNOLOGY Immune cells on the brain	SCIENCE			English	Editorial Material																			0	5	5	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					760	760		10.1126/science.353.6301.760	http://dx.doi.org/10.1126/science.353.6301.760			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZE	27540161				2022-12-28	WOS:000381561400031
J	Wallentin, L; Lindhagen, L; Arnstrom, E; Husted, S; Janzon, M; Johnsen, SP; Kontny, F; Kempf, T; Levin, LA; Lindahl, B; Stridsberg, M; Stahle, E; Venge, P; Wollert, KC; Swahn, E; Lagerqvist, B				Wallentin, Lars; Lindhagen, Lars; Arnstrom, Elisabet; Husted, Steen; Janzon, Magnus; Johnsen, Soren Paaske; Kontny, Frederic; Kempf, Tibor; Levin, Lars-Ake; Lindahl, Bertil; Stridsberg, Mats; Stahle, Elisabeth; Venge, Per; Wollert, Kai C.; Swahn, Eva; Lagerqvist, Bo		FRISC-II Study Grp	Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study	LANCET			English	Article							GROWTH-DIFFERENTIATION FACTOR-15; ARTERY-DISEASE; UNSTABLE ANGINA; MYOCARDIAL-INFARCTION; CONSERVATIVE TREATMENT; TROPONIN-T; PROGNOSTIC VALUE; STRATEGY; WOMEN; METAANALYSIS	Background The FRISC-II trial was the first randomised trial to show a reduction in death or myocardial infarction with an early invasive versus a non-invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome. Here we provide a remaining lifetime perspective on the effects on all cardiovascular events during 15 years' follow-up. Methods The FRISC-II prospective, randomised, multicentre trial was done at 58 Scandinavian centres in Sweden, Denmark, and Norway. Between June 17, 1996, and Aug 28, 1998, we randomly assigned (1:1) 2457 patients with non-ST-elevation acute coronary syndrome to an early invasive treatment strategy, aiming for revascularisation within 7 days, or a non-invasive strategy, with invasive procedures at recurrent symptoms or severe exercise-induced ischaemia. Plasma for biomarker analyses was obtained at randomisation. For long-term outcomes, we linked data with national health-care registers. The primary endpoint was a composite of death or myocardial infarction. Outcomes were compared as the average postponement of the next event, including recurrent events, calculated as the area between mean cumulative count-of-events curves. Analyses were done by intention to treat. Findings At a minimum of 15 years' follow-up on Dec 31, 2014, data for survival status and death were available for 2421 (99%) of the initially recruited 2457 patients, and for other events after 2 years for 2182 (89%) patients. During follow-up, the invasive strategy postponed death or next myocardial infarction by a mean of 549 days (95% CI 204-888; p= 0.0020) compared with the non-invasive strategy. This effect was larger in non-smokers (mean gain 809 days, 95% CI 402-1175; p(interaction) = 0.0182), patients with elevated troponin T (778 days, 357-1165; p (interaction) = 0.0241), and patients with high concentrations of growth differentiation factor-15 (1356 days, 507-1650; p (interaction) = 0.0210). The difference was mainly driven by postponement of new myocardial infarction, whereas the early difference in mortality alone was not sustained over time. The invasive strategy led to a mean of 1128 days (95% CI 830-1366) postponement of death or next readmission to hospital for ischaemic heart disease, which was consistent in all subgroups (p< 0.0001). Interpretation During 15 years of follow-up, an early invasive treatment strategy postponed the occurrence of death or next myocardial infarction by an average of 18 months, and the next readmission to hospital for ischaemic heart disease by 37 months, compared with a non-invasive strategy in patients with non-ST-elevation acute coronary syndrome. This remaining lifetime perspective supports that an early invasive treatment strategy should be the preferred option in most patients with non-ST-elevation acute coronary syndrome.	[Wallentin, Lars; Lindahl, Bertil; Lagerqvist, Bo] Uppsala Univ, Dept Med Sci, Cardiol, Uppsala, Sweden; [Wallentin, Lars; Lindhagen, Lars; Arnstrom, Elisabet; Lindahl, Bertil; Lagerqvist, Bo] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Stridsberg, Mats; Venge, Per] Uppsala Univ, Dept Med Sci, Clin Chem, Uppsala, Sweden; [Stahle, Elisabeth] Uppsala Univ, Dept Surg Sci, Thorac Surg, Uppsala, Sweden; [Husted, Steen] Hosp Unit West, Dept Med, Herning Holstebro, Denmark; [Janzon, Magnus; Levin, Lars-Ake; Swahn, Eva] Linkoping Univ, Dept Cardiol, Linkoping, Sweden; [Janzon, Magnus; Levin, Lars-Ake; Swahn, Eva] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Janzon, Magnus; Levin, Lars-Ake] Linkoping Univ, Div Hlth Care Anal, Dept Med & Hlth Sci, Ctr Med Technol Assessment, Linkoping, Sweden; [Johnsen, Soren Paaske] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Kontny, Frederic] Stavanger Univ Hosp, Dept Cardiol, Stavanger, Norway; [Kontny, Frederic] Drammen Heart Ctr, Drammen, Norway; [Kempf, Tibor; Wollert, Kai C.] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany	Uppsala University; Uppsala University; Uppsala University; Uppsala University; Linkoping University; Linkoping University; Linkoping University; Aarhus University; Stavanger University Hospital; Hannover Medical School	Wallentin, L (corresponding author), Uppsala Clin Res Ctr, Dag Hammarskjolds Vag 14B,MTC Bldg,Sci Pk, S-75237 Uppsala, Sweden.	lars.wallentin@ucr.uu.se	Kempf, Tibor/ABA-3167-2021	Kempf, Tibor/0000-0001-6901-8442	Swedish Heart-Lung Foundation; Swedish Foundation for Strategic Research; Uppsala Clinical Research Center	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Uppsala Clinical Research Center	Swedish Heart-Lung Foundation, Swedish Foundation for Strategic Research, and Uppsala Clinical Research Center.	Alfredsson J, 2014, AM HEART J, V168, P522, DOI 10.1016/j.ahj.2014.06.025; Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2645, DOI [10.1016/j.jacc.2014.09.016, 10.1016/j.jacc.2014.09.017]; Bavry AA, 2006, J AM COLL CARDIOL, V48, P1319, DOI 10.1016/j.jacc.2006.06.050; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Clayton TC, 2004, EUR HEART J, V25, P1641, DOI 10.1016/j.ehj.2004.07.032; Damman P, 2014, INT J CARDIOL, V172, P356, DOI 10.1016/j.ijcard.2014.01.025; de Winter RJ, 2005, NEW ENGL J MED, V353, P1095, DOI 10.1056/NEJMoa044259; Diderholm E, 2002, AM HEART J, V143, P760, DOI 10.1067/mhj.2002.121733; Dong HR, 2015, AM J EPIDEMIOL, V181, P532, DOI 10.1093/aje/kwu289; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Fox KAA, 2010, J AM COLL CARDIOL, V55, P2435, DOI 10.1016/j.jacc.2010.03.007; Hagstrom E, 2016, EUR HEART J, V37, P1325, DOI 10.1093/eurheartj/ehv491; Henderson RA, 2015, J AM COLL CARDIOL, V66, P511, DOI 10.1016/j.jacc.2015.05.051; Jernberg T, 2004, EUR J HEART FAIL, V6, P319, DOI 10.1016/j.ejheart.2004.01.007; Jernberg T, 2010, HEART, V96, P1617, DOI 10.1136/hrt.2010.198804; Lagerqvist B, 2002, J AM COLL CARDIOL, V40, P1902, DOI 10.1016/S0735-1097(02)02572-X; Lagerqvist B, 2001, J AM COLL CARDIOL, V38, P41, DOI 10.1016/S0735-1097(01)01308-0; Lagerqvist B, 2006, LANCET, V368, P998, DOI 10.1016/S0140-6736(06)69416-6; Lindahl B, 2001, J AM COLL CARDIOL, V38, P979, DOI 10.1016/S0735-1097(01)01501-7; Manfrini O, 2016, SCI REP-UK, V6, DOI 10.1038/srep27345; Morrow DA, 2001, JAMA-J AM MED ASSOC, V286, P2405, DOI 10.1001/jama.286.19.2405; O'Donoghue M, 2008, JAMA-J AM MED ASSOC, V300, P71, DOI 10.1001/jama.300.1.71; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Tegn N, 2016, LANCET, V387, P1057, DOI 10.1016/S0140-6736(15)01166-6; Venge P, 2002, AM J CARDIOL, V89, P1035, DOI 10.1016/S0002-9149(02)02271-3; Wallentin L, 1999, LANCET, V354, P708; Wallentin L, 2000, LANCET, V356, P9, DOI 10.1016/S0140-6736(00)02427-2; Wallentin L, 2014, CIRCULATION, V129, P293, DOI 10.1161/CIRCULATIONAHA.113.004420; Wollert KC, 2007, CIRCULATION, V116, P1540, DOI 10.1161/CIRCULATIONAHA.107.697714; Wollert KC, 2007, CIRCULATION, V115, P962, DOI 10.1161/CIRCULATIONAHA.106.650846	30	50	54	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 15	2016	388	10054					1903	1911		10.1016/S0140-6736(16)31276-4	http://dx.doi.org/10.1016/S0140-6736(16)31276-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ0AM	27585757				2022-12-28	WOS:000385499000034
J	Olsson, A; Venkatasubramanian, M; Chaudhri, VK; Aronow, BJ; Salomonis, N; Singh, H; Grimes, HL				Olsson, Andre; Venkatasubramanian, Meenakshi; Chaudhri, Viren K.; Aronow, Bruce J.; Salomonis, Nathan; Singh, Harinder; Grimes, H. Leighton			Single-cell analysis of mixed-lineage states leading to a binary cell fate choice	NATURE			English	Article							COLONY-STIMULATING FACTOR; GENE-EXPRESSION-DATA; EMBRYONIC STEM-CELLS; FLUORESCENT PROTEIN; RNA-SEQ; MYELOID PROGENITOR; HUMAN NEUTROPENIA; DEFICIENT MICE; HUMAN GENOME; DIFFERENTIATION	Delineating hierarchical cellular states, including rare intermediates and the networks of regulatory genes that orchestrate cell-type specification, are continuing challenges for developmental biology. Single-cell RNA sequencing is greatly accelerating such research, given its power to provide comprehensive descriptions of genomic states and their presumptive regulators(1-5). Haematopoietic multipotential progenitor cells, as well as bipotential intermediates, manifest mixed-lineage patterns of gene expression at a single-cell level(6,7). Such mixed-lineage states may reflect the molecular priming of different developmental potentials by co-expressed alternative-lineage determinants, namely transcription factors. Although a bistable gene regulatory network has been proposed to regulate the specification of either neutrophils or macrophages(7,8), the nature of the transition states manifested in vivo, and the underlying dynamics of the cell-fate determinants, have remained elusive. Here we use single-cell RNA sequencing coupled with a new analytic tool, iterative clustering and guide-gene selection, and clonogenic assays to delineate hierarchical genomic and regulatory states that culminate in neutrophil or macrophage specification in mice. We show that this analysis captured prevalent mixed-lineage intermediates that manifested concurrent expression of haematopoietic stem cell/progenitor and myeloid progenitor cell genes. It also revealed rare metastable intermediates that had collapsed the haematopoietic stem cell/progenitor gene expression programme, instead expressing low levels of the myeloid determinants, Irf8 and Gfi1 (refs 9-13). Genetic perturbations and chromatin immunoprecipitation followed by sequencing revealed Irf8 and Gfi1 as key components of counteracting myeloid-gene-regulatory networks. Combined loss of these two determinants 'trapped' the metastable intermediate. We propose that mixed-lineage states are obligatory during cell-fate specification, manifest differing frequencies because of their dynamic instability and are dictated by counteracting gene-regulatory networks.	[Olsson, Andre; Chaudhri, Viren K.; Singh, Harinder; Grimes, H. Leighton] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Olsson, Andre; Chaudhri, Viren K.; Singh, Harinder; Grimes, H. Leighton] Cincinnati Childrens Hosp Med Ctr, Ctr Syst Immunol, Cincinnati, OH 45229 USA; [Venkatasubramanian, Meenakshi; Aronow, Bruce J.; Salomonis, Nathan] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Grimes, H. Leighton] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Singh, H; Grimes, HL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA.; Singh, H; Grimes, HL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Ctr Syst Immunol, Cincinnati, OH 45229 USA.; Salomonis, N (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA.; Grimes, HL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.	nathan.salomonis@cchmc.org; harinder.singh@cchmc.org; Lee.grimes@cchmc.org	Chaudhri, Virendra/S-9767-2019	Chaudhri, Virendra/0000-0003-3528-4667; Singh, Harinder/0000-0002-6330-8526; Grimes, H. Leighton/0000-0001-8162-6758	NIH [AR-47363, DK78392, DK90971, RO1HL122661]; CCRF; CCHMC Divisions of Pathology and Oncology; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR047363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090971, P30DK078392] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCRF; CCHMC Divisions of Pathology and Oncology; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. C. Morse for supplying Irf8-GFP mice. We acknowledge the assistance of the Cincinnati Children's Hospital Medical Center (CCHMC) Research Flow Cytometry Core (supported in part by NIH grants AR-47363, NIH DK78392 and NIH DK90971) and DNA Sequencing and Genotyping Core. We thank S. Smith and H. C. Liang for optimizing and generating scRNA-seq libraries We thank S. Potter and J. Whitsett for advice on scRNA-seq experiments, P. Dexheimer and K. Chetal for assistance with RNA-seq data processing, and K Pollard, L. Omberg and A. Khan for discussions. This work was partly funded by contributions from CCRF (H.S. and N.S.), CCHMC Divisions of Pathology and Oncology, and NIH RO1HL122661 (H.L.G.).	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Brass AL, 1999, EMBO J, V18, P977, DOI 10.1093/emboj/18.4.977; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Emig D, 2010, NUCLEIC ACIDS RES, V38, pW755, DOI 10.1093/nar/gkq405; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Guibal FC, 2009, BLOOD, V114, P5415, DOI 10.1182/blood-2008-10-182071; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Kartashov AV, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0720-3; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kurotaki D, 2013, BLOOD, V121, P1839, DOI 10.1182/blood-2012-06-437863; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Marco E, 2014, P NATL ACAD SCI USA, V111, pE5643, DOI 10.1073/pnas.1408993111; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Spooner CJ, 2013, NAT IMMUNOL, V14, P1229, DOI 10.1038/ni.2743; Spooner CJ, 2009, IMMUNITY, V31, P576, DOI 10.1016/j.immuni.2009.07.011; Tamura T, 2000, IMMUNITY, V13, P155, DOI 10.1016/S1074-7613(00)00016-9; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Voehringer D, 2007, J LEUKOCYTE BIOL, V81, P1434, DOI 10.1189/jlb.1106686; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Wang HS, 2014, J IMMUNOL, V193, P1766, DOI 10.4049/jimmunol.1301939; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yucel R, 2004, J BIOL CHEM, V279, P40906, DOI 10.1074/jbc.M400808200; Zarebski A, 2008, IMMUNITY, V28, P370, DOI 10.1016/j.immuni.2007.12.020; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569	50	296	298	3	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2016	537	7622					698	+		10.1038/nature19348	http://dx.doi.org/10.1038/nature19348			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4DR	27580035	Green Accepted			2022-12-28	WOS:000384331700054
J	Myung, JH; Neagu, D; Miller, DN; Irvine, JTS				Myung, Jae-ha; Neagu, Dragos; Miller, David N.; Irvine, John T. S.			Switching on electrocatalytic activity in solid oxide cells	NATURE			English	Article							IN-SITU; PERFORMANCE; NICKEL	Solid oxide cells (SOCs) can operate with high efficiency in two ways-as fuel cells, oxidizing a fuel to produce electricity, and as electrolysis cells, electrolysing water to produce hydrogen and oxygen gases. Ideally, SOCs should perform well, be durable and be inexpensive, but there are often competitive tensions, meaning that, for example, performance is achieved at the expense of durability. SOCs consist of porous electrodes-the fuel and air electrodes-separated by a dense electrolyte. In terms of the electrodes, the greatest challenge is to deliver high, long-lasting electrocatalytic activity while ensuring cost-and time-efficient manufacture(1). This has typically been achieved through lengthy and intricate ex situ procedures. These often require dedicated precursors and equipment(1-3); moreover, although the degradation of such electrodes associated with their reversible operation can be mitigated(4), they are susceptible to many other forms of degradation(5). An alternative is to grow appropriate electrode nanoarchitectures under operationally relevant conditions, for example, via redox exsolution(6-10). Here we describe the growth of a finely dispersed array of anchored metal nanoparticles on an oxide electrode through electrochemical poling of a SOC at 2 volts for a few seconds. These electrode structures perform well as both fuel cells and electrolysis cells (for example, at 900 degrees C they deliver 2 watts per square centimetre of power in humidified hydrogen gas, and a current of 2.75 amps per square centimetre at 1.3 volts in 50% water/nitrogen gas). The nanostructures and corresponding electrochemical activity do not degrade in 150 hours of testing. These results not only prove that in operando methods can yield emergent nanomaterials, which in turn deliver exceptional performance, but also offer proof of concept that electrolysis and fuel cells can be unified in a single, high-performance, versatile and easily manufactured device. This opens up the possibility of simple, almost instantaneous production of highly active nanostructures for reinvigorating SOCs during operation.	[Myung, Jae-ha; Neagu, Dragos; Miller, David N.; Irvine, John T. S.] Univ St Andrews, Sch Chem, St Andrews KY16 9ST, Fife, Scotland	University of St Andrews	Myung, JH; Neagu, D; Irvine, JTS (corresponding author), Univ St Andrews, Sch Chem, St Andrews KY16 9ST, Fife, Scotland.	jm297@st-andrews.ac.uk; dn67@st-andrews.ac.uk; jtsi@st-andrews.ac.uk	Neagu, Dragos/U-8181-2019	Neagu, Dragos/0000-0001-7208-1055; Irvine, John/0000-0002-8394-3359; Myung, Jae-ha/0000-0002-7018-9668	Engineering and Physical Sciences Research Council (EPSRC) [EP/K015540/1]; EPSRC Material World Network [EP/J018414/1]; EPSRC [EP/K021036/1, EP/G01244X/1, EP/L017008/1]; Royal Society Wolfson Merit Award [WRMA 2012/R2]; EPSRC [EP/K021036/2, EP/J018414/1, EP/K015540/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G01244X/1, EP/L017008/1, EP/K021036/2, EP/K021036/1, EP/K015540/1, EP/J018414/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC Material World Network(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society Wolfson Merit Award(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge support from the Engineering and Physical Sciences Research Council (EPSRC) Platform (grant EP/K015540/1), the EPSRC Material World Network (EP/J018414/1), EPSRC SUPERGEN Projects (EP/K021036/1 and EP/G01244X/1), EPSRC Capital for Great Technologies grant (EP/L017008/1) and a Royal Society Wolfson Merit Award (WRMA 2012/R2).	Graves C, 2015, NAT MATER, V14, P239, DOI [10.1038/NMAT4165, 10.1038/nmat4165]; Irvine JTS, 2016, NAT ENERGY, V1, DOI 10.1038/NENERGY.2015.14; Irvine JTS., 2013, SOLID OXIDE FUELS CE, P163; Jiang SP, 2006, MAT SCI ENG A-STRUCT, V418, P199, DOI 10.1016/j.msea.2005.11.052; Jung W, 2014, ENERG ENVIRON SCI, V7, P1685, DOI 10.1039/c3ee43546f; Kobsiriphat W, 2010, J ELECTROCHEM SOC, V157, pB279, DOI 10.1149/1.3269993; Neagu D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9120; Neagu D, 2013, NAT CHEM, V5, P916, DOI [10.1038/nchem.1773, 10.1038/NCHEM.1773]; Neagu D, 2010, CHEM MATER, V22, P5042, DOI 10.1021/cm101508w; Nenning A, 2016, J PHYS CHEM C, V120, P1461, DOI 10.1021/acs.jpcc.5b08596; Nishihata Y, 2002, NATURE, V418, P164, DOI 10.1038/nature00893; Sengodan S, 2015, NAT MATER, V14, P205, DOI [10.1038/nmat4166, 10.1038/NMAT4166]; Tsekouras G, 2013, ENERG ENVIRON SCI, V6, P256, DOI 10.1039/c2ee22547f; Tsekouras G, 2011, J MATER CHEM, V21, P9367, DOI 10.1039/c1jm11313e	14	297	299	25	419	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2016	537	7621					528	+		10.1038/nature19090	http://dx.doi.org/10.1038/nature19090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW3MO	27548878	Green Accepted			2022-12-28	WOS:000383545900051
J	Andics, A; Gabor, A; Gacsi, M; Farago, T; Szabo, D; Miklosi, A				Andics, A.; Gabor, A.; Gacsi, M.; Farago, T.; Szabo, D.; Miklosi, A.			Neural mechanisms for lexical processing in dogs	SCIENCE			English	Article							AUDITORY-CORTEX; HUMAN BRAIN; SPEECH; REWARD; COMMUNICATION; CALLS; LATERALIZATION; VOCALIZATIONS; RESPONSES; INFANTS	During speech processing, human listeners can separately analyze lexical and intonational cues to arrive at a unified representation of communicative content. The evolution of this capacity can be best investigated by comparative studies. Using functional magnetic resonance imaging, we explored whether and how dog brains segregate and integrate lexical and intonational information. We found a left-hemisphere bias for processing meaningful words, independently of intonation; a right auditory brain region for distinguishing intonationally marked and unmarked words; and increased activity in primary reward regions only when both lexical and intonational information were consistent with praise. Neuralmechanisms to separately analyze and integrate word meaning and intonation in dogs suggest that this capacity can evolve in the absence of language.	[Andics, A.; Gacsi, M.; Farago, T.; Szabo, D.; Miklosi, A.] Eotvos Lorand Univ, MTA ELTE Comparat Ethol Res Grp, Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary; [Andics, A.; Gabor, A.; Szabo, D.; Miklosi, A.] Eotvos Lorand Univ, Dept Ethol, Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary; [Andics, A.] Semmelweis Univ, MR Res Ctr, Balassa U 6, H-1083 Budapest, Hungary	Eotvos Lorand University; MTA-ELTE Comparative Ethology Research Group; Eotvos Lorand University; Semmelweis University	Andics, A (corresponding author), Eotvos Lorand Univ, MTA ELTE Comparat Ethol Res Grp, Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary.; Andics, A (corresponding author), Eotvos Lorand Univ, Dept Ethol, Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary.; Andics, A (corresponding author), Semmelweis Univ, MR Res Ctr, Balassa U 6, H-1083 Budapest, Hungary.	attila.andics@gmail.com	Szabó, Dóra/H-6926-2017; Faragó, Tamás/A-5386-2009	Szabó, Dóra/0000-0001-7902-7713; Faragó, Tamás/0000-0001-5987-2629; Andics, Attila/0000-0002-5913-6100; Gabor, Anna/0000-0002-9832-776X; Gacsi, Marta/0000-0003-3080-7545	Hungarian Academy of Sciences [F01/031]; Hungarian Scientific Research Fund (OTKA) [K100695, K115862, PD116181]; Stanton Foundation	Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Stanton Foundation	The study was supported by the Hungarian Academy of Sciences [Bolyai Scholarship to A.A. and a grant to the MTA-ELTE Comparative Ethology Research Group (F01/031)], the Hungarian Scientific Research Fund (OTKA; grants K100695, K115862, and PD116181), and the Stanton Foundation (Next Generation Canine Research Grant to T.F.). We thank F. Szalay for anatomy advice, and we thank all dog owners. Data are stored at Figshare (http://dx.doi.org/10.6084/m9.figshare.3436538).	Andics A, 2014, CURR BIOL, V24, P574, DOI 10.1016/j.cub.2014.01.058; Belin P, 2008, P ROY SOC B-BIOL SCI, V275, P473, DOI 10.1098/rspb.2007.1460; Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; Berns GS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081698; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Briefer EF, 2012, J ZOOL, V288, P1, DOI 10.1111/j.1469-7998.2012.00920.x; Collier K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0263; Corballis MC, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001767; EHRET G, 1987, NATURE, V325, P249, DOI 10.1038/325249a0; Evans H.E., 2013, MILLERS ANATOMY DOG; Farago T, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0926; FERNALD A, 1989, CHILD DEV, V60, P1497, DOI 10.2307/1130938; Fruhholz S, 2016, NEUROSCI BIOBEHAV R, V68, P96, DOI 10.1016/j.neubiorev.2016.05.002; Gibson JM, 2014, ANIM BEHAV COGNITION, V1, P281, DOI [10.12966/abc.08.05.2014, DOI 10.12966/ABC.08.05.2014]; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Kaminski J, 2004, SCIENCE, V304, P1682, DOI 10.1126/science.1097859; Kerepesi A, 2015, BEHAV PROCESS, V110, P27, DOI 10.1016/j.beproc.2014.02.005; Kotz SA, 2011, LANG LINGUIST COMPAS, V5, P108, DOI 10.1111/j.1749-818x.2010.00267.x; Miklosi A, 2004, ANIM BEHAV, V67, P995, DOI 10.1016/j.anbehav.2003.10.008; Norman-Haignere S, 2013, J NEUROSCI, V33, P19451, DOI 10.1523/JNEUROSCI.2880-13.2013; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Pepperberg IM, 2001, J COMP PSYCHOL, V115, P376, DOI 10.1037//0735-7036.115.4.376; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Pongracz P, 2010, VET J, V183, P141, DOI 10.1016/j.tvjl.2008.12.010; Poremba A, 2004, NATURE, V427, P448, DOI 10.1038/nature02268; Ratcliffe VF, 2014, CURR BIOL, V24, DOI 10.1016/j.cub.2014.10.030; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Salimpoor VN, 2013, SCIENCE, V340, P216, DOI 10.1126/science.1231059; Sauter DA, 2010, P NATL ACAD SCI USA, V107, P2408, DOI 10.1073/pnas.0908239106; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SEYFARTH RM, 1980, SCIENCE, V210, P801, DOI 10.1126/science.7433999; Shtyrov Y, 2005, NEUROIMAGE, V27, P37, DOI 10.1016/j.neuroimage.2005.02.003; Topal J, 2009, SCIENCE, V325, P1269, DOI 10.1126/science.1176960; Voss HU, 2007, P NATL ACAD SCI USA, V104, P10667, DOI 10.1073/pnas.0611515104; Wetzel W, 2008, P NATL ACAD SCI USA, V105, P6753, DOI 10.1073/pnas.0707844105; Wildgruber D, 2006, PROG BRAIN RES, V156, P249, DOI 10.1016/S0079-6123(06)56013-3; Wilke M, 2006, NEUROIMAGE, V33, P522, DOI 10.1016/j.neuroimage.2006.07.010; Yip MJ, 2006, TRENDS COGN SCI, V10, P442, DOI 10.1016/j.tics.2006.08.001	38	88	90	8	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2016	353	6303					1030	1032		10.1126/science.aaf3777	http://dx.doi.org/10.1126/science.aaf3777			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9SU	27576923				2022-12-28	WOS:000382558900039
J	Bertelsmeier, C; Ollier, S				Bertelsmeier, Cleo; Ollier, Sebastien			Questioning Holocene community shifts	NATURE			English	Letter							ECOLOGY		[Bertelsmeier, Cleo] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Ollier, Sebastien] Univ Paris 11, CNRS, Ecol Systematique Evolut, F-91400 Orsay, France	University of Lausanne; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Bertelsmeier, C (corresponding author), Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland.	cleo.bertelsmeier@unil.ch		Lyons, S. Kathleen/0000-0001-5112-2508; Bertelsmeier, Cleo/0000-0003-3624-1300				Corlett RT, 2015, TRENDS ECOL EVOL, V30, P36, DOI 10.1016/j.tree.2014.10.007; Dietl GP, 2016, NATURE, V529, P29, DOI 10.1038/nature16329; Lyons SK, 2016, NATURE, V529, P80, DOI 10.1038/nature16447	3	2	2	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					E4	E5		10.1038/nature19110	http://dx.doi.org/10.1038/nature19110			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27582227				2022-12-28	WOS:000382426900059
J	Dobrovidova, O				Dobrovidova, Olga			A faltering recovery	NATURE			English	Editorial Material																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					S10	S11		10.1038/537S10a	http://dx.doi.org/10.1038/537S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU7XC	27580133	Bronze			2022-12-28	WOS:000382426900021
J	Tang, L; El-Din, TMG; Swanson, TM; Pryde, DC; Scheuer, T; Zheng, N; Catterall, WA				Tang, Lin; El-Din, Tamer M. Gamal; Swanson, Teresa M.; Pryde, David C.; Scheuer, Todd; Zheng, Ning; Catterall, William A.			Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs	NATURE			English	Article							CALCIUM-CHANNELS; SODIUM-CHANNEL; CRYSTAL-STRUCTURE; SKELETAL-MUSCLE; DIHYDROPYRIDINE BINDING; MOLECULAR DETERMINANTS; RECEPTOR; SUBUNIT; PHARMACOLOGY; MECHANISM	Ca2+ antagonist drugs are widely used in therapy of cardiovascular disorders(1,2). Three chemical classes of drugs bind to three separate, but allosterically interacting, receptor sites on Ca(v)1.2 channels, the most prominent voltage-gated Ca2+ (Ca-v) channel type in myocytes in cardiac and vascular smooth muscle'. The 1,4-dihydropyridines are used primarily for treatment of hypertension and angina pectoris and are thought to act as allosteric modulators of voltage-dependent Ca2+ channel activation, whereas phenylalkylamines and benzothiazepines are used primarily for treatment of cardiac arrhythmias and are thought to physically block the pore(1,2). The structural basis for the different binding, action, and therapeutic uses of these drugs remains unknown. Here we present crystallographic and functional analyses of drug binding to the bacterial homotetrameric model Cav channel Ca(v)Ab, which is inhibited by dihydropyridines and phenylalkylamines with nanomolar affinity in a state-dependent manner. The binding site for amlodipine and other dihydropyridines is located on the external, lipid-facing surface of the pore module, positioned at the interface of two subunits. Dihydropyridine binding allosterically induces an asymmetric conformation of the selectivity filter, in which partially dehydrated Ca2+ interacts directly with one subunit and blocks the pore. In contrast, the phenylalkylamine Br-verapamil binds in the central cavity of the pore on the intracellular side of the selectivity filter, physically blocking the ion-conducting pathway. Structure-based mutations of key amino-acid residues confirm drug binding at both sites. Our results define the structural basis for binding of dihydropyridines and phenylalkylamines at their distinct receptor sites on Cav channels and offer key insights into their fundamental mechanisms of action and differential therapeutic uses in cardiovascular diseases.	[Tang, Lin; El-Din, Tamer M. Gamal; Swanson, Teresa M.; Scheuer, Todd; Zheng, Ning; Catterall, William A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Tang, Lin; Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Pryde, David C.] Curadev Pharma, Discovery Pk, Sandwich CT14 9FF, Kent, England	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Tang, L (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.; Tang, L (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.			Catterall, William/0000-0001-5509-3580	National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health [R01 HL112808]; National Research Service Award [T32 GM008268]; Howard Hughes Medical Institute; National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health [R01 NS26254]; Neusentis; Pfizer Inc., Cambridge, UK; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112808, R01HL117896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022625] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health; Neusentis; Pfizer Inc., Cambridge, UK; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the beamline staff at the Advanced Light Source (BL8.2.1 and BL8.2.2) for their assistance during data collection. Research reported in this publication was supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health under award number R01 HL112808 (W.A.C. and N.Z.), and a National Research Service Award from training grant T32 GM008268 (T.M.S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was also supported by research grants from the Howard Hughes Medical Institute (N.Z.) and by the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health under award number R01 NS26254 (W.A.C.). D.C.P. acknowledges support from Neusentis, Pfizer Inc., Cambridge, UK during the course of this work.	BANGALORE R, 1994, MOL PHARMACOL, V46, P660; Catterall W. A., 2011, VOLTAGE GATED CALCIU; CATTERALL WA, 1992, TRENDS PHARMACOL SCI, V13, P256, DOI 10.1016/0165-6147(92)90079-L; Catterall WA, 2015, TRENDS BIOCHEM SCI, V40, P526, DOI 10.1016/j.tibs.2015.07.002; Cheng RCK, 2009, J BIOL CHEM, V284, P28332, DOI 10.1074/jbc.M109.027326; GLOSSMANN H, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1917; HermundstadAM BassettDS, 2013, P NATL ACAD SCI US, V110, P6169, DOI 10.1073/pnas.1219562110; HESCHELER J, 1982, PFLUG ARCH EUR J PHY, V393, P287, DOI 10.1007/BF00581411; HOCKERMAN GH, 1995, J BIOL CHEM, V270, P22119, DOI 10.1074/jbc.270.38.22119; Hockerman GH, 1997, ANNU REV PHARMACOL, V37, P361, DOI 10.1146/annurev.pharmtox.37.1.361; Hofmann F, 1999, REV PHYSIOL BIOCH P, V139, P33, DOI 10.1007/BFb0033648; HONDEGHEM LM, 1984, ANNU REV PHARMACOL, V24, P387, DOI 10.1146/annurev.pa.24.040184.002131; KASS RS, 1991, J GEN PHYSIOL, V98, P63, DOI 10.1085/jgp.98.1.63; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MURPHY KMM, 1983, P NATL ACAD SCI-BIOL, V80, P860, DOI 10.1073/pnas.80.3.860; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; PETERSON BZ, 1995, J BIOL CHEM, V270, P18201, DOI 10.1074/jbc.270.31.18201; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Striessnig J, 1999, CELL PHYSIOL BIOCHEM, V9, P242, DOI 10.1159/000016320; STRIESSNIG J, 1990, P NATL ACAD SCI USA, V87, P9108, DOI 10.1073/pnas.87.23.9108; TAKAHASHI M, 1987, P NATL ACAD SCI USA, V84, P5478, DOI 10.1073/pnas.84.15.5478; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; Tang L, 2014, NATURE, V505, P56, DOI 10.1038/nature12775; Tikhonov DB, 2009, J BIOL CHEM, V284, P19006, DOI 10.1074/jbc.M109.011296; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395; Yamaguchi S, 2003, MOL PHARMACOL, V64, P235, DOI 10.1124/mol.64.2.235; YATANI A, 1985, CIRC RES, V56, P868, DOI 10.1161/01.RES.56.6.868; Zamponi GW, 2015, PHARMACOL REV, V67, P821, DOI 10.1124/pr.114.009654; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	30	121	121	3	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					117	121		10.1038/nature19102	http://dx.doi.org/10.1038/nature19102			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27556947	Green Accepted			2022-12-28	WOS:000382426900050
J	Rimmer, A				Rimmer, Abi			Physician associates-what do they do?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												arimmer@bmj.com						NHS Health Education England, 2016, PRIM CAR WORKF COMM	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 31	2016	354								i4661	10.1136/bmj.i4661	http://dx.doi.org/10.1136/bmj.i4661			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AD	27580600				2022-12-28	WOS:000382792500012
J	Couzin-Frankel, J				Couzin-Frankel, Jennifer			CHILDREN'S HEALTH Cholesterol screening for kids sparks debate (again)	SCIENCE			English	News Item																			0	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					855	855		10.1126/science.353.6302.855	http://dx.doi.org/10.1126/science.353.6302.855			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU0CA	27563077				2022-12-28	WOS:000381867700010
J	Wachsmuth, D; Cohen, DA; Angelo, H				Wachsmuth, David; Cohen, Daniel Aldana; Angelo, Hillary			Expand the frontiers of urban sustainability	NATURE			English	Editorial Material							POLITICS		[Wachsmuth, David] McGill Univ, Sch Urban Planning, Montreal, PQ, Canada; [Cohen, Daniel Aldana] Univ Penn, Dept Sociol, Philadelphia, PA 19104 USA; [Angelo, Hillary] Univ Calif Santa Cruz, Dept Sociol, Santa Cruz, CA 95064 USA	McGill University; University of Pennsylvania; University of California System; University of California Santa Cruz	Wachsmuth, D (corresponding author), McGill Univ, Sch Urban Planning, Montreal, PQ, Canada.	david.wachsmuth@mcgill.ca		Cohen, Daniel Aldana/0000-0003-0396-7316; Angelo, Hillary/0000-0003-3921-9002; Wachsmuth, David/0000-0001-5689-9527				Agyeman J, 2003, URBAN IND ENVIRON, P1; Angelo H, 2015, INT J URBAN REGIONAL, V39, P16, DOI 10.1111/1468-2427.12105; Anguelovski I., 2016, J PLAN ED RES; Bawden T, 2016, INDEPENDENT; Checker M, 2011, CITY SOC, V23, P210, DOI 10.1111/j.1548-744X.2011.01063.x; Cohen DA, 2016, PUBLIC CULTURE, V28, P261, DOI 10.1215/08992363-3427451; Heinonen J, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/035050; Mossner S, 2015, REGIONS MAGAZINE, V300, P18; PELLOW DN, 2006, NATURE CITIES URBAN, P226; Stanton E. A., 2011, CONSUMPTION BASED EM	10	85	88	6	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					391	393		10.1038/536391a	http://dx.doi.org/10.1038/536391a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV0YL	27558049	Bronze			2022-12-28	WOS:000382646600018
J	Zhang, XC; Chen, MH; Wu, XB; Kodani, A; Fan, J; Doan, R; Ozawa, M; Ma, J; Yoshida, N; Reiter, JF; Black, DL; Kharchenko, PV; Sharp, PA; Walsh, CA				Zhang, Xiaochang; Chen, Ming Hui; Wu, Xuebing; Kodani, Andrew; Fan, Jean; Doan, Ryan; Ozawa, Manabu; Ma, Jacqueline; Yoshida, Nobuaki; Reiter, Jeremy F.; Black, Douglas L.; Kharchenko, Peter V.; Sharp, Phillip A.; Walsh, Christopher A.			Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex	CELL			English	Article							TRANSCRIPTIONAL HETEROGENEITY; NEURONAL REGULATION; BRAIN-DEVELOPMENT; GENE; EXPRESSION; MUTATIONS; REGULATOR; DISCOVERY; ALIGNMENT; INSIGHTS	Alternative splicing is prevalent in the mammalian brain. To interrogate the functional role of alternative splicing in neural development, we analyzed purified neural progenitor cells (NPCs) and neurons from developing cerebral cortices, revealing hundreds of differentially spliced exons that preferentially alter key protein domains-especially in cytoskeletal proteins-and can harbor disease-causing mutations. We show that Ptbp1 and Rbfox proteins antagonistically govern the NPC-to-neuron transition by regulating neuron-specific exons. Whereas Ptbp1 maintains apical progenitors partly through suppressing a poison exon of Flna in NPCs, Rbfox proteins promote neuronal differentiation by switching Ninein from a centrosomal splice form in NPCs to a non-centrosomal isoform in neurons. We further uncover an intronic human mutation within a PTBP1-binding site that disrupts normal skipping of the FLNA poison exon in NPCs and causes a brain-specific malformation. Our study indicates that dynamic control of alternative splicing governs cell fate in cerebral cortical development.	[Zhang, Xiaochang; Chen, Ming Hui; Doan, Ryan; Ma, Jacqueline; Walsh, Christopher A.] Boston Childrens Hosp, Howard Hughes Med Inst, Manton Ctr Orphan Dis Res, Div Genet & Genom, Boston, MA 02115 USA; [Zhang, Xiaochang; Doan, Ryan; Walsh, Christopher A.] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Zhang, Xiaochang; Doan, Ryan; Walsh, Christopher A.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Chen, Ming Hui] Boston Childrens Hosp, Dept Cardiol, Boston, MA 02215 USA; [Chen, Ming Hui] Harvard Med Sch, Boston, MA 02215 USA; [Wu, Xuebing; Sharp, Phillip A.] MIT, David H Koch Inst Integrat Canc Res, Dept Biol, Computat & Syst Biol Grad Program, Cambridge, MA 02139 USA; [Wu, Xuebing] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Kodani, Andrew; Reiter, Jeremy F.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Fan, Jean; Kharchenko, Peter V.] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Fan, Jean; Kharchenko, Peter V.; Walsh, Christopher A.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Ozawa, Manabu; Yoshida, Nobuaki] Univ Tokyo, Ctr Expt Med & Syst Biol, Lab Dev Genet, Tokyo 1088639, Japan; [Black, Douglas L.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Walsh, Christopher A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Harvard University; University of Tokyo; University of California System; University of California Los Angeles; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Zhang, XC; Walsh, CA (corresponding author), Boston Childrens Hosp, Howard Hughes Med Inst, Manton Ctr Orphan Dis Res, Div Genet & Genom, Boston, MA 02115 USA.; Zhang, XC; Walsh, CA (corresponding author), Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA.; Zhang, XC; Walsh, CA (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.; Walsh, CA (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Walsh, CA (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	xiaochang.zhang@childrens.harvard.edu; christopher.walsh@childrens.harvard.edu	Fan, Jean/AAR-6747-2020; Kodani, Andrew/AAA-5138-2022; Wu, Xuebing/C-9152-2013; Zhang, Xiaochang/G-4857-2014	Fan, Jean/0000-0002-0212-5451; Wu, Xuebing/0000-0003-0369-5269; Kodani, Andrew/0000-0001-9662-0615; Chen, Ming Hui/0000-0001-8043-894X; Walsh, Christopher/0000-0002-0156-2238; Zhang, Xiaochang/0000-0001-5768-7470	Manton Center for Orphan Disease Research; NINDS [R01-NS035129, R01-NS032457]; NIMH [K01-MH109747]; Charles A. King Trust Fellowship; HHMI International Student Research Fellowship; NSF [R01-GM34277]; NCI [P01-CA42063]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [F31CA206236, P01CA042063] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK098722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034277, R01GM049662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH109747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032457, R01NS035129] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15K18386] Funding Source: KAKEN; Div Of Biological Infrastructure [1452964] Funding Source: National Science Foundation	Manton Center for Orphan Disease Research; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Charles A. King Trust Fellowship; HHMI International Student Research Fellowship; NSF(National Science Foundation (NSF)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank B. Barry and J. Partlow for clinical information; Y.J. Yang, A. Lam, D. Gonzalez, and A. Rozzo for technical assistance; M. Bornens, V. Sheen, and G. Lian for reagents; the Orchestra research computing team at Harvard for computing resources; N. Francis of the IDDRC Flow Cytometry Core for technical assistance; and B. Bae, X. Cai, G. Evrony, R.S. Hill, E. Lim, M. Lodato, M. Johnson, and C.A.W. lab members for helpful discussions. We thank Qiufu Ma and Xi He for critical comments on the manuscript. This work was supported by the Manton Center for Orphan Disease Research and grants from the NINDS (R01-NS035129 and R01-NS032457) to C.A.W., NIMH grant (K01-MH109747) and Charles A. King Trust Fellowship to X.Z., HHMI International Student Research Fellowship to X.W., NSF graduate fellowship (DGE1144152) to J.F., NIGMS (R01-GM49662) to D.L.B., and NIGMS (R01-GM34277) and NCI (P01-CA42063) to P.A.S. C.A.W. is an Investigator of the Howard Hughes Medical Institute.	Ayoub AE, 2011, P NATL ACAD SCI USA, V108, P14950, DOI 10.1073/pnas.1112213108; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Baird DH, 2004, NEUROPHARMACOLOGY, V47, P677, DOI 10.1016/j.neuropharm.2004.07.016; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Belgard TG, 2011, NEURON, V71, P605, DOI 10.1016/j.neuron.2011.06.039; Bhalla K, 2004, J HUM GENET, V49, P308, DOI 10.1007/s10038-004-0145-4; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Darnell RB, 2013, ANNU REV NEUROSCI, V36, P243, DOI 10.1146/annurev-neuro-062912-114322; Dauber A, 2012, J CLIN ENDOCR METAB, V97, pE2140, DOI 10.1210/jc.2012-2150; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; Dillman AA, 2013, NAT NEUROSCI, V16, P499, DOI 10.1038/nn.3332; Fan J, 2016, NAT METHODS, V13, P241, DOI [10.1038/NMETH.3734, 10.1038/nmeth.3734]; Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104; Fietz SA, 2012, P NATL ACAD SCI USA, V109, P11836, DOI 10.1073/pnas.1209647109; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Gao P, 2014, CELL, V159, P775, DOI 10.1016/j.cell.2014.10.027; Gehman LT, 2011, NAT GENET, V43, P706, DOI 10.1038/ng.841; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Greig LC, 2013, NAT REV NEUROSCI, V14, P755, DOI 10.1038/nrn3586; Han A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003442; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huttner WB, 2013, NEURON, V80, P259, DOI 10.1016/j.neuron.2013.10.004; Iijima T, 2011, CELL, V147, P1601, DOI 10.1016/j.cell.2011.11.028; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Irimia M, 2014, CELL, V159, P1511, DOI 10.1016/j.cell.2014.11.035; Johnson MB, 2015, NAT NEUROSCI, V18, P637, DOI 10.1038/nn.3980; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Keppetipola N, 2012, CRIT REV BIOCHEM MOL, V47, P360, DOI 10.3109/10409238.2012.691456; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kuroyanagi H, 2009, CELL MOL LIFE SCI, V66, P3895, DOI 10.1007/s00018-009-0120-5; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lechler T, 2007, J CELL BIOL, V176, P147, DOI 10.1083/jcb.200609109; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Li YI, 2015, GENOME RES, V25, P1, DOI 10.1101/gr.181990.114; Lian GW, 2012, J NEUROSCI, V32, P7672, DOI 10.1523/JNEUROSCI.0894-12.2012; Linares AJ, 2015, ELIFE, V4, DOI 10.7554/eLife.09268; Lodato MA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003288; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Masuda A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00209; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Ohama Y, 2009, HISTOCHEM CELL BIOL, V132, P515, DOI 10.1007/s00418-009-0631-z; Raj B, 2015, NEURON, V87, P14, DOI 10.1016/j.neuron.2015.05.004; Raj B, 2011, MOL CELL, V43, P843, DOI 10.1016/j.molcel.2011.08.014; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shen Q, 2002, DEVELOPMENT, V129, P4843; Shibasaki T, 2013, CEREB CORTEX, V23, P1824, DOI 10.1093/cercor/bhs161; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vuong CK, 2016, NAT REV NEUROSCI, V17, P265, DOI 10.1038/nrn.2016.27; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Weyn-Vanhentenryck SM, 2014, CELL REP, V6, P1139, DOI 10.1016/j.celrep.2014.02.005; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045; Yan QH, 2015, P NATL ACAD SCI USA, V112, P3445, DOI 10.1073/pnas.1502849112	61	159	162	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1147	+		10.1016/j.cell.2016.07.025	http://dx.doi.org/10.1016/j.cell.2016.07.025			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27565344	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000382259500013
J	Lee, S; Kapustin, EA; Yaghi, OM				Lee, Seungkyu; Kapustin, Eugene A.; Yaghi, Omar M.			Coordinative alignment of molecules in chiral metal-organic frameworks	SCIENCE			English	Article							CRYSTALLINE SPONGE METHOD; X-RAY-STRUCTURE; ABSOLUTE-CONFIGURATION; POROUS COMPLEXES	A chiral metal-organic framework, MOF-520, was used to coordinatively bind and align molecules of varying size, complexity, and functionality. The reduced motional degrees of freedom obtained with this coordinative alignment method allowed the structures of molecules to be determined by single-crystal x-ray diffraction techniques. The chirality of the MOF backbone also served as a reference in the structure solution for an unambiguous assignment of the absolute configuration of bound molecules. Sixteen molecules representing four common functional groups (primary alcohol, phenol, vicinal diol, and carboxylic acid), ranging in complexity from methanol to plant hormones (gibberellins, containing eight stereocenters), were crystallized and had their precise structure determined. We distinguished single and double bonds in gibberellins, and we enantioselectively crystallized racemic jasmonic acid, whose absolute configuration had only been inferred from derivatives.	[Lee, Seungkyu; Kapustin, Eugene A.; Yaghi, Omar M.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Lee, Seungkyu; Kapustin, Eugene A.; Yaghi, Omar M.] Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Lee, Seungkyu; Kapustin, Eugene A.; Yaghi, Omar M.] Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; [Lee, Seungkyu; Kapustin, Eugene A.; Yaghi, Omar M.] Berkeley Global Sci Inst, Berkeley, CA 94720 USA; [Yaghi, Omar M.] King Abdulaziz City Sci & Technol, Riyadh 11442, Saudi Arabia	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; King Abdulaziz City for Science & Technology	Yaghi, OM (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Yaghi, OM (corresponding author), Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA.; Yaghi, OM (corresponding author), Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA.; Yaghi, OM (corresponding author), Berkeley Global Sci Inst, Berkeley, CA 94720 USA.; Yaghi, OM (corresponding author), King Abdulaziz City Sci & Technol, Riyadh 11442, Saudi Arabia.	yaghi@berkeley.edu	Lee, Seungkyu/AAL-2092-2021; McCoy, Tina/P-3402-2019; Yaghi, Omar M/C-6749-2013	Kapustin, Eugene/0000-0003-4095-9729; Yaghi, Omar/0000-0002-5611-3325	Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; NIH Shared Instrumentation grant [S10-RR027172]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027172] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); NIH Shared Instrumentation grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by BASF SE (Ludwigshafen, Germany) for the synthesis, and by King Abdulaziz City for Science and Technology (Center of Excellence for Nanomaterials and Clean Energy Applications) for the characterization of compounds. We thank S. Teat for synchrotron x-ray diffraction data acquisition support at beamline 11.3.1 [Advanced Light Source (ALS), Lawrence Berkeley National Laboratory (LBNL)]; K. Gagnon for discussion of structure refinement; and H.-B. Burgi for invaluable discussions of structure refinement and editing of this manuscript. NMR data were acquired at the Molecular Foundry, LBNL. Work performed at ALS and the Molecular Foundry is supported by the Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under contract DE-AC02-05CH11231 (ALS and Foundry). Use of CheXray facility at the College of Chemistry (UC Berkeley) is supported by NIH Shared Instrumentation grant S10-RR027172. Data reported in this paper are tabulated in the supplementary materials and archived at the Cambridge Crystallographic Data Centre under reference numbers CCDC 1488938 to 1488955.	Atwood J. L., 1984, INCLUSION COMPOUNDS; BIJVOET JM, 1951, NATURE, V168, P271, DOI 10.1038/168271a0; Flack HD, 2007, ACTA CRYSTALLOGR A, V63, P257, DOI 10.1107/S0108767307002802; Flack HD, 2006, ACTA CRYSTALLOGR B, V62, P695, DOI 10.1107/S0108768106021884; Flack HD, 2000, J APPL CRYSTALLOGR, V33, P1143, DOI 10.1107/S0021889800007184; Flack HD, 1999, ACTA CRYSTALLOGR A, V55, P908, DOI 10.1107/S0108767399004262; Furukawa H, 2013, SCIENCE, V341, P974, DOI 10.1126/science.1230444; Gandara F, 2014, J AM CHEM SOC, V136, P5271, DOI 10.1021/ja501606h; HILL RK, 1965, TETRAHEDRON, V21, P1501, DOI 10.1016/S0040-4020(01)98313-9; Holden A., 1982, CRYSTALS CRYSTAL GRO; Hoshino M, 2016, IUCRJ, V3, P139, DOI 10.1107/S2052252515024379; Inokuma Y, 2013, NATURE, V495, P461, DOI 10.1038/nature11990; Legrand YM, 2010, SCIENCE, V329, P299, DOI 10.1126/science.1188002; Ramadhar TR, 2015, ACTA CRYSTALLOGR A, V71, P46, DOI 10.1107/S2053273314019573; Sanna E, 2015, CHEM SCI, V6, P5466, DOI 10.1039/c5sc01838b; Yoshioka S, 2015, CHEM SCI, V6, P3765, DOI 10.1039/c5sc01681a	16	211	213	27	661	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					808	811		10.1126/science.aaf9135	http://dx.doi.org/10.1126/science.aaf9135			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZE	27540171				2022-12-28	WOS:000381561400042
J	Ostrov, N; Landon, M; Guell, M; Kuznetsov, G; Teramoto, J; Cervantes, N; Zhou, M; Singh, K; Napolitano, MG; Moosburner, M; Shrock, E; Pruitt, BW; Conway, N; Goodman, DB; Gardner, CL; Tyree, G; Gonzales, A; Wanner, BL; Norville, JE; Lajoie, MJ; Church, GM				Ostrov, Nili; Landon, Matthieu; Guell, Marc; Kuznetsov, Gleb; Teramoto, Jun; Cervantes, Natalie; Zhou, Minerva; Singh, Kerry; Napolitano, Michael G.; Moosburner, Mark; Shrock, Ellen; Pruitt, Benjamin W.; Conway, Nicholas; Goodman, Daniel B.; Gardner, Cameron L.; Tyree, Gary; Gonzales, Alexandra; Wanner, Barry L.; Norville, Julie E.; Lajoie, Marc J.; Church, George M.			Design, synthesis, and testing toward a 57-codon genome	SCIENCE			English	Article							GENETIC-CODE; ESCHERICHIA-COLI; CHEMICAL-SYNTHESIS; EXPRESSION; BIAS; ORGANISMS; CHROMOSOME; EVOLUTION; USAGE	Recoding-the repurposing of genetic codons-is a powerful strategy for enhancing genomes with functions not commonly found in nature. Here, we report computational design, synthesis, and progress toward assembly of a 3.97-megabase, 57-codon Escherichia coli genome in which all 62,214 instances of seven codons were replaced with synonymous alternatives across all protein-coding genes. We have validated 63% of recoded genes by individually testing 55 segments of 50 kilobases each. We observed that 91% of tested essential genes retained functionality with limited fitness effect. We demonstrate identification and correction of lethal design exceptions, only 13 of which were found in 2229 genes. This work underscores the feasibility of rewriting genomes and establishes a framework for large-scale design, assembly, troubleshooting, and phenotypic analysis of synthetic organisms.	[Ostrov, Nili; Landon, Matthieu; Guell, Marc; Kuznetsov, Gleb; Teramoto, Jun; Cervantes, Natalie; Napolitano, Michael G.; Moosburner, Mark; Shrock, Ellen; Goodman, Daniel B.; Gardner, Cameron L.; Tyree, Gary; Gonzales, Alexandra; Wanner, Barry L.; Norville, Julie E.; Lajoie, Marc J.; Church, George M.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Landon, Matthieu] Harvard Univ, Program Syst Biol, Cambridge, MA 02138 USA; [Landon, Matthieu] Mines Paristech, Ecole Mines Paris, F-75272 Paris, France; [Guell, Marc; Pruitt, Benjamin W.; Conway, Nicholas; Goodman, Daniel B.; Church, George M.] Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Kuznetsov, Gleb] Harvard Univ, Program Biophys, Boston, MA 02115 USA; [Teramoto, Jun] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Zhou, Minerva; Singh, Kerry] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Napolitano, Michael G.] Harvard Univ, Program Biol & Biomed Sci, Cambridge, MA 02138 USA; [Wanner, Barry L.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; Harvard University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Harvard Medical School	Lajoie, MJ; Church, GM (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Church, GM (corresponding author), Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	mlajoie@uw.edu; gchurch@genetics.med.harvard.edu	Güell, Marc/AAB-3054-2021; Güell, Marc/J-2970-2017	Güell, Marc/0000-0003-4000-7912; Güell, Marc/0000-0003-4000-7912; Moosburner, Mark/0000-0002-8672-8742; Gardner, Cameron/0000-0002-7884-4794; Shrock, Ellen/0000-0003-2484-4374; Norville, Julie/0000-0001-9205-8936; Goodman, Daniel/0000-0003-3759-6883; church, george/0000-0001-6232-9969	U.S Department of Energy [DE-FG02-02ER63445]; Defense Advanced Research Projects Agency [BAA-12-64]; NSF [106394]; DOD NDSEG Fellowship; NSF Graduate Research Fellowship; Origins of Life Initiative at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313] Funding Source: NIH RePORTER	U.S Department of Energy(United States Department of Energy (DOE)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF(National Science Foundation (NSF)); DOD NDSEG Fellowship; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Origins of Life Initiative at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work was provided by U.S Department of Energy grant DE-FG02-02ER63445 and Defense Advanced Research Projects Agency grant BAA-12-64. B.L.W. was supported by NSF grant 106394; G.K. was supported by DOD NDSEG Fellowship; D.B.G. was supported by NSF Graduate Research Fellowship; E.S. was supported by the Origins of Life Initiative at Harvard University. We thank Gen9 (D. Leake, I. Saaem, and E. Nickerson), SGI-DNA ( D. Gibson), and Twist (E. Leproust) for DNA synthesis and J. Aach for insightful comments. G.K., M.J.L., M.L., M.G.N., D.B.G., and G.M.C. are inventors on patent application #62350468 submitted by the President and Fellows of Harvard College. The authors declare competing financial interests: Details are available in the supplementary documents of the paper. All FASTQ sequence files have been submitted to the Sequence Read Archive (SRA) at National Center for Biotechnology Information submission number SUB1484507. Plasmids will be available under a materials transfer agreement with Addgene.	Ambrogelly A, 2007, NAT CHEM BIOL, V3, P29, DOI 10.1038/nchembio847; Annaluru N, 2014, SCIENCE, V344, P55, DOI 10.1126/science.1249252; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Boel G, 2016, NATURE, V529, P358, DOI 10.1038/nature16509; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; CRICK FHC, 1963, SCIENCE, V139, P461, DOI 10.1126/science.139.3554.461; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Hutchison CA, 2016, SCIENCE, V351, DOI 10.1126/science.aad6253; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; KANO A, 1991, J MOL BIOL, V221, P387, DOI 10.1016/0022-2836(91)80061-X; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lajoie MJ, 2013, SCIENCE, V342, P361, DOI 10.1126/science.1241460; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Ling JQ, 2015, NAT REV MICROBIOL, V13, P707, DOI 10.1038/nrmicro3568; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; MACINO G, 1979, P NATL ACAD SCI USA, V76, P3784, DOI 10.1073/pnas.76.8.3784; Mandell DJ, 2015, NATURE, V518, P55, DOI 10.1038/nature14121; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Marliere Philippe, 2009, Syst Synth Biol, V3, P77, DOI 10.1007/s11693-009-9040-9; OBA T, 1991, P NATL ACAD SCI USA, V88, P921, DOI 10.1073/pnas.88.3.921; OSAWA S, 1989, J MOL EVOL, V28, P271, DOI 10.1007/BF02103422; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Quax TEF, 2015, MOL CELL, V59, P149, DOI 10.1016/j.molcel.2015.05.035; Rovner AJ, 2015, NATURE, V518, P89, DOI 10.1038/nature14095; Salis HM, 2011, METHOD ENZYMOL, V498, P19, DOI 10.1016/B978-0-12-385120-8.00002-4; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Temme K, 2012, P NATL ACAD SCI USA, V109, P7085, DOI 10.1073/pnas.1120788109; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Yamazaki Yukiko, 2008, V416, P385, DOI 10.1007/978-1-59745-321-9_26; Yona AH, 2013, ELIFE, V2, DOI 10.7554/eLife.01339; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833	37	170	195	6	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					819	822		10.1126/science.aaf3639	http://dx.doi.org/10.1126/science.aaf3639			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZE	27540174				2022-12-28	WOS:000381561400045
J	Halperin, EC				Halperin, Edward C.			The art of medicine The Lancet in 19th-century America	LANCET			English	Editorial Material									[Halperin, Edward C.] New York Med Coll, Valhalla, NY 10595 USA; [Halperin, Edward C.] Touro Coll, Valhalla, NY 10595 USA	New York Medical College	Halperin, EC (corresponding author), New York Med Coll, Valhalla, NY 10595 USA.; Halperin, EC (corresponding author), Touro Coll, Valhalla, NY 10595 USA.	edward_halperin@nymc.edu						*AM MED ASS, J AM MED ASS; RICHARDSON MT, PRACTICAL CARRIAGE B; RICHARDSON MT, BLACKSMITH WHEELWRIG; RICHARDSON MT, EVERYBODYS PAINT BOO	4	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2016	388	10045					652	653		10.1016/S0140-6736(16)31283-1	http://dx.doi.org/10.1016/S0140-6736(16)31283-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT1UX	27551695				2022-12-28	WOS:000381268700014
J	Ekser, B; Mangus, RS				Ekser, Burcin; Mangus, Richard S.			Spontaneous bacterial peritonitis	LANCET			English	Editorial Material									[Ekser, Burcin; Mangus, Richard S.] Indiana Univ Sch Med, Transplant Div, Dept Surg, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Ekser, B (corresponding author), Indiana Univ Sch Med, Transplant Div, Dept Surg, Indianapolis, IN 46202 USA.	bekser@iupui.edu	Arroyo, Vicente/F-9189-2015	Arroyo, Vicente/0000-0002-2728-1848; Ekser, Burcin/0000-0003-0741-8007					0	2	4	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 18	2017	389	10070					735	735		10.1016/S0140-6736(16)30782-6	http://dx.doi.org/10.1016/S0140-6736(16)30782-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9KK	27570177				2022-12-28	WOS:000394938900033
J	Hohmann, EL				Hohmann, Elizabeth L.			Are Microbial Politics Local?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CLOSTRIDIUM-DIFFICILE INFECTION; TRANSPLANTATION		[Hohmann, Elizabeth L.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Hohmann, EL (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, 55 Fruit St, Boston, MA 02115 USA.	ehohmann@partners.org						Alang N, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv004; Cammarota G, 2014, J CLIN GASTROENTEROL, V48, P693, DOI 10.1097/MCG.0000000000000046; Donskey CJ, 2015, INFECT DIS CLIN N AM, V29, P13, DOI 10.1016/j.idc.2014.11.001; Kelly CR, 2016, ANN INTERN MED, V165, P609, DOI 10.7326/M16-0271; Li SS, 2016, SCIENCE, V352, P586, DOI 10.1126/science.aad8852; O'Brien CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062815; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Youngster I, 2014, JAMA-J AM MED ASSOC, V312, P1772, DOI 10.1001/jama.2014.13875	9	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	2016	165	9					667	668		10.7326/M16-1784	http://dx.doi.org/10.7326/M16-1784			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA8SJ	27548329				2022-12-28	WOS:000386908600010
J	Jaffe, GJ; Dick, AD; Brezin, AP; Nguyen, QD; Thorne, JE; Kestelyn, P; Barisani-Asenbauer, T; Franco, P; Heiligenhaus, A; Scales, D; Chu, DS; Camez, A; Kwatra, NV; Song, AP; Kron, M; Tari, S; Suhler, EB				Jaffe, Glenn J.; Dick, Andrew D.; Brezin, Antoine P.; Quan Dong Nguyen; Thorne, Jennifer E.; Kestelyn, Philippe; Barisani-Asenbauer, Talin; Franco, Pablo; Heiligenhaus, Arnd; Scales, David; Chu, David S.; Camez, Anne; Kwatra, Nisha V.; Song, Alexandra P.; Kron, Martina; Tari, Samir; Suhler, Eric B.			Adalimumab in Patients with Active Noninfectious Uveitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REFRACTORY UVEITIS; MULTICENTER; THERAPY; STANDARDIZATION; RECOMMENDATIONS; MANAGEMENT	BACKGROUND Patients with noninfectious uveitis are at risk for long-term complications of uncontrolled inflammation, as well as for the adverse effects of long-term glucocorticoid therapy. We conducted a trial to assess the efficacy and safety of adalimumab as a glucocorticoid-sparing agent for the treatment of noninfectious uveitis. METHODS This multinational phase 3 trial involved adults who had active noninfectious intermediate uveitis, posterior uveitis, or panuveitis despite having received prednisone treatment for 2 or more weeks. Investigators and patients were unaware of the study-group assignments. Patients were randomly assigned in a 1: 1 ratio to receive adalimumab ( a loading dose of 80 mg followed by a dose of 40 mg every 2 weeks) or matched placebo. All patients received a mandatory prednisone burst followed by tapering of prednisone over the course of 15 weeks. The primary efficacy end point was the time to treatment failure occurring at or after week 6. Treatment failure was a multicomponent outcome that was based on assessment of new inflammatory lesions, best corrected visual acuity, anterior chamber cell grade, and vitreous haze grade. Nine ranked secondary efficacy end points were assessed, and adverse events were reported. RESULTS The median time to treatment failure was 24 weeks in the adalimumab group and 13 weeks in the placebo group. Among the 217 patients in the intention-to-treat population, those receiving adalimumab were less likely than those in the placebo group to have treatment failure ( hazard ratio, 0.50; 95% confidence interval, 0.36 to 0.70; P<0.001). Outcomes with regard to three secondary end points ( change in anterior chamber cell grade, change in vitreous haze grade, and change in best corrected visual acuity) were significantly better in the adalimumab group than in the placebo group. Adverse events and serious adverse events were reported more frequently among patients who received adalimumab ( 1052.4 vs. 971.7 adverse events and 28.8 vs. 13.6 serious adverse events per 100 person-years). CONCLUSIONS In our trial, adalimumab was found to be associated with a lower risk of uveitic flare or visual impairment and with more adverse events and serious adverse events than was placebo. ( Funded by AbbVie; VISUAL I ClinicalTrials.gov number, NCT01138657.)	[Jaffe, Glenn J.] Duke Univ, Durham, NC USA; [Dick, Andrew D.] Univ Bristol, Bristol Eye Hosp, Bristol, Avon, England; [Dick, Andrew D.] Moorfields Eye Hosp, Natl Inst Hlth Res, Biomed Res Ctr, London, England; [Dick, Andrew D.] UCL, Inst Ophthalmol, London, England; [Brezin, Antoine P.] Univ Paris 05, Hop Cochin, Paris, France; [Quan Dong Nguyen] Univ Nebraska Med Ctr, Truhlsen Eye Inst, Omaha, NE USA; [Thorne, Jennifer E.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Kestelyn, Philippe] Ghent Univ Hosp, Ghent, Belgium; [Barisani-Asenbauer, Talin] Med Univ Vienna, Laura Bassi Ctr Expertise Ocuvac, Vienna, Austria; [Franco, Pablo] Org Med Invest, Buenos Aires, DF, Argentina; [Heiligenhaus, Arnd] St Franziskus Hosp Munster, Dept Ophthalmol, Munster, Germany; [Heiligenhaus, Arnd] Univ Duisburg Essen, Essen, Germany; [Camez, Anne; Kron, Martina] AbbVie Deutschland, Ludwigshafen, Germany; [Scales, David] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Chu, David S.] Metropolitan Eye Res & Surg Inst, Palisades Pk, NY USA; [Kwatra, Nisha V.; Song, Alexandra P.; Tari, Samir] AbbVie, N Chicago, IL USA; [Suhler, Eric B.] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; [Suhler, Eric B.] VA Portland Hlth Care Syst, Portland, OR USA	Duke University; Bristol Eye Hospital; University of Bristol; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Nebraska System; University of Nebraska Medical Center; Johns Hopkins University; Johns Hopkins Medicine; Ghent University; Ghent University Hospital; Medical University of Vienna; St. Franziskus-Hospital; University of Duisburg Essen; AbbVie; University of Texas System; University of Texas Health San Antonio; AbbVie; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System	Jaffe, GJ (corresponding author), Duke Eye Ctr, Box 3802, Durham, NC 27710 USA.	glenn.jaffe@duke.edu		Barisani-Asenbauer, Talin/0000-0002-8661-9183; Dick, Andrew/0000-0002-0742-3159	AbbVie	AbbVie(AbbVie)	Funded by AbbVie; VISUAL I ClinicalTrials.gov number, NCT01138657.	[Anonymous], 2014, HUM AD; Becker MD, 2005, DRUGS, V65, P497, DOI 10.2165/00003495-200565040-00005; Bidaut Garnier M, 2014, ACTA OPHTHALMOL    S, V92, ps253; Callejas-Rubio JL, 2008, J OCUL PHARMACOL TH, V24, P613, DOI 10.1089/jop.2008.0073; Cordero-Coma M, 2013, OCUL IMMUNOL INFLAMM, V21, P12, DOI 10.3109/09273948.2012.723107; Diaz-Llopis M, 2012, OPHTHALMOLOGY, V119, P1575, DOI 10.1016/j.ophtha.2012.02.018; Diaz-Llopis Manuel, 2009, Inflammation & Allergy Drug Targets, V8, P260; Dick AD, 2004, PROG RETIN EYE RES, V23, P617, DOI 10.1016/j.preteyeres.2004.06.005; Dobner BC, 2013, BRIT J OPHTHALMOL, V97, P134, DOI 10.1136/bjophthalmol-2011-301401; Durrani OM, 2004, BRIT J OPHTHALMOL, V88, P1159, DOI 10.1136/bjo.2003.037226; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Gritz DC, 2004, OPHTHALMOLOGY, V111, P491, DOI 10.1016/j.ophtha.2003.06.014; Hale S, 2006, CYTOKINE, V33, P231, DOI 10.1016/j.cyto.2005.12.012; Jabs DA, 2000, AM J OPHTHALMOL, V130, P492, DOI 10.1016/S0002-9394(00)00659-0; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Kempen JH, 2008, OPHTHAL EPIDEMIOL, V15, P47, DOI 10.1080/09286580701585892; Lacomba MS, 2001, OPHTHALMIC RES, V33, P251; Levy-Clarke G, 2014, OPHTHALMOLOGY, V121, P785, DOI 10.1016/j.ophtha.2013.09.048; Martel JN, 2012, OCUL IMMUNOL INFLAMM, V20, P18, DOI 10.3109/09273948.2011.633205; Menezo V, 2005, CLIN EXP OPHTHALMOL, V33, P16, DOI 10.1111/j.1442-9071.2005.00904.x; NUSSENBLATT RB, 1985, OPHTHALMOLOGY, V92, P467; NUSSENBLATT RB, 1990, INT OPHTHALMOL, V14, P303, DOI 10.1007/BF00163549; Suhler EB, 2013, BRIT J OPHTHALMOL, V97, P481, DOI 10.1136/bjophthalmol-2012-302292; Tomkins-Netzer O, 2014, OPHTHALMOLOGY, V121, P2387, DOI 10.1016/j.ophtha.2014.07.007	24	329	332	3	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2016	375	10					932	943		10.1056/NEJMoa1509852	http://dx.doi.org/10.1056/NEJMoa1509852			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU9IG	27602665	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000382529500006
J	James, SJ				James, Simon J.			The worlds of H. G. Wells	NATURE			English	Editorial Material									[James, Simon J.] Univ Durham, Dept English Studies, Durham DH1 3HP, England	Durham University	James, SJ (corresponding author), Univ Durham, Dept English Studies, Durham DH1 3HP, England.	s.j.james@durham.ac.uk						Wells H. G., 1894, NATURE, V50, P300; 1902, NATURE, V65, P326; 1898, NATURE, V57, P339; 1944, NATURE, V153, P395; 1946, NATURE, V158, P399; 1917, NATURE, V99, P186	6	1	1	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					162	164		10.1038/537162a	http://dx.doi.org/10.1038/537162a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU9LQ	27604935	Green Submitted, Bronze			2022-12-28	WOS:000382539100023
J	Moses, V				Moses, Vivian			The debate over GM crops is making history	NATURE			English	Editorial Material									[Moses, Vivian] Kings Coll London, Biotechnol, London WC2R 2LS, England	University of London; King's College London	Moses, V (corresponding author), Kings Coll London, Biotechnol, London WC2R 2LS, England.	v.moses@qmul.ac.uk							0	4	4	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					139	139		10.1038/537139a	http://dx.doi.org/10.1038/537139a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU9LQ	27604914	Bronze			2022-12-28	WOS:000382539100012
J	Saha, S; Weber, CA; Nousch, M; Adame-Arana, O; Hoege, C; Hein, MY; Osborne-Nishimura, E; Mahamid, J; Jahnel, M; Jawerth, L; Pozniakovski, A; Eckmann, CR; Julicher, F; Hyman, AA				Saha, Shambaditya; Weber, Christoph A.; Nousch, Marco; Adame-Arana, Omar; Hoege, Carsten; Hein, Marco Y.; Osborne-Nishimura, Erin; Mahamid, Julia; Jahnel, Marcus; Jawerth, Louise; Pozniakovski, Andrej; Eckmann, Christian R.; Juelicher, Frank; Hyman, Anthony A.			Polar Positioning of Phase-Separated Liquid Compartments in Cells Regulated by an mRNA Competition Mechanism	CELL			English	Article							CAENORHABDITIS-ELEGANS EMBRYOS; GERMLINE P-GRANULES; C. ELEGANS; CYTOPLASMIC LOCALIZATION; SINGLE-CELL; COPY-NUMBER; FUS PROTEIN; MEX-5; SPECIFICITY; TRANSITIONS	P granules are non-membrane-bound RNA-protein compartments that are involved in germline development in C. elegans. They are liquids that condense at one end of the embryo by localized phase separation, driven by gradients of polarity proteins such as the mRNA-binding protein MEX-5. To probe how polarity proteins regulate phase separation, we combined biochemistry and theoretical modeling. We reconstitute P granule-like droplets in vitro using a single protein PGL-3. By combining in vitro reconstitution with measurements of intracellular concentrations, we show that competition between PGL-3 and MEX-5 for mRNA can regulate the formation of PGL-3 droplets. Using theory, we show that, in a MEX-5 gradient, this mRNA competition mechanism can drive a gradient of P granule assembly with similar spatial and temporal characteristics to P granule assembly in vivo. We conclude that gradients of polarity proteins can position RNP granules during development by using RNA competition to regulate local phase separation.	[Saha, Shambaditya; Hoege, Carsten; Jahnel, Marcus; Jawerth, Louise; Pozniakovski, Andrej; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Weber, Christoph A.; Adame-Arana, Omar; Jawerth, Louise; Juelicher, Frank] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Nousch, Marco; Eckmann, Christian R.] Martin Luther Univ Halle Wittenberg, D-06120 Halle, Saale, Germany; [Hein, Marco Y.; Mahamid, Julia] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Osborne-Nishimura, Erin] Colorado State Univ, Ft Collins, CO 80523 USA	Max Planck Society; Max Planck Society; Martin Luther University Halle Wittenberg; Max Planck Society; Colorado State University	Hyman, AA (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.; Julicher, F (corresponding author), Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany.	julicher@pks.mpg.de; hyman@mpi-cbg.de	Julicher, Frank/B-1828-2009; Hyman, Tony/F-1923-2011; Hyman, Anthony A/B-3917-2017; Nousch, Marco/ABI-2324-2020; Hein, Marco/C-2994-2014	Julicher, Frank/0000-0003-4731-9185; Hyman, Anthony A/0000-0003-3664-154X; Hein, Marco/0000-0002-9490-2261; Jahnel, Marcus/0000-0002-8355-277X; Saha, Shambaditya/0000-0003-4734-1307; Osborne Nishimura, Erin/0000-0002-4313-4573; Adame Arana, Omar/0000-0001-5828-0584	Alexander von Humboldt foundation [USA/1153678 STP]; EMBO [ALTF 608-2013, ALTF 1131-2011]; Human Frontier Science Program [LT000685/2012-L]; Max Planck Research Network in Synthetic Biology (MaxSynBio); Max Planck Society; Deutsche Forschungsgemeinschaft [DFG EC369-2/3, EC369-3/1, EC369-5/1]; NIH [5R01GM104050]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104050] Funding Source: NIH RePORTER	Alexander von Humboldt foundation(Alexander von Humboldt Foundation); EMBO(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); Max Planck Research Network in Synthetic Biology (MaxSynBio); Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the A.A.H. lab for helpful discussions; Barbara Borgonovo (Chromatography Facility, MPI-CBG), David Drechsel, Regis Lemaitre, and Martine Ruer (Protein Expression and Purification Facility, MPI-CBG) for help with protein expression and purification; Bert Nitzsche and Britta Schroth-Diez (Light Microscopy Facility, MPI-CBG) for help with light microscopy; Julia Jarrells (Microarray Facility, MPI-CBG) for help with RNA preparations; Patrick Keller (Antibody Facility, MPI-CBG) and Anne Schwager for help with producing anti-PGL-3 antibody; Pietro Incardona (Sbalzarini group, MPI-CBG) for help with image analysis; David Murray (Zerial group, MPI-CBG) for introduction to lipid coating of microscopy chambers; Dirk Walther (Mann group, MPI-Biochemistry) for help with mass spectrometry; Andres Diaz (A.A.H. group, MPI-CBG) for the micrograph in the graphical abstract. We are grateful to Stephan Grill for support with optical tweezer-based experiments; to Wolfgang Baumeister for support with cryo-EMexperiments; to Matthias Mann for support with mass spectrometry. We gratefully acknowledge funding from the Alexander von Humboldt foundation (USA/1153678 STP to S.S.), EMBO (ALTF 608-2013 to S.S. and ALTF 1131-2011 to J.M.), Human Frontier Science Program (LT000685/2012-L to J.M.), Max Planck Research Network in Synthetic Biology (MaxSynBio), and Max Planck Society. M.N. and C.R.E. are supported by the Deutsche Forschungsgemeinschaft (DFG EC369-2/3, EC369-3/1, and EC369-5/1); E.O.-N. is supported by a grant from NIH (5R01GM104050). S.S. dedicates this work to his parents, Sukumar Saha and Madhuchhanda Saha.	Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Berry J, 2015, P NATL ACAD SCI USA, V112, pE5237, DOI 10.1073/pnas.1509317112; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; BRAY AJ, 1994, ADV PHYS, V43, P357, DOI 10.1080/00018739400101505; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Chen JX, 2016, MOL CELL PROTEOMICS, V15, P1642, DOI 10.1074/mcp.M115.053975; Colby R.H., 2003, POLYM PHYS; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Daniels BR, 2010, DEVELOPMENT, V137, P2579, DOI 10.1242/dev.051326; Dennis GR, 2013, COMPUT PHYS COMMUN, V184, P201, DOI 10.1016/j.cpc.2012.08.016; Dilao R, 2010, J THEOR BIOL, V264, P847, DOI 10.1016/j.jtbi.2010.03.012; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Farley BM, 2008, RNA, V14, P2685, DOI 10.1261/rna.1256708; Gallo CM, 2010, SCIENCE, V330, P1685, DOI 10.1126/science.1193697; Griffin EE, 2015, WIRES DEV BIOL, V4, P267, DOI 10.1002/wdev.177; Griffin EE, 2011, CELL, V146, P954, DOI 10.1016/j.cell.2011.08.012; Guo S, 1996, CURR OPIN GENET DEV, V6, P408, DOI 10.1016/S0959-437X(96)80061-X; Hanazawa M, 2011, J CELL BIOL, V192, P929, DOI 10.1083/jcb.201010106; Hird SN, 1996, DEVELOPMENT, V122, P1303; Hoege C, 2013, NAT REV MOL CELL BIO, V14, P315, DOI 10.1038/nrm3558; Hubstenberger A, 2013, DEV CELL, V27, P161, DOI 10.1016/j.devcel.2013.09.024; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jahnel M, 2011, OPT LETT, V36, P1260, DOI 10.1364/OL.36.001260; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Lee CF, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.088101; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Marinov GK, 2014, GENOME RES, V24, P496, DOI 10.1101/gr.161034.113; Mark J. E., 2007, PHYS PROPERTIES POLY; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Nishimura EO, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005117; Pagano JM, 2007, J BIOL CHEM, V282, P8883, DOI 10.1074/jbc.M700079200; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Rizk A, 2014, NAT PROTOC, V9, P586, DOI 10.1038/nprot.2014.037; Schisa JA, 2001, DEVELOPMENT, V128, P1287; Schwartz JC, 2013, CELL REP, V5, P918, DOI 10.1016/j.celrep.2013.11.017; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; Sheth U, 2010, DEVELOPMENT, V137, P1305, DOI 10.1242/dev.044255; Spike CA, 2008, DEVELOPMENT, V135, P983, DOI 10.1242/dev.015552; STROME S, 1982, P NATL ACAD SCI-BIOL, V79, P1558, DOI 10.1073/pnas.79.5.1558; Strzelecka M, 2010, NAT STRUCT MOL BIOL, V17, P403, DOI 10.1038/nsmb.1783; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Tenlen JR, 2008, DEVELOPMENT, V135, P3665, DOI 10.1242/dev.027060; Thandapani P, 2013, MOL CELL, V50, P613, DOI 10.1016/j.molcel.2013.05.021; Tintori S.C., 2016, BIORXIV; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Updike D, 2010, J ANDROL, V31, P53, DOI 10.2164/jandrol.109.008292; Updike DL, 2014, CURR BIOL, V24, P970, DOI 10.1016/j.cub.2014.03.015; Updike DL, 2011, J CELL BIOL, V192, P939, DOI 10.1083/jcb.201010104; Voronina E, 2013, MOL REPROD DEV, V80, P624, DOI 10.1002/mrd.22136; Wang J, 2014, ELIFE, V3, DOI 10.7554/eLife.03496; Wang XY, 2015, NUCLEIC ACIDS RES, V43, P7535, DOI 10.1093/nar/gkv679; Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033; Wisniewski JR, 2014, MOL CELL PROTEOMICS, V13, P3497, DOI 10.1074/mcp.M113.037309; Wu YJ, 2015, MOL BIOL CELL, V26, P2963, DOI 10.1091/mbc.E15-05-0302; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017	58	187	191	3	62	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2016	166	6					1572	+		10.1016/j.cell.2016.08.006	http://dx.doi.org/10.1016/j.cell.2016.08.006			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EA1GG	27594427	Green Accepted, Bronze			2022-12-28	WOS:000386339900027
J	Charo, RA				Charo, R. Alta			Whole Women's Victory - or Not?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Charo, R. Alta] Univ Wisconsin, Sch Law, Madison, WI 53706 USA; [Charo, R. Alta] Univ Wisconsin, Dept Med Hist & Bioeth, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Charo, RA (corresponding author), Univ Wisconsin, Sch Law, Madison, WI 53706 USA.; Charo, RA (corresponding author), Univ Wisconsin, Dept Med Hist & Bioeth, Sch Med & Publ Hlth, Madison, WI 53706 USA.			Charo, Robin Alta/0000-0003-3710-1043				Benson Gold R., 2016, ATTACKS ABORTION RIG; Charo RA, 2007, NEW ENGL J MED, V356, P2125, DOI 10.1056/NEJMp078055; DeFrancesco MS, 2015, MEDSCAPE; Eckholm E., 2016, NY TIMES; Royal College of Obstetricians and Gynaecologists,, 2010, FET AW REV RES REC P	5	9	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2016	375	9					809	811		10.1056/NEJMp1609167	http://dx.doi.org/10.1056/NEJMp1609167			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU9HA	27579630				2022-12-28	WOS:000382526000001
J	Harpole, WS; Sullivan, LL; Lind, EM; Firn, J; Adler, PB; Borer, ET; Chase, J; Fay, PA; Hautier, Y; Hillebrand, H; MacDougallm, AS; Seabloom, EW; Williams, R; Bakker, JD; Cadotte, MW; Chaneton, EJ; Chu, CJ; Cleland, EE; D'Antonio, C; Davies, KF; Gruner, DS; Hagenah, N; Kirkman, K; Knops, JMH; La Pierre, KJ; McCulley, RL; Moore, JL; Morgan, JW; Prober, SM; Risch, AC; Schuetz, M; Stevens, CJ; Wragg, PD				Harpole, W. Stanley; Sullivan, Lauren L.; Lind, Eric M.; Firn, Jennifer; Adler, Peter B.; Borer, Elizabeth T.; Chase, Jonathan; Fay, Philip A.; Hautier, Yann; Hillebrand, Helmut; MacDougallm, Andrew S.; Seabloom, Eric W.; Williams, Ryan; Bakker, Jonathan D.; Cadotte, Marc W.; Chaneton, Enrique J.; Chu, Chengjin; Cleland, Elsa E.; D'Antonio, Carla; Davies, Kendi F.; Gruner, Daniel S.; Hagenah, Nicole; Kirkman, Kevin; Knops, Johannes M. H.; La Pierre, Kimberly J.; McCulley, Rebecca L.; Moore, Joslin L.; Morgan, John W.; Prober, Suzanne M.; Risch, Anita C.; Schuetz, Martin; Stevens, Carly J.; Wragg, Peter D.			Addition of multiple limiting resources reduces grassland diversity	NATURE			English	Article							NUTRIENT ENRICHMENT; BIODIVERSITY LOSS; SPECIES RICHNESS; PLANT DIVERSITY; NITROGEN; LIMITATION; HERBIVORES; ECOLOGY	Niche dimensionality provides a general theoretical explanation for biodiversity-more niches, defined by more limiting factors, allow for more ways that species can coexist(1). Because plant species compete for the same set of limiting resources, theory predicts that addition of a limiting resource eliminates potential trade-offs, reducing the number of species that can coexist(2). Multiple nutrient limitation of plant production is common and therefore fertilization may reduce diversity by reducing the number or dimensionality of belowground limiting factors. At the same time, nutrient addition, by increasing biomass, should ultimately shift competition from belowground nutrients towards a one-dimensional competitive trade-off for light(3). Here we show that plant species diversity decreased when a greater number of limiting nutrients were added across 45 grassland sites from a multi-continent experimental network(4). The number of added nutrients predicted diversity loss, even after controlling for effects of plant biomass, and even where biomass production was not nutrient-limited. We found that elevated resource supply reduced niche dimensionality and diversity and increased both productivity(5) and compositional turnover. Our results point to the importance of understanding dimensionality in ecological systems that are undergoing diversity loss in response to multiple global change factors.	[Harpole, W. Stanley] UFZ Helmholtz Ctr Environm Res, Dept Physiol Divers, Permoserstr 15, D-04318 Leipzig, Germany; [Harpole, W. Stanley; Chase, Jonathan] German Ctr Integrat Biodivers Res iDiv, Deutsch Pl 5E, D-04103 Leipzig, Germany; [Harpole, W. Stanley; Chase, Jonathan] Univ Halle Wittenberg, Inst Biol, Kirchtor 1, D-06108 Halle, Saale, Germany; [Sullivan, Lauren L.; Lind, Eric M.; Borer, Elizabeth T.; Seabloom, Eric W.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Firn, Jennifer] Queensland Univ Technol, Sch Earth Environm & Biol Sci, Brisbane, Qld 4001, Australia; [Adler, Peter B.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Adler, Peter B.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Fay, Philip A.] ARS, USDA, Grassland Soil & Water Res Lab, Temple, TX 76502 USA; [Hautier, Yann] Univ Utrecht, Dept Biol, Ecol & Biodivers Grp, Padualaan 8, NL-3584 CH Utrecht, Netherlands; [Hillebrand, Helmut] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, Schleusenstr 1, D-026381 Wilhelmshaven, Germany; [MacDougallm, Andrew S.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Williams, Ryan] Iowa State Univ, Agr & Biosyst Engn, Ames, IA 50011 USA; [Bakker, Jonathan D.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Cadotte, Marc W.] Univ Toronto Scarborough, Dept Biol Sci, 1265 Mil Trail, Toronto, ON M1C 1A4, Canada; [Chaneton, Enrique J.] Univ Buenos Aires, IFEVA CONICET, Dept Recursos Nat & Ambiente, Fac Agron, Av San Martin 4453 C1417DSE, Buenos Aires, DF, Argentina; [Chu, Chengjin] Sun Yat Sen Univ, SYSU Alberta Joint Lab Biodivers Conservat, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Chu, Chengjin] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Cleland, Elsa E.] Univ Calif La Jolla, Ecol Behav & Evolut Sect, San Diego, CA 92093 USA; [D'Antonio, Carla] Univ Calif, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Davies, Kendi F.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Gruner, Daniel S.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Hagenah, Nicole; Kirkman, Kevin] Univ KwaZutu Natal, Sch Life Sci, ZA-3209 Pietermaritzburg, South Africa; [Knops, Johannes M. H.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [La Pierre, Kimberly J.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [McCulley, Rebecca L.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40546 USA; [Moore, Joslin L.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Morgan, John W.] La Trobe Univ, Dept Ecol Environm & Evolut, Bundoora, Vic 3086, Australia; [Prober, Suzanne M.] CSIRO Land & Water, Private Bag 5, Wembley, WA 6913, Australia; [Risch, Anita C.; Schuetz, Martin] Swiss Fed Inst Forest Snow & Landscape Res, Community Ecol, CH-8903 Birmensdorf, Switzerland; [Stevens, Carly J.] Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YQ, England; [Wragg, Peter D.] Yale Univ, Dept Ecol & Evolutionary Biol, 165 Prospect St, New Haven, CT 06511 USA	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Martin Luther University Halle Wittenberg; University of Minnesota System; University of Minnesota Twin Cities; Queensland University of Technology (QUT); Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; United States Department of Agriculture (USDA); Utrecht University; Carl von Ossietzky Universitat Oldenburg; University of Guelph; Iowa State University; University of Washington; University of Washington Seattle; University of Toronto; University Toronto Scarborough; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Sun Yat Sen University; Sun Yat Sen University; University of California System; University of California San Diego; University of California System; University of California Santa Barbara; University of Colorado System; University of Colorado Boulder; University System of Maryland; University of Maryland College Park; University of Nebraska System; University of Nebraska Lincoln; University of California System; University of California Berkeley; University of Kentucky; Monash University; La Trobe University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Lancaster University; Yale University	Harpole, WS (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Physiol Divers, Permoserstr 15, D-04318 Leipzig, Germany.	stan.harpole@idiv.de	Gruner, Daniel Stephen/A-5166-2010; Hillebrand, Helmut/I-1717-2014; Moore, Joslin/AAE-3819-2020; Kirkman, Kevin P/F-4160-2010; Bakker, Jonathan/I-6960-2013; Chu, Chu/T-6038-2019; Kirkman, Kevin/GNM-5334-2022; Hautier, Yann/D-5426-2015; B, A/AHB-5155-2022; Fay, Philip A./I-1853-2012; MacDougall, Andrew S/F-2037-2011; Risch, Anita C./A-9836-2012; Hautier, Yann/I-2526-2019; Cadotte, Marc/AAG-8147-2020; Wragg, Peter D/C-8385-2009; Prober, Suzanne/G-6465-2010; Harpole, William S/C-2814-2013; Moore, Joslin L/C-5270-2009; Knops, Johannes/AAA-8546-2020	Gruner, Daniel Stephen/0000-0002-3153-4297; Hillebrand, Helmut/0000-0001-7449-1613; Moore, Joslin/0000-0001-9809-5092; Kirkman, Kevin P/0000-0001-9580-5191; Bakker, Jonathan/0000-0002-8973-2771; Kirkman, Kevin/0000-0001-9580-5191; Hautier, Yann/0000-0003-4347-7741; Fay, Philip A./0000-0002-8291-6316; Risch, Anita C./0000-0003-0531-8336; Hautier, Yann/0000-0003-4347-7741; Cadotte, Marc/0000-0002-5816-7693; Wragg, Peter D/0000-0003-2361-4286; Prober, Suzanne/0000-0002-6518-239X; Harpole, William S/0000-0002-3404-9174; Moore, Joslin L/0000-0001-9809-5092; Seabloom, Eric/0000-0001-6780-9259; Chu, Chengjin/0000-0002-0606-449X; Stevens, Carly/0000-0002-2390-1763; Komatsu, Kimberly/0000-0001-7056-4547; Lind, Eric/0000-0003-3051-7724; Borer, Elizabeth/0000-0003-2259-5853	National Science Foundation Research Coordination Network [NSF-DEB-1042132]; Long Term Ecological Research program [NSF-DEB-1234162]; Institute on the Environment [DG-0001-13]; Konza Prairie LTER; Yale Institute for Biospheric Studies Pilot Grant; Natural Environment Research Council [ceh010010] Funding Source: researchfish; Direct For Biological Sciences [1234162] Funding Source: National Science Foundation; Division Of Environmental Biology [1440484] Funding Source: National Science Foundation; ARS [ARS-0429095] Funding Source: Federal RePORTER	National Science Foundation Research Coordination Network(National Science Foundation (NSF)); Long Term Ecological Research program; Institute on the Environment; Konza Prairie LTER; Yale Institute for Biospheric Studies Pilot Grant; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	We thank the Minnesota Supercomputer Institute for hosting project data, the University of Minnesota Institute on the Environment for hosting Nutrient Network meetings, and each site investigator for funding their site-level operations. Network coordination and data management were supported by funds from the National Science Foundation Research Coordination Network (NSF-DEB-1042132) to E.T.B. and E.W.S. from the Long Term Ecological Research program (NSF-DEB-1234162) to the Cedar Creek LTER, and from the Institute on the Environment (DG-0001-13). Konza NutNet site was funded by the Konza Prairie LTER; the Saline Experimental Range NutNet site was funded by a Yale Institute for Biospheric Studies Pilot Grant. Nitrogen fertilizer was donated to the Nutrient Network by Crop Production Services, Loveland, Colorado. We thank N. Gotelli for discussions.	Borer ET, 2014, NATURE, V508, P517, DOI 10.1038/nature13144; Borer ET, 2014, METHODS ECOL EVOL, V5, P65, DOI 10.1111/2041-210X.12125; Cardinale BJ, 2009, ECOL LETT, V12, P475, DOI 10.1111/j.1461-0248.2009.01317.x; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Chase JM, 2013, ECOL LETT, V16, P17, DOI 10.1111/ele.12112; Darwin C., 1877, ORIGIN SPECIES; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Fay PA, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.80, 10.1038/nplants.2015.80]; Flores-Moreno H, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0273; Foster BL, 1998, ECOLOGY, V79, P2593, DOI 10.1890/0012-9658(1998)079[2593:SRIASG]2.0.CO;2; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Harpole WS, 2011, ECOL LETT, V14, P852, DOI 10.1111/j.1461-0248.2011.01651.x; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; HUTCHINSON G, 1961, AM NAT, V95, P137, DOI 10.1086/282171; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Interlandi SJ, 2001, ECOLOGY, V82, P1270, DOI 10.2307/2679988; Isbell F, 2013, P NATL ACAD SCI USA, V110, P11911, DOI 10.1073/pnas.1310880110; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Ren ZW, 2010, J PLANT ECOL, V3, P25, DOI 10.1093/jpe/rtp034; Seabloom EW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8710; Silvertown J, 2009, ECOL LETT, V12, P165, DOI 10.1111/j.1461-0248.2008.01273.x; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Tilman D., 1982, Monographs in Population Biology, pi; Tilman D, 2001, P NATL ACAD SCI USA, V98, P5433, DOI 10.1073/pnas.091093198; Tilman D, 2014, ANNU REV ECOL EVOL S, V45, P471, DOI 10.1146/annurev-ecolsys-120213-091917; von Felten S, 2009, ECOLOGY, V90, P1389, DOI 10.1890/08-0802.1	26	260	274	49	669	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					93	96		10.1038/nature19324	http://dx.doi.org/10.1038/nature19324			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27556951	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000382426900045
J	Haumann, FA; Gruber, N; Munnich, M; Frenger, I; Kern, S				Haumann, F. Alexander; Gruber, Nicolas; Munnich, Matthias; Frenger, Ivy; Kern, Stefan			Sea-ice transport driving Southern Ocean salinity and its recent trends	NATURE			English	Article							DATA ASSIMILATION; CLIMATE-CHANGE; CIRCULATION; PACIFIC; CARBON	Recent salinity changes in the Southern Ocean(1-7) are among the most prominent signals of climate change in the global ocean, yet their underlying causes have not been firmly established(1,3,4,6). Here we propose that trends in the northward transport of Antarctic sea ice are a major contributor to these changes. Using satellite observations supplemented by sea-ice reconstructions, we estimate that wind-driven(8,9) northward freshwater transport by sea ice increased by 20 +/- 10 per cent between 1982 and 2008. The strongest and most robust increase occurred in the Pacific sector, coinciding with the largest observed salinity changes(4,5). We estimate that the additional freshwater for the entire northern sea-ice edge entails a freshening rate of -0.02 +/- 0.01 grams per kilogram per decade in the surface and intermediate waters of the open ocean, similar to the observed freshening(1-5). The enhanced rejection of salt near the coast of Antarctica associated with stronger sea-ice export counteracts the freshening of both continental shelf(2,10,11) and newly formed bottom waters(6) due to increases in glacial meltwater(12). Although the data sources underlying our results have substantial uncertainties, regional analyses(13) and independent data from an atmospheric reanalysis support our conclusions. Our finding that northward sea-ice freshwater transport is also a key determinant of the mean salinity distribution in the Southern Ocean further underpins the importance of the sea-ice-induced freshwater flux. Through its influence on the density structure of the ocean, this process has critical consequences for the global climate by affecting the exchange of heat, carbon and nutrients between the deep ocean and surface waters(14-17).	[Haumann, F. Alexander; Gruber, Nicolas; Munnich, Matthias; Frenger, Ivy] Swiss Fed Inst Technol, Inst Biogeochem & Pollutant Dynam, Environm Phys, Univ Str 16, CH-8092 Zurich, Switzerland; [Haumann, F. Alexander; Gruber, Nicolas] Swiss Fed Inst Technol, Ctr Climate Syst Modeling, Univ Str 16, CH-8092 Zurich, Switzerland; [Frenger, Ivy] GEOMAR Helmholtz Ctr Ocean Res Kiel, Biogeochem Modelling, Dusternbrooker Weg 20, D-24105 Kiel, Germany; [Kern, Stefan] Univ Hamburg, ICDC, Ctr Earth Syst Res & Sustainabil, Hamburg, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Hamburg	Haumann, FA (corresponding author), Swiss Fed Inst Technol, Inst Biogeochem & Pollutant Dynam, Environm Phys, Univ Str 16, CH-8092 Zurich, Switzerland.; Haumann, FA (corresponding author), Swiss Fed Inst Technol, Ctr Climate Syst Modeling, Univ Str 16, CH-8092 Zurich, Switzerland.	alexander.haumann@usys.ethz.ch	Gruber, Nicolas/B-7013-2009; Haumann, Alexander/J-6679-2014; Frenger, Ivy/B-9023-2017	Gruber, Nicolas/0000-0002-2085-2310; Haumann, Alexander/0000-0002-8218-977X; Frenger, Ivy/0000-0002-3490-7239; Kern, Stefan/0000-0001-7281-3746	ETH [CH2-01 11-1]; European Union (EU) [264879]; C2SM at ETH Zurich; Swiss National Science Foundation [P2EZP2-152133]; Center of Excellence for Climate System Analysis and Prediction (CliSAP), University of Hamburg, Germany; International Space Science Institute (ISSI), Bern, Switzerland [245]	ETH(ETH Zurich); European Union (EU)(CGIAREuropean Commission); C2SM at ETH Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Center of Excellence for Climate System Analysis and Prediction (CliSAP), University of Hamburg, Germany; International Space Science Institute (ISSI), Bern, Switzerland	This work was supported by ETH Research Grant CH2-01 11-1 and by European Union (EU) grant 264879 (CARBOCHANGE). I.F. was supported by C2SM at ETH Zurich and the Swiss National Science Foundation Grant P2EZP2-152133. S.K. was supported by the Center of Excellence for Climate System Analysis and Prediction (CliSAP), University of Hamburg, Germany. F.A.H. and S.K. acknowledge support from the International Space Science Institute (ISSI), Bern, Switzerland, under project #245. We are thankful to F. Massonnet for providing the sea-ice thickness reconstruction and discussion. The ICESat-1 sea-ice thickness data were provided by the NASA Goddard Space Flight Center. The ship-based sea-ice thickness data were provided by the SCAR Antarctic Sea Ice Processes and Climate (ASPeCt) programme. We appreciate the provision of sea-ice concentration and motion data by the National Snow and Ice Data Center, the Integrated Climate Data Center at the University of Hamburg and R. Kwok. We thank T. Frolicher, S. Yang, A. Stossel, M. Frischknecht, L. Papritz, P. Durack, M. van den Broecke, J. Lenaerts, J. van Angelen and M. Meredith for discussion, comments, and ideas.	Abernathey RP, 2016, NAT GEOSCI, V9, P596, DOI [10.1038/ngeo2749, 10.1038/NGEO2749]; Boning CW, 2008, NAT GEOSCI, V1, P864, DOI 10.1038/ngeo362; de Lavergne C, 2014, NAT CLIM CHANGE, V4, P278, DOI [10.1038/nclimate2132, 10.1038/NCLIMATE2132]; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Drucker R, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048668; Durack PJ, 2012, SCIENCE, V336, P455, DOI 10.1126/science.1212222; Ferrari R, 2014, P NATL ACAD SCI USA, V111, P8753, DOI 10.1073/pnas.1323922111; Fowler C., 1980, POLAR PATHFINDER DAI, V2; Frolicher TL, 2015, J CLIMATE, V28, P862, DOI 10.1175/JCLI-D-14-00117.1; Hellmer HH, 2011, OCEAN SCI, V7, P305, DOI 10.5194/os-7-305-2011; Helm KP, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044222; Holland PR, 2012, NAT GEOSCI, V5, P872, DOI [10.1038/ngeo1627, 10.1038/NGEO1627]; Jacobs SS, 2002, SCIENCE, V297, P386, DOI 10.1126/science.1069574; Jacobs SS, 2010, J CLIMATE, V23, P4508, DOI 10.1175/2010JCLI3284.1; Kirkman CH, 2011, J CLIMATE, V24, P2224, DOI 10.1175/2010JCLI3625.1; Komuro Y, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001476; Kurtz NT, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008141; Landschutzer P, 2015, SCIENCE, V349, P1221, DOI 10.1126/science.aab2620; Massom RA, 2001, REV GEOPHYS, V39, P413, DOI 10.1029/2000RG000085; Massonnet F, 2013, OCEAN MODEL, V64, P67, DOI 10.1016/j.ocemod.2013.01.003; Meier W., 1980, NOAA NSIDC CLIMATE D, V2; Nakayama Y, 2014, GEOPHYS RES LETT, V41, P7942, DOI 10.1002/2014GL061600; Naumann F. A., 2014, GEOPHYS RES LETT, V41, P8429; Paolo FS, 2015, SCIENCE, V348, P327, DOI 10.1126/science.aaa0940; Purkey SG, 2013, J CLIMATE, V26, P6105, DOI 10.1175/JCLI-D-12-00834.1; Saenko OA, 2002, J PHYS OCEANOGR, V32, P3376, DOI 10.1175/1520-0485(2002)032<3376:OTROWD>2.0.CO;2; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Talley LD, 2013, OCEANOGRAPHY, V26, P80, DOI 10.5670/oceanog.2013.07; Tamura T, 2011, SOLA, V7, P17, DOI 10.2151/sola.2011-005; Wong APS, 1999, NATURE, V400, P440, DOI 10.1038/22733	30	133	138	5	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					89	92		10.1038/nature19101	http://dx.doi.org/10.1038/nature19101			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27582222	Green Accepted			2022-12-28	WOS:000382426900044
J	Tollefson, J				Tollefson, Jeff			COMPUTERS ON THE REEF	NATURE			English	Editorial Material																			0	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					123	124		10.1038/537123a	http://dx.doi.org/10.1038/537123a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU7XC	27582223	Bronze			2022-12-28	WOS:000382426900054
J	Kaiser, J				Kaiser, Jocelyn			SCIENTIFIC MISCONDUCT Research watchdog's new leader faces staff revolt	SCIENCE			English	News Item																			0	0	0	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					856	857		10.1126/science.353.6302.856	http://dx.doi.org/10.1126/science.353.6302.856			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU0CA	27563078				2022-12-28	WOS:000381867700011
J	Loh, KH; Stawski, PS; Draycott, AS; Udeshi, ND; Lehrman, EK; Wilton, DK; Svinkina, T; Deerinck, TJ; Ellisman, MH; Stevens, B; Carr, SA; Ting, AY				Loh, Ken H.; Stawski, Philipp S.; Draycott, Austin S.; Udeshi, Namrata D.; Lehrman, Emily K.; Wilton, Daniel K.; Svinkina, Tanya; Deerinck, Thomas J.; Ellisman, Mark H.; Stevens, Beth; Carr, Steven A.; Ting, Alice Y.			Proteomic Analysis of Unbounded Cellular Compartments: Synaptic Clefts	CELL			English	Article							LIVING CELLS; IN-VIVO; PROTEINS; NEUROLIGIN-2; TRAFFICKING; PEROXIDASE; EXPRESSION; RECEPTORS; SYNAPSES; SITES	Cellular compartments that cannot be biochemically isolated are challenging to characterize. Here we demonstrate the proteomic characterization of the synaptic clefts that exist at both excitatory and inhibitory synapses. Normal brain function relies on the careful balance of these opposing neural connections, and understanding how this balance is achieved relies on knowledge of their protein compositions. Using a spatially restricted enzymatic tagging strategy, we mapped the proteomes of two of the most common excitatory and inhibitory synaptic clefts in living neurons. These proteomes reveal dozens of synaptic candidates and assign numerous known synaptic proteins to a specific cleft type. The molecular differentiation of each cleft allowed us to identify Mdga2 as a potential specificity factor influencing Neuroligin-2's recruitment of presynaptic neurotransmitters at inhibitory synapses.	[Loh, Ken H.; Stawski, Philipp S.; Draycott, Austin S.; Ting, Alice Y.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Udeshi, Namrata D.; Svinkina, Tanya; Carr, Steven A.; Ting, Alice Y.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Lehrman, Emily K.; Wilton, Daniel K.; Stevens, Beth] BCH, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Lehrman, Emily K.; Wilton, Daniel K.; Stevens, Beth] HMS, Boston, MA 02115 USA; [Deerinck, Thomas J.; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Deerinck, Thomas J.; Ellisman, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Ting, Alice Y.] Stanford Univ, Dept Genet, 318 Campus Dr, Stanford, CA 94305 USA; [Ting, Alice Y.] Stanford Univ, Dept Biol, 318 Campus Dr, Stanford, CA 94305 USA; [Ting, Alice Y.] Stanford Univ, Dept Chem, 318 Campus Dr, Stanford, CA 94305 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Santander; Harvard University; Harvard Medical School; University of California System; University of California San Diego; University of California System; University of California San Diego; Stanford University; Stanford University; Stanford University	Ting, AY (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.; Ting, AY (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Ting, AY (corresponding author), Stanford Univ, Dept Genet, 318 Campus Dr, Stanford, CA 94305 USA.; Ting, AY (corresponding author), Stanford Univ, Dept Biol, 318 Campus Dr, Stanford, CA 94305 USA.; Ting, AY (corresponding author), Stanford Univ, Dept Chem, 318 Campus Dr, Stanford, CA 94305 USA.	ayting@stanford.edu	Carr, Steven A./AAH-8366-2019	Erdmann, Philipp/0000-0001-8289-9133; Ting, Alice/0000-0002-8277-5226	U.S. NIH [R01-CA186568, P41GM103412, R01GM086197, R01-NS071008-01A1, R01-NS092578]; Howard Hughes Medical Institute Collaborative Initiative Award; Simons Center for the Social Brain Postdoctoral Fellowship; Feodor Lynen Research Fellowship from Alexander von Humboldt Foundation; NATIONAL CANCER INSTITUTE [R01CA186568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086197, P41GM103412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092578, R01NS071008] Funding Source: NIH RePORTER	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Collaborative Initiative Award; Simons Center for the Social Brain Postdoctoral Fellowship; Feodor Lynen Research Fellowship from Alexander von Humboldt Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Watson (Whitehead Institute Keck Microscopy Facility) for performing electron microscopy, J. Einstein for neuron cultures, A. Vignery (Yale) and J. Sedgwick (Schering-Plough) for CD200 knockout mice, and members of A. Ting's lab, especially V. Hung, K. Cox, S. Lam, and K. Pedram, for assistance with data analysis and manuscript editing. K. Tye and G. Matthews assisted with brain slice imaging. J. Sanes, K. Shen, and S. Slavoff provided experimental advice and feedback on the manuscript, and T. Hashimoto helped with data analysis. Funding was provided by the U.S. NIH (R01-CA186568 to A.Y.T.; P41GM103412 and R01GM086197 to M.H.E.; R01-NS071008-01A1 and R01-NS092578 to B.S.) and the Howard Hughes Medical Institute Collaborative Initiative Award (A.Y.T. and S.A.C.) P.S.S. was supported by a Simons Center for the Social Brain Postdoctoral Fellowship and Feodor Lynen Research Fellowship from the Alexander von Humboldt Foundation. The Massachusetts Institute of Technology has filed a patent covering the peroxidase-based proteomic mapping technology. The authors will deposit the genetic constructs used in this work with Addgene (www.addgene.org/).	Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059; Bayes A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046683; Biesemann C, 2014, EMBO J, V33, P157, DOI 10.1002/embj.201386120; Boyken J, 2013, NEURON, V78, P285, DOI 10.1016/j.neuron.2013.02.027; Chapman-Smith A, 1999, BIOMOL ENG, V16, P119, DOI 10.1016/S1050-3862(99)00046-7; Chen CL, 2015, P NATL ACAD SCI USA, V112, P12093, DOI 10.1073/pnas.1515623112; Chen JL, 2012, NEURON, V74, P361, DOI 10.1016/j.neuron.2012.02.030; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Ha Viet Cuong, 2011, Journal of ISSAAS (International Society for Southeast Asian Agricultural Sciences), V17, P70; Heller EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039572; HENN FA, 1976, BRAIN RES, V101, P341, DOI 10.1016/0006-8993(76)90274-2; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hung V, 2016, NAT PROTOC, V11, P456, DOI 10.1038/nprot.2016.018; Hung V, 2014, MOL CELL, V55, P332, DOI 10.1016/j.molcel.2014.06.003; Kang Y, 2014, J BIOL CHEM, V289, P29350, DOI 10.1074/jbc.M114.549279; Kraus DM, 2006, J IMMUNOL, V176, P4419, DOI 10.4049/jimmunol.176.7.4419; Krivosheya D, 2008, J BIOL CHEM, V283, P32944, DOI 10.1074/jbc.M800073200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kulik A, 2002, EUR J NEUROSCI, V15, P291, DOI 10.1046/j.0953-816x.2001.01855.x; Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179; Lee K, 2013, P NATL ACAD SCI USA, V110, P336, DOI 10.1073/pnas.1219987110; Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Martell JD, 2012, NAT BIOTECHNOL, V30, P1143, DOI 10.1038/nbt.2375; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Pettem KL, 2013, J CELL BIOL, V200, P321, DOI 10.1083/jcb.201206028; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pirooznia M, 2012, BIOINFORMATICS, V28, P897, DOI 10.1093/bioinformatics/bts040; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rees J. S., 2015, CURR PROTOC PROTEIN, V80; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Svinkina T, 2015, MOL CELL PROTEOMICS, V14, P2429, DOI 10.1074/mcp.O114.047555; Takahashi H, 2012, NAT NEUROSCI, V15, P389, DOI 10.1038/nn.3040; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410	40	190	194	5	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1295	+		10.1016/j.cell.2016.07.041	http://dx.doi.org/10.1016/j.cell.2016.07.041			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27565350	Green Accepted, Bronze			2022-12-28	WOS:000382259500024
J	Vidal, M				Vidal, Marc			Playing Hide-and-Seek with Yeast	CELL			English	Editorial Material																			0	0	0	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1069	1073		10.1016/j.cell.2016.08.018	http://dx.doi.org/10.1016/j.cell.2016.08.018			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27565335	Bronze			2022-12-28	WOS:000382259500004
J	McNeely, J; Wu, LT; Subramaniam, G; Sharma, G; Cathers, LA; Svikis, D; Sleiter, L; Russell, L; Nordeck, C; Sharma, A; O'Grady, KE; Bouk, LB; Cushing, C; King, J; Wahle, A; Schwartz, RP				McNeely, Jennifer; Wu, Li-Tzy; Subramaniam, Geetha; Sharma, Gaurav; Cathers, Lauretta A.; Svikis, Dace; Sleiter, Luke; Russell, Linnea; Nordeck, Courtney; Sharma, Anjalee; O'Grady, Kevin E.; Bouk, Leah B.; Cushing, Carol; King, Jacqueline; Wahle, Aimee; Schwartz, Robert P.			Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients	ANNALS OF INTERNAL MEDICINE			English	Article							BEHAVIORAL-COUNSELING INTERVENTIONS; DISORDERS IDENTIFICATION TEST; LONGITUDINAL DATA-ANALYSIS; POSITIVE PREVALENCE RATES; RANDOMIZED CLINICAL-TRIAL; SERVICES-TASK-FORCE; DRUG-USE; TEST ASSIST; PREVENTIVE-SERVICES; SELF-REPORTS	Background: Substance use, a leading cause of illness and death, is underidentified in medical practice. Objective: The Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) tool was developed to address the need for a brief screening and assessment instrument that includes all commonly used substances and fits into clinical work-flows. The goal of this study was to assess the performance of the TAPS tool in primary care patients. Design: Multisite study, conducted within the National Drug Abuse Treatment Clinical Trials Network, comparing the TAPS tool with a reference standard measure. (ClinicalTrials.gov: NCT02110693) Setting: 5 adult primary care clinics. Participants: 2000 adult patients consecutively recruited from clinic waiting areas. Measurements: Interviewer-and self-administered versions of the TAPS tool were compared with a reference standard, the modified World Mental Health Composite International Diagnostic Interview (CIDI), which measures problem use and substance use disorder (SUD). Results: Interviewer-and self-administered versions of the TAPS tool had similar diagnostic characteristics. For identifying problem use (at a cutoff of 1+), the TAPS tool had a sensitivity of 0.93 (95% CI, 0.90 to 0.95) and specificity of 0.87 (CI, 0.85 to 0.89) for tobacco and a sensitivity of 0.74 (CI, 0.70 to 0.78) and specificity of 0.79 (CI, 0.76 to 0.81) for alcohol. For problem use of illicit and prescription drugs, sensitivity ranged from 0.82 (CI, 0.76 to 0.87) for marijuana to 0.63 (CI, 0.47 to 0.78) for sedatives; specificity was 0.93 or higher. For identifying any SUD (at a cutoff of 2+), sensitivity was lower. Limitations: The low prevalence of some drug classes led to poor precision in some estimates. Research assistants were not blinded to participants' TAPS tool responses when they administered the CIDI. Conclusion: In a diverse population of adult primary care patients, the TAPS tool detected clinically relevant problem substance use. Although it also may detect tobacco, alcohol, and marijuana use disorders, further refinement is needed before it can be recommended broadly for SUD screening.	[McNeely, Jennifer] NYU, Sch Med, Dept Populat Hlth, 550 First Ave,VZ30 6th Floor, New York, NY 10016 USA; [McNeely, Jennifer] Dept Med, Div Gen Internal Med, 550 First Ave,VZ30 6th Floor, New York, NY 10016 USA; [Wu, Li-Tzy] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Dept Med, Durham, NC 27710 USA; [Wu, Li-Tzy] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27710 USA; [Subramaniam, Geetha; Cushing, Carol] NIDA, Ctr Clin Trials Network, NIH, 6001 Execut Blvd, Bethesda, MD 20892 USA; [Sharma, Anjalee; King, Jacqueline; Wahle, Aimee] EMMES Corp, 401 North Washington St, Rockville, MD 20850 USA; [Cathers, Lauretta A.] Virginia Commonwealth Univ, 730 East Broad St,Room 3076, Richmond, VA 23298 USA; [Svikis, Dace] Virginia Commonwealth Univ, POB 98034,1001 East Broad St,Room 305, Richmond, VA 23298 USA; [Sleiter, Luke; Russell, Linnea] NYU, Sch Med, 227 East 30th St,7th Floor, New York, NY 10016 USA; [Nordeck, Courtney; Sharma, Anjalee; Schwartz, Robert P.] Friends Res Inst, 1040 Pk Ave,Suite 103, Baltimore, MD 21201 USA; [O'Grady, Kevin E.] Univ Maryland, College Pk, MD 20742 USA; [Bouk, Leah B.] Duke Univ, Sch Med, Duke Translat Res Inst, Kannapolis, NC USA	New York University; Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Emmes Corporation; Virginia Commonwealth University; Virginia Commonwealth University; New York University; University System of Maryland; University of Maryland College Park; Duke University	McNeely, J (corresponding author), NYU, Sch Med, Dept Populat Hlth, 550 First Ave,VZ30 6th Floor, New York, NY 10016 USA.	Jennifer.McNeely@nyumc.org	WU, LI-TZY/I-7481-2012	WU, LI-TZY/0000-0002-5909-2259; McNeely, Jennifer/0000-0003-4601-6940; Nordeck, Courtney/0000-0002-3564-9139	National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [UG1DA013035, U10DA013727, UG1DA013727, UG1DA013034, UG1DA040317] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institute on Drug Abuse.	Ali R, 2013, DRUG ALCOHOL DEPEN, V132, P352, DOI 10.1016/j.drugalcdep.2013.03.001; Antoniou T, 2002, ANN PHARMACOTHER, V36, P1598, DOI 10.1345/aph.1A447; Arnsten JH, 2002, J GEN INTERN MED, V17, P377, DOI 10.1007/s11606-002-0044-3; BABOR TF, 1990, BEHAV ASSESS, V12, P5; Babor Thomas F, 2007, Subst Abus, V28, P7, DOI 10.1300/J465v28n03_03; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Bradley KA, 2011, J GEN INTERN MED, V26, P299, DOI 10.1007/s11606-010-1509-4; Campanelli P., 1997, B METHODOLOGIE SOCIO, P5, DOI DOI 10.1177/075910639705500103; Centers for Disease Control and Prevention (CDC), 2007, MMWR MORB MORTAL WKL, V56, P93; Centers for Medicare & Medicaid Services, 2014, 2014 CLIN QUAL MEAS; Centers for Medicare & Medicaid Services (CMS) HHS, 2012, Fed Regist, V77, P53967; Compton WM, 1996, DRUG ALCOHOL DEPEN, V41, P179, DOI 10.1016/0376-8716(96)01249-5; Cone EJ, 2002, J ANAL TOXICOL, V26, P541, DOI 10.1093/jat/26.8.541; Cooke F, 2008, NICOTINE TOB RES, V10, P607, DOI 10.1080/14622200801978680; Cottler L. B., 2000, COMPOSITE INT DIAGNO; COTTLER LB, 1989, BRIT J ADDICT, V84, P801; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; De Cock KM, 2012, AIDS, V26, P1205, DOI 10.1097/QAD.0b013e328354622a; Del Boca FK, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1359-6357.2003.00586.x; Des Jarlais DC, 1999, LANCET, V353, P1657, DOI 10.1016/S0140-6736(98)07026-3; Forman RF, 2004, J SUBST ABUSE TREAT, V27, P1, DOI 10.1016/j.jsat.2004.03.012; Ghitza UE, 2013, SUBST ABUSE REHABIL, V4, P3, DOI 10.2147/SAR.S39982; Gryczynski J, 2015, ADDICTION, V110, P240, DOI 10.1111/add.12767; Heltsley R, 2011, J ANAL TOXICOL, V35, P529, DOI 10.1093/anatox/35.8.529; Hides L, 2009, ADDICT BEHAV, V34, P821, DOI 10.1016/j.addbeh.2009.03.001; Hser Y I, 1997, NIDA Res Monogr, V167, P320; Humeniuk R, 2008, ADDICTION, V103, P1039, DOI 10.1111/j.1360-0443.2007.02114.x; Kim J, 2008, AMBUL PEDIATR, V8, P255, DOI 10.1016/j.ambp.2008.03.033; Lanier D., 2008, SCREENING PRIMARY CA; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lindsey WT, 2012, AM J DRUG ALCOHOL AB, V38, P334, DOI 10.3109/00952990.2011.643997; Maciosek MV, 2006, AM J PREV MED, V31, P52, DOI 10.1016/j.amepre.2006.03.012; Malta M, 2008, ADDICTION, V103, P1242, DOI 10.1111/j.1360-0443.2008.02269.x; McNeely J, 2016, ADDICTION, V111, P233, DOI 10.1111/add.13165; McNeely J, 2015, J GEN INTERN MED, V30, P1757, DOI 10.1007/s11606-015-3391-6; McNeely J, 2015, AM J MED, V128, DOI 10.1016/j.amjmed.2015.02.007; McNeely J, 2014, SUBST ABUS, V35, P12, DOI 10.1080/08897077.2013.789463; Merrill J, 2002, J GEN INTERN MED, V17, P327, DOI 10.1046/j.1525-1497.2002.10625.x; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Moyer VA, 2013, ANN INTERN MED, V159, P210, DOI 10.7326/0003-4819-159-3-201308060-00652; National Institute on Alcohol Abuse and Alcoholism National Institute on Alcohol Abuse and Alcoholism, 2005, HELP PAT WHO DRINK T; National Institute on Drug Abuse, 2010, SCREEN DRUG US MED S; Newcombe DAL, 2005, DRUG ALCOHOL REV, V24, P217, DOI 10.1080/09595230500170266; Paulozzi Leonard, 2012, Morbidity and Mortality Weekly Report, V61, P10; Pepe M. S., 2003, STAT EVALUATION MED; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Rogers SM, 1998, SUBST USE MISUSE, V33, P2179, DOI 10.3109/10826089809069820; Roy-Byrne P, 2014, JAMA-J AM MED ASSOC, V312, P492, DOI 10.1001/jama.2014.7860; Saitz R, 2014, JAMA-J AM MED ASSOC, V312, P502, DOI 10.1001/jama.2014.7862; Saitz R, 2010, J ADDICT MED, V4, P123, DOI 10.1097/ADM.0b013e3181db6b67; Secades-Villa R, 2003, ADDICT BEHAV, V28, P1175, DOI 10.1016/S0306-4603(02)00219-8; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Smith PC, 2010, ARCH INTERN MED, V170, P1155, DOI 10.1001/archinternmed.2010.140; Smith PC, 2009, J GEN INTERN MED, V24, P783, DOI 10.1007/s11606-009-0928-6; Solberg LI, 2008, AM J PREV MED, V34, P143, DOI 10.1016/j.amepre.2007.09.035; Spear SE, 2016, SUBST ABUS, V37, P299, DOI 10.1080/08897077.2015.1062460; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G; Tiet QQ, 2015, JAMA INTERN MED, V175, P1371, DOI 10.1001/jamainternmed.2015.2438; Tourangeau R, 1996, PUBLIC OPIN QUART, V60, P275, DOI 10.1086/297751; Whitlock EP, 2004, ANN INTERN MED, V140, P557, DOI 10.7326/0003-4819-140-7-200404060-00017; Wight RG, 2000, AIDS EDUC PREV, V12, P431; Williams EC, 2013, ADDICT SCI CLIN P S1, V8, pA85, DOI DOI 10.1186/1940-0640-8-S1-A85; Willis G.B., 1997, B METHODOL SOC, V5, P40, DOI [10.1177/075910639705500105, DOI 10.1177/075910639705500105]; WILLIS GB, 1991, APPL COGNITIVE PSYCH, V5, P251, DOI 10.1002/acp.2350050307; Wu LT, 2013, GEN HOSP PSYCHIAT, V35, P74, DOI 10.1016/j.genhosppsych.2012.06.014; Wu LT, 2012, J PSYCHIATR RES, V46, P360, DOI 10.1016/j.jpsychires.2011.12.002; Yudko E, 2007, J SUBST ABUSE TREAT, V32, P189, DOI 10.1016/j.jsat.2006.08.002; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	70	97	97	1	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	2016	165	10					690	+		10.7326/M16-0317	http://dx.doi.org/10.7326/M16-0317			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EC2RB	27595276	Green Accepted			2022-12-28	WOS:000387970500013
J	Weintraub, WS				Weintraub, William S.			Invasive management of acute coronary syndromes	LANCET			English	Editorial Material							ELEVATION MYOCARDIAL-INFARCTION; CONSERVATIVE TREATMENT; UNSTABLE ANGINA; STRATEGY; METAANALYSIS; THERAPY; ROUTINE		[Weintraub, William S.] Christiana Care Hlth Syst, Newark, DE 19718 USA	Christiana Care Health System	Weintraub, WS (corresponding author), Christiana Care Hlth Syst, Newark, DE 19718 USA.	wweintraub@christianacare.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104941] Funding Source: NIH RePORTER; NIGMS NIH HHS [U54 GM104941] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2645, DOI [10.1016/j.jacc.2014.09.016, 10.1016/j.jacc.2014.09.017]; Bavry AA, 2006, J AM COLL CARDIOL, V48, P1319, DOI 10.1016/j.jacc.2006.06.050; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Fox KAA, 2010, J AM COLL CARDIOL, V55, P2435, DOI 10.1016/j.jacc.2010.03.007; Gerber Y, 2009, J AM COLL CARDIOL, V54, P2382, DOI 10.1016/j.jacc.2009.09.020; Henderson RA, 2015, J AM COLL CARDIOL, V66, P511, DOI 10.1016/j.jacc.2015.05.051; Montalescot G, 2016, EUR HEART J, V37, P344, DOI 10.1093/eurheartj/ehv377; O'Donoghue M, 2008, JAMA-J AM MED ASSOC, V300, P71, DOI 10.1001/jama.300.1.71; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816; Wallentin L, 2000, LANCET, V356, P9, DOI 10.1016/S0140-6736(00)02427-2; Wallentin L, 2016, LANCET	13	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 15	2016	388	10054					1856	+		10.1016/S0140-6736(16)31273-9	http://dx.doi.org/10.1016/S0140-6736(16)31273-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DZ0AM	27585758	Green Accepted			2022-12-28	WOS:000385499000006
J	Kober, L; Thune, JJ; Nielsen, JC; Haarbo, J; Videbaek, L; Korup, E; Jensen, G; Hildebrandt, P; Steffensen, FH; Bruun, NE; Eiskjaer, H; Brandes, A; Thogersen, AM; Gustafsson, F; Egstrup, K; Videbaek, R; Hassager, C; Svendsen, JH; Hofsten, DE; Torp-Pedersen, C; Pehrson, S				Kober, Lars; Thune, Jens J.; Nielsen, Jens C.; Haarbo, Jens; Videbaek, Lars; Korup, Eva; Jensen, Gunnar; Hildebrandt, Per; Steffensen, Flemming H.; Bruun, Niels E.; Eiskjaer, Hans; Brandes, Axel; Thogersen, Anna M.; Gustafsson, Finn; Egstrup, Kenneth; Videbaek, Regitze; Hassager, Christian; Svendsen, Jesper H.; Hofsten, Dan E.; Torp-Pedersen, Christian; Pehrson, Steen		DANISH Investigators	Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIAC-RESYNCHRONIZATION THERAPY; CARDIOVERTER-DEFIBRILLATOR; DILATED CARDIOMYOPATHY; DEATH; PREVENTION; AMIODARONE; MORTALITY; TRIAL; RISK	BACKGROUND The benefit of an implantable cardioverter-defibrillator (ICD) in patients with symptomatic systolic heart failure caused by coronary artery disease has been well documented. However, the evidence for a benefit of prophylactic ICDs in patients with systolic heart failure that is not due to coronary artery disease has been based primarily on subgroup analyses. The management of heart failure has improved since the landmark ICD trials, and many patients now receive cardiac resynchronization therapy (CRT). METHODS In a randomized, controlled trial, 556 patients with symptomatic systolic heart failure (left ventricular ejection fraction, <= 35%) not caused by coronary artery disease were assigned to receive an ICD, and 560 patients were assigned to receive usual clinical care (control group). In both groups, 58% of the patients received CRT. The primary outcome of the trial was death from any cause. The secondary outcomes were sudden cardiac death and cardiovascular death. RESULTS After a median follow-up period of 67.6 months, the primary outcome had occurred in 120 patients (21.6%) in the ICD group and in 131 patients (23.4%) in the control group (hazard ratio, 0.87; 95% confidence interval [CI], 0.68 to 1.12; P = 0.28). Sudden cardiac death occurred in 24 patients (4.3%) in the ICD group and in 46 patients (8.2%) in the control group (hazard ratio, 0.50; 95% CI, 0.31 to 0.82; P = 0.005). Device infection occurred in 27 patients (4.9%) in the ICD group and in 20 patients (3.6%) in the control group (P = 0.29). CONCLUSIONS In this trial, prophylactic ICD implantation in patients with symptomatic systolic heart failure not caused by coronary artery disease was not associated with a significantly lower long-term rate of death from any cause than was usual clinical care. (Funded by Medtronic and others; DANISH ClinicalTrials. gov number, NCT00542945.)	[Kober, Lars; Thune, Jens J.; Gustafsson, Finn; Videbaek, Regitze; Hassager, Christian; Svendsen, Jesper H.; Hofsten, Dan E.; Pehrson, Steen] Univ Copenhagen, Rigshosp, Dept Cardiol, Copenhagen, Denmark; [Thune, Jens J.] Univ Copenhagen, Dept Cardiol, Bispebjerg Hosp, Copenhagen, Denmark; [Nielsen, Jens C.; Eiskjaer, Hans] Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark; [Haarbo, Jens; Bruun, Niels E.] Univ Copenhagen, Herlev & Gentofte Hosp, Dept Cardiol, Hellerup, Denmark; [Videbaek, Lars; Brandes, Axel] Odense Univ Hosp, Dept Cardiol, Odense, Denmark; [Korup, Eva; Thogersen, Anna M.; Torp-Pedersen, Christian] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Bruun, Niels E.] Aalborg Univ, Inst Clin, Aalborg, Denmark; [Jensen, Gunnar] Zealand Univ Hosp, Dept Cardiol, Roskilde, Denmark; [Hildebrandt, Per] Frederiksberg Heart Clin, Frederiksberg, Denmark; [Steffensen, Flemming H.] Lillebaelt Hosp, Dept Cardiol, Vejle, Denmark; [Egstrup, Kenneth] Odense Univ Hosp, Dept Cardiol, Svendborg, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; Aarhus University; University of Copenhagen; University of Southern Denmark; Odense University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; University of Southern Denmark; Odense University Hospital	Kober, L (corresponding author), Univ Hosp, Rigshosp, Dept Cardiol, Blegdamsvej 9, Copenhagen, Denmark.	lars.koeber@regionh.dk	Steffensen, Flemming Hald/AAH-8742-2020; sherief, irfan/AAL-4926-2020; Brandes, Axel/L-3609-2019; Nielsen, Olav Wendelboe/S-4390-2016; Svendsen, Jesper Hastrup/G-8573-2017	Brandes, Axel/0000-0001-9145-6887; Nielsen, Olav Wendelboe/0000-0003-3532-9431; Svendsen, Jesper Hastrup/0000-0001-8466-8515; Nielsen, Jens Cosedis/0000-0001-9414-1653; Thune, Jens Jakob/0000-0002-3621-3775; Hassager, Christian/0000-0002-1199-0981; Bruun, Niels Eske/0000-0002-5026-9193; Kober, Lars/0000-0002-6635-1466; Gustafsson, Finn/0000-0003-2144-341X	Medtronic; St. Jude Medical; TrygFonden; Danish Heart Foundation; Sanofi; Novartis; Bristol-Myers Squibb; Boston Scientific; Biosense Webster; Biotronik; AstraZeneca; Boehringer Ingelheim; Bayer; Pfizer; Gilead Sciences; Servier	Medtronic(Medtronic); St. Jude Medical(St. Jude Medical); TrygFonden; Danish Heart Foundation; Sanofi(Sanofi-Aventis); Novartis(Novartis); Bristol-Myers Squibb(Bristol-Myers Squibb); Boston Scientific(Boston Scientific); Biosense Webster; Biotronik; AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Bayer(Bayer AG); Pfizer(Pfizer); Gilead Sciences(Gilead Sciences); Servier(Servier)	Supported by unrestricted grants from Medtronic, St. Jude Medical, TrygFonden, and the Danish Heart Foundation.; Dr. Kober reports receiving lecture fees from Sanofi and Novartis; Dr. Thune, lecture fees from Bristol-Myers Squibb and personal fees and travel support from Novartis; Dr. Nielsen, consulting fees from Boston Scientific and lecture fees from Biosense Webster and Biotronik; Dr. Videbaek, fees for serving on advisory boards from Novartis, AstraZeneca, and Boehringer Ingelheim and lecture fees from Novartis; Dr. Bruun, receiving lecture fees from Biotronik; Dr. Brandes, receiving lecture fees from Bayer, Boehringer Ingelheim, and Pfizer; Dr. Svendsen, receiving fees for serving on an advisory board from Medtronic, lecture fees from Medtronic, Biotronik, AstraZeneca, and Boehringer Ingelheim, and grant support from Medtronic, Biotronik, and Gilead Sciences; Dr. Torp-Pedersen, lecture fees and grant support from Bayer; and Dr. Pehrson, lecture fees from Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, and Servier. No other potential conflict of interest relevant to this article was reported.	Bansch D, 2002, CIRCULATION, V105, P1453, DOI 10.1161/01.CIR.0000012350.99718.AD; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Barsheshet A, 2012, J AM COLL CARDIOL, V59, P2075, DOI 10.1016/j.jacc.2012.02.036; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Colquitt JL, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18560; Kadish A, 2004, NEW ENGL J MED, V350, P2151, DOI 10.1056/NEJMoa033088; Kirkfeldt RE, 2014, EUR HEART J, V35, P1186, DOI 10.1093/eurheartj/eht511; Lam SKH, 2007, BMJ-BRIT MED J, V335, P925, DOI 10.1136/bmj.39343.511389.BE; Marijon E, 2015, EUR HEART J, V36, P2767, DOI 10.1093/eurheartj/ehv455; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Moss AJ, 2012, NEW ENGL J MED, V367, P2275, DOI 10.1056/NEJMoa1211107; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Strickberger SA, 2003, J AM COLL CARDIOL, V41, P1707, DOI 10.1016/S0735-1097(03)00297-3; Thune JJ, 2016, AM HEART J, V179, P136, DOI 10.1016/j.ahj.2016.06.016; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	17	951	970	1	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 29	2016	375	13					1221	1230		10.1056/NEJMoa1608029	http://dx.doi.org/10.1056/NEJMoa1608029			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DX3HU	27571011	Green Published, Bronze			2022-12-28	WOS:000384265000004
J	Kappelman, J; Ketcham, RA; Pearce, S; Todd, L; Akins, W; Colbert, MW; Feseha, M; Maisano, JA; Witzel, A				Kappelman, John; Ketcham, Richard A.; Pearce, Stephen; Todd, Lawrence; Akins, Wiley; Colbert, Matthew W.; Feseha, Mulugeta; Maisano, Jessica A.; Witzel, Adrienne			Perimortem fractures in Lucy suggest mortality from fall out of tall tree	NATURE			English	Article							AUSTRALOPITHECUS-AFARENSIS; COMPUTED-TOMOGRAPHY; HADAR FORMATION; CLIMATE-CHANGE; BODY SIZE; ETHIOPIA; SKELETON; CLASSIFICATION; ENVIRONMENTS; PATTERNS	The Pliocene fossil `Lucy' (Australopithecus afarensis) was discovered in the Afar region of Ethiopia in 1974 and is among the oldest and most complete fossil hominin skeletons discovered. Here we propose, on the basis of close study of her skeleton, that her cause of death was a vertical deceleration event or impact following a fall from considerable height that produced compressive and hinge (greenstick) fractures in multiple skeletal elements. Impacts that are so severe as to cause concomitant fractures usually also damage internal organs; together, these injuries are hypothesized to have caused her death. Lucy has been at the centre of a vigorous debate about the role, if any, of arboreal locomotion in early human evolution. It is therefore ironic that her death can be attributed to injuries resulting from a fall, probably out of a tall tree, thus offering unusual evidence for the presence of arborealism in this species.	[Kappelman, John; Todd, Lawrence; Witzel, Adrienne] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Kappelman, John; Ketcham, Richard A.; Colbert, Matthew W.; Maisano, Jessica A.] Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA; [Pearce, Stephen] Austin Bone & Joint Clin, Austin, TX 78705 USA; [Akins, Wiley] Univ Texas Austin, Dept Radiotelevis Film, Austin, TX 78712 USA; [Feseha, Mulugeta] Univ Addis Ababa, Paleoanthropol & Paleoenvironm Program, Addis Ababa, Ethiopia	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Addis Ababa University	Kappelman, J (corresponding author), Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA.; Kappelman, J (corresponding author), Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA.	jkappelman@austin.utexas.edu	Todd, Lawrence/AAJ-3350-2021; Ketcham, Richard/B-5431-2011	Ketcham, Richard/0000-0002-2748-0409	Paleoanthropology Laboratory Fund; College of Liberal Arts UT Austin; Houston Museum of Natural Science; US National Science Foundation [EAR-0646848, EAR-0948842, EAR-1258878]; Directorate For Geosciences [1561622] Funding Source: National Science Foundation	Paleoanthropology Laboratory Fund; College of Liberal Arts UT Austin; Houston Museum of Natural Science; US National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the Authority for Research and Conservation of Cultural Heritage and the National Museum of Ethiopia of the Ministry of Tourism and Culture for permission to scan, study, and photograph Lucy; A. Admassu, K. Ayele, J. A. Bartsch, Y. Beyene, Y. Desta, R. Diehl, R. Flores, R. Harvey, G. Kebede, R. Lariviere, J. H. Mariam, S. M. Miller, L. Rebori, B. Roberts, J. Ten Barge, J. M. Sanchez, D. Slesnick, D. Van Tuerenhout, S. Wilson, M. Woldehan, and M. Yilma for facilitating and assisting with the scanning; T. Getachew and M. Endalamaw for assisting with the photography, and S. Mattox for many of the photographs; V. A. Lopez and S. Robertson for Fig. 2; C. Bramblett, B. Brown, C. Campisano, J. G. Fleagle, T. Helpenstell and colleagues at Olympia Orthopaedic Associates, A. L. Kappelman, J. A. Kappelman, S. Khosropour, H. Pontzer, D. Reed, C. B. Ruff, J. T. Stern Jr, and S. C. Ward for discussions; the Paleoanthropology Laboratory Fund, College of Liberal Arts UT Austin, and Houston Museum of Natural Science for financial and logistical support; and Owen-Coates Fund of the Geology Foundation of UT Austin for publication costs. The University of Texas High-Resolution X-ray CT Facility was supported by US National Science Foundation grants EAR-0646848, EAR-0948842, and EAR-1258878.	Alemseged Z, 2006, NATURE, V443, P296, DOI 10.1038/nature05047; Armitage BM, 2009, J BONE JOINT SURG AM, V91A, P2222, DOI 10.2106/JBJS.H.00881; Aronson JL, 2008, J HUM EVOL, V55, P532, DOI 10.1016/j.jhevol.2008.04.004; Aunon-Martin I., 2012, TRAUMA LIMB RECONSTR, V7, P141; Bonnefille R, 2004, P NATL ACAD SCI USA, V101, P12125, DOI 10.1073/pnas.0401709101; Campisano CJ, 2008, GEOL SOC AM SPEC PAP, V446, P179, DOI 10.1130/2008.2446(08); DORAN DM, 1993, AM J PHYS ANTHROPOL, V91, P99, DOI 10.1002/ajpa.1330910107; Edelson G, 2004, J BONE JOINT SURG BR, V86B, P413, DOI 10.1302/0301-620X.86B3.14428; GOONETILLEKE UKDA, 1980, MED SCI LAW, V20, P262, DOI 10.1177/002580248002000407; Grabowski M, 2015, J HUM EVOL, V85, P75, DOI 10.1016/j.jhevol.2015.05.005; Haile-Selassie Y, 2010, P NATL ACAD SCI USA, V107, P12121, DOI 10.1073/pnas.1004527107; HERMAN GT, 1979, PHYS MED BIOL, V24, P81, DOI 10.1088/0031-9155/24/1/008; Hernandez-Aguilar RA, 2013, AM J PRIMATOL, V75, P979, DOI 10.1002/ajp.22163; Jaiswal A, 2013, CHIN J TRAUMATOL, V16, P379, DOI 10.3760/cma.j.issn.1008-1275.2013.06.014; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P403, DOI 10.1002/ajpa.1330570403; JOHANSON DC, 1987, NATURE, V327, P205, DOI 10.1038/327205a0; JOHANSON DC, 1976, NATURE, V260, P293, DOI 10.1038/260293a0; Ketcham RA, 2001, COMPUT GEOSCI-UK, V27, P381, DOI 10.1016/S0098-3004(00)00116-3; Ketcham RA, 2006, P SOC PHOTO-OPT INS, V6318, pO3180, DOI 10.1117/12.680939; L'Abbe EN, 2015, SCI REP-UK, V5, DOI 10.1038/srep15120; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1077, DOI 10.2106/00004623-197052060-00001; Papadopoulos Iordanis N, 2011, J Trauma Manag Outcomes, V5, P2, DOI 10.1186/1752-2897-5-2; Pontzer H, 2004, J HUM EVOL, V46, P317, DOI 10.1016/j.jhevol.2003.12.006; Reed KE, 2008, J HUM EVOL, V54, P743, DOI 10.1016/j.jhevol.2007.08.013; SNYDER RG, 1963, AEROSPACE MED, V34, P695; Stern JT, 2000, EVOL ANTHROPOL, V9, P113, DOI 10.1002/1520-6505(2000)9:3<113::AID-EVAN2>3.0.CO;2-W; Stewart FA, 2013, AM J PRIMATOL, V75, P593, DOI 10.1002/ajp.22138; Twiss T., 2015, LNCS, P23, DOI [10.1007/978- 3- 319-08951-5, DOI 10.1007/978-3-319-08951-5]; Walker A., 1996, WISDOM BONES; WALTER RC, 1994, GEOLOGY, V22, P6, DOI 10.1130/0091-7613(1994)022<0006:AOLATF>2.3.CO;2; WARNER KG, 1986, ANN EMERG MED, V15, P1088, DOI 10.1016/S0196-0644(86)80134-2; Weilemann Y, 2008, FORENSIC SCI INT, V180, P81, DOI 10.1016/j.forsciint.2008.07.003; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; Yemane T., 1997, THESIS	34	39	39	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2016	537	7621					503	+		10.1038/nature19332	http://dx.doi.org/10.1038/nature19332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW3MO	27571283				2022-12-28	WOS:000383545900046
J	Jorgensen, PS; Wernli, D; Carroll, SP; Dunn, RR; Harbarth, S; Levin, SA; So, AD; Schluter, M; Laxminarayan, R				Jorgensen, Peter S.; Wernli, Didier; Carroll, Scott P.; Dunn, Robert R.; Harbarth, Stephan; Levin, Simon A.; So, Anthony D.; Schluter, Maja; Laxminarayan, Ramanan			Use antimicrobials wisely	NATURE			English	Editorial Material									[Jorgensen, Peter S.] Royal Swedish Acad Sci, Global Econ Dynam & Biosphere, Stockholm, Sweden; [Wernli, Didier] Univ Geneva, Global Studies Inst, Geneva, Switzerland	Royal Swedish Academy of Sciences; Global Economic Dynamics & Biosphere - The Erling-Persson Family Academy Program; University of Geneva	Jorgensen, PS (corresponding author), Royal Swedish Acad Sci, Global Econ Dynam & Biosphere, Stockholm, Sweden.	psjorgensen@kva.se	Levin, Simon A/J-1218-2014; Jørgensen, Peter Søgaard/AAF-8570-2020; Schlüter, Maja/C-2374-2015; Laxminarayan, Ramanan/ABD-5050-2021	Levin, Simon A/0000-0002-8216-5639; Jørgensen, Peter Søgaard/0000-0002-2621-378X; Schlüter, Maja/0000-0002-7780-1039; Wernli, Didier/0000-0002-1751-1961; Dunn, Robert/0000-0002-6030-4837; Carroll, Scott/0000-0003-2094-9398	Direct For Biological Sciences [1052875] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1639145] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		[Anonymous], 2016, REV ANT RES TACKL DR; Bigdeli M, 2014, MED HLTH SYSTEMS ADV; Biggs R, 2012, ANNU REV ENV RESOUR, V37, P421, DOI 10.1146/annurev-environ-051211-123836; Carroll SP, 2014, SCIENCE, V346, P313, DOI 10.1126/science.1245993; Hulcr J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047712; Laxminarayan R, 2016, LANCET, V387, P168, DOI 10.1016/S0140-6736(15)00474-2; Maron DF, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-48; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Wernli D, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001022; Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1	10	34	35	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					159	161		10.1038/537159a	http://dx.doi.org/10.1038/537159a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU9LQ	27604934	Bronze			2022-12-28	WOS:000382539100022
J	Bhatt, AB				Bhatt, Ami B.			Five People	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bhatt, Ami B.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Bhatt, AB (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	abhatt@mgh.harvard.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2016	316	9					929	930		10.1001/jama.2016.5091	http://dx.doi.org/10.1001/jama.2016.5091			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU8JV	27599326				2022-12-28	WOS:000382460200014
J	Edelman, EJ; Fiellin, DA				Edelman, E. Jennifer; Fiellin, David A.			Alcohol Use RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter							METAANALYSIS		[Edelman, E. Jennifer; Fiellin, David A.] Yale Univ, Sch Med, New Haven, CT 06520 USA	Yale University	Edelman, EJ (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.							Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Jonas DE, 2014, JAMA-J AM MED ASSOC, V311, P1889, DOI 10.1001/jama.2014.3628; Jonas DE, 2012, ANN INTERN MED, V157, P645, DOI 10.7326/0003-4819-157-9-201211060-00544; Nunes EV, 2004, JAMA-J AM MED ASSOC, V291, P1887, DOI 10.1001/jama.291.15.1887; Roerecke M, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0182-6	5	7	7	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2016	165	5					379	380		10.7326/L16-0107	http://dx.doi.org/10.7326/L16-0107			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3BC	27595223				2022-12-28	WOS:000382795000016
J	Ball, P				Ball, Philip			A New System of Chemical Philosophy	NATURE			English	Book Review												p.ball@btinternet.com						Dalton John, 1808, NEW SYSTEM CHEM PHIL, DOI [10.1017/CBO9780511736391, DOI 10.1017/CBO9780511736391]	1	1	1	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					32	33		10.1038/537032a	http://dx.doi.org/10.1038/537032a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU7XC	27582207	Bronze			2022-12-28	WOS:000382426900011
J	Katsnelson, A				Katsnelson, Alla			Big science spenders	NATURE			English	Editorial Material																			0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					S2	S3		10.1038/537S2a	http://dx.doi.org/10.1038/537S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VH2UH	27580138	Bronze			2022-12-28	WOS:000452224100001
J	Kornfeld, DS; Titus, SL				Kornfeld, Donald S.; Titus, Sandra L.			Stop ignoring misconduct	NATURE			English	Editorial Material									[Kornfeld, Donald S.] Columbia Univ, Psychiat, New York, NY 10027 USA; [Kornfeld, Donald S.] Columbia Univ, Coll Phys & Surg, New York, NY 10027 USA; [Titus, Sandra L.] US Off Res Integr, Germantown, MD USA	Columbia University; Columbia University	Kornfeld, DS (corresponding author), Columbia Univ, Psychiat, New York, NY 10027 USA.; Kornfeld, DS (corresponding author), Columbia Univ, Coll Phys & Surg, New York, NY 10027 USA.	dsk3@cumc.columbia.edu; sandra.titus@yahoo.com						Antes AL, 2010, ACAD MED, V85, P519, DOI 10.1097/ACM.0b013e3181cd1cc5; Bonito AJ, 2012, ACCOUNT RES, V19, P308, DOI 10.1080/08989621.2012.718683; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Eastwood Susan, 1996, Sci Eng Ethics, V2, P89, DOI 10.1007/BF02639320; Fanelli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005738; Fang FC, 2012, P NATL ACAD SCI USA, V109, P17028, DOI 10.1073/pnas.1212247109; Kornfeld DS, 2012, ACAD MED, V87, P877, DOI 10.1097/ACM.0b013e318257ee6a; Mobley A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063221; Titus SL, 2014, ACCOUNT RES, V21, P9, DOI 10.1080/08989621.2013.822264; Wright DE, 2008, SCI ENG ETHICS, V14, P323, DOI 10.1007/s11948-008-9074-5	10	16	17	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					29	30		10.1038/537029a	http://dx.doi.org/10.1038/537029a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU7XC	27582206				2022-12-28	WOS:000382426900010
J	Stamper-Kurn, DM; Marti, GE; Muller, H				Stamper-Kurn, D. M.; Marti, G. E.; Mueller, H.			Verifying quantum superpositions at metre scales	NATURE			English	Letter							INTERFERENCE		[Stamper-Kurn, D. M.; Mueller, H.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Stamper-Kurn, D. M.] Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA; [Marti, G. E.] NIST, JILA, Boulder, CO USA; [Marti, G. E.] Univ Colorado, Boulder, CO 80309 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder	Stamper-Kurn, DM (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	dmsk@berkeley.edu	Stamper-Kurn, Dan/B-5442-2015	Stamper-Kurn, Dan/0000-0002-4845-5835; Marti, G. Edward/0000-0002-3390-436X	Direct For Mathematical & Physical Scien [1405909] Funding Source: National Science Foundation	Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Anderson P. W., 1986, Lesson of Quantum Theory. Niels Bohr Centenary Symposium, P23; Andrews MR, 1997, SCIENCE, V275, P637, DOI 10.1126/science.275.5300.637; Bassi A, 2013, REV MOD PHYS, V85, P471, DOI 10.1103/RevModPhys.85.471; Javanainen J, 1996, PHYS REV LETT, V76, P161, DOI 10.1103/PhysRevLett.76.161; Kovachy T, 2015, NATURE, V528, P530, DOI 10.1038/nature16155; MAGYAR G, 1963, NATURE, V198, P255, DOI 10.1038/198255a0; Naraschewski M, 1996, PHYS REV A, V54, P2185, DOI 10.1103/PhysRevA.54.2185; Nimmrichter S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.160403; Snadden MJ, 1998, PHYS REV LETT, V81, P971, DOI 10.1103/PhysRevLett.81.971	9	9	9	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					E1	E2		10.1038/nature19108	http://dx.doi.org/10.1038/nature19108			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27582225	Green Submitted			2022-12-28	WOS:000382426900057
J	Sinnott, JD; Howlett, DC				Sinnott, Joseph Dalby; Howlett, David C.			SPOT DIAGNOSIS Cough and haemoptysis in an older woman	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sinnott, Joseph Dalby] East Sussex Hosp NHS Trust, Dept Surg, Eastbourne, E Sussex, England; [Howlett, David C.] East Sussex Hosp NHS Trust, Dept Radiol, Eastbourne, E Sussex, England		Sinnott, JD (corresponding author), East Sussex Hosp NHS Trust, Dept Surg, Eastbourne, E Sussex, England.	j.d.sinnott@gmail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 26	2016	354								i4493	10.1136/bmj.i4493	http://dx.doi.org/10.1136/bmj.i4493			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AB	27566752				2022-12-28	WOS:000382792300002
J	Jais, A; Solas, M; Backes, H; Chaurasia, B; Kleinridders, A; Theurich, S; Mauer, J; Steculorum, SM; Hampel, B; Goldau, J; Alber, J; Forster, CY; Eming, SA; Schwaninger, M; Ferrara, N; Karsenty, G; Bruning, JC				Jais, Alexander; Solas, Maite; Backes, Heiko; Chaurasia, Bhagirath; Kleinridders, Andre; Theurich, Sebastian; Mauer, Jan; Steculorum, Sophie M.; Hampel, Brigitte; Goldau, Julia; Alber, Jens; Forster, Carola Y.; Eming, Sabine A.; Schwaninger, Markus; Ferrara, Napoleone; Karsenty, Gerard; Bruning, Jens C.			Myeloid-Cell-Derived VEGF Maintains Brain Glucose Uptake and Limits Cognitive Impairment in Obesity (vol 165, pg 882, 2016)	CELL			English	Correction												bruening@sf.mpg.de	Solas, Maite/O-7845-2016; Theurich, Sebastian/AAB-2855-2022; Theurich, Sebastian/C-9995-2018; Jais, Alexander/AAQ-9102-2021; Steculorum, Sophie/R-2704-2017	Solas, Maite/0000-0001-7670-3237; Theurich, Sebastian/0000-0001-5706-8258; Jais, Alexander/0000-0002-9897-4983; Kleinridders, Andre/0000-0002-4248-6366; Steculorum, Sophie/0000-0002-5665-2732; Karsenty, Gerard/0000-0002-9253-7627				Jais A, 2016, CELL, V165, P882, DOI 10.1016/j.cell.2016.03.033	1	22	23	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1338	1340		10.1016/j.cell.2016.08.010	http://dx.doi.org/10.1016/j.cell.2016.08.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27565353	Green Published, Bronze			2022-12-28	WOS:000382259500027
J	Kleiger, G; Deshaies, R				Kleiger, Gary; Deshaies, Raymond			Tag Team Ubiquitin Ligases	CELL			English	Editorial Material							COMPLEXES	Cullin-RING (CRL) and RING1-IBR-RING2 (RBR) are two distinct types of ubiquitin ligases. In this issue, Scott et al. show that CRLs activate the RBR enzyme ARIH1 to initiate ubiquitin chains on CRL substrates, thereby marking an unexpected and important advance in our understanding of both enzymes.	[Kleiger, Gary] Univ Nevada, Dept Chem & Biochem, 4505 South Maryland Pkwy, Las Vegas, NV 89154 USA; [Deshaies, Raymond] CALTECH, Div Biol & Biol Engn, 1200 East Calif Blvd, Pasadena, CA 91125 USA; [Deshaies, Raymond] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; California Institute of Technology; Howard Hughes Medical Institute	Deshaies, R (corresponding author), CALTECH, Div Biol & Biol Engn, 1200 East Calif Blvd, Pasadena, CA 91125 USA.; Deshaies, R (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	deshaies@caltech.edu	Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065997] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM065997] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Kelsall IR, 2013, EMBO J, V32, P2848, DOI 10.1038/emboj.2013.209; Pierce NW, 2013, CELL, V153, P206, DOI 10.1016/j.cell.2013.02.024; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Scott DC, 2016, CELL, V166, P1198, DOI 10.1016/j.cell.2016.07.027; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025	10	12	12	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1080	1081		10.1016/j.cell.2016.08.014	http://dx.doi.org/10.1016/j.cell.2016.08.014			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27565338	Bronze			2022-12-28	WOS:000382259500007
J	Nagahama, Y; Howard, MA				Nagahama, Yasunori; Howard, Matthew A., III			Giant Thrombosed Intracranial Aneurysm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nagahama, Yasunori; Howard, Matthew A., III] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA	University of Iowa	Nagahama, Y (corresponding author), Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA.	yasunori-nagahama@uiowa.edu		Howard, Matthew/0000-0003-3935-8889					0	0	0	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2016	375	8					778	778		10.1056/NEJMicm1513571	http://dx.doi.org/10.1056/NEJMicm1513571			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9ET	27557304				2022-12-28	WOS:000381799300015
J	Li, CY; de Grijs, R; Deng, LC; Geller, AM; Xin, Y; Hu, Y; Faucher-Giguere, CA				Li, Chengyuan; de Grijs, Richard; Deng, Licai; Geller, Aaron M.; Xin, Yu; Hu, Yi; Faucher-Giguere, Claude-Andre			Formation of new stellar populations from gas accreted by massive young star clusters (vol 529, pg 502, 2016)	NATURE			English	Correction													de Grijs, Richard/AAI-5255-2020; Faucher-Giguere, Claude-Andre/AAC-5298-2019	de Grijs, Richard/0000-0002-7203-5996; hu, yi/0000-0003-3317-4771; Li, Chengyuan/0000-0002-3084-5157				Goudfrooij P, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/1/3	2	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2016	539	7627								10.1038/nature19336	http://dx.doi.org/10.1038/nature19336			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA5OJ	27602523	Bronze			2022-12-28	WOS:000386670100042
J	Kim, DH; Kim, CA; Placide, S; Lipsitz, LA; Marcantonio, ER				Kim, Dae Hyun; Kim, Caroline A.; Placide, Sebastian; Lipsitz, Lewis A.; Marcantonio, Edward R.			Preoperative Frailty Assessment and Outcomes at 6 Months or Later in Older Adults Undergoing Cardiac Surgical Procedures A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							AORTIC-VALVE IMPLANTATION; 6-MINUTE WALK TEST; LONG-TERM OUTCOMES; GAIT SPEED; FUNCTIONAL STATUS; 30-DAY MORTALITY; ELDERLY-PATIENTS; INCREASED RISK; HEALTH-STATUS; TRANSCATHETER	Background: Frailty assessment may inform surgical risk and prognosis not captured by conventional surgical risk scores. Purpose: To evaluate the evidence for various frailty instruments used to predict mortality, functional status, or major adverse cardiovascular and cerebrovascular events (MACCEs) in older adults undergoing cardiac surgical procedures. Data Sources: MEDLINE and EMBASE (without language restrictions), from their inception to 2 May 2016. Study Selection: Cohort studies evaluating the association between frailty and mortality or functional status at 6 months or later in patients aged 60 years or older undergoing major or minimally invasive cardiac surgical procedures. Data Extraction: 2 reviewers independently extracted study data and assessed study quality. Data Synthesis: Mobility, disability, and nutrition were frequently assessed domains of frailty in both types of procedures. In patients undergoing major procedures (n = 18 388; 8 studies), 9 frailty instruments were evaluated. There was moderate-quality evidence to assess mobility or disability and very-low- to low-quality evidence for using a multicomponent instrument to predict mortality or MACCEs. No studies examined functional status. In patients undergoing minimally invasive procedures (n = 5177; 17 studies), 13 frailty instruments were evaluated. There was moderate-to high-quality evidence for assessing mobility to predict mortality or functional status. Several multicomponent instruments predicted mortality, functional status, or MACCEs, but the quality of evidence was low to moderate. Multicomponent instruments that measure different frailty domains seemed to outperform single-component ones. Limitation: Heterogeneity of frailty assessment, limited generalizability of multicomponent frailty instruments, few validated frailty instruments, and potential publication bias. Conclusion: Frailty status, assessed by mobility, disability, and nutritional status, may predict mortality at 6 months or later after major cardiac surgical procedures and functional decline after minimally invasive cardiac surgery.	Harvard Med Sch, Boston, MA USA; [Placide, Sebastian] Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Kim, Dae Hyun; Kim, Caroline A.; Lipsitz, Lewis A.] Beth Israel Deaconess Med Ctr, 110 Francis St,Suite 1A, Boston, MA 02215 USA; [Marcantonio, Edward R.] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, 330 Brookline Ave,CO-216, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Kim, DH (corresponding author), Beth Israel Deaconess Med Ctr, 110 Francis St,Suite 1A, Boston, MA 02215 USA.	dkim2@bidmc.harvard.edu	Marcantonio, Edward R/U-3929-2017	Marcantonio, Edward R/0000-0002-2911-4250	Paul B. Beeson Clinical Scientist Development Award in Aging from the National Institute on Aging [K08AG051187]; American Federation for Aging Research; John A. Hartford Foundation; Atlantic Philanthropies; National Heart, Lung, and Blood Institute, National Institutes of Health [T32-HL007374]; National Institute on Aging [R01AG025037, R01AG041785, P01AG03172, R01AG030618, R01AG051658, K24AG035075]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031720, K08AG051187, R01AG051658, R01AG030618, R01AG025037, R01AG041785, K24AG035075] Funding Source: NIH RePORTER	Paul B. Beeson Clinical Scientist Development Award in Aging from the National Institute on Aging; American Federation for Aging Research; John A. Hartford Foundation; Atlantic Philanthropies; National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr. D.H. Kim is supported by the Paul B. Beeson Clinical Scientist Development Award in Aging (K08AG051187) from the National Institute on Aging, American Federation for Aging Research, The John A. Hartford Foundation, and The Atlantic Philanthropies. Dr. C.A. Kim is supported by a Training Program in Cardiovascular Research grant (T32-HL007374) from the National Heart, Lung, and Blood Institute, National Institutes of Health. Dr. Lipsitz is supported by grants R01AG025037 and R01AG041785 from the National Institute on Aging; he also holds the Irving and Edyth S. Usen and Family Chair in Geriatric Medicine at Hebrew SeniorLife. Dr. Marcantonio is supported by the following grants, all from the National Institute on Aging: P01AG03172, R01AG030618, R01AG051658, and K24AG035075.	Ad N, 2016, J CARDIAC SURG, V31, P187, DOI 10.1111/jocs.12699; Afilalo J, 2016, JAMA CARDIOL, V1, P314, DOI 10.1001/jamacardio.2016.0316; Afilalo J, 2014, J AM COLL CARDIOL, V63, P747, DOI 10.1016/j.jacc.2013.09.070; Afilalo J, 2010, J AM COLL CARDIOL, V56, P1668, DOI 10.1016/j.jacc.2010.06.039; Afilalo J, 2009, AM J CARDIOL, V103, P1616, DOI 10.1016/j.amjcard.2009.01.375; Alfredsson J, 2016, CIRCULATION, V133, P1351, DOI 10.1161/CIRCULATIONAHA.115.020279; American College of Cardiology, 2016, TAVR HOSP MORT RISK; Arnold SV, 2014, CIRCULATION, V129, P2682, DOI 10.1161/CIRCULATIONAHA.113.007477; Bagnall NM, 2013, INTERACT CARDIOV TH, V17, P398, DOI 10.1093/icvts/ivt197; Brennan JM, 2014, ANN THORAC SURG, V98, P2016, DOI 10.1016/j.athoracsur.2014.07.051; Castell MV, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-86; Cervera R, 2012, ANN THORAC SURG, V93, P1950, DOI 10.1016/j.athoracsur.2012.02.071; Cockburn J, 2015, CATHETER CARDIO INTE, V86, P1271, DOI 10.1002/ccd.25991; Codner P, 2015, AM J CARDIOL, V116, P1391, DOI 10.1016/j.amjcard.2015.08.004; de Arenaza DP, 2010, HEART, V96, P113, DOI 10.1136/hrt.2008.161174; DePew ZS, 2013, RESP CARE, V58, P2113, DOI 10.4187/respcare.02471; Dodson John A, 2011, Aging health, V7, P283; Dvir D, 2014, J AM COLL CARDIOL, V63, P269, DOI 10.1016/j.jacc.2013.09.024; Edwards FH, 2016, JAMA CARDIOL, V1, P46, DOI 10.1001/jamacardio.2015.0326; Ensrud KE, 2008, ARCH INTERN MED, V168, P382, DOI 10.1001/archinternmed.2007.113; euroSCORE, 2011, EUR CARD SURG SCOR S; Evans SJ, 2014, AGE AGEING, V43, P127, DOI 10.1093/ageing/aft156; Ewe SH, 2010, AM HEART J, V160, P1113, DOI 10.1016/j.ahj.2010.09.003; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Furukawa H, 2015, GEN THORAC CARDIOVAS, V63, P425, DOI 10.1007/s11748-015-0553-8; Gardner SC, 2001, ANN THORAC SURG, V72, P2033, DOI 10.1016/S0003-4975(01)03217-9; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; Green P, 2015, AM J CARDIOL, V116, P264, DOI 10.1016/j.amjcard.2015.03.061; Green P, 2013, AM J CARDIOL, V112, P700, DOI 10.1016/j.amjcard.2013.04.046; Guiding principles for the care of older adults with multimorbidity: an approach for clinicians, 2012, J Am Geriatr Soc, V60, pE1, DOI 10.1111/j.1532-5415.2012.04188.x; Harada ND, 1999, ARCH PHYS MED REHAB, V80, P837, DOI 10.1016/S0003-9993(99)90236-8; Hassan A, 2010, AM HEART J, V160, P958, DOI 10.1016/j.ahj.2010.06.052; HLATKY MA, 1989, AM J CARDIOL, V64, P651, DOI 10.1016/0002-9149(89)90496-7; Howlett SE, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0171-9; Lee DH, 2010, CIRCULATION, V121, P973, DOI 10.1161/CIRCULATIONAHA.108.841437; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Mok M, 2013, JACC-CARDIOVASC INTE, V6, P1072, DOI 10.1016/j.jcin.2013.06.008; Mok M, 2013, J AM COLL CARDIOL, V61, P897, DOI 10.1016/j.jacc.2012.10.050; Morley JE, 2013, J AM MED DIR ASSOC, V14, P392, DOI 10.1016/j.jamda.2013.03.022; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Muneretto C, 2011, INTERACT CARDIOV TH, V13, P123; Munoz-Garcia AJ, 2012, AM HEART J, V163, P288, DOI 10.1016/j.ahj.2011.11.013; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; Oresanya LB, 2014, JAMA-J AM MED ASSOC, V311, P2110, DOI 10.1001/jama.2014.4573; Osnabrugge RL, 2015, JACC-CARDIOVASC INTE, V8, P315, DOI 10.1016/j.jcin.2014.08.016; Peters LL, 2012, J AM MED DIR ASSOC, V13, P546, DOI 10.1016/j.jamda.2012.04.007; Puls M, 2014, EUROINTERVENTION, V10, P609, DOI 10.4244/EIJY14M08_03; Rapp-Kesek D, 2004, CLIN NUTR, V23, P1398, DOI 10.1016/j.clnu.2004.06.006; Reuben DB, 2009, HAZZARDS GERIATRIC M; Robinson TN, 2013, ANN SURG, V258, P582, DOI 10.1097/SLA.0b013e3182a4e96c; Rockwood K, 2007, J AM MED DIR ASSOC, V8, P595, DOI 10.1016/j.jamda.2007.07.012; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Rodes-Cabau J, 2012, J AM COLL CARDIOL, V60, P1864, DOI 10.1016/j.jacc.2012.08.960; Rodes-Cabau J, 2012, JACC-CARDIOVASC INTE, V5, P982, DOI 10.1016/j.jcin.2012.07.002; Rodes-Cabau J, 2010, J AM COLL CARDIOL, V55, P1080, DOI 10.1016/j.jacc.2009.12.014; Rowe R, 2014, OPEN HEART, V1, DOI 10.1136/openhrt-2013-000033; Rubenstein LZ, 2001, J GERONTOL A-BIOL, V56, pM366, DOI 10.1093/gerona/56.6.M366; Saliba D, 2001, J AM GERIATR SOC, V49, P1691, DOI 10.1046/j.1532-5415.2001.49281.x; Savva GM, 2013, J GERONTOL A-BIOL, V68, P441, DOI 10.1093/gerona/gls190; Schoenenberger AW, 2013, EUR HEART J, V34, P684, DOI 10.1093/eurheartj/ehs304; Schwarze ML, 2014, JAMA SURG, V149, P631, DOI 10.1001/jamasurg.2013.5143; Seiffert M, 2014, CLIN RES CARDIOL, V103, P631, DOI 10.1007/s00392-014-0692-4; Sepehri A, 2014, J THORAC CARDIOV SUR, V148, P3110, DOI 10.1016/j.jtcvs.2014.07.087; Stortecky S, 2012, JACC-CARDIOVASC INTE, V5, P489, DOI 10.1016/j.jcin.2012.02.012; Strandberg TE, 2007, LANCET, V369, P1328, DOI 10.1016/S0140-6736(12)62167-9; Sundermann S, 2011, EUR J CARDIO-THORAC, V39, P33, DOI 10.1016/j.ejcts.2010.04.013; Sundermann SH, 2014, INTERACT CARDIOV TH, V18, P580, DOI 10.1093/icvts/ivu006; The Society of Thoracic Surgeons, 2016, ONLINE STS ADULT CAR; Van Kan GA, 2008, J NUTR HEALTH AGING, V12, P29, DOI 10.1007/BF02982161; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881	70	130	133	1	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	2016	165	9					650	+		10.7326/M16-0652	http://dx.doi.org/10.7326/M16-0652			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EA8SJ	27548070	Green Accepted			2022-12-28	WOS:000386908600007
J	Cayla, G; Cuisset, T; Silvain, J; Leclercq, F; Manzo-Silberman, S; Saint-Etienne, C; Delarche, N; Bellemain-Appaix, A; Range, G; El Mahmoud, R; Carrie, D; Belle, L; Souteyrand, G; Aubry, P; Sabouret, P; du Fretay, XH; Beygui, F; Bonnet, JL; Lattuca, B; Pouillot, C; Varenne, O; Boueri, Z; Van Belle, E; Henry, P; Motreff, P; Elhadad, S; Salem, JE; Abtan, J; Rousseau, H; Collet, JP; Vicaut, E; Montalescot, G				Cayla, Guillaume; Cuisset, Thomas; Silvain, Johanne; Leclercq, Florence; Manzo-Silberman, Stephane; Saint-Etienne, Christophe; Delarche, Nicolas; Bellemain-Appaix, Anne; Range, Gregoire; El Mahmoud, Rami; Carrie, Didier; Belle, Loic; Souteyrand, Geraud; Aubry, Pierre; Sabouret, Pierre; du Fretay, Xavier Halna; Beygui, Farzin; Bonnet, Jean-Louis; Lattuca, Benoit; Pouillot, Christophe; Varenne, Olivier; Boueri, Ziad; Van Belle, Eric; Henry, Patrick; Motreff, Pascal; Elhadad, Simon; Salem, Joe-Elie; Abtan, Jeremie; Rousseau, Helene; Collet, Jean-Philippe; Vicaut, Eric; Montalescot, Gilles		ANTARCTIC Investigators	Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial	LANCET			English	Article							ANTITHROMBOTIC THERAPY; DOSE CLOPIDOGREL; REACTIVITY; PRASUGREL; INTERVENTION; REVASCULARIZATION; IMPLANTATION; THROMBOSIS; CARDIOLOGY; OUTCOMES	Background Elderly patients are at high risk of ischaemic and bleeding events. Platelet function monitoring offers the possibility to individualise antiplatelet therapy to improve the therapeutic risk-benefit ratio. We aimed to assess the effect of platelet function monitoring with treatment adjustment in elderly patients stented for an acute coronary syndrome. Methods We did this multicentre, open-label, blinded-endpoint, randomised controlled superiority study at 35 centres in France. Patients aged 75 years or older who had undergone coronary stenting for acute coronary syndrome were randomly assigned (1: 1), via a central interactive voice-response system based on a computer-generated permutedblock randomisation schedule with randomly selected block sizes, to receive oral prasugrel 5 mg daily with dose or drug adjustment in case of inadequate response (monitoring group) or oral prasugrel 5 mg daily with no monitoring or treatment adjustment (conventional group). Randomisation was stratified by centre. Platelet function testing was done 14 days after randomisation and repeated 14 days after treatment adjustment in patients in the monitoring group. Study investigators and patients were not masked to treatment allocation, but allocation was concealed from an independent clinical events committee responsible for endpoint adjudication. The primary endpoint was a composite of cardiovascular death, myocardial infarction, stroke, stent thrombosis, urgent revascularisation, and Bleeding Academic Research Consortium-defined bleeding complications (types 2, 3, or 5) at 12 months' follow-up. We did analysis by intention to treat. This trial is registered with ClinicalTrials. gov, number NCT01538446. Findings Between March 27, 2012, and May 19, 2015, we randomly assigned 877 patients to the monitoring group (n=442) or the conventional group (n=435). The primary endpoint occurred in 120 (28%) patients in the monitoring group compared with 123 (28%) patients in the conventional group (hazard ratio [HR], 1.003, 95% CI 0.78-1.29; p=0.98). Rates of bleeding events did not differ significantly between groups. Interpretation Platelet function monitoring with treatment adjustment did not improve the clinical outcome of elderly patients treated with coronary stenting for an acute coronary syndrome. Platelet function testing is still being used in many centres and international guidelines still recommend platelet function testing in high-risk situations. Our study does not support this practice or these recommendations. Funding Eli Lilly and Company, Daiichi Sankyo, Stentys, Accriva Diagnostics, Medtronic, and Fondation Coeur et Recherche.	[Cayla, Guillaume; Lattuca, Benoit] Univ Montpellier, Ctr Hosp Univ Nimes, Serv Cardiol, ACTION Study Grp, Nimes, France; [Cuisset, Thomas; Bonnet, Jean-Louis] Ctr Hosp Univ Timone, Dept Cardiol, Marseille, France; [Cuisset, Thomas; Bonnet, Jean-Louis] Aix Marseille Univ, Fac Med, INSERM, INRA UMR1260,UMR1062,Nutr Obes & Risk Thrombosis, Marseille, France; [Silvain, Johanne; Sabouret, Pierre; Collet, Jean-Philippe; Montalescot, Gilles] Univ Paris 06, Hop Pitie Salpetriere, AP HP, Inst Cardiol,INSERM,ACT Study Grp,UMRS 1166, Paris, France; [Leclercq, Florence] Ctr Hosp Univ Montpellier, Dept Cardiol, Montpellier, France; [Manzo-Silberman, Stephane; Henry, Patrick] Hop Lariboisiere, Serv Cardiol, F-75475 Paris, France; [Saint-Etienne, Christophe] Ctr Hosp Univ Tours, Serv Cardiol, Tours, France; [Delarche, Nicolas] Hop Francois Mitterrand, Ctr Hosp Pau, Pau, France; [Bellemain-Appaix, Anne] Ctr Hosp Antibes Juans Les Pins, Serv Cardiol, ACT Study Grp, Antibes, France; [Range, Gregoire] Hop Chartres, Serv Cardiol, Chartres, France; [El Mahmoud, Rami] Hop Ambroise Pare, Boulogne, France; [Carrie, Didier] Ctr Hosp Univ Toulouse, Serv Cardiol, Toulouse, France; [Belle, Loic] Ctr Hosp Annecy, Serv Cardiol, Annecy, France; [Souteyrand, Geraud; Motreff, Pascal] Ctr Hosp Univ Clermont Ferrand, Serv Cardiol, Clermont Ferrand, France; [Aubry, Pierre; du Fretay, Xavier Halna; Abtan, Jeremie] Hop Bichat Claude Bernard, Serv Cardiol, F-75877 Paris 18, France; [Beygui, Farzin] Ctr Hosp Univ Caen, Serv Cardiol, ACT Study Grp, Caen, France; [Pouillot, Christophe] St Denis La Reunion, Clin Sainte Clotilde, La Reunion, France; [Varenne, Olivier] Hop Cochin, Serv Cardiol, Paris, France; [Boueri, Ziad] Ctr Hosp Bastia, Serv Cardiol Bastia, Bastia, France; [Van Belle, Eric] Ctr Hosp Univ Lille, Serv Cardiol, Lille, France; [Elhadad, Simon] Ctr Hosp Lagny Marne Vallee, Jossigny, France; [Salem, Joe-Elie] Hop La Pitie Salpetriere, AP HP, INSERM, ICAN,Dept Pharmacol,CIC 1421,U1166, Paris, France; [Rousseau, Helene; Vicaut, Eric] ACT Study Grp, Unite Rech Clin Lariboisiere, Paris, France	Universite de Montpellier; CHU de Nimes; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Tours; Centre Hospitalier de Pau; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; CHU de Toulouse; Centre Hospitalier Annecy Genevois; CHU Clermont Ferrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Caen NORMANDIE; Universite de Caen Normandie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Montalescot, G (corresponding author), Hop La Pitie Salpetriere, Inst Cardiol, ACT Study Grp, F-75013 Paris, France.	gilles.montalescot@aphp.fr	Manzo-Silberman, Stéphane/ABB-9864-2021; Sabouret, Pierre/AAE-3459-2020; Aubry, Pierre/ABF-1167-2021	Sabouret, Pierre/0000-0002-0243-3673; CARRIE, didier/0000-0003-2479-8144; VAN BELLE, ERIC/0000-0001-6509-443X; Manzo-Silberman, stephane/0000-0003-0009-9525; Salem, Joe-Elie/0000-0002-0331-3307	Eli Lilly and Company; Daiichi Sankyo; Stentys; Accriva Diagnostics; Medtronic; Fondation Coeur et Recherche; Assistance Publique des Hopitaux de Paris (Paris, France)	Eli Lilly and Company(Eli Lilly); Daiichi Sankyo(Daiichi Sankyo Company Limited); Stentys; Accriva Diagnostics; Medtronic(Medtronic); Fondation Coeur et Recherche; Assistance Publique des Hopitaux de Paris (Paris, France)	Eli Lilly and Company, Daiichi Sankyo, Stentys, Accriva Diagnostics, Medtronic, and Fondation Coeur et Recherche.r The study was led by the academic research organisation Allies in Cardiovascular Trials, Initiatives, and Organized Networks (ACTION), sponsored by the Assistance Publique des Hopitaux de Paris (Paris, France), and funded by Eli Lilly, Daiichi Sankyo, Stentys, Accriva Diagnostics, Medtronic, Fondation Coeur et Recherche. We thank Karine Brochard, Nabil Brouk, Delphine Brugier, Veronique Jouis, Nathalie Kingue-Elessa, Walid Makhlouf, Luminata Neculaita, and Yannick Vacher for their help and assistance.	Alexander KP, 2007, CIRCULATION, V115, P2549, DOI 10.1161/CIRCULATIONAHA.107.182615; Andreotti F, 2015, EUR HEART J, V36, P3238, DOI 10.1093/eurheartj/ehv304; Aradi D, 2015, EUR HEART J, V36, P1762, DOI 10.1093/eurheartj/ehv104; Aradi D, 2014, J AM COLL CARDIOL, V63, P1061, DOI 10.1016/j.jacc.2013.12.023; Aradi D, 2013, INT J CARDIOL, V167, P2140, DOI 10.1016/j.ijcard.2012.05.100; Bonello L, 2012, J THROMB HAEMOST, V10, P1999, DOI 10.1111/j.1538-7836.2012.04875.x; Bonello L, 2008, J AM COLL CARDIOL, V51, P1404, DOI 10.1016/j.jacc.2007.12.044; Breet NJ, 2010, JAMA-J AM MED ASSOC, V303, P754, DOI 10.1001/jama.2010.181; Campo G, 2011, J AM COLL CARDIOL, V57, P2474, DOI 10.1016/j.jacc.2010.12.047; Capodanno D, 2010, J AM COLL CARDIOL, V56, P1683, DOI 10.1016/j.jacc.2010.04.063; Cayla G, 2014, AM HEART J, V168, P674, DOI 10.1016/j.ahj.2014.07.026; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Erlinge D, 2013, J AM COLL CARDIOL, V62, P577, DOI 10.1016/j.jacc.2013.05.023; Food and Drug Administration Health and Human Services, 2012, FED REGISTER, V77, P9948; Gurbel PA, 2012, JAMA-J AM MED ASSOC, V308, P1785, DOI 10.1001/jama.2012.17312; Kolh P, 2014, EUR HEART J, V35, P3235, DOI 10.1093/eurheartj/ehu422; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Mayer K, 2014, THROMB HAEMOSTASIS, V112, P342, DOI 10.1160/TH13-10-0874; Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475; Montalescot G, 2014, CIRCULATION, V129, P2136, DOI 10.1161/CIRCULATIONAHA.113.007524; Neubauer H, 2013, NEW ENGL J MED, V368, P870, DOI 10.1056/NEJMc1300053; Pfisterer M, 2001, LANCET, V358, P951; Price MJ, 2011, CIRCULATION, V124, P1132, DOI 10.1161/CIRCULATIONAHA.111.029165; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Rich MW, 2016, J AM COLL CARDIOL, V67, P2419, DOI 10.1016/j.jacc.2016.03.004; Roe MT, 2013, CIRCULATION, V128, P823, DOI 10.1161/CIRCULATIONAHA.113.002303; Savonitto S, 2012, JACC-CARDIOVASC INTE, V5, P906, DOI 10.1016/j.jcin.2012.06.008; Schoenenberger AW, 2016, EUR HEART J, V37, P1304, DOI 10.1093/eurheartj/ehv698; Sibbing D, 2010, J THROMB HAEMOST, V8, P250, DOI 10.1111/j.1538-7836.2009.03709.x; Silvain J, 2012, EUR HEART J, V33, P1241, DOI 10.1093/eurheartj/ehr407; Stone GW, 2013, LANCET, V382, P614, DOI 10.1016/S0140-6736(13)61170-8; Tantry US, 2013, J AM COLL CARDIOL, V62, P2261, DOI 10.1016/j.jacc.2013.07.101; Tegn N, 2016, LANCET, V387, P1057, DOI 10.1016/S0140-6736(15)01166-6; Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	36	233	247	2	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2016	388	10055					2015	2022		10.1016/S0140-6736(16)31323-X	http://dx.doi.org/10.1016/S0140-6736(16)31323-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ6EQ	27581531				2022-12-28	WOS:000385954800031
J	Radha, B; Esfandiar, A; Wang, FC; Rooney, AP; Gopinadhan, K; Keerthi, A; Mishchenko, A; Janardanan, A; Blake, P; Fumagalli, L; Lozada-Hidalgo, M; Garaj, S; Haigh, SJ; Grigorieva, IV; Wu, HA; Geim, AK				Radha, B.; Esfandiar, A.; Wang, F. C.; Rooney, A. P.; Gopinadhan, K.; Keerthi, A.; Mishchenko, A.; Janardanan, A.; Blake, P.; Fumagalli, L.; Lozada-Hidalgo, M.; Garaj, S.; Haigh, S. J.; Grigorieva, I. V.; Wu, H. A.; Geim, A. K.			Molecular transport through capillaries made with atomic-scale precision	NATURE			English	Article							CARBON NANOTUBE MEMBRANES; DER-WAALS HETEROSTRUCTURES; FAST WATER TRANSPORT; POROUS GRAPHENE; MASS-TRANSPORT; GRAPHITE; DYNAMICS; FLOW; NANOFLUIDICS; INTERFACES	Nanometre-scale pores and capillaries have long been studied because of their importance in many natural phenomena and their use in numerous applications(1). A more recent development is the ability to fabricate artificial capillaries with nanometre dimensions, which has enabled new research on molecular transport and led to the emergence of nanofluidics(2-4). But surface roughness in particular makes it challenging to produce capillaries with precisely controlled dimensions at this spatial scale. Here we report the fabrication of narrow and smooth capillaries through van der Waals assembly(5), with atomically flat sheets at the top and bottom separated by spacers made of two-dimensional crystals(6) with a precisely controlled number of layers. We use graphene and its multilayers as archetypal two-dimensional materials to demonstrate this technology, which produces structures that can be viewed as if individual atomic planes had been removed from a bulk crystal to leave behind flat voids of a height chosen with atomic-scale precision. Water transport through the channels, ranging in height from one to several dozen atomic planes, is characterized by unexpectedly fast flow (up to 1 metre per second) that we attribute to high capillary pressures (about 1,000 bar) and large slip lengths. For channels that accommodate only a few layers of water, the flow exhibits a marked enhancement that we associate with an increased structural order in nanoconfined water. Our work opens up an avenue to making capillaries and cavities with sizes tunable to angstrom precision, and with permeation properties further controlled through a wide choice of atomically flat materials available for channel walls.	[Radha, B.; Esfandiar, A.; Gopinadhan, K.; Keerthi, A.; Mishchenko, A.; Janardanan, A.; Fumagalli, L.; Lozada-Hidalgo, M.; Grigorieva, I. V.; Geim, A. K.] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Wang, F. C.; Wu, H. A.] Chinese Acad Sci, Univ Sci & Technol China, Dept Modern Mech, Key Lab Mech Behav & Design Mat, Hefei 230027, Anhui, Peoples R China; [Rooney, A. P.; Haigh, S. J.] Univ Manchester, Sch Mat, Manchester M13 9PL, Lancs, England; [Blake, P.; Fumagalli, L.] Univ Manchester, Natl Graphene Inst, Booth St East, Manchester M13 9PL, Lancs, England; [Garaj, S.] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore	University of Manchester; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Manchester; University of Manchester; National University of Singapore	Radha, B; Geim, AK (corresponding author), Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England.; Wang, FC (corresponding author), Chinese Acad Sci, Univ Sci & Technol China, Dept Modern Mech, Key Lab Mech Behav & Design Mat, Hefei 230027, Anhui, Peoples R China.	radha.boya@manchester.ac.uk; wangfc@ustc.edu.cn; andre.k.geim@manchester.ac.uk	Esfandiar, Ali/M-7949-2017; Geim, Andre K/J-7888-2012; Boya, Radha/A-2602-2012; Kalon, Gopinadhan/K-3698-2012; Keerthi, Ashok/T-4643-2018; Mishchenko, Artem/C-7561-2011; Lozada-Hidalgo, Marcelo/U-1642-2017; Garaj, Slaven/AAA-9824-2020; Wu, Hengan/A-3646-2009; Garaj, Slaven/B-9782-2013; Keerthi, Ashok/J-1291-2014; Wang, Fengchao/G-1708-2012; Boya, Radha/G-7794-2017; Haigh, Sarah/D-1309-2014	Esfandiar, Ali/0000-0002-3636-3837; Geim, Andre K/0000-0003-2861-8331; Boya, Radha/0000-0002-1495-1961; Kalon, Gopinadhan/0000-0001-8137-1521; Keerthi, Ashok/0000-0002-8479-4762; Mishchenko, Artem/0000-0002-0427-5664; Lozada-Hidalgo, Marcelo/0000-0003-3216-7537; Wu, Hengan/0000-0003-0288-1617; Garaj, Slaven/0000-0001-5529-4040; Wang, Fengchao/0000-0002-5954-3881; Boya, Radha/0000-0003-1345-7029; Janardanan, Amritha/0000-0002-5104-7402; Conlan, Aidan/0000-0002-1333-9359; Haigh, Sarah/0000-0001-5509-6706; Fumagalli, Laura/0000-0003-1749-2905	Lloyd's Register Foundation; European Research Council; Royal Society; EPSRC NowNANO programme [EP/M022498/1, EP/K016946/1]; DTRA [HDTRA1-12-1-0013]; Engineering and Physical Sciences Research Council [EP/N010345/1, EP/K005014/1] Funding Source: researchfish; EPSRC [EP/N010345/1, EP/K005014/1] Funding Source: UKRI	Lloyd's Register Foundation; European Research Council(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); EPSRC NowNANO programme(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); DTRA(United States Department of DefenseDefense Threat Reduction Agency); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Lloyd's Register Foundation, the European Research Council and the Royal Society. B.R. and K.G. acknowledge Marie Curie International Incoming Fellowships. S.J.H. and A.P.R. acknowledge the EPSRC NowNANO programme, EP/M022498/1, EP/K016946/1 and DTRA (HDTRA1-12-1-0013) for funding.	Abascal JLF, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2121687; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bocquet L, 2007, SOFT MATTER, V3, P685, DOI 10.1039/b616490k; Bocquet L, 2010, CHEM SOC REV, V39, P1073, DOI 10.1039/b909366b; Celebi K, 2014, SCIENCE, V344, P289, DOI 10.1126/science.1249097; Cussler E. L, 2009, DIFFUSION MASS TRANS; DASGUPTA S, 1993, J COLLOID INTERF SCI, V157, P332, DOI 10.1006/jcis.1993.1194; Duan CH, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4794973; Duan CH, 2010, NAT NANOTECHNOL, V5, P848, DOI [10.1038/nnano.2010.233, 10.1038/NNANO.2010.233]; Eijkel JCT, 2005, MICROFLUID NANOFLUID, V1, P249, DOI 10.1007/s10404-004-0012-9; Falk K, 2010, NANO LETT, V10, P4067, DOI 10.1021/nl1021046; Garaj S, 2010, NATURE, V467, P190, DOI 10.1038/nature09379; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Gravelle S, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.033123; Haigh SJ, 2012, NAT MATER, V11, P764, DOI [10.1038/nmat3386, 10.1038/NMAT3386]; Hinds BJ, 2004, SCIENCE, V303, P62, DOI 10.1126/science.1092048; Hirunsit P, 2007, J PHYS CHEM C, V111, P1709, DOI 10.1021/jp063718v; Holt JK, 2006, SCIENCE, V312, P1034, DOI 10.1126/science.1126298; Howorka S, 2009, CHEM SOC REV, V38, P2360, DOI 10.1039/b813796j; Hu S, 2014, NATURE, V516, P227, DOI 10.1038/nature14015; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P3, DOI 10.1016/B978-0-12-375182-9.10001-6; Jain T, 2015, NAT NANOTECHNOL, V10, P1053, DOI [10.1038/NNANO.2015.222, 10.1038/nnano.2015.222]; Kannam K. S., 2012, J CHEM PHYS, V136; Kannam SK, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4793396; Koenig SP, 2012, NAT NANOTECHNOL, V7, P728, DOI [10.1038/NNANO.2012.162, 10.1038/nnano.2012.162]; Koga K, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1861879; Kumar P, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051503; Li JL, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.235412; Livesey R. G., 1998, FDN VACUUM SCI TECHN; Lukas M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2399; Majumder M, 2005, NATURE, V438, P44, DOI 10.1038/43844a; Majumder M, 2011, ACS NANO, V5, P3867, DOI 10.1021/nn200222g; Mate CM, 2011, IEEE T MAGN, V47, P124, DOI 10.1109/TMAG.2010.2073691; Mijatovic D, 2005, LAB CHIP, V5, P492, DOI 10.1039/b416951d; Mosaddeghi H, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4763984; Mucksch C, 2015, J PHYS CHEM C, V119, P12496, DOI 10.1021/acs.jpcc.5b02948; Neek-Amal M, 2016, ACS NANO, V10, P3685, DOI 10.1021/acsnano.6b00187; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; O'Hern SC, 2015, NANO LETT, V15, P3254, DOI 10.1021/acs.nanolett.5b00456; Pang P, 2011, ACS NANO, V5, P7277, DOI 10.1021/nn202115s; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Qin XC, 2011, NANO LETT, V11, P2173, DOI 10.1021/nl200843g; Raviv U, 2001, NATURE, V413, P51, DOI 10.1038/35092523; Schaffer M, 2012, ULTRAMICROSCOPY, V114, P62, DOI 10.1016/j.ultramic.2012.01.005; Schoch RB, 2008, REV MOD PHYS, V80, P839, DOI 10.1103/RevModPhys.80.839; Stein D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.035901; Thomas JA, 2008, NANO LETT, V8, P2788, DOI 10.1021/nl8013617; Wang LD, 2015, NAT NANOTECHNOL, V10, P785, DOI [10.1038/NNANO.2015.158, 10.1038/nnano.2015.158]; Werder T, 2003, J PHYS CHEM B, V107, P1345, DOI 10.1021/jp0268112; White FM., 1991, VISCOUS FLUID FLOW; Withers F, 2015, NAT MATER, V14, P301, DOI 10.1038/nmat4205; Zhao WH, 2014, ACCOUNTS CHEM RES, V47, P2505, DOI 10.1021/ar5001549	53	360	368	54	741	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2016	538	7624					222	+		10.1038/nature19363	http://dx.doi.org/10.1038/nature19363			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA5OS	27602512	Green Submitted			2022-12-28	WOS:000386671000040
J	Bzdusek, T; Wu, QS; Ruegg, A; Sigrist, M; Soluyanov, AA				Bzdusek, Tomas; Wu, QuanSheng; Ruegg, Andreas; Sigrist, Manfred; Soluyanov, Alexey A.			Nodal-chain metals	NATURE			English	Article							WEYL FERMION SEMIMETAL; FLAT BANDS; TRANSITION; DISCOVERY	The band theory of solids is arguably the most successful theory of condensed-matter physics, providing a description of the electronic energy levels in various materials. Electronic wavefunctions obtained from the band theory enable a topological characterization of metals for which the electronic spectrum may host robust, topologically protected, fermionic quasiparticles. Many of these quasiparticles are analogues of the elementary particles of the Standard Model(1-10), but others do not have a counterpart in relativistic high-energy theories(11-18). A complete list of possible quasiparticles in solids is lacking, even in the non-interacting case. Here we describe the possible existence of a hitherto unrecognized type of fermionic excitation in metals. This excitation forms a nodal chain-a chain of connected loops in momentum space-along which conduction and valence bands touch. We prove that the nodal chain is topologically distinct from previously reported excitations. We discuss the symmetry requirements for the appearance of this excitation and predict that it is realized in an existing material, iridium tetrafluoride (IrF4), as well as in other compounds of this class of materials. Using IrF4 as an example, we provide a discussion of the topological surface states associated with the nodal chain. We argue that the presence of the nodal-chain fermions will result in anomalous magnetotransport properties, distinct from those of materials exhibiting previously known excitations.	[Bzdusek, Tomas; Wu, QuanSheng; Ruegg, Andreas; Sigrist, Manfred; Soluyanov, Alexey A.] ETH, Inst Theoret Phys, CH-8093 Zurich, Switzerland; [Wu, QuanSheng; Soluyanov, Alexey A.] ETH, Stn Zurich Q, CH-8093 Zurich, Switzerland; [Soluyanov, Alexey A.] St Petersburg State Univ, Dept Phys, St Petersburg 199034, Russia	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Saint Petersburg State University	Bzdusek, T (corresponding author), ETH, Inst Theoret Phys, CH-8093 Zurich, Switzerland.	bzdusek@itp.phys.ethz.ch	Wu, QuanSheng/Q-2316-2016; Bzdušek, Tomáš/U-4786-2018; Sigrist, Manfred/C-4570-2008; Ruegg, Andreas/B-4498-2010; Wu, QuanSheng/AAL-3118-2021	Wu, QuanSheng/0000-0002-9154-4489; Bzdušek, Tomáš/0000-0001-6904-5264; Sigrist, Manfred/0000-0002-8627-5093; Wu, QuanSheng/0000-0002-9154-4489; Soluyanov, Alexey/0000-0003-3539-1024	ETH research grant; Swiss National Science Foundation; Microsoft Research; Swiss National Science Foundation through the National Competence Centre in Research MARVEL; Swiss National Science Foundation through the National Competence Centre in Research QSIT	ETH research grant; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Microsoft Research(Microsoft); Swiss National Science Foundation through the National Competence Centre in Research MARVEL; Swiss National Science Foundation through the National Competence Centre in Research QSIT	The crystal structures in Fig. 3 were plotted using VESTA 3. We thank A. Bouhon, C. L. Kane, G. E. Volovik, B. A. Bernevig and R. J. Cava for discussions. T.B., A.R. and M.S. acknowledge financial support through an ETH research grant and the Swiss National Science Foundation. Q.S.W. and A.A.S. acknowledge the support of Microsoft Research and the Swiss National Science Foundation through the National Competence Centres in Research MARVEL and QSIT.	Bradley C., 1972, MATH THEORY SYMMETRY; Burkov AA, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.235126; Chang P.-Y, 2016, PREPRINT; Fang C, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.081201; Habermehl K., 2010, THESIS; Heikkila TT, 2011, JETP LETT+, V94, P233, DOI 10.1134/S0021364011150045; Heikkila TT, 2016, SPRINGER SER MATER S, V244, P123, DOI 10.1007/978-3-319-39355-1_6; Huang SM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8373; Huang XC, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031023; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; Liu ZK, 2014, SCIENCE, V343, P864, DOI 10.1126/science.1245085; Lv BQ, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031013; Murakami S, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/9/356; NIELSEN HB, 1983, PHYS LETT B, V130, P389, DOI 10.1016/0370-2693(83)91529-0; Rao P. R., 1976, J INORG NUCL CHEM, V28, P23; Rhim JW, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.045126; Soluyanov AA, 2015, NATURE, V527, P495, DOI 10.1038/nature15768; Volovik G.E., 2003, UNIVERSE HELIUM DROP; Wan XG, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205101; Wang ZJ, 2016, NATURE, V532, P189, DOI 10.1038/nature17410; Wang ZJ, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.195320; Weng HM, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.045108; Weng HM, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.011029; Wieder BJ, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.186402; Xu SY, 2015, SCIENCE, V349, P613, DOI 10.1126/science.aaa9297; Yang BJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5898; Young SM, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.140405; Yudin D, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.070403	30	380	386	10	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2016	538	7623					75	78		10.1038/nature19099	http://dx.doi.org/10.1038/nature19099			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX8LD	27556949	Green Submitted			2022-12-28	WOS:000384638900036
J	Luo, C; Lim, JH; Lee, Y; Granter, SR; Thomas, A; Vazquez, F; Widlund, HR; Puigserver, P				Luo, Chi; Lim, Ji-Hong; Lee, Yoonjin; Granter, Scott R.; Thomas, Ajith; Vazquez, Francisca; Widlund, Hans R.; Puigserver, Pere			A PGC1 alpha-mediated transcriptional axis suppresses melanoma metastasis	NATURE			English	Article							OXIDATIVE-METABOLISM; MALIGNANT-MELANOMA; ID PROTEINS; DIFFERENTIATION; INHIBITOR; RECEPTORS; ADHESION; CELLS; BETA	Melanoma is the deadliest form of commonly encountered skin cancer because of its rapid progression towards metastasis(1,2). Although metabolic reprogramming is tightly associated with tumour progression, the effect of metabolic regulatory circuits on metastatic processes is poorly understood. PGC1 alpha is a transcriptional coactivator that promotes mitochondrial biogenesis, protects against oxidative stress(3) and reprograms melanoma metabolism to influence drug sensitivity and survival(4,5). Here, we provide data indicating that PGC1 alpha suppresses melanoma metastasis, acting through a pathway distinct from that of its bioenergetic functions. Elevated PGC1 alpha expression inversely correlates with vertical growth in human melanoma specimens. PGC1 alpha silencing makes poorly metastatic melanoma cells highly invasive and, conversely, PGC1 alpha reconstitution suppresses metastasis. Within populations of melanoma cells, there is a marked heterogeneity in PGC1 alpha levels, which predicts their inherent high or low metastatic capacity. Mechanistically, PGC1 alpha directly increases transcription of ID2, which in turn binds to and inactivates the transcription factor TCF4. Inactive TCF4 causes downregulation of metastasis-related genes, including integrins that are known to influence invasion and metastasis(6-8). Inhibition of BRAF(V600E) using vemurafenib(9), independently of its cytostatic effects, suppresses metastasis by acting on the PGC1 alpha-ID2-TCF4-integrin axis. Together, our findings reveal that PGC1 alpha maintains mitochondrial energetic metabolism and suppresses metastasis through direct regulation of parallel acting transcriptional programs. Consequently, components of these circuits define new therapeutic opportunities that may help to curb melanoma metastasis.	[Luo, Chi; Lim, Ji-Hong; Lee, Yoonjin; Thomas, Ajith; Vazquez, Francisca; Puigserver, Pere] Harvard Med Sch, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Luo, Chi; Lim, Ji-Hong; Lee, Yoonjin; Thomas, Ajith; Vazquez, Francisca; Puigserver, Pere] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Lee, Yoonjin] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Granter, Scott R.] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Vazquez, Francisca] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Vazquez, Francisca] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Widlund, Hans R.] Harvard Med Sch, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Lim, Ji-Hong] Konkuk Univ, Dept Biomed Chem, Coll Biomed & Hlth Sci, Chungju 380701, Chung, South Korea	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Konkuk University	Puigserver, P (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.; Puigserver, P (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.	pere_puigserver@dfci.harvard.edu	Thomas, Ajith/AAX-9054-2020; Vazquez, Francisca/ABC-4620-2020; Vazquez, Francisca/AAA-3751-2020	Vazquez, Francisca/0000-0002-2857-4685; Widlund, Hans/0000-0002-7506-2447; LUO, CHI/0000-0001-7669-9506	American Heart Association [13POST14750008]; National Research Foundation from South-Korean government [2015R1A2A2A01002483]; Claudia Adams Barr Program in Cancer Research; Dana-Farber Cancer Institute; NIH [R01CA181217]; Friends of Dana-Farber Award; NATIONAL CANCER INSTITUTE [R01CA181217] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Research Foundation from South-Korean government; Claudia Adams Barr Program in Cancer Research; Dana-Farber Cancer Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Friends of Dana-Farber Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Bronson for his critical analysis of the mouse histology, the Nikon Imaging Center at Harvard Medical School for help with light microscopy and members of the Puigserver laboratory for discussions. J.-H.L was supported in part by a postdoctoral fellowship from the American Heart Association (13POST14750008) and the National Research Foundation from the South-Korean government (2015R1A2A2A01002483). These studies were funded in part by the Claudia Adams Barr Program in Cancer Research (to P.P.), Dana-Farber Cancer Institute internal funds (to P.P.) and NIH R01CA181217 (to P.P.), as well as the Friends of Dana-Farber Award (to C.L.).	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Busse A, 2011, CURR PHARM BIOTECHNO, V12, P2165, DOI 10.2174/138920111798808437; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Foley CJ, 2012, J BIOL CHEM, V287, P24330, DOI 10.1074/jbc.M112.356303; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Langlands K, 1997, J BIOL CHEM, V272, P19785, DOI 10.1074/jbc.272.32.19785; Lim JH, 2014, CANCER RES, V74, P3535, DOI 10.1158/0008-5472.CAN-13-2893-T; Luo C, 2013, CANCER RES, V73, P4337, DOI 10.1158/0008-5472.CAN-12-4454; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Naba A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014647; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Norton JD, 2000, J CELL SCI, V113, P3897; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pencheva N, 2014, CELL, V156, P986, DOI 10.1016/j.cell.2014.01.038; Pinon P, 2011, PIGM CELL MELANOMA R, V24, P282, DOI 10.1111/j.1755-148X.2010.00806.x; PLANTEFABER LC, 1989, CELL, V56, P281, DOI 10.1016/0092-8674(89)90902-1; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Sanchez-Laorden B, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004815; Scatolini M, 2010, INT J CANCER, V126, P1869, DOI 10.1002/ijc.24899; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Torrano V, 2016, NAT CELL BIOL, V18, P645, DOI 10.1038/ncb3357; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646; Zebedee Z, 2001, ONCOGENE, V20, P8317, DOI 10.1038/sj.onc.1205092	36	134	137	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2016	537	7620					422	+		10.1038/nature19347	http://dx.doi.org/10.1038/nature19347			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV7EC	27580028	Green Accepted			2022-12-28	WOS:000383098000058
J	Rollig, M				Roellig, Markus			ASTROPHYSICS Violent emissions of newborn stars	NATURE			English	Editorial Material							ORION BAR; REGION		[Roellig, Markus] Univ Cologne, Phys Inst, D-50937 Cologne, Germany	University of Cologne	Rollig, M (corresponding author), Univ Cologne, Phys Inst, D-50937 Cologne, Germany.	roellig@ph1.uni-koeln.de	Roellig, Markus/B-8845-2013	Roellig, Markus/0000-0001-6205-2242				Andree-Labsch S., 2014, PREPRINT; Goicoechea JR, 2016, NATURE, V537, P207, DOI 10.1038/nature18957; HOGERHEIJDE MR, 1995, ASTRON ASTROPHYS, V294, P792; Hollenbach DJ, 1997, ANNU REV ASTRON ASTR, V35, P179, DOI 10.1146/annurev.astro.35.1.179; Krumholz M. R., 2014, PROTOSTARS PLANETS, P243; Martins F, 2005, ASTRON ASTROPHYS, V436, P1049, DOI 10.1051/0004-6361:20042386; PARMAR PS, 1991, ASTROPHYS J, V372, pL25, DOI 10.1086/186015; Walmsley CM, 2000, ASTRON ASTROPHYS, V364, P301	10	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					174	175		10.1038/537174a	http://dx.doi.org/10.1038/537174a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU9LQ	27604945				2022-12-28	WOS:000382539100034
J	Walker, DH				Walker, David H.			Scrub Typhus - Scientific Neglect, Ever-Widening Impact	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Walker, David H.] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Walker, DH (corresponding author), Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.							Horton KC, 2016, AM J TROP MED HYG, V95, P462, DOI 10.4269/ajtmh.15-0775; Moron CG, 2001, MODERN PATHOL, V14, P752, DOI 10.1038/modpathol.3880385; Paris DH, 2015, J IMMUNOL, V194, P1702, DOI 10.4049/jimmunol.1402244; Paris DH, 2013, AM J TROP MED HYG, V89, P301, DOI 10.4269/ajtmh.13-0064; Valbuena G, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2012.00170	5	62	64	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2016	375	10					913	915		10.1056/NEJMp1608499	http://dx.doi.org/10.1056/NEJMp1608499			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU9IG	27602663	Bronze			2022-12-28	WOS:000382529500003
J	Larochelle, MR; Liebschutz, JM; Zhang, F; Ross-Degnan, D; Wharam, JF				Larochelle, Marc R.; Liebschutz, Jane M.; Zhang, Fang; Ross-Degnan, Dennis; Wharam, J. Frank			Opioid Prescribing After Nonfatal Overdose and Association With Repeated Overdose RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter							TIME-VARYING COVARIATE; KAPLAN-MEIER ESTIMATOR; IMPACT		[Larochelle, Marc R.; Liebschutz, Jane M.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Larochelle, Marc R.; Liebschutz, Jane M.] Boston Med Ctr, Boston, MA USA; [Zhang, Fang; Ross-Degnan, Dennis; Wharam, J. Frank] Harvard Med Sch, Boston, MA 02115 USA; [Zhang, Fang; Ross-Degnan, Dennis; Wharam, J. Frank] Harvard Pilgrim Hlth Care Inst, Boston, MA USA	Boston University; Boston Medical Center; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Larochelle, MR (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.		Zhang, Fang/HHN-2153-2022	Wharam, James/0000-0003-2053-0757				Beyersmann J, 2006, AM STAT, V60, P295; Snapinn SM, 2005, AM STAT, V59, P301, DOI 10.1198/000313005X70371	2	14	14	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2016	165	5					376	377		10.7326/L16-0168	http://dx.doi.org/10.7326/L16-0168			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3BC	27595218				2022-12-28	WOS:000382795000011
J	Pan, KH; Zheng, MH				Pan, Ke-Hua; Zheng, Ming-Hua			SPOT DIAGNOSIS A young man with recurrent limb shaking	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CORPUS-CALLOSUM; AGENESIS		[Pan, Ke-Hua] Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiol, Wenzhou, Zhejiang, Peoples R China; [Zheng, Ming-Hua] Wenzhou Med Univ, Liver Res Ctr, Dept Hepatol, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Zheng, MH (corresponding author), Wenzhou Med Univ, Liver Res Ctr, Dept Hepatol, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China.	zhengmh@wmu.edu.cn	Zheng, Ming-Hua/H-5584-2019	Zheng, Ming-Hua/0000-0003-4984-2631				Popa RT, 2010, MED ULTRASON, V12, P249; Ramelli GP, 2006, SWISS MED WKLY, V136, P404	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2016	354								i4502	10.1136/bmj.i4502	http://dx.doi.org/10.1136/bmj.i4502			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV7EX	27595998				2022-12-28	WOS:000383100200001
J	Lyons, SK; Miller, JH; Toth, A; Amatangelo, KL; Behrensmeyer, AK; Bercovici, A; Blois, JL; Davis, M; Dimichelle, WA; Du, A; Eronen, JT; Faith, JT; Graves, GR; Jud, N; Labandeira, C; Looy, CV; McGill, B; Patterson, D; Pineda-Munoz, S; Potts, R; Riddle, B; Terry, R; Ulrich, W; Villasenor, A; Wing, S; Anderson, H; Anderson, J; Gotelli, NJ				Lyons, S. Kathleen; Miller, Joshua H.; Toth, Aniko; Amatangelo, Kathryn L.; Behrensmeyer, Anna K.; Bercovici, Antoine; Blois, Jessica L.; Davis, Matt; Dimichelle, William A.; Du, Andrew; Eronen, Jussi T.; Faith, J. Tyler; Graves, Gary R.; Jud, Nathan; Labandeira, Conrad; Looy, Cindy V.; McGill, Brian; Patterson, David; Pineda-Munoz, Silvia; Potts, Richard; Riddle, Brett; Terry, Rebecca; Ulrich, Werner; Villasenor, Amelia; Wing, Scott; Anderson, Heidi; Anderson, John; Gotelli, Nicholas J.			Questioning Holocene community shifts Reply	NATURE			English	Letter									[Lyons, S. Kathleen; Toth, Aniko; Behrensmeyer, Anna K.; Bercovici, Antoine; Labandeira, Conrad; Pineda-Munoz, Silvia; Wing, Scott] Smithsonian Inst, Natl Museum Nat Hist, Dept paleobiol, Washington, DC 20013 USA; [Miller, Joshua H.] Univ Cincinnati, Dept Geol, Cincinnati, OH 45221 USA; [Amatangelo, Kathryn L.; Dimichelle, William A.] SUNY Coll Brockport, Dept Environm Sci & Biol, Brockport, NY 14420 USA; [Blois, Jessica L.] Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA; [Davis, Matt] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Du, Andrew; Patterson, David; Villasenor, Amelia] George Washington Univ, Dept Anthropol, Ctr Adv Study Hominid Paleobiol, Hominid Paleobiol Doctoral Program, Washington, DC 20052 USA; [Eronen, Jussi T.] Univ Helsinki, Dept Geosci & Geography, FIN-00014 Helsinki, Finland; [Faith, J. Tyler] Univ Queensland, Sch Social Sci, Brisbane, Qld 4072, Australia; [Graves, Gary R.] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC 20013 USA; [Graves, Gary R.] Univ Copenhagen, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen, Denmark; [Jud, Nathan] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Labandeira, Conrad] Univ Maryland Coll Pk, Dept Entomol, College Pk, MD USA; [Labandeira, Conrad] Capital Normal Univ, Key Lab Insect Evolut & Environ Changes, Beijing 100048, Peoples R China; [Looy, Cindy V.] Univ Calif Berkeley, Dept Integrative Biol & Museum Paleontol, Berkeley, CA 94720 USA; [McGill, Brian] Univ Maine, Sch Biol Ecol & Sustainabil Solut Initiat, Orono, ME 04469 USA; [Potts, Richard] Smithsonian Inst, Natl Museum Nat Hist, Dept Anthropol, Human Origins Program, Washington, DC 20013 USA; [Riddle, Brett] Univ Nevada Las Vegas, Sch Life Sci, Las Vegas, NV USA; [Terry, Rebecca] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Ulrich, Werner] Nicholas Copernicus Univ, Chair Ecol & Biogeog, PL-87100 Torun, Poland; [Anderson, Heidi; Anderson, John] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Gotelli, Nicholas J.] Univ Vermont, Dept Biol, Burlington, VT 05405 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; University System of Ohio; University of Cincinnati; State University of New York (SUNY) System; University of California System; University of California Merced; Yale University; George Washington University; University of Helsinki; University of Queensland; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Copenhagen; State University System of Florida; University of Florida; University System of Maryland; University of Maryland College Park; Capital Normal University; University of California System; University of California Berkeley; University of Maine System; University of Maine Orono; Smithsonian Institution; Smithsonian National Museum of Natural History; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Oregon State University; Nicolaus Copernicus University; University of Witwatersrand; University of Vermont	Lyons, SK (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept paleobiol, Washington, DC 20013 USA.	lyonss2@si.edu	Villasenor, Amelia/AAR-5965-2021; Graves, Gary R/P-1003-2017; Pineda-Munoz, Silvia/AAR-2292-2020; Blois, Jessica/G-5893-2011; Eronen, Jussi T./B-7978-2013; Jud, Nathan/AAI-2384-2020; Terry, Rebecca/L-7019-2017; Tóth, Anikó/AAT-6084-2021	Graves, Gary R/0000-0003-1406-5246; Pineda-Munoz, Silvia/0000-0003-0597-4456; Blois, Jessica/0000-0003-4048-177X; Eronen, Jussi T./0000-0002-0390-8044; Jud, Nathan/0000-0001-6100-9779; Terry, Rebecca/0000-0002-9803-6292; Tóth, Anikó/0000-0002-3063-1917; Faith, J. Tyler/0000-0002-1101-7161; Ulrich, Werner/0000-0002-8715-6619; Wing, Scott/0000-0002-2954-8905; DiMichele, William/0000-0002-7270-220X				Bertelsmeier C, 2016, NATURE, V537, pE4, DOI 10.1038/nature19110; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Lyons SK, 2016, NATURE, V529, P80, DOI 10.1038/nature16447; ULRICH W, 2010, PARIS FORTRAN PROGR	4	0	0	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					E5	E6		10.1038/nature19111	http://dx.doi.org/10.1038/nature19111			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27582228				2022-12-28	WOS:000382426900060
J	Nogrady, B				Nogrady, Bianca			Balancing act	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					S14	S15		10.1038/537S14a	http://dx.doi.org/10.1038/537S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU7XC	27580135	Bronze			2022-12-28	WOS:000382426900023
J	Matheson, A				Matheson, Alastair			Ghostwriting: the importance of definition and its place in contemporary drug marketing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SPONSORED CLINICAL-RESEARCH; GOOD PUBLICATION PRACTICE; MEDICAL KNOWLEDGE; MAJOR DEPRESSION; PAROXETINE; AUTHORSHIP; IMIPRAMINE; EFFICACY; WRITERS; GHOSTS					amatheson@outlook.com						Amsterdam Jay D, 2012, Int J Risk Saf Med, V24, P221, DOI 10.3233/JRS-2012-0571; [Anonymous], 1993, LANCET, V342, P1498; Battisti WP, 2015, ANN INTERN MED, V163, P461, DOI 10.7326/M15-0288; Clark J, 2010, INT J CLIN PRACT, V64, P1028, DOI 10.1111/j.1742-1241.2010.02416.x; Council of Science Editors, 2008 2009 CSE ED POL; Council of Science Editors, CSES WHITE PAP PROM; Davidoff F, 2000, REPORT TO THE COUNCI; DEBAKEY L, 1995, JAMA-J AM MED ASSOC, V274, P870; FLANAGIN A, 1995, JAMA-J AM MED ASSOC, V273, P73, DOI 10.1001/jama.1995.03520250089041; Fontanarosa PB, 2005, JAMA-J AM MED ASSOC, V294, P110, DOI 10.1001/jama.294.1.110; Fugh-Berman A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001716; Fugh-Berman AJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000335; Ghostwriter, 2015, GHOSTWR; Graf C, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4330; Grossman L, 1998, LANCET, V351, P1741, DOI 10.1016/S0140-6736(05)77785-0; Hamilton CW, 2010, ARCH IMMUNOL THER EX, V58, P255, DOI 10.1007/s00005-010-0080-3; Heres S, 2006, AM J PSYCHIAT, V163, P185, DOI 10.1176/appi.ajp.163.2.185; Hirsch LJ, 2009, MAYO CLIN PROC, V84, P811, DOI 10.1016/S0025-6196(11)60491-6; Hoekman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045984; ICMJE, REC COND REP ED PUBL; International Society for Medical Publication Professionals Issues and Actions Committee, 2010, GHOSTWR PROF MED WRI; Jacobs A, 2005, CURR MED RES OPIN, V21, P317, DOI 10.1185/030079905X25578; Jacobs A, 2005, CURR MED RES OPIN, V21, P311, DOI 10.1185/030079905X25569; Keller MB, 2001, J AM ACAD CHILD PSY, V40, P762, DOI 10.1097/00004583-200107000-00010; Laine C, 2005, ANN INTERN MED, V143, P611, DOI 10.7326/0003-4819-143-8-200510180-00013; Le Noury J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4320; Leo J, 2011, SOCIETY, V48, P371, DOI 10.1007/s12115-011-9455-2; Lexchin Joel, 2012, Int J Risk Saf Med, V24, P233, DOI 10.3233/JRS-2012-0574; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; Mansi BA, 2012, MAYO CLIN PROC, V87, P424, DOI 10.1016/j.mayocp.2012.02.009; Marchington J, 2011, CURR MED RES OPIN, V27, pS5; Matheson A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001072; Matheson A, 2008, BIOSOCIETIES, V3, P355, DOI 10.1017/S1745855208006297; McHenry L, 2012, ETHICAL HUM PSYCHOL, V14, P156, DOI [10.1891/1559-4343.14.3.156, DOI 10.1891/1559-4343.14.3.156]; McHenry LB, 2008, ACCOUNT RES, V15, P152, DOI 10.1080/08989620802194384; Morcos A., 1999, CBE VIEWS, V22, P189; Nemeroff CB, 2001, AM J PSYCHIAT, V158, P906, DOI 10.1176/appi.ajp.158.6.906; Neurology, INF AUTH; Pharmaceutical Research Manufacturers of America, 2011, PRINC COND CLIN TRIA; Reidenberg JW, 2001, CLIN PHARMACOL THER, V70, P208, DOI 10.1067/mcp.2001.118631; RENNIE D, 1994, JAMA-J AM MED ASSOC, V271, P469, DOI 10.1001/jama.271.6.469; Ross JS, 2008, JAMA-J AM MED ASSOC, V299, P1800, DOI 10.1001/jama.299.15.1800; Sismondo S, 2007, PLOS MED, V4, P1429, DOI 10.1371/journal.pmed.0040286; Sismondo S, 2013, J LAW MED ETHICS, V41, P635, DOI 10.1111/jlme.12073; Smith R, 2005, PLOS MED, V2, P364, DOI 10.1371/journal.pmed.0020138.g001; Thomson Reuters, 2009, KEY OP LEAD ID SEL; Wager E, 2003, CURR MED RES OPIN, V19, P149, DOI 10.1185/030079903125001767; Wager E, 1998, CBE VIEWS, V22, P41; Wittek MR, 2009, CURR MED RES OPIN, V25, P2723, DOI 10.1185/03007990903297782; Woolley K, 2005, AMWA J, V20, P184; Woolley KL, 2006, CHEST, V130, P921, DOI 10.1378/chest.130.3.921; WOOLLEY KL, 2009, PLOS MED, V6	52	15	15	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2016	354								i4578	10.1136/bmj.i4578	http://dx.doi.org/10.1136/bmj.i4578			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DV3AC	27576493				2022-12-28	WOS:000382792400002
J	Kumar, A				Kumar, Amit			Adaptability in life and work	SCIENCE			English	Editorial Material									[Kumar, Amit] MIT, Cambridge, MA 02139 USA; [Kumar, Amit] Harvard Univ, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Harvard University	Kumar, A (corresponding author), MIT, Cambridge, MA 02139 USA.; Kumar, A (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	SciCareerEditor@aaas.org							0	2	2	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					954	954		10.1126/science.353.6302.954	http://dx.doi.org/10.1126/science.353.6302.954			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU0CA	27563097				2022-12-28	WOS:000381867700042
J	Gordon, S				Gordon, Siamon			Phagocytosis: The Legacy of Metchnikoff	CELL			English	Editorial Material								This year is the centenary of the death of Elie Metchnikoff, the father of innate immunity. His work on phagocytosis has continued to flourish, particularly over the past half century.	[Gordon, Siamon] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan 33302, Taiwan; [Gordon, Siamon] Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England	Chang Gung University; University of Oxford	Gordon, S (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan 33302, Taiwan.; Gordon, S (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	Siamon.gordon@path.ox.ac.uk						Gilbert S.F., 1994, FOREWORD DEV BIOL; Gordon S, 2016, IMMUNITY, V44, P463, DOI 10.1016/j.immuni.2016.02.026; Metchnikoff E., 1905, IMMUNITY INFECT DIS; Metchnikoff E., 1959, MEMORIES OF THE PAST; Metchnikoff E., 1968, LECT COMP PATHOLOGY; Metchnikoff E, 2016, J INNATE IMMUNITY S, V8, P223, DOI [10.1159/000443331, DOI 10.1159/000443331]; Metchnikoff O., 1921, LIFE E METCHNIKOFF 1; MOBERG CL, 2012, ENTERING UNSEEN WORL; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Stossel TR, 1999, ADV CELL MOL BIOL ME, V5, P3, DOI 10.1016/S1874-5172(99)80025-X; Tauber AI, 1991, METCHNIKOFF ORIGINS; VANFURTH R, 1985, MONONUCLEAR PHAGOCYT; Vikhanski L., 2016, E METCHNIKOFF CHANGE	13	38	38	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1065	1068		10.1016/j.cell.2016.08.017	http://dx.doi.org/10.1016/j.cell.2016.08.017			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27565334	Bronze			2022-12-28	WOS:000382259500003
J	Padma, TV				Padma, T. V.			INDIA	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					S26	S26		10.1038/536S26a	http://dx.doi.org/10.1038/536S26a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV0YL	27557160				2022-12-28	WOS:000382646600007
J	Yockey, LJ; Varela, L; Rakib, T; Khoury-Hanold, W; Fink, SL; Stutz, B; Szigeti-Buck, K; Van den Pol, A; Lindenbach, BD; Horvath, TL; Iwasaki, A				Yockey, Laura J.; Varela, Luis; Rakib, Tasfia; Khoury-Hanold, William; Fink, Susan L.; Stutz, Bernardo; Szigeti-Buck, Klara; Van den Pol, Anthony; Lindenbach, Brett D.; Horvath, Tamas L.; Iwasaki, Akiko			Vaginal Exposure to Zika Virus during Pregnancy Leads to Fetal Brain Infection	CELL			English	Article							MALE SEXUAL TRANSMISSION; TOLL-LIKE RECEPTORS; INNATE IMMUNITY; UNITED-STATES; MOUSE MODEL; RIG-I; CELLS; ENCEPHALITIS; RECOGNITION; INDUCTION	Zika virus (ZIKV) can be transmitted sexually between humans. However, it is unknown whether ZIKV replicates in the vagina and impacts the unborn fetus. Here, we establish a mouse model of vaginal ZIKV infection and demonstrate that, unlike other routes, ZIKV replicates within the genital mucosa even in wild-type (WT) mice. Mice lacking RNA sensors or transcription factors IRF3 and IRF7 resulted in higher levels of local viral replication. Furthermore, mice lacking the type I interferon (IFN) receptor (IFNAR) became viremic and died of infection after a high-dose vaginal ZIKV challenge. Notably, vaginal infection of pregnant dams during early pregnancy led to fetal growth restriction and infection of the fetal brain in WT mice. This was exacerbated in mice deficient in IFN pathways, leading to abortion. Our study highlights the vaginal tract as a highly susceptible site of ZIKV replication and illustrates the dire disease consequences during pregnancy.	[Yockey, Laura J.; Rakib, Tasfia; Khoury-Hanold, William; Fink, Susan L.; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Varela, Luis; Stutz, Bernardo; Szigeti-Buck, Klara; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA; [Fink, Susan L.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Van den Pol, Anthony] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA; [Lindenbach, Brett D.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA; [Iwasaki, Akiko] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.; Iwasaki, A (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu	Varela, Luis/ABG-7581-2020; Iwasaki, Akiko/Z-1591-2019	Varela, Luis/0000-0001-7794-7241; Iwasaki, Akiko/0000-0002-7824-9856; Fink, Susan/0000-0003-1705-0103; Stutz, Bernardo/0000-0001-5282-6400	Howard Hughes Medical Institute; National Institutes of Health (NIH) [R01 AI054359]; NIH Medical Scientist Training Program Training Grant [T32 GM007205];  [K08 AI119142]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI119142, R01AI054359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Medical Scientist Training Program Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Huiping Dong for technical support and the members of the Erol Fikrig laboratory for helpful discussions. We thank Dr. Marie Flamand at the Institut Pasteur in Paris for providing us the antibody to NS1. This work was supported by the Howard Hughes Medical Institute, and National Institutes of Health (NIH) grants R01 AI054359 (A.I.). L.J.Y. is supported by NIH Medical Scientist Training Program Training Grant T32 GM007205. S.L.F. is supported by K08 AI119142.	Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008; Bruni D, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa1552; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; CROOKS AJ, 1994, J GEN VIROL, V75, P3453, DOI 10.1099/0022-1317-75-12-3453; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; Daffis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000607; Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2; Decembre E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004434; Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3; Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999; Foxman EF, 2015, P NATL ACAD SCI USA, V112, P827, DOI 10.1073/pnas.1411030112; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009; Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477; Haller O, 2015, TRENDS MICROBIOL, V23, P154, DOI 10.1016/j.tim.2014.12.003; Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Ko MSH, 2001, TRENDS BIOTECHNOL, V19, P511, DOI 10.1016/S0167-7799(01)01806-6; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16; Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9; Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Nazmi A, 2014, NEUROBIOL DIS, V69, P235, DOI 10.1016/j.nbd.2014.05.036; PARR MB, 1994, LAB INVEST, V70, P369; Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2; Pillai PS, 2016, SCIENCE, V352, P463, DOI 10.1126/science.aaf3926; Prisant N., 2016, LANCET INFECT DIS; Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111; Rowland A, 2016, J ASSIST REPROD GEN, V33, P435, DOI 10.1007/s10815-016-0684-6; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Schmid S, 2010, J BIOL CHEM, V285, P42013, DOI 10.1074/jbc.M110.165936; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355; Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x; Town T, 2009, IMMUNITY, V30, P242, DOI 10.1016/j.immuni.2008.11.012; Venturi G., 2016, EURO SURVEILL, V21; Wang JP, 2006, J IMMUNOL, V177, P7114, DOI 10.4049/jimmunol.177.10.7114; Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006; Welte T, 2009, J GEN VIROL, V90, P2660, DOI 10.1099/vir.0.011783-0; Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58	53	271	278	1	80	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1247	+		10.1016/j.cell.2016.08.004	http://dx.doi.org/10.1016/j.cell.2016.08.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27565347	Bronze, Green Accepted			2022-12-28	WOS:000382259500020
J	King, NB; Strumpf, E; Harper, S				King, Nicholas B.; Strumpf, Erin; Harper, Sam			Has the Increase in Disability Insurance Participation Contributed to Increased Opioid-Related Mortality?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							UNITED-STATES		[King, Nicholas B.; Strumpf, Erin; Harper, Sam] McGill Univ, Montreal, PQ, Canada; [King, Nicholas B.] McGill Univ, Biomed Eth Unit, 3647 Peel St, Montreal, PQ H3A 1X1, Canada; [Strumpf, Erin] McGill Univ, Dept Econ, Leacock 418,855 Sherbrooke St West, Montreal, PQ H3A 2T7, Canada; [Harper, Sam] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Purvis Hall,1020 Pine Ave West, Montreal, PQ H3A 1A2, Canada	McGill University; McGill University; McGill University; McGill University	King, NB (corresponding author), McGill Univ, Biomed Eth Unit, 3647 Peel St, Montreal, PQ H3A 1X1, Canada.		Harper, Sam/A-3406-2008	Harper, Sam/0000-0002-2767-1053; King, Nicholas/0000-0002-2093-3380				Autor David, 2006, Q J ECON, V118, P157; Chen LH, 2015, MMWR-MORBID MORTAL W, V64, P32; Hansen H, 2014, SOC SCI MED, V103, P76, DOI 10.1016/j.socscimed.2013.06.033; Insurance Supervision Agency, 2015, ANN REP INS MARK REP; King NB, 2014, AM J PUBLIC HEALTH, V104, pE32, DOI 10.2105/AJPH.2014.301966; Lakdawalla DN, 2004, HEALTH AFFAIR, V23, P168, DOI 10.1377/hlthaff.23.1.168; Liebman JB, 2015, J ECON PERSPECT, V29, P123, DOI 10.1257/jep.29.2.123; Meara E., 2016, N ENGL J MED; Pacula RL, 2015, 21072 NBER; Wamhoff Steve, 2005, Soc Secur Bull, V66, P21	10	7	7	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	2016	165	10					729	+		10.7326/M16-0918	http://dx.doi.org/10.7326/M16-0918			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EC2RB	27571480				2022-12-28	WOS:000387970500017
J	Oshima, J; Martin, GM				Oshima, Junko; Martin, George M.			AGEING Dietary protection for genes	NATURE			English	Editorial Material							COCKAYNE-SYNDROME	Dietary restriction is known to extend lifespan in many species. It has now been shown to reduce DNA damage and extend lifespan in mice modelling human DNA-repair disorders. See Letter p.427	[Oshima, Junko; Martin, George M.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Oshima, J (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	picard@u.washington.edu; gmmartin@u.washington.edu			NCI NIH HHS [R01 CA210916] Funding Source: Medline; NIA NIH HHS [R24 AG042328] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA210916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R24AG042328] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Hisama FM, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a025882; Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360; Laugel V, 2013, MECH AGEING DEV, V134, P161, DOI 10.1016/j.mad.2013.02.006; Liao CY, 2013, EXP GERONTOL, V48, P1025, DOI 10.1016/j.exger.2013.03.010; Manandhar M, 2015, GENE, V569, P153, DOI 10.1016/j.gene.2015.06.026; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Saha B, 2014, AGING CELL, V13, P573, DOI 10.1111/acel.12190; Vermeij WP, 2016, NATURE, V537, P427, DOI 10.1038/nature19329; VERMEULEN W, 1993, AM J HUM GENET, V53, P185	10	0	0	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2016	537	7620					316	317		10.1038/nature19427	http://dx.doi.org/10.1038/nature19427			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV7EC	27556941	Green Accepted			2022-12-28	WOS:000383098000038
J	Bourzac, K				Bourzac, Katherine			Power to the patients	NATURE			English	Editorial Material																		CHIAUZZI E, 2016, PATIENT; Katic B, 2015, SLEEP MED, V16, P1332, DOI 10.1016/j.sleep.2015.07.024	2	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					S66	S68		10.1038/537S66a	http://dx.doi.org/10.1038/537S66a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU9LQ	27602745	Bronze			2022-12-28	WOS:000382539100006
J	Lim, X				Lim, Xiaozhi			CHEMISTRY ON THE FAST TRACK	NATURE			English	News Item							PHOTOREDOX CATALYSIS; ALKYLATION; AMINATION; LIGAND; SALTS; IRON							Waldrop, M Mitchell/0000-0002-8063-1472				Aragones AC, 2016, NATURE, V531, P88, DOI 10.1038/nature16989; Benedetti E, 2015, CHEM COMMUN, V51, P6076, DOI 10.1039/c4cc10190a; Bligaard T, 2016, ACS CATAL, V6, P2590, DOI 10.1021/acscatal.6b00183; Breitenfeld J, 2013, J AM CHEM SOC, V135, P12004, DOI 10.1021/ja4051923; Corcoran EB, 2016, SCIENCE, V353, P279, DOI 10.1126/science.aag0209; Csok Z, 2008, J AM CHEM SOC, V130, P8156, DOI 10.1021/ja8025938; Ichiishi N, 2013, ORG LETT, V15, P5134, DOI 10.1021/ol4025716; Key HM, 2016, NATURE, V534, P534, DOI 10.1038/nature17968; Li RG, 2014, ENERG ENVIRON SCI, V7, P1369, DOI 10.1039/c3ee43304h; Liu J, 2015, CHEM COMMUN, V51, P13731, DOI 10.1039/c5cc04590h; Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; Rak MJ, 2014, CHEM COMMUN, V50, P12482, DOI 10.1039/c4cc04749d; Romero NA, 2015, SCIENCE, V349, P1326, DOI 10.1126/science.aac9895; Sauer DF, 2015, ACS CATAL, V5, P7519, DOI 10.1021/acscatal.5b01792; Vechorkin O, 2010, ANGEW CHEM INT EDIT, V49, P3061, DOI 10.1002/anie.200907040; Vechorkin O, 2009, J AM CHEM SOC, V131, P12078, DOI 10.1021/ja906040t	16	14	14	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					156	158		10.1038/537156a	http://dx.doi.org/10.1038/537156a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9LQ	27604933	Bronze			2022-12-28	WOS:000382539100021
J	Scott, AR				Scott, Andrew R.			Read the instructions	NATURE			English	Editorial Material																		Goldfeder RL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0269-0; Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49	2	6	6	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					S54	S56		10.1038/537S54a	http://dx.doi.org/10.1038/537S54a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU9LQ	27602740	Bronze			2022-12-28	WOS:000382539100001
J	Braillon, A; Menkes, DB				Braillon, Alain; Menkes, David B.			Alcohol Use	ANNALS OF INTERNAL MEDICINE			English	Letter									[Braillon, Alain] Univ Hosp, Amiens, France; [Menkes, David B.] Univ Auckland, Hamilton, New Zealand	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; University of Auckland	Braillon, A (corresponding author), Univ Hosp, Amiens, France.							Edelman EJ, 2016, ANN INTERN MED, V164, pITC1, DOI 10.7326/AITC201601050; Glass JE, 2015, ADDICTION, V110, P1404, DOI 10.1111/add.12950; Hall K, 2016, ADDICTION, V111, P1144, DOI 10.1111/add.13014; Menkes David B, 2014, Int J Risk Saf Med, V26, P163, DOI 10.3233/JRS-140632; Wise J, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i109	5	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2016	165	5					378	379		10.7326/L16-0109	http://dx.doi.org/10.7326/L16-0109			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3BC	27595221				2022-12-28	WOS:000382795000014
J	Gagnon, D; Romero, SA; Cramer, MN; Jay, O; Crandall, CG				Gagnon, Daniel; Romero, Steven A.; Cramer, Matthew N.; Jay, Ollie; Crandall, Craig G.			Cardiac and Thermal Strain of Elderly Adults Exposed to Extreme Heat and Humidity With and Without Electric Fan Use	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							HEALTH		[Gagnon, Daniel; Romero, Steven A.; Cramer, Matthew N.; Crandall, Craig G.] Univ Texas Southwestern Med Ctr Dallas, Inst Exercise & Environm Med, 7232 Greenville Ave, Dallas, TX 75231 USA; [Jay, Ollie] Univ Sydney, Fac Hlth Sci, Lidcombe, Australia	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Sydney	Crandall, CG (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Inst Exercise & Environm Med, 7232 Greenville Ave, Dallas, TX 75231 USA.	craigcrandall@texashealth.org	Jay, Ollie/AAD-8009-2020; Gagnon, Daniel/O-7832-2017	Gagnon, Daniel/0000-0001-5396-9489; Jay, Ollie/0000-0002-6076-6337; Cramer, Matthew/0000-0001-7400-8353; Crandall, Craig/0000-0001-7792-9713	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068865] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM068865, GM-068865] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Gupta Saurabh, 2012, Cochrane Database Syst Rev, pCD009888, DOI 10.1002/14651858.CD009888.pub2; Kenney WL, 2014, MED SCI SPORT EXER, V46, P1891, DOI 10.1249/MSS.0000000000000325; Patz JA, 2014, JAMA-J AM MED ASSOC, V312, P1565, DOI 10.1001/jama.2014.13186; Ravanelli NM, 2015, JAMA-J AM MED ASSOC, V313, P724, DOI 10.1001/jama.2015.153; Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203; World Health Organization, PUBL HLTH ADV PREV H	6	17	17	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2016	316	9					989	991		10.1001/jama.2016.10550	http://dx.doi.org/10.1001/jama.2016.10550			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU8JV	27599335	Bronze, Green Accepted			2022-12-28	WOS:000382460200023
J	Odutayo, A; Wong, CX; Hsiao, AJ; Hopewell, S; Altman, DG; Emdin, CA				Odutayo, Ayodele; Wong, Christopher X.; Hsiao, Allan J.; Hopewell, Sally; Altman, Douglas G.; Emdin, Connor A.			Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ACUTE MYOCARDIAL-INFARCTION; VENTRICULAR SYSTOLIC DYSFUNCTION; AORTIC-VALVE-REPLACEMENT; INCIDENT HEART-FAILURE; SUDDEN CARDIAC DEATH; LONG-TERM OUTCOMES; ISCHEMIC-STROKE; PROGNOSTIC-SIGNIFICANCE; FOLLOW-UP; ATHEROSCLEROSIS-RISK	OBJECTIVE To quantify the association between atrial fibrillation and cardiovascular disease, renal disease, and death. Design Systematic review and meta-analysis. Data sources Medline and Embase. Eligibility criteria Cohort studies examining the association between atrial fibrillation and cardiovascular disease, renal disease, and death. Two reviewers independently extracted study characteristics and the relative risk of outcomes associated with atrial fibrillation: specifically, all cause mortality, cardiovascular mortality, major cardiovascular events, any stroke, ischaemic stroke, haemorrhagic stroke, ischaemic heart disease, sudden cardiac death, congestive heart failure, chronic kidney disease, and peripheral arterial disease. Estimates were pooled with inverse variance weighted random effects meta-analysis. Results 104 eligible cohort studies involving 9 686 513 participants (587 867 with atrial fibrillation) were identified. Atrial fibrillation was associated with an increased risk of all cause mortality (relative risk 1.46, 95% confidence interval 1.39 to 1.54), cardiovascular mortality (2.03, 1.79 to 2.30), major cardiovascular events (1.96, 1.53 to 2.51), stroke (2.42, 2.17 to 2.71), ischaemic stroke (2.33, 1.84 to 2.94), ischaemic heart disease (1.61, 1.38 to 1.87), sudden cardiac death (1.88, 1.36 to 2.60), heart failure (4.99, 3.04 to 8.22), chronic kidney disease (1.64, 1.41 to 1.91), and peripheral arterial disease (1.31, 1.19 to 1.45) but not haemorrhagic stroke (2.00, 0.67 to 5.96). Among the outcomes examined, the highest absolute risk increase was for heart failure. Associations between atrial fibrillation and included outcomes were broadly consistent across subgroups and in sensitivity analyses. Conclusions Atrial fibrillation is associated with an increased risk of death and an increased risk of cardiovascular and renal disease. Interventions aimed at reducing outcomes beyond stroke are warranted in patients with atrial fibrillation.	[Odutayo, Ayodele; Hopewell, Sally; Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Wong, Christopher X.] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Hsiao, Allan J.] MIT, Dept Econ, Cambridge, MA 02139 USA; [Emdin, Connor A.] Univ Oxford, St Johns Coll, Oxford, England	University of Oxford; University of Oxford; Massachusetts Institute of Technology (MIT); University of Oxford	Odutayo, A (corresponding author), Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England.	ayodele.odutayo@bnc.ox.ac.uk	Wong, Christopher X/A-3227-2011	Hopewell, Sally/0000-0002-6881-6984; Wong, Christopher/0000-0002-1913-6675	Rhodes Trust	Rhodes Trust	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. AO, CXW, AJH, and CAE are supported by the Rhodes Trust.	Abbott KC, 2003, AM J TRANSPLANT, V3, P471, DOI 10.1034/j.1600-6143.2003.00071.x; Ahmed A, 2004, EUR J HEART FAIL, V6, P421, DOI 10.1016/j.ejheart.2003.11.011; Andersson T, 2014, INT J CARDIOL, V177, P91, DOI 10.1016/j.ijcard.2014.09.092; Aronow WS, 1999, AM J CARDIOL, V84, P468, DOI 10.1016/S0002-9149(99)00336-7; Aronow WS, 2001, AM J CARDIOL, V87, P224, DOI 10.1016/S0002-9149(00)01324-2; Aronow WS, 1996, J AM GERIATR SOC, V44, P521, DOI 10.1111/j.1532-5415.1996.tb01436.x; Asanin M, 2005, EUR J HEART FAIL, V7, P671, DOI 10.1016/j.ejheart.2004.07.018; Baidasseroni S, 2002, EUR HEART J, V23, P1692, DOI 10.1053/euhj.2001.3157; Bajaj NS, 2014, AM J CARDIOL, V114, P909, DOI 10.1016/j.amjcard.2014.05.045; Bang CN, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000382; Bang CN, 2012, AM HEART J, V163, P690, DOI 10.1016/j.ahj.2012.01.026; Bansal Nisha, 2013, Circulation, V127, P569, DOI 10.1161/CIRCULATIONAHA.112.123992; Bansal N, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001303; BEHAR S, 1992, EUR HEART J, V13, P45, DOI 10.1093/oxfordjournals.eurheartj.a060046; Bejot Y, 2009, NEUROLOGY, V72, P346, DOI 10.1212/01.wnl.0000341280.31919.bd; Benetos A, 2007, B ACAD NAT MED PARIS, V191, P791, DOI 10.1016/S0001-4079(19)33017-1; Bengtson LGS, 2014, AM J CARDIOL, V114, P692, DOI 10.1016/j.amjcard.2014.05.059; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Biblo LA, 2001, AM J CARDIOL, V87, P346, DOI 10.1016/S0002-9149(00)01374-6; Bilato C, 2009, AM J CARDIOL, V104, P1092, DOI 10.1016/j.amjcard.2009.05.058; Bishara R, 2011, THROMB HAEMOSTASIS, V106, P877, DOI 10.1160/TH11-05-0343; Bogale N, 2012, EUR J HEART FAIL, V14, P61, DOI 10.1093/eurjhf/hfr158; Bouzas-Mosquera A, 2010, AM J CARDIOL, V105, P1207, DOI 10.1016/j.amjcard.2009.12.037; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Caldeira D, 2012, ARCH CARDIOVASC DIS, V105, P226, DOI 10.1016/j.acvd.2011.11.005; Centers for Disease Control and Prevention, CHRON KIDN DIS CKD S; Centers for Disease Control and Prevention (CDC), NVSS MORT DAT; Chamberlain AM, 2011, CIRC-HEART FAIL, V4, P740, DOI 10.1161/CIRCHEARTFAILURE.111.962688; Chang CJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003002; Chao TF, 2012, STROKE, V43, P2551, DOI 10.1161/STROKEAHA.112.667865; Chen LY, 2013, JAMA INTERN MED, V173, P29, DOI 10.1001/2013.jamainternmed.744; Cheng M, 2014, EUR J HEART FAIL, V16, P1317, DOI 10.1002/ejhf.187; Chopard R, 2015, JACC-CARDIOVASC INTE, V8, P1346, DOI 10.1016/j.jcin.2015.06.010; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Conen D, 2011, JAMA-J AM MED ASSOC, V305, P2080, DOI 10.1001/jama.2011.659; Desai H, 2010, AM J CARDIOL, V105, P1336, DOI 10.1016/j.amjcard.2009.12.057; Dries DL, 1998, J AM COLL CARDIOL, V32, P695, DOI 10.1016/S0735-1097(98)00297-6; Duncan A, 2015, JACC-CARDIOVASC INTE, V8, P645, DOI 10.1016/j.jcin.2015.01.009; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feng She-jun, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P983; Friberg J, 2004, AM J CARDIOL, V94, P889, DOI 10.1016/j.amjcard.2004.06.023; Fu SH, 2014, CLIN INTERV AGING, V9, P301, DOI 10.2147/CIA.S55972; Genovesi S, 2009, NEPHROL DIAL TRANSPL, V24, P2529, DOI 10.1093/ndt/gfp104; GOLDBERG RJ, 1990, AM HEART J, V119, P996, DOI 10.1016/S0002-8703(05)80227-3; Grover SA, 2007, ARCH INTERN MED, V167, P2296, DOI 10.1001/archinte.167.21.2296; Hamaguchi S, 2009, CIRC J, V73, P2084, DOI 10.1253/circj.CJ-09-0316; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Henriksson KM, 2010, INT J CARDIOL, V141, P18, DOI 10.1016/j.ijcard.2008.11.122; Hermann DM, 2013, STROKE, V44, P1008, DOI 10.1161/STROKEAHA.111.678078; Hillen T, 2003, STROKE, V34, P1457, DOI 10.1161/01.STR.0000072985.24967.7F; Hippisley-Cox J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2573; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6624; Iwahana H, 2011, J EPIDEMIOL, V21, P95, DOI 10.2188/jea.JE20090149; Jabre P, 2011, CIRCULATION, V123, P2094, DOI 10.1161/CIRCULATIONAHA.110.990192; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Kaarisalo MM, 1997, J AM GERIATR SOC, V45, P1297, DOI 10.1111/j.1532-5415.1997.tb02927.x; Kamel H, 2012, J STROKE CEREBROVASC, V21, P726, DOI 10.1016/j.jstrokecerebrovasdis.2011.03.008; Kammersgaard LP, 2006, CEREBROVASC DIS, V21, P187, DOI 10.1159/000090531; Kimura K, 2005, CEREBROVASC DIS, V19, P171, DOI 10.1159/000083252; Kinjo K, 2003, AM J CARDIOL, V92, P1150, DOI 10.1016/j.amjcard.2003.07.021; KOBER L, 1994, EUR HEART J, V15, P382, DOI 10.1093/oxfordjournals.eurheartj.a060507; Kober L, 2006, EUR J HEART FAIL, V8, P591, DOI 10.1016/j.ejheart.2005.11.007; LAKE FR, 1989, AUST NZ J MED, V19, P321, DOI 10.1111/j.1445-5994.1989.tb00271.x; Lau DH, 2009, AM J CARDIOL, V104, P1317, DOI 10.1016/j.amjcard.2009.06.055; Lau KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088283; Leong DP, 2013, EUR HEART J, V34, P1027, DOI 10.1093/eurheartj/eht044; Liu XF, 2006, CEREBROVASC DIS, V22, P130, DOI 10.1159/000093241; Manolis AJ, 2012, J HYPERTENS, V30, P239, DOI 10.1097/HJH.0b013e32834f03bf; Manzano JJF, 2012, ATHEROSCLEROSIS, V223, P219, DOI 10.1016/j.atherosclerosis.2012.04.009; Marijon E, 2013, CIRCULATION, V128, P2192, DOI 10.1161/CIRCULATIONAHA.112.000491; Marijon E, 2009, AM HEART J, V157, P391, DOI 10.1016/j.ahj.2008.09.023; Marini C, 2005, STROKE, V36, P1115, DOI 10.1161/01.STR.0000166053.83476.4a; McManus DD, 2013, AM J CARDIOL, V111, P1460, DOI 10.1016/j.amjcard.2013.01.298; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nakayama T, 1997, STROKE, V28, P45, DOI 10.1161/01.STR.28.1.45; O'Neal WT, 2015, INT J CARDIOL, V185, P219, DOI 10.1016/j.ijcard.2015.03.104; O'Neal WT, 2014, CLIN CARDIOL, V37, P750, DOI 10.1002/clc.22339; Ohsawa M, 2007, CIRC J, V71, P814, DOI 10.1253/circj.71.814; Okin PM, 2013, CIRC-ARRHYTHMIA ELEC, V6, P243, DOI 10.1161/CIRCEP.112.977777; Olsson LG, 2006, J AM COLL CARDIOL, V47, P1997, DOI 10.1016/j.jacc.2006.01.060; Oluleye OW, 2014, CIRC-HEART FAIL, V7, P960, DOI 10.1161/CIRCHEARTFAILURE.114.001523; Patsopoulos NA, 2008, INT J EPIDEMIOL, V37, P1148, DOI 10.1093/ije/dyn065; Pedersen OD, 2006, EUR HEART J, V27, P290, DOI 10.1093/eurheartj/ehi629; Pedersen OD, 2006, EUR HEART J, V27, P2866, DOI 10.1093/eurheartj/ehl359; Piccini JP, 2014, EUR HEART J, V35, P1873, DOI 10.1093/eurheartj/ehu083; Pilgrim T, 2013, EUROINTERVENTION, V8, P1061, DOI 10.4244/EIJV8I9A163; Pizzetti F, 2001, HEART, V86, P527, DOI 10.1136/heart.86.5.527; Potpara TS, 2013, EUR J HEART FAIL, V15, P415, DOI 10.1093/eurjhf/hft004; Rathore SS, 2000, CIRCULATION, V101, P969, DOI 10.1161/01.CIR.101.9.969; Raunso J, 2010, EUR J HEART FAIL, V12, P692, DOI 10.1093/eurjhf/hfq052; Rodgers H, 2004, STROKE, V35, P7, DOI 10.1161/01.STR.0000106914.60740.78; Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789; Ruel M, 2004, ANN THORAC SURG, V78, P77, DOI 10.1016/j.athoracsur.2003.12.058; Ruel M, 2006, CIRCULATION, V114, pI541, DOI 10.1161/CIRCULATIONAHA.105.000976; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Ruff CT, 2014, INT J CARDIOL, V170, P413, DOI 10.1016/j.ijcard.2013.11.030; Ruigomez A, 2009, INT J CARDIOL, V136, P186, DOI 10.1016/j.ijcard.2008.04.050; Saczynski JS, 2009, AM J CARDIOL, V104, P169, DOI 10.1016/j.amjcard.2009.03.011; Sakata K, 1997, AM J CARDIOL, V80, P1522, DOI 10.1016/S0002-9149(97)00746-7; Sampson UK, 2007, EUR HEART J, V28, P685, DOI 10.1093/eurheartj/ehl197; Santini M, 2011, J AM COLL CARDIOL, V57, P167, DOI 10.1016/j.jacc.2010.08.624; Saposnik G, 2011, CIRCULATION, V123, P739, DOI 10.1161/CIRCULATIONAHA.110.983353; Saxena A, 2013, INTERACT CARDIOV TH, V16, P488, DOI 10.1093/icvts/ivs538; Schnabel RB, 2013, EUR J HEART FAIL, V15, P843, DOI 10.1093/eurjhf/hft041; Simons LA, 1998, STROKE, V29, P1341, DOI 10.1161/01.STR.29.7.1341; Siontis KC, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001002; Smit MD, 2006, HEART RHYTHM, V3, P1397, DOI 10.1016/j.hrthm.2006.08.006; Soliman EZ, 2015, CIRCULATION, V131, P1843, DOI 10.1161/CIRCULATIONAHA.114.014145; Soliman EZ, 2014, JAMA INTERN MED, V174, pE107, DOI 10.1001/jamainternmed.2013.11912; Soliman EZ, 2011, STROKE, V42, P2950, DOI 10.1161/STROKEAHA.111.621367; Stein KM, 2009, EUROPACE, V11, P734, DOI 10.1093/europace/eup055; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Stortecky S, 2013, CIRC-CARDIOVASC INTE, V6, P77, DOI 10.1161/CIRCINTERVENTIONS.112.000124; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Suzuki S, 2012, AM J CARDIOL, V110, P678, DOI 10.1016/j.amjcard.2012.04.049; Thrall G, 2006, AM J MED, V119, DOI 10.1016/jamjmed.2005.10.057; Torres Marcia, 2008, Rev Port Cardiol, V27, P1407; Tveit A, 2011, CLIN CARDIOL, V34, P537, DOI 10.1002/clc.20939; van Wijk I, 2008, J NEUROL NEUROSUR PS, V79, P895, DOI 10.1136/jnnp.2007.133132; Wang TJ, 2013, ACTA OPHTHALMOL, V91, P226, DOI 10.1111/j.1755-3768.2011.02359.x; Wasmer K, 2015, INT J CARDIOL, V199, P223, DOI 10.1016/j.ijcard.2015.06.094; Watanabe H, 2009, AM HEART J, V158, P629, DOI 10.1016/j.ahj.2009.06.031; Wells G., NEWCASTLE OTTAWA SCA; Wetmore JB, 2013, ANN EPIDEMIOL, V23, P112, DOI 10.1016/j.annepidem.2012.12.011; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561; Wolf PA, 1998, ARCH INTERN MED, V158, P229, DOI 10.1001/archinte.158.3.229; Wong CK, 2000, AM HEART J, V140, P878, DOI 10.1067/mhj.2000.111108; Wyse DG, 2001, J INTERV CARD ELECTR, V5, P267, DOI 10.1023/A:1011460631369; Xu GL, 2007, CEREBROVASC DIS, V23, P117, DOI 10.1159/000097047	131	366	375	6	35	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2016	354								i4482	10.1136/bmj.i4482	http://dx.doi.org/10.1136/bmj.i4482			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV7FB	27599725	hybrid, Green Published			2022-12-28	WOS:000383100600002
J	Kolokolova, L				Kolokolova, Ludmilla			Cometary dust under the microscope	NATURE			English	Editorial Material									[Kolokolova, Ludmilla] Univ Maryland, Dept Astron, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Kolokolova, L (corresponding author), Univ Maryland, Dept Astron, College Pk, MD 20742 USA.	ludmilla@astro.umd.edu						A'Hearn MF, 2004, NATURE, V429, P818, DOI 10.1038/429818a; Bentley MS, 2016, NATURE, V537, P73, DOI 10.1038/nature19091; Dominik C, 2009, ASTR SOC P, V414, P494; GREENBERG JM, 1986, ASTEROIDS COMETS MET, V2, P221; Kearsley AT, 2008, METEORIT PLANET SCI, V43, P41, DOI 10.1111/j.1945-5100.2008.tb00609.x; Sandford S. A., 1987, Fundamentals of Cosmic Physics, V12, P1; Schulz R, 2015, NATURE, V518, P216, DOI 10.1038/nature14159; Skorov Y, 2012, ICARUS, V221, P1, DOI 10.1016/j.icarus.2012.01.012; Tilton G. R., 1988, METEORITES EARLY SOL, P259; Weiss-Wrana K., 1985, PROPERTIES INTERACTI, P223	10	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					37	38		10.1038/537037a	http://dx.doi.org/10.1038/537037a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU7XC	27582215				2022-12-28	WOS:000382426900029
J	McGilvray, A				McGilvray, Annabel			The brain-gain game	NATURE			English	Editorial Material																			0	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					S16	S17		10.1038/537S16a	http://dx.doi.org/10.1038/537S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU7XC	27580136	Bronze			2022-12-28	WOS:000382426900024
J	Edwards, N				Edwards, Nigel			THE BEST POLICY Why size matters at times of great change	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Edwards, Nigel] Nuffield Trust, London, England		Edwards, N (corresponding author), Nuffield Trust, London, England.	nigel.edwards@nuffieldtrust.org.uk						Rosen R, 2016, IS BIGGER BETTER LES	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2016	354								i4679	10.1136/bmj.i4679	http://dx.doi.org/10.1136/bmj.i4679			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AC	27576677				2022-12-28	WOS:000382792400009
J	Gerstoft, P; Bromirski, PD				Gerstoft, Peter; Bromirski, Peter D.			"Weather bomb" induced seismic signals	SCIENCE			English	Editorial Material							MICROSEISMS		[Gerstoft, Peter; Bromirski, Peter D.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Gerstoft, P (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	gerstoft@ucsd.edu	Gerstoft, Peter/B-2842-2009	Gerstoft, Peter/0000-0002-0471-062X				Ardhuin F, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC006952; Bromirski PD, 2013, J GEOPHYS RES-SOL EA, V118, P3610, DOI 10.1002/jgrb.50268; Gerstoft P, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027270; HASSELMANN K, 1963, REV GEOPHYS, V1, P177, DOI 10.1029/RG001i002p00177; HAUBRICH RA, 1969, REV GEOPHYS, V7, P539, DOI 10.1029/RG007i003p00539; Landes F., 2010, J GEOPHYS RES, DOI [10.1029/2009JB006918, DOI 10.1029/2009JB006918]; Liu QX, 2016, EARTH PLANET SC LETT, V449, P39, DOI 10.1016/j.epsl.2016.05.035; Nishida K, 2016, SCIENCE, V353, P919, DOI 10.1126/science.aaf7573; Nishida K, 2013, ANNU REV EARTH PL SC, V41, P719, DOI 10.1146/annurev-earth-050212-124020; Poli P, 2012, SCIENCE, V338, P1063, DOI 10.1126/science.1228194; SANDERS F, 1980, MON WEATHER REV, V108, P1589, DOI 10.1175/1520-0493(1980)108<1589:SDCOT>2.0.CO;2; Sufri O, 2014, EARTH PLANET SC LETT, V402, P324, DOI 10.1016/j.epsl.2013.10.015; Traer J, 2014, J GEOPHYS RES-SOL EA, V119, P3317, DOI 10.1002/2013JB010504; Zhang J, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044288	14	16	16	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					869	870		10.1126/science.aag1616	http://dx.doi.org/10.1126/science.aag1616			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU0CA	27563085				2022-12-28	WOS:000381867700018
J	Kupferschmidt, K				Kupferschmidt, Kai			EUROPE'S NEW HEPATITIS PROBLEM	SCIENCE			English	Editorial Material																			0	27	27	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					862	863		10.1126/science.353.6302.862	http://dx.doi.org/10.1126/science.353.6302.862			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU0CA	27563081				2022-12-28	WOS:000381867700014
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Staff hold the answer to our failing NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 26	2016	354								i4690	10.1136/bmj.i4690	http://dx.doi.org/10.1136/bmj.i4690			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AB	27566009	Bronze, Green Published			2022-12-28	WOS:000382792300010
J	Voulgarelis, M; Tsichlis, PN				Voulgarelis, Michael; Tsichlis, Philip N.			Proline hydroxylation linked to Akt activation	SCIENCE			English	Editorial Material							KINASE; CANCER; RESISTANCE; MECHANISM; HYPOXIA; TARGET		[Voulgarelis, Michael; Tsichlis, Philip N.] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA	Tufts Medical Center	Tsichlis, PN (corresponding author), Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA.	ptsichlis@tuftsmedicalcenter.org			NCI NIH HHS [R01 CA186729, R01 CA198117] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA198117, R01CA186729] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		An JB, 2005, MOL CELL BIOL, V25, P7546, DOI 10.1128/MCB.25.17.7546-7556.2005; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Chan TO, 2011, P NATL ACAD SCI USA, V108, pE1120, DOI 10.1073/pnas.1109879108; Clem BF, 2016, QJM-INT J MED, V109, P367, DOI 10.1093/qjmed/hcv181; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991; Guo JP, 2016, SCIENCE, V353, P929, DOI 10.1126/science.aad5755; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Polytarchou C, 2011, CANCER RES, V71, P4720, DOI 10.1158/0008-5472.CAN-11-0365; Risso G, 2015, BIOCHEM J, V468, P203, DOI 10.1042/BJ20150041; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Wang P, 2016, ONCOTARGET	15	4	4	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					870	871		10.1126/science.aah6254	http://dx.doi.org/10.1126/science.aah6254			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU0CA	27563086				2022-12-28	WOS:000381867700019
J	Benner, T				Benner, Tom			SINGAPORE	NATURE			English	Editorial Material																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					S28	S28		10.1038/536S28a	http://dx.doi.org/10.1038/536S28a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV0YL	27557161	Bronze			2022-12-28	WOS:000382646600008
J	Ge, PS; Runyon, BA				Ge, Phillip S.; Runyon, Bruce A.			Treatment of Patients with Cirrhosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SPONTANEOUS BACTERIAL PERITONITIS; FATTY LIVER-DISEASE; BETA-BLOCKERS; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; HEPATIC-ENCEPHALOPATHY; HEPATORENAL-SYNDROME; REFRACTORY ASCITES; RISK-FACTORS; ALL-CAUSE		[Ge, Phillip S.] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Los Angeles, CA 90095 USA; [Runyon, Bruce A.] Univ New Mexico, Div Gastroenterol & Hepatol, Albuquerque, NM 87131 USA; [Runyon, Bruce A.] Northern Navajo Med Ctr, Indian Hlth Serv, Shiprock, NM USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of New Mexico	Runyon, BA (corresponding author), Univ New Mexico, Div Gastroenterol & Hepatol, Albuquerque, NM 87131 USA.	bruceallenrunyonmd@gmail.com						Addolorato G, 2007, LANCET, V370, P1915, DOI 10.1016/S0140-6736(07)61814-5; Andersson KL, 2008, CLIN GASTROENTEROL H, V6, P1418, DOI 10.1016/j.cgh.2008.08.005; Angeli P, 1999, HEPATOLOGY, V29, P1690, DOI 10.1002/hep.510290629; Bader T, 2010, AM J GASTROENTEROL, V105, P978, DOI 10.1038/ajg.2010.102; Befeler AS, 2005, ARCH SURG-CHICAGO, V140, P650, DOI 10.1001/archsurg.140.7.650; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chang TS, 2015, AM J GASTROENTEROL, V110, P836, DOI 10.1038/ajg.2015.100; Charlton M, 2015, GASTROENTEROLOGY, V149, P649, DOI 10.1053/j.gastro.2015.05.010; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Cordoba J, 2004, J HEPATOL, V41, P38, DOI 10.1016/j.jhep.2004.03.023; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; de Franchis R, 2015, J HEPATOL, V63, P743, DOI 10.1016/j.jhep.2015.05.022; El Khoury AC, 2012, J VIRAL HEPATITIS, V19, P153, DOI 10.1111/j.1365-2893.2011.01563.x; Ellis EL, 2012, J HEPATOL, V56, P1171, DOI 10.1016/j.jhep.2011.09.024; Everhart JE, 1998, LIVER TRANSPLANT SUR, V4, P285, DOI 10.1002/lt.500040402; Fernandez J, 2006, GASTROENTEROLOGY, V131, P1049, DOI 10.1053/j.gastro.2006.07.010; Fleming KM, 2012, LIVER INT, V32, P79, DOI 10.1111/j.1478-3231.2011.02517.x; Foster T, 2011, AM J GASTROENTEROL, V106, P71, DOI 10.1038/ajg.2010.299; Francque S, 2010, EUR J GASTROEN HEPAT, V22, P1449, DOI 10.1097/MEG.0b013e32833f14a1; Ge PS, 2014, J HEPATOL, V60, P643, DOI 10.1016/j.jhep.2013.09.016; GINES P, 1987, HEPATOLOGY, V7, P122, DOI 10.1002/hep.1840070124; Gordon SC, 2014, CLIN GASTROENTEROL H, V12, P885, DOI 10.1016/j.cgh.2013.09.062; Grabau CM, 2004, HEPATOLOGY, V40, P484, DOI 10.1002/hep.20317; Groszmann RJ, 2005, NEW ENGL J MED, V353, P2254, DOI 10.1056/NEJMoa044456; Heimbach JK, 2013, AM J TRANSPLANT, V13, P363, DOI 10.1111/j.1600-6143.2012.04318.x; Hwang JH, 2014, GASTROINTEST ENDOSC, V80, P221, DOI 10.1016/j.gie.2013.07.023; Kim JJ, 2014, AM J GASTROENTEROL, V109, P1436, DOI 10.1038/ajg.2014.212; Krag A, 2010, GUT, V59, P105, DOI 10.1136/gut.2009.180570; Krag A, 2012, GUT, V61, P967, DOI 10.1136/gutjnl-2011-301348; LEBREC D, 1981, NEW ENGL J MED, V305, P1371, DOI 10.1056/NEJM198112033052302; Lin SY, 2007, HEPATOLOGY, V46, P1034, DOI 10.1002/hep.21784; LLACH J, 1988, GASTROENTEROLOGY, V94, P482, DOI 10.1016/0016-5085(88)90441-6; Mandorfer M, 2014, GASTROENTEROLOGY, V146, P1680, DOI 10.1053/j.gastro.2014.03.005; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Molloy R M, 1997, Liver Transpl Surg, V3, P177, DOI 10.1002/lt.500030212; Morando F, 2013, J HEPATOL, V59, P257, DOI 10.1016/j.jhep.2013.03.010; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Northup PG, 2005, ANN SURG, V242, P244, DOI 10.1097/01.sla.0000171327.29262.e0; Novella M, 1997, HEPATOLOGY, V25, P532, DOI 10.1002/hep.510250306; O'Leary JG, 2015, CLIN GASTROENTEROL H, V13, P753, DOI 10.1016/j.cgh.2014.07.060; PASCAL JP, 1987, NEW ENGL J MED, V317, P856, DOI 10.1056/NEJM198710013171403; Planas R, 2006, CLIN GASTROENTEROL H, V4, P1385, DOI 10.1016/j.cgh.2006.08.007; Plank LD, 2008, HEPATOLOGY, V48, P557, DOI 10.1002/hep.22367; Plauth M, 2006, CLIN NUTR, V25, P285, DOI 10.1016/j.clnu.2006.01.018; Poca M, 2012, CLIN GASTROENTEROL H, V10, P309, DOI 10.1016/j.cgh.2011.11.012; Rumack BH, 2002, J TOXICOL-CLIN TOXIC, V40, P3, DOI 10.1081/CLT-120002882; Runyon BA, 2013, HEPATOLOGY, V57, P1651, DOI 10.1002/hep.26359; Russo MW, 2014, HEPATOLOGY, V60, P679, DOI 10.1002/hep.27157; Saab S, 2009, AM J GASTROENTEROL, V104, P993, DOI 10.1038/ajg.2009.3; Serste T, 2015, LIVER INT, V35, P1974, DOI 10.1111/liv.12786; Serste T, 2011, J HEPATOL, V55, P794, DOI 10.1016/j.jhep.2011.01.034; Serste T, 2010, HEPATOLOGY, V52, P1017, DOI 10.1002/hep.23775; Singh V, 2012, J HEPATOL, V56, P348, DOI 10.1016/j.jhep.2011.04.027; Sort P, 1999, NEW ENGL J MED, V341, P403, DOI 10.1056/NEJM199908053410603; Spahr L, 2007, AM J GASTROENTEROL, V102, P744, DOI 10.1111/j.1572-0241.2006.01028.x; Teh SH, 2007, GASTROENTEROLOGY, V132, P1261, DOI 10.1053/j.gastro.2007.01.040; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Veldt BJ, 2002, J HEPATOL, V36, P93, DOI 10.1016/S0168-8278(01)00228-8; Volk ML, 2012, AM J GASTROENTEROL, V107, P247, DOI 10.1038/ajg.2011.314; White DL, 2012, CLIN GASTROENTEROL H, V10, P1342, DOI 10.1016/j.cgh.2012.10.001; Wong F, 2012, GUT, V61, P108, DOI 10.1136/gutjnl-2011-300157	61	162	169	2	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2016	375	8					767	777		10.1056/NEJMra1504367	http://dx.doi.org/10.1056/NEJMra1504367			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9ET	27557303				2022-12-28	WOS:000381799300014
J	Kessl, JJ; Kutluay, SB; Townsend, D; Rebensburg, S; Slaughter, A; Larue, RC; Shkriabai, N; Bakouche, N; Fuchs, JR; Bieniasz, PD; Kvaratskhelia, M				Kessl, Jacques J.; Kutluay, Sebla B.; Townsend, Dana; Rebensburg, Stephanie; Slaughter, Alison; Larue, Ross C.; Shkriabai, Nikoloz; Bakouche, Nordine; Fuchs, James R.; Bieniasz, Paul D.; Kvaratskhelia, Mamuka			HIV-1 Integrase Binds the Viral RNA Genome and Is Essential during Virion Morphogenesis	CELL			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NUCLEOCAPSID PROTEIN; REPLICATION; INHIBITOR; MULTIMERIZATION; MECHANISM; LEDGF/P75; REVEALS; CELLS; GENE	While an essential role of HIV-1 integrase (IN) for integration of viral cDNA into human chromosome is established, studies with IN mutants and allosteric IN inhibitors (ALLINIs) have suggested that IN can also influence viral particle maturation. However, it has remained enigmatic as to how IN contributes to virion morphogenesis. Here, we demonstrate that IN directly binds the viral RNA genome in virions. These interactions have specificity, as IN exhibits distinct preference for select viral RNA structural elements. We show that IN substitutions that selectively impair its binding to viral RNA result in eccentric, non-infectious virions without affecting nucleocapsid-RNA interactions. Likewise, ALLINIs impair IN binding to viral RNA in virions of wildtype, but not escape mutant, virus. These results reveal an unexpected biological role of IN binding to the viral RNA genome during virion morphogenesis and elucidate the mode of action of ALLINIs.	[Kessl, Jacques J.; Rebensburg, Stephanie; Slaughter, Alison; Larue, Ross C.; Shkriabai, Nikoloz; Bakouche, Nordine; Kvaratskhelia, Mamuka] Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Kessl, Jacques J.; Rebensburg, Stephanie; Slaughter, Alison; Larue, Ross C.; Shkriabai, Nikoloz; Bakouche, Nordine; Fuchs, James R.; Kvaratskhelia, Mamuka] Ohio State Univ, Coll Pharm, 500 W 12Th Ave, Columbus, OH 43210 USA; [Kutluay, Sebla B.; Townsend, Dana] Washington Univ, Dept Mol Microbiol, Sch Med, St Louis, MO 63110 USA; [Kutluay, Sebla B.; Bieniasz, Paul D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, Lab Retrovirol, New York, NY 10016 USA; [Bieniasz, Paul D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, Howard Hughes Med Inst, New York, NY 10016 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Washington University (WUSTL); Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Kvaratskhelia, M (corresponding author), Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA.; Kvaratskhelia, M (corresponding author), Ohio State Univ, Coll Pharm, 500 W 12Th Ave, Columbus, OH 43210 USA.	kvaratskhelia.1@osu.edu	Kessl, Jacques/AAV-2526-2021	Fuchs, James/0000-0002-8743-6389; Larue, Ross/0000-0002-0170-7345	NIH [R01AI062520, P50GM103368, R01AI110310, R01AI116258, P50GM103297, R21AI110270, R01AI050111]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050111, K22AI116258, R01AI110310, R21AI110270, R01AI062520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM103297, P50GM103368] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R01AI062520, P50GM103368, and R01AI110310 (to M.K.), R01AI116258 and P50GM103297 (to S.B.K.), R01AI110310 (to J.R.F.), R21AI110270 (to J.J.K), and P50GM103297 and R01AI050111 (to P.D.B.).	ALLEN P, 1995, VIROLOGY, V209, P327, DOI 10.1006/viro.1995.1264; Andersen ES, 2004, J BIOL CHEM, V279, P22243, DOI 10.1074/jbc.M314326200; Athanassiou Z, 2007, BIOCHEMISTRY-US, V46, P741, DOI 10.1021/bi0619371; Balakrishnan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074163; Bouyac-Bertoia M, 2001, MOL CELL, V7, P1025, DOI 10.1016/S1097-2765(01)00240-4; Bukovsky A, 1996, J VIROL, V70, P6820, DOI 10.1128/JVI.70.10.6820-6825.1996; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Cherepanov P, 2011, CURR OPIN STRUC BIOL, V21, P249, DOI 10.1016/j.sbi.2010.12.005; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; Das AT, 2007, J VIROL, V81, P7742, DOI 10.1128/JVI.00392-07; Debyser Z, 2015, TRENDS BIOCHEM SCI, V40, P108, DOI 10.1016/j.tibs.2014.12.001; Deprez E, 2000, BIOCHEMISTRY-US, V39, P9275, DOI 10.1021/bi000397j; Desimmie BA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-57; Engelman A, 1999, ADV VIRUS RES, V52, P411, DOI 10.1016/S0065-3527(08)60309-7; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; Fadel HJ, 2014, J VIROL, V88, P9704, DOI 10.1128/JVI.01397-14; Fader LD, 2014, ACS MED CHEM LETT, V5, P422, DOI 10.1021/ml500002n; Feng L, 2013, J BIOL CHEM, V288, P15813, DOI 10.1074/jbc.M112.443390; Fontana J, 2015, J VIROL, V89, P9765, DOI 10.1128/JVI.01522-15; Gupta K, 2014, J BIOL CHEM, V289, P20477, DOI 10.1074/jbc.M114.551119; Jurado KA, 2013, P NATL ACAD SCI USA, V110, P8690, DOI 10.1073/pnas.1300703110; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; Kessl JJ, 2011, NUCLEIC ACIDS RES, V39, P9009, DOI 10.1093/nar/gkr581; Kotova S, 2010, J MOL BIOL, V399, P491, DOI 10.1016/j.jmb.2010.04.026; Kulkosky J, 1999, VIROLOGY, V255, P77, DOI 10.1006/viro.1998.9544; Kutluay SB, 2014, CELL, V159, P1096, DOI 10.1016/j.cell.2014.09.057; Kvaratskhelia Mamuka, 2008, V488, P213, DOI 10.1007/978-1-60327-475-3_15; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Rouzic E, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-144; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Mckee CJ, 2008, J BIOL CHEM, V283, P31802, DOI 10.1074/jbc.M805843200; Mori M, 2015, CURR TOP MICROBIOL, V389, P53, DOI 10.1007/82_2015_433; Munk C, 2002, P NATL ACAD SCI USA, V99, P13843, DOI 10.1073/pnas.212400099; Nocera TM, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/49/495704; Rihn SJ, 2015, J VIROL, V89, P552, DOI 10.1128/JVI.02451-14; Sharma A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004171; Shkriabai N, 2014, J BIOL CHEM, V289, P26430, DOI 10.1074/jbc.M114.589572; Slaughter A, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0100-1; Tsuruyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053572; van Bel N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103552; Wachter A, 2014, TRENDS GENET, V30, P172, DOI 10.1016/j.tig.2014.03.001; Wang H, 2012, NUCLEIC ACIDS RES, V40, P11518, DOI 10.1093/nar/gks913; Wang Y, 2007, ULTRAMICROSCOPY, V107, P293, DOI 10.1016/j.ultramic.2006.08.004	47	72	72	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1257	+		10.1016/j.cell.2016.07.044	http://dx.doi.org/10.1016/j.cell.2016.07.044			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27565348	Green Accepted, Bronze			2022-12-28	WOS:000382259500021
J	Kaufman, AM; Tai, ME; Lukin, A; Rispoli, M; Schittko, R; Preiss, PM; Greiner, M				Kaufman, Adam M.; Tai, M. Eric; Lukin, Alexander; Rispoli, Matthew; Schittko, Robert; Preiss, Philipp M.; Greiner, Markus			Quantum thermalization through entanglement in an isolated many-body system	SCIENCE			English	Article							STATISTICAL-MECHANICS; MOTT INSULATOR; EQUILIBRIUM; ENTROPY; LOCALIZATION; RELAXATION	Statistical mechanics relies on the maximization of entropy in a system at thermal equilibrium. However, an isolated quantum many-body system initialized in a pure state remains pure during Schrodinger evolution, and in this sense it has static, zero entropy. We experimentally studied the emergence of statistical mechanics in a quantum state and observed the fundamental role of quantum entanglement in facilitating this emergence. Microscopy of an evolving quantum system indicates that the full quantum state remains pure, whereas thermalization occurs on a local scale. We directly measured entanglement entropy, which assumes the role of the thermal entropy in thermalization. The entanglement creates local entropy that validates the use of statistical physics for local observables. Our measurements are consistent with the eigenstate thermalization hypothesis.	[Kaufman, Adam M.; Tai, M. Eric; Lukin, Alexander; Rispoli, Matthew; Schittko, Robert; Preiss, Philipp M.; Greiner, Markus] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University	Greiner, M (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	greiner@physics.harvard.edu			NSF; Gordon and Betty Moore Foundation's Emergent Phenomena in Quantum Systems initiative [GBMF3795]; Multidisciplinary University Research Initiative of the Air Force Office of Scientific Research; Army Research Office	NSF(National Science Foundation (NSF)); Gordon and Betty Moore Foundation's Emergent Phenomena in Quantum Systems initiative; Multidisciplinary University Research Initiative of the Air Force Office of Scientific Research; Army Research Office	We acknowledge helpful discussions with S. Choi, S. Dickerson, J. Eisert, M. Foss-Feig, D. Greif, M. Headrick, D. Huse, M. Olshanii, C. Regal, J. Schachenmayer, and M. Wall. We are supported by grants from the NSF, including an NSF Graduate Research Fellowship (to M.R.); the Gordon and Betty Moore Foundation's Emergent Phenomena in Quantum Systems initiative (grant GBMF3795); and the Multidisciplinary University Research Initiative programs of the Air Force Office of Scientific Research and the Army Research Office.	Amico L, 2008, REV MOD PHYS, V80, P517, DOI 10.1103/RevModPhys.80.517; [Anonymous], 1963, STAT MECH; Bakr WS, 2010, SCIENCE, V329, P547, DOI 10.1126/science.1192368; Bardarson JH, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.017202; Calabrese P, 2004, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2004/06/P06002; Cheneau M, 2012, NATURE, V481, P484, DOI 10.1038/nature10748; Daley AJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.020505; Deutsch JM, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.042135; DEUTSCH JM, 1991, PHYS REV A, V43, P2046, DOI 10.1103/PhysRevA.43.2046; Eisert J, 2015, NAT PHYS, V11, P124, DOI [10.1038/nphys3215, 10.1038/NPHYS3215]; Eisert J, 2010, REV MOD PHYS, V82, P277, DOI 10.1103/RevModPhys.82.277; Geiger R, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/5/053034; Grover T, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.042308; Hazzard KRA, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.063622; Horodecki R, 1996, PHYS REV A, V54, P1838, DOI 10.1103/PhysRevA.54.1838; Horodecki R, 2009, REV MOD PHYS, V81, P865, DOI 10.1103/RevModPhys.81.865; Hyungwon K., 2014, THESIS; Islam R, 2015, NATURE, V528, P77, DOI 10.1038/nature15750; JENSEN RV, 1985, PHYS REV LETT, V54, P1879, DOI 10.1103/PhysRevLett.54.1879; Kinoshita T, 2006, NATURE, V440, P900, DOI 10.1038/nature04693; Langen T, 2013, NAT PHYS, V9, P639, DOI 10.1038/NPHYS2739; Langen T, 2015, SCIENCE, V348, P207, DOI 10.1126/science.1257026; Ma S. K., 1985, STAT MECH; Nandkishore R, 2015, ANNU REV CONDEN MA P, V6, P15, DOI 10.1146/annurev-conmatphys-031214-014726; PAGE DN, 1993, PHYS REV LETT, V71, P1291, DOI 10.1103/PhysRevLett.71.1291; Palmer RN, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.042335; Richerme P, 2014, NATURE, V511, P198, DOI 10.1038/nature13450; Rigol M, 2008, NATURE, V452, P854, DOI 10.1038/nature06838; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; Sakurai JJ., 1993, MODERN QUANTUM MECH; Santos LF, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.010102; Schachenmayer J, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.031015; Schreiber M, 2015, SCIENCE, V349, P842, DOI 10.1126/science.aaa7432; Serbyn M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.260601; Sherson JF, 2010, NATURE, V467, P68, DOI 10.1038/nature09378; SREDNICKI M, 1994, PHYS REV E, V50, P888, DOI 10.1103/PhysRevE.50.888; Trotzky S, 2012, NAT PHYS, V8, P325, DOI [10.1038/nphys2232, 10.1038/NPHYS2232]; Wolf MM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.070502; Yurovsky VA, 2011, J PHYS CHEM B, V115, P5340, DOI 10.1021/jp109388x; Znidaric M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.064426; Zupancic P, 2016, OPT EXPRESS, V24, P13881, DOI 10.1364/OE.24.013881	42	591	592	3	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					794	800		10.1126/science.aaf6725	http://dx.doi.org/10.1126/science.aaf6725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZE	27540168	Green Submitted			2022-12-28	WOS:000381561400039
J	King, GE; Herman, F; Guralnik, B				King, Georgina E.; Herman, Frederic; Guralnik, Benny			Northward migration of the eastern Himalayan syntaxis revealed by OSL thermochronometry	SCIENCE			English	Article							NAMCHE-BARWA SYNTAXIS; RIVER INCISION; TSANGPO GORGE; NANGA-PARBAT; EXHUMATION; EROSION; EVOLUTION; CLIMATE; CONSTRAINTS; KINEMATICS	Erosion influences the dynamical evolution of mountains. However, evidence for the impact of surface processes on tectonics mostly relies on the circumstantial coincidence of rugged topography, high stream power, erosion, and rock uplift. Using the optically stimulated luminescence (OSL) thermochronometry technique, we quantified the spatial and temporal exhumation of the eastern Himalayan syntaxis. We found increasing exhumation rates within the past million years at the northeast end of the Namche Barwa-Gyala Peri dome. These observations imply headward propagation of erosion in the Parlung River, suggesting that the locus of high exhumation has migrated northward. Although surface processes influence exhumation rates, they do not necessarily engage in a feedback that sets the location of tectonic deformation.	[King, Georgina E.; Herman, Frederic] Univ Lausanne, Inst Earth Surface Dynam, CH-1015 Lausanne, Switzerland; [King, Georgina E.] Univ Cologne, Inst Geog, D-50923 Cologne, Germany; [Guralnik, Benny] Wageningen Univ, Netherlands Ctr Luminescence Dating, POB 47, NL-6700 AA Wageningen, Netherlands; [Guralnik, Benny] Wageningen Univ, Soil Geog & Landscape Grp, POB 47, NL-6700 AA Wageningen, Netherlands	University of Lausanne; University of Cologne; Wageningen University & Research; Wageningen University & Research	King, GE (corresponding author), Univ Lausanne, Inst Earth Surface Dynam, CH-1015 Lausanne, Switzerland.; King, GE (corresponding author), Univ Cologne, Inst Geog, D-50923 Cologne, Germany.	georgina.king@gmail.com	; King, Georgina/N-1183-2015	Guralnik, Benny/0000-0003-3095-3868; Herman, Frederic/0000-0002-7237-4656; King, Georgina/0000-0003-1059-8192	Swiss National Fund [PP00P2-38956, 200021-127127]; Netherlands Organisation for Scientific Research (NWO) [863.15.026]	Swiss National Fund(Swiss National Science Foundation (SNSF)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was funded by Swiss National Fund grants PP00P2-38956 and 200021-127127 and Netherlands Organisation for Scientific Research (NWO) Veni grant 863.15.026. R. Lambert, P. Valla, S. Willett, and O. Korup are thanked for insightful discussions. J.-P. Burg is thanked for providing samples and feedback. All of the raw data are available in the supplementary materials. The comments of three anonymous reviewers substantially improved the manuscript.	[Anonymous], 2001, GSA TODAY, DOI [10.1130/1052-5173(2001)0112.0.CO;2, DOI 10.1130/1052-5173(2001)011<0004:EHGATG>2.0.C0;2]; Beaumont C, 2001, NATURE, V414, P738, DOI 10.1038/414738a; Bendick R, 2014, GEOPHYS RES LETT, V41, P5861, DOI 10.1002/2014GL061026; Berger AL, 2008, EARTH PLANET SC LETT, V270, P13, DOI 10.1016/j.epsl.2008.02.034; Bracciali L, 2015, EARTH PLANET SC LETT, V415, P25, DOI 10.1016/j.epsl.2015.01.022; Braun J., 2006, QUANTITATIVE THERMOC; Brozovic N, 1997, SCIENCE, V276, P571, DOI 10.1126/science.276.5312.571; Burg JP, 1998, J ASIAN EARTH SCI, V16, P239, DOI 10.1016/S0743-9547(98)00002-6; Burg JP, 1999, INT J EARTH SCI, V88, P190, DOI 10.1007/s005310050259; Burg JP, 1997, TERRA NOVA, V9, P53, DOI 10.1111/j.1365-3121.1997.tb00001.x; Castelltort S, 2012, NAT GEOSCI, V5, P744, DOI [10.1038/ngeo1582, 10.1038/NGEO1582]; Champagnac JD, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008348; Clark MK, 2004, TECTONICS, V23, DOI 10.1029/2002TC001402; Dadson SJ, 2003, NATURE, V426, P648, DOI 10.1038/nature02150; Dahlen F.A., 1988, GEOL SOC AM SPEC PAP, P161, DOI DOI 10.1130/SPE218-P161; Egholm DL, 2009, NATURE, V460, P884, DOI 10.1038/nature08263; Enkelmann E, 2011, EARTH PLANET SC LETT, V307, P323, DOI 10.1016/j.epsl.2011.05.004; Finnegan NJ, 2008, GEOL SOC AM BULL, V120, P142, DOI 10.1130/B26224.1; Gupta TD, 2015, TECTONOPHYSICS, V655, P15, DOI 10.1016/j.tecto.2015.04.017; Guralnik B, 2015, EARTH PLANET SC LETT, V423, P232, DOI 10.1016/j.epsl.2015.04.032; Hallet B, 2001, J GEOPHYS RES-SOL EA, V106, P13697, DOI 10.1029/2000JB900335; Herman F, 2013, NATURE, V504, P423, DOI 10.1038/nature12877; King GE, 2016, QUAT GEOCHRONOL, V33, P76, DOI 10.1016/j.quageo.2016.01.004; Koons PO, 2003, GEOLOGY, V31, P3, DOI 10.1130/0091-7613(2003)031<0003:IOEOTS>2.0.CO;2; Koons PO, 2002, AM J SCI, V302, P749, DOI 10.2475/ajs.302.9.749; Korup O, 2008, NATURE, V455, P786, DOI 10.1038/nature07322; Lang KA, 2014, EARTH PLANET SC LETT, V397, P145, DOI 10.1016/j.epsl.2014.04.026; Lei Y. L., 2008, QUAT SCI, P584; Molnar P, 2004, ANNU REV EARTH PL SC, V32, P67, DOI 10.1146/annurev.earth.32.091003.143456; Owen LA, 2008, J QUATERNARY SCI, V23, P513, DOI 10.1002/jqs.1203; Schmidt JL, 2015, EARTH PLANET SC LETT, V430, P448, DOI 10.1016/j.epsl.2015.08.041; SEEBER L, 1983, TECTONOPHYSICS, V92, P335, DOI 10.1016/0040-1951(83)90201-9; Seward D, 2008, TECTONOPHYSICS, V451, P282, DOI 10.1016/j.tecto.2007.11.057; Thiede RC, 2004, EARTH PLANET SC LETT, V222, P791, DOI 10.1016/j.epsl.2004.03.015; Tu JY, 2015, J ASIAN EARTH SCI, V105, P223, DOI 10.1016/j.jseaes.2015.03.035; Wang P, 2015, SCIENCE, V349; Wang P, 2014, SCIENCE, V346, P978, DOI 10.1126/science.1259041; Whipp DM, 2014, J GEOPHYS RES-SOL EA, V119, P5077, DOI 10.1002/2013JB010929; Whipple KX, 2009, NAT GEOSCI, V2, P97, DOI 10.1038/ngeo413; Whipple KX, 1999, J GEOPHYS RES-SOL EA, V104, P17661, DOI 10.1029/1999JB900120; Willett SD, 2014, SCIENCE, V343, P1117, DOI 10.1126/science.1248765; Yu XJ, 2011, CHINESE SCI BULL, V56, P1123, DOI 10.1007/s11434-011-4419-x; Zeitler PK, 2015, SCIENCE, V349; Zeitler PK, 2014, GEOL SOC AM SPEC PAP, V507, P23, DOI 10.1130/2014.2507(02)	44	63	73	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					800	804		10.1126/science.aaf2637	http://dx.doi.org/10.1126/science.aaf2637			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZE	27540169				2022-12-28	WOS:000381561400040
J	Sandhu, AT; Ollendorf, DA; Chapman, RH; Pearson, SD; Heidenreich, PA				Sandhu, Alexander T.; Ollendorf, Daniel A.; Chapman, Richard H.; Pearson, Steven D.; Heidenreich, Paul A.			Cost-Effectiveness of Sacubitril-Valsartan in Patients With Heart Failure With Reduced Ejection Fraction	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ASSOCIATION TASK-FORCE; NEPRILYSIN INHIBITION; ANGIOTENSIN-RECEPTOR; RESOURCE USE; PRACTICE GUIDELINES; AMERICAN-COLLEGE; TERM MORTALITY; UNITED-STATES; PARADIGM-HF	Background: Sacubitril-valsartan therapy reduces cardiovascular mortality compared with enalapril therapy in patients with heart failure with reduced ejection fraction. Objective: To evaluate the cost-effectiveness of sacubitril-valsartan versus angiotensin-converting enzyme inhibitor therapy in patients with chronic heart failure. Design: Markov decision model. Data Sources: Clinical trials, observational analyses, reimbursement data from the Centers for Medicare & Medicaid Services, drug pricing databases, and Centers for Disease Control and Prevention life tables. Target Population: Patients at an average age of 64 years, New York Heart Association (NYHA) class II to IV heart failure, and left ventricular ejection fraction of 0.40 or less. Time Horizon: Lifetime. Perspective: Societal. Intervention: Treatment with sacubitril-valsartan or lisinopril. Outcome Measures: Life-years, quality-adjusted life-years (QALYs), costs, heart failure hospitalizations, and incremental cost-effectiveness ratios. Results of Base-Case Analysis: The sacubitril-valsartan group experienced 0.08 fewer heart failure hospitalization, 0.69 additional life-year, 0.62 additional QALY, and $29 203 in incremental costs, equating to a cost per QALY gained of $47 053. The cost per QALY gained was $44 531 in patients with NYHA class II heart failure and $58 194 in those with class III or IV heart failure. Results of Sensitivity Analysis: Sacubitril-valsartan treatment was most sensitive to the duration of improved outcomes, with a cost per QALY gained of $120 623 if the duration was limited to the length of the trial (median, 27 months). No variations in other parameters caused the cost to exceed $100 000 per QALY gained. Limitation: The benefit of sacubitril-valsartan is based on a single clinical trial. Conclusion: Treatment with sacubitril-valsartan provides reasonable value in reducing cardiovascular mortality and morbidity in patients with NYHA class II to IV heart failure.	Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Sandhu, Alexander T.] Stanford Univ, Ctr Primary Care & Outcomes Res, 117 Encina Commons, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Ollendorf, Daniel A.; Chapman, Richard H.; Pearson, Steven D.] Inst Clin & Econ Review, Two Liberty Sq,9th Floor, Boston, MA 02109 USA; [Heidenreich, Paul A.] Palo Alto VA Med Ctr, 3801 Miranda Ave, Palo Alto, CA 94304 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Sandhu, AT (corresponding author), Stanford Univ, Ctr Primary Care & Outcomes Res, 117 Encina Commons, Stanford, CA 94305 USA.	ats114@stanford.edu	Heidenreich, Paul/AAU-6864-2021	Heidenreich, Paul/0000-0001-7730-8490	U.S. Department of Veterans Affairs; Institute for Clinical and Economic Review	U.S. Department of Veterans Affairs(US Department of Veterans Affairs); Institute for Clinical and Economic Review	This study was funded in part by the U.S. Department of Veterans Affairs (Drs. Sandhu and Heidenreich) and the Institute for Clinical and Economic Review (Drs. Ollendorf, Chapman, and Pearson).	Agency for Healthcare Research and Quality, 2016, NAT INP SAMPL NAT ST; Ahmed A, 2007, AM J CARDIOL, V99, P549, DOI 10.1016/j.amjcard.2006.08.065; Anderson JL, 2014, J AM COLL CARDIOL, V63, P2304, DOI 10.1016/j.jacc.2014.03.016; [Anonymous], 2015, RED BOOK ONL; Arias Elizabeth, 2013, Natl Vital Stat Rep, V61, P1; Braunwald E, 2015, J AM COLL CARDIOL, V65, P1029, DOI 10.1016/j.jacc.2015.01.033; Califf RM, 2015, EUR HEART J, V36, P410, DOI 10.1093/eurheartj/ehu501; Caro JJ, 2012, MED DECIS MAKING, V32, P667, DOI 10.1177/0272989X12454577; Center for Drug Evaluation and Research, 2014, MED REV APPL REV; Centers for Medicare and Medicaid Services, 2016, PHYS FEE SCHEDULE; Centers for Medicare & Medicaid Services, 2013, HOSP OUTP PROSP PAYM; Centers for Medicare & Medicaid Services, 2014, FY 2015 HOSP INP PPS; Claggett B, 2015, NEW ENGL J MED, V373, P2289, DOI 10.1056/NEJMc1509753; Congressional Budget Office, 2007, PRESCR DRUG PRIC PRI; Desai AS, 2015, EUR HEART J, V36, P1990, DOI 10.1093/eurheartj/ehv186; Dunlay SM, 2011, CIRC-CARDIOVASC QUAL, V4, P68, DOI 10.1161/CIRCOUTCOMES.110.957225; Feldman AM, 2016, JAMA-J AM MED ASSOC, V315, P25, DOI 10.1001/jama.2015.17632; Gaziano TA, 2016, JAMA CARDIOL, V1, P666, DOI 10.1001/jamacardio.2016.1747; Gohler A, 2009, VALUE HEALTH, V12, P185, DOI 10.1111/j.1524-4733.2008.00425.x; Gustafsson F, 2004, EUR HEART J, V25, P1711, DOI 10.1016/j.ehj.2004.07.007; Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a; Heran BS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008167.pub3; Jaagosild P, 1998, ARCH INTERN MED, V158, P1081, DOI 10.1001/archinte.158.10.1081; Jhund PS, 2015, EUR HEART J, V36, P2576, DOI 10.1093/eurheartj/ehv330; Kaplinsky E, 2015, J GERIATR CARDIOL, V12, P470, DOI 10.11909/j.issn.1671-5411.2015.05.010; King JB, 2016, JACC-HEART FAIL, V4, P392, DOI 10.1016/j.jchf.2016.02.007; King JB, 2015, PHARMACOTHERAPY, V35, P823, DOI 10.1002/phar.1629; KJEKSHUS J, 1992, AM J CARDIOL, V69, P103, DOI 10.1016/0002-9149(92)90683-P; Liao L, 2007, AM HEART J, V153, P245, DOI 10.1016/j.ahj.2006.11.010; Lillyblad MP, 2015, ANN PHARMACOTHER, V49, P1237, DOI 10.1177/1060028015593093; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Nanas JN, 2000, J AM COLL CARDIOL, V36, P2090, DOI 10.1016/S0735-1097(00)01025-1; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Ollendorf DA, 2015, CARDIOMEMS HF SYSTEM; Ollendorf DA, 2016, JAMA INTERN MED, V176, P249, DOI 10.1001/jamainternmed.2015.7661; Packer M, 1999, CIRCULATION, V100, P2312, DOI 10.1161/01.CIR.100.23.2312; Packer M, 2016, JACC-HEART FAIL, V4, P403, DOI 10.1016/j.jchf.2016.02.012; Packer M, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.116.002837; Packer M, 2015, CIRCULATION, V131, P54, DOI 10.1161/CIRCULATIONAHA.114.013748; Poole-Wilson PA, 2003, LANCET, V362, P7, DOI 10.1016/S0140-6736(03)13800-7; Reed SD, 2012, AM J CARDIOL, V110, P1150, DOI 10.1016/j.amjcard.2012.05.059; Rogers JK, 2012, CIRCULATION, V126, P2317, DOI 10.1161/CIRCULATIONAHA.112.110536; Sayer G, 2014, CARDIOL CLIN, V32, P21, DOI 10.1016/j.ccl.2013.09.002; Shah MR, 2016, ANN INTERN MED, V164, P125, DOI 10.7326/M15-2587; Solomon SD, 2016, J AM COLL CARDIOL, V67, P1349, DOI 10.1016/S0735-1097(16)31350-X; Stout NK, 2009, PHARMACOECONOMICS, V27, P533, DOI 10.2165/11314830-000000000-00000; Swedberg K, 1999, EUR HEART J, V20, P136, DOI 10.1053/euhj.1998.1098; Swedberg K., 2015, EUR SOC CARD WORLD C; Tu K, 2005, AM J CARDIOL, V95, P283, DOI 10.1016/j.amjcard.2004.08.097; US Department of Labor, 2016, CONS PRIC IND; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Ziaeian B, 2015, AM HEART J, V169, P282, DOI 10.1016/j.ahj.2014.11.007	54	49	50	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	2016	165	10					681	+		10.7326/M16-0057	http://dx.doi.org/10.7326/M16-0057			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC2RB	27571284				2022-12-28	WOS:000387970500012
J	Brinkman, SA; Johnson, SE; Codde, JP; Hart, MB; Straton, JA; Mittinty, MN; Silburn, SR				Brinkman, Sally A.; Johnson, Sarah E.; Codde, James P.; Hart, Michael B.; Straton, Judith A.; Mittinty, Murthy N.; Silburn, Sven R.			Efficacy of infant simulator programmes to prevent teenage pregnancy: a school-based cluster randomised controlled trial in Western Australia	LANCET			English	Article							CONSORT STATEMENT; EXTENSION	Background Infant simulator-based programmes, which aim to prevent teenage pregnancy, are used in high-income as well as low-income and middle-income countries but, despite growing popularity, no published evidence exists of their long-term effect. The aim of this trial was to investigate the effect of such a programme, the Virtual Infant Parenting (VIP) programme, on pregnancy outcomes of birth and induced abortion in Australia. Methods In this school-based pragmatic cluster randomised controlled trial, eligible schools in Perth, Western Australia, were enrolled and randomised 1:1 to the intervention and control groups. Randomisation using a table of random numbers without blocking, stratification, or matching was done by a researcher who was masked to the identity of the schools. Between 2003 and 2006, the VIP programme was administered to girls aged 13-15 years in the intervention schools, while girls of the same age in the control schools received the standard health education curriculum. Participants were followed until they reached 20 years of age via data linkage to hospital medical and abortion clinic records. The primary endpoint was the occurrence of pregnancy during the teenage years. Binomial and Cox proportional hazards regression was used to test for differences in pregnancy rates between study groups. This study is registered as an international randomised controlled trial, number ISRCTN24952438. Findings 57 (86%) of 66 eligible schools were enrolled into the trial and randomly assigned 1:1 to the intervention (28 schools) or the control group (29 schools). Then, between Feb 1, 2003, and May 31, 2006, 1267 girls in the intervention schools received the VIP programme while 1567 girls in the control schools received the standard health education curriculum. Compared with girls in the control group, a higher proportion of girls in the intervention group recorded at least one birth (97 [8%] of 1267 in the intervention group vs 67 [4%] of 1567 in the control group) or at least one abortion as the first pregnancy event (113 [9%] vs 101 [6%]). After adjustment for potential confounders, the intervention group had a higher overall pregnancy risk than the control group (relative risk 1.36 [95% CI 1.10-1.67], p=0.003). Similar results were obtained with the use of proportional hazard models (hazard ratio 1.35 [95% CI 1.10-1.67], p=0.016). Interpretation The infant simulator-based VIP programme did not achieve its aim of reducing teenage pregnancy. Girls in the intervention group were more likely to experience a birth or an induced abortion than those in the control group before they reached 20 years of age.	[Brinkman, Sally A.] Univ Western Australia, Telethon Kids Inst, Level 8,31 Flinders St, Adelaide, SA 5000, Australia; [Brinkman, Sally A.; Mittinty, Murthy N.] Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia; [Johnson, Sarah E.; Straton, Judith A.] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia; [Codde, James P.] Univ Notre Dame, Fremantle, WA, Australia; [Hart, Michael B.] Royal Australasian Coll Phys, Social Determinants Hlth Alliance, Sydney, NSW, Australia; [Silburn, Sven R.] Menzies Sch Hlth Res, Casuarina, NT, Australia	Telethon Kids Institute; University of Western Australia; University of Adelaide; Telethon Kids Institute; University of Western Australia; University of Notre Dame Australia; Charles Darwin University; Menzies School of Health Research	Brinkman, SA (corresponding author), Univ Western Australia, Telethon Kids Inst, Level 8,31 Flinders St, Adelaide, SA 5000, Australia.	sally.brinkman@telethonkids.org.au	Codde, James P/N-8517-2015; Brinkman, Sally/GZL-4613-2022; Johnson, Sarah/AHB-5296-2022	Codde, James P/0000-0001-7924-1357; Brinkman, Sally/0000-0001-7538-4844; Johnson, Sarah/0000-0003-4089-2376	Western Australian Health Promotion Foundation (Healthway), Lotteries WA; Western Australian Department of Education and Training; Western Australian Department of Health	Western Australian Health Promotion Foundation (Healthway), Lotteries WA; Western Australian Department of Education and Training; Western Australian Department of Health	Western Australian Health Promotion Foundation (Healthway), Lotteries WA, the Western Australian Department of Education and Training, and the Western Australian Department of Health.	[Anonymous], 2011, LIVE IT LEARN IT EXP; Australian Bureau of Statistics, 2011, MIGR AUSTR 2009 10; Australian Bureau of Statistics, 2008, SOC IND AR SEIFA 200; Bennett SE, 2005, J ADOLESCENT HEALTH, V36, P72, DOI 10.1016/j.jadohealth.2003.11.097; Brinkman SA, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-100; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Chavaudra N, 2007, J FAM PLAN REPROD H, V33, P35, DOI 10.1783/147118907779399611; Cochrane K, 1997, NEST ENHANCEMENT PIL; Fogg BJ, 2009, HUM FACTORS ERGON, P109; Goesling B, 2014, J ADOLESCENT HEALTH, V54, P499, DOI 10.1016/j.jadohealth.2013.12.004; Hart MB, 2000, INT J MENT HEALTH PR, V2, P27; Herrman JW, 2011, JOGNN-J OBST GYN NEO, V40, P322, DOI 10.1111/j.1552-6909.2011.01248.x; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Joyce A, 2011, STAT SERIES GOVT W A, V90; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kralewski J, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.3.e30; Lavin C, 2012, CURR OPIN PEDIATR, V24, P462, DOI 10.1097/MOP.0b013e3283555bee; McCormack Brandi, 2005, Aust Fam Physician, V34, P17; Oringanje C, 2016, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD005215.PUB3; SCHOENFELD DA, 1982, BIOMETRICS, V38, P163, DOI 10.2307/2530299; Straton J, 2006, STAT SERIES DEPT HLT, V80; Swann C, 2003, TEENAGE PREGNANCY PA; UNICEF, 2001, LEAGUE TABLE TEENAGE; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	24	27	27	1	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 5	2016	388	10057					2264	2271		10.1016/S0140-6736(16)30384-1	http://dx.doi.org/10.1016/S0140-6736(16)30384-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EA8MO	27570178				2022-12-28	WOS:000386889300032
J	Knowles, B; Silveira, CB; Bailey, BA; Barott, K; Cantu, VA; Cobian-Guemes, AG; Coutinho, FH; Dinsdale, EA; Felts, B; Furby, KA; George, EE; Green, KT; Gregoracci, GB; Haas, AF; Haggerty, JM; Hester, ER; Hisakawa, N; Kelly, LW; Lim, YW; Little, M; Luque, A; McDole-Somera, T; McNair, K; de Oliveira, LS; Quistad, SD; Robinett, NL; Sala, E; Salamon, P; Sanchez, SE; Sandin, S; Silva, GGZ; Smith, J; Sullivan, C; Thompson, C; Vermeij, MJA; Youle, M; Young, C; Zgliczynski, B; Brainard, R; Edwards, RA; Nulton, J; Thompson, F; Rohwer, F				Knowles, B.; Silveira, C. B.; Bailey, B. A.; Barott, K.; Cantu, V. A.; Cobian-Guemes, A. G.; Coutinho, F. H.; Dinsdale, E. A.; Felts, B.; Furby, K. A.; George, E. E.; Green, K. T.; Gregoracci, G. B.; Haas, A. F.; Haggerty, J. M.; Hester, E. R.; Hisakawa, N.; Kelly, L. W.; Lim, Y. W.; Little, M.; Luque, A.; McDole-Somera, T.; McNair, K.; de Oliveira, L. S.; Quistad, S. D.; Robinett, N. L.; Sala, E.; Salamon, P.; Sanchez, S. E.; Sandin, S.; Silva, G. G. Z.; Smith, J.; Sullivan, C.; Thompson, C.; Vermeij, M. J. A.; Youle, M.; Young, C.; Zgliczynski, B.; Brainard, R.; Edwards, R. A.; Nulton, J.; Thompson, F.; Rohwer, F.			Lytic to temperate switching of viral communities (vol 531, pg 466, 2016)	NATURE			English	Correction													Vermeij, Mark/AAR-6757-2020; Vermeij, Mark/B-2752-2013; Rohwer, Forest/AAC-5315-2019; Gregoracci, Gustavo B/E-1848-2013	Vermeij, Mark/0000-0001-9612-9527; Vermeij, Mark/0000-0001-9612-9527; Rohwer, Forest/0000-0003-1548-5429; Quistad, Steven/0000-0003-4384-8100; Edwards, Robert/0000-0001-8383-8949				Knowles B, 2016, NATURE, V531, P466, DOI 10.1038/nature17193	1	5	5	3	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2016	539	7627					123	123		10.1038/nature19335	http://dx.doi.org/10.1038/nature19335			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VH2UM	27556939	Bronze, Green Published			2022-12-28	WOS:000452229400001
J	Vidal-Petiot, E; Ford, I; Greenlaw, N; Ferrari, R; Fox, KM; Tardif, JC; Tendera, M; Tavazzi, L; Bhatt, DL; Steg, PG				Vidal-Petiot, Emmanuelle; Ford, Ian; Greenlaw, Nicola; Ferrari, Roberto; Fox, Kim M.; Tardif, Jean-Claude; Tendera, Michal; Tavazzi, Luigi; Bhatt, Deepak L.; Steg, Philippe Gabriel		CLARIFY Investigators	Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIALS; J-CURVE; HYPERTENSIVE PATIENTS; ONGOING TELMISARTAN; RISK; COMBINATION; OUTCOMES; TARGETS; METAANALYSIS; PREVALENCE	Background The optimum blood pressure target in hypertension remains debated, especially in coronary artery disease, given concerns for reduced myocardial perfusion if diastolic blood pressure is too low. We aimed to study the association between achieved blood pressure and cardiovascular outcomes in patients with coronary artery disease and hypertension. Methods We analysed data from 22 672 patients with stable coronary artery disease enrolled (from Nov 26, 2009, to June 30, 2010) in the CLARIFY registry (including patients from 45 countries) and treated for hypertension. Systolic and diastolic blood pressures before each event were averaged and categorised into 10 mm Hg increments. The primary outcome was the composite of cardiovascular death, myocardial infarction, or stroke. Hazard ratios (HRs) were estimated with multivariable adjusted Cox proportional hazards models, using the 120-129 mm Hg systolic blood pressure and 70-79 mm Hg diastolic blood pressure subgroups as reference. Findings After a median follow-up of 5.0 years, increased systolic blood pressure of 140 mm Hg or more and diastolic blood pressure of 80 mm Hg or more were each associated with increased risk of cardiovascular events. Systolic blood pressure of less than 120 mm Hg was also associated with increased risk for the primary outcome (adjusted HR 1.56, 95% CI 1.36-1.81). Likewise, diastolic blood pressure of less than 70 mm Hg was associated with an increase in the primary outcome (adjusted HR 1.41 [1. 24-1. 61] for diastolic blood pressure of 60-69 mm Hg and 2.01 [1. 50-2. 70] for diastolic blood pressure of less than 60 mm Hg). Interpretation In patients with hypertension and coronary artery disease from routine clinical practice, systolic blood pressure of less than 120 mm Hg and diastolic blood pressure of less than 70 mm Hg were each associated with adverse cardiovascular outcomes, including mortality, supporting the existence of a J-curve phenomenon. This finding suggests that caution should be taken in the use of blood pressure-lowering treatment in patients with coronary artery disease.	[Vidal-Petiot, Emmanuelle; Steg, Philippe Gabriel] Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Dept Hosp Univ FIRE, Dept Cardiol, Paris, France; [Vidal-Petiot, Emmanuelle; Steg, Philippe Gabriel] Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Dept Hosp Univ FIRE, Dept Physiol, Paris, France; [Vidal-Petiot, Emmanuelle; Steg, Philippe Gabriel] Sorbonne Paris Cite, Paris, France; [Ford, Ian; Greenlaw, Nicola] Univ Glasgow, Glasgow, Lanark, Scotland; [Ferrari, Roberto] ES Hlth Sci Fdn, Maria Cecilia Hosp, GVM Care & Res, Cotignola, Italy; [Ferrari, Roberto] Univ Ferrara, Dept Cardiol, Cotignola, Italy; [Ferrari, Roberto] Univ Ferrara, LTTA Ctr, Cotignola, Italy; [Fox, Kim M.; Steg, Philippe Gabriel] Royal Brompton Hosp, Natl Heart & Lung Inst, Inst Cardiovasc Med & Sci, Imperial Coll, London, England; [Tardif, Jean-Claude] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Tendera, Michal] Med Univ Silesia, Katowice, Poland; [Bhatt, Deepak L.] Harvard Med Sch, Heart & Vasc Ctr, Brigham & Womens Hosp, Boston, MA USA; [Vidal-Petiot, Emmanuelle] INSERM, U1149, Paris, France; [Steg, Philippe Gabriel] INSERM, U1148, F CRIN Network, French Alliance Cardiovasc Trials, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; University of Glasgow; Maria Cecilia Hospital; University of Ferrara; University of Ferrara; Imperial College London; Royal Brompton Hospital; Universite de Montreal; Medical University Silesia; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Steg, PG (corresponding author), Hop Bichat Claude Bernard, Dept Cardiol, F-75018 Paris, France.	gabriel.steg@aphp.fr	Tavazzi, Luigi/ABD-5119-2020; STEG, Philippe Gabriel/Z-1567-2019; Hairullina, Adelya/AAF-6013-2019; FERRARI, ROBERTO/ABD-5169-2020; Tendera, Michal/AAA-1875-2022; Ford, Ian/ABE-6145-2020	Tavazzi, Luigi/0000-0003-0336-8356; Hairullina, Adelya/0000-0002-7832-2267; STEG, Philippe Gabriel/0000-0001-6896-2941; Tendera, Michal/0000-0002-0812-6113; Vidal-Petiot, Emmanuelle/0000-0001-9356-7302; Ferrari, Roberto/0000-0003-2046-9175; TAVAZZI, LUIGI/0000-0003-4448-5209	Servier	Servier(Servier)	Servier.	Bangalore S, 2010, EUR HEART J, V31, P2897, DOI 10.1093/eurheartj/ehq328; Benavente OR, 2013, LANCET, V382, P507, DOI 10.1016/S0140-6736(13)60852-1; Boutitie F, 2002, ANN INTERN MED, V136, P438, DOI 10.7326/0003-4819-136-6-200203190-00007; Cooper-DeHoff RM, 2010, JAMA-J AM MED ASSOC, V304, P61, DOI 10.1001/jama.2010.884; CRUICKSHANK JM, 1987, LANCET, V1, P581; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Filipovsky J, 2016, BLOOD PRESSURE, V25, P228, DOI 10.3109/08037051.2015.1134086; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; HEINZL H, KB196 SAS; Jones DW, 2016, HYPERTENSION, V67, P261, DOI 10.1161/HYPERTENSIONAHA.115.06723; Kjeldsen SE, 2016, HYPERTENSION, V67, P808, DOI 10.1161/HYPERTENSIONAHA.116.07257; Lonn EM, 2016, NEW ENGL J MED, V374, P2009, DOI 10.1056/NEJMoa1600175; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Mancia G, 2014, HYPERTENSION, V63, P29, DOI [10.1161/HYPERTENSIONAHA.113.01922, 10.1161/01.hyp.0000441190.09494.e9]; Mancia G, 2011, CIRCULATION, V124, P1727, DOI 10.1161/CIRCULATIONAHA.110.008870; Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005; Messerli FH, 2009, J AM COLL CARDIOL, V54, P279, DOI [10.1016/j.jacc.2009.03.053, 10.1016/j.jacc.2009.05.073]; Ovbiagele B, 2011, JAMA-J AM MED ASSOC, V306, P2137, DOI 10.1001/jama.2011.1650; Redon J, 2012, J AM COLL CARDIOL, V59, P74, DOI 10.1016/j.jacc.2011.09.040; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Schiffrin EL, 2016, AM J HYPERTENS, V29, P2, DOI 10.1093/ajh/hpv190; Sim JJ, 2014, J AM COLL CARDIOL, V64, P588, DOI 10.1016/j.jacc.2014.04.065; Sleight P, 2009, J HYPERTENS, V27, P1360, DOI 10.1097/HJH.0b013e32832d7370; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Steg PG, 2014, JAMA INTERN MED, V174, P1651, DOI 10.1001/jamainternmed.2014.3773; Sundstrom J, 2014, LANCET, V384, P591, DOI 10.1016/S0140-6736(14)61212-5; Verdecchia P, 2014, HYPERTENSION, V63, P37, DOI [10.1161/01.hyp.0000439102.43479.43, 10.1161/HYPERTENSIONAHA.113.01018]; Xie XF, 2016, LANCET, V387, P435, DOI 10.1016/S0140-6736(15)00805-3; Zanchetti A, 2015, CIRC RES, V116, P1058, DOI 10.1161/CIRCRESAHA.116.303641	31	273	285	2	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 29	2016	388	10056					2142	2152		10.1016/S0140-6736(16)31326-5	http://dx.doi.org/10.1016/S0140-6736(16)31326-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA1DJ	27590221	Green Accepted, Green Submitted			2022-12-28	WOS:000386332400035
J	Lyons, SK; Amatangelo, KL; Behrensmeyer, AK; Bercovici, A; Blois, JL; Davis, M; DiMichele, WA; Du, A; Eronen, JT; Faith, JT; Graves, GR; Jud, N; Labandeira, C; Looy, CV; McGill, B; Miller, JH; Patterson, D; Pineda-Munoz, S; Potts, R; Riddle, B; Terry, R; Toth, A; Ulrich, W; Villasenor, A; Wing, S; Anderson, H; Anderson, J; Waller, D; Gotelli, NJ				Lyons, S. Kathleen; Amatangelo, Kathryn L.; Behrensmeyer, Anna K.; Bercovici, Antoine; Blois, Jessica L.; Davis, Matt; DiMichele, William A.; Du, Andrew; Eronen, Jussi T.; Faith, J. Tyler; Graves, Gary R.; Jud, Nathan; Labandeira, Conrad; Looy, Cindy V.; McGill, Brian; Miller, Joshua H.; Patterson, David; Pineda-Munoz, Silvia; Potts, Richard; Riddle, Brett; Terry, Rebecca; Toth, Aniko; Ulrich, Werner; Villasenor, Amelia; Wing, Scott; Anderson, Heidi; Anderson, John; Waller, Donald; Gotelli, Nicholas J.			Holocene shifts in the assembly of plant and animal communities implicate human impacts (vol 529, pg 80, 2016)	NATURE			English	Correction													Tóth, Anikó/AAT-6084-2021; Blois, Jessica/G-5893-2011; Jud, Nathan/AAI-2384-2020; Villasenor, Amelia/AAR-5965-2021; Pineda-Munoz, Silvia/AAR-2292-2020; Eronen, Jussi T./B-7978-2013; aubertin, rebeckah/O-9624-2015	Tóth, Anikó/0000-0002-3063-1917; Blois, Jessica/0000-0003-4048-177X; Jud, Nathan/0000-0001-6100-9779; Pineda-Munoz, Silvia/0000-0003-0597-4456; Eronen, Jussi T./0000-0002-0390-8044; Du, Andrew/0000-0002-7381-5089; aubertin, rebeckah/0000-0002-0558-7571	Direct For Biological Sciences [1257625] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Lyons SK, 2016, NATURE, V529, P80, DOI 10.1038/nature16447	1	1	1	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2016	538	7626					542	542		10.1038/nature19104	http://dx.doi.org/10.1038/nature19104			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VH2UL	27556944	Bronze			2022-12-28	WOS:000452228900002
J	Rosenfeld, RM				Rosenfeld, Richard M.			Acute Sinusitis in Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DIAGNOSED ACUTE RHINOSINUSITIS; ACUTE BACTERIAL RHINOSINUSITIS; CLINICAL-PRACTICE GUIDELINE; RESPIRATORY-INFECTIONS; ANTIMICROBIAL THERAPY; ALLERGIC RHINITIS; NO EVIDENCE; ANTIBIOTICS; METAANALYSIS; EFFICACY	A 28-year-old woman presents with an acute onset of nasal discharge, a frontal headache, and a temperature of 39.5 degrees C. Her temperature normalizes within 2 days, but after 12 days she has bothersome nasal congestion and purulent postnasal drip that does not improve. Does this pattern of illness suggest acute bacterial sinusitis or a persistent viral upper respiratory infection? How should this case be managed?	[Rosenfeld, Richard M.] Suny Downstate Med Ctr, Dept Otolaryngol, 450 Clarkson Ave,MSC 126, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Rosenfeld, RM (corresponding author), Suny Downstate Med Ctr, Dept Otolaryngol, 450 Clarkson Ave,MSC 126, Brooklyn, NY 11203 USA.	richard.rosenfeld@downstate.edu						BERG O, 1988, ACTA OTO-LARYNGOL, V105, P343, DOI 10.3109/00016488809097017; Berrettini S, 1999, ALLERGY, V54, P242, DOI 10.1034/j.1398-9995.1999.00813.x; Blackwell D., 2015, TABLES SUMMARY HLTH; Bookstaver PB, 2015, PHARMACOTHERAPY, V35, P1052, DOI 10.1002/phar.1649; Braun JJ, 1997, ALLERGY, V52, P650, DOI 10.1111/j.1398-9995.1997.tb01044.x; Brook I, 2011, ANN OTO RHINOL LARYN, V120, P707, DOI 10.1177/000348941112001103; Bucher HC, 2003, ARCH INTERN MED, V163, P1793, DOI 10.1001/archinte.163.15.1793; Burgstaller JM, 2016, EUR ARCH OTO-RHINO-L, V273, P1067, DOI 10.1007/s00405-015-3506-z; Caspersen LA, 2015, OTOLARYNG HEAD NECK, V153, P161, DOI 10.1177/0194599815587677; Chow AW, 2012, CLIN INFECT DIS, V54, pE72, DOI [10.1093/cid/cis370, 10.1093/cid/cir1043]; Corti M, 2009, CURR OPIN PULM MED, V15, P209, DOI 10.1097/MCP.0b013e328329bd2c; Deshazo RD, 2009, MED MYCOL, V47, pS309, DOI 10.1080/13693780802213399; Desrosiers M, 2011, ALLERGY ASTHMA CL IM, V7, DOI 10.1186/1710-1492-7-2; Donnelly JP, 2014, ANTIMICROB AGENTS CH, V58, P1451, DOI 10.1128/AAC.02039-13; Falagas ME, 2008, LANCET INFECT DIS, V8, P543, DOI 10.1016/S1473-3099(08)70202-0; Falagas ME, 2009, BRIT J CLIN PHARMACO, V67, P161, DOI 10.1111/j.1365-2125.2008.03306.x; FDA Drug Safety Communication, 2016, FDA DRUG SAF COMM FD; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fokkens WJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5703; Garbutt JM, 2012, JAMA-J AM MED ASSOC, V307, P685, DOI 10.1001/jama.2012.138; Gulliford MC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006245; GWALTNEY JM, 1992, J ALLERGY CLIN IMMUN, V90, P457, DOI 10.1016/0091-6749(92)90169-3; Gwaltney JM, 1996, CLIN INFECT DIS, V23, P1209, DOI 10.1093/clinids/23.6.1209; Gwaltney JM, 2002, AM J MED, V112, p13S; Hauer AJ, 2014, OTOLARYNG HEAD NECK, V150, P28, DOI 10.1177/0194599813510891; Hayward G, 2012, ANN FAM MED, V10, P241, DOI 10.1370/afm.1338; Hoxworth JM, 2010, NEUROIMAG CLIN N AM, V20, P511, DOI 10.1016/j.nic.2010.07.004; Hur K, 2014, INT FORUM ALLERGY RH, V4, P22, DOI 10.1002/alr.21232; Inanli S, 2002, LARYNGOSCOPE, V112, P320; Incaudo GA, 2004, CLIN REV ALLERG IMMU, V27, P159, DOI 10.1385/CRIAI:27:2:159; Jones BE, 2015, ANN INTERN MED, V163, P73, DOI 10.7326/M14-1933; Karageorgopoulos DE, 2008, CAN MED ASSOC J, V178, P845, DOI 10.1503/cmaj.071157; King D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006821.pub3; Lemiengre MB, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006089.pub4; Lindbaek M, 1996, Fam Med, V28, P183; Lindbaek M, 2002, BRIT J GEN PRACT, V52, P491; Mohan S, 2014, AM J RHINOL ALLERGY, V28, P487, DOI 10.2500/ajra.2014.28.4101; Mortuaire G, 2013, EUR ANN OTORHINOLARY, V130, P137, DOI 10.1016/j.anorl.2012.09.005; Puhakka T, 1998, J ALLERGY CLIN IMMUN, V102, P403, DOI 10.1016/S0091-6749(98)70127-7; Rabago D, 2002, J FAM PRACTICE, V51, P1049; Rosenfeld RM, 2007, OTOLARYNG HEAD NECK, V137, pS32, DOI 10.1016/j.otohns.2007.06.724; Rosenfeld RM, 2015, OTOLARYNG HEAD NECK, V152, pS1, DOI 10.1177/0194599815572097; Sng WJ, 2015, RHINOLOGY, V53, P3, DOI 10.4193/Rhino13.225; Sokol W, 2001, Am J Med, V111 Suppl 9A, p19S; Tan RA, 2011, IMMUNOL ALLERGY CLIN, V31, P481, DOI 10.1016/j.iac.2011.05.010; Trestioreanu AZ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005149.pub4; van den Broek MFM, 2014, OTOLARYNG HEAD NECK, V150, P533, DOI 10.1177/0194599814522595; Venekamp RP, 2015, JAMA-J AM MED ASSOC, V313, P1258, DOI 10.1001/jama.2014.14418; Venekamp RP, 2012, CAN MED ASSOC J, V184, pE751, DOI 10.1503/cmaj.120430; Young J, 2008, LANCET, V371, P908, DOI 10.1016/S0140-6736(08)60416-X	50	33	38	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2016	375	10					962	970		10.1056/NEJMcp1601749	http://dx.doi.org/10.1056/NEJMcp1601749			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU9IG	27602668				2022-12-28	WOS:000382529500009
J	Parmar, D; Stavropoulou, C; Ioannidis, JPA				Parmar, Divya; Stavropoulou, Charitini; Ioannidis, John P. A.			Health outcomes during the 2008 financial crisis in Europe: systematic literature review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SELF-RATED HEALTH; ECONOMIC-CRISIS; MENTAL-HEALTH; SOCIOECONOMIC-FACTORS; GREAT RECESSION; SUICIDE RATES; IMPACT; UNEMPLOYMENT; AUSTERITY; SPAIN	OBJECTIVE To systematically identify, critically appraise, and synthesise empirical studies about the impact of the 2008 financial crisis in Europe on health outcomes. Design Systematic literature review. Data sources Structural searches of key databases, healthcare journals, and organisation based websites. Review methods Empirical studies reporting on the impact of the financial crisis on health outcomes in Europe, published from January 2008 to December 2015, were included. All selected studies were assessed for risk of bias. Owing to the heterogeneity of studies in terms of study design and analysis and the use of overlapping datasets across studies, studies were analysed thematically per outcome, and the evidence was synthesised on different health outcomes without formal meta-analysis. Results 41 studies met the inclusion criteria, and focused on suicide, mental health, self rated health, mortality, and other health outcomes. Of those studies, 30 (73%) were deemed to be at high risk of bias, nine (22%) at moderate risk of bias, and only two (5%) at low risk of bias, limiting the conclusions that can be drawn. Although there were differences across countries and groups, there was some indication that suicides increased and mental health deteriorated during the crisis. The crisis did not seem to reverse the trend of decreasing overall mortality. Evidence on self rated health and other indicators was mixed. Conclusions Most published studies on the impact of financial crisis on health in Europe had a substantial risk of bias; therefore, results need to be cautiously interpreted. Overall, the financial crisis in Europe seemed to have had heterogeneous effects on health outcomes, with the evidence being most consistent for suicides and mental health. There is a need for better empirical studies, especially those focused on identifying mechanisms that can mitigate the adverse effects of the crisis.	[Parmar, Divya; Stavropoulou, Charitini] City Univ London, Sch Hlth Sci, London EC1V 0HB, England; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	City University London; Stanford University	Stavropoulou, C (corresponding author), City Univ London, Sch Hlth Sci, London EC1V 0HB, England.	C.Stavropoulou@city.ac.uk	Ioannidis, John P. A./G-9836-2011	Stavropoulou, Charitini/0000-0003-4307-1848; Parmar, Divya/0000-0002-7979-3140	pump priming scheme from the School of Health Sciences at City University London	pump priming scheme from the School of Health Sciences at City University London	The study was financially supported by a pump priming scheme from the School of Health Sciences at City University London. The funder was not involved in the research and preparation of the article, including study design; collection, analysis, and interpretation of data; writing of the article; nor in the decision to submit it for publication.	Aguilar-Palacio I, 2015, INT J PUBLIC HEALTH, V60, P427, DOI 10.1007/s00038-015-0668-9; [Anonymous], 2009, SYSTEMATIC REV; Antonakakis N, 2014, SOC SCI MED, V112, P39, DOI 10.1016/j.socscimed.2014.04.019; Cordoba-Dona JA, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-55; Astell-Burt T, 2013, PLOS ONE, V8; Barr Ben, 2012, BMJ, V345, pe5142, DOI 10.1136/bmj.e5142; Barr B, 2015, SOC SCI MED, V147, P324, DOI 10.1016/j.socscimed.2015.11.009; Bartoll X, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2204-5; Bartoll X, 2014, EUR J PUBLIC HEALTH, V24, P415, DOI 10.1093/eurpub/ckt208; Bernal JAL, 2013, EUR J PUBLIC HEALTH, V23, P732, DOI 10.1093/eurpub/ckt083; Brainerd E, 2005, J ECON PERSPECT, V19, P107, DOI 10.1257/0895330053147921; Branas CC, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005619; Catalano R, 2011, ANNU REV PUBL HEALTH, V32, P431, DOI 10.1146/annurev-publhealth-031210-101146; Chang SS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5239; Coope C, 2014, SOC SCI MED, V117, P76, DOI 10.1016/j.socscimed.2014.07.024; Corcoran P, 2015, INT J EPIDEMIOL, V44, P969, DOI 10.1093/ije/dyv058; Correia T, 2015, HEALTH POLICY, V119, P1600, DOI 10.1016/j.healthpol.2015.08.009; Curl A, 2015, SOC POLICY SOC, V14, P217, DOI 10.1017/S1474746414000475; Cylus J, 2015, EC CRISIS HLTH SYSTE; De Vogli R, 2014, EUR J PUBLIC HEALTH, V24, P419, DOI 10.1093/eurpub/ckt173; Drydakis N, 2015, SOC SCI MED, V128, P43, DOI 10.1016/j.socscimed.2014.12.025; Economou M, 2013, J AFFECT DISORDERS, V145, P308, DOI 10.1016/j.jad.2012.08.008; Eiriksdottir VH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138534; Eiriksdottir VH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080499; Ferrarini T, 2014, J EPIDEMIOL COMMUN H, V68, P657, DOI 10.1136/jech-2013-203721; Filippidis FT, 2014, EUR J PUBLIC HEALTH, V24, P974, DOI 10.1093/eurpub/cku028; Fountoulakis KN, 2014, BRIT J PSYCHIAT, V205, P486, DOI 10.1192/bjp.bp.114.147454; Fountoulakis KN, 2014, ANN GEN PSYCHIATR, V13, DOI 10.1186/1744-859X-13-12; Gili M, 2013, EUR J PUBLIC HEALTH, V23, P103, DOI 10.1093/eurpub/cks035; Gotsens M, 2015, EUR J PUBLIC HEALTH, V25, P923, DOI 10.1093/eurpub/ckv126; Granados JAT, 2015, HEALTH POLICY, V119, P941, DOI 10.1016/j.healthpol.2015.04.009; Granados JAT, 2009, P NATL ACAD SCI USA, V106, P17290, DOI 10.1073/pnas.0904491106; Hessel P, 2014, PUBLIC HEALTH, V128, P911, DOI 10.1016/j.puhe.2014.08.004; Huijts T, 2015, EUR J PUBLIC HEALTH, V25, P801, DOI 10.1093/eurpub/ckv108; Karanikolos M, 2013, LANCET, V381, P1323, DOI 10.1016/S0140-6736(13)60102-6; Katikireddi SV, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001790; Kentikelenis A, 2011, LANCET, V378, P1457, DOI 10.1016/S0140-6736(11)61556-0; Kontaxakis V, 2013, Psychiatriki, V24, P170; Laanani M, 2015, J EPIDEMIOL COMMUN H, V69, P103, DOI 10.1136/jech-2013-203624; Madianos MG, 2014, EUR J PSYCHIAT, V28, P39, DOI 10.4321/S0213-61632014000100004; Malard L, 2015, J AFFECT DISORDERS, V178, P52, DOI 10.1016/j.jad.2015.02.027; McClure CB, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001386; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Quaglio G, 2013, HEALTH POLICY, V113, P13, DOI 10.1016/j.healthpol.2013.09.005; Rachiotis G, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007295; Rachiotis G, 2014, INT J MED SCI, V11, P442, DOI 10.7150/ijms.7933; Rajmil L, 2014, INT J ENV RES PUB HE, V11, P6528, DOI 10.3390/ijerph110606528; Rajmil L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003286; Reeves A, 2014, LANCET INFECT DIS, V14, P1105, DOI 10.1016/S1473-3099(14)70927-2; Reeves A, 2014, BRIT J PSYCHIAT, V205, P246, DOI 10.1192/bjp.bp.114.144766; Regidor E, 2014, J EPIDEMIOL COMMUN H, V68, P280, DOI 10.1136/jech-2013-202944; Reile R, 2014, J EPIDEMIOL COMMUN H, V68, P1072, DOI 10.1136/jech-2014-204196; Ronda E, 2016, HEALTH EXPECT, V19, P416, DOI 10.1111/hex.12365; Ruhm C, 2015, 21604 NAT BUR EC RES; Saurina C, 2013, J EPIDEMIOL COMMUN H, V67, P779, DOI 10.1136/jech-2013-202645; Simou E, 2014, HEALTH POLICY, V115, P111, DOI 10.1016/j.healthpol.2014.02.002; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Van Hal G, 2015, PSYCHOL RES BEHAV MA, V8, P17, DOI 10.2147/PRBM.S44732; Vandoros S, 2013, EUR J PUBLIC HEALTH, V23, P727, DOI 10.1093/eurpub/ckt020; Viswanathan M, 2012, J CLIN EPIDEMIOL, V65, P163, DOI 10.1016/j.jclinepi.2011.05.008; Wagenaar AC, 2009, ADDICTION, V104, P179, DOI 10.1111/j.1360-0443.2008.02438.x; Wells G., NEWCASTLE OTTAWA SCA; Moya ARZ, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0217-4; Zavras D, 2013, EUR J PUBLIC HEALTH, V23, P206, DOI 10.1093/eurpub/cks143	65	117	122	0	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2016	354								i4588	10.1136/bmj.i4588	http://dx.doi.org/10.1136/bmj.i4588			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DV7FB	27601477	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000383100600003
J	Bentley, MS; Schmied, R; Mannel, T; Torkar, K; Jeszenszky, H; Romstedt, J; Levasseur-Regourd, AC; Weber, I; Jessberger, EK; Ehrenfreund, P; Koeberl, C; Havnes, O				Bentley, Mark S.; Schmied, Roland; Mannel, Thurid; Torkar, Klaus; Jeszenszky, Harald; Romstedt, Jens; Levasseur-Regourd, Anny-Chantal; Weber, Iris; Jessberger, Elmar K.; Ehrenfreund, Pascale; Koeberl, Christian; Havnes, Ove			Aggregate dust particles at comet 67P/Churyumov-Gerasimenko	NATURE			English	Article							INTERSTELLAR DUST; 81P/WILD 2; GRAINS; SYSTEM; MIDAS; MODEL	Comets are thought to preserve almost pristine dust particles, thus providing a unique sample of the properties of the early solar nebula. The microscopic properties of this dust played a key part in particle aggregation during the formation of the Solar System(1,2). Cometary dust was previously considered to comprise irregular, fluffy agglomerates on the basis of interpretations of remote observations in the visible and infrared(3-6) and the study of chondritic porous interplanetary dust particles(7) that were thought, but not proved, to originate in comets. Although the dust returned by an earlier mission(8) has provided detailed mineralogy of particles from comet 81P/Wild, the fine-grained aggregate component was strongly modified during collection. Here we report in situ measurements of dust particles at comet 67P/Churyumov-Gerasimenko. The particles are aggregates of smaller, elongated grains, with structures at distinct sizes indicating hierarchical aggregation. Topographic images of selected dust particles with sizes of one micrometre to a few tens of micrometres show a variety of morphologies, including compact single grains and large porous aggregate particles, similar to chondritic porous interplanetary dust particles. The measured grain elongations are similar to the value inferred for interstellar dust and support the idea that such grains could represent a fraction of the building blocks of comets. In the subsequent growth phase, hierarchical agglomeration could be a dominant process(10) and would produce aggregates that stick more easily at higher masses and velocities than homogeneous dust particles(11). The presence of hierarchical dust aggregates in the near surface of the nucleus of comet 67P also provides a mechanism for lowering the tensile strength of the dust layer and aiding dust release(12).	[Bentley, Mark S.; Schmied, Roland; Mannel, Thurid; Torkar, Klaus; Jeszenszky, Harald] Austrian Acad Sci, Space Res Inst, Schmiedlstr 6, A-8042 Graz, Austria; [Mannel, Thurid] Graz Univ, Inst Phys, Univ Pl 5, A-8010 Graz, Austria; [Romstedt, Jens] European Space Technol Ctr, Future Missions Off SREF, Noordwijk, Netherlands; [Levasseur-Regourd, Anny-Chantal] Univ Paris 06, Sorbonne Univ, BC 102,4 Pl Jussieu, F-75005 Paris, France; [Levasseur-Regourd, Anny-Chantal] CNRS, INSU, BC 102,4 Pl Jussieu, F-75005 Paris, France; [Levasseur-Regourd, Anny-Chantal] IPSL, LATMOS, BC 102,4 Pl Jussieu, F-75005 Paris, France; [Weber, Iris; Jessberger, Elmar K.] Univ Munster, Inst Planetol, Wilhelm Klemm Str 10, D-48149 Munster, Germany; [Ehrenfreund, Pascale] Leiden Observ, Postbus 9513, NL-2300 RA Leiden, Netherlands; [Ehrenfreund, Pascale] George Washington Univ, Inst Space Policy, Washington, DC 20052 USA; [Koeberl, Christian] Univ Vienna, Dept Lithospher Res, Althanstr 14, A-1090 Vienna, Austria; [Koeberl, Christian] Nat Hist Museum, Burgring 7, A-1010 Vienna, Austria; [Havnes, Ove] UiT, Dept Phys & Technol, N-9037 Tromso, Norway	Austrian Academy of Sciences; University of Graz; European Space Agency; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris Saclay; University of Munster; George Washington University; University of Vienna; UiT The Arctic University of Tromso	Bentley, MS (corresponding author), Austrian Acad Sci, Space Res Inst, Schmiedlstr 6, A-8042 Graz, Austria.	mark.bentley@oeaw.ac.at		Mannel, Thurid/0000-0003-1846-173X; Bentley, Mark/0000-0002-4780-1767	European Space Agency's PRODEX programme; Austrian Space Agency; Austrian Academy of Sciences; German funding agency DARA; DLR; French Space Agency, CNES; Austrian Science Fund (FWF) [P 28100-N36]; Steiermarkische Sparkasse; Karl-Franzens Universitat Graz; NASA Astrobiology Institute; Austrian Research Promotion Agency (FFG)	European Space Agency's PRODEX programme; Austrian Space Agency; Austrian Academy of Sciences; German funding agency DARA; DLR(Helmholtz AssociationGerman Aerospace Centre (DLR)); French Space Agency, CNES(Centre National D'etudes Spatiales); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Steiermarkische Sparkasse; Karl-Franzens Universitat Graz; NASA Astrobiology Institute; Austrian Research Promotion Agency (FFG)	Rosetta is an ESA mission with contributions from its member states and NASA. We also thank the Rosetta Science Ground Segment and Mission Operations Centre for their support in acquiring the presented data. MIDAS became possible through support from funding agencies including the European Space Agency's PRODEX programme, the Austrian Space Agency, the Austrian Academy of Sciences and the German funding agency DARA (later DLR). A.-C.L.-R. acknowledges support from the French Space Agency, CNES. M.S.B. and T.M. acknowledge funding from the Austrian Science Fund (FWF): P 28100-N36. T.M. also acknowledges the Steiermarkische Sparkasse and the Karl-Franzens Universitat Graz for their financial support. P.E. acknowledges support from the NASA Astrobiology Institute. R.S. thanks F. Hofer and H. Plank for discussions and the Austrian Research Promotion Agency (FFG) for financial support. All data presented here will be made available in the ESA Planetary Science Archive (http://www.cosmos.esa.int/web/psa/rosetta).	Bentley MS, 2016, ACTA ASTRONAUT, V125, P11, DOI 10.1016/j.actaastro.2016.01.012; Blum J, 2000, ICARUS, V143, P138, DOI 10.1006/icar.1999.6234; BROWNLEE DE, 1987, PHILOS T R SOC A, V323, P305, DOI 10.1098/rsta.1987.0087; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; DOLLFUS A, 1989, ASTRON ASTROPHYS, V213, P469; Dominik C, 2009, ASTR SOC P, V414, P494; Dominik C., 2006, PROTOSTARS PLANETS 5, P783; Flynn GJ, 2006, SCIENCE, V314, P1731, DOI 10.1126/science.1136141; GREENBERG JM, 1990, ASTROPHYS J, V361, P260, DOI 10.1086/169191; GREENBERG JM, 1981, ASTRON ASTROPHYS, V93, P35; Hanner MS, 2003, J QUANT SPECTROSC RA, V79, P695, DOI 10.1016/S0022-4073(02)00315-1; Hilchenbach M, 2016, ASTROPHYS J LETT, V816, DOI 10.3847/2041-8205/816/2/L32; Johansen A., 2014, PROTOSTARS PLANETS, P547, DOI DOI 10.2458/AZU_UAPRESS_9780816531240-CH024; Kolokolova L, 2004, SPACE SCI S, P577; Kolokolova L, 2010, EARTH PLANETS SPACE, V62, P17, DOI 10.5047/eps.2008.12.001; Langevin Y, 2016, ICARUS, V271, P76, DOI 10.1016/j.icarus.2016.01.027; Lasue J, 2006, J QUANT SPECTROSC RA, V100, P220, DOI 10.1016/j.jqsrt.2005.11.040; Levasseur-Regourd AC, 2007, PLANET SPACE SCI, V55, P1010, DOI 10.1016/j.pss.2006.11.014; MATHIS JS, 1990, ANNU REV ASTRON ASTR, V28, P37, DOI 10.1146/annurev.aa.28.090190.000345; Paszun D, 2006, ICARUS, V182, P274, DOI 10.1016/j.icarus.2005.12.018; Riedler W, 2007, SPACE SCI REV, V128, P869, DOI 10.1007/s11214-006-9040-y; Rotundi A, 2008, METEORIT PLANET SCI, V43, P367, DOI 10.1111/j.1945-5100.2008.tb00628.x; Skorov Y, 2012, ICARUS, V221, P1, DOI 10.1016/j.icarus.2012.01.012; STEPHENS JR, 1991, ICARUS, V94, P209, DOI 10.1016/0019-1035(91)90151-I; Stodolna J, 2014, EARTH PLANET SC LETT, V388, P367, DOI 10.1016/j.epsl.2013.12.018; Wozniakiewicz PJ, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/2/164	26	120	120	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					73	75		10.1038/nature19091	http://dx.doi.org/10.1038/nature19091			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27582221	Green Submitted			2022-12-28	WOS:000382426900040
J	Clark, F				Clark, Fiona			Gaps remain in Russia's response to HIV/AIDS	LANCET			English	Editorial Material																			0	16	17	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 27	2016	388	10047					857	858		10.1016/S0140-6736(16)31480-5	http://dx.doi.org/10.1016/S0140-6736(16)31480-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU0RI	27597456				2022-12-28	WOS:000381911800012
J	Guo, JP; Chakraborty, AA; Liu, PD; Gan, WJ; Zheng, XN; Inuzuka, H; Wang, B; Zhang, JF; Zhang, LL; Yuan, M; Novak, J; Cheng, JQ; Toker, A; Signoretti, S; Zhang, Q; Asara, JM; Kaelin, WG; Wei, WY				Guo, Jianping; Chakraborty, Abhishek A.; Liu, Pengda; Gan, Wenjian; Zheng, Xingnan; Inuzuka, Hiroyuki; Wang, Bin; Zhang, Jinfang; Zhang, Linli; Yuan, Min; Novak, Jesse; Cheng, Jin Q.; Toker, Alex; Signoretti, Sabina; Zhang, Qing; Asara, John M.; Kaelin, William G.; Wei, Wenyi			pVHL suppresses kinase activity of Akt in a proline-hydroxylation-dependent manner	SCIENCE			English	Article							RENAL-CELL CARCINOMA; PROLYL HYDROXYLATION; KIDNEY CANCER; HIF-ALPHA; VHL; PROTEIN; BINDING; MTOR; HYDROXYPROLINE; RECOGNITION	Activation of the serine-threonine kinase Akt promotes the survival and proliferation of various cancers. Hypoxia promotes the resistance of tumor cells to specific therapies. We therefore explored a possible link between hypoxia and Akt activity. We found that Akt was prolyl-hydroxylated by the oxygen-dependent hydroxylase EglN1. The von Hippel-Lindau protein (pVHL) bound directly to hydroxylated Akt and inhibited Akt activity. In cells lacking oxygen or functional pVHL, Akt was activated to promote cell survival and tumorigenesis. We also identified cancer-associated Akt mutations that impair Akt hydroxylation and subsequent recognition by pVHL, thus leading to Akt hyperactivation. Our results show that microenvironmental changes, such as hypoxia, can affect tumor behaviors by altering Akt activation, which has a critical role in tumor growth and therapeutic resistance.	[Guo, Jianping; Liu, Pengda; Gan, Wenjian; Inuzuka, Hiroyuki; Wang, Bin; Zhang, Jinfang; Zhang, Linli; Toker, Alex; Wei, Wenyi] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Chakraborty, Abhishek A.; Kaelin, William G.] Harvard Med Sch, Dept Med, Dana Farber Canc Inst, Boston, MA 02215 USA; [Chakraborty, Abhishek A.; Novak, Jesse; Signoretti, Sabina; Kaelin, William G.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02215 USA; [Zheng, Xingnan; Zhang, Qing] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Yuan, Min; Asara, John M.] Harvard Med Sch, Div Signal Transduct, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Yuan, Min; Asara, John M.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Novak, Jesse; Signoretti, Sabina] Harvard Med Sch, Dept Pathol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Cheng, Jin Q.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Kaelin, William G.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; H Lee Moffitt Cancer Center & Research Institute; Howard Hughes Medical Institute	Wei, WY (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA.	wwei2@bidmc.harvard.edu	ZHANG, QING/AGY-7972-2022; Wang, Bin/W-9917-2019	ZHANG, QING/0000-0002-6595-8995; Wang, Bin/0000-0001-5574-1760; Gan, Wenjian/0000-0001-7599-5020	NIH [GM094777, CA177910, 1S10OD010612, 5P01CA120964, 5P30CA006516];  [5T32HL007893-17]; NATIONAL CANCER INSTITUTE [K99CA207867, R01CA200573, P01CA120964, R01CA177910, P30CA006516, R01CA200651] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094777, R01GM089763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG041218] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010612] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. North, L. Wan, and other Wei laboratory members for critical reading of the manuscript; W. Yu for his critical help in providing the triple mutant form of VHL to analyze the critical amino acids in proline-hydroxylation binding pocket of VHL that mediates its interaction with hydroxylated Akt1; as well as members of Kaelin, Zhang, Toker, and Cheng laboratories for helpful discussions. J.G. is an NRSA T32 trainee and supported by 5T32HL007893-17. W.W. is an ACS research scholar. This work was supported in part by NIH grants (W.W., GM094777; W.W. and A.T., CA177910; and J.A., 1S10OD010612, 5P01CA120964, and 5P30CA006516).	Aoki M, 1998, P NATL ACAD SCI USA, V95, P14950, DOI 10.1073/pnas.95.25.14950; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; CHEN F, 1995, HUM MUTAT, V5, P66, DOI 10.1002/humu.1380050109; Gan BY, 2010, CANCER CELL, V18, P472, DOI 10.1016/j.ccr.2010.10.019; Gossage L, 2015, NAT REV CANCER, V15, P55, DOI 10.1038/nrc3844; Hager M, 2009, J CELL MOL MED, V13, P2181, DOI 10.1111/j.1582-4934.2008.00488.x; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Huang D, 2014, CELL REP, V8, P1930, DOI 10.1016/j.celrep.2014.08.028; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li J, 2002, NATURE, V420, P716, DOI 10.1038/nature01307; LI L, MOL CELL BIOL, V27, P5381; Lonergan KM, 1998, MOL CELL BIOL, V18, P732, DOI 10.1128/MCB.18.2.732; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zhang H., CANC CELL, V11, P407; Zhang JH, 1999, ANAL BIOCHEM, V271, P137, DOI 10.1006/abio.1999.4135; Zheng XN, 2014, GENE DEV, V28, P1429, DOI 10.1101/gad.242131.114	30	123	129	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					929	932		10.1126/science.aad5755	http://dx.doi.org/10.1126/science.aad5755			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU0CA	27563096	Green Accepted, Green Submitted			2022-12-28	WOS:000381867700039
J	Voosen, P				Voosen, Paul			STRATIGRAPHY Anthropocene pinned to postwar period	SCIENCE			English	News Item																			0	12	12	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					852	853		10.1126/science.353.6302.852	http://dx.doi.org/10.1126/science.353.6302.852			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU0CA	27563075				2022-12-28	WOS:000381867700008
J	Mallapaty, S				Mallapaty, Smriti			JAPAN	NATURE			English	Editorial Material																			0	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					S14	+		10.1038/536S14a	http://dx.doi.org/10.1038/536S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV0YL	27557156	Bronze			2022-12-28	WOS:000382646600004
J	Roos, N; Tuncalp, O; Kerber, K; Allanson, E; Costello, A; Askew, I; Mathai, M				Roos, Nathalie; Tuncalp, Ozge; Kerber, Kate; Allanson, Emma; Costello, Anthony; Askew, Ian; Mathai, Matthews			Learning from every stillbirth and neonatal death	LANCET			English	Editorial Material									[Roos, Nathalie; Kerber, Kate; Costello, Anthony; Mathai, Matthews] WHO, Dept Maternal Newborn Child & Adolescent Hlth, Geneva, Switzerland; [Tuncalp, Ozge; Allanson, Emma; Askew, Ian] WHO, Dept Reprod Hlth & Res, Geneva, Switzerland; [Mathai, Matthews] Univ Liverpool Liverpool Sch Trop Med, Ctr Maternal & Newborn Hlth, Liverpool, Merseyside, England	World Health Organization; World Health Organization; Liverpool School of Tropical Medicine	Roos, N (corresponding author), WHO, Dept Maternal Newborn Child & Adolescent Hlth, Geneva, Switzerland.	roosn@who.int	Tunçalp, Ӧzge/Y-2724-2018; Mathai, Matthews/F-8605-2017	Tunçalp, Ӧzge/0000-0002-5370-682X; Roos, Nathalie/0000-0001-9752-2355; Mathai, Matthews/0000-0002-7352-9330	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Darmstadt GL, 2014, LANCET, V384, P174, DOI 10.1016/S0140-6736(14)60458-X; Froen JF, 2016, LANCET, V387, P574, DOI 10.1016/S0140-6736(15)00818-1; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; UNICEF WHO & World Bank Group., 2021, LEVELS TRENDS CHILD; WHO, 2016, MAK EV BAB COUNT AUD; WHO, 2013, MAT DEATH SURV RESP; World Health Organization, 2016, WHO APPL ICD 10 DEAT; World Health Organization, 2012, WHO APPL ICD 10 DEAT	9	1	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 20	2016	388	10046					741	743		10.1016/S0140-6736(16)31352-6	http://dx.doi.org/10.1016/S0140-6736(16)31352-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT6UH	27560261	Green Accepted			2022-12-28	WOS:000381619200009
J	Walley, JW; Sartor, RC; Shen, ZX; Schmitz, RJ; Wu, KJ; Urich, MA; Nery, JR; Smith, LG; Schnable, JC; Ecker, JR; Briggs, SP				Walley, Justin W.; Sartor, Ryan C.; Shen, Zhouxin; Schmitz, Robert J.; Wu, Kevin J.; Urich, Mark A.; Nery, Joseph R.; Smith, Laurie G.; Schnable, James C.; Ecker, Joseph R.; Briggs, Steven P.			Integration of omic networks in a developmental atlas of maize	SCIENCE			English	Article							MESSENGER-RNA; REGULATORY NETWORKS; PROTEIN EXPRESSION; CELL-LINE; REVEALS; LEAF; INFERENCE; COEXPRESSION; DISCOVERY; ABUNDANCE	Coexpression networks and gene regulatory networks (GRNs) are emerging as important tools for predicting functional roles of individual genes at a system-wide scale. To enable network reconstructions, we built a large-scale gene expression atlas composed of 62,547 messenger RNAs (mRNAs), 17,862 nonmodified proteins, and 6227 phosphoproteins harboring 31,595 phosphorylation sites quantified across maize development. Networks in which nodes are genes connected on the basis of highly correlated expression patterns of mRNAs were very different from networks that were based on coexpression of proteins. Roughly 85% of highly interconnected hubs were not conserved in expression between RNA and protein networks. However, networks from either data type were enriched in similar ontological categories and were effective in predicting known regulatory relationships. Integration of mRNA, protein, and phosphoprotein data sets greatly improved the predictive power of GRNs.	[Walley, Justin W.; Sartor, Ryan C.; Shen, Zhouxin; Wu, Kevin J.; Smith, Laurie G.; Briggs, Steven P.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Walley, Justin W.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA 50011 USA; [Schmitz, Robert J.; Urich, Mark A.; Ecker, Joseph R.] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Schmitz, Robert J.; Urich, Mark A.; Nery, Joseph R.; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Schnable, James C.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68583 USA; [Ecker, Joseph R.] Howard Hughes Med Inst, Salk Inst Biol Studies, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Schmitz, Robert J.] Davison Life Sci, Dept Genet, 120 East Green St, Athens, GA 30602 USA	University of California System; University of California San Diego; Iowa State University; Salk Institute; Salk Institute; University of Nebraska System; University of Nebraska Lincoln; Howard Hughes Medical Institute; Salk Institute	Briggs, SP (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	sbriggs@ucsd.edu	Nery, Joseph/AAE-8422-2019; Schmitz, Robert/AAY-7659-2020; Ecker, Joseph R/B-9144-2008; Walley, Justin/E-5594-2015	Nery, Joseph/0000-0003-0153-5659; Schmitz, Robert/0000-0001-7538-6663; Ecker, Joseph R/0000-0001-5799-5895; Walley, Justin/0000-0001-7553-2237	NSF [0924023, MCB-0929402, MCB1122246]; NIH National Research Service Award Postdoctoral Fellowship [F32GM096707]; Howard Hughes Medical Institute; Gordon and Betty Moore Foundation [GBMF3034]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM096707] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH National Research Service Award Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Walbot for tassel and anther tissues, F. Hochholdinger for root tissues, and J. Fowler for pollen tissues. This work was supported by the NSF (grant 0924023 to S.P.B. and grants MCB-0929402 and MCB1122246 to J.R.E.), an NIH National Research Service Award Postdoctoral Fellowship (F32GM096707 to J.W.W.), and the Howard Hughes Medical Institute and the Gordon and Betty Moore Foundation (grant GBMF3034 to J.R.E.). Sequence data can be downloaded from the National Center for Biotechnology Information's Sequence Read Archive (accession number GSE50191). Raw mass spectra have been deposited at the Mass Spectrometry Interactive Virtual Environment (MassIVE) repository (accession numbers MSV000079290 and MSV000079303). Normalized expression data have been integrated into the genome browser and individual gene model pages at the central Maize Genetics and Genomics Database (www.maizegdb.org/).	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956; Baerenfaller K, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.39; Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Bolduc N, 2012, GENE DEV, V26, P1685, DOI 10.1101/gad.193433.112; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Chang KN, 2013, ELIFE, V2, DOI 10.7554/eLife.00675; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Facette MR, 2013, PLANT CELL, V25, P2798, DOI 10.1105/tpc.113.112227; Gallavotti A, 2010, DEVELOPMENT, V137, P2849, DOI 10.1242/dev.051748; Gardner TS, 2005, PHYS LIFE REV, V2, P65, DOI 10.1016/j.plrev.2005.01.001; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Krouk G, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-123; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li CB, 2015, PLANT CELL, V27, P532, DOI 10.1105/tpc.114.134858; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/NMETH.2016, 10.1038/nmeth.2016]; Marcon C, 2015, PLANT PHYSIOL, V168, P233, DOI 10.1104/pp.15.00138; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Ponnala L, 2014, PLANT J, V78, P424, DOI 10.1111/tpj.12482; Qiao H, 2012, SCIENCE, V338, P390, DOI 10.1126/science.1225974; Schnable JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017855; SCHNEEBERGER RG, 1995, GENE DEV, V9, P2292, DOI 10.1101/gad.9.18.2292; Schrynemackers Marie, 2013, Frontiers in Genetics, V4, P262, DOI 10.3389/fgene.2013.00262; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; van Noort V, 2003, TRENDS GENET, V19, P238, DOI 10.1016/S0168-9525(03)00056-8; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Walley JW, 2013, P NATL ACAD SCI USA, V110, pE4808, DOI 10.1073/pnas.1319113110; Washburn MP, 2003, P NATL ACAD SCI USA, V100, P3107, DOI 10.1073/pnas.0634629100	35	221	224	8	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					814	818		10.1126/science.aag1125	http://dx.doi.org/10.1126/science.aag1125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZE	27540173	Green Accepted			2022-12-28	WOS:000381561400044
J	Tang, VL; Covinsky, K				Tang, Victoria L.; Covinsky, Kenneth			Frailty and Surgical Decision Making	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MORTALITY		[Tang, Victoria L.; Covinsky, Kenneth] Univ Calif San Francisco, San Francisco, CA USA; [Tang, Victoria L.] 4150 Clement St,181G, San Francisco, CA 94121 USA; [Covinsky, Kenneth] 4150 Clement St,111G, San Francisco, CA 94121 USA	University of California System; University of California San Francisco	Tang, VL (corresponding author), 4150 Clement St,181G, San Francisco, CA 94121 USA.	victoria.tang@ucsf.edu			NIA NIH HHS [P30 AG044281, T32 AG000212] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG044281, T32AG000212] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Afilalo J, 2016, JAMA CARDIOL, V1, P314, DOI 10.1001/jamacardio.2016.0316; Alfredsson J, 2016, CIRCULATION, V133, P1351, DOI 10.1161/CIRCULATIONAHA.115.020279; Finlayson E, 2012, J AM GERIATR SOC, V60, P967, DOI 10.1111/j.1532-5415.2012.03915.x; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Kim DH, 2016, ANN INTERN MED, V165, P650, DOI 10.7326/M16-0652; Lilley EJ, 2016, JAMA SURG, V151, P172, DOI 10.1001/jamasurg.2015.3625; Lipsitz LA, 2002, J GERONTOL A-BIOL, V57, pB115, DOI 10.1093/gerona/57.3.B115; Mitnitski A, 2005, J AM GERIATR SOC, V53, P2184, DOI 10.1111/j.1532-5415.2005.00506.x; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722	10	10	10	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	2016	165	9					669	+		10.7326/M16-1866	http://dx.doi.org/10.7326/M16-1866			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EA8SJ	27548427	Green Accepted			2022-12-28	WOS:000386908600012
J	Nutman, AP; Bennett, VC; Friend, CRL; Van Kranendonk, MJ; Chivas, AR				Nutman, Allen P.; Bennett, Vickie C.; Friend, Clark R. L.; Van Kranendonk, Martin J.; Chivas, Allan R.			Rapid emergence of life shown by discovery of 3,700-million-year-old microbial structures	NATURE			English	Article							ISUA SUPRACRUSTAL BELT; SEDIMENTARY-ROCKS; GREENSTONE-BELT; PILBARA CRATON; WEST GREENLAND; DOLOMITE; CARBON; MECHANISM; MEDIATION; ORIGIN	Biological activity is a major factor in Earth's chemical cycles, including facilitating CO2 sequestration and providing climate feedbacks. Thus a key question in Earth's evolution is when did life arise and impact hydrosphere-atmosphere-lithosphere chemical cycles? Until now, evidence for the oldest life on Earth focused on debated stable isotopic signatures of 3,800-3,700 million year (Myr)-old metamorphosed sedimentary rocks and minerals(1,2) from the Isua supracrustal belt (ISB), southwest Greenland(3). Here we report evidence for ancient life from a newly exposed outcrop of 3,700-Myr-old metacarbonate rocks in the ISB that contain 1-4-cm-high stromatolites-macroscopically layered structures produced by microbial communities. The ISB stromatolites grew in a shallow marine environment, as indicated by seawater-like rare-earth element plus yttrium trace element signatures of the metacarbonates, and by interlayered detrital sedimentary rocks with cross-lamination and storm-wave generated breccias. The ISB stromatolites predate by 220 Myr the previous most convincing and generally accepted multidisciplinary evidence for oldest life remains in the 3,480-Myr-old Dresser Formation of the Pilbara Craton, Australia(4,5). The presence of the ISB stromatolites demonstrates the establishment of shallow marine carbonate production with biotic CO2 sequestration by 3,700 million years ago (Ma), near the start of Earth's sedimentary record. A sophistication of life by 3,700 Ma is in accord with genetic molecular clock studies placing life's origin in the Hadean eon (> 4,000 Ma)(6) .	[Nutman, Allen P.; Chivas, Allan R.] Univ Wollongong, Sch Earth & Environm Sci, GeoQuEST Res Ctr, Wollongong, NSW 2522, Australia; [Nutman, Allen P.; Van Kranendonk, Martin J.] Univ New South Wales, Australian Ctr Astrobiol, Kensington, NSW 2052, Australia; [Bennett, Vickie C.] Australian Natl Univ, Res Sch Earth Sci, GPO Box 4, Canberra, ACT 0200, Australia; [Friend, Clark R. L.] Glendale, Oxford OX9 2LQ, Oxon, England; [Van Kranendonk, Martin J.] Univ New South Wales, Sch Biol Earth & Environm Sci, Kensington, NSW 2052, Australia; [Van Kranendonk, Martin J.] Univ New South Wales, Sch Biol Earth & Environm Sci, Australian Res Council Ctr Excellence Core Crust, Kensington, NSW 2052, Australia	University of Wollongong; University of New South Wales Sydney; Australian National University; University of New South Wales Sydney; University of New South Wales Sydney	Nutman, AP (corresponding author), Univ Wollongong, Sch Earth & Environm Sci, GeoQuEST Res Ctr, Wollongong, NSW 2522, Australia.; Nutman, AP (corresponding author), Univ New South Wales, Australian Ctr Astrobiol, Kensington, NSW 2052, Australia.	anutman@uow.edu.au	Van Kranendonk, Martin J/J-8755-2012	Van Kranendonk, Martin J/0000-0002-0611-2703; Bennett, Vickie/0000-0003-0937-3471	Australian Research Council [DP120100273]; GeoQuEST Research Centre, University of Wollongong (UOW); University of New South Wales; Australian Research Council Centre of Excellence for Core to Crust Fluid Systems (CCFS); DEST Systemic Infrastructure Grants; ARC LIEF; NCRIS/Auscope industry partners; Macquarie University	Australian Research Council(Australian Research Council); GeoQuEST Research Centre, University of Wollongong (UOW); University of New South Wales; Australian Research Council Centre of Excellence for Core to Crust Fluid Systems (CCFS)(Australian Research Council); DEST Systemic Infrastructure Grants(Australian GovernmentDepartment of Industry, Innovation and Science); ARC LIEF(Australian Research Council); NCRIS/Auscope industry partners(Australian GovernmentDepartment of Industry, Innovation and Science); Macquarie University	Support provided by Australian Research Council grant DP120100273 and the GeoQuEST Research Centre, University of Wollongong (UOW). D. Wheeler, UOW, is thanked for technical assistance in carbon and oxygen isotopic analysis. L. Kinsley, Research School of Earth Sciences, Australian National University is thanked for assistance with LA-ICP-MS data acquisition. D. Adams of the Department of Earth & Planetary Sciences, Macquarie University is thanked for assistance with mineral analyses. M. Nancarrow of the Electron Microscopy Centre, UOW is thanked for assistance with SEM-imaging and mineral analyses. P. Gadd of the Australian Nuclear Science and Technology Organisation is thanked for undertaking ITRAX analyses. M.J.V.K. acknowledges support by the University of New South Wales and the Australian Research Council Centre of Excellence for Core to Crust Fluid Systems (CCFS). This is contribution 837 from the ARC Centre of Excellence for Core to Crust Fluid Systems (http://www.ccfs.mq.edu.au). Some analytical data were obtained using instrumentation funded by DEST Systemic Infrastructure Grants, ARC LIEF, NCRIS/Auscope industry partners and Macquarie University.	Allwood AC, 2006, NATURE, V441, P714, DOI 10.1038/nature04764; Dauphas N, 2004, SCIENCE, V306, P2077, DOI 10.1126/science.1104639; Feneyrol J, 2012, CAN MINERAL, V50, P745, DOI 10.3749/canmin.50.3.745; Friedman I., 1977, DATA GEOCHEMISTRY; Friend CRL, 2008, CONTRIB MINERAL PETR, V155, P229, DOI 10.1007/s00410-007-0239-z; Grotzinger JP, 1996, NATURE, V383, P423, DOI 10.1038/383423a0; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Lindsay JF, 2005, PRECAMBRIAN RES, V143, P1, DOI 10.1016/j.precamres.2005.09.003; MCLENNAN SM, 1989, REV MINERAL, V21, P169; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; Muller SG, 2005, GEOLOGY, V33, P577, DOI 10.1130/G21482.1; NORTHROP DA, 1966, J GEOL, V74, P174, DOI 10.1086/627153; Nutman AP, 2012, AUST J EARTH SCI, V59, P167, DOI 10.1080/08120099.2012.618512; Nutman A. P., 2015, SPECIAL PUBLICATIONS, P113; Nutman AP, 2010, PRECAMBRIAN RES, V183, P725, DOI 10.1016/j.precamres.2010.08.006; Nutman AP, 2009, PRECAMBRIAN RES, V172, P189, DOI 10.1016/j.precamres.2009.03.017; NUTMAN AP, 1984, PRECAMBRIAN RES, V25, P365, DOI 10.1016/0301-9268(84)90010-X; Philippot P, 2007, SCIENCE, V317, P1534, DOI 10.1126/science.1145861; Polat A, 2003, GEOCHIM COSMOCHIM AC, V67, P441, DOI 10.1016/S0016-7037(02)01094-3; Riding R., 2011, ADV STROMATOLITE GEO; Roberts JA, 2004, GEOLOGY, V32, P277, DOI 10.1130/G20246.2; Rollinson H, 2003, PRECAMBRIAN RES, V126, P181, DOI 10.1016/S0301-9268(03)00094-9; ROSENBAUM J, 1986, GEOCHIM COSMOCHIM AC, V50, P1147, DOI 10.1016/0016-7037(86)90396-0; Rosing MT, 1999, SCIENCE, V283, P674, DOI 10.1126/science.283.5402.674; SCHIDLOWSKI M, 1979, GEOCHIM COSMOCHIM AC, V43, P189, DOI 10.1016/0016-7037(79)90238-2; SHEPPARD SMF, 1986, REV MINERAL, V16, P165; Sugitani K, 2010, ASTROBIOLOGY, V10, P899, DOI 10.1089/ast.2010.0513; Van Kranendonk MJ, 2003, GEOBIOLOGY, V1, P91, DOI 10.1046/j.1472-4669.2003.00014.x; Van Kranendonk MJ, 2008, PRECAMBRIAN RES, V167, P93, DOI 10.1016/j.precamres.2008.07.003; Van Kranendonk MJ, 2011, LECT NOTES EARTH SCI, P517, DOI DOI 10.1016/0016-7037(76)90129-0; van Zuilen MA, 2002, NATURE, V418, P627, DOI 10.1038/nature00934; VASCONCELOS C, 1995, NATURE, V377, P220, DOI 10.1038/377220a0; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; Walter M. R., W AUST NAT PERTH, V284, P443	34	301	322	14	265	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2016	537	7621					535	+		10.1038/nature19355	http://dx.doi.org/10.1038/nature19355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW3MO	27580034	Green Submitted			2022-12-28	WOS:000383545900053
J	Daley, D; Zambirinis, CP; Seifert, L; Akkad, N; Mohan, N; Werba, G; Barilla, R; Torres-Hernandez, A; Hundeyin, M; Mani, VRK; Avanzi, A; Tippens, D; Narayanan, R; Jang, JE; Newman, E; Pillarisetty, VG; Dustin, ML; Bar-Sagi, D; Hajdu, C; Miller, G				Daley, Donnele; Zambirinis, Constantinos Pantelis; Seifert, Lena; Akkad, Neha; Mohan, Navyatha; Werba, Gregor; Barilla, Rocky; Torres-Hernandez, Alejandro; Hundeyin, Mautin; Mani, Vishnu Raj Kumar; Avanzi, Antonina; Tippens, Daniel; Narayanan, Rajkishen; Jang, Jung-Eun; Newman, Elliot; Pillarisetty, Venu Gopal; Dustin, Michael Loran; Bar-Sagi, Dafna; Hajdu, Cristina; Miller, George			gamma delta T Cells Support Pancreatic Oncogenesis by Restraining alpha beta T Cell Activation	CELL			English	Article							CANCER METASTASIS; TUMOR-IMMUNITY; IMMUNOTHERAPY; PROMOTES; MICE; NEOPLASIA; ADENOCARCINOMA; CARCINOGENESIS; MACROPHAGES; LYMPHOCYTES	Inflammation is paramount in pancreatic oncogenesis. We identified a uniquely activated gamma delta T cell population, which constituted similar to 40% of tumor-infiltrating T cells in human pancreatic ductal adenocarcinoma (PDA). Recruitment and activation of gamma delta T cells was contingent on diverse chemokine signals. Deletion, depletion, or blockade of gamma delta T cell recruitment was protective against PDA and resulted in increased infiltration, activation, and Th1 polarization of alpha beta T cells. Although alpha beta T cells were dispensable to outcome in PDA, they became indispensable mediators of tumor protection upon gamma delta T cell ablation. PDAinfiltrating gamma delta T cells expressed high levels of exhaustion ligands and thereby negated adaptive anti-tumor immunity. Blockade of PD-L1 in gamma delta T cells enhanced CD4(+) and CD8(+) T cell infiltration and immunogenicity and induced tumor protection suggesting that gamma delta T cells are critical sources of immune-suppressive checkpoint ligands in PDA. We describe gamma delta T cells as central regulators of effector T cell activation in cancer via novel cross-talk.	[Daley, Donnele; Zambirinis, Constantinos Pantelis; Seifert, Lena; Akkad, Neha; Mohan, Navyatha; Werba, Gregor; Barilla, Rocky; Torres-Hernandez, Alejandro; Hundeyin, Mautin; Mani, Vishnu Raj Kumar; Avanzi, Antonina; Tippens, Daniel; Narayanan, Rajkishen; Newman, Elliot; Miller, George] NYU, Sch Med, Dept Surg, S Arthur Localio Lab, 430 East 29th St, New York, NY 10016 USA; [Jang, Jung-Eun; Bar-Sagi, Dafna] NYU, Sch Med, Dept Biochem, 430 East 29th St, New York, NY 10016 USA; [Jang, Jung-Eun; Dustin, Michael Loran; Hajdu, Cristina] NYU, Sch Med, Dept Pathol, 430 East 29th St, New York, NY 10016 USA; [Pillarisetty, Venu Gopal] Univ Washington, Dept Surg, Sch Med, 1959 NE Pacific St, Seattle, WA 98195 USA; [Dustin, Michael Loran] Univ Oxford, Kennedy Inst Rheumatol, Roosevelt Dr, Headington Oxford OX3 7FY, England; [Daley, Donnele; Zambirinis, Constantinos Pantelis; Seifert, Lena; Miller, George] NYU, Sch Med, Dept Cell Biol, 430 East 29th St, New York, NY 10016 USA	New York University; New York University; New York University; University of Washington; University of Washington Seattle; University of Oxford; New York University	Miller, G (corresponding author), NYU, Sch Med, Dept Surg, S Arthur Localio Lab, 430 East 29th St, New York, NY 10016 USA.; Miller, G (corresponding author), NYU, Sch Med, Dept Cell Biol, 430 East 29th St, New York, NY 10016 USA.	george.miller@nyumc.org	Dustin, Michael/AAM-4611-2020; Hundeyin, Mautin/AAU-6792-2020; Mani, Vishnu/AAF-1916-2020; Pillarisetty, Venu/AAF-4425-2020	Mani, Vishnu/0000-0003-3121-9497; Pillarisetty, Venu/0000-0002-1162-9643; Bar-Sagi, Dafna/0000-0003-2597-8948; Seifert, Lena/0000-0003-4763-8127; Werba, Gregor/0000-0003-1464-9065; Barilla, Rocky/0000-0002-8062-7246	German Research Foundation; National Pancreas Foundation; Pancreatic Cancer Action Network; Lustgarten Foundation; National Institute of Health Awards [CA155649, CA168611, CA193111]; Cancer Center Support Grant [P30CA016087]; National Center for the Advancement of Translational Science (NCATS) [UL1 TR000038]; NATIONAL CANCER INSTITUTE [R21CA155649, T32CA193111, P30CA016087, R01CA168611] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001445, UL1TR000038] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); National Pancreas Foundation; Pancreatic Cancer Action Network; Lustgarten Foundation; National Institute of Health Awards; Cancer Center Support Grant; National Center for the Advancement of Translational Science (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by grants for the German Research Foundation (L.S.), the National Pancreas Foundation (C.P.Z.), the Pancreatic Cancer Action Network (G.M.), the Lustgarten Foundation (G.M.), and National Institute of Health Awards CA155649 (G.M.), CA168611 (G.M.), and CA193111 (G.M. and A.T.-H.). We thank the New York University Langone Medical Center (NYU LMC) Histopathology Core Facility, the NYU LMC Flow Cytometry Core Facility, the NYU LMC Microscopy Core Facility, and the NYU LMC BioRepository Center, each supported in part by the Cancer Center Support Grant P30CA016087 and by grant UL1 TR000038 from the National Center for the Advancement of Translational Science (NCATS).	AndrenSandberg A, 1997, SCAND J GASTROENTERO, V32, P97, DOI 10.3109/00365529709000177; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Bedrosian AS, 2011, GASTROENTEROLOGY, V141, P1915, DOI 10.1053/j.gastro.2011.07.033; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Connolly MK, 2010, J LEUKOCYTE BIOL, V87, P713, DOI 10.1189/jlb.0909607; Cordova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049878; De Monte L, 2011, J EXP MED, V208, P469, DOI 10.1084/jem.20101876; Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110; Fukunaga A, 2004, PANCREAS, V28, pE26, DOI 10.1097/00006676-200401000-00023; Gao YF, 2003, J EXP MED, V198, P433, DOI 10.1084/jem.20030584; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Goggins M, 1998, CANCER RES, V58, P5329; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Hao JL, 2011, J IMMUNOL, V187, P4979, DOI 10.4049/jimmunol.1101389; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Izumi T, 2013, CYTOTHERAPY, V15, P481, DOI 10.1016/j.jcyt.2012.12.004; Joyce JA, 2015, SCIENCE, V348, P74, DOI 10.1126/science.aaa6204; Kang N, 2009, IMMUNOL LETT, V125, P105, DOI 10.1016/j.imlet.2009.06.005; Kunzmann V, 2012, J IMMUNOTHER, V35, P205, DOI 10.1097/CJI.0b013e318245bb1e; Lanca T, 2012, ONCOIMMUNOLOGY, V1, P717, DOI 10.4161/onci.20068; Liou GY, 2015, CANCER DISCOV, V5, P52, DOI 10.1158/2159-8290.CD-14-0474; Ma SB, 2014, CANCER RES, V74, P1969, DOI 10.1158/0008-5472.CAN-13-2534; McAllister F, 2014, CANCER CELL, V25, P621, DOI 10.1016/j.ccr.2014.03.014; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Oberg HH, 2014, CANCER RES, V74, P1349, DOI 10.1158/0008-5472.CAN-13-0675; Ochi A, 2012, J CLIN INVEST, V122, P4118, DOI 10.1172/JCI63606; Ochi A, 2012, J EXP MED, V209, P1671, DOI 10.1084/jem.20111706; Peng G, 2007, IMMUNITY, V27, P334, DOI 10.1016/j.immuni.2007.05.020; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Rehman A, 2013, J IMMUNOL, V190, P4640, DOI 10.4049/jimmunol.1202312; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Seifert L, 2016, NATURE, V532, P245, DOI 10.1038/nature17403; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Todaro M, 2009, J IMMUNOL, V182, P7287, DOI 10.4049/jimmunol.0804288; Wu HH, 2015, J EXP MED, V212, P333, DOI 10.1084/jem.20141702; Wu P, 2014, IMMUNITY, V40, P785, DOI 10.1016/j.immuni.2014.03.013; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Yang J, 2010, P NATL ACAD SCI USA, V107, P4716, DOI 10.1073/pnas.0911587107; Zambirinis CP, 2015, J EXP MED, V212, P2077, DOI 10.1084/jem.20142162; Zheng L, 2013, GASTROENTEROLOGY, V144, P1230, DOI 10.1053/j.gastro.2012.12.042; Zhu Y, 2014, CANCER RES, V74, P5057, DOI 10.1158/0008-5472.CAN-13-3723	43	195	207	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2016	166	6					1485	+		10.1016/j.cell.2016.07.046	http://dx.doi.org/10.1016/j.cell.2016.07.046			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EA1GG	27569912	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000386339900020
J	Villa, R; Schauer, T; Smialowski, P; Straub, T; Becker, PB				Villa, Raffaella; Schauer, Tamas; Smialowski, Pawel; Straub, Tobias; Becker, Peter B.			PionX sites mark the X chromosome for dosage compensation	NATURE			English	Article							BINDING-SPECIFICITY; SEX-CHROMOSOMES; MSL PROTEINS; CXC DOMAIN; DNA SHAPE; DROSOPHILA; COMPLEX; RECOGNITION; SEQUENCE; NETWORK	The rules defining which small fraction of related DNA sequences can be selectively bound by a transcription factor are poorly understood. One of the most challenging tasks in DNA recognition is posed by dosage compensation systems that require the distinction between sex chromosomes and autosomes. In Drosophila melanogaster, the male-specific lethal dosage compensation complex (MSL-DCC) doubles the level of transcription from the single male X chromosome, but the nature of this selectivity is not known(1). Previous efforts to identify X-chromosome-specific target sequences were unsuccessful as the identified MSL recognition elements lacked discriminative power(2,3). Therefore, additional determinants such as co-factors, chromatin features, RNA and chromosome conformation have been proposed to refine targeting further(4). Here, using an in vitro genome-wide DNA binding assay, we show that recognition of the X chromosome is an intrinsic feature of the MSL-DCC. MSL2, the male-specific organizer of the complex, uses two distinct DNA interaction surfaces-the CXC and proline/basic-residue-rich domains-to identify complex DNA elements on the X chromosome. Specificity is provided by the CXC domain, which binds a novel motif defined by DNA sequence and shape. This motif characterizes a subclass of MSL2-binding sites, which we name PionX (pioneering sites on the X) as they appeared early during the recent evolution of an X chromosome in D. miranda and are the first chromosomal sites to be bound during de novo MSL-DCC assembly. Our data provide the first, to our knowledge, documented molecular mechanism through which the dosage compensation machinery distinguishes the X chromosome from an autosome. They highlight fundamental principles in the recognition of complex DNA elements by protein that will have a strong impact on many aspects of chromosome biology.	[Villa, Raffaella; Schauer, Tamas; Becker, Peter B.] Univ Munich, Div Mol Biol, Biomed Ctr, D-82152 Planegg Martinsried, Germany; [Villa, Raffaella; Schauer, Tamas; Becker, Peter B.] Univ Munich, Ctr Integrated Prot Sci Munich, D-82152 Planegg Martinsried, Germany; [Smialowski, Pawel; Straub, Tobias] Univ Munich, Bioinformat Unit, Biomed Ctr, D-82152 Planegg Martinsried, Germany	University of Munich; University of Munich; University of Munich	Becker, PB (corresponding author), Univ Munich, Div Mol Biol, Biomed Ctr, D-82152 Planegg Martinsried, Germany.; Becker, PB (corresponding author), Univ Munich, Ctr Integrated Prot Sci Munich, D-82152 Planegg Martinsried, Germany.; Straub, T (corresponding author), Univ Munich, Bioinformat Unit, Biomed Ctr, D-82152 Planegg Martinsried, Germany.	tstraub@med.uni-muenchen.de; pbecker@med.uni-muenchen.de	Straub, Tobias/B-2023-2009; Villa, Raffaella/D-5223-2018	Straub, Tobias/0000-0002-0547-0453; Becker, Peter/0000-0001-7186-0372; Schauer, Tamas/0000-0001-9602-4557	European Research Council under European Union/ERC [293948]; German Research Council [CRC 1064]	European Research Council under European Union/ERC(European Research Council (ERC)); German Research Council(German Research Foundation (DFG))	This work was supported by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement number 293948 (PBB) and the German Research Council (CRC 1064, T.St.). We thank P. Korber for suggesting the DIP experiment, F. Gebauer for sharing her antibody against SXL, and S. Schunter, V. Flynn, S. Krause and A. Zabel for technical assistance. We thank N. Gompel for critical reading of the manuscript and S. Krebs and H. Blum for their sequencing service.	Abe N, 2015, CELL, V161, P307, DOI 10.1016/j.cell.2015.02.008; Alekseyenko AA, 2008, CELL, V134, P599, DOI 10.1016/j.cell.2008.06.033; Alekseyenko AA, 2013, GENE DEV, V27, P853, DOI 10.1101/gad.215426.113; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Copps K, 1998, EMBO J, V17, P5409, DOI 10.1093/emboj/17.18.5409; Dahlsveen IK, 2006, PLOS GENET, V2, P104, DOI 10.1371/journal.pgen.0020005; Ellison CE, 2013, SCIENCE, V342, P846, DOI 10.1126/science.1239552; Fauth T, 2010, NUCLEIC ACIDS RES, V38, P3209, DOI 10.1093/nar/gkq026; Gossett A. J, 2008, CSH PROTOC, V2008; Guertin MJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002610; Hallacli E, 2012, MOL CELL, V48, P587, DOI 10.1016/j.molcel.2012.09.014; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Jolma A, 2015, NATURE, V527, P384, DOI 10.1038/nature15518; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li F, 2008, MOL CELL BIOL, V28, P1252, DOI 10.1128/MCB.00910-07; LUCCHESI JC, 1978, SCIENCE, V202, P711, DOI 10.1126/science.715437; Lucchesi JC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019398; McElroy KA, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140006; Park Y, 2002, SCIENCE, V298, P1620, DOI 10.1126/science.1076686; Ramirez F, 2015, MOL CELL, V60, P146, DOI 10.1016/j.molcel.2015.08.024; Schauer T, 2013, CELL REP, V5, P271, DOI 10.1016/j.celrep.2013.09.001; Soruco MML, 2013, GENE DEV, V27, P1551, DOI 10.1101/gad.214585.113; Straub T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000302; Summer M., 2005, SPEEDING LOGISTIC MO, P675; Villa R, 2012, MOL CELL, V48, P647, DOI 10.1016/j.molcel.2012.09.012; Zheng SD, 2014, GENE DEV, V28, P2652, DOI 10.1101/gad.250936.114; Zhou Q, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001711; Zhou TY, 2013, NUCLEIC ACIDS RES, V41, pW56, DOI 10.1093/nar/gkt437	30	43	43	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					244	+		10.1038/nature19338	http://dx.doi.org/10.1038/nature19338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9LQ	27580037				2022-12-28	WOS:000382539100050
J	Weir, JR; Faesen, AC; Klare, K; Petrovic, A; Basilico, F; Fischbock, J; Pentakota, S; Keller, J; Pesenti, ME; Pan, DQ; Vogt, D; Wohlgemuth, S; Herzog, F; Musacchio, A				Weir, John R.; Faesen, Alex C.; Klare, Kerstin; Petrovic, Arsen; Basilico, Federica; Fischboeck, Josef; Pentakota, Satyakrishna; Keller, Jenny; Pesenti, Marion E.; Pan, Dongqing; Vogt, Doro; Wohlgemuth, Sabine; Herzog, Franz; Musacchio, Andrea			Insights from biochemical reconstitution into the architecture of human kinetochores	NATURE			English	Article							CENP-A NUCLEOSOMES; MICROTUBULE-ATTACHMENT; CENTROMERIC CHROMATIN; OUTER KINETOCHORE; NDC80 COMPLEX; MOLECULAR ARCHITECTURE; MIS12 COMPLEX; PROTEIN; DNA; RECOGNITION	Chromosomes are carriers of genetic material and their accurate transfer from a mother cell to its two daughters during cell division is of paramount importance for life. Kinetochores are crucial for this process, as they connect chromosomes with microtubules in the mitotic spindle(1). Kinetochores are multi-subunit complexes that assemble on specialized chromatin domains, the centromeres, that are able to enrich nucleosomes containing the histone H3 variant centromeric protein A (CENP-A)(2). A group of several additional CENPs, collectively known as constitutive centromere associated network (CCAN)(3-6), establish the inner kinetochore, whereas a ten-subunit assembly known as the KMN network creates a microtubule-binding site in the outer kinetochore(7,8). Interactions between CENP-A and two CCAN subunits, CENP-C and CENP-N, have been previously described(9-11), but a comprehensive understanding of CCAN organization and of how it contributes to the selective recognition of CENP-A has been missing. Here we use biochemical reconstitution to unveil fundamental principles of kinetochore organization and function. We show that cooperative interactions of a seven-subunit CCAN subcomplex, the CHIKMLN complex, determine binding selectivity for CENP-A over H3-nucleosomes. The CENP-A: CHIKMLN complex binds directly to the KMN network, resulting in a 21-subunit complex that forms a minimal high-affinity linkage between CENP-A nucleosomes and microtubules in vitro. This structural module is related to fungal point kinetochores, which bind a single microtubule. Its convolution with multiple CENP-A proteins may give rise to the regional kinetochores of higher eukaryotes, which bind multiple microtubules. Biochemical reconstitution paves the way for mechanistic and quantitative analyses of kinetochores.	[Weir, John R.; Faesen, Alex C.; Klare, Kerstin; Petrovic, Arsen; Basilico, Federica; Pentakota, Satyakrishna; Keller, Jenny; Pesenti, Marion E.; Pan, Dongqing; Vogt, Doro; Wohlgemuth, Sabine; Musacchio, Andrea] Max Planck Inst Mol Physiol, Dept Mech Cell Biol, Otto Hahn Str 11, D-44227 Dortmund, Germany; [Fischboeck, Josef; Herzog, Franz] Univ Munich, Gene Ctr Munich, Feodor Lynen Str 25, D-81377 Munich, Germany; [Musacchio, Andrea] Univ Duisburg Essen, Fac Biol, Ctr Med Biotechnol, Univ Str, D-45141 Essen, Germany	Max Planck Society; University of Munich; University of Duisburg Essen	Weir, JR; Musacchio, A (corresponding author), Max Planck Inst Mol Physiol, Dept Mech Cell Biol, Otto Hahn Str 11, D-44227 Dortmund, Germany.; Musacchio, A (corresponding author), Univ Duisburg Essen, Fac Biol, Ctr Med Biotechnol, Univ Str, D-45141 Essen, Germany.	john.weir@mpi-dortmund.mpg.de; andrea.musacchio@mpi-dortmund.mpg.de	Herzog, Franz/G-4832-2012; Weir, John R./AAF-5435-2020; Faesen, Alex/GXA-1482-2022	Herzog, Franz/0000-0001-8270-1449; Weir, John R./0000-0002-6904-0284; Faesen, Alex/0000-0002-4685-1463; Pan, Dongqing/0000-0003-3701-8442; Petrovic, Arsen/0000-0003-4448-4230; Pesenti, Marion/0000-0003-3361-8133; Killinger, Kerstin/0000-0002-1278-0302; Musacchio, Andrea/0000-0003-2362-8784; pentakota, satya/0000-0002-7894-4146	EMBO long-term fellowship [ALTF 1096-2012]; Marie Curie Intra-European Fellowship; European Union; Horizon 2020 ERC RECEPIANCE; DFG's Collaborative Research Centre [1093]; European Research Council (MolStruKT StG) [638218]; LMU excellent junior grant	EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Marie Curie Intra-European Fellowship(European Commission); European Union(European Commission); Horizon 2020 ERC RECEPIANCE; DFG's Collaborative Research Centre(German Research Foundation (DFG)); European Research Council (MolStruKT StG); LMU excellent junior grant	We are grateful to F. Martino and D. Rhodes for help in setting up NCP preparations, to A. F. Straight for providing plasmids for expression of CENP-A: H4, to K. A. Davey for plasmids to produce the '601' 145-bp nucleosomal DNA, to C. Smith for setting up conditions for CENP-H depletion, to G. Ossolengo of the antibody facility at the European Institute of Oncology in Milan (Italy) for help with antibody production, and all other members of the Musacchio laboratory for discussions. A. C. F. is supported by an EMBO long-term fellowship (ALTF 1096-2012) and Marie Curie Intra-European Fellowship. A.M. acknowledges funding by the European Union's 7th Framework Program Integrated Project MitoSys, the Horizon 2020 ERC agreement RECEPIANCE, and the DFG's Collaborative Research Centre 1093. F.H. is supported by the European Research Council (MolStruKT StG number 638218) and by an LMU excellent junior grant.	Akiyoshi B, 2010, NATURE, V468, P576, DOI 10.1038/nature09594; Basilico F, 2014, ELIFE, V3, DOI 10.7554/eLife.02978; Bieniossek C, 2012, TRENDS BIOCHEM SCI, V37, P49, DOI 10.1016/j.tibs.2011.10.005; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Bodor DL, 2014, ELIFE, V3, DOI 10.7554/eLife.02137; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Catania S, 2014, CURR OPIN CELL BIOL, V26, P41, DOI 10.1016/j.ceb.2013.09.004; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Cohen RL, 2008, MOL BIOL CELL, V19, P4480, DOI 10.1091/mbc.E08-03-0297; Dambacher S, 2012, NUCLEUS-PHILA, V3, P101, DOI 10.4161/nucl.18955; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Dunleavy EM, 2011, NUCLEUS-PHILA, V2, P146, DOI 10.4161/nucl.2.2.15211; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fukagawa T, 2014, DEV CELL, V30, P497, DOI 10.1016/j.devcel.2014.08.016; Gascoigne KE, 2011, CELL, V145, P410, DOI 10.1016/j.cell.2011.03.031; Ghongane P, 2014, J CELL SCI, V127, P3415, DOI 10.1242/jcs.149922; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gonen S, 2012, NAT STRUCT MOL BIOL, V19, P925, DOI 10.1038/nsmb.2358; Grimm M, 2015, NUCLEIC ACIDS RES, V43, pW362, DOI 10.1093/nar/gkv463; Guse A, 2012, NAT PROTOC, V7, P1847, DOI 10.1038/nprot.2012.112; Guse A, 2011, NATURE, V477, P354, DOI 10.1038/nature10379; Hashimoto Y, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-12; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Herzog F, 2012, SCIENCE, V337, P1348, DOI 10.1126/science.1221483; Hinshaw SM, 2013, CELL REP, V5, P29, DOI 10.1016/j.celrep.2013.08.036; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Hornung P, 2011, J MOL BIOL, V405, P548, DOI 10.1016/j.jmb.2010.11.012; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Kato H, 2013, SCIENCE, V340, P1110, DOI 10.1126/science.1235532; Kiyomitsu T, 2010, J CELL BIOL, V188, P791, DOI 10.1083/jcb.200908096; Klare K, 2015, J CELL BIOL, V210, P11, DOI 10.1083/jcb.201412028; London N, 2014, NAT REV MOL CELL BIO, V15, P735, DOI 10.1038/nrm3888; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Maskell DP, 2010, J CELL BIOL, V190, P823, DOI 10.1083/jcb.201002059; McKinley KL, 2015, MOL CELL, V60, P886, DOI 10.1016/j.molcel.2015.10.027; Milks KJ, 2009, MOL BIOL CELL, V20, P4246, DOI 10.1091/mbc.E09-05-0378; Moree B, 2011, J CELL BIOL, V194, P855, DOI 10.1083/jcb.201106079; Nagpal H, 2015, MOL BIOL CELL, V26, P3768, DOI 10.1091/mbc.E15-07-0531; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Petrovic A, 2014, MOL CELL, V53, P591, DOI 10.1016/j.molcel.2014.01.019; Petrovic A, 2010, J CELL BIOL, V190, P835, DOI 10.1083/jcb.201002070; Przewloka MR, 2011, CURR BIOL, V21, P399, DOI 10.1016/j.cub.2011.02.005; Schleiffer A, 2012, NAT CELL BIOL, V14, P604, DOI 10.1038/ncb2493; Screpanti E, 2011, CURR BIOL, V21, P391, DOI 10.1016/j.cub.2010.12.039; Shim Y, 2012, ANAL BIOCHEM, V427, P190, DOI 10.1016/j.ab.2012.05.006; Suzuki A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9161; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Westermann S, 2013, TRENDS CELL BIOL, V23, P260, DOI 10.1016/j.tcb.2013.01.010; Westhorpe FG, 2012, CELL, V150, P245, DOI 10.1016/j.cell.2012.07.003	55	100	100	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					249	+		10.1038/nature19333	http://dx.doi.org/10.1038/nature19333			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9LQ	27580032	Green Submitted			2022-12-28	WOS:000382539100051
J	Bibbins-Domingo, K; Grossman, DC; Curry, SJ; Bauman, L; Davidson, KW; Epling, JW; Garcia, FAR; Herzstein, J; Kemper, AR; Krist, AH; Kurth, AE; Landefeld, S; Mangione, CM; Phillips, WR; Phipps, MG; Pignone, MP				Bibbins-Domingo, Kirsten; Grossman, David C.; Curry, Susan J.; Bauman, Linda; Davidson, Karina W.; Epling, John W., Jr.; Garcia, Francisco A. R.; Herzstein, Jessica; Kemper, Alex R.; Krist, Alex H.; Kurth, Ann E.; Landefeld, Seth; Mangione, Carol M.; Phillips, William R.; Phipps, Maureen G.; Pignone, Michael P.		US Preventive Serv Task Force	Screening for Latent Tuberculosis Infection in Adults US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RIFAMPIN	IMPORTANCE Tuberculosis remains an important preventable disease in the United States. An effective strategy for reducing the transmission, morbidity, and mortality of active disease is the identification and treatment of latent tuberculosis infection (LTBI) to prevent progression to active disease. OBJECTIVE To issue a current US Preventive Services Task Force (USPSTF) recommendation on screening for LTBI. EVIDENCE REVIEW The USPSTF reviewed the evidence on screening for LTBI in asymptomatic adults seen in primary care, including evidence dating from the inception of searched databases. FINDINGS The USPSTF found adequate evidence that accurate screening tests for LTBI are available, treatment of LTBI provides a moderate health benefit in preventing progression to active disease, and the harms of screening and treatment are small. The USPSTF has moderate certainty that screening for LTBI in persons at increased risk for infection provides a moderate net benefit. CONCLUSIONS AND RECOMMENDATION The USPSTF recommends screening for LTBI in populations at increased risk. (B recommendation)	[Bibbins-Domingo, Kirsten] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Grossman, David C.] Grp Hlth Res Inst, Seattle, WA USA; [Curry, Susan J.] Univ Iowa, Iowa City, IA USA; [Bauman, Linda] Univ Wisconsin, Madison, WI USA; [Davidson, Karina W.] Columbia Univ, New York, NY USA; [Epling, John W., Jr.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Garcia, Francisco A. R.] Pima Cty Dept Hlth, Tucson, AZ USA; [Kemper, Alex R.] Duke Univ, Durham, NC USA; [Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Kurth, Ann E.] Yale Univ, New Haven, CT USA; [Landefeld, Seth] Univ Alabama Birmingham, Birmingham, AL USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Phillips, William R.] Univ Washington, Seattle, WA 98195 USA; [Phipps, Maureen G.] Brown Univ, Providence, RI 02912 USA; [Pignone, Michael P.] Univ Texas Austin, Austin, TX 78712 USA	University of California System; University of California San Francisco; University of Iowa; University of Wisconsin System; University of Wisconsin Madison; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Duke University; Virginia Commonwealth University; Yale University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; Brown University; University of Texas System; University of Texas Austin	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.		Phillips, William R./V-1065-2017; Davidson, Karina/AAG-2388-2019; Davidson, Karina/GWC-0996-2022; Epling, John W/J-1097-2019	Phillips, William R./0000-0003-2802-4349; Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X; Epling, John W/0000-0001-9445-8669; Kemper, Alex/0000-0001-5491-3997				Centers for Disease Control and Prevention, 2014, TEST TUB TB; Centers for Disease Control and Prevention, 2014, LAT TUB INF GUID PRI; Centers for Disease Control and Prevention, 2015, FACT SHEET INT GAMM; Centers for Disease Control and Prevention, 2014, REP TUB US; Centers for Disease Control and Prevention, 2015, TB CORR FAC US; Centers for Disease Control and Prevention, 2014, TB PREGN; Centers for Disease Control and Prevention, 2016, INF CONTR HLTH CAR S; Centers for Disease Control and Prevention, 2016, FACT SHEET TUB SKIN; Centers for Disease Control and Prevention, 2016, TREATM REG LAT TB IN; Centers for Disease Control and Prevention, 2015, FACT SHEET TRENDS TU; Centers for Disease Control and Prevention, 2012, TB GUID; Centers for Disease Control and Prevention, 2013, TARG TEST TUB; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; Collins LF, 2016, ANN INTERN MED, V164, P122, DOI 10.7326/M15-1522; Getahun H, 2015, NEW ENGL J MED, V372, P2127, DOI 10.1056/NEJMra1405427; GRZYBOWSKI S, 1975, Bulletin of the International Union Against Tuberculosis, V50, P90; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Kahwati LC, 2016, AHRQ PUBLICATION, V14-05212-EF-1; Kahwati LC, 2016, JAMA-J AM MED ASSOC, V316, P970, DOI 10.1001/jama.2016.10357; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; Menzies D, 2004, AM J RESP CRIT CARE, V170, P445, DOI 10.1164/rccm.200404-478OC; Menzies D, 2008, ANN INTERN MED, V149, P689, DOI 10.7326/0003-4819-149-10-200811180-00003; Miramontes R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140881; National Institutes of Health, 2016, AIDSINFO GUID PREV T; Salinas JL, 2016, MMWR-MORBID MORTAL W, V65, P273, DOI 10.15585/mmwr.mm6511a2; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555; White MC, 2012, J CORRECT HEALTH CAR, V18, P131, DOI 10.1177/1078345811435973; WHO. World Health Organization, 2016, TUBERCULOSIS TB; World Health Organisation, 2015, GUID MAN LAT TUB INF; World Health Organization, 2015, GLOB TUB REP 2015	33	122	123	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2016	316	9					962	969		10.1001/jama.2016.11046	http://dx.doi.org/10.1001/jama.2016.11046			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU8JV	27599331	Bronze			2022-12-28	WOS:000382460200019
J	Dooley, DP; Brown, TM				Dooley, David P.; Brown, Thomas M.			Alcohol Use	ANNALS OF INTERNAL MEDICINE			English	Letter									[Dooley, David P.; Brown, Thomas M.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Dooley, David P.; Brown, Thomas M.] Audie L Murphy Vet Affairs Med Ctr, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Dooley, DP (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.							Brown TM, 2015, PSYCHOSOMATICS, V56, P12, DOI 10.1016/j.psym.2014.05.010; Edelman EJ, 2016, ANN INTERN MED, V164, pITC1, DOI 10.7326/AITC201601050; Veerapaneni Karthika, 2014, Prim Care Companion CNS Disord, V16, DOI 10.4088/PCC.14br01649	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2016	165	5					379	379		10.7326/L16-0108	http://dx.doi.org/10.7326/L16-0108			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3BC	27595224				2022-12-28	WOS:000382795000015
J	Galishoff, ML				Galishoff, Mitchel L.			Follow-up to Nonfatal Opioid Overdoses	ANNALS OF INTERNAL MEDICINE			English	Letter									[Galishoff, Mitchel L.] Valley Med & Surg Clin, Valley, AL 36854 USA		Galishoff, ML (corresponding author), Valley Med & Surg Clin, Valley, AL 36854 USA.							Gregg J, 2016, ANN INTERN MED, V164, P62, DOI 10.7326/M15-2687; Larochelle MR, 2016, ANN INTERN MED, V164, P1, DOI 10.7326/M15-0038	2	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2016	165	5					378	378		10.7326/L16-0111	http://dx.doi.org/10.7326/L16-0111			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3BC	27595222				2022-12-28	WOS:000382795000013
J	Voelker, R				Voelker, Rebecca			Relief From Dry Eye Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2016	316	9					918	918		10.1001/jama.2016.11454	http://dx.doi.org/10.1001/jama.2016.11454			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU8JV	27599324				2022-12-28	WOS:000382460200009
J	Oeffinger, M				Oeffinger, Marlene			Moulding the ribosome	NATURE			English	Editorial Material							EUKARYOTIC RIBOSOME; BIOGENESIS; RNA		[Oeffinger, Marlene] Inst Rech Clin Montreal, Dept Syst Biol, Montreal, PQ H2W 1R7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Oeffinger, M (corresponding author), Inst Rech Clin Montreal, Dept Syst Biol, Montreal, PQ H2W 1R7, Canada.	marlene.oeffinger@ircm.qc.ca	Oeffinger, Marlene/J-7538-2013	Oeffinger, Marlene/0000-0001-6427-1393				Chaker-Margot M, 2015, NAT STRUCT MOL BIOL, V22, P920, DOI 10.1038/nsmb.3111; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Dutca LM, 2011, NUCLEIC ACIDS RES, V39, P5164, DOI 10.1093/nar/gkr044; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Henras A. K., 2014, REV RNA, V6, P225, DOI [10.1002/wrna.126925346433, DOI 10.1002/WRNA.126925346433]; Kornprobst M, 2016, CELL, V166, P380, DOI 10.1016/j.cell.2016.06.014; Kuhlbrandt W, 2014, ELIFE, V3, DOI 10.7554/eLife.03678; KUMAR A, 1972, J MOL BIOL, V63, P233, DOI 10.1016/0022-2836(72)90372-5; WARNER JR, 1967, P NATL ACAD SCI USA, V58, P1984, DOI 10.1073/pnas.58.5.1984; WEINBERG RA, 1967, P NATL ACAD SCI USA, V58, P1088, DOI 10.1073/pnas.58.3.1088; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197	11	0	0	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					38	40		10.1038/537038a	http://dx.doi.org/10.1038/537038a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU7XC	27582216				2022-12-28	WOS:000382426900030
J	Lloyd-Sherlock, PG; Ebrahim, S; McKee, M; James, M				Lloyd-Sherlock, Peter G.; Ebrahim, Shah; McKee, Martin; James, Martin			Institutional ageism in global health policy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NONCOMMUNICABLE DISEASES; DISCRIMINATION; MORTALITY; BURDEN; TRENDS		[Lloyd-Sherlock, Peter G.] Univ East Anglia, Sch Dev Studies, Norwich NR4 7TJ, Norfolk, England; [Ebrahim, Shah] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London, England; [McKee, Martin] London Sch Hyg & Trop Med, ECOHOST, London, England; [James, Martin] Kings Coll London, Inst Psychiat, London WC2R 2LS, England	University of East Anglia; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London	Lloyd-Sherlock, PG (corresponding author), Univ East Anglia, Sch Dev Studies, Norwich NR4 7TJ, Norfolk, England.	p.lloyd-sherlock@uea.ac.uk	Prince, Martin J/A-9170-2010; Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011	Prince, Martin J/0000-0003-1379-7146; Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X; Lloyd-Sherlock, Peter/0000-0002-1367-0703				Albone R, 2011, HIV STAT TARGETS EXC; Alleyne G, 2013, LANCET, V381, P566, DOI 10.1016/S0140-6736(12)61806-6; Almeida C, 2001, LANCET, V357, P1692, DOI 10.1016/S0140-6736(00)04825-X; Alves CG, 2015, CIENC SAUDE COLETIVA, V20, P641, DOI 10.1590/1413-81232015203.15342014; Arnesen T, 2004, HEALTH POLICY, V70, P137, DOI 10.1016/j.healthpol.2003.08.004; BICKNELL WJ, 1989, SOC SCI MED, V28, P59, DOI 10.1016/0277-9536(89)90307-9; Bretton Woods Project, 2006, WORLD BANK AG; Butler R. N., 1975, WHY SURVIVE BEING OL; CALLAHAN D, 1994, GERONTOLOGIST, V34, P393, DOI 10.1093/geront/34.3.393; Carers UK, 2015, FACTS ABOUT CARERS; Dotchin CL, 2013, AGE AGEING, V42, P124, DOI 10.1093/ageing/afs119; Fukuda-Parr S., 2013, DEVELOPMENT, V56, P58, DOI DOI 10.1057/DEV.2013.8; Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012; Gaynor EJ, 2014, AGE AGEING, V43, P429, DOI 10.1093/ageing/afu026; Kontis V, 2014, LANCET, V384, P427, DOI 10.1016/S0140-6736(14)60616-4; Kydd A, 2015, MATURITAS, V81, P432, DOI 10.1016/j.maturitas.2015.05.002; Becca RL, 2007, SEX TRANSM DIS, V34, P541, DOI 10.1097/01.olq.0000253342.75908.05; Lloyd-Sherlock P., 2002, HLTH POLICY GLOBALIS, P195; Lloyd-Sherlock P, 2014, INT J EPIDEMIOL, V43, P116, DOI 10.1093/ije/dyt215; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Norheim OF, 2015, LANCET, V385, P239, DOI 10.1016/S0140-6736(14)61591-9; NUESSEL FH, 1982, GERONTOLOGIST, V22, P273, DOI 10.1093/geront/22.3.273; Ordunez P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141685; Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7; Rippon I, 2014, AGE AGEING, V43, P379, DOI 10.1093/ageing/aft146; Roscigno VJ, 2007, SOC FORCES, V86, P313, DOI 10.1353/sof.2007.0109; Santosa A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0313-8; Tinney J, 2015, INT PSYCHOGERIATR, V27, P1411, DOI 10.1017/S1041610214002671; United Nations, 2002, MADR INT PLAN ACT AG, DOI DOI 10.1111/J.1468-2451.2008.00660.X; Wheller Levin, 2006, Health Stat Q, P34; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2000, WHO GLOBAL STRATEGY; Williams A, 1997, HEALTH ECON, V6, P117, DOI 10.1002/(SICI)1099-1050(199703)6:2<117::AID-HEC256>3.0.CO;2-B; World Bank, 1993, WORLD DEV REP INV HL; World Health Organisation, 2015, WHO WORLD REP AG HLT; World Health Organization, 2008, 2008 2013 ACT PLAN G; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616	37	37	37	2	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 31	2016	354								i4514	10.1136/bmj.i4514	http://dx.doi.org/10.1136/bmj.i4514			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DV3AD	27582131	Green Published, Green Accepted			2022-12-28	WOS:000382792500005
J	McGilvray, A				McGilvray, Annabel			NEW ZEALAND	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					S30	S30		10.1038/536S30a	http://dx.doi.org/10.1038/536S30a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV0YL	27557162	Bronze			2022-12-28	WOS:000382646600009
J	Zhu, LQ; Finkelstein, D; Gao, CL; Shi, L; Wang, YD; Lopez-Terrada, D; Wang, K; Utley, S; Pounds, S; Neale, G; Ellison, D; Onar-Thomas, A; Gilbertson, RJ				Zhu, Liqin; Finkelstein, David; Gao, Culian; Shi, Lei; Wang, Yongdong; Lopez-Terrada, Dolores; Wang, Kasper; Utley, Sarah; Pounds, Stanley; Neale, Geoffrey; Ellison, David; Onar-Thomas, Arzu; Gilbertson, Richard James			Multi-organ Mapping of Cancer Risk	CELL			English	Article							STEM-CELLS; HEMATOPOIETIC STEM; BETA-CATENIN; INFLAMMATION; MODEL; WNT; PROLIFERATION; EXPRESSION; MUTATIONS; RENEWAL	Cancers are distributed unevenly across the body, but the importance of cell intrinsic factors such as stem cell function in determining organ cancer risk is unknown. Therefore, we used Cre-recombination of conditional lineage tracing, oncogene, and tumor suppressor alleles to define populations of stem and non-stem cells in mouse organs and test their lifelong susceptibility to tumorigenesis. We show that tumor incidence is determined by the life-long generative capacity of mutated cells. This relationship held true in the presence of multiple genotypes and regardless of developmental stage, strongly supporting the notion that stem cells dictate organ cancer risk. Using the liver as a model system, we further show that damage-induced activation of stem cell function markedly increases cancer risk. Therefore, we propose that a combination of stem cell mutagenesis and extrinsic factors that enhance the proliferation of these cell populations, creates a "perfect storm" that ultimately determines organ cancer risk.	[Zhu, Liqin] St Jude Childrens Res Hosp, Dept Dev Neurobiol, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Finkelstein, David; Wang, Yongdong] St Jude Childrens Res Hosp, Dept Computat Biol, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Gao, Culian; Shi, Lei; Pounds, Stanley; Onar-Thomas, Arzu] St Jude Childrens Res Hosp, Dept Biostat, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Lopez-Terrada, Dolores] Baylor Coll Med, Dept Pathol & Immunol, 1 Baylor Plaza, Houston, TX 77030 USA; [Wang, Kasper; Utley, Sarah] Childrens Hosp Los Angeles, Div Pediat Surg, Dev Biol Regenerat Med & Stem Cell, 4650 Sunset Blvd, Los Angeles, CA 90027 USA; [Neale, Geoffrey] St Jude Childrens Res Hosp, Hartwell Ctr, Memphis, TN 38105 USA; [Ellison, David] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Gilbertson, Richard James] Dept Oncol, Robinson Way, Cambridge CB2 0RE, England; [Gilbertson, Richard James] CRUK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Baylor College of Medicine; Children's Hospital Los Angeles; St Jude Children's Research Hospital; St Jude Children's Research Hospital; CRUK Cambridge Institute	Onar-Thomas, A (corresponding author), St Jude Childrens Res Hosp, Dept Biostat, 262 Danny Thomas Pl, Memphis, TN 38105 USA.; Gilbertson, RJ (corresponding author), Dept Oncol, Robinson Way, Cambridge CB2 0RE, England.; Gilbertson, RJ (corresponding author), CRUK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England.	arzu.onar@stjude.org; richard.gilbertson@cruk.cam.ac.uk	Zhu, Liqin/N-8126-2018; Gilbertson, Richard James/ABE-1346-2021; Pounds, Stanley B/N-2480-2018; Ellison, David/N-4806-2018; Onar-Thomas, Arzu/M-9356-2018	Zhu, Liqin/0000-0002-2346-150X; Gilbertson, Richard James/0000-0001-7539-9472; Pounds, Stanley B/0000-0002-9167-2114; 	NIH [P01CA96832, P30CA021765]; American Lebanese Syrian Associated Charities; Cancer Research UK; NATIONAL CANCER INSTITUTE [P30CA021765, P01CA096832] Funding Source: NIH RePORTER; Cancer Research UK [22492] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK)	This work was supported by grants from the NIH (P01CA96832, R01, and P30CA021765 to R.J.G.), the American Lebanese Syrian Associated Charities, and Cancer Research UK. We are grateful to the staff of the Hartwell Center for Bioinformatics and Biotechnology, the Cell and Tissue Imaging Shared Resource, and the ARC at St. Jude Children's Research Hospital for technical assistance.	Arndt K, 2013, P NATL ACAD SCI USA, V110, P5582, DOI 10.1073/pnas.1215438110; Ashford NA, 2015, SCIENCE, V347, P727, DOI 10.1126/science.aaa6246; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; BENNOUN M, 1993, AM J PATHOL, V143, P1326; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Block TM, 2003, ONCOGENE, V22, P5093, DOI 10.1038/sj.onc.1206557; Boyce S, 2008, LAB ANIMAL, V37, P529, DOI 10.1038/laban1108-529; Calmon MF, 2015, EPIGENETICS-US, V10, P622, DOI 10.1080/15592294.2015.1050173; Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; Clark PE, 2011, AM J PATHOL, V179, P3045, DOI 10.1016/j.ajpath.2011.08.006; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Engreitz JM, 2010, J BIOMED INFORM, V43, P932, DOI 10.1016/j.jbi.2010.07.001; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gotay C, 2015, SCIENCE, V347, P728, DOI 10.1126/science.aaa6462; Hand NJ, 2009, HEPATOLOGY, V49, P618, DOI 10.1002/hep.22656; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Howlader N, 2012, SEER CANC STAT REV; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Jones C, 2014, NAT REV CANCER, V14, P651, DOI 10.1038/nrc3811; Kinkel SA, 2015, BLOOD, V125, P1890, DOI 10.1182/blood-2014-10-603969; Kong DH, 1997, NAT GENET, V17, P143, DOI 10.1038/ng1097-143; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Lopez-Terrada D, 2009, HUM PATHOL, V40, P783, DOI 10.1016/j.humpath.2008.07.022; McCulloch C. E., 2008, GEN LINEAR MIXED MOD; Melero I, 2015, NAT REV CANCER, V15, P457, DOI 10.1038/nrc3973; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Callaghan M, 2015, SCIENCE, V347, P729, DOI 10.1126/science.aaa6212; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Potter JD, 2015, SCIENCE, V347, P727, DOI 10.1126/science.aaa6507; Preisegger KH, 1999, LAB INVEST, V79, P103; Raimondi AR, 2006, AM J PATHOL, V168, P1654, DOI 10.2353/ajpath.2006.050847; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Risinger JI, 1997, CANCER RES, V57, P4736; Shalapour S, 2015, J CLIN INVEST, V125, P3347, DOI 10.1172/JCI80007; Shupe Thomas D., 2009, V482, P387, DOI 10.1007/978-1-59745-060-7_24; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Skaug H. J., 2014, GEN LINEAR MIXED MOD; Song MY, 2015, SCIENCE, V347, P728, DOI 10.1126/science.aaa6094; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863; Wild C, 2015, CANC RISK ROLE CHANC, V2015, P728; Wu S, 2016, NATURE, V529, P43, DOI 10.1038/nature16166; Xin L, 2003, P NATL ACAD SCI USA, V100, P11896, DOI 10.1073/pnas.1734139100; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	53	78	81	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1132	+		10.1016/j.cell.2016.07.045	http://dx.doi.org/10.1016/j.cell.2016.07.045			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27565343	Green Accepted, Bronze			2022-12-28	WOS:000382259500012
J	Wingerchuk, DM; Weinshenker, BG				Wingerchuk, Dean M.; Weinshenker, Brian G.			Disease modifying therapies for relapsing multiple sclerosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; TECHNOLOGY-ASSESSMENT SUBCOMMITTEE; PLACEBO-CONTROLLED PHASE-3; STEM-CELL TRANSPLANTATION; DOUBLE-BLIND; INTERFERON-BETA; GLATIRAMER ACETATE; FOLLOW-UP; NATURAL-HISTORY; INTRAMUSCULAR INTERFERON	Multiple sclerosis (MS) is a common, disabling, putatively autoimmune neurological disease with worldwide distribution. It typically begins as a relapsing disorder that later evolves to a secondary progressive phase. Inflammatory and neurodegenerative mechanisms seem to operate in both phases, but their relative contributions and interactions are incompletely understood. Disease modifying therapies (DMTs) approved for relapsing multiple sclerosis interfere with a variety of immunological mechanisms to reduce rates of relapse, accumulation of disease burden measured by magnetic resonance imaging (MRI), and decline in neurological function over the two to three year duration of typical randomized controlled trials. Benefits of longer duration of therapy on disability are less clear, as data beyond three years are largely limited to observational studies. However, current DMTs do not slow accrual of disability once progressive multiple sclerosis is established. This review summarizes the evidence about the use of approved DMTs and examines how to individualize treatment despite the absence of validated biomarkers to guide drug selection. Methods such as stratifying patients on the basis of estimated risk for future disability, weighing patient specific factors and preferences, and using objective outcomes to adjudicate treatment success are discussed. Emerging drug therapies and strategies are also reviewed.	[Wingerchuk, Dean M.] Mayo Clin, Dept Neurol, 13400 EShea Blvd, Scottsdale, AZ 85259 USA; [Weinshenker, Brian G.] Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic	Wingerchuk, DM (corresponding author), Mayo Clin, Dept Neurol, 13400 EShea Blvd, Scottsdale, AZ 85259 USA.	wingerchuk.dean@mayo.edu	Weinshenker, Brian G/ABH-6146-2020	Weinshenker, Brian G/0000-0001-5806-6203	Alexion; TerumoBCT	Alexion; TerumoBCT	We have read and understood BMJ policy on declaration of interests and declare the following interests: DMW receives research support from Alexion and TerumoBCT and personal compensation for consulting services provided to MedImmune for a neuromyelitis optica clinical trial adjudication panel; he has received personal compensation for consulting services from Chugai; BGW receives personal compensation for consulting services provided to MedImmune for a neuromyelitis optica clinical trial adjudication panel and for MS clinical trial DSMB membership from Novartis and Mitsubishi; he receives royalties from RSR Ltd and Oxford University for a patent on NMO-IgG as a diagnostic test for neuromyelitis optica and related disorders and has received personal compensation for consulting services from Elan, Chord Pharmaceuticals, GSK Pharmaceuticals, Ono Pharmaceuticals, and Chugai and MS clinical trial DSMB membership from Biogen.	Achtnichts L, 2015, JAMA NEUROL, V72, P1203, DOI 10.1001/jamaneurol.2015.1746; Alonso A, 2008, NEUROLOGY, V70, pA333, DOI 10.1212/01.wnl.0000316802.35974.34; Alping P, 2016, ANN NEUROL, V79, P950, DOI 10.1002/ana.24651; Andersen O, 2010, BRAIN, V133, P1863, DOI 10.1093/brain/awq182; Arvin AM, 2015, JAMA NEUROL, V72, P31, DOI 10.1001/jamaneurol.2014.3065; Atkins HL, 2016, LANCET, VS0140-6736; Barbin L, 2016, NEUROLOGY, V86, P771, DOI 10.1212/WNL.0000000000002395; Belbasis L, 2015, LANCET NEUROL, V14, P263, DOI 10.1016/S1474-4422(14)70267-4; Bergamaschi R, 2016, MULT SCLER J, V22, P1732, DOI 10.1177/1352458512445941; Berger JR, 2016, J NEUROVIROL, V22, P533, DOI 10.1007/s13365-016-0427-6; Bermel RA, 2013, ANN NEUROL, V73, P95, DOI 10.1002/ana.23758; Bevan CJ, 2014, JAMA NEUROL, V71, P269, DOI 10.1001/jamaneurol.2013.5486; Biogen, 2016, TYSABRI NAT PML INC; Blair NF, 2012, NEUROLOGY, V78, P507, DOI 10.1212/WNL.0b013e318246d6d8; Bloomgren G, 2012, NEW ENGL J MED, V366, P1870, DOI 10.1056/NEJMoa1107829; Boneschi FM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002127.pub3; Brosseau MSG, 2016, NEUROLOGY, V86, P484, DOI 10.1212/WNL.0000000000002330; Burt RK, 2015, JAMA-J AM MED ASSOC, V313, P275, DOI 10.1001/jama.2014.17986; Buttmann M, 2016, NEUROLOGY, V86, P2203, DOI 10.1212/WNL.0000000000002745; Calabresi PA, 2014, LANCET NEUROL, V13, P657, DOI 10.1016/S1474-4422(14)70068-7; Calabresi PA, 2014, LANCET NEUROL, V13, P545, DOI 10.1016/S1474-4422(14)70049-3; Claussen MC, 2012, CLIN IMMUNOL, V142, P49, DOI 10.1016/j.clim.2011.02.011; ClinicalTrials.gov, 2016, EFF SAF OF COMP TER; ClinicalTrials.gov, 2016, EFF SAF TOL LAQ SUBJ; Cobo-Calvo A, 2015, EUR NEUROL, V73, P220, DOI 10.1159/000375371; Cohen J, 2015, JAMA NEUROL, V72, P1433, DOI 10.1001/jamaneurol.2015.2154; Cohen JA, 2012, LANCET, V380, P1819, DOI 10.1016/S0140-6736(12)61769-3; Cohen JA, 2011, ANN NEUROL, V69, P759, DOI 10.1002/ana.22426; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Coles AJ, 2012, NEUROLOGY, V78, P1069, DOI 10.1212/WNL.0b013e31824e8ee7; Coles AJ, 2006, J NEUROL, V253, P98, DOI 10.1007/s00415-005-0934-5; Coles AJ, 2008, NEW ENGL J MED, V359, P1786, DOI 10.1056/NEJMoa0802670; Coles AJ, 2012, LANCET, V380, P1829, DOI 10.1016/S0140-6736(12)61768-1; Colombo E, 2014, ANN NEUROL, V76, P325, DOI 10.1002/ana.24217; Comabella M, 2016, CURR OPIN NEUROL, V29, P254, DOI 10.1097/WCO.0000000000000336; Comi G, 2009, LANCET, V374, P1503, DOI 10.1016/S0140-6736(09)61259-9; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Comi G, 2001, ANN NEUROL, V49, P290, DOI 10.1002/ana.64.abs; Confavreux C, 2006, BRAIN, V129, P595, DOI 10.1093/brain/awh714; Confavreux C, 2000, NEW ENGL J MED, V343, P1430, DOI 10.1056/NEJM200011163432001; Confavreux C, 2014, LANCET NEUROL, V13, P247, DOI 10.1016/S1474-4422(13)70308-9; Correale J, 2012, MULT SCLER J, V18, P210, DOI 10.1177/1352458511419702; Cree BAC, 2004, NEUROLOGY, V63, P2039, DOI 10.1212/01.WNL.0000145762.60562.5D; Derfuss T, 2015, CURR MED RES OPIN, V31, P1687, DOI 10.1185/03007995.2015.1067191; Derfuss T, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-116; Devonshire V, 2012, LANCET NEUROL, V11, P420, DOI 10.1016/S1474-4422(12)70056-X; Dilokthornsakul P, 2016, NEUROLOGY, V86, P1014, DOI 10.1212/WNL.0000000000002469; Dubey D, 2015, EXPERT REV NEUROTHER, V15, P339, DOI 10.1586/14737175.2015.1025755; DUQUETTE P, 1995, NEUROLOGY, V45, P1277; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Ebers G, 2010, BRAIN, V133, DOI 10.1093/brain/awq226; Edan G, 2011, J NEUROL NEUROSUR PS, V82, P1344, DOI 10.1136/jnnp.2010.229724; Edan G, 2013, CNS DRUGS, V27, P403, DOI 10.1007/s40263-013-0065-y; Ermis U, 2013, NEW ENGL J MED, V368, P1657, DOI 10.1056/NEJMc1211805; European Medicines Agency, 2016, ZINBR; European Medicines Agency, 2015, NEW REC MIN RISKS RA; European Medicines Agency, 2015, UPD REC MIN RISK RAR; Farez MF, 2015, J NEUROL NEUROSUR PS, V86, P26, DOI 10.1136/jnnp-2014-307928; Fazekas F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00010; Filippi M, 2016, LANCET NEUROL, V15, P292, DOI 10.1016/S1474-4422(15)00393-2; Fine AJ, 2014, ANN NEUROL, V75, P108, DOI 10.1002/ana.24051; Fisniku LK, 2008, BRAIN, V131, P808, DOI 10.1093/brain/awm329; Ford C, 2010, MULT SCLER, V16, P342, DOI 10.1177/1352458509358088; Forrestel AK, 2016, JAMA NEUROL, V73, P355, DOI 10.1001/jamaneurol.2015.4259; Fox RJ, 2012, NEW ENGL J MED, V367, P1087, DOI 10.1056/NEJMoa1206328; Freedman MS, 2013, CAN J NEUROL SCI, V40, P307, DOI 10.1017/S0317167100014244; Freedman MS, 2015, MULT SCLER; Giovannoni G, 2012, MULT SCLER J, V18, P932, DOI 10.1177/1352458511433302; Gold R, 2016, NEUROL THER, V5, P45, DOI 10.1007/s40120-016-0042-8; Gold R, 2013, LANCET, V381, P2167, DOI 10.1016/S0140-6736(12)62190-4; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Goodin DS, 2007, NEUROLOGY, V68, P977, DOI 10.1212/01.wnl.0000258545.73854.cf; Goodin DS, 2012, NEUROLOGY, V78, P1315, DOI 10.1212/WNL.0b013e3182535cf6; Goodin DS, 2012, J NEUROL NEUROSUR PS, V83, P282, DOI 10.1136/jnnp-2011-301178; Goodin DS, 2008, NEUROLOGY, V71, pS8, DOI 10.1212/WNL.0b013e31818f3d8b; Graber JJ, 2011, J NEUROL SCI, V305, P1, DOI 10.1016/j.jns.2011.03.026; Granberg T, 2013, MULT SCLER J, V19, P271, DOI 10.1177/1352458512451943; Hartung HP, 2002, LANCET, V360, P2018, DOI 10.1016/S0140-6736(02)12023-X; Hatcher SE, 2016, JAMA NEUROL, V73, P790, DOI 10.1001/jamaneurol.2016.0826; Hauser S, 2016, NEUROLOGY S, V86, P1526; Havrdova E, 2015, MULT SCLER J, V21, P45; He A, 2015, JAMA NEUROL, V72, P950, DOI 10.1001/jamaneurol.2015.1752; He D, 2016, COCHRANE DB SYST REV, V3; Hellwig K, 2015, JAMA NEUROL, V72, P1132, DOI 10.1001/jamaneurol.2015.1806; Herbstritt S, 2016, MULT SCLER J, V22, P810, DOI 10.1177/1352458515623366; Hirst C, 2008, J NEUROL, V255, P280, DOI 10.1007/s00415-008-0743-8; Huang DR, 2015, NEUROLOGY, V85, P1001, DOI 10.1212/WNL.0000000000001929; Iaffaldano P, 2015, BRAIN, V138, DOI 10.1093/brain/awv260; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Jain N, 2012, NEUROLOGY, V78, P672, DOI 10.1212/WNL.0b013e318248deea; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Jokubaitis VG, 2014, NEUROLOGY, V82, P1204, DOI 10.1212/WNL.0000000000000283; Kalincik T, 2015, ANN NEUROL, V77, P425, DOI 10.1002/ana.24339; Kappos L, 2006, NEUROLOGY, V67, P1242, DOI 10.1212/01.wnl.0000237641.33768.8d; Kappos L, 2015, NEW ENGL J MED, V373, P1418, DOI 10.1056/NEJMoa1501481; Kappos L, 2007, LANCET, V370, P389, DOI 10.1016/S0140-6736(07)61194-5; Kappos L, 2015, NEUROLOGY, V85, P29, DOI 10.1212/WNL.0000000000001706; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Khan O, 2013, ANN NEUROL, V73, P705, DOI 10.1002/ana.23938; Kieseier BC, 2014, THER ADV NEUROL DISO, V7, P1, DOI 10.1177/1756285614529615; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; La Mantia L, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009371.pub2; La Mantia L, 2015, J NEUROL NEUROSUR PS, V86, P1016, DOI 10.1136/jnnp-2014-309243; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; Leray E, 2010, BRAIN, V133, P1900, DOI 10.1093/brain/awq076; Longbrake Erin E, 2015, Mult Scler J Exp Transl Clin, V1; Lublin Fred D., 2003, Neurology, V61, P1528; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; Lublin FD, 2013, ANN NEUROL, V73, P327, DOI 10.1002/ana.23863; Mackenzie IS, 2014, J NEUROL NEUROSUR PS, V85, P76, DOI 10.1136/jnnp-2013-305450; Mancardi GL, 2015, NEUROLOGY, V84, P981, DOI 10.1212/WNL.0000000000001329; Marrie RA, 2015, NEUROLOGY, V85, P240, DOI 10.1212/WNL.0000000000001718; Marrie RA, 2015, MULT SCLER J, V21, P263, DOI 10.1177/1352458514564491; Marriott JJ, 2010, NEUROLOGY, V74, P1463, DOI 10.1212/WNL.0b013e3181dc1ae0; Menon S, 2013, J NEUROL NEUROSUR PS, V84, P1192, DOI 10.1136/jnnp-2013-304951; Miller AE, 2014, LANCET NEUROL, V13, P977, DOI 10.1016/S1474-4422(14)70191-7; Miller DH, 2014, MULT SCLER J, V20, P527, DOI 10.1177/1352458513519840; Miller DH, 2012, LANCET NEUROL, V11, P157, DOI 10.1016/S1474-4422(11)70274-5; Montalban X, 2015, MULT SCLER J, V21, P781; Multiple Sclerosis Coalition, 2015, US DIS MOD THER MULT; Multiple Sclerosis International Federation, 2013, ATL MS 2013 MAPP MUL; Munger KL, 2015, NEUROLOGY, V85, P1694, DOI 10.1212/WNL.0000000000002099; Nash RA, 2015, JAMA NEUROL, V72, P159, DOI 10.1001/jamaneurol.2014.3780; Noseworthy JH, 2006, NEUROLOGY, V67, P930, DOI 10.1212/01.wnl.0000241080.31577.df; O'Connor P, 2011, NEW ENGL J MED, V365, P1293, DOI 10.1056/NEJMoa1014656; Okuda DT, 2009, NEUROLOGY, V72, P800, DOI 10.1212/01.wnl.0000335764.14513.1a; Okuda DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090509; Oliver BJ, 2011, J NEUROL SCI, V302, P96, DOI 10.1016/j.jns.2010.11.003; Ontaneda D, 2015, CURR OPIN NEUROL, V28, P237, DOI 10.1097/WCO.0000000000000195; Ontaneda D, 2015, LANCET NEUROL, V14, P208, DOI 10.1016/S1474-4422(14)70264-9; Palace J, 2015, LANCET NEUROL, V14, P497, DOI 10.1016/S1474-4422(15)00018-6; Pelletier D, 2012, NEW ENGL J MED, V366, P339, DOI 10.1056/NEJMct1101691; Pittock SJ, 2008, CURR TOP MICROBIOL, V318, P1; Plavina T, 2014, ANN NEUROL, V76, P802, DOI 10.1002/ana.24286; Polman Chris H, 2006, N Engl J Med, V354, P899; Polman Chris H, 2011, Ann Neurol, V69, P292, DOI 10.1002/ana.22366; Pozuelo-Moyano B, 2013, NEUROEPIDEMIOLOGY, V40, P147, DOI 10.1159/000345122; Pucci E, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007621.pub2; Raffel J, 2015, MULT SCLER J, V21, P1833, DOI 10.1177/1352458515599681; Ramanujam R, 2015, JAMA NEUROL, V72, P1117, DOI 10.1001/jamaneurol.2015.1788; Ransohoff RM, 2007, NEW ENGL J MED, V356, P2622, DOI 10.1056/NEJMct071462; Ransohoff RM, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.14; Rau D, 2015, INT J MOL SCI, V16, P14669, DOI 10.3390/ijms160714669; Richert ND, 2000, MULT SCLER, V6, P86, DOI 10.1177/135245850000600206; Riera Rachel, 2016, Cochrane Database Syst Rev, V4, pCD011203, DOI 10.1002/14651858.CD011203.pub2; Rio J, 2009, MULT SCLER, V15, P848, DOI 10.1177/1352458509104591; Rosenkranz T, 2015, NEW ENGL J MED, V372, P1476, DOI 10.1056/NEJMc1415408; Rotstein DL, 2015, JAMA NEUROL, V72, P152, DOI 10.1001/jamaneurol.2014.3537; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Rush CA, 2015, NAT REV NEUROL, V11, P379, DOI 10.1038/nrneurol.2015.85; Sawcer S, 2014, LANCET NEUROL, V13, P700, DOI 10.1016/S1474-4422(14)70041-9; Scalfari A, 2010, BRAIN, V133, P1914, DOI 10.1093/brain/awq118; Schwab N, 2016, MULT SCLER J, V22, P1048, DOI 10.1177/1352458515607651; Schwab N, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000195; Scolding Neil, 2015, Pract Neurol, V15, P273, DOI 10.1136/practneurol-2015-001139; Shirani A, 2012, JAMA-J AM MED ASSOC, V308, P247, DOI 10.1001/jama.2012.7625; Siger M, 2011, J NEUROL SCI, V303, P50, DOI 10.1016/j.jns.2011.01.016; Soilu-Hanninen M, 2012, J NEUROL NEUROSUR PS, V83, P566, DOI 10.1136/jnnp-2011-301876; Soldan MMP, 2015, NEUROLOGY, V84, P81, DOI 10.1212/WNL.0000000000001094; Solomon AJ, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0403-y; Sorensen PS, 2005, EUR J NEUROL, V12, P817, DOI 10.1111/j.1468-1331.2005.01386.x; Sormani MP, 2013, MULT SCLER J, V19, P605, DOI 10.1177/1352458512460605; Steinvorth SM, 2013, MULT SCLER J, V19, P1580, DOI 10.1177/1352458513481009; Subei AM, 2015, CNS DRUGS, V29, P565, DOI 10.1007/s40263-015-0261-z; Tedeholm H, 2013, MULT SCLER J, V19, P765, DOI 10.1177/1352458512463764; Thiel S, 2016, MULT SCLER J, V22, P801, DOI 10.1177/1352458516634872; Tintore M, 2008, J NEUROL, V255, P37, DOI 10.1007/s00415-008-1006-4; Tintore M, 2015, BRAIN, V138, P1863, DOI 10.1093/brain/awv105; Tobin WO, 2015, MULT SCLER RELAT DIS, V4, P437, DOI 10.1016/j.msard.2015.07.004; Traboulsee A, 2016, AM J NEURORADIOL, V37, P394, DOI 10.3174/ajnr.A4539; Tramacere I, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011381.pub2; Tramacere I, 2016, JAMA-J AM MED ASSOC, V315, P409, DOI 10.1001/jama.2015.18984; Trisonlini M, 2010, GLOBAL EC IMPACT MUL; Trojano M, 2007, ANN NEUROL, V61, P300, DOI 10.1002/ana.21102; Tsivgoulis G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116511; Tuohy O, 2015, J NEUROL NEUROSUR PS, V86, P208, DOI 10.1136/jnnp-2014-307721; US Food and Drug Administration, 2016, FDA APPR ZINBR TREAT; US Food and Drug Administration, 2015, FDA DRUG SAF COMM FD; US Food and Drug Administration, 2014, FDA DRUG SAF COMM FD; US Food and Drug Administration, 2016, DRUG SAF LAB CHANG; van Oosten BW, 2013, NEW ENGL J MED, V368, P1658, DOI 10.1056/NEJMc1215357; Vermersch P, 2014, MULT SCLER J, V20, P705, DOI 10.1177/1352458513507821; Villar LM, 2015, ANN NEUROL, V77, P447, DOI 10.1002/ana.24345; Vollmer T, 2008, MULT SCLER J, V14, P663, DOI 10.1177/1352458507085759; Warnke C, 2014, ANN NEUROL, V76, P792, DOI 10.1002/ana.24153; Wattjes MP, 2015, J NEUROL NEUROSUR PS, V86, P793, DOI 10.1136/jnnp-2014-308630; Wattjes MP, 2014, ANN NEUROL, V75, P462, DOI 10.1002/ana.24110; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133; West TW, 2010, ANN NEUROL, V68, P395, DOI 10.1002/ana.22163; Wiendl H, 2013, NAT REV NEUROL, V9, P394, DOI 10.1038/nrneurol.2013.95; Willis MD, 2015, MULT SCLER; Wingerchuk DM, 2014, MAYO CLIN PROC, V89, P225, DOI 10.1016/j.mayocp.2013.11.002; Xu Z, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011076.pub2; Zhang TT, 2016, NEUROLOGY, V86, P1287, DOI 10.1212/WNL.0000000000002543; Ziemssen T, 2016, J NEUROL, V263, P1053, DOI 10.1007/s00415-015-7986-y	198	100	102	1	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 22	2016	354								i3518	10.1136/bmj.i3518	http://dx.doi.org/10.1136/bmj.i3518			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV2ZX	27549763				2022-12-28	WOS:000382791900001
J	Piccini, JP; Fauchier, L				Piccini, Jonathan P.; Fauchier, Laurent			Rhythm control in atrial fibrillation	LANCET			English	Article							ANTIARRHYTHMIC-DRUG THERAPY; RADIOFREQUENCY CATHETER ABLATION; LEFT-VENTRICULAR HYPERTROPHY; PULMONARY VEIN ISOLATION; QUALITY-OF-LIFE; SINUS RHYTHM; FOLLOW-UP; ANTICOAGULATION MANAGEMENT; VERNAKALANT HYDROCHLORIDE; 1ST-LINE TREATMENT	Many patients with atrial fibrillation have substantial symptoms despite ventricular rate control and require restoration of sinus rhythm to improve their quality of life. Acute restoration (ie, cardioversion) and maintenance of sinus rhythm in patients with atrial fibrillation are referred to as rhythm control. The decision to pursue rhythm control is based on symptoms, the type of atrial fibrillation (paroxysmal, persistent, or long-standing persistent), patient comorbidities, general health status, and anticoagulation status. Many patients have recurrent atrial fibrillation and require further intervention to maintain long term sinus rhythm. Antiarrhythmic drug therapy is generally recommended as a first-line therapy and drug selection is on the basis of the presence or absence of structural heart disease or heart failure, electrocardiographical variables, renal function, and other comorbidities. In patients who continue to have recurrent atrial fibrillation despite medical therapy, catheter ablation has been shown to substantially reduce recurrent atrial fibrillation, decrease symptoms, and improve quality of life, although recurrence is common despite continued advancement in ablation techniques.	[Piccini, Jonathan P.] Duke Univ, Med Ctr, Duke Ctr Atrial Fibrillat, Clin Cardiac Electrophysiol, Durham, NC 27710 USA; [Fauchier, Laurent] CHU Trousseau, Tours, France	Duke University; CHU Tours	Piccini, JP (corresponding author), Duke Univ, Med Ctr, Electrophysiol Sect, Duke Ctr Atrial Fibrillat,Duke Clin Res Inst, POB 17969, Durham, NC 27710 USA.	jonathan.piccini@duke.edu	Fauchier, Laurent/AAE-6366-2021; fauchier, laurent/HDN-2353-2022	Fauchier, Laurent/0000-0002-9267-1658; 	Agency for Healthcare Research and Quality; ARCA biopharma; Boston Scientific; Gilead; Johnson Johnson; ResMed; St Jude Medical; Agency of Healthcare Research and Quality [1U19 HS021092]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U19HS021092] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); ARCA biopharma; Boston Scientific(Boston Scientific); Gilead(Gilead Sciences); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); ResMed; St Jude Medical(St. Jude Medical); Agency of Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	JPP received grants for clinical research from the Agency for Healthcare Research and Quality, ARCA biopharma, Boston Scientific, Gilead, Johnson & Johnson, ResMed, and St Jude Medical, and is a consultant to Bayer Healthcare, BMS/Pfizer, Janssen Pharmaceuticals, and Medtronic. LF serves on a consultant or advisory board for Bayer, BMS/Pfizer, Boehringer Ingelheim, Medtronic, and Novartis, and receives honoraria for speakers bureau from Bayer, BMS/Pfizer, Boehringer Ingelheim, Boston Scientific, and Medtronic. JPP is supported (in part) by funding from the Agency of Healthcare Research and Quality through cooperative agreement number 1U19 HS021092.	Alboni P, 2004, NEW ENGL J MED, V351, P2384, DOI 10.1056/NEJMoa041233; Aleong RG, 2013, JACC-HEART FAIL, V1, P338, DOI 10.1016/j.jchf.2013.04.002; [Anonymous], 1989, NEW ENGL J MED, V321, P406; Barnett AS, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.115.003299; Bianconi L, 1996, J AM COLL CARDIOL, V28, P700, DOI 10.1016/0735-1097(96)00230-6; Boriani G, 2015, EUROPACE, V17, P1169, DOI 10.1093/europace/euv202; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Calkins H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P349, DOI 10.1161/CIRCEP.108.824789; Camm AJ, 2012, EUR HEART J, V33; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Cappato R, 2015, EUR HEART J, V36, P1805, DOI 10.1093/eurheartj/ehv177; Cappato R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P32, DOI 10.1161/CIRCEP.109.859116; Chao TF, 2011, J AM COLL CARDIOL, V58, P2380, DOI 10.1016/j.jacc.2011.08.045; Chen SA, 1999, CIRCULATION, V100, P1879, DOI 10.1161/01.CIR.100.18.1879; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Chung R, 2014, PACE, V37, P1338, DOI 10.1111/pace.12426; Connolly SJ, 2011, NEW ENGL J MED, V365, P2268, DOI 10.1056/NEJMoa1109867; Cox JL, 1999, J THORAC CARDIOV SUR, V118, P833, DOI 10.1016/S0022-5223(99)70052-8; COX JL, 1991, JAMA-J AM MED ASSOC, V266, P1976, DOI 10.1001/jama.266.14.1976; Crystal E, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003611.PUB2; Cummings JE, 2006, ANN INTERN MED, V144, P572, DOI 10.7326/0003-4819-144-8-200604180-00007; Dagres N, 2011, J CARD FAIL, V17, P964, DOI 10.1016/j.cardfail.2011.07.009; Darbar D, 2007, HEART RHYTHM, V4, P743, DOI 10.1016/j.hrthm.2007.02.006; Deshmukh A, 2013, CIRCULATION, V128, P2104, DOI 10.1161/CIRCULATIONAHA.113.003862; Di Biase L, 2016, CIRCULATION, V133, P1637, DOI 10.1161/CIRCULATIONAHA.115.019406; Di Biase L, 2014, CIRCULATION, V129, P2638, DOI 10.1161/CIRCULATIONAHA.113.006426; Di Biase L, 2014, HEART RHYTHM, V11, P791, DOI 10.1016/j.hrthm.2014.03.003; Dimitri H, 2012, HEART RHYTHM, V9, P321, DOI 10.1016/j.hrthm.2011.10.017; Forleo GB, 2009, J CARDIOVASC ELECTR, V20, P22, DOI 10.1111/j.1540-8167.2008.01275.x; Freemantle N, 2011, EUROPACE, V13, P329, DOI 10.1093/europace/euq450; Fuster V, 2006, J AM COLL CARDIOL, V48, P854, DOI 10.1016/j.jacc.2006.07.009; Gallagher MM, 2002, J AM COLL CARDIOL, V40, P926, DOI 10.1016/S0735-1097(02)02052-1; Gaztanaga L, 2013, HEART RHYTHM, V10, P2, DOI 10.1016/j.hrthm.2012.09.005; Gillinov M, 2016, J THORAC CARDIOV SUR, V151, P1506, DOI 10.1016/j.jtcvs.2016.02.033; Gillis AM, 1998, J CARDIOVASC ELECTR, V9, P988, DOI 10.1111/j.1540-8167.1998.tb00140.x; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Healey JS, 2005, J AM COLL CARDIOL, V45, P1832, DOI 10.1016/j.jacc.2004.11.070; Hess PL, 2013, AM J MED, V126, P625, DOI 10.1016/j.amjmed.2013.01.037; Hohnloser SH, 2009, NEW ENGL J MED, V360, P668, DOI 10.1056/NEJMoa0803778; Holmes DR, 2009, JACC-CARDIOVASC INTE, V2, P267, DOI 10.1016/j.jcin.2008.12.014; Jais P, 2008, CIRCULATION, V118, P2498, DOI 10.1161/CIRCULATIONAHA.108.772582; January CT, 2014, J AM COLL CARDIOL, V64, P2304, DOI 10.1016/j.jacc.2014.04.004; Kawasaki R, 2014, J CARDIOVASC ELECTR, V25, P787, DOI 10.1111/jce.12426; Kirchhof P, 2002, LANCET, V360, P1275, DOI 10.1016/S0140-6736(02)11315-8; Kirchhof P, 2013, AM HEART J, V166, P442, DOI 10.1016/j.ahj.2013.05.015; Klein AL, 2001, NEW ENGL J MED, V344, P1411, DOI 10.1056/NEJM200105103441901; Kober L, 2008, NEW ENGL J MED, V358, P2678, DOI 10.1056/NEJMoa0800456; KONDILI A, 1990, WIEN KLIN WOCHENSCHR, V102, P510; Krittayaphong Rungroj, 2003, J Med Assoc Thai, V86 Suppl 1, pS8; Kuck KH, 2016, NEW ENGL J MED, V374, P2235, DOI 10.1056/NEJMoa1602014; Letelier LM, 2003, ARCH INTERN MED, V163, P777, DOI 10.1001/archinte.163.7.777; Manios EG, 2003, CARDIOVASC DRUG THER, V17, P31, DOI 10.1023/A:1024203824761; Martinez-Marcos FJ, 2000, AM J CARDIOL, V86, P950, DOI 10.1016/S0002-9149(00)01128-0; Mont L, 2014, EUR HEART J, V35, P501, DOI 10.1093/eurheartj/eht457; Morillo CA, 2014, JAMA-J AM MED ASSOC, V311, P692, DOI 10.1001/jama.2014.467; Nakagawa H, 2007, J CARDIOVASC ELECTR, V18, P136, DOI 10.1111/j.1540-8167.2006.00715.x; Narayan SM, 2014, J AM COLL CARDIOL, V63, P1761, DOI 10.1016/j.jacc.2014.02.543; Naruse Y, 2013, HEART RHYTHM, V10, P331, DOI 10.1016/j.hrthm.2012.11.015; Nielsen JC, 2012, NEW ENGL J MED, V367, P1587, DOI 10.1056/NEJMoa1113566; Noseworthy PA, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002597; Nuotio I, 2014, JAMA-J AM MED ASSOC, V312, P647, DOI 10.1001/jama.2014.3824; Oral H, 2006, NEW ENGL J MED, V354, P934, DOI 10.1056/NEJMoa050955; Ouyang F, 2010, CIRCULATION, V122, P2368, DOI 10.1161/CIRCULATIONAHA.110.946806; Packer DL, 2013, J AM COLL CARDIOL, V61, P1713, DOI 10.1016/j.jacc.2012.11.064; Pappone C, 2006, J AM COLL CARDIOL, V48, P2340, DOI 10.1016/j.jacc.2006.08.037; Parkash R, 2011, J CARDIOVASC ELECTR, V22, P729, DOI 10.1111/j.1540-8167.2011.02010.x; Pathak RK, 2015, J AM COLL CARDIOL, V65, P2159, DOI 10.1016/j.jacc.2015.03.002; Pathak RK, 2014, J AM COLL CARDIOL, V64, P2222, DOI 10.1016/j.jacc.2014.09.028; Patti G, 2006, CIRCULATION, V114, P1455, DOI 10.1161/CIRCULATIONAHA.106.621763; Piccini JP, 2016, HEART RHYTHM, V13, P1777, DOI 10.1016/j.hrthm.2016.04.012; Piccini JP, 2012, CIRCULATION, V126, P2200, DOI 10.1161/CIRCULATIONAHA.112.109330; Piccini JP, 2009, CIRC-ARRHYTHMIA ELEC, V2, P626, DOI 10.1161/CIRCEP.109.856633; Piccini JP, 2009, J AM COLL CARDIOL, V54, P1089, DOI 10.1016/j.jacc.2009.04.085; Pratt CM, 2010, AM J CARDIOL, V106, P1277, DOI 10.1016/j.amjcard.2010.06.054; Pritchett ELC, 2003, AM J CARDIOL, V92, P941, DOI 10.1016/S0002-9149(03)00974-3; Reisinger J, 2004, EUR HEART J, V25, P1318, DOI 10.1016/j.ehj.2004.04.030; Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789; Roy D, 2008, CIRCULATION, V117, P1518, DOI 10.1161/CIRCULATIONAHA.107.723866; Sairaku A, 2016, EUROPACE, V18, P1352, DOI 10.1093/europace/euv424; Shah RU, 2012, J AM COLL CARDIOL, V59, P143, DOI 10.1016/j.jacc.2011.08.068; Sidorova TN, 2015, J MOL CELL CARDIOL, V79, P295, DOI 10.1016/j.yjmcc.2014.11.013; Singh BN, 2007, NEW ENGL J MED, V357, P987, DOI 10.1056/NEJMoa054686; Stabile G, 2006, EUR HEART J, V27, P216, DOI 10.1093/eurheartj/ehi583; Suman-Horduna I, 2013, J AM COLL CARDIOL, V61, P455, DOI 10.1016/j.jacc.2012.10.031; Themistoclakis S, 2006, HEART RHYTHM, V3, P44, DOI 10.1016/j.hrthm.2005.10.005; Van Wagoner DR, 2015, HEART RHYTHM, V12, pE5, DOI 10.1016/j.hrthm.2014.11.011; Verma A, 2015, NEW ENGL J MED, V372, P1812, DOI 10.1056/NEJMoa1408288; Wazni OM, 2005, JAMA-J AM MED ASSOC, V293, P2634, DOI 10.1001/jama.293.21.2634; Weerasooriya R, 2011, J AM COLL CARDIOL, V57, P160, DOI 10.1016/j.jacc.2010.05.061; Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029; Wokhlu A, 2010, J AM COLL CARDIOL, V55, P2308, DOI 10.1016/j.jacc.2010.01.040; Wolbrette DL, 2003, AM J CARDIOL, V91, p39D, DOI 10.1016/S0002-9149(02)03378-7; Zheng Z, 2016, NEW ENGL J MED, V374, P1744, DOI 10.1056/NEJMoa1507750	93	80	85	1	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 20	2016	388	10046					829	840		10.1016/S0140-6736(16)31277-6	http://dx.doi.org/10.1016/S0140-6736(16)31277-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT6UH	27560278				2022-12-28	WOS:000381619200031
J	Kipnis, J				Kipnis, Jonathan			Multifaceted interactions between adaptive immunity and the central nervous system	SCIENCE			English	Review							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CD4(+) T-CELLS; MYELIN BASIC-PROTEIN; MHC CLASS-I; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; UNEXPECTED ROLE; LYMPHATIC VASCULATURE; SYNAPSE ELIMINATION; CEREBROSPINAL-FLUID	Neuroimmunologists seek to understand the interactions between the central nervous system (CNS) and the immune system, both under homeostatic conditions and in diseases. Unanswered questions include those relating to the diversity and specificity of the meningeal T cell repertoire; the routes taken by immune cells that patrol the meninges under healthy conditions and invade the parenchyma during pathology; the opposing effects (beneficial or detrimental) of these cells on CNS function; the role of immune cells after CNS injury; and the evolutionary link between the two systems, resulting in their tight interaction and interdependence. This Review summarizes the current standing of and challenging questions related to interactions between adaptive immunity and the CNS and considers the possible directions in which these aspects of neuroimmunology will be heading over the next decade.	[Kipnis, Jonathan] Univ Virginia, Sch Med, Dept Neurosci, Ctr Brain Immunol & Glia BIG, Charlottesville, VA 22908 USA	University of Virginia	Kipnis, J (corresponding author), Univ Virginia, Sch Med, Dept Neurosci, Ctr Brain Immunol & Glia BIG, Charlottesville, VA 22908 USA.	kipnis@virginia.edu	Kipnis, Jonathan/AGG-9735-2022	Kipnis, Jonathan/0000-0002-3714-517X	NIH [AG034113, NS096967]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS096967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034113] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	I thank S. Smith for editing the manuscript, A. Impagliazzo for the artwork, and all members of my lab for valuable comments during multiple discussions of this work. This work was supported by NIH grants AG034113 and NS096967.	ADER R, 1975, PSYCHOSOM MED, V37, P333, DOI 10.1097/00006842-197507000-00007; ADER R, 1982, SCIENCE, V215, P1534, DOI 10.1126/science.7063864; Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; ANDRES KH, 1987, ANAT EMBRYOL, V175, P289, DOI 10.1007/BF00309843; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Aspelund A, 2014, J CLIN INVEST, V124, P3975, DOI 10.1172/JCI75395; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Aube B, 2014, J IMMUNOL, V193, P2438, DOI 10.4049/jimmunol.1400401; Baruch K, 2016, NAT MED, V22, P135, DOI 10.1038/nm.4022; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; Broux B, 2015, SEMIN IMMUNOPATHOL, V37, P577, DOI 10.1007/s00281-015-0516-2; Brynskikh A, 2008, BRAIN BEHAV IMMUN, V22, P861, DOI 10.1016/j.bbi.2007.12.008; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; COHEN IR, 1992, IMMUNOL TODAY, V13, P490, DOI 10.1016/0167-5699(92)90024-2; Colonna M, 2016, NAT REV NEUROSCI, V17, P201, DOI 10.1038/nrn.2016.7; Croxford AL, 2015, TRENDS IMMUNOL, V36, P651, DOI 10.1016/j.it.2015.08.004; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; delRio-Hortega P., 1932, CYTOLOGY CELLULAR PA, V2, P483; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Dhabhar FS, 2000, P NATL ACAD SCI USA, V97, P2846, DOI 10.1073/pnas.050569397; Engelhardt B, 2005, TRENDS IMMUNOL, V26, P485, DOI 10.1016/j.it.2005.07.004; Farez MF, 2015, CELL, V162, P1338, DOI 10.1016/j.cell.2015.08.025; Filiano AJ, 2016, NATURE, V535, P425, DOI 10.1038/nature18626; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Gadani SP, 2015, NEURON, V85, P703, DOI 10.1016/j.neuron.2015.01.013; Goldmann J, 2006, J LEUKOCYTE BIOL, V80, P797, DOI 10.1189/jlb.0306176; Gourraud PA, 2014, ANN NEUROL, V76, P633, DOI 10.1002/ana.24282; Harris MG, 2014, SCI REP-UK, V4, DOI 10.1038/srep04422; HASEK M, 1977, NATURE, V268, P68, DOI 10.1038/268068a0; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Ingram WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075246; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Kioussis D, 2009, IMMUNITY, V31, P705, DOI 10.1016/j.immuni.2009.09.009; Kipnis J, 2000, P NATL ACAD SCI USA, V97, P7446, DOI 10.1073/pnas.97.13.7446; Kipnis J, 2002, P NATL ACAD SCI USA, V99, P15620, DOI 10.1073/pnas.232565399; Kipnis J, 2001, J NEUROSCI, V21, P4564, DOI 10.1523/JNEUROSCI.21-13-04564.2001; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P8180, DOI 10.1073/pnas.0402268101; Kipnis J, 2008, TRENDS IMMUNOL, V29, P455, DOI 10.1016/j.it.2008.07.007; Kipnis J, 2012, NAT REV IMMUNOL, V12, P662, DOI 10.1038/nri3280; Kivisakk P, 2003, P NATL ACAD SCI USA, V100, P8389, DOI 10.1073/pnas.1433000100; Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379; Kuchroo VK, 2002, ANNU REV IMMUNOL, V20, P101, DOI 10.1146/annurev.immunol.20.081701.141316; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; Larochelle C, 2015, ANN NEUROL, V78, P39, DOI 10.1002/ana.24415; Lecuyer MA, 2016, BBA-MOL BASIS DIS, V1862, P472, DOI 10.1016/j.bbadis.2015.10.004; Lee HM, 2014, NATURE, V509, P195, DOI 10.1038/nature13154; LIDER O, 1988, SCIENCE, V239, P181, DOI 10.1126/science.2447648; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lui HS, 2016, CELL, V165, P921, DOI 10.1016/j.cell.2016.04.001; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Marsh SE, 2016, P NATL ACAD SCI USA, V113, pE1316, DOI 10.1073/pnas.1525466113; Mascanfroni ID, 2013, NAT IMMUNOL, V14, P1054, DOI 10.1038/ni.2695; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Mayo L, 2014, NAT MED, V20, P1147, DOI 10.1038/nm.3681; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Nedergaard M, 2013, SCIENCE, V340, P1529, DOI 10.1126/science.1240514; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pavlov VA, 2015, IMMUNOL RES, V63, P38, DOI 10.1007/s12026-015-8718-1; Peters A, 2011, IMMUNITY, V35, P986, DOI 10.1016/j.immuni.2011.10.015; Petrovich E, 2016, FASEB J, V30, P1767, DOI 10.1096/fj.201500046; Pikor N, 2012, MULT SCLER RELAT DIS, V1, P123, DOI 10.1016/j.msard.2012.03.006; PRINEAS JW, 1979, SCIENCE, V203, P1123, DOI 10.1126/science.424741; Radjavi A, 2014, MOL PSYCHIATR, V19, P531, DOI 10.1038/mp.2013.79; Radjavi A, 2014, BRAIN BEHAV IMMUN, V35, P58, DOI 10.1016/j.bbi.2013.08.013; Rajasethupathy P, 2016, CELL, V165, P524, DOI 10.1016/j.cell.2016.03.047; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Russo MV, 2015, TRENDS IMMUNOL, V36, P637, DOI 10.1016/j.it.2015.08.002; Schlager C, 2016, NATURE, V530, P349, DOI 10.1038/nature16939; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Serpe CJ, 1999, J NEUROSCI, V19; Shatz CJ, 2009, NEURON, V64, P40, DOI 10.1016/j.neuron.2009.09.044; Shechter R, 2013, NAT REV IMMUNOL, V13, P206, DOI 10.1038/nri3391; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Simmons SB, 2013, TRENDS IMMUNOL, V34, P410, DOI 10.1016/j.it.2013.04.006; Steinman L, 2003, J EXP MED, V197, P1065, DOI 10.1084/jem.20030320; STEINMAN L, 1982, NATURE, V299, P738, DOI 10.1038/299738a0; Steinman L, 2014, ANNU REV IMMUNOL, V32, P257, DOI 10.1146/annurev-immunol-032713-120227; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Talbot S, 2015, NEURON, V87, P341, DOI 10.1016/j.neuron.2015.06.007; Tracey KJ, 2016, CELL, V164, P343, DOI 10.1016/j.cell.2016.01.018; VARGA L, 1966, ACTA MED HUNG, V22, P15; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; von Hehn CA, 2012, NEURON, V73, P638, DOI 10.1016/j.neuron.2012.02.008; Walsh JT, 2015, J CLIN INVEST, V125, P699, DOI [10.1172/JCI176210, 10.1172/JCI76210]; Walsh JT, 2014, J IMMUNOL, V193, P5013, DOI 10.4049/jimmunol.1302401; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Weiner HL, 2009, ANN NEUROL, V65, P239, DOI 10.1002/ana.21640; Wekerle H, 2006, CURR TOP MICROBIOL, V305, P25, DOI 10.1007/3-540-29714-6_2; Weller RO, 2009, ACTA NEUROPATHOL, V117, P1, DOI 10.1007/s00401-008-0457-0; Wheeler MA, 2016, NAT NEUROSCI, V19, P756, DOI 10.1038/nn.4265; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yang Y, 2014, J CLIN INVEST, V124, P888, DOI 10.1172/JCI71609; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; ZAMVIL S, 1985, NATURE, V317, P355, DOI 10.1038/317355a0; ZAMVIL SS, 1985, J EXP MED, V162, P2107, DOI 10.1084/jem.162.6.2107	104	213	217	2	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					766	771		10.1126/science.aag2638	http://dx.doi.org/10.1126/science.aag2638			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZE	27540163	Green Accepted			2022-12-28	WOS:000381561400033
J	Barnett, R				Barnett, Richard			Case histories Cushing's syndrome	LANCET			English	Editorial Material												richard@richardbarnettwriter.com							0	3	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2016	388	10045					649	649		10.1016/S0140-6736(16)31280-6	http://dx.doi.org/10.1016/S0140-6736(16)31280-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT1UX	27551694				2022-12-28	WOS:000381268700011
J	Vestbo, J; Leather, D; Bakerly, ND; New, J; Gibson, JM; McCorkindale, S; Collier, S; Crawford, J; Frith, L; Harvey, C; Svedsater, H; Woodcock, A				Vestbo, Jorgen; Leather, David; Bakerly, Nawar Diar; New, John; Gibson, J. Martin; McCorkindale, Sheila; Collier, Susan; Crawford, Jodie; Frith, Lucy; Harvey, Catherine; Svedsater, Henrik; Woodcock, Ashley		Salford Lung Study Investigators	Effectiveness of Fluticasone Furoate-Vilanterol for COPD in Clinical Practice	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIALS; WORLD EFFECTIVENESS TRIAL; SALFORD LUNG; ASTHMA; PROTOCOL; DISEASE	BACKGROUND Evidence for the management of chronic obstructive pulmonary disease (COPD) comes from closely monitored efficacy trials involving groups of patients who were selected on the basis of restricted entry criteria. There is a need for randomized trials to be conducted in conditions that are closer to usual clinical practice. METHODS In a controlled effectiveness trial conducted in 75 general practices, we randomly assigned 2799 patients with COPD to a once-daily inhaled combination of fluticasone furoate at a dose of 100 mu g and vilanterol at a dose of 25 mu g (the fluticasone furoate-vilanterol group) or to usual care (the usual-care group). The primary outcome was the rate of moderate or severe exacerbations among patients who had had an exacerbation within 1 year before the trial. Secondary outcomes were the rates of primary care contact (contact with a general practitioner, nurse, or other health care professional) and secondary care contact (inpatient admission, outpatient visit with a specialist, or visit to the emergency department), modification of the initial trial treatment for COPD, and the rate of exacerbations among patients who had had an exacerbation within 3 years before the trial, as assessed in a time-to-event analysis. RESULTS The rate of moderate or severe exacerbations was significantly lower, by 8.4% (95% confidence interval, 1.1 to 15.2), with fluticasone furoate-vilanterol therapy than with usual care (P=0.02). There was no significant difference in the annual rate of COPD-related contacts to primary or secondary care. There were no significant between-group differences in the rates of the first moderate or severe exacerbation and the first severe exacerbation in the time-to-event analyses. There were no excess serious adverse events of pneumonia in the fluticasone furoate-vilanterol group. The numbers of other serious adverse events were similar in the two groups. CONCLUSIONS In patients with COPD and a history of exacerbations, a once-daily treatment regimen of combined fluticasone furoate and vilanterol was associated with a lower rate of exacerbations than usual care, without a greater risk of serious adverse events. (Funded by GlaxoSmithKline; Salford Lung Study ClinicalTrials.govnumber, NCT01551758.)	[Vestbo, Jorgen; Woodcock, Ashley] Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Resp Med & Allergy, Manchester, Lancs, England; [Vestbo, Jorgen; Woodcock, Ashley] Univ Manchester, Univ Hosp South Manchester NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Gibson, J. Martin] Salford Royal NHS Fdn Trust, Manchester, Lancs, England; [McCorkindale, Sheila] NIHR Clin Res Network Greater Manchester, Manchester, Lancs, England; [Leather, David] GlaxoSmithKline UK, Global Resp Franchise, Brentford, England; [Collier, Susan; Crawford, Jodie; Frith, Lucy; Svedsater, Henrik] GlaxoSmithKline UK, Resp Res & Dev, Brentford, England; [Bakerly, Nawar Diar; New, John; Gibson, J. Martin] Salford Royal NHS Fdn Trust, Salford, Lancs, England; [New, John; Gibson, J. Martin] NorthWest EHlth, Salford, Lancs, England; [McCorkindale, Sheila] NHS Salford Clin Commissioning Grp, Salford, Lancs, England; [Harvey, Catherine] GlaxoSmithKline UK, Global Clin Safety & Pharmacovigilance, Safety Evaluat & Risk Management, Uxbridge, Middx, England	University of Manchester; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Salford Royal NHS Foundation Trust; GlaxoSmithKline; GlaxoSmithKline; Salford Royal NHS Foundation Trust; GlaxoSmithKline	Vestbo, J (corresponding author), Univ Hosp South Manchester, Ctr Resp Med & Allergy, Educ & Res Ctr, 2nd Fl,Southmoor Rd, Manchester M23 9LT, Lancs, England.	jorgen.vestbo@manchester.ac.uk	Vestbo, Jorgen/Y-2912-2019	Vestbo, Jorgen/0000-0001-6355-6362; Woodcock, Ashley/0000-0002-5428-8578; New, John/0000-0003-4146-025X; Diar Bakerly, Nawar/0000-0003-2102-1997; gibson, martin/0000-0002-1331-1524	GlaxoSmithKline; National Institute for Health Research [NF-SI-0510-10249, NF-SI-0513-10040] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by GlaxoSmithKline.	Agusti A, 2014, EUR RESPIR J, V43, P763, DOI 10.1183/09031936.00054213; Bakerly ND, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0267-6; Berger ML, 2012, VALUE HEALTH, V15, P217, DOI 10.1016/j.jval.2011.12.010; Chalkidou K, 2012, CLIN TRIALS, V9, P436, DOI 10.1177/1740774512450097; Dransfield MT, 2013, LANCET RESP MED, V1, P210, DOI 10.1016/S2213-2600(13)70040-7; Elkhenini HF, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0132-z; Fiore LD, 2016, NEW ENGL J MED, V374, P2152, DOI 10.1056/NEJMra1510057; Herland K, 2005, RESP MED, V99, P11, DOI 10.1016/j.rmed.2004.03.026; Jones PW, 2013, COPD, V10, P269, DOI 10.3109/15412555.2013.776920; New JP, 2014, THORAX, V69, P1152, DOI 10.1136/thoraxjnl-2014-205259; Postma DS, 2015, NEW ENGL J MED, V373, P1241, DOI 10.1056/NEJMra1411863; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wedzicha JA, 2016, NEW ENGL J MED, V374, P2222, DOI 10.1056/NEJMoa1516385; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Woodcock A, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0150-8	15	138	145	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 29	2016	375	13					1253	1260		10.1056/NEJMoa1608033	http://dx.doi.org/10.1056/NEJMoa1608033			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DX3HU	27593504	Green Submitted, Bronze			2022-12-28	WOS:000384265000007
J	Sipila, M; Sarnela, N; Jokinen, T; Henschel, H; Junninen, H; Kontkanen, J; Richters, S; Kangasluoma, J; Franchin, A; Perakyla, O; Rissanen, MP; Ehn, M; Vehkamaki, H; Kurten, T; Berndt, T; Petaja, T; Worsnop, D; Ceburnis, D; Kerminen, VM; Kulmala, M; O'Dowd, C				Sipila, Mikko; Sarnela, Nina; Jokinen, Tuija; Henschel, Henning; Junninen, Heikki; Kontkanen, Jenni; Richters, Stefanie; Kangasluoma, Juha; Franchin, Alessandro; Perakyla, Otso; Rissanen, Matti P.; Ehn, Mikael; Vehkamaki, Hanna; Kurten, Theo; Berndt, Torsten; Petaja, Tuukka; Worsnop, Douglas; Ceburnis, Darius; Kerminen, Veli-Matti; Kulmala, Markku; O'Dowd, Colin			Molecular-scale evidence of aerosol particle formation via sequential addition of HIO3	NATURE			English	Article							MARINE BOUNDARY-LAYER; IODINE OXIDE; COASTAL ANTARCTICA; FORMATION EVENTS; SULFURIC-ACID; NUCLEATION; EMISSIONS; CHEMISTRY; MACROALGAE; PRECURSOR	Homogeneous nucleation and subsequent cluster growth leads to the formation of new aerosol particles in the atmosphere(1). The nucleation of sulfuric acid and organic vapours is thought to be responsible for the formation of new particles over continents(1,2), whereas iodine oxide vapours have been implicated in particle formation over coastal regions(3-7). The molecular clustering pathways that are involved in atmospheric particle formation have been elucidated in controlled laboratory studies of chemically simple systems(2,8-10), but direct molecular-level observations of nucleation in atmospheric field conditions that involve sulfuric acid, organic or iodine oxide vapours have yet to be reported(11). Here we present field data from Mace Head, Ireland, and supporting data from northern Greenland and Queen Maud Land, Antarctica, that enable us to identify the molecular steps involved in new particle formation in an iodine-rich, coastal atmospheric environment. We find that the formation and initial growth process is almost exclusively driven by iodine oxoacids and iodine oxide vapours, with average oxygen-to-iodine ratios of 2.4 found in the clusters. On the basis of this high ratio, together with the high concentrations of iodic acid (HIO3) observed, we suggest that cluster formation primarily proceeds by sequential addition of HIO3, followed by intracluster restructuring to I2O5 and recycling of water either in the atmosphere or on dehydration. Our study provides ambient atmospheric molecular-level observations of nucleation, supporting the previously suggested role of iodine-containing species in the formation of new aerosol particles(3-7,12-18), and identifies the key nucleating compound.	[Sipila, Mikko; Sarnela, Nina; Jokinen, Tuija; Henschel, Henning; Junninen, Heikki; Kontkanen, Jenni; Kangasluoma, Juha; Franchin, Alessandro; Perakyla, Otso; Rissanen, Matti P.; Ehn, Mikael; Vehkamaki, Hanna; Petaja, Tuukka; Worsnop, Douglas; Kerminen, Veli-Matti; Kulmala, Markku] Univ Helsinki, Dept Phys, Helsinki, Finland; [Richters, Stefanie; Berndt, Torsten] Leibniz Inst Tropospher Res TROPOS, Leipzig, Germany; [Kurten, Theo] Univ Helsinki, Dept Chem, Helsinki, Finland; [Worsnop, Douglas] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Worsnop, Douglas] Aerodyne Res Inc, Billerica, MA 01821 USA; [Worsnop, Douglas] Finnish Meteorol Inst, Helsinki, Finland; [Ceburnis, Darius; O'Dowd, Colin] Natl Univ Ireland Galway, Sch Phys, Univ Rd, Galway, Ireland; [Ceburnis, Darius; O'Dowd, Colin] Natl Univ Ireland Galway, Ryan Inst, Ctr Climate & Air Pollut Studies, Univ Rd, Galway, Ireland	University of Helsinki; Leibniz Institut fur Tropospharenforschung (TROPOS); University of Helsinki; University of Eastern Finland; Aerodyne Research; Finnish Meteorological Institute; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Sipila, M (corresponding author), Univ Helsinki, Dept Phys, Helsinki, Finland.	mikko.sipila@helsinki.fi	Kurtén, Theo C/G-2120-2012; Petäjä, Tuukka/A-8009-2008; Kulmala, Markku T/I-7671-2016; Jokinen, Tuija/B-3365-2014; Henschel, Henning/A-5060-2012; Franchin, Alessandro/GVR-8219-2022; Sipilä, Mikko/G-3024-2010; Vehkamäki, Hanna/A-8262-2008; Kontkanen, Jenni/AAL-1368-2020; Kangasluoma, Juha/AAY-7941-2021; Sarnela, Nina/AAE-1372-2020; Franchin, Alessandro/AAH-3069-2019; Ehn, Mikael/N-2571-2016; Worsnop, Douglas R/D-2817-2009; Ceburnis, Darius/C-1293-2012; O'Dowd, Colin D/K-8904-2012; kangasluoma, juha/W-7450-2019; Junninen, Heikki/C-2157-2014	Kurtén, Theo C/0000-0002-6416-4931; Petäjä, Tuukka/0000-0002-1881-9044; Kulmala, Markku T/0000-0003-3464-7825; Jokinen, Tuija/0000-0002-1280-1396; Henschel, Henning/0000-0001-7196-661X; Sipilä, Mikko/0000-0002-8594-7003; Vehkamäki, Hanna/0000-0002-5018-1255; Kontkanen, Jenni/0000-0002-5373-3537; Kangasluoma, Juha/0000-0002-1639-1187; Ehn, Mikael/0000-0002-0215-4893; Worsnop, Douglas R/0000-0002-8928-8017; Ceburnis, Darius/0000-0003-0231-5324; O'Dowd, Colin D/0000-0002-3068-2212; Sarnela, Nina/0000-0003-1874-3235; Rissanen, Matti/0000-0003-0463-8098; Perakyla, Otso/0000-0002-2089-0106; Junninen, Heikki/0000-0001-7178-9430	Academy of Finland (Centre of Excellence) [1118615, 251427, 266388]; PEGASOS project - European Commission [FP7-ENV-2010-265148]; ACTRIS; EPA-Ireland; Nordic Centre of Excellence (CRAICC); Finnish Antarctic Research Program; European Research Council [227463, 257360, 638703]; Villum Fonden [00007236] Funding Source: researchfish	Academy of Finland (Centre of Excellence)(Academy of Finland); PEGASOS project - European Commission(European Commission); ACTRIS; EPA-Ireland(United States Environmental Protection Agency); Nordic Centre of Excellence (CRAICC); Finnish Antarctic Research Program; European Research Council(European Research Council (ERC)European Commission); Villum Fonden(Villum Fonden)	This work was partly funded by the Academy of Finland (Centre of Excellence Project 1118615 and Projects 251427 and 266388), the PEGASOS project (funded by the European Commission under the Framework Program 7 (FP7-ENV-2010-265148)), ACTRIS, the EPA-Ireland, the Nordic Centre of Excellence (CRAICC), the Finnish Antarctic Research Program and the European Research Council (ATMNUCLE grant 227463, MOCAPAF grant 257360 and COALA grant 638703).	Alicke B, 1999, NATURE, V397, P572, DOI 10.1038/17508; Allan JD, 2015, ATMOS CHEM PHYS, V15, P5599, DOI 10.5194/acp-15-5599-2015; Atkinson HM, 2012, ATMOS CHEM PHYS, V12, P11229, DOI 10.5194/acp-12-11229-2012; Atkinson R, 2000, J PHYS CHEM REF DATA, V29, P167, DOI 10.1063/1.556058; Bloss WJ, 2001, J PHYS CHEM A, V105, P7840, DOI 10.1021/jp0044936; Ehn M, 2014, NATURE, V506, P476, DOI 10.1038/nature13032; Ehn M, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014292; Hoffmann T, 2001, GEOPHYS RES LETT, V28, P1949, DOI 10.1029/2000GL012399; Huang RJ, 2010, ATMOS CHEM PHYS, V10, P4823, DOI 10.5194/acp-10-4823-2010; Jimenez JL, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002452; Kirkby J, 2016, NATURE, V533, P521, DOI 10.1038/nature17953; Kirkby J, 2011, NATURE, V476, P429, DOI 10.1038/nature10343; Kurten A, 2014, P NATL ACAD SCI USA, V111, P15019, DOI 10.1073/pnas.1404853111; Kulmala M, 2014, ANNU REV PHYS CHEM, V65, P21, DOI 10.1146/annurev-physchem-040412-110014; Kulmala M, 2013, SCIENCE, V339, P943, DOI 10.1126/science.1227385; Lawler MJ, 2014, ATMOS CHEM PHYS, V14, P2669, DOI 10.5194/acp-14-2669-2014; Mahajan AS, 2011, ATMOS CHEM PHYS, V11, P2545, DOI 10.5194/acp-11-2545-2011; Mahajan AS, 2010, ATMOS CHEM PHYS, V10, P4611, DOI 10.5194/acp-10-4611-2010; Mahajan AS, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013665; McFiggans G, 2004, ATMOS CHEM PHYS, V4, P701, DOI 10.5194/acp-4-701-2004; McFiggans G, 2010, ATMOS CHEM PHYS, V10, P2975, DOI 10.5194/acp-10-2975-2010; O'Dowd C. D., 2002, J GEOPHYS RES, V107; O'Dowd CD, 2002, NATURE, V417, P632, DOI 10.1038/nature00775; O'Dowd CD, 2007, PHILOS T R SOC A, V365, P1753, DOI 10.1098/rsta.2007.2043; Riccobono F, 2014, SCIENCE, V344, P717, DOI 10.1126/science.1243527; Roscoe HK, 2015, J GEOPHYS RES-ATMOS, V120, P7144, DOI 10.1002/2015JD023301; Saiz-Lopez A, 2008, ATMOS CHEM PHYS, V8, P887, DOI 10.5194/acp-8-887-2008; Saiz-Lopez A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019215; Saiz-Lopez A, 2012, CHEM REV, V112, P1773, DOI 10.1021/cr200029u; Saunders RW, 2010, Z PHYS CHEM, V224, P1095, DOI 10.1524/zpch.2010.6143; Saunders RW, 2005, ENVIRON CHEM, V2, P299, DOI 10.1071/EN05079; SUNDER S, 1987, CAN J SPECTROSC, V32, P45; Yoon YJ, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006284	33	163	167	22	249	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2016	537	7621					532	534		10.1038/nature19314	http://dx.doi.org/10.1038/nature19314			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW3MO	27580030	Green Accepted			2022-12-28	WOS:000383545900052
J	McEvoy, RD; Antic, NA; Heeley, E; Luo, YM; Ou, Q; Zhang, XL; Mediano, O; Chen, R; Drager, LF; Liu, ZH; Chen, GF; Du, BL; McArdle, N; Mukherjee, S; Tripathi, M; Billot, L; Li, Q; Lorenzi-Filho, G; Barbe, F; Redline, S; Wang, JG; Arima, H; Neal, B; White, DP; Grunstein, RR; Zhong, NS; Anderson, CS				McEvoy, R. Doug; Antic, Nick A.; Heeley, Emma; Luo, Yuanming; Ou, Qiong; Zhang, Xilong; Mediano, Olga; Chen, Rui; Drager, Luciano F.; Liu, Zhihong; Chen, Guofang; Du, Baoliang; McArdle, Nigel; Mukherjee, Sutapa; Tripathi, Manjari; Billot, Laurent; Li, Qiang; Lorenzi-Filho, Geraldo; Barbe, Ferran; Redline, Susan; Wang, Jiguang; Arima, Hisatomi; Neal, Bruce; White, David P.; Grunstein, Ron R.; Zhong, Nanshan; Anderson, Craig S.		SAVE Investigators Coordinators	CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITIVE AIRWAY PRESSURE; RANDOMIZED CONTROLLED-TRIAL; BLOOD-PRESSURE; HEART HEALTH; END-POINTS; ASSOCIATION; HYPERTENSION; METAANALYSIS; STROKE; RISK	BACKGROUND Obstructive sleep apnea is associated with an increased risk of cardiovascular events; whether treatment with continuous positive airway pressure ( CPAP) prevents major cardiovascular events is uncertain. METHODS After a 1-week run-in period during which the participants used sham CPAP, we randomly assigned 2717 eligible adults between 45 and 75 years of age who had moderate-to-severe obstructive sleep apnea and coronary or cerebrovascular disease to receive CPAP treatment plus usual care ( CPAP group) or usual care alone ( usual-care group). The primary composite end point was death from cardiovascular causes, myocardial infarction, stroke, or hospitalization for unstable angina, heart failure, or transient ischemic attack. Secondary end points included other cardiovascular outcomes, health-related quality of life, snoring symptoms, daytime sleepiness, and mood. RESULTS Most of the participants were men who had moderate-to-severe obstructive sleep apnea and minimal sleepiness. In the CPAP group, the mean duration of adherence to CPAP therapy was 3.3 hours per night, and the mean apnea-hypopnea index ( the number of apnea or hypopnea events per hour of recording) decreased from 29.0 events per hour at baseline to 3.7 events per hour during follow-up. After a mean follow-up of 3.7 years, a primary end-point event had occurred in 229 participants in the CPAP group ( 17.0%) and in 207 participants in the usual-care group ( 15.4%) ( hazard ratio with CPAP, 1.10; 95% confidence interval, 0.91 to 1.32; P = 0.34). No significant effect on any individual or other composite cardiovascular end point was observed. CPAP significantly reduced snoring and daytime sleepiness and improved health-related quality of life and mood. CONCLUSIONS Therapy with CPAP plus usual care, as compared with usual care alone, did not prevent cardiovascular events in patients with moderate-to-severe obstructive sleep apnea and established cardiovascular disease. (Funded by the National Health and Medical Research Council of Australia and others; SAVE ClinicalTrials.gov number, NCT00738179; Australian New Zealand Clinical Trials Registry number, ACTRN12608000409370.)	[McEvoy, R. Doug; Antic, Nick A.] Flinders Univ S Australia, Adelaide Inst Sleep Hlth, Adelaide, SA, Australia; [McEvoy, R. Doug; Antic, Nick A.; Heeley, Emma; Neal, Bruce; Anderson, Craig S.] Flinders Univ S Australia, Sch Med, Fac Med Nursing & Hlth Sci, Adelaide, SA, Australia; [McEvoy, R. Doug; Antic, Nick A.; Mukherjee, Sutapa] Southern Adelaide Local Hlth Network, Sleep Hlth Serv, Resp & Sleep Serv, Adelaide, SA, Australia; [Heeley, Emma; Billot, Laurent; Li, Qiang; Arima, Hisatomi; Neal, Bruce; Anderson, Craig S.] Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia; [Heeley, Emma; Billot, Laurent; Li, Qiang; Arima, Hisatomi; Neal, Bruce; Anderson, Craig S.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Grunstein, Ron R.] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW, Australia; [Grunstein, Ron R.] Royal Prince Alfred Hosp, Sydney Hlth Partners, Dept Resp & Sleep Med, Sydney, NSW, Australia; [Anderson, Craig S.] Royal Prince Alfred Hosp, Dept Neurol, Sydney, NSW, Australia; [McArdle, Nigel; Mukherjee, Sutapa] Sir Charles Gairdner Hosp, Western Australian Sleep Disorders Res Inst, Perth, WA, Australia; [Luo, Yuanming; Zhong, Nanshan] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Ou, Qiong] Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China; [Ou, Qiong] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China; [Zhang, Xilong] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Chen, Rui] Soochow Univ, Affiliated Hosp 2, Suzhou, Peoples R China; [Liu, Zhihong] Peking Univ, Dept Cardiol, Fuwai Hosp, Hlth Sci Ctr, Beijing, Peoples R China; [Anderson, Craig S.] Peking Univ, George Inst Global Hlth China, Hlth Sci Ctr, Beijing, Peoples R China; [Chen, Guofang] Xuzhou Cent Hosp, Dept Neurol, Xuzhou, Peoples R China; [Du, Baoliang] Hejian Municipal Peoples Hosp, Hejian, Peoples R China; [Wang, Jiguang] Shanghai Jiao Tong Univ, Shanghai Inst Hypertens, Ruijin Hosp, Shanghai, Peoples R China; [Mediano, Olga] Univ Hosp Guadalajara, Guadalajara, Spain; [Barbe, Ferran] Inst Recerca Biomed Lleida, Resp Dept, Lleida, Spain; [Barbe, Ferran] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain; [Drager, Luciano F.; Lorenzi-Filho, Geraldo] Inst Coracao Incor, Sao Paulo, Brazil; [Drager, Luciano F.; Lorenzi-Filho, Geraldo] Univ Hosp, Sao Paulo, Brazil; [Drager, Luciano F.] Univ Sao Paulo, Hypertens Unit, Div Renal, Sch Med, Sao Paulo, Brazil; [Tripathi, Manjari] All India Inst Med Sci, Dept Neurol, Delhi, India; [Redline, Susan; White, David P.] Brigham & Womens Hosp, Div Sleep & Circadian Disorders, Boston, MA USA; [Redline, Susan; White, David P.] Harvard Med Sch, Boston, MA USA	Flinders University South Australia; Flinders University South Australia; George Institute for Global Health; University of Sydney; University of Sydney; University of Sydney; Woolcock Institute of Medical Research; University of Sydney; University of Sydney; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Nanjing Medical University; Soochow University - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking University; Peking University; Shanghai Jiao Tong University; Institut de Recerca Biomedica - IRB Lleida; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Universidade de Sao Paulo; Universidade de Sao Paulo; All India Institute of Medical Sciences (AIIMS) New Delhi; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	McEvoy, RD (corresponding author), Flinders Univ S Australia, Adelaide Inst Sleep Hlth, Adelaide, SA, Australia.; McEvoy, RD (corresponding author), Rep Gen Hosp, Resp & Sleep Serv, Southern Adelaide Local Hlth Network, Adelaide, SA 5041, Australia.; Luo, YM (corresponding author), Guangzhou Med Univ, State Key Lab Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	doug.mcevoy@flinders.edu.au; yuanmingluo9431@yahoo.co.uk	Drager, Luciano F/A-1535-2014; Wang, Ji Guang/AAP-4045-2021; McEvoy, Doug/ABB-8052-2020; Mediano, Olga/AAZ-2784-2021; Lorenzi-Filho, Geraldo GLF/E-1062-2012; Billot, Laurent/Y-1241-2019; Mukherjee, Sutapa/U-7262-2017; Palmer, Lyle John/K-3196-2014; Marks, Guy B./F-5058-2013; Demchuk, Andrew M/E-1103-2012; Barbé, Ferran/A-5988-2010	Wang, Ji Guang/0000-0001-8511-1524; Mediano, Olga/0000-0001-7824-1523; Lorenzi-Filho, Geraldo GLF/0000-0002-7011-7373; Billot, Laurent/0000-0002-4975-9793; Mukherjee, Sutapa/0000-0001-5021-1648; Palmer, Lyle John/0000-0002-1628-3055; Marks, Guy B./0000-0002-8976-8053; Demchuk, Andrew M/0000-0002-4930-7789; Barbé, Ferran/0000-0002-2340-8928; Masdeu Margalef, Maria Jose/0000-0003-0437-2074; Neal, Bruce/0000-0002-0490-7465; Li, Qiang/0000-0002-4384-8226; Epton, Michael/0000-0003-4644-366X; Anderson, Craig/0000-0002-7248-4863; Egea, Carlos/0000-0002-7618-7444; Carcel, Cheryl/0000-0001-8942-953X; Pinar, Maria/0000-0003-1613-839X; Senior, Hugh/0000-0002-7081-2499; McKenna, Amanda/0000-0002-5481-6094; Heeley, Emma/0000-0001-9190-2832; Liu, Zhihong/0000-0001-8639-6306; Freed, Ruth/0000-0003-4170-1746; VIGIL GIMENEZ, LAURA/0000-0002-0837-9524	National Health and Medical Research Council of Australia; Grants-in-Aid for Scientific Research [15H04773] Funding Source: KAKEN	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funded by the National Health and Medical Research Council of Australia and others; SAVE ClinicalTrials.gov number, NCT00738179; Australian New Zealand Clinical Trials Registry number, ACTRN12608000409370.	Antic NA, 2015, SLEEP, V38, P1247, DOI 10.5665/sleep.4902; Arzt M, 2005, AM J RESP CRIT CARE, V172, P1447, DOI 10.1164/rccm.200505-702OC; Barbe F, 2012, JAMA-J AM MED ASSOC, V307, P2161, DOI 10.1001/jama.2012.4366; Cadby G, 2015, CHEST, V148, P945, DOI 10.1378/chest.15-0229; Campos-Rodriguez F, 2012, ANN INTERN MED, V156, P115, DOI 10.7326/0003-4819-156-2-201201170-00006; Chai-Coetzer CL, 2011, THORAX, V66, P213, DOI 10.1136/thx.2010.152801; Craig SE, 2012, THORAX, V67, P1090, DOI 10.1136/thoraxjnl-2012-202178; Gaisl T, 2015, EUR RESPIR J, V46, P532, DOI 10.1183/09031936.00029315; Gantner D, 2010, RESPIROLOGY, V15, P952, DOI 10.1111/j.1440-1843.2010.01797.x; Gottlieb DJ, 2014, NEW ENGL J MED, V370, P2276, DOI 10.1056/NEJMoa1306766; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Heeley E, 2016, INT J STROKE, V11, P148, DOI 10.1177/1747493015607504; Hohl M, 2014, CURR CARDIOL REV, V10, P362, DOI 10.2174/1573403X1004140707125137; HUNG J, 1990, LANCET, V336, P261, DOI 10.1016/0140-6736(90)91799-G; Iftikhar IH, 2015, J CLIN SLEEP MED, V11, P475, DOI 10.5664/jcsm.4610; Iftikhar IH, 2014, J HYPERTENS, V32, P2341, DOI 10.1097/HJH.0000000000000372; Johnson KG, 2010, J CLIN SLEEP MED, V6, P131; Lavie L, 2015, SLEEP MED REV, V20, P27, DOI 10.1016/j.smrv.2014.07.003; Lee CH, 2016, CIRCULATION, V133, P2008, DOI 10.1161/CIRCULATIONAHA.115.019392; Loke YK, 2012, CIRC-CARDIOVASC QUAL, V5, P720, DOI 10.1161/CIRCOUTCOMES.111.964783; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marin JM, 2012, JAMA-J AM MED ASSOC, V307, P2169, DOI 10.1001/jama.2012.3418; Montesi SB, 2012, J CLIN SLEEP MED, V8, P587, DOI 10.5664/jcsm.2170; Parra O, 2011, EUR RESPIR J, V37, P1128, DOI 10.1183/09031936.00034410; Peker Y, 2016, AM J RESP CRIT CARE; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Phillips CL, 2012, THORAX, V67, P639, DOI 10.1136/thoraxjnl-2011-200874; Pressman GS, 2015, AM J CARDIOL, V115, P1563, DOI 10.1016/j.amjcard.2015.02.061; Redline S, 2010, AM J RESP CRIT CARE, V182, P269, DOI 10.1164/rccm.200911-1746OC; Schwarz EI, 2015, RESPIROLOGY, V20, P889, DOI 10.1111/resp.12573; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; Weaver Terri E, 2008, Proc Am Thorac Soc, V5, P173, DOI 10.1513/pats.200708-119MG; Worsnop CJ, 1998, AM J RESP CRIT CARE, V157, P111, DOI 10.1164/ajrccm.157.1.9609063	33	1054	1102	10	227	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2016	375	10					919	931		10.1056/NEJMoa1606599	http://dx.doi.org/10.1056/NEJMoa1606599			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU9IG	27571048	Green Published, Bronze			2022-12-28	WOS:000382529500005
J	Savage, N				Savage, Neil			THE MYTH OF ANONYMITY	NATURE			English	Editorial Material																			0	6	8	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					S70	S72		10.1038/537S70a	http://dx.doi.org/10.1038/537S70a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU9LQ	27602747	Bronze			2022-12-28	WOS:000382539100008
J	Cole, TB				Cole, Thomas B.			Nocturne Ben Shahn	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2016	316	9					910	911		10.1001/jama.2015.14460	http://dx.doi.org/10.1001/jama.2015.14460			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU8JV	27599317				2022-12-28	WOS:000382460200001
J	Calverley, PMA				Calverley, Peter M. A.			COPD therapy: if two is good, is three better?	LANCET			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; INHALED FLUTICASONE FUROATE; DOUBLE-BLIND; PARALLEL-GROUP; EXACERBATIONS; VILANTEROL; INDACATEROL; WITHDRAWAL; TIOTROPIUM		[Calverley, Peter M. A.] Univ Liverpool, Sch Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Calverley, PMA (corresponding author), Univ Liverpool, Sch Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England.	pmacal@liverpool.ac.uk						Decramer M, 2014, LANCET RESP MED, V2, P472, DOI 10.1016/S2213-2600(14)70065-7; Decramer ML, 2013, LANCET RESP MED, V1, P524, DOI 10.1016/S2213-2600(13)70158-9; Dransfield MT, 2013, LANCET RESP MED, V1, P210, DOI 10.1016/S2213-2600(13)70040-7; Magnussen H, 2014, NEW ENGL J MED, V371, P1285, DOI 10.1056/NEJMoa1407154; Mahler DA, 2014, EUR RESPIR J, V43, P1599, DOI 10.1183/09031936.00124013; Pascoe S, 2015, LANCET RESP MED, V3, P435, DOI 10.1016/S2213-2600(15)00106-X; Singh D, 2016, LANCET, V388, P963, DOI 10.1016/S0140-6736(16)31354-X; Vestbo J, 2016, LANCET, V387, P1817, DOI 10.1016/S0140-6736(16)30069-1; Watz H, 2016, LANCET RESP MED, V4, P390, DOI 10.1016/S2213-2600(16)00100-4; Wedzicha JA, 2016, NEW ENGL J MED, V374, P2222, DOI 10.1056/NEJMoa1516385; Welte T, 2009, AM J RESP CRIT CARE, V180, P741, DOI 10.1164/rccm.200904-0492OC	11	4	4	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2016	388	10048					937	938		10.1016/S0140-6736(16)31464-7	http://dx.doi.org/10.1016/S0140-6736(16)31464-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU9GL	27598662				2022-12-28	WOS:000382524400004
J	Dhawan, NS; Scopton, AP; Dar, AC				Dhawan, Neil S.; Scopton, Alex P.; Dar, Arvin C.			Small molecule stabilization of the KSR inactive state antagonizes oncogenic Ras signalling	NATURE			English	Article							KINASE SUPPRESSOR; MEK INHIBITION; COMPLEX REVEALS; GENE ENCODES; C-ELEGANS; ACTIVATION; PROTEIN; MECHANISM; BRAF; SCAFFOLD	Deregulation of the Ras-mitogen activated protein kinase (MAPK) pathway is an early event in many different cancers and a key driver of resistance to targeted therapies'. Sustained signalling through this pathway is caused most often by mutations in K-Ras, which biochemically favours the stabilization of active RAF signalling complexes'. Kinase suppressor of Ras (KSR) is a MAPK scaffold(3-5) that is subject to allosteric regulation through dimerization with RAF(6,7). Direct targeting of KSR could have important therapeutic implications for cancer; however, testing this hypothesis has been difficult owing to a lack of small-molecule antagonists of KSR function. Guided by KSR mutations that selectively suppress oncogenic, but not wild-type, Ras signalling, we developed a class of compounds that stabilize a previously unrecognized inactive state of KSR. These compounds, exemplified by APS-2-79, modulate KSR-dependent MAPK signalling by antagonizing RAF heterodimerization as well as the conformational changes required for phosphorylation and activation of KSR-bound MEK (mitogen-activated protein kinase kinase). Furthermore, APS-2-79 increased the potency of several MEK inhibitors specifically within Ras mutant cell lines by antagonizing release of negative feedback signalling, demonstrating the potential of targeting KSR to improve the efficacy of current MAPK inhibitors. These results reveal conformational switching in KSR as a druggable regulator of oncogenic Ras, and further suggest co-targeting of enzymatic and scaffolding activities within Ras-MAPK signalling complexes as a therapeutic strategy for overcoming Ras-driven cancers.	[Dhawan, Neil S.; Scopton, Alex P.; Dar, Arvin C.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Oncol Sci, New York, NY 10029 USA; [Dhawan, Neil S.; Scopton, Alex P.; Dar, Arvin C.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Struct & Chem Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Dhawan, NS (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Oncol Sci, New York, NY 10029 USA.; Dhawan, NS (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Struct & Chem Biol, New York, NY 10029 USA.				NIH [1DP2CA186570-01]; Damon Runyon-Rachleff Foundation; NATIONAL CANCER INSTITUTE [P30CA196521, DP2CA186570] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon-Rachleff Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank K. Shokat, R. Fisher, R. Cagan, S. Aaronson, M. Lazarus, E. Bernstein, and members of the Dar laboratory for comments on the manuscript; A. Maldonado and L. Silber for technical support; and staff at the Advanced Photon Source (Beamline 23-ID-B) for help with X-ray diffraction experiments. The Dar laboratory is supported by innovation awards from the NIH (1DP2CA186570-01) and Damon Runyon-Rachleff Foundation. A.C.D. is a Pew-Stewart Scholar in Cancer Research and Young Investigator of the Pershing-Square Sohn Cancer Research Alliance.	Brennan DF, 2011, NATURE, V472, P366, DOI 10.1038/nature09860; Chapman PB, 2014, CANCER CELL, V26, P603, DOI 10.1016/j.ccell.2014.10.017; Douziech M, 2006, GENE DEV, V20, P807, DOI 10.1101/gad.1390406; Fernandez MR, 2012, MOL CELL BIOL, V32, P3718, DOI 10.1128/MCB.06754-11; Haling JR, 2014, CANCER CELL, V26, P402, DOI 10.1016/j.ccr.2014.07.007; Hatzivassiliou G, 2013, NATURE, V501, P232, DOI 10.1038/nature12441; Hu JC, 2013, CELL, V154, P1036, DOI 10.1016/j.cell.2013.07.046; Karim FD, 1996, GENETICS, V143, P315; KORNFELD K, 1995, CELL, V83, P903, DOI 10.1016/0092-8674(95)90206-6; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; Lavoie H, 2013, NAT CHEM BIOL, V9, P428, DOI [10.1038/NCHEMBIO.1257, 10.1038/nchembio.1257]; Le Borgne M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057137; Lito P, 2014, CANCER CELL, V25, P697, DOI 10.1016/j.ccr.2014.03.011; McKay MM, 2011, CURR BIOL, V21, P563, DOI 10.1016/j.cub.2011.02.033; McKay MM, 2009, P NATL ACAD SCI USA, V106, P11022, DOI 10.1073/pnas.0901590106; Michaud NR, 1997, P NATL ACAD SCI USA, V94, P12792, DOI 10.1073/pnas.94.24.12792; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Sos ML, 2014, CELL REP, V8, P1037, DOI 10.1016/j.celrep.2014.07.010; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Stewart S, 1999, MOL CELL BIOL, V19, P5523; SUNDARAM M, 1995, CELL, V83, P889, DOI 10.1016/0092-8674(95)90205-8; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; Xie T, 2014, NAT CHEM BIOL, V10, P1006, DOI 10.1038/nchembio.1658; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377	27	60	61	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					112	116		10.1038/nature19327	http://dx.doi.org/10.1038/nature19327			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27556948	Green Submitted, Green Accepted			2022-12-28	WOS:000382426900049
J	Kmietowicz, Z				Kmietowicz, Zosia			NICE recommends 3D heart imaging for diagnosing heart disease	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Institute for Health and Care Excellence, 2016, HEARTFLOW FFRCT EST	1	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 26	2016	354								i4662	10.1136/bmj.i4662	http://dx.doi.org/10.1136/bmj.i4662			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AB	27566719				2022-12-28	WOS:000382792300005
J	Lauby-Secretan, B; Scoccianti, C; Loomis, D; Grosse, Y; Bianchini, F; Straif, K				Lauby-Secretan, Beatrice; Scoccianti, Chiara; Loomis, Dana; Grosse, Yann; Bianchini, Franca; Straif, Kurt		Int Agcy Res Canc Handbook	Body Fatness and Cancer - Viewpoint of the IARC Working Group	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MASS INDEX; POOLED ANALYSIS; ANTHROPOMETRIC FACTORS; RISK; METAANALYSIS; OBESITY; WEIGHT		[Lauby-Secretan, Beatrice; Scoccianti, Chiara; Loomis, Dana; Grosse, Yann; Straif, Kurt] Int Agcy Res Canc, Lyon, France; [Bianchini, Franca] German Canc Res Ctr, Heidelberg, Germany	World Health Organization; International Agency for Research on Cancer (IARC); Helmholtz Association; German Cancer Research Center (DKFZ)	Lauby-Secretan, B (corresponding author), Int Agcy Res Canc, Lyon, France.		Loomis, Dana/AAE-3988-2019; Weiderpass, Elisabete/AAP-2747-2021; Weiderpass, Elisabete/M-4029-2016; Breda, Joao/J-9371-2014	Weiderpass, Elisabete/0000-0003-2237-0128; Weiderpass, Elisabete/0000-0003-2237-0128; Lauby-Secretan, Beatrice/0000-0001-6559-3351; Wade, Kaitlin/0000-0003-3362-6280; anderson, annie/0000-0002-0047-4500; Loomis, Dana/0000-0003-3297-5200; Breda, Joao/0000-0002-8177-4926; Di Cesare, Mariachiara/0000-0002-3934-3364	American Cancer Society; Centers for Disease Control and Prevention; NATIONAL CANCER INSTITUTE [U01CA206110, R01CA207371, R01CA189184] Funding Source: NIH RePORTER; Cancer Research UK [17962] Funding Source: researchfish	American Cancer Society(American Cancer Society); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK)	Volume 16 of the IARC Handbooks was partially funded by the American Cancer Society and the Centers for Disease Control and Prevention.	Arnold M, 2016, CANCER EPIDEMIOL, V41, P8, DOI 10.1016/j.canep.2016.01.003; Beral V, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001200; Brinton LA, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt465; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Chen Y, 2013, CANCER EPIDEM BIOMAR, V22, P1395, DOI 10.1158/1055-9965.EPI-13-0042; Chen Y, 2012, EUR J CANCER, V48, P2137, DOI 10.1016/j.ejca.2012.02.063; Chlebowski RT, 2006, BREAST CANCER RES TR, V100, pS16; Cleary MP, 2013, J MAMMARY GLAND BIOL, V18, P333, DOI 10.1007/s10911-013-9300-x; Crosbie EJ, 2010, CANCER EPIDEM BIOMAR, V19, P3119, DOI 10.1158/1055-9965.EPI-10-0832; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Eliassen AH, 2006, JAMA-J AM MED ASSOC, V296, P193, DOI 10.1001/jama.296.2.193; Genkinger JM, 2011, INT J CANCER, V129, P1708, DOI 10.1002/ijc.25794; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoyo C, 2012, INT J EPIDEMIOL, V41, P1706, DOI 10.1093/ije/dys176; International Agency for Research on Cancer, 2002, IARC HDB CANC PREVEN, V6; Jee SH, 2008, INT J CANCER, V123, P1892, DOI 10.1002/ijc.23719; Kitahara CM, 2016, THYROID, V26, P306, DOI 10.1089/thy.2015.0319; Ma YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053916; Nead KT, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv178; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Niedermaier T, 2015, NEUROLOGY, V85, P1342, DOI 10.1212/WNL.0000000000002020; Patel AV, 2013, LEUKEMIA LYMPHOMA, V54, P1221, DOI 10.3109/10428194.2012.742523; Ray A, 2013, ADIPOSE TISSUE CANC, P99; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Renehan AG, 2015, NAT REV CANCER, V15, P484, DOI 10.1038/nrc3967; Setiawan VW, 2013, J CLIN ONCOL, V31, P2607, DOI 10.1200/JCO.2012.48.2596; Smith MT, 2016, ENVIRON HEALTH PERSP, V124, P713, DOI 10.1289/ehp.1509912; Tee MC, 2013, SURG ENDOSC, V27, P4449, DOI 10.1007/s00464-013-3127-9; Teras LR, 2014, BRIT J HAEMATOL, V166, P667, DOI 10.1111/bjh.12935; Thompson HJ, 2003, J MAMMARY GLAND BIOL, V8, P133, DOI 10.1023/A:1025743607445; Thrift AP, 2015, CANCER EPIDEM BIOMAR, V24, P1024, DOI 10.1158/1055-9965.EPI-14-1309; Thrift AP, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju252; Wang FR, 2014, INT J CANCER, V135, P1673, DOI 10.1002/ijc.28813; World Cancer Research Fund, 2014, CONT UPD PROJ REP DI; [World Cancer Research Fund/ American Institute for Cancer Research W. C. R. F. I. A. I. f. C. Research], 2015, CONT UPD PROJ DIET N	36	1493	1535	8	114	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2016	375	8					794	798		10.1056/NEJMsr1606602	http://dx.doi.org/10.1056/NEJMsr1606602			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9ET	27557308	Green Accepted, Green Submitted, Bronze, Green Published			2022-12-28	WOS:000381799300019
J	Mayor, S				Mayor, Susan			Some breast cancer patients with low genetic risk may not need chemotherapy, trial shows	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Cardoso F, 2016, NEW ENGL J MED, V375, P717, DOI 10.1056/NEJMoa1602253; Hudis CA, 2016, NEW ENGL J MED, V375, P790, DOI 10.1056/NEJMe1607947	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 25	2016	354								i4635	10.1136/bmj.i4635	http://dx.doi.org/10.1136/bmj.i4635			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AA	27561820				2022-12-28	WOS:000382792200005
J	Scott, DC; Rhee, DY; Duda, DM; Kelsall, IR; Olszewski, JL; Paulo, JA; de Jong, A; Ovaa, H; Alpi, AF; Harper, JW; Schulman, BA				Scott, Daniel C.; Rhee, David Y.; Duda, David M.; Kelsall, Ian R.; Olszewski, Jennifer L.; Paulo, Joao A.; de Jong, Annemieke; Ovaa, Huib; Alpi, Arno F.; Harper, J. Wade; Schulman, Brenda A.			Two Distinct Types of E3 Ligases Work in Unison to Regulate Substrate Ubiquitylation	CELL			English	Article							UBIQUITIN LIGASES; LIGATION MECHANISM; SCF COMPLEXES; INSIGHTS; IDENTIFICATION; DEGRADATION; CONJUGATION; CANCER; HHARI; NEDD8	Hundreds of human cullin-RING E3 ligases (CRLs) modify thousands of proteins with ubiquitin (UB) to achieve vast regulation. Current dogma posits that CRLs first catalyze UB transfer from an E2 to their client substrates and subsequent polyubiquitylation from various linkage-specific E2s. We report an alternative E3-E3 tagging cascade: many cellular NEDD8-modified CRLs associate with a mechanistically distinct thioester-forming RBR-type E3, ARIH1, and rely on ARIH1 to directly add the first UB and, in some cases, multiple additional individual mono-ubiquitin modifications onto CRL client substrates. Our data define ARIH1 as a component of the human CRL system, demonstrate that ARIH1 can efficiently and specifically mediate monoubiquitylation of several CRL substrates, and establish principles for how two distinctive E3s can reciprocally control each other for simultaneous and joint regulation of substrate ubiquitylation. These studies have broad implications for CRL-dependent proteostasis and mechanisms of E3-mediated UB ligation.	[Scott, Daniel C.; Duda, David M.; Olszewski, Jennifer L.; Schulman, Brenda A.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Scott, Daniel C.; Duda, David M.; Schulman, Brenda A.] St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA; [Rhee, David Y.; Paulo, Joao A.; Harper, J. Wade] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Kelsall, Ian R.; Alpi, Arno F.] MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland; [de Jong, Annemieke; Ovaa, Huib] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands; [Ovaa, Huib] Leiden Univ, Med Ctr, Dept Chem Immunol, NL-2333 ZA Leiden, Netherlands	St Jude Children's Research Hospital; Howard Hughes Medical Institute; St Jude Children's Research Hospital; Harvard University; Harvard Medical School; Netherlands Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Schulman, BA (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA.; Schulman, BA (corresponding author), St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA.; Harper, JW (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu; brenda.schulman@stjude.org	Paulo, Joao/AAO-3981-2020; ovaa, huib/M-2334-2016	Paulo, Joao/0000-0002-4291-413X; Alpi, Arno/0000-0002-9572-7266; ovaa, huib/0000-0002-0068-054X; Rhee, David/0000-0002-6911-4941; Schulman, Brenda/0000-0002-3083-1126; Harper, Jeffrey/0000-0002-6944-7236; Kelsall, Ian/0000-0002-7501-6504	NIH [R37NS083524, AG011085, R37GM069530, P30CA021765, K01 DK098285]; ALSAC; HHMI; ERC [281699]; SCILLS; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK098285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM069530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS083524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); HHMI(Howard Hughes Medical Institute); ERC(European Research Council (ERC)European Commission); SCILLS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. McGourty, M. Rape, D. van Dalen, A. Ordureau, J. Lee, and D. Miller. Funding was supplied by NIH R37NS083524 and AG011085 (to J.W.H.); ALSAC, HHMI, and NIH R37GM069530, P30CA021765 (to B.A.S.); NIH K01 DK098285 (to J.A.P.); ERC grant 281699 (to H.O.); and SCILLS (to A.F.A.). B.A.S. is a Howard Hughes Medical Institute Investigator.	Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Ceccarelli DF, 2011, CELL, V145, P1075, DOI 10.1016/j.cell.2011.05.039; Dove KK, 2016, EMBO REP, V17, P1221, DOI 10.15252/embr.201642641; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Duda DM, 2013, STRUCTURE, V21, P1030, DOI 10.1016/j.str.2013.04.019; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Harper JW, 2012, MOL CELL PROTEOMICS, V11, P1541, DOI 10.1074/mcp.R112.021154; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Jubelin G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001128; Kelsall IR, 2013, EMBO J, V32, P2848, DOI 10.1038/emboj.2013.209; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Lechtenberg BC, 2016, NATURE, V529, P546, DOI 10.1038/nature16511; Lee JE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006460; Lydeard JR, 2013, EMBO REP, V14, P1050, DOI 10.1038/embor.2013.173; Marcotte R, 2016, CELL, V164, P293, DOI 10.1016/j.cell.2015.11.062; Marin I, 2009, J MOL EVOL, V69, P54, DOI 10.1007/s00239-009-9252-3; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Moynihan TP, 1999, J BIOL CHEM, V274, P30963, DOI 10.1074/jbc.274.43.30963; Pierce NW, 2013, CELL, V153, P206, DOI 10.1016/j.cell.2013.02.024; Polley SRG, 2014, GENETICS, V196, P211, DOI 10.1534/genetics.113.158485; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Scott DC, 2014, CELL, V157, P1671, DOI 10.1016/j.cell.2014.04.037; Shirane M, 1999, J BIOL CHEM, V274, P13886, DOI 10.1074/jbc.274.20.13886; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stieglitz B, 2013, NATURE, V503, P422, DOI 10.1038/nature12638; Streich FC, 2014, ANNU REV BIOPHYS, V43, P357, DOI 10.1146/annurev-biophys-051013-022958; Vittal V, 2015, J BIOL CHEM, V290, P21244, DOI 10.1074/jbc.R115.675165; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Wu SD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2636; Xing WM, 2013, NATURE, V496, P64, DOI 10.1038/nature11964; Yamoah K, 2008, P NATL ACAD SCI USA, V105, P12230, DOI 10.1073/pnas.0806155105; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462; Yoo SH, 2013, CELL, V152, P1091, DOI 10.1016/j.cell.2013.01.055; Yoshida Y, 2015, P NATL ACAD SCI USA, V112, P4630, DOI 10.1073/pnas.1422313112; Yu C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10053; Zemla A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2628; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	52	116	116	2	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1198	+		10.1016/j.cell.2016.07.027	http://dx.doi.org/10.1016/j.cell.2016.07.027			41	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27565346	Green Accepted, Bronze			2022-12-28	WOS:000382259500017
J	Denniston, AK; Sen, HN				Denniston, Alastair K.; Sen, H. Nida			VISUALising a new framework for the treatment of uveitis	LANCET			English	Editorial Material							CHIMERIC MONOCLONAL-ANTIBODY; NECROSIS-FACTOR-ALPHA; INTERMEDIATE; PANUVEITIS; POSTERIOR; DISEASE; CA2		[Denniston, Alastair K.] Univ Hosp Birmingham NHS Fdn Trust, Birmingham B15 2GW, W Midlands, England; [Denniston, Alastair K.] Univ Birmingham, Acad Unit Ophthalmol, Inst Inflammat & Ageing, Birmingham B15 2TT, W Midlands, England; [Sen, H. Nida] NEI, NIH, Bethesda, MD 20892 USA	University of Birmingham; University of Birmingham; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Denniston, AK (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Birmingham B15 2GW, W Midlands, England.; Denniston, AK (corresponding author), Univ Birmingham, Acad Unit Ophthalmol, Inst Inflammat & Ageing, Birmingham B15 2TT, W Midlands, England.	a.denniston@bham.ac.uk	Denniston, Alastair/ABD-1238-2020	Denniston, Alastair/0000-0001-7849-0087	MRC [G0600416] Funding Source: UKRI; NATIONAL EYE INSTITUTE [ZIAEY000557, ZIEEY000482] Funding Source: NIH RePORTER; Medical Research Council [G0600416] Funding Source: Medline; National Institute for Health Research [CL-2009-09-002] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))		Barry RJ, 2015, CURR PHARM DESIGN, V21, P4682, DOI 10.2174/1381612821666150909094907; Denniston AK, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0318-6; Dick AD, 1996, EUR J IMMUNOL, V26, P1018, DOI 10.1002/eji.1830260510; Dick AD, 2016, OPHTHALMOLOGY, V123, P655, DOI 10.1016/j.ophtha.2015.10.028; Durrani OM, 2004, OPHTHALMOLOGICA, V218, P223, DOI 10.1159/000078612; ELLIOTT MJ, 1994, LANCET, V344, P1105, DOI 10.1016/S0140-6736(94)90628-9; European Commission, PROD INF HUM; Jaffe GJ, 2015, ANN RHEUM DIS, V74, P849, DOI 10.1136/annrheumdis-2015-eular.2799; Nguyen QD, 2016, LANCET; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; US Food and Drug Administration, 2016, HIGHL PRESCR INF	11	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2016	388	10050					1134	1136		10.1016/S0140-6736(16)31327-7	http://dx.doi.org/10.1016/S0140-6736(16)31327-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW5RA	27542304				2022-12-28	WOS:000383703100007
J	Milano, F; Gooley, T; Wood, B; Woolfrey, A; Flowers, ME; Doney, K; Witherspoon, R; Mielcarek, M; Deeg, JH; Sorror, M; Dahlberg, A; Sandmaier, BM; Salit, R; Petersdorf, E; Appelbaum, FR; Delaney, C				Milano, Filippo; Gooley, Ted; Wood, Brent; Woolfrey, Ann; Flowers, Mary E.; Doney, Kristine; Witherspoon, Robert; Mielcarek, Marco; Deeg, Joachim H.; Sorror, Mohamed; Dahlberg, Ann; Sandmaier, Brenda M.; Salit, Rachel; Petersdorf, Effie; Appelbaum, Frederick R.; Delaney, Colleen			Cord-Blood Transplantation in Patients with Minimal Residual Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; HEMATOPOIETIC-CELL TRANSPLANTATION; 2ND COMPLETE REMISSION; UNRELATED DONORS; BONE-MARROW; STEM-CELLS; OUTCOMES; ADULTS; ENGRAFTMENT; RECIPIENTS	BACKGROUND The majority of patients in need of a hematopoietic-cell transplant do not have a matched related donor. Data are needed to inform the choice among various alternative donor-cell sources. METHODS In this retrospective analysis, we compared outcomes in 582 consecutive patients with acute leukemia or the myelodysplastic syndrome who received a first myeloablative hematopoietic-cell transplant from an unrelated cord-blood donor ( 140 patients), an HLA-matched unrelated donor ( 344), or an HLA-mismatched unrelated donor ( 98). RESULTS The relative risks of death and relapse between the cord-blood group and the two other unrelated-donor groups appeared to vary according to the presence of minimal residual disease status before transplantation. Among patients with minimal residual disease, the risk of death was higher in the HLA-mismatched group than in the cord-blood group ( hazard ratio, 2.92; 95% confidence interval [ CI], 1.52 to 5.63; P = 0.001); the risk was also higher in the HLA-matched group than in the cord-blood group but not significantly so ( hazard ratio, 1.69; 95% CI, 0.94 to 3.02; P = 0.08). Among patients without minimal residual disease, the hazard ratios were lower ( hazard ratio in the HLA-mismatched group, 1.36; 95% CI, 0.76 to 2.46; P = 0.30; hazard ratio in the HLA-matched group, 0.78; 95% CI, 0.48 to 1.28; P = 0.33). The risk of relapse among patients with minimal residual disease was significantly higher in the two unrelated-donor groups than in the cord-blood group ( hazard ratio in the HLA-mismatched group, 3.01; 95% CI, 1.22 to 7.38; P = 0.02; hazard ratio in the HLA-matched group, 2.92; 95% CI, 1.34 to 6.35; P = 0.007). Among patients without minimal residual disease, the magnitude of these associations was lower ( hazard ratio in the HLA-mismatched group, 1.28; 95% CI, 0.51 to 3.25; P = 0.60; hazard ratio in the HLA-matched group, 1.30; 95% CI, 0.65 to 2.58; P = 0.46). CONCLUSIONS Our data suggest that among patients with pretransplantation minimal residual disease, the probability of overall survival after receipt of a transplant from a cord-blood donor was at least as favorable as that after receipt of a transplant from an HLA-matched unrelated donor and was significantly higher than the probability after receipt of a transplant from an HLA-mismatched unrelated donor. Furthermore, the probability of relapse was lower in the cord-blood group than in either of the other groups.	[Milano, Filippo; Gooley, Ted; Woolfrey, Ann; Flowers, Mary E.; Doney, Kristine; Witherspoon, Robert; Mielcarek, Marco; Deeg, Joachim H.; Sorror, Mohamed; Dahlberg, Ann; Sandmaier, Brenda M.; Salit, Rachel; Petersdorf, Effie; Appelbaum, Frederick R.; Delaney, Colleen] Univ Washington, Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98195 USA; [Milano, Filippo; Wood, Brent; Flowers, Mary E.; Mielcarek, Marco; Deeg, Joachim H.; Sorror, Mohamed; Sandmaier, Brenda M.; Salit, Rachel; Petersdorf, Effie; Appelbaum, Frederick R.] Univ Washington, Dept Med, Seattle, WA USA; [Woolfrey, Ann; Dahlberg, Ann; Delaney, Colleen] Univ Washington, Dept Pediat, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Milano, F (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,MD B306, Seattle, WA 98109 USA.	fmilano@fredhutch.org	Hourigan, Christopher/S-2476-2016	Hourigan, Christopher/0000-0002-6189-8067	NHLBI NIH HHS [RC2 HL101844, K23 HL077446, P50 HL110787] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL110787, RC2HL101844, K23HL077446] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anasetti C, 2012, NEW ENGL J MED, V367, P1487, DOI 10.1056/NEJMoa1203517; Armand P, 2014, BLOOD, V123, P3664, DOI 10.1182/blood-2014-01-552984; Atsuta Y, 2012, BIOL BLOOD MARROW TR, V18, P780, DOI 10.1016/j.bbmt.2011.10.008; Atsuta Y, 2009, BLOOD, V113, P1631, DOI 10.1182/blood-2008-03-147041; Bachanova V, 2012, BIOL BLOOD MARROW TR, V18, P963, DOI 10.1016/j.bbmt.2012.02.012; Bar M, 2014, LEUK RES TREATMENT, V2014; Brunstein CG, 2010, BLOOD, V116, P4693, DOI 10.1182/blood-2010-05-285304; de Lima M, 2012, NEW ENGL J MED, V367, P2305, DOI 10.1056/NEJMoa1207285; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Eapen M, 2007, LANCET, V369, P1947, DOI 10.1016/S0140-6736(07)60915-5; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; Gragert L, 2014, NEW ENGL J MED, V371, P339, DOI 10.1056/NEJMsa1311707; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kurtzberg J, 1996, NEW ENGL J MED, V335, P157, DOI 10.1056/NEJM199607183350303; Laughlin MJ, 2001, NEW ENGL J MED, V344, P1815, DOI 10.1056/NEJM200106143442402; Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; Marks DI, 2014, HAEMATOLOGICA, V99, P322, DOI 10.3324/haematol.2013.094193; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; Ruggeri A, 2012, LEUKEMIA, V26, P2455, DOI 10.1038/leu.2012.123; Storer BE, 2008, LIFETIME DATA ANAL, V14, P484, DOI 10.1007/s10985-008-9098-9; Tucunduva L, 2014, BRIT J HAEMATOL, V166, P749, DOI 10.1111/bjh.12970; Walter RB, 2013, BLOOD, V122, P1813, DOI 10.1182/blood-2013-06-506725; Wood Brent L, 2013, Methods Mol Biol, V999, P123, DOI 10.1007/978-1-62703-357-2_8	25	250	260	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2016	375	10					944	953		10.1056/NEJMoa1602074	http://dx.doi.org/10.1056/NEJMoa1602074			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU9IG	27602666	Green Accepted, Bronze			2022-12-28	WOS:000382529500007
J	Weitzel, T; Dittrich, S; Lopez, J; Phuklia, W; Martinez-Valdebenito, C; Velasquez, K; Blacksell, SD; Paris, DH; Abarca, K				Weitzel, Thomas; Dittrich, Sabine; Lopez, Javier; Phuklia, Weerawat; Martinez-Valdebenito, Constanza; Velasquez, Katia; Blacksell, Stuart D.; Paris, Daniel H.; Abarca, Katia			Endemic Scrub Typhus in South America	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RICKETTSIAL DISEASES; DIAGNOSIS; CHILE	Scrub typhus is a life-threatening zoonosis caused by Orientia tsutsugamushi organisms that are transmitted by the larvae of trombiculid mites. Endemic scrub typhus was originally thought to be confined to the so called "tsutsugamushi triangle" within the Asia-Pacific region. In 2006, however, two individual cases were detected in the Middle East and South America, which suggested that the pathogen was present farther afield. Here, we report three autochthonous cases of scrub typhus caused by O. tsutsugamushi acquired on Chiloe Island in southern Chile, which suggests the existence of an endemic focus in South America. (Funded by the Chilean Comision Nacional de Investigacion Cientifica y Tecnologica and the Wellcome Trust.)	[Weitzel, Thomas] Univ Desarrollo, Fac Med Clin Alemana, Clin Alemana Santiago, Santiago, Chile; [Lopez, Javier] Pontificia Univ Catolica Chile, Vet Hosp Puente Alto, Santiago, Chile; [Martinez-Valdebenito, Constanza; Abarca, Katia] Pontificia Univ Catolica Chile, Dept Enfermedades Infecciosas & Inmunol Pediat, Santiago, Chile; [Abarca, Katia] Pontificia Univ Catolica Chile, Millennium Inst Immunol & Immunotherapy, Santiago, Chile; [Velasquez, Katia] Pontificia Univ Catolica Chile, Escuela Med, Santiago, Chile; [Velasquez, Katia] Hosp Ancud, Ancud, Chile; [Dittrich, Sabine; Phuklia, Weerawat] Lao Oxford Mahosot Hosp, Wellcome Trust Res Unit, Viangchan, Laos; [Dittrich, Sabine; Blacksell, Stuart D.; Paris, Daniel H.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England; [Blacksell, Stuart D.; Paris, Daniel H.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand	Clinica Alemana; Universidad del Desarrollo; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University	Abarca, K (corresponding author), Pontificia Univ Catolica Chile, Infect Dis & Mol Virol Lab, Marcoleta 391, Santiago, Chile.; Weitzel, T (corresponding author), Clin Alemana Santiago, Lab Clin, Vitacura 5951, Santiago, Chile.	tweitzel@alemana.cl; katia@med.puc.cl	Blacksell, Stuart/D-5530-2018; ABARCA, KATIA/HDM-9351-2022; Paris, Daniel/GLN-7566-2022; Paris, Daniel/AFV-4762-2022	Blacksell, Stuart/0000-0001-6576-726X; Weitzel, Thomas/0000-0002-9804-2123; Phuklia, Weerawat/0000-0003-1468-5138	Chilean Comision Nacional de Investigacion Cientifica y Tecnologica; Wellcome Trust	Chilean Comision Nacional de Investigacion Cientifica y Tecnologica; Wellcome Trust(Wellcome TrustEuropean Commission)	Funded by the Chilean Comision Nacional de Investigacion Cientifica y Tecnologica and the Wellcome Trust.	Abarca K, 2014, REV CHIL INFECTOL, V31, P569, DOI 10.4067/S0716-10182014000500009; Balcells ME, 2011, EMERG INFECT DIS, V17, P1659, DOI 10.3201/eid1709.100960; Blacksell SD, 2007, CLIN INFECT DIS, V44, P391, DOI 10.1086/510585; Blacksell SD, 2016, CLIN VACCINE IMMUNOL, V23, P148, DOI 10.1128/CVI.00553-15; Chikeka I, 2015, CLIN MICROBIOL INFEC, V21, P404, DOI 10.1016/j.cmi.2015.04.022; Derne B, 2015, ACTA TROP, V143, P121, DOI 10.1016/j.actatropica.2014.10.012; Diaz MF, 2007, REV CHIL HIST NAT, V80, P13; Dittrich S, 2015, LANCET GLOB HEALTH, V3, pE104, DOI 10.1016/S2214-109X(14)70289-X; Izzard L, 2010, J CLIN MICROBIOL, V48, P4404, DOI 10.1128/JCM.01526-10; Janardhanan J, 2014, EXPERT REV ANTI-INFE, V12, P1533, DOI 10.1586/14787210.2014.974559; Kelly DJ, 2009, CLIN INFECT DIS, V48, pS203, DOI 10.1086/596576; Kikuchi Y, 2005, MICROBIAL ECOL, V49, P265, DOI 10.1007/s00248-004-0140-5; Koh GCKW, 2010, AM J TROP MED HYG, V82, P368, DOI 10.4269/ajtmh.2010.09-0233; Labruna MB, 2009, ANN NY ACAD SCI, V1166, P156, DOI 10.1111/j.1749-6632.2009.04516.x; Lim C, 2015, J CLIN MICROBIOL, V53, P3663, DOI 10.1128/JCM.01680-15; Luce-Fedrow A, 2015, FUTURE MICROBIOL, V10, P537, DOI [10.2217/fmb.14.141, 10.2217/FMB.14.141]; Lyu YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063668; Paris DH, 2013, AM J TROP MED HYG, V89, P301, DOI 10.4269/ajtmh.13-0064; Richards AL, 2012, FEMS IMMUNOL MED MIC, V64, P107, DOI 10.1111/j.1574-695X.2011.00875.x; Slesak G, 2015, P NATL ACAD SCI USA, V112, pE6593, DOI 10.1073/pnas.1515229112; Taylor AJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003971; Weller, 2011, TROPICAL INFECT DIS, P334; World Health Organization Department of Communicable Disease Surveillance and Response, 1999, WHO REC SURV STAND, V2	23	134	136	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2016	375	10					954	961		10.1056/NEJMoa1603657	http://dx.doi.org/10.1056/NEJMoa1603657			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU9IG	27602667	Bronze, Green Published			2022-12-28	WOS:000382529500008
J	Hampton, T				Hampton, Tracy			Liquid Biopsy to Evaluate Efficacy of Cancer Therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																		Khoo BL, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600274	1	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2016	316	9					917	917		10.1001/jama.2016.12068	http://dx.doi.org/10.1001/jama.2016.12068			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU8JV	27599320				2022-12-28	WOS:000382460200005
J	Costanzo, MR; Ponikowski, P; Javaheri, S; Augostini, R; Goldberg, L; Holcomb, R; Kao, A; Khayat, RN; Oldenburg, O; Stellbrink, C; Abraham, WT				Costanzo, Maria Rosa; Ponikowski, Piotr; Javaheri, Shahrokh; Augostini, Ralph; Goldberg, Lee; Holcomb, Richard; Kao, Andrew; Khayat, Rami N.; Oldenburg, Olaf; Stellbrink, Christoph; Abraham, William T.		Remede Syst Pivotal	Transvenous neurostimulation for central sleep apnoea: a randomised controlled trial	LANCET			English	Article							HEART-FAILURE PATIENTS; ADAPTIVE SERVO-VENTILATION; CHEYNE-STOKES RESPIRATION; PHRENIC-NERVE STIMULATION; POSITIVE AIRWAY PRESSURE; SERVOVENTILATION; PREVALENCE; MANAGEMENT	Background Central sleep apnoea is a serious breathing disorder associated with poor outcomes. The remede system (Respicardia Inc, Minnetonka, MN, USA) is an implantable device which transvenously stimulates a nerve causing diaphragmatic contraction similar to normal breathing. We evaluated the safety and effectiveness of unilateral neurostimulation in patients with central sleep apnoea. Methods We recruited patients from 31 hospital-based centres in Germany, Poland, and the USA in this prospective, multicentre, randomised trial. Participants had to have been medically stable for at least 30 days and have received appropriate guideline recommended therapy, be aged at least 18 years, be expected to tolerate study procedures, and willing and able to comply with study requirements. Eligible patients with an apnoea-hypopnoea index (AHI) of at least 20 events per h, tested by a polysomnography, underwent device implantation and were randomly assigned (1: 1) by a computer-generated method stratified by site to either stimulation (treatment) or no stimulation (control) for 6 months. The primary eff ectiveness endpoint in the intention-to-treat population was the comparison of the proportions of patients in the treatment versus control groups achieving a 50% or greater AHI reduction from baseline to 6 months, measured by a full-night polysomnography assessed by masked investigators in a core laboratory. The primary safety endpoint of 12-month freedom from serious adverse events related to the procedure, system, or therapy was evaluated in all patients. This trial is active, but not recruiting, and is registered with ClinicalTrials.gov (NCT01816776). Findings Between April 17, 2013, and May 28, 2015, we randomly assigned 151 eligible patients to the treatment (n= 73) or control (n= 78) groups. In the analysis of the intention-to-treat population, significantly more patients in the treatment group (35 [51%] of 68) had an AHI reduction from baseline of 50% or greater at 6 months than had those in the control group (eight [11%] of 73; difference between groups 41%, 95% CI 25-54, p< 0.0001). 138 (91%) of 151 patients had no serious-related adverse events at 12 months. Seven (9%) cases of related-serious adverse events occurred in the control group and six (8%) cases were reported in the treatment group. Seven patients died (unrelated to implant, system, or therapy), four deaths (two in treatment group and two in control group) during the 6-month randomisation period when neurostimulation was delivered to only the treatment group and was off in the control group, and three deaths between 6 months and 12 months of follow-up when all patients received neurostimulation. 27 (37%) of 73 patients in the treatment group reported non-serious therapy-related discomfort that was resolved with simple system reprogramming in 26 (36%) patients, but was unresolved in one (1%) patient. Interpretation Transvenous neurostimulation significantly reduced the severity of central sleep apnoea, including improvements in sleep metrics, and was well tolerated. The clinically meaningful effects of the therapy are supported by the concordant improvements in oxygenation and quality of life, making transvenous neurostimulation a promising therapeutic approach for central sleep apnoea.	[Costanzo, Maria Rosa] Advocate Heart Inst, Naperville, IL USA; [Ponikowski, Piotr] Med Univ, Mil Hosp, Dept Heart Dis, Wroclaw, Poland; [Javaheri, Shahrokh] Bethesda N Hosp, Cincinnati, OH USA; [Augostini, Ralph; Khayat, Rami N.; Abraham, William T.] Ohio State Univ, Columbus, OH 43210 USA; [Goldberg, Lee] Univ Penn, Philadelphia, PA 19104 USA; [Holcomb, Richard] Independent Biostat, Minneapolis, MN USA; [Kao, Andrew] Mid Amer Heart Inst, Kansas City, MO USA; [Oldenburg, Olaf] Bad Oeynhausen Heart & Diabet Ctr, Bad Oeynhausen, Germany; [Stellbrink, Christoph] Bielefeld Med Ctr, Bielefeld, Germany	Wroclaw Medical University; University System of Ohio; Ohio State University; University of Pennsylvania; Saint Luke's Mid America Heart Institute; Ruhr University Bochum	Costanzo, MR (corresponding author), Edward Heart, Advocate Med Grp Midwest Heart Specialists, Naperville, IL 60566 USA.	mariarosa.costanzo@advocatehealth.com	Stellbrink, Christoph/AAX-7701-2021; Ponikowski, Piotr/O-6454-2015	Ponikowski, Piotr/0000-0002-3391-7064; Goldberg, Lee/0000-0002-7906-9638	Respicardia Inc.	Respicardia Inc.	Respicardia Inc.; We thank the contributions of the investigators and coordinators at each participating centre. We thank Wendy Gattis Stough for scientific writing assistance, who was funded by Respicardia Inc and worked under the direction and supervision of Medical Research Council; and thank Manya R Harsch and Tyson Rogers for their statistical support.	Abraham WT, 2015, JACC-HEART FAIL, V3, P360, DOI 10.1016/j.jchf.2014.12.013; Arzt M, 2007, CIRCULATION, V115, P3173, DOI 10.1161/CIRCULATIONAHA.106.683482; Arzt M, 2016, JACC-HEART FAIL, V4, P116, DOI 10.1016/j.jchf.2015.09.014; Arzt M, 2013, EUR RESPIR J, V42, P1244, DOI 10.1183/09031936.00083312; Bitter T, 2011, EUR HEART J, V32, P61, DOI 10.1093/eurheartj/ehq327; Bradley TD, 2005, NEW ENGL J MED, V353, P2025, DOI 10.1056/NEJMoa051001; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Costanzo MR, 2015, J CARD FAIL, V21, P892, DOI 10.1016/j.cardfail.2015.08.344; Costanzo MR, 2015, J AM COLL CARDIOL, V65, P72, DOI 10.1016/j.jacc.2014.10.025; Cowie MR, 2016, NEW ENGL J MED, V374, P690, DOI 10.1056/NEJMc1515007; Cowie MR, 2015, NEW ENGL J MED, V373, P1095, DOI 10.1056/NEJMoa1506459; Eckert DJ, 2007, CHEST, V131, P595, DOI 10.1378/chest.06.2287; Floras JS, 2015, EUR HEART J, V36, P1974, DOI 10.1093/eurheartj/ehv087; Hastings PC, 2010, INT J CARDIOL, V139, P17, DOI 10.1016/j.ijcard.2008.08.022; Herrscher TE, 2011, J CARD FAIL, V17, P420, DOI 10.1016/j.cardfail.2011.01.013; Hetzenecker A, 2016, SLEEP MED, V17, P25, DOI 10.1016/j.sleep.2015.08.020; Javaheri S, 2013, COMPR PHYSIOL, V3, P141, DOI 10.1002/cphy.c110057; Javaheri S, 2006, INT J CARDIOL, V106, P21, DOI 10.1016/j.ijcard.2004.12.068; Kasai T, 2010, CIRC-HEART FAIL, V3, P140, DOI 10.1161/CIRCHEARTFAILURE.109.868786; Khayat R, 2012, J CARD FAIL, V18, P534, DOI 10.1016/j.cardfail.2012.05.003; Lavergne F, 2015, J THORAC DIS, V7, pE575, DOI 10.3978/j.issn.2072-1439.2015.12.57; Linde C, 2008, J AM COLL CARDIOL, V52, P1834, DOI 10.1016/j.jacc.2008.08.027; Linhart M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133176; Minic M, 2014, J CLIN SLEEP MED, V10, P277, DOI 10.5664/jcsm.3528; Naughton MT, 2012, THORAX, V67, P357, DOI 10.1136/thoraxjnl-2011-200927; Oldenburg O, 2014, HERZ, V39, P84, DOI 10.1007/s00059-013-4043-4; Oldenburg O, 2016, EUR HEART J, V37, P1695, DOI 10.1093/eurheartj/ehv624; Philippe C, 2006, HEART, V92, P337, DOI 10.1136/hrt.2005.060038; Ponikowski P, 2012, EUR HEART J, V33, P889, DOI 10.1093/eurheartj/ehr298; Spaak J, 2005, HYPERTENSION, V46, P1327, DOI 10.1161/01.HYP.0000193497.45200.66; Takama N, 2012, CIRC J, V76, P661, DOI 10.1253/circj.CJ-11-0299; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yoshihisa A, 2013, HEART VESSELS, V28, P728, DOI 10.1007/s00380-012-0303-0; Zhang XL, 2012, CHEST, V142, P927, DOI 10.1378/chest.11-1899	34	90	92	1	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2016	388	10048					974	982		10.1016/S0140-6736(16)30961-8	http://dx.doi.org/10.1016/S0140-6736(16)30961-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU9GL	27598679				2022-12-28	WOS:000382524400027
J	McGilvray, A				McGilvray, Annabel			High-tech transformation	NATURE			English	Editorial Material																			0	2	2	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					S8	S9		10.1038/537S8a	http://dx.doi.org/10.1038/537S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU7XC	27580142	Bronze			2022-12-28	WOS:000382426900020
J	Lamain-de Ruiter, M; Kwee, A; Naaktgeboren, CA; de Groot, I; Evers, IM; Groenendaal, F; Hering, YR; Huisjes, AJM; Kirpestein, C; Monincx, WM; Siljee, JE; Van't Zelfde, A; van Oirschot, CM; Vankan-Buitelaar, SA; Vonk, MAAW; Wiegers, TA; Zwart, JJ; Franx, A; Moons, KGM; Koster, MPH				Lamain-de Ruiter, Marije; Kwee, Anneke; Naaktgeboren, Christiana A.; de Groot, Inge; Evers, Inge M.; Groenendaal, Floris; Hering, Yolanda R.; Huisjes, Anjoke J. M.; Kirpestein, Cornel; Monincx, Wilma M.; Siljee, Jacqueline E.; Van't Zelfde, Annewil; van Oirschot, Charlotte M.; Vankan-Buitelaar, Simone A.; Vonk, Mariska A. A. W.; Wiegers, Therese A.; Zwart, Joost J.; Franx, Arie; Moons, Karel G. M.; Koster, Maria P. H.			External validation of prognostic models to predict risk of gestational diabetes mellitus in one Dutch cohort: prospective multicentre cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTERNATIONAL ASSOCIATION; MATERNAL CHARACTERISTICS; PREGNANCY; WOMEN; DIAGNOSIS; HYPERGLYCEMIA; INTERVENTION; METFORMIN	OBJECTIVE To perform an external validation and direct comparison of published prognostic models for early prediction of the risk of gestational diabetes mellitus, including predictors applicable in the first trimester of pregnancy. DESIGN External validation of all published prognostic models in large scale, prospective, multicentre cohort study. SETTING 31 independent midwifery practices and six hospitals in the Netherlands. PARTICIPANTS Women recruited in their first trimester (<14 weeks) of pregnancy between December 2012 and January 2014, at their initial prenatal visit. Women with pre-existing diabetes mellitus of any type were excluded. MAIN OUTCOME MEASURES Discrimination of the prognostic models was assessed by the C statistic, and calibration assessed by calibration plots. RESULTS 3723 women were included for analysis, of whom 181 (4.9%) developed gestational diabetes mellitus in pregnancy. 12 prognostic models for the disorder could be validated in the cohort. C statistics ranged from 0.67 to 0.78. Calibration plots showed that eight of the 12 models were well calibrated. The four models with the highest C statistics included almost all of the following predictors: maternal age, maternal body mass index, history of gestational diabetes mellitus, ethnicity, and family history of diabetes. Prognostic models had a similar performance in a subgroup of nulliparous women only. Decision curve analysis showed that the use of these four models always had a positive net benefit. CONCLUSIONS In this external validation study, most of the published prognostic models for gestational diabetes mellitus show acceptable discrimination and calibration. The four models with the highest discriminative abilities in this study cohort, which also perform well in a subgroup of nulliparous women, are easy models to apply in clinical practice and therefore deserve further evaluation regarding their clinical impact.	[Lamain-de Ruiter, Marije; Kwee, Anneke; Franx, Arie; Koster, Maria P. H.] Univ Med Ctr Utrecht, Div Woman & Baby, Dept Obstet, KE-04-123-1,POB 85090, NL-3508 AB Utrecht, Netherlands; [Naaktgeboren, Christiana A.; Moons, Karel G. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [de Groot, Inge] Livive, Ctr Obstet, Tilburg, Netherlands; [Evers, Inge M.] Meander Med Ctr, Dept Obstet, Amersfoort, Netherlands; [Groenendaal, Floris] Univ Med Ctr Utrecht, Div Woman & Baby, Dept Neonatol, Utrecht, Netherlands; [Hering, Yolanda R.] Zuwe Hofpoort Hosp, Dept Obstet, Woerden, Netherlands; [Huisjes, Anjoke J. M.] Gelre Hosp, Dept Obstet, Apeldoorn, Netherlands; [Kirpestein, Cornel] Hosp Rivierenland, Dept Obstet, Tiel, Netherlands; [Monincx, Wilma M.] St Antonius Hosp, Dept Obstet, Nieuwegein, Netherlands; [Siljee, Jacqueline E.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Res Diagnost & Screening IDS, Bilthoven, Netherlands; [Van't Zelfde, Annewil] Midwifery Practice Verloskundigen Amersfoort, Amersfoort, Netherlands; [van Oirschot, Charlotte M.] St Elizabeth Hosp, Dept Obstet, Tilburg, Netherlands; [Vankan-Buitelaar, Simone A.] Midwifery Practice GCM, Maarssenbroek, Netherlands; [Vonk, Mariska A. A. W.] Midwifery Practice Het Wonder, Houten, Netherlands; [Wiegers, Therese A.] Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands; [Zwart, Joost J.] Deventer Hosp, Dept Obstet, Deventer, Netherlands; [Koster, Maria P. H.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Obstet & Gynaecol, Rotterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Meander Medisch Centrum; Utrecht University; Utrecht University Medical Center; Gelre Hospitals; St. Antonius Hospital Utrecht; Netherlands National Institute for Public Health & the Environment; Elisabeth-TweeSteden Ziekenhuis (ETZ); Netherlands Institute for Health Services Research; Deventer Hospital; Erasmus University Rotterdam; Erasmus MC	Lamain-de Ruiter, M (corresponding author), Univ Med Ctr Utrecht, Div Woman & Baby, Dept Obstet, KE-04-123-1,POB 85090, NL-3508 AB Utrecht, Netherlands.	m.deruiter-7@umcutrecht.nl	Franx, Arie/AAA-1739-2021; Groenendaal, Floris/P-6872-2019	Groenendaal, Floris/0000-0002-9284-1637	Netherlands Organisation for Health Research and Development [50-50200-98-060]	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	This study has been conducted with the support of the Netherlands Organisation for Health Research and Development (project no 50-50200-98-060). The funding source had no role in the design, conduct, analyses, or reporting of the study or in the decision to submit the manuscript for publication.	Agarwal MM, 2014, DIABETES RES CLIN PR, V103, P341, DOI 10.1016/j.diabres.2013.10.012; Ainuddin JA, 2015, JCPSP-J COLL PHYSICI, V25, P237, DOI 04.2015/JCPSP.237241; Alwan N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003395.pub2; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 2015, Ann Intern Med, V162, P600, DOI 10.7326/L15-0078-4; Bain E, 2015, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD010443.PUB2; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Caliskan E, 2004, ACTA OBSTET GYN SCAN, V83, P524, DOI 10.1111/j.0001-6349.2004.00389.x; Clausen TD, 2008, DIABETES CARE, V31, P340, DOI 10.2337/dc07-1596; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Collins GS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3186; DeSisto CL, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130415; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Eleftheriades M, 2014, METABOLISM, V63, P1419, DOI 10.1016/j.metabol.2014.07.016; Gabbay-Benziv R, 2015, J PERINAT MED, V43, P283, DOI 10.1515/jpm-2014-0149; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; James JE, 2014, EUR J EPIDEMIOL, V29, P383, DOI 10.1007/s10654-014-9898-z; Janssen KJM, 2009, CAN J ANAESTH, V56, P194, DOI 10.1007/s12630-009-9041-x; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Kleinrouweler CE, 2016, AM J OBSTET GYNECOL, V214, P79, DOI 10.1016/j.ajog.2015.06.013; Lovati E, 2013, DIABETES RES CLIN PR, V100, P340, DOI 10.1016/j.diabres.2013.04.002; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Moher David, 2009, Open Med, V3, pe123; Nanda S, 2011, PRENATAL DIAG, V31, P135, DOI 10.1002/pd.2636; Nankervis A, 2008, AUSTRALAS DIABETES P, P1; National Institute for Health and Care Excellence, 2015, DIAB PREGN; Naylor CD, 1997, NEW ENGL J MED, V337, P1591, DOI 10.1056/NEJM199711273372204; Nederlandse Diabetes Federatie (Dutch Diabetes Federation), 2015, NDF ZORGST DIAB; Pintaudi B, 2014, EUR J ENDOCRINOL, V170, P87, DOI 10.1530/EJE-13-0759; Popova PV, 2015, MINERVA ENDOCRINOL, V40, P239; Sanabria-Martinez G, 2015, BJOG-INT J OBSTET GY, V122, P1167, DOI 10.1111/1471-0528.13429; Savona-Ventura C, 2013, INT J GYNECOL OBSTET, V122, P88, DOI 10.1016/j.ijgo.2013.04.002; Savvidou M, 2010, DIABETES, V59, P3017, DOI 10.2337/db10-0688; Shirazian N, 2009, ARCH GYNECOL OBSTET, V280, P933, DOI 10.1007/s00404-009-1027-y; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Syngelaki A, 2015, FETAL DIAGN THER, V38, P14, DOI 10.1159/000369970; Syngelaki A, 2011, FETAL DIAGN THER, V30, P250, DOI 10.1159/000328083; Teede HJ, 2011, AUST NZ J OBSTET GYN, V51, P499, DOI 10.1111/j.1479-828X.2011.01356.x; Teh WT, 2011, AUST NZ J OBSTET GYN, V51, P26, DOI 10.1111/j.1479-828X.2011.01292.x; Theriault S, 2014, DIABETES RES CLIN PR, V103, P419, DOI 10.1016/j.diabres.2013.12.009; Tran TS, 2013, DIABETES CARE, V36, P618, DOI 10.2337/dc12-1418; Van Calster B, 2016, J CLIN EPIDEMIOL, V74, P167, DOI 10.1016/j.jclinepi.2015.12.005; van Leeuwen M, 2010, BJOG-INT J OBSTET GY, V117, P69, DOI 10.1111/j.1471-0528.2009.02425.x; van Leeuwen M, 2009, DIABETES RES CLIN PR, V85, P96, DOI 10.1016/j.diabres.2009.04.025; Vergouwe Y, 2005, J CLIN EPIDEMIOL, V58, P475, DOI 10.1016/j.jclinepi.2004.06.017; Viana LV, 2014, DIABETES CARE, V37, P3345, DOI 10.2337/dc14-1530; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Visser GHA, 2009, EARLY HUM DEV, V85, P737, DOI 10.1016/j.earlhumdev.2009.09.008; Werner EF, 2012, DIABETES CARE, V35, P529, DOI 10.2337/dc11-1643; World Health Organization, 1999, DEF DIAGN CLASS DI 1; Zhuo ZH, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/381231	54	59	61	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2016	354								i4338	10.1136/bmj.i4338	http://dx.doi.org/10.1136/bmj.i4338			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AC	27576867	Green Published, hybrid			2022-12-28	WOS:000382792400001
J	Kagan, CR; Lifshitz, E; Sargent, EH; Talapin, DV				Kagan, Cherie R.; Lifshitz, Efrat; Sargent, Edward H.; Talapin, Dmitri V.			Building devices from colloidal quantum dots	SCIENCE			English	Review							FIELD-EFFECT TRANSISTORS; LIGHT-EMITTING-DIODES; MULTIPLE EXCITON GENERATION; ATOMIC LAYER DEPOSITION; NANOCRYSTAL SOLIDS; SEMICONDUCTOR NANOCRYSTALS; SURFACE-CHEMISTRY; SOLAR-CELLS; LOW-VOLTAGE; CDSE NANOCRYSTALS	The continued growth of mobile and interactive computing requires devices manufactured with low-cost processes, compatible with large-area and flexible form factors, and with additional functionality. We review recent advances in the design of electronic and optoelectronic devices that use colloidal semiconductor quantum dots (QDs). The properties of materials assembled of QDs may be tailored not only by the atomic composition but also by the size, shape, and surface functionalization of the individual QDs and by the communication among these QDs. The chemical and physical properties of QD surfaces and the interfaces in QD devices are of particular importance, and these enable the solution-based fabrication of low-cost, large-area, flexible, and functional devices. We discuss challenges that must be addressed in the move to solution-processed functional optoelectronic nanomaterials.	[Kagan, Cherie R.] Univ Penn, Dept Elect & Syst Engn, Dept Mat Sci & Engn, 200 South 33rd St, Philadelphia, PA 19104 USA; [Kagan, Cherie R.] Univ Penn, Dept Chem, 200 South 33rd St, Philadelphia, PA 19104 USA; [Lifshitz, Efrat] Technion, Schulich Fac Chem, Inst Solid State, IL-32000 Haifa, Israel; [Lifshitz, Efrat] Technion, Russell Berrie Nanotechnol Inst, IL-32000 Haifa, Israel; [Sargent, Edward H.] Dept Elect & Comp Engn, 10 Kings Coll Rd, Toronto, ON M5S 3G4, Canada; [Talapin, Dmitri V.] Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA; [Talapin, Dmitri V.] Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA; [Talapin, Dmitri V.] Argonne Natl Lab, Ctr Nanoscale Mat, 9700 S Cass Ave, Argonne, IL 60439 USA	University of Pennsylvania; University of Pennsylvania; Technion Israel Institute of Technology; Technion Israel Institute of Technology; University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory	Kagan, CR (corresponding author), Univ Penn, Dept Elect & Syst Engn, Dept Mat Sci & Engn, 200 South 33rd St, Philadelphia, PA 19104 USA.; Kagan, CR (corresponding author), Univ Penn, Dept Chem, 200 South 33rd St, Philadelphia, PA 19104 USA.; Lifshitz, E (corresponding author), Technion, Schulich Fac Chem, Inst Solid State, IL-32000 Haifa, Israel.; Lifshitz, E (corresponding author), Technion, Russell Berrie Nanotechnol Inst, IL-32000 Haifa, Israel.; Sargent, EH (corresponding author), Dept Elect & Comp Engn, 10 Kings Coll Rd, Toronto, ON M5S 3G4, Canada.; Talapin, DV (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.; Talapin, DV (corresponding author), Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA.; Talapin, DV (corresponding author), Argonne Natl Lab, Ctr Nanoscale Mat, 9700 S Cass Ave, Argonne, IL 60439 USA.	kagan@seas.upenn.edu; ssefrat@technion.ac.il; ted.sargent@utoronto.ca; dvtalapin@uchicago.edu	Sargent, Edward H./O-9520-2014	Sargent, Edward H./0000-0003-0396-6495	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Science and Engineering [DE-SC0002158]; Israel Council for High Education-Focal Area Technology [872967]; Volkswagen Stiftung [88116, ZN2916]; Israel Science Foundation [914/15, 1508/14]; Horizon2020 PHONSI project; King Abdullah University of Science and Technology (KAUST) [KUS-11-009-21]; U.S. Department of Defense (DOD) Office of Naval Research [N00014-13-1-0490]	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Science and Engineering(United States Department of Energy (DOE)); Israel Council for High Education-Focal Area Technology; Volkswagen Stiftung(Volkswagen); Israel Science Foundation(Israel Science Foundation); Horizon2020 PHONSI project; King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); U.S. Department of Defense (DOD) Office of Naval Research	C.R.K. gratefully acknowledges the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Science and Engineering, under award DE-SC0002158 for support. E.L. thanks the Israel Council for High Education-Focal Area Technology (grant 872967), the Volkswagen Stiftung (grants 88116 and ZN2916), the Israel Science Foundation (grants 914/15 and 1508/14), and the Horizon2020 PHONSI project for their support. E.H.S. acknowledges award (KUS-11-009-21) from the King Abdullah University of Science and Technology (KAUST). D.V.T. acknowledges support by the U.S. Department of Defense (DOD) Office of Naval Research grant N00014-13-1-0490. C.R.K., E.H.S., and D.V.T. hold and have applied for several patents related to QD assemblies in devices. E.H.S. has a financial interest in and serves as Chief Technology Officer and director of InVisage Technologies.	Abe T, 2011, J PHYS CHEM C, V115, P7701, DOI 10.1021/jp1094992; Adachi MM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9694; Adinolfi V, 2015, ACS NANO, V9, P356, DOI 10.1021/nn5053537; Aguirre CM, 2009, ADV MATER, V21, P3087, DOI 10.1002/adma.200900550; An JM, 2007, NANO LETT, V7, P2129, DOI 10.1021/nl071219f; Anderson NC, 2013, J AM CHEM SOC, V135, P18536, DOI 10.1021/ja4086758; Badia A, 1997, J AM CHEM SOC, V119, P2682, DOI 10.1021/ja963571t; Beard MC, 2007, NANO LETT, V7, P2506, DOI 10.1021/nl071486l; Boles MA, 2016, NAT MATER, V15, P141, DOI [10.1038/NMAT4526, 10.1038/nmat4526]; Bozyigit D, 2016, NATURE, V531, P618, DOI 10.1038/nature16977; Bozyigit D, 2013, NANO LETT, V13, P5284, DOI 10.1021/nl402803h; Brown PR, 2014, ACS NANO, V8, P5863, DOI 10.1021/nn500897c; BRUS L, 1986, J PHYS CHEM-US, V90, P2555, DOI 10.1021/j100403a003; BRUS LE, 1984, J CHEM PHYS, V80, P4403, DOI 10.1063/1.447218; Carey GH, 2015, ADV MATER, V27, P3325, DOI 10.1002/adma.201405782; Cargnello M, 2015, NATURE, V524, P450, DOI 10.1038/nature14872; Chen O, 2013, NAT MATER, V12, P445, DOI [10.1038/nmat3539, 10.1038/NMAT3539]; Chen Y, 2008, J AM CHEM SOC, V130, P5026, DOI 10.1021/ja711379k; CHEPIC DI, 1990, J LUMIN, V47, P113, DOI 10.1016/0022-2313(90)90007-X; Choi JH, 2016, SCIENCE, V352, P205, DOI 10.1126/science.aad0371; Choi JH, 2013, ACS NANO, V7, P8275, DOI 10.1021/nn403752d; Choi JH, 2012, NANO LETT, V12, P2631, DOI 10.1021/nl301104z; Chung DS, 2012, NANO LETT, V12, P1813, DOI 10.1021/nl203949n; Clifford JP, 2009, NAT NANOTECHNOL, V4, P40, DOI 10.1038/NNANO.2008.313; Collier CP, 1997, SCIENCE, V277, P1978, DOI 10.1126/science.277.5334.1978; Dai XL, 2014, NATURE, V515, P96, DOI 10.1038/nature13829; Dirin DN, 2014, J AM CHEM SOC, V136, P6550, DOI 10.1021/ja5006288; Dolzhnikov DS, 2015, SCIENCE, V347, P425, DOI 10.1126/science.1260501; EKIMOV AI, 1985, SOLID STATE COMMUN, V56, P921, DOI 10.1016/S0038-1098(85)80025-9; Fafarman AT, 2011, J AM CHEM SOC, V133, P15753, DOI 10.1021/ja206303g; Goldberger J, 2005, J PHYS CHEM B, V109, P9, DOI 10.1021/jp0452599; GREEN MLH, 1995, J ORGANOMET CHEM, V500, P127, DOI 10.1016/0022-328X(95)00508-N; Greenham NC, 1996, PHYS REV B, V54, P17628, DOI 10.1103/PhysRevB.54.17628; Guyot-Sionnest P, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2004818; Guyot-Sionnest P, 2015, APPL PHYS LETT, V107, DOI 10.1063/1.4938135; Ha MJ, 2013, NANO LETT, V13, P954, DOI 10.1021/nl3038773; Hens Z, 2013, CHEM MATER, V25, P1211, DOI 10.1021/cm303361s; Herlogsson L, 2010, ADV MATER, V22, P72, DOI 10.1002/adma.200901850; Huynh WU, 2002, SCIENCE, V295, P2425, DOI 10.1126/science.1069156; Ip AH, 2015, ACS NANO, V9, P8833, DOI 10.1021/acsnano.5b02164; Ip AH, 2012, NAT NANOTECHNOL, V7, P577, DOI [10.1038/nnano.2012.127, 10.1038/NNANO.2012.127]; Ivanov SA, 2007, J AM CHEM SOC, V129, P11708, DOI 10.1021/ja068351m; Jang E, 2010, ADV MATER, V22, P3076, DOI 10.1002/adma.201000525; Kagan CR, 2015, NAT NANOTECHNOL, V10, P1013, DOI [10.1038/NNANO.2015.247, 10.1038/nnano.2015.247]; Kagan CR, 1996, PHYS REV LETT, V76, P1517, DOI 10.1103/PhysRevLett.76.1517; Kagan CR, 1996, PHYS REV B, V54, P8633, DOI 10.1103/PhysRevB.54.8633; Kim DK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2218; Kim DK, 2011, ACS NANO, V5, P10074, DOI 10.1021/nn203948x; Kim D, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.196802; Kim W, 2003, NANO LETT, V3, P193, DOI 10.1021/nl0259232; Kim YH, 2012, NATURE, V489, P128, DOI 10.1038/nature11434; Klauk H, 2007, NATURE, V445, P745, DOI 10.1038/nature05533; Koh WK, 2011, NANO LETT, V11, P4764, DOI 10.1021/nl202578g; Konstantatos G, 2008, NANO LETT, V8, P1446, DOI 10.1021/nl080373e; Konstantatos G, 2007, NAT PHOTONICS, V1, P531, DOI 10.1038/nphoton.2007.147; Konstantatos G, 2006, NATURE, V442, P180, DOI 10.1038/nature04855; Kovalenko MV, 2010, J AM CHEM SOC, V132, P10085, DOI 10.1021/ja1024832; Kovalenko MV, 2009, SCIENCE, V324, P1417, DOI 10.1126/science.1170524; Lai YM, 2014, ACS NANO, V8, P9664, DOI 10.1021/nn504303b; Lan XZ, 2016, ADV MATER, V28, P299, DOI 10.1002/adma.201503657; Lee JS, 2011, NAT NANOTECHNOL, V6, P348, DOI [10.1038/nnano.2011.46, 10.1038/NNANO.2011.46]; Li C, 2015, SCI REP-UK, V5, DOI 10.1038/srep17777; Lifshitz E, 2015, J PHYS CHEM LETT, V6, P4336, DOI 10.1021/acs.jpclett.5b01567; Lim J, 2014, ADV MATER, V26, P8034, DOI 10.1002/adma.201403620; Liu H, 2014, J APPL PHYS, V115, DOI 10.1063/1.4871682; Liu ML, 2015, ACS NANO, V9, P12079, DOI 10.1021/acsnano.5b05085; Liu WY, 2013, J AM CHEM SOC, V135, P1349, DOI 10.1021/ja308200f; Liu Y, 2013, NANO LETT, V13, P1578, DOI 10.1021/nl304753n; Liu Y, 2010, NANO LETT, V10, P1960, DOI 10.1021/nl101284k; Llordes A, 2013, NATURE, V500, P323, DOI 10.1038/nature12398; Luther JM, 2013, ACS NANO, V7, P1845, DOI 10.1021/nn401100n; Ma W, 2009, NANO LETT, V9, P1699, DOI 10.1021/nl900388a; McDonald SA, 2005, NAT MATER, V4, P138, DOI 10.1038/nmat1299; Mcguire JA, 2008, ACCOUNTS CHEM RES, V41, P1810, DOI 10.1021/ar800112v; Miller OD, 2012, IEEE J PHOTOVOLT, V2, P303, DOI 10.1109/JPHOTOV.2012.2198434; Moreels I, 2007, CHEM MATER, V19, P6101, DOI 10.1021/cm071410q; Murray CB, 2000, ANNU REV MATER SCI, V30, P545, DOI 10.1146/annurev.matsci.30.1.545; Nasilowski M, 2015, NANO LETT, V15, P3953, DOI 10.1021/acs.nanolett.5b00838; Ning ZJ, 2015, NATURE, V523, P324, DOI 10.1038/nature14563; Ning ZJ, 2014, NAT MATER, V13, P822, DOI [10.1038/NMAT4007, 10.1038/nmat4007]; Nozik AJ, 2002, PHYSICA E, V14, P115, DOI 10.1016/S1386-9477(02)00374-0; Nozik AJ, 2008, CHEM PHYS LETT, V457, P3, DOI 10.1016/j.cplett.2008.03.094; Oh SJ, 2014, NANO LETT, V14, P6210, DOI [10.1021/1502491d, 10.1021/nl502491d]; Oh SJ, 2014, NANO LETT, V14, P1559, DOI 10.1021/nl404818z; Oh SJ, 2013, ACS NANO, V7, P2413, DOI 10.1021/nn3057356; Ong WL, 2013, NAT MATER, V12, P410, DOI [10.1038/NMAT3596, 10.1038/nmat3596]; Oron D, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.115333; Osedach TP, 2012, ACS NANO, V6, P3121, DOI 10.1021/nn3008788; Osovsky R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.197401; Pal BN, 2012, NANO LETT, V12, P331, DOI 10.1021/nl203620f; Panthani MG, 2012, J PHYS CHEM C, V116, P22463, DOI 10.1021/jp308545q; Porter VJ, 2008, J PHYS CHEM C, V112, P2308, DOI 10.1021/jp710173q; Pourret A, 2009, ADV MATER, V21, P232, DOI 10.1002/adma.200801313; Protesescu L, 2015, J AM CHEM SOC, V137, P1862, DOI 10.1021/ja510862c; Reineke S, 2009, NATURE, V459, P234, DOI 10.1038/nature08003; Ren ZW, 2015, CHEM MATER, V27, P8398, DOI 10.1021/acs.chemmater.5b03864; Schapotschnikow P, 2009, J PHYS CHEM C, V113, P12690, DOI 10.1021/jp903291d; Schimpf AM, 2015, ACCOUNTS CHEM RES, V48, P1929, DOI 10.1021/acs.accounts.5b00181; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; Shim M, 2000, NATURE, V407, P981, DOI 10.1038/35039577; Shirasaki Y, 2013, NAT PHOTONICS, V7, P13, DOI 10.1038/nphoton.2012.328; Stinner FS, 2015, NANO LETT, V15, P7155, DOI 10.1021/acs.nanolett.5b03363; Sukhovatkin V, 2009, SCIENCE, V324, P1542, DOI 10.1126/science.1173812; Sun B, 2005, NANO LETT, V5, P2408, DOI 10.1021/nl051586w; Supran GJ, 2013, MRS BULL, V38, P703, DOI 10.1557/mrs.2013.181; Talapin DV, 2010, CHEM REV, V110, P389, DOI 10.1021/cr900137k; Talapin DV, 2005, SCIENCE, V310, P86, DOI 10.1126/science.1116703; Tang J, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1993567; Tilchin J, 2015, ACS NANO, V9, P7840, DOI 10.1021/acsnano.5b02597; Vaxenburg R, 2016, NANO LETT, V16, P2503, DOI 10.1021/acs.nanolett.6b00066; Yan H, 2008, ADV MATER, V20, P3393, DOI 10.1002/adma.200800629; Yang J, 2016, ADV MATER, V28, P1176, DOI 10.1002/adma.201502851; Yoon W, 2013, SCI REP-UK, V3, DOI 10.1038/srep02225; Zhang H, 2014, ACS NANO, V8, P7359, DOI 10.1021/nn502470v; Zherebetskyy D, 2014, SCIENCE, V344, P1380, DOI 10.1126/science.1252727; Zhitomirsky D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4803	116	771	777	69	1438	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302							aac5523	10.1126/science.aac5523	http://dx.doi.org/10.1126/science.aac5523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU0CA	27563099				2022-12-28	WOS:000381867700027
J	Changeux, JP; Christopoulos, A				Changeux, Jean-Pierre; Christopoulos, Arthur			Allosteric Modulation as a Unifying Mechanism for Receptor Function and Regulation	CELL			English	Review							PROTEIN-COUPLED RECEPTORS; GATED ION-CHANNEL; NICOTINIC ACETYLCHOLINE-RECEPTOR; LIGAND-BINDING DOMAIN; X-RAY-STRUCTURE; DEPOLARIZED SMOOTH-MUSCLE; THYROID-HORMONE RECEPTOR; UNION-OF-PHARMACOLOGY; CRYSTAL-STRUCTURE; TYROSINE KINASES	Four major receptor families enable cells to respond to chemical and physical signals from their proximal environment. The ligand-and voltage-gated ion channels, G-protein-coupled receptors, nuclear hormone receptors, and receptor tyrosine kinases are all allosteric proteins that carry multiple, spatially distinct, yet conformationally linked ligand-binding sites. Recent studies point to common mechanisms governing the allosteric transitions of these receptors, including the impact of oligomerization, pre-existing and functionally distinct conformational ensembles, intrinsically disordered regions, and the occurrence of allosteric modulatory sites. Importantly, synthetic allosteric modulators are being discovered for these receptors, providing an enriched, yet challenging, landscape for novel therapeutics.	[Changeux, Jean-Pierre] Inst Pasteur, Coll France, F-75015 Paris, France; [Changeux, Jean-Pierre] Inst Pasteur, CNRS URA 2182, F-75015 Paris, France; [Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia; [Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Dept Pharmacol, Parkville, Vic 3052, Australia	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; PSL Research University Paris; College de France; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Monash University; Monash University	Changeux, JP (corresponding author), Inst Pasteur, Coll France, F-75015 Paris, France.; Changeux, JP (corresponding author), Inst Pasteur, CNRS URA 2182, F-75015 Paris, France.; Christopoulos, A (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia.; Christopoulos, A (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Dept Pharmacol, Parkville, Vic 3052, Australia.	changeux@noos.fr; arthur.christopoulos@monash.edu						Agnati LF, 2016, REV NEUROSCIENCE, V27, P1, DOI 10.1515/revneuro-2015-0024; Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Arnold LA, 2005, J BIOL CHEM, V280, P43048, DOI 10.1074/jbc.M506693200; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Baconguis I, 2013, CURR OPIN STRUC BIOL, V23, P277, DOI 10.1016/j.sbi.2013.04.005; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; Bhaskar V, 2012, DIABETES, V61, P1263, DOI 10.2337/db11-1578; BLACK J, 1989, SCIENCE, V245, P486, DOI 10.1126/science.2569237; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Bono F, 2013, CANCER CELL, V23, P477, DOI 10.1016/j.ccr.2013.02.019; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Bovet D, 1964, NOBEL LECT PHYSL MED, P552; Brannigan G, 2008, P NATL ACAD SCI USA, V105, P14418, DOI 10.1073/pnas.0803029105; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Burris TP, 2013, PHARMACOL REV, V65, P710, DOI 10.1124/pr.112.006833; Buzon V, 2012, MOL CELL ENDOCRINOL, V348, P394, DOI 10.1016/j.mce.2011.08.012; Calimet N, 2013, P NATL ACAD SCI USA, V110, pE3987, DOI 10.1073/pnas.1313785110; Canals M, 2011, TRENDS BIOCHEM SCI, V36, P663, DOI 10.1016/j.tibs.2011.08.005; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Catterall WA, 2015, MOL PHARMACOL, V88, P141, DOI 10.1124/mol.114.097659; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Cecchini M, 2015, NEUROPHARMACOLOGY, V96, P137, DOI 10.1016/j.neuropharm.2014.12.006; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chandra V, 2013, NATURE, V495, P394, DOI 10.1038/nature11966; CHANGEUX J, 1965, B SOC CHIM BIOL, V47, P281; Changeux J.P., 2011, F1000 BIOL REP; CHANGEUX JEAN-PIERRE, 1964, BROOKHAVEN SYMP BIOL, V17, P232; Changeux JP, 2013, NAT REV MOL CELL BIO, V14, P819, DOI 10.1038/nrm3695; Changeux Jean-Pierre, 2013, Drug Discov Today Technol, V10, pe223, DOI 10.1016/j.ddtec.2012.07.007; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; CHANGEUX JP, 1961, COLD SPRING HARB SYM, V26, P313, DOI 10.1101/SQB.1961.026.01.037; CHANGEUX JP, 1967, P NATL ACAD SCI USA, V57, P335, DOI 10.1073/pnas.57.2.335; Chatzidaki A, 2015, BIOCHEM PHARMACOL, V97, P408, DOI 10.1016/j.bcp.2015.07.028; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Christopoulos A, 2014, MOL PHARMACOL, V86, P463, DOI 10.1124/mol.114.094342; Christopoulos A, 2014, PHARMACOL REV, V66, P918, DOI 10.1124/pr.114.008862; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Corbin JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088684; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; De Smet F, 2014, NAT BIOTECHNOL, V32, P1113, DOI 10.1038/nbt.3028; Deupi X, 2012, BIOCHEM SOC T, V40, P383, DOI 10.1042/BST20120001; DeVree BT, 2016, NATURE, V535, P182, DOI 10.1038/nature18324; Didenko T, 2013, CURR OPIN STRUC BIOL, V23, P740, DOI 10.1016/j.sbi.2013.07.011; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Durr KL, 2014, CELL, V158, P778, DOI 10.1016/j.cell.2014.07.023; Dunker A K, 1998, Pac Symp Biocomput, P473; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Edelstein SJ, 2010, BIOPHYS J, V98, P2045, DOI 10.1016/j.bpj.2010.01.050; Eginton C, 2015, J MOL BIOL, V427, P1695, DOI 10.1016/j.jmb.2015.02.021; Ellis IR, 2007, EXP CELL RES, V313, P732, DOI 10.1016/j.yexcr.2006.11.016; Endres NF, 2014, TRENDS BIOCHEM SCI, V39, P437, DOI 10.1016/j.tibs.2014.08.001; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Estebanez-Perpina E, 2007, MOL ENDOCRINOL, V21, P2919, DOI 10.1210/me.2007-0174; Estebanez-Perpina E, 2007, P NATL ACAD SCI USA, V104, P16074, DOI 10.1073/pnas.0708036104; Fabbro D, 2015, MOL PHARMACOL, V87, P766, DOI 10.1124/mol.114.095489; Fischer E.H., 1992, NOBEL LECT; Flock T, 2015, NATURE, V524, P173, DOI 10.1038/nature14663; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Fourati Z, 2015, ACTA CRYSTALLOGR D, V71, P454, DOI 10.1107/S1399004714026698; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Galzi JL, 1996, P NATL ACAD SCI USA, V93, P1853, DOI 10.1073/pnas.93.5.1853; Galzi JL, 1996, EMBO J, V15, P5824, DOI 10.1002/j.1460-2075.1996.tb00969.x; GALZI JL, 1994, CURR OPIN STRUC BIOL, V4, P554, DOI 10.1016/S0959-440X(94)90218-6; Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713; Gentry PR, 2015, J BIOL CHEM, V290, P19478, DOI 10.1074/jbc.R115.662759; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Hall JM, 2002, MOL ENDOCRINOL, V16, P469, DOI 10.1210/me.16.3.469; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Henin J, 2014, BIOPHYS J, V106, P1938, DOI 10.1016/j.bpj.2014.03.024; Herbert C, 2013, CANCER CELL, V23, P489, DOI 10.1016/j.ccr.2013.02.018; HERZ JM, 1989, J BIOL CHEM, V264, P12439; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hicklin DJ, 2001, DRUG DISCOV TODAY, V6, P517, DOI 10.1016/S1359-6446(01)01759-7; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hill KK, 2012, MOL CELL ENDOCRINOL, V348, P418, DOI 10.1016/j.mce.2011.07.017; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Horst R, 2013, ANGEW CHEM INT EDIT, V52, P331, DOI 10.1002/anie.201205474; Huang ZM, 2011, NUCLEIC ACIDS RES, V39, pD663, DOI 10.1093/nar/gkq1022; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Hubbard SR, 1999, PROG BIOPHYS MOL BIO, V71, P343, DOI 10.1016/S0079-6107(98)00047-9; Hubner CA, 2002, HUM MOL GENET, V11, P2435, DOI 10.1093/hmg/11.20.2435; Hughes TS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jang SW, 2007, P NATL ACAD SCI USA, V104, P16329, DOI 10.1073/pnas.0706662104; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jordan VC, 2007, NAT REV CANCER, V7, P46, DOI 10.1038/nrc2048; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; KARLIN A, 1967, J THEOR BIOL, V16, P306, DOI 10.1016/0022-5193(67)90011-2; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; KENAKIN T, 1995, TRENDS PHARMACOL SCI, V16, P232, DOI 10.1016/S0165-6147(00)89032-X; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Kniazeff J, 2011, PHARMACOL THERAPEUT, V130, P9, DOI 10.1016/j.pharmthera.2011.01.006; Kojetin DJ, 2008, ENDOCR-RELAT CANCER, V15, P851, DOI 10.1677/ERC-07-0281; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Krause RM, 1998, MOL PHARMACOL, V53, P283, DOI 10.1124/mol.53.2.283; Kruse AC, 2014, NAT REV DRUG DISCOV, V13, P549, DOI 10.1038/nrd4295; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; Kuzmenkin A, 2004, J GEN PHYSIOL, V124, P349, DOI 10.1085/jgp.200409139; Lamichhane R, 2015, P NATL ACAD SCI USA, V112, P14254, DOI 10.1073/pnas.1519626112; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Le Novere N, 2002, P NATL ACAD SCI USA, V99, P3210, DOI 10.1073/pnas.042699699; Leach K, 2015, TRENDS PHARMACOL SCI, V36, P215, DOI 10.1016/j.tips.2015.02.004; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Lee JH, 2014, CELL, V157, P1393, DOI 10.1016/j.cell.2014.03.064; Leff P, 1997, TRENDS PHARMACOL SCI, V18, P355, DOI 10.1016/S0165-6147(97)90664-7; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lewis M, 2005, CR BIOL, V328, P521, DOI 10.1016/j.crvi.2005.04.004; Lewis M, 1996, SCIENCE, V274, P1931, DOI 10.1126/science.274.5294.1931; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Li Y, 2003, STRUCTURE, V11, P741, DOI 10.1016/S0969-2126(03)00133-3; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Mackinnon JAG, 2014, MOL CELL ENDOCRINOL, V393, P75, DOI 10.1016/j.mce.2014.05.017; MAGUIRE ME, 1976, MOL PHARMACOL, V12, P335; Manglik A, 2014, CURR OPIN CELL BIOL, V27, P136, DOI 10.1016/j.ceb.2014.01.008; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Meyerson JR, 2014, NATURE, V514, P328, DOI 10.1038/nature13603; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Minezaki Y, 2007, J MOL BIOL, V368, P902, DOI 10.1016/j.jmb.2007.02.033; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; Moore TW, 2010, MOL ENDOCRINOL, V24, P683, DOI 10.1210/me.2009-0362; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Mukund S, 2013, J BIOL CHEM, V288, P36168, DOI 10.1074/jbc.M113.496984; MULLE C, 1992, NEURON, V8, P937, DOI 10.1016/0896-6273(92)90208-U; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Nussinov R, 2014, CHEM BIOL, V21, P311, DOI 10.1016/j.chembiol.2013.12.015; Olsen RW, 2014, NEUROCHEM RES, V39, P1924, DOI 10.1007/s11064-014-1382-3; Orlov I, 2012, EMBO J, V31, P291, DOI 10.1038/emboj.2011.445; Partin KM, 2015, CURR OPIN PHARMACOL, V20, P46, DOI 10.1016/j.coph.2014.11.002; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Perez DM, 2005, MOL PHARMACOL, V67, P1383, DOI 10.1124/mol.105.011890; Prevost MS, 2013, P NATL ACAD SCI USA, V110, P17113, DOI 10.1073/pnas.1317009110; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; Purohit P, 2007, NATURE, V446, P930, DOI 10.1038/nature05721; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Regalado MP, 2001, NEURON, V32, P1085, DOI 10.1016/S0896-6273(01)00539-6; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Rizk SS, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-014-0080-8; Rondard P, 2015, CURR OPIN PHARMACOL, V20, P95, DOI 10.1016/j.coph.2014.12.001; Rowlinson SW, 2008, NAT CELL BIOL, V10, P740, DOI 10.1038/ncb1737; RUBIN MM, 1966, J MOL BIOL, V21, P265, DOI 10.1016/0022-2836(66)90097-0; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Sawyer GW, 2002, J BIOL CHEM, V277, P50036, DOI 10.1074/jbc.M209281200; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schurpf T, 2011, EMBO J, V30, P4712, DOI 10.1038/emboj.2011.333; Schwarz M, 2006, CIRC RES, V99, P25, DOI 10.1161/01.RES.0000232317.84122.0c; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; Sharon M, 2015, CURR OPIN STRUC BIOL, V34, P7, DOI 10.1016/j.sbi.2015.05.002; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Simon AJ, 2014, P NATL ACAD SCI USA, V111, P15048, DOI 10.1073/pnas.1410796111; Simons SS, 2014, MOL ENDOCRINOL, V28, P173, DOI 10.1210/me.2013-1334; Smith GB, 2000, NEUROPHARMACOLOGY, V39, P55, DOI 10.1016/S0028-3908(99)00104-5; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; SPEDDING M, 1985, J PHARMACOL-PARIS, V16, P319; SPEDDING M, 1985, N-S ARCH PHARMACOL, V328, P464, DOI 10.1007/BF00692917; SPEDDING M, 1984, N-S ARCH PHARMACOL, V328, P69, DOI 10.1007/BF00496109; Steinlein OK, 2012, CHEM REV, V112, P6334, DOI 10.1021/cr300044d; Striessnig J, 1999, CELL PHYSIOL BIOCHEM, V9, P242, DOI 10.1159/000016320; Suh JM, 2014, NATURE, V513, P436, DOI 10.1038/nature13540; Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Tao YX, 2008, PHARMACOL THERAPEUT, V120, P129, DOI 10.1016/j.pharmthera.2008.07.005; Tenbaum S, 1997, INT J BIOCHEM CELL B, V29, P1325, DOI 10.1016/S1357-2725(97)00087-3; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Tsai CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003394; Tsigelny IF, 2015, ONCOTARGET, DOI 10.18632/oncotarget.5633; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; van der Westhuizen ET, 2015, J PHARMACOL EXP THER, V353, P246, DOI 10.1124/jpet.114.221606; Vassart G, 2011, NAT REV ENDOCRINOL, V7, P362, DOI 10.1038/nrendo.2011.20; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; VERNINO S, 1992, NEURON, V8, P127, DOI 10.1016/0896-6273(92)90114-S; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; WEBER G, 1972, BIOCHEMISTRY-US, V11, P864, DOI 10.1021/bi00755a028; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; Wootten D, 2013, NAT REV DRUG DISCOV, V12, P630, DOI 10.1038/nrd4052; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2; Yelshanskaya MV, 2014, SCIENCE, V345, P1070, DOI 10.1126/science.1256508; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3; Zhu SJ, 2015, CURR OPIN PHARMACOL, V20, P14, DOI 10.1016/j.coph.2014.10.009; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101; Zwick E, 2001, ENDOCR-RELAT CANCER, V8, P161, DOI 10.1677/erc.0.0080161; [No title captured]	213	165	166	3	109	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1084	1102		10.1016/j.cell.2016.08.015	http://dx.doi.org/10.1016/j.cell.2016.08.015			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27565340	Bronze			2022-12-28	WOS:000382259500009
J	Wehner, M; Truby, RL; Fitzgerald, DJ; Mosadegh, B; Whitesides, GM; Lewis, JA; Wood, RJ				Wehner, Michael; Truby, Ryan L.; Fitzgerald, Daniel J.; Mosadegh, Bobak; Whitesides, George M.; Lewis, Jennifer A.; Wood, Robert J.			An integrated design and fabrication strategy for entirely soft, autonomous robots	NATURE			English	Article							LOGIC; FLOW	Soft robots possess many attributes that are difficult, if not impossible, to achieve with conventional robots composed of rigid materials(1,2). Yet, despite recent advances, soft robots must still be tethered to hard robotic control systems and power sources(3-10). New strategies for creating completely soft robots, including soft analogues of these crucial components, are needed to realize their full potential. Here we report the untethered operation of a robot composed solely of soft materials. The robot is controlled with microfluidic logic(11) that autonomously regulates fluid flow and, hence, catalytic decomposition of an on-board monopropellant fuel supply. Gas generated from the fuel decomposition inflates fluidic networks downstream of the reaction sites, resulting in actuation(12). The body and microfluidic logic of the robot are fabricated using moulding and soft lithography, respectively, and the pneumatic actuator networks, on-board fuel reservoirs and catalytic reaction chambers needed for movement are patterned within the body via a multi-material, embedded 3D printing technique(13,14). The fluidic and elastomeric architectures required for function span several orders of magnitude from the microscale to the macroscale. Our integrated design and rapid fabrication approach enables the programmable assembly of multiple materials within this architecture, laying the foundation for completely soft, autonomous robots.	[Wehner, Michael; Truby, Ryan L.; Fitzgerald, Daniel J.; Lewis, Jennifer A.; Wood, Robert J.] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Wehner, Michael; Truby, Ryan L.; Fitzgerald, Daniel J.; Whitesides, George M.; Lewis, Jennifer A.; Wood, Robert J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Mosadegh, Bobak] Weill Cornell Med, Dalio Inst Cardiovasc Imaging, New York, NY 10021 USA; [Mosadegh, Bobak] New York Presbyterian Hosp, New York, NY 10021 USA; [Mosadegh, Bobak] Weill Cornell Med, Dept Radiol, New York, NY 10021 USA; [Whitesides, George M.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Cornell University; NewYork-Presbyterian Hospital; Cornell University; Harvard University	Lewis, JA; Wood, RJ (corresponding author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.; Lewis, JA; Wood, RJ (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.	jalewis@seas.harvard.edu; rjwood@seas.harvard.edu	Lewis, Jennifer/HCH-4635-2022; Truby, Ryan/ABA-7417-2021; Truby, Ryan/A-9866-2017	Truby, Ryan/0000-0002-1313-6463; Lewis, Jennifer/0000-0002-0280-2774	National Science Foundation through Harvard MRSEC [DMR-1420570]; Wyss Institute for Biologically Inspired Engineering; National Science Foundation [1541959]; National Security Science and Engineering Faculty Fellowship	National Science Foundation through Harvard MRSEC; Wyss Institute for Biologically Inspired Engineering; National Science Foundation(National Science Foundation (NSF)); National Security Science and Engineering Faculty Fellowship	We thank D. Gessel, G. Leyh, M. Pauline, N. W. Bartlett, M. A. Skylar-Scott, T. J. Ober and J. T. Muth for their comments and discussions. We thank L. K. Sanders for assistance with photography and videography and J. C. Weaver for assistance with electron microscopy. We acknowledge support from the National Science Foundation through the Harvard MRSEC (grant no. DMR-1420570) and the Wyss Institute for Biologically Inspired Engineering. This work was performed in part at the Harvard University Center for Nanoscale Systems (CNS), a member of the National Nanotechnology Coordinated Infrastructure Network (NNCI), which is supported by the National Science Foundation under NSF award no. 1541959. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. R.L.T. acknowledges support from a National Science Foundation Graduate Research Fellowship and J.A.L. acknowledges support from the National Security Science and Engineering Faculty Fellowship.	Anderson IA, 2012, J APPL PHYS, V112, DOI 10.1063/1.4740023; [Anonymous], [No title captured]; Barnes HA, 1997, J NON-NEWTON FLUID, V70, P1, DOI 10.1016/S0377-0257(97)00004-9; Bartlett NW, 2015, SCIENCE, V349, P161, DOI 10.1126/science.aab0129; Brown E, 2010, P NATL ACAD SCI USA, V107, P18809, DOI 10.1073/pnas.1003250107; Gorissen B, 2011, SENSOR ACTUAT A-PHYS, V168, P58, DOI 10.1016/j.sna.2011.03.057; Groisman A, 2003, SCIENCE, V300, P955, DOI 10.1126/science.1083694; Ionov L, 2013, ADV FUNCT MATER, V23, P4555, DOI 10.1002/adfm.201203692; Jensen EC, 2007, J MICROELECTROMECH S, V16, P1378, DOI 10.1109/JMEMS.2007.906080; Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506; Lin HT, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/2/026007; Marchese AD, 2014, SOFT ROBOT, V1, P75, DOI 10.1089/soro.2013.0009; Mosadegh B, 2014, ADV FUNCT MATER, V24, P2163, DOI 10.1002/adfm.201303288; Mosadegh B, 2011, LAB CHIP, V11, P738, DOI 10.1039/c0lc00112k; Mosadegh B, 2010, NAT PHYS, V6, P433, DOI [10.1038/NPHYS1637, 10.1038/nphys1637]; Mullins L., 1969, RUBBER CHEM TECHNOL, V42, P339, DOI [10.5254/1.3539210, DOI 10.5254/1.3539210]; Muth JT, 2014, ADV MATER, V26, P6307, DOI 10.1002/adma.201400334; Palleau E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3257; Peele BN, 2015, BIOINSPIR BIOMIM, V10, DOI 10.1088/1748-3190/10/5/055003; Prakash M, 2007, SCIENCE, V315, P832, DOI 10.1126/science.1136907; Randall GC, 2005, P NATL ACAD SCI USA, V102, P10813, DOI 10.1073/pnas.0503287102; Rhee M, 2009, LAB CHIP, V9, P3131, DOI 10.1039/b904354c; Rus D, 2015, NATURE, V521, P467, DOI 10.1038/nature14543; Shepherd RF, 2013, ADV MATER, V25, P6709, DOI 10.1002/adma.201303175; Shepherd RF, 2013, ANGEW CHEM INT EDIT, V52, P2892, DOI 10.1002/anie.201209540; Shepherd RF, 2011, P NATL ACAD SCI USA, V108, P20400, DOI 10.1073/pnas.1116564108; Suzumori K, 1996, ROBOTICA, V14, P493, DOI 10.1017/S0263574700019974; Suzumori K, 1996, ROBOT AUTON SYST, V18, P135, DOI 10.1016/0921-8890(95)00078-X; Toepke MW, 2007, LAB CHIP, V7, P1449, DOI 10.1039/b708764k; Tolley MT, 2014, SOFT ROBOT, V1, P213, DOI 10.1089/soro.2014.0008; Wang LY, 2015, IEEE ROBOT AUTOM MAG, V22, P125, DOI 10.1109/MRA.2015.2448277; Weaver JA, 2010, NAT PHYS, V6, P218, DOI 10.1038/NPHYS1513; Wehner M, 2014, SOFT ROBOT, V1, P263, DOI 10.1089/soro.2014.0018; Whitesides GM, 2011, LAB CHIP, V11, P191, DOI 10.1039/c0lc90101f; Wu W, 2011, ADV MATER, V23, pH178, DOI 10.1002/adma.201004625	35	1136	1193	162	2057	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					451	+		10.1038/nature19100	http://dx.doi.org/10.1038/nature19100			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0YL	27558065	Green Submitted, Green Published			2022-12-28	WOS:000382646600040
J	Freedman, B; Potpara, TS; Lip, GYH				Freedman, Ben; Potpara, Tatjana S.; Lip, Gregory Y. H.			Stroke prevention in atrial fibrillation	LANCET			English	Article							VITAMIN-K ANTAGONIST; TRANSIENT ISCHEMIC ATTACK; RHYTHM ASSOCIATION EHRA; ADDITIONAL RISK-FACTOR; ANTITHROMBOTIC THERAPY; BLEEDING RISK; HEART RHYTHM; ORAL ANTICOAGULANTS; UNDETERMINED SOURCE; SAME-TT2R2 SCORE	Atrial fibrillation is found in a third of all ischaemic strokes, even more after post-stroke atrial fibrillation monitoring. Data from stroke registries show that both unknown and untreated or under treated atrial fibrillation is responsible for most of these strokes, which are often fatal or debilitating. Most could be prevented if efforts were directed towards detection of atrial fibrillation before stroke occurs, through screening or case finding, and treatment of all patients with atrial fibrillation at increased risk of stroke with well-controlled vitamin K antagonists or non-vitamin K antagonist anticoagulants. The default strategy should be to off er anticoagulant thromboprophylaxis to all patients with atrial fibrillation unless defined as truly low risk by simple validated risk scores, such as CHA(2)DS(2)-VASc. Assessment of bleeding risk using the HAS-BLED score should focus attention on reversible bleeding risk factors. Finally, patients need support from physicians and various other sources to start anticoagulant treatment and to ensure adherence to and persistence with treatment in the long term.	[Freedman, Ben] Univ Sydney, Heart Res Inst, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Freedman, Ben] Concord Hosp, Dept Cardiol, Concord, NSW, Australia; [Freedman, Ben] Concord Hosp, Anzac Res Inst, Concord, NSW, Australia; [Potpara, Tatjana S.] Univ Belgrade, Cardiol Clin, Clin Ctr Serbia, Sch Med, Belgrade, Serbia; [Lip, Gregory Y. H.] Univ Birmingham, Inst Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England; [Lip, Gregory Y. H.] Aalborg Univ, Aalborg Thrombosis Res Unit, Dept Clin Med, Aalborg, Denmark	University of Sydney; Heart Research Institute; Concord Repatriation General Hospital; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; Clinical Centre of Serbia; University of Belgrade; University of Birmingham; Aalborg University	Freedman, B (corresponding author), Univ Sydney, Heart Res Inst, Charles Perkins Ctr, Sydney, NSW 2006, Australia.	ben.freedman@sydney.edu.au	Verheugt, F.W.A./H-8105-2014; Freedman, Ben/C-1625-2013	Potpara, Tatjana/0000-0001-6285-6902; Freedman, Ben/0000-0002-3809-2911	Bristol-Myers Squibb/Pfizer; Bayer; Boehringer Ingelheim	Bristol-Myers Squibb/Pfizer(Bristol-Myers SquibbPfizer); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim)	BF has received research grants to undertake investigator-initiated studies from Bristol-Myers Squibb/Pfizer, Bayer, and Boehringer Ingelheim; has been a consultant for Bayer, Bristol-Myers Squibb/Pfizer, Boehringer Ingelheim, Servier, AstraZeneca, and Gilead; and has been a speaker for Bayer, Bristol-Myers Squibb/Pfizer, and AstraZeneca. TSP has been a consultant for Bayer, AstraZeneca, and Pfizer; and a speaker for Bayer, Pfizer, and AstraZeneca. GYHL has been a consultant for Bayer/Janssen, Bristol-Myers Squibb/Pfizer, Biotronik, Medtronic, Boehringer Ingelheim, Microlife, and Daiichi Sankyo; and a speaker for Bayer, Bristol-Myers Squibb/Pfizer, Medtronic, Boehringer Ingelheim, Microlife, Roche, and Daiichi Sankyo.	Agarwal S, 2012, ARCH INTERN MED, V172, P623, DOI 10.1001/archinternmed.2012.121; Apostolakis S, 2013, CHEST, V144, P1555, DOI 10.1378/chest.13-0054; Esteve-Pastor MA, 2016, EXPERT REV CARDIOVAS, V14, P177, DOI 10.1586/14779072.2016.1116941; Banerjee A, 2012, EUR J HEART FAIL, V14, P295, DOI 10.1093/eurjhf/hfs005; Ben Freedman S, 2015, JAMA-J AM MED ASSOC, V314, P1911, DOI 10.1001/jama.2015.9846; Ben Freedman S, 2015, EUR HEART J, V36, P653, DOI 10.1093/eurheartj/ehu494; Bjorck F, 2016, JAMA CARDIOL, V1, P172, DOI 10.1001/jamacardio.2016.0199; Bjorck S, 2013, STROKE, V44, P3103, DOI 10.1161/STROKEAHA.113.002329; Bonde AN, 2014, J AM COLL CARDIOL, V64, P2471, DOI 10.1016/j.jacc.2014.09.051; Boriani G, 2015, AM J MED, V128, P509, DOI 10.1016/j.amjmed.2014.11.026; Brambatti M, 2014, CIRCULATION, V129, P2094, DOI 10.1161/CIRCULATIONAHA.113.007825; Camm AJ, 2016, EUR HEART J, V37, P1145, DOI 10.1093/eurheartj/ehv466; Camm AJ, 2012, EUR HEART J, V33; Chao TF, 2015, J AM COLL CARDIOL, V66, P1339, DOI 10.1016/j.jacc.2015.07.026; Chao TF, 2015, J AM COLL CARDIOL, V65, P635, DOI 10.1016/j.jacc.2014.11.046; Chiang CE, 2014, THROMB HAEMOSTASIS, V111, P789, DOI 10.1160/TH13-11-0948; Clarkesmith DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074037; De Caterina R, 2013, THROMB HAEMOSTASIS, V110, P1087, DOI 10.1160/TH13-06-0443; Diener HC, 2017, EUR HEART J, V38, P860, DOI 10.1093/eurheartj/ehw069; Diener HC, 2015, INT J STROKE, V10, P1309, DOI 10.1111/ijs.12630; Fauchier L, 2016, STROKE, V47, P1831, DOI 10.1161/STROKEAHA.116.013253; Fitzmaurice DA, 2007, BRIT MED J, V335, P383, DOI 10.1136/bmj.39280.660567.55; Freedman B, 2016, JAMA CARDIOL, V1, P366, DOI 10.1001/jamacardio.2016.0393; Freedman SB, 2015, EUR HEART J, V36, P862; Friberg L, 2015, EUR HEART J, V36, P297, DOI 10.1093/eurheartj/ehu139; Friberg L, 2014, STROKE, V45, P2599, DOI 10.1161/STROKEAHA.114.006070; Gallagher C, 2016, EXPERT REV CARDIOVAS, V14, P799, DOI 10.1080/14779072.2016.1179581; Gladstone DJ, 2014, NEW ENGL J MED, V370, P2467, DOI 10.1056/NEJMoa1311376; Gladstone DJ, 2009, STROKE, V40, P235, DOI 10.1161/STROKEAHA.108.516344; Glotzer TV, 2003, CIRCULATION, V107, P1614, DOI 10.1161/01.CIR.0000057981.70380.45; Gorst-Rasmussen A, 2015, J THROMB HAEMOST, V13, P495, DOI 10.1111/jth.12845; Hart RG, 2007, NEUROLOGY, V69, P546; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hart RG, 2014, LANCET NEUROL, V13, P429, DOI 10.1016/S1474-4422(13)70310-7; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; Hendriks JML, 2012, EUR HEART J, V33, P2692, DOI 10.1093/eurheartj/ehs071; Hsu JC, 2015, AM J MED, V128, DOI 10.1016/j.amjmed.2014.11.035; January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1016/j.jacc.2014.03.022, 10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000142]; Jorgensen HS, 1996, STROKE, V27, P1765, DOI 10.1161/01.STR.27.10.1765; Kakkar AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063479; Kamel H, 2016, STROKE, V47, P895, DOI 10.1161/STROKEAHA.115.012004; Kimura K, 2005, J NEUROL NEUROSUR PS, V76, P679, DOI 10.1136/jnnp.2004.048827; Kirchhof P, 2016, EUROPACE, V18, P37, DOI 10.1093/europace/euv304; Larsen BS, 2015, J AM COLL CARDIOL, V66, P232, DOI 10.1016/j.jacc.2015.05.018; Larsen TB, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3189; Levin LA, 2015, EUROPACE, V17, P207, DOI 10.1093/europace/euu213; Leyden JM, 2013, STROKE, V44, P1226, DOI 10.1161/STROKEAHA.113.675140; Li LX, 2015, LANCET NEUROL, V14, P903, DOI 10.1016/S1474-4422(15)00132-5; Lip GYH, 2016, J THROMB HAEMOST, V14, P1711, DOI 10.1111/jth.13386; Lip GYH, 2016, CIRCULATION, V133, P1498, DOI 10.1161/CIRCULATIONAHA.115.016713; Lip GYH, 2015, EUR HEART J, V36, P3265, DOI 10.1093/eurheartj/ehv415; Lip GYH, 2015, THROMB HAEMOSTASIS, V114, P826, DOI 10.1160/TH15-07-0565; Lip GYH, 2015, J AM COLL CARDIOL, V65, P1385, DOI 10.1016/j.jacc.2015.01.044; Lip GYH, 2014, EUR HEART J, V35, P3155, DOI 10.1093/eurheartj/ehu298; Lip GYH, 2015, STROKE, V46, P143, DOI 10.1161/STROKEAHA.114.007199; Lip GYH, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001179; Lip GYH, 2014, CHEST, V146, P719, DOI 10.1378/chest.13-2976; Lip GYH, 2013, EUR HEART J, V34, P1041, DOI 10.1093/eurheartj/ehs435; Lip GYH, 2011, NAT REV CARDIOL, V8, P602, DOI 10.1038/nrcardio.2011.112; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lowres N, 2014, THROMB HAEMOSTASIS, V111, P1167, DOI 10.1160/TH14-03-0231; Lowres N, 2013, THROMB HAEMOSTASIS, V110, P213, DOI 10.1160/TH13-02-0165; Marini C, 2005, STROKE, V36, P1115, DOI 10.1161/01.STR.0000166053.83476.4a; Martin DT, 2015, EUR HEART J, V36, P1660, DOI 10.1093/eurheartj/ehv115; Martinez C, 2016, THROMB HAEMOSTASIS, V115, P31, DOI 10.1160/TH15-04-0350; Martinez C, 2014, THROMB HAEMOSTASIS, V112, P276, DOI 10.1160/TH4-04-0383; McManus DD, 2013, HEART RHYTHM, V10, P315, DOI 10.1016/j.hrthm.2012.12.001; Meier B, 2014, EUROPACE, V16, P1397, DOI 10.1093/europace/euu174; Miller JD, 2015, J AM COLL CARDIOL, V66, P2899, DOI 10.1016/j.jacc.2015.10.047; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; NICE, 2014, NICE GUIDELINES CG18; NICE, ATR FIBR MAN; Nielsen PB, 2016, SCI REP-UK, V6, DOI 10.1038/srep27410; Nielsen PB, 2015, CIRCULATION, V132, P517, DOI 10.1161/CIRCULATIONAHA.115.015735; Ntaios G, 2015, STROKE, V46, P176, DOI 10.1161/STROKEAHA.114.007240; Ogawa S, 2013, J ARRYTHM, V29, P190, DOI 10.1016/j.joa.2013.03.002; Piccini JP, 2016, JAMA CARDIOL, V1, P282, DOI 10.1001/jamacardio.2016.0529; Pisters R, 2012, CIRC J, V76, P2289, DOI 10.1253/circj.CJ-12-1036; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Potter BJ, 2015, LANCET, V386, P113, DOI 10.1016/S0140-6736(14)61991-7; Proietti M, 2016, INT J CARDIOL, V216, P168, DOI 10.1016/j.ijcard.2016.04.131; Proietti M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24376; Rillig A, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.115.003461; Romanelli RJ, 2016, CIRC-CARDIOVASC QUAL, V9, P126, DOI 10.1161/CIRCOUTCOMES.115.002369; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Sanna T, 2014, NEW ENGL J MED, V370, P2478, DOI 10.1056/NEJMoa1313600; Senoo K, 2016, AM J MED, V129, P600, DOI 10.1016/j.amjmed.2015.10.001; Shore S, 2014, AM HEART J, V167, P810, DOI 10.1016/j.ahj.2014.03.023; Siontis KC, 2016, HEART RHYTHM, V13, P1418, DOI 10.1016/j.hrthm.2016.03.003; Sjalander S, 2014, EUROPACE, V16, P631, DOI 10.1093/europace/eut333; Sposato LA, 2015, LANCET NEUROL, V14, P377, DOI 10.1016/S1474-4422(15)70027-X; Staerk L, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5876; Sticherling C, 2015, EUROPACE, V17, P1197, DOI 10.1093/europace/euv190; Svennberg E, 2015, CIRCULATION, V131, P2176, DOI 10.1161/CIRCULATIONAHA.114.014343; Tieleman RG, 2014, EUROPACE, V16, P1291, DOI 10.1093/europace/euu057; Tsang TS, 2011, CAN J CARDIOL, V27, pS122, DOI 10.1016/j.cjca.2011.07.121; Turakhia MP, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1040, DOI 10.1161/CIRCEP.114.003057; Verberk WJ, 2016, INT J CARDIOL, V203, P465, DOI 10.1016/j.ijcard.2015.10.182; Wagstaff AJ, 2014, QJM-INT J MED, V107, P955, DOI 10.1093/qjmed/hcu054; Wang KL, 2015, STROKE, V46, P2555, DOI 10.1161/STROKEAHA.115.009947; Wang SV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2607; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Xiong QM, 2015, INT J CARDIOL, V195, P237, DOI 10.1016/j.ijcard.2015.05.115; Yiin GSC, 2014, CIRCULATION, V130, P1236, DOI 10.1161/CIRCULATIONAHA.114.010942; Yiin GS, 2015, J NEUROL NEUROSURG P, DOI 10.1136/jnnp-2015-311947; Zhu WG, 2015, TEX HEART I J, V42, P6, DOI 10.14503/THIJ-14-4353	106	232	237	11	74	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 20	2016	388	10046					806	817		10.1016/S0140-6736(16)31257-0	http://dx.doi.org/10.1016/S0140-6736(16)31257-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT6UH	27560276				2022-12-28	WOS:000381619200029
J	Fearnside, PM				Fearnside, Philip M.			Brazilian politics threaten environmental policies	SCIENCE			English	Editorial Material							AMAZON		[Fearnside, Philip M.] Natl Inst Res Amazonia INPA, BR-69067375 Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia	Fearnside, PM (corresponding author), Natl Inst Res Amazonia INPA, BR-69067375 Manaus, Amazonas, Brazil.	pmfearn@inpa.gov.br	Fearnside, Philip M/GQA-6023-2022; Fearnside, Philip M/D-6559-2011	Fearnside, Philip M/0000-0003-3672-9082; Fearnside, Philip M/0000-0003-3672-9082				[Anonymous], 2016, BANCADA TENTA REVERT, pA; [Anonymous], 2014, SENADOR ELEITO MAIS; Baquero M., 2015, REV DEBATES, V9, P139; Barcelos I., 2016, FOLHA SAO PAULO, pB; Bergamon M., 2016, FOLHA SAO PAULO, pA; CFBio (Conselho Federal de Biologia), 2016, CFBIO ENTREGA OFICIO; Fearnside PM, 2007, ENVIRON MANAGE, V39, P601, DOI 10.1007/s00267-006-0149-2; Fearnside PM, 2014, WATER ALTERN, V7, P256; FEARNSIDE PM, 1995, ENVIRON CONSERV, V22, P7, DOI 10.1017/S0376892900034020; FEARNSIDE PM, 2015, GLOBAL LAND PROJ NEW, V0012, P00022; Ferreira J, 2014, SCIENCE, V346, P706, DOI 10.1126/science.1260194; Hernndez FD, 2011, NOVOS CAD NAEA, V14, P79; ISA, 2016, NOTA TECNICO JURIDIC; LIMA Gilsileide Cristina Barros, 2016, THESIS, P101; Lopes R. J., 2011, FOLHA SAO PAULO; Metzger JP, 2010, SCIENCE, V329, P276, DOI 10.1126/science.329.5989.276-b; [Ministerio Publico Federal Grupo de Trabalho Intercameral], 2016, NOTA TECNICA A PEC 6; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; OEco, 2015, RURALISTAS NAO DESIS; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Zucco C, 2011, LEGIS STUD QUART, V36, P363, DOI 10.1111/j.1939-9162.2011.00019.x	21	117	119	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					746	748		10.1126/science.aag0254	http://dx.doi.org/10.1126/science.aag0254			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5ZE	27540150				2022-12-28	WOS:000381561400018
J	Russo, MV; McGavern, DB				Russo, Matthew V.; McGavern, Dorian B.			Inflammatory neuroprotection following traumatic brain injury	SCIENCE			English	Editorial Material							SPINAL-CORD; T-CELLS	Traumatic brain injury (TBI) elicits an inflammatory response in the central nervous system (CNS) that involves both resident and peripheral immune cells. Neuroinflammation can persist for years following a single TBI and may contribute to neurodegeneration. However, administration of anti-inflammatory drugs shortly after injury was not effective in the treatment of TBI patients. Some components of the neuroinflammatory response seem to play a beneficial role in the acute phase of TBI. Indeed, following CNS injury, early inflammation can set the stage for proper tissue regeneration and recovery, which can, perhaps, explain why general immunosuppression in TBI patients is disadvantageous. Here, we discuss some positive attributes of neuroinflammation and propose that inflammation be therapeutically guided in TBI patients rather than globally suppressed.	[Russo, Matthew V.; McGavern, Dorian B.] NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bethesda, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	McGavern, DB (corresponding author), NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bethesda, MD 20852 USA.	mcgavernd@mail.nih.gov	McGavern, Dorian/HCH-3601-2022	McGavern, Dorian/0000-0001-9568-545X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003112] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA NS003112-07] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Edwards P, 2005, LANCET, V365, P1957; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Lampron A, 2015, J EXP MED, V212, P481, DOI 10.1084/jem.20141656; Lou NH, 2016, P NATL ACAD SCI USA, V113, P1074, DOI 10.1073/pnas.1520398113; Raposo C, 2014, J NEUROSCI, V34, P10141, DOI 10.1523/JNEUROSCI.0076-14.2014; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Stirling DP, 2009, J NEUROSCI, V29, P753, DOI 10.1523/JNEUROSCI.4918-08.2009; Walsh JT, 2015, J CLIN INVEST, V125, P699, DOI [10.1172/JCI176210, 10.1172/JCI76210]; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304	15	207	216	6	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					783	785		10.1126/science.aaf6260	http://dx.doi.org/10.1126/science.aaf6260			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZE	27540166	Green Accepted			2022-12-28	WOS:000381561400036
J	Sinsky, C; Colligan, L; Li, L; Prgomet, M; Reynolds, S; Goeders, L; Westbrook, J; Tutty, M; Blike, G				Sinsky, Christine; Colligan, Lacey; Li, Ling; Prgomet, Mirela; Reynolds, Sam; Goeders, Lindsey; Westbrook, Johanna; Tutty, Michael; Blike, George			Allocation of Physician Time in Ambulatory Practice: A Time and Motion Study in 4 Specialties	ANNALS OF INTERNAL MEDICINE			English	Article							ELECTRONIC MEDICAL-RECORDS; PRIMARY-CARE PRACTICES; WORK-LIFE BALANCE; EXAMINATION ROOM; HEALTH RECORDS; OFFICE VISITS; PATIENT-CARE; SATISFACTION; DOCTORS; BURNOUT	Background: Little is known about how physician time is allocated in ambulatory care. Objective: To describe how physician time is spent in ambulatory practice. Design: Quantitative direct observational time and motion study (during office hours) and self-reported diary (after hours). Setting: U.S. ambulatory care in 4 specialties in 4 states (Illinois, New Hampshire, Virginia, and Washington). Participants: 57 U. S. physicians in family medicine, internal medicine, cardiology, and orthopedics who were observed for 430 hours, 21 of whom also completed after-hours diaries. Measurements: Proportions of time spent on 4 activities (direct clinical face time, electronic health record [EHR] and desk work, administrative tasks, and other tasks) and self-reported afterhours work. Results: During the office day, physicians spent 27.0% of their total time on direct clinical face time with patients and 49.2% of their time on EHR and desk work. While in the examination room with patients, physicians spent 52.9% of the time on direct clinical face time and 37.0% on EHR and desk work. The 21 physicians who completed after-hours diaries reported 1 to 2 hours of after-hours work each night, devoted mostly to EHR tasks. Limitations: Data were gathered in self-selected, high-performing practices and may not be generalizable to other settings. The descriptive study design did not support formal statistical comparisons by physician and practice characteristics. Conclusion: For every hour physicians provide direct clinical face time to patients, nearly 2 additional hours is spent on EHR and desk work within the clinic day. Outside office hours, physicians spend another 1 to 2 hours of personal time each night doing additional computer and other clerical work.	[Sinsky, Christine; Goeders, Lindsey; Tutty, Michael] Amer Med Assoc, 330 North Wabash Ave,Suite 39300, Chicago, IL 60611 USA; [Colligan, Lacey] Sharp End Advisory LLC, POB 222, Hanover, NH 03755 USA; [Li, Ling; Prgomet, Mirela; Westbrook, Johanna] Macquarie Univ, Ctr Hlth Syst & Safety Res, Australian Inst Hlth Innovat, Fac Med & Hlth Sci, Level 6,75 Talavera Rd, Sydney, NSW 2109, Australia; [Reynolds, Sam] Amer Med Assoc, 4622 North Damen Ave, Chicago, IL 60625 USA; [Blike, George] Dartmouth Hitchcock Med Ctr, 1 Med Ctr Dr,Bldg 50, Lebanon, NH 03756 USA	American Medical Association; Macquarie University; American Medical Association; Dartmouth College	Li, L (corresponding author), Macquarie Univ, Ctr Hlth Syst & Safety Res, Australian Inst Hlth Innovat, Fac Med & Hlth Sci, Level 6,75 Talavera Rd, Sydney, NSW 2109, Australia.	Ling.Li@mq.edu.au	Colligan, Lacey/AAC-7076-2020; Prgomet, Mirela/AAJ-7735-2020; Westbrook, Johanna I/J-9045-2018	Prgomet, Mirela/0000-0001-5629-3680; Westbrook, Johanna I/0000-0003-1083-8192; Li, Ling/0000-0002-1642-142X	American Medical Association	American Medical Association	American Medical Association.	[Anonymous], AHRQ PUBLICATION; Arabadzhiyska PN, 2013, INTERN MED J, V43, P1321, DOI 10.1111/imj.12223; Arndt B, 2015, N AM PRIM CAR RES GR; Arya R, 2010, ACAD EMERG MED, V17, P490, DOI 10.1111/j.1553-2712.2010.00718.x; Babbott S, 2014, J AM MED INFORM ASSN, V21, pE100, DOI 10.1136/amiajnl-2013-001875; Ballermann MA, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-32; Bank AJ, 2013, CLINICOECONOMIC OUTC, V5, P399, DOI 10.2147/CEOR.S49010; Baron RJ, 2010, NEW ENGL J MED, V362, P1632, DOI 10.1056/NEJMon0910793; Black AD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000387; Casalino LP, 2016, HEALTH AFFAIR, V35, P401, DOI 10.1377/hlthaff.2015.1258; Chen MA, 2011, J GEN INTERN MED, V26, P58, DOI 10.1007/s11606-010-1494-7; Colligan L, 2015, INT J MED INFORM, V84, P469, DOI 10.1016/j.ijmedinf.2015.03.003; Devine EB, 2010, HEALTH SERV RES, V45, P152, DOI 10.1111/j.1475-6773.2009.01063.x; Doerr E, 2010, J GEN INTERN MED, V25, P1289, DOI 10.1007/s11606-010-1470-2; Farber J, 2007, ANN INTERN MED, V147, P693, DOI 10.7326/0003-4819-147-10-200711200-00005; Fiks AG, 2011, J AM MED INFORM ASSN, V18, P38, DOI 10.1136/jamia.2010.004135; Friedberg M.W., 2013, FACTORS AFFECTING PH; Ghorob A, 2012, J AM BOARD FAM MED, V25, P143, DOI 10.3122/jabfm.2012.02.120007; Gilchrist V, 2005, ANN FAM MED, V3, P494, DOI 10.1370/afm.391; Gottschalk A, 2005, ANN FAM MED, V3, P488, DOI 10.1370/afm.404; Grumbach K, 2004, JAMA-J AM MED ASSOC, V291, P1246, DOI 10.1001/jama.291.10.1246; Himmelstein DU, 2010, AM J MED, V123, P40, DOI 10.1016/j.amjmed.2009.09.004; Holman GT, 2016, J AM MED INFORM ASSN, V23, P29, DOI 10.1093/jamia/ocv107; Hopkins Kevin, 2014, Fam Pract Manag, V21, P23; Howard KA., 2012, ADAPTING EHR SCRIBE; Jamoom Eric, 2013, NCHS Data Brief, P1; Koshy S, 2010, J UROLOGY, V184, P258, DOI 10.1016/j.juro.2010.03.040; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Li L, 2015, CRIT CARE RESUSC, V17, P159; McDonald CJ, 2014, JAMA INTERN MED, V174, P1860, DOI 10.1001/jamainternmed.2014.4506; McDonald CJ, 2012, ARCH INTERN MED, V172, P285, DOI 10.1001/archinternmed.2011.1678; McGinn T, 2004, CAN MED ASSOC J, V171, P1369, DOI 10.1503/cmaj.1031981; Misra-Hebert AD, 2015, AM J MED, V128, P1025, DOI 10.1016/j.amjmed.2015.03.035; Montague E, 2014, INT J MED INFORM, V83, P225, DOI 10.1016/j.ijmedinf.2013.11.003; Murphy DR, 2012, AM J MED, V125, P209, DOI 10.1016/j.amjmed.2011.07.029; Ratanawongsa N, 2016, JAMA INTERN MED, V176, P125, DOI 10.1001/jamainternmed.2015.6186; Ratwani RM, 2015, J AM MED INFORM ASSN, V22, P1179, DOI 10.1093/jamia/ocv050; Reuben DB, 2014, JAMA INTERN MED, V174, P1190, DOI 10.1001/jamainternmed.2014.1315; Romano MJ, 2011, ARCH INTERN MED, V171, P897, DOI 10.1001/archinternmed.2010.527; Shanafelt TD, 2016, MAYO CLIN PROC, V91, P836, DOI 10.1016/j.mayocp.2016.05.007; Shanafelt TD, 2015, MAYO CLIN PROC, V90, P1600, DOI 10.1016/j.mayocp.2015.08.023; Shanafelt TD, 2012, ARCH INTERN MED, V172, P1377, DOI 10.1001/archinternmed.2012.3199; Sinsky CA, 2013, ANN FAM MED, V11, P272, DOI 10.1370/afm.1531; Sinsky CA, 2010, HEALTH AFFAIR, V29, P966, DOI 10.1377/hlthaff.2010.0356; Walter SR, 2014, BMJ QUAL SAF, V23, P231, DOI 10.1136/bmjqs-2013-002097; Westbrook JI., 2014, WORK OBSERVATION MET; Westbrook JI, 2008, MED J AUSTRALIA, V188, P506, DOI 10.5694/j.1326-5377.2008.tb01762.x; Westbrook JI, 2013, J AM MED INFORM ASSN, V20, P1150, DOI 10.1136/amiajnl-2012-001414; Westbrook JI, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-319; Westbrook JI, 2010, QUAL SAF HEALTH CARE, V19, P284, DOI 10.1136/qshc.2009.039255; Westbrook Johanna I, 2009, Int J Med Inform, V78 Suppl 1, pS25, DOI 10.1016/j.ijmedinf.2008.09.003; Willard-Grace R, 2014, J AM BOARD FAM MED, V27, P229, DOI 10.3122/jabfm.2014.02.130215	52	621	623	3	73	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2016	165	11					753	+		10.7326/M16-0961	http://dx.doi.org/10.7326/M16-0961			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE0KO	27595430				2022-12-28	WOS:000389263900002
J	Chua, MLK; Chan, ATC				Chua, Melvin L. K.; Chan, Anthony T. C.			Gemcitabine: a game changer in nasopharyngeal carcinoma	LANCET			English	Editorial Material							PHASE-II; CARBOPLATIN; PACLITAXEL; TRIAL		[Chua, Melvin L. K.] Natl Canc Ctr Singapore, Div Radiat Oncol, Singapore 169610, Singapore; [Chua, Melvin L. K.] Duke NUS Grad Med Sch, Singapore, Singapore; [Chan, Anthony T. C.] Chinese Univ Hong Kong, Hong Kong Canc Inst, Dept Clin Oncol, State Key Lab Oncol South China,Sir YK Pao Ctr Ca, Hong Kong, Hong Kong, Peoples R China	National Cancer Centre Singapore (NCCS); National University of Singapore; Chinese University of Hong Kong; State Key Lab Oncology South China	Chua, MLK (corresponding author), Natl Canc Ctr Singapore, Div Radiat Oncol, Singapore 169610, Singapore.; Chua, MLK (corresponding author), Duke NUS Grad Med Sch, Singapore, Singapore.	melvin.chua.l.k@nccs.com.sg	Chua, Melvin LK/ABG-6045-2020; Chan, Anthony Tak Cheung/R-3940-2018	Chua, Melvin LK/0000-0002-1648-1473; Chan, Anthony Tak Cheung/0000-0002-6912-8091				Chua MLK, 2016, LANCET, V387, P1012, DOI 10.1016/S0140-6736(15)00055-0; Foo KF, 2002, ANN ONCOL, V13, P150, DOI 10.1093/annonc/mdf002; Lee AWM, 2015, J CLIN ONCOL, V33, P3356, DOI 10.1200/JCO.2015.60.9347; Leong SS, 2005, CANCER-AM CANCER SOC, V103, P569, DOI 10.1002/cncr.20804; Lin DC, 2014, NAT GENET, V46, P866, DOI 10.1038/ng.3006; Ma BBY, 2009, ANN ONCOL, V20, P1854, DOI 10.1093/annonc/mdp065; Ngan RKC, 2002, ANN ONCOL, V13, P1252, DOI 10.1093/annonc/mdf200; Tan T, 2015, INT J RADIAT ONCOL, V91, P952, DOI 10.1016/j.ijrobp.2015.01.002; Tsao SW, 2012, SEMIN CANCER BIOL, V22, P137, DOI 10.1016/j.semcancer.2012.02.004; Zhang L, 2016, LANCET	10	19	19	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 15	2016	388	10054					1853	1854		10.1016/S0140-6736(16)31394-0	http://dx.doi.org/10.1016/S0140-6736(16)31394-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DZ0AM	27567280				2022-12-28	WOS:000385499000004
J	Sohn, E				Sohn, Emily			A clear answer	NATURE			English	Editorial Material																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					S64	S65		10.1038/537S64a	http://dx.doi.org/10.1038/537S64a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU9LQ	27602744	Bronze			2022-12-28	WOS:000382539100005
J	Venkataram, S; Dunn, B; Li, YP; Agarwala, A; Chang, J; Ebel, ER; Geiler-Samerotte, K; Herissant, L; Blundell, JR; Levy, SF; Fisher, DS; Sherlock, G; Petrov, DA				Venkataram, Sandeep; Dunn, Barbara; Li, Yuping; Agarwala, Atish; Chang, Jessica; Ebel, Emily R.; Geiler-Samerotte, Kerry; Herissant, Lucas; Blundell, Jamie R.; Levy, Sasha F.; Fisher, Daniel S.; Sherlock, Gavin; Petrov, Dmitri A.			Development of a Comprehensive Genotype-to-Fitness Map of Adaptation-Driving Mutations in Yeast	CELL			English	Article							REPLICATIVE LIFE-SPAN; POPULATION GENOMICS; CLONAL INTERFERENCE; EVOLUTION; SELECTION; INSIGHT; GENES; LEVEL	Adaptive evolution plays a large role in generating the phenotypic diversity observed in nature, yet current methods are impractical for characterizing the molecular basis and fitness effects of large numbers of individual adaptive mutations. Here, we used a DNA barcoding approach to generate the genotype-to-fitness map for adaptation-driving mutations from a Saccharomyces cerevisiae population experimentally evolved by serial transfer under limiting glucose. We isolated and measured the fitness of thousands of independent adaptive clones and sequenced the genomes of hundreds of clones. We found only two major classes of adaptive mutations: self-diploidization and mutations in the nutrient-responsive Ras/PKA and TOR/Sch9 pathways. Our large sample size and precision of measurement allowed us to determine that there are significant differences in fitness between mutations in different genes, between different paralogs, and even between different classes of mutations within the same gene.	[Venkataram, Sandeep; Li, Yuping; Ebel, Emily R.; Geiler-Samerotte, Kerry; Fisher, Daniel S.; Petrov, Dmitri A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Dunn, Barbara; Chang, Jessica; Herissant, Lucas; Sherlock, Gavin] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Agarwala, Atish] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Blundell, Jamie R.; Fisher, Daniel S.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Blundell, Jamie R.; Levy, Sasha F.] SUNY Stony Brook, Laufer Ctr Phys & Quantitat Biol, Stony Brook, NY 11794 USA; [Levy, Sasha F.] SUNY Stony Brook, Dept Biochem & Cellular Biol, Stony Brook, NY 11794 USA	Stanford University; Stanford University; Stanford University; Stanford University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Petrov, DA (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.; Sherlock, G (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	gsherloc@stanford.edu; dpetrov@stanford.edu	Sherlock, Gavin J/E-9110-2012; Li, Yuping/AAL-6956-2020; Herissant, Lucas/AAU-9682-2021	Li, Yuping/0000-0003-2057-3271; Herissant, Lucas/0000-0003-0065-5608; Venkataram, Sandeep/0000-0002-2012-2633; Fisher, Daniel/0000-0002-5559-2491; Dunn, Barbara/0000-0002-7041-0035; Blundell, Jamie Rees/0000-0001-9747-7363; Ebel, Emily/0000-0002-3244-4250; Sherlock, Gavin/0000-0002-1692-4983; Petrov, Dmitri/0000-0002-3664-9130	NIH/NHGRI [T32 HG000044]; Stanford Center for Computational, Human and Evolutionary Genomics (CEHG); NSF GFRP [DGE-1247312]; NSF GRFP [DGE-114747]; NIH [R01 GM110275, R01 HG003328, GM110275, R01 GM115919, GM10036601, GM097415]; Stanford Bio-X Bowes Fellowship; CEHG; Louis and Beatrice Laufer Center; NSF [PHY-1305433]; NIH S10 Shared Instrument grant [RR027431]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036601] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027431] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003328, T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118165, R01GM110275, R01GM097415, R01GM100366, R01GM115919] Funding Source: NIH RePORTER; Division Of Physics [1305433] Funding Source: National Science Foundation	NIH/NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Stanford Center for Computational, Human and Evolutionary Genomics (CEHG); NSF GFRP; NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Bio-X Bowes Fellowship; CEHG; Louis and Beatrice Laufer Center; NSF(National Science Foundation (NSF)); NIH S10 Shared Instrument grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We wish to thank all members of the D.A.P., G.S., and D.S.F. labs for useful discussions, and Michael Desai, Sergey Kryazhimskiy, Katja Schwartz, Dave Yuan, and Jake Cherry for technical help. We thank the Stanford Shared FACS facility for use of their flow cytometers, and the Stanford Center for Personalized Genomics and Medicine and NextSEQ for Illumina sequencing services. S.V. is supported by NIH/NHGRI T32 HG000044 and the Stanford Center for Computational, Human and Evolutionary Genomics (CEHG); E.E. by NSF GFRP DGE-1247312; J.C. by NSF GRFP DGE-114747; A.A. by a Stanford Bio-X Bowes Fellowship; L.H. by NIH grant R01 GM110275 and a fellowship from CEHG; J.B. and S.F.L. by the Louis and Beatrice Laufer Center; and D.S.F. by NSF PHY-1305433 and NIH R01 HG003328. The work was supported by NIH grants R01 HG003328 and GM110275 to G.S. and R01 GM115919, GM10036601, and GM097415 to D.A.P. Data were collected on an instrument in the Shared FACS Facility obtained using NIH S10 Shared Instrument grant RR027431.	ADAMS J, 1974, GENETICS, V76, P327; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bozek K, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001871; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Cousin A, 2009, CYTOM PART A, V75A, P1015, DOI 10.1002/cyto.a.20816; Darwin C, 1872, ORIGIN SPECIES; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; Desai MM, 2007, GENETICS, V176, P1759, DOI 10.1534/genetics.106.067678; Dettman JR, 2012, MOL ECOL, V21, P2058, DOI 10.1111/j.1365-294X.2012.05484.x; Fabrizio P, 2004, FEBS LETT, V557, P136, DOI 10.1016/S0014-5793(03)01462-5; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; Gerstein AC, 2006, PLOS GENET, V2, P1396, DOI 10.1371/journal.pgen.0020145; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Givnish TJ, 2015, NEW PHYTOL, V207, P297, DOI 10.1111/nph.13482; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303; Herron MD, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001490; Hietpas RT, 2013, EVOLUTION, V67, P3512, DOI 10.1111/evo.12207; Hong JE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004041; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kao KC, 2008, NAT GENET, V40, P1499, DOI 10.1038/ng.280; Korolev KS, 2014, NAT REV CANCER, V14, P371, DOI 10.1038/nrc3712; Kryazhimskiy S, 2014, SCIENCE, V344, P1519, DOI 10.1126/science.1250939; Kvitek DJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003972; Kvitek DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002056; Lachance J, 2013, ANNU REV ECOL EVOL S, V44, P123, DOI 10.1146/annurev-ecolsys-110512-135833; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lang GI, 2013, NATURE, V500, P571, DOI 10.1038/nature12344; Levy SF, 2015, NATURE, V519, P181, DOI 10.1038/nature14279; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; LONDESBOROUGH J, 1980, J BIOL CHEM, V255, P9262; Long A, 2015, NAT REV GENET, V16, P567, DOI 10.1038/nrg3937; Marcet-Houben M, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002220; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Oleksyk TK, 2010, PHILOS T R SOC B, V365, P185, DOI 10.1098/rstb.2009.0219; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Palmer AC, 2013, NAT REV GENET, V14, P243, DOI 10.1038/nrg3351; Parts L, 2011, GENOME RES, V21, P1131, DOI 10.1101/gr.116731.110; Pennings PS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002527; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rich MS, 2016, GENETICS, V203, P191, DOI 10.1534/genetics.116.188037; SHORTLE D, 1984, P NATL ACAD SCI-BIOL, V81, P4889, DOI 10.1073/pnas.81.15.4889; Sliwa P, 2005, P NATL ACAD SCI USA, V102, P17670, DOI 10.1073/pnas.0505517102; Soulebeau A, 2015, ORG DIVERS EVOL, V15, P747, DOI 10.1007/s13127-015-0220-z; Stinchcombe JR, 2008, HEREDITY, V100, P158, DOI 10.1038/sj.hdy.6800937; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; Toprak E, 2012, NAT GENET, V44, P101, DOI 10.1038/ng.1034; UPSHALL A, 1977, J GEN MICROBIOL, V100, P413, DOI 10.1099/00221287-100-2-413; Vitti JJ, 2013, ANNU REV GENET, V47, P97, DOI 10.1146/annurev-genet-111212-133526; Voordeckers K, 2015, CURR OPIN MICROBIOL, V28, P1, DOI 10.1016/j.mib.2015.06.018; Warringer J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002111; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wenger JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002202; Zeyl C, 2003, SCIENCE, V299, P555, DOI 10.1126/science.1078417; Zorgo E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003388	59	102	103	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2016	166	6					1585	+		10.1016/j.cell.2016.08.002	http://dx.doi.org/10.1016/j.cell.2016.08.002			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EA1GG	27594428	Green Accepted, Bronze			2022-12-28	WOS:000386339900028
J	Dupuis-Girod, S; Ambrun, A; Decullier, E; Fargeton, AE; Roux, A; Breant, V; Colombet, B; Riviere, S; Cartier, C; Lacombe, P; Chinet, T; Blivet, S; Blondel, JH; Gilbert-Dussardier, B; Dufour, X; Michel, J; Harle, JR; Dessi, P; Faure, F				Dupuis-Girod, Sophie; Ambrun, Alexis; Decullier, Evelyne; Fargeton, Anne-Emmanuelle; Roux, Adeline; Breant, Valentine; Colombet, Bettina; Riviere, Sophie; Cartier, Cesar; Lacombe, Pascal; Chinet, Thierry; Blivet, Sandra; Blondel, Jean-Hugues; Gilbert-Dussardier, Brigitte; Dufour, Xavier; Michel, Justin; Harle, Jean-Robert; Dessi, Patrick; Faure, Frederic			Effect of Bevacizumab Nasal Spray on Epistaxis Duration in Hereditary Hemorrhagic Telangectasia A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEPTUM PERFORATION; TELANGIECTASIA; SUBMUCOSAL; THERAPY; AVASTIN; GENE	BACKGROUND Epistaxis is the most frequent and disabling manifestation of hereditary hemorrhagic telangiectasia (HHT). The efficacy of intravenous bevacizumab (an anti-vascular endothelial growth factor monoclonal antibody) for epistaxis has been shown. However, the efficacy of intranasal bevacizumab has yet to be evaluated. OBJECTIVE To evaluate the efficacy of 3 different doses of bevacizumab administered as a nasal spray in a repeated manner for the duration of nosebleeds in patients with HHT. DESIGN, SETTING, AND PARTICIPANTS Randomized, multicenter, placebo-controlled, phase 2/3 clinical trial with dose selection at an intermediate analysis and prespecified stopping rules (nonbinding stopping for futility). Patients aged 18 years or older with a diagnosis of HHT were recruited from 5 French centers from April 2014 to January 2015 with a 6-month follow-up after the end of treatment. Participants had a history of self-reported nosebleeds with a monthly duration of more than 20 minutes in at least the 3 months prior to inclusion corroborated by epistaxis grids completed during the same preinclusion period. INTERVENTIONS Eighty consecutive HHT patients were randomized and treated in the phase 2 study, with 4 parallel groups in a 1: 1: 1: 1 ratio. One group received placebo (n = 21); the other 3 received bevacizumab nasal spray. Each bevacizumab group received a different dose of the drug (25mg [n = 20], 50mg [n = 20], or 75mg [n = 19] per treatment) in 3 doses 14 days apart for a total treatment duration of 4 weeks, resulting in a total dose of 75mg, 150mg, and 225mg in each treatment group. MAIN OUTCOMES AND MEASURES Mean monthly epistaxis duration for 3 consecutive months immediately after the end of the treatment. RESULTS Of the 80 patients who were randomized (mean age, 60.47 [SD, 10.61] years; 37 women [46.25%]), 75 completed the study. Mean monthly epistaxis duration measured at 3 months was not significantly different in the 59 patients receiving bevacizumab in comparison with the placebo group (P = .57) or between the bevacizumab groups. The mean monthly epistaxis duration was 259.2 minutes (95% CI, 82.1-436.3 minutes) in the 25-mg group, 244.0 minutes (95% CI, 81.8-406.2 minutes) in the 50-mg group, 215.0 minutes (95% CI, 102.8-327.2 minutes) in the 75-mg group, and 200.4 minutes (95% CI, 109.3-291.5 minutes) in the placebo group. Toxicity was low and no severe adverse events were reported. This study was terminated prior to phase 3 for treatment futility after interim analysis on the recommendations of an independent data monitoring committee. CONCLUSIONS AND RELEVANCE In patients with HHT, a bevacizumab nasal spray treatment of 3 administrations at 14-day intervals with doses of 25mg, 50mg, or 75mg per spray, compared with a placebo, did not reduce monthly epistaxis duration in the 3 consecutive months immediately after the end of treatment.	[Dupuis-Girod, Sophie] Hop Femme Mere Enfants, Hosp Civils Lyon, Serv Genet, Bron, France; [Dupuis-Girod, Sophie] Ctr Reference Maladie Rendu Osler, F-69677 Bron, France; [Dupuis-Girod, Sophie; Fargeton, Anne-Emmanuelle] Univ Lyon 1, Fac Med, Lyon, France; [Ambrun, Alexis] Hop Croix Rousse, Hosp Civils Lyon, Serv ORL, Lyon, France; [Decullier, Evelyne; Roux, Adeline] Hosp Civils Lyon, Pole IMER, Lyon, France; [Decullier, Evelyne] Univ Lyon 1, Lyon, France; [Breant, Valentine; Colombet, Bettina] Hop Louis Pradel, Hosp Civils Lyon, Pharm, Bron, France; [Riviere, Sophie] CHU Montpellier, Serv Med Interne A, Montpellier, France; [Cartier, Cesar] CHU Montpellier, Serv ORL, Montpellier, France; [Lacombe, Pascal] Univ Paris Ile de France Ouest, Hop Ambroise Pare, AP HP, Serv Radiol, Boulogne, France; [Chinet, Thierry; Blivet, Sandra] Univ Paris Ile de France Ouest, Hop Ambroise Pare, AP HP, Serv Pneumol, Boulogne, France; [Blondel, Jean-Hugues] Univ Paris Ile de France Ouest, Hop Ambroise Pare, AP HP, Serv ORL, Boulogne, France; [Gilbert-Dussardier, Brigitte] Univ Poitiers, CHU Poitiers, Serv Genet Med, Poitiers, France; [Dufour, Xavier] CHU Miletrie, Serv ORL, Poitiers, France; [Michel, Justin; Harle, Jean-Robert] CHU Marseille, Hop Concept, Serv Med Interne, Marseille, France; [Dessi, Patrick] CHU Marseille, Hop Timone, Serv ORL, Marseille, France; [Faure, Frederic] Hop Edouard Herriot, Hosp Civils Lyon, Serv ORL, Lyon, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Lyon	Dupuis-Girod, S (corresponding author), Ctr Reference Maladie Rendu Osler, F-69677 Bron, France.; Dupuis-Girod, S (corresponding author), Hop Femme Mere Enfants, Serv Genet, F-69677 Bron, France.	sophie.dupuis-girod@chu-lyon.fr	decullier, evelyne/AAL-5861-2021; Dupuis-Girod, Sophie/D-6268-2014	GILBERT-DUSSARDIER, Brigitte/0000-0001-7182-9914; Dupuis-Girod, Sophie/0000-0002-8834-5526	Hospices Civils de Lyon grant - National Research Program (PHRC); patients' association (Association Pour la Maladie de Rendu-Osler)	Hospices Civils de Lyon grant - National Research Program (PHRC); patients' association (Association Pour la Maladie de Rendu-Osler)	This work was financed by the Hospices Civils de Lyon grant supported by the National Research Program (PHRC 2013) and by the patients' association (Association Pour la Maladie de Rendu-Osler).	BAUER P, 1994, BIOMETRICS, V50, P1029, DOI 10.2307/2533441; Bretz F, 2009, STAT MED, V28, P1181, DOI 10.1002/sim.3538; Brinkerhoff BT, 2012, AM J OTOLARYNG, V33, P349, DOI 10.1016/j.amjoto.2011.07.012; Brinkerhoff BT, 2011, NEW ENGL J MED, V364, P688, DOI 10.1056/NEJMc1012774; Chen S, 2011, LARYNGOSCOPE, V121, P644, DOI 10.1002/lary.21345; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Davidson TM, 2010, LARYNGOSCOPE, V120, P432, DOI 10.1002/lary.20757; Dupuis-Girod S, 2014, MABS-AUSTIN, V6, P793, DOI 10.4161/mabs.28025; Dupuis-Girod S, 2012, JAMA-J AM MED ASSOC, V307, P948, DOI 10.1001/jama.2012.250; Fakih MG, 2006, ONCOLOGIST, V11, P85, DOI 10.1634/theoncologist.11-1-85; Gaillard S, 2014, J THROMB HAEMOST, V12, P1494, DOI 10.1111/jth.12654; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Guldmann R, 2012, LARYNGOSCOPE, V122, P953, DOI 10.1002/lary.23230; Haitjema T., 1996, Rhinology (Utrecht), V34, P176; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Karnezis TT, 2012, LARYNGOSCOPE, V122, P495, DOI 10.1002/lary.22501; Karnezis TT, 2011, LARYNGOSCOPE, V121, P636, DOI 10.1002/lary.21415; Lesnik GT, 2007, AM J RHINOL, V21, P312, DOI 10.2500/ajr.2007.21.3017; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Riss D, 2015, HEAD NECK-J SCI SPEC, V37, P783, DOI 10.1002/hed.23655; Rohrmeier C, 2012, EUR ARCH OTO-RHINO-L, V269, P531, DOI 10.1007/s00405-011-1721-9; Ruiz N, 2007, J CLIN ONCOL, V25, P3376, DOI 10.1200/JCO.2007.12.0006; Saif MW, 2006, EXPERT OPIN DRUG SAF, V5, P553, DOI 10.1517/14740338.5.4.553; Samson G, 2012, EUR J PHARM BIOPHARM, V80, P465, DOI 10.1016/j.ejpb.2011.11.004; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Simonds J, 2009, LARYNGOSCOPE, V119, P988, DOI 10.1002/lary.20159; Traina TA, 2006, ONCOLOGIST, V11, P1070, DOI 10.1634/theoncologist.11-10-1070	27	40	41	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2016	316	9					934	942		10.1001/jama.2016.11387	http://dx.doi.org/10.1001/jama.2016.11387			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU8JV	27599328	Bronze			2022-12-28	WOS:000382460200016
J	Hirsch, FR; Suda, K; Wiens, J; Bunn, PA				Hirsch, Fred R.; Suda, Kenichi; Wiens, Jacinta; Bunn, Paul A., Jr.			New and emerging targeted treatments in advanced non-small-cell lung cancer	LANCET			English	Article							CISPLATIN PLUS GEMCITABINE; MULTICENTER PHASE-II; ADULT PATIENTS PTS; OPEN-LABEL; GROWTH-FACTOR; 1ST-LINE TREATMENT; EGFR MUTATIONS; ACQUIRED-RESISTANCE; CLINICAL ACTIVITY; SINGLE-ARM	Targeted therapies are substantially changing the management of lung cancers. These treatments include drugs that target driver mutations, those that target presumed important molecules in cancer cell proliferation and survival, and those that inhibit immune checkpoint molecules. This area of research progresses day by day, with novel target discoveries, novel drug development, and use of novel combination treatments. Researchers and clinicians have also extensively investigated the predictive biomarkers and the molecular mechanisms underlying inherent or acquired resistance to these targeted therapies. We review recent progress in the development of targeted treatments for patients with advanced non-small-cell lung cancer, especially focusing on data from published clinical trials.	[Hirsch, Fred R.; Suda, Kenichi; Bunn, Paul A., Jr.] Univ Colorado, Ctr Canc, Dept Med, Div Med Oncol, Aurora, CO USA; [Hirsch, Fred R.; Suda, Kenichi; Bunn, Paul A., Jr.] Univ Colorado, Ctr Canc, Dept Pathol, Aurora, CO USA; [Hirsch, Fred R.; Wiens, Jacinta] Int Assoc Study Lung Canc, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Hirsch, FR (corresponding author), Univ Colorado, Dept Med, Anschutz Med Campus,Res 1 South L18-8119, Aurora, CO 80045 USA.	fred.hirsch@ucdenver.edu		Suda, Kenichi/0000-0002-0842-8832	University of Colorado from Genentech; BMS; Lilly; Amgen; Bayer; Claris; AstraZeneca; Merck; Novartis; Pfizer; Genentech/Roche; Celgene; Daiichi	University of Colorado from Genentech; BMS(Bristol-Myers Squibb); Lilly(Eli Lilly); Amgen(Amgen); Bayer(Bayer AG); Claris; AstraZeneca(AstraZeneca); Merck(Merck & Company); Novartis(Novartis); Pfizer(Pfizer); Genentech/Roche(Roche HoldingGenentech); Celgene(Bristol-Myers SquibbCelgene Corporation); Daiichi(Daiichi Sankyo Company Limited)	FRH has participated in scientific advisory boards for Genentech/Roche, BMS, Merck, AstraZeneca, Boehringer Ingelheim, Lilly, Pfizer, Novartis, Ventana, and HTG. FRH is a co-investigator of a University of Colorado-owned patent. FRH's laboratory has received research funding through the University of Colorado from Genentech, BMS, Lilly, Amgen, Bayer, and Claris. PAB has received consulting fees from AstraZeneca, BMS, Merck, Novartis, Pfizer, Lilly, Genentech/Roche, Celgene, and Daiichi. JW and KS declare no competing interests.	Antonia S, 2016, LANCET ONCOL, V17, P299, DOI 10.1016/S1470-2045(15)00544-6; Awad MM, 2016, J CLIN ONCOL, V34, P879, DOI 10.1200/JCO.2015.64.2777; Barlesi F, 2016, LANCET, V387, P1415, DOI 10.1016/S0140-6736(16)00004-0; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Brose MS, 2002, CANCER RES, V62, P6997; Calles A, 2015, J THORAC ONCOL, V10, P1726, DOI 10.1097/JTO.0000000000000687; Camidge DR, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.8001; Cascone T, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.9069; Ciardiello F, 2001, CLIN CANCER RES, V7, P2958; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; De Greve J, 2012, LUNG CANCER, V76, P123, DOI 10.1016/j.lungcan.2012.01.008; Dhanasekaran SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6893; Dietlein F, 2015, CELL, V162, P146, DOI 10.1016/j.cell.2015.05.053; Drilon A.R., 2016, J CLIN ONCOL S, V34, DOI DOI 10.1200/JC0.2016.34.15_SUPPL.108; Drilon A, 2013, CANCER DISCOV, V3, P630, DOI 10.1158/2159-8290.CD-13-0035; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ercan D, 2015, CLIN CANCER RES, V21, P3913, DOI 10.1158/1078-0432.CCR-14-2789; Farago AF, 2015, J THORAC ONCOL, V10, P1670, DOI 10.1097/01.JTO.0000473485.38553.f0; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Felip E, 2015, J CLIN ONCOL, V33; Fernandez-Cuesta L, 2014, CANCER DISCOV, V4, P415, DOI 10.1158/2159-8290.CD-13-0633; Gandhi L, 2014, J CLIN ONCOL, V32, P68, DOI 10.1200/JCO.2012.47.2787; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Garon EB, 2014, LANCET, V384, P665, DOI 10.1016/S0140-6736(14)60845-X; Gautschi O, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.9014; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; Gettinger SN, 2015, J CLIN ONCOL, V33, P2004, DOI 10.1200/JCO.2014.58.3708; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; Hata AN, 2016, NAT MED, V22, P262, DOI 10.1038/nm.4040; Hellmann MD, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.3001; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Hirsch FR, 2013, J THORAC ONCOL, V8, P373, DOI 10.1097/JTO.0b013e31827ed0ff; Horn L, 2014, J CLIN ONCOL, V32, p5s; Hrustanovic G, 2015, NAT MED, V21, P1038, DOI 10.1038/nm.3930; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Jia Y, 2016, NATURE, V534, P129, DOI 10.1038/nature17960; Jia Y, 2016, CANCER RES, V76, P1591, DOI 10.1158/0008-5472.CAN-15-2581; Justilien V, 2014, CANCER CELL, V25, P139, DOI 10.1016/j.ccr.2014.01.008; Kang D, 2016, INT J PRECIS ENG MAN, V17, P5, DOI 10.1007/s12541-016-0001-4; Kim HS, 2013, LUNG CANCER, V80, P249, DOI 10.1016/j.lungcan.2013.02.015; Kim HR, 2013, J CLIN ONCOL, V31, P731, DOI 10.1200/JCO.2012.43.8622; Kim MY, 2015, LUNG CANCER, V88, P24, DOI 10.1016/j.lungcan.2015.01.016; Kim Y, 2014, J CLIN ONCOL, V32, P121, DOI 10.1200/JCO.2013.50.8556; Kinno T, 2014, ANN ONCOL, V25, P138, DOI 10.1093/annonc/mdt495; Kitai H, 2016, CANCER DISCOV, V6, P754, DOI 10.1158/2159-8290.CD-15-1377; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Kris MG, 2015, ANN ONCOL, V26, P1421, DOI 10.1093/annonc/mdv186; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Langer CJ, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.9057; Lee SH, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.9013; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; Litvak AM, 2014, J THORAC ONCOL, V9, P1669, DOI 10.1097/JTO.0000000000000344; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Ma PC, 2005, CANCER RES, V65, P1479, DOI 10.1158/0008-5472.CAN-04-2650; Ma WJ, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0277-y; Maemondo M, 2010, N ENGL J MED; Manchado E, 2016, NATURE, V534, P647, DOI 10.1038/nature18600; Matikas A, 2016, CLIN LUNG CANCER, V17, P474, DOI 10.1016/j.cllc.2016.05.006; Mazieres J, 2015, J CLIN ONCOL, V33, P992, DOI 10.1200/JCO.2014.58.3302; Mazieres J, 2013, J CLIN ONCOL, V31, P1997, DOI 10.1200/JCO.2012.45.6095; Mitsudomi T, 2013, NAT REV CLIN ONCOL, V10, P235, DOI 10.1038/nrclinonc.2013.22; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok T, 2015, J CLIN ONCOL, V33; Nakaoku T, 2014, CLIN CANCER RES, V20, P3087, DOI 10.1158/1078-0432.CCR-14-0107; Naoki K, 2002, CANCER RES, V62, P7001; Nokihara H, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.9008; Onozato R, 2009, J THORAC ONCOL, V4, P5, DOI 10.1097/JTO.0b013e3181913e0e; Ou SHI, 2016, J CLIN ONCOL, V34, P661, DOI 10.1200/JCO.2015.63.9443; Ou SHI, 2011, J THORAC ONCOL, V6, P942, DOI 10.1097/JTO.0b013e31821528d3; Oxnard GR, 2016, J CLIN ONCOL, V34, P3375, DOI 10.1200/JCO.2016.66.7162; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Paik PK, 2015, J CLIN ONCOL, V33; Paik PK, 2011, J CLIN ONCOL, V29, P2046, DOI 10.1200/JCO.2010.33.1280; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Park K, 2016, LANCET ONCOL, V17, P577, DOI 10.1016/S1470-2045(16)30033-X; Park K, 2015, J CLIN ONCOL, V33; Paz-Ares L, 2016, ANN ONCOL, V27, P1573, DOI 10.1093/annonc/mdw214; Paz-Ares L, 2016, J THORAC ONCOL, V11, pS153, DOI 10.1016/S1556-0864(16)30326-4; Paz-Ares L, 2015, LANCET ONCOL, V16, P328, DOI 10.1016/S1470-2045(15)70046-X; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Pennell NA, 2015, SEMIN ONCOL, V42, pS3, DOI 10.1053/j.seminoncol.2015.09.016; Pirker R, 2009, LANCET, V373, P1525, DOI 10.1016/S0140-6736(09)60569-9; Planchard D, 2016, LANCET ONCOL, V17, P894; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Ramalingam S, 2016, J THORAC ONCOL, V11, pS152, DOI 10.1016/S1556-0864(16)30324-0; Reck M, 2014, LANCET ONCOL, V15, P143, DOI 10.1016/S1470-2045(13)70586-2; Reck M, 2009, J CLIN ONCOL, V27, P1227, DOI 10.1200/JCO.2007.14.5466; Redig AJ, 2015, J CLIN ONCOL, V33, P975, DOI 10.1200/JCO.2014.59.8433; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rizvi NA, 2015, J CLIN ONCOL, V33; Rizvi NA, 2015, LANCET ONCOL, V16, P257, DOI 10.1016/S1470-2045(15)70054-9; Rosell R, 2016, J THORAC ONCOL, V11, pS114, DOI 10.1016/S1556-0864(16)30245-3; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sacher AG, 2016, JAMA ONCOL, V2, P1014, DOI 10.1001/jamaoncol.2016.0173; Sacher AG, 2016, JAMA ONCOL, DOI [10.1001/jamaoncol.2016.0639, DOI 10.1001/JAMAONCOL.2016]; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Sequist LV, 2015, NEW ENGL J MED, V373, P578, DOI 10.1056/NEJMc1506831; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Seto T, 2006, LUNG CANCER-J IASLC, V53, P91, DOI 10.1016/j.lungcan.2006.02.009; Seto T, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.9012; Seto T, 2014, LANCET ONCOL, V15, P1236, DOI 10.1016/S1470-2045(14)70381-X; Seto T, 2013, LANCET ONCOL, V14, P590, DOI 10.1016/S1470-2045(13)70142-6; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shaw AT, 2016, LANCET ONCOL, V17, P234, DOI 10.1016/S1470-2045(15)00488-X; Shaw AT, 2014, NEW ENGL J MED, V371, P1963, DOI 10.1056/NEJMoa1406766; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shaw AT, 2015, J CLIN ONCOL, V33; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Skoulidis F, 2015, CANCER DISCOV, V5, P860, DOI 10.1158/2159-8290.CD-14-1236; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Solomon BJ, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.9009; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Soria JC, 2015, LANCET ONCOL, V16, P990, DOI 10.1016/S1470-2045(15)00121-7; Subbiah V, 2016, P NATL ACAD SCI USA, V113, pE1419, DOI 10.1073/pnas.1522052113; Suda K, 2015, SCI REP-UK, V5, DOI 10.1038/srep14447; Suda K, 2015, ARCH TOXICOL, V89, P1227, DOI 10.1007/s00204-015-1524-7; Suda K, 2012, CANCER METAST REV, V31, P807, DOI 10.1007/s10555-012-9391-7; Suda K, 2011, J THORAC ONCOL, V6, P1152, DOI 10.1097/JTO.0b013e318216ee52; Suda K, 2010, CANCER METAST REV, V29, P49, DOI 10.1007/s10555-010-9209-4; Takano T, 2008, J CLIN ONCOL, V26, P5589, DOI 10.1200/JCO.2008.16.7254; Takeuchi K, 2016, ANN ONCOL, V27, P185, DOI 10.1093/annonc/mdv501; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Takezawa K, 2012, CANCER DISCOV, V2, P922, DOI 10.1158/2159-8290.CD-12-0108; Tan DSW, 2016, J THORAC ONCOL, V11, P946, DOI 10.1016/j.jtho.2016.05.008; Tao Z, 2016, CLIN CANCER RES, V22, P122, DOI 10.1158/1078-0432.CCR-15-0589; Thatcher N, 2015, LANCET ONCOL, V16, P763, DOI 10.1016/S1470-2045(15)00021-2; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Togashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031323; Tomizawa K, 2011, LUNG CANCER, V74, P139, DOI 10.1016/j.lungcan.2011.01.014; Tsao AS, 2016, J THORAC ONCOL, V11, P613, DOI 10.1016/j.jtho.2016.03.012; Vaishnavi A, 2013, NAT MED, V19, P1469, DOI 10.1038/nm.3352; Van der Steen N, 2016, J THORAC ONCOL, V11, P1423, DOI 10.1016/j.jtho.2016.05.005; Wang R, 2012, J CLIN ONCOL, V30, P4352, DOI 10.1200/JCO.2012.44.1477; Wang SH, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0268-z; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Wu YL, 2013, LANCET ONCOL, V14, P777, DOI 10.1016/S1470-2045(13)70254-7; Yang JCH, 2015, LANCET ONCOL, V16, P830, DOI 10.1016/S1470-2045(15)00026-1; Yang JCH, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.9002; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Yu HA, 2013, J THORAC ONCOL, V8, P346, DOI 10.1097/JTO.0b013e31827e1f83; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Zhu VW, 2016, LUNG CANCER, V97, P48, DOI 10.1016/j.lungcan.2016.04.013; Zou HLY, 2015, P NATL ACAD SCI USA, V112, P3493, DOI 10.1073/pnas.1420785112	158	309	319	11	151	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2016	388	10048					1012	1024		10.1016/S0140-6736(16)31473-8	http://dx.doi.org/10.1016/S0140-6736(16)31473-8			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU9GL	27598681				2022-12-28	WOS:000382524400031
J	Williams, AR; Bisaga, A				Williams, Arthur R.; Bisaga, Adam			From AIDS to Opioids - How to Combat an Epidemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES		[Williams, Arthur R.; Bisaga, Adam] Columbia Univ, Dept Psychiat, Div Subst Abuse, New York State Psychiat Inst, New York, NY 10027 USA	Columbia University; New York State Psychiatry Institute	Williams, AR (corresponding author), Columbia Univ, Dept Psychiat, Div Subst Abuse, New York State Psychiat Inst, New York, NY 10027 USA.		Williams, Arthur Robin/H-8511-2019; BISAGA, Adam/R-4898-2019	Williams, Arthur Robin/0000-0002-7380-6203; Bisaga, Adam/0000-0003-4243-6462	NIDA NIH HHS [T32 DA007294, K24 DA029647] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA029647] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Bentzley BS, 2015, J SUBST ABUSE TREAT, V52, P48, DOI 10.1016/j.jsat.2014.12.011; Buck JA, 2011, HEALTH AFFAIR, V30, P1402, DOI 10.1377/hlthaff.2011.0480; Nosyk B, 2013, HEALTH AFFAIR, V32, P1462, DOI 10.1377/hlthaff.2012.0846; Sigmon SC, 2015, JAMA PSYCHIAT, V72, P395, DOI 10.1001/jamapsychiatry.2014.2421; Wen HF, 2013, JAMA PSYCHIAT, V70, P1355, DOI 10.1001/jamapsychiatry.2013.2169	5	54	54	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2016	375	9					813	815		10.1056/NEJMp1604223	http://dx.doi.org/10.1056/NEJMp1604223			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU9HA	27579632	Bronze, Green Accepted			2022-12-28	WOS:000382526000003
J	Eichenbaum, H				Eichenbaum, Howard			NEUROSCIENCE Memories linked within a window of time	NATURE			English	Editorial Material							HIPPOCAMPUS; DISTINCT		[Eichenbaum, Howard] Boston Univ, Ctr Memory & Brain, Boston, MA 02215 USA	Boston University	Eichenbaum, H (corresponding author), Boston Univ, Ctr Memory & Brain, Boston, MA 02215 USA.	hbe@bu.edu						Cai DJ, 2016, NATURE, V534, P115, DOI 10.1038/nature17955; Ezzyat Y, 2014, NEURON, V81, P1179, DOI 10.1016/j.neuron.2014.01.042; Howard MW, 2013, J EXP PSYCHOL GEN, V142, P1211, DOI 10.1037/a0033621; Hsieh LT, 2014, NEURON, V81, P1165, DOI 10.1016/j.neuron.2014.01.015; Mankin EA, 2012, P NATL ACAD SCI USA, V109, P19462, DOI 10.1073/pnas.1214107109; Manns JR, 2007, NEURON, V56, P530, DOI 10.1016/j.neuron.2007.08.017; McKenzie S, 2014, NEURON, V83, P202, DOI 10.1016/j.neuron.2014.05.019; Rashid AJ, 2016, SCIENCE, V353, P383, DOI 10.1126/science.aaf0594; Ross W.D., 1930, WORKS ARISTOTLE, V3; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	10	2	2	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					405	407		10.1038/536405a	http://dx.doi.org/10.1038/536405a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV0YL	27558060				2022-12-28	WOS:000382646600030
J	Reiss-Brennan, B; Brunisholz, KD; Dredge, C; Briot, P; Grazier, K; Wilcox, A; Savitz, L; James, B				Reiss-Brennan, Brenda; Brunisholz, Kimberly D.; Dredge, Carter; Briot, Pascal; Grazier, Kyle; Wilcox, Adam; Savitz, Lucy; James, Brent			Association of Integrated Team-Based Care With Health Care Quality, Utilization, and Cost	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CENTERED MEDICAL HOME; MENTAL-HEALTH; PROGRAM; CHALLENGES; COUNTRIES; SERVICES; IMPACT	IMPORTANCE The value of integrated team delivery models is not firmly established. OBJECTIVE To evaluate the association of receiving primary care in integrated team-based care (TBC) practices vs traditional practice management (TPM) practices (usual care) with patient outcomes, health care utilization, and costs. DESIGN A retrospective, longitudinal, cohort study to assess the association of integrating physical and mental health over time in TBC practices with patient outcomes and costs. SETTING AND PARTICIPANTS Adult patients (aged >= 18 years) who received primary care at 113 unique Intermountain Healthcare Medical Group primary care practices from 2003 through 2005 and had yearly encounters with Intermountain Healthcare through 2013, including some patients who received care in both TBC and TPM practices. EXPOSURES Receipt of primary care in TBC practices compared with TPM practices for patients treated in internal medicine, family practice, and geriatrics practices. MAIN OUTCOMES AND MEASURES Outcomes included 7 quality measures, 6 health care utilization measures, payments to the delivery system, and program investment costs. RESULTS During the study period (January 2010-December 2013), 113 452 unique patients (mean age, 56.1 years; women, 58.9%) accounted for 163 226 person-years of exposure in 27 TBC practices and 171 915 person-years in 75 TPM practices. Patients treated in TBC practices compared with those treated in TPM practices had higher rates of active depression screening (46.1% for TBC vs 24.1% for TPM; odds ratio [OR], 1.91 [95% CI, 1.75 to 2.08), adherence to a diabetes care bundle (24.6% for TBC vs 19.5% for TPM; OR, 1.26 [95% CI, 1.11 to 1.42]), and documentation of self-care plans (48.4% for TBC vs 8.7% for TPM; OR, 5.59 [95% CI, 4.27 to 7.33]), lower proportion of patients with controlled hypertension (< 140/ 90mmHg) (85.0% for TBC vs 97.7% for TPM; OR, 0.87 [95% CI, 0.80 to 0.95]), and no significant differences in documentation of advanced directives (9.6% for TBC vs 9.9% for TPM; OR, 0.97 [95% CI, 0.91 to 1.03]). Per 100 person-years, rates of health care utilizationwere lower for TBC patients compared with TPM patients for emergency department visits (18.1 for TBC vs 23.5 for TPM; incidence rate ratio [IRR], 0.77 [95% CI, 0.74 to 0.80]), hospital admissions (9.5 for TBC vs 10.6 for TPM; IRR, 0.89 [95% CI, 0.85 to 0.94]), ambulatory care sensitive visits and admissions (3.3 for TBC vs 4.3 for TPM; IRR, 0.77 [95% CI, 0.70 to 0.85]), and primary care physician encounters (232.8 for TBC vs 250.4 for TPM; IRR, 0.93 [95% CI, 0.92 to 0.94]), with no significant difference in visits to urgent care facilities (55.7 for TBC vs 56.2 for TPM; IRR, 0.99 [95% CI, 0.97 to 1.02]) and visits to specialty care physicians (213.5 for TBC vs 217.9 for TPM; IRR, 0.98 [95% CI, 0.97 to 0.99], P >.008). Payments to the delivery systemwere lower in the TBC group vs the TPM group ($3400.62 for TBC vs $3515.71 for TPM; beta, -$115.09 [95% CI, -$199.64 to -$30.54]) and were less than investment costs of the TBC program. CONCLUSIONS AND RELEVANCE Among adults enrolled in an integrated health care system, receipt of primary care at TBC practices compared with TPM practices was associated with higher rates of some measures of quality of care, lower rates for some measures of acute care utilization, and lower actual payments received by the delivery system.	[Reiss-Brennan, Brenda; Brunisholz, Kimberly D.; Dredge, Carter; Briot, Pascal; Wilcox, Adam; Savitz, Lucy; James, Brent] Intermt Healthcare, 36 S State, Salt Lake City, UT 84111 USA; [Briot, Pascal] Inst Driot & Sante, Paris, France; [Grazier, Kyle] Univ Michigan, Ann Arbor, MI 48109 USA	Intermountain Healthcare; Intermountain Medical Center; University of Michigan System; University of Michigan	Reiss-Brennan, B (corresponding author), Intermt Healthcare, 36 S State, Salt Lake City, UT 84111 USA.	brenda.reiss-brennan@imail.org			Intermountain Healthcare's Medical Group; Primary Care Clinical Program; Institute for Healthcare Leadership; Office of Research; Office of Population Health	Intermountain Healthcare's Medical Group; Primary Care Clinical Program; Institute for Healthcare Leadership; Office of Research; Office of Population Health	This research was supported by Intermountain Healthcare's Medical Group, Primary Care Clinical Program, Institute for Healthcare Leadership, Office of Research, and Office of Population Health.	Bayley KB, 2013, MED CARE, V51, pS80, DOI 10.1097/MLR.0b013e31829b1d48; Bodenheimer T, 2011, NEW ENGL J MED, V365, P5, DOI 10.1056/NEJMp1104942; Boult C, 2011, ARCH INTERN MED, V171, P460, DOI 10.1001/archinternmed.2010.540; Collins C., 2010, EVOLVING MODELS BEHA; Dorr DA, 2005, HEALTH SERV RES, V40, P1400, DOI 10.1111/j.1475-6773.2005.00423.x; Friedberg MW, 2014, JAMA-J AM MED ASSOC, V311, P815, DOI 10.1001/jama.2014.353; Ghorob A, 2012, NEW ENGL J MED, V366, P1955, DOI 10.1056/NEJMp1202775; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; James BC, 2011, HEALTH AFFAIR, V30, P1185, DOI 10.1377/hlthaff.2011.0358; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Kessler R, 2014, J AM BOARD FAM MED, V27, P637, DOI 10.3122/jabfm.2014.05.140021; Lewis MW, 2015, P NATL ACAD SCI USA, V112, P6871, DOI 10.1073/pnas.1411261111; Mukamel DB, 2006, GERONTOLOGIST, V46, P227, DOI 10.1093/geront/46.2.227; Osborn R, 2015, HEALTH AFFAIR, V34, P2104, DOI 10.1377/hlthaff.2015.1018; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Reid RJ, 2010, HEALTH AFFAIR, V29, P835, DOI 10.1377/hlthaff.2010.0158; Reiss-Brennan B, 2014, J PRIM CARE COMMUNIT, V5, P55, DOI 10.1177/2150131913508983; Reiss-Brennan B, 2010, J HEALTHC MANAG, V55, P97, DOI 10.1097/00115514-201003000-00006; Rogers E., 2003, DIFFUSION INNOVATION, VFifth; Rosenthal MB, 2013, JAMA INTERN MED, V173, P1907, DOI 10.1001/jamainternmed.2013.10063; Twisk JWR, 2003, APPL LONGITUDINAL DA; Veazie PJ, 2006, HEALTH SERV RES, V41, P804, DOI 10.1111/j.1475-6773.2006.00512.x; Werner RM, 2013, MED CARE, V51, P487, DOI 10.1097/MLR.0b013e31828d4d29	23	145	147	1	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2016	316	8					826	834		10.1001/jama.2016.11232	http://dx.doi.org/10.1001/jama.2016.11232			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT8JL	27552616	Bronze			2022-12-28	WOS:000381736200013
J	Quinlivan, JA				Quinlivan, Julie A.			Magic dolls: no quick fix for teenage pregnancy	LANCET			English	Editorial Material							BIRTH		[Quinlivan, Julie A.] Univ Notre Dame Australia, Inst Hlth Res, POB 1225, Fremantle, WA 6959, Australia	University of Notre Dame Australia	Quinlivan, JA (corresponding author), Univ Notre Dame Australia, Inst Hlth Res, POB 1225, Fremantle, WA 6959, Australia.	julie.quinlivan@nd.edu.au		Quinlivan, Julie/0000-0003-4706-2412				Brinkman SA, 2016, LANCET; Chisholm JS, 2005, HUM NATURE-INT BIOS, V16, P233, DOI 10.1007/s12110-005-1009-0; Condon JT, 2001, J ADOLESCENCE, V24, P729, DOI 10.1006/jado.2001.0439; Corkindale CJ, 2009, J ADOLESCENCE, V32, P995, DOI 10.1016/j.adolescence.2008.08.008; GERONIMUS AT, 1992, Q J ECON, V107, P1187, DOI 10.2307/2118385; GERONIMUS AT, 1993, AM J EPIDEMIOL, V137, P213, DOI 10.1093/oxfordjournals.aje.a116662; Herrman JW, 2011, JOGNN-J OBST GYN NEO, V40, P322, DOI 10.1111/j.1552-6909.2011.01248.x; Hofferth SL, 1987, NATL RES COUNCIL US, VII; Holtz VJ, 1996, CHIC POLICY REV, V64, P55; Oringanje C, 2016, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD005215.PUB3; Quinlivan JA, 2005, AUST NZ J PSYCHIAT, V39, P915, DOI 10.1080/j.1440-1614.2005.01664.x; Quinlivan JA, 2004, BJOG-INT J OBSTET GY, V111, P571, DOI 10.1111/j.1471-0528.2004.00146.x	12	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 5	2016	388	10057					2214	2215		10.1016/S0140-6736(16)31411-8	http://dx.doi.org/10.1016/S0140-6736(16)31411-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EA8MO	27570176				2022-12-28	WOS:000386889300007
J	Hirsch, JA; Chandra, RV				Hirsch, Joshua A.; Chandra, Ronil V.			Resurrection of evidence for vertebroplasty?	LANCET			English	Editorial Material							NEUROINTERVENTIONAL SURGERY; PERCUTANEOUS VERTEBROPLASTY; VERTEBRAL AUGMENTATION; RANDOMIZED-TRIAL; FRACTURES; SOCIETY; SPINE		[Hirsch, Joshua A.] Massachusetts Gen Hosp, Neuroendovasc Program, Boston, MA 02114 USA; [Hirsch, Joshua A.] Massachusetts Gen Hosp, NeuroIntervent Spine Serv, Boston, MA 02114 USA; [Hirsch, Joshua A.] Harvard Med Sch, Boston, MA 02115 USA; [Chandra, Ronil V.] Monash Hlth, Monash Imaging, Diagnost & Intervent Neuroradiol, Melbourne, Vic, Australia; [Chandra, Ronil V.] Monash Univ, Dept Med, Melbourne, Vic, Australia; [Chandra, Ronil V.] Monash Univ, Dept Surg, Melbourne, Vic, Australia	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Monash University; Monash University	Hirsch, JA (corresponding author), Massachusetts Gen Hosp, Neuroendovasc Program, Boston, MA 02114 USA.; Hirsch, JA (corresponding author), Massachusetts Gen Hosp, NeuroIntervent Spine Serv, Boston, MA 02114 USA.; Hirsch, JA (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	jahirsch@mgh.harvard.edu	Chandra, Ronil/GPK-0357-2022	Chandra, Ronil/0000-0001-7555-2297				Barr JD, 2014, J VASC INTERV RADIOL, V25, P171, DOI 10.1016/j.jvir.2013.10.001; Blasco J, 2012, J BONE MINER RES, V27, P1159, DOI 10.1002/jbmr.1564; Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429; Chandra RV, 2014, J NEUROINTERV SURG, V6, DOI 10.1136/neurintsurg-2013-011012; Clark W, 2016, LANCET; Farrokhi MR, 2011, J NEUROSURG-SPINE, V14, P561, DOI 10.3171/2010.12.SPINE10286; Hochmuth K, 2006, EUR RADIOL, V16, P998, DOI 10.1007/s00330-005-0067-3; Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563; Kaufmann TJ, 2006, AM J NEURORADIOL, V27, P1933; Klazen CAH, 2010, LANCET, V376, P1085, DOI 10.1016/S0140-6736(10)60954-3; Manchikanti L, 2013, J NEUROINTERV SURG, V5, P467, DOI 10.1136/neurintsurg-2012-010337; Medical Services Advisory Committee, 2011, 271 MED SERV ADV COM; The National Institute for Health and Clinical Excellence, 2013, NICE TECHN APPR GUID; Wilson DJ, 2011, EUR RADIOL, V21, P1772, DOI 10.1007/s00330-011-2115-5	14	10	10	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2016	388	10052					1356	1357		10.1016/S0140-6736(16)31356-3	http://dx.doi.org/10.1016/S0140-6736(16)31356-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DX5FD	27544375				2022-12-28	WOS:000384404300009
J	Shihoya, W; Nishizawa, T; Okuta, A; Tani, K; Dohmae, N; Fujiyoshi, Y; Nureki, O; Doi, T				Shihoya, Wataru; Nishizawa, Tomohiro; Okuta, Akiko; Tani, Kazutoshi; Dohmae, Naoshi; Fujiyoshi, Yoshinori; Nureki, Osamu; Doi, Tomoko			Activation mechanism of endothelin ETB receptor by endothelin-1	NATURE			English	Article							G-PROTEIN; CRYSTAL-STRUCTURE; B RECEPTOR; PEPTIDE; BINDING; THERMOSTABILIZATION; PHARMACOLOGY; SELECTIVITY; ANTAGONISTS; AFFINITY	Endothelin, a 21-amino-acid peptide, participates in various physiological processes, such as regulation of vascular tone, humoral homeostasis, neural crest cell development and neurotransmission. Endothelin and its G-protein-coupled receptor are involved in the development of various diseases, such as pulmonary arterial hypertension, and thus are important therapeutic targets. Here we report crystal structures of human endothelin type B receptor in the ligand-free form and in complex with the endogenous agonist endothelin-1. The structures and mutation analysis reveal the mechanism for the isopeptide selectivity between endothelin-1 and -3. Transmembrane helices 1, 2, 6 and 7 move and envelop the entire endothelin peptide, in a virtually irreversible manner. The agonist-induced conformational changes are propagated to the receptor core and the cytoplasmic G-protein coupling interface, and probably induce conformational flexibility in TM6. A comparison with the M2 muscarinic receptor suggests a shared mechanism for signal transduction in class A G-protein-coupled receptors.	[Shihoya, Wataru; Fujiyoshi, Yoshinori] Nagoya Univ, Grad Sch Pharmaceut Sci, Dept Basic Med Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Shihoya, Wataru; Okuta, Akiko; Tani, Kazutoshi; Fujiyoshi, Yoshinori] Nagoya Univ, Cellular & Struct Physiol Inst, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Shihoya, Wataru; Nishizawa, Tomohiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan; [Nishizawa, Tomohiro] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan; [Dohmae, Naoshi] RIKEN Ctr Sustainable Resource Sci, Biomol Characterizat Unit, Wako, Saitama 3510198, Japan; [Doi, Tomoko] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan	Nagoya University; Nagoya University; University of Tokyo; Japan Science & Technology Agency (JST); RIKEN; Kyoto University	Nureki, O (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan.; Doi, T (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan.	nureki@bs.s.u-tokyo.ac.jp; doi@mb.biophys.kyoto-u.ac.jp	Dohmae, Naoshi/C-2040-2011; NUREKI, OSAMU/G-4960-2014; Tani, Kazutoshi/B-3705-2008	Dohmae, Naoshi/0000-0002-5242-9410; Tani, Kazutoshi/0000-0003-4835-154X	Japan Society for the Promotion of Science KAKENHI [15J09780, 22227004, 24227004, 25650019, 26440024, 26640102]; Core Research for Evolutional Science and Technology Program; Platform for Drug Discovery, Information, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan New Energy and Industrial Technology Development Organization (NEDO); Japan Agency for Medical Research and Development (AMED); National Institute of Biomedical Innovation; Grants-in-Aid for Scientific Research [26440024, 16H06294] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Core Research for Evolutional Science and Technology Program(Core Research for Evolutional Science and Technology (CREST)); Platform for Drug Discovery, Information, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Nishimura and K. Kumazaki for discussions, Y. Oomae and K. Yamaguchi for ET<INF>B</INF> mutant preparations, the beamline staff at BL32XU of SPring-8 (Hyogo, Japan) for technical help during data collection, and T. Suzuki for the mass spectrometry. This work was supported by Japan Society for the Promotion of Science KAKENHI grant numbers 15J09780, 22227004, 24227004, 25650019, 26440024, and 26640102; the Core Research for Evolutional Science and Technology Program; Platform for Drug Discovery, Information, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; the Japan New Energy and Industrial Technology Development Organization (NEDO), the Japan Agency for Medical Research and Development (AMED) and the National Institute of Biomedical Innovation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ANDERSEN NH, 1992, BIOCHEMISTRY-US, V31, P1280, DOI 10.1021/bi00120a003; AUMELAS A, 1995, BIOCHEMISTRY-US, V34, P4546, DOI 10.1021/bi00014a007; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Barton M, 2008, CAN J PHYSIOL PHARM, V86, P485, DOI 10.1139/Y08-059; Bremnes T, 2000, J BIOL CHEM, V275, P17596, DOI 10.1074/jbc.M000142200; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chen JM, 2013, PROTEIN SCI, V22, P510, DOI 10.1002/pro.2230; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CLOZEL M, 1993, NATURE, V365, P759, DOI 10.1038/365759a0; Davenport AP, 2002, PHARMACOL REV, V54, P219, DOI 10.1124/pr.54.2.219; De Mey JG, 2009, MOL CELL PHARM, V1, P246; Desmarets J, 1996, BIOCHEMISTRY-US, V35, P14868, DOI 10.1021/bi961238w; Doi T, 1997, EUR J BIOCHEM, V248, P139, DOI 10.1111/j.1432-1033.1997.00139.x; Doi T, 1999, BIOCHEMISTRY-US, V38, P3090, DOI 10.1021/bi981919m; ELSHOURBAGY NA, 1992, MOL PHARMACOL, V41, P465; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERGUL A, 1995, CIRC RES, V77, P1087, DOI 10.1161/01.RES.77.6.1087; GALANTINO M, 1995, PEPTIDE RES, V8, P154; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; HilalDandan R, 1997, J PHARMACOL EXP THER, V281, P267; Huang WJ, 2015, NATURE, V524, P315, DOI 10.1038/nature14886; JANES RW, 1994, NAT STRUCT BIOL, V1, P311, DOI 10.1038/nsb0594-311; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; Kedzierski RM, 2001, ANNU REV PHARMACOL, V41, P851, DOI 10.1146/annurev.pharmtox.41.1.851; KIKUCHI T, 1993, J MED CHEM, V36, P4087, DOI 10.1021/jm00077a013; Kohan DE, 2011, PHYSIOL REV, V91, P1, DOI 10.1152/physrev.00060.2009; Krumm BE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8895; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Lattig J, 2009, J PEPT SCI, V15, P479, DOI 10.1002/psc.1146; LEE JA, 1994, BIOCHEMISTRY-US, V33, P14543, DOI 10.1021/bi00252a022; Maguire JJ, 2014, BRIT J PHARMACOL, V171, P5555, DOI 10.1111/bph.12874; Maguire JJ, 2012, LIFE SCI, V91, P544, DOI 10.1016/j.lfs.2012.03.021; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; NAKAJIMA K, 1989, BIOCHEM BIOPH RES CO, V163, P424, DOI 10.1016/0006-291X(89)92153-0; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Okamoto Y, 1997, J BIOL CHEM, V272, P21589, DOI 10.1074/jbc.272.34.21589; Okuta A, 2016, J MOL BIOL, V428, P2265, DOI 10.1016/j.jmb.2016.03.024; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Remuzzi G, 2002, NAT REV DRUG DISCOV, V1, P986, DOI 10.1038/nrd962; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rosano L, 2013, NAT REV CANCER, V13, P637, DOI 10.1038/nrc3546; Rosano L, 2009, P NATL ACAD SCI USA, V106, P2806, DOI 10.1073/pnas.0807158106; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; SAEKI T, 1991, BIOCHEM BIOPH RES CO, V179, P286, DOI 10.1016/0006-291X(91)91367-L; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Sidharta PN, 2011, EUR J CLIN PHARMACOL, V67, P977, DOI 10.1007/s00228-011-1043-2; Sounier R, 2015, NATURE, V524, P375, DOI 10.1038/nature14680; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Takashima H, 2004, J AM CHEM SOC, V126, P4504, DOI 10.1021/ja031637w; TAKASUKA T, 1994, J BIOL CHEM, V269, P7509; TAKASUKA T, 1992, J BIOCHEM-TOKYO, V112, P396, DOI 10.1093/oxfordjournals.jbchem.a123911; Talbodec A, 2000, MOL PHARMACOL, V57, P797, DOI 10.1124/mol.57.4.797; TAM JP, 1994, PEPTIDES, V15, P703, DOI 10.1016/0196-9781(94)90099-X; Thorsen TS, 2014, STRUCTURE, V22, P1657, DOI 10.1016/j.str.2014.08.022; Vatter H, 2006, CARDIOVASC DRUG REV, V24, P63, DOI 10.1111/j.1527-3466.2006.00063.x; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; WADA K, 1990, BIOCHEM BIOPH RES CO, V167, P251, DOI 10.1016/0006-291X(90)91758-K; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	65	99	102	3	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2016	537	7620					363	+		10.1038/nature19319	http://dx.doi.org/10.1038/nature19319			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV7EC	27595334				2022-12-28	WOS:000383098000046
J	Hiley, CT; Le Quesne, J; Santis, G; Sharpe, R; de Castro, DG; Middleton, G; Swanton, C				Hiley, Crispin T.; Le Quesne, John; Santis, George; Sharpe, Rowena; de Castro, David Gonzalez; Middleton, Gary; Swanton, Charles			Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease	LANCET			English	Article							CIRCULATING TUMOR-CELLS; TRANSBRONCHIAL NEEDLE ASPIRATION; PREVIOUSLY TREATED PATIENTS; FACTOR RECEPTOR MUTATIONS; EML4-ALK FUSION GENE; PHASE-III; TYROSINE KINASE; INTRATUMOR HETEROGENEITY; ACQUIRED-RESISTANCE; PD-L1 EXPRESSION	Lung cancer diagnostics have progressed greatly in the previous decade. Development of molecular testing to identify an increasing number of potentially clinically actionable genetic variants, using smaller samples obtained via minimally invasive techniques, is a huge challenge. Tumour heterogeneity and cancer evolution in response to therapy means that repeat biopsies or circulating biomarkers are likely to be increasingly useful to adapt treatment as resistance develops. We highlight some of the current challenges faced in clinical practice for molecular testing of EGFR, ALK, and new biomarkers such as PDL1. Implementation of next generation sequencing platforms for molecular diagnostics in non-small-cell lung cancer is increasingly common, allowing testing of multiple genetic variants from a single sample. The use of next generation sequencing to recruit for molecularly stratified clinical trials is discussed in the context of the UK Stratified Medicine Programme and The UK National Lung Matrix Trial.	[Hiley, Crispin T.; Swanton, Charles] Francis Crick Inst, Translat Canc Therapeut Lab, London, England; [Hiley, Crispin T.] Kings Coll London, Div Canc Studies, London, England; [Le Quesne, John] Univ Leicester, Dept Canc Studies, Leicester, Leics, England; [Santis, George] Kings Coll London, Dept Resp Med & Allergy, London WC2R 2LS, England; [Sharpe, Rowena] Canc Res UK, London, England; [de Castro, David Gonzalez] Royal Marsden Hosp, Ctr Mol Pathol, Sutton, Surrey, England; [de Castro, David Gonzalez] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland; [Middleton, Gary] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England; [Middleton, Gary] Queen Elizabeth Hosp, Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Swanton, Charles] UCL Canc Inst, CRUK Lung Canc Ctr Excellence, London, England	Francis Crick Institute; University of London; King's College London; University of Leicester; University of London; King's College London; Cancer Research UK; Royal Marsden NHS Foundation Trust; Queens University Belfast; University of Birmingham; University of Birmingham; University of London; University College London	Swanton, C (corresponding author), Francis Crick Inst, London WC2A 3LY, England.	charles.swanton@crick.ac.uk		Hiley, Crispin/0000-0002-5869-0775; Le Quesne, John/0000-0003-3552-7446; Middleton, Gary/0000-0001-5695-3474; Swanton, Charles/0000-0002-4299-3018	Roche; Pfizer; Celgene; Boehringer Ingelheim; Novartis; Glaxo Smithkline; Eli Lilly; Francis Crick Institute from Cancer Research UK [FC001169]; UK Medical Research Council [FC001169, MR/FC001169/1]; Wellcome Trust [FC001169]; Cancer Research UK (TRACERx); CRUK Lung Cancer Centre of Excellence, Stand Up 2 Cancer (SU2C); Rosetrees Trust; NovoNordisk Foundation [16584]; Prostate Cancer Foundation; Breast Cancer Research Foundation; European Research Council (THESEUS); National Institute for Health Research; University College London Hospitals Biomedical Research Centre; Cancer Research UK University College London Experimental Cancer Medicine Centre; MRC [MC_UP_1203/1] Funding Source: UKRI; Cancer Research UK [20466] Funding Source: researchfish; Medical Research Council [MC_UP_1203/1] Funding Source: researchfish; National Institute for Health Research [CL-2015-17-002] Funding Source: researchfish; Novo Nordisk Fonden [NNF15OC0016584] Funding Source: researchfish	Roche(Roche Holding); Pfizer(Pfizer); Celgene(Bristol-Myers SquibbCelgene Corporation); Boehringer Ingelheim(Boehringer Ingelheim); Novartis(Novartis); Glaxo Smithkline(GlaxoSmithKline); Eli Lilly(Eli Lilly); Francis Crick Institute from Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK (TRACERx); CRUK Lung Cancer Centre of Excellence, Stand Up 2 Cancer (SU2C); Rosetrees Trust(Rosetrees Trust); NovoNordisk Foundation(Novo Nordisk FoundationNovocure Limited); Prostate Cancer Foundation; Breast Cancer Research Foundation; European Research Council (THESEUS)(European Research Council (ERC)); National Institute for Health Research(National Institute for Health Research (NIHR)); University College London Hospitals Biomedical Research Centre(General Electric); Cancer Research UK University College London Experimental Cancer Medicine Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation)	CS declares advisory board or speaker fees on laboratory research over the last 3 years for Roche, Pfizer, Celgene, Boehringer Ingelheim, Novartis, Glaxo Smithkline, and Eli Lilly. CS sits on the scientific advisory board and holds stock options for Epic Biosciences and Grail and is a founder of Achilles Therapeutics. CS is Royal Society Napier Research Professor. This work was supported by the Francis Crick Institute which receives its core funding from Cancer Research UK (FC001169), the UK Medical Research Council (FC001169), and the Wellcome Trust (FC001169); by the UK Medical Research Council (grant reference MR/FC001169/1); CS is funded by Cancer Research UK (TRACERx), the CRUK Lung Cancer Centre of Excellence, Stand Up 2 Cancer (SU2C), the Rosetrees Trust, NovoNordisk Foundation (ID 16584), the Prostate Cancer Foundation, the Breast Cancer Research Foundation, the European Research Council (THESEUS) and Support was provided to CS by the National Institute for Health Research, the University College London Hospitals Biomedical Research Centre, and the Cancer Research UK University College London Experimental Cancer Medicine Centre.	Adler IA, 1912, PRIMARY MALIGNANT GR; Akbay EA, 2013, CANCER DISCOV, V3, P1355, DOI 10.1158/2159-8290.CD-13-0310; Alix-Panabieres C, 2016, CANCER DISCOV, V6, P479, DOI 10.1158/2159-8290.CD-15-1483; Alix-Panabieres C, 2014, NAT REV CANCER, V14, P623, DOI 10.1038/nrc3820; [Anonymous], 2015, LUNG CANC KEY STAT; Audit NLC, 2015, AUD NLC NLCA ANN REP; Barlesi F, 2016, LANCET, V387, P1415, DOI 10.1016/S0140-6736(16)00004-0; Bell DW, 2005, J CLIN ONCOL, V23, P8081, DOI 10.1200/JCO.2005.02.7078; Biankin AV, 2015, NATURE, V526, P361, DOI 10.1038/nature15819; Birkbak NJ, 2015, J CLIN ONCOL, V33, P3681, DOI 10.1200/JCO.2015.63.2976; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Brown SD, 2014, GENOME RES, V24, P743, DOI 10.1101/gr.165985.113; Cai WJ, 2015, J CLIN ONCOL, V33, P3701, DOI 10.1200/JCO.2014.58.8293; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Ciuleanu T, 2009, LANCET, V374, P1432, DOI 10.1016/S0140-6736(09)61497-5; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Davare MA, 2015, BIOL CELL, V107, P111, DOI 10.1111/boc.201400096; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Dienstmann R, 2015, CANCER DISCOV, V5, P118, DOI 10.1158/2159-8290.CD-14-1118; Doebele RC, 2012, CLIN CANCER RES, V18, P1472, DOI 10.1158/1078-0432.CCR-11-2906; Drilon A, 2015, CLIN CANCER RES, V21, P3631, DOI 10.1158/1078-0432.CCR-14-2683; Favero F, 2015, ANN ONCOL, V26, P64, DOI 10.1093/annonc/mdu479; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Fisher R, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0433-z; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hata AN, 2016, NAT MED, V22, P262, DOI 10.1038/nm.4040; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hiley C, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0453-8; Hodgkinson CL, 2014, NAT MED, V20, P897, DOI 10.1038/nm.3600; Hou JM, 2011, AM J PATHOL, V178, P989, DOI 10.1016/j.ajpath.2010.12.003; Hou LK, 2015, J CLIN ONCOL, V33; Inukai M, 2006, CANCER RES, V66, P7854, DOI 10.1158/0008-5472.CAN-06-1951; Iyevleva AG, 2015, CANCER LETT, V362, P116, DOI 10.1016/j.canlet.2015.03.028; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Jamal-Hanjani M, 2016, ANN ONCOL, V27, P862, DOI 10.1093/annonc/mdw037; Jamal-Hanjani M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001906; Jang JS, 2016, J THORAC ONCOL, V11, P1891, DOI 10.1016/j.jtho.2016.06.001; Juric D, 2015, NATURE, V518, P240, DOI 10.1038/nature13948; Kanagal-Shamanna R, 2014, MODERN PATHOL, V27, P314, DOI 10.1038/modpathol.2013.122; Katayama R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003316; Kelly K, 2001, J CLIN ONCOL, V19, P3210, DOI 10.1200/JCO.2001.19.13.3210; Kerr KM, 2014, ANN ONCOL, V25, P1681, DOI 10.1093/annonc/mdu145; Kinsey CM, 2014, AM J RESP CRIT CARE, V189, P640, DOI 10.1164/rccm.201311-2007CI; Konig K, 2015, J THORAC ONCOL, V10, P1049, DOI 10.1097/JTO.0000000000000570; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Konishi J, 2004, CLIN CANCER RES, V10, P5094, DOI 10.1158/1078-0432.CCR-04-0428; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lai ZW, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw227; Lindeman NI, 2013, J THORAC ONCOL, V8, P823, DOI 10.1097/JTO.0b013e318290868f; Lohr JG, 2014, NAT BIOTECHNOL, V32, P479, DOI 10.1038/nbt.2892; Lopez-Chavez A, 2015, J CLIN ONCOL, V33, P1000, DOI 10.1200/JCO.2014.58.2007; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maheswaran S, 2008, N ENGL J MED; Masters GA, 2015, J CLIN ONCOL, V33, P3488, DOI 10.1200/JCO.2015.62.1342; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; McLaughlin J, 2016, JAMA ONCOL, V2, P46, DOI 10.1001/jamaoncol.2015.3638; Melchor L, 2014, LEUKEMIA, V28, P1705, DOI 10.1038/leu.2014.13; Middleton G, 2015, ANN ONCOL, V26, P2464, DOI 10.1093/annonc/mdv394; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Nakajima T, 2011, CHEST, V140, P1319, DOI 10.1378/chest.10-3186; Navani N, 2012, AM J RESP CRIT CARE, V185, P1316, DOI 10.1164/rccm.201202-0294OC; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; Oxnard GR, 2014, CLIN CANCER RES, V20, P1698, DOI 10.1158/1078-0432.CCR-13-2482; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Park S, 2009, J THORAC ONCOL, V4, P809, DOI 10.1097/JTO.0b013e3181a94af4; Patel SP, 2015, MOL CANCER THER, V14, P847, DOI 10.1158/1535-7163.MCT-14-0983; Pearson A, 2016, CANCER DISCOV, V6, P838, DOI 10.1158/2159-8290.CD-15-1246; Piotrowska Z, 2015, CANCER DISCOV, V5, P713, DOI 10.1158/2159-8290.CD-15-0399; Pirker Robert, 2010, J Thorac Oncol, V5, P1706, DOI 10.1097/JTO.0b013e3181f1c8de; Qiu T, 2015, SCI REP-UK, V5, DOI 10.1038/srep11317; Reck M, 2014, ANN ONCOL, V25, P27, DOI 10.1093/annonc/mdu199; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; Rivera MP, 2013, CHEST, V143, pE142, DOI 10.1378/chest.12-2353; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Santis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025191; Sasaki T, 2011, CANCER RES, V71, P6051, DOI 10.1158/0008-5472.CAN-11-1340; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Scagliotti GV, 2002, J CLIN ONCOL, V20, P4285, DOI 10.1200/JCO.2002.02.068; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Sequist LV, 2015, NEW ENGL J MED, V372, P1700, DOI 10.1056/NEJMoa1413654; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shaw AT, 2016, NEW ENGL J MED, V374, P54, DOI 10.1056/NEJMoa1508887; Shaw AT, 2014, NEW ENGL J MED, V371, P1963, DOI 10.1056/NEJMoa1406766; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shaw EC, 2012, J CLIN PATHOL, V65, P403, DOI 10.1136/jclinpath-2011-200369; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Su KY, 2012, J CLIN ONCOL, V30, P433, DOI 10.1200/JCO.2011.38.3224; Swanton C, 2016, NEW ENGL J MED, V374, P1864, DOI 10.1056/NEJMra1504688; Takeuchi K, 2016, ANN ONCOL, V27, P185, DOI 10.1093/annonc/mdv501; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Terry J, 2010, AM J SURG PATHOL, V34, P1805, DOI 10.1097/PAS.0b013e3181f7dae3; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Thress KS, 2015, LUNG CANCER, V90, P509, DOI 10.1016/j.lungcan.2015.10.004; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Tsao MS, 2013, IASLC ATLAS ALK TEST; Vaishnavi A, 2013, NAT MED, V19, P1469, DOI 10.1038/nm.3352; van Eijk R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017791; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Velcheti V, 2014, LAB INVEST, V94, P107, DOI 10.1038/labinvest.2013.130; Williams C, 1999, AM J PATHOL, V155, P1467, DOI 10.1016/S0002-9440(10)65461-2; Wong SQ, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-23; Yang JCH, 2015, LANCET ONCOL, V16, P830, DOI 10.1016/S1470-2045(15)00026-1; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317; Yoshida A, 2011, AM J SURG PATHOL, V35, P1226, DOI 10.1097/PAS.0b013e3182233e06; Zhang C, 2014, AM J CLIN PATHOL, V142, P320, DOI 10.1309/AJCPGA0IUA8BHQEZ; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930; Zhao WJ, 2016, LUNG CANCER, V94, P22, DOI 10.1016/j.lungcan.2016.01.011	132	109	111	1	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2016	388	10048					1002	1011		10.1016/S0140-6736(16)31340-X	http://dx.doi.org/10.1016/S0140-6736(16)31340-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU9GL	27598680	Green Accepted, Green Submitted			2022-12-28	WOS:000382524400030
J	Bock, C				Bock, Christoph			Preserve personal freedom in networked societies	NATURE			English	Editorial Material									[Bock, Christoph] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences	Bock, C (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria.	cbock@cemm.oeaw.ac.at	Bock, Christoph/AAE-7618-2019	Bock, Christoph/0000-0001-6091-3088					0	2	2	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					9	9		10.1038/537009a	http://dx.doi.org/10.1038/537009a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU7XC	27582189	Bronze			2022-12-28	WOS:000382426900003
J	Mann, J; Morenga, LT; McLean, R; Swinburn, B; Mhurchu, CN; Jackson, R; Kennedy, J; Beaglehole, R				Mann, Jim; Morenga, Lisa Te; McLean, Rachael; Swinburn, Boyd; Mhurchu, Cliona Ni; Jackson, Rod; Kennedy, Jonathan; Beaglehole, Robert			Dietary guidelines on trial: the charges are not evidence based	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; FATTY-ACIDS; LIFE-STYLE; METAANALYSIS; PREVENTION; MANAGEMENT; OBESITY; RISK		[Mann, Jim; Morenga, Lisa Te; McLean, Rachael] Univ Otago, Dept Human Nutr, Dunedin, New Zealand; [Mann, Jim] Univ Otago, Dept Med, Dunedin, New Zealand; [McLean, Rachael] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand; [Mann, Jim; Morenga, Lisa Te] Univ Otago, Riddet Inst, Dunedin, New Zealand; [Mhurchu, Cliona Ni] Univ Auckland, Natl Inst Hlth Innovat, Auckland, New Zealand; [Swinburn, Boyd; Jackson, Rod] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand; [Swinburn, Boyd] Deakin Univ, Ctr Populat Hlth Res, Melbourne, Vic, Australia; [Kennedy, Jonathan] Univ Otago, Dept Primary Hlth Care & Gen Practice, Wellington, New Zealand; [Beaglehole, Robert] Univ Auckland, Auckland, New Zealand; [Mann, Jim; Morenga, Lisa Te; Mhurchu, Cliona Ni; Jackson, Rod] Univ Otago, Dept Med, Healthier Lives Natl Sci Challenge, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago; University of Otago; University of Auckland; University of Auckland; Deakin University; University of Otago; University of Auckland; University of Otago	Mann, J (corresponding author), Univ Otago, Dept Human Nutr, Dunedin, New Zealand.; Mann, J (corresponding author), Univ Otago, Dept Med, Dunedin, New Zealand.; Mann, J (corresponding author), Univ Otago, Riddet Inst, Dunedin, New Zealand.; Mann, J (corresponding author), Univ Otago, Dept Med, Healthier Lives Natl Sci Challenge, Dunedin, New Zealand.	jim.mann@otago.ac.nz	McLean, Rachael/AAF-7596-2019; Te Morenga, Lisa/C-4459-2011	McLean, Rachael/0000-0002-0005-328X; Ni Mhurchu, Cliona/0000-0002-1144-9167; Jackson, Rod/0000-0001-5914-6934; Te Morenga, Lisa/0000-0003-3526-0091				Bloomfield HE, 2016, ANN INTERN MED, V165, P491, DOI 10.7326/M16-0361; Cleland V, 2013, OBESITY, V21, pE448, DOI 10.1002/oby.20172; de Souza RJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3978; Dietary Guidelines Advisory Committee to the US Department of Health and Human Services and the US Department of Agriculture, 2015, SCI REP 2015 DIET D; Guasch-Ferre M, 2015, AM J CLIN NUTR, V102, P1563, DOI 10.3945/ajcn.115.116046; Hession M, 2009, OBES REV, V10, P36, DOI 10.1111/j.1467-789X.2008.00518.x; Hooper L, 2015, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD011737, 10.1002/14651858.CD011583.pub2]; Hooper L, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7666; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; Ley SH, 2014, LANCET, V383, P1999, DOI 10.1016/S0140-6736(14)60613-9; Mann J, 2014, LANCET, V384, P1479, DOI 10.1016/S0140-6736(14)61413-6; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Michas G, 2014, ATHEROSCLEROSIS, V234, P320, DOI 10.1016/j.atherosclerosis.2014.03.013; Mortality Trends, 2014, TRENDS NAT MORT RAT; Nordic Council of Ministers, 2013, NORD NUTR REC 2012 1; O'Flaherty M, 2013, HEART, V99, P159, DOI 10.1136/heartjnl-2012-302300; Tobias DK, 2015, LANCET DIABETES ENDO, V3, P968, DOI 10.1016/S2213-8587(15)00367-8; WHO, 2015, SUG INT AD CHILDR; [WHO Expert Consultation Joint Food and Agriculture Organization of the United Nations], 2008, WHO EXP CONS FATS FA; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	20	5	5	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 27	2016	388	10047					851	853		10.1016/S0140-6736(16)31278-8	http://dx.doi.org/10.1016/S0140-6736(16)31278-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU0RI	27597453				2022-12-28	WOS:000381911800009
J	Clever, D; Roychoudhuri, R; Constantinides, MG; Askenase, MH; Sukumar, M; Klebanoff, CA; Eil, RL; Hickman, HD; Yu, ZY; Pan, JH; Palmer, DC; Phan, AT; Goulding, J; Gattinoni, L; Goldrath, AW; Belkaid, Y; Restifo, NP				Clever, David; Roychoudhuri, Rahul; Constantinides, Michael G.; Askenase, Michael H.; Sukumar, Madhusudhanan; Klebanoff, Christopher A.; Eil, Robert L.; Hickman, Heather D.; Yu, Zhiya; Pan, Jenny H.; Palmer, Douglas C.; Phan, Anthony T.; Goulding, John; Gattinoni, Luca; Goldrath, Ananda W.; Belkaid, Yasmine; Restifo, Nicholas P.			Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche	CELL			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; DENDRITIC CELLS; METABOLIC CHECKPOINT; EXPRESSION; INDUCTION; DIFFERENTIATION; HOMEOSTASIS; RESPONSES; SUBSETS; MEMORY	Cancer cells must evade immune responses at distant sites to establish metastases. The lung is a frequent site for metastasis. We hypothesized that lung-specific immunoregulatory mechanisms create an immunologically permissive environment for tumor colonization. We found that T-cell-intrinsic expression of the oxygen-sensing prolyl-hydroxylase (PHD) proteins is required to maintain local tolerance against innocuous antigens in the lung but powerfully licenses colonization by circulating tumor cells. PHD proteins limit pulmonary type helper (Th)-1 responses, promote CD4(+)-regulatory T (Treg) cell induction, and restrain CD8(+) T cell effector function. Tumor colonization is accompanied by PHD-protein-dependent induction of pulmonary Treg cells and suppression of IFN-g-dependent tumor clearance. T-cell-intrinsic deletion or pharmacological inhibition of PHD proteins limits tumor colonization of the lung and improves the efficacy of adoptive cell transfer immunotherapy. Collectively, PHD proteins function in T cells to coordinate distinct immunoregulatory programs within the lung that are permissive to cancer metastasis.	[Clever, David; Roychoudhuri, Rahul; Sukumar, Madhusudhanan; Klebanoff, Christopher A.; Eil, Robert L.; Yu, Zhiya; Pan, Jenny H.; Palmer, Douglas C.; Restifo, Nicholas P.] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA; [Clever, David] Ohio State Univ, Coll Med, Med Scientist Training Program, Columbus, OH 43210 USA; [Roychoudhuri, Rahul] Babraham Inst, Lab Lymphocyte Signaling & Dev, Cambridge CB22 3AT, England; [Constantinides, Michael G.; Askenase, Michael H.; Belkaid, Yasmine] NIAID, Mucosal Immunol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Belkaid, Yasmine] NIAID, NIAID Microbiome Program Initiat, NIH, Bethesda, MD 20892 USA; [Klebanoff, Christopher A.] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10065 USA; [Klebanoff, Christopher A.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Hickman, Heather D.] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA; [Phan, Anthony T.; Goulding, John; Goldrath, Ananda W.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Gattinoni, Luca] NCI, Expt Transplantat Immunol Branch, NIH, Bethesda, MD 20892 USA; [Restifo, Nicholas P.] NCI, Ctr Cell Based Therapy, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Ohio; Ohio State University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Clever, D; Restifo, NP (corresponding author), NCI, Surg Branch, NIH, Bethesda, MD 20892 USA.; Clever, D (corresponding author), Ohio State Univ, Coll Med, Med Scientist Training Program, Columbus, OH 43210 USA.; Restifo, NP (corresponding author), NCI, Ctr Cell Based Therapy, NIH, Bethesda, MD 20892 USA.	david.clever@osumc.edu; restifo@nih.gov	Restifo, Nicholas Phillip/M-6549-2019; Restifo, Nicholas Phillip/Z-1614-2019; Gattinoni, Luca/A-2281-2008; Roychoudhuri, Rahul/A-7442-2010; Palmer, Douglas/B-9454-2008	Gattinoni, Luca/0000-0003-2239-3282; Roychoudhuri, Rahul/0000-0002-5392-1853; Hickman, Heather/0000-0003-4168-4894; Belkaid, Yasmine/0000-0001-9962-3571; Restifo, Nicholas P./0000-0003-4229-4580; Constantinides, Michael/0000-0003-4770-7751; Clever, David/0000-0002-9137-8177; Klebanoff, Christopher/0000-0001-9645-3896; Palmer, Douglas/0000-0001-5018-5734; Goldrath, Ananda/0000-0002-5900-508X; Phan, Anthony/0000-0003-2935-6070	NCI; NIAID; Wellcome Trust/Royal Society [105663/Z/14/Z]; UK Biotechnology and Biological Sciences Research Council [BB/N007794/1]; Cancer Research Institute; BBSRC [BBS/E/B/000C0409, BB/N007794/1, 1642652, BBS/E/B/000C0407] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0407, BB/N007794/1, BBS/E/B/000C0409] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [ZIABC010763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072117, R01AI096852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust/Royal Society; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research Institute; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Intramural Research Programs of the NCI and NIAID and by charitable gifts from Li Jinyuan and the Tiens Charitable Foundation and the Milstein Family Foundation. R.R. was supported by the Wellcome Trust/Royal Society (grant 105663/Z/14/Z) and the UK Biotechnology and Biological Sciences Research Council (grant BB/N007794/1). M.G.C. is a Cancer Research Institute Irvington Fellow supported by the Cancer Research Institute. We thank G.H. Fong for providing Egln1-3<SUP>fl/fl</SUP> mice, D. Haines for pathologic analysis of H&E-stained tissues, R. Johnson, A. Palazon, and P. Tyrakis for technical advice.	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Doedens AL, 2010, CANCER RES, V70, P7465, DOI 10.1158/0008-5472.CAN-10-1439; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Koch MA, 2012, IMMUNITY, V37, P501, DOI 10.1016/j.immuni.2012.05.031; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393; Massague J, 2016, NATURE, V529, P298, DOI 10.1038/nature17038; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Molinero LL, 2011, J IMMUNOL, V186, P4609, DOI 10.4049/jimmunol.1002361; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Pardoll DM, 1998, CURR OPIN IMMUNOL, V10, P588, DOI 10.1016/S0952-7915(98)80228-8; Ryan HE, 2000, CANCER RES, V60, P4010; SAKAGUCHI S, 1985, J EXP MED, V161, P72, DOI 10.1084/jem.161.1.72; Semenza GL, 2010, WIRES SYST BIOL MED, V2, P336, DOI 10.1002/wsbm.69; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Strickland DH, 2006, J EXP MED, V203, P2649, DOI 10.1084/jem.20060155; Stumbles PA, 1998, J EXP MED, V188, P2019, DOI 10.1084/jem.188.11.2019; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Wikstrom ME, 2007, IMMUNOL CELL BIOL, V85, P182, DOI 10.1038/sj.icb.7100039; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822	50	153	161	0	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1117	+		10.1016/j.cell.2016.07.032	http://dx.doi.org/10.1016/j.cell.2016.07.032			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27565342	Green Accepted, Bronze			2022-12-28	WOS:000382259500011
J	Croce, CM				Croce, Carlo M.			Alfred G. Knudson (1922-2016)	NATURE			English	Biographical-Item									[Croce, Carlo M.] Ohio State Univ, Dept Canc Biol & Genet, Columbus, OH 43210 USA; [Croce, Carlo M.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA	University System of Ohio; Ohio State University; The Wistar Institute	Croce, CM (corresponding author), Ohio State Univ, Dept Canc Biol & Genet, Columbus, OH 43210 USA.; Croce, CM (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	carlo.croce@osumc.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647					0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					397	397		10.1038/536397a	http://dx.doi.org/10.1038/536397a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0YL	27558057	Bronze			2022-12-28	WOS:000382646600025
J	McGhee, K				McGhee, Karen			AUSTRALIA	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					S18	+		10.1038/536S18a	http://dx.doi.org/10.1038/536S18a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV0YL	27557157	Bronze			2022-12-28	WOS:000382646600005
J	Zastrow, M				Zastrow, Mark			SOUTH KOREA	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					S22	S22		10.1038/536S22a	http://dx.doi.org/10.1038/536S22a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV0YL	27557159	Bronze			2022-12-28	WOS:000382646600006
J	Mahajan, P; Kuppermann, N; Mejias, A; Suarez, N; Chaussabel, D; Casper, TC; Smith, B; Alpern, ER; Anders, J; Atabaki, SM; Bennett, JE; Blumberg, S; Bonsu, B; Borgialli, D; Brayer, A; Browne, L; Cohen, DM; Crain, EF; Cruz, AT; Dayan, PS; Gattu, R; Greenberg, R; Hoyle, JD; Jaffe, DM; Levine, DA; Lillis, K; Linakis, JG; Muenzer, J; Nigrovic, LE; Powell, EC; Rogers, AJ; Roosevelt, G; Ruddy, RM; Saunders, M; Tunik, MG; Tzimenatos, L; Vitale, M; Dean, JM; Ramilo, O				Mahajan, Prashant; Kuppermann, Nathan; Mejias, Asuncion; Suarez, Nicolas; Chaussabel, Damien; Casper, T. Charles; Smith, Bennett; Alpern, Elizabeth R.; Anders, Jennifer; Atabaki, Shireen M.; Bennett, Jonathan E.; Blumberg, Stephen; Bonsu, Bema; Borgialli, Dominic; Brayer, Anne; Browne, Lorin; Cohen, Daniel M.; Crain, Ellen F.; Cruz, Andrea T.; Dayan, Peter S.; Gattu, Rajender; Greenberg, Richard; Hoyle, John D., Jr.; Jaffe, David M.; Levine, Deborah A.; Lillis, Kathleen; Linakis, James G.; Muenzer, Jared; Nigrovic, Lise E.; Powell, Elizabeth C.; Rogers, Alexander J.; Roosevelt, Genie; Ruddy, Richard M.; Saunders, Mary; Tunik, Michael G.; Tzimenatos, Leah; Vitale, Melissa; Dean, J. Michael; Ramilo, Octavio		PECARN	Association of RNA Biosignatures With Bacterial Infections in Febrile Infants Aged 60 Days or Younger	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EMERGENCY-DEPARTMENT; BLOOD CULTURES; CHILDREN; EXPRESSION; BACTEREMIA; PATHOGENS; MICROBIOLOGY; TUBERCULOSIS; STRATEGIES; GENOMICS	IMPORTANCE Young febrile infants are at substantial risk of serious bacterial infections; however, the current culture-based diagnosis has limitations. Analysis of host expression patterns ("RNA biosignatures") in response to infections may provide an alternative diagnostic approach. OBJECTIVE To assess whether RNA biosignatures can distinguish febrile infants aged 60 days or younger with and without serious bacterial infections. DESIGN, SETTING, AND PARTICIPANTS Prospective observational study involving a convenience sample of febrile infants 60 days or younger evaluated for fever (temperature > 38 degrees C) in 22 emergency departments from December 2008 to December 2010 who underwent laboratory evaluations including blood cultures. A random sample of infants with and without bacterial infections was selected for RNA biosignature analysis. Afebrile healthy infants served as controls. Blood samples were collected for cultures and RNA biosignatures. Bioinformatics tools were applied to define RNA biosignatures to classify febrile infants by infection type. EXPOSURE RNA biosignatures compared with cultures for discriminating febrile infants with and without bacterial infections and infants with bacteremia from those without bacterial infections. MAIN OUTCOMES AND MEASURES Bacterial infection confirmed by culture. Performance of RNA biosignatures was compared with routine laboratory screening tests and Yale Observation Scale (YOS) scores. RESULTS Of 1883 febrile infants (median age, 37 days; 55.7% boys), RNA biosignatures were measured in 279 randomly selected infants (89 with bacterial infections-including 32 with bacteremia and 15 with urinary tract infections-and 190 without bacterial infections), and 19 afebrile healthy infants. Sixty-six classifier genes were identified that distinguished infants with and without bacterial infections in the test set with 87%(95% CI, 73%-95%) sensitivity and 89%(95% CI, 81%-93%) specificity. Ten classifier genes distinguished infants with bacteremia from those without bacterial infections in the test set with 94%(95% CI, 70%-100%) sensitivity and 95%(95% CI, 88%-98%) specificity. The incremental C statistic for the RNA biosignatures over the YOS score was 0.37 (95% CI, 0.30-0.43). CONCLUSIONS AND RELEVANCE In this preliminary study, RNA biosignatures were defined to distinguish febrile infants aged 60 days or younger with vs without bacterial infections. Further research with larger populations is needed to refine and validate the estimates of test accuracy and to assess the clinical utility of RNA biosignatures in practice.	[Mahajan, Prashant] Wayne State Univ, Dept Pediat, Div Emergency Med, Childrens Hosp Michigan, Detroit, MI 48202 USA; [Kuppermann, Nathan; Tzimenatos, Leah] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA; [Mejias, Asuncion; Suarez, Nicolas; Smith, Bennett; Ramilo, Octavio] Nationwide Childrens Hosp, Div Pediat Infect Dis, Columbus, OH USA; [Mejias, Asuncion; Suarez, Nicolas; Smith, Bennett; Ramilo, Octavio] Nationwide Childrens Hosp, Ctr Vaccines & Immun, Columbus, OH USA; [Mejias, Asuncion; Suarez, Nicolas; Smith, Bennett; Cohen, Daniel M.; Ramilo, Octavio] Ohio State Univ, Columbus, OH 43210 USA; [Chaussabel, Damien] Virginia Mason & Sidra Med & Res Ctr, Benaroya Res Inst, Seattle, WA USA; [Chaussabel, Damien] Virginia Mason & Sidra Med & Res Ctr, Benaroya Res Inst, Doha, Qatar; [Casper, T. Charles; Dean, J. Michael] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Alpern, Elizabeth R.] Childrens Hosp Philadelphia, Dept Pediat, Div Emergency Med, Philadelphia, PA 19104 USA; [Alpern, Elizabeth R.] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Feinberg Sch Med, Chicago, IL 60611 USA; [Anders, Jennifer] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA; [Atabaki, Shireen M.] George Washington Sch Med & Hlth Sci, Div Emergency Med, Dept Pediat, Childrens Natl Med Ctr, Washington, DC USA; [Bennett, Jonathan E.; Crain, Ellen F.] Alfred I DuPont Hosp Children, Div Pediat Emergency Med, Nemours Childrens Hlth Syst, Wilmington, DE USA; [Blumberg, Stephen] Albert Einstein Coll Med, Dept Pediat, Jacobi Med Ctr, New York, NY USA; [Bonsu, Bema] Nationwide Childrens Hosp, Med Sect, Dept Pediat, Columbus, OH USA; [Borgialli, Dominic] Hurley Med Ctr, Dept Emergency Med, Flint, MI USA; [Borgialli, Dominic] Univ Michigan, Flint, MI 48503 USA; [Brayer, Anne] Univ Rochester, Med Ctr, Dept Emergency Med, Rochester, NY 14642 USA; [Brayer, Anne] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; [Browne, Lorin; Saunders, Mary] Childrens Hosp Wisconsin, Dept Pediat, Med Coll Wisconsin, Milwaukee, WI 53201 USA; [Browne, Lorin] Childrens Hosp Wisconsin, Dept Emergency Med, Med Coll Wisconsin, Milwaukee, WI 53201 USA; [Cohen, Daniel M.] Nationwide Childrens Hosp, Sect Emergency Med, Dept Pediat, Columbus, OH USA; [Cruz, Andrea T.] Texas Childrens Hosp, Baylor Coll Med, Sect Emergency Med, Houston, TX 77030 USA; [Cruz, Andrea T.] Texas Childrens Hosp, Baylor Coll Med, Sect Infect Dis, Houston, TX 77030 USA; [Dayan, Peter S.] Columbia Univ Coll Phys & Surg, Dept Pediat, Div Emergency Med, New York, NY 10032 USA; [Gattu, Rajender] Univ Maryland, Dept Pediat, Med Ctr, Div Emergency Med, Baltimore, MD 21201 USA; [Greenberg, Richard] Univ Utah, Dept Pediat, Primary Childrens Med Ctr, Salt Lake City, UT USA; [Hoyle, John D., Jr.] Helen DeVos Childrens Hosp Spectrum Hlth, Dept Emergency Med, Grand Rapids, MI USA; [Hoyle, John D., Jr.] Western Michigan Univ Homer Stryker, Sch Med, MD, Dept Emergency Med, Kalamazoo, MI USA; [Hoyle, John D., Jr.] Western Michigan Univ Homer Stryker, Sch Med, MD, Dept Pediat, Kalamazoo, MI USA; [Jaffe, David M.] Washington Univ, Dept Pediat, St Louis Childrens Hosp, St Louis, MO 63130 USA; [Jaffe, David M.] Univ Calif San Francisco, Div Pediat Emergency Med, Sch Med, San Francisco, CA 94143 USA; [Levine, Deborah A.; Muenzer, Jared; Tunik, Michael G.] NYU, Dept Pediat, Langone Ctr, Bellevue Hosp, New York, NY 10016 USA; [Lillis, Kathleen] SUNY Buffalo, Dept Pediat, Women & Childrens Hosp Buffalo, Buffalo, NY USA; [Linakis, James G.] Hasbro Childrens Hosp, Dept Emergency Med & Pediat, Providence, RI USA; [Linakis, James G.] Brown Univ, Providence, RI 02912 USA; [Muenzer, Jared] Phoenix Childrens Hosp, Dept Emergency Med, Phoenix, AZ USA; [Nigrovic, Lise E.] Harvard Univ, Boston Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; [Powell, Elizabeth C.] Northwestern Univ, Dept Pediat, Div Emergency Med, Ann & Robert H Lurie Childrens Hosp Chicago,Feinb, Chicago, IL 60611 USA; [Rogers, Alexander J.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Rogers, Alexander J.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Roosevelt, Genie] Univ Colorado Denver, Dept Pediat, Childrens Hosp Colorado, Aurora, CO USA; [Ruddy, Richard M.] Univ Cincinnati, Coll Med, Dept Pediat, Div Emergency Med,Cincinnati Childrens Hosp Med C, Cincinnati, OH USA; [Saunders, Mary] Univ Colorado, Childrens Hosp Colorado, Sch Med, Aurora, CO USA; [Vitale, Melissa] Univ Pittsburgh, Sch Med, Dept Pediat, Div Pediat Emergency Med,Childrens Hosp Pittsburg, Pittsburgh, PA 15261 USA	Children's Hospital of Michigan; Wayne State University; University of California System; University of California Davis; University of California System; University of California Davis; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Benaroya Research Institute; Virginia Mason Medical Center; Utah System of Higher Education; University of Utah; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Johns Hopkins University; Children's National Health System; George Washington University; Nemours Alfred I. duPont Hospital for Children; Jacobi Medical Center; Yeshiva University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University of Michigan System; University of Michigan; University of Michigan Flint; University of Rochester; University of Rochester; Children's Hospital of Wisconsin; Medical College of Wisconsin; Children's Hospital of Wisconsin; Medical College of Wisconsin; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Baylor College of Medicine; Baylor College of Medicine; Columbia University; University System of Maryland; University of Maryland Baltimore; Utah System of Higher Education; University of Utah; Western Michigan University; Western Michigan University; St. Louis Children's Hospital; Washington University (WUSTL); University of California System; University of California San Francisco; Bellevue Hospital Center; New York University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Women & Children's Hospital of Buffalo; Hasbro Children's Hospital; Brown University; Phoenix Children's Hospital; Harvard University; Boston Children's Hospital; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ramilo, O (corresponding author), Nationwide Childrens Hosp, Div Infect Dis, Ste C5C,700 Childrens Dr, Columbus, OH 43205 USA.	octavio.ramilo@nationwidechildrens.org	Cruz, Andrea/GWQ-5824-2022; Mejias, Asuncion/AAC-5998-2019; Chaussabel, Damien/AAX-1909-2020	Mejias, Asuncion/0000-0002-5983-8006; Tunik, Michael/0000-0002-2368-5933; Alpern, Elizabeth/0000-0001-7887-3563; Chaussabel, Damien/0000-0002-6131-7242; Nigrovic, Lise/0000-0002-6369-3997; Powell, Elizabeth/0000-0003-3147-9889	Health Resources and Services Administration, Emergency Services for Children [H34MCO8509]; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health [R01HD062477]; Health Resources and Services Administration (HRSA); Maternal and Child Health Bureau (MCHB); Emergency Medical Services for Children (EMSC) Network Development Demonstration Program [U03MC00008, U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC22684, U03MC22685]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD062477] Funding Source: NIH RePORTER	Health Resources and Services Administration, Emergency Services for Children; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Health Resources and Services Administration (HRSA)(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Maternal and Child Health Bureau (MCHB); Emergency Medical Services for Children (EMSC) Network Development Demonstration Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The research was supported in part by grant H34MCO8509 from Health Resources and Services Administration, Emergency Services for Children and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health under Award Number R01HD062477. This project was also supported in part by the Health Resources and Services Administration (HRSA), Maternal and Child Health Bureau (MCHB), Emergency Medical Services for Children (EMSC) Network Development Demonstration Program under cooperative agreements U03MC00008, U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC22684, and U03MC22685.	Anderson ST, 2014, NEW ENGL J MED, V370, P1712, DOI 10.1056/NEJMoa1303657; Ardura MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005446; Banchereau R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034390; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bressan S, 2012, ACTA PAEDIATR, V101, P271, DOI 10.1111/j.1651-2227.2011.02478.x; Byington CL, 2003, PEDIATRICS, V111, P964, DOI 10.1542/peds.111.5.964; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chaussabel D, 2014, NAT REV IMMUNOL, V14, P271, DOI 10.1038/nri3642; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Connell TG, 2007, PEDIATRICS, V119, P891, DOI 10.1542/peds.2006-0440; Cummings CA, 2002, SCIENCE, V296, P1976, DOI 10.1126/science.1073125; DEANGELIS C, 1983, AM J DIS CHILD, V137, P1146, DOI 10.1001/archpedi.1983.02140380006003; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Gomez B, 2012, PEDIATRICS, V130, P815, DOI 10.1542/peds.2011-3575; Greenhow TL, 2012, PEDIATRICS, V129, pE590, DOI 10.1542/peds.2011-1546; Herberg JA, 2013, J INFECT DIS, V208, P1664, DOI 10.1093/infdis/jit348; Hoberman A, 1997, PEDIATR INFECT DIS J, V16, P11, DOI 10.1097/00006454-199701000-00004; Hu XR, 2013, P NATL ACAD SCI USA, V110, P12792, DOI 10.1073/pnas.1302968110; Huppler AR, 2010, PEDIATRICS, V125, P228, DOI 10.1542/peds.2009-1070; Kaforou M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001538; Kellogg JA, 1997, PEDIATR INFECT DIS J, V16, P381, DOI 10.1097/00006454-199704000-00009; Kirn TJ, 2013, CLIN MICROBIOL INFEC, V19, P513, DOI 10.1111/1469-0691.12180; Levine DA, 2004, PEDIATRICS, V113, P1728, DOI 10.1542/peds.113.6.1728; Mahajan P, 2015, PEDIATR EMERG CARE, V31, P1, DOI 10.1097/PEC.0000000000000324; Mahajan P, 2013, JAMA PEDIATR, V167, P888, DOI 10.1001/jamapediatrics.2013.2491; MCCARTHY PL, 1982, PEDIATRICS, V70, P802; Mejias A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001549; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Relman DA, 2002, NAT GENET, V30, P131, DOI 10.1038/ng0202-131; Relman DA, 2002, J INFECT DIS, V186, pS254, DOI 10.1086/344935; Wilson ML, 1997, AM J CLIN PATHOL, V107, P154, DOI 10.1093/ajcp/107.2.154; Zaas AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006280; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006; Zwang O, 2006, J HOSP MED, V1, P272, DOI 10.1002/jhm.115	34	138	139	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2016	316	8					846	857		10.1001/jama.2016.9207	http://dx.doi.org/10.1001/jama.2016.9207			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT8JL	27552618	Bronze, Green Accepted			2022-12-28	WOS:000381736200015
J	Ohrstrom, L				Ohrstrom, Lars			Now you see me too	SCIENCE			English	Editorial Material							METAL-ORGANIC FRAMEWORKS; DATABASE		[Ohrstrom, Lars] Chalmers, Dept Chem & Chem Engn, Gothenburg, Sweden	Chalmers University of Technology	Ohrstrom, L (corresponding author), Chalmers, Dept Chem & Chem Engn, Gothenburg, Sweden.	ohrstrom@chalmers.se	Öhrström, Lars/C-2158-2008	Öhrström, Lars/0000-0002-6420-2141				Batten SR, 2013, PURE APPL CHEM, V85, P1715, DOI 10.1351/PAC-REC-12-11-20; Gandara F, 2014, J AM CHEM SOC, V136, P5271, DOI 10.1021/ja501606h; Ghazzali M, 2011, CRYSTENGCOMM, V13, P5813, DOI 10.1039/c1ce05527e; Groom CR, 2016, ACTA CRYSTALLOGR B, V72, P171, DOI 10.1107/S2052520616003954; Inokuma Y, 2013, NATURE, V495, P461, DOI 10.1038/nature11990; Lee S, 2016, SCIENCE, V353, P808, DOI 10.1126/science.aaf9135; Mahato P, 2016, J AM CHEM SOC, V138, P6541, DOI 10.1021/jacs.6b01652; O'Keeffe M, 2008, ACCOUNTS CHEM RES, V41, P1782, DOI 10.1021/ar800124u; Scarso A, 2003, J AM CHEM SOC, V125, P13981, DOI 10.1021/ja037808e; Yoshioka S, 2015, CHEM SCI, V6, P3765, DOI 10.1039/c5sc01681a	10	1	1	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					754	755		10.1126/science.aah5367	http://dx.doi.org/10.1126/science.aah5367			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZE	27540155				2022-12-28	WOS:000381561400023
J	Hingle, S				Hingle, Susan			Electronic Health Records: An Unfulfilled Promise and a Call to Action	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SATISFACTION; PHYSICIANS; BURNOUT		[Hingle, Susan] SIU Sch Med, 801 North Rutledge,MC 9628, Springfield, IL 62794 USA	Southern Illinois University System; Southern Illinois University	Hingle, S (corresponding author), SIU Sch Med, 801 North Rutledge,MC 9628, Springfield, IL 62794 USA.	shingle@siumed.edu						Farber NJ, 2015, J FAM PRACTICE, V64, P687; Kazmi Zainab, 2013, Inform Prim Care, V21, P30, DOI 10.14236/jhi.v21i1.37; Kuhn T, 2015, ANN INTERN MED, V162, P301, DOI 10.7326/M14-2128; Shanafelt TD, 2016, MAYO CLIN PROC, V91, P836, DOI 10.1016/j.mayocp.2016.05.007; Shanafelt TD, 2012, ARCH INTERN MED, V172, P1377, DOI 10.1001/archinternmed.2012.3199; Sinsky C, 2016, ANN INTERN MED, V165, P753, DOI 10.7326/M16-0961; Street RL, 2014, PATIENT EDUC COUNS, V96, P315, DOI 10.1016/j.pec.2014.05.004; Wachter RM, 2016, ANN INTERN MED, V165, pH02, DOI 10.7326/M16-1367	8	11	11	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2016	165	11					818	819		10.7326/M16-1757	http://dx.doi.org/10.7326/M16-1757			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0KO	27595501				2022-12-28	WOS:000389263900014
J	Le Pechoux, C; Dhermain, F; Besse, B				Le Pechoux, Cecile; Dhermain, Frederic; Besse, Benjamin			Whole brain radiotherapy in patients with NSCLC and brain metastases	LANCET			English	Editorial Material							CELL LUNG-CANCER; STEREOTACTIC RADIOSURGERY; RADIATION-THERAPY; SURVIVAL		[Le Pechoux, Cecile; Dhermain, Frederic] Gustave Roussy Canc Campus, Dept Radiat Oncol, F-94800 Villejuif, France; [Besse, Benjamin] Gustave Roussy Canc Campus, Dept Med Oncol, F-94800 Villejuif, France; [Besse, Benjamin] Univ Paris 11, Fac Med, Le Kremlin Bicetre, France	UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Le Pechoux, C (corresponding author), Gustave Roussy Canc Campus, Dept Radiat Oncol, F-94800 Villejuif, France.	cecile.lepechoux@gustaveroussy.fr	Besse, Benjamin/V-1523-2019	Besse, Benjamin/0000-0001-5090-8189				Aoyama H, 2006, JAMA-J AM MED ASSOC, V295, P2483, DOI 10.1001/jama.295.21.2483; Besse B, 2014, ANN ONCOL, V25, P1475, DOI 10.1093/annonc/mdu123; Brown PD, 2015, ASCO M S, V33, pLBA4; Chang EL, 2009, LANCET ONCOL, V10, P1037, DOI 10.1016/S1470-2045(09)70263-3; Heon S, 2012, CLIN CANCER RES, V18, P4406, DOI 10.1158/1078-0432.CCR-12-0357; Kocher M, 2011, J CLIN ONCOL, V29, P134, DOI 10.1200/JCO.2010.30.1655; Le Pechoux C, 2016, LANCET ONCOL, V17, pE277, DOI 10.1016/S1470-2045(16)30065-1; Li J, 2007, J CLIN ONCOL, V25, P1260, DOI 10.1200/JCO.2006.09.2536; Mulvenna P, 2016, LANCET; Shi WY, 2016, J CLIN ONCOL, V34, P107, DOI 10.1200/JCO.2015.63.9682; Sperduto PW, 2012, J CLIN ONCOL, V30, P419, DOI 10.1200/JCO.2011.38.0527; Yamamoto M, 2014, LANCET ONCOL, V15, P387, DOI 10.1016/S1470-2045(14)70061-0; Zhang I, 2015, LANCET ONCOL, V16, pE510, DOI 10.1016/S1470-2045(15)00013-3	13	11	12	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2016	388	10055					1960	1962		10.1016/S0140-6736(16)31391-5	http://dx.doi.org/10.1016/S0140-6736(16)31391-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ6EQ	27604505	hybrid			2022-12-28	WOS:000385954800006
J	Kronzer, VL; Avidan, MS				Kronzer, Vanessa L.; Avidan, Michael S.			Preventing postoperative delirium: all that glisters is not gold	LANCET			English	Editorial Material							MECHANICALLY VENTILATED PATIENTS; CRITICALLY-ILL PATIENTS; DEXMEDETOMIDINE; SEDATION		[Kronzer, Vanessa L.; Avidan, Michael S.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Avidan, MS (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	avidanm@anest.wustl.edu	Kronzer, Vanessa/Y-4687-2019	Kronzer, Vanessa/0000-0002-7489-3134; Avidan, Michael/0000-0001-6248-044X				Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; McDaniel M, 2012, CURR OPIN CRIT CARE, V18, P372, DOI 10.1097/MCC.0b013e3283557211; Nuzzo R, 2014, NATURE, V506, P150, DOI 10.1038/506150a; Oto J, 2012, INTENS CARE MED, V38, P1982, DOI 10.1007/s00134-012-2685-y; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Prasad V, 2013, MAYO CLIN PROC, V88, P790, DOI 10.1016/j.mayocp.2013.05.012; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Salluh JIF, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/bmj.h2538, 10.1136/bmj.h3129]; Sharma PT, 2005, ANESTH ANALG, V101, P1215, DOI 10.1213/01.ane.0000167383.44984.e5; Su X, 2016, LANCET; van Eijk MMJ, 2010, LANCET, V376, P1829, DOI 10.1016/S0140-6736(10)61855-7	11	4	4	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 15	2016	388	10054					1854	+		10.1016/S0140-6736(16)31353-8	http://dx.doi.org/10.1016/S0140-6736(16)31353-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DZ0AM	27542301				2022-12-28	WOS:000385499000005
J	Choueiri, RM; Galati, E; Therien-Aubin, H; Klinkova, A; Larin, EM; Querejeta-Fernandez, A; Han, LL; Xin, HL; Gang, O; Zhulina, EB; Rubinstein, M; Kumacheva, E				Choueiri, Rachelle M.; Galati, Elizabeth; Therien-Aubin, Heloise; Klinkova, Anna; Larin, Egor M.; Querejeta-Fernandez, Ana; Han, Lili; Xin, Huolin L.; Gang, Oleg; Zhulina, Ekaterina B.; Rubinstein, Michael; Kumacheva, Eugenia			Surface patterning of nanoparticles with polymer patches	NATURE			English	Article							LIGAND SHELL; SOLVENTS; COLLOIDS; BRUSHES; CHAINS	Patterning of colloidal particles with chemically or topographically distinct surface domains (patches) has attracted intense research interest(1-3). Surface-patterned particles act as colloidal analogues of atoms and molecules(4,5), serve as model systems in studies of phase transitions in liquid systems(6), behave as 'colloidal surfactants'(7) and function as templates for the synthesis of hybrid particles(8). The generation of micrometre- and submicrometre-sized patchy colloids is now efficient(9-11), but surface patterning of inorganic colloidal nanoparticles with dimensions of the order of tens of nanometres is uncommon. Such nanoparticles exhibit size-and shape-dependent optical, electronic and magnetic properties, and their assemblies show new collective properties(12). At present, nanoparticle patterning is limited to the generation of two-patch nanoparticles(13-15), and nanoparticles with surface ripples(16) or a 'raspberry' surface morphology(17). Here we demonstrate nanoparticle surface patterning, which utilizes thermodynamically driven segregation of polymer ligands from a uniform polymer brush into surface-pinned micelles following a change in solvent quality. Patch formation is reversible but can be permanently preserved using a photocrosslinking step. The methodology offers the ability to control the dimensions of patches, their spatial distribution and the number of patches per nanoparticle, in agreement with a theoretical model. The versatility of the strategy is demonstrated by patterning nanoparticles with different dimensions, shapes and compositions, tethered with various types of polymers and subjected to different external stimuli. These patchy nanocolloids have potential applications in fundamental research, the self-assembly of nanomaterials, diagnostics, sensing and colloidal stabilization.	[Choueiri, Rachelle M.; Galati, Elizabeth; Therien-Aubin, Heloise; Klinkova, Anna; Larin, Egor M.; Querejeta-Fernandez, Ana; Kumacheva, Eugenia] Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada; [Han, Lili; Xin, Huolin L.; Gang, Oleg] Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11973 USA; [Han, Lili] Tianjin Univ, Inst New Energy Mat, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China; [Zhulina, Ekaterina B.] Russian Acad Sci, Inst Macromol Cpds, St Petersburg 199004, Russia; [Zhulina, Ekaterina B.] St Petersburg Natl Univ Informat Technol Mech & O, St Petersburg 197101, Russia; [Rubinstein, Michael] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Kumacheva, Eugenia] Univ Toronto, Inst Biomat & Biomed Engn, 4 Taddle Creek Rd, Toronto, ON M5S 3G9, Canada; [Kumacheva, Eugenia] Univ Toronto, Dept Chem Engn & Appl Chem, 200 Coll St, Toronto, ON M5S 3E5, Canada; [Gang, Oleg] Columbia Univ, Dept Chem Engn, New York, NY 10027 USA; [Gang, Oleg] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10027 USA	University of Toronto; United States Department of Energy (DOE); Brookhaven National Laboratory; Tianjin University; Russian Academy of Sciences; Institute of Macromolecular Compounds of the Russian Academy of Sciences; ITMO University; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; University of Toronto; Columbia University; Columbia University	Kumacheva, E (corresponding author), Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada.; Kumacheva, E (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, 4 Taddle Creek Rd, Toronto, ON M5S 3G9, Canada.; Kumacheva, E (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, 200 Coll St, Toronto, ON M5S 3E5, Canada.	ekumache@chem.utoronto.ca	Zhulina, Ekaterina B/G-5177-2011; Therien-Aubin, Heloise/O-9906-2016; Larin, Egor/AAM-3831-2020; Kumacheva, Eugenia/U-7612-2019; Querejeta-Fernández, Ana/G-8924-2015; Xin, Huolin L./E-2747-2010	Therien-Aubin, Heloise/0000-0003-4567-516X; Larin, Egor/0000-0003-4986-1373; Querejeta-Fernández, Ana/0000-0002-9900-5367; Xin, Huolin L./0000-0002-6521-868X; Zhulina, Ekaterina/0000-0001-9139-3484; Klinkova, Anna/0000-0003-0337-0579; Choueiri, Rachelle/0000-0002-9810-657X	Connaught Foundation; National Science and Engineering Research Council of Canada; Russian Foundation for Basic Research [14-03-00372a]; Government of Russian Federation [074-U01]; National Science Foundation [DMR-1309892, DMR-1436201, DMR-1121107]; National Institutes of Health [P01-HL108808, 1UH2HL123645]; Cystic Fibrosis Foundation; US Department of Energy, Office of Basic Energy Sciences [DE-SC0012704]; Natural Sciences and Engineering Research Council of Canada; Direct For Mathematical & Physical Scien [1309892] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL108808, UH3HL123645] Funding Source: NIH RePORTER	Connaught Foundation(University of Toronto); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Government of Russian Federation; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the Connaught Foundation and the National Science and Engineering Research Council of Canada (Discovery and Canada Research Chair programmes) for financial support of this work. E.B.Z. acknowledges partial support from the Russian Foundation for Basic Research (grant 14-03-00372a) and from the Government of Russian Federation (grant 074-U01). M.R. acknowledges financial support from the National Science Foundation (grants DMR-1309892, DMR-1436201 and DMR-1121107), the National Institutes of Health (grants P01-HL108808 and 1UH2HL123645), and the Cystic Fibrosis Foundation. Research was in part carried out at the Center for Functional Nanomaterials, Brookhaven National Laboratory supported by the US Department of Energy, Office of Basic Energy Sciences (under contract number DE-SC0012704). R.M.C. acknowledges the Natural Sciences and Engineering Research Council of Canada for a PGS-D scholarship. A.K. acknowledges an Ontario Trillium Scholarship. We thank M. Michaelis and S. Lin for initiating preliminary experiments and I. Gourevich for help with imaging experiments.	Andala DM, 2012, ACS NANO, V6, P1044, DOI 10.1021/nn202556b; Bao CH, 2014, MACROMOLECULES, V47, P6824, DOI 10.1021/ma501474m; Bianchi E, 2011, PHYS CHEM CHEM PHYS, V13, P6397, DOI 10.1039/c0cp02296a; Binks BP, 2002, CURR OPIN COLLOID IN, V7, P21, DOI 10.1016/S1359-0294(02)00008-0; Burgi T, 2015, NANOSCALE, V7, P15553, DOI 10.1039/c5nr03497c; Chen Q, 2011, NATURE, V469, P381, DOI 10.1038/nature09713; Chen T, 2010, CHEM MATER, V22, P3826, DOI 10.1021/cm101155v; Choi BC, 2013, LANGMUIR, V29, P5841, DOI 10.1021/la400066d; Choueiri RM, 2013, J AM CHEM SOC, V135, P10262, DOI 10.1021/ja404341r; Erathodiyil N, 2011, ACCOUNTS CHEM RES, V44, P925, DOI 10.1021/ar2000327; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; Groschel AH, 2013, NATURE, V503, P247, DOI 10.1038/nature12610; Jackson AM, 2004, NAT MATER, V3, P330, DOI 10.1038/nmat1116; Kern N, 2003, J CHEM PHYS, V118, P9882, DOI 10.1063/1.1569473; Khabibullin A, 2016, ADV POLYM SCI, V270, P29, DOI 10.1007/12_2015_311; Klinkova A, 2014, NANO LETT, V14, P6314, DOI 10.1021/nl502746h; Koutsos V, 1997, MACROMOLECULES, V30, P4719, DOI 10.1021/ma961625d; Lattuada M, 2011, NANO TODAY, V6, P286, DOI 10.1016/j.nantod.2011.04.008; Lukach A, 2012, J AM CHEM SOC, V134, P18853, DOI 10.1021/ja309475e; Minelli C, 2010, SMALL, V6, P2336, DOI 10.1002/smll.201000523; Nie ZH, 2010, NAT NANOTECHNOL, V5, P15, DOI [10.1038/NNANO.2009.453, 10.1038/nnano.2009.453]; Pawar AB, 2010, MACROMOL RAPID COMM, V31, P150, DOI 10.1002/marc.200900614; Preisler Z, 2014, SOFT MATTER, V10, P5121, DOI 10.1039/c4sm00505h; Rubinstein M., 2003, POLYM PHYS, V53; Sacanna S, 2011, CURR OPIN COLLOID IN, V16, P96, DOI 10.1016/j.cocis.2011.01.003; Saha K, 2012, CHEM REV, V112, P2739, DOI 10.1021/cr2001178; Vilain C, 2007, J MATER CHEM, V17, P3509, DOI 10.1039/b706613a; Wang YF, 2012, NATURE, V491, P51, DOI 10.1038/nature11564; WILLIAMS DRM, 1993, J PHYS II, V3, P1313; WOLF BA, 1978, MAKROMOL CHEM, V179, P2265; ZHULINA EB, 1995, MACROMOLECULES, V28, P8612, DOI 10.1021/ma00129a021; Zohar N, 2014, J PHOTOCH PHOTOBIO C, V21, P26, DOI 10.1016/j.jphotochemrev.2014.10.002	32	195	197	27	669	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2016	538	7623					79	83		10.1038/nature19089	http://dx.doi.org/10.1038/nature19089			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX8LD	27556943	Green Submitted, Green Accepted			2022-12-28	WOS:000384638900037
J	Abbasi, J				Abbasi, Jennifer			Expanding the Health Care Response to Mass Violence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2016	316	10					1031	1033		10.1001/jama.2016.10371	http://dx.doi.org/10.1001/jama.2016.10371			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV5TB	27552681				2022-12-28	WOS:000382991100002
J	Paterleni, M				Paterleni, Marta			Profile: Istituto Superiore di Sanita, Rome, Italy	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2016	388	10049					1044	1044		10.1016/S0140-6736(16)31498-2	http://dx.doi.org/10.1016/S0140-6736(16)31498-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DV0OD	27590219				2022-12-28	WOS:000382616900015
J	Blumenthal, D; Chernof, B; Fulmer, T; Lumpkin, J; Selberg, J				Blumenthal, David; Chernof, Bruce; Fulmer, Terry; Lumpkin, John; Selberg, Jeffrey			Caring for High-Need, High-Cost Patients - An Urgent Priority	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Blumenthal, David] Commonwealth Fund, New York, NY 10021 USA; [Fulmer, Terry] John A Hartford Fdn, New York, NY USA; [Selberg, Jeffrey] Peterson Ctr Healthcare, New York, NY USA; [Chernof, Bruce] SCAN Fdn, Long Beach, CA USA; [Lumpkin, John] Robert Wood Johnson Fdn, Princeton, NJ 08540 USA	Commonwealth Fund; Robert Wood Johnson Foundation (RWJF)	Blumenthal, D (corresponding author), Commonwealth Fund, New York, NY 10021 USA.							Anderson GF, 2015, AM J MANAG CARE, V21, pE597; Hong C.S., 2014, CARING HIGH NEED HIG; Muhlestein D, 2016, HLTH AFFAIRS BLOG; Rieder C, 2010, ACHIEVING BETTER CHR; Rodriguez S., 2014, EFFECTIVE MANAGEMENT	5	190	192	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2016	375	10					909	911		10.1056/NEJMp1608511	http://dx.doi.org/10.1056/NEJMp1608511			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU9IG	27602661				2022-12-28	WOS:000382529500001
J	Hansen, R; Randeria, S				Hansen, Randall; Randeria, Shalini			Tensions of refugee politics in Europe	SCIENCE			English	Editorial Material									[Hansen, Randall] Univ Toronto, Munk Sch Global Affairs, Ctr European Russian & Eurasian Studies, Toronto, ON M5S 3K7, Canada; [Hansen, Randall] Univ Toronto, Dept Polit Sci, Toronto, ON M5S 3K7, Canada; [Randeria, Shalini] Inst Human Sci, A-1090 Vienna, Austria; [Randeria, Shalini] Grad Inst Int & Dev Studies, CH-1202 Geneva, Switzerland	University of Toronto; University of Toronto	Hansen, R (corresponding author), Univ Toronto, Munk Sch Global Affairs, Ctr European Russian & Eurasian Studies, Toronto, ON M5S 3K7, Canada.; Hansen, R (corresponding author), Univ Toronto, Dept Polit Sci, Toronto, ON M5S 3K7, Canada.	r.hansen@utoronto.ca						[Anonymous], 2016, ELECTION PRESIDENTIE; [Anonymous], 2015, WND WORLDNETDAI 0924; Appadurai A., 2006, FEAR SMALL NUMBERS E, DOI [10.1215/9780822387541, DOI 10.1215/9780822387541]; Barigassi J., 2016, POLITICO PAVIA  0607; Brinbaum M., 2016, WASHINGTON POST; Business and Human Rights Resource Center, 2016, EUR BUS TAK STEPS OF; Edwards A., 2016, GLOBAL FORCED DISPLA; German Federal Office for Migration and Refugees (BAMF), 2016, AS MON MARZ 2016, P10; Hall Peter, 2000, VARIETIES CAPITALISM; Jacoby T, 2014, ATLANTIC; Keleman R.D., 2015, FOREIGN AFFAIRS; Martin PL, 2016, MIGR LETT, V13, P307; Mucci A., 2016, POLITICO PAVIA  0129; Robinson D., 2016, FINANCIAL TIMES; Stokes B., 2016, EUROSKEPTICISM BREXI; Wike Richard, 2016, SHARP IDEOLOGICAL DI	16	6	6	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2016	353	6303					994	995		10.1126/science.aag1556	http://dx.doi.org/10.1126/science.aag1556			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU9SU	27562957				2022-12-28	WOS:000382558900022
J	Jordan, NV; Bardia, A; Wittner, BS; Benes, C; Ligorio, M; Zheng, Y; Yu, M; Sundaresan, TK; Licausi, JA; Desai, R; O'Keefe, RM; Ebright, RY; Boukhali, M; Sil, S; Onozato, ML; Iafrate, AJ; Kapur, R; Sgroi, D; Ting, DT; Toner, M; Ramaswamy, S; Haas, W; Maheswaran, S; Haber, DA				Jordan, Nicole Vincent; Bardia, Aditya; Wittner, Ben S.; Benes, Cyril; Ligorio, Matteo; Zheng, Yu; Yu, Min; Sundaresan, Tilak K.; Licausi, Joseph A.; Desai, Rushil; O'Keefe, Ryan M.; Ebright, Richard Y.; Boukhali, Myriam; Sil, Srinjoy; Onozato, Maristela L.; Iafrate, Anthony J.; Kapur, Ravi; Sgroi, Dennis; Ting, David T.; Toner, Mehmet; Ramaswamy, Sridhar; Haas, Wilhelm; Maheswaran, Shyamala; Haber, Daniel A.			HER2 expression identifies dynamic functional states within circulating breast cancer cells	NATURE			English	Article							TUMOR-CELLS; STEM-CELLS; SIGNALING PATHWAYS; HEDGEHOG PATHWAY; NOTCH; INHIBITOR; TUMORIGENESIS; TRASTUZUMAB; RECURRENCE; AXIS	Circulating tumour cells in women with advanced oestrogen receptor (ER)-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer acquire a HER2-positive subpopulation after multiple courses of therapy(1,2). In contrast to HER2-amplified primary breast cancer, which is highly sensitive to HER2-targeted therapy, the clinical significance of acquired HER2 heterogeneity during the evolution of metastatic breast cancer is unknown. Here we analyse circulating tumour cells from 19 women with ER+/HER2(-) primary tumours, 84% of whom had acquired circulating tumour cells expressing HER2. Cultured circulating tumour cells maintain discrete HER2(+) and HER2(-) subpopulations: HER2+ circulating tumour cells are more proliferative but not addicted to HER2(-), consistent with activation of multiple signalling pathways; HER2(-) circulating tumour cells show activation of Notch and DNA damage pathways, exhibiting resistance to cytotoxic chemotherapy, but sensitivity to Notch inhibition. HER2(+) and HER2(-) circulating tumour cells interconvert spontaneously, with cells of one phenotype producing daughters of the opposite within four cell doublings. Although HER2(+) and HER2(-) circulating tumour cells have comparable tumour initiating potential, differential proliferation favours the HER2(+) state, while oxidative stress or cytotoxic chemotherapy enhances transition to the HER2(-) phenotype. Simultaneous treatment with paclitaxel and Notch inhibitors achieves sustained suppression of tumorigenesis in orthotopic circulating tumour cell-derived tumour models. Together, these results point to distinct yet interconverting phenotypes within patient-derived circulating tumour cells, contributing to progression of breast cancer and acquisition of drug resistance.	[Jordan, Nicole Vincent; Bardia, Aditya; Wittner, Ben S.; Benes, Cyril; Ligorio, Matteo; Zheng, Yu; Yu, Min; Sundaresan, Tilak K.; Licausi, Joseph A.; Desai, Rushil; O'Keefe, Ryan M.; Ebright, Richard Y.; Boukhali, Myriam; Sil, Srinjoy; Onozato, Maristela L.; Iafrate, Anthony J.; Sgroi, Dennis; Ting, David T.; Ramaswamy, Sridhar; Haas, Wilhelm; Maheswaran, Shyamala; Haber, Daniel A.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Bardia, Aditya; Wittner, Ben S.; Benes, Cyril; Sundaresan, Tilak K.; Ting, David T.; Ramaswamy, Sridhar; Haas, Wilhelm; Haber, Daniel A.] Harvard Med Sch, Dept Med, Boston, MA 02114 USA; [Ligorio, Matteo; Toner, Mehmet; Maheswaran, Shyamala] Harvard Med Sch, Dept Surg, Boston, MA 02114 USA; [Onozato, Maristela L.; Iafrate, Anthony J.; Sgroi, Dennis] Harvard Med Sch, Dept Pathol, Boston, MA 02114 USA; [Kapur, Ravi; Toner, Mehmet] Harvard Med Sch, Ctr Bioengn Med, Boston, MA 02114 USA; [Kapur, Ravi; Toner, Mehmet] Harvard Med Sch, Shriners Hosp, Boston, MA 02114 USA; [Haber, Daniel A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Yu, Min] Univ Southern Calif, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA 90033 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Southern California	Jordan, NV (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.		Sgroi, Dennis/AAV-2487-2021; Ting, David/F-4389-2017	Yu, Min/0000-0002-3969-8720; Sil, Srinjoy/0000-0002-6722-4311; Ting, David/0000-0002-3261-2322	National Institutes of Health (NIH) [2RO1CA129933]; Howard Hughes Medical Institute; Breast Cancer Research Foundation; National Foundation for Cancer Research; Wellcome Trust [102696]; NIH [2U01EB012493, T32 CA009361]; Susan G. Komen Foundation [PDF16376429, K12 5K12CA087723]; NATIONAL CANCER INSTITUTE [T32CA009361, R01CA129933, F32CA009361, K12CA087723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB012493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Breast Cancer Research Foundation; National Foundation for Cancer Research; Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the patients who participated in this study. This work was supported by National Institutes of Health (NIH) 2RO1CA129933, the Howard Hughes Medical Institute, the Breast Cancer Research Foundation, the National Foundation for Cancer Research (DAH) and Wellcome Trust 102696 (C.B.), NIH Quantum 2U01EB012493 (M.T., D.A.H.), T32 CA009361, Susan G. Komen Foundation PDF16376429 (N.V.J.), K12 5K12CA087723 (A.B.) and T32GM007753 (RYE.). We thank D. Dombrowski (NIH 1S100D1016372-01) for expert flow cytometry.	Abravanel DL, 2015, J CLIN INVEST, V125, P2484, DOI 10.1172/JCI74883; Amakye D, 2013, NAT MED, V19, P1410, DOI 10.1038/nm.3389; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Bidard FC, 2015, J CLIN ONCOL, V33, P1622, DOI 10.1200/JCO.2014.57.9714; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Houssami N, 2011, BREAST CANCER RES TR, V129, P659, DOI 10.1007/s10549-011-1632-x; Ignatiadis M, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.SABCS14-OT1-2-02; Ithimakin S, 2013, CANCER RES, V73, P1635, DOI 10.1158/0008-5472.CAN-12-3349; Kim EJ, 2014, CLIN CANCER RES, V20, P5937, DOI 10.1158/1078-0432.CCR-14-1269; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Korkaya H, 2009, CLIN CANCER RES, V15, P1845, DOI 10.1158/1078-0432.CCR-08-3087; Krop I, 2012, J CLIN ONCOL, V30, P2307, DOI 10.1200/JCO.2011.39.1540; Lawson DA, 2015, NATURE, V526, P131, DOI 10.1038/nature15260; LoRusso PM, 2011, CLIN CANCER RES, V17, P2502, DOI 10.1158/1078-0432.CCR-10-2745; Martz CA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.aaa1877; Osipo C, 2008, ONCOGENE, V27, P5019, DOI 10.1038/onc.2008.149; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Pandya K, 2011, BRIT J CANCER, V105, P796, DOI 10.1038/bjc.2011.321; Schramm A., 2015, ASCO M, V33; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Wakabayashi N, 2014, MOL CELL BIOL, V34, P653, DOI 10.1128/MCB.01408-13; Yu M, 2014, SCIENCE, V345, P216, DOI 10.1126/science.1253533	25	234	240	16	194	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					102	106		10.1038/nature19328	http://dx.doi.org/10.1038/nature19328			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27556950	Green Accepted, Green Submitted			2022-12-28	WOS:000382426900047
J	Albrecht-Schmitt, TE				Albrecht-Schmitt, Thomas E.			INORGANIC CHEMISTRY Fleeting glimpse of an elusive element	NATURE			English	Editorial Material									[Albrecht-Schmitt, Thomas E.] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Albrecht-Schmitt, TE (corresponding author), Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA.	albrecht-schmitt@chem.fsu.edu						BURNS JH, 1973, J INORG NUCL CHEM, V35, P1171, DOI 10.1016/0022-1902(73)80189-7; De Sio SM, 2014, INORG CHEM, V53, P12643, DOI 10.1021/ic502376m; Ferrier M. G., 2016, NATURE COMMUN; Janoschek M, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500188; Polinski MJ, 2014, NAT CHEM, V6, P387, DOI [10.1038/nchem.1896, 10.1038/NCHEM.1896]; Ruiz-Martinez A, 2009, CHEM-EUR J, V15, P7470, DOI 10.1002/chem.200900547; Ulmert D, 2015, J NUCL MED, V56; Zalutsky MR, 2000, CURR PHARM DESIGN, V6, P1433, DOI 10.2174/1381612003399275	8	2	2	3	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					404	405		10.1038/536404a	http://dx.doi.org/10.1038/536404a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV0YL	27558059				2022-12-28	WOS:000382646600029
J	Palumbo, A; Chanan-Khan, A; Weisel, K; Nooka, AK; Masszi, T; Beksac, M; Spicka, I; Hungria, V; Munder, M; Mateos, MV; Mark, TM; Qi, M; Schecter, J; Amin, H; Qin, X; Deraedt, W; Ahmadi, T; Spencer, A; Sonneveld, P				Palumbo, Antonio; Chanan-Khan, Asher; Weisel, Katja; Nooka, Ajay K.; Masszi, Tamas; Beksac, Meral; Spicka, Ivan; Hungria, Vania; Munder, Markus; Mateos, Maria V.; Mark, Tomer M.; Qi, Ming; Schecter, Jordan; Amin, Himal; Qin, Xiang; Deraedt, William; Ahmadi, Tahamtan; Spencer, Andrew; Sonneveld, Pieter		CASTOR Investigators	Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIBODY DARATUMUMAB; MONOTHERAPY; PHASE-2; TRIAL; CD38	BACKGROUND Daratumumab, a human IgG kappa monoclonal antibody that targets CD38, induces direct and indirect antimyeloma activity and has shown substantial efficacy as monotherapy in heavily pretreated patients with multiple myeloma, as well as in combination with bortezomib in patients with newly diagnosed multiple myeloma. METHODS In this phase 3 trial, we randomly assigned 498 patients with relapsed or relapsed and refractory multiple myeloma to receive bortezomib (1.3 mg per square meter of body-surface area) and dexamethasone (20 mg) alone (control group) or in combination with daratumumab (16 mg per kilogram of body weight) (daratumumab group). The primary end point was progression-free survival. RESULTS A prespecified interim analysis showed that the rate of progression-free survival was significantly higher in the daratumumab group than in the control group; the 12-month rate of progression-free survival was 60.7% in the daratumumab group versus 26.9% in the control group. After a median follow-up period of 7.4 months, the median progression-free survival was not reached in the daratumumab group and was 7.2 months in the control group (hazard ratio for progression or death with daratumumab vs. control, 0.39; 95% confidence interval, 0.28 to 0.53; P < 0.001). The rate of overall response was higher in the daratumumab group than in the control group (82.9% vs. 63.2%, P < 0.001), as were the rates of very good partial response or better (59.2% vs. 29.1%, P < 0.001) and complete response or better (19.2% vs. 9.0%, P = 0.001). Three of the most common grade 3 or 4 adverse events reported in the daratumumab group and the control group were thrombocytopenia (45.3% and 32.9%, respectively), anemia (14.4% and 16.0%, respectively), and neutropenia (12.8% and 4.2%, respectively). Infusion-related reactions that were associated with daratumumab treatment were reported in 45.3% of the patients in the daratumumab group; these reactions were mostly grade 1 or 2 (grade 3 in 8.6% of the patients), and in 98.2% of these patients, they occurred during the first infusion. CONCLUSIONS Among patients with relapsed or relapsed and refractory multiple myeloma, daratumumab in combination with bortezomib and dexamethasone resulted in significantly longer progression-free survival than bortezomib and dexamethasone alone and was associated with infusion-related reactions and higher rates of thrombocytopenia and neutropenia than bortezomib and dexamethasone alone. (Funded by Janssen Research and Development; ClinicalTrials.gov number, NCT02136134.)	[Palumbo, Antonio] Univ Turin, Dept Hematol, Via Genova 3, I-10126 Turin, Italy; [Chanan-Khan, Asher] Mayo Clin Florida, Div Hematol & Med Oncol, Jacksonville, FL USA; [Weisel, Katja] Univ Tubingen, Univ Klinikum Tuebingen, Abt Innere Med 2, Tubingen, Germany; [Munder, Markus] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 3, Mainz, Germany; [Nooka, Ajay K.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Masszi, Tamas] Semmelweis Univ, St Laszlo Hosp, Dept Hematol & Stem Cell Transplantat, Budapest, Hungary; [Beksac, Meral] Ankara Univ, Dept Hematol, Ankara, Turkey; [Spicka, Ivan] Charles Univ Prague, Dept Med 1, Dept Clin Hematol, Prague, Czech Republic; [Hungria, Vania] Irmandade Santa Casa Misericordia Sao Paulo, Sao Paulo, Brazil; [Mateos, Maria V.] Univ Hosp Salamanca, Inst Invest Biomed Salamanca, Salamanca, Spain; [Mark, Tomer M.] Weill Cornell Med Coll, New York, NY USA; [Qi, Ming; Qin, Xiang; Ahmadi, Tahamtan] Janssen Res & Dev, Spring House, PA USA; [Schecter, Jordan; Amin, Himal] Janssen Res & Dev, Raritan, NJ USA; [Deraedt, William] Janssen Res & Dev, Beerse, Belgium; [Spencer, Andrew] Monash Univ, Alfred Hlth, Malignant Haematol & Stem Cell Transplantat Serv, Melbourne, Vic, Australia; [Sonneveld, Pieter] Dept Hematol, Erasmus MC, Rotterdam, Netherlands	University of Turin; Mayo Clinic; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Johannes Gutenberg University of Mainz; Emory University; Semmelweis University; Szent Laszlo Hospital; Ankara University; Charles University Prague; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); Cornell University; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals; Monash University; Erasmus University Rotterdam; Erasmus MC	Palumbo, A (corresponding author), Univ Turin, Dept Hematol, Via Genova 3, I-10126 Turin, Italy.	appalumbo@yahoo.com	Croockewit, A.J./L-4255-2015; martinez, joaquin/AAN-6939-2020; Hernandez-Rivas, Jose-Angel/ADF-6441-2022; Corradini, Paolo/N-7584-2017; Hacıhanefioğlu, Abdullah/G-1501-2018; Hajek, Roman/I-6639-2017; Munder, Markus/K-6737-2013	martinez, joaquin/0000-0001-7908-0063; Hernandez-Rivas, Jose-Angel/0000-0003-4550-757X; Corradini, Paolo/0000-0002-9186-1353; Hajek, Roman/0000-0001-6955-6267; Masszi, Tamas/0000-0003-2322-9863; Mun, Yeung-Chul/0000-0002-1882-3983; lipe, brea/0000-0002-7596-2015; CAVO, MICHELE/0000-0003-4514-3227; Spicka, Ivan/0000-0002-5451-5283; Grosicki, Sebastian/0000-0003-2644-1050; Warzocha, Krzysztof/0000-0002-2396-3905; de la Rubia, Javier/0000-0002-8354-768X	Janssen Research and Development	Janssen Research and Development	Supported by Janssen Research and Development.	Anderson KC, 2016, J NATL COMPR CANC NE, V14, P389, DOI 10.6004/jnccn.2016.0046; Chari A, 2015, AM SOC HEM 56 ANN M; de Weers M, 2011, J IMMUNOL, V186, P1840, DOI 10.4049/jimmunol.1003032; DeMets D L, 1995, Cancer Treat Res, V75, P1; Dimopoulos MA, 2016, LANCET ONCOL, V17, P27, DOI 10.1016/S1470-2045(15)00464-7; Dimopoulos MA, 2015, NAT REV CLIN ONCOL, V12, P42, DOI 10.1038/nrclinonc.2014.200; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Durie BGM, 2015, LEUKEMIA, V29, P2416, DOI 10.1038/leu.2015.290; Endell J, 2011, 2011 AM SOC CLIN ONC; Jakubowiak A, 2016, BLOOD, V127, P2833, DOI 10.1182/blood-2016-01-694604; Jansen JHM, 2012, AM SOC HEM 54 ANN M; Krejcik J, 2016, BLOOD, V128, P384, DOI 10.1182/blood-2015-12-687749; Lammerts van Bueren JJ, 2014, AM SOC HEM 56 ANN M; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lin P, 2004, AM J CLIN PATHOL, V121, P482, DOI 10.1039/74R4TB90BUWH27JX; Lokhorst HM, 2015, NEW ENGL J MED, V373, P1207, DOI 10.1056/NEJMoa1506348; Lonial S, 2016, LANCET, V387, P1551, DOI 10.1016/S0140-6736(15)01120-4; Lonial S, 2011, CLIN CANCER RES, V17, P1264, DOI 10.1158/1078-0432.CCR-10-1805; Mateos MV, 2015, 20 C EUR HEM ASS VIE; McCudden C, 2016, CLIN CHEM LAB MED, V54, P1095, DOI 10.1515/cclm-2015-1031; McKeage K, 2016, DRUGS, V76, P275, DOI 10.1007/s40265-015-0536-1; Overdijk MB, 2015, MABS-AUSTIN, V7, P311, DOI 10.1080/19420862.2015.1007813; Plesner T., 2015, AM SOC HEM 57 ANN M; Rajkumar SV, 2016, MAYO CLIN PROC, V91, P101, DOI 10.1016/j.mayocp.2015.11.007; Rajkumar SV, 2011, BLOOD, V117, P4691, DOI 10.1182/blood-2010-10-299487; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Rollig C, 2015, LANCET, V385, P2197, DOI 10.1016/S0140-6736(14)60493-1; San-Miguel JF, 2014, LANCET ONCOL, V15, P1195, DOI 10.1016/S1470-2045(14)70440-1; Santonocito AM, 2004, LEUKEMIA RES, V28, P469, DOI 10.1016/j.leukres.2003.09.015; Usmani SZ, 2016, BLOOD, V128, P37, DOI 10.1182/blood-2016-03-705210; van der Veer MS, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.42; Yannakou CK, 2014, BLOOD, V124	32	967	1000	3	73	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2016	375	8					754	766		10.1056/NEJMoa1606038	http://dx.doi.org/10.1056/NEJMoa1606038			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9ET	27557302	Bronze, Green Published			2022-12-28	WOS:000381799300013
J	Van Vranken, JG; Rutter, J				Van Vranken, Jonathan G.; Rutter, Jared			The Whole (Cell) Is Less Than the Sum of Its Parts	CELL			English	Editorial Material								Despite advances in metabolite profiling, a full picture of the metabolic landscape of the cell has been limited by sub-cellular compartmentalization, which segregates distinct nutrient pools into membrane-bound organelles. Now, Chen et al. describe methods for overcoming this hurdle and provide a new quantitative picture of the mitochondrial metabolome.	[Van Vranken, Jonathan G.; Rutter, Jared] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84132 USA; [Rutter, Jared] Univ Utah, Sch Med, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Rutter, J (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84132 USA.; Rutter, J (corresponding author), Univ Utah, Sch Med, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA.	rutter@biochem.utah.edu			NIGMS NIH HHS [R01 GM110755, R01 GM115129, R01 GM115174] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110755, R01GM115129, R01GM115174] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Chen WW, 2016, CELL, V166, P1324, DOI 10.1016/j.cell.2016.07.040; Jiang L, 2016, NATURE, V532, P255, DOI 10.1038/nature17393; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Pagliarini DJ, 2013, GENE DEV, V27, P2615, DOI 10.1101/gad.229724.113; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017	7	8	8	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1078	1079		10.1016/j.cell.2016.08.011	http://dx.doi.org/10.1016/j.cell.2016.08.011			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27565337	Bronze, Green Accepted			2022-12-28	WOS:000382259500006
J	Wright, JD; Chen, L; Burke, WM; Hou, JY; Tergas, AI; Ananth, CV; Hershman, DL				Wright, Jason D.; Chen, Ling; Burke, William M.; Hou, June Y.; Tergas, Ana I.; Ananth, Cande V.; Hershman, Dawn L.			Trends in Use and Outcomes of Women Undergoing Hysterectomy With Electric Power Morcellation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							MINIMALLY INVASIVE HYSTERECTOMY		[Wright, Jason D.; Chen, Ling; Hou, June Y.; Tergas, Ana I.; Ananth, Cande V.] Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, 161 Ft Washington Ave,Eighth Floor, New York, NY 10032 USA; [Hershman, Dawn L.] Columbia Univ Coll Phys & Surg, Dept Med, 161 Ft Washington Ave,Eighth Floor, New York, NY 10032 USA	Columbia University; Columbia University	Wright, JD (corresponding author), Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, Div Gynecol Oncol, 161 Ft Washington Ave,Eighth Floor, New York, NY 10032 USA.	jw2459@columbia.edu	Hou, June/L-6992-2019; Hershman, Dawn/AAG-2114-2020		NATIONAL CANCER INSTITUTE [R01CA169121, R01CA134964] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA169121-01A1, R01CA134964] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barron KI, 2015, OBSTET GYNECOL, V126, P1174, DOI 10.1097/AOG.0000000000001111; Harris JA, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.08.047; Wright JD, 2014, JAMA-J AM MED ASSOC, V312, P1253, DOI 10.1001/jama.2014.9005; Wright JD, 2013, JAMA-J AM MED ASSOC, V309, P689, DOI 10.1001/jama.2013.186	4	39	39	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2016	316	8					877	878		10.1001/jama.2016.9432	http://dx.doi.org/10.1001/jama.2016.9432			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT8JL	27552622	Bronze			2022-12-28	WOS:000381736200019
J	[Anonymous]				[Anonymous]			A Safe and Sane Fourth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2016	316	8					812	812		10.1001/jama.2015.17099	http://dx.doi.org/10.1001/jama.2015.17099			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL9WG	27552633				2022-12-28	WOS:000394970200004
J	Birchler, JA				Birchler, James A.			PLANT SCIENCE Hybrid vigour characterized	NATURE			English	Editorial Material							HETEROSIS; BALANCE; TOMATO; YIELD	Crossing different plant varieties to improve yield and fertility is common practice. A dissection of the genomic architecture that underlies such hybrid vigour might help to inform future crop-improvement strategies. See Article p.629	[Birchler, James A.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Birchler, JA (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	birchlerj@missouri.edu						Birchler JA, 2016, PLANT SCI, V245, P128, DOI 10.1016/j.plantsci.2016.02.002; Birchler JA, 2012, P NATL ACAD SCI USA, V109, P14746, DOI 10.1073/pnas.1207726109; BUSBICE TH, 1966, EUPHYTICA, V15, P52; Chen ZJ, 2013, NAT REV GENET, V14, P471, DOI 10.1038/nrg3503; East EM, 1936, GENETICS, V21, P375; Huang XH, 2016, NATURE, V537, P629, DOI 10.1038/nature19760; Jiang K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004043; Jones DF, 1917, GENETICS, V2, P466; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; Park SJ, 2014, NAT GENET, V46, P1337, DOI 10.1038/ng.3131; Schnable PS, 2013, ANNU REV PLANT BIOL, V64, P71, DOI 10.1146/annurev-arplant-042110-103827; Singh R, 2013, NATURE, V500, P340, DOI 10.1038/nature12356; Yao H, 2013, P NATL ACAD SCI USA, V110, P2665, DOI 10.1073/pnas.1221966110	13	8	9	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2016	537	7622					620	621		10.1038/nature19433	http://dx.doi.org/10.1038/nature19433			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4DR	27602522				2022-12-28	WOS:000384331700032
J	Voelker, R				Voelker, Rebecca			New Lens Helps Patients See Near, Far, and In-between	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2016	316	9					918	918		10.1001/jama.2016.11448	http://dx.doi.org/10.1001/jama.2016.11448			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU8JV	27599323				2022-12-28	WOS:000382460200008
J	[Anonymous]				[Anonymous]			Case Finding in Tuberculosis (Reprint of vol 116, pg 2278-2279, 1941)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		REILING J, 1941, JAMA-J AM MED ASSOC, V116, P2278	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2016	316	9					997	997		10.1001/jama.2015.17100	http://dx.doi.org/10.1001/jama.2015.17100			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU8JV	27599347				2022-12-28	WOS:000382460200034
J	Reiman, EM				Reiman, Eric M.			Attack on amyloid-beta protein	NATURE			English	Editorial Material							DISEASE		[Reiman, Eric M.] Banner Alzheimers Inst, Phoenix, AZ 85006 USA	Banner Research; Banner Health; Banner Alzheimer's Institute	Reiman, EM (corresponding author), Banner Alzheimers Inst, Phoenix, AZ 85006 USA.	eric.reiman@bannerhealth.com						Fleisher AS, 2015, JAMA NEUROL, V72, P316, DOI 10.1001/jamaneurol.2014.3314; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Reiman EM, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.177; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P367, DOI 10.1016/j.jalz.2011.05.2351; Yu YJ, 2013, NEUROTHERAPEUTICS, V10, P459, DOI 10.1007/s13311-013-0187-4	7	35	37	4	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					36	37		10.1038/537036a	http://dx.doi.org/10.1038/537036a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU7XC	27582214				2022-12-28	WOS:000382426900028
J	Hatzes, AP				Hatzes, Artie P.			ASTRONOMY Earth-like planet around Sun's neighbour	NATURE			English	Editorial Material							SPECTRUM; STAR		[Hatzes, Artie P.] Thuringian State Observ, D-07778 Tautenburg, Germany		Hatzes, AP (corresponding author), Thuringian State Observ, D-07778 Tautenburg, Germany.	artie@tls-tautenburg.de						Adams FC, 1997, REV MOD PHYS, V69, P337, DOI 10.1103/RevModPhys.69.337; Anglada-Escude G, 2016, NATURE, V536, P437, DOI 10.1038/nature19106; Bean JL, 2010, NATURE, V468, P669, DOI 10.1038/nature09596; de Kok RJ, 2013, ASTRON ASTROPHYS, V554, DOI 10.1051/0004-6361/201321381; Gudel M, 2004, ASTRON ASTROPHYS, V416, P713, DOI 10.1051/0004-6361:20031471; Pepe F, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201117055; Ricker GR, 2015, J ASTRON TELESC INST, V1, DOI 10.1117/1.JATIS.1.1.014003	10	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					408	409		10.1038/536408a	http://dx.doi.org/10.1038/536408a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV0YL	27558062				2022-12-28	WOS:000382646600032
J	Huang, PX; Nedelcu, D; Watanabe, M; Jao, C; Kim, Y; Liu, J; Salic, A				Huang, Pengxiang; Nedelcu, Daniel; Watanabe, Miyako; Jao, Cindy; Kim, Youngchang; Liu, Jing; Salic, Adrian			Cellular Cholesterol Directly Activates Smoothened in Hedgehog Signaling	CELL			English	Article							PRIMARY CILIUM; PROTEIN; CELLS; RECEPTOR; PATHWAY; BINDING; OXYSTEROLS; MODULATION; MECHANISM; COMPLEX	In vertebrates, sterols are necessary for Hedgehog signaling, a pathway critical in embryogenesis and cancer. Sterols activate the membrane protein Smoothened by binding its extracellular, cysteine-rich domain (CRD). Major unanswered questions concern the nature of the endogenous, activating sterol and the mechanism by which it regulates Smoothened. We report crystal structures of CRD complexed with sterols and alone, revealing that sterols induce a dramatic conformational change of the binding site, which is sufficient for Smoothened activation and is unique among CRD-containing receptors. We demonstrate that Hedgehog signaling requires sterol binding to Smoothened and define key residues for sterol recognition and activity. We also show that cholesterol itself binds and activates Smoothened. Furthermore, the effect of oxysterols is abolished in Smoothened mutants that retain activation by cholesterol and Hedgehog. We propose that the endogenous Smoothened activator is cholesterol, not oxysterols, and that vertebrate Hedgehog signaling controls Smoothened by regulating its access to cholesterol.	[Huang, Pengxiang; Nedelcu, Daniel; Watanabe, Miyako; Jao, Cindy; Liu, Jing; Salic, Adrian] Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA; [Kim, Youngchang] Argonne Natl Lab, Biosci Div, Struct Biol Ctr, Argonne, IL 60439 USA	Harvard University; Harvard Medical School; United States Department of Energy (DOE); Argonne National Laboratory	Salic, A (corresponding author), Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	asalic@hms.harvard.edu	Liu, Jing/C-9666-2014; Salic, Adrian/GXG-1611-2022	Liu, Jing/0000-0001-9513-3591; Kim, Youngchang/0000-0002-1610-4889	NIH [RO1 GM092924, GM110041]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110041, R01GM092924] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants RO1 GM092924 and GM110041 to A.S. We thank members of the Salic lab for helpful discussions and members of the Structural Biology Center at Argonne National Laboratory for help with data collection at the 19-ID beam line.	Aanstad P, 2009, CURR BIOL, V19, P1034, DOI 10.1016/j.cub.2009.04.053; Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Bazan JF, 2009, CELL, V138, P1055, DOI 10.1016/j.cell.2009.09.006; Braberg H, 2012, BIOINFORMATICS, V28, P2072, DOI 10.1093/bioinformatics/bts302; Carroll JN, 1998, CHEM PHYS LIPIDS, V94, P209, DOI 10.1016/S0009-3084(98)00058-9; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Cooper MK, 2003, NAT GENET, V33, P508, DOI 10.1038/ng1134; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Dijkgraaf GJP, 2011, CANCER RES, V71, P435, DOI 10.1158/0008-5472.CAN-10-2876; Dorn KV, 2012, DEV CELL, V23, P823, DOI 10.1016/j.devcel.2012.07.004; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; GIMPL G, 1995, BIOCHEMISTRY-US, V34, P13794, DOI 10.1021/bi00042a010; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Jao CY, 2015, CHEMBIOCHEM, V16, P611, DOI 10.1002/cbic.201402715; Kim WK, 2007, J BONE MINER RES, V22, P1711, DOI 10.1359/JBMR.070710; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Myers BR, 2013, DEV CELL, V26, P346, DOI 10.1016/j.devcel.2013.07.015; Nachtergaele S, 2013, ELIFE, V2, DOI 10.7554/eLife.01340; Nachtergaele S, 2012, NAT CHEM BIOL, V8, P211, DOI 10.1038/nchembio.765; NAKANO Y, 1989, NATURE, V341, P508, DOI 10.1038/341508a0; Nedelcu D, 2013, NAT CHEM BIOL, V9, P557, DOI [10.1038/NCHEMBIO.1290, 10.1038/nchembio.1290]; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Tukachinsky H, 2012, CELL REPORTS, V2, P308, DOI 10.1016/j.celrep.2012.07.010; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Xie CL, 1999, P NATL ACAD SCI USA, V96, P11992, DOI 10.1073/pnas.96.21.11992; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386	44	223	229	1	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1176	+		10.1016/j.cell.2016.08.003	http://dx.doi.org/10.1016/j.cell.2016.08.003			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27545348	Green Accepted, Bronze			2022-12-28	WOS:000382259500015
J	Topol, E				Topol, Eric			Digital medicine: empowering both patients and clinicians	LANCET			English	Editorial Material									[Topol, Eric] Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Topol, Eric] Scripps Res Inst, La Jolla, CA 92037 USA; [Topol, Eric] Scripps Hlth, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Topol, E (corresponding author), Scripps Translat Sci Inst, La Jolla, CA 92037 USA.; Topol, E (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.; Topol, E (corresponding author), Scripps Hlth, La Jolla, CA 92037 USA.	etopol@scripps.edu						[Anonymous], 2015, ECONOMIST; Steinhubl SR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3487; Topol E., 2015, PATIENT WILL SEE YOU; Topol EJ, 2015, JAMA-J AM MED ASSOC, V313, P353, DOI 10.1001/jama.2014.17125	4	21	22	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 20	2016	388	10046					740	741		10.1016/S0140-6736(16)31355-1	http://dx.doi.org/10.1016/S0140-6736(16)31355-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT6UH	27560260				2022-12-28	WOS:000381619200008
J	Powers, BW; Rinefort, S; Jain, SH				Powers, Brian W.; Rinefort, Scott; Jain, Sachin H.			Nonemergency Medical Transportation Delivering Care in the Era of Lyft and Uber	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH-CARE		[Powers, Brian W.] Harvard Med Sch, Boston, MA USA; [Powers, Brian W.] Harvard Sch Business, Boston, MA USA; [Powers, Brian W.; Rinefort, Scott; Jain, Sachin H.] Anthem Inc, CareMore Hlth Syst, 12900 Pk Plaza Dr,Ste 150, Cerritos, CA 90703 USA; [Jain, Sachin H.] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA	Harvard University; Harvard Medical School; Harvard University; Stanford University	Jain, SH (corresponding author), Anthem Inc, CareMore Hlth Syst, 12900 Pk Plaza Dr,Ste 150, Cerritos, CA 90703 USA.	sachin.jain@caremore.com						Chan KE, 2014, J AM SOC NEPHROL, V25, P2642, DOI 10.1681/ASN.2013111160; Detsky AS, 2016, NEW ENGL J MED, V374, P806, DOI 10.1056/NEJMp1512206; Government Accountability Office, 2016, NON MED TRANSP UPD M; Swanson BL, STATE 2016 MEDICARE; Syed ST, 2013, J COMMUN HEALTH, V38, P976, DOI 10.1007/s10900-013-9681-1; Transit Cooperative Research Program, 2005, COST BEN AN PROV NON	6	63	64	0	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2016	316	9					921	922		10.1001/jama.2016.9970	http://dx.doi.org/10.1001/jama.2016.9970			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU8JV	27599325				2022-12-28	WOS:000382460200010
J	Horton, R				Horton, Richard			Offline: Africa-the incarceration of a continent	LANCET			English	Editorial Material												richard.horton@lancet.com							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2016	388	10048					946	946		10.1016/S0140-6736(16)31531-8	http://dx.doi.org/10.1016/S0140-6736(16)31531-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU9GL	27598665	Bronze			2022-12-28	WOS:000382524400009
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Groundhog days for doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2016	354								i4726	10.1136/bmj.i4726	http://dx.doi.org/10.1136/bmj.i4726			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AF	27590196	Green Published, Bronze			2022-12-28	WOS:000382792700001
J	Kovachy, T; Asenbaum, P; Overstreet, C; Donnelly, CA; Dickerson, SM; Sugarbaker, A; Hogan, JM; Kasevich, MA				Kovachy, T.; Asenbaum, P.; Overstreet, C.; Donnelly, C. A.; Dickerson, S. M.; Sugarbaker, A.; Hogan, J. M.; Kasevich, M. A.			Verifying quantum superpositions at metre scales Reply	NATURE			English	Letter									[Kovachy, T.; Asenbaum, P.; Overstreet, C.; Donnelly, C. A.; Dickerson, S. M.; Sugarbaker, A.; Hogan, J. M.; Kasevich, M. A.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA	Stanford University	Kovachy, T (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.	kasevich@stanford.edu		Hogan, Jason/0000-0003-1218-2692				[Anonymous], 1965, FEYNMAN LECT PHYS QU; COHENTANNOUDJI C, 1977, QUANTUM MECH, V1, pCHE3; Hogan J. M., 2009, P INT SCH PHYS, P411, DOI [DOI 10.3254/978-1-58603-990-5-411, 10.3254/978-1-58603-990-5-411]; Javanainen J, 1999, PHYS REV A, V60, P2351, DOI 10.1103/PhysRevA.60.2351; Kovachy T, 2015, NATURE, V528, P530, DOI 10.1038/nature16155; PFLEEGOR RL, 1967, PHYS REV, V159, P1084, DOI 10.1103/PhysRev.159.1084; STAMPERKURN D, 2016, NATURE, V537	7	5	5	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					E2	E3		10.1038/nature19109	http://dx.doi.org/10.1038/nature19109			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27582226				2022-12-28	WOS:000382426900058
J	Hand, E				Hand, Eric			ATMOSPHERIC SCIENCE NASA flies into Namibia's cloud laboratory	SCIENCE			English	News Item																			0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					853	854		10.1126/science.353.6302.853	http://dx.doi.org/10.1126/science.353.6302.853			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU0CA	27563076				2022-12-28	WOS:000381867700009
J	Ye, H; Sugihara, G				Ye, Hao; Sugihara, George			Information leverage in interconnected ecosystems: Overcoming the curse of dimensionality	SCIENCE			English	Article							CHAOS	In ecological analysis, complexity has been regarded as an obstacle to overcome. Here we present a straightforward approach for addressing complexity in dynamic interconnected systems. We show that complexity, in the form of multiple interacting components, can actually be an asset for studying natural systems from temporal data. The central idea is that multidimensional time series enable system dynamics to be reconstructed from multiple viewpoints, and these viewpoints can be combined into a single model. We show how our approach, multiview embedding (MVE), can improve forecasts for simulated ecosystems and a mesocosm experiment. By leveraging complexity, MVE is particularly effective for overcoming the limitations of short and noisy time series and should be highly relevant for many areas of science.	[Ye, Hao; Sugihara, George] Univ Calif San Diego, Scripps Inst Oceanog, 9500 Gilman Dr 0202, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Sugihara, G (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, 9500 Gilman Dr 0202, La Jolla, CA 92093 USA.	gsugihara@ucsd.edu	Ye, Hao/HGD-5399-2022	Ye, Hao/0000-0002-8630-1458	U.S. Department of Defense Strategic Environmental Research and Development Program [15 RC-2509]; Lenfest Ocean Program award [00028335]; NSF [DEB-1020372]; McQuown Chair in the Natural Sciences; Sugihara Family Trust	U.S. Department of Defense Strategic Environmental Research and Development Program(United States Department of Defense); Lenfest Ocean Program award; NSF(National Science Foundation (NSF)); McQuown Chair in the Natural Sciences; Sugihara Family Trust	We thank S. Glaser, C. Hsieh, E. Deyle, and S. Munch for suggestions and feedback on early drafts of this work. This work was supported by U.S. Department of Defense Strategic Environmental Research and Development Program 15 RC-2509, Lenfest Ocean Program award 00028335, NSF grant DEB-1020372, the McQuown Chair in the Natural Sciences, and the Sugihara Family Trust. Mesocosm data are available in the appendix of (28); model simulation data are available in Data S1.	Beninca E, 2009, ECOL LETT, V12, P1367, DOI 10.1111/j.1461-0248.2009.01391.x; Boyd D, 2012, INFORM COMMUN SOC, V15, P662, DOI 10.1080/1369118X.2012.678878; Carroll TL, 2012, CHAOS, V22, DOI 10.1063/1.3702566; CASDAGLI M, 1991, PHYSICA D, V51, P52, DOI 10.1016/0167-2789(91)90222-U; Clark AT, 2015, ECOLOGY, V96, P1174, DOI 10.1890/14-1479.1; DeAngelis DL, 2015, P NATL ACAD SCI USA, V112, P3856, DOI 10.1073/pnas.1503154112; Dennis B, 2001, ECOL MONOGR, V71, P277, DOI 10.1890/0012-9615(2001)071[0277:ECACDI]2.0.CO;2; Deyle ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018295; Dixon PA, 1999, SCIENCE, V283, P1528, DOI 10.1126/science.283.5407.1528; Donoho D. L., 2000, AM MATH SOC MATH CHA; Duda RO, 2001, PATTERN CLASSIFICATI, V2nd, P20; Fan JQ, 2014, NATL SCI REV, V1, P293, DOI 10.1093/nsr/nwt032; Fulton E. A., 2001, THESIS; HASTINGS A, 1991, ECOLOGY, V72, P896, DOI 10.2307/1940591; Heerkloss R, 1998, INT VER THEOR ANGEW, V26, P1952; Hsieh CH, 2008, AM NAT, V171, P71, DOI 10.1086/524202; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; Kalman RE., 1960, T ASME J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; McBride JC, 2015, NEUROIMAGE-CLIN, V7, P258, DOI 10.1016/j.nicl.2014.12.005; OTT E, 1990, PHYS REV LETT, V64, P1196, DOI 10.1103/PhysRevLett.64.1196; Rikkert MGMO, 2016, CRIT CARE MED, V44, P601, DOI 10.1097/CCM.0000000000001564; SAUER T, 1991, J STAT PHYS, V65, P579, DOI 10.1007/BF01053745; SAUER T, 1992, PHYSICA D, V58, P193, DOI 10.1016/0167-2789(92)90108-Y; STONE CJ, 1977, ANN STAT, V5, P595, DOI 10.1214/aos/1176343886; SUGIHARA G, 1990, NATURE, V344, P734, DOI 10.1038/344734a0; SUGIHARA G, 1994, PHILOS T R SOC A, V348, P477, DOI 10.1098/rsta.1994.0106; Sugihara G, 2012, SCIENCE, V338, P496, DOI 10.1126/science.1227079; Takens F., 1981, DYNAMICAL SYSTEMS TU, V898, P366, DOI [10.1007/bfb0091924, DOI 10.1007/BFB0091924, 10.1007/BFb0091924]	30	72	73	7	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					922	925		10.1126/science.aag0863	http://dx.doi.org/10.1126/science.aag0863			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU0CA	27563095				2022-12-28	WOS:000381867700037
J	Shekhar, K; Lapan, SW; Whitney, IE; Tran, NM; Macosko, EZ; Kowalczyk, M; Adiconis, X; Levin, JZ; Nemesh, J; Goldman, M; McCarroll, SA; Cepko, CL; Regev, A; Sanes, JR				Shekhar, Karthik; Lapan, Sylvain W.; Whitney, Irene E.; Tran, Nicholas M.; Macosko, Evan Z.; Kowalczyk, Monika; Adiconis, Xian; Levin, Joshua Z.; Nemesh, James; Goldman, Melissa; McCarroll, Steven A.; Cepko, Constance L.; Regev, Aviv; Sanes, Joshua R.			Comprehensive Classification of Retinal Bipolar Neurons by Single-Cell Transcriptomics	CELL			English	Article							RNA-SEQ; AMACRINE CELLS; EXPRESSION; PATHWAYS; PROTEIN; PARALLEL; GANGLION; IDENTIFICATION; HETEROGENEITY; LOCALIZATION	Patterns of gene expression can be used to characterize and classify neuronal types. It is challenging, however, to generate taxonomies that fulfill the essential criteria of being comprehensive, harmonizing with conventional classification schemes, and lacking superfluous subdivisions of genuine types. To address these challenges, we used massively parallel single-cell RNA profiling and optimized computational methods on a heterogeneous class of neurons, mouse retinal bipolar cells (BCs). From a population of similar to 25,000 BCs, we derived a molecular classification that identified 15 types, including all types observed previously and two novel types, one of which has a non-canonical morphology and position. We validated the classification scheme and identified dozens of novel markers using methods that match molecular expression to cell morphology. This work provides a systematic methodology for achieving comprehensive molecular classification of neurons, identifies novel neuronal types, and uncovers transcriptional differences that distinguish types within a class.	[Shekhar, Karthik; Kowalczyk, Monika; Adiconis, Xian; Levin, Joshua Z.; Regev, Aviv] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Lapan, Sylvain W.; Macosko, Evan Z.; Nemesh, James; Goldman, Melissa; McCarroll, Steven A.; Cepko, Constance L.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Cepko, Constance L.] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA; [Whitney, Irene E.; Tran, Nicholas M.; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02130 USA; [Whitney, Irene E.; Tran, Nicholas M.; Sanes, Joshua R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02130 USA; [Macosko, Evan Z.; Adiconis, Xian; Levin, Joshua Z.; Nemesh, James; Goldman, Melissa; McCarroll, Steven A.] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [McCarroll, Steven A.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Lapan, Sylvain W.; Cepko, Constance L.; Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02139 USA; [Regev, Aviv] MIT, Koch Inst, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Regev, A (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.; Cepko, CL (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Cepko, CL (corresponding author), Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA.; Sanes, JR (corresponding author), Harvard Univ, Ctr Brain Sci, Cambridge, MA 02130 USA.; Sanes, JR (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02130 USA.; Cepko, CL; Regev, A (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Regev, A (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.; Regev, A (corresponding author), MIT, Koch Inst, Cambridge, MA 02139 USA.	cepko@genetics.med.harvard.edu; aregev@broadinstitute.org; sanesj@mcb.harvard.edu	Macosko, Evan/X-4664-2019	Levin, Joshua/0000-0002-0170-3598; Tran, Nicholas/0000-0002-4213-3499	Klarman Cell Observatory; National Institute of Mental Health (NIMH) [U01MH105960, EY024833-02]; Charles A. King Trust Postdoctoral Research Fellowship Program, Bank of America, N.A.; imeon J. Fortin Charitable Foundation, Bank of America, N.A.; NATIONAL EYE INSTITUTE [F32EY024833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH094612, U01MH105960] Funding Source: NIH RePORTER	Klarman Cell Observatory; National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Charles A. King Trust Postdoctoral Research Fellowship Program, Bank of America, N.A.; imeon J. Fortin Charitable Foundation, Bank of America, N.A.; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Klarman Cell Observatory (A.R., K.S., M.K., X.A. and J.Z.L.) and National Institute of Mental Health (NIMH) grants U01MH105960 (S.A.M., A.R., and J.R.S.) and EY024833-02 (S.W.L.). C.L.C. and A.R. are investigators of the Howard Hughes Medical Institute. A.R. is a member of the Scientific Advisory Board for Thermo Fisher Scientific and Syros Pharmaceuticals and a consultant for Driver Genomics. E.Z.M., S.A.M., and A.R. have filed a patent for the Drop-seq method. M.S.K. is a recipient of Charles A. King Trust Postdoctoral Research Fellowship Program, Bank of America, N.A., Co-Trustee and the Simeon J. Fortin Charitable Foundation, Bank of America, N.A. We thank Leslie Gaffney and Lior Friedman for artwork and Mark Springel for his contribution to generating the lentiviral vector. The Broad Institute has filed a provisional patent application based on the work in this manuscript.	Baas D, 2000, MOL BRAIN RES, V78, P26, DOI 10.1016/S0169-328X(00)00060-7; Berglund K, 2006, BRAIN CELL BIOL, V35, P207, DOI 10.1007/s11068-008-9019-6; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Borghuis BG, 2014, J NEUROSCI, V34, P6128, DOI 10.1523/JNEUROSCI.4941-13.2014; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breuninger T, 2011, J NEUROSCI, V31, P6504, DOI 10.1523/JNEUROSCI.0616-11.2011; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Cai D, 2013, NAT METHODS, V10, P540, DOI [10.1038/NMETH.2450, 10.1038/nmeth.2450]; Chow RL, 2004, P NATL ACAD SCI USA, V101, P1754, DOI 10.1073/pnas.0306520101; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Della Santina L., 2016, CURR BIOL; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duan X, 2015, NEURON, V85, P1244, DOI 10.1016/j.neuron.2015.02.017; Duan X, 2014, CELL, V158, P793, DOI 10.1016/j.cell.2014.06.047; Elshatory Y, 2007, J COMP NEUROL, V503, P182, DOI 10.1002/cne.21390; Emerson MM, 2011, DEV BIOL, V360, P241, DOI 10.1016/j.ydbio.2011.09.012; Euler T, 2014, NAT REV NEUROSCI, V15, P507, DOI 10.1038/nrn3783; Greene MJ, 2016, CELL REP, V14, P1892, DOI 10.1016/j.celrep.2016.02.001; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Haverkamp S, 2005, J NEUROSCI, V25, P5438, DOI 10.1523/JNEUROSCI.1117-05.2005; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; Haverkamp S, 2009, NEUROSCIENCE, V160, P126, DOI 10.1016/j.neuroscience.2009.01.081; Heimberg G, 2016, CELL SYST, V2, P239, DOI 10.1016/j.cels.2016.04.001; Hellmer CB, 2016, NEUROSCIENCE, V315, P246, DOI 10.1016/j.neuroscience.2015.12.016; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Huang LQ, 2003, J COMP NEUROL, V455, P1, DOI 10.1002/cne.10396; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kay JN, 2012, NATURE, V483, P465, DOI 10.1038/nature10877; Kim DS, 2008, J COMP NEUROL, V507, P1795, DOI 10.1002/cne.21639; Kim DS, 2008, J NEUROSCI, V28, P7748, DOI 10.1523/JNEUROSCI.0397-08.2008; Kim JS, 2014, NATURE, V509, P331, DOI 10.1038/nature13240; KOESTER SE, 1992, J NEUROSCI, V12, P1382; Krishnaswamy A, 2015, NATURE, V524, P466, DOI 10.1038/nature14682; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marcenko V. A., 1967, MATH USSR, V1, P457, DOI [10.1070/SM1967v001n04ABEH001994, DOI 10.1070/SM1967V001N04ABEH001994]; Matutano J.C., 2014, THESIS; McDavid A, 2013, BIOINFORMATICS, V29, P461, DOI 10.1093/bioinformatics/bts714; Misgeld T, 2007, NAT METHODS, V4, P559, DOI 10.1038/NMETH1055; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Prince JEA, 2013, DEVELOPMENT, V140, P2398, DOI 10.1242/dev.087262; Puller C, 2013, NEUROSCIENCE, V243, P136, DOI 10.1016/j.neuroscience.2013.03.054; Puthussery T, 2010, J COMP NEUROL, V518, P513, DOI 10.1002/cne.22234; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Sanes JR, 2015, ANNU REV NEUROSCI, V38, P221, DOI 10.1146/annurev-neuro-071714-034120; Schubert T, 2008, J NEUROPHYSIOL, V100, P304, DOI 10.1152/jn.90202.2008; Seung HS, 2014, NEURON, V83, P1262, DOI 10.1016/j.neuron.2014.08.054; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Taylor WR, 2012, VISUAL NEUROSCI, V29, P73, DOI 10.1017/S0952523811000393; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; Ueda Y, 1997, J NEUROSCI, V17, P3014; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Wagner F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143196; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934	69	558	560	6	85	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1308	+		10.1016/j.cell.2016.07.054	http://dx.doi.org/10.1016/j.cell.2016.07.054			46	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27565351	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000382259500025
J	[Anonymous]				[Anonymous]			RELOCATING SCIENCE	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					S2	S3		10.1038/536S2a	http://dx.doi.org/10.1038/536S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VI2OC	27557158	Bronze			2022-12-28	WOS:000465264600002
J	Passman, R				Passman, Rod			Time in Therapeutic Range in Warfarin-Treated Patients Is Very Good Good Enough?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NORMALIZED RATIO CONTROL; ATRIAL-FIBRILLATION; STROKE PREVENTION; EFFICACY; SAFETY; RIVAROXABAN; HEMORRHAGE; DABIGATRAN; APIXABAN; TRIAL	Importance Vitamin K antagonist (eg, warfarin) use is nowadays challenged by the nonvitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation (AF). NOAC studies were based on comparisons with warfarin arms with times in therapeutic range (TTRs) of 55.2% to 64.9%, making the results less credible in health care systems with higher TTRs. Objectives To evaluate the efficacy and safety of well-managed warfarin therapy in patients with nonvalvular AF, the risk of complications, especially intracranial bleeding, in patients with concomitant use of aspirin, and the impact of international normalized ratio (INR) control. Design, Setting, and Participants A retrospective, multicenter cohort study based on Swedish registries, especially AuriculA, a quality register for AF and oral anticoagulation, was conducted. The register contains nationwide data, including that from specialized anticoagulation clinics and primary health care centers. A total of 40 449 patients starting warfarin therapy owing to nonvalvular AF during the study period were monitored until treatment cessation, death, or the end of the study. The study was conducted from January 1, 2006, to December 31, 2011, and data were analyzed between February 1 and November 15, 2015. Associating complications with risk factors and individual INR control, we evaluated the efficacy and safety of warfarin treatment in patients with concomitant aspirin therapy and those with no additional antiplatelet medications. Exposures Use of warfarin with and without concomitant therapy with aspirin. Main Outcomes and Measures Annual incidence of complications in association with individual TTR (iTTR), INR variability, and aspirin use and identification of factors indicating the probability of intracranial bleeding. Results Of the 40 449 patients included in the study, 16?201 (40.0%) were women; mean (SD) age of the cohort was 72.5 (10.1) years, and the mean CHA2DS2-VASc (cardiac failure or dysfunction, hypertension, age =75 years [doubled], diabetes mellitus, stroke [doubled]vascular disease, age 65-74 years, and sex category [female]) score was 3.3 at baseline. The annual incidence, reported as percentage (95% CI) of all-cause mortality was 2.19% (2.07-2.31) and, for intracranial bleeding, 0.44% (0.39-0.49). Patients receiving concomitant aspirin had annual rates of any major bleeding of 3.07% (2.70-3.44) and thromboembolism of 4.90% (4.43-5.37), and those with renal failure were at higher risk of intracranial bleeding (hazard ratio, 2.25; 95% CI, 1.32-3.82). Annual rates of any major bleeding and any thromboembolism in iTTR less than 70% were 3.81% (3.51-4.11) and 4.41% (4.09-4.73), respectively, and, in high INR variability, were 3.04% (2.85-3.24) and 3.48% (3.27-3.69), respectively. For patients with iTTR 70% or greater, the level of INR variability did not alter event rates. Conclusions and Relevance Well-managed warfarin therapy is associated with a low risk of complications and is still a valid alternative for prophylaxis of AF-associated stroke. Therapy should be closely monitored for patients with renal failure, concomitant aspirin use, and poor INR control.	[Passman, Rod] Northwestern Univ, Dept Med, Bluhm Cardiovasc Inst, Feinberg Sch Med, 676 N St Claire St,Ste 600, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Passman, R (corresponding author), Northwestern Univ, Feinberg Sch Med, Bluhm Cardiovasc Inst, 676 N St Claire St,Ste 600, Chicago, IL 60611 USA.	r-passman@northwestern.edu						Apostolakis S, 2013, CHEST, V144, P1555, DOI 10.1378/chest.13-0054; Bjorck F, 2016, JAMA CARDIOL, V1, P172, DOI 10.1001/jamacardio.2016.0199; Cressman AM, 2015, AM HEART J, V170, P133, DOI 10.1016/j.ahj.2015.03.014; Hankey GJ, 2014, STROKE, V45, P1304, DOI 10.1161/STROKEAHA.113.004506; Harrington AR, 2013, STROKE, V44, P1676, DOI 10.1161/STROKEAHA.111.000402; Rose AJ, 2011, CIRC-CARDIOVASC QUAL, V4, P22, DOI 10.1161/CIRCOUTCOMES.110.957738; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Singer DE, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000067; Wallentin L, 2013, CIRCULATION, V127, P2166, DOI 10.1161/CIRCULATIONAHA.112.142158; Wallentin L, 2010, LANCET, V376, P975, DOI 10.1016/S0140-6736(10)61194-4	10	9	9	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2016	316	8					872	873		10.1001/jama.2016.10402	http://dx.doi.org/10.1001/jama.2016.10402			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT8JL	27552620				2022-12-28	WOS:000381736200017
J	Polkovnikov, A; Sels, D				Polkovnikov, Anatoli; Sels, Dries			Thermalization in small quantum systems	SCIENCE			English	Editorial Material							MANY-BODY LOCALIZATION; STATISTICAL-MECHANICS; ENTANGLEMENT; CHAOS		[Polkovnikov, Anatoli; Sels, Dries] Boston Univ, Dept Phys, Boston, MA 02215 USA	Boston University	Polkovnikov, A (corresponding author), Boston Univ, Dept Phys, Boston, MA 02215 USA.	asp@buphy.bu.edu	Polkovnikov, Anatoli/HDM-9329-2022					Borgonovi F, 2016, PHYS REP, V626, P1, DOI 10.1016/j.physrep.2016.02.005; Choi JY, 2016, SCIENCE, V352, P1547, DOI 10.1126/science.aaf8834; D'Alessio L, 2016, ADV PHYS, V65, P239, DOI 10.1080/00018732.2016.1198134; Daley AJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.020505; DEUTSCH JM, 1991, PHYS REV A, V43, P2046, DOI 10.1103/PhysRevA.43.2046; Eisert J, 2015, NAT PHYS, V11, P124, DOI [10.1038/nphys3215, 10.1038/NPHYS3215]; Goldstein S, 2010, P ROY SOC A-MATH PHY, V466, P3203, DOI 10.1098/rspa.2009.0635; Islam R, 2015, NATURE, V528, P77, DOI 10.1038/nature15750; Kaufman AM, 2016, SCIENCE, V353, P794, DOI 10.1126/science.aaf6725; Rigol M, 2008, NATURE, V452, P854, DOI 10.1038/nature06838; Schreiber M, 2015, SCIENCE, V349, P842, DOI 10.1126/science.aaa7432; SREDNICKI M, 1994, PHYS REV E, V50, P888, DOI 10.1103/PhysRevE.50.888	12	7	7	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					752	753		10.1126/science.aah5776	http://dx.doi.org/10.1126/science.aah5776			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZE	27540153	Green Submitted			2022-12-28	WOS:000381561400021
J	Berg, CD				Berg, Christine D.			Breast Cancer Screening Interval: Risk Level May Matter	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TRIAL; LUNG		[Berg, Christine D.] Johns Hopkins Med, Bethesda, MD 20852 USA	Johns Hopkins University; Johns Hopkins Medicine	Berg, CD (corresponding author), Johns Hopkins Med, Bethesda, MD 20852 USA.	drchrisberg@aol.com						Bernardi D, 2012, RADIOL MED, V117, P519, DOI 10.1007/s11547-011-0777-3; Kovalchik SA, 2013, NEW ENGL J MED, V369, P245, DOI 10.1056/NEJMoa1301851; Moss SM, 2015, LANCET ONCOL, V16, P1123, DOI 10.1016/S1470-2045(15)00128-X; Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783; Pinsky PF, 2007, AM J EPIDEMIOL, V165, P874, DOI 10.1093/aje/kwk075; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Siu AL, 2016, ANN INTERN MED, V164, P279, DOI 10.7326/M15-2886; Trentham-Dietz A, 2016, ANN INTERN MED, V165, P700, DOI 10.7326/M16-0476	8	0	0	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	2016	165	10					737	738		10.7326/M16-1791	http://dx.doi.org/10.7326/M16-1791			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC2RB	27548697				2022-12-28	WOS:000387970500021
J	Kelly, CR; Khoruts, A; Staley, C; Sadowsky, MJ; Abd, M; Alani, M; Bakow, B; Curran, P; McKenney, J; Tisch, A; Reinert, SE; Machan, JT; Brandt, LJ				Kelly, Colleen R.; Khoruts, Alexander; Staley, Christopher; Sadowsky, Michael J.; Abd, Mortadha; Alani, Mustafa; Bakow, Brianna; Curran, Patrizia; McKenney, Joyce; Tisch, Allison; Reinert, Steven E.; Machan, Jason T.; Brandt, Lawrence J.			Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CLINICAL-TRIAL; IRRITABLE-BOWEL-SYNDROME; DISEASE; EPIDEMIOLOGY; VANCOMYCIN; PREVENTION; GUIDELINES; RESOLUTION; DIAGNOSIS; DIARRHEA	Background: To date, evidence for the efficacy of fecal microbiota transplantation (FMT) in recurrent Clostridium difficile infection (CDI) has been limited to case series and open-label clinical trials. Objective: To determine the efficacy and safety of FMT for treatment of recurrent CDI. Design: Randomized, controlled, double-blind clinical trial. (ClinicalTrials.gov: NCT01703494) Setting: Two academic medical centers. Patients: 46 patients who had 3 or more recurrences of CDI and received a full course of vancomycin for their most recent acute episode. Intervention: Fecal microbiota transplantation with donor stool (heterologous) or patient's own stool (autologous) administered by colonoscopy. Measurements: The primary end point was resolution of diarrhea without the need for further anti-CDI therapy during the 8-week follow-up. Safety data were compared between treatment groups via review of adverse events (AEs), serious AEs (SAEs), and new medical conditions for 6 months after FMT. Fecal microbiota analyses were performed on patients' stool before and after FMT and also on donors' stool. Results: In the intention-to-treat analysis, 20 of 22 patients (90.9%) in the donor FMT group achieved clinical cure compared with 15 of 24 (62.5%) in the autologous FMT group (P = 0.042). Resolution after autologous FMT differed by site (9 of 10 vs. 6 of 14 [ P = 0.033]). All 9 patients who developed recurrent CDI after autologous FMT were free of further CDI after subsequent donor FMT. There were no SAEs related to FMT. Donor FMT restored gut bacterial community diversity and composition to resemble that of healthy donors. Limitation: The study included only patients who had 3 or more recurrences and excluded those who were immunocompromised and aged 75 years or older. Conclusion: Donor stool administered via colonoscopy seemed safe and was more efficacious than autologous FMT in preventing further CDI episodes.	Brown Univ, Miriam Hosp, Warren Alpert Med Sch, Providence, RI 02912 USA; Lifespan Hosp Syst, Providence, RI USA; Univ Minnesota, Minneapolis, MN USA; Albert Einstein Coll Med, Montefiore Med Ctr, Bronx, NY 10467 USA; Univ Rhode Isl, Kingston, RI 02881 USA; [Kelly, Colleen R.; Curran, Patrizia; McKenney, Joyce] Miriam Hosp, Womens Med Collaborat, 146 West River St,Suite 11C, Providence, RI 02904 USA; [Khoruts, Alexander] Univ Minnesota, Dept Med, Div Gastroenterol Hepatol & Nutr, 420 Delaware St SE,MMC 36, Minneapolis, MN 55455 USA; [Staley, Christopher; Sadowsky, Michael J.] Inst Biotechnol, 1479 Gortner Ave,Suite 140, St Paul, MN 55108 USA; [Abd, Mortadha; Brandt, Lawrence J.] Albert Einstein Coll Med, 625 Ullmann Bldg,1300 Morris Pk Ave, Bronx, NY 10461 USA; [Alani, Mustafa] Albert Einstein Coll Med, Montefiore Med Ctr, Div Gastroenterol, Dept Med, 111 East 210th St, Bronx, NY 10467 USA; [Bakow, Brianna] Brown Univ, Warren Alpert Med Sch, Box G-A1, Providence, RI 02912 USA; [Tisch, Allison] Optum Care Plus, 475 Kilvert St,Suite 310, Warwick, RI 02886 USA; [Reinert, Steven E.] Lifespan Informat Serv, Coro Bldg,167 Point St, Providence, RI 02903 USA; [Machan, Jason T.] Rhode Isl Hosp, Lifespan Biostat Core, 593 Eddy St,Grads Dorm 206A, Providence, RI 02903 USA	Brown University; Lifespan Health Rhode Island; Miriam Hospital; Lifespan Health Rhode Island; University of Minnesota System; University of Minnesota Twin Cities; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Rhode Island; Lifespan Health Rhode Island; Miriam Hospital; University of Minnesota System; University of Minnesota Twin Cities; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Brown University; Optum; Lifespan Health Rhode Island; Rhode Island Hospital	Kelly, CR (corresponding author), Miriam Hosp, Womens Med Collaborat, 146 West River St,Suite 11C, Providence, RI 02904 USA.	colleen_r_kelly@brown.edu	Khoruts, Alexander/ABF-5119-2020; Abd, Mortadha/AAX-4717-2020; Staley, Christopher/K-1142-2019; Machan, Jason/D-3897-2013; Sadowsky, Michael/J-2507-2016	Khoruts, Alexander/0000-0002-3205-3188; Staley, Christopher/0000-0002-2309-0083; Machan, Jason/0000-0003-2048-4914; Sadowsky, Michael/0000-0001-8779-2781	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health [1R21DK0939839]; National Institutes of Health [R21AI114722-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI114722] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Drs. Kelly and Brandt received funding from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (1R21DK0939839). Drs. Khoruts and Sadowsky received grant support from the National Institutes of Health (R21AI114722-01).	Acar EF, 2013, BIOMETRICS, V69, P427, DOI 10.1111/biom.12006; Agrawal M, 2016, J CLIN GASTROENTEROL, V50, P403, DOI 10.1097/MCG.0000000000000410; Baxter M, 2015, CLIN INFECT DIS, V61, P140, DOI 10.1093/cid/civ247; Brandt LJ, 2012, AM J GASTROENTEROL, V107, P1079, DOI 10.1038/ajg.2012.60; Cammarota G, 2015, ALIMENT PHARM THER, V41, P835, DOI 10.1111/apt.13144; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Gerding DN, 2015, JAMA-J AM MED ASSOC, V313, P1719, DOI 10.1001/jama.2015.3725; Gough E, 2011, CLIN INFECT DIS, V53, P994, DOI 10.1093/cid/cir632; Guo B, 2012, ALIMENT PHARM THER, V35, P865, DOI 10.1111/j.1365-2036.2012.05033.x; Hamilton MJ, 2013, GUT MICROBES, V4, P125, DOI 10.4161/gmic.23571; Jackson M., 2015, J CLIN GASTROENTEROL; Kassam Z, 2013, AM J GASTROENTEROL, V108, P500, DOI 10.1038/ajg.2013.59; Kelly CR, 2014, AM J GASTROENTEROL, V109, P1065, DOI 10.1038/ajg.2014.133; Koo HL, 2014, INFECT CONT HOSP EP, V35, P667, DOI 10.1086/676433; Lee CH, 2016, JAMA-J AM MED ASSOC, V315, P142, DOI 10.1001/jama.2015.18098; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; McFarland LV, 1999, INFECT CONT HOSP EP, V20, P43, DOI 10.1086/501553; McFarland LV, 2002, AM J GASTROENTEROL, V97, P1769, DOI 10.1111/j.1572-0241.2002.05839.x; Piche T, 2007, CAN J GASTROENTEROL, V21, P727, DOI 10.1155/2007/262478; Pimentel M, 2011, NEW ENGL J MED, V364, P22, DOI 10.1056/NEJMoa1004409; Polage CR, 2015, JAMA INTERN MED, V175, P1792, DOI 10.1001/jamainternmed.2015.4114; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shankar V, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-13; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Surawicz CM, 2000, CLIN INFECT DIS, V31, P1012, DOI 10.1086/318130; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Wilcox MH, 2010, J CLIN MICROBIOL, V48, P4347, DOI 10.1128/JCM.02028-10; Zipursky JS, 2012, CLIN INFECT DIS, V55, P1652, DOI 10.1093/cid/cis809	29	365	380	2	67	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	2016	165	9					609	+		10.7326/M16-0271	http://dx.doi.org/10.7326/M16-0271			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA8SJ	27547925	Green Accepted			2022-12-28	WOS:000386908600003
J	Fiedorczuk, K; Letts, JA; Degliesposti, G; Kaszuba, K; Skehel, M; Sazanov, LA				Fiedorczuk, Karol; Letts, James A.; Degliesposti, Gianluca; Kaszuba, Karol; Skehel, Mark; Sazanov, Leonid A.			Atomic structure of the entire mammalian mitochondrial complex I	NATURE			English	Article							CRYSTAL-STRUCTURE; MEMBRANE DOMAIN; NADH; UBIQUINONE; PREDICTION; MODEL; ARCHITECTURE; RESOLUTION; MECHANISM; SITE	Mitochondrial complex I (also known as NADH: ubiquinone oxidoreductase) contributes to cellular energy production by transferring electrons from NADH to ubiquinone coupled to proton translocation across the membrane(1,2). It is the largest protein assembly of the respiratory chain with a total mass of 970 kilodaltons(3). Here we present a nearly complete atomic structure of ovine (Ovis aries) mitochondrial complex I at 3.9 angstrom resolution, solved by cryo-electron microscopy with cross-linking and mass-spectrometry mapping experiments. All 14 conserved core subunits and 31 mitochondria-specific supernumerary subunits are resolved within the L-shaped molecule. The hydrophilic matrix arm comprises flavin mononucleotide and 8 iron-sulfur clusters involved in electron transfer, and the membrane arm contains 78 transmembrane helices, mostly contributed by antiporter-like subunits involved in proton translocation. Supernumerary subunits form an interlinked, stabilizing shell around the conserved core. Tightly bound lipids (including cardiolipins) further stabilize interactions between the hydrophobic subunits. Subunits with possible regulatory roles contain additional cofactors, NADPH and two phosphopantetheine molecules, which are shown to be involved in inter-subunit interactions. We observe two different conformations of the complex, which may be related to the conformationally driven coupling mechanism and to the active-deactive transition of the enzyme. Our structure provides insight into the mechanism, assembly, maturation and dysfunction of mitochondrial complex I, and allows detailed molecular analysis of disease-causing mutations.	[Fiedorczuk, Karol; Letts, James A.; Kaszuba, Karol; Sazanov, Leonid A.] IST Austria, A-3400 Klosterneuburg, Austria; [Fiedorczuk, Karol] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Degliesposti, Gianluca; Skehel, Mark] MRC, Mol Biol Lab, Cambridge CB2 OQH, England	Institute of Science & Technology - Austria	Sazanov, LA (corresponding author), IST Austria, A-3400 Klosterneuburg, Austria.	sazanov@ist.ac.at	Sazanov, Leonid A/ABF-2125-2021; Degliesposti, Gianluca/AAR-3501-2020; Letts, James Anthony/AAN-6632-2020; Fiedorczuk, Karol/ABC-1161-2021	Sazanov, Leonid A/0000-0002-0977-7989; Degliesposti, Gianluca/0000-0001-6387-2533; Letts, James Anthony/0000-0002-9864-3586; 	Medical Research Council UK; FEBS; European Union [701309]; MRC [MC_U105674180, MC_U105178788] Funding Source: UKRI; Medical Research Council [MC_U105674180, 1601061, MC_U105178788, 1373852] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FEBS; European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the ETH Zurich ScopeM Center for access to Titan Krios EM. Data processing was performed at the IST high-performance computer cluster. K.F. is partially funded by the Medical Research Council UK PhD fellowship. J.A.L. holds a long-term fellowship from FEBS. This project has received funding from the European Union's 2020 research and innovation programme under grant agreement No 701309.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allegretti M, 2014, ELIFE, V3, DOI 10.7554/eLife.01963; Angerer Heike, 2015, Biology-Basel, V4, P133, DOI 10.3390/biology4010133; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Belevich G, 2011, MOL MICROBIOL, V82, P1086, DOI 10.1111/j.1365-2958.2011.07883.x; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Cronan JE, 2014, BIOCHEM J, V460, P157, DOI 10.1042/BJ20140239; DiMaio F, 2015, NAT METHODS, V12, P361, DOI [10.1038/nmeth.3286, 10.1038/NMETH.3286]; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159; Galkin A, 2006, BBA-BIOENERGETICS, V1757, P1575, DOI 10.1016/j.bbabio.2006.10.001; Kahraman A, 2011, BIOINFORMATICS, V27, P2163, DOI 10.1093/bioinformatics/btr348; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kmita K, 2015, P NATL ACAD SCI USA, V112, P5685, DOI 10.1073/pnas.1424353112; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leitner A, 2014, NAT PROTOC, V9, P120, DOI 10.1038/nprot.2013.168; Letts J. A., 2016, NATURE; Letts JA, 2015, CURR OPIN STRUC BIOL, V33, P135, DOI 10.1016/j.sbi.2015.08.008; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meents A, 2010, P NATL ACAD SCI USA, V107, P1094, DOI 10.1073/pnas.0905481107; Moser CC, 2006, BBA-BIOENERGETICS, V1757, P1096, DOI 10.1016/j.bbabio.2006.04.015; Oteiza PI, 2012, FREE RADICAL BIO MED, V53, P1748, DOI 10.1016/j.freeradbiomed.2012.08.568; Palmisano G, 2007, PROTEOMICS, V7, P1575, DOI 10.1002/pmic.200600801; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sanchez-Caballero L, 2016, BBA-BIOENERGETICS, V1857, P980, DOI 10.1016/j.bbabio.2016.03.031; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2000, BIOCHEMISTRY-US, V39, P7229, DOI 10.1021/bi000335t; Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Sharpley MS, 2006, BIOCHEMISTRY-US, V45, P241, DOI 10.1021/bi051809x; Shinzawa-Itoh K, 2010, BIOCHEMISTRY-US, V49, P487, DOI 10.1021/bi9016318; Vinogradov AD, 2001, IUBMB LIFE, V52, P129, DOI 10.1080/15216540152845920; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Wikstrom M, 2015, CHEM REV, V115, P2196, DOI 10.1021/cr500448t; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095; Zhu JP, 2015, P NATL ACAD SCI USA, V112, P12087, DOI 10.1073/pnas.1510577112; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859; Zickermann V, 2010, FEBS LETT, V584, P2516, DOI 10.1016/j.febslet.2010.04.021	54	311	314	6	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2016	538	7625					406	+		10.1038/nature19794	http://dx.doi.org/10.1038/nature19794			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA5PJ	27595392	Green Accepted			2022-12-28	WOS:000386673100044
J	Meyerson, JR; Chittori, S; Merk, A; Rao, P; Han, TH; Serpe, M; Mayer, ML; Subramaniam, S				Meyerson, Joel R.; Chittori, Sagar; Merk, Alan; Rao, Prashant; Han, Tae Hee; Serpe, Mihaela; Mayer, Mark L.; Subramaniam, Sriram			Structural basis of kainate subtype glutamate receptor desensitization	NATURE			English	Article							LIGAND-BINDING DOMAIN; CRYSTAL-STRUCTURES; AMPA; ACTIVATION; MUTATIONS; COMPLEXES; DYNAMICS; SYSTEM; IMAGE	Glutamate receptors are ligand-gated tetrameric ion channels that mediate synaptic transmission in the central nervous system. They are instrumental in vertebrate cognition and their dysfunction underlies diverse diseases(1,2). In both the resting and desensitized states of AMPA and kainate receptor subtypes, the ion channels are closed, whereas the ligand-binding domains, which are physically coupled to the channels, adopt markedly different conformations(3-6). Without an atomic model for the desensitized state, it is not possible to address a central problem in receptor gating: how the resting and desensitized receptor states both display closed ion channels, although they have major differences in the quaternary structure of the ligand-binding domain. Here, by determining the structure of the kainate receptor GluK2 subtype in its desensitized state by cryo-electron microscopy (cryo-EM) at 3.8 angstrom resolution, we show that desensitization is characterized by the establishment of a ringlike structure in the ligand-binding domain layer of the receptor. Formation of this 'desensitization ring' is mediated by staggered helix contacts between adjacent subunits, which leads to a pseudo-four-fold symmetric arrangement of the ligand-binding domains, illustrating subtle changes in symmetry that are important for the gating mechanism. Disruption of the desensitization ring is probably the key switch that enables restoration of the receptor to its resting state, thereby completing the gating cycle.	[Meyerson, Joel R.; Chittori, Sagar; Merk, Alan; Rao, Prashant; Subramaniam, Sriram] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA; [Chittori, Sagar; Mayer, Mark L.] NICHD, Lab Cellular & Mol Neurophysiol, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA; [Han, Tae Hee; Serpe, Mihaela] NICHD, Program Cellular Regulat & Metab, NIH, Bethesda, MD 20892 USA; [Meyerson, Joel R.] Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Brandeis University; Howard Hughes Medical Institute	Meyerson, JR; Subramaniam, S (corresponding author), NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA.; Mayer, ML (corresponding author), NICHD, Lab Cellular & Mol Neurophysiol, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA.; Meyerson, JR (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA.	jmeyerson@brandeis.edu; mayerm@mail.nih.gov; ss1@nih.gov	Chittori, Sagar/B-9412-2009; Mayer, Mark/AAE-7356-2019	Chittori, Sagar/0000-0003-1417-6552; Mayer, Mark/0000-0003-4378-8451; Serpe, Mihaela/0000-0002-9205-8589; Subramaniam, Sriram/0000-0003-4231-4115	NCI; NICHD, NIH; IATAP program at NIH; NIH-FEI Living Laboratory for Structural Biology; US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008914] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010824] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); IATAP program at NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-FEI Living Laboratory for Structural Biology; US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the intramural programs of the NCI, and NICHD, NIH, the IATAP program at NIH, and the NIH-FEI Living Laboratory for Structural Biology. Synchrotron diffraction data was collected at Southeast Regional Collaborative Access Team (SER-CAT) 22-ID beamline at the Advanced Photon Source (APS), Argonne National Laboratory. Use of APS was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract number W-31-109-Eng-38. We thank D. Bleakman for the gift of LY466195, C. Glasser for preparing DNA constructs, and F. DiMaio and colleagues for assistance with use of the program Rosetta. We also thank V. Falconieri for preparing the schematic illustration panel. This study used the capabilities of the HPC Biowulf cluster at NIH, Bethesda, MD (http://hpc.nih.gov).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alushin GM, 2011, NEUROPHARMACOLOGY, V60, P126, DOI 10.1016/j.neuropharm.2010.06.002; Burnashev N, 2015, CURR OPIN PHARMACOL, V20, P73, DOI 10.1016/j.coph.2014.11.008; Carbone AL, 2012, NEURON, V74, P845, DOI 10.1016/j.neuron.2012.04.020; Chaudhry C, 2009, P NATL ACAD SCI USA, V106, P12329, DOI 10.1073/pnas.0904175106; Chen L, 2014, SCIENCE, V345, P1021, DOI 10.1126/science.1258409; Dawe GB, 2016, NEURON, V89, P1264, DOI 10.1016/j.neuron.2016.01.038; Durr KL, 2014, CELL, V158, P778, DOI 10.1016/j.cell.2014.07.023; Dutta A, 2015, STRUCTURE, V23, P1692, DOI 10.1016/j.str.2015.07.002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fleck MW, 2003, J NEUROSCI, V23, P1219; Herguedas B, 2016, SCIENCE, V352, DOI 10.1126/science.aad3873; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Jones KA, 1997, NEUROPHARMACOLOGY, V36, P853, DOI 10.1016/S0028-3908(97)00066-X; Lesca G, 2013, NAT GENET, V45, P1061, DOI 10.1038/ng.2726; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Meyerson JR, 2014, SCI REP-UK, V4, DOI 10.1038/srep07084; Meyerson JR, 2014, NATURE, V514, P328, DOI 10.1038/nature13603; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Moykkynen T, 2014, J BIOL CHEM, V289, P13197, DOI 10.1074/jbc.M113.526301; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; PATNEAU DK, 1992, J NEUROSCI, V12, P595; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plested AJR, 2008, NEURON, V58, P720, DOI 10.1016/j.neuron.2008.04.001; Schauder DM, 2013, P NATL ACAD SCI USA, V110, P5921, DOI 10.1073/pnas.1217549110; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; The PyMOL Molecular Graphics System, 2002, PYMOL MOL GRAPH SYST; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Twomey EC, 2016, SCIENCE, V353, P83, DOI 10.1126/science.aaf8411; Wang RYR, 2015, NAT METHODS, V12, P335, DOI [10.1038/nmeth.3287, 10.1038/NMETH.3287]; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121; Yelshanskaya MV, 2014, SCIENCE, V345, P1070, DOI 10.1126/science.1256508; Zhao Y, 2016, NATURE, V536, P108, DOI 10.1038/nature18961	40	62	62	4	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2016	537	7621					567	+		10.1038/nature19352	http://dx.doi.org/10.1038/nature19352			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW3MO	27580033	Green Accepted			2022-12-28	WOS:000383545900060
J	Kocher, KE; Ayanian, JZ				Kocher, Keith E.; Ayanian, John Z.			Flipping the Script - A Patient-Centered Approach to Fixing Acute Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kocher, Keith E.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Ayanian, John Z.] Univ Michigan, Div Gen Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Kocher, Keith E.] Univ Michigan, Sch Med, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [Kocher, Keith E.; Ayanian, John Z.] Univ Michigan, Inst Health Policy & Innovat, Ann Arbor, MI 48109 USA; [Ayanian, John Z.] Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA; [Ayanian, John Z.] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kocher, KE (corresponding author), Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA.; Kocher, KE (corresponding author), Univ Michigan, Sch Med, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA.; Kocher, KE (corresponding author), Univ Michigan, Inst Health Policy & Innovat, Ann Arbor, MI 48109 USA.			Kocher, Keith/0000-0001-7256-8859	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS024160] Funding Source: NIH RePORTER; AHRQ HHS [K08 HS024160] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Giesen P, 2011, ANN INTERN MED, V155, P108, DOI 10.7326/0003-4819-155-2-201107190-00006; Kaplan G., 2015, TRANSFORMING HLTH CA; Pines JM, 2016, ANN EMERG MED; Pitts SR, 2010, HEALTH AFFAIR, V29, P1620, DOI 10.1377/hlthaff.2009.1026; Selevan J, 2015, POPUL HEALTH MANAG, V18, P233, DOI 10.1089/pop.2014.0157	5	10	10	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2016	375	10					915	917		10.1056/NEJMp1601899	http://dx.doi.org/10.1056/NEJMp1601899			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU9IG	27602664				2022-12-28	WOS:000382529500004
J	Torjesen, I				Torjesen, Ingrid			Will new sepsis guidance prompt a surge in unnecessary use of antibiotics?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												ingrid_torjesen@hotmail.com						[Anonymous], 2004, WHO DRUG INFORM, V18; [Anonymous], 2016, BNF; Daniels R, 2011, J ANTIMICROB CHEMOTH, V66, pII11, DOI 10.1093/jac/dkq515; FDA, 2013, DRUG SAF COMM AZ ZIT; Garnacho-Montero J, 2014, INTENS CARE MED, V40, P32, DOI 10.1007/s00134-013-3077-7; McPherson D, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002586; NICE, 2016, SEPS REC ASS EARL MA; Powers JH, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4744; Public Health England, 2015, START SMART THEN FOC; Review on Antimicrobial Resistance, TACKLING DRUG RESIST; Rhee C, 2014, NEW ENGL J MED, V370, P1673, DOI 10.1056/NEJMp1400276; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; TORJESEN I, 2016, BMJ-BRIT MED J, V354, P2113, DOI DOI 10.1136/BMJ.I3906	13	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 7	2016	354								i4209	10.1136/bmj.i4209	http://dx.doi.org/10.1136/bmj.i4209			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV7FG	27604788				2022-12-28	WOS:000383101100001
J	Ray, JG; Vermeulen, MJ; Bharatha, A; Montanera, WJ; Park, AL				Ray, Joel G.; Vermeulen, Marian J.; Bharatha, Aditya; Montanera, Walter J.; Park, Alison L.			Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONTRAST-MEDIA; 1.5 T; RESONANCE; FETUS; LACTATION; TRIMESTER; BENEFITS; WEIGHTS; SAFETY; WOMEN	IMPORTANCE Fetal safety of magnetic resonance imaging (MRI) during the first trimester of pregnancy or with gadolinium enhancement at any time of pregnancy is unknown. OBJECTIVE To evaluate the long-term safety after exposure to MRI in the first trimester of pregnancy or to gadolinium at any time during pregnancy. DESIGN, SETTING, AND PARTICIPANTS Universal health care databases in the province of Ontario, Canada, were used to identify all births of more than 20 weeks, from 2003-2015. EXPOSURES Magnetic resonance imaging exposure in the first trimester of pregnancy, or gadolinium MRI exposure at any time in pregnancy. MAIN OUTCOMES AND MEASURES For first-trimester MRI exposure, the risk of stillbirth or neonatal death within 28 days of birth and any congenital anomaly, neoplasm, and hearing or vision loss was evaluated from birth to age 4 years. For gadolinium-enhanced MRI in pregnancy, connective tissue or skin disease resembling nephrogenic systemic fibrosis (NSF-like) and a broader set of rheumatological, inflammatory, or infiltrative skin conditions from birth were identified. RESULTS Of 1 424 105 deliveries (48% girls; mean gestational age, 39 weeks), the overall rate of MRI was 3.97 per 1000 pregnancies. Comparing first-trimester MRI (n = 1737) to no MRI (n = 1 418 451), there were 19 stillbirths or deaths vs 9844 in the unexposed cohort (adjusted relative risk [RR], 1.68; 95% CI, 0.97 to 2.90) for an adjusted risk difference of 4.7 per 1000 person-years (95% CI, -1.6 to 11.0). The risk was also not significantly higher for congenital anomalies, neoplasm, or vision or hearing loss. Comparing gadolinium MRI (n = 397) with no MRI (n = 1 418 451), the hazard ratio for NSF-like outcomes was not statistically significant. The broader outcome of any rheumatological, inflammatory, or infiltrative skin condition occurred in 123 vs 384 180 births (adjusted HR, 1.36; 95% CI, 1.09 to 1.69) for an adjusted risk difference of 45.3 per 1000 person-years (95% CI, 11.3 to 86.8). Stillbirths and neonatal deaths occurred among 7 MRI-exposed vs 9844 unexposed pregnancies (adjusted RR, 3.70; 95% CI, 1.55 to 8.85) for an adjusted risk difference of 47.5 per 1000 pregnancies (95% CI, 9.7 to 138.2). CONCLUSIONS AND RELEVANCE Exposure to MRI during the first trimester of pregnancy compared with nonexposure was not associated with increased risk of harm to the fetus or in early childhood. Gadolinium MRI at any time during pregnancy was associated with an increased risk of a broad set of rheumatological, inflammatory, or infiltrative skin conditions and for stillbirth or neonatal death. The study may not have been able to detect rare adverse outcomes.	[Ray, Joel G.] St Michaels Hosp, Dept Med, Toronto, ON, Canada; [Ray, Joel G.] St Michaels Hosp, Dept Obstet & Gynecol, Toronto, ON, Canada; [Ray, Joel G.; Vermeulen, Marian J.; Park, Alison L.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Ray, Joel G.; Vermeulen, Marian J.; Bharatha, Aditya; Montanera, Walter J.] Univ Toronto, Toronto, ON, Canada; [Bharatha, Aditya; Montanera, Walter J.] St Michaels Hosp, Dept Med Imaging, Toronto, ON, Canada; [Ray, Joel G.; Park, Alison L.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Ray, JG (corresponding author), St Michaels Hosp, Dept Med, 30 Bond St, Toronto, ON M5B 1W8, Canada.	rayj@smh.ca			Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)	Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC).	[Anonymous], 2004, OBSTET GYNECOL, V104, P647; Birchard KR, 2005, AM J ROENTGENOL, V184, P452, DOI 10.2214/ajr.184.2.01840452; BLACK WC, 1993, NEW ENGL J MED, V328, P1237, DOI 10.1056/NEJM199304293281706; Bulas D, 2013, SEMIN PERINATOL, V37, P301, DOI 10.1053/j.semperi.2013.06.005; Butt K, 2014, J OBSTET GYNAECOL CA, V36, P171, DOI 10.1016/S1701-2163(15)30664-2; Chen MM, 2008, OBSTET GYNECOL, V112, P333, DOI 10.1097/AOG.0b013e318180a505; Cho JY, 2014, ULTRASONOGRAPHY, V33, P240, DOI 10.14366/usg.14019; Choi JS, 2015, J OBSTET GYNAECOL, V35, P871, DOI 10.3109/01443615.2015.1017559; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Cowper SE, 2003, CURR OPIN RHEUMATOL, V15, P785, DOI 10.1097/00002281-200311000-00017; De Santis M, 2007, ACTA OBSTET GYN SCAN, V86, P99, DOI 10.1080/00016340600804639; Elmholdt TR, 2011, BRIT J DERMATOL, V165, P828, DOI 10.1111/j.1365-2133.2011.10465.x; Emes J, 2016, INTERPROVINCIAL MIGR; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Glenn OA, 2009, CLIN PERINATOL, V36, P273, DOI 10.1016/j.clp.2009.03.016; Hartwig V, 2009, INT J ENV RES PUB HE, V6, P1778, DOI 10.3390/ijerph6061778; Hubbard AM, 2000, BEST PRACT RES CL OB, V14, P629, DOI 10.1053/beog.1999.0101; Jaffe TA, 2007, AM J ROENTGENOL, V189, P1128, DOI 10.2214/AJR.07.2277; Kanal E, 2007, AM J ROENTGENOL, V188, P1447, DOI 10.2214/AJR.06.1616; Kikuchi S, 2010, PHYS MED BIOL, V55, P2411, DOI 10.1088/0031-9155/55/8/018; Kok RD, 2004, MAGN RESON IMAGING, V22, P851, DOI 10.1016/j.mri.2004.01.047; McLeod Lynne, 2002, Community Genet, V5, P33, DOI 10.1159/000064629; NOVAK Z, 1993, INVEST RADIOL, V28, P828; Oh KY, 2015, RADIOLOGY, V276, P110, DOI 10.1148/radiol.15141488; Patenaude Y, 2014, J OBSTET GYNAECOL CA, V36, P349, DOI 10.1016/S1701-2163(15)30612-5; Pediaditis M, 2008, PHYS MED BIOL, V53, P7187, DOI 10.1088/0031-9155/53/24/012; Salmasi G, 2010, ACTA OBSTET GYN SCAN, V89, P423, DOI 10.3109/00016340903505748; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Strizek B, 2015, RADIOLOGY, V275, P530, DOI 10.1148/radiol.14141382; Sundgren PC, 2011, J MAGN RESON IMAGING, V34, P750, DOI 10.1002/jmri.22413; TYNDALL DA, 1991, TERATOLOGY, V43, P263, DOI 10.1002/tera.1420430310; Webb JAW, 2005, EUR RADIOL, V15, P1234, DOI 10.1007/s00330-004-2583-y; Wood R, 2012, CADTH Technol Overv, V2, pe2201; You JJ, 2010, CAN MED ASSOC J, V182, P143, DOI 10.1503/cmaj.090979	34	344	369	1	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2016	316	9					952	961		10.1001/jama.2016.12126	http://dx.doi.org/10.1001/jama.2016.12126			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU8JV	27599330	Bronze			2022-12-28	WOS:000382460200018
J	Arzt, M				Arzt, Michael			Neurostimulation in patients with heart failure and central sleep apnoea	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; ADAPTIVE SERVO-VENTILATION; POSITIVE AIRWAY PRESSURE; PROGNOSTIC IMPACT; DYSFUNCTION		[Arzt, Michael] Univ Med Ctr Regensburg, Ctr Sleep Med, Dept Internal Med 2, D-93053 Regensburg, Germany	University of Regensburg	Arzt, M (corresponding author), Univ Med Ctr Regensburg, Ctr Sleep Med, Dept Internal Med 2, D-93053 Regensburg, Germany.	michael.arzt@ukr.de						Arzt M, 2013, EUR RESPIR J, V42, P1244, DOI 10.1183/09031936.00083312; Aurora RN, 2016, J CLIN SLEEP MED, V12, P757, DOI 10.5664/jcsm.5812; Bradley TD, 2005, NEW ENGL J MED, V353, P2025, DOI 10.1056/NEJMoa051001; Costanzo MR, 2016, LANCET, V388, P974, DOI 10.1016/S0140-6736(16)30961-8; Cowie MR, 2016, NEW ENGL J MED, V374, P690, DOI 10.1056/NEJMc1515007; Damy T, 2012, EUR J HEART FAIL, V14, P1009, DOI 10.1093/eurjhf/hfs085; Hetzenecker A, 2016, SLEEP MED, V17, P25, DOI 10.1016/j.sleep.2015.08.020; Jilek C, 2011, EUR J HEART FAIL, V13, P68, DOI 10.1093/eurjhf/hfq183; Linde C, 2008, J AM COLL CARDIOL, V52, P1834, DOI 10.1016/j.jacc.2008.08.027; Reinhard W, 2013, SLEEP MED, V14, P502, DOI 10.1016/j.sleep.2012.12.014; Ruttanaumpawan P, 2009, SLEEP, V32, P91; Yumino D, 2009, J CARD FAIL, V15, P279, DOI 10.1016/j.cardfail.2008.11.015	12	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2016	388	10048					938	940		10.1016/S0140-6736(16)31526-4	http://dx.doi.org/10.1016/S0140-6736(16)31526-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU9GL	27598663				2022-12-28	WOS:000382524400005
J	Limb, M				Limb, Matthew			Physician assistants can lighten doctors' workload but are a challenge to professional boundaries	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												limb@btinternet.com						Limb M., 2016, EXPAND NONMEDICAL RO	1	0	0	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 31	2016	354								i4664	10.1136/bmj.i4664	http://dx.doi.org/10.1136/bmj.i4664			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AD	27581341				2022-12-28	WOS:000382792500013
J	Iordache, A; Young, P				Iordache, Adrian; Young, Paul			SPOT DIAGNOSIS Losing a marble	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Iordache, Adrian; Young, Paul] James Cook Univ Hosp, Middlesbrough, Cleveland, England	James Cook University Hospital	Iordache, A (corresponding author), James Cook Univ Hosp, Middlesbrough, Cleveland, England.	adrian.iordache@nhs.net		Young, Paul/0000-0002-7885-4597				CLAVIEN PA, 1990, BRIT J SURG, V77, P737, DOI 10.1002/bjs.1800770707; Nuno-Guzman CM, 2016, WORLD J GASTRO SURG, V8, P65, DOI 10.4240/wjgs.v8.i1.65	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 26	2016	354								i4486	10.1136/bmj.i4486	http://dx.doi.org/10.1136/bmj.i4486			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AB	27565174				2022-12-28	WOS:000382792300001
J	O'Dowd, A				O'Dowd, Adrian			Children's emergency service is suspended at Stafford hospital on safety grounds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mashta O, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1141; Mooney H, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1137; O'Dowd A, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3308; Torjesen I, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4495	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 26	2016	354								i4686	10.1136/bmj.i4686	http://dx.doi.org/10.1136/bmj.i4686			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AB	27565849				2022-12-28	WOS:000382792300008
J	McCarthy, M				McCarthy, Michael			Conflicts of interest common among US cancer guideline authors, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mitchell AP, 2016, JAMA ONCOL, V2, P1628, DOI 10.1001/jamaoncol.2016.2710; Nipp RD, 2016, JAMA ONCOL, V2, P1631, DOI 10.1001/jamaoncol.2016.2726	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 25	2016	354								i4660	10.1136/bmj.i4660	http://dx.doi.org/10.1136/bmj.i4660			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AA	27562447				2022-12-28	WOS:000382792200009
J	Snyder, A				Snyder, Alison			Irving Gottesman Obituary	LANCET			English	Biographical-Item																		GOTTESMAN I, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2016	388	10045					654	654		10.1016/S0140-6736(16)31284-3	http://dx.doi.org/10.1016/S0140-6736(16)31284-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UX	27551696	Bronze			2022-12-28	WOS:000381268700015
J	Zhang, WF; Cao, GX; Li, XL; Zhang, HY; Wang, C; Liu, QQ; Chen, XP; Cui, ZL; Shen, JB; Jiang, RF; Mi, GH; Miao, YX; Zhang, FS; Dou, ZX				Zhang, Weifeng; Cao, Guoxin; Li, Xiaolin; Zhang, Hongyan; Wang, Chong; Liu, Quanqing; Chen, Xinping; Cui, Zhenling; Shen, Jianbo; Jiang, Rongfeng; Mi, Guohua; Miao, Yuxin; Zhang, Fusuo; Dou, Zhengxia			Closing yield gaps in China by empowering smallholder farmers	NATURE			English	Article							GLOBAL FOOD SECURITY; MANAGEMENT; INTENSIFICATION; FERTILIZER; SYSTEMS; GROWTH; WHEAT	Sustainably feeding the world's growing population is a challenge(1-3), and closing yield gaps (that is, differences between farmers' yields and what are attainable for a given region)(4-6) is a vital strategy to address this challenge(3,4,7). The magnitude of yield gaps is particularly large in developing countries where smallholder farming dominates the agricultural landscape(4,7). Many factors and constraints interact to limit yields(3-6,8-10), and progress in problem-solving to bring about changes at the ground level is rare. Here we present an innovative approach for enabling smallholders to achieve yield and economic gains sustainably via the Science and Technology Backyard (STB) platform. STB involves agricultural scientists living in villages among farmers, advancing participatory innovation and technology transfer, and garnering public and private support. We identified multifaceted yield-limiting factors involving agronomic, infrastructural, and socioeconomic conditions. When these limitations and farmers' concerns were addressed, the farmers adopted recommended management practices, thereby improving production outcomes. In one region in China, the five-year average yield increased from 67.9% of the attainable level to 97.0% among 71 leading farmers, and from 62.8% to 79.6% countywide (93,074 households); this was accompanied by resource and economic benefits.	[Zhang, Weifeng; Cao, Guoxin; Li, Xiaolin; Zhang, Hongyan; Wang, Chong; Chen, Xinping; Cui, Zhenling; Shen, Jianbo; Jiang, Rongfeng; Mi, Guohua; Miao, Yuxin; Zhang, Fusuo] China Agr Univ, Minist Educ, Key Lab Plant Soil Interact, Coll Resources & Environm Sci, Beijing 100193, Peoples R China; [Liu, Quanqing] Hebei Acad Agr & Forestry Sci, Inst Resources & Environm Sci, Shijiazhuang 050051, Peoples R China; [Dou, Zhengxia] Univ Penn, Sch Vet Med, Ctr Anim Hlth & Prod, Kennett Sq, PA 19348 USA	China Agricultural University; Hebei Academy of Agricultural & Forestry Sciences; University of Pennsylvania	Zhang, FS (corresponding author), China Agr Univ, Minist Educ, Key Lab Plant Soil Interact, Coll Resources & Environm Sci, Beijing 100193, Peoples R China.	zhangfs@cau.edu.cn	Shen, Jianbo/Y-3591-2019; Zhang, Fusuo/AAV-4517-2021; JIANG, Rongfeng/B-2486-2012	Shen, Jianbo/0000-0001-8943-948X; zhang, fusuo/0000-0001-8971-0129	China 973 Program [2015CB150405]; Innovative Group Grant of the Natural Science Foundation of China [31421092]; Special Fund for Agro Scientific Research in the Public Interest [201203079]; Program for New Century Excellent Talents in University [2016QC125]	China 973 Program(National Basic Research Program of China); Innovative Group Grant of the Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro Scientific Research in the Public Interest; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	We thank P.M. Vitousek, P.A Matson, P. Christian T.H. Misselbrook, G. P. Robertson, D. R. Chadwick, I. Ortiz-Monasterio, X.J. Liu and J. D. Toth for their comments/editing assistance. We thank Q. F. Meng, D. J. Lu, P. Yan, X. Q. Jiao and M. L. Guo for joint field experiment and data analysis. Many individuals were involved in the STB Network in Quzhou and elsewhere in China. This work was sponsored by the China 973 Program (Grant 2015CB150405), the Innovative Group Grant of the Natural Science Foundation of China (Grant 31421092), the Special Fund for Agro Scientific Research in the Public Interest (Grant 201203079), and the Program for New Century Excellent Talents in University (Grant 2016QC125).	Cash DW, 2003, P NATL ACAD SCI USA, V100, P8086, DOI 10.1073/pnas.1231332100; Chen JY, 2003, ENVIRON GEOL, V44, P564, DOI 10.1007/s00254-003-0792-3; Chen XP, 2011, P NATL ACAD SCI USA, V108, P6399, DOI 10.1073/pnas.1101419108; Chen XP, 2014, NATURE, V514, P486, DOI 10.1038/nature13609; Denning G, 2009, PLOS BIOL, V7, P2, DOI 10.1371/journal.pbio.1000023; Fan S., 2013, SUBSISTENCE PROFIT T; Fisher M., 2012, CSA NEWS; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; George T, 2014, GLOB FOOD SECUR-AGR, V3, P49, DOI 10.1016/j.gfs.2013.10.002; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Jia W. Z., 2009, LAND PRODUCTIVITY IN; Jia XP, 2013, J INTEGR AGR, V12, P364, DOI [10.1016/S2095-3119(13)60237-3, 10.1016/s2095-3119(13)60237-3]; Li YX, 2013, J ENVIRON QUAL, V42, P972, DOI 10.2134/jeq2012.0465; Lobell DB, 2009, ANNU REV ENV RESOUR, V34, P179, DOI 10.1146/annurev.environ.041008.093740; Lu DJ, 2015, AGRON J, V107, P2294, DOI 10.2134/agronj15.0008; MacMillan T, 2014, NATURE, V509, P25, DOI 10.1038/509025a; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; National Bureau of Statistics of China, 2015, HAND STAT YB; Niu LA, 2011, PEDOSPHERE, V21, P813, DOI 10.1016/S1002-0160(11)60185-9; Noort P. C. van den, 1987, Land Use Policy, V4, P11, DOI 10.1016/0264-8377(87)90004-4; Ray DK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2296; Rosegrant MW, 2003, SCIENCE, V302, P1917, DOI 10.1126/science.1092958; SAS Institute, 1998, SAS US GUID STAT; Swanson B.E., 2002, J INT AGR EXTENSION, V9, P5; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tittonell P, 2013, FIELD CROP RES, V143, P76, DOI 10.1016/j.fcr.2012.10.007; van Ittersum MK, 2013, FIELD CROP RES, V143, P4, DOI 10.1016/j.fcr.2012.09.009; Vereijken P, 1997, EUR J AGRON, V7, P235, DOI 10.1016/S1161-0301(97)00039-7; Waddington H., 2014, FARMER FIELD SCH AGR, V17; West PC, 2014, SCIENCE, V345, P325, DOI 10.1126/science.1246067; [张宁 ZHANG Ning], 2009, [河北农业大学学报, Journal of Agricultural University of Hebei], V32, P7; Zhang XY, 2004, HYDROL PROCESS, V18, P2275, DOI 10.1002/hyp.5533; Zhao Y, 2015, FIELD CROP RES, V183, P31, DOI 10.1016/j.fcr.2015.07.004	34	303	356	66	737	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2016	537	7622					671	+		10.1038/nature19368	http://dx.doi.org/10.1038/nature19368			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4DR	27602513				2022-12-28	WOS:000384331700048
J	Pocock, SJ; Stone, GW				Pocock, Stuart J.; Stone, Gregg W.			The Primary Outcome Is Positive - Is That Good Enough?	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PERCUTANEOUS CORONARY INTERVENTION; ELEVATION MYOCARDIAL-INFARCTION; DUAL ANTIPLATELET THERAPY; RANDOMIZED-TRIAL; HEART-FAILURE; FOLLOW-UP; REVASCULARIZATION; LEVOSIMENDAN; METAANALYSIS; DOBUTAMINE		[Pocock, Stuart J.] London Sch Hyg & Trop Med, Dept Med Stat, Keppel St, London WC1E 7HT, England; [Stone, Gregg W.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY USA; [Stone, Gregg W.] Cardiovasc Res Fdn, New York, NY USA	University of London; London School of Hygiene & Tropical Medicine; Columbia University; NewYork-Presbyterian Hospital; Cardiovascular Research Foundation (CRF)	Pocock, SJ (corresponding author), London Sch Hyg & Trop Med, Dept Med Stat, Keppel St, London WC1E 7HT, England.	stuart.pocock@lshtm.ac.uk						[Anonymous], 1989, NEW ENGL J MED, V321, P406; Bavry AA, 2006, J AM COLL CARDIOL, V48, P1319, DOI 10.1016/j.jacc.2006.06.050; Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Carroll KJ, 2013, STAT BIOPHARM RES, V5, P91, DOI 10.1080/19466315.2013.783878; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; De Bruyne B, 2014, NEW ENGL J MED, V371, P1208, DOI 10.1056/NEJMoa1408758; Drazen JM, 2015, NEW ENGL J MED, V373, P2174, DOI 10.1056/NEJMe1513991; Engstrom T, 2015, LANCET, V386, P665, DOI 10.1016/S0140-6736(15)60648-1; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585; FDA, 2008, GUID IND DIAB MELL E; Follath F, 2002, LANCET, V360, P196, DOI 10.1016/S0140-6736(02)09455-2; Fox KAA, 2005, LANCET, V366, P914, DOI 10.1016/S0140-6736(05)67222-4; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Fox KAA, 2010, J AM COLL CARDIOL, V55, P2435, DOI 10.1016/j.jacc.2010.03.007; Frobert O, 2013, NEW ENGL J MED, V369, P1587, DOI 10.1056/NEJMoa1308789; Fuster V, 2015, J AM COLL CARDIOL, V66, P2909, DOI 10.1016/j.jacc.2015.11.011; Gershlick AH, 2015, J AM COLL CARDIOL, V65, P963, DOI 10.1016/j.jacc.2014.12.038; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Howard JP, 2016, CIRC-CARDIOVASC QUAL, V9, P14, DOI 10.1161/CIRCOUTCOMES.115.002533; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Jolly SS, 2015, NEW ENGL J MED, V372, P1389, DOI 10.1056/NEJMoa1415098; Krantz MJ, 2013, J AM COLL CARDIOL, V62, P777, DOI 10.1016/j.jacc.2013.05.024; Lees KR, 2006, NEW ENGL J MED, V354, P588, DOI 10.1056/NEJMoa052980; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Mebazaa A, 2007, JAMA-J AM MED ASSOC, V297, P1883, DOI 10.1001/jama.297.17.1883; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Mentzer RM, 2008, ANN THORAC SURG, V85, P1261, DOI 10.1016/j.athoracsur.2007.10.054; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; O'Riordan M, 2015, EZETIMIBE FAILS GARN; Palmerini T, 2015, J AM COLL CARDIOL, V65, P2496, DOI 10.1016/j.jacc.2015.04.017; Pocock S, 1999, LANCET, V353, P943, DOI 10.1016/S0140-6736(98)00379-1; Pocock SJ, 2016, NEW ENGL J MED, V375, P861, DOI 10.1056/NEJMra1510064; Pocock SJ, 2014, AM HEART J, V168, P607, DOI 10.1016/j.ahj.2014.08.003; Pocock SJ, 2009, LANCET, V373, P1926, DOI 10.1016/S0140-6736(09)60499-2; Shuaib A, 2007, NEW ENGL J MED, V357, P562, DOI 10.1056/NEJMoa070240; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Sun ZZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055124, 10.1371/journal.pone.0055249, 10.1371/journal.pone.0074672]; Tepel M, 2000, NEW ENGL J MED, V343, P180, DOI 10.1056/NEJM200007203430304; Vlaar PJ, 2008, LANCET, V371, P1915, DOI 10.1016/S0140-6736(08)60833-8; Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Windecker S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3859; Yeh RW, 2016, JAMA-J AM MED ASSOC, V315, P1735, DOI 10.1001/jama.2016.3775; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	49	90	95	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2016	375	10					971	979		10.1056/NEJMra1601511	http://dx.doi.org/10.1056/NEJMra1601511			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU9IG	27602669	Bronze, Green Published			2022-12-28	WOS:000382529500010
J	Kahwati, LC; Feltner, C; Halpern, M; Woodell, CL; Boland, E; Amick, HR; Weber, RP; Jonas, DE				Kahwati, Leila C.; Feltner, Cynthia; Halpern, Michael; Woodell, Carol L.; Boland, Erin; Amick, Halle R.; Weber, Rachel Palmieri; Jonas, Daniel E.			Primary Care Screening and Treatment for Latent Tuberculosis Infection in Adults Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							GAMMA RELEASE ASSAY; QUANTIFERON-TB GOLD; LINKED IMMUNOSPOT ASSAY; IN-TUBE ASSAY; INTERFERON-GAMMA; SKIN-TEST; DIAGNOSTIC PERFORMANCE; ACTIVE TUBERCULOSIS; DIFFERENTIAL-DIAGNOSIS; CLINICAL-EVALUATION	IMPORTANCE Five to ten percent of individuals with latent tuberculosis infection (LTBI) progress to active tuberculosis (TB) disease. Identifying and treating LTBI is a key component of the strategy for reducing the burden of TB disease. OBJECTIVE To review the evidence about targeted screening and treatment for LTBI among adults in primary care settings to support the US Preventive Services Task Force in updating its 1996 recommendation. DATA SOURCES MEDLINE, Cochrane Library, and trial registries, searched through August 3, 2015; references from pertinent articles; and experts. Literature surveillance was conducted through May 31, 2016. STUDY SELECTION English-language studies of LTBI screening, LTBI treatment with recommended pharmacotherapy, or accuracy of the tuberculin skin test (TST) or interferon-gamma release assays (IGRAs). Studies of individuals for whom LTBI screening and treatment is part of public health surveillance or disease management were excluded. DATA EXTRACTION AND SYNTHESIS Two investigators independently reviewed abstracts and full-text articles. When at least 3 similar studies were available, random-effects meta-analysis was used to generate pooled estimates of outcomes. MAIN OUTCOMES AND MEASURES Sensitivity, specificity, reliability, active TB disease, mortality, hepatotoxicity, and other harms. RESULTS The review included 72 studies (n = 51 711). No studies evaluated benefits and harms of screening compared with no screening. Pooled estimates for sensitivity of the TST at both 5-mm and 10-mm induration thresholds were 0.79 (5-mm: 95% CI, 0.69-0.89 [8 studies, n = 803]; 10 mm: 95% CI, 0.71-0.87 [11 studies; n = 988]), and those for IGRAs ranged from 0.77 to 0.90 (57 studies; n = 4378). Pooled estimates for specificity of the TST at the 10-mm and 15-mm thresholds and for IGRAs ranged from 0.95 to 0.99 (34 studies; n = 23 853). A randomized clinical trial (RCT) of 24 weeks of isoniazid in individuals with pulmonary fibrotic lesions and LTBI (n = 27 830) found a reduction in absolute risk of active TB at 5 years from 1.4% to 0.5%(relative risk [RR], 0.35 [95% CI, 0.24-0.52]) and an increase in absolute risk for hepatoxicity from 0.1% to 0.5%(RR, 4.59 [95% CI, 2.03-10.39]) for 24 weeks of daily isoniazid compared with placebo. An RCT (n = 6886) found that 3 months of once-weekly rifapentine plus isoniazid was noninferior to 9 months of isoniazid alone for preventing active TB. The risk difference for hepatoxicity comparing isoniazid with rifampin ranged from 3% to 7%, with a pooled RR of 3.29 (95% CI, 1.72-6.28 [3 RCTs; n = 1327]). CONCLUSIONS AND RELEVANCE No studies evaluated the benefits and harms of screening compared with no screening. Both the TST and IGRAs are moderately sensitive and highly specific within countries with low TB burden. Treatment reduced the risk of active TB among the populations included in this review. Isoniazid is associated with higher rates of hepatotoxicity than placebo or rifampin.	[Kahwati, Leila C.; Feltner, Cynthia; Halpern, Michael; Woodell, Carol L.; Boland, Erin; Amick, Halle R.; Weber, Rachel Palmieri; Jonas, Daniel E.] RTI Int, 3040 E Cornwallis Rd, Res Triangle Pk, NC 27709 USA; [Kahwati, Leila C.; Feltner, Cynthia; Halpern, Michael; Woodell, Carol L.; Boland, Erin; Amick, Halle R.; Weber, Rachel Palmieri; Jonas, Daniel E.] Univ N Carolina, Evidence Based Practice Ctr, Chapel Hill, NC USA; [Feltner, Cynthia; Jonas, Daniel E.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Feltner, Cynthia; Amick, Halle R.; Weber, Rachel Palmieri; Jonas, Daniel E.] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA	Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Kahwati, LC (corresponding author), RTI Int, 3040 E Cornwallis Rd, Res Triangle Pk, NC 27709 USA.	lkahwati@rti.org		Weber, Rachel/0000-0001-7119-7734; Kahwati, Leila/0000-0001-6963-2848	Agency for Healthcare Research and Quality (AHRQ); Centers for Disease Control and Prevention (CDC) (Agency for Healthcare Research and Quality) [HHSA-290-2012-00015i]	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Centers for Disease Control and Prevention (CDC) (Agency for Healthcare Research and Quality)	This research was co-funded by the Agency for Healthcare Research and Quality (AHRQ) and Centers for Disease Control and Prevention (CDC) under a contract to support the US Preventive Services Task Force (USPSTF) (Agency for Healthcare Research and Quality contract HHSA-290-2012-00015i; Task Order 4).	Adetifa IMO, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-122; Ak O, 2009, JPN J INFECT DIS, V62, P149; American Thoracic Society, 2000, AM J RESP CRIT CARE, V49, P1, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_3.ATS600; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; BAILEY WC, 1974, ANN INTERN MED, V81, P200, DOI 10.7326/0003-4819-81-2-200; Bellete B, 2002, CLIN INFECT DIS, V34, P1449, DOI 10.1086/340397; Berkel GM, 2005, INT J TUBERC LUNG D, V9, P310; Bienek DR, 2009, INT J TUBERC LUNG D, V13, P1416; Bocchino M, 2010, RESP MED, V104, P1551, DOI 10.1016/j.rmed.2010.05.011; Boyd AE, 2011, J INFECTION, V62, P456, DOI 10.1016/j.jinf.2011.04.003; Bua A, 2007, NEW MICROBIOL, V30, P477; BUSH OB, 1965, AM REV RESPIR DIS, V92, P732; BYRD RB, 1977, ARCH INTERN MED, V137, P1130, DOI 10.1001/archinte.137.9.1130; Chee CBE, 2008, J CLIN MICROBIOL, V46, P1935, DOI 10.1128/JCM.02403-07; Cho OH, 2011, J INFECTION, V63, P362, DOI 10.1016/j.jinf.2011.06.010; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; Dewan PK, 2007, CLIN INFECT DIS, V44, P69, DOI 10.1086/509928; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350; Dilektasli AG, 2010, JPN J INFECT DIS, V63, P433; Dorman SE, 2014, AM J RESP CRIT CARE, V189, P77, DOI 10.1164/rccm.201302-0365OC; Erdem H, 2014, CLIN MICROBIOL INFEC, V20, pO600, DOI 10.1111/1469-0691.12478; FALK A, 1978, CHEST, V73, P44, DOI 10.1378/chest.73.1.44; Feng JY, 2013, DIAGN MICR INFEC DIS, V77, P46, DOI 10.1016/j.diagmicrobio.2013.05.020; FEREBEE SH, 1963, AM REV RESPIR DIS, V88, P161; Fietta A, 2003, AM J INFECT CONTROL, V31, P347, DOI 10.1016/S0196-6553(02)48240-5; Franken WPJ, 2009, CLIN VACCINE IMMUNOL, V16, P1439, DOI 10.1128/CVI.00456-08; GEITER L, 2000, ENDING NEGLECT ELIMI; Goletti D, 2006, CLIN MICROBIOL INFEC, V12, P544, DOI 10.1111/j.1469-0691.2006.01391.x; Harada N, 2008, J INFECTION, V56, P348, DOI 10.1016/j.jinf.2008.02.011; Hardy RJ, 1996, STAT MED, V15, P619, DOI 10.1002/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Higuchi K, 2009, MED MICROBIOL IMMUN, V198, P33, DOI 10.1007/s00430-008-0102-5; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Jackson D, 2010, STAT MED, V29, P1282, DOI 10.1002/sim.3602; Janssens JP, 2007, EUR RESPIR J, V30, P722, DOI 10.1183/09031936.00028507; Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756; Katsenos S, 2010, INT J TUBERC LUNG D, V14, P545; Kim CH, 2014, CLIN INFECT DIS, V58, P986, DOI 10.1093/cid/ciu045; Kim EY, 2011, DIAGN MICR INFEC DIS, V70, P324, DOI 10.1016/j.diagmicrobio.2011.02.011; Kim S, 2013, DIAGN MICR INFEC DIS, V75, P68, DOI 10.1016/j.diagmicrobio.2012.09.015; Kobashi Y, 2008, INTERNAL MED, V47, P237, DOI 10.2169/internalmedicine.47.0389; Kobashi Y, 2008, SCAND J INFECT DIS, V40, P629, DOI 10.1080/00365540801932454; Kobashi Y, 2008, CHEST, V133, P1196, DOI 10.1378/chest.07-1995; Kobashi Y, 2012, INTERNAL MED, V51, P1199, DOI 10.2169/internalmedicine.51.5703; Kobashi Y, 2009, INTERNAL MED, V48, P137, DOI 10.2169/internalmedicine.48.1432; Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930; Kontopantelis E, 2010, STATA J, V10, P395, DOI 10.1177/1536867X1001000307; La Jeon Y, 2013, J INFECTION, V67, P288, DOI 10.1016/j.jinf.2013.06.005; Lai CC, 2011, DIAGN MICR INFEC DIS, V71, P139, DOI 10.1016/j.diagmicrobio.2011.05.013; Lai CC, 2011, DIAGN MICR INFEC DIS, V70, P60, DOI 10.1016/j.diagmicrobio.2010.11.012; Lee J, 2013, J INFECTION, V66, P338, DOI 10.1016/j.jinf.2012.08.020; Lee YJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-107; Legesse M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-354; Lempp JM, 2015, ASSESSMENT QUANTIFER; Li SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127538; Losi M, 2007, EUR RESPIR J, V30, P1173, DOI 10.1183/09031936.00067307; Lui G, 2011, J INFECTION, V62, P440, DOI 10.1016/j.jinf.2011.04.011; Mancuso JD, 2012, AM J RESP CRIT CARE, V185, P427, DOI 10.1164/rccm.201107-1244OC; Mazurek GH, 2007, CLIN INFECT DIS, V45, P837, DOI 10.1086/521107; Mazurek GH, 2007, CLIN INFECT DIS, V45, P826, DOI 10.1086/521106; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mazurek GH, 2001, JAMA-J AM MED ASSOC, V286, P1740, DOI 10.1001/jama.286.14.1740; Menzies D, 2004, AM J RESP CRIT CARE, V170, P445, DOI 10.1164/rccm.200404-478OC; Menzies D, 2008, ANN INTERN MED, V149, P689, DOI 10.7326/0003-4819-149-10-200811180-00003; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Metcalfe JZ, 2010, AM J RESP CRIT CARE, V181, P87, DOI 10.1164/rccm.200906-0981OC; Min JW, 2013, CLIN VACCINE IMMUNOL, V20, P1377, DOI 10.1128/CVI.00290-13; Miramontes R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140881; Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39; O'Shea MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097366; Pai M, 2007, INFECTION, V35, P98, DOI 10.1007/s15010-007-6114-z; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Painter JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082727; Park SY, 2009, SCAND J INFECT DIS, V41, P818, DOI 10.3109/00365540903214298; Qian FC, 2013, INDIAN J PATHOL MICR, V56, P125, DOI 10.4103/0377-4929.118694; Ra SW, 2011, INT J TUBERC LUNG D, V15, P635, DOI 10.5588/ijtld.10.0485; Rucker G, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-79; Ruhwald M, 2011, TUBERCULOSIS, V91, P260, DOI 10.1016/j.tube.2011.01.001; Saigal S, 2001, J GASTROEN HEPATOL, V16, P1028, DOI 10.1046/j.1440-1746.2001.02570.x; SEIBERT AF, 1991, CHEST, V99, P883, DOI 10.1378/chest.99.4.883; Smieja M, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001363; Soysal A, 2008, INT J TUBERC LUNG D, V12, P50; StataCorp, 2013, STATA STAT SOFTW REL; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875; Taggart EW, 2006, AM J CLIN PATHOL, V125, P467, DOI [10.1309/LTETF72AHG94KGUY, 10.1309/LTET-F72A-HG94-KGUY]; Taggart EW, 2004, CLIN DIAGN LAB IMMUN, V11, P1089, DOI 10.1128/CDLI.11.6.1089-1093.2004; Taki-Eddin L, 2012, J INFECT DEV COUNTR, V6, P67, DOI 10.3855/jidc.2098; Tan CK, 2010, SCAND J INFECT DIS, V42, P752, DOI 10.3109/00365548.2010.490237; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555; Tsiouris SJ, 2006, J CLIN MICROBIOL, V44, P2844, DOI 10.1128/JCM.02411-05; United Nations Development Programme, 2014, UNDP HUM DEV REP 201; US Preventive Services Task Force, 2016, TOP WORK PLAN DEV US; Veening G J, 1968, Bull Int Union Tuberc, V41, P169; Villarino ME, 1999, JAMA-J AM MED ASSOC, V281, P169, DOI 10.1001/jama.281.2.169; Villarino ME, 2000, AM J RESP CRIT CARE, V161, P1167, DOI 10.1164/ajrccm.161.4.9906050; Walsh MC, 2011, INT J TUBERC LUNG D, V15, P179; Wang S, 2013, CLIN VACCINE IMMUNOL, V20, P69, DOI 10.1128/CVI.00481-12; West SL., 2010, AHRQ PUBLICATION; White MC, 2012, J CORRECT HEALTH CAR, V18, P131, DOI 10.1177/1078345811435973; Whitworth WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086721; Whitworth WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043790; Wlodarczyk M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107208; World Health Organization, 2014, TUB COUNTR PROF; World Health Organization (WHO), 2015, GUIDELINES MANAGEMEN	106	45	48	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2016	316	9					970	983		10.1001/jama.2016.10357	http://dx.doi.org/10.1001/jama.2016.10357			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU8JV	27599332				2022-12-28	WOS:000382460200020
J	Peters, SP; Bleecker, ER; Canonica, GW; Park, YB; Ramirez, R; Hollis, S; Fjallbrant, H; Jorup, C; Martin, UJ				Peters, Stephen P.; Bleecker, Eugene R.; Canonica, Giorgio W.; Park, Yong B.; Ramirez, Ricardo; Hollis, Sally; Fjallbrant, Harald; Jorup, Carin; Martin, Ubaldo J.			Serious Asthma Events with Budesonide plus Formoterol vs. Budesonide Alone	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACTING BETA-AGONISTS; DOUBLE-BLIND; INHALED CORTICOSTEROIDS; RELIEVER THERAPY; CLINICAL-TRIALS; SINGLE INHALER; SAFETY; BUDESONIDE/FORMOTEROL; MAINTENANCE; EXACERBATIONS	BACKGROUND Concerns remain about the safety of adding long-acting beta(2)-agonists to inhaled glucocorticoids for the treatment of asthma. In a postmarketing safety study mandated by the Food and Drug Administration, we evaluated whether the addition of formoterol to budesonide maintenance therapy increased the risk of serious asthma-related events in patients with asthma. METHODS In this multicenter, double-blind, 26-week study, we randomly assigned patients, 12 years of age or older, who had persistent asthma, were receiving daily asthma medication, and had had one to four asthma exacerbations in the previous year to receive budesonide-formoterol or budesonide alone. Patients with a history of life-threatening asthma were excluded. The primary end point was the first serious asthma-related event (a composite of adjudicated death, intubation, and hospitalization), as assessed in a time-to-event analysis. The noninferiority of budesonide-formoterol to budesonide was defined as an upper limit of the 95% confidence interval for the risk of the primary safety end point of less than 2.0. The primary efficacy end point was the first asthma exacerbation, as assessed in a time-to-event analysis. RESULTS A total of 11,693 patients underwent randomization, of whom 5846 were assigned to receive budesonide-formoterol and 5847 to receive budesonide. A serious asthma-related event occurred in 43 patients who were receiving budesonide-formoterol and in 40 patients who were receiving budesonide (hazard ratio, 1.07; 95% confidence interval [CI], 0.70 to 1.65]); budesonide-formoterol was shown to be noninferior to budesonide alone. There were two asthma-related deaths, both in the budesonide-formoterol group; one of these patients had undergone an asthma-related intubation. The risk of an asthma exacerbation was 16.5% lower with budesonide-formoterol than with budesonide (hazard ratio, 0.84; 95% CI, 0.74 to 0.94; P = 0.002). CONCLUSIONS Among adolescents and adults with predominantly moderate-to-severe asthma, treatment with budesonide-formoterol was associated with a lower risk of asthma exacerbations than budesonide and a similar risk of serious asthma-related events. (Funded by AstraZeneca; ClinicalTrials.gov number, NCT01444430.)	[Peters, Stephen P.; Bleecker, Eugene R.] Wake Forest Sch Med, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Canonica, Giorgio W.] Univ Genoa, Genoa, Italy; [Park, Yong B.] Hallym Univ, Seoul, South Korea; [Ramirez, Ricardo] Ctr Invest & Atenc Integral, Durango, Mexico; [Hollis, Sally] AstraZeneca, Macclesfield, Cheshire, England; [Fjallbrant, Harald; Jorup, Carin] AstraZeneca Res & Dev, Gothenburg, Sweden; [Martin, Ubaldo J.] AstraZeneca, Gaithersburg, MD USA	Wake Forest University; University of Genoa; Hallym University; AstraZeneca; AstraZeneca; AstraZeneca	Peters, SP (corresponding author), Wake Forest Sch Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	sppeters@wakehealth.edu	canonica, giorgio walter/ABF-2037-2020	canonica, giorgio walter/0000-0001-8467-2557; Park, Yong Bum/0000-0002-5814-6104	AstraZeneca	AstraZeneca(AstraZeneca)	Funded by AstraZeneca; ClinicalTrials.gov number, NCT01444430.	[Anonymous], 2007, 3 NAT I HLTH NAT HEA; Bousquet J, 2007, RESP MED, V101, P2437, DOI 10.1016/j.rmed.2007.07.014; Brown RW, 2012, J ALLERGY CLIN IMMUN, V130, P362, DOI 10.1016/j.jaci.2012.03.028; CASTLE W, 1993, BRIT MED J, V306, P1034, DOI 10.1136/bmj.306.6884.1034; Chowdhury BA, 2011, NEW ENGL J MED, V364, P2473, DOI 10.1056/NEJMp1104375; Chowdhury BA, 2010, NEW ENGL J MED, V362, P1169, DOI 10.1056/NEJMp1002074; Global Initiative for Asthma (GINA), 2010, 2010 GINA REP GLOB S; Global Initiative for Asthma (GINA), 2016, 2016 GINA REP GLOB S; Kuna P, 2007, INT J CLIN PRACT, V61, P725, DOI 10.1111/j.1742-1241.2007.01338.x; LOFDAHL CG, 1991, EUR RESPIR J, V4, P218; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; National Asthma Council Australia, 2003, INH CORT PRACT PERSP; Nelson H, 2010, J ALLERGY CLIN IMMUN, V125, P390, DOI 10.1016/j.jaci.2009.11.036; Nelson HS, 2009, ANN ALLERG ASTHMA IM, V102, P11, DOI 10.1016/S1081-1206(10)60101-9; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; O'Byrne PM, 2005, AM J RESP CRIT CARE, V171, P129, DOI 10.1164/rccm.200407-884OC; Ortega VE, 2014, LANCET RESP MED, V2, P204, DOI 10.1016/S2213-2600(13)70289-3; Rabe KF, 2006, CHEST, V129, P246, DOI 10.1378/chest.129.2.246; Rabe KF, 2006, LANCET, V368, P744, DOI 10.1016/S0140-6736(06)69284-2; Scicchitano R, 2004, CURR MED RES OPIN, V20, P1403, DOI 10.1185/030079904X2051; Sears MR, 2009, EUR RESPIR J, V33, P21, DOI 10.1183/09031936.00145006; Sears MR, 2014, EUR RESPIR J, V43, P103, DOI 10.1183/09031936.00004713; Sears MR, 2009, RESP MED, V103, P1960, DOI 10.1016/j.rmed.2009.08.007; Stempel DA, 2016, NEW ENGL J MED, V374, P1822, DOI 10.1056/NEJMoa1511049	24	79	79	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2016	375	9					850	860		10.1056/NEJMoa1511190	http://dx.doi.org/10.1056/NEJMoa1511190			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU9HA	27579635	Bronze			2022-12-28	WOS:000382526000008
J	Boseley, S				Boseley, Sarah			Profile Joanne Liu, MSF International President: a need for greater humanity	LANCET			English	Biographical-Item																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 27	2016	388	10047					861	861		10.1016/S0140-6736(16)31422-2	http://dx.doi.org/10.1016/S0140-6736(16)31422-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU0RI	27597457				2022-12-28	WOS:000381911800014
J	Kapur, N				Kapur, Narinder			PERSONAL VIEW Keeping Kate Granger's legacy alive	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kapur, Narinder] UCL, London, England	University of London; University College London	Kapur, N (corresponding author), UCL, London, England.	n.kapur@ucl.ac.uk						Elcock K, 1996, Br J Nurs, V5, P1376; Granger K, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5833; Hartley J., 2016, HLTH SERV J; Hickerton BC, 2014, BMJ QUAL SAF, V23, P543, DOI 10.1136/bmjqs-2013-002445; Kmietowicz Z, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h588; O'Dowd A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4144; Phillips Mike J, 2015, J Perioper Pract, V25, P68; Rimmer A., 2016, BMJ CAREERS; Sevdalis N., 2007, DESIGN SPECIFICATION; Slattery TJ, 2013, ATTEN PERCEPT PSYCHO, V75, P1275, DOI 10.3758/s13414-013-0463-8	10	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 26	2016	354								i4589	10.1136/bmj.i4589	http://dx.doi.org/10.1136/bmj.i4589			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AB	27566662				2022-12-28	WOS:000382792300003
J	Anglada-Escude, G; Amado, PJ; Barnes, J; Berdinas, ZM; Butler, RP; Coleman, GAL; de la Cueva, I; Dreizler, S; Endl, M; Giesers, B; Jeffers, SV; Jenkins, JS; Jones, HRA; Kiraga, M; Kurster, M; Lopez-Gonzalez, MJ; Marvin, CJ; Morales, N; Morin, J; Nelson, RP; Ortiz, JL; Ofir, A; Paardekooper, SJ; Reiners, A; Rodriguez, E; Rodriguez-Lopez, C; Sarmiento, LF; Strachan, JP; Tsapras, Y; Tuomi, M; Zechmeister, M				Anglada-Escude, Guillem; Amado, Pedro J.; Barnes, John; Berdinas, Zaira M.; Butler, R. Paul; Coleman, Gavin A. L.; de la Cueva, Ignacio; Dreizler, Stefan; Endl, Michael; Giesers, Benjamin; Jeffers, Sandra V.; Jenkins, James S.; Jones, Hugh R. A.; Kiraga, Marcin; Kuerster, Martin; Lopez-Gonzalez, Maria J.; Marvin, Christopher J.; Morales, Nicolas; Morin, Julien; Nelson, Richard P.; Ortiz, Jose L.; Ofir, Aviv; Paardekooper, Sijme-Jan; Reiners, Ansgar; Rodriguez, Eloy; Rodriguez-Lopez, Cristina; Sarmiento, Luis F.; Strachan, John P.; Tsapras, Yiannis; Tuomi, Mikko; Zechmeister, Mathias			A terrestrial planet candidate in a temperate orbit around Proxima Centauri	NATURE			English	Article							TIME-SERIES ANALYSIS; MAIN-SEQUENCE STARS; RADIAL-VELOCITY; HABITABLE ZONE; SOUTHERN STARS; SUPER-EARTH; SPACED DATA; NO PLANET; GJ 221; SEARCH	At a distance of 1.295 parsecs(1), the red dwarf Proxima Centauri (a Centauri C, GL 551, HIP 70890 or simply Proxima) is the Sun's closest stellar neighbour and one of the best-studied low-mass stars. It has an effective temperature of only around 3,050 kelvin, a luminosity of 0.15 per cent of that of the Sun, a measured radius of 14 per cent of the radius of the Sun2 and a mass of about 12 per cent of the mass of the Sun. Although Proxima is considered a moderately active star, its rotation period is about 83 days (ref. 3) and its quiescent activity levels and X-ray luminosity(4) are comparable to those of the Sun. Here we report observations that reveal the presence of a small planet with a minimum mass of about 1.3 Earth masses orbiting Proxima with a period of approximately 11.2 days at a semi-major-axis distance of around 0.05 astronomical units. Its equilibrium temperature is within the range where water could be liquid on its surface(5).	[Anglada-Escude, Guillem; Coleman, Gavin A. L.; Nelson, Richard P.; Paardekooper, Sijme-Jan; Strachan, John P.] Queen Mary Univ London, Sch Phys & Astron, 327 Mile End Rd, London E1 4NS, England; [Amado, Pedro J.; Berdinas, Zaira M.; Lopez-Gonzalez, Maria J.; Morales, Nicolas; Ortiz, Jose L.; Rodriguez, Eloy; Rodriguez-Lopez, Cristina] CSIC, Inst Astrofis Andalucia, Glorieta Astron S-N, E-18008 Granada, Spain; [Barnes, John] Open Univ, Dept Phys Sci, Walton Hall, Milton Keynes MK7 6AA, Bucks, England; [Butler, R. Paul] Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA; [de la Cueva, Ignacio] Astroimagen, C Abad & Lasierra 58 Bis,6-2, Ibiza 07800, Spain; [Dreizler, Stefan; Giesers, Benjamin; Jeffers, Sandra V.; Marvin, Christopher J.; Reiners, Ansgar; Sarmiento, Luis F.; Zechmeister, Mathias] Univ Gottingen, Inst Astrophys, Friedrich Hund Pl 1, D-37077 Gottingen, Germany; [Endl, Michael] Univ Texas Austin, McDonald Observ, 2515 Speedway,C1400, Austin, TX 78712 USA; [Jenkins, James S.] Univ Chile, Dept Astron, Camino El Observ 1515, Santiago, Chile; [Jones, Hugh R. A.; Tuomi, Mikko] Univ Hertfordshire, Sci & Technol Res Inst, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England; [Kiraga, Marcin] Univ Warsaw Observ, Aleje Ujazdowskie 4, Warsaw, Poland; [Kuerster, Martin] Max Planck Inst Astron, Konigstuhl 17, D-69117 Heidelberg, Germany; [Morin, Julien] Univ Montpellier, Lab Univers & Particules Montpellier, Pl E Bataillon CC 72, F-34095 Montpellier 05, France; [Ofir, Aviv] Weizmann Inst Sci, Dept Earth & Planetary Sci, 234 Herzl St, IL-76100 Rehovot, Israel; [Tsapras, Yiannis] Astron Rech Inst, Monchhofstr 12-14, D-69120 Heidelberg, Germany	University of London; Queen Mary University London; University College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); Open University - UK; Carnegie Institution for Science; University of Gottingen; University of Texas System; University of Texas Austin; Universidad de Chile; University of Hertfordshire; University of Warsaw; Warsaw University Observatory; Max Planck Society; Universite de Montpellier; Weizmann Institute of Science; Ruprecht Karls University Heidelberg	Anglada-Escude, G (corresponding author), Queen Mary Univ London, Sch Phys & Astron, 327 Mile End Rd, London E1 4NS, England.	g.anglada@qmul.ac.uk	Jenkins, James/I-5284-2016; Lopez-Gonzalez, Maria Jose/AAB-9217-2019; Butler, Robert Paul/B-1125-2009; Amado, Pedro J./G-3450-2011; Gonzalez, Maria Jose Lopez/L-4596-2017; Anglada-Escudé, Guillem/Y-3162-2018; Ortiz, Jose L./L-3192-2014	Lopez-Gonzalez, Maria Jose/0000-0001-8104-5128; Butler, Robert Paul/0000-0003-1305-3761; Amado, Pedro J./0000-0002-8388-6040; Gonzalez, Maria Jose Lopez/0000-0001-8104-5128; Anglada-Escudé, Guillem/0000-0002-3645-5977; Ortiz, Jose L./0000-0002-8690-2413; Jenkins, James/0000-0003-2733-8725; Jones, Hugh/0000-0003-0433-3665; Kiraga, Marcin/0000-0001-8045-9484; Rodriguez, Eloy/0000-0001-6827-9077; Reiners, Ansgar/0000-0003-1242-5922; Rodriguez-Lopez, Cristina/0000-0001-5559-7850; Coleman, Gavin/0000-0001-5111-8963; Tsapras, Yiannis/0000-0001-8411-351X; Morin, Julien/0000-0002-4996-6901; Morales Palomino, Nicolas F./0000-0003-0419-1599	Leverhulme Trust/UK [RPG-2014-281]; MINECO/Spain [ESP2014-54362-P, AYA-2014-54348-C3-1-R, AYA-2014-56637-C2-1-P]; J. A./Spain [2012-FQM1776]; CATA-Basal/Chile PB06 Conicyt; Fondecyt/Chile [1161218]; STFC/UK [ST/M001008/1, ST/L000776/1]; ERC/EU [279347]; DFG/Germany Research [RE 1664/9-2, RE 1664/12-1]; DFG/Germany Colloborative Research Center 963; DFG/Germany Research Training Group 1351; NSF/USA [AST-1313075]; ESO Telescopes at the La Silla Paranal Observatory [096.C-0082, 191.C-0505]; STFC [ST/L000776/1, ST/F007280/1, ST/G002622/1, ST/M001202/1, ST/L001403/1, ST/M001008/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/L000776/1, ST/G002622/1, ST/M001008/1, ST/F007280/1, ST/L001403/1] Funding Source: researchfish	Leverhulme Trust/UK(Leverhulme Trust); MINECO/Spain; J. A./Spain; CATA-Basal/Chile PB06 Conicyt; Fondecyt/Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); STFC/UK(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); ERC/EU; DFG/Germany Research; DFG/Germany Colloborative Research Center 963; DFG/Germany Research Training Group 1351; NSF/USA(National Science Foundation (NSF)); ESO Telescopes at the La Silla Paranal Observatory; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank E. Gerlach, R. Street and U. Seemann for their support to the science preparations. We thank P. Micakovic, M. M. Mutter (QMUL), R. Ivison, G. Hussain, I. Saviane, O. Sandu, L. L. Christensen, R. Hook and the personnel at La Silla (ESO) for making the PRD campaign possible. The authors acknowledge support from the following funding grants: Leverhulme Trust/UK RPG-2014-281 (H. R. A. J., G. A.-E. and M. T.); MINECO/Spain AYA-2014-54348-C3-1-R (P. J. A., C. R.-L., Z. M. B. and E. R.); MINECO/Spain ESP2014-54362-P (M. J. L.-G.); MINECO/Spain AYA-2014-56637-C2-1-P (J. L. O. and N. M.); J. A./Spain 2012-FQM1776 (J. L. O. and N. M.); CATA-Basal/Chile PB06 Conicyt (J. S. J.); Fondecyt/Chile project # 1161218 (J. S. J.); STFC/UK ST/M001008/1 (R. P. N., G. A. L. C. and G. A.-E.); STFC/UK ST/L000776/1 (J. B.); ERC/EU Starting Grant # 279347 (A. R., L. F. S. and S. V. J.); DFG/Germany Research Grants RE 1664/9-2 (A. R.); RE 1664/12-1 (M. Z.); DFG/Germany Colloborative Research Center 963 (C. J. M. and S. D.); DFG/Germany Research Training Group 1351 (L. F. S.); and NSF/USA grant AST-1313075 (M. E.). Study based on observations made with ESO Telescopes at the La Silla Paranal Observatory under programmes 096. C-0082 and 191. C-0505. Observations were obtained with ASH2, which is supported by the Instituto de Astrofisica de Andalucia and Astroimagen. This work makes use of observations from the LCOGT network. We acknowledge the effort of the UVES/M-dwarf and the HARPS/Geneva teams, who obtained a substantial amount of the data used in this work.	Aigrain S, 2012, MON NOT R ASTRON SOC, V419, P3147, DOI 10.1111/j.1365-2966.2011.19960.x; Anglada-Escude G, 2013, ASTRON ASTROPHYS, V556, DOI 10.1051/0004-6361/201321331; Anglada-Escude G, 2012, ASTROPHYS J SUPPL S, V200, DOI 10.1088/0067-0049/200/2/15; Arriagada P, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/1/42; BALIUNAS SL, 1995, ASTROPHYS J, V438, P269, DOI 10.1086/175072; Baluev RV, 2013, MON NOT R ASTRON SOC, V429, P2052, DOI 10.1093/mnras/sts476; Baluev RV, 2009, MON NOT R ASTRON SOC, V393, P969, DOI 10.1111/j.1365-2966.2008.14217.x; Barnes JR, 2014, MON NOT R ASTRON SOC, V439, P3094, DOI 10.1093/mnras/stu172; Barnes JR, 2012, MON NOT R ASTRON SOC, V424, P591, DOI 10.1111/j.1365-2966.2012.21236.x; Berdinas ZM, 2016, MON NOT R ASTRON SOC, V459, P3551, DOI 10.1093/mnras/stw906; Berger JO., 1980, STAT DECISION THEORY; Bolmont E., 2016, PREPRINT; Bonfils X, 2007, ASTRON ASTROPHYS, V474, P293, DOI 10.1051/0004-6361:20077068; Bonfils X, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201014704; Boyajian TS, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/112; Brown TM, 2013, PUBL ASTRON SOC PAC, V125, P1031, DOI 10.1086/673168; Butler RP, 1996, PUBL ASTRON SOC PAC, V108, P500, DOI 10.1086/133755; Collins K. A., 2016, PREPRINT; Cumming A, 2004, MON NOT R ASTRON SOC, V354, P1165, DOI 10.1111/j.1365-2966.2004.08275.x; Dawson RI, 2010, ASTROPHYS J, V722, P937, DOI 10.1088/0004-637X/722/1/937; Delfosse X, 2000, ASTRON ASTROPHYS, V364, P217; Donati JF, 1997, ASTRON ASTROPHYS, V326, P1135; Endl M, 2008, ASTRON ASTROPHYS, V488, P1149, DOI 10.1051/0004-6361:200810058; FERRAZMELLO S, 1981, ASTRON J, V86, P619, DOI 10.1086/112924; da Silva JG, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201118598; Gudel M, 2004, ASTRON ASTROPHYS, V416, P713, DOI 10.1051/0004-6361:20031471; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.1093/biomet/57.1.97; Jenkins JS, 2008, ASTRON ASTROPHYS, V485, P571, DOI 10.1051/0004-6361:20078611; Jenkins JS, 2006, MON NOT R ASTRON SOC, V372, P163, DOI 10.1111/j.1365-2966.2006.10811.x; Kiraga M, 2007, ACTA ASTRONOM, V57, P149; Kopparapu RK, 2016, ASTROPHYS J, V819, DOI 10.3847/0004-637X/819/1/84; Kurster M, 2003, ASTRON ASTROPHYS, V403, P1077, DOI 10.1051/0004-6361:20030396; LOMB NR, 1976, ASTROPHYS SPACE SCI, V39, P447, DOI 10.1007/BF00648343; Lubin P., 2016, PREPRINT; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; NEWTON MA, 1994, J R STAT SOC B, V56, P3; Ofir A, 2014, ASTRON ASTROPHYS, V561, DOI 10.1051/0004-6361/201220860; Pascual-Granado J, 2015, ASTRON ASTROPHYS, V581, DOI 10.1051/0004-6361/201425596; Pepe F, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201117055; Press W., 1992, NUMERICAL RECIPES FO; Queloz D, 2001, ASTRON ASTROPHYS, V379, P279, DOI 10.1051/0004-6361:20011308; Rajpaul V, 2016, MON NOT R ASTRON SOC, V456, pL6, DOI 10.1093/mnrasl/slv164; Reiners A, 2008, ASTRON ASTROPHYS, V489, pL45, DOI 10.1051/0004-6361:200810491; Robertson P, 2014, SCIENCE, V345, P440, DOI [10.1126/science.1253253, 10.1126/science.1255525]; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; SCARGLE JD, 1981, ASTROPHYS J SUPPL S, V45, P1, DOI 10.1086/190706; Sicardy B, 2011, NATURE, V478, P493, DOI 10.1038/nature10550; Snellen I, 2015, ASTRON ASTROPHYS, V576, DOI 10.1051/0004-6361/201425018; Southworth J, 2014, MON NOT R ASTRON SOC, V444, P776, DOI 10.1093/mnras/stu1492; Tanaka H, 2002, ASTROPHYS J, V565, P1257, DOI 10.1086/324713; Tuomi M, 2013, ASTRON ASTROPHYS, V556, DOI 10.1051/0004-6361/201321174; Tuomi M, 2013, ASTRON ASTROPHYS, V551, DOI 10.1051/0004-6361/201220509; Tuomi M, 2012, ASTRON ASTROPHYS, V543, DOI 10.1051/0004-6361/201118518; Tuomi M, 2014, MON NOT R ASTRON SOC, V441, P1545, DOI 10.1093/mnras/stu358; Tuomi M, 2014, MON NOT R ASTRON SOC, V440, pL1, DOI 10.1093/mnrasl/slu014; van Leeuwen F, 2007, ASTRON ASTROPHYS, V474, P653, DOI 10.1051/0004-6361:20078357; Vidotto AA, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201321504; Wright JT, 2009, ASTROPHYS J SUPPL S, V182, P205, DOI 10.1088/0067-0049/182/1/205; Zechmeister M, 2009, ASTRON ASTROPHYS, V505, P859, DOI 10.1051/0004-6361/200912479; Zuluaga JI, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/23	64	605	612	31	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					437	+		10.1038/nature19106	http://dx.doi.org/10.1038/nature19106			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0YL	27558064	Green Submitted, Green Accepted			2022-12-28	WOS:000382646600037
J	Fleming, N				Fleming, Nic			Naturejobs CAREER GUIDE ASIA-PACIFIC	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					S1	S1		10.1038/536S1a	http://dx.doi.org/10.1038/536S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VI2OC	27557155	Bronze			2022-12-28	WOS:000465264600001
J	Mayor, S				Mayor, Susan			Donor faecal transplantation is highly curative in recurrent C difficile infection, trial finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Kelly CR, 2016, ANN INTERN MED, V165, P609, DOI 10.7326/M16-0271	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 24	2016	354								i4638	10.1136/bmj.i4638	http://dx.doi.org/10.1136/bmj.i4638			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV2ZZ	27558248				2022-12-28	WOS:000382792100001
J	Mayor, S				Mayor, Susan			Deaths from heart disease in UK fall, but prevalence is unchanged	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Bhatnagar P, 2016, HEART, V102, P1945, DOI 10.1136/heartjnl-2016-309573	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2016	354								i4609	10.1136/bmj.i4609	http://dx.doi.org/10.1136/bmj.i4609			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV2ZY	27554402				2022-12-28	WOS:000382792000012
J	Poku, NK				Poku, Nana K.			UN political declaration on HIV and AIDS: where to begin?	LANCET			English	Editorial Material									[Poku, Nana K.] Univ KwaZulu Natal, Private Bag X54001, ZA-4000 Durban, South Africa	University of Kwazulu Natal	Poku, NK (corresponding author), Univ KwaZulu Natal, Private Bag X54001, ZA-4000 Durban, South Africa.	poku@ukzn.ac.za						[Anonymous], 2016, 14 ANN N MAND LECT J; Diependaele L, 2017, DEV WORLD BIOETH, V17, P11, DOI 10.1111/dewb.12105; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Hallett TB, 2006, SEX TRANSM INFECT, V82, pI1, DOI 10.1136/sti.2005.016014; Isbell MT, 2016, LANCET HIV, V3, pE284, DOI 10.1016/S2352-3018(16)30058-3; Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK ENDING AI; Kates J, 2016, FINANCING RESPONSE A; Moberg K, 2014, J PAT TRADEMARK OFF, V96, P228; Poku N, GLOB PUBLIC IN PRESS; Qiao S, 2014, AIDS BEHAV, V18, P419, DOI 10.1007/s10461-013-0561-6; Sidibe M, 2016, UNIVERSAL HLTH COVER; Sidibe M, 2016, OP 21 INT AIDS C DUR; t Hoen TE, 2002, CHIC J INT LAW, V3, P1; UN General Assembly, 2016, FAST TRACK END AIDS; Yu DB, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-8	15	5	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 20	2016	388	10046					743	744		10.1016/S0140-6736(16)31336-8	http://dx.doi.org/10.1016/S0140-6736(16)31336-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT6UH	27560262				2022-12-28	WOS:000381619200010
J	Franzen, O; Ermel, R; Cohain, A; Akers, NK; Di Narzo, A; Talukdar, HA; Foroughi-Asl, H; Giambartolomei, C; Fullard, JF; Sukhavasi, K; Koks, S; Gan, LM; Giannarelli, C; Kovacic, JC; Betsholtz, C; Losic, B; Michoel, T; Hao, K; Roussos, P; Skogsberg, J; Ruusalepp, A; Schadt, EE; Bjorkegren, JLM				Franzen, Oscar; Ermel, Raili; Cohain, Ariella; Akers, Nicholas K.; Di Narzo, Antonio; Talukdar, Husain A.; Foroughi-Asl, Hassan; Giambartolomei, Claudia; Fullard, John F.; Sukhavasi, Katyayani; Koks, Sulev; Gan, Li-Ming; Giannarelli, Chiara; Kovacic, Jason C.; Betsholtz, Christer; Losic, Bojan; Michoel, Tom; Hao, Ke; Roussos, Panos; Skogsberg, Josefin; Ruusalepp, Arno; Schadt, Eric E.; Bjorkegren, Johan L. M.			Cardiometabolic risk loci share downstream cis- and trans-gene regulation across tissues and diseases	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; SUSCEPTIBILITY LOCI; INSULIN-RESISTANCE; COMMON VARIANTS; METAANALYSIS; EXPRESSION; GWAS; EPISTASIS; PATHWAYS	Genome-wide association studies (GWAS) have identified hundreds of cardiometabolic disease (CMD) risk loci. However, they contribute little to genetic variance, and most downstream gene-regulatory mechanisms are unknown. We genotyped and RNA-sequenced vascular and metabolic tissues from 600 coronary artery disease patients in the Stockholm-Tartu Atherosclerosis Reverse Networks Engineering Task study (STARNET). Gene expression traits associated with CMD risk single-nucleotide polymorphism (SNPs) identified by GWAS were more extensively found in STARNET than in tissue-and disease-unspecific gene-tissue expression studies, indicating sharing of downstream cis-/trans-gene regulation across tissues and CMDs. In contrast, the regulatory effects of other GWAS risk SNPs were tissue-specific; abdominal fat emerged as an important gene-regulatory site for blood lipids, such as for the low-density lipoprotein cholesterol and coronary artery disease risk gene PCSK9. STARNET provides insights into gene-regulatory mechanisms for CMD risk loci, facilitating their translation into opportunities for diagnosis, therapy, and prevention.	[Franzen, Oscar; Cohain, Ariella; Akers, Nicholas K.; Di Narzo, Antonio; Giannarelli, Chiara; Losic, Bojan; Hao, Ke; Roussos, Panos; Schadt, Eric E.; Bjorkegren, Johan L. M.] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, One Gustave L Levy Pl, New York, NY 10029 USA; [Franzen, Oscar; Ruusalepp, Arno; Bjorkegren, Johan L. M.] Clin Gene Networks AB, Jungfrugatan 10, S-11444 Stockholm, Sweden; [Ermel, Raili; Sukhavasi, Katyayani; Koks, Sulev; Ruusalepp, Arno; Bjorkegren, Johan L. M.] Univ Tartu, Inst Biomed & Translat Med, Dept Pathophysiol, Biomeedikum, Ravila 19, EE-50411 Tartu, Estonia; [Ermel, Raili; Ruusalepp, Arno] Tartu Univ Hosp, Dept Cardiac Surg, 1a Ludwig Puusepa St, EE-50406 Tartu, Estonia; [Talukdar, Husain A.; Foroughi-Asl, Hassan; Skogsberg, Josefin; Bjorkegren, Johan L. M.] Karolinska Inst, Div Vasc Biol, Dept Med Biochem & Biophys, Scheeles Vag 2, S-17177 Stockholm, Sweden; [Giambartolomei, Claudia; Fullard, John F.; Roussos, Panos] Icahn Sch Med Mt Sinai, Dept Psychiat, Div Psychiat Genom, One Gustave L Levy Pl, New York, NY 10029 USA; [Giambartolomei, Claudia; Fullard, John F.; Roussos, Panos] Icahn Sch Med Mt Sinai, Friedman Brain Inst, One Gustave L Levy Pl, New York, NY 10029 USA; [Gan, Li-Ming] AstraZeneca, Innovat Med & Early Dev Biotech Unit, Cardiovasc & Metab Dis, Pepparedsleden 1, S-43183 Molndal, Sweden; [Giannarelli, Chiara; Kovacic, Jason C.] Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, One Gustave L Levy Pl, New York, NY 10029 USA; [Betsholtz, Christer] Novum, Karolinska Inst, AstraZeneca Karolinska Integrated CardioMetab Ctr, S-14157 Huddinge, Sweden; [Betsholtz, Christer] Dept Immunol Genet & Pathol, Dag Hammarskjolds Vag 20, S-75185 Uppsala, Sweden; [Michoel, Tom] Univ Edinburgh, Roslin Inst, Old Coll, Div Genet & Genom, Edinburgh EH8 9YL, Midlothian, Scotland; [Roussos, Panos] JJ Peters VA Med Ctr, MIRECC, Dept Psychiat, 130 West Kingsbridge Rd, Bronx, NY 10468 USA	Icahn School of Medicine at Mount Sinai; University of Tartu; Karolinska Institutet; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; AstraZeneca; Icahn School of Medicine at Mount Sinai; Karolinska Institutet; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Bjorkegren, JLM (corresponding author), Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, One Gustave L Levy Pl, New York, NY 10029 USA.; Bjorkegren, JLM (corresponding author), Clin Gene Networks AB, Jungfrugatan 10, S-11444 Stockholm, Sweden.; Bjorkegren, JLM (corresponding author), Univ Tartu, Inst Biomed & Translat Med, Dept Pathophysiol, Biomeedikum, Ravila 19, EE-50411 Tartu, Estonia.; Bjorkegren, JLM (corresponding author), Karolinska Inst, Div Vasc Biol, Dept Med Biochem & Biophys, Scheeles Vag 2, S-17177 Stockholm, Sweden.	johan.bjorkegren@mssm.edu	Sukhavasi, Katyayani/AAA-3640-2021; Koks, Sulev/H-3655-2015	Sukhavasi, Katyayani/0000-0001-5627-0163; Koks, Sulev/0000-0001-6087-6643; Kovacic, Jason/0000-0003-4555-769X; Michoel, Tom/0000-0003-4749-4725; Foroughi Asl, Hassan/0000-0002-6925-9040; Ruusalepp, Arno/0000-0001-5816-8613	University of Tartu [SP1GVARENG]; Estonian Research Council (ETF) [8853]; Astra-Zeneca Translational Science Centre-Karolinska Institutet; Clinical Gene Networks AB (CGN) as an SME of the FP6/FP7 EU [HEALTH-F2-2013-601456]; Leducq transatlantic networks; CAD Genomics; Sphingonet; Torsten and Ragnar Soderberg Foundation; Knut and Alice Wallenberg Foundation; American Heart Association [A14SFRN20840000]; National Institutes of Health [NIH NHLBI R01HL125863, NIH NHLBI R01HL71207, R01AG050986, NIH NHLBI K23HL111339, NIH NHLBI K08HL111330]; Veterans Affairs [BX002395]; Swedish Research Council [VR-RF1]; Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX); BBSRC [BBS/E/D/20211551] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20211551] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071207, K23HL111339, K08HL111330, R01HL125863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG050986] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002395] Funding Source: NIH RePORTER	University of Tartu; Estonian Research Council (ETF); Astra-Zeneca Translational Science Centre-Karolinska Institutet; Clinical Gene Networks AB (CGN) as an SME of the FP6/FP7 EU; Leducq transatlantic networks; CAD Genomics; Sphingonet; Torsten and Ragnar Soderberg Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	The STARNET study was supported by the University of Tartu (SP1GVARENG to J.L.M.B.), the Estonian Research Council (ETF grant 8853 to A.R. and J.L.M.B.), the Astra-Zeneca Translational Science Centre-Karolinska Institutet (a joint research program in translational science, to J.L.M.B.), Clinical Gene Networks AB (CGN) as an SME of the FP6/FP7 EU-funded integrated project CVgenes@target (HEALTH-F2-2013-601456), the Leducq transatlantic networks, CAD Genomics (C.G., E.E.S., and J.L.M.B.), Sphingonet (C.B.), the Torsten and Ragnar Soderberg Foundation (C.B.), the Knut and Alice Wallenberg Foundation (C.B.), the American Heart Association (A14SFRN20840000 to J.C.K., E.E.S., and J.L.M.B.), the National Institutes of Health (NIH NHLBI R01HL125863 to J.L.M.B.; NIH NHLBI R01HL71207 to E.E.S.; R01AG050986 to P.R.; NIH NHLBI K23HL111339 to C.G.; NIH NHLBI K08HL111330 to J.C.K.), and the Veterans Affairs (Merit grant BX002395 to P.R.). The DNA genotyping and RNA sequencing were in part performed by the SNP&SEQ technology platform at Science for Life Laboratory the National Genomics Infrastructure (NGI) in Uppsala and Stockholm supported by the Swedish Research Council (VR-RF1), the Knut and Alice Wallenberg Foundation, and Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX). CGN has financially contributed to the STARNET study. J.L.M.B. is the founder and chairman of CGN. J.L.M.B., E.E.S., and A.R. are on the board of directors for CGN. J.L.M.B., T.M., and A.R. own equity in CGN and receive financial compensation from CGN. This work was supported in part through the computational resources and staff expertise provided by Scientific Computing at the Icahn School of Medicine at Mount Sinai. The STARNET data is accessible through the Database of Genotypes and Phenotypes (dbGAP).	An P, 2014, METABOLISM, V63, P461, DOI 10.1016/j.metabol.2013.11.018; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Asl HF, 2015, CIRC-CARDIOVASC GENE, V8, P305, DOI 10.1161/CIRCGENETICS.114.000640; Cui Y, 2013, J AUTOIMMUN, V41, P25, DOI 10.1016/j.jaut.2013.01.008; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Greenawalt DM, 2011, GENOME RES, V21, P1008, DOI 10.1101/gr.112821.110; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Leander K, 2016, CIRCULATION, V133, P1230, DOI 10.1161/CIRCULATIONAHA.115.018531; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Millstein J, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-23; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Shulman GI, 2014, NEW ENGL J MED, V371, P2237; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Talukdar HA, 2016, CELL SYST, V2, P196, DOI 10.1016/j.cels.2016.02.002; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wang IM, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.24; Wei WH, 2014, NAT REV GENET, V15, P722, DOI 10.1038/nrg3747; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	30	153	153	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					827	830		10.1126/science.aad6970	http://dx.doi.org/10.1126/science.aad6970			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZE	27540175	Green Accepted			2022-12-28	WOS:000381561400047
J	Briasoulis, A; Afonso, L				Briasoulis, Alexandros; Afonso, Luis			Do NOACs ENSURE safe cardioversion in atrial fibrillation?	LANCET			English	Editorial Material							ORAL ANTICOAGULANTS; EFFICACY; WARFARIN; OUTCOMES; RISK		[Briasoulis, Alexandros] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA; [Afonso, Luis] Wayne State Univ, Div Cardiol, Detroit, MI USA	Mayo Clinic; Wayne State University	Briasoulis, A (corresponding author), Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA.	alexbriasoulis@gmail.com	Briasoulis, Alexandros/AAD-3965-2019	Briasoulis, Alexandros/0000-0002-5740-9670				Berger M, 1998, AM J CARDIOL, V82, P1545, DOI 10.1016/S0002-9149(98)00704-8; Cappato R, 2014, EUR HEART J, V35, P3346, DOI 10.1093/eurheartj/ehu367; Coleman CM, 2015, PACE, V38, P731, DOI 10.1111/pace.12618; Flaker G, 2014, J AM COLL CARDIOL, V63, P1082, DOI 10.1016/j.jacc.2013.09.062; FLEGEL KM, 1987, LANCET, V1, P526; Goette A, 2016, LANCET; Hansen ML, 2015, EUROPACE, V17, P18, DOI 10.1093/europace/euu189; January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1016/j.jacc.2014.03.022, 10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000142]; Klein AL, 2001, NEW ENGL J MED, V344, P1411, DOI 10.1056/NEJM200105103441901; Nagarakanti R, 2011, CIRCULATION, V123, P131, DOI 10.1161/CIRCULATIONAHA.110.977546; Piccini JP, 2013, J AM COLL CARDIOL, V61, P1998, DOI 10.1016/j.jacc.2013.02.025; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0	12	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2016	388	10055					1958	1960		10.1016/S0140-6736(16)31410-6	http://dx.doi.org/10.1016/S0140-6736(16)31410-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ6EQ	27590222				2022-12-28	WOS:000385954800005
J	Savolainen, O; Lascoux, M				Savolainen, Outi; Lascoux, Martin			GENOMICS Geography matters for Arabidopsis	NATURE			English	Editorial Material							DIVERSITY; THALIANA	A free database describes genome sequences, gene expression and molecular modifications to DNA for more than 1,000 Arabidopsis thaliana plants, providing valuable information on the complex history and current variation of this species.	[Savolainen, Outi] Univ Oulu, Dept Genet & Physiol, Oulu 90014, Finland; [Savolainen, Outi] Univ Oulu, Bioctr Oulu, Oulu 90014, Finland; [Lascoux, Martin] Uppsala Univ, Dept Ecol & Genet, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden	University of Oulu; University of Oulu; Uppsala University	Savolainen, O (corresponding author), Univ Oulu, Dept Genet & Physiol, Oulu 90014, Finland.; Savolainen, O (corresponding author), Univ Oulu, Bioctr Oulu, Oulu 90014, Finland.	outi.savolainen@oulu.fi						Alonso-Blanco C, 2016, CELL, V166, P481, DOI 10.1016/j.cell.2016.05.063; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Dubin MJ, 2015, ELIFE, V4, DOI 10.7554/eLife.05255; Kawakatsu T, 2016, CELL, V166, P492, DOI 10.1016/j.cell.2016.06.044; Lack JB, 2015, GENETICS, V199, P1229, DOI 10.1534/genetics.115.174664; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Neale DB, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r59; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Rellosa MC, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-7; Savolainen O, 2013, NAT REV GENET, V14, P807, DOI 10.1038/nrg3522; Williamson RJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004622	13	0	0	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2016	537	7620					314	315		10.1038/nature19466	http://dx.doi.org/10.1038/nature19466			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV7EC	27602515				2022-12-28	WOS:000383098000036
J	Greenwood, JP; Ripley, DP; Berry, C; McCann, GP; Plein, S; Bucciarelli-Ducci, C; Dall'Armellina, E; Prasad, A; Bijsterveld, P; Foley, JR; Mangion, K; Sculpher, M; Walker, S; Everett, CC; Cairns, DA; Sharples, LD; Brown, JM				Greenwood, John P.; Ripley, David P.; Berry, Colin; McCann, Gerry P.; Plein, Sven; Bucciarelli-Ducci, Chiara; Dall'Armellina, Erica; Prasad, Abhiram; Bijsterveld, Petra; Foley, James R.; Mangion, Kenneth; Sculpher, Mark; Walker, Simon; Everett, Colin C.; Cairns, David A.; Sharples, Linda D.; Brown, Julia M.		CE-MARC 2 Investigators	Effect of Care Guided by Cardiovascular Magnetic Resonance, Myocardial Perfusion Scintigraphy, or NICE Guidelines on Subsequent Unnecessary Angiography Rates The CE-MARC 2 Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY-DISEASE; TASK-FORCE; COMPUTED-TOMOGRAPHY; HEART-ASSOCIATION; AMERICAN-COLLEGE; DIAGNOSIS; SOCIETY; APPROPRIATENESS; CATHETERIZATION; MANAGEMENT	IMPORTANCE Among patients with suspected coronary heart disease (CHD), rates o angiography are considered too high. OBJECTIVE To test the hypothesis that among patients with suspected CHD, cardiovascular magnetic resonance (CMR)-guided care is superior to National Institute for Health and Care Excellence (NICE) guidelines-directed care and myocardial perfusion scintigraphy (MPS)-guided care in reducing unnecessary angiography. DESIGN, SETTING, AND PARTICIPANTS Multicenter, 3-parallel group, randomized clinical trial using a pragmatic comparative effectiveness design. From 6 UK hospitals, 1202 symptomatic patients with suspected CHD and a CHD pretest likelihood of 10% to 90% were recruited. First randomization was November 23, 2012; last 12-month follow-up was March 12, 2016. INTERVENTIONS Patients were randomly assigned (240:481:481) to management according to UK NICE guidelines or to guided care based on the results of CMR or MPS testing. MAIN OUTCOMES AND MEASURES The primary end point was protocol-defined unnecessary coronary angiography (normal fractional flow reserve >0.8 or quantitative coronary angiography [QCA] showing no percentage diameter stenosis >70% in lview or >50% in 2 orthogonal views in all coronary vessels >2.5 mm diameter) within 12 months. Secondary end points included positive angiography, major adverse cardiovascular events (MACEs), and procedural complications. RESULTS Among 1202 symptomatic patients (mean age, 56.3 years [SD, 9.0]; women, 564 [46.9%]; mean CHD pretest likelihood, 49.5% [SD, 23.8%]), number of patients with invasive coronary angiography after 12 months was 102 in the NICE guidelines group (42.5% [95% Cl, 36.2%-49.0%])], 85 in the CMR group (17.7% [95% CI, 14.4%-21.4%]); and 78 in the MPS group (16.2% [95% Cl, 13.0%.19.8%]). Study-defined unnecessary angiography occurred in 69(28.8%) in the NICE guidelines group, 36(7.5%) in the CMR group, and 34(7.1%) in the MPS group; adjusted odds ratio of unnecessary angiography: CMR group vs NICE guidelines group, 0.21(95% Cl, 0.12-0.34, P < .001); CMR group vs the MPS group, 1.27(95% CI, 0.792.03, P =.32). Positive angiography proportions were 12.1% (95% Cl, 8.2%-16.9%; 29/240 patients) for the NICE guidelines group, 9.8% (95% Cl, 7.3%12.8%; 47/481 patients) for the CMR group, and 8.7% (95% Cl, 6.4%-11.6%; 42/481 patients) for the MPS group. A MACE was reported at a minimum of 12 months in 1.7% of patients in the NICE guidelines group, 2.5% in the CMR group, and 2.5% in the MPS group (adjusted hazard ratios: CMR group vs NICE guidelines group, 1.37 [95% Cl, 0.52-3.57]; CMR group vs MPS group, 0.95 [95% CI, 0.46-1.95]). CONCLUSIONS AND RELEVANCE In patients with suspected angina, investigation by CMR resulted in a lower probability of unnecessary angiography within 12 months than NICE guideline-directed care, with no statistically significant difference between CMR and MPS strategies. There were no statistically significant differences in MACE rates.	[Greenwood, John P.; Ripley, David P.; Plein, Sven; Bijsterveld, Petra; Foley, James R.] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Div Biomed Imaging, Multidisciplinary Cardiovasc Res Ctr, Leeds LS2 9JT, W Yorkshire, England; [Berry, Colin; Mangion, Kenneth] Univ Glasgow, Inst Cardiovasc & Med Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [McCann, Gerry P.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [McCann, Gerry P.] Glenfield Hosp, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester, Leics, England; [Bucciarelli-Ducci, Chiara] Univ Bristol, Cardiovasc Magnet Resonance Unit, Bristol Cardiovasc Biomed Res Unit, Natl Inst Hlth Res,Bristol Heart Inst, Bristol, Avon, England; [Dall'Armellina, Erica] Univ Oxford, Acute Vasc Imaging Ctr, Radcliffe Dept Med, John Radcliffe Hosp, Oxford, England; [Prasad, Abhiram] St Georges Univ London, Cardiovasc Sci Res Ctr, London, England; [Sculpher, Mark; Walker, Simon] Univ York, Ctr Hlth Econ, York, N Yorkshire, England; [Everett, Colin C.; Cairns, David A.; Sharples, Linda D.; Brown, Julia M.] Univ Leeds, Clin Trials Res Unit, Leeds Inst Clin Trials Res, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; University of Glasgow; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Bristol; University of Oxford; St Georges University London; University of York - UK; University of Leeds	Greenwood, JP (corresponding author), Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Clarendon Way, Leeds LS2 9JT, W Yorkshire, England.	j.greenwood@leeds.ac.uk	Cairns, David/A-6577-2009; Berry, Colin/AAF-5268-2020; Bucciarelli-Ducci, Chiara/ABE-8891-2020	Cairns, David/0000-0002-2338-0179; Prasad, Abhiram/0000-0001-9252-5602; Bijsterveld, Petra/0000-0002-9257-5850; Walker, Simon Mark/0000-0002-5750-3691; Sharples, Linda/0000-0003-0894-966X; Ripley, David/0000-0001-8460-9873; brown, julia/0000-0002-2719-7064; Plein, Sven/0000-0002-0997-4384; Sculpher, Mark/0000-0003-3746-9913; Bucciarelli-Ducci, Chiara/0000-0002-2515-0852; McCann, Gerry/0000-0002-5542-8448	British Heart Foundation [SP/12/1/29062, FS/15/54/31639, FS/1062/28409]; Leeds Teaching Hospital Charitable Foundation; National Institute for Health Research (NIHR), through the Local Clinical Research Networks; Leeds Clinical Research Facility; NIHR Biomedical Research Unit in Cardiovascular Disease at the University Hospitals Bristol National Health Service Foundation Trust; University of Bristol; Scottish Funding Council; British Heart Foundation Centre of Research Excellence award [RE/13/5/30177]; NIHR; MRC [MR/N003403/1] Funding Source: UKRI; British Heart Foundation [FS/13/71/30378, FS/14/15/30661] Funding Source: researchfish; Medical Research Council [MR/N003403/1] Funding Source: researchfish; National Institute for Health Research [CDF-2014-07-045] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Leeds Teaching Hospital Charitable Foundation; National Institute for Health Research (NIHR), through the Local Clinical Research Networks; Leeds Clinical Research Facility; NIHR Biomedical Research Unit in Cardiovascular Disease at the University Hospitals Bristol National Health Service Foundation Trust; University of Bristol; Scottish Funding Council; British Heart Foundation Centre of Research Excellence award; NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This trial was funded by grant SP/12/1/29062 and fellowships FS/15/54/31639 (Dr Mangion) and FS/1062/28409 (Dr Piein) from the British Heart Foundation; the Leeds Teaching Hospital Charitable Foundation and the National Institute for Health Research (NIHR), through the Local Clinical Research Networks and the Leeds Clinical Research Facility; the NIHR Biomedical Research Unit in Cardiovascular Disease at the University Hospitals Bristol National Health Service Foundation Trust and the University of Bristol (Dr Bucciarelli-Ducci); by a senior fellowship from the Scottish Funding Council and grant RE/13/5/30177 from the British Heart Foundation Centre of Research Excellence award (Dr Berry); and by NIHR postdoctoral and career development fellowships (Dr McCann).	Abbara Suhny, 2009, J Cardiovasc Comput Tomogr, V3, P190, DOI 10.1016/j.jcct.2009.03.004; Bradley SM, 2014, JAMA INTERN MED, V174, P1630, DOI 10.1001/jamainternmed.2014.3904; Cheng VY, 2011, CIRCULATION, V124, P2424, DOI 10.1161/CIRCULATIONAHA.111.039255; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; Douglas PS, 2015, NEW ENGL J MED, V372, P1291, DOI 10.1056/NEJMoa1415516; Fihn SD, 2012, CIRCULATION, V126, pE354, DOI 10.1161/CIR.0b013e318277d6a0; FLEISS JL, 1980, BIOMETRICS, V36, P343, DOI 10.2307/2529990; Fox KAA, 2010, HEART, V96, P903, DOI 10.1136/hrt.2010.197947; Genders TSS, 2011, EUR HEART J, V32, P1316, DOI 10.1093/eurheartj/ehr014; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Greenwood JP, 2016, ANN INTERN MED, V165, P1, DOI 10.7326/M15-1801; Greenwood JP, 2012, LANCET, V379, P453, DOI 10.1016/S0140-6736(11)61335-4; Hannan EL, 2014, CIRC-CARDIOVASC INTE, V7, P19, DOI 10.1161/CIRCINTERVENTIONS.113.000741; Hendel RC, 2009, CIRCULATION, V119, pE561, DOI 10.1161/CIRCULATIONAHA.109.192519; Hesse B, 2008, EUR J NUCL MED MOL I, V35, P851, DOI 10.1007/s00259-007-0694-9; Holly TA, 2010, J NUCL CARDIOL, V17, P941, DOI 10.1007/s12350-010-9246-y; Kramer CM, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-35; Kuznetsova OM, 2012, STAT MED, V31, P701, DOI 10.1002/sim.4447; Marwick TH, 2015, J AM COLL CARDIOL, V65, P2747, DOI 10.1016/j.jacc.2015.04.060; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Nakanishi R, 2011, CIRCULATION, V124; Patel M. R., 2014, AM HEART J, V167; Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272; PRYOR DB, 1993, ANN INTERN MED, V118, P81, DOI 10.7326/0003-4819-118-2-199301150-00001; Ripley DP, 2015, AM HEART J, V169, P17, DOI 10.1016/j.ahj.2014.10.008; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Schonenberger E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000246; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	28	168	189	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2016	316	10					1051	1060		10.1001/jama.2016.12680	http://dx.doi.org/10.1001/jama.2016.12680			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV5TB	27570866	Green Published, Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000382991100017
J	Hodson, R				Hodson, Richard			PRECISION MEDICINE	NATURE			English	Editorial Material																			0	112	113	5	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					S49	S49		10.1038/537S49a	http://dx.doi.org/10.1038/537S49a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9LQ	27602738	Bronze			2022-12-28	WOS:000382539100057
J	Donohoe, M				Donohoe, Martin			Academic Medicine and Concierge Practice	ANNALS OF INTERNAL MEDICINE			English	Letter							PHYSICIANS; PATIENT; CARE		[Donohoe, Martin] Portland State Univ, Portland, OR 97207 USA	Portland State University	Donohoe, M (corresponding author), Portland State Univ, Portland, OR 97207 USA.							Alexander GC, 2005, J GEN INTERN MED, V20, P1079, DOI 10.1111/j.1525-1497.2005.0233.x; Doherty R, 2015, ANN INTERN MED, V163, P949, DOI 10.7326/M15-0366; Donohoe M, 2004, J GEN INTERN MED, V19, P90, DOI 10.1111/j.1525-1497.2004.20631.x; Donohoe MT., 2007, IDEOLOGICAL DEBATES; Wolfe SM, 2002, ACAD MED, V77, P5, DOI 10.1097/00001888-200201000-00004	5	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2016	165	5					375	375		10.7326/L16-0103	http://dx.doi.org/10.7326/L16-0103			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3BC	27595216				2022-12-28	WOS:000382795000008
J	Voelker, R				Voelker, Rebecca			Noninvasive Tremor Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2016	316	9					918	918		10.1001/jama.2016.11385	http://dx.doi.org/10.1001/jama.2016.11385			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU8JV	27599322				2022-12-28	WOS:000382460200007
J	Extance, A				Extance, Andy			COULD THE MOLECULE KNOWN FOR STORING GENETIC INFORMATION ALSO STORE THE WORLD'S DATA?	NATURE			English	News Item							DNA							Waldrop, M Mitchell/0000-0002-8063-1472				Bornholt J., 2016, P 21 INT C ARCH SUPP, V44, P637; Church GM, 2012, SCIENCE, V337, P1628, DOI 10.1126/science.1226355; Goldman N, 2013, NATURE, V494, P77, DOI 10.1038/nature11875; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Yazdi SMHT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14138; Zhirnov V, 2016, NAT MATER, V15, P366, DOI 10.1038/nmat4594	6	47	59	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					22	24		10.1038/537022a	http://dx.doi.org/10.1038/537022a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27582204	Bronze			2022-12-28	WOS:000382426900008
J	Lampson, BL; Gray, SW; Cibas, ES; Levy, BD; Loscalzo, J				Lampson, Benjamin L.; Gray, Stacy W.; Cibas, Edmund S.; Levy, Bruce D.; Loscalzo, Joseph			Tip of the Tongue	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LUNG-CANCER PATIENTS; CEREBROSPINAL-FLUID CYTOLOGY; LEPTOMENINGEAL METASTASES; ANTIRETROVIRAL THERAPY; HIV-INFECTION; SOLID TUMORS; CARCINOMATOSIS; ERA		[Lampson, Benjamin L.; Levy, Bruce D.; Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Cibas, Edmund S.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Gray, Stacy W.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Lampson, Benjamin L.; Gray, Stacy W.; Cibas, Edmund S.; Levy, Bruce D.; Loscalzo, Joseph] Harvard Med Sch, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Levy, BD (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	blevy@partners.org	Gray, Stacy/AAJ-2956-2020; Loscalzo, Joseph/ABD-8980-2021; Gray, Stacy/GRF-6833-2022	Gray, Stacy/0000-0001-6948-0143; 				Boogerd W, 2004, EUR J CANCER, V40, P2726, DOI 10.1016/j.ejca.2004.08.012; Chamberlain M, 2014, NEURO-ONCOLOGY, V16, P1176, DOI 10.1093/neuonc/nou089; Chou SHS, 2014, RADIOGRAPHICS, V34, P895, DOI 10.1148/rg.344130115; Clarke JL, 2010, NEUROLOGY, V74, P1449, DOI 10.1212/WNL.0b013e3181dc1a69; D'Jaen GA, 2010, CLIN LUNG CANCER, V11, P396, DOI 10.3816/CLC.2010.n.051; Foppen MHG, 2016, ANN ONCOL, V27, P1138, DOI 10.1093/annonc/mdw134; Gainor JF, 2015, J THORAC ONCOL, V10, P232, DOI 10.1097/JTO.0000000000000455; Glantz MJ, 1998, CANCER, V82, P733, DOI 10.1002/(SICI)1097-0142(19980215)82:4<733::AID-CNCR17>3.0.CO;2-Z; Grossman SA, 1999, CANCER TREAT REV, V25, P103, DOI 10.1053/ctrv.1999.0119; KAPLAN JG, 1990, J NEURO-ONCOL, V9, P225, DOI 10.1007/BF02341153; Keane JR, 1996, ARCH NEUROL-CHICAGO, V53, P561, DOI 10.1001/archneur.1996.00550060105023; Kirk GD, 2007, CLIN INFECT DIS, V45, P103, DOI 10.1086/518606; Lee SJ, 2013, J THORAC ONCOL, V8, P185, DOI 10.1097/JTO.0b013e3182773f21; Liao BC, 2015, J THORAC ONCOL, V10, P1754, DOI 10.1097/JTO.0000000000000669; Straathof CSM, 1999, J NEUROL, V246, P810, DOI 10.1007/s004150050459; WASSERSTROM WR, 1982, CANCER, V49, P759, DOI 10.1002/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7	16	0	0	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2016	375	9					880	886		10.1056/NEJMcps1414168	http://dx.doi.org/10.1056/NEJMcps1414168			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU9HA	27579639				2022-12-28	WOS:000382526000013
J	Olken, BA				Olken, Benjamin A.			Hassles versus prices	SCIENCE			English	Editorial Material							FIELD EXPERIMENT		[Olken, Benjamin A.] MIT, Dept Econ, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Olken, BA (corresponding author), MIT, Dept Econ, Cambridge, MA 02139 USA.	bolken@mit.edu						Abdul Latif Jameel Poverty Action Lab (JPAL), 2011, THE PRIC IS WRONG; Alatas V, 2016, J POLIT ECON, V124, P371, DOI 10.1086/685299; [Anonymous], 2015, ELICITING UTILIZING; Ashraf N, 2010, AM ECON REV, V100, P2383, DOI 10.1257/aer.100.5.2383; Cohen J, 2010, Q J ECON, V125, P1, DOI 10.1162/qjec.2010.125.1.1; Dupas P, 2016, SCIENCE, V353, P889, DOI 10.1126/science.aaf6288; Dupas P, 2014, SCIENCE, V345, P1279, DOI 10.1126/science.1256973; Dutta P., 2012, 6003 WORLD BANK; MARGO RA, 1991, J ECON HIST, V51, P333, DOI 10.1017/S0022050700038973; NICHOLS AL, 1982, AM ECON REV, V72, P372	10	4	4	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					864	865		10.1126/science.aah5055	http://dx.doi.org/10.1126/science.aah5055			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU0CA	27563082	Green Published			2022-12-28	WOS:000381867700015
J	Bourouiba, L				Bourouiba, Lydia			A Sneeze	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bourouiba, Lydia] MIT, Fluid Dynam Dis Transmiss Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Bourouiba, L (corresponding author), MIT, Fluid Dynam Dis Transmiss Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lbouro@mit.edu							0	71	71	2	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2016	375	8					E15	E15		10.1056/NEJMicm1501197	http://dx.doi.org/10.1056/NEJMicm1501197			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9ET	27557321				2022-12-28	WOS:000381799300001
J	Kanthor, R				Kanthor, Rebecca			CHINA	NATURE			English	Editorial Material																			0	0	0	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					S6	+		10.1038/536S6a	http://dx.doi.org/10.1038/536S6a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV0YL	27557163	Bronze			2022-12-28	WOS:000382646600003
J	Fraser, B				Fraser, Barbara			Peru's new health minister outlines priorities	LANCET			English	Editorial Material																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 20	2016	388	10046					745	746		10.1016/S0140-6736(16)31415-5	http://dx.doi.org/10.1016/S0140-6736(16)31415-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT6UH	27560263				2022-12-28	WOS:000381619200011
J	Morgan, J				Morgan, Jules			Frontline: Providing health care in Greece's refugee camps	LANCET			English	Editorial Material																			0	3	3	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 20	2016	388	10046					748	748		10.1016/S0140-6736(16)31417-9	http://dx.doi.org/10.1016/S0140-6736(16)31417-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT6UH	27560265				2022-12-28	WOS:000381619200013
J	Ransohoff, RM				Ransohoff, Richard M.			How neuroinflammation contributes to neurodegeneration	SCIENCE			English	Review							CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; MICROGLIAL PHYSIOLOGY; FRACTALKINE RECEPTOR; MOTOR-NEURONS; MYELOID CELLS; AXONAL-INJURY; GLIAL-CELLS	Neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and frontotemporal lobar dementia are among the most pressing problems of developed societies with aging populations. Neurons carry out essential functions such as signal transmission and network integration in the central nervous system and are the main targets of neurodegenerative disease. In this Review, I address how the neuron's environment also contributes to neurodegeneration. Maintaining an optimal milieu for neuronal function rests with supportive cells termed glia and the blood-brain barrier. Accumulating evidence suggests that neurodegeneration occurs in part because the environment is affected during disease in a cascade of processes collectively termed neuroinflammation. These observations indicate that therapies targeting glial cells might provide benefit for those afflicted by neurodegenerative disorders.	[Ransohoff, Richard M.] Biogen, 225 Binney St, Cambridge, MA 02142 USA	Biogen	Ransohoff, RM (corresponding author), Biogen, 225 Binney St, Cambridge, MA 02142 USA.	richard.ransohoff@biogen.com						Absinta M, 2015, NEUROLOGY, V85, P18, DOI 10.1212/WNL.0000000000001587; Ajroud-Driss S, 2015, BBA-MOL BASIS DIS, V1852, P679, DOI 10.1016/j.bbadis.2014.08.010; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Bianchin MM, 2004, CELL MOL NEUROBIOL, V24, P1, DOI 10.1023/B:CEMN.0000012721.08168.ee; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Bruck D, 2016, NEUROBIOL DIS, V85, P262, DOI 10.1016/j.nbd.2015.03.003; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chouraki V, 2014, ADV GENET, V87, P245, DOI 10.1016/B978-0-12-800149-3.00005-6; Cree BAC, 2014, HAND CLINIC, V122, P211, DOI 10.1016/B978-0-444-52001-2.00042-X; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Fellner L, 2011, ACTA NEUROPATHOL, V121, P675, DOI 10.1007/s00401-011-0833-z; Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630; Franklin RJM, 2012, NAT REV NEUROL, V8, P624, DOI 10.1038/nrneurol.2012.200; Goedert M, 2001, PHILOS T ROY SOC B, V356, P213, DOI 10.1098/rstb.2000.0767; Gu XL, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-12; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Holtman IR, 2015, GLIA, V63, P1495, DOI 10.1002/glia.22810; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Jaturapatporn D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006378.pub2; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kang ZH, 2013, NAT NEUROSCI, V16, P1401, DOI 10.1038/nn.3505; Kantarci OH, 2016, ANN NEUROL, V79, P288, DOI 10.1002/ana.24564; Klunemann HH, 2005, NEUROLOGY, V64, P1502, DOI 10.1212/01.WNL.0000160304.00003.CA; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Kovacs GG, 2014, NEUROSCIENCE, V269, P152, DOI 10.1016/j.neuroscience.2014.03.045; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Lardenoije R, 2015, PROG NEUROBIOL, V131, P21, DOI 10.1016/j.pneurobio.2015.05.002; Leicht H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070018; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Lui HS, 2016, CELL, V165, P921, DOI 10.1016/j.cell.2016.04.001; Madabhushi R, 2014, NEURON, V83, P266, DOI 10.1016/j.neuron.2014.06.034; Magliozzi R, 2010, ANN NEUROL, V68, P477, DOI 10.1002/ana.22230; Marchetti L, 2004, J BIOL CHEM, V279, P32869, DOI 10.1074/jbc.M311766200; Masuch A, 2016, GLIA, V64, P1285, DOI 10.1002/glia.23002; McGann JC, 2012, CURR OPIN NEUROBIOL, V22, P850, DOI 10.1016/j.conb.2012.03.009; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Montalbetti L, 2005, FUNCT NEUROL, V20, P71; Munger Kassandra L, 2007, Expert Rev Clin Immunol, V3, P739, DOI 10.1586/1744666X.3.5.739; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Nishiyama A, 2016, BRAIN RES, V1638, P116, DOI 10.1016/j.brainres.2015.08.013; O'Rourke M, 2014, NEURAL REGEN RES, V9, P1261, DOI 10.4103/1673-5374.137571; Obermeier B, 2008, NAT MED, V14, P688, DOI 10.1038/nm1714; Obermeier B, 2016, HAND CLINIC, V133, P39, DOI 10.1016/B978-0-444-63432-0.00003-7; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Perry VH, 2010, ACTA NEUROPATHOL, V120, P277, DOI 10.1007/s00401-010-0722-x; Phimister EG, 2015, NEW ENGL J MED, V372, P2564, DOI 10.1056/NEJMcibr1503954; Poliani PL, 2015, J CLIN INVEST, V125, P2161, DOI 10.1172/JCI77983; Price DL, 2000, ANN NY ACAD SCI, V920, P179; Qiang L, 2013, NEURON, V78, P957, DOI 10.1016/j.neuron.2013.06.002; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Ransohoff RM, 2016, NATURE, V532, P185, DOI 10.1038/nature17881; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Ransohoff RM, 2010, NAT IMMUNOL, V11, P570, DOI 10.1038/ni0710-570; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Redmann M, 2016, AGING DIS, V7, P150, DOI 10.14336/AD.2015.0820; Rogers J, 1996, NEUROBIOL AGING, V17, P681, DOI 10.1016/0197-4580(96)00115-7; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Talbot W. S., 2015, COLD SPRING HARB PER; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Villegas-Llerena C, 2016, CURR OPIN NEUROBIOL, V36, P74, DOI 10.1016/j.conb.2015.10.004; Walker LC, 2013, JAMA NEUROL, V70, P304, DOI 10.1001/jamaneurol.2013.1453; Walter J, 2016, J BIOL CHEM, V291, P4334, DOI 10.1074/jbc.R115.704981; Watters O, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-87; Waxman SG, 2006, TRENDS MOL MED, V12, P192, DOI 10.1016/j.molmed.2006.03.001; Wendland JR, 2016, BIOL PSYCHIAT, V79, P650, DOI 10.1016/j.biopsych.2015.04.027; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zhang PW, 2016, GLIA, V64, P63, DOI 10.1002/glia.22903; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067	87	1008	1040	24	598	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					777	783		10.1126/science.aag2590	http://dx.doi.org/10.1126/science.aag2590			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZE	27540165				2022-12-28	WOS:000381561400035
J	Azofeifa, A; Mattson, ME; Grant, A				Azofeifa, Alejandro; Mattson, Margaret E.; Grant, Althea			Monitoring Marijuana Use in the United States Challenges in an Evolving Environment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH		[Azofeifa, Alejandro; Mattson, Margaret E.] Subst Abuse & Mental Hlth Serv Adm, 5600 Fisher Ln,Room 15E-29D, Rockville, MD 20857 USA; [Grant, Althea] Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Azofeifa, A (corresponding author), Subst Abuse & Mental Hlth Serv Adm, 5600 Fisher Ln,Room 15E-29D, Rockville, MD 20857 USA.	alejandro.azofeifa@samhsa.hhs.gov						Azofeifa A, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6511a1; Batalla A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055821; Center for Behavioral Health Statistics and Quality, 2015, NSDUH SER H; ElSohly MA, 2016, BIOL PSYCHIAT, V79, P613, DOI 10.1016/j.biopsych.2016.01.004; Hall W, 2014, DRUG TEST ANAL, V6, P39, DOI 10.1002/dta.1506; National Institute on Drug Abuse, 2016, NIH PUBL; Volkow ND, 2014, NEW ENGL J MED, V370, P2219, DOI 10.1056/NEJMra1402309; Whiting PF, 2015, JAMA-J AM MED ASSOC, V313, P2456, DOI 10.1001/jama.2015.6358	8	21	21	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2016	316	17					1765	1766		10.1001/jama.2016.13696	http://dx.doi.org/10.1001/jama.2016.13696			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA4GP	27583699				2022-12-28	WOS:000386569300012
J	Mancia, G				Mancia, Giuseppe			Should blood pressure reduction be aggressive in patients with hypertension and coronary artery disease?	LANCET			English	Editorial Material									[Mancia, Giuseppe] Univ Milano Bicocca, IRCCS Ist Auxol Italiano, I-20126 Milan, Italy	IRCCS Istituto Auxologico Italiano; University of Milano-Bicocca	Mancia, G (corresponding author), Univ Milano Bicocca, IRCCS Ist Auxol Italiano, I-20126 Milan, Italy.	giuseppe.mancia@unimib.it						Arima H, 2006, J HYPERTENS, V24, P1201, DOI 10.1097/01.hjh.0000226212.34055.86; Chrysant SG, 2010, AM J CARDIOL, V106, P825, DOI 10.1016/j.amjcard.2010.05.006; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Hirakawa Y, 2016, J HYPERTENS, V34, P781, DOI 10.1097/HJH.0000000000000841; Mancia Giuseppe, 2016, Eur Heart J, V37, P955, DOI 10.1093/eurheartj/ehv633; Mancia G, 2014, HYPERTENSION, V63, P29, DOI [10.1161/HYPERTENSIONAHA.113.01922, 10.1161/01.hyp.0000441190.09494.e9]; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Ovbiagele B, 2011, JAMA-J AM MED ASSOC, V306, P2137, DOI 10.1001/jama.2011.1650; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Vickrey BG, 2002, STROKE, V33, P901, DOI 10.1161/hs0402.105246; Vidal-Petiot E, 2016, LANCET, V388, P2142, DOI 10.1016/S0140-6736(16)31326-5; Zanchetti A, 2010, EUR HEART J, V31, P2837, DOI 10.1093/eurheartj/ehq281	12	2	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 29	2016	388	10056					2061	2062		10.1016/S0140-6736(16)31398-8	http://dx.doi.org/10.1016/S0140-6736(16)31398-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA1DJ	27590220				2022-12-28	WOS:000386332400005
J	Su, X; Meng, ZT; Wu, XH; Cui, F; Li, HL; Wang, DX; Zhu, X; Zhu, SN; Maze, M; Ma, DQ				Su, Xian; Meng, Zhao-Ting; Wu, Xin-Hai; Cui, Fan; Li, Hong-Liang; Wang, Dong-Xin; Zhu, Xi; Zhu, Sai-Nan; Maze, Mervyn; Ma, Daqing			Dexmedetomidine for prevention of delirium in elderly patients after non-cardiac surgery: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; CONFUSION ASSESSMENT METHOD; MECHANICALLY VENTILATED PATIENTS; POSTOPERATIVE DELIRIUM; RISK-FACTORS; CAM-ICU; HEMODYNAMIC-CHANGES; PROSPECTIVE COHORT; SLEEP QUALITY	Background Delirium is a postoperative complication that occurs frequently in patients older than 65 years, and presages adverse outcomes. We investigated whether prophylactic low-dose dexmedetomidine, a highly selective a 2 adrenoceptor agonist, could safely decrease the incidence of delirium in elderly patients after non-cardiac surgery. Methods We did this randomised, double-blind, placebo-controlled trial in two tertiary-care hospitals in Beijing, China. We enrolled patients aged 65 years or older, who were admitted to intensive care units after non-cardiac surgery, with informed consent. We used a computer-generated randomisation sequence (in a 1:1 ratio) to randomly assign patients to receive either intravenous dexmedetomidine (0.1 mu g/kg per h, from intensive care unit admission on the day of surgery until 0800 h on postoperative day 1), or placebo (intravenous normal saline). Participants, care providers, and investigators were all masked to group assignment. The primary endpoint was the incidence of delirium, assessed twice daily with the Confusion Assessment Method for intensive care units during the first 7 postoperative days. Analyses were done by intention-to-treat and safety populations. This study is registered with Chinese Clinical Trial Registry, www.chictr.org.cn, number ChiCTR-TRC-10000802. Findings Between Aug 17, 2011, and Nov 20, 2013, of 2016 patients assessed, 700 were randomly assigned to receive either placebo (n=350) or dexmedetomidine (n=350). The incidence of postoperative delirium was significantly lower in the dexmedetomidine group (32 [9%] of 350 patients) than in the placebo group (79 [23%] of 350 patients; odds ratio [OR] 0.35, 95% CI 0.22-0.54; p<0.0001). Regarding safety, the incidence of hypertension was higher with placebo (62 [18%] of 350 patients) than with dexmedetomidine (34 [10%] of 350 patients; 0.50, 0.32-0.78; p=0.002). Tachycardia was also higher in patients given placebo (48 [14%] of 350 patients) than in patients given dexmedetomidine (23 [7%] of 350 patients; 0.44, 0.26-0.75; p=0.002). Occurrence of hypotension and bradycardia did not differ between groups. Interpretation For patients aged over 65 years who are admitted to the intensive care unit after non-cardiac surgery, prophylactic low-dose dexmedetomidine significantly decreases the occurrence of delirium during the first 7 days after surgery. The therapy is safe.	[Su, Xian; Meng, Zhao-Ting; Wu, Xin-Hai; Cui, Fan; Wang, Dong-Xin] Peking Univ, Hosp 1, Dept Anaesthesiol & Crit Care Med, Beijing 100034, Peoples R China; [Zhu, Sai-Nan] Peking Univ, Hosp 1, Dept Biostat, Beijing, Peoples R China; [Li, Hong-Liang; Zhu, Xi] Peking Univ, Hosp 3, Dept Crit Care Med, Beijing, Peoples R China; [Maze, Mervyn] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Ma, Daqing] Imperial Coll London, Chelsea & Westminster Hosp, Sect Anaesthet Pain Management & Intens Care, Dept Surg & Canc, London, England	Peking University; Peking University; Peking University; University of California System; University of California San Francisco; Imperial College London	Wang, DX (corresponding author), Peking Univ, Hosp 1, Dept Anaesthesiol & Crit Care Med, Beijing 100034, Peoples R China.; Ma, DQ (corresponding author), Imperial Coll London, Chelsea & Westminster Hosp, Dept Surg & Canc, Anaesthet Pain Med & Intens Care,Fac Med, London, England.	wangdongxin@hotmail.com; d.ma@imperial.ac.uk	Ma, Daqing/GLT-2735-2022	Ma, Daqing/0000-0003-1235-0537; Ma, Daqing/0000-0002-0688-2097; , Hong-Liang/0000-0001-5543-7726	Braun Anaesthesia Scientific Research Fund; Wu Jieping Medical Foundation, Beijing, China	Braun Anaesthesia Scientific Research Fund; Wu Jieping Medical Foundation, Beijing, China	Braun Anaesthesia Scientific Research Fund and Wu Jieping Medical Foundation, Beijing, China. Study drugs were manufactured and supplied by Jiangsu Hengrui Medicine Co, Ltd, Jiangsu, China.	Abelha FJ, 2013, CRIT CARE, V17, DOI 10.1186/cc13084; Alexopoulou C, 2014, ANESTHESIOLOGY, V121, P801, DOI 10.1097/ALN.0000000000000361; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Bilotta F, 2013, MINERVA ANESTESIOL, V79, P1066; BLOOR BC, 1992, ANESTHESIOLOGY, V77, P1134, DOI 10.1097/00000542-199212000-00014; Burkhart CS, 2010, J CARDIOTHOR VASC AN, V24, P555, DOI 10.1053/j.jvca.2010.01.003; Capri M, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00173; Chalikonda S. A., 2009, J AM ASS NURSE ANEST, V77, P103; Chrysostomou C, 2008, EXPERT OPIN DRUG MET, V4, P619, DOI [10.1517/17425255.4.5.619, 10.1517/17425255.4.5.619 ]; Cole MG, 2004, AM J GERIAT PSYCHIAT, V12, P7, DOI 10.1176/appi.ajgp.12.1.7; Coull JT, 2004, NEUROIMAGE, V22, P315, DOI 10.1016/j.neuroimage.2003.12.022; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Flink BJ, 2012, ANESTHESIOLOGY, V116, P788, DOI 10.1097/ALN.0b013e31824b94fc; Fraser GL, 2013, CRIT CARE MED, V41, pS30, DOI 10.1097/CCM.0b013e3182a16898; Gu J, 2011, ACTA ANAESTH SCAND, V55, P1272, DOI 10.1111/j.1399-6576.2011.02526.x; Iirola T, 2011, CRIT CARE, V15, DOI 10.1186/cc10518; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Inouye SK, 2003, ARCH INTERN MED, V163, P958, DOI 10.1001/archinte.163.8.958; Kim HJ, 2015, CLIN EXP OTORHINOLAR, V8, P46, DOI 10.3342/ceo.2015.8.1.46; Kosar CM, 2014, LANCET PSYCHIAT, V1, P431, DOI 10.1016/S2215-0366(14)00006-6; Kuczmarska A, 2016, J GEN INTERN MED, V31, P297, DOI 10.1007/s11606-015-3514-0; Lin TF, 2009, BRIT J ANAESTH, V102, P117, DOI 10.1093/bja/aen320; Memis D, 2007, BRIT J ANAESTH, V98, P550, DOI 10.1093/bja/aem017; Mo Y, 2013, ANN PHARMACOTHER, V47, P869, DOI 10.1345/aph.1AR708; Mu DL, 2010, CRIT CARE, V14, DOI 10.1186/cc9393; Munk L, 2016, ACTA ANAESTH SCAND, V60, P1059, DOI 10.1111/aas.12717; Nelson LE, 2003, ANESTHESIOLOGY, V98, P428, DOI 10.1097/00000542-200302000-00024; Nishimura K, 2016, HEART LUNG, V45, P15, DOI 10.1016/j.hrtlng.2015.11.001; Oto J, 2012, INTENS CARE MED, V38, P1982, DOI 10.1007/s00134-012-2685-y; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Pasin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082913; Peterson JF, 2006, J AM GERIATR SOC, V54, P479, DOI 10.1111/j.1532-5415.2005.00621.x; Reade MC, 2016, JAMA-J AM MED ASSOC, V315, P1460, DOI 10.1001/jama.2016.2707; Reade MC, 2014, NEW ENGL J MED, V370, P444, DOI 10.1056/NEJMra1208705; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Ritmala-Castren M, 2014, SCAND J CARING SCI, V28, P435, DOI 10.1111/scs.12072; Rosenberg J, 2001, SLEEP MED REV, V5, P129, DOI 10.1053/smrv.2000.0121; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Shi CM, 2010, CHINESE MED J-PEKING, V123, P993, DOI 10.3760/cma.j.issn.0366-6999.2010.08.004; Siddiqi N, 2006, AGE AGEING, V35, P350, DOI 10.1093/ageing/afl005; Silverstein JH, 2007, ANESTHESIOLOGY, V106, P622, DOI 10.1097/00000542-200703000-00026; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; van Eijk MM, 2011, AM J RESP CRIT CARE, V184, P340, DOI 10.1164/rccm.201101-0065OC; Vasilevskis EE, 2012, BEST PRACT RES-CLIN, V26, P277, DOI 10.1016/j.bpa.2012.07.003; Voga G, 2010, CRIT CARE, V14, DOI 10.1186/cc9085; Wan YJ, 2007, ANESTHESIOLOGY, V106, P436, DOI 10.1097/00000542-200703000-00007; Wang CL, 2013, J CRIT CARE, V28, P223, DOI 10.1016/j.jcrc.2012.10.004; Wang W, 2012, CRIT CARE MED, V40, P731, DOI 10.1097/CCM.0b013e3182376e4f; Wunsch H, 2010, ANESTHESIOLOGY, V113, P386, DOI 10.1097/ALN.0b013e3181e74116; Xia ZQ, 2013, J SURG RES, V185, P833, DOI 10.1016/j.jss.2013.06.062; Xiang H, 2014, INFLAMMATION, V37, P1763, DOI 10.1007/s10753-014-9906-1	52	362	407	16	128	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 15	2016	388	10054					1893	1902		10.1016/S0140-6736(16)30580-3	http://dx.doi.org/10.1016/S0140-6736(16)30580-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ0AM	27542303	Green Submitted, Green Published			2022-12-28	WOS:000385499000033
J	Goddard, AF				Goddard, Andrew F.			Lessons to Be Learned From the UK Junior Doctors' Strike	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Goddard, Andrew F.] Royal Coll Physicians, 11 St Andrews Pl,Regents Pk, London NW1 4LE, England	Royal College of Physicians	Goddard, AF (corresponding author), Royal Coll Physicians, 11 St Andrews Pl,Regents Pk, London NW1 4LE, England.	andrew.goddard@rcplondon.ac.uk						Aldridge C, 2016, LANCET, V388, P178, DOI 10.1016/S0140-6736(16)30442-1; Chaudhuri E, 2013, MED REGISTRAR EMPOWE; Freemantle N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4596; Goddard AF, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3702; Leong KS, 2015, J ROY COLL PHYS EDIN, V45, P260, DOI 10.4997/JRCPE.2015.402; Review Body on Doctors' and Dentists' Remuneration, 2015, REV BODY DOCTORS DEN; Rimmer A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5624	7	14	14	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2016	316	14					1445	1446		10.1001/jama.2016.12029	http://dx.doi.org/10.1001/jama.2016.12029			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DY1TC	27548903				2022-12-28	WOS:000384876300012
J	Rauhut, R; Fabrizio, P; Dybkov, O; Hartmuth, K; Pena, V; Chari, A; Kumar, V; Lee, CT; Urlaub, H; Kastner, B; Stark, H; Luhrmann, R				Rauhut, Reinhard; Fabrizio, Patrizia; Dybkov, Olexandr; Hartmuth, Klaus; Pena, Vladimir; Chari, Ashwin; Kumar, Vinay; Lee, Chung-Tien; Urlaub, Henning; Kastner, Berthold; Stark, Holger; Luehrmann, Reinhard			Molecular architecture of the Saccharomyces cerevisiae activated spliceosome	SCIENCE			English	Article							U4/U6.U5 TRI-SNRNP; GROUP-II INTRON; CRYSTAL-STRUCTURE; CATALYTIC ACTIVATION; YEAST SPLICEOSOME; STRUCTURAL BASIS; PRP2 ATPASE; BOX PROTEIN; BRANCH-SITE; 1ST STEP	The activated spliceosome (B-act) is in a catalytically inactive state and is remodeled into a catalytically active machine by the RNA helicase Prp2, but the mechanism is unclear. Here, we describe a 3D electron cryomicroscopy structure of the Saccharomyces cerevisiae B-act complex at 5.8-angstrom resolution. Our model reveals that in B-act, the catalytic U2/U6 RNA-Prp8 ribonucleoprotein core is already established, and the 5' splice site (ss) is oriented for step 1 catalysis but occluded by protein. The first-step nucleophile-the branchsite adenosine-is sequestered within the Hsh155 HEAT domain and is held 50 angstroms away from the 5' ss. Our structure suggests that Prp2 adenosine triphosphatase-mediated remodeling leads to conformational changes in Hsh155's HEAT domain that liberate the first-step reactants for catalysis.	[Rauhut, Reinhard; Fabrizio, Patrizia; Dybkov, Olexandr; Hartmuth, Klaus; Kumar, Vinay; Kastner, Berthold; Luehrmann, Reinhard] Max Planck Inst MPI Biophys Chem, Dept Cellular Biochem, Fassberg 11, D-37077 Gottingen, Germany; [Pena, Vladimir] MPI Biophys Chem, Res Grp Macromol Crystallog, Fassberg 11, D-37077 Gottingen, Germany; [Chari, Ashwin; Stark, Holger] MPI Biophys Chem, Electron Cryomicroscopy Grp 3D, Fassberg 11, D-37077 Gottingen, Germany; [Lee, Chung-Tien; Urlaub, Henning] MPI Biophys Chem, Bioanalyt Mass Spectrometry, Fassberg 11, D-37077 Gottingen, Germany; [Lee, Chung-Tien; Urlaub, Henning] Univ Med Ctr, Inst Clin Chem, Bioanalyt Grp, Robert Koch Str 40, D-37075 Gottingen, Germany; [Stark, Holger] Univ Gottingen, Dept Electron Cryomicroscopy 3D, Justus von Liebig Weg 11, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society; Max Planck Society; University of Gottingen; University of Gottingen	Kastner, B; Luhrmann, R (corresponding author), Max Planck Inst MPI Biophys Chem, Dept Cellular Biochem, Fassberg 11, D-37077 Gottingen, Germany.; Stark, H (corresponding author), MPI Biophys Chem, Electron Cryomicroscopy Grp 3D, Fassberg 11, D-37077 Gottingen, Germany.; Stark, H (corresponding author), Univ Gottingen, Dept Electron Cryomicroscopy 3D, Justus von Liebig Weg 11, D-37077 Gottingen, Germany.	b.kastner@mpi-bpc.mpg.de; hstark1@gwdg.de; reinhard.luehrmann@mpi-bpc.mpg.de	Chari, Ashwin/ABC-5304-2020	Chari, Ashwin/0000-0001-6220-9828	Deutsche Forschungsgemeinschaft [SFB 860]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank T. Conrad for yeast production in a bioreactor and M. Raabe and U. Plessmann for excellent technical assistance. We are very grateful to N. Rigo and C. L. Will for advice and many helpful discussions and to J. Schmitzova for the gift of the dominant-negative Prp2 mutant. The EM map has been deposited in the Electron Microscopy Data Bank with the accession code EMD-4099. The atomic coordinates have been deposited in the Protein Data Bank with the accession code 5LQW. This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 860) to R.L., H.S., and H.U.	Absmeier E, 2015, GENE DEV, V29, P2576, DOI 10.1101/gad.271528.115; Agafonov DE, 2016, SCIENCE, V351, P1416, DOI 10.1126/science.aad2085; Alsafadi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10615; Bessonov S, 2010, RNA, V16, P2384, DOI 10.1261/rna.2456210; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Buchwald G, 2013, P NATL ACAD SCI USA, V110, pE4611, DOI 10.1073/pnas.1314684110; Chan RT, 2012, NAT STRUCT MOL BIOL, V19, P555, DOI 10.1038/nsmb.2270; Chari A, 2015, NAT METHODS, V12, P859, DOI [10.1038/NMETH.3493, 10.1038/nmeth.3493]; Chiang TW, 2013, MOL CELL BIOL, V33, P1746, DOI 10.1128/MCB.00035-13; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Cook AG, 2010, CURR OPIN STRUC BIOL, V20, P247, DOI 10.1016/j.sbi.2010.01.012; Cretu C, 2016, MOL CELL, V64, P307, DOI 10.1016/j.molcel.2016.08.036; Darman RB, 2015, CELL REP, V13, P1033, DOI 10.1016/j.celrep.2015.09.053; Edwalds-Gilbert G, 2004, RNA, V10, P210, DOI 10.1261/rna.5151404; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Fica SM, 2014, NAT STRUCT MOL BIOL, V21, P464, DOI 10.1038/nsmb.2815; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; Galej WP, 2013, NATURE, V493, P638, DOI 10.1038/nature11843; Grainger RJ, 2005, RNA, V11, P533, DOI 10.1261/rna.2220705; Hang J, 2015, SCIENCE, V349, P1191, DOI 10.1126/science.aac8159; Kappel C, 2010, BIOPHYS J, V99, P1596, DOI 10.1016/j.bpj.2010.06.032; Keating KS, 2010, RNA, V16, P1, DOI 10.1261/rna.1791310; Kim SH, 1996, MOL CELL BIOL, V16, P6810; Lardelli RM, 2010, RNA, V16, P516, DOI 10.1261/rna.2030510; Lindsey-Boltz LA, 2000, RNA, V6, P1289, DOI 10.1017/S1355838200000327; Liu HL, 2012, MOL CELL BIOL, V32, P5056, DOI 10.1128/MCB.01109-12; MADHANI HD, 1992, CELL, V71, P803, DOI 10.1016/0092-8674(92)90556-R; Marcia M, 2012, CELL, V151, P497, DOI 10.1016/j.cell.2012.09.033; McPheeters DS, 2003, MOL CELL BIOL, V23, P4174, DOI 10.1128/MCB.23.12.4174-4186.2003; NEWMAN AJ, 1992, CELL, V68, P743, DOI 10.1016/0092-8674(92)90149-7; Ohrt T, 2012, RNA, V18, P1244, DOI 10.1261/rna.033316.112; Query CC, 1996, EMBO J, V15, P1392, DOI 10.1002/j.1460-2075.1996.tb00481.x; RYMOND BC, 1985, NATURE, V317, P735, DOI 10.1038/317735a0; Sander B, 2006, MOL CELL, V24, P267, DOI 10.1016/j.molcel.2006.08.021; Schneider C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005539; SONTHEIMER EJ, 1993, SCIENCE, V262, P1989, DOI 10.1126/science.8266094; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Steckelberg AL, 2012, CELL REP, V2, P454, DOI 10.1016/j.celrep.2012.08.017; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Nguyen THD, 2016, NATURE, V530, P298, DOI 10.1038/nature16940; Nguyen THD, 2015, NATURE, V523, P47, DOI 10.1038/nature14548; Nguyen THD, 2013, STRUCTURE, V21, P910, DOI 10.1016/j.str.2013.04.017; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wan RX, 2016, SCIENCE, V351, P466, DOI 10.1126/science.aad6466; Warkocki Z, 2015, GENE DEV, V29, P94, DOI 10.1101/gad.253070.114; Warkocki Z, 2009, NAT STRUCT MOL BIOL, V16, P1237, DOI 10.1038/nsmb.1729; Will CL, 2001, EMBO J, V20, P4536, DOI 10.1093/emboj/20.16.4536; Wlodaver AM, 2014, RNA, V20, P282, DOI 10.1261/rna.042598.113; Yan CY, 2016, SCIENCE, V353, P904, DOI 10.1126/science.aag0291; Yan CY, 2015, SCIENCE, V349, P1182, DOI 10.1126/science.aac7629; Yeh TC, 2011, MOL CELL BIOL, V31, P43, DOI 10.1128/MCB.00801-10; Yokoi A, 2011, FEBS J, V278, P4870, DOI 10.1111/j.1742-4658.2011.08387.x	53	124	125	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2016	353	6306					1399	1405		10.1126/science.aag1906	http://dx.doi.org/10.1126/science.aag1906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5TB	27562955				2022-12-28	WOS:000383708700035
J	Song, K; Wang, H; Kamm, GB; Pohle, J; Reis, FD; Heppenstall, P; Wende, H; Siemens, J				Song, Kun; Wang, Hong; Kamm, Gretel B.; Pohle, Joerg; Reis, Fernanda de Castro; Heppenstall, Paul; Wende, Hagen; Siemens, Jan			The TRPM2 channel is a hypothalamic heat sensor that limits fever and can drive hypothermia	SCIENCE			English	Article							INDUCED MEMBRANE DEPOLARIZATION; POTENTIAL CATION CHANNEL; 2-AMINOETHOXYDIPHENYL BORATE; CA2+ INFLUX; BEHAVIORAL THERMOREGULATION; BODY-TEMPERATURE; NERVOUS-SYSTEM; ADP-RIBOSE; RECEPTOR; NEURONS	Body temperature homeostasis is critical for survival and requires precise regulation by the nervous system. The hypothalamus serves as the principal thermostat that detects and regulates internal temperature. We demonstrate that the ion channel TRPM2 [ of the transient receptor potential (TRP) channel family] is a temperature sensor in a subpopulation of hypothalamic neurons. TRPM2 limits the fever response and may detect increased temperatures to prevent overheating. Furthermore, chemogenetic activation and inhibition of hypothalamic TRPM2-expressing neurons in vivo decreased and increased body temperature, respectively. Such manipulation may allow analysis of the beneficial effects of altered body temperature on diverse disease states. Identification of a functional role for TRP channels in monitoring internal body temperature should promote further analysis of molecular mechanisms governing thermoregulation and foster the genetic dissection of hypothalamic circuits involved with temperature homeostasis.	[Song, Kun; Wang, Hong; Kamm, Gretel B.; Pohle, Joerg; Wende, Hagen; Siemens, Jan] Heidelberg Univ, Dept Pharmacol, Neuenheimer Feld 366, D-69120 Heidelberg, Germany; [Reis, Fernanda de Castro; Heppenstall, Paul] EMBL, Adriano Buzzati Traverso Campus,Via Ramarini 32, I-00016 Monterotondo, Italy; [Heppenstall, Paul; Siemens, Jan] EMBL, Mol Med Partnership Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Song, Kun] Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Siemens, J (corresponding author), Heidelberg Univ, Dept Pharmacol, Neuenheimer Feld 366, D-69120 Heidelberg, Germany.; Siemens, J (corresponding author), EMBL, Mol Med Partnership Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	jan.siemens@pharma.uni-heidelberg.de		Siemens, Jan/0000-0001-9051-9217; Wende, Hagen/0000-0002-9168-8095; Song, Kun/0000-0001-6216-8157	European Research Council [ERC-2011-StG-280565]; Alexander von Humboldt Foundation (German Federal Ministry for Education and Research, BMBF); German Research Foundation [SFB-1158]; CellNetworks Cluster of Excellence	European Research Council(European Research Council (ERC)European Commission); Alexander von Humboldt Foundation (German Federal Ministry for Education and Research, BMBF); German Research Foundation(German Research Foundation (DFG)); CellNetworks Cluster of Excellence	We thank Y. Mori for Trpm2<SUP>-/-</SUP> mice and TRPM2 antisera; B. Lowell for Vgat-Cre mice; members of R. Kuner's laboratory, the Nikon Imaging Center, and V. Grinevich for sharing reagents, equipment, and expertise; A. von Seggern and C. Steinmeyer-Stannek for technical support; K. Schrenk-Siemens, W. de Lima, and P. Bengtson for help with calcium imaging; and C. Bohlen and A. Littlewood-Evans for criticism and reading of the manuscript. All data necessary to understand the study and its conclusions are in the body of the manuscript and in the supplementary materials. All primary data are archived on secure servers at the University Hospital Heidelberg. All data will be made available upon request. This work was supported by the European Research Council (grant ERC-2011-StG-280565 to J.S.), the Alexander von Humboldt Foundation (German Federal Ministry for Education and Research, BMBF; fellowship to G.B.K. and grant to J.S.), and the German Research Foundation (grants as part of the Collaborative Research Center SFB-1158 to P.H. and J.S.). Additional support came from the CellNetworks Cluster of Excellence. J.S., together with K.S., H.Wa., and G.B.K., conceived the project and designed the experiments. K.S. designed and conducted the cellular screen and analysis; J.P. designed and performed electrophysiological experiments; G.B.K. conceived the slice physiology and fever experiments; and H.Wa. conceived and conducted the chemogenetic experiments and, together with H.We., P.H., and F.d.C.R., generated Trpm2-Cre mice. H.We. and H.Wa. conducted histochemical analysis. J.S. wrote the paper. All authors commented on and approved the paper.	BALDWIN BA, 1967, J PHYSIOL-LONDON, V191, P375, DOI 10.1113/jphysiol.1967.sp008256; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Borgius L, 2010, MOL CELL NEUROSCI, V45, P245, DOI 10.1016/j.mcn.2010.06.016; Boulant JA, 2006, J APPL PHYSIOL, V100, P1347, DOI 10.1152/japplphysiol.01064.2005; Boulant JA, 2006, AM J PHYSIOL-REG I, V290, pR1481, DOI 10.1152/ajpregu.00655.2005; BOULANT JA, 1986, ANNU REV PHYSIOL, V48, P639, DOI 10.1146/annurev.ph.48.030186.003231; Cai CQ, 2012, NEUROSCI LETT, V506, P336, DOI 10.1016/j.neulet.2011.11.041; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cheshire WP, 2016, AUTON NEUROSCI-BASIC, V196, P91, DOI 10.1016/j.autneu.2016.01.001; CHOWERS I, 1968, AM J PHYSIOL, V214, P538, DOI 10.1152/ajplegacy.1968.214.3.538; Clapham DE, 2003, PHARMACOL REV, V55, P591, DOI 10.1124/pr.55.4.6; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Di AK, 2012, NAT IMMUNOL, V13, P29, DOI 10.1038/ni.2171; Dietrich WD, 2016, BRAIN RES, V1640, P94, DOI 10.1016/j.brainres.2015.12.034; Eberwine J, 2011, PHARMACOL THERAPEUT, V129, P241, DOI 10.1016/j.pharmthera.2010.09.010; Evans SS, 2015, NAT REV IMMUNOL, V15, P335, DOI 10.1038/nri3843; FOLKOW B, 1949, ACTA PHYSIOL SCAND, V17, P317, DOI 10.1111/j.1748-1716.1949.tb00578.x; FUSCO MM, 1961, AM J PHYSIOL, V200, P572, DOI 10.1152/ajplegacy.1961.200.3.572; Gordon CJ, 1993, TEMPERATURE REGULATI, DOI 10.1017/CBO9780511565595; HAMMEL HT, 1960, AM J PHYSIOL, V198, P481, DOI 10.1152/ajplegacy.1960.198.3.481; Harden LM, 2008, BRAIN BEHAV IMMUN, V22, P838, DOI 10.1016/j.bbi.2007.12.006; Heller H C, 1978, Experientia Suppl, V32, P267; HELLER HC, 1978, SCI AM, V239, P102, DOI 10.1038/scientificamerican0878-102; Horvath Tamas L., 2014, Yale Journal of Biology and Medicine, V87, P149; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Kashio M, 2012, P NATL ACAD SCI USA, V109, P6745, DOI 10.1073/pnas.1114193109; Knowles H, 2013, IMMUNOL RES, V55, P241, DOI 10.1007/s12026-012-8373-8; Kobayashi S, 2006, AM J PHYSIOL-REG I, V290, pR1479, DOI 10.1152/ajpregu.00655.2005; Koch M, 2015, NATURE, V519, P45, DOI 10.1038/nature14260; Lazarus M, 2007, NAT NEUROSCI, V10, P1131, DOI 10.1038/nn1949; Madden CJ, 2009, AM J PHYSIOL-REG I, V296, pR831, DOI 10.1152/ajpregu.91007.2008; Magoun HW, 1938, J NEUROPHYSIOL, V1, P101, DOI 10.1152/jn.1938.1.2.101; Matsuoka Y, 2003, P NATL ACAD SCI USA, V100, P4132, DOI 10.1073/pnas.0633341100; McAllen RM, 2010, EUR J APPL PHYSIOL, V109, P27, DOI 10.1007/s00421-009-1295-z; MCCLELLAN JL, 1994, AM J PHYSIOL, V267, pR705, DOI 10.1152/ajpregu.1994.267.3.R705; Morrison SF, 2016, AUTON NEUROSCI-BASIC, V196, P14, DOI 10.1016/j.autneu.2016.02.010; Musselman ME, 2013, AM J HEALTH-SYST PH, V70, P34, DOI 10.2146/ajhp110543; NAKAYAMA T, 1961, SCIENCE, V134, P560, DOI 10.1126/science.134.3478.560; NAKAYAMA T, 1963, AM J PHYSIOL, V204, P1122, DOI 10.1152/ajplegacy.1963.204.6.1122; Oliver AE, 2000, BIOPHYS J, V78, P2116, DOI 10.1016/S0006-3495(00)76758-0; Palkar R, 2015, CURR OPIN NEUROBIOL, V34, P14, DOI 10.1016/j.conb.2015.01.010; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Riedel W, 1999, MOL CELL BIOCHEM, V196, P125, DOI 10.1023/A:1006936111474; Roth BL, 2016, NEURON, V89, P683, DOI 10.1016/j.neuron.2016.01.040; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Saper CB, 2012, NAT NEUROSCI, V15, P1088, DOI 10.1038/nn.3159; SATINOFF E, 1964, AM J PHYSIOL, V206, P1389, DOI 10.1152/ajplegacy.1964.206.6.1389; Scammell TE, 1996, J NEUROSCI, V16, P6246; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Tabarean IV, 2005, NEUROSCIENCE, V135, P433, DOI 10.1016/j.neuroscience.2005.06.053; Togashi K, 2008, BRIT J PHARMACOL, V153, P1324, DOI 10.1038/sj.bjp.0707675; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Vay L, 2012, BRIT J PHARMACOL, V165, P787, DOI 10.1111/j.1476-5381.2011.01601.x; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Vriens J, 2014, NAT REV NEUROSCI, V15, P573, DOI 10.1038/nrn3784; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Wang Hong, 2015, Temperature (Austin), V2, P178, DOI 10.1080/23328940.2015.1040604; Wu TC, 2013, LANCET NEUROL, V12, P275, DOI 10.1016/S1474-4422(13)70013-9; Xiao BL, 2011, NAT CHEM BIOL, V7, P351, DOI [10.1038/NCHEMBIO.558, 10.1038/nchembio.558]; Xu SZ, 2005, BRIT J PHARMACOL, V145, P405, DOI 10.1038/sj.bjp.0706197; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Zimmermann K, 2011, P NATL ACAD SCI USA, V108, P18114, DOI 10.1073/pnas.1115387108	64	196	201	3	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2016	353	6306					1393	1398		10.1126/science.aaf7537	http://dx.doi.org/10.1126/science.aaf7537			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5TB	27562954	Green Accepted			2022-12-28	WOS:000383708700034
J	Michaelides, A				Michaelides, Angelos			NANOSCIENCE Slippery when narrow	NATURE			English	Editorial Material							CARBON NANOTUBES; WATER; TRANSPORT; FLOW		[Michaelides, Angelos] UCL, Dept Phys & Astron, Thomas Young Ctr, London WC1H 0AH, England; [Michaelides, Angelos] UCL, London Ctr Nanotechnol, London WC1H 0AH, England	University of London; University College London; University of London; University College London	Michaelides, A (corresponding author), UCL, Dept Phys & Astron, Thomas Young Ctr, London WC1H 0AH, England.; Michaelides, A (corresponding author), UCL, London Ctr Nanotechnol, London WC1H 0AH, England.	angelos.michaelides@ucl.ac.uk		Michaelides, Angelos/0000-0002-9169-169X				Al-Hamdani YS, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4945783; Holt JK, 2006, SCIENCE, V312, P1034, DOI 10.1126/science.1126298; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; Kannam SK, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4793396; Laohakunakorn N, 2013, NANO LETT, V13, P5141, DOI 10.1021/nl402350a; Ma J, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.033402; Majumder M, 2005, NATURE, V438, P44, DOI 10.1038/43844a; Park HG, 2014, CHEM SOC REV, V43, P565, DOI 10.1039/c3cs60253b; Secchi E, 2016, NATURE, V537, P210, DOI 10.1038/nature19315; Tocci G, 2014, NANO LETT, V14, P6872, DOI 10.1021/nl502837d; Whitby M, 2007, NAT NANOTECHNOL, V2, P87, DOI 10.1038/nnano.2006.175	11	20	20	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					171	172		10.1038/537171a	http://dx.doi.org/10.1038/537171a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU9LQ	27604943				2022-12-28	WOS:000382539100032
J	Sidik, SM; Huet, D; Ganesan, SM; Huynh, MH; Wang, T; Nasamu, AS; Thiru, P; Saeij, JPJ; Carruthers, VB; Niles, JC; Lourido, S				Sidik, Saima M.; Huet, Diego; Ganesan, Suresh M.; Huynh, My-Hang; Wang, Tim; Nasamu, Armiyaw S.; Thiru, Prathapan; Saeij, Jeroen P. J.; Carruthers, Vern B.; Niles, Jacquin C.; Lourido, Sebastian			A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes	CELL			English	Article							MITOCHONDRIAL METABOLISM; MICRONEME DISCHARGE; GONDII; EXPRESSION; PARASITE; MUTATIONS; VIRULENCE; TRANSFECTION; PREDICTION; PROTEINS	Apicomplexan parasites are leading causes of human and livestock diseases such as malaria and toxoplasmosis, yet most of their genes remain uncharacterized. Here, we present the first genome-wide genetic screen of an apicomplexan. We adapted CRISPR/Cas9 to assess the contribution of each gene from the parasite Toxoplasma gondii during infection of human fibroblasts. Our analysis defines similar to 200 previously uncharacterized, fitness-conferring genes unique to the phylum, from which 16 were investigated, revealing essential functions during infection of human cells. Secondary screens identify as an invasion factor the claudin-like apicomplexan microneme protein (CLAMP), which resembles mammalian tight-junction proteins and localizes to secretory organelles, making it critical to the initiation of infection. CLAMP is present throughout sequenced apicomplexan genomes and is essential during the asexual stages of the malaria parasite Plasmodium falciparum. These results provide broad-based functional information on T. gondii genes and will facilitate future approaches to expand the horizon of antiparasitic interventions.	[Sidik, Saima M.; Huet, Diego; Wang, Tim; Thiru, Prathapan; Lourido, Sebastian] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Ganesan, Suresh M.; Nasamu, Armiyaw S.; Niles, Jacquin C.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Huynh, My-Hang; Carruthers, Vern B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Wang, Tim] MIT, Dept Biol, Cambridge, MA 02139 USA; [Wang, Tim] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Saeij, Jeroen P. J.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Michigan System; University of Michigan; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Davis	Lourido, S (corresponding author), Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	lourido@wi.mit.edu		Nasamu, Armiyaw/0000-0002-0719-8473; Wang, Timothy/0000-0001-5730-3019; Huet, Diego/0000-0003-4989-8918	NIGMS Center for Integrative Synthetic Biology Grant [P50GM098792]; NIH National Research Service Award [F31 CA189437]; NIH [1DP2OD007124, 1DP5OD017892, R01AI46675]; NATIONAL CANCER INSTITUTE [F31CA189437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080621, R01AI046675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM098792] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007124, DP5OD017892] Funding Source: NIH RePORTER	NIGMS Center for Integrative Synthetic Biology Grant; NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Emily Shortt for technical support; George Bell for bioinformatics advice; L. David Sibley, Dominique Soldati-Favre, and Lilach Sheiner for the SAG1, MIC8, MYOA, and MYS antibodies; Ke Hu for the NeonGreen plasmid; David S. Roos and Maria Alejandra Diaz-Miranda for the RNA-sequencing data; Markus Meissner for the DiCre strain; and Gail Eskes for naming CLAMP. This work would not have been possible without EupathDB, and we thank all members of the community who have worked to generate this resource. This work was supported by NIGMS Center for Integrative Synthetic Biology Grant P50GM098792, NIH National Research Service Award F31 CA189437 to T.W., NIH Research Project Grant R01AI46675 to V.B.C., and the NIH Director's New Innovator Award 1DP2OD007124 to J.C.N. and Early Independence Award 1DP5OD017892 to S.L.	ACHBAROU A, 1991, MOL BIOCHEM PARASIT, V47, P223, DOI 10.1016/0166-6851(91)90182-6; Bargieri D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004273; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Bullen HE, 2016, CELL HOST MICROBE, V19, P349, DOI 10.1016/j.chom.2016.02.006; BURG JL, 1988, J IMMUNOL, V141, P3584; Carruthers VB, 1999, BIOCHEM J, V342, P379, DOI 10.1042/0264-6021:3420379; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Checkley W, 2015, LANCET INFECT DIS, V15, P85, DOI 10.1016/S1473-3099(14)70772-8; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Crabb BS, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-21; Croken MM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-515; Dobson L, 2015, NUCLEIC ACIDS RES, V43, pW408, DOI 10.1093/nar/gkv451; DONALD RGK, 1995, P NATL ACAD SCI USA, V92, P5749, DOI 10.1073/pnas.92.12.5749; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; Farrell A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-354; Flannery EL, 2013, J MED CHEM, V56, P7761, DOI 10.1021/jm400325j; Frenal K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004504; Ganesan SM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10727; Garcia-Reguet N, 2000, CELL MICROBIOL, V2, P353, DOI 10.1046/j.1462-5822.2000.00064.x; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gomes AR, 2015, CELL HOST MICROBE, V17, P404, DOI 10.1016/j.chom.2015.01.014; Hu K, 2004, J CELL SCI, V117, P5697, DOI 10.1242/jcs.01494; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Ingram JR, 2015, P NATL ACAD SCI USA, V112, pE4975, DOI 10.1073/pnas.1505914112; Jiang WZ, 2014, EUKARYOT CELL, V13, P1465, DOI 10.1128/EC.00213-14; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Kafsack BFC, 2009, SCIENCE, V323, P530, DOI 10.1126/science.1165740; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kessler H, 2008, J CELL SCI, V121, P947, DOI 10.1242/jcs.022350; KIM K, 1995, EXP PARASITOL, V80, P46, DOI 10.1006/expr.1995.1006; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Kremer K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003213; Lamarque MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5098; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEVINE N. D., 1988, PROTOZOAN PHYLUM API, VI; Liu GW, 2015, CELL, V163, P1388, DOI 10.1016/j.cell.2015.10.069; Lourido S, 2012, EMBO J, V31, P4524, DOI 10.1038/emboj.2012.299; Lourido S, 2010, NATURE, V465, P359, DOI 10.1038/nature09022; Ma C, 2008, GENETICS, V180, P845, DOI 10.1534/genetics.108.092494; MacRae JI, 2012, CELL HOST MICROBE, V12, P682, DOI 10.1016/j.chom.2012.09.013; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Meier A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004343; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Pieperhoff MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130356; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seeber F, 2008, TRENDS PARASITOL, V24, P468, DOI 10.1016/j.pt.2008.07.004; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sheiner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002392; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; Sidik SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100450; Simske JS, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.25502; SOLDATI D, 1993, SCIENCE, V260, P349, DOI 10.1126/science.8469986; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Treeck M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000322; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; WELLEMS TE, 1991, P NATL ACAD SCI USA, V88, P3382, DOI 10.1073/pnas.88.8.3382; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	63	377	383	4	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 8	2016	166	6					1423	+		10.1016/j.cell.2016.08.019	http://dx.doi.org/10.1016/j.cell.2016.08.019			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EA1GG	27594426	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000386339900015
J	Uprety, S; Sharma, R				Uprety, Shraddha; Sharma, Ramesh			Kerion - A Boggy Lump	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Uprety, Shraddha; Sharma, Ramesh] Tribhuvan Univ, Bharatpur, Nepal	Tribhuvan University	Uprety, S (corresponding author), Tribhuvan Univ, Bharatpur, Nepal.	maitreeye@gmail.com							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2016	375	10					980	980		10.1056/NEJMicm1514152	http://dx.doi.org/10.1056/NEJMicm1514152			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU9IG	27602670				2022-12-28	WOS:000382529500011
J	Wilkinson, R				Wilkinson, Ryan			More is less	NATURE			English	Editorial Material														Wilkinson, Ryan/0000-0003-3280-1841					0	0	0	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					42	42		10.1038/537042a	http://dx.doi.org/10.1038/537042a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU7XC	27582219	Bronze			2022-12-28	WOS:000382426900032
J	Lobstein, T; McPherson, K				Lobstein, Tim; McPherson, Klim			Nothing new in UK's strategy on childhood obesity	LANCET			English	Editorial Material									[Lobstein, Tim] World Obes Federat, London, England; [McPherson, Klim] Univ Oxford, Oxford OX1 3BN, England	University of Oxford	McPherson, K (corresponding author), Univ Oxford, Oxford OX1 3BN, England.	klim.mcpherson@obs-gyn.ox.ac.uk						Butland B, 2007, TACKL OB FUT CHOIC P; Michail N, 2016, PUT SUGAR TAX HOLD U; Ofcom, 2010, HFSS ADV RESTR FIN R; World Health Organization, 2016, REP COMM END CHILDH	4	6	6	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 27	2016	388	10047					853	854		10.1016/S0140-6736(16)31471-4	http://dx.doi.org/10.1016/S0140-6736(16)31471-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU0RI	27597454				2022-12-28	WOS:000381911800010
J	Adams, WM				Adams, W. M.			Do you speak lion?	SCIENCE			English	Editorial Material							MANAGEMENT; SCIENCE; KNOWLEDGE		[Adams, W. M.] Univ Cambridge, Dept Geog, Downing Pl, Cambridge CB2 3EN, England	University of Cambridge	Adams, WM (corresponding author), Univ Cambridge, Dept Geog, Downing Pl, Cambridge CB2 3EN, England.	wa12@cam.ac.uk						Bernstein JH, 2015, J RES PRACT, V11; Bromham L, 2016, NATURE, V534, P684, DOI 10.1038/nature18315; Dicks LV, 2014, TRENDS ECOL EVOL, V29, P607, DOI 10.1016/j.tree.2014.09.004; Dicks LV, 2014, CONSERV LETT, V7, P119, DOI 10.1111/conl.12046; Evans LA, 2016, LAND USE POLICY, V51, P215, DOI 10.1016/j.landusepol.2015.11.008; Game ET, 2014, CONSERV LETT, V7, P271, DOI 10.1111/conl.12050; Graham MD, 2010, SYST BIODIVERS, V8, P435, DOI 10.1080/14772000.2010.533716; Ledford H, 2015, NATURE, V525, P308, DOI 10.1038/525308a; Mistry J, 2016, SCIENCE, V352, P1274, DOI 10.1126/science.aaf1160; Moon K, 2014, CONSERV BIOL, V28, P1167, DOI 10.1111/cobi.12326; Nursey-Bray MJ, 2014, ENVIRON SCI POLICY, V38, P107, DOI 10.1016/j.envsci.2013.10.010; Pooley SP, 2014, CONSERV BIOL, V28, P22, DOI 10.1111/cobi.12183; Reuter K, 2016, NATURE, V531, P173, DOI 10.1038/531173c; Stier C., 2016, CONSERV LETT, DOI [10.1111/conl.12245, DOI 10.1111/CONL.12245]; Viseu A, 2015, NATURE, V525, P291, DOI 10.1038/525291a; Wittgenstein L., 1967, PHILOS INVESTIGATION	16	7	7	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					867	868		10.1126/science.aaf8056	http://dx.doi.org/10.1126/science.aaf8056			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU0CA	27563084				2022-12-28	WOS:000381867700017
J	Gury-BenAri, M; Thaiss, CA; Serafini, N; Winter, DR; Giladi, A; Lara-Astiaso, D; Levy, M; Salame, TM; Weiner, A; David, E; Shapiro, H; Dori-Bachash, M; Pevsner-Fischer, M; Lorenzo-Vivas, E; Keren-Shaul, H; Paul, F; Harmelin, A; Eberl, G; Itzkovitz, S; Tanay, A; Di Santo, JP; Elinav, E; Amit, I				Gury-BenAri, Meital; Thaiss, Christoph A.; Serafini, Nicolas; Winter, Deborah R.; Giladi, Amir; Lara-Astiaso, David; Levy, Maayan; Salame, Tomer Meir; Weiner, Assaf; David, Eyal; Shapiro, Hagit; Dori-Bachash, Mally; Pevsner-Fischer, Meirav; Lorenzo-Vivas, Erika; Keren-Shaul, Hadas; Paul, Franziska; Harmelin, Alon; Eberl, Gerard; Itzkovitz, Shalev; Tanay, Amos; Di Santo, James P.; Elinav, Eran; Amit, Ido			The Spectrum and Regulatory Landscape of Intestinal Innate Lymphoid Cells Are Shaped by the Microbiome	CELL			English	Article							TRANSCRIPTION FACTOR GATA3; ROR-GAMMA-T; RNA-SEQ; FUNCTIONAL PLASTICITY; COMMENSAL MICROFLORA; NKP46(+) CELLS; INFLAMMATION; HOMEOSTASIS; FATE; DIFFERENTIATION	Innate lymphoid cells (ILCs) are critical modulators of mucosal immunity, inflammation, and tissue homeostasis, but their full spectrum of cellular states and regulatory landscapes remains elusive. Here, we combine genome-wide RNA-seq, ChIP-seq, and ATAC-seq to compare the transcriptional and epigenetic identity of small intestinal ILCs, identifying thousands of distinct gene profiles and regulatory elements. Single-cell RNA-seq and flow and mass cytometry analyses reveal compartmentalization of cytokine expression and metabolic activity within the three classical ILC subtypes and highlight transcriptional states beyond the current canonical classification. In addition, using antibiotic intervention and germ-free mice, we characterize the effect of the microbiome on the ILC regulatory landscape and determine the response of ILCs to microbial colonization at the single-cell level. Together, our work characterizes the spectrum of transcriptional identities of small intestinal ILCs and describes how ILCs differentially integrate signals from the microbial microenvironment to generate phenotypic and functional plasticity.	[Gury-BenAri, Meital; Thaiss, Christoph A.; Winter, Deborah R.; Giladi, Amir; Lara-Astiaso, David; Levy, Maayan; Weiner, Assaf; David, Eyal; Shapiro, Hagit; Dori-Bachash, Mally; Pevsner-Fischer, Meirav; Lorenzo-Vivas, Erika; Keren-Shaul, Hadas; Paul, Franziska; Elinav, Eran; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Serafini, Nicolas; Di Santo, James P.] Inst Pasteur, Innate Immun Unit, F-75015 Paris, France; [Serafini, Nicolas; Di Santo, James P.] INSERM, U1223, Paris, France; [Salame, Tomer Meir] Weizmann Inst Sci, Biol Serv Unit, IL-76100 Rehovot, Israel; [Harmelin, Alon] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel; [Eberl, Gerard] Inst Pasteur, Dept Immunol, F-75015 Paris, France; [Eberl, Gerard] CNRS, URA 1961, F-75015 Paris, France; [Itzkovitz, Shalev] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Tanay, Amos] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Tanay, Amos] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Weizmann Institute of Science; Weizmann Institute of Science; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Elinav, E; Amit, I (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	eran.elinav@weizmann.ac.il; ido.amit@weizmann.ac.il	Elinav, Eran/ABE-8881-2020; SERAFINI, nicolas/S-5675-2019; Eberl, Gerard/A-1160-2013; Shapiro, Hagit/F-8648-2015; Di Santo, James P/M-4298-2014; Winter, Deborah R./AAQ-9253-2020	Elinav, Eran/0000-0002-5775-2110; SERAFINI, nicolas/0000-0002-7440-4353; Di Santo, James P/0000-0002-7146-1862; Winter, Deborah R./0000-0003-1806-673X; Eberl, Gerard/0000-0002-1119-5638; Lorenzo Vivas, Erika/0000-0002-8150-5902; Paul, Franziska/0000-0003-0344-6764	Boehringer Ingelheim Fonds PhD Fellowship; Abisch Frenkel Foundation for the Promotion of Life Sciences; Gurwin Family Fund for Scientific Research; Leona M. and Harry B. Helmsley Charitable Trust; Crown Endowment Fund for Immunological Research; estate of J. Gitlitz; estate of L. Hershkovich; Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; French National Center for Scientific Research (CNRS); European Research Council; Marie Curie Integration grant; German-Israeli Foundation for Scientific Research and Development; Israel Science Foundation; Minerva Foundation; Rising Tide Foundation; Helmholtz Foundation; European Foundation for the Study of Diabetes; European Research Council [309788]; Israel Science foundation [782/11]; BLUEPRINT FP7 consortium; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Minerva Stiftung research grant; National Human Genome Research Institute Center for Excellence in Genome Science [1P50HG006193]; Israeli Ministry of Science, Technology and Space; David and Fela Shapell Family Foundation; Abramson Family Center for Young Scientists; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER	Boehringer Ingelheim Fonds PhD Fellowship(Boehringer Ingelheim); Abisch Frenkel Foundation for the Promotion of Life Sciences; Gurwin Family Fund for Scientific Research; Leona M. and Harry B. Helmsley Charitable Trust; Crown Endowment Fund for Immunological Research; estate of J. Gitlitz; estate of L. Hershkovich; Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; French National Center for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS)); European Research Council(European Research Council (ERC)European Commission); Marie Curie Integration grant; German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Rising Tide Foundation; Helmholtz Foundation(Helmholtz Association); European Foundation for the Study of Diabetes; European Research Council(European Research Council (ERC)European Commission); Israel Science foundation(Israel Science Foundation); BLUEPRINT FP7 consortium; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Minerva Stiftung research grant; National Human Genome Research Institute Center for Excellence in Genome Science; Israeli Ministry of Science, Technology and Space(Ministry of Science, Technology and Space (MOST), Israel); David and Fela Shapell Family Foundation; Abramson Family Center for Young Scientists; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the members of I.A.'s and E.E.'s labs for fruitful discussions, Carmit Bar-Nathan for GF mouse care taking, Elena Kartvelishvily for help with electron microscopy, Melanie Flach for technical advice, and Maayan Wigelmann for art work. C.A.T. received a Boehringer Ingelheim Fonds PhD Fellowship. E.E. is supported by Y. and R. Ungar; the Abisch Frenkel Foundation for the Promotion of Life Sciences; the Gurwin Family Fund for Scientific Research; the Leona M. and Harry B. Helmsley Charitable Trust; the Crown Endowment Fund for Immunological Research; the estate of J. Gitlitz; the estate of L. Hershkovich; the Benoziyo Endowment Fund for the Advancement of Science; the Adelis Foundation; J.L. and V. Schwartz; A. and G. Markovitz; A. and C. Adelson; the French National Center for Scientific Research (CNRS); D.L. Schwarz; the V.R. Schwartz Research Fellow Chair; L. Steinberg; J.N. Halpern; A. Edelheit, and by grants funded by the European Research Council; a Marie Curie Integration grant; the German-Israeli Foundation for Scientific Research and Development; the Israel Science Foundation; the Minerva Foundation; the Rising Tide Foundation; the Helmholtz Foundation; and the European Foundation for the Study of Diabetes. E.E. is the incumbent of the Rina Gudinski Career Development Chair and a senior fellow of the Canadian Institute For Advanced Research (CIFAR). I. A. is supported by the European Research Council (309788), the I-CORE for chromatin and RNA regulation, and personal grants from the Israel Science foundation (782/11) and the BLUEPRINT FP7 consortium, the Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine, a Minerva Stiftung research grant, the National Human Genome Research Institute Center for Excellence in Genome Science (1P50HG006193), the Israeli Ministry of Science, Technology and Space, the David and Fela Shapell Family Foundation, and the Abramson Family Center for Young Scientists. I.A. is the incumbent of the Alan and Laraine Fischer Career Development Chair.	Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Bal SM, 2016, NAT IMMUNOL, V17, P636, DOI 10.1038/ni.3444; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Cording S, 2014, FEBS LETT, V588, P4176, DOI 10.1016/j.febslet.2014.03.034; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Eberl G, 2015, NAT IMMUNOL, V16, P1, DOI 10.1038/ni.3059; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hepworth MR, 2015, SCIENCE, V348, P1031, DOI 10.1126/science.aaa4812; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Koues OI, 2016, CELL, V165, P1134, DOI 10.1016/j.cell.2016.04.014; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Lim AI, 2016, J EXP MED, V213, P569, DOI 10.1084/jem.20151750; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Monticelli LA, 2016, NAT IMMUNOL, V17, P656, DOI 10.1038/ni.3421; Monticelli LA, 2015, P NATL ACAD SCI USA, V112, P10762, DOI 10.1073/pnas.1509070112; Ohne Y, 2016, NAT IMMUNOL, V17, P646, DOI 10.1038/ni.3447; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Setty M, 2016, NAT BIOTECHNOL, V34, P637, DOI 10.1038/nbt.3569; Shekhar K, 2014, P NATL ACAD SCI USA, V111, P202, DOI 10.1073/pnas.1321405111; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Silver JS, 2016, NAT IMMUNOL, V17, P626, DOI 10.1038/ni.3443; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Spitzer MH, 2016, CELL, V165, P780, DOI 10.1016/j.cell.2016.04.019; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; Verrier T, 2016, J IMMUNOL, V196, P4731, DOI 10.4049/jimmunol.1502673; von Burg N, 2014, P NATL ACAD SCI USA, V111, P12835, DOI 10.1073/pnas.1406908111; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Xu W, 2013, J IMMUNOL, V191, P4489, DOI 10.4049/jimmunol.1301759	61	349	362	11	131	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1231	+		10.1016/j.cell.2016.07.043	http://dx.doi.org/10.1016/j.cell.2016.07.043			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27545347	Bronze			2022-12-28	WOS:000382259500019
J	Lenzer, J				Lenzer, Jeanne			CONFLICTS OF INTEREST Two years of sunshine: has openness about payments reduced industry influence in healthcare?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PHYSICIAN; DISCLOSURE; PATTERNS; ACT					jlenzer@bmj.com						Agrawal S, 2013, NEW ENGL J MED, V368, P2054, DOI 10.1056/NEJMp1303523; AMA, 2016, POLICY AND MEDICINE; American Medical Association, 2016, SUNSH ACT PHYS FIN T; [Anonymous], 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001210; Cain DM, 2005, J LEGAL STUD, V34, P1, DOI 10.1086/426699; Campbell EG, 2010, ARCH INTERN MED, V170, P1820, DOI 10.1001/archinternmed.2010.383; De Vries R, 2006, J GEN INTERN MED, V21, P1003, DOI 10.1007/BF02743153; DeJong C, 2016, JAMA INTERN MED, V176, P1114, DOI 10.1001/jamainternmed.2016.2765; Gabel JR, 2008, HEALTH AFFAIR, V27, pW165, DOI 10.1377/hlthaff.27.3.w165; Merino JG, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4828; Rickert J, 2015, HLTH AFFAIRS BLOG; Rosenthal MB, 2013, NEW ENGL J MED, V368, P2052, DOI 10.1056/NEJMp1305090; Sah S, 2013, J PERS SOC PSYCHOL, V104, P289, DOI 10.1037/a0030527; Silverman E, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4704; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; SWEDLOW A, 1992, NEW ENGL J MED, V327, P1502, DOI 10.1056/NEJM199211193272107; US Senate Committee on Finance, 2016, PHYS OWN DISTR UPD K	17	9	9	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 25	2016	354								i4608	10.1136/bmj.i4608	http://dx.doi.org/10.1136/bmj.i4608			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DV3AA	27562781				2022-12-28	WOS:000382792200002
J	Sullivan, F; Daly, F; Gagyor, I				Sullivan, Frank; Daly, Fergus; Gagyor, Ildiko			Antiviral Agents Added to Corticosteroids for Early Treatment of Adults With Acute Idiopathic Facial Nerve Paralysis (Bell Palsy)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								CLINICAL QUESTION Compared with oral corticosteroids alone, are oral antiviral drugs associated with improved outcomes when combined with oral corticosteroids in patients presenting within 72 hours of the onset of Bell palsy? BOTTOM LINE Compared with oral corticosteroids alone, the addition of acyclovir, valacyclovir, or famcyclovir to oral corticosteroids for treatment of Bell palsy was associated with a higher proportion of people who recovered at 3- to 12- month follow-up. The quality of evidence is limited by heterogeneity, imprecision of the result estimates, and risk of bias.	[Sullivan, Frank] North York Gen Hosp, Toronto, ON, Canada; [Sullivan, Frank] Univ Toronto, Dept Family & Community Med, 500 Univ Ave, Toronto, ON M5G 1V7, Canada; [Sullivan, Frank] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Sullivan, Frank] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Daly, Fergus] Frontier Sci Ltd, Grampian View, Scotland; [Gagyor, Ildiko] Goettingen Univ Med Ctr, Dept Gen Practice, Gottingen, Germany	University of Toronto; University Toronto Affiliates; North York General Hospital; University of Toronto; University of Toronto; University of Toronto	Sullivan, F (corresponding author), Univ Toronto, Dept Family & Community Med, 500 Univ Ave, Toronto, ON M5G 1V7, Canada.	frank.sullivan@nygh.on.ca	Sullivan, Frank/L-8286-2019; Gagyor, Ildiko/AAG-9765-2021	Sullivan, Frank/0000-0002-6623-4964; Gagyor, Ildiko/0000-0002-7974-7603				Baugh RF, 2013, OTOLARYNG HEAD NECK, V149, pS1, DOI 10.1177/0194599813505967; de Almeida JR, 2014, CAN MED ASSOC J, V186, P917, DOI 10.1503/cmaj.131801; De Diego-Sastre JI, 2005, REV NEUROLOGIA, V41, P287, DOI 10.33588/rn.4105.2004593; Fattah AY, 2015, PLAST RECONSTR SURG, V135, P569, DOI 10.1097/PRS.0000000000000905; Gagyor I, 2015, COCHRANE DATABASE SY; Holland NJ, 2004, BMJ-BRIT MED J, V329, P553, DOI 10.1136/bmj.329.7465.553; Morales DR, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003121; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221	8	11	14	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2016	316	8					874	875		10.1001/jama.2016.10160	http://dx.doi.org/10.1001/jama.2016.10160			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT8JL	27552621				2022-12-28	WOS:000381736200018
J	Mayor, S				Mayor, Susan			Colour coded warnings on how medicines affect driving do not work, study shows	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Orriols L, 2016, BRIT J CLIN PHARMACO, V82, P1625, DOI 10.1111/bcp.13075	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 22	2016	354								i4600	10.1136/bmj.i4600	http://dx.doi.org/10.1136/bmj.i4600			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV2ZX	27549392				2022-12-28	WOS:000382791900011
J	Steinhubl, SR; Muse, ED; Barrett, PM; Topol, EJ				Steinhubl, Steven R.; Muse, Evan D.; Barrett, Paddy M.; Topol, Eric J.			Off the cuff : rebooting blood pressure treatment	LANCET			English	Editorial Material									[Steinhubl, Steven R.; Muse, Evan D.; Barrett, Paddy M.; Topol, Eric J.] Scripps Translat Sci Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Steinhubl, SR (corresponding author), Scripps Translat Sci Inst, La Jolla, CA 92037 USA.				NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001114] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1TR001114] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))			0	12	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 20	2016	388	10046					749	749		10.1016/S0140-6736(16)31348-4	http://dx.doi.org/10.1016/S0140-6736(16)31348-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT6UH	27560266				2022-12-28	WOS:000381619200014
J	Guthrie, B; Kavanagh, K; Robertson, C; Barnett, K; Treweek, S; Petrie, D; Ritchie, L; Bennie, M				Guthrie, Bruce; Kavanagh, Kimberley; Robertson, Chris; Barnett, Karen; Treweek, Shaun; Petrie, Dennis; Ritchie, Lewis; Bennie, Marion			Data feedback and behavioural change intervention to improve primary care prescribing safety (EFIPPS): multicentre, three arm, cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ADVERSE DRUG EVENTS; HOSPITAL ADMISSIONS; POPULATION; PHYSICIANS; CRITERIA	OBJECTIVE To evaluate the effectiveness of feedback on safety of prescribing compared with moderately enhanced usual care. Design Three arm, highly pragmatic cluster randomised trial. Setting and participants 262/278 (94%) primary care practices in three Scottish health boards. Interventions Practices were randomised to: "usual care," consisting of emailed educational material with support for searching to identify patients (88 practices at baseline, 86 analysed); usual care plus feedback on practice's high risk prescribing sent quarterly on five occasions (87 practices, 86 analysed); or usual care plus the same feedback incorporating a behavioural change component (87 practices, 86 analysed). Main outcome measures The primary outcome was a patient level composite of six prescribing measures relating to high risk use of antipsychotics, non-steroidal anti-inflammatories, and antiplatelets. Secondary outcomes were the six individual measures. The primary analysis compared high risk prescribing in the two feedback arms against usual care at 15 months. Secondary analyses examined immediate change and change in trend of high risk prescribing associated with implementation of the intervention within each arm. Results In the primary analysis, high risk prescribing as measured by the primary outcome fell from 6.0% (3332/55 896) to 5.1% (2845/55 872) in the usual care arm, compared with 5.9% (3341/56 194) to 4.6% (2587/56 478) in the feedback only arm (odds ratio 0.88 (95% confidence interval 0.80 to 0.96) compared with usual care; P=0.007) and 6.2% (3634/58 569) to 4.6% (2686/58 582) in the feedback plus behavioural change component arm (0.86 (0.78 to 0.95); P=0.002). In the pre-specified secondary analysis of change in trend within each arm, the usual care educational intervention had no effect on the existing declining trend in high risk prescribing. Both types of feedback were associated with significantly more rapid decline in high risk prescribing after the intervention compared with before. Conclusions Feedback of prescribing safety data was effective at reducing high risk prescribing. The intervention would be feasible to implement at scale in contexts where electronic health records are in general use.	[Guthrie, Bruce] Univ Dundee, Populat Hlth Sci Div, Dundee DD2 4BF, Scotland; [Kavanagh, Kimberley; Robertson, Chris] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland; [Barnett, Karen] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Treweek, Shaun] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; [Petrie, Dennis] Univ Melbourne, Ctr Hlth Policy, Melbourne, Vic, Australia; [Ritchie, Lewis] Univ Aberdeen, Dept Acad Primary Care, Aberdeen, Scotland; [Bennie, Marion] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Bennie, Marion] NHS Natl Serv Scotland, Informat Serv Div, Edinburgh, Midlothian, Scotland	University of Dundee; University of Strathclyde; University of Edinburgh; University of Aberdeen; University of Melbourne; University of Aberdeen; University of Strathclyde; NHS National Services Scotland	Guthrie, B (corresponding author), Univ Dundee, Populat Hlth Sci Div, Dundee DD2 4BF, Scotland.	b.guthrie@dundee.ac.uk	Petrie, Dennis/AAK-5153-2020; Guthrie, Bruce/HHM-9696-2022; Petrie, Dennis/L-7689-2018; Treweek, Shaun/AAE-8006-2019	Petrie, Dennis/0000-0002-3882-2531; Petrie, Dennis/0000-0002-3882-2531; Treweek, Shaun/0000-0002-7239-7241; Kavanagh, Kimberley/0000-0002-2679-5409	Scottish Government Chief Scientist Office [CZH/3/17]; Chief Scientist Office of the Scottish Government Health Directorates; MRC [MR/K007017/1] Funding Source: UKRI; Medical Research Council [MR/K007017/1, MC_PC_13040] Funding Source: researchfish; Chief Scientist Office [HSRU2, CZH/3/17] Funding Source: researchfish	Scottish Government Chief Scientist Office; Chief Scientist Office of the Scottish Government Health Directorates; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	The study was funded by Scottish Government Chief Scientist Office project grant CZH/3/17. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or the writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication. ST works at the Health Services Research Unit, University of Aberdeen, which is funded by the Chief Scientist Office of the Scottish Government Health Directorates.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Avery AJ, 2012, LANCET, V379, P1310, DOI 10.1016/S0140-6736(11)61817-5; Avery AJ, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X588501; Ballard C, 2008, PLOS MED, V5, P587, DOI 10.1371/journal.pmed.0050076; Ballard C, 2009, LANCET NEUROL, V8, P151, DOI 10.1016/S1474-4422(08)70295-3; Banerjee S., 2009, USE ANTIPSYCHOTIC ME, DOI DOI 10.1111/J.1532-5415.2012.03923.X; Barnett KN, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0133-9; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Curtis JR, 2005, AM J MANAG CARE, V11, P537; de Groot DA, 2014, AGE AGEING, V43, P773, DOI 10.1093/ageing/afu075; Donnar A, 2000, DESIGN ANAL CLUSTER; Dreischulte T, 2016, NEW ENGL J MED, V374, P1053, DOI 10.1056/NEJMsa1508955; Dreischulte T, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-24; Dreischulte Tobias, 2012, BMC Clin Pharmacol, V12, P5, DOI 10.1186/1472-6904-12-5; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Grudniewicz A, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0347-5; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Guthrie B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068976; Guthrie B, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-002359; Guthrie Bruce, 2011, BMJ, V342, pd3514, DOI 10.1136/bmj.d3514; Hallsworth M, 2016, LANCET, V387, P1743, DOI 10.1016/S0140-6736(16)00215-4; Holland R, 2008, BRIT J CLIN PHARMACO, V65, P303, DOI 10.1111/j.1365-2125.2007.03071.x; HOLM M, 1990, Scandinavian Journal of Primary Health Care, V8, P113, DOI 10.3109/02813439008994941; Howard RL, 2007, BRIT J CLIN PHARMACO, V63, P136, DOI 10.1111/j.1365-2125.2006.02698.x; Hui Chen L, 2014, DRUG POISONING DEATH, P1999; Ivers N, 2012, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD000259.PUB3; Judge J, 2006, J AM MED INFORM ASSN, V13, P385, DOI 10.1197/jamia.M1945; O'Mahony D, 2010, EUR GERIATR MED, V1, P45, DOI 10.1016/j.eurger.2010.01.007; Peterson JF, 2007, STUD HEALTH TECHNOL, V129, P1037; Pimlott NJG, 2003, CAN MED ASSOC J, V168, P835; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Rotondi M., 2011, CRTSIZE SAMPLE SIZE; Royal S, 2006, QUAL SAF HEALTH CARE, V15, P23, DOI 10.1136/qshc.2004.012153; Ruscitto A, 2015, EUR J PAIN, V19, P59, DOI 10.1002/ejp.520; Schwarzer R., 1992, SELF EFFICACY THOUGH, P217; Shojania Kaveh G, 2009, Cochrane Database Syst Rev, pCD001096, DOI 10.1002/14651858.CD001096.pub2; Spencer R, 2014, BRIT J GEN PRACT, V64, pE181, DOI 10.3399/bjgp14X677806; Tamblyn R, 2003, CAN MED ASSOC J, V169, P549; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x	40	23	23	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 18	2016	354								i4079	10.1136/bmj.i4079	http://dx.doi.org/10.1136/bmj.i4079			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9HB	27540041	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000381806600001
J	Jeschek, M; Reuter, R; Heinisch, T; Trindler, C; Klehr, J; Panke, S; Ward, TR				Jeschek, Markus; Reuter, Raphael; Heinisch, Tillmann; Trindler, Christian; Klehr, Juliane; Panke, Sven; Ward, Thomas R.			Directed evolution of artificial metalloenzymes for in vivo metathesis	NATURE			English	Article							OLEFIN-METATHESIS; PROTEIN; STREPTAVIDIN; CATALYSTS; ENZYMES; AVIDIN	The field of biocatalysis has advanced from harnessing natural enzymes to using directed evolution to obtain new biocatalysts with tailor-made functions(1). Several tools have recently been developed to expand the natural enzymatic repertoire with abiotic reactions(2,3). For example, artificial metalloenzymes, which combine the versatile reaction scope of transition metals with the beneficial catalytic features of enzymes, offer an attractive means to engineer new reactions. Three complementary strategies exist(3): repurposing natural metalloenzymes for abiotic transformations(2,4); in silico metalloenzyme (re-)design(5-7); and incorporation of abiotic cofactors into proteins(8-11). The third strategy offers the opportunity to design a wide variety of artificial metalloenzymes for non-natural reactions. However, many metal cofactors are inhibited by cellular components and therefore require purification of the scaffold protein(12-15). This limits the throughput of genetic optimization schemes applied to artificial metalloenzymes and their applicability in vivo to expand natural metabolism. Here we report the compartmentalization and in vivo evolution of an artificial metalloenzyme for olefin metathesis, which represents an archetypal organometallic reaction(16-22) without equivalent in nature. Building on previous work(6) on an artificial metallohydrolase, we exploit the periplasm of Escherichia coli as a reaction compartment for the 'metathase' because it offers an auspicious environment for artificial metalloenzymes, mainly owing to low concentrations of inhibitors such as glutathione, which has recently been identified as a major inhibitor(15). This strategy facilitated the assembly of a functional metathase in vivo and its directed evolution with substantially increased throughput compared to conventional approaches that rely on purified protein variants. The evolved metathase compares favourably with commercial catalysts, shows activity for different metathesis substrates and can be further evolved in different directions by adjusting the workflow. Our results represent the systematic implementation and evolution of an artificial metalloenzyme that catalyses an abiotic reaction in vivo, with potential applications in, for example, non-natural metabolism.	[Jeschek, Markus; Panke, Sven] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Reuter, Raphael; Heinisch, Tillmann; Trindler, Christian; Klehr, Juliane; Ward, Thomas R.] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel	Panke, S (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland.; Ward, TR (corresponding author), Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.	sven.panke@bsse.ethz.ch; thomas.ward@unibas.ch	Jeschek, Markus/AAK-5360-2021; Jeschek, Markus/O-7109-2018	Jeschek, Markus/0000-0003-1317-2461; Jeschek, Markus/0000-0003-1317-2461; Trindler, Christian/0000-0002-5321-3558; Panke, Sven/0000-0002-9368-539X	European Commission [289572-METACODE]; Swiss National Science Foundation as part of the NCCR Molecular Systems Engineering	European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation as part of the NCCR Molecular Systems Engineering	We thank P Marliere for discussions. This work was supported by funding from the European Commission Seventh Framework Programme [289572-METACODE] and the Swiss National Science Foundation as part of the NCCR Molecular Systems Engineering. We thank M. Dessing and the single-cell facility (D-BSSE, ETH Zurich) for assistance with flow cytometry.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; Burtscher D, 2009, ANGEW CHEM INT EDIT, V48, P442, DOI 10.1002/anie.200801451; Chauvin Y, 2006, ANGEW CHEM INT EDIT, V45, P3740, DOI 10.1002/anie.200601234; Coelho PS, 2013, SCIENCE, V339, P307, DOI 10.1126/science.1231434; Creus M, 2008, ANGEW CHEM INT EDIT, V47, P1400, DOI 10.1002/anie.200704865; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Furstner A, 2013, SCIENCE, V341, P1357, DOI 10.1126/science.1229713; Gallizia A, 1998, PROTEIN EXPRES PURIF, V14, P192, DOI 10.1006/prep.1998.0930; Grubbs RH, 2006, ANGEW CHEM INT EDIT, V45, P3760, DOI 10.1002/anie.200600680; Hoveyda AH, 2007, NATURE, V450, P243, DOI 10.1038/nature06351; Humbert Nicolas, 2008, V418, P101; Hyster TK, 2016, ANGEW CHEM INT EDIT, V55, P7344, DOI 10.1002/anie.201508816; Ilie A, 2015, ISR J CHEM, V55, P51, DOI 10.1002/ijch.201400087; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kada G, 1999, BBA-GEN SUBJECTS, V1427, P33, DOI 10.1016/S0304-4165(98)00178-0; Kajetanowicz A, 2014, CATAL LETT, V144, P373, DOI 10.1007/s10562-013-1179-z; Key HM, 2016, NATURE, V534, P534, DOI 10.1038/nature17968; Khare SD, 2012, NAT CHEM BIOL, V8, P294, DOI [10.1038/NCHEMBIO.777, 10.1038/nchembio.777]; Lewis JC, 2013, ACS CATAL, V3, P2954, DOI 10.1021/cs400806a; Lin YA, 2008, J AM CHEM SOC, V130, P9642, DOI 10.1021/ja8026168; Lo C, 2011, CHEM COMMUN, V47, P12065, DOI 10.1039/c1cc15004a; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Reetz MT, 2008, CHEMBIOCHEM, V9, P1797, DOI 10.1002/cbic.200800298; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Reetz MT, 2006, CHEM COMMUN, P4318, DOI 10.1039/b610461d; Renata H, 2015, ANGEW CHEM INT EDIT, V54, P3351, DOI 10.1002/anie.201409470; Sambrook J., 2001, MOL CLONING LAB MANU; Sauer DF, 2015, ACS CATAL, V5, P7519, DOI 10.1021/acscatal.5b01792; Schrock RR, 2006, ANGEW CHEM INT EDIT, V45, P3748, DOI 10.1002/anie.200600085; Song WJ, 2014, SCIENCE, V346, P1525, DOI 10.1126/science.1259680; Srivastava P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8789; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Volker T, 2014, ANGEW CHEM INT EDIT, V53, P10536, DOI 10.1002/anie.201404547; Volkmer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023126; Ward TR, 2011, ACCOUNTS CHEM RES, V44, P47, DOI 10.1021/ar100099u; WILSON ME, 1978, J AM CHEM SOC, V100, P306, DOI 10.1021/ja00469a064; Wilson YM, 2014, J AM CHEM SOC, V136, P8928, DOI 10.1021/ja500613n; Yu FT, 2014, CHEM REV, V114, P3495, DOI 10.1021/cr400458x; Zastrow ML, 2012, NAT CHEM, V4, P118, DOI [10.1038/NCHEM.1201, 10.1038/nchem.1201]	41	258	259	13	336	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2016	537	7622					661	+		10.1038/nature19114	http://dx.doi.org/10.1038/nature19114			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4DR	27571282	Green Accepted			2022-12-28	WOS:000384331700046
J	Connolly, SJ; Milling, TJ; Eikelboom, JW; Gibson, CM; Curnutte, JT; Gold, A; Bronson, MD; Lu, GM; Conley, PB; Verhamme, P; Schmidt, J; Middeldorp, S; Cohen, AT; Beyer-Westendorf, J; Albaladejo, P; Lopez-Sendon, J; Goodman, S; Leeds, J; Wiens, BL; Siegal, DM; Zotova, E; Meeks, B; Nakamya, J; Lim, WT; Crowther, M				Connolly, Stuart J.; Milling, Truman J., Jr.; Eikelboom, John W.; Gibson, C. Michael; Curnutte, John T.; Gold, Alex; Bronson, Michele D.; Lu, Genmin; Conley, Pamela B.; Verhamme, Peter; Schmidt, Jeannot; Middeldorp, Saskia; Cohen, Alexander T.; Beyer-Westendorf, Jan; Albaladejo, Pierre; Lopez-Sendon, Jose; Goodman, Shelly; Leeds, Janet; Wiens, Brian L.; Siegal, Deborah M.; Zotova, Elena; Meeks, Brandi; Nakamya, Juliet; Lim, W. Ting; Crowther, Mark		ANNEXA-4 Investigators	Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REVERSAL; APIXABAN	BACKGROUND Andexanet alfa (andexanet) is a recombinant modified human factor Xa decoy protein that has been shown to reverse the inhibition of factor Xa in healthy volunteers. METHODS In this multicenter, prospective, open-label, single-group study, we evaluated 67 patients who had acute major bleeding within 18 hours after the administration of a factor Xa inhibitor. The patients all received a bolus of andexanet followed by a 2-hour infusion of the drug. Patients were evaluated for changes in measures of anti-factor Xa activity and were assessed for clinical hemostatic efficacy during a 12-hour period. All the patients were subsequently followed for 30 days. The efficacy population of 47 patients had a baseline value for anti-factor Xa activity of at least 75 ng per milliliter (or = 0.5 IU per milliliter for those receiving enoxaparin) and had confirmed bleeding severity at adjudication. RESULTS The mean age of the patients was 77 years; most of the patients had substantial cardiovascular disease. Bleeding was predominantly gastrointestinal or intracranial. The mean (+/- SD) time from emergency department presentation to the administration of the andexanet bolus was 4.8 +/- 1.8 hours. After the bolus administration, the median anti-factor Xa activity decreased by 89% (95% confidence interval [CI], 58 to 94) from baseline among patients receiving rivaroxaban and by 93% (95% CI, 87 to 94) among patients receiving apixaban. These levels remained similar during the 2-hour infusion. Four hours after the end of the infusion, there was a relative decrease from baseline of 39% in the measure of anti-factor Xa activity among patients receiving rivaroxaban and of 30% among those receiving apixaban. Twelve hours after the andexanet infusion, clinical hemostasis was adjudicated as excellent or good in 37 of 47 patients in the efficacy analysis (79%; 95% CI, 64 to 89). Thrombotic events occurred in 12 of 67 patients (18%) during the 30-day follow-up. CONCLUSIONS On the basis of a descriptive preliminary analysis, an initial bolus and subsequent 2-hour infusion of andexanet substantially reduced anti-factor Xa activity in patients with acute major bleeding associated with factor Xa inhibitors, with effective hemostasis occurring in 79%. (Funded by Portola Pharmaceuticals; ANNEXA-4 ClinicalTrials.gov number, NCT02329327.)	[Connolly, Stuart J.; Eikelboom, John W.; Siegal, Deborah M.; Zotova, Elena; Meeks, Brandi; Nakamya, Juliet; Lim, W. Ting; Crowther, Mark] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Milling, Truman J., Jr.] Seton Dell Med Sch, Stroke Inst, Austin, TX USA; [Gibson, C. Michael] Harvard Med Sch, Boston, MA USA; [Curnutte, John T.; Gold, Alex; Bronson, Michele D.; Lu, Genmin; Conley, Pamela B.; Goodman, Shelly; Leeds, Janet; Wiens, Brian L.] Portola Pharmaceut, San Francisco, CA USA; [Verhamme, Peter] Univ Leuven, Leuven, Belgium; [Schmidt, Jeannot] Ctr Hosp Univ Clermont Ferrand, Clermont Ferrand, France; [Albaladejo, Pierre] Grenoble Alpes Univ Hosp, Grenoble, France; [Middeldorp, Saskia] Acad Med Ctr, Amsterdam, Netherlands; [Cohen, Alexander T.] Kings Coll London, Guys & St Thomas Hosp, London, England; [Beyer-Westendorf, Jan] Univ Hosp Carl Gustav Carus Dresden, Dresden, Germany; [Lopez-Sendon, Jose] Hosp Univ La Paz, Madrid, Spain	McMaster University; Population Health Research Institute; Harvard University; Harvard Medical School; KU Leuven; CHU Clermont Ferrand; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); University of Amsterdam; Academic Medical Center Amsterdam; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Hospital Universitario La Paz	Connolly, SJ (corresponding author), McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada.	connostu@phri.ca	Demchuk, Andrew M/E-1103-2012; Eikelboom, John/AAG-6117-2019; Milling, Truman J/N-6601-2017; Middeldorp, Saskia/ABI-8197-2020; Gibson, C. Michael/AAE-8212-2019; Beyer-Westendorf, Jan/K-7569-2019	Demchuk, Andrew M/0000-0002-4930-7789; Eikelboom, John/0000-0003-4126-1285; Milling, Truman J/0000-0002-5588-0426; Middeldorp, Saskia/0000-0002-1006-6420; Beyer-Westendorf, Jan/0000-0002-6983-9993; Lotfipour, Shahram/0000-0003-3437-9410; Siegal, Deborah/0000-0003-3806-3245	Portola Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL127227] Funding Source: NIH RePORTER	Portola Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by Portola Pharmaceuticals; ANNEXA-4 ClinicalTrials.gov number, NCT02329327.	Agnelli G, 2013, NEW ENGL J MED, V369, P799, DOI 10.1056/NEJMoa1302507; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Colman RW, 2006, HEMOSTASIS THROMBOSI, V5th, P1; Ghadimi K, 2016, EXPERT REV HEMATOL, V9, P115, DOI 10.1586/17474086.2016.1135046; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hahn G., 1991, STAT INTERVALS GUIDE; Lu GM, 2013, NAT MED, V19, P446, DOI 10.1038/nm.3102; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pollack Jr CV, 2015, NEW ENGL J MED, V373, P511, DOI 10.1056/NEJMoa1502000; Sarode R, 2013, CIRCULATION, V128, P1234, DOI 10.1161/CIRCULATIONAHA.113.002283; Siegal DM, 2015, NEW ENGL J MED, V373, P2413, DOI 10.1056/NEJMoa1510991	11	508	523	1	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2016	375	12					1131	1141		10.1056/NEJMoa1607887	http://dx.doi.org/10.1056/NEJMoa1607887			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW3JE	27573206	Green Submitted, Green Accepted			2022-12-28	WOS:000383537100006
J	Sanchez, S; Tafforeau, P; Clack, JA; Ahlberg, PE				Sanchez, Sophie; Tafforeau, Paul; Clack, Jennifer A.; Ahlberg, Per E.			Life history of the stem tetrapod Acanthostega revealed by synchrotron microtomography	NATURE			English	Article							EARLY EVOLUTION; EAST GREENLAND; PECTORAL FIN; ORIGIN; COMPETITION; PATTERNS; SKELETON; GUNNARI; BONE	The transition from fish to tetrapod was arguably the most radical series of adaptive shifts in vertebrate evolutionary history. Data are accumulating rapidly for most aspects of these events(1-5), but the life histories of the earliest tetrapods remain completely unknown, leaving a major gap in our understanding of these organisms as living animals. Symptomatic of this problem is the unspoken assumption that the largest known Devonian tetrapod fossils represent adult individuals. Here we present the first, to our knowledge, life history data for a Devonian tetrapod, from the Acanthostega mass-death deposit of Stensio Bjerg, East Greenland(6,7). Using propagation phase-contrast synchrotron microtomography (PPC-SR mu CT)(8) to visualize the histology of humeri (upper arm bones) and infer their growth histories, we show that even the largest individuals from this deposit are juveniles. A long early juvenile stage with unossified limb bones, during which individuals grew to almost final size, was followed by a slow-growing late juvenile stage with ossified limbs that lasted for at least six years in some individuals. The late onset of limb ossification suggests that the juveniles were exclusively aquatic, and the predominance of juveniles in the sample suggests segregated distributions of juveniles and adults at least at certain times. The absolute size at which limb ossification began differs greatly between individuals, suggesting the possibility of sexual dimorphism, adaptive strategies or competition-related size variation.	[Sanchez, Sophie; Ahlberg, Per E.] Sci Life Lab, Norbyvagen 18A, S-75236 Uppsala, Sweden; [Sanchez, Sophie; Ahlberg, Per E.] Uppsala Univ, Subdept Evolut & Dev, Dept Organismal Biol, Evolutionary Biol Ctr, Norbyvagen 18A, S-75236 Uppsala, Sweden; [Sanchez, Sophie; Tafforeau, Paul] European Synchrotron Radiat Facil, 71 Ave Martyrs,CS 40220, F-38043 Grenoble, France; [Clack, Jennifer A.] Univ Cambridge, Univ Museum Zool, Dept Zool, Downing St, Cambridge CB2 3EJ, England	Uppsala University; European Synchrotron Radiation Facility (ESRF); University of Cambridge	Sanchez, S (corresponding author), Sci Life Lab, Norbyvagen 18A, S-75236 Uppsala, Sweden.; Sanchez, S (corresponding author), Uppsala Univ, Subdept Evolut & Dev, Dept Organismal Biol, Evolutionary Biol Ctr, Norbyvagen 18A, S-75236 Uppsala, Sweden.; Sanchez, S (corresponding author), European Synchrotron Radiat Facil, 71 Ave Martyrs,CS 40220, F-38043 Grenoble, France.	sophie.sanchez@ebc.uu.se	Sanchez, Sophie/AAE-1168-2022	Tafforeau, Paul/0000-0002-5962-1683; Ahlberg, Per/0000-0001-9054-2900; Sanchez, Sophie/0000-0002-3611-6836	ERC [233111]; Vetenskapsradet [201504335]	ERC(European Research Council (ERC)European Commission); Vetenskapsradet(Swedish Research Council)	Beamtime was allocated as inhouse beamtime and thanks to a proposal accepted by the ESRF (EC203, S.S.). This research was supported by an ERC grant (233111, P.E.A.) and a grant from the Vetenskapsradet (201504335, S.S.). The authors thank J. Castanet, J.-S. Steyer, G. Clement, M. Coates, T. Smithson, A. R. Milner, H. Blom, D. Snitting, I. Adameyko, A. Soler, S. Martin and R. R. Schoch for discussions; G. Cuny and B. E. Kramer Lindow for access to the collections housed in the Natural History Museum of Denmark; and M. Lowe for access to the collections of the University Museum of Zoology, Cambridge.	AHLBERG PE, 1994, NATURE, V368, P507, DOI 10.1038/368507a0; Astin TR, 2010, GEOL SOC SPEC PUBL, V339, P93, DOI 10.1144/SP339.9; Badyaev AV, 2002, TRENDS ECOL EVOL, V17, P369, DOI 10.1016/S0169-5347(02)02569-7; Bishop PJ, 2014, ALCHERINGA, V38, P209, DOI 10.1080/03115518.2014.861320; Blom H., 2005, MEDDELELSER GRONLAND, p[43, 4]; Blom H, 2007, GEODIVERSITAS, V29, P119; Boisvert CA, 2008, NATURE, V456, P636, DOI 10.1038/nature07339; Callier V, 2009, SCIENCE, V324, P364, DOI 10.1126/science.1167542; Castanet J., 2003, Amphibian Biology, V5, P1598; Castanet J., 1993, BONE, V7; Clack J.A., 2012, GAINING GROUND, VSecond; Clack JA, 2002, T ROY SOC EDIN-EARTH, V93, P17, DOI 10.1017/S0263593300000304; Coates MI, 1996, T ROY SOC EDIN-EARTH, V87, P363, DOI 10.1017/S0263593300006787; Coates MI, 2008, ANNU REV ECOL EVOL S, V39, P571, DOI 10.1146/annurev.ecolsys.38.091206.095546; Francillon-Vieillot H., 1990, P471; Friedman M, 2007, EVOL DEV, V9, P329, DOI 10.1111/j.1525-142X.2007.00169.x; Frobisch NB, 2008, BIOL REV, V83, P571, DOI 10.1111/j.1469-185X.2008.00055.x; Johanson Zerina, 1998, Records of the Australian Museum, V50, P315; Kind P. K., 2002, THESIS; Labiche JC, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2783112; Laurin M, 2007, J PALEONTOL, V81, P143, DOI 10.1666/0022-3360(2007)81[143:AMAHSO]2.0.CO;2; Niedzwiedzki G, 2010, NATURE, V463, P43, DOI 10.1038/nature08623; Padian K, 2012, NATURE, V487, P310, DOI 10.1038/nature11382; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; Peacor SD, 2006, J ANIM ECOL, V75, P990, DOI 10.1111/j.1365-2656.2006.01119.x; Sanchez S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0299; Sanchez S, 2008, BIOL LETTERS, V4, P411, DOI 10.1098/rsbl.2008.0159; Sanchez S, 2012, MICROSC MICROANAL, V18, P1095, DOI 10.1017/S1431927612001079; Schoch RR, 2004, J VERTEBR PALEONTOL, V24, P309, DOI 10.1671/1950; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; Sparreboom Max, 2014, P9; WARBURTON F, 1961, EVOLUTION, V15, P566, DOI 10.2307/2406325; Witzmann F, 2006, J VERTEBR PALEONTOL, V26, P7, DOI 10.1671/0272-4634(2006)26[7:DPAOSI]2.0.CO;2	33	29	29	4	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2016	537	7620					408	+		10.1038/nature19354	http://dx.doi.org/10.1038/nature19354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV7EC	27602519	Green Accepted			2022-12-28	WOS:000383098000055
J	Wu, JP; Yan, Z; Li, ZQ; Qian, XY; Lu, S; Dong, MQ; Zhou, Q; Yan, NE				Wu, Jianping; Yan, Zhen; Li, Zhangqiang; Qian, Xingyang; Lu, Shan; Dong, Mengqiu; Zhou, Qiang; Yan, Nieng			Structure of the voltage-gated calcium channel Ca(v)1.1 at 3.6 angstrom resolution	NATURE			English	Article							CA2+ CHANNEL; CRYSTAL-STRUCTURE; SKELETAL-MUSCLE; SODIUM-CHANNEL; BETA-SUBUNIT; ALPHA(2)DELTA SUBUNITS; ACCURATE DETERMINATION; RECEPTOR; INACTIVATION; RESTORATION	The voltage-gated calcium (Ca-v) channels convert membrane electrical signals to intracellular Ca2+-mediated events. Among the ten subtypes of Ca-v channel in mammals, Ca(v)1.1 is specified for the excitation-contraction coupling of skeletal muscles. Here we present the cryo-electron microscopy structure of the rabbit Ca(v)1.1 complex at a nominal resolution of 3.6 angstrom. The inner gate of the ion-conducting alpha 1-subunit is closed and all four voltage-sensing domains adopt an 'up' conformation, suggesting a potentially inactivated state. The extended extracellular loops of the pore domain, which are stabilized by multiple disulfide bonds, form a windowed dome above the selectivity filter. One side of the dome provides the docking site for the angstrom 2 delta-1-subunit, while the other side may attract cations through its negative surface potential. The intracellular I-II and III-IV linker helices interact with the beta(1a)-subunit and the carboxy-terminal domain of alpha 1, respectively. Classification of the particles yielded two additional reconstructions that reveal pronounced displacement of beta(1a) and adjacent elements in alpha 1. The atomic model of the Ca(v)1.1 complex establishes a foundation for mechanistic understanding of excitation-contraction coupling and provides a three-dimensional template for molecular interpretations of the functions and disease mechanisms of Ca-v and Na-v channels.	[Wu, Jianping; Yan, Zhen; Li, Zhangqiang; Zhou, Qiang; Yan, Nieng] Tsinghua Univ, Sch Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China; [Wu, Jianping; Yan, Zhen; Li, Zhangqiang; Zhou, Qiang; Yan, Nieng] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Wu, Jianping; Yan, Zhen; Li, Zhangqiang; Zhou, Qiang; Yan, Nieng] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Sch Life Sci, Beijing 100084, Peoples R China; [Wu, Jianping; Li, Zhangqiang; Qian, Xingyang; Yan, Nieng] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China; [Lu, Shan; Dong, Mengqiu] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; National Institute of Biological Sciences, Beijing	Yan, NE (corresponding author), Tsinghua Univ, Sch Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China.; Yan, NE (corresponding author), Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.; Yan, NE (corresponding author), Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Sch Life Sci, Beijing 100084, Peoples R China.; Yan, NE (corresponding author), Tsinghua Univ, Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China.	nyan@tsinghua.edu.cn	Lu, Shan/ABI-5830-2020	Yan, Zhen/0000-0002-1999-8451; Lu, Shan/0000-0003-4740-0610; Wu, Jianping/0000-0001-9869-7691	Ministry of Science and Technology of China [2015CB9101012014, 2016YFA0500402, ZX09507003006]; National Natural Science Foundation of China [31321062]; International Early Career Scientist grant from the Howard Hughes Medical Institute; Bayer Healthcare	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Early Career Scientist grant from the Howard Hughes Medical Institute(Howard Hughes Medical Institute); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals)	We thank J. Lei, Y. Xu, and X. Li for technical support. We thank the Tsinghua University Branch of the China National Center for Protein Sciences (Beijing) for providing the facility support. The computation was completed on the 'Explorer 100' cluster system of Tsinghua National Laboratory for Information Science and Technology. This work was supported by funds from the Ministry of Science and Technology of China (2015CB9101012014, 2016YFA0500402, ZX09507003006) and the National Natural Science Foundation of China (project 31321062). The research of N.Y. was supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute and an endowed professorship from Bayer Healthcare.	ADAMS BA, 1990, NATURE, V346, P569, DOI 10.1038/346569a0; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahuja S, 2015, SCIENCE, V350, DOI 10.1126/science.aac5464; Almagor L, 2012, J NEUROSCI, V32, P7602, DOI 10.1523/JNEUROSCI.5727-11.2012; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Andronache Z, 2007, P NATL ACAD SCI USA, V104, P17885, DOI 10.1073/pnas.0704340104; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; Bannister RA, 2013, BBA-BIOMEMBRANES, V1828, P1587, DOI 10.1016/j.bbamem.2012.09.007; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Cheng WJ, 2005, P NATL ACAD SCI USA, V102, P19225, DOI 10.1073/pnas.0504334102; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cloues RK, 2000, J GEN PHYSIOL, V116, P569, DOI 10.1085/jgp.116.4.569; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; Davies A, 2010, P NATL ACAD SCI USA, V107, P1654, DOI 10.1073/pnas.0908735107; DeLano W.L, PYMOL MOL GRAPHICS S; DiMaio F, 2015, NAT METHODS, V12, P361, DOI [10.1038/nmeth.3286, 10.1038/NMETH.3286]; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Efremov RG, 2015, NATURE, V517, P39, DOI 10.1038/nature13916; ELLINOR PT, 1995, NEURON, V15, P1121, DOI 10.1016/0896-6273(95)90100-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; FLECKENSTEIN A, 1983, CIRC RES, V52, P3; Gong X, 2016, CELL, V165, P1467, DOI 10.1016/j.cell.2016.05.022; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; Guo JT, 2016, NATURE, V531, P196, DOI 10.1038/nature16446; Hille B., 2001, ION CHANNELS EXCITAB, P814; Kang MG, 2003, J BIOL CHEM, V278, P21315, DOI 10.1074/jbc.R300004200; Kintzer AF, 2016, NATURE, V531, P258, DOI 10.1038/nature17194; KOHLHARDT M, 1977, N-S ARCH PHARMACOL, V298, P267, DOI 10.1007/BF00500899; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; LEE KS, 1985, J PHYSIOL-LONDON, V364, P395, DOI 10.1113/jphysiol.1985.sp015752; Li XM, 2015, J STRUCT BIOL, V192, P174, DOI 10.1016/j.jsb.2015.09.003; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lu S, 2015, NAT METHODS, V12, P329, DOI [10.1038/nmeth.3283, 10.1038/NMETH.3283]; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RIOS E, 1987, NATURE, V325, P717, DOI 10.1038/325717a0; Rohl CA, 1999, BIOCHEMISTRY-US, V38, P855, DOI 10.1021/bi9823380; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schredelseker J, 2005, P NATL ACAD SCI USA, V102, P17219, DOI 10.1073/pnas.0508710102; Simske JS, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.25502; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Stotz SC, 2004, J PHYSIOL-LONDON, V554, P263, DOI 10.1113/jphysiol.2003.047068; TAKEKURA H, 1994, BIOPHYS J, V67, P793, DOI 10.1016/S0006-3495(94)80539-9; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tang L, 2014, NATURE, V505, P56, DOI 10.1038/nature12775; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Wang CJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5896; Wang CJ, 2012, STRUCTURE, V20, P1167, DOI 10.1016/j.str.2012.05.001; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; Yuan ZF, 2012, PROTEOMICS, V12, P226, DOI 10.1002/pmic.201100081; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950; Zamponi GW, 2015, PHARMACOL REV, V67, P821, DOI 10.1124/pr.114.009654; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	70	261	273	10	180	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					191	+		10.1038/nature19321	http://dx.doi.org/10.1038/nature19321			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9LQ	27580036				2022-12-28	WOS:000382539100039
J	Doherty, R				Doherty, Robert			Academic Medicine and Concierge Practice RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Doherty, Robert] Amer Coll Physicians, Washington, DC 20001 USA	American College of Physicians	Doherty, R (corresponding author), Amer Coll Physicians, Washington, DC 20001 USA.								0	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2016	165	5					375	376		10.7326/L16-0104	http://dx.doi.org/10.7326/L16-0104			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3BC	27595217				2022-12-28	WOS:000382795000009
J	Coopes, A				Coopes, Amy			SEXUAL HARASSMENT Operate with respect: how Australia is confronting sexual harassment of trainees	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DISCRIMINATION					coopesafp@gmail.com						[Anonymous], AGE; [Anonymous], 2015, ABC NEWS; Beyond Blue, 2013, NAT MENT HLTH SURV D; Expert Advisory Group on Discrimination Bullying And Sexual Harassment, 2015, BULL SEX HAR SUMM FA; Expert Advisory Group on Discrimination Bullying And Sexual Harassment, 2015, REP ROYAL AUSTR COLL; Expert Advisory Group on Discrimination Bullying And Sexual Harassment, 2015, BULL SEX HAR; Expert Advisory Group Royal Australasian College of Surgeons, 2015, CONF DRAFT RES REP; Fnais N, 2014, ACAD MED, V89, P817, DOI 10.1097/ACM.0000000000000200; Grigg M., 2015, COMMUNICATION; McDermott Q, 2015, ABC; Medew J., 2015, AGE; RACS, 2011, COD COND; RACS, 2016, COD COND; Scott KM, 2015, MED J AUSTRALIA, V203, P1; Walton MM, 2015, MED J AUSTRALIA, V203, P167, DOI 10.5694/mja15.00379	15	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2016	354								i4210	10.1136/bmj.i4210	http://dx.doi.org/10.1136/bmj.i4210			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3AE	27587299	Green Accepted			2022-12-28	WOS:000382792600001
J	Fanucchi, L; Lofwall, MR				Fanucchi, Laura; Lofwall, Michelle R.			Putting Parity into Practice - Integrating Opioid-Use Disorder Treatment into the Hospital Setting	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RANDOMIZED CLINICAL-TRIAL		[Fanucchi, Laura] Univ Kentucky, Coll Med, Ctr Hlth Serv Res, Lexington, KY 40506 USA; [Lofwall, Michelle R.] Univ Kentucky, Coll Med, Ctr Drug & Alcohol Res, Lexington, KY 40506 USA	University of Kentucky; University of Kentucky	Fanucchi, L (corresponding author), Univ Kentucky, Coll Med, Ctr Hlth Serv Res, Lexington, KY 40506 USA.							D'Onofrio G, 2015, JAMA-J AM MED ASSOC, V313, P1636, DOI 10.1001/jama.2015.3474; Liebschutz JM, 2014, JAMA INTERN MED, V174, P1369, DOI 10.1001/jamainternmed.2014.2556; Ronan MV, 2016, HEALTH AFFAIR, V35, P832, DOI 10.1377/hlthaff.2015.1424; Shrestha NK, 2015, ANN THORAC SURG, V100, P875, DOI 10.1016/j.athoracsur.2015.03.019; Volkow ND, 2014, NEW ENGL J MED, V370, P2063, DOI 10.1056/NEJMp1402780	5	37	37	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2016	375	9					811	813		10.1056/NEJMp1606157	http://dx.doi.org/10.1056/NEJMp1606157			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU9HA	27579631	Green Published, Bronze			2022-12-28	WOS:000382526000002
J	Worley, G				Worley, Gordon			Case 14-2016: A Woman with a Thyroid Nodule and Psychosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Worley, Gordon] Duke Univ, Med Ctr, Durham, NC 27708 USA	Duke University	Worley, G (corresponding author), Duke Univ, Med Ctr, Durham, NC 27708 USA.	gordon.worley@duke.edu						[Anonymous], 2016, N ENGL J MED, V374, P1875; Chong JY, 2003, ARCH NEUROL-CHICAGO, V60, P164, DOI 10.1001/archneur.60.2.164	2	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2016	375	9								10.1056/NEJMc1607733	http://dx.doi.org/10.1056/NEJMc1607733			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU9HA	27579662				2022-12-28	WOS:000382526000036
J	Freedhoff, Y; Hall, KD				Freedhoff, Yoni; Hall, Kevin D.			Weight loss diet studies: we need help not hype	LANCET			English	Editorial Material							ADHERENCE; ADULTS		[Freedhoff, Yoni] Bariatr Med Inst, Ottawa, ON, Canada; [Hall, Kevin D.] NIDDK, Integrat Physiol Sect, Lab Biol Modeling, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hall, KD (corresponding author), NIDDK, Integrat Physiol Sect, Lab Biol Modeling, Bethesda, MD 20892 USA.	kevinh@niddk.nih.gov	Hall, Kevin/F-2383-2010	Hall, Kevin/0000-0003-4062-3133	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK013036, ZIADK013037] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bray MS, 2016, OBESITY, V24, P14, DOI 10.1002/oby.21381; Das SK, 2007, AM J CLIN NUTR, V85, P1023, DOI 10.1093/ajcn/85.4.1023; Dhurandhar NV, 2015, INT J OBESITY, V39, P1109, DOI 10.1038/ijo.2014.199; Foster GD, 1997, J CONSULT CLIN PSYCH, V65, P79, DOI 10.1037/0022-006X.65.1.79; Fothergill E, 2016, OBESITY, V24, P1612, DOI 10.1002/oby.21538; Franz MJ, 2007, J AM DIET ASSOC, V107, P1755, DOI 10.1016/j.jada.2007.07.017; Greenberg I, 2009, J AM COLL NUTR, V28, P159, DOI 10.1080/07315724.2009.10719767; Johnston BC, 2014, JAMA-J AM MED ASSOC, V312, P923, DOI 10.1001/jama.2014.10397; MacLean PS, 2015, OBESITY, V23, P7, DOI 10.1002/oby.20967; Polidori D, OBESITY SIL IN PRESS; Sanghvi A, 2015, AM J CLIN NUTR, V102, P353, DOI 10.3945/ajcn.115.111070; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Tobias DK, 2015, LANCET DIABETES ENDO, V3, P968, DOI 10.1016/S2213-8587(15)00367-8	13	31	31	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 27	2016	388	10047					849	851		10.1016/S0140-6736(16)31338-1	http://dx.doi.org/10.1016/S0140-6736(16)31338-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU0RI	27597452				2022-12-28	WOS:000381911800008
J	Bohmer, RMJ				Bohmer, Richard M. J.			The Hard Work of Health Care Transformation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bohmer, Richard M. J.] Nuffield Trust, London, England		Bohmer, RMJ (corresponding author), Nuffield Trust, London, England.							Bohmer RMJ, 2009, PRACTICE BASED LEARN; Imison C, 2014, RECONFIGURATION CLIN; Schwartz AL, 2015, JAMA INTERN MED, V175, P1815, DOI 10.1001/jamainternmed.2015.4525	3	53	53	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2016	375	8					709	711		10.1056/NEJMp1606458	http://dx.doi.org/10.1056/NEJMp1606458			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT9ET	27557297				2022-12-28	WOS:000381799300008
J	Choy, E; Hornicek, FJ; Chen, YL; Rosenthal, DI; Kerr, DA				Choy, Edwin; Hornicek, Francis J.; Chen, Yen-Lin; Rosenthal, Daniel I.; Kerr, Darcy A.			Case 26-2016: A 28-Year-Old Woman with Back Pain and a Lesion in the Lumbar Spine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GIANT-CELL TUMOR; ANTIANGIOGENIC THERAPY; RECEIVING DENOSUMAB; BONE; BISPHOSPHONATE; RISK; RADIOTHERAPY; RECURRENT; EFFICACY; SAFETY		[Choy, Edwin] Massachusetts Gen Hosp, Dept Med, Div Hematol Oncol, Boston, MA 02114 USA; [Hornicek, Francis J.] Massachusetts Gen Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Chen, Yen-Lin] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02115 USA; [Rosenthal, Daniel I.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02115 USA; [Kerr, Darcy A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA; [Choy, Edwin] Harvard Med Sch, Dept Med, Boston, MA USA; [Hornicek, Francis J.] Harvard Med Sch, Dept Orthoped Surg, Boston, MA USA; [Chen, Yen-Lin] Harvard Med Sch, Dept Radiat Oncol, Boston, MA USA; [Rosenthal, Daniel I.] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Kerr, Darcy A.] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Choy, E (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Hematol Oncol, Boston, MA 02114 USA.				Bayer; Amgen; EMD Serono; Pfizer; NPS Pharmaceuticals; Stryker	Bayer(Bayer AG); Amgen(Amgen); EMD Serono; Pfizer(Pfizer); NPS Pharmaceuticals; Stryker	Dr. Choy reports receiving fees for serving on advisory boards from Bayer, Amgen, and EMD Serono, consulting fees from Pfizer and NPS Pharmaceuticals, and grant support from Amgen; and Dr. Hornicek, receiving fees for educational courses from Stryker. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2021, DIAGN PATHOL; Arpornchayanon Olarn, 2008, Journal of the Medical Association of Thailand, V91, P1609; Balke M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-462; Bertoni F, 2003, CANCER, V97, P2520, DOI 10.1002/cncr.11359; Bhatia S, 2011, RARE TUMORS, V3, P150, DOI 10.4081/rt.2011.e48; Boquete-Castro A, 2016, CLIN ORAL IMPLAN RES, V27, P367, DOI 10.1111/clr.12556; Chakravarti A, 1999, J BONE JOINT SURG AM, V81A, P1566, DOI 10.2106/00004623-199911000-00008; Chan CM, 2015, J BONE JOINT SURG AM, V97A, P420, DOI 10.2106/JBJS.N.00678; Chaudhary P, 2011, ONKOLOGIE, V34, P702, DOI 10.1159/000334549; Chawla S, 2013, LANCET ONCOL, V14, P901, DOI 10.1016/S1470-2045(13)70277-8; Cowan RW, 2013, BONE, V52, P238, DOI 10.1016/j.bone.2012.10.002; Drampalos E, 2014, ACTA ORTHOP, V85, P3, DOI 10.3109/17453674.2013.854668; Hakozaki M, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-111; Hosalkar HS, 2007, SPINE, V32, P1107, DOI 10.1097/01.brs.0000261558.94247.8d; JACOBS PA, 1985, CLIN ORTHOP RELAT R, P149; Kaban LB, 2002, J ORAL MAXIL SURG, V60, P1103, DOI 10.1053/joms.2002.34975; Kaban LB, 1999, PEDIATRICS, V103, P1145, DOI 10.1542/peds.103.6.1145; Kaban LB, 2007, J ORAL MAXIL SURG, V65, P2018, DOI 10.1016/j.joms.2007.03.030; Mak IWY, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.M.01332; MALONE S, 1995, INT J RADIAT ONCOL, V33, P689, DOI 10.1016/0360-3016(95)00159-V; Mankin HJ, 2005, CLIN ORTHOP RELAT R, P144, DOI 10.1097/01.blo.0000174684.85250.b5; Martin Christopher, 2010, Iowa Orthop J, V30, P69; Organization WH, 2013, CLASS TUM SOFT TISS; Qi WX, 2014, INT J CLIN ONCOL, V19, P403, DOI 10.1007/s10147-013-0561-6; Raskin KA, 2013, J AM ACAD ORTHOP SUR, V21, P118, DOI 10.5435/JAAOS-21-02-118; Rogers Michael J., 2000, Cancer, V88, P2961, DOI 10.1002/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.3.CO;2-C; Sakanoue I, 2016, GEN THORAC CARDIOVAS; Shi WY, 2013, AM J CLIN ONCOL-CANC, V36, P505, DOI 10.1097/COC.0b013e3182568fb6; Thomas D, 2010, LANCET ONCOL, V11, P275, DOI 10.1016/S1470-2045(10)70010-3; Tse LF, 2008, BONE, V42, P68, DOI 10.1016/j.bone.2007.08.038; TURCOTTE RE, 1993, CLIN ORTHOP RELAT R, P215; van der Heijden L, 2014, ONCOLOGIST, V19, P550, DOI 10.1634/theoncologist.2013-0432; Wojcik J, 2016, AM J SURG PATHOL, V40, P72, DOI 10.1097/PAS.0000000000000506	33	0	0	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2016	375	8					779	788		10.1056/NEJMcpc1505482	http://dx.doi.org/10.1056/NEJMcpc1505482			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9ET	27557305				2022-12-28	WOS:000381799300016
J	Freed, EO				Freed, Eric O.			Getting IN on Viral RNA Condensation and Virion Maturation	CELL			English	Editorial Material							HIV-1 INTEGRASE	The retroviral enzyme integrase plays an essential role in the virus replication cycle by catalyzing the covalent insertion of newly synthesized viral DNA into the host cell chromosome early after infection. Now, Kessl et al. report a second function of integrase: binding to the viral RNA genome in virion particles late in the virus replication cycle to promote particle maturation.	[Freed, Eric O.] NCI, Virus Cell Interact Sect, HIV Dynam & Replicat Program, Ctr Canc Res, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Freed, EO (corresponding author), NCI, Virus Cell Interact Sect, HIV Dynam & Replicat Program, Ctr Canc Res, Frederick, MD 21702 USA.	efreed@nih.gov			NATIONAL CANCER INSTITUTE [ZIABC010778] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA BC010778-11] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Balakrishnan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074163; Desimmie BA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-57; Engelman A, 1999, ADV VIRUS RES, V52, P411, DOI 10.1016/S0065-3527(08)60309-7; Fontana J, 2015, J VIROL, V89, P9765, DOI 10.1128/JVI.01522-15; Freed EO, 2015, NAT REV MICROBIOL, V13, P484, DOI 10.1038/nrmicro3490; HICKMAN AB, 1994, J BIOL CHEM, V269, P29279; Jurado KA, 2013, P NATL ACAD SCI USA, V110, P8690, DOI 10.1073/pnas.1300703110; Jurado KA, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.15; Kessl JJ, 2016, CELL, V166, P1257, DOI 10.1016/j.cell.2016.07.044; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488	10	1	1	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1082	1083		10.1016/j.cell.2016.08.013	http://dx.doi.org/10.1016/j.cell.2016.08.013			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27565339	Green Accepted, Bronze			2022-12-28	WOS:000382259500008
J	Rangan, A; Hanchard, N; McDaid, C				Rangan, Amar; Hanchard, Nigel; McDaid, Catriona			UNCERTAINTIES What is the most effective treatment for frozen shoulder?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADHESIVE CAPSULITIS; DISTENSION; DISORDERS; MANAGEMENT; DIAGNOSIS; PATTERNS		[Rangan, Amar] James Cook Univ Hosp, Orthopaed Surg, Middlesbrough TS4 3BW, Cleveland, England; [Rangan, Amar] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Orthopaed Surg, Oxford OX3 7HE, England; [Rangan, Amar] Univ York, Dept Hlth Sci, York Trials Unit, Orthopaed Surg, York YO10 5DD, N Yorkshire, England; [McDaid, Catriona] Univ York, Dept Hlth Sci, York Trials Unit, York YO10 5DD, N Yorkshire, England; [Hanchard, Nigel] Univ Teesside, Sch Hlth & Social Care, Orthopaed, Middlesbrough TS1 3BX, Cleveland, England	James Cook University Hospital; University of Oxford; University of York - UK; University of York - UK; University of Teesside	Rangan, A (corresponding author), James Cook Univ Hosp, Orthopaed Surg, Middlesbrough TS4 3BW, Cleveland, England.; Rangan, A (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Orthopaed Surg, Oxford OX3 7HE, England.; Rangan, A (corresponding author), Univ York, Dept Hlth Sci, York Trials Unit, Orthopaed Surg, York YO10 5DD, N Yorkshire, England.	amar.rangan@york.ac.uk		Rangan, Amar/0000-0002-5452-8578; McDaid, Catriona Maria/0000-0002-3751-7260	National Institute for Health Research [09/13/02, 13/26/01] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Bae JH, 2014, ANN REHABIL MED-ARM, V38, P360, DOI 10.5535/arm.2014.38.3.360; Boyle-Walker K L, 1997, J Hand Ther, V10, P222; Buchbinder R, 2006, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD006189; Codman E., 1934, RUPTURE SUPRASPINATU; Dawson J, 2010, SHOULDER ELBOW, V2, P232, DOI [10.1111/j.1758-5740.2010.00067.x, DOI 10.1111/J.1758-5740.2010.00067.X]; Hanchard NCA, 2012, PHYSIOTHERAPY, V98, P118, DOI 10.1016/j.physio.2012.01.001; Hanchard NCA, 2011, PHYSIOTHERAPY, V97, P115, DOI 10.1016/j.physio.2010.08.012; Hand C, 2008, J SHOULDER ELB SURG, V17, P231, DOI 10.1016/j.jse.2007.05.009; Jones S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003452; Maund E, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16110; Noboa E, 2015, Rev Esp Cir Ortop Traumatol, V59, P354, DOI 10.1016/j.recot.2014.10.005; Ostor AJK, 2005, RHEUMATOLOGY, V44, P800, DOI 10.1093/rheumatology/keh598; Page MJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011275; Page MJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011324; Park KD, 2012, ANN REHABIL MED-ARM, V36, P88, DOI 10.5535/arm.2012.36.1.88; Park SW, 2014, J PHYS THER SCI, V26, P1767, DOI 10.1589/jpts.26.1767; Rundquist PJ, 2004, CLIN BIOMECH, V19, P810, DOI 10.1016/j.clinbiomech.2004.05.006; Rundquist PJ, 2003, ARCH PHYS MED REHAB, V84, P1473, DOI 10.1016/S0003-9993(03)00359-9; Uppal HS, 2015, WORLD J ORTHOP, V6, P263, DOI 10.5312/wjo.v6.i2.263; VANDERWINDT DAWM, 1995, ANN RHEUM DIS, V54, P959, DOI 10.1136/ard.54.12.959; Walker-Bone K, 2004, ARTHRIT RHEUM-ARTHR, V51, P642, DOI 10.1002/art.20535; Walmsley S, 2014, PHYSIOTHERAPY, V100, P336, DOI 10.1016/j.physio.2014.02.001; Wolf Eugene M, 2010, Orthopedics, V33, DOI 10.3928/01477447-20100329-11	23	24	24	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2016	354								i4162	10.1136/bmj.i4162	http://dx.doi.org/10.1136/bmj.i4162			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV2ZY	27554676	Green Accepted, Green Published			2022-12-28	WOS:000382792000001
J	Van Gelder, IC; Rienstra, M; Crijns, HJGM; Olshansky, B				Van Gelder, Isabelle C.; Rienstra, Michiel; Crijns, Harry J. G. M.; Olshansky, Brian			Rate control in atrial fibrillation	LANCET			English	Article							CARDIAC RESYNCHRONIZATION THERAPY; HEART RHYTHM ASSOCIATION; VENTRICULAR RATE CONTROL; STRICT RATE CONTROL; ATRIOVENTRICULAR JUNCTION ABLATION; RATE CONTROL EFFICACY; LONG-TERM SURVIVAL; TASK-FORCE; EUROPEAN-SOCIETY; BETA-BLOCKERS	Control of the heart rate (rate control) is central to atrial fibrillation management, even for patients who ultimately require control of the rhythm. We review heart rate control in patients with atrial fibrillation, including the rationale for the intervention, patient selection, and the treatments available. The choice of rate control depends on the symptoms and clinical characteristics of the patient, but for all patients with atrial fibrillation, rate control is part of the management. Choice of drugs is patient-dependent. beta blockers, alone or in combination with digoxin, or non-dihydropyridine calcium-channel blockers (not in heart failure) effectively lower the heart rate. Digoxin is least effective, but a reasonable choice for physically inactive patients aged 80 years or older, in whom other treatments are ineffective or are contraindicated, and as an additional drug to other rate-controlling drugs, especially in heart failure when instituted cautiously. Atrioventricular node ablation with pacemaker insertion for rate control should be used as an approach of last resort but is also an option early in the management of patients with atrial fibrillation treated with cardiac resynchronisation therapy. However, catheter ablation of atrial fibrillation should be considered before atrioventricular node ablation. Although rate control is a top priority and one of the first management issues for all patients with atrial fibrillation, many issues remain.	[Van Gelder, Isabelle C.; Rienstra, Michiel] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Thoraxctr, NL-9700 RB Groningen, Netherlands; [Crijns, Harry J. G. M.] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Crijns, Harry J. G. M.] Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Olshansky, Brian] Mercy Med Ctr North Iowa, Mercy Heart & Vasc Inst, Mason City, IA USA	University of Groningen; Maastricht University; Maastricht University	Van Gelder, IC (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Thoraxctr, NL-9700 RB Groningen, Netherlands.	i.c.van.gelder@umcg.nl	Olshansky, Brian/S-3671-2016	Olshansky, Brian/0000-0002-6044-045X; Rienstra, Michiel/0000-0002-2581-070X	Netherlands Cardiovascular Research Initiative: an initiative - Netherlands Heart Foundation [CVON 2014-9]	Netherlands Cardiovascular Research Initiative: an initiative - Netherlands Heart Foundation	We acknowledge support from the Netherlands Cardiovascular Research Initiative: an initiative supported by the Netherlands Heart Foundation, CVON 2014-9: "Reappraisal of Atrial Fibrillation: interaction between hyperCoagulability, Electrical remodelling, and Vascular destabilization in the progression of AF (RACE V)" (ICVG, MR, HJGMC).	Adam SS, 2012, ANN INTERN MED, V157, P796, DOI 10.7326/0003-4819-157-10-201211200-00532; Ahmed A, 2006, EUR HEART J, V27, P178, DOI 10.1093/eurheartj/ehi687; Ahmed S, 2011, CLIN ENDOCRINOL, V75, P388, DOI 10.1111/j.1365-2265.2011.04087.x; Allen LA, 2015, J AM COLL CARDIOL, V65, P2691, DOI 10.1016/j.jacc.2015.04.045; Bianchi S, 2015, CIRC-ARRHYTHMIA ELEC, V8, P562, DOI 10.1161/CIRCEP.114.002588; Boriani G, 2007, AM HEART J, V154, P193, DOI 10.1016/j.ahj.2007.04.001; Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Brignole M, 2011, EUR HEART J, V32, P2420, DOI 10.1093/eurheartj/ehr162; BRODSKY M, 1994, AM HEART J, V127, P572, DOI 10.1016/0002-8703(94)90665-3; Bun SS, 2015, EUR HEART J, V36, P2356, DOI 10.1093/eurheartj/ehv118; Calkins H, 2012, EUROPACE, V14, P528, DOI 10.1093/europace/eus027; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Camm J, 2012, INT J CARDIOL, V155, P362, DOI 10.1016/j.ijcard.2011.06.012; Carlsson J, 2003, J AM COLL CARDIOL, V41, P1690, DOI 10.1016/S0735-1097(03)00332-2; Chamaria S, 2015, CARDIOL RES PRACT, V2015, DOI 10.1155/2015/314041; Connolly SJ, 2011, NEW ENGL J MED, V365, P2268, DOI 10.1056/NEJMoa1109867; Corley SD, 2004, CIRCULATION, V109, P1509, DOI 10.1161/01.CIR.0000121736.16643.11; CRIJNS HJ, 1988, AM J CARDIOL, V62, P1303, DOI 10.1016/0002-9149(88)90282-2; Curtis AB, 2013, NEW ENGL J MED, V368, P1585, DOI 10.1056/NEJMoa1210356; Daoud EG, 1996, AM J CARDIOL, V78, P1433, DOI 10.1016/S0002-9149(97)89297-1; Davy JM, 2008, AM HEART J, V156, DOI 10.1016/j.ahj.2008.06.010; Farshi R, 1999, J AM COLL CARDIOL, V33, P304, DOI 10.1016/S0735-1097(98)00561-0; Fischer A, 2012, HEART RHYTHM, V9, P24, DOI 10.1016/j.hrthm.2011.08.005; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Ganesan AN, 2012, J AM COLL CARDIOL, V59, P719, DOI 10.1016/j.jacc.2011.10.891; Gasparini M, 2008, EUR HEART J, V29, P1644, DOI 10.1093/eurheartj/ehn133; Gasparini M, 2013, JACC-HEART FAIL, V1, P500, DOI 10.1016/j.jchf.2013.06.003; Gheorghiade M, 2013, EUR HEART J, V34, P1489, DOI 10.1093/eurheartj/eht120; Gopinathannair R, 2015, J AM COLL CARDIOL, V66, P1714, DOI 10.1016/j.jacc.2015.08.038; Groenveld HF, 2011, J AM COLL CARDIOL, V58, P1795, DOI 10.1016/j.jacc.2011.06.055; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hohnloser SH, 2000, LANCET, V356, P1789, DOI 10.1016/S0140-6736(00)03230-X; HOU ZY, 1995, EUR HEART J, V16, P521, DOI 10.1093/oxfordjournals.eurheartj.a060945; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; January CT, 2014, J AM COLL CARDIOL, V64, P2304, DOI 10.1016/j.jacc.2014.04.004; Kao DP, 2013, EUR J HEART FAIL, V15, P324, DOI 10.1093/eurjhf/hfs181; Kerr AJ, 2001, AM J CARDIOL, V87, P1116, DOI 10.1016/S0002-9149(01)01475-8; Khan MN, 2008, NEW ENGL J MED, V359, P1778, DOI 10.1056/NEJMoa0708234; Khand AU, 2003, J AM COLL CARDIOL, V42, P1944, DOI 10.1016/j.jacc.2003.07.020; Kirchhof P, 2016, EUROPACE, V18, P37, DOI 10.1093/europace/euv304; Kirchhof P, 2013, AM HEART J, V166, P442, DOI 10.1016/j.ahj.2013.05.015; Kochiadakis GE, 2001, EUROPACE, V3, P73, DOI 10.1053/eupc.2000.0140; Kotecha D, 2014, LANCET, V384, P2235, DOI 10.1016/S0140-6736(14)61373-8; KUCK KH, 1984, AM HEART J, V107, P179, DOI 10.1016/0002-8703(84)90158-3; Laskey WK, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001626; LATINI R, 1988, J AM COLL CARDIOL, V11, P209, DOI 10.1016/0735-1097(88)90192-1; Lee AY, 2015, HEART RHYTHM, V12, P2010, DOI 10.1016/j.hrthm.2015.05.016; Lip GYH, 2014, EUROPACE, V16, P308, DOI 10.1093/europace/eut373; Mareev Y, 2015, CLIN THER, V37, P2215, DOI 10.1016/j.clinthera.2015.08.017; MCKIBBIN JK, 1984, BRIT HEART J, V51, P157; Mont L, 2014, EUR HEART J, V35, P501, DOI 10.1093/eurheartj/eht457; Morillo CA, 2014, JAMA-J AM MED ASSOC, V311, P692, DOI 10.1001/jama.2014.467; Mulder BA, 2014, HEART RHYTHM, V11, P1543, DOI 10.1016/j.hrthm.2014.06.007; Nieuwlaat R, 2005, EUR HEART J, V26, P2422, DOI 10.1093/eurheartj/ehi505; Ogawa S, 2009, CIRC J, V73, P242, DOI 10.1253/circj.CJ-08-0608; Okin PM, 2015, J HYPERTENS, V33, P1480, DOI 10.1097/HJH.0000000000000559; Opolski G, 2004, CHEST, V126, P476, DOI 10.1378/chest.126.2.476; Ozcan C, 2001, NEW ENGL J MED, V344, P1043, DOI 10.1056/NEJM200104053441403; Packer DL, 2013, J AM COLL CARDIOL, V61, P1713, DOI 10.1016/j.jacc.2012.11.064; Page RL, 2016, CIRCULATION, V133, pE506, DOI 10.1161/CIR.0000000000000311; Parvez B, 2012, J AM COLL CARDIOL, V59, P49, DOI 10.1016/j.jacc.2011.08.061; Peterson ED, 2014, J AM COLL CARDIOL, V64, P2133, DOI [10.1016/j.jacc.2014.09.003, 10.1161/CIR.0000000000000139]; Ponikowski P, 2016, EUR J HEART FAIL, V18, P891, DOI 10.1002/ejhf.592; Poole JE, 2010, CIRCULATION, V122, P1553, DOI 10.1161/CIRCULATIONAHA.110.976076; Rau T, 2012, CLIN PHARMACOL THER, V92, P21, DOI 10.1038/clpt.2012.18; RAWLES JM, 1990, BRIT HEART J, V63, P157; Rienstra M, 2008, CURR OPIN CARDIOL, V23, P23, DOI 10.1097/HCO.0b013e3282f24046; Rienstra M, 2013, JACC-HEART FAIL, V1, P21, DOI 10.1016/j.jchf.2012.09.002; Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789; Santhanakrishnan R, 2016, CIRCULATION, V133, P484, DOI 10.1161/CIRCULATIONAHA.115.018614; Smit MD, 2011, J AM COLL CARDIOL, V58, P942, DOI 10.1016/j.jacc.2011.04.030; Steinberg BA, 2013, AM HEART J, V165, P622, DOI 10.1016/j.ahj.2012.12.019; Tse HF, 2001, CLIN EXP PHARMACOL P, V28, P446, DOI 10.1046/j.1440-1681.2001.03454.x; Ulimoen SR, 2014, CLIN CARDIOL, V37, P422, DOI 10.1002/clc.22281; Ulimoen SR, 2014, EUR HEART J, V35, P517, DOI 10.1093/eurheartj/eht429; Ulimoen SR, 2013, AM J CARDIOL, V111, P225, DOI 10.1016/j.amjcard.2012.09.020; Upadhyay GA, 2012, HEART RHYTHM, V9, pS51, DOI 10.1016/j.hrthm.2012.04.030; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; Van Gelder IC, 2006, AM HEART J, V152, P420, DOI 10.1016/j.ahj.2006.02.033; Van Gelder IC, 2011, PACE, V34, P1070, DOI 10.1111/j.1540-8159.2011.03124.x; Van Gelder IC, 2010, NEW ENGL J MED, V362, P1363, DOI 10.1056/NEJMoa1001337; Verma A, 2014, CAN J CARDIOL, V30, P1114, DOI 10.1016/j.cjca.2014.08.001; Wang RX, 2013, HEART RHYTHM, V10, P696, DOI 10.1016/j.hrthm.2013.01.021; Washam JB, 2015, LANCET, V385, P2363, DOI 10.1016/S0140-6736(14)61836-5; Whitbeck MG, 2013, EUR HEART J, V34, P1481, DOI 10.1093/eurheartj/ehs348; Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029; Wilkoff BL, 2002, JAMA-J AM MED ASSOC, V288, P3115; Wilkoff BL, 2008, J AM COLL CARDIOL, V52, P541, DOI 10.1016/j.jacc.2008.05.011; Wyse DG, 2008, J CARDIOVASC PHARM, V52, P11, DOI 10.1097/FJC.0b013e31816d5f49; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; Ziff OJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4451	91	83	85	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 20	2016	388	10046					818	828		10.1016/S0140-6736(16)31258-2	http://dx.doi.org/10.1016/S0140-6736(16)31258-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT6UH	27560277				2022-12-28	WOS:000381619200030
J	Singh, AM				Singh, Amar M.			Choosing the nontenure track	SCIENCE			English	Editorial Material									[Singh, Amar M.] Univ Georgia, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Singh, AM (corresponding author), Univ Georgia, Athens, GA 30602 USA.	SciCareerEditor@aaas.org							0	0	0	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301					838	838		10.1126/science.353.6301.838	http://dx.doi.org/10.1126/science.353.6301.838			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5ZE	27540176				2022-12-28	WOS:000381561400048
J	Shah, ASV; Lee, KK; McAllister, DA; Hunter, A; Nair, H; Whiteley, W; Langrish, JP; Newby, DE; Mills, NL				Shah, Anoop S. V.; Lee, Kuan Ken; McAllister, David A.; Hunter, Amanda; Nair, Harish; Whiteley, William; Langrish, Jeremy P.; Newby, David E.; Mills, Nicholas L.			Short term exposure to air pollution and stroke: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DAILY HOSPITAL ADMISSIONS; CAUSE-SPECIFIC MORTALITY; CASE-CROSSOVER ANALYSIS; EMERGENCY-DEPARTMENT VISITS; TRANSIENT ISCHEMIC ATTACK; 11 EUROPEAN COHORTS; PARTICULATE MATTER; CARDIOVASCULAR-DISEASES; SAHARAN DUST; CIRCULATORY-SYSTEM	OBJECTIVE To review the evidence for the short term association between air pollution and stroke. DESIGN Systematic review and meta-analysis of observational studies DATA SOURCES Medline, Embase, Global Health, Cumulative Index to Nursing and Allied Health Literature (CINAHL), and Web of Science searched to January 2014 with no language restrictions. ELIGIBILITY CRITERIA Studies investigating the short term associations (up to lag of seven days) between daily increases in gaseous pollutants (carbon monoxide, sulphur dioxide, nitrogen dioxide, ozone) and particulate matter (< 2.5 mu m or < 10 mu m diameter (PM2.5 and PM10)), and admission to hospital for stroke or mortality. MAIN OUTCOME MEASURES Admission to hospital and mortality from stroke. RESULTS From 2748 articles, 238 were reviewed in depth with 103 satisfying our inclusion criteria and 94 contributing to our meta-estimates. This provided a total of 6.2 million events across 28 countries. Admission to hospital for stroke or mortality from stroke was associated with an increase in concentrations of carbon monoxide (relative risk 1.015 per 1 ppm, 95% confidence interval 1.004 to 1.026), sulphur dioxide (1.019 per 10 ppb, 1.011 to 1.027), and nitrogen dioxide (1.014 per 10 ppb, 1.009 to 1.019). Increases in PM2.5 and PM10 concentration were also associated with admission and mortality (1.011 per 10 (I) over cap1/4g/m(3) (1.011 to 1.012) and 1.003 per 10 mu g/m(3) (1.002 to 1.004), respectively). The weakest association was seen with ozone (1.001 per 10 ppb, 1.000 to 1.002). Strongest associations were observed on the day of exposure with more persistent effects observed for PM2-5. CONCLUSION Gaseous and particulate air pollutants have a marked and close temporal association with admissions to hospital for stroke or mortality from stroke. Public and environmental health policies to reduce air pollution could reduce the burden of stroke.	[Shah, Anoop S. V.; Lee, Kuan Ken; Hunter, Amanda; Langrish, Jeremy P.; Newby, David E.; Mills, Nicholas L.] Univ Edinburgh, BHF Univ Ctr Cardiovasc Sci, Edinburgh EH16 4SB, Midlothian, Scotland; [McAllister, David A.; Nair, Harish] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH16 4SB, Midlothian, Scotland; [Whiteley, William] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh EH16 4SB, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Shah, ASV (corresponding author), Univ Edinburgh, BHF Univ Ctr Cardiovasc Sci, Edinburgh EH16 4SB, Midlothian, Scotland.	anoopsshah@gmail.com	Newby, David Ernest/AAB-1364-2019; Nair, Harish/E-7431-2010	Nair, Harish/0000-0002-9432-9100; Whiteley, William/0000-0002-4816-8991; Shah, Anoop/0000-0002-2825-3419; McAllister, David/0000-0003-3550-1764; Mills, Nicholas/0000-0003-0533-7991	British Heart Foundation [RG/10/9/28286, SS/CH/09/002, FS/10/024/28266, CH/09/002]; MRC [G0902303] Funding Source: UKRI; British Heart Foundation [PG/11/27/28842] Funding Source: researchfish; Medical Research Council [G0902303] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by a British Heart Foundation programme grant (RG/10/9/28286). ASVS, DEN, and NLM were supported by a British Heart Foundation clinical research scholarship (SS/CH/09/002), intermediate fellowship (FS/10/024/28266), chair award (CH/09/002), and programme grant (RG/10/9/28286), respectively. The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Adar SD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001430; Alessandrini ER, 2013, EPIDEMIOL PREV, V37, P220; Alessandrini ER, 2013, OCCUP ENVIRON MED, V70, P432, DOI 10.1136/oemed-2012-101182; Amancio CT, 2012, BRAZ J MED BIOL RES, V45, P1080, DOI 10.1590/S0100-879X2012007500131; Andersen ZJ, 2010, EUR HEART J, V31, P2034, DOI 10.1093/eurheartj/ehq188; Anderson HR, 2001, OCCUP ENVIRON MED, V58, P504, DOI 10.1136/oem.58.8.504; Atkinson RW, 2014, THORAX, V69, P660, DOI 10.1136/thoraxjnl-2013-204492; Ballester F, 2001, J EPIDEMIOL COMMUN H, V55, P57, DOI 10.1136/jech.55.1.57; Barnett AG, 2006, ENVIRON HEALTH PERSP, V114, P1018, DOI 10.1289/ehp.8674; Bedada GB, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-77; Beelen R, 2014, LANCET, V383, P785, DOI 10.1016/S0140-6736(13)62158-3; Bell ML, 2008, OCCUP ENVIRON MED, V65, P104, DOI 10.1136/oem.2006.031500; Bell ML, 2009, CIRCULATION, V120, P949, DOI 10.1161/CIRCULATIONAHA.109.851113; Briggs D, 2003, BRIT MED BULL, V68, P1, DOI 10.1093/bmb/ldg019; Brook RD, 2002, CIRCULATION, V105, P1534, DOI 10.1161/01.CIR.0000013838.94747.64; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Burnett RT, 1999, ARCH ENVIRON HEALTH, V54, P130, DOI 10.1080/00039899909602248; Carlsen HK, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-28; Cesaroni G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7412; Chan CC, 2006, EUR HEART J, V27, P1238, DOI 10.1093/eurheartj/ehi835; Chen RJ, 2013, STROKE, V44, P954, DOI 10.1161/STROKEAHA.111.673442; Chiu HF, 2013, J TOXICOL ENV HEAL A, V76, P1188, DOI 10.1080/15287394.2013.842463; Chiusolo M, 2011, ENVIRON HEALTH PERSP, V119, P1233, DOI 10.1289/ehp.1002904; Corea F, 2012, NEUROL INT, V4, P44, DOI 10.4081/ni.2012.e11; Nascimento LFC, 2012, CAD SAUDE PUBLICA, V28, P1319, DOI 10.1590/S0102-311X2012000700010; Diaz J, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-11; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Donaldson K, 2013, NANOMEDICINE-UK, V8, P403, DOI [10.2217/NNM.13.16, 10.2217/nnm.13.16]; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Forastiere F, 2008, EPIDEMIOLOGY, V19, P571, DOI 10.1097/EDE.0b013e3181761f8a; Franklin M, 2008, EPIDEMIOLOGY, V19, P680, DOI 10.1097/EDE.0b013e3181812bb7; Franklin M, 2007, J EXPO SCI ENV EPID, V17, P279, DOI 10.1038/sj.jes.7500530; Fung KY, 2003, INT J EPIDEMIOL, V32, P1064, DOI 10.1093/ije/dyg246; Gianicolo EAL, 2013, INT J ENVIRON HEAL R, V23, P446, DOI 10.1080/09603123.2012.755154; Goldstein LB, 1998, STROKE, V29, P1602, DOI 10.1161/01.STR.29.8.1602; Guttikunda S., 2009, WORKING PAPER SERIES, V25; Haley VB, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-42; Halonen JI, 2010, J EPIDEMIOL COMMUN H, V64, P814, DOI 10.1136/jech.2009.087106; Halonen JI, 2009, EPIDEMIOLOGY, V20, P143, DOI 10.1097/EDE.0b013e31818c7237; Henrotin JB, 2007, OCCUP ENVIRON MED, V64, P439, DOI 10.1136/oem.2006.029306; Henrotin JB, 2010, HEART, V96, P1990, DOI 10.1136/hrt.2010.200337; Hoek G, 2001, EPIDEMIOLOGY, V12, P355, DOI 10.1097/00001648-200105000-00017; Hong YC, 2002, STROKE, V33, P2165, DOI 10.1161/01.STR.0000026865.52610.5B; Hong YC, 2002, ENVIRON HEALTH PERSP, V110, P187, DOI 10.1289/ehp.02110187; Hori A, 2012, INT J ENVIRON HEAL R, V22, P416, DOI 10.1080/09603123.2011.650155; Bin J, 2006, J EXPO SCI ENV EPID, V16, P225, DOI 10.1038/sj.jea.7500451; Jimenez E, 2011, INT J ENVIRON HEAL R, V21, P372, DOI 10.1080/09603123.2011.560251; Johnsen SP, 2002, J CLIN EPIDEMIOL, V55, P602, DOI 10.1016/S0895-4356(02)00391-8; Kan Haidong, 2010, Res Rep Health Eff Inst, P17; Kan HD, 2003, J OCCUP HEALTH, V45, P321, DOI 10.1539/joh.45.321; Kelley George A, 2012, World J Methodol, V2, P27, DOI 10.5662/wjm.v2.i4.27; Kettunen J, 2007, STROKE, V38, P918, DOI 10.1161/01.STR.0000257999.49706.3b; Kim H, 2003, INT J BIOMETEOROL, V48, P25, DOI 10.1007/s00484-003-0176-0; Kim SY, 2012, ENVIRON HEALTH PERSP, V120, P1094, DOI 10.1289/ehp.1104721; Kloog I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034664; Lall R, 2011, ENVIRON HEALTH PERSP, V119, P455, DOI 10.1289/ehp.1002638; Langrish JP, 2012, ENVIRON HEALTH PERSP, V120, P367, DOI 10.1289/ehp.1103898; Larrieu S, 2007, SCI TOTAL ENVIRON, V387, P105, DOI 10.1016/j.scitotenv.2007.07.025; Le Tertre A, 2002, J EPIDEMIOL COMMUN H, V56, P773, DOI 10.1136/jech.56.10.773; Leiva MA, 2013, ENVIRON POLLUT, V181, P1, DOI 10.1016/j.envpol.2013.05.057; Li GX, 2011, SCI TOTAL ENVIRON, V409, P1811, DOI 10.1016/j.scitotenv.2011.02.005; Li XY, 2012, CNS NEUROSCI THER, V18, P501, DOI 10.1111/j.1755-5949.2012.00325.x; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Linn WS, 2000, ENVIRON HEALTH PERSP, V108, P427, DOI 10.2307/3454383; Lippmann M, 2000, Res Rep Health Eff Inst, P5; Lisabeth LD, 2008, ANN NEUROL, V64, P53, DOI 10.1002/ana.21403; Lokken PR, 2009, EPIDEMIOLOGY, V20, P137, DOI 10.1097/EDE.0b013e31818ef34a; Low RB, 2006, STROKE, V37, P951, DOI 10.1161/01.STR.0000214681.94680.66; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lucking AJ, 2011, CIRCULATION, V123, P1721, DOI 10.1161/CIRCULATIONAHA.110.987263; Lucking AJ, 2008, EUR HEART J, V29, P3043, DOI 10.1093/eurheartj/ehn464; Lumley T, 2000, ENVIRONMETRICS, V11, P689, DOI 10.1002/1099-095X(200011/12)11:6<689::AID-ENV439>3.0.CO;2-N; Lundback M, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-7; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Mallone S, 2011, ENVIRON HEALTH PERSP, V119, P1409, DOI [10.12989/ehp.1003026, 10.1289/ehp.1003026]; Mate T, 2010, SCI TOTAL ENVIRON, V408, P5750, DOI 10.1016/j.scitotenv.2010.07.083; Mateen FJ, 2011, JAMA-J AM MED ASSOC, V305, P1240, DOI 10.1001/jama.2011.352; McCormick N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092286; Mechtouff L, 2012, INT J STROKE, V7, P669, DOI 10.1111/j.1747-4949.2011.00737.x; Metzger KB, 2004, EPIDEMIOLOGY, V15, P46, DOI 10.1097/01.EDE.0000101748.28283.97; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Mills NL, 2011, EUR HEART J, V32, P2660, DOI 10.1093/eurheartj/ehr195; Mills NL, 2009, NAT CLIN PRACT CARD, V6, P36, DOI 10.1038/ncpcardio1399; Moolgavkar SH, 2000, ENVIRON HEALTH PERSP, V108, P777, DOI 10.2307/3434732; Moolgavkar SH, 2000, J AIR WASTE MANAGE, V50, P1199, DOI 10.1080/10473289.2000.10464162; Morgan G, 2010, EPIDEMIOLOGY, V21, P47, DOI 10.1097/EDE.0b013e3181c15d5a; Mustafic H, 2012, JAMA-J AM MED ASSOC, V307, P713, DOI 10.1001/jama.2012.126; Nabavi SM, 2012, INT J PREVENTIVE MED, V3, P723; Neuberger M, 2007, ATMOS ENVIRON, V41, P8549, DOI 10.1016/j.atmosenv.2007.07.013; O'Donnell MJ, 2011, EPIDEMIOLOGY, V22, P422, DOI 10.1097/EDE.0b013e3182126580; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Oudin A, 2010, NEUROEPIDEMIOLOGY, V34, P131, DOI 10.1159/000274807; Peel JL, 2007, AM J EPIDEMIOL, V165, P625, DOI 10.1093/aje/kwk051; Perez L, 2012, ENVIRON INT, V48, P150, DOI 10.1016/j.envint.2012.07.001; Poloniecki JD, 1997, OCCUP ENVIRON MED, V54, P535, DOI 10.1136/oem.54.8.535; Ponka A, 1996, AM J PUBLIC HEALTH, V86, P1273, DOI 10.2105/AJPH.86.9.1273; Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888; Qian YF, 2013, J EPIDEMIOL COMMUN H, V67, P635, DOI 10.1136/jech-2012-201096; Qian ZM, 2008, ENVIRON HEALTH PERSP, V116, P1172, DOI 10.1289/ehp.10847; Qian ZM, 2008, ENVIRON INT, V34, P248, DOI 10.1016/j.envint.2007.08.006; Qian ZM, 2007, ENVIRON RES, V105, P380, DOI 10.1016/j.envres.2007.05.007; Qian Z, 2007, J AIR WASTE MANAGE, V57, P785, DOI 10.3155/1047-3289.57.7.785; Qian Zhengmin, 2010, Res Rep Health Eff Inst, P91; Qian ZM, 2010, J AIR WASTE MANAGE, V60, P481, DOI 10.3155/1047-3289.60.4.481; Ren C, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-3; Revich B, 2010, AIR QUAL ATMOS HLTH, V3, P117, DOI 10.1007/s11869-009-0058-7; Romieu Isabelle, 2012, Res Rep Health Eff Inst, P5; Samoli E, 2013, ENVIRON HEALTH PERSP, V121, P932, DOI 10.1289/ehp.1206124; Scarinzi C, 2013, EPIDEMIOL PREV, V37, P230; Shah ASV, 2013, LANCET, V382, P1039, DOI 10.1016/S0140-6736(13)60898-3; Shah ASV, 2010, HEART, V96, P1953, DOI 10.1136/hrt.2010.205583; Sicard P, 2011, ATMOS ENVIRON, V45, P1145, DOI 10.1016/j.atmosenv.2010.12.052; Stafoggia M, 2014, ENVIRON HEALTH PERSP, V122, P919, DOI 10.1289/ehp.1307301; Stafoggia M, 2010, AM J RESP CRIT CARE, V182, P376, DOI 10.1164/rccm.200908-1269OC; Sunyer J, 2003, EUR HEART J, V24, P752, DOI 10.1016/S0195-668X(02)00808-4; Szyszkowicz M, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/824724; Szyszkowicz M, 2008, INT J OCCUP MED ENV, V21, P295, DOI 10.2478/v10001-008-0029-5; Thach TQ, 2010, ATMOS ENVIRON, V44, P1437, DOI 10.1016/j.atmosenv.2010.01.036; Tsai SS, 2003, STROKE, V34, P2612, DOI 10.1161/01.STR.0000095564.33543.64; Turin TC, 2012, NEUROEPIDEMIOLOGY, V38, P84, DOI 10.1159/000335654; Valdes A, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-82; Vichit-Vadakan N, 2010, HLTH EFFECTS I, V154, P231; Vidale S, 2010, NEUROL SCI, V31, P179, DOI 10.1007/s10072-009-0206-8; Villeneuve PJ, 2006, EUR J EPIDEMIOL, V21, P689, DOI 10.1007/s10654-006-9050-9; Villeneuve PJ, 2012, SCI TOTAL ENVIRON, V430, P193, DOI 10.1016/j.scitotenv.2012.05.002; Wang Y, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000983; Wellenius GA, 2005, STROKE, V36, P2549, DOI 10.1161/01.STR.0000189687.78760.47; Wellenius GA, 2013, STROKE, V44, P1533, DOI 10.1161/STROKEAHA.111.000395; Wellenius GA, 2012, ARCH INTERN MED, V172, P229, DOI 10.1001/archinternmed.2011.732; Wichmann J, 2012, INT J ENV RES PUB HE, V9, P3978, DOI 10.3390/ijerph9113978; Wong CA, 1999, J EPIDEMIOL COMMUN H, V53, P580, DOI 10.1136/jech.53.9.580; Wong TW, 2002, OCCUP ENVIRON MED, V59, P30, DOI 10.1136/oem.59.1.30; Wong TW, 1999, OCCUP ENVIRON MED, V56, P679, DOI 10.1136/oem.56.10.679; Wordley J, 1997, OCCUP ENVIRON MED, V54, P108, DOI 10.1136/oem.54.2.108; World Bank, WE CLASS COUNTR; Xiang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061168; Xu XH, 2013, NEUROEPIDEMIOLOGY, V41, P2, DOI 10.1159/000345138; Yamazaki S, 2007, OCCUP ENVIRON MED, V64, P17, DOI 10.1136/oem.2005.021097; Yorifuji T, 2013, J OCCUP ENVIRON MED, V55, P768, DOI 10.1097/JOM.0b013e3182973092; Yorifuji T, 2011, J OCCUP ENVIRON MED, V53, P124, DOI 10.1097/JOM.0b013e3182099175; Yu XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095682; Zanobetti A, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-58; Zeka A, 2006, AM J EPIDEMIOL, V163, P849, DOI 10.1093/aje/kwj116; Zheng S, 2013, INT J ENV RES PUB HE, V10, P462, DOI 10.3390/ijerph10020462	147	447	466	9	47	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2015	350								h1295	10.1136/bmj.h1295	http://dx.doi.org/10.1136/bmj.h1295			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NO	27600637	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000352028800002
J	Clynes, T				Clynes, Tom			How to raise a genius	NATURE			English	News Item							STEM											Dweck C.S., 2006, MINDSET NEW PSYCHOL; Heller K. A., 2013, TALENT DEV EXCELLENC, V5, P51; Heller K. A., 2010, MUNICH STUDIES GIFTE, P3; Heller K. A., 2010, MUNICH STUDIES GIFTE, P433; Kell HJ, 2013, PSYCHOL SCI, V24, P1831, DOI 10.1177/0956797613478615; Koshy V, 2013, BRIT EDUC RES J, V39, P953, DOI 10.1002/berj.3021; Lubinski D, 2014, PSYCHOL SCI, V25, P2217, DOI 10.1177/0956797614551371; Makel MC, 2016, PSYCHOL SCI, V27, P1004, DOI 10.1177/0956797616644735; ODEN MH, 1968, GENET PSYCHOL MONOGR, V77, P3; Park G, 2013, J EDUC PSYCHOL, V105, P176, DOI 10.1037/a0029481; Steenbergen-Hu S, 2011, GIFTED CHILD QUART, V55, P39, DOI 10.1177/0016986210383155; Terman LM, 1954, AM PSYCHOL, V9, P221, DOI 10.1037/h0060516; Wai J, 2014, INTELLIGENCE, V45, P74, DOI 10.1016/j.intell.2013.08.009; Wai J, 2010, J EDUC PSYCHOL, V102, P860, DOI 10.1037/a0019454	14	19	20	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					152	155		10.1038/537152a	http://dx.doi.org/10.1038/537152a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU9LQ	27734890	Bronze			2022-12-28	WOS:000382539100020
